Citrus Sinensis ID: 002382
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 929 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.927 | 0.927 | 0.493 | 0.0 | |
| Q9FZB8 | 871 | Probable LRR receptor-lik | no | no | 0.890 | 0.949 | 0.347 | 1e-135 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.869 | 0.926 | 0.343 | 1e-131 | |
| Q9ZQR3 | 868 | Leucine-rich repeat recep | no | no | 0.864 | 0.925 | 0.362 | 1e-130 | |
| Q9ZQQ7 | 886 | Putative leucine-rich rep | no | no | 0.909 | 0.953 | 0.355 | 1e-129 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.891 | 0.930 | 0.341 | 1e-129 | |
| Q9LIG2 | 899 | Receptor-like protein kin | no | no | 0.877 | 0.906 | 0.346 | 1e-128 | |
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.872 | 0.924 | 0.339 | 1e-127 | |
| C0LGG6 | 876 | Probable LRR receptor-lik | no | no | 0.867 | 0.920 | 0.339 | 1e-125 | |
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.886 | 0.935 | 0.328 | 1e-125 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 861 bits (2224), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/883 (49%), Positives = 584/883 (66%), Gaps = 21/883 (2%)
Query: 15 SVLILLLLDSSSAQMPGFVSLNCGGNENFTD-EIGLQWIADDHLI-YGEISNISVANETR 72
+V L L+ +Q+ FVS++CG + N+TD GL W++D +I G+ ++ N
Sbjct: 9 AVTCLFLVPFVLSQVTEFVSIDCGCSSNYTDPRTGLGWVSDSEIIKQGKPVTLANTNWNS 68
Query: 73 KQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTI 132
QY R FP D++KYCY+L R RY++R TFLYG + YPKF + L T W+T+
Sbjct: 69 MQYRRRRDFPTDNKKYCYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKWATV 128
Query: 133 VISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLS 192
I + + + V ELI A+S +DVC+ A TG PF+STLELR N S+Y T +ED ++L
Sbjct: 129 TIQEVSRVYVEELIVRATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNFFLK 188
Query: 193 VSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDEL 252
V+AR+NFGA + +RYPDDP+DRIWESD K+ NYLV VA GT +++T I+ + E
Sbjct: 189 VAARVNFGAPNMDALRYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTREY 248
Query: 253 PPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDV 312
PP KVMQTAVVGT G ++YRLNL+ FP A YFAEIE+L +E+RKF+LV P PD
Sbjct: 249 PPMKVMQTAVVGTQGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDY 308
Query: 313 SKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYL---- 368
S A+VNI ENA G Y +YEP Y N++L FVL+F FGKT DS++GPLLNA+EI+KYL
Sbjct: 309 SNAVVNIAENANGSYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISV 368
Query: 369 --ERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSK 426
+R+D S+ + ++ S+ +DWA EGGDPC+PV WSW+ C+S P +T I LS K
Sbjct: 369 KTDRSDVSV----LDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRK 424
Query: 427 NLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNL 486
NL G IP + + +L ELWLD N LTG +PD S +L+I+HLE+NQL+G LP L +L
Sbjct: 425 NLRGEIPPGINYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHL 484
Query: 487 PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVL- 545
PNL+EL ++NN G +PS+LL V+ Y N L + KH I+G S+ A +
Sbjct: 485 PNLQELSIENNSFKGKIPSALLKGKVLFKYNNNPELQNEAQ-RKHFWQILGISIAAVAIL 543
Query: 546 ----LLATVVSCLFMHKGKKNNYDK-EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIED 600
+ V+ C + + D E + L V + A+ +L +E+
Sbjct: 544 LLLVGGSLVLLCALRKTKRADKGDSTETKKKGLVAYSAVRGGHLLDEGVAYFISLPVLEE 603
Query: 601 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 660
AT KK+G G FG VYYG++KDGKE+AVK+ S R+F EV LLSRIHHRNLV
Sbjct: 604 ATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLV 663
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+GYC+E R +LVYE+MHNG+L +HL+G+ ++ ++W+ RL+IA+DAAKG+EYLHTG
Sbjct: 664 PLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKP-LDWLTRLQIAQDAAKGLEYLHTG 722
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
C P+IIHRD+KSSNILLD +MRAKVSDFGLS+ + +HVSS+ +GTVGYLDPEYY SQ
Sbjct: 723 CNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQ 782
Query: 781 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840
QLT+KSDVYSFGV+L EL+SG++ +S E FG NIV WA+ I GD+ GIIDP +
Sbjct: 783 QLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPEL-NIVHWARSLIRKGDVCGIIDPCIAS 841
Query: 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 883
I+S+W++ E A CV GH RP + EV+ IQDAI IER
Sbjct: 842 NVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIER 884
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 484 bits (1245), Expect = e-135, Method: Compositional matrix adjust.
Identities = 327/942 (34%), Positives = 509/942 (54%), Gaps = 115/942 (12%)
Query: 1 MERRRRLLLPFSVASVLILLLLDSSSAQMP-GFVSLNCG----GNENFTDEIGLQWIADD 55
MER + FS L+L AQ P GF++L+CG G+ GL + +DD
Sbjct: 1 MERHCLFFVIFS-------LILHLVQAQDPIGFINLDCGLSIQGSPYKESSTGLTYTSDD 53
Query: 56 HLIY-GEISNISVANET--RKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFD 112
+ G+I I+ E+ +K TLR+FP D + C+ L+V T+YLI+ TFLYGN+D
Sbjct: 54 GFVQSGKIGKITKELESLYKKPERTLRYFP-DGVRNCFSLNVTRGTKYLIKPTFLYGNYD 112
Query: 113 NNNVYPKFDISLGPTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLE 172
NV P FD+ +GP W T+ + ++E++ ++ S + VCL T P+I+TLE
Sbjct: 113 GRNVIPDFDLYIGPNMWITVNTDNT----IKEILHVSKSNTLQVCLVKTGTSIPYINTLE 168
Query: 173 LRQFNGSVYLTPFEDRYYLSVSARINF-----GADSEAPVRYPDDPFDRIWESDSLKKAN 227
LR P D Y + S +N+ ++ + + YPDD DRIW+ L +
Sbjct: 169 LR---------PLADDIYTNESGSLNYLFRVYYSNLKGYIEYPDDVHDRIWK-QILPYQD 218
Query: 228 YLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLT---YRLNLDGFPGFGWA 284
+ + ++T L I++ +D PQ+VM+TAV S T + NL+ +
Sbjct: 219 WQI--------LTTNLQINVSNDYDLPQRVMKTAVTPIKASTTTMEFPWNLEPPTSQFYL 270
Query: 285 VTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLS 344
+FAE++ L +E+R+F +VL N ++ Y P + + + +
Sbjct: 271 FLHFAELQSLQANETREFNVVL---------------NGNVTFKSYSPKFLEMQTVYSTA 315
Query: 345 ----------FKFGKTYDSSRGPLLNAMEINKYLE--RNDGSIDGV-AIVSVISLY--SS 389
+ KT S+ PL+NAME L+ + + ++D V AI ++ S Y S
Sbjct: 316 PKQCDGGKCLLQLVKTSRSTLPPLINAMEAYTVLDFPQIETNVDEVIAIKNIQSTYGLSK 375
Query: 390 ADWAQEGGDPCLPVPWSW--LQCN----SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLV 443
W GDPC+P + W L CN S P P IT ++LSS LTG I + L++L
Sbjct: 376 TTWQ---GDPCVPKKFLWDGLNCNNSDDSTP-PIITSLNLSSSGLTGIIVLTIQNLANLQ 431
Query: 444 ELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT 502
EL L N+L+G +P+F + L +I+L N L+G +P L+ L+ N L+ T
Sbjct: 432 ELDLSNNNLSGGVPEFLADMKSLLVINLSGNNLSGVVPQKLIEKKMLKLNIEGNPKLNCT 491
Query: 503 VPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAV-LLLATVVSCLFMHKGKK 561
V S ++K+ EGGR K + I I +S+G+ V +A ++ C+ +K
Sbjct: 492 V-ESCVNKD-----------EEGGRQIKSMTIPIVASIGSVVAFTVALMIFCVV----RK 535
Query: 562 NNYDKEQHRHSLPVQRPVSSLNDAPAEAAHC--FTLSDIEDATKMLEKKIGSGGFGVVYY 619
NN ++ S P S + P FT +++ T +K +G GGFG+VYY
Sbjct: 536 NNPSNDEAPTS--CMLPADSRSSEPTIVTKNKKFTYAEVLTMTNNFQKILGKGGFGIVYY 593
Query: 620 GKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679
G + +++AVK+L+ +S QG ++F EV LL R+HH+NLV +GYC+E + L+YE+M
Sbjct: 594 GSVNGTEQVAVKMLSHSSAQGYKQFKAEVELLLRVHHKNLVGLVGYCEEGDKLALIYEYM 653
Query: 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 739
NG L EH+ G +NW RL+IA +AA+G+EYLH GC P ++HRD+K++NILL++
Sbjct: 654 ANGDLDEHMSGK-RGGSILNWGTRLKIALEAAQGLEYLHNGCKPLMVHRDVKTTNILLNE 712
Query: 740 HMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLEL 798
H K++DFGLS+ F ++G +HVS++V GT+GYLDPEYY + LT+KSDVYSFGV+LL +
Sbjct: 713 HFDTKLADFGLSRSFPIEGETHVSTVVAGTIGYLDPEYYRTNWLTEKSDVYSFGVVLLVM 772
Query: 799 ISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCV 858
I+ Q I + R+I +W + GDI+ I DP+LL +Y+ S+WK E A+ C+
Sbjct: 773 ITNQPVIDQNR---EKRHIAEWVGGMLTKGDIKSITDPNLLGDYNSGSVWKAVELAMSCM 829
Query: 859 LPHGHMRPSISEVLKDIQDAIVIE--REAAAARDGNSDDMSR 898
P RP++S+V+ ++++ + E RE + M+R
Sbjct: 830 NPSSMTRPTMSQVVFELKECLASESSREVSMTFGTEVAPMAR 871
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 471 bits (1211), Expect = e-131, Method: Compositional matrix adjust.
Identities = 315/916 (34%), Positives = 486/916 (53%), Gaps = 108/916 (11%)
Query: 20 LLLDSSSAQ-MPGFVSLNCG---GNENFTDEI-GLQWIADDHLI-YGEISNISV--ANET 71
++L+S AQ GF+SL+CG N +T++ + + +D + I G + IS +
Sbjct: 16 VILESVQAQDQLGFISLDCGLVPKNATYTEKTTNITYKSDANYIDSGLVGRISAEYKAQL 75
Query: 72 RKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWST 131
++Q T+R FP R CY ++ ++RYLIRATF YGN+D PKFDI +GP+ W++
Sbjct: 76 QQQTWTVRSFPEGERN-CYNFNLTAKSRYLIRATFTYGNYDGLRQVPKFDIHIGPSKWTS 134
Query: 132 IVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYL 191
+ + V E+I + + ++ +CL G PFIS+LELR N + YLT L
Sbjct: 135 VKLDGVGNGAVLEMIHVLTQDRLQICLVKTGKGIPFISSLELRPLNNNTYLT---QSGSL 191
Query: 192 SVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDE 251
AR+ F A + +RY +D DR+W + G + +ST L +D +
Sbjct: 192 IGFARVFFSA-TPTFIRYDEDIHDRVW----------VRQFGNGLKSISTDLLVDTSNPY 240
Query: 252 LPPQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQ 309
PQ V +TA V +N S L + LD + +FAEI+ L ++ R+F + G
Sbjct: 241 DVPQAVAKTACVPSNASQPLIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREFNITYNG- 299
Query: 310 PDVSKAIVNIQENAQGKYRVYEPGYTNLSLPF----------VLSFKFGKTYDSSRGPLL 359
Q Y P +S F S F KT +S+ PL+
Sbjct: 300 -------------GQNVYSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNSTLPPLI 346
Query: 360 NAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQE---GGDPCLPVPWSW--LQC---N 411
N +EI K L+ + D + ++I++ ++ D +++ GDPC P + W L C N
Sbjct: 347 NGLEIYKVLDLLELETDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPN 406
Query: 412 SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHL 470
SD QP I ++L+ LTG I +++KL+ L+EL L N L+G IP+ F+ L++I+L
Sbjct: 407 SD-QPRIISLNLAENKLTGTITPEISKLTQLIELDLSKNDLSGEIPEFFADMKLLKLINL 465
Query: 471 EDN-QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGA 529
N L +P S+ + + L + +LS TV +K V L G+
Sbjct: 466 SGNLGLNSTIPDSIQQRLDSKSLIL---ILSKTV-----TKTVTLK----------GKSK 507
Query: 530 KHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEA 589
K I I +SV A V L +++ F+ + K +K + + +R +
Sbjct: 508 KVPMIPIVASV-AGVFALLVILAIFFVVRRKNGESNKGTNPSIITKERRI---------- 556
Query: 590 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVT 649
T ++ T E+ +G GGFG VY+G L+D ++AVK+L+ +S QG +EF EV
Sbjct: 557 ----TYPEVLKMTNNFERVLGKGGFGTVYHGNLED-TQVAVKMLSHSSAQGYKEFKAEVE 611
Query: 650 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 709
LL R+HHRNLV +GYC + L+YE+M NG LKE++ G + W R++IA +
Sbjct: 612 LLLRVHHRNLVGLVGYCDDGDNLALIYEYMANGDLKENMSGK-RGGNVLTWENRMQIAVE 670
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGT 768
AA+G+EYLH GC P ++HRD+K++NILL++ AK++DFGLS+ F VDG SHVS++V GT
Sbjct: 671 AAQGLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSRSFPVDGESHVSTVVAGT 730
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 828
GYLDPEYY + L++KSDVYSFGV+LLE+++ Q + +I +W + G
Sbjct: 731 PGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVTDKTR---ERTHINEWVGSMLTKG 787
Query: 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAA 888
DI+ I+DP L+ +YD WKI E AL CV P + RP+++ V+ ++ + + +E A
Sbjct: 788 DIKSILDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVTELNECVALEN---AR 844
Query: 889 RDGNSDDMSRNSLHSS 904
R G R +H+S
Sbjct: 845 RQG------REEMHTS 854
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQR3|Y2451_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14510 OS=Arabidopsis thaliana GN=At2g14510 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 466 bits (1200), Expect = e-130, Method: Compositional matrix adjust.
Identities = 332/915 (36%), Positives = 483/915 (52%), Gaps = 112/915 (12%)
Query: 1 MERRRRLLLPFSVASVLILLLLDSSSAQMPGFVSLNCG--GNENFTD-EIGLQWIADDHL 57
ME R + +L + A+ I+ L+ S + Q GF+SL+CG E++ + L +I+D +
Sbjct: 1 METRNKFML-LACATFSIMSLVKSQNQQ--GFISLDCGLPSKESYIEPSSNLTFISDVNF 57
Query: 58 I----YGEISNISVANETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDN 113
I G I N S N K + LR+FP D + CY L V T+YLIR F YGN+D
Sbjct: 58 IRGGKTGNIQNNSRTNFIFKPFKVLRYFP-DGIRNCYSLSVKQGTKYLIRTLFYYGNYDG 116
Query: 114 NNVYPKFDISLGPTHWSTI--VISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTL 171
N P+FD+ LGP W+++ +I+D V E++ + S +D+CL T P IS +
Sbjct: 117 LNTSPRFDLFLGPNIWTSVDVLIADVGDGVVEEIVHVTRSNILDICLVKTGTSTPMISAI 176
Query: 172 ELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVD 231
ELR Y L A F EA +RYP+D +DR+W S +
Sbjct: 177 ELRPLRYDTYTARTGS---LKSMAHFYFTNSDEA-IRYPEDVYDRVWMPYSQPEWT---- 228
Query: 232 VAAGTEKVSTKLPIDLRSDEL-PPQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVTYF 288
+++T + SD PPQ V+QTA + TNGS LT+ NL+ +A +F
Sbjct: 229 ------QINTTRNVSGFSDGYNPPQGVIQTASIPTNGSEPLTFTWNLESSDDETYAYLFF 282
Query: 289 AEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPF------- 341
AEI+ L +E+R+F+++ G + Y ++ LS P
Sbjct: 283 AEIQQLKVNETREFKILANGVDYID-------------YTPWKFEARTLSNPAPLKCEGG 329
Query: 342 VLSFKFGKTYDSSRGPLLNAMEINKYLE--RNDGSIDGV-AIVSVISLY--SSADWAQEG 396
V + KT S+ PL+NA+EI ++ ++D + D V AI + S Y S W
Sbjct: 330 VCRVQLSKTPKSTLPPLMNAIEIFSVIQFPQSDTNTDEVIAIKKIQSTYQLSRISWQ--- 386
Query: 397 GDPCLPVPWSWL--QCN----SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGN 450
GDPC+P +SW+ CN S P P I + LS LTG I + L+ L EL L N
Sbjct: 387 GDPCVPKQFSWMGVSCNVIDISTP-PRIISLDLSLSGLTGVISPSIQNLTMLRELDLSNN 445
Query: 451 SLTGPIPDF-SGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
+LTG +P+F + L +IHL N L G +P +L + RE
Sbjct: 446 NLTGEVPEFLATIKPLLVIHLRGNNLRGSVPQALQD----RE------------------ 483
Query: 510 KNVVLNYAGNINLHEGGRGAKH--LNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKE 567
KN L + N+ G+ L I+ S AV ++ V+ +F+ + +K++ K
Sbjct: 484 KNDGLKLFVDPNITRRGKHQPKSWLVAIVASISCVAVTIIVLVL--IFIFRRRKSSTRK- 540
Query: 568 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE 627
V RP + + F S++++ T E +G GGFGVVY+G L + ++
Sbjct: 541 -------VIRPSLEMKN------RRFKYSEVKEMTNNFEVVLGKGGFGVVYHGFL-NNEQ 586
Query: 628 IAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH 687
+AVKVL+ +S QG +EF EV LL R+HH NLV +GYC E L+YEFM NG LKEH
Sbjct: 587 VAVKVLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDEGIDLALIYEFMENGNLKEH 646
Query: 688 LYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 747
L G +NW RL+IA ++A GIEYLH GC P ++HRD+KS+NILL AK++D
Sbjct: 647 LSGK-RGGSVLNWSSRLKIAIESALGIEYLHIGCQPPMVHRDVKSTNILLGLRFEAKLAD 705
Query: 748 FGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806
FGLS+ F V +HVS+ V GT+GYLDPEYY+ LT+KSDVYSFG++LLE I+GQ I
Sbjct: 706 FGLSRSFLVGSQAHVSTNVAGTLGYLDPEYYLKNWLTEKSDVYSFGIVLLESITGQPVIE 765
Query: 807 NEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP 866
+ + IV+WAK + +GDI+ I+DP+L +YD S WK E A++C+ P RP
Sbjct: 766 QSR---DKSYIVEWAKSMLANGDIESIMDPNLHQDYDSSSSWKALELAMLCINPSSTQRP 822
Query: 867 SISEVLKDIQDAIVI 881
+++ V ++ + + I
Sbjct: 823 NMTRVAHELNECLEI 837
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQQ7|Y2144_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14440 OS=Arabidopsis thaliana GN=At2g14440 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 464 bits (1194), Expect = e-129, Method: Compositional matrix adjust.
Identities = 332/933 (35%), Positives = 496/933 (53%), Gaps = 88/933 (9%)
Query: 1 MERRRRLLLPFSVASVLILLLLDSSSAQMPGFVSLNCGGNENFTDEI----GLQWIADDH 56
ME R +L+L + A+ I+ L+ S + Q GF+SL CG N + I L +I+D +
Sbjct: 1 METRSKLML-LACATFSIISLVKSQNQQ--GFISLYCGLPSNESPYIEPLTNLTYISDVN 57
Query: 57 LI----YGEISNISVANETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFD 112
+ G I N S + T + Y LR+FP R CY L V T+YLIR F YGN+D
Sbjct: 58 FVRGGKTGNIKNNSDIDFTSRPYKVLRYFPEGIRN-CYSLSVKQGTKYLIRTLFFYGNYD 116
Query: 113 NNNVYPKFDISLGPTHWSTIVIS--DAATIEVRELIFLASSPKIDVCLSNATTGQPFIST 170
N P+FD+ LGP W+++ + D + E+I + +D+CL T P IS
Sbjct: 117 GLNTSPRFDLFLGPNIWTSVDVQKVDGGDGVIEEIIHVTRCNILDICLVKTGTTTPMISA 176
Query: 171 LELRQFNGSVYLTPFEDRYYLSVSARINF-GADSEAPVRYPDDPFDRIWESDSLKKANYL 229
+ELR Y S+ ++F +S VRYP+D +DR+W S +
Sbjct: 177 IELRPLRYDTYTARTG-----SLKKILHFYFTNSGKEVRYPEDVYDRVWIPHSQPEWT-- 229
Query: 230 VDVAAGTEKVSTKLPIDLRSDEL-PPQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVT 286
+++T + SD PPQ V++TA + TN S LT+ + +A
Sbjct: 230 --------QINTTRNVSGFSDGYNPPQDVIKTASIPTNVSEPLTFTWMSESSDDETYAYL 281
Query: 287 YFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPF---VL 343
YFAEI+ L +E+R+F++++ G V + K+ E T +L V
Sbjct: 282 YFAEIQQLKANETRQFKILVNG--------VYYIDYIPRKFEA-ETLITPAALKCGGGVC 332
Query: 344 SFKFGKTYDSSRGPLLNAMEINKYLE--RNDGSIDGV-AIVSVISLY--SSADWAQEGGD 398
+ KT S+ P +NA+EI ++ ++D + D V AI ++ S Y S W GD
Sbjct: 333 RVQLSKTPKSTLPPQMNAIEIFSVIQFPQSDTNTDEVIAIKNIQSTYKVSRISWQ---GD 389
Query: 399 PCLPVPWSWL--QCN----SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSL 452
PC+P+ +SW+ CN S P P I + LSS LTG I + L+ L EL L N+L
Sbjct: 390 PCVPIQFSWMGVSCNVIDISTP-PRIISLDLSSSGLTGVITPSIQNLTMLRELDLSNNNL 448
Query: 453 TGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511
TG IP LR + L +N LTG +P L + L ++++ N L G+VP +L +
Sbjct: 449 TGVIPPSLQNLTMLRELDLSNNNLTGEVPEFLATIKPLLVIHLRGNNLRGSVPQALQDRE 508
Query: 512 VVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRH 571
N G + L G K + I +S+ + + +V +F+ + +K++ K
Sbjct: 509 ---NNDG-LKLLRGKHQPKSWLVAIVASISCVAVTIIVLV-LIFIFRRRKSSTRK----- 558
Query: 572 SLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVK 631
V RP + + F S++++ T E +G GGFGVVY+G L + +++AVK
Sbjct: 559 ---VIRPSLEMKN------RRFKYSEVKEMTNNFEVVLGKGGFGVVYHGFL-NNEQVAVK 608
Query: 632 VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGT 691
VL+ +S QG +EF EV LL R+HH NLV +GYC + L+YEFM NG LKEHL G
Sbjct: 609 VLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGK 668
Query: 692 LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751
+NW RL+IA ++A GIEYLH GC P ++HRD+KS+NILL AK++DFGLS
Sbjct: 669 -RGGPVLNWPGRLKIAIESALGIEYLHIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLS 727
Query: 752 K-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810
+ F V +HVS+ V GT+GYLDPEYY LT+KSDVYSFG++LLE+I+GQ I +
Sbjct: 728 RSFLVGSQTHVSTNVAGTLGYLDPEYYQKNWLTEKSDVYSFGIVLLEIITGQPVIEQSR- 786
Query: 811 GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISE 870
+ IV+WAK + +GDI+ I+D +L +YD S WK E A++C+ P +RP+++
Sbjct: 787 --DKSYIVEWAKSMLANGDIESIMDRNLHQDYDTSSSWKALELAMLCINPSSTLRPNMTR 844
Query: 871 VLKDIQDAIVIEREAAAARDGNSDDMSRNSLHS 903
V ++ + + I R + S++S H+
Sbjct: 845 VAHELNECLEIYN--LTKRRSQDQNSSKSSGHT 875
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 463 bits (1191), Expect = e-129, Method: Compositional matrix adjust.
Identities = 320/938 (34%), Positives = 490/938 (52%), Gaps = 110/938 (11%)
Query: 16 VLILLLLDSSSAQ-MPGFVSLNCG---GNENFTDE-IGLQWIAD-DHLIYGEISNISVAN 69
++ +L S AQ GF+SL+CG +T++ + + +D D++ G + I+ A
Sbjct: 12 IIAFTVLRSVEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSDVDYIDSGLVGKINDAY 71
Query: 70 ETR--KQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPT 127
+T+ +Q +R FP R CY +++ +YLIR TF+YGN+D N +P FD+ +GP
Sbjct: 72 KTQFQQQVWAVRSFPVGQRN-CYNVNLTANNKYLIRGTFVYGNYDGLNQFPSFDLHIGPN 130
Query: 128 HWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFED 187
WS++ I + E+I + ++VCL PFIS+LE+R N YLT
Sbjct: 131 KWSSVKILGVTNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLNNESYLT---Q 187
Query: 188 RYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDL 247
L + AR+ F + S + +RY +D DR+W S + + T +ST LPID
Sbjct: 188 SGSLMLFARVYFPSSSSSFIRYDEDIHDRVWNSFTDDE----------TVWISTDLPIDT 237
Query: 248 RSDELPPQKVMQTAVVGTNGSLTYRL--NLDGFPGFGWAVTYFAEIEDLDPDESRKFRLV 305
+ PQ VM+TA V N S + L LD + +FAE+++L +E+R+F
Sbjct: 238 SNSYDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREF--- 294
Query: 306 LPGQPDVSKAIVNIQENAQGKYRVY-EPGYTNLSLPF----------VLSFKFGKTYDSS 354
NI N ++ Y P ++S F + +F F T +S+
Sbjct: 295 ------------NITYNGGLRWFSYLRPPNLSISTIFNPRAVSSSNGIFNFTFAMTGNST 342
Query: 355 RGPLLNAMEINKY-----LERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSW-- 407
PLLNA+EI LE N + A++++ Y + GDPC P + W
Sbjct: 343 LPPLLNALEIYTVVDILQLETNKDEVS--AMMNIKETYGLSKKISWQGDPCAPQLYRWEG 400
Query: 408 LQCN-SDPQPS-ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPD 464
L C+ D + S I ++L+ LTG+I SD++KL+ L L L N L+G IP F+
Sbjct: 401 LNCSYPDSEGSRIISLNLNGSELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKS 460
Query: 465 LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL----SKNVVLNYAGNI 520
L++I+L N PNL N+ + +P SL SK++ L N+
Sbjct: 461 LKLINLSGN-------------PNL-------NLTA--IPDSLQQRVNSKSLTLILGENL 498
Query: 521 NLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLP------ 574
L K + I +SV A V L +++ F+ K K + + H+ P
Sbjct: 499 TLTPKKESKKVPMVAIAASV-AGVFALLVILAIFFVIKRK----NVKAHKSPGPPPLVTP 553
Query: 575 --VQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKV 632
V+ S N + T ++ T E+ +G GGFG VY+G L DG E+AVK+
Sbjct: 554 GIVKSETRSSNPSIITRERKITYPEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAVKM 612
Query: 633 LTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL 692
L+ +S QG +EF EV LL R+HHR+LV +GYC + L+YE+M NG L+E++ G
Sbjct: 613 LSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGK- 671
Query: 693 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
+ W R++IA +AA+G+EYLH GC P ++HRD+K++NILL++ AK++DFGLS+
Sbjct: 672 RGGNVLTWENRMQIAVEAAQGLEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSR 731
Query: 753 -FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 811
F +DG HVS++V GT GYLDPEYY + L++KSDVYSFGV+LLE+++ Q I +
Sbjct: 732 SFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVIDKTR-- 789
Query: 812 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV 871
+I W + GDI+ I+DP L+ +YD WKI E AL CV P + RP+++ V
Sbjct: 790 -ERPHINDWVGFMLTKGDIKSIVDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHV 848
Query: 872 LKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS 909
+ ++ D + +E A R G+ + S S+ SL+ S
Sbjct: 849 VMELNDCVALEN---ARRQGSEEMYSMGSVDYSLSSTS 883
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 459 bits (1181), Expect = e-128, Method: Compositional matrix adjust.
Identities = 318/919 (34%), Positives = 473/919 (51%), Gaps = 104/919 (11%)
Query: 31 GFVSLNCGGNEN---FTD-EIGLQWIADDHLIY-GEISNISVANET--RKQYMTLRHFPA 83
GF+SL+CG N + D GL + DD + G+ I A E+ K + LR+FP
Sbjct: 32 GFISLDCGSLPNEPPYNDPSTGLTYSTDDGFVQSGKTGRIQKAFESIFSKPSLKLRYFP- 90
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVR 143
D + CY L+V T YLI+A F+YGN+D N P FD+ LGP W T+ ++ ++
Sbjct: 91 DGFRNCYTLNVTQDTNYLIKAVFVYGNYDGLNNPPSFDLYLGPNLWVTVDMNGRTNGTIQ 150
Query: 144 ELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLT-----PFEDRYYLSVSARIN 198
E+I S + VCL T P I+TLELR + Y T + RYY S S +
Sbjct: 151 EIIHKTISKSLQVCLVKTGTSSPMINTLELRPLKNNTYNTQSGSLKYFFRYYFSGSGQ-- 208
Query: 199 FGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVM 258
+RYPDD DR W D TE ++T L I+ + PP+ VM
Sbjct: 209 -------NIRYPDDVNDRKWYP--------FFDAKEWTE-LTTNLNINSSNGYAPPEVVM 252
Query: 259 QTAV--VGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAI 316
+A + T G+ + L + +FAEI+ L ++R+F++ L
Sbjct: 253 ASASTPISTFGTWNFSWLLPSSTTQFYVYMHFAEIQTLRSLDTREFKVTL---------- 302
Query: 317 VNIQENAQGKYRVYEPGYTNLSLPFVLS----------FKFGKTYDSSRGPLLNAMEINK 366
N + Y Y P F + + KT S+ PL+NA+E+
Sbjct: 303 -----NGKLAYERYSPKTLATETIFYSTPQQCEDGTCLLELTKTPKSTLPPLMNALEVFT 357
Query: 367 YL---ERNDGSIDGVAIVSVISLY--SSADWAQEGGDPCLPVPWSW--LQCN----SDPQ 415
+ + D AI S+ S Y S W GDPC+P + W L CN S P
Sbjct: 358 VIDFPQMETNPDDVAAIKSIQSTYGLSKISWQ---GDPCVPKQFLWEGLNCNNLDNSTP- 413
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQ 474
P +T ++LSS +LTG I + L+ L EL L N+LTG IP+F + L +I+L N
Sbjct: 414 PIVTSLNLSSSHLTGIIAQGIQNLTHLQELDLSNNNLTGGIPEFLADIKSLLVINLSGNN 473
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNI 534
G +P L+ L+ + N L + + +N AGN GAK +N+
Sbjct: 474 FNGSIPQILLQKKGLKLILEGNANL-------ICPDGLCVNKAGN-------GGAKKMNV 519
Query: 535 IIG--SSVGAAVLL---LATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEA 589
+I +SV V+L LA + + V R + S A
Sbjct: 520 VIPIVASVAFVVVLGSALAFFFIFKKKKTSNSQDLGPSSYTQVSEV-RTIRSSESAIMTK 578
Query: 590 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVT 649
FT S++ T E+ +G GGFG+VY+G + + +++AVK+L+ +S QG +EF EV
Sbjct: 579 NRRFTYSEVVTMTNNFERVLGKGGFGMVYHGTVNNTEQVAVKMLSHSSSQGYKEFKAEVE 638
Query: 650 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 709
LL R+HH+NLV +GYC E L+YE+M NG L+EH+ G +NW RL+I +
Sbjct: 639 LLLRVHHKNLVGLVGYCDEGENLALIYEYMANGDLREHMSGK-RGGSILNWETRLKIVVE 697
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGT 768
+A+G+EYLH GC P ++HRD+K++NILL++H+ AK++DFGLS+ F ++G +HVS++V GT
Sbjct: 698 SAQGLEYLHNGCKPPMVHRDVKTTNILLNEHLHAKLADFGLSRSFPIEGETHVSTVVAGT 757
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 828
GYLDPEYY + L +KSDVYSFG++LLE+I+ Q I+ + +I +W L + G
Sbjct: 758 PGYLDPEYYRTNWLNEKSDVYSFGIVLLEIITNQLVINQSR---EKPHIAEWVGLMLTKG 814
Query: 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAA 888
DIQ I+DP L +YD S+W+ E A+ C+ P RP++S+V+ ++ + + E A
Sbjct: 815 DIQNIMDPKLYGDYDSGSVWRAVELAMSCLNPSSARRPTMSQVVIELNECLSYEN----A 870
Query: 889 RDGNSDDM-SRNSLHSSLN 906
R G S +M S +S+ S+N
Sbjct: 871 RGGTSQNMNSESSIEVSMN 889
|
Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 455 bits (1170), Expect = e-127, Method: Compositional matrix adjust.
Identities = 315/929 (33%), Positives = 495/929 (53%), Gaps = 118/929 (12%)
Query: 8 LLPF-SVASVLILLLLDSSSAQMPGFVSLNCGGNEN---FTDEIGLQWIADDHLI-YGEI 62
LP S AS +++L+L + Q GFVS++CG E+ + ++ +++I+D + G I
Sbjct: 6 FLPLVSFASFVVVLVLVCAQDQ-SGFVSIDCGIPEDSSYYDEKTDIKYISDAAFVESGTI 64
Query: 63 SNISVANETR---KQYMTLRHFPADSRKYCYKLDVITRT--RYLIRATFLYGNFDNNNVY 117
+I + + KQ+ +R FP + +K CY + +YLIR F+YGN+DN
Sbjct: 65 HSIDSKFQKKNLEKQFQKVRSFP-EGKKNCYDVQPPQGKGFKYLIRTRFMYGNYDNLGKA 123
Query: 118 PKFDISLGPTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFN 177
P FD+ LG W ++ + ++ TI +E+I+ S K+ VCL + G PF+S LELR
Sbjct: 124 PDFDLYLGVNLWDSVTLENSTTIVTKEIIYTLRSDKVHVCLVDKERGTPFLSVLELRLLK 183
Query: 178 GSVYLTPFEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTE 237
++Y T + L + R + GA + P RY DD FDR W L N+L+
Sbjct: 184 NNIYETASDS---LMLYRRWDLGATGDLPARYKDDIFDRFWMP--LMFPNFLI------- 231
Query: 238 KVSTKLPIDLRSDE--LPPQKVMQTAVVGTNGS----LTYRLNLDGFPGFGWAV-TYFAE 290
++T L ID S LPP VM TAV N S + Y D P + + + +FAE
Sbjct: 232 -LNTSLMIDPTSSNGFLPPSVVMSTAVAPMNSSIEQIMVYWEPRD--PNWKFYIYIHFAE 288
Query: 291 IEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTN--LSLPFVLSFKFG 348
+E L +E+R+F + L +K ++ + Y + Y +S PF L F
Sbjct: 289 VEKLPSNETREFSVFL------NKEQIDTTSVFRPSYLYTDTLYVQNPVSGPF-LEFVLR 341
Query: 349 KTYDSSRGPLLNAMEI---NKYLERNDGSIDGVAIVSVISLYSSA-DWAQEGGDPCLPV- 403
+ S+R P++NA+E N++L+ D AI+ + + Y +W GDPC P
Sbjct: 342 QGVKSTRPPIMNAIETYRTNEFLDLPTDQNDVDAIMKIKTKYKVKKNWL---GDPCAPFG 398
Query: 404 -PWSWLQCN--SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFS 460
PW + C+ ++ P I ++LS LTG I P F
Sbjct: 399 YPWQGINCSYTANNPPRIISVNLSFSGLTGQID-----------------------PVFI 435
Query: 461 GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN----VVLNY 516
L+ + L +N+LTG +P L NLP+L EL ++ N L+G +P LL ++ + L
Sbjct: 436 TLTPLQKLDLSNNRLTGTVPDFLANLPDLTELNLEENKLTGILPEKLLERSKDGSLSLRV 495
Query: 517 AGNINL--HEGGRGAK-----HLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQH 569
GN +L + R K ++ + S G LLLA + F + +
Sbjct: 496 GGNPDLCVSDSCRNKKTERKEYIIPSVASVTGLFFLLLALISFWQFKKRQQ--------- 546
Query: 570 RHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIA 629
S+ P + + S+I + T E+ +G GGFG VYYG L+ G+++A
Sbjct: 547 -----------SVKTGPLDTKRYYKYSEIVEITNNFERVLGQGGFGKVYYGVLR-GEQVA 594
Query: 630 VKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY 689
+K+L+ +S QG +EF EV LL R+HH+NL+ +GYC E + L+YE++ NGTL ++L
Sbjct: 595 IKMLSKSSAQGYKEFRAEVELLLRVHHKNLIALIGYCHEGDQMALIYEYIGNGTLGDYLS 654
Query: 690 GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749
G + ++W +RL+I+ DAA+G+EYLH GC P I+HRD+K +NIL+++ ++AK++DFG
Sbjct: 655 GK--NSSILSWEERLQISLDAAQGLEYLHNGCKPPIVHRDVKPTNILINEKLQAKIADFG 712
Query: 750 LSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808
LS+ F ++G S VS+ V GT+GYLDPE+Y QQ ++KSDVYSFGV+LLE+I+GQ IS
Sbjct: 713 LSRSFTLEGDSQVSTEVAGTIGYLDPEHYSMQQFSEKSDVYSFGVVLLEVITGQPVISRS 772
Query: 809 KFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI 868
+ N R+I L + GDI+ I+DP L + ++ WKI E AL C R ++
Sbjct: 773 RTEEN-RHISDRVSLMLSKGDIKSIVDPKLGERFNAGLAWKITEVALACASESTKTRLTM 831
Query: 869 SEVLKDIQDAIVIEREAAAARDGNSDDMS 897
S+V+ ++++++ R + G+S D+S
Sbjct: 832 SQVVAELKESLCRARTS-----GDSGDIS 855
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 451 bits (1159), Expect = e-125, Method: Compositional matrix adjust.
Identities = 307/903 (33%), Positives = 479/903 (53%), Gaps = 97/903 (10%)
Query: 16 VLILLLLDSSSAQ-MPGFVSLNCG----------GNENFTDEIGLQWIADDHLIYGEISN 64
+ + +L AQ GF+SL+CG + N T +I D + G+I+
Sbjct: 8 IFVFAVLGLVQAQDQSGFISLDCGLVPTEITYVEKSTNITYRSDATYI--DSGVPGKINE 65
Query: 65 ISVANETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISL 124
+ + ++Q LR FP R CY + + +YLIR TF+YGN+D N P FD+ +
Sbjct: 66 V-YRTQFQQQIWALRSFPEGQRN-CYNFSLTAKRKYLIRGTFIYGNYDGLNQLPSFDLYI 123
Query: 125 GPTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTP 184
GP W+++ I V E+I + + +CL PFIS+LELR N + Y+T
Sbjct: 124 GPNKWTSVSIPGVRNGSVSEMIHVLRQDHLQICLVKTGETTPFISSLELRPLNNNTYVTK 183
Query: 185 FEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLP 244
L V AR+ F + + +RY +D DRIW L N L +ST+L
Sbjct: 184 SGS---LIVVARLYF-SPTPPFLRYDEDVHDRIW-IPFLDNKNSL---------LSTELS 229
Query: 245 IDLRSDELPPQKVMQTAVVGTNGSLTYRLN--LDGFPGFGWAVTYFAEIEDLDPDESRKF 302
+D + PQ V +TA V N + ++N LD + +FAEIE+L+ +E+R+F
Sbjct: 230 VDTSNFYNVPQTVAKTAAVPLNATQPLKINWSLDDITSQSYIYMHFAEIENLEANETREF 289
Query: 303 RLVLPGQPDVSKAIVNIQENAQGKYR--------VYEPGYTNLSLPFVLSFKFGKTYDSS 354
+ G EN +R VY P + SL +F F T +S+
Sbjct: 290 NITYNG-----------GENWFSYFRPPKFRITTVYNPAAVS-SLDGNFNFTFSMTGNST 337
Query: 355 RGPLLNAMEINKYLE--RNDGSIDGV-AIVSVISLYSSADWAQEGGDPCLPVPWSW--LQ 409
PL+N +EI + LE + D D V A++++ ++Y + + GDPC P + W L
Sbjct: 338 HPPLINGLEIYQVLELPQLDTYQDEVSAMMNIKTIYGLSKRSSWQGDPCAPELYRWEGLN 397
Query: 410 C---NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDL 465
C N P P I ++LS NL+G I SD++KL+ L EL L N L+G IP FS +L
Sbjct: 398 CSYPNFAP-PQIISLNLSGSNLSGTITSDISKLTHLRELDLSNNDLSGDIPFVFSDMKNL 456
Query: 466 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG 525
+I+L N+ L+ +VP +L + + N + + E
Sbjct: 457 TLINLSGNK-----------------------NLNRSVPETLQKR--IDNKSLTLIRDET 491
Query: 526 GRGAKHLNIIIGSSVGA--AVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLN 583
G+ + ++ + I +SV + AVL++ +V + K + N + + V+ S +
Sbjct: 492 GKNSTNV-VAIAASVASVFAVLVILAIVFVVIRKKQRTNEASGPRSFTTGTVKSDARSSS 550
Query: 584 DAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE 643
+ FT S++ TK E+ +G GGFG VY+G L D ++AVK+L+ +S QG +E
Sbjct: 551 SSIITKERKFTYSEVLKMTKNFERVLGKGGFGTVYHGNLDD-TQVAVKMLSHSSAQGYKE 609
Query: 644 FTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI-NWIK 702
F EV LL R+HHR+LV +GYC + L+YE+M G L+E++ G H + +W
Sbjct: 610 FKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMEKGDLRENMSG--KHSVNVLSWET 667
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHV 761
R++IA +AA+G+EYLH GC P ++HRD+K +NILL++ +AK++DFGLS+ F VDG SHV
Sbjct: 668 RMQIAVEAAQGLEYLHNGCRPPMVHRDVKPTNILLNERSQAKLADFGLSRSFPVDGESHV 727
Query: 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 821
++V GT GYLDPEYY + L++KSDVYSFGV+LLE+++ Q ++ + +I +W
Sbjct: 728 MTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVMNKNR---ERPHINEWV 784
Query: 822 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881
+ +GDI+ I+DP L ++YD +WK+ E AL CV P RP++ V+ ++ + + +
Sbjct: 785 MFMLTNGDIKSIVDPKLNEDYDTNGVWKVVELALACVNPSSSRRPTMPHVVMELNECLAL 844
Query: 882 ERE 884
E E
Sbjct: 845 EIE 847
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 449 bits (1156), Expect = e-125, Method: Compositional matrix adjust.
Identities = 309/942 (32%), Positives = 494/942 (52%), Gaps = 118/942 (12%)
Query: 8 LLPFSVASVLILLLLDSSSAQMPGFVSLNCGGNEN--FTDEI-GLQWIADDHLI-YGEIS 63
L+ F+ + +LL+ + GFVS++CG E+ + DE +++++D + G I
Sbjct: 9 LIIFACFFAVFVLLV--RAQDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIH 66
Query: 64 NISVANET---RKQYMTLRHFPADSRKYCYKLDVITRT--RYLIRATFLYGNFDNNNVYP 118
+I +T KQ+ +R FP +R CY + +YLIR F+YGN+DN P
Sbjct: 67 SIDPEFQTSSLEKQFQNVRSFPEGNRN-CYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAP 125
Query: 119 KFDISLGPTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNG 178
FD+ LG W ++ I +A TI +E+I S + VCL + G PF+S LE+R
Sbjct: 126 DFDLYLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKS 185
Query: 179 SVYLTPFEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEK 238
+ Y TP++ L + R + G PVRY DD FDRIW L+ Y +
Sbjct: 186 NTYETPYDS---LILFKRWDLGGLGALPVRYKDDVFDRIWIP--LRFPKYTI-------- 232
Query: 239 VSTKLPIDLRSDE--LPPQKVMQTAVVGTNGSLTYRLNLD-GFPGFGWAV-TYFAEIEDL 294
+ L ID ++E P + VM TA + S + + P + + V +FAE+ +L
Sbjct: 233 FNASLTIDSNNNEGFQPARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVEL 292
Query: 295 DPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFV--------LSFK 346
+E+R+F+++L ++ +N+ + P Y FV L F+
Sbjct: 293 PSNETREFKVLL------NEKEINMSS--------FSPRYLYTDTLFVQNPVSGPKLEFR 338
Query: 347 FGKTYDSSRGPLLNAME---INKYLERNDGSIDGVAIVSVISLYS-SADWAQEGGDPCLP 402
+T S+ P++NA+E +N++L+ D AI+ + S Y W GDPC P
Sbjct: 339 LQQTPRSTLPPIINAIETYRVNEFLQSPTDQQDVDAIMRIKSKYGVKKSWL---GDPCAP 395
Query: 403 V--PWSWLQCN--SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD 458
V PW + C+ + P I ++LSS LTG I + + L+ L
Sbjct: 396 VKYPWKDINCSYVDNESPRIISVNLSSSGLTGEIDAAFSNLTLL---------------- 439
Query: 459 FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN----VVL 514
I+ L +N LTG +P L NL NL EL ++ N LSG +P LL ++ ++L
Sbjct: 440 -------HILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSNKKLILL 492
Query: 515 NYAGNINLHEGG-------RGAKHLNII--IGSSVGAAVLLLATVVSCLFMHKGKKNNYD 565
GN +L + K++ II + S VG L+LA + L+
Sbjct: 493 RIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLAIALFLLY---------- 542
Query: 566 KEQHRHSLPVQRPVSSLNDAPAEAA-HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD 624
K++HR + P + + S++ T E+ +G GGFG VY+G L D
Sbjct: 543 KKRHRRG-----GSGGVRAGPLDTTKRYYKYSEVVKVTNNFERVLGQGGFGKVYHGVLND 597
Query: 625 GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684
++AVK+L+ +S QG +EF EV LL R+HH+NL +GYC E + L+YEFM NGTL
Sbjct: 598 -DQVAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEGKKMALIYEFMANGTL 656
Query: 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 744
++L G ++ ++W +RL+I+ DAA+G+EYLH GC P I+ RD+K +NIL+++ ++AK
Sbjct: 657 GDYLSGEKSYV--LSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPANILINEKLQAK 714
Query: 745 VSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 803
++DFGLS+ A+DG + ++ V GT+GYLDPEY+++Q+L++KSD+YSFGV+LLE++SGQ
Sbjct: 715 IADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGVVLLEVVSGQP 774
Query: 804 AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGH 863
I+ + A +I L + +GDI+GI+DP L + +D S WKI E A+ C
Sbjct: 775 VIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAWKITEVAMACASSSSK 834
Query: 864 MRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSL 905
RP++S V+ ++++++ R + + D + + S +
Sbjct: 835 NRPTMSHVVAELKESVSRARAGGGSGASSVTDPAMTNFDSGM 876
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 929 | ||||||
| 224068652 | 924 | predicted protein [Populus trichocarpa] | 0.973 | 0.978 | 0.812 | 0.0 | |
| 356570730 | 936 | PREDICTED: probable LRR receptor-like se | 0.967 | 0.960 | 0.804 | 0.0 | |
| 356503698 | 937 | PREDICTED: probable LRR receptor-like se | 0.987 | 0.978 | 0.785 | 0.0 | |
| 224138590 | 921 | predicted protein [Populus trichocarpa] | 0.972 | 0.980 | 0.810 | 0.0 | |
| 255568426 | 900 | Nodulation receptor kinase precursor, pu | 0.946 | 0.976 | 0.808 | 0.0 | |
| 297741494 | 924 | unnamed protein product [Vitis vinifera] | 0.990 | 0.995 | 0.790 | 0.0 | |
| 225439769 | 927 | PREDICTED: probable LRR receptor-like se | 0.976 | 0.978 | 0.793 | 0.0 | |
| 357510569 | 932 | Leucine-rich repeat receptor-like protei | 0.969 | 0.966 | 0.782 | 0.0 | |
| 449440057 | 897 | PREDICTED: probable LRR receptor-like se | 0.947 | 0.981 | 0.758 | 0.0 | |
| 356545961 | 902 | PREDICTED: probable LRR receptor-like se | 0.939 | 0.967 | 0.776 | 0.0 |
| >gi|224068652|ref|XP_002326166.1| predicted protein [Populus trichocarpa] gi|222833359|gb|EEE71836.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1540 bits (3988), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 738/908 (81%), Positives = 822/908 (90%), Gaps = 4/908 (0%)
Query: 24 SSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPA 83
+SSAQ PGF+SL+CGG NFTD++GL W +D + YG ++ISVANETRKQY T+RHFPA
Sbjct: 19 ASSAQ-PGFLSLDCGGPVNFTDDLGLSWTSDFNFSYGAAASISVANETRKQYTTVRHFPA 77
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVR 143
DSRKYCY+LDV +RTRYL+RATFLYGNFD+NNVYPKFDIS+GPTHWSTIVISDA TIE
Sbjct: 78 DSRKYCYRLDVTSRTRYLLRATFLYGNFDSNNVYPKFDISVGPTHWSTIVISDANTIEST 137
Query: 144 ELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADS 203
ELIFLASS + VCLSNATTGQPFISTLELRQFNGSVY T FE+++YLS+SARINFGAD+
Sbjct: 138 ELIFLASSSSMSVCLSNATTGQPFISTLELRQFNGSVYYTEFENQFYLSMSARINFGADN 197
Query: 204 EAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVV 263
EAP+RYPDDP+DRIWESDS+KKANYLVDVAAGT+KVST +PID+ DE PP++VMQTAVV
Sbjct: 198 EAPIRYPDDPYDRIWESDSVKKANYLVDVAAGTKKVSTDMPIDVNIDERPPERVMQTAVV 257
Query: 264 GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENA 323
GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDP+ESRKFRLVLPG PD+SKAIVNI+ENA
Sbjct: 258 GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPEESRKFRLVLPGYPDMSKAIVNIEENA 317
Query: 324 QGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSV 383
QGKYR+YEPGYTNLSLPFVLSF+FGKT DSSRGPL+NAMEI+KYLE+NDG++DG I V
Sbjct: 318 QGKYRLYEPGYTNLSLPFVLSFRFGKTSDSSRGPLVNAMEIHKYLEKNDGTLDGYVISRV 377
Query: 384 ISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLV 443
I +S+ DWAQEGGDPCLPVPWSW+QCNSD +P I + LSSKNL+GN+PS LT L+ LV
Sbjct: 378 ILSHSTEDWAQEGGDPCLPVPWSWVQCNSDARPRIVKLSLSSKNLSGNVPSGLTMLTGLV 437
Query: 444 ELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTV 503
ELWLDGNSLTGPIPDF+GC L IIHLE+NQLTG LPSSL+NLPNLRELYVQNN+LSGT+
Sbjct: 438 ELWLDGNSLTGPIPDFTGCTGLEIIHLENNQLTGELPSSLLNLPNLRELYVQNNLLSGTI 497
Query: 504 PSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNN 563
PS LS+ V LNY+GNINL EG R +H++IIIGSSVGAAVLL+AT+VSCLFMHKGKK +
Sbjct: 498 PSG-LSRKVALNYSGNINLREGARRGRHMDIIIGSSVGAAVLLIATIVSCLFMHKGKKRH 556
Query: 564 YDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK 623
D+EQ R SLP+Q VSSL +AP EAAHCFT +IEDATK EKKIGSGGFGVVYYGK+K
Sbjct: 557 PDQEQLRDSLPMQMVVSSLRNAPGEAAHCFTTFEIEDATKKFEKKIGSGGFGVVYYGKMK 616
Query: 624 DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683
DG+EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE+G+S+LVYEFMHNGT
Sbjct: 617 DGREIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEDGKSMLVYEFMHNGT 676
Query: 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 743
LKEHLYG L + INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL+DK+MRA
Sbjct: 677 LKEHLYGPLKRGKSINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILVDKNMRA 736
Query: 744 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 803
KV+DFGLSK AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLEL+SGQE
Sbjct: 737 KVADFGLSKLAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELMSGQE 796
Query: 804 AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGH 863
AISNE FG NCRNIVQWAKLHIESGDIQGIIDPSL EYDIQSMWKI EKALMCV PHGH
Sbjct: 797 AISNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLCGEYDIQSMWKIAEKALMCVQPHGH 856
Query: 864 MRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDE 921
MRPSISEVLK+IQDAI+IERE AAR+ SD+MSRNS+HSSLN+GS GG EN+L+LDE
Sbjct: 857 MRPSISEVLKEIQDAILIEREVTAAREDISDEMSRNSVHSSLNLGSLDLGGAENYLALDE 916
Query: 922 SIVRPSAR 929
SI +P+AR
Sbjct: 917 SIAQPTAR 924
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356570730|ref|XP_003553538.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1536 bits (3976), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 731/909 (80%), Positives = 810/909 (89%), Gaps = 10/909 (1%)
Query: 29 MPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADSRKY 88
M GFVSL+CGG E FTDE+GL W DD L YG+IS ISVANETRKQY TLRHFPADSRKY
Sbjct: 30 MQGFVSLDCGGTEKFTDELGLHWTPDDKLTYGQISTISVANETRKQYTTLRHFPADSRKY 89
Query: 89 CYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVRELIFL 148
CY L+V++RTRYL+RA+FLYGNFDNNNVYPKFDIS+G THWSTIVISDA +IE+RELIFL
Sbjct: 90 CYTLEVVSRTRYLLRASFLYGNFDNNNVYPKFDISVGATHWSTIVISDANSIEMRELIFL 149
Query: 149 ASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAPVR 208
ASSP + VCLSNATTGQPFISTLELRQFNGSVY T FE +YLSVSARINFGA+S+AP+R
Sbjct: 150 ASSPTVSVCLSNATTGQPFISTLELRQFNGSVYYTQFEQHFYLSVSARINFGAESDAPIR 209
Query: 209 YPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGS 268
YPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST +PID+ DE+PP KVMQTAVVGTNGS
Sbjct: 210 YPDDPFDRIWESDSVKKANYLVDVAAGTEKISTTVPIDVNRDEMPPVKVMQTAVVGTNGS 269
Query: 269 LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYR 328
LTYRLNLDGFPG GWA TYFAEIEDLDPDESRKFRLVLPGQPD+SKA+VNI+ENAQGKYR
Sbjct: 270 LTYRLNLDGFPGTGWAFTYFAEIEDLDPDESRKFRLVLPGQPDISKAVVNIEENAQGKYR 329
Query: 329 VYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYS 388
+YEPG+TN+SLPFVLSF+FGKTYDSSRGPLLNAMEIN YLE+NDGS+DG I +++S YS
Sbjct: 330 LYEPGFTNISLPFVLSFRFGKTYDSSRGPLLNAMEINMYLEKNDGSLDGATISNILSHYS 389
Query: 389 SADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLD 448
+ADW QEGGDPCLPVPWSW++CNSDPQP I I LS+KNLTGNIP D+TKL LVELWLD
Sbjct: 390 AADWLQEGGDPCLPVPWSWVRCNSDPQPRIVSILLSNKNLTGNIPLDITKLVGLVELWLD 449
Query: 449 GNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL 508
GN LTGP PDF+GC DL+IIHLE+NQLTG LP+SL NLP+LRELYVQNNMLSGT+PS LL
Sbjct: 450 GNMLTGPFPDFTGCMDLKIIHLENNQLTGVLPTSLTNLPSLRELYVQNNMLSGTIPSELL 509
Query: 509 SKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQ 568
SK++VLNY+GNINLH R H+ +IIGSSVGA+VLLLAT++SCL+MHKGK+ + EQ
Sbjct: 510 SKDLVLNYSGNINLHRESRIKGHMYVIIGSSVGASVLLLATIISCLYMHKGKRRYH--EQ 567
Query: 569 HR------HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKL 622
R SLP QR S +D PAEAAHCF+ S+IE+AT EKKIGSGGFGVVYYGKL
Sbjct: 568 GRILNSCIDSLPTQRLASWKSDDPAEAAHCFSYSEIENATNNFEKKIGSGGFGVVYYGKL 627
Query: 623 KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682
KDGKEIAVKVLTSNSYQGKREF+NEVTLLSRIHHRNLVQ LGYC++E S+LVYEFMHNG
Sbjct: 628 KDGKEIAVKVLTSNSYQGKREFSNEVTLLSRIHHRNLVQLLGYCRDEENSMLVYEFMHNG 687
Query: 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 742
TLKEHLYG L H + INWIKRLEIAEDAAKGIEYLHTGCVP +IHRDLKSSNILLDKHMR
Sbjct: 688 TLKEHLYGPLVHGRSINWIKRLEIAEDAAKGIEYLHTGCVPVVIHRDLKSSNILLDKHMR 747
Query: 743 AKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
AKVSDFGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ
Sbjct: 748 AKVSDFGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 807
Query: 803 EAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHG 862
EAISNE FG NCRNIVQWAKLHIESGDIQGIIDP L ++YD+QSMWKI EKALMCV PHG
Sbjct: 808 EAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPLLRNDYDLQSMWKIAEKALMCVQPHG 867
Query: 863 HMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLD 920
HMRPSISE LK+IQDAI IER+A A R+GNSDDMS+NS HSS+N+GS GG E++LS+D
Sbjct: 868 HMRPSISEALKEIQDAISIERQAEALREGNSDDMSKNSFHSSMNMGSMDLGGAESYLSID 927
Query: 921 ESIVRPSAR 929
ESI +P+AR
Sbjct: 928 ESIAQPTAR 936
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503698|ref|XP_003520642.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1531 bits (3963), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 728/927 (78%), Positives = 818/927 (88%), Gaps = 10/927 (1%)
Query: 11 FSVASVLILLLLDSSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANE 70
F+++ LIL SS+ M GFVSL+CGG E F DEIGL W DD L YG+IS ISV NE
Sbjct: 13 FALSLSLILHSPFSSAQIMQGFVSLDCGGTEKFADEIGLHWTPDDKLTYGQISTISVVNE 72
Query: 71 TRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWS 130
TRKQY TLRHFPADSRKYCY L+V++RTRYL+RA+FLYGNFD+NNVYPKFDIS+GPTHWS
Sbjct: 73 TRKQYTTLRHFPADSRKYCYTLEVVSRTRYLLRASFLYGNFDDNNVYPKFDISIGPTHWS 132
Query: 131 TIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYY 190
TIVISDA +IE+RELIFLASSP + VCLSNATTGQPFISTLELRQFNGSVY T FE+ +Y
Sbjct: 133 TIVISDANSIEMRELIFLASSPTVSVCLSNATTGQPFISTLELRQFNGSVYYTQFEEHFY 192
Query: 191 LSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSD 250
LSVSARINFGA+S+AP+RYPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST +PID+ D
Sbjct: 193 LSVSARINFGAESDAPIRYPDDPFDRIWESDSVKKANYLVDVAAGTEKISTTVPIDVNRD 252
Query: 251 ELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQP 310
E+PP KVMQTAVVGTNGSLTYRLNLDGFPG GWA TYFAEIEDLDP+ESRKFRLVLPGQP
Sbjct: 253 EMPPVKVMQTAVVGTNGSLTYRLNLDGFPGTGWAFTYFAEIEDLDPNESRKFRLVLPGQP 312
Query: 311 DVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLER 370
D+SKA+VNI+ENAQGKYR+YEPG+TN+SLPFVLSF+FGKTYDSSRGPLLNAMEIN YLE+
Sbjct: 313 DISKAVVNIEENAQGKYRLYEPGFTNISLPFVLSFRFGKTYDSSRGPLLNAMEINMYLEK 372
Query: 371 NDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTG 430
NDGS+DG I +++S YS+ DWAQEGGDPCLPVPWSW++CNSDPQP I I LS+KNLTG
Sbjct: 373 NDGSLDGATISNILSHYSAEDWAQEGGDPCLPVPWSWVRCNSDPQPRIVSILLSNKNLTG 432
Query: 431 NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 490
NIP D+TKL LVELWLDGN LTGP PDF+GC DL+IIHLE+NQLTG LP+SL NLP+LR
Sbjct: 433 NIPMDITKLVGLVELWLDGNMLTGPFPDFTGCMDLKIIHLENNQLTGVLPTSLTNLPSLR 492
Query: 491 ELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATV 550
ELYVQNNMLSGT+PS LLSK++VLNY+GNINLH R H+ +IIGSSVGA+VLLLAT+
Sbjct: 493 ELYVQNNMLSGTIPSELLSKDLVLNYSGNINLHRESRIKGHMYVIIGSSVGASVLLLATI 552
Query: 551 VSCLFMHKGKKNNYDKEQHR------HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKM 604
+SCL+M KGK+ + EQ R SLP QR S +D PAEAAHCF+ +IE+AT
Sbjct: 553 ISCLYMRKGKRRYH--EQGRILNNRIDSLPTQRLASWKSDDPAEAAHCFSFPEIENATNN 610
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
E KIGSGGFG+VYYGKLKDGKEIAVKVLTSNSYQGKREF+NEVTLLSRIHHRNLVQ LG
Sbjct: 611 FETKIGSGGFGIVYYGKLKDGKEIAVKVLTSNSYQGKREFSNEVTLLSRIHHRNLVQLLG 670
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
YC++E S+LVYEFMHNGTLKEHLYG L H + INWIKRLEIAEDAAKGIEYLHTGC+P
Sbjct: 671 YCRDEESSMLVYEFMHNGTLKEHLYGPLVHGRSINWIKRLEIAEDAAKGIEYLHTGCIPV 730
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
+IHRDLKSSNILLDKHMRAKVSDFGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTD
Sbjct: 731 VIHRDLKSSNILLDKHMRAKVSDFGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTD 790
Query: 785 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844
KSDVYSFGVILLELISGQEAISNE FG NCRNIVQWAKLHIESGDIQGIIDP L ++YD+
Sbjct: 791 KSDVYSFGVILLELISGQEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPLLRNDYDL 850
Query: 845 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSS 904
QSMWKI EKALMCV PHGHMRP+ISEV+K+IQDAI IER+A A R+GNSDDMS++S HSS
Sbjct: 851 QSMWKIAEKALMCVQPHGHMRPTISEVIKEIQDAISIERQAEALREGNSDDMSKHSFHSS 910
Query: 905 LNVGS--FGGTENFLSLDESIVRPSAR 929
+N+GS GG E++LS+DESI +P+AR
Sbjct: 911 MNMGSMDLGGAESYLSIDESIAQPTAR 937
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138590|ref|XP_002322852.1| predicted protein [Populus trichocarpa] gi|222867482|gb|EEF04613.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1529 bits (3958), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 736/908 (81%), Positives = 820/908 (90%), Gaps = 5/908 (0%)
Query: 24 SSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPA 83
+SSAQ PGF+SL+CGG NFTD +GL W +D + IYGE ++ISVANETRKQY T+RHFPA
Sbjct: 17 ASSAQ-PGFLSLDCGGPANFTDALGLSWTSDVNFIYGEAASISVANETRKQYTTVRHFPA 75
Query: 84 DSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVR 143
D+RKYCY+LDV +RTRYL+RATFLYG+FDNNNVYPKFDIS+GPTHWSTIVISDA TIE
Sbjct: 76 DTRKYCYRLDVTSRTRYLLRATFLYGDFDNNNVYPKFDISVGPTHWSTIVISDANTIESI 135
Query: 144 ELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADS 203
ELIFLASS I VCLSNATTGQPFISTLELRQFNGSVY T FE++++LSVSARINFGADS
Sbjct: 136 ELIFLASSSSISVCLSNATTGQPFISTLELRQFNGSVYFTAFENQFFLSVSARINFGADS 195
Query: 204 EAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVV 263
PVRYPDDP+DRIWESDS+KKANYLVDVAAGT+KVST +PI++ DE PP+KVMQTAVV
Sbjct: 196 VDPVRYPDDPYDRIWESDSVKKANYLVDVAAGTKKVSTDMPINVNIDERPPEKVMQTAVV 255
Query: 264 GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENA 323
GTNGSLTYRLNLDGFPGFGWA TYFAEIEDLDP ESRKFRLVLPG PD+SKA+VNI+ENA
Sbjct: 256 GTNGSLTYRLNLDGFPGFGWACTYFAEIEDLDPTESRKFRLVLPGNPDMSKAVVNIEENA 315
Query: 324 QGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSV 383
QGKYR+YEPGYTNLSLPFVLSF+FGKT DSSRGPLLNAMEINKYLE+NDGS+DG I V
Sbjct: 316 QGKYRLYEPGYTNLSLPFVLSFRFGKTSDSSRGPLLNAMEINKYLEKNDGSLDGDVISGV 375
Query: 384 ISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLV 443
I LYS+ADWAQEGGDPC+PVPWSW+QCNS+ +P I + LSSKNL+G++PSDLTKL+ LV
Sbjct: 376 ILLYSTADWAQEGGDPCMPVPWSWVQCNSEARPRIVKLSLSSKNLSGSVPSDLTKLTGLV 435
Query: 444 ELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTV 503
ELWLDGNSLTGPIPDF+GC DL IIHLE+NQLTG LPSSL+NLPNLRELYVQNNMLSGT+
Sbjct: 436 ELWLDGNSLTGPIPDFTGCTDLEIIHLENNQLTGELPSSLLNLPNLRELYVQNNMLSGTI 495
Query: 504 PSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNN 563
PS L + VVLNY+GNINLHEG R +H+ IIIGSSVGAAVLL+ T+VSC+FM KGKK +
Sbjct: 496 PSG-LGRKVVLNYSGNINLHEGARRGRHMGIIIGSSVGAAVLLITTLVSCMFMQKGKKRH 554
Query: 564 YDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK 623
D+EQ R SLPVQR VS+L++AP EAAH FT +IEDATK EKKIGSGGFGVVYYGK+K
Sbjct: 555 PDQEQLRDSLPVQRVVSTLSNAPGEAAHRFTSFEIEDATKKFEKKIGSGGFGVVYYGKMK 614
Query: 624 DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683
DG+EIAVKVLTSNS+QGKREF+NEV+LLSRIHHRNLVQFLG+CQE G+S+LVYEFMHNGT
Sbjct: 615 DGREIAVKVLTSNSFQGKREFSNEVSLLSRIHHRNLVQFLGFCQEVGKSMLVYEFMHNGT 674
Query: 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 743
LKEHLYG L + I+WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK+SNILLDK+MRA
Sbjct: 675 LKEHLYGPLKQGRSISWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKTSNILLDKNMRA 734
Query: 744 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 803
KV+DFGLSK AVDGASHVSSIVRGTVGYLDPEYYISQQLT+KSDVYSFGVILLEL+SGQE
Sbjct: 735 KVADFGLSKLAVDGASHVSSIVRGTVGYLDPEYYISQQLTNKSDVYSFGVILLELMSGQE 794
Query: 804 AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGH 863
AISNE FG NCRNIVQWAKLHIESGDIQGIIDPSL +E+DIQSMWKI EKAL CV PHGH
Sbjct: 795 AISNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLCNEFDIQSMWKIAEKALTCVQPHGH 854
Query: 864 MRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDE 921
MRPSISEVLK+IQDAI+IERE AAR G SD+MSRNS+ SS N+GS GGTEN L+LDE
Sbjct: 855 MRPSISEVLKEIQDAILIEREVTAAR-GFSDEMSRNSVQSSFNLGSLDLGGTENCLALDE 913
Query: 922 SIVRPSAR 929
SI RP+AR
Sbjct: 914 SIARPTAR 921
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568426|ref|XP_002525187.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223535484|gb|EEF37153.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1512 bits (3915), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 734/908 (80%), Positives = 803/908 (88%), Gaps = 29/908 (3%)
Query: 25 SSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPAD 84
SSAQMPGFVSLNCGG ENFTDE+GL W +DD LIYGE + ISVANETRKQY TLRHFPAD
Sbjct: 19 SSAQMPGFVSLNCGGKENFTDELGLVWTSDDSLIYGEPATISVANETRKQYKTLRHFPAD 78
Query: 85 SRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVRE 144
SRKYCY LDVI+RTRYL+RATFLYGNFDNNNVYPKFDIS+G THWSTIVISDA TIE E
Sbjct: 79 SRKYCYTLDVISRTRYLLRATFLYGNFDNNNVYPKFDISVGATHWSTIVISDANTIESIE 138
Query: 145 LIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSE 204
LIFLASSP I VCLSNATTGQPFISTLELRQFNGSVY T FE+++YLS+SARINFGADSE
Sbjct: 139 LIFLASSPTISVCLSNATTGQPFISTLELRQFNGSVYYTSFENQFYLSISARINFGADSE 198
Query: 205 APVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVG 264
APVRYPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST + ID+ +DE PP+KVMQTAVVG
Sbjct: 199 APVRYPDDPFDRIWESDSVKKANYLVDVAAGTEKISTNMSIDVSNDERPPEKVMQTAVVG 258
Query: 265 TNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQ 324
TNGSLTYRLNLDGFPGFGWAVTYFAEIEDL PDESRKFRL+LPG PD+SK IVNIQENAQ
Sbjct: 259 TNGSLTYRLNLDGFPGFGWAVTYFAEIEDLAPDESRKFRLILPGFPDMSKPIVNIQENAQ 318
Query: 325 GKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVI 384
GKYR+Y+PGY N+SLPFVLSF+FGKT DSSRGPLLNAMEINKYLE+NDGS+DG I SVI
Sbjct: 319 GKYRLYQPGYPNISLPFVLSFRFGKTSDSSRGPLLNAMEINKYLEKNDGSLDGEVIASVI 378
Query: 385 SLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVE 444
SLY+S DWAQEGGDPCLPVPWSWLQCNSD +P I I LSSKNLTGNIPSDL KL L E
Sbjct: 379 SLYTSTDWAQEGGDPCLPVPWSWLQCNSDARPRIIKISLSSKNLTGNIPSDLPKLKGLAE 438
Query: 445 LWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 504
L E+NQLTG LPSSLMNLP+LRELYVQNN+LSGTVP
Sbjct: 439 FHL-----------------------ENNQLTGGLPSSLMNLPHLRELYVQNNLLSGTVP 475
Query: 505 SSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNY 564
S LL KN+ LNY+GN+++HEGGR KH IIIGSSVGAAVLL+AT+ SC F+ +GKK+N+
Sbjct: 476 SGLLDKNLFLNYSGNLHVHEGGRREKHTGIIIGSSVGAAVLLIATIASCFFIRRGKKSNH 535
Query: 565 DKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD 624
D E HR PVQR VS+LND PAE A+CFT S+IEDAT+ LEKKIGSGGFG+VYYGKLK+
Sbjct: 536 DYEHHRVPPPVQRLVSTLNDNPAEGAYCFTFSEIEDATRKLEKKIGSGGFGIVYYGKLKN 595
Query: 625 GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684
GKEIAVKVLT+NS+QGKREF+NEVTLLSRIHHRNLVQFLG+CQE+GRS+LVYE+MHNGTL
Sbjct: 596 GKEIAVKVLTNNSFQGKREFSNEVTLLSRIHHRNLVQFLGFCQEDGRSMLVYEYMHNGTL 655
Query: 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 744
KEHLYG + + INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK+SNILLDKHMRAK
Sbjct: 656 KEHLYG--SRGRSINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKTSNILLDKHMRAK 713
Query: 745 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 804
VSDFGLSK A+DGASHVSS+VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLEL+SG+EA
Sbjct: 714 VSDFGLSKLALDGASHVSSVVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELMSGKEA 773
Query: 805 ISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL-LDEYDIQSMWKIEEKALMCVLPHGH 863
ISNE FG NCRNIVQWAKLHIESGDIQG+ID S DEYDIQSMWKI EKALMCV PHGH
Sbjct: 774 ISNE-FGTNCRNIVQWAKLHIESGDIQGVIDSSFDDDEYDIQSMWKIAEKALMCVQPHGH 832
Query: 864 MRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDE 921
MRPSISEVLK+IQDAI IERE+ A R+GNSDDMSRNS+HSSLN+GS GGTEN+LSLDE
Sbjct: 833 MRPSISEVLKEIQDAIAIERESVAVREGNSDDMSRNSVHSSLNLGSLELGGTENYLSLDE 892
Query: 922 SIVRPSAR 929
S+ RP+AR
Sbjct: 893 SVARPTAR 900
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741494|emb|CBI32626.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1511 bits (3913), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 731/925 (79%), Positives = 818/925 (88%), Gaps = 5/925 (0%)
Query: 6 RLLLPFSVASVLILLLLDSSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNI 65
RLLL F +VL L+D+++AQMPGFVS +CGG+ENFTD++GL W +DD L+YGEI+ I
Sbjct: 4 RLLLLFLSVTVL---LMDAANAQMPGFVSFDCGGSENFTDDLGLWWTSDDQLMYGEIATI 60
Query: 66 SVANETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLG 125
SVANETRKQY TLRHFPAD+RKYCY LDVI+RTRYL+RATFLYGNFDNN VYPKFDISLG
Sbjct: 61 SVANETRKQYTTLRHFPADNRKYCYTLDVISRTRYLVRATFLYGNFDNNKVYPKFDISLG 120
Query: 126 PTHWSTIVISDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPF 185
T WSTIVISDA TIE ELIFLAS P I VCLSNATTGQPFISTLELRQFNGS+Y T +
Sbjct: 121 ATPWSTIVISDANTIESSELIFLASDPTISVCLSNATTGQPFISTLELRQFNGSIYYTEY 180
Query: 186 EDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPI 245
E+ ++LSVSAR+NFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVA GTEKVST++PI
Sbjct: 181 EEDFFLSVSARVNFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAPGTEKVSTQMPI 240
Query: 246 DLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLV 305
D+ D PP+KVMQTAVVG NG+L+YRLNLDGFPGFGWA TY AEIEDL P+E+RKFRL+
Sbjct: 241 DVNKDSRPPEKVMQTAVVGRNGTLSYRLNLDGFPGFGWAFTYLAEIEDLGPEETRKFRLI 300
Query: 306 LPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEIN 365
LP PD+SK VNIQENAQGKYR+YEPGY N+SLPFVLSFKFGKT DSS+GPLLNAMEIN
Sbjct: 301 LPNMPDLSKPAVNIQENAQGKYRLYEPGYPNISLPFVLSFKFGKTSDSSQGPLLNAMEIN 360
Query: 366 KYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSS 425
KYLE+ DG +DG AI S++ YSS DWA+EGGDPCLPVPWSW+ CNSDPQP I IHLS
Sbjct: 361 KYLEKRDGCLDGSAIASIVLQYSSEDWAKEGGDPCLPVPWSWVACNSDPQPRIVSIHLSG 420
Query: 426 KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN 485
KNLTGNIP+DLTKLS LVELWLDGN+L GPIPDF+G +L+ IHLE+NQL+G LPSSL++
Sbjct: 421 KNLTGNIPTDLTKLSGLVELWLDGNALAGPIPDFTGLINLKTIHLENNQLSGELPSSLVD 480
Query: 486 LPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVL 545
L +L+ELYVQNNMLSG VPS LL++N+ NY+GN NLH+G G +H+ IIIGSSVGA VL
Sbjct: 481 LQSLKELYVQNNMLSGKVPSGLLNENLDFNYSGNDNLHKGSTGGRHIGIIIGSSVGAVVL 540
Query: 546 LLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKML 605
L+AT+ SCLFMHKGKK Y+++Q H LP QR VSSLNDA EAA+CF+LS+IEDAT+
Sbjct: 541 LIATIASCLFMHKGKKRYYEQDQLGHGLPAQRIVSSLNDAATEAANCFSLSEIEDATRKF 600
Query: 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
EKKIGSGGFGVVYYGK+KDGKEIAVKVL +NSYQG REF+NEVTLLSRIHHRNLVQFLGY
Sbjct: 601 EKKIGSGGFGVVYYGKMKDGKEIAVKVLINNSYQGNREFSNEVTLLSRIHHRNLVQFLGY 660
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 725
CQEEGRS+LVYEFMHNGTLKEHLYG LT E+ I+WIKRLEIAEDAAKGIEYLHTGCVP+I
Sbjct: 661 CQEEGRSMLVYEFMHNGTLKEHLYGPLTRERAISWIKRLEIAEDAAKGIEYLHTGCVPSI 720
Query: 726 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 785
IHRDLKSSNILLDK+M+AKVSDFGLSK AVDG+SHVSS+VRGTVGYLDPEYYISQQLTDK
Sbjct: 721 IHRDLKSSNILLDKYMKAKVSDFGLSKLAVDGSSHVSSVVRGTVGYLDPEYYISQQLTDK 780
Query: 786 SDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ 845
SDVYSFGVILLELISGQEAISNE FG NCRNIVQWAKLHIESGDIQGIIDPSL DEYDIQ
Sbjct: 781 SDVYSFGVILLELISGQEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLRDEYDIQ 840
Query: 846 SMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSL 905
SMWKI EKALMCV PHG MRP ISEV+K+IQ+AI IER A AAR+GNS D SRNS+HSS+
Sbjct: 841 SMWKIAEKALMCVQPHGSMRPPISEVIKEIQEAISIERGAEAAREGNS-DASRNSIHSSI 899
Query: 906 NVG-SFGGTENFLSLDESIVRPSAR 929
N+G G TEN+LS DESI RP+ R
Sbjct: 900 NMGIDVGPTENYLSFDESIARPTPR 924
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439769|ref|XP_002275389.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1502 bits (3889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 723/911 (79%), Positives = 809/911 (88%), Gaps = 4/911 (0%)
Query: 22 LDSSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHF 81
+D+++AQMPGFVS +CGG+ENFTD++GL W +DD L+YGEI+ ISVANETRKQY TLRHF
Sbjct: 18 MDAANAQMPGFVSFDCGGSENFTDDLGLWWTSDDQLMYGEIATISVANETRKQYTTLRHF 77
Query: 82 PADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIE 141
PAD+RKYCY LDVI+RTRYL+RATFLYGNFDNN VYPKFDISLG T WSTIVISDA TIE
Sbjct: 78 PADNRKYCYTLDVISRTRYLVRATFLYGNFDNNKVYPKFDISLGATPWSTIVISDANTIE 137
Query: 142 VRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGA 201
ELIFLAS P I VCLSNATTGQPFISTLELRQFNGS+Y T +E+ ++LSVSAR+NFGA
Sbjct: 138 SSELIFLASDPTISVCLSNATTGQPFISTLELRQFNGSIYYTEYEEDFFLSVSARVNFGA 197
Query: 202 DSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTA 261
DSEAPVRYPDDPFDRIWESDSLKKANYLVDVA GTEKVST++PID+ D PP+KVMQTA
Sbjct: 198 DSEAPVRYPDDPFDRIWESDSLKKANYLVDVAPGTEKVSTQMPIDVNKDSRPPEKVMQTA 257
Query: 262 VVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQE 321
VVG NG+L+YRLNLDGFPGFGWA TY AEIEDL P+E+RKFRL+LP PD+SK VNIQE
Sbjct: 258 VVGRNGTLSYRLNLDGFPGFGWAFTYLAEIEDLGPEETRKFRLILPNMPDLSKPAVNIQE 317
Query: 322 NAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIV 381
NAQGKYR+YEPGY N+SLPFVLSFKFGKT DSS+GPLLNAMEINKYLE+ DG +DG AI
Sbjct: 318 NAQGKYRLYEPGYPNISLPFVLSFKFGKTSDSSQGPLLNAMEINKYLEKRDGCLDGSAIA 377
Query: 382 SVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSS 441
S++ YSS DWA+EGGDPCLPVPWSW+ CNSDPQP I IHLS KNLTGNIP+DLTKLS
Sbjct: 378 SIVLQYSSEDWAKEGGDPCLPVPWSWVACNSDPQPRIVSIHLSGKNLTGNIPTDLTKLSG 437
Query: 442 LVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 501
LVELWLDGN+L GPIPDF+G +L+ IHLE+NQL+G LPSSL++L +L+ELYVQNNMLSG
Sbjct: 438 LVELWLDGNALAGPIPDFTGLINLKTIHLENNQLSGELPSSLVDLQSLKELYVQNNMLSG 497
Query: 502 TVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKK 561
VPS LL++N+ NY+GN NLH+G G +H+ IIIGSSVGA VLL+AT+ SCLFMHKGKK
Sbjct: 498 KVPSGLLNENLDFNYSGNDNLHKGSTGGRHIGIIIGSSVGAVVLLIATIASCLFMHKGKK 557
Query: 562 NNYDKEQHR--HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 619
Y++ H+ H LP QR VSSLNDA EAA+CF+LS+IEDAT+ EKKIGSGGFGVVYY
Sbjct: 558 RYYEQGMHQLGHGLPAQRIVSSLNDAATEAANCFSLSEIEDATRKFEKKIGSGGFGVVYY 617
Query: 620 GKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679
GK+KDGKEIAVKVL +NSYQG REF+NEVTLLSRIHHRNLVQFLGYCQEEGRS+LVYEFM
Sbjct: 618 GKMKDGKEIAVKVLINNSYQGNREFSNEVTLLSRIHHRNLVQFLGYCQEEGRSMLVYEFM 677
Query: 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 739
HNGTLKEHLYG LT E+ I+WIKRLEIAEDAAKGIEYLHTGCVP+IIHRDLKSSNILLDK
Sbjct: 678 HNGTLKEHLYGPLTRERAISWIKRLEIAEDAAKGIEYLHTGCVPSIIHRDLKSSNILLDK 737
Query: 740 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 799
+M+AKVSDFGLSK AVDG+SHVSS+VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI
Sbjct: 738 YMKAKVSDFGLSKLAVDGSSHVSSVVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 797
Query: 800 SGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVL 859
SGQEAISNE FG NCRNIVQWAKLHIESGDIQGIIDPSL DEYDIQSMWKI EKALMCV
Sbjct: 798 SGQEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLRDEYDIQSMWKIAEKALMCVQ 857
Query: 860 PHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVG-SFGGTENFLS 918
PHG MRP ISEV+K+IQ+AI IER A AAR+GNS D SRNS+HSS+N+G G TEN+LS
Sbjct: 858 PHGSMRPPISEVIKEIQEAISIERGAEAAREGNS-DASRNSIHSSINMGIDVGPTENYLS 916
Query: 919 LDESIVRPSAR 929
DESI RP+ R
Sbjct: 917 FDESIARPTPR 927
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357510569|ref|XP_003625573.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|355500588|gb|AES81791.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1482 bits (3837), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 707/903 (78%), Positives = 793/903 (87%), Gaps = 2/903 (0%)
Query: 29 MPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADSRKY 88
M GFVSL+CGG+E+FTD+IGL W D+ L YGEIS ISV NETRKQY TLRHFPADSRKY
Sbjct: 30 MQGFVSLDCGGSESFTDDIGLDWTPDNKLTYGEISTISVVNETRKQYTTLRHFPADSRKY 89
Query: 89 CYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVRELIFL 148
CY LDVI+RTRYL+RA+FLYGNFDNNNVYPKFDIS+G THWSTIVISDA IE+RELIFL
Sbjct: 90 CYTLDVISRTRYLLRASFLYGNFDNNNVYPKFDISVGATHWSTIVISDANIIEMRELIFL 149
Query: 149 ASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAPVR 208
ASS + VCLSNATTGQPFISTLELRQFNGS+Y T FE ++YLSVSARINFGA+++AP+R
Sbjct: 150 ASSSTVSVCLSNATTGQPFISTLELRQFNGSIYYTQFEQQFYLSVSARINFGAETDAPIR 209
Query: 209 YPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGS 268
YPDDPFDRIWESDS+KKANYLVDVA GTEKVST +PI + D++PP KVMQTAVVGTNGS
Sbjct: 210 YPDDPFDRIWESDSVKKANYLVDVAVGTEKVSTNVPILVNRDDVPPVKVMQTAVVGTNGS 269
Query: 269 LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYR 328
LTYRLNLDGFPG WAVTYFAEIEDL P+ESRKFRLVLPGQP++SKAIVNI+ENA GKYR
Sbjct: 270 LTYRLNLDGFPGNAWAVTYFAEIEDLSPNESRKFRLVLPGQPEISKAIVNIEENAFGKYR 329
Query: 329 VYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYS 388
+YEPG+TNLSLPFVLSFKF KT DSS+GPL+NAMEINKYLE+NDGS D AI V+S YS
Sbjct: 330 LYEPGFTNLSLPFVLSFKFAKTPDSSKGPLVNAMEINKYLEKNDGSPDVEAISGVLSHYS 389
Query: 389 SADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLD 448
SA+W QEGGDPCLPVPWSW++C+SDPQP I I LS KNLTGNIPSD+TKL LVELWLD
Sbjct: 390 SANWTQEGGDPCLPVPWSWIRCSSDPQPRIISILLSGKNLTGNIPSDITKLVGLVELWLD 449
Query: 449 GNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL 508
GN LTGPIPDF+GC DL+IIHLE+NQ G LP+SL NLP+LRELYVQNNMLSG VP LL
Sbjct: 450 GNMLTGPIPDFTGCMDLKIIHLENNQFNGVLPASLANLPSLRELYVQNNMLSGEVPPHLL 509
Query: 509 SKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQ 568
SK+++LNY+GN NLH+ R H+ IIIGS+VGA+VLLLATV+SCL +HKGK+ Y+K+
Sbjct: 510 SKDLILNYSGNTNLHKQSRIKSHMYIIIGSAVGASVLLLATVISCLVIHKGKRRYYEKDH 569
Query: 569 HRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI 628
++P QRP S +D PAEAAHCF+L++IE AT EK+IGSGGFG+VYYGKLK+GKEI
Sbjct: 570 IVSAVPTQRPDSWKSDDPAEAAHCFSLAEIETATNNFEKRIGSGGFGIVYYGKLKEGKEI 629
Query: 629 AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL 688
AVKVL +NSYQGKREF+NEVTLLSRIHHRNLVQ +GYC+EE S+LVYEFMHNGTLKEHL
Sbjct: 630 AVKVLRNNSYQGKREFSNEVTLLSRIHHRNLVQLIGYCREEENSILVYEFMHNGTLKEHL 689
Query: 689 YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 748
YGTL H + INWIKRLEIAEDAAKGIEYLHTGCVP +IHRDLK+SNILLD+ MRAKVSDF
Sbjct: 690 YGTLEHGRSINWIKRLEIAEDAAKGIEYLHTGCVPVVIHRDLKTSNILLDRQMRAKVSDF 749
Query: 749 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808
GLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE
Sbjct: 750 GLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 809
Query: 809 KFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI 868
FG +CRNIVQWAKLHIESGDIQGIIDP L YD+QSMWKI EKALMCV PHG MRPSI
Sbjct: 810 SFGLHCRNIVQWAKLHIESGDIQGIIDPLLGSNYDLQSMWKIAEKALMCVQPHGDMRPSI 869
Query: 869 SEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDESIVRP 926
SEVLK+IQDAI IE+EA R+GNSD+ SRNS SS+N+GS G E+FLS+DESI +P
Sbjct: 870 SEVLKEIQDAISIEKEAETLREGNSDEASRNSFQSSMNIGSMDLGRAESFLSIDESIAQP 929
Query: 927 SAR 929
+AR
Sbjct: 930 TAR 932
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440057|ref|XP_004137801.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] gi|449524194|ref|XP_004169108.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1435 bits (3714), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 690/910 (75%), Positives = 784/910 (86%), Gaps = 30/910 (3%)
Query: 23 DSSSAQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFP 82
D S AQMPGFVSL+CGG E+FTD+IGL+W D + +GE NISVANETRKQYMTLRHFP
Sbjct: 15 DVSFAQMPGFVSLDCGGQESFTDDIGLEWDPDTQVRFGEAVNISVANETRKQYMTLRHFP 74
Query: 83 ADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEV 142
ADSRKYCY L+V +RTRYL+RATFLYGNFDNNNVYPKFDISLG THWSTIVISDA TIEV
Sbjct: 75 ADSRKYCYSLNVTSRTRYLLRATFLYGNFDNNNVYPKFDISLGATHWSTIVISDANTIEV 134
Query: 143 RELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGAD 202
RELIFLAS+P + VCLSNATTGQPFISTLELRQFNGS Y T FED++YLSVSARINFGAD
Sbjct: 135 RELIFLASTPTVSVCLSNATTGQPFISTLELRQFNGSAYYTQFEDQFYLSVSARINFGAD 194
Query: 203 SEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAV 262
SEAPVRYPDDPFDR+WESDS++KANYLVDVAAGTEKVSTKLPID+ DE PPQKVMQTAV
Sbjct: 195 SEAPVRYPDDPFDRMWESDSVRKANYLVDVAAGTEKVSTKLPIDVDRDERPPQKVMQTAV 254
Query: 263 VGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQEN 322
VG NGSLTYRLNLDGFPGFGWAVTYFAEIEDL P ++RKFRLVLPG P++SKA+VNI+EN
Sbjct: 255 VGRNGSLTYRLNLDGFPGFGWAVTYFAEIEDLGPTDTRKFRLVLPGMPEISKAVVNIEEN 314
Query: 323 AQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVS 382
AQGKYR+YEPG+TN++LPFVLSF+FGKT DSS GPLLNAMEINKYLE++DGS+DG + S
Sbjct: 315 AQGKYRLYEPGFTNITLPFVLSFRFGKTQDSSLGPLLNAMEINKYLEKSDGSLDGAVVAS 374
Query: 383 VISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSL 442
VIS + S+DW EGGDPC+PVPWSWLQCNSDPQP I I LS +NL+GNIP+D+ KLS L
Sbjct: 375 VISKFPSSDW-DEGGDPCMPVPWSWLQCNSDPQPRIIKISLSKQNLSGNIPTDIAKLSGL 433
Query: 443 VELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 501
VE L+ N LTG +P + P+LR +++++N MLSG
Sbjct: 434 VEFHLENNQLTGELPSSLASLPNLRELYVQNN------------------------MLSG 469
Query: 502 TVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKK 561
TVPS LLSKN+V++Y+GNINLHEGG+ H+ II+GS +GA VLLLATVVSC F+HKG++
Sbjct: 470 TVPSGLLSKNLVVDYSGNINLHEGGK-KNHVYIIVGSVIGAVVLLLATVVSCYFLHKGRR 528
Query: 562 NNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK 621
++++ SL VQR VSS DA E AHCF++++I ATK E+KIGSGGFGVVYYGK
Sbjct: 529 RYHEQDLPEESLAVQRFVSSKGDASKETAHCFSVNEIVQATKDFERKIGSGGFGVVYYGK 588
Query: 622 LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681
L DGKEIAVKVLTSNS+QG+REF NEVTLLSRIHHRNLVQFLGYCQE+ RS+L+YEFMHN
Sbjct: 589 LNDGKEIAVKVLTSNSFQGRREFANEVTLLSRIHHRNLVQFLGYCQEQDRSMLIYEFMHN 648
Query: 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 741
GTLKEHLYG LT E+ I+WIKRLEIAEDAA+G+EYLHTGC+PAIIHRDLKSSNILLD+HM
Sbjct: 649 GTLKEHLYGPLTREKTISWIKRLEIAEDAARGVEYLHTGCIPAIIHRDLKSSNILLDRHM 708
Query: 742 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
+AKVSDFGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG
Sbjct: 709 KAKVSDFGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 768
Query: 802 QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPH 861
QEAISN FGANCRNIVQWAKLHIESGDIQGIIDPSL +EYDIQSMWKI EKALMCV +
Sbjct: 769 QEAISNVNFGANCRNIVQWAKLHIESGDIQGIIDPSLRNEYDIQSMWKIAEKALMCVQAN 828
Query: 862 GHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGSFG--GTENFLSL 919
GH+RPSISEVLK+IQD+I+IERE+ A ++GNSDDMSRNS+H SLN+GS G EN++S
Sbjct: 829 GHLRPSISEVLKEIQDSILIERESTATKEGNSDDMSRNSVH-SLNMGSLDLCGNENYVSF 887
Query: 920 DESIVRPSAR 929
DESI RP+AR
Sbjct: 888 DESIARPTAR 897
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545961|ref|XP_003541401.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1434 bits (3712), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 703/905 (77%), Positives = 773/905 (85%), Gaps = 32/905 (3%)
Query: 27 AQMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADSR 86
AQMPGFVSL+CGG ENFTDEIGL W D L YGEISNISVANETRKQY LRHFPADSR
Sbjct: 28 AQMPGFVSLDCGGKENFTDEIGLNWTPDK-LRYGEISNISVANETRKQYTALRHFPADSR 86
Query: 87 KYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVRELI 146
KYCY LDV++RTRYL+RA+FLYGNFD NNVYPKFDI +G THWSTIVISDA TIE+RELI
Sbjct: 87 KYCYTLDVVSRTRYLLRASFLYGNFDANNVYPKFDIFIGATHWSTIVISDANTIEMRELI 146
Query: 147 FLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEAP 206
FLA SP + VCLSNATTG+PFISTLELRQFNGSVY T E+ +YLSVSARINFGADS+AP
Sbjct: 147 FLALSPTVSVCLSNATTGKPFISTLELRQFNGSVYYTYTEEHFYLSVSARINFGADSDAP 206
Query: 207 VRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTN 266
+RYPDDPFDRIWESDS+KKANYLVDVAAGT K+ST ID+ SDE+PP KVMQTAVVGTN
Sbjct: 207 IRYPDDPFDRIWESDSVKKANYLVDVAAGTRKISTNKSIDVNSDEMPPMKVMQTAVVGTN 266
Query: 267 GSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGK 326
GSLTYRLNLDGFPGF WA TYFAEIEDL +ESRKFRLVLPG D+SKA+VNI+ENA GK
Sbjct: 267 GSLTYRLNLDGFPGFAWAFTYFAEIEDLAENESRKFRLVLPGHSDISKAVVNIEENAPGK 326
Query: 327 YRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISL 386
YR+YEPGYTNLSLPFVLSF+FGKT DSSRGPLLNAMEIN+YLE+NDGS DG I SV+S
Sbjct: 327 YRLYEPGYTNLSLPFVLSFRFGKTSDSSRGPLLNAMEINEYLEKNDGSPDGEVISSVLSH 386
Query: 387 YSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELW 446
Y SADWAQEGGDPCLPVPWSW++C+SD QP I I LSSKNLTGNIP D+TKL+ LVEL
Sbjct: 387 YFSADWAQEGGDPCLPVPWSWVRCSSDQQPKIISILLSSKNLTGNIPLDITKLTGLVEL- 445
Query: 447 LDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS 506
HLE+NQLTG L +SL NLPNLRELYVQNNMLSGTVPS
Sbjct: 446 ----------------------HLENNQLTGALSTSLANLPNLRELYVQNNMLSGTVPSD 483
Query: 507 LLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDK 566
LLSK++ LNY GN NLH+G R HL +IIGS+VGAAVLL+AT++SCL M KGK Y++
Sbjct: 484 LLSKDLDLNYTGNTNLHKGSRKKSHLYVIIGSAVGAAVLLVATIISCLVMRKGKTKYYEQ 543
Query: 567 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGK 626
S P Q SS + P+E AHCF+ S+IE++T EKKIGSGGFGVVYYGKLKDGK
Sbjct: 544 NS-LVSHPSQSMDSSKSIGPSEVAHCFSFSEIENSTNNFEKKIGSGGFGVVYYGKLKDGK 602
Query: 627 EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 686
EIAVKVLTSNSYQGKREF+NEVTLLSRIHHRNLVQ LGYC+EEG S+L+YEFMHNGTLKE
Sbjct: 603 EIAVKVLTSNSYQGKREFSNEVTLLSRIHHRNLVQLLGYCREEGNSMLIYEFMHNGTLKE 662
Query: 687 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746
HLYG LTH + INW+KRLEIAED+AKGIEYLHTGCVPA+IHRDLKSSNILLDKHMRAKVS
Sbjct: 663 HLYGPLTHGRSINWMKRLEIAEDSAKGIEYLHTGCVPAVIHRDLKSSNILLDKHMRAKVS 722
Query: 747 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806
DFGLSK AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSD+YSFGVILLELISGQEAIS
Sbjct: 723 DFGLSKLAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDIYSFGVILLELISGQEAIS 782
Query: 807 NEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP 866
N+ FGANCRNIVQWAKLHIESGDIQGIIDP L + YD+QSMWKI EKALMCV PHGHMRP
Sbjct: 783 NDSFGANCRNIVQWAKLHIESGDIQGIIDPVLQNNYDLQSMWKIAEKALMCVQPHGHMRP 842
Query: 867 SISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDESIV 924
SISEVLK+IQDAI IEREA +GNSD+ RNS+HSS+N+GS TEN+LS+DESI
Sbjct: 843 SISEVLKEIQDAIAIEREA----EGNSDE-PRNSVHSSINMGSMDLAATENYLSIDESIA 897
Query: 925 RPSAR 929
+P AR
Sbjct: 898 QPIAR 902
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 929 | ||||||
| TAIR|locus:2057991 | 934 | AT2G37050 [Arabidopsis thalian | 0.969 | 0.964 | 0.705 | 0.0 | |
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.964 | 0.964 | 0.468 | 1.3e-217 | |
| TAIR|locus:2055165 | 868 | AT2G14510 [Arabidopsis thalian | 0.454 | 0.486 | 0.386 | 1.3e-126 | |
| TAIR|locus:2066158 | 884 | AT2G28990 [Arabidopsis thalian | 0.642 | 0.675 | 0.357 | 1.7e-124 | |
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.462 | 0.490 | 0.370 | 1.9e-123 | |
| TAIR|locus:2066163 | 872 | AT2G29000 [Arabidopsis thalian | 0.455 | 0.485 | 0.395 | 1.7e-122 | |
| TAIR|locus:2047675 | 881 | AT2G19210 [Arabidopsis thalian | 0.452 | 0.476 | 0.368 | 5.8e-122 | |
| TAIR|locus:2066133 | 880 | AT2G28960 [Arabidopsis thalian | 0.456 | 0.481 | 0.382 | 3.2e-121 | |
| TAIR|locus:2078171 | 883 | AT3G46400 [Arabidopsis thalian | 0.460 | 0.484 | 0.358 | 3.6e-120 | |
| TAIR|locus:2059093 | 876 | FRK1 "FLG22-induced receptor-l | 0.460 | 0.488 | 0.384 | 9.5e-120 |
| TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3387 (1197.3 bits), Expect = 0., P = 0.
Identities = 643/912 (70%), Positives = 747/912 (81%)
Query: 28 QMPGFVSLNCGGNENFTDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPADSRK 87
Q PGFVSL+CGG E FTDE+GL+W D+HLIYGE +NIS NETR QY TLRHFPADSRK
Sbjct: 24 QAPGFVSLDCGGAEPFTDELGLKWSPDNHLIYGETANISSVNETRTQYTTLRHFPADSRK 83
Query: 88 YCYKLDVITRTRYLIRATFLYGNFDN-NNVYPKFDISLGPTHWSTIVISDAATIEVRELI 146
YCY L+V +R RYLIRATFLYGNFDN NNVYPKFDISLG THW+TIVIS+ IE EL+
Sbjct: 84 YCYTLNVTSRNRYLIRATFLYGNFDNSNNVYPKFDISLGATHWATIVISETYIIETAELV 143
Query: 147 FLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPF-EDRYYLSVSARINFGADSEA 205
FLASSP + VCLSNATTGQPFISTLELRQ +GS+Y + EDR+YLSV+ARINFGA+SEA
Sbjct: 144 FLASSPTVSVCLSNATTGQPFISTLELRQLSGSMYGSMLSEDRFYLSVAARINFGAESEA 203
Query: 206 PVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGT 265
VRYPDDP+DRIWESD KK NYLVDVAAGT +VST LPI+ R D+ PPQKVMQTAVVGT
Sbjct: 204 SVRYPDDPYDRIWESDLQKKPNYLVDVAAGTVRVSTTLPIESRVDDRPPQKVMQTAVVGT 263
Query: 266 NGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQG 325
NGSLTYR+NLDGFPGFGWA TYFAEIEDL DESRKFRLVLP QP+ SK++VNI+EN Q
Sbjct: 264 NGSLTYRMNLDGFPGFGWAFTYFAEIEDLAEDESRKFRLVLPEQPEYSKSVVNIKENTQR 323
Query: 326 KYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVIS 385
YRVY PGY N++LPFVL+F+F KT DSSRGP+LNAMEI+KYL ++DGS+D + +V S
Sbjct: 324 PYRVYAPGYPNITLPFVLNFRFAKTADSSRGPILNAMEISKYLRKSDGSVDATVMANVAS 383
Query: 386 LYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVEL 445
LYSS +WAQEGGDPC P PWSW+QCNSDPQP + I LSS NLTGNIPSDL KL+ LVEL
Sbjct: 384 LYSSTEWAQEGGDPCSPSPWSWVQCNSDPQPRVVAIKLSSMNLTGNIPSDLVKLTGLVEL 443
Query: 446 WLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSGTVPS 505
WLDGNS TGPIPDFS CP+L IIHLE+N+LTG +ELY+QNN+L+GT+PS
Sbjct: 444 WLDGNSFTGPIPDFSRCPNLEIIHLENNRLTGKIPSSLTKLPNLKELYLQNNVLTGTIPS 503
Query: 506 SLLSKNVVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCLFMHKGKKNNY- 564
L +K+V+ N++GN+NL + G K L +II C+ M K KKNN
Sbjct: 504 DL-AKDVISNFSGNLNLEKSGDKGKKLGVIIGASVGAFVLLIATIISCIVMCKSKKNNKL 562
Query: 565 ---DKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK 621
E LP+QR S+L++A +AAHCFTL +IE+ATK EK+IGSGGFG+VYYGK
Sbjct: 563 GKTSAELTNRPLPIQRVSSTLSEAHGDAAHCFTLYEIEEATKKFEKRIGSGGFGIVYYGK 622
Query: 622 LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681
++GKEIAVKVL +NSYQGKREF NEVTLLSRIHHRNLVQFLGYCQEEG+++LVYEFMHN
Sbjct: 623 TREGKEIAVKVLANNSYQGKREFANEVTLLSRIHHRNLVQFLGYCQEEGKNMLVYEFMHN 682
Query: 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 741
GTLKEHLYG + ++RI+WIKRLEIAEDAA+GIEYLHTGCVPAIIHRDLK+SNILLDKHM
Sbjct: 683 GTLKEHLYGVVPRDRRISWIKRLEIAEDAARGIEYLHTGCVPAIIHRDLKTSNILLDKHM 742
Query: 742 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
RAKVSDFGLSKFAVDG SHVSSIVRGTVGYLDPEYYISQQLT+KSDVYSFGVILLEL+SG
Sbjct: 743 RAKVSDFGLSKFAVDGTSHVSSIVRGTVGYLDPEYYISQQLTEKSDVYSFGVILLELMSG 802
Query: 802 QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL-DEYDIQSMWKIEEKALMCVLP 860
QEAISNE FG NCRNIVQWAK+HI++GDI+GIIDP+L D+Y +QSMWKI EKAL+CV P
Sbjct: 803 QEAISNESFGVNCRNIVQWAKMHIDNGDIRGIIDPALAEDDYSLQSMWKIAEKALLCVKP 862
Query: 861 HGHMRPSISEVLKDIQXXXXXXXXXXXXXXGNSDDMSRNSLHSS-LNVG--SFGGTENFL 917
HG+MRPS+SEV KDIQ G SD+ SR+S HSS LN+G G+++++
Sbjct: 863 HGNMRPSMSEVQKDIQDAIRIEKEALAARGGISDEFSRSSAHSSSLNMGMLDLAGSQSYV 922
Query: 918 SLDESIVRPSAR 929
S+DES+++P+AR
Sbjct: 923 SIDESVLQPTAR 934
|
|
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2102 (745.0 bits), Expect = 1.3e-217, P = 1.3e-217
Identities = 428/914 (46%), Positives = 574/914 (62%)
Query: 28 QMPGFVSLNCGGNENFTD-EIGLQWIADDHLI-YGEISNISVANETRKQYMTLRHFPADS 85
Q+ FVS++CG + N+TD GL W++D +I G+ ++ N QY R FP D+
Sbjct: 22 QVTEFVSIDCGCSSNYTDPRTGLGWVSDSEIIKQGKPVTLANTNWNSMQYRRRRDFPTDN 81
Query: 86 RKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVISDAATIEVREL 145
+KYCY+L R RY++R TFLYG + YPKF + L T W+T+ I + + + V EL
Sbjct: 82 KKYCYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKWATVTIQEVSRVYVEEL 141
Query: 146 IFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFGADSEA 205
I A+S +DVC+ A TG PF+STLELR N S+Y T +ED ++L V+AR+NFGA +
Sbjct: 142 IVRATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNFFLKVAARVNFGAPNMD 201
Query: 206 PVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGT 265
+RYPDDP+DRIWESD K+ NYLV VA GT +++T I+ + E PP KVMQTAVVGT
Sbjct: 202 ALRYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTREYPPMKVMQTAVVGT 261
Query: 266 NGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQG 325
G ++YRLNL+ FP A YFAEIE+L +E+RKF+LV P PD S A+VNI ENA G
Sbjct: 262 QGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDYSNAVVNIAENANG 321
Query: 326 KYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLE---RNDGSIDGVAIVS 382
Y +YEP Y N++L FVL+F FGKT DS++GPLLNA+EI+KYL + D S V+++
Sbjct: 322 SYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISVKTDRS--DVSVLD 379
Query: 383 VI-SLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSS 441
I S+ +DWA EGGDPC+PV WSW+ C+S P +T I LS KNL G IP + + +
Sbjct: 380 AIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLRGEIPPGINYMEA 439
Query: 442 LVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSG 501
L ELWLD N LTG +PD S +L+I+HLE+NQL+G +EL ++NN G
Sbjct: 440 LTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNLQELSIENNSFKG 499
Query: 502 TVPSSLLSKNVVLNYAGNINLHEGGRGAKH----LNIIIXXXXXXXXXXXXXXXXCLFMH 557
+PS+LL V+ Y N L + KH L I I +
Sbjct: 500 KIPSALLKGKVLFKYNNNPELQNEAQ-RKHFWQILGISIAAVAILLLLVGGSLVLLCALR 558
Query: 558 KGKK-NNYDK-EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFG 615
K K+ + D E + L V + A+ +L +E+AT KK+G G FG
Sbjct: 559 KTKRADKGDSTETKKKGLVAYSAVRGGHLLDEGVAYFISLPVLEEATDNFSKKVGRGSFG 618
Query: 616 VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675
VYYG++KDGKE+AVK+ S R+F EV LLSRIHHRNLV +GYC+E R +LV
Sbjct: 619 SVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIGYCEEADRRILV 678
Query: 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 735
YE+MHNG+L +HL+G+ ++ ++W+ RL+IA+DAAKG+EYLHTGC P+IIHRD+KSSNI
Sbjct: 679 YEYMHNGSLGDHLHGSSDYKP-LDWLTRLQIAQDAAKGLEYLHTGCNPSIIHRDVKSSNI 737
Query: 736 LLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVIL 795
LLD +MRAKVSDFGLS+ + +HVSS+ +GTVGYLDPEYY SQQLT+KSDVYSFGV+L
Sbjct: 738 LLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEKSDVYSFGVVL 797
Query: 796 LELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKAL 855
EL+SG++ +S E FG NIV WA+ I GD+ GIIDP + I+S+W++ E A
Sbjct: 798 FELLSGKKPVSAEDFGPEL-NIVHWARSLIRKGDVCGIIDPCIASNVKIESVWRVAEVAN 856
Query: 856 MCVLPHGHMRPSISEVLKDIQXXXXXXXXXXXXXXGNSDDMSRNSLHSSLNVGSFGGTEN 915
CV GH RP + EV+ IQ +S S+ + SF E+
Sbjct: 857 QCVEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSKAQSSRKTLLTSFLELES 916
Query: 916 FLSLDESIVRPSAR 929
+ + + P+AR
Sbjct: 917 -PDISRNSLAPAAR 929
|
|
| TAIR|locus:2055165 AT2G14510 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 743 (266.6 bits), Expect = 1.3e-126, Sum P(2) = 1.3e-126
Identities = 172/445 (38%), Positives = 250/445 (56%)
Query: 435 DLTKLSSLVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELY 493
D++ ++ L L + LTG I P LR + L +N LTG ++
Sbjct: 406 DISTPPRIISLDLSLSGLTGVISPSIQNLTMLRELDLSNNNLTGEVPEFLATIKPLLVIH 465
Query: 494 VQNNMLSGTVPSSLLS--KNVVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXX 551
++ N L G+VP +L KN L + N+ G+ ++
Sbjct: 466 LRGNNLRGSVPQALQDREKNDGLKLFVDPNITRRGKHQPKSWLVAIVASISCVAVTIIVL 525
Query: 552 XCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGS 611
+F+ + +K++ K V RP + + F S++++ T E +G
Sbjct: 526 VLIFIFRRRKSSTRK--------VIRPSLEMKNRR------FKYSEVKEMTNNFEVVLGK 571
Query: 612 GGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 671
GGFGVVY+G L + +++AVKVL+ +S QG +EF EV LL R+HH NLV +GYC E
Sbjct: 572 GGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDEGID 630
Query: 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 731
L+YEFM NG LKEHL G +NW RL+IA ++A GIEYLH GC P ++HRD+K
Sbjct: 631 LALIYEFMENGNLKEHLSGKRGGSV-LNWSSRLKIAIESALGIEYLHIGCQPPMVHRDVK 689
Query: 732 SSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYS 790
S+NILL AK++DFGLS+ F V +HVS+ V GT+GYLDPEYY+ LT+KSDVYS
Sbjct: 690 STNILLGLRFEAKLADFGLSRSFLVGSQAHVSTNVAGTLGYLDPEYYLKNWLTEKSDVYS 749
Query: 791 FGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 850
FG++LLE I+GQ I + + IV+WAK + +GDI+ I+DP+L +YD S WK
Sbjct: 750 FGIVLLESITGQPVIEQSR---DKSYIVEWAKSMLANGDIESIMDPNLHQDYDSSSSWKA 806
Query: 851 EEKALMCVLPHGHMRPSISEVLKDI 875
E A++C+ P RP+++ V ++
Sbjct: 807 LELAMLCINPSSTQRPNMTRVAHEL 831
|
|
| TAIR|locus:2066158 AT2G28990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 893 (319.4 bits), Expect = 1.7e-124, Sum P(2) = 1.7e-124
Identities = 238/665 (35%), Positives = 358/665 (53%)
Query: 239 VSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTY--FAEIEDLDP 296
++T L I+ + P+ ++QTA + N S + D P Y FAEI+ L+
Sbjct: 224 ITTDLNINNSNAYEIPKNILQTAAIPRNASAPLIITWDPLPINAEVYLYMHFAEIQTLEA 283
Query: 297 DESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVY--EP---GYTNLSLPFVLSFKFGKTY 351
+E+R+F ++L G + S + +Y EP G L V KT
Sbjct: 284 NETRQFDVILRGNFNHS----GFSPTKLKVFTLYTEEPMKCGSEGCYLQLV------KTP 333
Query: 352 DSSRGPLLNAMEINKYLERN--DGSIDGV-AIVSVISLY--SSADWAQEGGDPCLPVPWS 406
+S+ PL+NA+E +E + + S+ V AI ++ + Y + W GDPCLP S
Sbjct: 334 NSTLPPLINAIEAYSVIEFSQLETSLSDVDAIKNIKNTYKLNKITWQ---GDPCLPQDLS 390
Query: 407 W--LQC---NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG 461
W ++C + P+I + LS L G+IP L + L EL L NSLTGP+P F
Sbjct: 391 WESIRCTYVDGSTSPTIISLDLSKSGLNGSIPQILQNFTQLQELDLSNNSLTGPVPIFLA 450
Query: 462 CPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSGTVPSSLLSKN---VVLNYAG 518
+++ + L + L+G NN LSG+VP +LL K +VL G
Sbjct: 451 --NMKTLSLIN--LSG------------------NN-LSGSVPQALLDKEKEGLVLKLEG 487
Query: 519 NINLHEGG--RGAKHLNIIIXXXXXXXXXXXXXXXXCLFMHKGKKNNYDKEQHRH-SLPV 575
N +L + K ++ LF KK H S+PV
Sbjct: 488 NPDLCKSSFCNTEKKNKFLLPVIASAASLVIVVVVVALFFVFRKKKASPSNLHAPPSMPV 547
Query: 576 QRPV-SSLNDAPAEAAHC-FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL 633
P +S +++ + FT S++++ T +K +G GGFGVVY+G + +++AVK+L
Sbjct: 548 SNPGHNSQSESSFTSKKIRFTYSEVQEMTNNFDKALGEGGFGVVYHGFVNVIEQVAVKLL 607
Query: 634 TSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT 693
+ +S QG + F EV LL R+HH NLV +GYC E L+YE+M NG LK+HL G
Sbjct: 608 SQSSSQGYKHFKAEVELLMRVHHINLVSLVGYCDEGEHLALIYEYMPNGDLKQHLSGK-- 665
Query: 694 HEQRI-NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
H + +W RL+I DAA G+EYLHTGCVP ++HRD+K++NILLD+H++AK++DFGLS+
Sbjct: 666 HGGFVLSWESRLKIVLDAALGLEYLHTGCVPPMVHRDIKTTNILLDQHLQAKLADFGLSR 725
Query: 753 -FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 811
F + +VS++V GT GYLDPEYY + LT+KSD+YSFG++LLE+IS + I +
Sbjct: 726 SFPIGNEKNVSTVVAGTPGYLDPEYYQTNWLTEKSDIYSFGIVLLEIISNRPIIQQSR-- 783
Query: 812 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV 871
+IV+W I GD++ I+DP+L +YDI S+WK E A+ CV RP++S V
Sbjct: 784 -EKPHIVEWVSFMITKGDLRSIMDPNLHQDYDIGSVWKAIELAMSCVSLSSARRPNMSRV 842
Query: 872 LKDIQ 876
+ +++
Sbjct: 843 VNELK 847
|
|
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 763 (273.6 bits), Expect = 1.9e-123, Sum P(2) = 1.9e-123
Identities = 168/454 (37%), Positives = 263/454 (57%)
Query: 434 SDLTKLSSLVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXREL 492
SD + L L + LTG I P F+ + + L +N LTG EL
Sbjct: 403 SDNNTSPKSIALNLSSSGLTGQIDPAFANLTSINKLDLSNNSLTGKVPDFLASLPNLTEL 462
Query: 493 YVQNNMLSGTVPSSLLSKN----VVLNYAGNINLHEGGR----GAKHLNIIIXXXXXXXX 544
++ N L+G++P+ LL K+ + L + GN +L + K + I+
Sbjct: 463 NLEGNKLTGSIPAKLLEKSKDGSLSLRFGGNPDLCQSPSCQTTTKKKIGYIVPVVASLAG 522
Query: 545 XXXXXXXXCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAA-HCFTLSDIEDATK 603
L H + K R ++ +P+ +N P + A F S++ + T
Sbjct: 523 LLIVLTALALIWH------FKKRSRRGTIS-NKPLG-VNTGPLDTAKRYFIYSEVVNITN 574
Query: 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
E+ +G GGFG VY+G L +G ++AVK+L+ S QG +EF EV LL R+HH NL +
Sbjct: 575 NFERVLGKGGFGKVYHGFL-NGDQVAVKILSEESTQGYKEFRAEVELLMRVHHTNLTSLI 633
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
GYC E+ L+YE+M NG L ++L G + ++W +RL+I+ DAA+G+EYLH GC P
Sbjct: 634 GYCNEDNHMALIYEYMANGNLGDYLSGKSS--LILSWEERLQISLDAAQGLEYLHYGCKP 691
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I+HRD+K +NILL+++++AK++DFGLS+ F V+G+S VS++V GT+GYLDPEYY ++Q+
Sbjct: 692 PIVHRDVKPANILLNENLQAKIADFGLSRSFPVEGSSQVSTVVAGTIGYLDPEYYATRQM 751
Query: 783 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 842
+KSDVYSFGV+LLE+I+G+ AI + + ++ + +GDI+GI+D L D +
Sbjct: 752 NEKSDVYSFGVVLLEVITGKPAIWHSR--TESVHLSDQVGSMLANGDIKGIVDQRLGDRF 809
Query: 843 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876
++ S WKI E AL C RP++S+V+ +++
Sbjct: 810 EVGSAWKITELALACASESSEQRPTMSQVVMELK 843
|
|
| TAIR|locus:2066163 AT2G29000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 767 (275.1 bits), Expect = 1.7e-122, Sum P(2) = 1.7e-122
Identities = 174/440 (39%), Positives = 243/440 (55%)
Query: 442 LVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLS 500
++ L L L G I P L + L N+L+G + + N L
Sbjct: 408 IISLDLSNRGLKGIIEPVLQNLTQLEKLDLSINRLSGEVPEFLANMKSLSNINLSWNNLK 467
Query: 501 GTVPSSLLSKN---VVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCLFMH 557
G +P +L K + LN GN NL G + + L +
Sbjct: 468 GLIPPALEEKRKNGLKLNTQGNQNLCPGDECKRSIPKFPVTTVVSISAILLTVVVLLIVF 527
Query: 558 KGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVV 617
KK K +HR LP+ + S + FT S++E T E+ IG GGFG+V
Sbjct: 528 IYKKKKTSKVRHR--LPITK--SEILTKKRR----FTYSEVEAVTNKFERVIGEGGFGIV 579
Query: 618 YYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677
Y+G L D +++AVK+L+ +S QG ++F EV LL R+HH NLV +GYC EE LVYE
Sbjct: 580 YHGHLNDTEQVAVKLLSHSSTQGYKQFKAEVELLLRVHHTNLVNLVGYCNEEDHLALVYE 639
Query: 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 737
+ NG LK+HL G + +NW RL IA + A+G+EYLH GC P +IHRD+K++NILL
Sbjct: 640 YAANGDLKQHLSGE-SSSAALNWASRLGIATETAQGLEYLHIGCEPPMIHRDVKTTNILL 698
Query: 738 DKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 796
D+H AK++DFGLS+ F V SHVS+ V GT GYLDPEYY + LT+KSDVYS G++LL
Sbjct: 699 DEHFHAKLADFGLSRSFPVGVESHVSTNVAGTPGYLDPEYYRTNWLTEKSDVYSMGIVLL 758
Query: 797 ELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALM 856
E+I+ Q I + +I +W L + GDI+ I+DP L EYD S+WK E A+
Sbjct: 759 EIITNQPVIQQVR---EKPHIAEWVGLMLTKGDIKSIMDPKLNGEYDSSSVWKALELAMS 815
Query: 857 CVLPHGHMRPSISEVLKDIQ 876
CV P RP++S+V+ +++
Sbjct: 816 CVNPSSGGRPTMSQVISELK 835
|
|
| TAIR|locus:2047675 AT2G19210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 723 (259.6 bits), Expect = 5.8e-122, Sum P(2) = 5.8e-122
Identities = 165/448 (36%), Positives = 254/448 (56%)
Query: 442 LVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLS 500
++ + L + LTG I FS L I+ L +N LTG EL ++ N LS
Sbjct: 415 IISVNLSSSGLTGEIDAAFSNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLS 474
Query: 501 GTVPSSLLSKN----VVLNYAGNINL------HEGGRGAKHLNIIIXXXXXXXXXXXXXX 550
G +P LL ++ ++L GN +L K II
Sbjct: 475 GAIPVKLLERSNKKLILLRIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVL 534
Query: 551 XXCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAA-HCFTLSDIEDATKMLEKKI 609
LF+ Y K++HR + P + + S++ T E+ +
Sbjct: 535 AIALFLL------Y-KKRHRRG-----GSGGVRAGPLDTTKRYYKYSEVVKVTNNFERVL 582
Query: 610 GSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE 669
G GGFG VY+G L D ++AVK+L+ +S QG +EF EV LL R+HH+NL +GYC E
Sbjct: 583 GQGGFGKVYHGVLNDD-QVAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEG 641
Query: 670 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRD 729
+ L+YEFM NGTL ++L G ++ ++W +RL+I+ DAA+G+EYLH GC P I+ RD
Sbjct: 642 KKMALIYEFMANGTLGDYLSGEKSYV--LSWEERLQISLDAAQGLEYLHNGCKPPIVQRD 699
Query: 730 LKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDV 788
+K +NIL+++ ++AK++DFGLS+ A+DG + ++ V GT+GYLDPEY+++Q+L++KSD+
Sbjct: 700 VKPANILINEKLQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDI 759
Query: 789 YSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMW 848
YSFGV+LLE++SGQ I+ + A +I L + +GDI+GI+DP L + +D S W
Sbjct: 760 YSFGVVLLEVVSGQPVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAW 819
Query: 849 KIEEKALMCVLPHGHMRPSISEVLKDIQ 876
KI E A+ C RP++S V+ +++
Sbjct: 820 KITEVAMACASSSSKNRPTMSHVVAELK 847
|
|
| TAIR|locus:2066133 AT2G28960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 728 (261.3 bits), Expect = 3.2e-121, Sum P(2) = 3.2e-121
Identities = 170/445 (38%), Positives = 241/445 (54%)
Query: 442 LVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLS 500
++ L L L G I P F +LR + L +N TG + + N L+
Sbjct: 410 IISLDLSSRGLKGVIAPAFQNLTELRKLDLSNNSFTGGVPEFLASMKSLSIINLNWNDLT 469
Query: 501 GTVPSSLLS--KN-VVLNYAGNINLHEGGRGAKHLN---II-IXXXXXXXXXXXXXXXXC 553
G +P LL KN + L GN L + N I+ +
Sbjct: 470 GPLPKLLLDREKNGLKLTIQGNPKLCNDASCKNNNNQTYIVPVVASVASVLIIIAVLILI 529
Query: 554 LFMHKGKKNNYDK-EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSG 612
L K + D +H LP RP S FT S++E T E+ +G G
Sbjct: 530 LVFKKRRPTQVDSLPTVQHGLP-NRP-SIFTQTKR-----FTYSEVEALTDNFERVLGEG 582
Query: 613 GFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672
GFGVVY+G L + IAVK+L+ +S QG +EF EV LL R+HH NLV +GYC EE
Sbjct: 583 GFGVVYHGILNGTQPIAVKLLSQSSVQGYKEFKAEVELLLRVHHVNLVSLVGYCDEESNL 642
Query: 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 732
L+YE+ NG LK+HL G + W RL+I + A+G+EYLHTGC P ++HRD+K+
Sbjct: 643 ALLYEYAPNGDLKQHLSGERGGSP-LKWSSRLKIVVETAQGLEYLHTGCKPPMVHRDVKT 701
Query: 733 SNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 791
+NILLD+H +AK++DFGLS+ F V G +HVS+ V GT GYLDPEYY + +L +KSDVYSF
Sbjct: 702 TNILLDEHFQAKLADFGLSRSFPVGGETHVSTAVAGTPGYLDPEYYRTNRLNEKSDVYSF 761
Query: 792 GVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIE 851
G++LLE+I+ + I + +I W + GDI+ ++DP L +Y+ S+WK
Sbjct: 762 GIVLLEIITSRPVIQQTR---EKPHIAAWVGYMLTKGDIENVVDPRLNRDYEPTSVWKAL 818
Query: 852 EKALMCVLPHGHMRPSISEVLKDIQ 876
E A+ CV P RP++S+V +++
Sbjct: 819 EIAMSCVNPSSEKRPTMSQVTNELK 843
|
|
| TAIR|locus:2078171 AT3G46400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 709 (254.6 bits), Expect = 3.6e-120, Sum P(2) = 3.6e-120
Identities = 158/441 (35%), Positives = 242/441 (54%)
Query: 442 LVELWLDGNSLTGPIPDFSGCPDLRIIH---LEDNQLTGXXXXXXXXXXXXRELYVQNNM 498
+ L L + L G IP SG + ++ L +N LTG + ++ N
Sbjct: 413 ITSLNLSSSGLVGTIP--SGIQNFTLLEKLDLSNNNLTGLVPEFLAKMETLLFIDLRKNK 470
Query: 499 LSGTVPSSLLS--KNVVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCLFM 556
L+G++P++L K + + N ++I +F+
Sbjct: 471 LNGSIPNTLRDREKKGLQIFVDGDNTCLSCVPKNKFPMMIAALAASAIVVAILVLILIFV 530
Query: 557 HKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGV 616
KK + E ++ + S + F S++ + TK EK +G GGFG+
Sbjct: 531 FTKKKWSTHMEVILPTMDIMSKTISEQLIKTKRRR-FAYSEVVEMTKKFEKALGEGGFGI 589
Query: 617 VYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676
VY+G LK+ +++AVKVL+ +S QG + F EV LL R+HH NLV +GYC E+ L+Y
Sbjct: 590 VYHGYLKNVEQVAVKVLSQSSSQGYKHFKAEVELLLRVHHINLVSLVGYCDEKDHLALIY 649
Query: 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 736
E+M NG LK+HL G + + W RL+IA D A G+EYLH GC P+++HRD+KS+NIL
Sbjct: 650 EYMPNGDLKDHLSGK-QGDSVLEWTTRLQIAVDVALGLEYLHYGCRPSMVHRDVKSTNIL 708
Query: 737 LDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVIL 795
LD AK++DFGLS+ F V S +S++V GT GYLDPEYY + +L + SDVYSFG++L
Sbjct: 709 LDDQFMAKIADFGLSRSFKVGDESEISTVVAGTPGYLDPEYYRTSRLAEMSDVYSFGIVL 768
Query: 796 LELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKAL 855
LE+I+ Q + G +I +W + GDI I+DP+L EY+ +S+W+ E A+
Sbjct: 769 LEIITNQRVFDQAR-GKI--HITEWVAFMLNRGDITRIVDPNLHGEYNSRSVWRAVELAM 825
Query: 856 MCVLPHGHMRPSISEVLKDIQ 876
C P RP++S+V+ +++
Sbjct: 826 SCANPSSEYRPNMSQVVIELK 846
|
|
| TAIR|locus:2059093 FRK1 "FLG22-induced receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 726 (260.6 bits), Expect = 9.5e-120, Sum P(2) = 9.5e-120
Identities = 175/455 (38%), Positives = 259/455 (56%)
Query: 432 IPSDLTKLSSLVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXR 490
I SD T +V L + + L G I P FS +R + L N LTG
Sbjct: 406 IQSDNTTNPRVVSLNISFSELRGQIDPAFSNLTSIRKLDLSGNTLTGEIPAFLANLPNLT 465
Query: 491 ELYVQNNMLSGTVPSSL--LSKN--VVLNYAGNINL----HEGGRGAKHLNIIIXXXXXX 542
EL V+ N L+G VP L SKN + L + N +L K+ N I
Sbjct: 466 ELNVEGNKLTGIVPQRLHERSKNGSLSLRFGRNPDLCLSDSCSNTKKKNKNGYIIPLVVV 525
Query: 543 XXXXXXXXXXCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDAT 602
LF + K+Q R +L +R N A F S++ + T
Sbjct: 526 GIIVVLLTALALF------RRFKKKQQRGTLG-ER-----NGPLKTAKRYFKYSEVVNIT 573
Query: 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 662
E+ IG GGFG VY+G + +G+++AVKVL+ S QG +EF EV LL R+HH NL
Sbjct: 574 NNFERVIGKGGFGKVYHGVI-NGEQVAVKVLSEESAQGYKEFRAEVDLLMRVHHTNLTSL 632
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+GYC E VL+YE+M N L ++L G + ++W +RL+I+ DAA+G+EYLH GC
Sbjct: 633 VGYCNEINHMVLIYEYMANENLGDYLAGKRSFI--LSWEERLKISLDAAQGLEYLHNGCK 690
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
P I+HRD+K +NILL++ ++AK++DFGLS+ F+V+G+ +S++V G++GYLDPEYY ++Q
Sbjct: 691 PPIVHRDVKPTNILLNEKLQAKMADFGLSRSFSVEGSGQISTVVAGSIGYLDPEYYSTRQ 750
Query: 782 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841
+ +KSDVYS GV+LLE+I+GQ AI++ K +I + + +GDI+GI+D L +
Sbjct: 751 MNEKSDVYSLGVVLLEVITGQPAIASSK--TEKVHISDHVRSILANGDIRGIVDQRLRER 808
Query: 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876
YD+ S WK+ E AL C RP++S+V+ +++
Sbjct: 809 YDVGSAWKMSEIALACTEHTSAQRPTMSQVVMELK 843
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_280116 | hypothetical protein (924 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 929 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 3e-89 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-44 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-35 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-32 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-31 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-30 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-28 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-27 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-19 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-07 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 286 bits (735), Expect = 3e-89
Identities = 126/352 (35%), Positives = 180/352 (51%), Gaps = 36/352 (10%)
Query: 35 LNCG--GNENFTDEI-GLQWIADDHLIY-GEISNISVANETR---KQYMTLRHFPADSRK 87
++CG NE++TD G+ W++D I G+ NIS N + K Y TLR FP D ++
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSDAGFIDTGKSGNISKENSSSFLSKPYKTLRSFP-DGKR 59
Query: 88 YCYKLDVIT--RTRYLIRATFLYGNFDNNN---VYPKFDISLGPTHWSTIVISDAA--TI 140
CY L V T+YLIRATFLYGN+D N P FD+ LG W+T+ +S+ + ++
Sbjct: 60 NCYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGDSV 119
Query: 141 EVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYLTPFEDRYYLSVSARINFG 200
+I + S + VCL N TG PFIS LELR S+Y + L + AR+NFG
Sbjct: 120 VKEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSGGS-QALKLVARLNFG 178
Query: 201 ADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSD---ELPPQKV 257
+RYPDD +DRIWE + G ++ST L +D+ S+ +PP V
Sbjct: 179 GSEGT-IRYPDDVYDRIWEPFF---------SSPGWSQISTSLSVDISSNNAPYIPPSAV 228
Query: 258 MQTAVVGTNGSLTYRLNLD-GFPGFG-WAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKA 315
+QTAV TN S D P F + +FAEI+ L E+R+F + + G+
Sbjct: 229 LQTAVTPTNASAPLNFTWDLVDPNFEYYVYLHFAEIQSL---ETREFDIYINGKTVYGD- 284
Query: 316 IVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKY 367
V+ + +Y N+S +L+ T S+ PLLNA+EI K
Sbjct: 285 -VSPKYLGTDTGALYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 3e-50
Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 13/206 (6%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGK-----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 658
L KK+G G FG VY GKLK E+AVK L + S Q EF E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+V+ LG C EE +V E+M G L +L + +++ L A A+G+EYL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
+ IHRDL + N L+ +++ K+SDFGLS+ D + + + ++ PE
Sbjct: 120 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 779 SQQLTDKSDVYSFGVILLELIS-GQE 803
+ T KSDV+SFGV+L E+ + G++
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQ 202
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 5e-50
Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 12/206 (5%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGK-----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 658
L KK+G G FG VY G LK E+AVK L + S Q EF E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+V+ LG C EE ++V E+M G L ++L + ++ L A A+G+EYL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
+ IHRDL + N L+ +++ K+SDFGLS+ D + + + ++ PE
Sbjct: 121 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 779 SQQLTDKSDVYSFGVILLELIS-GQE 803
+ T KSDV+SFGV+L E+ + G+E
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEE 203
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 1e-48
Identities = 75/204 (36%), Positives = 117/204 (57%), Gaps = 13/204 (6%)
Query: 609 IGSGGFGVVYYGK-LKDGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
+G GGFG VY + K GK++A+K++ +S E E+ +L +++H N+V+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAI 725
++E LV E+ G+LK+ L +E +++ + L I +G+EYLH G I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSNG----I 113
Query: 726 IHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ-LT 783
IHRDLK NILLD + + K++DFGLSK S + +IV GT Y+ PE + + +
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYS 172
Query: 784 DKSDVYSFGVILLELISGQEAISN 807
+KSD++S GVIL EL ++ I
Sbjct: 173 EKSDIWSLGVILYELPELKDLIRK 196
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 66/202 (32%), Positives = 112/202 (55%), Gaps = 15/202 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
+ +K+G G FG VY + K GK +A+KV+ + RE E+ +L ++ H N+V+
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
++E + LV E+ G L + L G L+ ++ +++ +I +EYLH+
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLR--QILS----ALEYLHSK 116
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I+HRDLK NILLD+ K++DFGL++ +D +++ V GT Y+ PE + +
Sbjct: 117 G---IVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
D++S GVIL EL++G+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 73/204 (35%), Positives = 114/204 (55%), Gaps = 16/204 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
L +K+GSG FG VY K K GK +AVK+L S + + E+ +L R+ H N+V+
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+ +++ LV E+ G L ++L G L+ ++ ++ +G+EYLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQI------LRGLEYLH- 115
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
IIHRDLK NILLD++ K++DFGL+K + +S +++ V GT Y+ PE +
Sbjct: 116 --SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLG 172
Query: 780 QQL-TDKSDVYSFGVILLELISGQ 802
K DV+S GVIL EL++G+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 71/209 (33%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 607 KKIGSGGFGVVYYGKLKDGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQ 661
KK+G G FG VY GKLK E+AVK L + S + +++F E ++ ++ H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIEY 716
LG C EE LV E+M G L ++L + ++ L A AKG+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-----IVRGTVGY 771
L + +HRDL + N L+ + + K+SDFGLS+ D + +R +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ PE T KSDV+SFGV+L E+ +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 6e-44
Identities = 69/204 (33%), Positives = 108/204 (52%), Gaps = 13/204 (6%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE-----IAVKVLT-SNSYQGKREFTNEVTLLSRIHHRN 658
L KK+G G FG VY G LK E +AVK L S + + EF E +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+V+ LG C + +V E+M G L + L H +++ L++A AKG+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYY 777
+ +HRDL + N L+ +++ K+SDFGLS+ D + + ++ PE
Sbjct: 120 SKN---FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 778 ISQQLTDKSDVYSFGVILLELISG 801
+ T KSDV+SFGV+L E+ +
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 3e-37
Identities = 139/485 (28%), Positives = 234/485 (48%), Gaps = 54/485 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+ + LS L+G IP +L+ LV L L N L+G IP FS P L + L NQ
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS--LLSKNVVLNYAGNINLHEGG------ 526
L+G +P +L N+ +L ++ + +N L G++PS+ L+ N AGNI+L G
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINAS-AVAGNIDLCGGDTTSGLP 617
Query: 527 -----RGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDK--EQHRHSLPVQRPV 579
R I ++GA L+LA V +G+ N K E + +Q
Sbjct: 618 PCKRVRKTPSWWFYITCTLGA-FLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD 676
Query: 580 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNS 637
S + + T++DI + K E I G G Y GK +K+G + VK + NS
Sbjct: 677 S-------KVSKSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS 728
Query: 638 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 697
++E+ + ++ H N+V+ +G C+ E + L++E++ L E L
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------- 776
Query: 698 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAV 755
++W +R +IA AK + +LH C PA++ +L I++D ++S GL
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGL--LCT 834
Query: 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 815
D +SS Y+ PE ++ +T+KSD+Y FG+IL+EL++G+ ++ +FG +
Sbjct: 835 DTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSP-ADAEFGVH-G 886
Query: 816 NIVQWAKLHIESGDIQGIIDPSLLDEYDI--QSMWKIEEKALMCVLPHGHMRPSISEVLK 873
+IV+WA+ + IDPS+ + + + ++ AL C RP ++VLK
Sbjct: 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
Query: 874 DIQDA 878
++ A
Sbjct: 947 TLESA 951
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 17/204 (8%)
Query: 607 KKIGSGGFGVVYYGKLKD-GKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +G G FG VY KD G+ +AVK L+ +S + E+ +LS + H N+V++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 664 G-YCQEEGRSVLVY-EFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
G EE ++ ++ E++ G+L L +G L I++ +G+ YLH+
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKY--TRQILEGLAYLHS 119
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYI 778
I+HRD+K +NIL+D K++DFG +K D + VRGT ++ PE
Sbjct: 120 NG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 779 SQQLTDKSDVYSFGVILLELISGQ 802
++ +D++S G ++E+ +G+
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 69/200 (34%), Positives = 111/200 (55%), Gaps = 15/200 (7%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
+KIG GGFG VY + + GKE+A+KV+ S + K + NE+ +L + H N+V++ G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 666 CQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
++ +V EF G+LK+ TLT E +I ++ + + KG+EYLH+
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQTLT-ESQIAYVCK-----ELLKGLEYLHSN-- 117
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
IIHRD+K++NILL K+ DFGLS D + + + GT ++ PE +
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPY 174
Query: 783 TDKSDVYSFGVILLELISGQ 802
K+D++S G+ +EL G+
Sbjct: 175 DYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 7/198 (3%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
K++GSG FGVV+ GK + ++A+K++ + + +F E ++ ++ H NLVQ
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLY 65
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
G C ++ +V E+M NG L +L + ++ L++ D + +EYL +
Sbjct: 66 GVCTKQRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLESNGF- 121
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
IHRDL + N L+ + KVSDFGL+++ +D S + V + PE + + +
Sbjct: 122 --IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 784 DKSDVYSFGVILLELISG 801
KSDV+SFGV++ E+ S
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 68/195 (34%), Positives = 111/195 (56%), Gaps = 9/195 (4%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
K++G+G FGVV YGK + ++A+K++ S + EF E ++ ++ H LVQ G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 726
++ +V E+M NG L +L H +R + LE+ +D +G+ YL + I
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLR---EHGKRFQPSQLLEMCKDVCEGMAYLES---KQFI 122
Query: 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQLTDK 785
HRDL + N L+D KVSDFGLS++ +D + SS+ + V + PE + + + K
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 786 SDVYSFGVILLELIS 800
SDV++FGV++ E+ S
Sbjct: 182 SDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 607 KKIGSGGFGVVYYGKL-----KDGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 660
K++G G FG V + G+++AVK L S Q + +F E+ +L + H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 661 QFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
++ G C++ G L+ E++ +G+L+++L H +IN + L + KG++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLG 126
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV--DGASHVSSIVRGTVGYLDPEY 776
+ IHRDL + NIL++ K+SDFGL+K +V + + PE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183
Query: 777 YISQQLTDKSDVYSFGVILLELIS 800
+ + + SDV+SFGV L EL +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-31
Identities = 151/593 (25%), Positives = 250/593 (42%), Gaps = 68/593 (11%)
Query: 13 VASVLILLLLDSSSAQMPGFVSLNCGGNENF-TDEIGLQWIADDHLIYGEISNISVANET 71
+A+ +L +L S ++ P + ++CG N T W D G +N + +
Sbjct: 6 LAASALLAVLASLASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTGGIPANATRPSFI 65
Query: 72 RKQYMTLRHFP-ADSRKYCYKLDVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWS 130
TLR+FP +D + CY ++ + + Y +R F N + P FD+S+ T S
Sbjct: 66 APPLKTLRYFPLSDGPENCYNINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQIS 125
Query: 131 TIVI---SDAATIEVRELIFLASSPKIDVCLSNATTGQPFISTLELRQFNGSVYL--TPF 185
++ S + L+FL +C + G P I ++E+ Q + Y +
Sbjct: 126 SLKSGWSSHDEQVFAEALVFLTDG-SASICFHSTGHGDPAILSIEILQVDDKAYNFGPSW 184
Query: 186 EDRYYLSVSARINFGA-DSEAPVRYPDDPF--DRIWESDSLKKANYLVDVAAGTEKVSTK 242
L + R++ GA S+ Y D + DR W + D A TE V K
Sbjct: 185 GQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSG--SDQAISTENVIKK 242
Query: 243 LPIDLRSDELPPQKVMQTAVVGTNG--SLTYRLNLDGFPGFGWAV-TYFAEIED-LDPDE 298
+ P+ + Q+A+V T+ L+Y +++D P ++V +FAEI++ + +
Sbjct: 243 A---SNAPNFYPESLYQSALVSTDTQPDLSYTMDVD--PNRNYSVWLHFAEIDNSITAEG 297
Query: 299 SRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLP---FVLSFKFGKTYDSSR 355
R F +++ G D + V+I + + +Y T L L V +
Sbjct: 298 KRVFDVLING--DTAFKDVDIVKMSGERY-------TALVLNKTVAVSGRTLTIVLQPKK 348
Query: 356 GP--LLNAMEINKYLERNDGSIDGVA-----IVSVISLYSSADWAQEGGDPCLPV--PWS 406
G ++NA+E+ + + ++ + S + L W GDPC+P PWS
Sbjct: 349 GTHAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGW---NGDPCVPQQHPWS 405
Query: 407 WLQCNSDPQPS---ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGC 462
C D I + L ++ L G IP+D++KL L + L GNS+ G IP
Sbjct: 406 GADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI 465
Query: 463 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 519
L ++ L N G +P SL L +LR L + N LSG VP++L L N+ N
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
Query: 520 INL------HEGGR----GAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKN 562
L G GAK IG + G +V L V+ + K ++N
Sbjct: 526 AGLCGIPGLRACGPHLSVGAK-----IGIAFGVSVAFLFLVICAMCWWKRRQN 573
|
Length = 623 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 3e-30
Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 48/284 (16%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-TSNSYQGKREFT-NEVTLLSRIHHRNLVQ 661
+ K+IG G FG VY + DGK +K + SN + +RE NEV +L +++H N+++
Sbjct: 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL------YGTLTHEQRINWIKRLEIAEDAAKGIE 715
+ +E+G+ +V E+ G L + + EQ ++W +L ++
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALK 117
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
YLH+ I+HRD+K NI L + K+ DFG+SK ++V GT YL PE
Sbjct: 118 YLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE 173
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE------SGD 829
++ KSD++S G +L EL + + E I+ K S +
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL---KGQYPPIPSQYSSE 230
Query: 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 873
++ ++ SLL K E+ RPSI+++L+
Sbjct: 231 LRNLVS-SLL--------QKDPEE-----------RPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 65/199 (32%), Positives = 108/199 (54%), Gaps = 13/199 (6%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L ++IGSG FG+V+ G + +++A+K + + +F E ++ ++ H LVQ G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
C E LV+EFM +G L ++L G + E L + D +G+ YL +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQE------TLLGMCLDVCEGMAYLESSN 120
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
V IHRDL + N L+ ++ KVSDFG+++F +D S+ + V + PE + +
Sbjct: 121 V---IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 782 LTDKSDVYSFGVILLELIS 800
+ KSDV+SFGV++ E+ S
Sbjct: 178 YSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 74/202 (36%), Positives = 103/202 (50%), Gaps = 20/202 (9%)
Query: 609 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 664
+G G FG V + KD GK A+KVL ++E E +LSRI+H +V+ L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK-LH 59
Query: 665 YC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 720
Y Q E + LV E+ G L HL G + E+R R AE +EYLH+ G
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFS-EERA----RFYAAE-IVLALEYLHSLG 113
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
II+RDLK NILLD K++DFGL+K S ++ GT YL PE + +
Sbjct: 114 ----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGK 168
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
D +S GV+L E+++G+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 66/192 (34%), Positives = 103/192 (53%), Gaps = 11/192 (5%)
Query: 609 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE 668
IG G FG V G + G+++AVK L +S + F E ++++ + H NLVQ LG +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 669 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHR 728
+V E+M G+L ++L I ++L A D +G+EYL +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHR 126
Query: 729 DLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDV 788
DL + N+L+ + + AKVSDFGL+K AS + V + PE ++ + KSDV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 789 YSFGVILLELIS 800
+SFG++L E+ S
Sbjct: 183 WSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (297), Expect = 9e-29
Identities = 70/212 (33%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRI-HHRNL 659
+ +K+G G FG VY + D K +A+KVL + + F E+ +L+ + H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
V+ + Q+EG LV E++ G+L++ L + + ++ + L I +EYLH+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 720 GCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVS-----SIVRGTVGYLD 773
IIHRD+K NILLD+ K+ DFGL+K D S S S GT GY+
Sbjct: 120 KG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 774 PEYYISQQL---TDKSDVYSFGVILLELISGQ 802
PE + L + SD++S G+ L EL++G
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 6/196 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
LE+K+GSG FG V+ G K+ +A+K+L S+ +++F EV L R+ H++L+
Sbjct: 10 LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
C ++ E M G+L L Q + +++A A+G+ YL
Sbjct: 70 VCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEE---QN 124
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
IHRDL + NIL+ + + KV+DFGL++ + ++SS + + PE +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTFST 183
Query: 785 KSDVYSFGVILLELIS 800
KSDV+SFG++L E+ +
Sbjct: 184 KSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 7/203 (3%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 655
++E ++ K+G G +G VY G K +AVK L ++ + + EF E ++ I
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 60
Query: 656 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
H NLVQ LG C E ++ EFM G L ++L + Q +N + L +A + +E
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAME 118
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
YL IHRDL + N L+ ++ KV+DFGLS+ + + + + PE
Sbjct: 119 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 776 YYISQQLTDKSDVYSFGVILLEL 798
+ + KSDV++FGV+L E+
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 68/197 (34%), Positives = 105/197 (53%), Gaps = 8/197 (4%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGY 665
+KIG G FG VY G LK E+AVK S KR+F E +L + H N+V+ +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 725
C ++ +V E + G+L L + R+ K L+++ DAA G+EYL +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKNC--- 114
Query: 726 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VGYLDPEYYISQQLTD 784
IHRDL + N L+ ++ K+SDFG+S+ G VS ++ + + PE + T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 785 KSDVYSFGVILLELISG 801
+SDV+S+G++L E S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 604 MLEKKIGSGGFGVVYYG-KLKDGKEIAVK--VLTSNSYQGKREFTNEVTLLSRIHHRNLV 660
L IG G FGVVY G L+ G +A+K L + + E+ LL + H N+V
Sbjct: 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+++G + ++ E+ NG+L++ + +G ++ ++ +G+ YLH
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV------LQGLAYLH 116
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
+IHRD+K++NIL K K++DFG++ ++ S + V GT ++ PE
Sbjct: 117 E---QGVIHRDIKAANILTTKDGVVKLADFGVAT-KLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 779 SQQLTDKSDVYSFGVILLELISGQ 802
+ SD++S G ++EL++G
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
+KIG G G VY GKE+A+K + Q K NE+ ++ H N+V +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYD- 82
Query: 666 CQEEGRSV-LVYEFMHNGTLKEHLYGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
G + +V E+M G+L + + +E +I ++ R E+ + G+EYLH+
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCR-EVLQ----GLEYLHSQ-- 135
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD---GASHVSSIVRGTVGYLDPEYYIS 779
+IHRD+KS NILL K K++DFG FA S +S+V GT ++ PE
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFG---FAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190
Query: 780 QQLTDKSDVYSFGVILLELISGQ 802
+ K D++S G++ +E+ G+
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 64/197 (32%), Positives = 107/197 (54%), Gaps = 13/197 (6%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
K++GSG FGVV+ GK + ++A+K + + + +F E ++ ++ H LVQ G C
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 667 QEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
++ +V EFM NG L +L G L+ + L + +D +G+EYL
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML------LSMCQDVCEGMEYLERN--- 119
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
+ IHRDL + N L+ KVSDFG++++ +D SS + V + PE + + +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 784 DKSDVYSFGVILLELIS 800
KSDV+SFGV++ E+ +
Sbjct: 180 SKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 609 IGSGGFGVVYYG-KLKDGKEIAVKV--LTSNSYQGK---REFTNEVTLLSRIHHRNLVQF 662
+GSG FG VY G L DG AVK L + G+ ++ E+ LLS++ H N+VQ+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
LG +EE + E + G+L + L YG+ + +++ G+EYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI------LLGLEYLHDR 121
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
+HRD+K +NIL+D + K++DFG++K V+ + S +G+ ++ PE Q
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQ 176
Query: 781 QLTD-KSDVYSFGVILLELISGQ 802
+D++S G +LE+ +G+
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 59/205 (28%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 604 MLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRN 658
+EK IG G FG V G+L K ++A+K L + S +R +F E +++ + H N
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+++ G + +++ E+M NG+L + L ++ + + + + A G++YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLR---ENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLDPE 775
+HRDL + NIL++ ++ KVSDFGLS+ S + +G + + PE
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSR--RLEDSEATYTTKGGKIPIRWTAPE 178
Query: 776 YYISQQLTDKSDVYSFGVILLELIS 800
++ T SDV+SFG+++ E++S
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 656
+I+ + L +K+G+G FG V+ G + +AVK L + K +F E ++ ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRH 60
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG----TLTHEQRINWIKRLEIAEDAAK 712
L+Q C E +V E M G+L E+L G L Q I ++A A
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI------DMAAQVAS 114
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
G+ YL IHRDL + N+L+ ++ KV+DFGL++ + + + +
Sbjct: 115 GMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT 171
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELIS 800
PE + + + KSDV+SFG++L E+++
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 605 LEKKIGSGGFGVVYYGKL-----KDGKEI-AVKVLT-SNSYQGKREFTNEVTLLSRIHHR 657
L++++G G FG V+ G+ ++ KE+ AVK L + S +++F E LL+ H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------YGTLTHEQRINWIKRLEIA 707
N+V+F G C E ++V+E+M +G L + L + + + L+IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 708 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 767
A G+ YL + +HRDL + N L+ + K+ DFG+S+ D + V G
Sbjct: 129 VQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGG 182
Query: 768 T----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ ++ PE + ++ T +SDV+SFGV+L E+ +
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLG 664
K +G G GVVY + K GK A+K + + + +++ E+ L +V+ G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL---EIAEDAAKGIEYLHTGC 721
+EG +V E+M G+L + L +++ I IA KG++YLHT
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLL-------KKVGKIPEPVLAYIARQILKGLDYLHT-- 117
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
IIHRD+K SN+L++ K++DFG+SK + ++ V GTV Y+ PE +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGES 176
Query: 782 LTDKSDVYSFGVILLELISGQ 802
+ +D++S G+ LLE G+
Sbjct: 177 YSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 6/196 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
LE+K+G+G FG V+ G ++AVK L + F E ++ ++ H LVQ
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
C EE +V E+M G+L + L + R+ + +++A A+G+ YL +
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP--QLVDMAAQIAEGMAYLES---RN 123
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
IHRDL + NIL+ +++ K++DFGL++ D + + + PE + T
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 785 KSDVYSFGVILLELIS 800
KSDV+SFG++L E+++
Sbjct: 184 KSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 47/219 (21%)
Query: 607 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+++G G FG V Y L+D G+ +AVK L ++ + R+F E+ +L + H N+V+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 662 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+ G C GR LV E++ G+L+++L H +R++ K L A KG+EYL +
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
+HRDL + NIL++ R K+ DFGL+K V D EYY
Sbjct: 127 ---KRYVHRDLATRNILVESENRVKIGDFGLTK----------------VLPQDKEYYKV 167
Query: 780 QQ-------------LTD-----KSDVYSFGVILLELIS 800
++ LT+ SDV+SFGV+L EL +
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 39/227 (17%)
Query: 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREF-TNEVTLLSRI-HHR 657
K IG G F V K K KE A+K+L + K ++ E +L+R+ H
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-DKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 715
+++ Q+E V E+ NG L +++ YG+L E+ + AE +E
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD-EKCTRFY----AAE-ILLALE 116
Query: 716 YLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF----------AVDGASHVSSI 764
YLH+ G IIHRDLK NILLDK M K++DFG +K D + S I
Sbjct: 117 YLHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 765 VR---------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
+ GT Y+ PE + SD+++ G I+ ++++G+
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLT-SNSYQGKREFT 645
LS + +++G G FG VY G+L +A+K L + + ++EF
Sbjct: 2 IPLSAVR-----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR 56
Query: 646 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE---------- 695
E L+S + H N+V LG C +E + +++E++ +G L E L H
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 696 --QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753
++ L IA A G+EYL + +HRDL + N L+ + + K+SDFGLS+
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR- 172
Query: 754 AVDGASH----VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
D S V S V ++ PE + + T +SD++SFGV+L E+ S
Sbjct: 173 --DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 15/217 (6%)
Query: 609 IGSGGFG-VVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
+G G FG Y + +D + K LT S + +R+ NE+ +LS + H N++ + +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 666 CQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
++ ++ E+ + GTL + G L E+ + W + Y+H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY-----LFQIVSAVSYIHKA-- 120
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I+HRD+K+ NI L K K+ DFG+SK S ++V GT Y+ PE +
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178
Query: 783 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
KSD+++ G +L EL++ + IVQ
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 18/200 (9%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
KKIG G FG +Y K K D + +K LT + K EV LL+++ H N+V F
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 719
QE GR +V E+ G L + + G L E +I +W ++ + G++++H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD 119
Query: 720 GCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
I+HRD+KS NI L K+ M AK+ DFG+++ ++ + ++ GT YL PE
Sbjct: 120 ---RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 779 SQQLTDKSDVYSFGVILLEL 798
++ +K+D++S G +L EL
Sbjct: 176 NRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 66/196 (33%), Positives = 106/196 (54%), Gaps = 13/196 (6%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L + IG G FG V G+ G+++AVK + + + F E +++++HH+NLV+ LG
Sbjct: 10 LGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLG 66
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
G + V E M G L L ++ I+ L+ + D A+G+EYL +
Sbjct: 67 VILHNGLYI-VMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLES---KK 120
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
++HRDL + NIL+ + AKVSDFGL++ G + V+ T PE ++ +
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTA----PEALKHKKFSS 176
Query: 785 KSDVYSFGVILLELIS 800
KSDV+S+GV+L E+ S
Sbjct: 177 KSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 13/197 (6%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L + IG G FG V G + G ++AVK + +++ + F E ++++++ H NLVQ LG
Sbjct: 10 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 665 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
EE + +V E+M G+L ++L + L+ + D + +EYL
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN--- 121
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
+HRDL + N+L+ + AKVSDFGL+K AS + V + PE ++ +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 784 DKSDVYSFGVILLELIS 800
KSDV+SFG++L E+ S
Sbjct: 178 TKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 5e-23
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 21/205 (10%)
Query: 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLT--SNSYQGKRE---FTNEVTLLSRIHHRNLV 660
K +G G FG VY D G+E+AVK + +S + K+E E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 661 QFLGYCQEEGRSVLVY-EFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
Q+ G C + ++ ++ E+M G++K+ L YG LT + + +I E G+EYL
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR--QILE----GVEYL 120
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLDPE 775
H+ I+HRD+K +NIL D K+ DFG SK S + + V GT ++ PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 776 YYISQQLTDKSDVYSFGVILLELIS 800
+ K+DV+S G ++E+++
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 19/203 (9%)
Query: 607 KKIGSGGFGVVYYG--KLKDGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQ 661
K++G G FG V G +K GKE+ AVK L GK+EF E ++++++ H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
+G C+ E +LV E G L ++L + I E+A A G+ YL +
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-- 113
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPE--YY 777
+HRDL + N+LL +AK+SDFG+S+ G+ + + G + + PE Y
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 778 ISQQLTDKSDVYSFGVILLELIS 800
+ + KSDV+S+GV L E S
Sbjct: 173 --GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 66/209 (31%), Positives = 114/209 (54%), Gaps = 23/209 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 659
+E+ IG+G FG V G+LK GK +A+K L S + + +R+F +E +++ + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+ G + +++ EFM NG L L ++ + I+ + + A G++YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS---HVSSI-----VRGTVGY 771
+HRDL + NIL++ ++ KVSDFGLS+F D S + SS+ +R T
Sbjct: 125 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA-- 179
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELIS 800
PE ++ T SDV+S+G+++ E++S
Sbjct: 180 --PEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 3e-22
Identities = 62/210 (29%), Positives = 114/210 (54%), Gaps = 13/210 (6%)
Query: 598 IEDATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQGKREFTNEVTLLS 652
I+ + +EK IG+G FG V G+LK +EI V + T + + +R+F +E +++
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60
Query: 653 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 712
+ H N++ G + ++V E+M NG+L L H+ + I+ + + A
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIAS 117
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVG 770
G++YL +HRDL + NIL++ ++ KVSDFGLS+ D A++ + + +
Sbjct: 118 GMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ PE ++ T SDV+S+G+++ E++S
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 9/218 (4%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+ KIG G FGVV+ K D + A+K L+ + + + E +E +L+++ +++
Sbjct: 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
+ ++G+ +V E+ NG L + L + + R I G+ +LH+
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHLHSK- 120
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
I+HRD+KS N+ LD + K+ D G++K D + ++IV GT YL PE +
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKP 177
Query: 782 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
+KSDV++ GV+L E +G+ GA I++
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L KK+G+G FG V+ G ++A+K L S F E L+ ++ H LV+
Sbjct: 10 LVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYA 68
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
+E ++ E+M NG+L + L + IN K +++A A+G+ ++
Sbjct: 69 VVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGMAFIE---RKN 122
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
IHRDL+++NIL+ + + K++DFGL++ D + + + PE T
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 785 KSDVYSFGVILLELIS 800
KSDV+SFG++L E+++
Sbjct: 183 KSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 7e-22
Identities = 77/278 (27%), Positives = 131/278 (47%), Gaps = 37/278 (13%)
Query: 609 IGSGGFGVVYYGKLKDGKEIAVKVL---TSNSYQGKREFTN---EVTLLSRIHHRNLVQF 662
+G G +G VY G G+ IAVK + TSN ++E+ EV LL + H N+VQ+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
LG C ++ + EF+ G++ L +G L + K++ G+ YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI------LDGVAYLHNN 121
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSS----IVRGTVGYLDPE 775
CV +HRD+K +N++L + K+ DFG + + A G S + GT ++ PE
Sbjct: 122 CV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835
KSD++S G + E+ +G+ +++ A A +I G +G++
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--------AMFYI--GAHRGLM- 227
Query: 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 873
P L D + ++ + C+ H RPS ++L+
Sbjct: 228 PRLPDSFSAAAI----DFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 7e-22
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
LE K+G G FG V+ G +A+K L + F E ++ ++ H LVQ
Sbjct: 10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
EE +V E+M G+L + L G + R+ + +++A A G+ Y+
Sbjct: 69 VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVER---MN 122
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 785 KSDVYSFGVILLELIS 800
KSDV+SFG++L EL +
Sbjct: 183 KSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 608 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
++G G G V +LK+ I A+K + T + +++ E+ + +V++ G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 666 CQEEGRSVL--VYEFMHNGTLKEHLYG-TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+E S + E+ G+L + +Y RI +IAE KG+ YLH+
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--- 123
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
IIHRD+K SNILL + + K+ DFG+S V + ++ GT Y+ PE +
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFTGTSFYMAPERIQGKPY 180
Query: 783 TDKSDVYSFGVILLELISG 801
+ SDV+S G+ LLE+
Sbjct: 181 SITSDVWSLGLTLLEVAQN 199
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 73/252 (28%), Positives = 106/252 (42%), Gaps = 40/252 (15%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 664
I G +G V+ K K +I A+KV+ K + E +LS+ +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 665 YCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
Q + LV E++ G L G+L + + R+ IAE +EYLH+
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----VARIYIAE-IVLALEYLHSN-- 112
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV--------DGASHVSSIVRGTVGYLDP 774
IIHRDLK NIL+D + K++DFGLSK + D IV GT Y+ P
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAP 170
Query: 775 EYYISQQLTDKSDVYSFGVILLELISG----QEAISNEKFGANCRNIVQWAKLHIESGDI 830
E + Q + D +S G IL E + G E F +I +G I
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ------------NILNGKI 218
Query: 831 QGIIDPSLLDEY 842
+ D + DE
Sbjct: 219 EWPEDVEVSDEA 230
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 77/278 (27%), Positives = 125/278 (44%), Gaps = 40/278 (14%)
Query: 607 KKIGSGGFGVVYYGKLKDG------KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 660
+ +G G FG+V+ + K K+I V+ +T + + NE +L + H N++
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNII 62
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
++ E+ ++V E+ GTL E++ ++ + + I + + LH
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYI-----QKRCNSLLDEDTILHFFVQILLALHHV 117
Query: 721 CVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
I+HRDLK+ NILLDKH M K+ DFG+SK + + + V GT Y+ PE
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYTVVGTPCYISPELCEG 175
Query: 780 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID---P 836
+ KSD+++ G +L EL S + A AN +V L I SG I D P
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFE----AANLPALV----LKIMSGTFAPISDRYSP 227
Query: 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
L I SM + RP +S+++
Sbjct: 228 DL--RQLILSMLNL----------DPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 20/206 (9%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFL 663
KIG G FG VY L G+ +AVK + K +E +E+ +L + H NLV++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRIN-WIKRLEIAEDAAKGIEYLHTGC 721
G + + E+ GTL+E L +G + E I + +L +G+ YLH+
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL------LEGLAYLHSH- 118
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLDPEYYI 778
I+HRD+K +NI LD + K+ DFG + + + + V+ G Y+ PE
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 779 SQQLTDK---SDVYSFGVILLELISG 801
+ +D++S G ++LE+ +G
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 68/295 (23%), Positives = 128/295 (43%), Gaps = 58/295 (19%)
Query: 609 IGSGGFGVVYYGKLK----DGKE--IAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQ 661
+G G FG V+ K K +G E + VK L + + EF E+ + ++ H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-----QRINWIKRLEIAEDAAKGIEY 716
LG C+E ++ E+ G LK+ L T + + ++ +++ + A G+++
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVRGTVGYLDP 774
L +HRDL + N L+ KVS LSK + + ++++ + +L P
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI--PLRWLAP 187
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLHIESGDI 830
E + KSDV+SFGV++ E+ + E +S+E+ +++G +
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR-----------LQAGKL 236
Query: 831 QGIIDPSLLDEYDIQSMWKIEEKA------LM--CVLPHGHMRPSISEVLKDIQD 877
+ + E LM C + RPS SE++ + +
Sbjct: 237 E----------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 59/202 (29%), Positives = 113/202 (55%), Gaps = 13/202 (6%)
Query: 606 EKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLV 660
+K IG+G FG V+ G LK G++ +A+K L + +R +F +E +++ + H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ G + ++++ E+M NG L ++L H+ + + + + A G++YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLR---DHDGEFSSYQLVGMLRGIAAGMKYLSD- 125
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVGYLDPEYYI 778
+HRDL + NIL++ ++ KVSDFGLS+ D ++ +S + + + PE
Sbjct: 126 --MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 779 SQQLTDKSDVYSFGVILLELIS 800
++ T SDV+SFG+++ E++S
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 609 IGSGGFGVVYYGKL--KDGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRIHHRNLVQFL 663
IG G FG VY+G L DG++I AVK L + +F E ++ H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 664 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAAKGIEYLHTGC 721
G C EG ++V +M +G L+ + E +K L AKG+EYL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI----RSETHNPTVKDLIGFGLQVAKGMEYLAS-- 116
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYI 778
+HRDL + N +LD+ KV+DFGL++ D + H + + V ++ E
Sbjct: 117 -KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 779 SQQLTDKSDVYSFGVILLELIS 800
+Q+ T KSDV+SFGV+L EL++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 607 KKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 660
K +GSG FG VY G E +A+KVL S + +E +E +++ + H ++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYL 717
+ LG C + L+ + M G L +++ + + +NW AKG+ YL
Sbjct: 73 RLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEY 776
++HRDL + N+L+ K++DFGL+K VD + + + + ++ E
Sbjct: 126 EE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 777 YISQQLTDKSDVYSFGVILLELIS 800
+ + T KSDV+S+GV + EL++
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 4e-21
Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 21/214 (9%)
Query: 604 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 657
+L++++G G FG V+ + +D +AVK L S +++F E LL+ + H
Sbjct: 8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 67
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-----GTLTHE----QRINWIKRLEIAE 708
++V+F G C E ++V+E+M +G L + L L E + + L IA+
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 709 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVR 766
A G+ YL + +HRDL + N L+ +++ K+ DFG+S+ ++ D V
Sbjct: 128 QIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD-YYRVGGHTM 183
Query: 767 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ ++ PE + ++ T +SDV+S GV+L E+ +
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLG 664
++IG G FG V+ G+L+ D +AVK K +F E +L + H N+V+ +G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
C ++ +V E + G L T R+ + +++ E+AA G+EYL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKHC-- 115
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VGYLDPEYYISQQLT 783
IHRDL + N L+ + K+SDFG+S+ DG + ++ V + PE + +
Sbjct: 116 -IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 784 DKSDVYSFGVILLELIS 800
+SDV+SFG++L E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 26/221 (11%)
Query: 609 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE----------FTNEVTLLSRIHHR 657
IG G +G VY + G+ +AVK + + R +E+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 715
N+VQ+LG+ E + E++ G++ L YG EQ + + E +G+
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRF-EEQLVRFF-----TEQVLEGLA 122
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDP 774
YLH+ I+HRDLK+ N+L+D K+SDFG+SK + D + ++ ++G+V ++ P
Sbjct: 123 YLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 775 EYYISQQ--LTDKSDVYSFGVILLELISGQEAISN-EKFGA 812
E S + K D++S G ++LE+ +G+ S+ E A
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
++G+G GVV + GK +AVK L N K+ E+ +L + + +V F
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ-ILRELDILHKCNSPYIVGFY 65
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL---EIAEDAAKGIEYLHTG 720
G G + E+M G+L + L ++ I +IA KG+ YLH
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILGKIAVAVLKGLTYLHE- 118
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
IIHRD+K SNIL++ + K+ DFG+S V+ + GT Y+ PE
Sbjct: 119 -KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGN 174
Query: 781 QLTDKSDVYSFGVILLELISGQEAISNEKFGAN 813
+ KSD++S G+ L+EL +G+ E +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 7e-21
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 607 KKIGSGGFGVVY---YGKLKD--GKEIAVKVLTS-NSYQGKREFTNEVTLLSRIHHRNLV 660
+ +G G FG V Y D G+ +AVK L Q + E+ +L ++H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 661 QFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
++ G C E+G L+ E++ G+L+++L + ++N + L A+ +G+ YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPEY 776
+ IHRDL + N+LLD K+ DFGL+K +G + V V + E
Sbjct: 125 S---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 777 YISQQLTDKSDVYSFGVILLELIS 800
+ + SDV+SFGV L EL++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 7e-21
Identities = 62/222 (27%), Positives = 110/222 (49%), Gaps = 34/222 (15%)
Query: 604 MLEKKIGSGGFGVVYYGK------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 657
+L++++G G FG V+ + KD +AVK L + +++F E LL+ + H
Sbjct: 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 67
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIKRLE 705
++V+F G C + ++V+E+M +G L + L + + + L
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 706 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-------FAVDGA 758
IA A G+ YL + +HRDL + N L+ ++ K+ DFG+S+ + V G
Sbjct: 128 IASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG- 183
Query: 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
H +R ++ PE + ++ T +SDV+SFGVIL E+ +
Sbjct: 184 -HTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 28/211 (13%)
Query: 609 IGSGGFGVVYYG-KLKDGKEIAVK--VLTSNSYQGKRE-------FTNEVTLLSRIHHRN 658
IGSG FG VY G G+ +AVK L S S K E+ LL + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+VQ+LG + + E++ G++ L YG N+++++ KG+ Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI------LKGLNY 121
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK------FAVDGASHVSSIVRGTVG 770
LH IIHRD+K +NIL+D K+SDFG+SK + S+ +G+V
Sbjct: 122 LHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL-QGSVF 177
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELISG 801
++ PE T K+D++S G +++E+++G
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 9e-21
Identities = 81/293 (27%), Positives = 126/293 (43%), Gaps = 60/293 (20%)
Query: 604 MLEKKIGSGGFGVVYYGK---------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI 654
+L++++G G FG VY K LK KEI V L N + E LLS++
Sbjct: 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKL 59
Query: 655 HHRNLVQFLG-------------YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 701
H +V+F YC+ + E H G TL+ Q W
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK-------TLSENQVCEWF 112
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761
+L + G+ Y+H I+HRDLK+ NI L ++ K+ DFG+S+ + G+ +
Sbjct: 113 IQLLL------GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDL 161
Query: 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 821
++ GT Y+ PE Q KSD++S G IL E+ A + F + IV+
Sbjct: 162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-- 219
Query: 822 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
G PSL + Y + + I + L +RPS +E+L++
Sbjct: 220 ------GPT-----PSLPETYS-RQLNSIMQSMLN---KDPSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-20
Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 35/224 (15%)
Query: 606 EKKIGSGGFGVVYYGK---LKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 658
+ IG G FG V+ + L + +AVK+L S + +F E L++ H N
Sbjct: 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQ------------------RINW 700
+V+ LG C L++E+M G L E L Q ++
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 701 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVD-- 756
++L IA+ A G+ YL +HRDL + N L+ ++M K++DFGLS+ ++ D
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
AS +I + ++ PE + T +SDV+++GV+L E+ S
Sbjct: 187 KASENDAI---PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN--EVTLLSRIHHRNLVQFL 663
KIG G +GVVY + K EI A+K + T E+ LL ++H N+++ L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 715
+ +G LV+EFM LY + QR + E K G+
Sbjct: 65 DVFRHKGDLYLVFEFMD-----TDLYKLIKDRQR-------GLPESLIKSYLYQLLQGLA 112
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDP 774
+ H+ I+HRDLK N+L++ K++DFGL++ F + +V T Y P
Sbjct: 113 FCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV--TRWYRAP 167
Query: 775 E-YYISQQLTDKSDVYSFGVILLELISGQ 802
E + + D++S G I EL+S +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 23/202 (11%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-------AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
IG G FG V + +D K++ K + S + NE +L ++H LV
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL---NERRILQELNHPFLVN 64
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
Q+E LV + + G L+ HL + EQ + I E +EYLH+
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ-----VKFWICE-IVLALEYLHS 118
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
IIHRD+K NILLD+ ++DF ++ S GT GY+ PE
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS--TSGTPGYMAPEVLCR 173
Query: 780 QQLTDKSDVYSFGVILLELISG 801
Q + D +S GV E + G
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLV 660
+ IG G FG V + K DGK + K + Y + K++ +EV +L + H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEI---DYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 661 QFLGYCQEEGRSVL--VYEFMHNGTL--------KEHLYGTLTHEQRINWIKRLEIAEDA 710
++ + L V E+ G L KE Y + E + +L +A
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY--IEEEFIWRILTQLLLA--- 117
Query: 711 AKGIEYLHTGCVP--AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 768
+ H P ++HRDLK +NI LD + K+ DFGL+K +S + V GT
Sbjct: 118 ---LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GT 173
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
Y+ PE +KSD++S G ++ EL +
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L KK+G+G FG V+ G ++AVK L + F E ++ ++ H LVQ
Sbjct: 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYA 68
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
EE +V E+M G+L + L + + +++A A G+ Y+
Sbjct: 69 VVSEE-PIYIVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER---MN 122
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
IHRDL+S+NIL+ + K++DFGL++ D + + + PE + + T
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 785 KSDVYSFGVILLELIS 800
KSDV+SFG++L EL++
Sbjct: 183 KSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 605 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHR 657
L + +G G FG VY G + D E+ V V T S S Q + +F E ++S+ +H+
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGI 714
N+V+ +G E ++ E M G LK L +R + L A D AKG
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 715 EYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGT--V 769
+YL IHRD+ + N LL AK++DFG+++ + AS+ R +
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-DIYRASYYRKGGRAMLPI 185
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
++ PE ++ T K+DV+SFGV+L E+ S
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 23/216 (10%)
Query: 604 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 657
+L+ ++G G FG V+ + +D +AVK L S +++F E LL+ + H+
Sbjct: 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQ 67
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-----------GTLTHEQRINWIKRLEI 706
++V+F G C E ++V+E+M +G L L G ++ + L I
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 707 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSI 764
A A G+ YL + +HRDL + N L+ + + K+ DFG+S+ ++ D V
Sbjct: 128 ASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGR 183
Query: 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ ++ PE + ++ T +SD++SFGV+L E+ +
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 29/209 (13%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQG-----KREFTNEVTLLSRIHHRNL 659
+IG G +G VY + K G+ +A+K + N +G RE + LL ++ H N+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIRE----IKLLQKLRHPNI 60
Query: 660 VQFLGYCQEEGR-SV-LVYEFM-H--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
V+ +G+ S+ +V+E+M H G L T Q ++K+L +G+
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV-KFTESQIKCYMKQL------LEGL 113
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 773
+YLH+ I+HRD+K SNIL++ K++DFGL+ + ++ ++ V T+ Y
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169
Query: 774 PEYYI-SQQLTDKSDVYSFGVILLELISG 801
PE + + + + D++S G IL EL G
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 41/222 (18%)
Query: 605 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHR 657
L +++G G FG+VY G K +A+K + N+ +R EF NE +++ +
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLE 705
++V+ LG +++V E M G LK +L G T ++ I
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM----- 124
Query: 706 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-------FAVDGA 758
A + A G+ YL +HRDL + N ++ + + K+ DFG+++ + G
Sbjct: 125 -AAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ VR ++ PE T KSDV+SFGV+L E+ +
Sbjct: 181 GLLP--VR----WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 609 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQ 667
+G G FG V+ G LKD +AVK + Q K +F +E +L + H N+V+ +G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 668 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAII 726
+ +V E + G L + + + ++ A DAA G+ YL + C I
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLESKNC----I 115
Query: 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 786
HRDL + N L+ ++ K+SDFG+S+ DG S + + + + PE + + +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 787 DVYSFGVILLELIS 800
DV+S+G++L E S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 7e-20
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 607 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLV 660
+ +G G FG V Y D G+++AVK L S + E+ +L ++H N+V
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 661 QFLGYCQEEG-RSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
++ G C E+G + L+ EF+ +G+LKE+L IN ++L+ A KG++YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLG 126
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPEY 776
+ +HRDL + N+L++ + K+ DFGL+K + V + V + PE
Sbjct: 127 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 777 YISQQLTDKSDVYSFGVILLELIS 800
I + SDV+SFGV L EL++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (225), Expect = 8e-20
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 34/211 (16%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKV---------LTSNSYQGKREFTNEVTLLSRIHH 656
+K+G G +GVVY + K G+ +A+K + S + + E++LL + H
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-------EISLLKELKH 57
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKG 713
N+V+ L E + LV+E+ LK + G L+ N IK I +G
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS----PNLIKS--IMYQLLRG 110
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYL 772
+ Y H+ I+HRDLK NIL+++ K++DFGL++ F + ++ +V T+ Y
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYR 165
Query: 773 DPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
PE + + + D++S G I E+I+G+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 54/201 (26%), Positives = 103/201 (51%), Gaps = 7/201 (3%)
Query: 600 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 659
++ K++ KK+G+G FG V+ G + ++AVK L + + F E L+ + H L
Sbjct: 6 ESIKLV-KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKL 63
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
V+ +E ++ E+M G+L + L ++ K ++ + A+G+ Y+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
IHRDL+++N+L+ + + K++DFGL++ D + + + PE
Sbjct: 122 ---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 178
Query: 780 QQLTDKSDVYSFGVILLELIS 800
T KSDV+SFG++L E+++
Sbjct: 179 GSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 7/204 (3%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 656
+I + LEKK+G+G FG V+ ++AVK + S F E ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH 60
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
LV+ +E ++ EFM G+L + L +Q + K ++ + A+G+ +
Sbjct: 61 DKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAF 117
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
+ IHRDL+++NIL+ + K++DFGL++ D + + + PE
Sbjct: 118 IEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 777 YISQQLTDKSDVYSFGVILLELIS 800
T KSDV+SFG++L+E+++
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 607 KKIGSGGFGVVYYGKLKD--GKEI--AVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQ 661
KK+G G FGVV G+ GK I AVK L S+ +F E ++ + H NL++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAAKGIEYLHTG 720
G ++V E G+L + L I L + A A G+ YL +
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLDRLR---KDALGHFLISTLCDYAVQIANGMRYLES- 115
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV--GYLDPEYYI 778
IHRDL + NILL + K+ DFGL + H V + PE
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 779 SQQLTDKSDVYSFGVILLELIS-GQE 803
++ + SDV+ FGV L E+ + G+E
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEE 199
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLK--DGK--EIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRN 658
L K +G G FG V G+L DG ++AVK L ++Y EF +E + H N
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62
Query: 659 LVQFLGYC------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI--KRLEIAEDA 710
+++ +G C Q+ + +++ FM +G L L + L+ D
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-IVRGTV 769
A G+EYL IHRDL + N +L + M V+DFGLSK G + I + V
Sbjct: 123 ALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 802
++ E + T KSDV++FGV + E+ + GQ
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 75/278 (26%), Positives = 128/278 (46%), Gaps = 44/278 (15%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
KK+G G +G VY K L D + A+K L S S + + + NE+ +L+ ++H N++ +
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 664 GYCQEEGRSVLVYEFMHNGTL-----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ + +V E+ G L K L EQ I W +++ +G++ LH
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI-WRIFIQLL----RGLQALH 120
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
I+HRDLKS+NILL + K+ D G+SK +++ GT Y+ PE +
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWK 174
Query: 779 SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL----HIESGDIQGII 834
+ + KSD++S G +L E+ + + + R VQ K I S D+Q I
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI 233
Query: 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 872
++++ V P +RP+ ++L
Sbjct: 234 ------------------RSMLQVKP--KLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 24/206 (11%)
Query: 607 KKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKREF--TNEVTLLSRIHHRNLV 660
K +G G FG V+ + G + A+KVL + + + E +L+ ++H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTL-----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
+ Q EG+ L+ +F+ G L KE ++ T E + +AE A ++
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF---TEED-----VKFYLAE-LALALD 112
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH+ II+RDLK NILLD+ K++DFGLSK ++D S GTV Y+ PE
Sbjct: 113 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPE 168
Query: 776 YYISQQLTDKSDVYSFGVILLELISG 801
+ T +D +SFGV++ E+++G
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGKE---------------IAVKVLTSNSYQGKR-EFTNE 647
L++K+G G FG V+ + + E +AVK+L ++ + R +F E
Sbjct: 8 RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKE 67
Query: 648 VTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIK 702
+ ++SR+ + N+++ LG C + ++ E+M NG L + L T TH I +
Sbjct: 68 IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 703 R---LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759
L +A A G++YL + +HRDL + N L+ H K++DFG+S+ G
Sbjct: 128 IANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 760 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ + + ++ E + + T SDV++FGV L E+ +
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 5e-19
Identities = 74/230 (32%), Positives = 111/230 (48%), Gaps = 46/230 (20%)
Query: 599 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRI 654
ED E IG G FG V +K DG ++ A+K+L S R+F E+ +L ++
Sbjct: 2 EDIK--FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 655 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTL-----------------KEH-LYGTLTHE 695
HH N++ LG C+ G + E+ G L KEH TLT +
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 696 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755
Q L+ A D A G++YL IHRDL + N+L+ +++ +K++DFGLS+
Sbjct: 120 QL------LQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGE- 169
Query: 756 DGASHVSSIVRGTVGYLDPEYYISQQL-----TDKSDVYSFGVILLELIS 800
V+ T+G L + + L T KSDV+SFGV+L E++S
Sbjct: 170 ------EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 26/221 (11%)
Query: 601 ATKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTS-NSYQGKREFTNEVTLLSRI 654
A + +E+ +G FG +Y G L + +A+K L N+ Q EF E +L++ +
Sbjct: 6 AVRFMEE-LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL 64
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-------------EQRINWI 701
HH N+V LG +E +++E+++ G L E L H + ++
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGAS 759
L IA A G+EYL + +H+DL + NIL+ + + K+SD GLS+ ++ D
Sbjct: 125 DFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD-YY 180
Query: 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
V + ++ PE + + + SD++SFGV+L E+ S
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 29/208 (13%)
Query: 609 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 667
+G G +G+VY + L IA+K + + + E+ L S + HRN+VQ+LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 668 EEGRSVLVYEFMHNGTLKEHL---YGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
E G + E + G+L L +G L +EQ I + + +I E G++YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QILE----GLKYLHDN--- 127
Query: 724 AIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I+HRD+K N+L++ + K+SDFG SK + G + + GT+ Y+ PE +
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSK-RLAGINPCTETFTGTLQYMAPE------V 180
Query: 783 TDK--------SDVYSFGVILLELISGQ 802
DK +D++S G ++E+ +G+
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 71/223 (31%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 609 IGSGGFGVVYYGKLKD----GKE---IAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLV 660
+GSG FG VY G D G +AVK L + Q K+EF E L+S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYG---TLTHEQRINWIKRLEIAEDAAKGIEYL 717
+ LG C ++ E M G L +L + + L+I D AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 718 HTGCVPAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKFAVDGASHVSSIVRG----T 768
IHRDL + N L+ D K+ DFGL++ D G
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKSDYYRKEGEGLLP 176
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQE---AISN 807
V ++ PE + + T +SDV+SFGV++ E+++ GQ+ A++N
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN 219
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 79/275 (28%), Positives = 133/275 (48%), Gaps = 36/275 (13%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFL 663
KKIG G FG K K DGK+ +K + + K E EV +LS + H N+VQ+
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 719
+E G +V ++ G L + + G L E +I +W ++ +A ++++H
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHD 119
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
I+HRD+KS NI L K K+ DFG+++ ++ ++ GT YL PE +
Sbjct: 120 ---RKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPEICEN 175
Query: 780 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP-SL 838
+ +KSD+++ G +L E+ + + A N +N+V L I I+G P S
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFE----AGNMKNLV----LKI----IRGSYPPVSS 223
Query: 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 873
YD++++ L P RPS++ +L+
Sbjct: 224 HYSYDLRNLV----SQLFKRNPRD--RPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 609 IGSGGFGVVYYGKLK-DGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRI-HHRNLVQFL 663
IG G FG V ++K DG + A+K + S R+F E+ +L ++ HH N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR------------LEIAEDAA 711
G C+ G L E+ +G L + L + E + L A D A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
+G++YL IHRDL + NIL+ ++ AK++DFGLS+ V+ T+G
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMGR 172
Query: 772 LDPEYYISQQL-----TDKSDVYSFGVILLELIS 800
L + + L T SDV+S+GV+L E++S
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 67/253 (26%), Positives = 95/253 (37%), Gaps = 49/253 (19%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT----NEVTLLSRIHHRNLVQ 661
K IG G FG V+ + KD ++ A+KVL S KR E +L+ +V+
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
Q+E LV E+M G L L E R IAE ++ +H
Sbjct: 66 LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-----TARFYIAELVL-ALDSVHK 119
Query: 720 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGAS------------------ 759
G IHRD+K NIL+D K++DFGL K
Sbjct: 120 LGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 760 ----------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809
+S V GT Y+ PE + D +S GVIL E++ G ++
Sbjct: 176 RRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 810 FGANCRNIVQWAK 822
I+ W +
Sbjct: 235 LQETYNKIINWKE 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 609 IGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGK---REFTNEVTLLSRI-HHRNLVQFL 663
IG G FG V ++ KDG + + Y K R+F E+ +L ++ HH N++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE------------QRINWIKRLEIAEDAA 711
G C+ G L E+ +G L + L + E ++ + L A D A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
+G++YL IHRDL + NIL+ ++ AK++DFGLS+ V+ T+G
Sbjct: 135 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMGR 184
Query: 772 LDPEYYISQQL-----TDKSDVYSFGVILLELIS 800
L + + L T SDV+S+GV+L E++S
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 61/225 (27%), Positives = 110/225 (48%), Gaps = 31/225 (13%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTSNSYQGK-REFTNEVTLLSRIHH 656
+L K +G G FG V K +AVK+L N+ + R+ +E LL +++H
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH 62
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------------YGTLTH--EQ 696
++++ G C ++G +L+ E+ G+L+ L L + E+
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 697 RINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756
+ + A ++G++YL ++HRDL + N+L+ + + K+SDFGLS+ +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 757 GASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
S+V S R V ++ E T +SDV+SFGV+L E+++
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L+ K+G G FG V+ G ++A+K L + F E ++ ++ H LV
Sbjct: 10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLY-GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
EE +V EFM G+L + L G + + + +++A A G+ Y+
Sbjct: 69 VVSEE-PIYIVTEFMGKGSLLDFLKEGDGKY---LKLPQLVDMAAQIADGMAYIER---M 121
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
IHRDL+++NIL+ ++ K++DFGL++ D + + + PE + + T
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 784 DKSDVYSFGVILLELIS 800
KSDV+SFG++L EL++
Sbjct: 182 IKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 664
+G GGFG V +++ GK A K L +G+ NE +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS-LA 66
Query: 665 YCQEEGRSV-LVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
Y E ++ LV M+ G LK H+Y G E+ + + A + G+E LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG----RAVFYAAEICCGLEDLHQ-- 120
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
I++RDLK NILLD H ++SD GL+ +G + + GTVGY+ PE +++
Sbjct: 121 -ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNER 177
Query: 782 LTDKSDVYSFGVILLELISGQEAISNEK 809
T D ++ G +L E+I+GQ K
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 61/200 (30%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 609 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 664
+G GGFG V ++K GK A K L + ++ NE +L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS-LA 59
Query: 665 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTGCV 722
Y E + LV M+ G LK H+Y + R A G+E+LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIY---NVGEPGFPEARAIFYAAQIICGLEHLHQ--- 113
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I++RDLK N+LLD H ++SD GL+ G GT GY+ PE +
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVY 171
Query: 783 TDKSDVYSFGVILLELISGQ 802
D ++ G L E+I+G+
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-18
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG 664
+IGSG G VY + G+ A+KV+ N +R+ E+ +L ++H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
G ++ EFM G+L+ + EQ + ++A GI YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGT---HIADEQFLA-----DVARQILSGIAYLHR---RH 188
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
I+HRD+K SN+L++ K++DFG+S+ +S V GT+ Y+ PE I+ L
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPE-RINTDLNH 246
Query: 785 ------KSDVYSFGVILLELISGQ 802
D++S GV +LE G+
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 27/219 (12%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT----SNSYQGK--REFTNEVTLLSRIHHRNL 659
+++G+G F Y + +K G +AVK +T ++S Q + E+ L++R++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
++ LG E+ L E+M G++ L YG IN+ ++L +G+ YL
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYL 119
Query: 718 HTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLS-KFAVD--GASHVSSIVRGTVGYLD 773
H IIHRD+K +N+L+D R +++DFG + + A GA + GT+ ++
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 774 PEYYISQQLTDKSDVYSFGVILLELISGQ-----EAISN 807
PE +Q DV+S G +++E+ + + E SN
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 12/204 (5%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
KIG G G+V G+++AVK + Q + NEV ++ H N+V+
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 725
+V EF+ G L + + T +E++I + K + +LH +
Sbjct: 85 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLAVLKALSFLHA---QGV 136
Query: 726 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD- 784
IHRD+KS +ILL R K+SDFG S+V GT ++ PE IS+
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPE-VISRLPYGT 194
Query: 785 KSDVYSFGVILLELISGQEAISNE 808
+ D++S G++++E++ G+ NE
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 6e-18
Identities = 64/224 (28%), Positives = 112/224 (50%), Gaps = 34/224 (15%)
Query: 604 MLEKKIGSGGFGVVY----YGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRI 654
+L K +G G FG V YG K + +AVK+L N + + + +E+ L+ I
Sbjct: 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLI 74
Query: 655 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------------GTLTHEQRINWI 701
H+N++ LG C +EG ++ E+ G L+E L T E+++++
Sbjct: 75 GKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ G +
Sbjct: 135 DLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDI 187
Query: 762 -----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+S R V ++ PE + T +SDV+SFG+++ E+ +
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 74/291 (25%), Positives = 132/291 (45%), Gaps = 45/291 (15%)
Query: 607 KKIGSGGFGVVY----YGKLKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNL 659
+++G G FG+VY G +KD E V + T N RE F NE +++ + ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI------KRLEIAEDAAKG 713
V+ LG + ++++ E M G LK +L + K +++A + A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TVGY 771
+ YL+ +HRDL + N ++ + K+ DFG+++ + + +G V +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRW 187
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLHIES 827
+ PE T SDV+SFGV+L E+ + E +SNE+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV----------------- 230
Query: 828 GDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877
++ +++ LLD+ D M + E MC + MRPS E++ I++
Sbjct: 231 --LRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 32/277 (11%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIA---VKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 660
+EKKIG G F VVY L DG+ +A V++ + +++ E+ LL ++ H N++
Sbjct: 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVI 65
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIE 715
++L E +V E G L + L E+ I W +++ +E
Sbjct: 66 KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-WKYFVQLCS----ALE 120
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
++H+ I+HRD+K +N+ + K+ D GL +F + S+V GT Y+ PE
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835
KSD++S G +L E+ + Q +K N ++ + IE D
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCK----KIEKCDYP---- 226
Query: 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 872
P D Y + + + C+ P RP IS VL
Sbjct: 227 PLPADHYSEE----LRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 57/201 (28%), Positives = 105/201 (52%), Gaps = 16/201 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +K+G G +G VY K+ G+ +A+KV+ +E E+++L + +V++
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYY 64
Query: 664 GYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
G + +V E+ G+ + + TLT E+ I I KG+EYLH+
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT-EEEIAAILY-----QTLKGLEYLHSN 118
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
IHRD+K+ NILL++ +AK++DFG+S D + ++++ GT ++ PE
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEI 174
Query: 781 QLTDKSDVYSFGVILLELISG 801
+K+D++S G+ +E+ G
Sbjct: 175 GYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 53/229 (23%)
Query: 595 LSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKR------EFT 645
L +D K+ ++IG G FG VY+ + E+ A+K + SY GK+ +
Sbjct: 7 LFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM---SYSGKQSNEKWQDII 63
Query: 646 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF----------MHNGTLKEHLYGTLTHE 695
EV L ++ H N +++ G E + LV E+ +H L+E
Sbjct: 64 KEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQE--------- 114
Query: 696 QRINWIKRLEIA---EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
+EIA A +G+ YLH+ IHRD+K+ NILL + K++DFG +
Sbjct: 115 --------VEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSAS 163
Query: 753 FAVDGASHVSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLEL 798
S V GT ++ PE ++ Q K DV+S G+ +EL
Sbjct: 164 LVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 15/240 (6%)
Query: 608 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
KIG G G+V K GK++AVK + Q + NEV ++ HH N+V
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 726
+V EF+ G L + + T +E++I + + + YLH +I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHN---QGVI 140
Query: 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 786
HRD+KS +ILL R K+SDFG S+V GT ++ PE +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 787 DVYSFGVILLELISGQEAISNEKFGANCRNI-----VQWAKLHIESGDIQGIIDPSLLDE 841
D++S G++++E+I G+ NE R I + H S ++G +D L+ E
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 600 DATKMLEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGK-REFTNEVTLLSRIHHR 657
D +++E IG G VVY E +A+K + Q E EV +S+ +H
Sbjct: 1 DDYELIEV-IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 658 NLVQFLGYCQ-EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA---EDAAK 712
N+V++ Y G + LV ++ G+L + + IA ++ K
Sbjct: 60 NVVKY--YTSFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLK 113
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR----GT 768
G+EYLH+ IHRD+K+ NILL + K++DFG+S DG + VR GT
Sbjct: 114 GLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD-RTRKVRKTFVGT 169
Query: 769 VGYLDPEYYISQQ--LTDKSDVYSFGVILLELISG 801
++ PE + Q K+D++SFG+ +EL +G
Sbjct: 170 PCWMAPE-VMEQVHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 12/218 (5%)
Query: 594 TLSDIEDATKMLEK--KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTL 650
T+ I D K + KIG G G V+ + G+E+A+K + K NE+ +
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 651 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 710
+ + + N+V FL +V E++ G+L + + T E +I + R +
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR-----EC 124
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
+ +E+LH +IHRD+KS N+LL K++DFG S S++V GT
Sbjct: 125 LQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY 180
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808
++ PE + K D++S G++ +E++ G+ NE
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 608 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLG 664
+G G +GVV + K EI A+K S + ++ EV +L ++ H N+V
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHL----YGTLTHE-QRINWIKRLEIAEDAAKGIEYLHT 719
+ +GR LV+E++ TL E L G + W + I Y H+
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIW--------QLLQAIAYCHS 118
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI 778
IIHRD+K NIL+ + K+ DFG ++ AS ++ V T Y PE +
Sbjct: 119 H---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLV 174
Query: 779 SQQLTDKS-DVYSFGVILLELISGQ 802
K DV++ G I+ EL+ G+
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 31/212 (14%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
L ++IGSG +G VY + + G+ +A+KV+ E+++L H N+V +
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLY----GTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
G + +V E+ G+L++ +Y G L+ E +I ++ R + KG+ YLH
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLS-ELQIAYVCR-----ETLKGLAYLHE 119
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-----GTVGYLDP 774
IHRD+K +NILL + K++DFG+S A ++I + GT ++ P
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFGVS------AQLTATIAKRKSFIGTPYWMAP 170
Query: 775 EYYISQQLTD----KSDVYSFGVILLELISGQ 802
E + + K D+++ G+ +EL Q
Sbjct: 171 E-VAAVERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-17
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 14/219 (6%)
Query: 594 TLSDIEDATKMLEK--KIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTL 650
T+ + D K + KIG G G VY + G+E+A+K + K NE+ +
Sbjct: 10 TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69
Query: 651 LSRIHHRNLVQFL-GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 709
+ H N+V +L Y + V V E++ G+L + + T E +I + R +
Sbjct: 70 MRENKHPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTETCMDEGQIAAVCR-----E 123
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
+ +E+LH+ V IHRD+KS NILL K++DFG S S++V GT
Sbjct: 124 CLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 179
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808
++ PE + K D++S G++ +E++ G+ NE
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 607 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ 661
++GSG FG V Y K K +AVK+L +N K E E ++ ++ + +V+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
+G C+ E +LV E G L + L + + E+ + G++YL
Sbjct: 61 MIGICEAESW-MLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEET- 114
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYIS 779
+HRDL + N+LL AK+SDFGLSK ++ + G V + PE
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 780 QQLTDKSDVYSFGVILLELIS-GQE 803
+ + KSDV+SFGV++ E S GQ+
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 30/278 (10%)
Query: 604 MLEKKIGSGGFGVVYYGK-LKDGKEIAVK---VLTSNSYQGKREFTNEVTLLSRIHHRNL 659
+EKKIG G F VY L D K +A+K + + +++ E+ LL +++H N+
Sbjct: 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNV 64
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE----QRINWIKRLEIAEDAAKGIE 715
+++L E+ +V E G L + + + +R W +++ +E
Sbjct: 65 IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS----AVE 120
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
++H+ ++HRD+K +N+ + K+ D GL +F + S+V GT Y+ PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835
KSD++S G +L E+ + Q +K N ++ Q IE D
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFSLCQ----KIEQCDY----- 225
Query: 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 873
P L E+ + K+ E MC+ P RP I V +
Sbjct: 226 PPLPTEHYSE---KLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKVLT--SNSYQGKREFTN---EVTLLSRIHHRNLV 660
K +G G FG VY + G+E+A K + S + +E + E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 661 QFLGYCQEEGRSVLV--YEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 716
Q+ G ++ L E+M G++K+ L YG LT + +++ +G+ Y
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSY 121
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVGYL 772
LH+ I+HRD+K +NIL D K+ DFG SK + G S V GT ++
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS--VTGTPYWM 176
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELIS 800
PE + K+DV+S G ++E+++
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSN--SYQGKREFTN---EVTLLSRIHHRN 658
L K +G G FG VY D G+E+AVK + + S + +E E+ LL + H
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 659 LVQFLGYCQEEGRSVL--VYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGI 714
+VQ+ G ++ L E M G++K+ L YG LT + +++ +G+
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI------LEGV 119
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVG 770
YLH+ I+HRD+K +NIL D K+ DFG SK + G S V GT
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPY 174
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELIS 800
++ PE + K+D++S G ++E+++
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 14/210 (6%)
Query: 597 DIEDATKMLEK--KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR 653
D D +LE KIG G G+V + K G+++AVK++ Q + NEV ++
Sbjct: 15 DQGDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 74
Query: 654 IHHRNLVQ-FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 712
H+N+V+ + Y E VL+ EF+ G L + + + R+N + + E +
Sbjct: 75 YQHQNVVEMYKSYLVGEELWVLM-EFLQGGALTD-----IVSQTRLNEEQIATVCESVLQ 128
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
+ YLH+ +IHRD+KS +ILL R K+SDFG S+V GT ++
Sbjct: 129 ALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWM 184
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELISGQ 802
PE + D++S G++++E++ G+
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 17/202 (8%)
Query: 612 GGFGVVYYGKLKDGK-----EIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQFLGY 665
G FG ++YG L D K E+ VK + ++ + + E LL + H+N++ L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 666 CQEEGRSVLV-YEFMHNGTLKEHL----YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
C E+G V Y +M+ G LK L G + Q ++ + + +A A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVRGTVGYLDPEYYI 778
+IH+D+ + N ++D+ ++ K++D LS+ F +D + R V ++ E +
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR-PVKWMALESLV 192
Query: 779 SQQLTDKSDVYSFGVILLELIS 800
+++ + SDV+SFGV+L EL++
Sbjct: 193 NKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 6e-17
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSY--QGKREFT-NEVTLLSRIHHRNLVQF 662
K +G+G FG V + K + A+K+L+ + E NE +L I H LV
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 714
G Q++ LV E++ G L HL R E A+ +
Sbjct: 67 YGSFQDDSNLYLVMEYVPGGELFSHL----------RKSGRFP--EPVARFYAAQVVLAL 114
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
EYLH+ I++RDLK N+LLD K++DFG +K + GT YL P
Sbjct: 115 EYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAP 167
Query: 775 EYYISQQLTDKS-DVYSFGVILLELISG 801
E I + K+ D ++ G+++ E+++G
Sbjct: 168 E-IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-17
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 607 KKIGSGGFGVVY----YGKLKDGK--EIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 658
K +G+G FG V YG K ++AVK+L ++ +RE +E+ ++S + +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+V LG C G +++ E+ G L L E + L + AKG+ +L
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 719 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT----VGYLD 773
+ C IHRDL + N+LL K+ DFGL++ D + + +V+G V ++
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNYVVKGNARLPVKWMA 211
Query: 774 PEYYISQQLTDKSDVYSFGVILLELIS 800
PE + T +SDV+S+G++L E+ S
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 1e-16
Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 25/220 (11%)
Query: 599 EDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKR------EFTNEVTL 650
ED K+ ++IG G FG VY+ + D + V + SY GK+ + EV
Sbjct: 21 EDPEKLFTDLREIGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78
Query: 651 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 710
L RI H N +++ G E + LV E+ G+ + L H++ + ++ I A
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGA 134
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
+G+ YLH+ +IHRD+K+ NILL + + K++DFG + A S V GT
Sbjct: 135 LQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPY 186
Query: 771 YLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISN 807
++ PE ++ Q K DV+S G+ +EL + + N
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 10/202 (4%)
Query: 608 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
KIG G G+V +K GK +AVK + Q + NEV ++ H N+V+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 726
+V EF+ G L + + T +E++I + K + LH +I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGVI 138
Query: 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 786
HRD+KS +ILL R K+SDFG S+V GT ++ PE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEV 197
Query: 787 DVYSFGVILLELISGQEAISNE 808
D++S G++++E++ G+ NE
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+KIG G +GVVY + G+ +A+K L + + E++LL ++H N+V+ L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
E + LV+EF+H LK+ + + + IK +G+ + H+ V
Sbjct: 66 DVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCHSHRV- 121
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 781
+HRDLK N+L++ K++DFGL++ F V ++ +V T+ Y PE + +
Sbjct: 122 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 177
Query: 782 LTDKSDVYSFGVILLELIS 800
+ D++S G I E+++
Sbjct: 178 YSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTN---EVTLLSRIHHRN 658
L K +G G FG VY D G+E+AVK + +S + +E E+ LL + H
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65
Query: 659 LVQFLGYCQ--EEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGI 714
+VQ+ G + EE + + E+M G++K+ L YG LT + +++ +G+
Sbjct: 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI------LQGV 119
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVG 770
YLH+ I+HRD+K +NIL D K+ DFG SK + G S V GT
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS--VTGTPY 174
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELIS 800
++ PE + K+DV+S ++E+++
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 664
+G GGFG V +++ GK A K L + ++ NE +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 66
Query: 665 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 720
Y E ++ LV M+ G LK H+Y E+R + A + G+E LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY-----AAEITCGLEDLHR- 120
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I++RDLK NILLD + ++SD GL+ +G + + GTVGY+ PE ++
Sbjct: 121 --ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKNE 176
Query: 781 QLTDKSDVYSFGVILLELISGQEAISNEK 809
+ T D + G ++ E+I G+ K
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 608 KIGSGGFGVVYYGKLKDGK---EIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFL 663
++GSG FG V G K K ++A+KVL + + + R E E ++ ++ + +V+ +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
G C+ E +LV E G L + L G + I +E+ + G++YL
Sbjct: 62 GVCEAEAL-MLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEG---K 114
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRGTVGYLDPEYYISQQ 781
+HRDL + N+LL AK+SDFGLSK A D S + + + PE ++
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 782 LTDKSDVYSFGVILLELIS-GQE 803
+ +SDV+S+G+ + E S GQ+
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
+KIG G G VY + G+E+A++ + K NE+ ++ + N+V +L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 725
+V E++ G+L + + T E +I + R + + +E+LH+ +
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN---QV 137
Query: 726 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 785
IHRD+KS NILL K++DFG S S++V GT ++ PE + K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196
Query: 786 SDVYSFGVILLELISGQEAISNE 808
D++S G++ +E+I G+ NE
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 606 EKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN-----EVTLLSRIHHRNL 659
KK+G G + VVY + + G+ +A+K + + ++ N E+ LL + H N+
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG----TLTHEQRINWIKRLEIAEDAAKGIE 715
+ L + LV+EFM T E + LT +++ +G+E
Sbjct: 65 IGLLDVFGHKSNINLVFEFME--TDLEKVIKDKSIVLTPADIKSYMLMT------LRGLE 116
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
YLH+ I+HRDLK +N+L+ K++DFGL++ ++ V T Y PE
Sbjct: 117 YLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPE 172
Query: 776 -YYISQQLTDKSDVYSFGVILLELI 799
+ ++ D++S G I EL+
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 608 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGK---REFTNEVTLLSRIHHRNLVQFL 663
++G GG+G V+ K KD EI A+K + + R E +L+ LV+ L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
Q++ L E++ G + L G L+ + R +AE ++ LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH-----ARFYMAEMFE-AVDALHE-- 119
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
IHRDLK N L+D K++DFGLSK V ++ +S+V G+ Y+ PE +
Sbjct: 120 -LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANSVV-GSPDYMAPEVLRGKG 174
Query: 782 LTDKSDVYSFGVILLELISGQEAIS----NEKFGANCRNIVQWAK 822
D +S G +L E + G S NE + N+ W +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW----ENLKYWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
+KIG G G VY + G+E+A+K + K NE+ ++ + N+V +L
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 725
+V E++ G+L + + T E +I + R + + +++LH+ +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALDFLHSN---QV 136
Query: 726 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 785
IHRD+KS NILL K++DFG S S++V GT ++ PE + K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 786 SDVYSFGVILLELISGQEAISNE 808
D++S G++ +E++ G+ NE
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 605 LEKKIGSGGFGVVY---YGKLKDGK-EIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 659
L + IG G FG VY Y ++ K +AVK + + RE F E ++ + H ++
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI---AEDAAKGIEY 716
V+ +G E +V E G L+ +L + + + + + + Y
Sbjct: 70 VKLIGVI-TENPVWIVMELAPLGELRSYL------QVNKYSLDLASLILYSYQLSTALAY 122
Query: 717 LH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
L V HRD+ + N+L+ K+ DFGLS++ D + + +S + + ++ PE
Sbjct: 123 LESKRFV----HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 776 YYISQQLTDKSDVYSFGVILLELIS 800
++ T SDV+ FGV + E++
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 664
+G GGFG V +++ GK A K L +G+ NE +L +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN-LA 66
Query: 665 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 720
Y E ++ LV M+ G LK H+Y E+R L A + G+E LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA-----LFYAAEILCGLEDLHR- 120
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
++RDLK NILLD + ++SD GL+ +G S + GTVGY+ PE +Q
Sbjct: 121 --ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNNQ 176
Query: 781 QLTDKSDVYSFGVILLELISGQEAISNEK 809
+ T D + G ++ E+I GQ K
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 62/224 (27%), Positives = 113/224 (50%), Gaps = 34/224 (15%)
Query: 604 MLEKKIGSGGFGVVYYG------KLKDGK--EIAVKVLTSNSYQGK-REFTNEVTLLSRI 654
+L K +G G FG V K K + ++AVK+L S++ + + +E+ ++ I
Sbjct: 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 80
Query: 655 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWI 701
H+N++ LG C ++G ++ E+ G L+E+L T E+++++
Sbjct: 81 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ H+
Sbjct: 141 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 193
Query: 762 SSIVRGTVG-----YLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ T G ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 605 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 654
L K +G G FG V K K+ +AVK+L ++ + + +E+ ++ I
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 78
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 702
H+N++ LG C ++G ++ E+ G L+E+L ++++ +
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
+ A+G+EYL + IHRDL + N+L+ ++ K++DFGL++ V+ +
Sbjct: 139 LVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR-DVNNIDYYK 194
Query: 763 SIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
G V ++ PE + T +SDV+SFGV++ E+ +
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 662
L + IG G +G VY + K G+ +A+K++ + E E +L + +H N+ F
Sbjct: 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATF 68
Query: 663 LG-YCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGI 714
G + ++ LV E G++ + + G +R+ WI I + +G+
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILRETLRGL 126
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
YLH V IHRD+K NILL K+ K+ DFG+S +D + GT ++ P
Sbjct: 127 AYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTFIGTPYWMAP 182
Query: 775 EYYISQQLTD-----KSDVYSFGVILLELISGQ 802
E + D +SDV+S G+ +EL G+
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 40/225 (17%)
Query: 605 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 656
L K +G G FG V + +AVK+L ++ + + +E+ ++ I H
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 75
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRL 704
+N++ LG C +EG +V E+ +G L++ L E+ + +
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 705 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS---------KFAV 755
A A+G+E+L + IHRDL + N+L+ + K++DFGL+ +
Sbjct: 136 SFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+G R V ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 193 NG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 661
K IG G FG V K K DGK AVKVL + K+E LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
Q + V ++++ G L HL E+ + A + A + YLH+
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHS-- 114
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
II+RDLK NILLD ++DFGL K ++ + S+ GT YL PE + +Q
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPE-VLRKQ 171
Query: 782 LTDKS-DVYSFGVILLELISG 801
D++ D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 17/207 (8%)
Query: 609 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHH---RNLVQFL 663
IG G +G VY GK + G+ +A+K++ ++ + EV LLS++ N+ ++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 664 GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
G +G + ++ E+ G+++ + E+ I+ I R + ++Y+H
Sbjct: 69 G-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIHKV-- 120
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
+IHRD+K++NIL+ K+ DFG++ +S S+ V GT ++ PE +
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 783 TD-KSDVYSFGVILLELISGQEAISNE 808
D K+D++S G+ + E+ +G S+
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDV 205
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN-EVTLLSRIHHRNLVQF 662
L + IG G FG VY K + +A+KV+ + + E E+ LS+ + ++
Sbjct: 5 LLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKY 64
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
G + + ++ E+ G+ + L G L E I +I R + G+EYLH
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLLKPGKL-DETYIAFILR-----EVLLGLEYLHEEG 118
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
IHRD+K++NILL + K++DFG+S S ++ V GT ++ PE I Q
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPE-VIKQS 173
Query: 782 LTD-KSDVYSFGVILLELISG 801
D K+D++S G+ +EL G
Sbjct: 174 GYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 19/214 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTS--NSYQGKREFTNEVTLLSRIHHRN 658
L + +G G FG V +LK +++AVK+L + S EF E + H N
Sbjct: 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPN 62
Query: 659 LVQFLG---YCQEEGR---SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR--LEIAEDA 710
+++ +G + +GR +++ FM +G L L + E+ + + D
Sbjct: 63 VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTV 769
A G+EYL + IHRDL + N +L+++M V+DFGLSK G + + V
Sbjct: 123 ASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 802
+L E T SDV++FGV + E+++ GQ
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-16
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 608 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKR------EFTNEVTLLSRIHHRNLV 660
+IG G FG VY+ E+ AVK + SY GK+ + EV L ++ H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKM---SYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
++ G +E + LV E+ G+ + L H++ + ++ I A +G+ YLH+
Sbjct: 85 EYKGCYLKEHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
+IHRD+K+ NILL + + K++DFG + + S V GT ++ PE ++
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192
Query: 781 ---QLTDKSDVYSFGVILLELISGQEAISN 807
Q K DV+S G+ +EL + + N
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 68/275 (24%), Positives = 127/275 (46%), Gaps = 35/275 (12%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +G G +G V + + DGK+ +K L + S + ++ E LLS++ H N+V +
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 664 GYCQ-EEGRSVLVYEFMHNG----TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ E+G +V F G LKE L Q + W ++ +A ++YLH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQYLH 119
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
I+HRDLK+ N+ L + KV D G+++ ++ ++S + GT Y+ PE +
Sbjct: 120 E---KHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPELFS 175
Query: 779 SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838
++ KSDV++ G + E+ + + A + + + I++ KL P +
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKL------------PPM 222
Query: 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 873
+Y + I ++ P RPS+ +L+
Sbjct: 223 PKDYSPELGELI--ATMLSKRP--EKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 604 MLEKKIGSGGFG--VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+ + +G G FG ++ D K ++ S + E LL+++ H N+V
Sbjct: 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYL 717
F + +G +V E+ G L + + G L E I W ++ + G++++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 777
H ++HRD+KS NI L ++ + K+ DFG ++ ++ + V GT Y+ PE +
Sbjct: 117 HE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW 172
Query: 778 ISQQLTDKSDVYSFGVILLEL 798
+ +KSD++S G IL EL
Sbjct: 173 ENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEI---AVKVLTSN--SYQGKREFTNEVTLLSRIHHRNL 659
L K +G G FG V G+L I AVK + + +F +E + H N+
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 660 VQFLGYC----QEEG--RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL--EIAEDAA 711
++ +G C + EG V++ FM +G L L + + ++ + D A
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-IVRGTVG 770
G+EYL + + IHRDL + N +L+++M V+DFGLSK +G + I + V
Sbjct: 123 SGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 802
++ E + T KSDV+SFGV + E+ + GQ
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 608 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFLG 664
+IG G G+V+ K + G+ +A+K + +G + E+ L H +V+ L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYLHTGC 721
VLV E+M + L L E+R +K KG+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSY--MRMLLKGVAYMHAN- 118
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE-YYISQ 780
I+HRDLK +N+L+ K++DFGL++ + + S T Y PE Y ++
Sbjct: 119 --GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
+ D+++ G I EL++G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 609 IGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRI---HHRNLVQF 662
IG G +G VY + L G+ +A+K V S +G T E+ LL ++ H N+V+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 663 LGYCQ----EEGRSV-LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
L C + + LV+E + T + I + R ++ +G++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR-QLL----RGVD 121
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH+ I+HRDLK NIL+ + K++DFGL++ + S +V T+ Y PE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176
Query: 776 YYISQQLTDKSDVYSFGVILLEL 798
+ D++S G I EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG 664
+G+G G V K + G +A KV+ + +++ E+ ++ +V F G
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
E + EFM G+L G + E +IA +G+ YL+ V
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVE------ILGKIAVAVVEGLTYLYN--V 122
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I+HRD+K SNIL++ + K+ DFG+S ++ ++ GT Y+ PE +
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQGGKY 179
Query: 783 TDKSDVYSFGVILLELISGQ 802
T KSDV+S G+ ++EL G+
Sbjct: 180 TVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT-----NEVTLLSR------I 654
K +G G FG V +LK E A+K L K++ E T++ R
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKAL-------KKDVVLEDDDVECTMVERRVLALAW 53
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
H L Q + V E+++ G L H+ + ++ EI G+
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEII----CGL 109
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
++LH II+RDLK N+LLDK K++DFG+ K ++G S+ GT Y+ P
Sbjct: 110 QFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAP 165
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808
E Q+ + D +SFGV+L E++ GQ E
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 606 EK--KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQG-KREFTNEVTLLSRIHHRNLV 660
EK +IG G +G+VY + EI KV N G E+TLL + H N+V
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV 69
Query: 661 QFLGYCQEEGRSV----LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
+ G+ + LV E+ +L +++ + Q +K L + +G+
Sbjct: 70 ELKEVVV--GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQ----VKCLML--QLLRGL 121
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
+YLH IIHRDLK SN+LL K++DFGL++ A ++ V T+ Y P
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177
Query: 775 EYYI-SQQLTDKSDVYSFGVILLELISGQ 802
E + T D+++ G IL EL++ +
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 14/206 (6%)
Query: 600 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHH 656
D TK+ +KIG G +GVVY G+ K G+ +A+K + S + T E++LL + H
Sbjct: 1 DYTKI--EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH 58
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
N+V +E R L++EF+ + LK++L +L Q ++ +GI +
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFL-SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE 775
H+ ++HRDLK N+L+D K++DFGL++ F + + +V T+ Y PE
Sbjct: 117 CHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPE 171
Query: 776 YYI-SQQLTDKSDVYSFGVILLELIS 800
+ S + + D++S G I E+ +
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 588 EAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---- 642
+ A F D E L ++IG G FG VY+ + +++ + +A+K + SY GK+
Sbjct: 3 DVAELFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEK 58
Query: 643 --EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 700
+ EV L ++ H N +Q+ G E + LV E+ G+ + L H++ +
Sbjct: 59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQE 114
Query: 701 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760
++ + A +G+ YLH+ +IHRD+K+ NILL + K+ DFG +
Sbjct: 115 VEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF 171
Query: 761 VSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLEL 798
V GT ++ PE ++ Q K DV+S G+ +EL
Sbjct: 172 V-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-15
Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 12/208 (5%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 654
D E+ LEK IG G FG V+ G + K +A+K++ + + E E+T+LS+
Sbjct: 1 DPEELFTKLEK-IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
+ ++ G ++ + ++ E++ G+ + L E +I I R + KG+
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGL 114
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
+YLH+ IHRD+K++N+LL +H K++DFG++ D ++ V GT ++ P
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 170
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQ 802
E K+D++S G+ +EL G+
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 30/237 (12%)
Query: 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 664
+G GGFG V +++ GK A K L + ++ + E +L+++H R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
Q + LV M+ G L+ H+Y + G+E+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
II+RDLK N+LLD ++SD GL+ DG S GT G++ PE ++
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYDF 176
Query: 785 KSDVYSFGVILLELISGQ-------EAISN---------------EKFGANCRNIVQ 819
D ++ GV L E+I+ + E + N +KF ++ +
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 67/216 (31%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTN-EVTLLS 652
D+ D + E IGSG G VY + K G +AVK + T N + KR + +V L S
Sbjct: 13 DLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS 70
Query: 653 RIHHR--NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 710
H +V+ GY + + E M T + L + + + ++ +A
Sbjct: 71 ---HDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA--I 123
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
K + YL +IHRD+K SNILLD K+ DFG+S VD + S G
Sbjct: 124 VKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS--AGCAA 179
Query: 771 YLDPEYYISQQLTDK----SDVYSFGVILLELISGQ 802
Y+ PE K +DV+S G+ L+EL +GQ
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 660
K +GSG FG V+ G + +G I A+K + S Q +E T+ + + + H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 661 QFLGYCQEEGRSV-LVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEY 716
+ LG C G S+ LV + G+L +H+ +L ++ +NW ++ AKG+ Y
Sbjct: 73 RLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYY 124
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPE 775
L ++HR+L + NILL +++DFG++ D + S + + ++ E
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 776 YYISQQLTDKSDVYSFGVILLELIS 800
+ + T +SDV+S+GV + E++S
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 69/234 (29%), Positives = 99/234 (42%), Gaps = 33/234 (14%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR-----NLV 660
K I G FG VY K + G A+KVL + K + TN V I +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYVA 60
Query: 661 QFLGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
+ Q + LV E+++ G +L + L G L + W K+ IAE G+E L
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPED----WAKQY-IAE-VVLGVEDL 113
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 777
H IIHRD+K N+L+D+ K++DFGLS+ + GT YL PE
Sbjct: 114 HQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETI 165
Query: 778 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831
+ SD +S G ++ E + G F A + V + I S I
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPP-----FHAETPDAV-FDN--ILSRRIN 211
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-15
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR------IHHRNL 659
K +G G FG V+ +LK + A+K L + + E T++ + H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFL 58
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
Q + V E+++ G L H+ + + + A + G+++LH+
Sbjct: 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHS 114
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
I++RDLK NILLD K++DFG+ K + G + + GT Y+ PE +
Sbjct: 115 ---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLG 170
Query: 780 QQLTDKSDVYSFGVILLELISGQ 802
Q+ D +SFGV+L E++ GQ
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 664
+G GGFG V +++ GK A K L +G+ NE +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS-LA 66
Query: 665 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 720
Y E ++ LV M+ G LK H+Y EQR + A + G+E L
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRA-----IFYAAELCCGLEDLQR- 120
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I++RDLK NILLD ++SD GL+ +G + + GTVGY+ PE ++
Sbjct: 121 --ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNE 176
Query: 781 QLTDKSDVYSFGVILLELISGQEAISNEK 809
+ T D + G ++ E+I GQ K
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-14
Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 660
K +GSG FG VY G + +G+ + A+K+L + + EF +E +++ + H +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ LG C LV + M +G L ++++ H+ I L AKG+ YL
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIAKGMMYLEE- 127
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYIS 779
++HRDL + N+L+ K++DFGL++ D + + + + ++ E
Sbjct: 128 --RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 780 QQLTDKSDVYSFGVILLELIS 800
++ T +SDV+S+GV + EL++
Sbjct: 186 RKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV----- 660
K +G G FG V +LK G+ AVK L + + E T++ + R L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDV--ECTMVEK---RVLALAWEN 55
Query: 661 QFLG--YC--QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
FL YC Q + V EF++ G L H+ + R + + A + G+++
Sbjct: 56 PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRFDLYRATFYAAEIVCGLQF 111
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
LH+ II+RDLK N++LD+ K++DFG+ K V G + S+ GT Y+ PE
Sbjct: 112 LHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEI 167
Query: 777 YISQQLTDKSDVYSFGVILLELISGQ 802
+ T D +SFGV+L E++ GQ
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 67/271 (24%), Positives = 118/271 (43%), Gaps = 22/271 (8%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVK---VLTSNSYQGKREFTNEVTLLSRIHHRNLV 660
+EKKIG G F VY L DG +A+K + + + + E+ LL +++H N++
Sbjct: 6 IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 65
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
++ E+ +V E G L + ++ I + +E++H+
Sbjct: 66 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS- 124
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
++HRD+K +N+ + K+ D GL +F + S+V GT Y+ PE
Sbjct: 125 --RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 181
Query: 781 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840
KSD++S G +L E+ + Q +K N+ K IE D P L
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCK-KIEQCDY-----PPLPS 230
Query: 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEV 871
++ + + ++ MC+ P RP I+ V
Sbjct: 231 DHYSEELRQLVN---MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 56/204 (27%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLV 660
K +GSG FG VY G + DG+ + A+KVL N S + +E +E +++ + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYL 717
+ LG C LV + M G L +++ + + +NW ++ AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA-VDGASHVSSIVRGTVGYLDPEY 776
++HRDL + N+L+ K++DFGL++ +D + + + + ++ E
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 777 YISQQLTDKSDVYSFGVILLELIS 800
+ ++ T +SDV+S+GV + EL++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 667
+G G FG VY + K+ A K++ S + +F E+ +LS H N+V
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 668 EEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
E + ++ EF G L L LT E +I ++ R + + +LH+
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLT-EPQIRYVCR-----QMLEALNFLHSH---K 123
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
+IHRDLK+ NILL K++DFG+S + + GT ++ PE + D
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKD 182
Query: 785 -----KSDVYSFGVILLEL 798
K+D++S G+ L+EL
Sbjct: 183 NPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 59/208 (28%), Positives = 109/208 (52%), Gaps = 22/208 (10%)
Query: 603 KMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLV 660
K LEK +G G + VY G+ + EI A+K + ++ +G E++L+ + H N+V
Sbjct: 3 KQLEK-LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIE 715
+ E + +LV+E+M + LK+++ G L ++ +L KGI
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL------LKGIA 114
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDP 774
+ H ++HRDLK N+L++K K++DFGL++ F + + + +V T+ Y P
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAP 169
Query: 775 EYYI-SQQLTDKSDVYSFGVILLELISG 801
+ + S+ + D++S G I+ E+I+G
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 608 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
++G G FG VY K K+ G A KV+ + S + ++ E+ +L+ +H +V+ LG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 726
+G+ ++ EF G + + L ++ + + I + ++YLH+ II
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVICRQMLEALQYLHS---MKII 132
Query: 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 784
HRDLK+ N+LL K++DFG+S V S + GT ++ PE + + + D
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTP 191
Query: 785 ---KSDVYSFGVILLEL 798
K+D++S G+ L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 74/225 (32%), Positives = 109/225 (48%), Gaps = 28/225 (12%)
Query: 594 TLSDIEDATKMLEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 652
+L D D +++E IG G +G VY KDG AVK+L S E E +L
Sbjct: 16 SLGDPTDTWEIIET-IGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQ 73
Query: 653 RI-HHRNLVQFLG--YCQEE---GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 706
+ +H N+V+F G Y ++ G+ LV E + G++ E + G L QR++ I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 707 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766
A G+++LH IIHRD+K +NILL K+ DFG+S A S+ +R
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS------AQLTSTRLR 184
Query: 767 -----GTVGYLDPEYYISQQLTDKS-----DVYSFGVILLELISG 801
GT ++ PE +Q D S DV+S G+ +EL G
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 28/202 (13%)
Query: 609 IGSGGFGVVYYG-KLKDGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
+G G G VY L + +AVKV+ + + + +++ +E+ +L + ++ F G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 667 QEEGRSVLVYEFMHNGTLK------EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
E R + EFM G+L EH+ G IA KG+ YL +
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG--------------RIAVAVVKGLTYLWS- 113
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I+HRD+K SN+L++ + K+ DFG+S V+ ++ GT Y+ PE +
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGE 168
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
Q SDV+S G+ +EL G+
Sbjct: 169 QYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 57/231 (24%), Positives = 112/231 (48%), Gaps = 37/231 (16%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGKE-----------------IAVKVLTSNSYQGKR-EFT 645
+ ++K+G G FG V+ ++ + ++ +AVK+L ++ + R +F
Sbjct: 8 LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFL 67
Query: 646 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-------- 697
EV +LSR+ N+++ LG C +E ++ E+M NG L + L ++
Sbjct: 68 KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 698 -------INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750
I++ L +A A G++YL + +HRDL + N L+ +++ K++DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 751 SKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
S+ G + + + ++ E + + T SDV++FGV L E++
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 65/200 (32%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 661
K IG G FG V K K DG AVKVL + K+E + + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
Q + V ++++ G L HL E+ + A + A I YLH+
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLHS-- 114
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
II+RDLK NILLD ++DFGL K V+ S+ GT YL PE +
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEP 172
Query: 782 LTDKSDVYSFGVILLELISG 801
D + G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-14
Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 609 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYC 666
+G+G +G VY G+ +K G+ A+KV+ + + E E+ +L + HHRN+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 667 QEEG------RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
++ + LV EF G++ + + T + + WI I + +G+ +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
+IHRD+K N+LL ++ K+ DFG+S +D + GT ++ PE
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 781 QLTD-----KSDVYSFGVILLELISG 801
+ D KSD++S G+ +E+ G
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 65/224 (29%), Positives = 96/224 (42%), Gaps = 33/224 (14%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN----- 646
FT D++D +IG G FG V K G +AVK + S ++E
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DEKEQKRLLMDL 53
Query: 647 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-- 704
+V + S +V+F G EG + E M + Y + + + +
Sbjct: 54 DVVMRSS-DCPYIVKFYGALFREGDCWICMELMD--ISLDKFYKYVYEVLKSVIPEEILG 110
Query: 705 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764
+IA K + YL IIHRD+K SNILLD++ K+ DFG+S VD SI
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD------SI 162
Query: 765 VR----GTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISG 801
+ G Y+ PE +SDV+S G+ L E+ +G
Sbjct: 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-14
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 26/200 (13%)
Query: 625 GKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFL--GYCQEEGRSVLVYEFM 679
G E+A+K+L +++ + + + F E L +R++H N+V L G G V+E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 680 HNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 737
TL+E L G L + + ++ A A H I+HRDLK NI++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACA------HNQ---GIVHRDLKPQNIMV 112
Query: 738 ---DKHMRAKVSDFGLSKFAVD-GASHVSSIVR-----GTVGYLDPEYYISQQLTDKSDV 788
AKV DFG+ + V+++ R GT Y PE + +T SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 789 YSFGVILLELISGQEAISNE 808
Y++G+I LE ++GQ +
Sbjct: 173 YAWGLIFLECLTGQRVVQGA 192
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 61/236 (25%)
Query: 607 KKIGSGGFGVVYYGK--------LKDGKE---------IAVKVLTSN-SYQGKREFTNEV 648
+K+G G FG V+ + K E +AVKVL + S + +F EV
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR----- 703
+LSR+ N+ + LG C + ++ E+M NG L + L H + +
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQ---KHVAETSGLACNSKSL 127
Query: 704 -----LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK------ 752
L +A A G+ YL + +HRDL + N L+ K+ K++DFG+S+
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 753 -FAVDGASHV-------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ V G + + S++ G + T KSDV++FGV L E+++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLG-------------KFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQFLG 664
++IG G FG VY G KE+ A+K++ + + E E+T+LS+ + ++ G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
+ + ++ E++ G+ + L E I I R + KG++YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYLHS---ER 121
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
IHRD+K++N+LL + K++DFG++ D ++ V GT ++ PE I Q D
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE-VIKQSAYD 179
Query: 785 -KSDVYSFGVILLELISGQEAISN 807
K+D++S G+ +EL G+ S+
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-14
Identities = 66/201 (32%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 661
K IG G FG V K K DGK AVKVL ++E LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTG 720
Q + V +F++ G L HL + E R R AE A + YLH+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR----ARFYAAE-IASALGYLHS- 114
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I++RDLK NILLD ++DFGL K + + ++ GT YL PE Q
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC-GTPEYLAPEVIRKQ 171
Query: 781 QLTDKSDVYSFGVILLELISG 801
+ D + G +L E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 74/293 (25%), Positives = 136/293 (46%), Gaps = 45/293 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 657
L +++G G FG+VY G +D +AVK + S S + + EF NE +++
Sbjct: 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN-------WIKRLEIAEDA 710
++V+ LG + +++V E M +G LK +L +L E N + +++A +
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 768
A G+ YL+ +HRDL + N ++ K+ DFG+++ + + +G
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLP 184
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLH 824
V ++ PE T SD++SFGV+L E+ S E +SNE+
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV-------------- 230
Query: 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877
++ ++D LD+ D ++ + MC + MRP+ E++ ++D
Sbjct: 231 -----LKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 605 LEKKIGSGGFGVVYYG------KLKDGK--EIAVKVLTSNSY-QGKREFTNEVTLLSRI- 654
L K +G G FG V K K K +AVK+L ++ + + +E+ ++ I
Sbjct: 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL---------YGTLT---HEQRINWIK 702
H+N++ LG C ++G ++ E+ G L+E+L Y T E+++ +
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ V +
Sbjct: 136 LVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLAR-DVHNIDYYK 191
Query: 763 SIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
G V ++ PE + T +SDV+SFGV+L E+ +
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 22/222 (9%)
Query: 595 LSDIEDATKMLE--KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLL 651
LS + D + E + +G+G +G VY G+ +K G+ A+KV+ + + E E+ +L
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINML 66
Query: 652 SRI-HHRNLVQFLGY------CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 704
+ HHRN+ + G + + LV EF G++ + + T + + +WI
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY- 125
Query: 705 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764
I + +G+ +LH +IHRD+K N+LL ++ K+ DFG+S +D +
Sbjct: 126 -ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNT 180
Query: 765 VRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISG 801
GT ++ PE + D +SD++S G+ +E+ G
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 7e-14
Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 38/218 (17%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT---SNSYQGKREFTNEVTLLSRI-HHRNL 659
+ +K+G G +G+V+ + KE+ A+K + N+ +R F E+ L + H N+
Sbjct: 11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNI 69
Query: 660 VQFLG-YCQEEGRSV-LVYEFM----HN----GTLKEHLYGTLTHEQRINWIKRLEIAED 709
V+ L E + + LV+E+M H L++ H++ I +
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED------VHKRYIMY--------Q 115
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGT 768
K ++Y+H+G +IHRDLK SNILL+ R K++DFGL++ + + + ++
Sbjct: 116 LLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172
Query: 769 VG---YLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
V Y PE + S + T D++S G IL E++ G+
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 7e-14
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 662
K +G G FG V + K GK A+K+L K E + +T +L H L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
Q + R V E+++ G L HL + E+ + + + ++YLH+G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLHSG-- 114
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I++RDLK N++LDK K++DFGL K + A+ + + GT YL PE
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDY 172
Query: 783 TDKSDVYSFGVILLELISGQEAISNE 808
D + GV++ E++ G+ N+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 70/225 (31%), Positives = 95/225 (42%), Gaps = 48/225 (21%)
Query: 595 LSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREF--------- 644
LSD E + + +G+G FG V K K G+ A+K L KRE
Sbjct: 17 LSDFE-----MGETLGTGSFGRVRIAKHKGTGEYYAIKCLK------KREILKMKQVQHV 65
Query: 645 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 704
E ++L + H +V + Q+E R + EF+ G L HL K
Sbjct: 66 AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR------------KAG 113
Query: 705 EIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756
D AK EYLH+ II+RDLK N+LLD KV+DFG +K D
Sbjct: 114 RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170
Query: 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
+ GT YL PE S+ D ++ GV+L E I+G
Sbjct: 171 RTFTLC----GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEI----AVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 660
K +GSG FG VY G + +G+++ A+K L + S + +E +E +++ + + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ LG C L+ + M G L +++ H+ I L AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEE- 127
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYIS 779
++HRDL + N+L+ K++DFGL+K D + + + + ++ E +
Sbjct: 128 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185
Query: 780 QQLTDKSDVYSFGVILLELIS 800
+ T +SDV+S+GV + EL++
Sbjct: 186 RIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 606 EKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQF 662
+KIG G +GVVY + + E IA+K + T E++LL + H N+V+
Sbjct: 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
E R LV+E++ + LK+H+ + + IK +GI Y H+
Sbjct: 67 QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTY--LYQILRGIAYCHSH-- 121
Query: 723 PAIIHRDLKSSNILLDKHMRA-KVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-S 779
++HRDLK N+L+D+ A K++DFGL++ F + + +V T+ Y PE + S
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLGS 178
Query: 780 QQLTDKSDVYSFGVILLELIS 800
+ + D++S G I E+++
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 609 IGSGGFGVVYYGKLKDG-------KEIAVKVLTSNSYQGKRE-------FTNEVTLL-SR 653
+GSG FG VY + K+ KEI V + KRE +EVT++ +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNP--AFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 654 IHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
+ H N+V++ E R +V + + L EH +QR + I
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
+ YLH I+HRDL +NI+L + + ++DFGL+K S ++S+V GT+ Y
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV-GTILYSC 181
Query: 774 PEYYISQQLTDKSDVYSFGVILLEL 798
PE ++ +K+DV++FG IL ++
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-13
Identities = 44/120 (36%), Positives = 68/120 (56%), Gaps = 8/120 (6%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGC 462
W + CN+ + + I LS KN++G I S + +L + + L N L+GPIPD F+
Sbjct: 60 WQGITCNNSSR--VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS 117
Query: 463 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI 520
LR ++L +N TG +P ++PNL L + NNMLSG +P+ + S VL+ GN+
Sbjct: 118 SSLRYLNLSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175
|
Length = 968 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 609 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRN--LVQF 662
IG GGFG VY + D GK A+K L QG+ NE +LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 663 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+ Y + + + M+ G L HL +G + + + A + G+E++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY------AAEIILGLEHMHN 115
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
V ++RDLK +NILLD+H ++SD GL+ H S GT GY+ PE
Sbjct: 116 RFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169
Query: 780 QQLTDKS-DVYSFGVILLELISGQ 802
D S D +S G +L +L+ G
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 609 IGSGGFGVVYYGKLK---DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+G G +GVV K++ G +AVK + T NS + KR + + + V F
Sbjct: 9 LGRGAYGVVD--KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLY-GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
G EG + E M T + Y I +IA K +EYLH+
Sbjct: 67 GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL- 123
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY---IS 779
++IHRD+K SN+L++++ + K+ DFG+S + VD S +I G Y+ PE ++
Sbjct: 124 -SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYMAPERINPELN 180
Query: 780 QQLTD-KSDVYSFGVILLELISG 801
Q+ D KSDV+S G+ ++EL +G
Sbjct: 181 QKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 3e-13
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 39/219 (17%)
Query: 604 MLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNL 659
L K IGSG +GVV + G+++A+K ++ + KR E+ LL + H N+
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENI 61
Query: 660 VQ----FLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAK- 712
+ E+ V +V E M T H IK + +D +
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELME----------TDLH----KVIKSPQPLTDDHIQY 107
Query: 713 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 765
G++YLH+ +IHRDLK SNIL++ + K+ DFGL++ +
Sbjct: 108 FLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
Query: 766 RGTVG--YLDPEYYISQQLTDKS-DVYSFGVILLELISG 801
V Y PE +S K+ D++S G I EL++
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYG--KLKDGKEIAVKVLT---SNSYQGKREFTNEVTLL 651
++++ + +E+ +G+G FG + G KL +E+ V + T S + +R F E L
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 652 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 711
+ H N+V+ G ++V E+M NG L L HE ++ + + + A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLA 117
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TV 769
G++YL +H+ L + +L++ + K+S F + D + + + + G V
Sbjct: 118 SGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPV 172
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ PE + SDV+SFG+++ E++S
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN-----EVTLLS-RI----- 654
K +G G FG V +LK E+ AVKVL K++ E T+ R+
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVL-------KKDVILQDDDVECTMTEKRVLALAG 53
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAK 712
H L Q Q + R V E+++ G L H+ G + + A +
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY------AAEIVL 107
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
G+++LH II+RDLK N+LLD K++DFG+ K + G S+ GT Y+
Sbjct: 108 GLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYI 163
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELISGQ 802
PE Q D ++ GV+L E+++GQ
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 609 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRN--LVQF 662
IG GGFG VY + D GK A+K L QG+ NE +LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 663 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+ Y + + + M+ G L HL +G + ++ + A + G+E++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY------ATEIILGLEHMHN 115
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
V ++RDLK +NILLD+H ++SD GL+ H S GT GY+ PE
Sbjct: 116 RFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169
Query: 780 QQLTDKS-DVYSFGVILLELISGQEAISNEK 809
D S D +S G +L +L+ G K
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 605 LEKKIGSGGFGVVYY----GKLKDGKEIAVKVLTSNSYQGKR---EFT-NEVTLLSRIHH 656
L + +G+G +G V+ G GK A+KVL + K E T E +L +
Sbjct: 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR 63
Query: 657 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK---RLEIAEDAAK 712
+ L Y Q + + L+ ++++ G L HLY QR ++ + R+ IAE
Sbjct: 64 CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY------QREHFTESEVRVYIAE-IVL 116
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
+++LH II+RD+K NILLD ++DFGLSK + + GT+ Y+
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 773 DPEYYISQQL--TDKSDVYSFGVILLELISG 801
PE D +S GV+ EL++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 5e-13
Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN--EVTLLSRI-HHRNLVQF 662
K++G G FG VY + K+ E+ A+K + + E N EV L ++ H N+V+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 663 LGYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+E V+E+M +K+ + + I ++ +G+ ++H
Sbjct: 64 KEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQI------LQGLAHIHK 117
Query: 720 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
G HRDLK N+L+ K++DFGL++
Sbjct: 118 HG----FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 12/208 (5%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 654
D E+ LE+ IG G FG V+ G + + +A+K++ + + E E+T+LS+
Sbjct: 1 DPEELFTKLER-IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
+ ++ G + + ++ E++ G+ + L E +I + ++ KG+
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI-----ATMLKEILKGL 114
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
+YLH+ IHRD+K++N+LL + K++DFG++ D ++ V GT ++ P
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 170
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQ 802
E K+D++S G+ +EL G+
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 608 KIGSGGFGVVYYGKLKD-GKEIAVK--VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
KIG G +GVV+ + ++ G+ +A+K V + + K+ E+ +L ++ H NLV +
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 665 YCQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 720
+ + + LV+E+ + L E + G H IK+ I + + + H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHL-----IKK--IIWQTLQAVNFCHKHN 120
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
C IHRD+K NIL+ K + K+ DFG ++ + V T Y PE +
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGD 175
Query: 781 -QLTDKSDVYSFGVILLELISGQ 802
Q DV++ G + EL++GQ
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 8e-13
Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 14/216 (6%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 664
IG G FG V + +D + I A+K + + E T+ E T+L++++ +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAKGIEYLHTGCVP 723
Q + LV F++ G L HL E R + + R AE +E LH V
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL----QREGRFDLSRARFYTAE-LLCALENLHKFNV- 114
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
I+RDLK NILLD + DFGL K + ++ GT YL PE + T
Sbjct: 115 --IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYT 171
Query: 784 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
D ++ GV+L E+++G +E R I+Q
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 9e-13
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIA---VKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 662
+IG+G FG V G+ G A VK L S + + F EV ++H N++Q
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE-IAEDAAKGIEYLHTGC 721
LG C E +LV EF G LK +L ++ L+ +A + A G+ +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLS------KFAVDGASHVSSIVRGTVGYLDPE 775
IH DL N L + K+ D+GL+ + + H + +L PE
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPL-----RWLAPE 172
Query: 776 YYISQQ-------LTDKSDVYSFGVILLEL 798
+ T KS+++S GV + EL
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 43/106 (40%), Positives = 64/106 (60%), Gaps = 3/106 (2%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 475
S+ + L+S L G IP +L ++ SL ++L N+L+G IP + G L + L N L
Sbjct: 189 SLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
TGP+PSSL NL NL+ L++ N LSG +P S+ L K + L+ + N
Sbjct: 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294
|
Length = 968 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 58/231 (25%)
Query: 605 LEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGK-------REFTNEVTLLSRI 654
+E IG G +G VY K K DGKE A+K + Q RE + LL +
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLREL 59
Query: 655 HHRNLVQFLGYCQEEG-RSV-LVYEFMHNGTLKEH-LYGTLTHEQRINWIKRLEIAEDAA 711
H N+V + E +SV L++++ EH L+ + ++ KR+ I
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQA---KRVSIPPSMV 110
Query: 712 K--------GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSK------- 752
K G+ YLH+ ++HRDLK +NIL+ + K+ D GL++
Sbjct: 111 KSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 753 --FAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELIS 800
+D V T+ Y PE + ++ T D+++ G I EL++
Sbjct: 168 PLADLDP-------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 15/206 (7%)
Query: 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQFLG 664
+G G FG V +LK G+ AVKVL + + +T +LS + + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 665 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
C Q R V EF++ G L H+ + +R + + A + + +LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEITSALMFLHD---K 115
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQQL 782
II+RDLK N+LLD K++DFG+ K + +G + +S GT Y+ PE
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEMLY 173
Query: 783 TDKSDVYSFGVILLELISGQEAISNE 808
D ++ GV+L E++ G E
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHH 656
D+ + LEK +G G + VY GK K +GK +A+KV+ +G FT E +LL + H
Sbjct: 5 DSYEKLEK-LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKH 62
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
N+V + LV+E++H + +H G ++ + L +G
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLL-------RG 115
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
+ Y+H I+HRDLK N+L+ K++DFGL++ A SH S T+ Y
Sbjct: 116 LSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRP 171
Query: 774 PEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEK 809
P+ + S + + D++ G I +E+I G A K
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 592 CFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK---REFTNEV 648
C DI+ T +L I +Y G + KE+ ++ K NE+
Sbjct: 14 CIESDDIDKYTSVL---IKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEI 69
Query: 649 TLLSRIHHRNLVQFLGY----CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 704
L RI N+++ G+ + R L+ E+ G L+E L E+ +++ +L
Sbjct: 70 KNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKL 125
Query: 705 EIAEDAAKGIEYLHTGC-VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVS 762
++A D KG+ L+ P +++L S + L+ ++ + K+ GL K + +V+
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182
Query: 763 SIVRGTVGYLDPEYY--ISQQLTDKSDVYSFGVILLELISG 801
+V Y + I + T K D+YS GV+L E+ +G
Sbjct: 183 FMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 608 KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLG 664
KIG G +G V+ K ++ EI +V + +G E+ LL + H+N+V+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 665 YCQEEGRSVLVYEFMHNGTLK--EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+ + LV+E+ K + G + E +++ +L KG+ + H+
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------LKGLAFCHS--- 117
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
++HRDLK N+L++K+ K++DFGL++ F + + + +V T+ Y P+ +
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAK 175
Query: 782 LTDKS-DVYSFGVILLELISG 801
L S D++S G I EL +
Sbjct: 176 LYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 37/212 (17%)
Query: 609 IGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQF 662
IG G +G VY + KD E+ KV N +G F E+ +L +++HRN+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKILRQLNHRNIVNL 71
Query: 663 ----------LGYCQEEGRSVLVYEFM-HN--GTLKEHLYGTLTHEQRINWIKRLEIAED 709
L + +++G LV+E+M H+ G L+ L + + +++K+L
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV-HFSEDHIKSFMKQL----- 125
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRG 767
+G+ Y H +HRD+K SNILL+ + K++DFGL++ + + + + ++
Sbjct: 126 -LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-- 179
Query: 768 TVGYLDPEYYISQQLTDKS-DVYSFGVILLEL 798
T+ Y PE + ++ + DV+S G IL EL
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 662
K +G G FG V + K GK A+K+L K E + +T +L H L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
Q R V E+ + G L HL + ++ R AE + YLH+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAE-IVSALGYLHSC 114
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYIS 779
+++RDLK N++LDK K++DFGL K + DGA+ GT YL PE
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLED 169
Query: 780 QQLTDKSDVYSFGVILLELISGQ 802
D + GV++ E++ G+
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 29/205 (14%)
Query: 608 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFLG 664
KIG G +GVVY + G+ +A+K + + T E++LL ++H N+V+ L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEY 716
E + LV+EF+ LK+++ + + K GI Y
Sbjct: 66 VVHSENKLYLVFEFLDL-DLKKYM----------DSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE 775
H+ ++HRDLK N+L+D+ K++DFGL++ F V ++ +V T+ Y PE
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 169
Query: 776 YYI-SQQLTDKSDVYSFGVILLELI 799
+ S+Q + D++S G I E++
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 58/208 (27%), Positives = 86/208 (41%), Gaps = 30/208 (14%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLL----------SRI 654
+G G FG V + K E+ A+K L K+ +EV L +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKAL-------KKGDIIARDEVESLMCEKRIFETANSE 59
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
H LV Q E V E+ G L H+ H + + + A G+
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVLGL 114
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
+YLH I++RDLK N+LLD K++DFGL K + G +S GT +L P
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM-GFGDRTSTFCGTPEFLAP 170
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQ 802
E T D + GV++ E++ G+
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 70/218 (32%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRN---LVQ 661
IG G FG VY + KD + I A+KVL+ K+E + E +L R +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAKGIEYLHTG 720
Q + LV ++M G L HL E R + + + IAE +E+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL----QKEGRFSEDRAKFYIAE-LVLALEHLHKY 115
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I++RDLK NILLD + DFGLSK A + ++ GT YL PE + +
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 781 Q-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817
+ T D +S GV++ E+ G E RNI
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 608 KIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
+G G +G+V K K+ G+ +A+K + + K+ E+ +L ++ H NLV +
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 665 YCQEEGRSVLVYEFMHNGTLK--EHLYGTLTHE--QRINWIKRLEIAEDAAKGIEYLHTG 720
+ + R LV+EF+ + L E L ++ + +GIE+ H+
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF--------QILRGIEFCHSH 119
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYIS 779
IIHRD+K NIL+ + K+ DFG ++ A G + + T Y PE +
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV--ATRWYRAPELLVG 174
Query: 780 QQLTDKS-DVYSFGVILLELISGQ 802
++ D+++ G ++ E+++G+
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 608 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLVQ 661
+IG G +G VY + G +A+K V + G T EV LL R+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 662 FLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+ C E + LV+E + + L+ +L IK ++ +G+++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDF 123
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
LH C I+HRDLK NIL+ + K++DFGL++ + +V T+ Y PE
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEV 178
Query: 777 YISQQLTDKSDVYSFGVILLEL 798
+ D++S G I E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 39/180 (21%)
Query: 592 CFTLSDIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFT--NEV 648
C L D E + K+G G FG VY ++K G+ +A+K + ++ + T E+
Sbjct: 4 CSKLRDYE-----ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREI 58
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSV--------LVYEFM--------HNGTLKEHLYGTL 692
+L ++ H N+V + E +V +M N ++K L
Sbjct: 59 KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK------L 112
Query: 693 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
T Q ++ +L +GI YLH I+HRD+K++NIL+D K++DFGL++
Sbjct: 113 TESQIKCYMLQL------LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 608 KIGSGGFGVVYYGKLKDGKEIAV-KVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
++G G FG VY + K+ +A KV+ + S + ++ E+ +L+ H N+V+ L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 726
E ++ EF G + + L E+ + + + + + + YLH II
Sbjct: 72 YYENNLWILIEFCAGGAVDAVM---LELERPLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 784
HRDLK+ NIL K++DFG+S S + GT ++ PE + + D
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 184
Query: 785 ---KSDVYSFGVILLEL 798
K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 62/201 (30%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 661
K IG G FG V + K + K AVKVL + K+E + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTG 720
Q + V ++++ G L HL +R R A + A + YLH+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHL-----QRERCFLEPRARFYAAEIASALGYLHS- 114
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I++RDLK NILLD ++DFGL K ++ S+ GT YL PE Q
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQ 171
Query: 781 QLTDKSDVYSFGVILLELISG 801
D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 607 KKIGSGGFGVVYYGKLKDG---KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQF 662
K+IG+G FG V G++ G ++ VK L + S Q + +F E + H NL+Q
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE-IAEDAAKGIEYLHTGC 721
LG C E +LV EF G LK +L E L+ +A + A G+ +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
IH DL N LL + K+ D+GLS +V+ P +I+ +
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV-----PLRWIAPE 172
Query: 782 LTDK-------------SDVYSFGVILLEL 798
L D+ S+V+S GV + EL
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 663
+K+G G + VY G + +G+ +A+KV++ + +G FT E +LL + H N+V
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLH 69
Query: 664 GYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ V+E+MH + +H G + R+ + L +G+ Y+H
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL-------RGLAYIHG- 121
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI- 778
I+HRDLK N+L+ K++DFGL++ ++ ++ S +V T+ Y P+ +
Sbjct: 122 --QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLG 177
Query: 779 SQQLTDKSDVYSFGVILLELISGQEA 804
+ + D++ G I +E++ GQ A
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 60/234 (25%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVK-------VLTSNSYQGKREFTNEV 648
D+ K +E IGSG +GVV + GK++A+K V T KR E+
Sbjct: 2 DVGSRYKPIEN-IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTL----AKRTL-REL 55
Query: 649 TLLSRIHHRNLV---QFLGYCQEEGRSV-LVYEFM----H-----NGTLKEH-----LYG 690
+L H N++ L + + V +V + M H + L E LY
Sbjct: 56 KILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115
Query: 691 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG- 749
L +G++Y+H+ V IHRDLK SN+L+++ ++ DFG
Sbjct: 116 LL-------------------RGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGM 153
Query: 750 ---LSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELI 799
LS + ++ V T Y PE +S + T D++S G I E++
Sbjct: 154 ARGLSSSPTEHKYFMTEYV-ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 29/222 (13%)
Query: 605 LEKKIGSGGFGVVYY----GKLKDGKE-------------IAVKVLTSNSYQGKR-EFTN 646
++K+G G FG V+ G K + +AVK+L ++ + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 647 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-------GTLTHEQRIN 699
E+ ++SR+ N+++ L C ++ E+M NG L + L I+
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 700 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759
+ + +A A G++YL + +HRDL + N L+ K+ K++DFG+S+ G
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 760 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ + + ++ E + + T SDV++FGV L E+++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-12
Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 1/99 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
P + + +S+ NL G I S + SL L L N G +PD G L + L NQ
Sbjct: 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQF 487
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS-KNVV 513
+G +P L +L L +L + N LSG +P L S K +V
Sbjct: 488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV 526
|
Length = 968 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
L ++IGSG +G VY + + G+ A+KV+ + E+ ++ H N+V +
Sbjct: 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 664 GYCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
G + + EF G+L++ H+ G L+ E +I ++ R + +G+ YLH+
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLS-ESQIAYVSR-----ETLQGLYYLHS-- 124
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
+HRD+K +NILL + K++DFG+S + S + GT ++ PE ++
Sbjct: 125 -KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVER 182
Query: 782 ---LTDKSDVYSFGVILLEL 798
D+++ G+ +EL
Sbjct: 183 KGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-12
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 662
K IGSG G+V G +AVK L+ N KR + E+ LL ++H+N++
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85
Query: 663 LGY-----CQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
L EE + V LV E M + L + ++ L HE R++++ + GI++
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHE-RMSYLLYQMLC-----GIKH 138
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
LH+ IIHRDLK SNI++ K+ DFGL++ A +V T Y PE
Sbjct: 139 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEV 193
Query: 777 YISQQLTDKSDVYSFGVILLELISG 801
+ + D++S G I+ EL+ G
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 8e-12
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 607 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 660
K IGSG G+V Y G+ +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 22 KPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNII 78
Query: 661 QFLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
L EE + V LV E M + L + + L HE R++++ + GI
Sbjct: 79 GLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHE-RMSYLLYQMLC-----GI 131
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
++LH+ IIHRDLK SNI++ K+ DFGL++ A +V T Y P
Sbjct: 132 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAP 186
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQ 802
E + + D++S G I+ E+I G
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 36/89 (40%), Positives = 54/89 (60%), Gaps = 1/89 (1%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 475
S+ I+L NL+G IP ++ L+SL L L N+LTGPIP +L+ + L N+L
Sbjct: 213 SLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL 272
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVP 504
+GP+P S+ +L L L + +N LSG +P
Sbjct: 273 SGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 63/226 (27%), Positives = 109/226 (48%), Gaps = 18/226 (7%)
Query: 594 TLSDIEDATKMLEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 652
+ D D +++E IG G +G V+ K+G + AVK+L + E E +L
Sbjct: 12 SFPDPSDTWEIIET-IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILK 69
Query: 653 RIH-HRNLVQFLG-YCQEEGRS----VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 706
+ H N+V+F G Y +++ ++ LV E + G++ + + G L +R+ I
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 707 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766
+A G+++LH V IHRD+K +NILL K+ DFG+S + +
Sbjct: 130 LHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSA-QLTSTRLRRNTSV 185
Query: 767 GTVGYLDPEYYISQQLTDKS-----DVYSFGVILLELISGQEAISN 807
GT ++ PE +Q D + DV+S G+ +EL G +++
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 1e-11
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 607 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 661
K IGSG G+V Y + D + +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 23 KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 80
Query: 662 FLGY-----CQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
L EE + V LV E M + L + + L HE R++++ + GI+
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 133
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH+ IIHRDLK SNI++ K+ DFGL++ A G S + + T Y PE
Sbjct: 134 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 188
Query: 776 YYISQQLTDKSDVYSFGVILLELI 799
+ + D++S G I+ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 25/225 (11%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKRE-FTNEVT 649
+I +T +++G FG VY G L + + +A+K L + RE F +E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 650 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH------------EQR 697
+ SR+ H N+V LG +E +++ + + L E L H +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 698 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAV 755
+ + I A G+E+L + V +H+DL + N+L+ + K+SD GL + +A
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHV---VHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
D + + + + ++ PE + + + SD++S+GV+L E+ S
Sbjct: 178 DYYKLMGNSLL-PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 607 KKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKREFTN----EVTLLSRIHHRN 658
K +G GG+G V+ + G + A+KVL + ++ T E +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAK----- 712
+V + Q G+ L+ E++ G L HL +R I ED A
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHL-------------EREGIFMEDTACFYLSE 108
Query: 713 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
+E+LH II+RDLK NILLD K++DFGL K ++ + V+ GT+
Sbjct: 109 ISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTI 164
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808
Y+ PE + D +S G ++ ++++G + E
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-11
Identities = 38/92 (41%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDN 473
++TV+ LS+ NLTG IP L +L +L L NSL G IP C LR + L+DN
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 505
+G LPS LP + L + NN L G + S
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446
|
Length = 968 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSN----------SYQGKREFTNEVTLLSRIHHR 657
+G G FG V + K E+ A+K+L + + KR + L +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV----LALPGKPPF- 62
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---GI 714
L Q Q R V E+++ G L H+ Q++ K AA+ G+
Sbjct: 63 -LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-------QQVGKFKEPHAVFYAAEIAIGL 114
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
+LH+ II+RDLK N++LD K++DFG+ K + G + GT Y+ P
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAP 170
Query: 775 EYYISQQLTDKS-DVYSFGVILLELISGQ 802
E I+ Q KS D ++FGV+L E+++GQ
Sbjct: 171 E-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 605 LEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
L +++GSG +G VY L G+ AVK++ E+ ++ H N+V +
Sbjct: 13 LIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 664 GYCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
G + + E+ G+L++ H+ G L+ E +I ++ R + +G+ YLH+
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYHVTGPLS-ELQIAYVCR-----ETLQGLAYLHS-- 124
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
+HRD+K +NILL + K++DFG+ +K A S I GT ++ PE +
Sbjct: 125 -KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVE 181
Query: 781 Q---LTDKSDVYSFGVILLEL 798
+ D+++ G+ +EL
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 607 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQF 662
K +G+G FG V+ + + + A+KV+ + ++ NE +L + H +++
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
++ ++ E++ G L+ L + R + L A + +EYLH+
Sbjct: 67 FWTEHDQRFLYMLMEYVPGG----ELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS--- 119
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I++RDLK NILLDK K++DFG +K D + GT YL PE S+
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEVIQSKGH 175
Query: 783 TDKSDVYSFGVILLELISG 801
D ++ G+++ E++ G
Sbjct: 176 NKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 608 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 661
+I G +GVVY + K EI A+K L + ++E T+ E+ +L ++ H N+V
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKL---KMEKEKEGFPITSLREINILLKLQHPNIVT 68
Query: 662 F----LGYCQEEGRSVLVYEFMHNG--TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
+G + + +V E++ + +L E + + + +L G+
Sbjct: 69 VKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQL------LSGVA 120
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH I+HRDLK+SN+LL+ K+ DFGL++ + +V T+ Y PE
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPE 176
Query: 776 YYISQQL-TDKSDVYSFGVILLELISG 801
+ + + D++S G I EL++
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 31/227 (13%)
Query: 593 FTLSDIEDATKMLEKK------IGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQG 640
F +I D+T + K+ IGSG G+V Y L+ + +A+K L+ N
Sbjct: 10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 641 KREFTNEVTLLSRIHHRNLVQFLGY-----CQEEGRSVLVYEFMHNGTLKEHLYGTLTHE 695
KR + E+ L+ ++H+N++ L EE + V + + + L + + L HE
Sbjct: 68 KRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126
Query: 696 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755
R++++ + GI++LH+ IIHRDLK SNI++ K+ DFGL++ A
Sbjct: 127 -RMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 176
Query: 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
G S + + T Y PE + + D++S G I+ E+I G
Sbjct: 177 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 6e-11
Identities = 67/260 (25%), Positives = 101/260 (38%), Gaps = 58/260 (22%)
Query: 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEV----TLLSRIHHRNLVQ 661
K IG G FG V + KD G A+K L S ++E V +L+ + +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 662 FLGYC--QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
Y Q+E L+ E++ G + L T T E+ R IAE I+ +
Sbjct: 66 L--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE-----TRFYIAE-TILAIDSI 117
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK---------------------FAVD 756
H IHRD+K N+LLD K+SDFGL F
Sbjct: 118 HK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 757 GASHVSSIVR----------------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ +SS + GT Y+ PE ++ + D +S GVI+ E++
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 801 GQEAISNEKFGANCRNIVQW 820
G ++ R I+ W
Sbjct: 235 GYPPFCSDNPQETYRKIINW 254
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 6e-11
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQF 662
IG G +G+V K G ++A+K ++ +Q + T E+ +L R H N++
Sbjct: 9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGI 68
Query: 663 LGYCQ----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 712
L + E V +V E M + LY IK ++ D +
Sbjct: 69 LDIIRPPSFESFNDVYIVQELM-----ETDLYKL---------IKTQHLSNDHIQYFLYQ 114
Query: 713 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--G 767
G++Y+H+ V +HRDLK SN+LL+ + K+ DFGL++ A H +
Sbjct: 115 ILRGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 768 TVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 801
T Y PE ++ + K+ D++S G IL E++S
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 13/207 (6%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 662
K +G G FG V K K G+ A+K+L K E + +T +L H L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
Q R V E+ + G L HL + E+ + + + ++YLH+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSE-- 114
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQQ 781
+++RDLK N++LDK K++DFGL K + DGA+ + GT YL PE
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GTPEYLAPEVLEDND 172
Query: 782 LTDKSDVYSFGVILLELISGQEAISNE 808
D + GV++ E++ G+ N+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQ 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 52/217 (23%)
Query: 608 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN--EVTLLSRI-HHRNLVQFL 663
KIG G F V + K GK A+K + ++ + N E+ L R+ H N+++ +
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 664 G--YCQEEGRSVLVYEFMHNGTLKEHLYGTLTH--EQRI-NWIKRLEIAEDAAKGIEYLH 718
+ ++ GR LV+E M + L E + G E+R+ +++ +L K ++++H
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQL------LKSLDHMH 117
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY-- 776
I HRD+K NIL+ K++DFG S RG Y P Y
Sbjct: 118 RN---GIFHRDIKPENILIKDD-ILKLADFG-------------SC-RGI--YSKPPYTE 157
Query: 777 YISQQ--------LTD-----KSDVYSFGVILLELIS 800
YIS + LTD K D+++ G + E++S
Sbjct: 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 609 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLG 664
+G GGFG V ++K+ GK A K L + G++ E +L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN-LA 59
Query: 665 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
Y E + LV M+ G LK H+Y + + + + GI +LH+
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERV--IHYSAQITCGILHLHS---M 114
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
I++RD+K N+LLD ++SD GL+ DG + GT GY+ PE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPEILKEEPYS 172
Query: 784 DKSDVYSFGVILLELISGQEAISNEK 809
D ++ G + E+++G+ + K
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 12/206 (5%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 662
K +G G FG V + K G+ A+K+L K E + VT +L H L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
Q R V E+ + G L HL + E+ + + +EYLH+ V
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRDV 116
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
++RD+K N++LDK K++DFGL K + + + + GT YL PE
Sbjct: 117 ---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDY 172
Query: 783 TDKSDVYSFGVILLELISGQEAISNE 808
D + GV++ E++ G+ N+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 29/205 (14%)
Query: 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 664
+G GGFG V K+K + A+K + + +E +L +H +V+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEY 716
+++ ++ E+ G L L R E A+ EY
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR------------DRGLFDEYTARFYIACVVLAFEY 108
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
LH II+RDLK N+LLD + K+ DFG +K G + GT Y+ PE
Sbjct: 109 LHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC--GTPEYVAPEI 163
Query: 777 YISQQLTDKSDVYSFGVILLELISG 801
+++ D +S G++L EL++G
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 41/229 (17%)
Query: 605 LEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKRE------------FT--NEVT 649
+G G +G V GK +A+K + FT E+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 650 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 709
+++ I H N++ + E LV + M + K E ++ I L+I
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCI-LLQIL-- 129
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGAS--------- 759
G+ LH +HRDL +NI ++ K++DFGL+ ++ S
Sbjct: 130 --NGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 760 -----HVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
S +V T+ Y PE + +++ D++S G I EL++G+
Sbjct: 185 QRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 29/213 (13%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG----KREFTNEVTLLSRIHHRNL 659
++ IG G FGVV+ +DGK +A+K + N +Q KR F E+ +L H N+
Sbjct: 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMP-NVFQNLVSCKRVF-RELKMLCFFKHDNV 61
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------- 712
+ L Q ++ ++ L+ + Q + + D K
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPL--------SSDHVKVFLYQIL 113
Query: 713 -GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVG 770
G++YLH+ I+HRD+K N+L++ + K+ DFGL++ D + H++ V T
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 771 YLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
Y PE + S+ T D++S G I EL+ +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 2e-10
Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 36/227 (15%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-----KREFTNEVTLLSRIHHRNLVQ 661
KKIG+G FG V+ K K +E + SY+G K + EV ++ + H+N+V+
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEFFC--WKAISYRGLKEREKSQLVIEVNVMRELKHKNIVR 76
Query: 662 FLGYCQEEGRSVL--VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
++ + L + EF G L ++ +I ++I + Y H
Sbjct: 77 YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136
Query: 720 ----GCVPAIIHRDLKSSNILLDKHMR-----------------AKVSDFGLSK-FAVDG 757
++HRDLK NI L +R AK+ DFGLSK ++
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES 196
Query: 758 ASHVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQ 802
+H S V GT Y PE + ++ DKSD+++ G I+ EL SG+
Sbjct: 197 MAH--SCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 49/149 (32%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEY 716
+V F G +G + E M G+L + L RI N + ++ IA +G+ Y
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQ----VLKKAGRIPENILGKISIA--VLRGLTY 114
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
L I+HRD+K SNIL++ K+ DFG+S +D S +S V GT Y+ PE
Sbjct: 115 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPER 169
Query: 777 YISQQLTDKSDVYSFGVILLELISGQEAI 805
T +SD++S G+ L+E+ G+ I
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 9/167 (5%)
Query: 640 GKREFT-NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 698
G+R T E +L I+H +++Q G + L+ K LY L ++ I
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP-----RYKTDLYCYLAAKRNI 179
Query: 699 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758
L I + I+YLH IIHRD+K+ NI ++ + DFG + F VD
Sbjct: 180 AICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236
Query: 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 805
++ GT+ PE D++S G++L E+ + +++
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 608 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 665
++G+G GVV + K I + L + + + E+ +L + +V F G
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVP 723
+G + E M G+L + L +RI + ++ IA +G+ YL
Sbjct: 72 FYSDGEISICMEHMDGGSLDQ----VLKEAKRIPEEILGKVSIA--VLRGLAYLREK--H 123
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
I+HRD+K SNIL++ K+ DFG+S +D S +S V GT Y+ PE +
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYS 180
Query: 784 DKSDVYSFGVILLELISGQEAI 805
+SD++S G+ L+EL G+ I
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 609 IGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 665
+G G +GVV + K+ KEI K S + +E T E+ +L + N+V+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 666 CQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+ G+ LV+E++ L+ E G + R ++I +L K I + H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-SYIYQL------IKAIHWCHKN-- 119
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I+HRD+K N+L+ + K+ DFG ++ +G++ + T Y PE +
Sbjct: 120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 783 TDKSDVYSFGVILLELISGQEAISNE 808
D++S G IL EL GQ E
Sbjct: 179 GKAVDMWSVGCILGELSDGQPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 600 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIHH 656
DA + LEK IG G +G VY + GK +A+K +G E++LL +
Sbjct: 1 DAYEKLEK-IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSE 59
Query: 657 RN-LVQFLGYCQEEGRS-----VLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIA 707
+V+ L E ++ LV+E++ + LK+ + IK
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMY- 117
Query: 708 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSK-FAVDGASHVSSIV 765
KG+ + H ++HRDLK N+L+DK K++D GL + F++ S+ IV
Sbjct: 118 -QLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 766 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
T+ Y PE + S + D++S G I E+ Q
Sbjct: 174 --TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLSR--IHHRN----LVQ 661
+G G FG V + K E+ A+K+L + + E T++ + + ++ L Q
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV--ECTMVEKRVLALQDKPPFLTQ 65
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
Q R V E+++ G L H+ G Q + + A + + G+ +LH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISVGLFFLHR 119
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 778
II+RDLK N++LD K++DFG+ K VDG + + GT Y+ PE
Sbjct: 120 ---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIA 174
Query: 779 SQQLTDKSDVYSFGVILLELISGQEAISNE 808
Q D +++GV+L E+++GQ E
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 605 LEKKIGSGGFGVVYY----GKLKDGKEIAVKVLTSNSYQGKREFTNEVT-----LLSRIH 655
L K +G+G +G V+ GK A+KVL + ++ T E T +L +
Sbjct: 4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-QKAKTVEHTRTERNVLEHVR 62
Query: 656 HRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 712
+ L Y Q E + L+ +++ G + HLY QR N+ +ED +
Sbjct: 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY------QRDNF------SEDEVRFY 110
Query: 713 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766
+E+LH I++RD+K NILLD ++DFGLSK + +
Sbjct: 111 SGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC 167
Query: 767 GTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 801
GT+ Y+ PE + K+ D +S G+++ EL++G
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 28/208 (13%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQ 661
K++GSG +G V + G+++A+K L S +Q KR + E+TLL + H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAY-RELTLLKHMQHENVIG 78
Query: 662 FLGY--CQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
L G LV +M K + G E ++ ++ G++
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQK--IMGHPLSEDKVQYL-----VYQMLCGLK 131
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
Y+H+ IIHRDLK N+ +++ K+ DFGL++ A A +V T Y PE
Sbjct: 132 YIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVV--TRWYRAPE 184
Query: 776 YYIS-QQLTDKSDVYSFGVILLELISGQ 802
++ D++S G I+ E+++G+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 661
K +G G FG V +LK E+ A+KVL + + T + L H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
Q + R V E+++ G L + ++ + + A + + +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI----QRSRKFDEPRSRFYAAEVTLALMFLHRH- 115
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
+I+RDLK NILLD K++DFG+ K + ++ GT Y+ PE +
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEILQELE 172
Query: 782 LTDKSDVYSFGVILLELISGQ 802
D ++ GV++ E+++GQ
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-10
Identities = 48/164 (29%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 646 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE 705
+E+ L+ H +V+ + + + +L+ E+ G L + + +QR+ + L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI------KQRLK--EHLP 165
Query: 706 IAEDAAKGIEY--------LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757
E + Y +H+ ++HRDLKS+NI L K+ DFG SK D
Sbjct: 166 FQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222
Query: 758 AS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
S V+S GT YL PE + ++ + K+D++S GVIL EL++
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLS-RIHHRN-----LVQ 661
+G G FG V + K E+ A+K+L + + E T++ R+ + L Q
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV--ECTMVEKRVLALSGKPPFLTQ 65
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR---LEIAEDAAKGIEYLH 718
Q R V E+++ G L + Q++ K + A + A G+ +LH
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQI-------QQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYY 777
+ II+RDLK N++LD K++DFG+ K + DG + + GT Y+ PE
Sbjct: 119 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAPEII 173
Query: 778 ISQQLTDKSDVYSFGVILLELISGQEAISNE 808
Q D ++FGV+L E+++GQ E
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 608 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 665
++G+G GVV+ K I + L + + + E+ +L + +V F G
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 725
+G + E M G+L + L ++I + ++ IA KG+ YL I
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIA--VIKGLTYLREK--HKI 125
Query: 726 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 785
+HRD+K SNIL++ K+ DFG+S +D S +S V GT Y+ PE + +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSVQ 182
Query: 786 SDVYSFGVILLELISGQEAI 805
SD++S G+ L+E+ G+ I
Sbjct: 183 SDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 32/163 (19%)
Query: 608 KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT----NEVTLLSRIHHRNLVQ 661
KIG G FG V+ + K K+I KVL N +G F E+ +L + H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVVN 75
Query: 662 FLGYCQEE--------GRSVLVYEFMHNGTLKEH-LYGTLTHEQ---RINWIKRLEIAED 709
+ C+ + G LV+EF EH L G L+++ ++ IK+ + +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFC------EHDLAGLLSNKNVKFTLSEIKK--VMKM 127
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
G+ Y+H I+HRD+K++NIL+ K K++DFGL++
Sbjct: 128 LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQ 661
+ + +GSG G V K + DG+ AVKV+ K EV L ++V+
Sbjct: 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK 95
Query: 662 FLGYCQEE------------GRSVLVYEFMHNGTLKEHLYGT-------LTHEQRINWIK 702
C E+ LV ++ + G L++ + HE + +I+
Sbjct: 96 ----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHV 761
L + ++H+ +IHRD+KS+NILL + K+ DFG SK +A + V
Sbjct: 152 VL-------LAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201
Query: 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
GT Y+ PE + + + K+D++S GV+L EL++
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQF 662
K IG G FG V + K +++ L S KR F E +++ + +VQ
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 714
Q++ +V E+M G L +N + ++ E AK +
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 773
+ +H+ +IHRD+K N+LLDKH K++DFG K G + V GT Y+
Sbjct: 156 DAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYIS 211
Query: 774 PEYYISQ----QLTDKSDVYSFGVILLELISG 801
PE SQ + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-09
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 662
K IG G FG V + K K++ A+K+L+ + + F E +++ + +VQ
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 714
Q++ +V E+M G L +N + +I E A+ +
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDL-------------VNLMSNYDIPEKWARFYTAEVVLAL 155
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 773
+ +H+ IHRD+K N+LLDK K++DFG K +G + V GT Y+
Sbjct: 156 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYIS 211
Query: 774 PEYYISQ----QLTDKSDVYSFGVILLELISG 801
PE SQ + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 605 LEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSYQGKREFT----NEVTLLSRIHH 656
L K +G+G +G V+ + GK A+KVL + K + T E +L I
Sbjct: 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 63
Query: 657 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK---RLEIAEDAAK 712
+ L Y Q + + L+ ++++ G L HL QR + + ++ E
Sbjct: 64 SPFLVTLHYAFQTDTKLHLILDYINGGELFTHL------SQRERFKEQEVQIYSGE-IVL 116
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 771
+E+LH II+RD+K NILLD + ++DFGLSK F D S GT+ Y
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-GTIEY 172
Query: 772 LDPEYYISQQLT-DKS-DVYSFGVILLELISG 801
+ P+ DK+ D +S GV++ EL++G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 43/214 (20%)
Query: 609 IGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 663
+GSG +G V +A+K L S +Q KR + E+ LL + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKL-SRPFQSAIHAKRTY-RELRLLKHMDHENVIGLL 80
Query: 664 -----GYCQEEGRSV-LVYEFMH---NGTLKEHLYGTLTHEQRINWIKRL--EIAEDAAK 712
E+ + V LV M N +K L+ + I+ L +I +
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ---KLSDDH----IQFLVYQIL----R 129
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG-- 770
G++Y+H+ IIHRDLK SNI +++ K+ DFGL A H + G V
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL-------ARHTDDEMTGYVATR 179
Query: 771 -YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 802
Y PE ++ D++S G I+ EL++G+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 609 IGSGGFGVVYYGKLKDGK--------EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 660
+G G F ++ G ++ E+ +KVL + F +++S++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
G C S++V E++ G+L +L ++ IN +LE+A+ A + +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLK---KNKNLINISWKLEVAKQLAWALHFLED- 118
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVGYLDPE-Y 776
+ H ++ + N+LL + K + K + G S I+ + ++ PE
Sbjct: 119 --KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 777 YISQQLTDKSDVYSFGVILLELISG 801
Q L+ +D +SFG L E+ SG
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQ 661
K++GSG +G V + G ++A+K L +Q KR + E+ LL + H N++
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAY-RELRLLKHMKHENVIG 78
Query: 662 FLG-YCQEEGRS-----VLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
L + + LV FM G L +H E RI ++ KG
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFL-----VYQMLKG 130
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV---G 770
++Y+H IIHRDLK N+ +++ K+ DFGL A S + G V
Sbjct: 131 LKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL-------ARQTDSEMTGYVVTRW 180
Query: 771 YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 802
Y PE ++ T D++S G I+ E+++G+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-09
Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 3/100 (3%)
Query: 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPLPS 481
L L+G IP + L L+ L L NSL+G IP+ +L I+HL N TG +P
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326
Query: 482 SLMNLPNLRELYVQNNMLSGTVPSSLLSKN--VVLNYAGN 519
+L +LP L+ L + +N SG +P +L N VL+ + N
Sbjct: 327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-09
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 1/92 (1%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 475
++ ++HL S N TG IP LT L L L L N +G IP + +L ++ L N L
Sbjct: 309 NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
TG +P L + NL +L + +N L G +P SL
Sbjct: 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 608 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFLGY 665
++G G +G VY + G +A+K + + K + E+ +L + +V F G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL---HTGCV 722
EG + E+M G+L + LY + I I KG+++L H
Sbjct: 68 FFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--- 123
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLDPEYYIS 779
IIHRD+K +N+L++ + + K+ DFG+S + V+S+ + +G Y+ PE S
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 780 QQLTD------KSDVYSFGVILLELISG 801
+SDV+S G+ +LE+ G
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 662
+ +G G FG+V + G+ +A+K + S KR + E+ LL + H N++
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENII-- 72
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE------IAEDAAKGIEY 716
S + + + L GT H R+ + LE +G++Y
Sbjct: 73 -------SLSDIFISPLEDIYFVTELLGTDLH--RLLTSRPLEKQFIQYFLYQILRGLKY 123
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
+H+ V +HRDLK SNIL++++ K+ DFGL++ ++ V T Y PE
Sbjct: 124 VHSAGV---VHRDLKPSNILINENCDLKICDFGLARIQ---DPQMTGYV-STRYYRAPEI 176
Query: 777 YISQQLTD-KSDVYSFGVILLELISGQ 802
++ Q D + D++S G I E++ G+
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 54/171 (31%), Positives = 79/171 (46%), Gaps = 29/171 (16%)
Query: 598 IEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 656
IE+ + K I G FG VY G K + K AVKV+ K + N+ +
Sbjct: 3 IEEFV--IVKPISRGAFGKVYLGRKKNNSKLYAVKVVK------KADMINKNMVHQVQAE 54
Query: 657 RNLV-----QF---LGYCQEEGRSV-LVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLE 705
R+ + F L Y + +V LV E++ G +K H+YG E + +I +
Sbjct: 55 RDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVA 114
Query: 706 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756
+A D YLH IIHRDLK N+L+ K++DFGLSK ++
Sbjct: 115 LALD------YLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 608 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGY 665
K+G G + V+ G+ K +A+K + +G EV+LL + H N+V
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 666 CQEEGRSVLVYEFMHNGTLKEHL--YGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGC 721
E LV+E++ + LK++L G L H +I + L +G+ Y H
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL-------RGLSYCHK-- 121
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI-S 779
I+HRDLK N+L+++ K++DFGL++ +V ++ + +V T+ Y P+ + S
Sbjct: 122 -RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGS 178
Query: 780 QQLTDKSDVYSFGVILLELISGQ 802
+ + D++ G IL E+ +G+
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 21/191 (10%)
Query: 647 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-INWIKRLE 705
E LL ++H ++++ + +V LY LT R + + L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLP-----HYSSDLYTYLTKRSRPLPIDQALI 161
Query: 706 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 765
I + +G+ YLH IIHRD+K+ NI ++ + + D G ++F V + + +
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216
Query: 766 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI------SNEKFGANCRN--- 816
GTV PE + K+D++S G++L E+++ I + E++ +C +
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL 276
Query: 817 -IVQWAKLHIE 826
I+ K+H E
Sbjct: 277 KIISTLKVHPE 287
|
Length = 357 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-09
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 1/93 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG-CPDLRIIHLEDNQ 474
P++ + LS+ L+G IP+D+ SSL L L GN L G IP+ L + L NQ
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
L G +P L + +L+ +Y+ N LSG +P +
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232
|
Length = 968 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 37/219 (16%)
Query: 607 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNLVQ 661
K I +G +G VY + K+ ++ A+K + + Q ++ F E +L+ + +V
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVS 65
Query: 662 FLGYCQEEGRSVL--VYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+C E + L V E++ G TL +++ G L + + R+ AE +EY
Sbjct: 66 M--FCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVD-----MARMYFAE-TVLALEY 116
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--------------AVDGASHVS 762
LH I+HRDLK N+L+ K++DFGLSK D +
Sbjct: 117 LHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
V GT Y+ PE + Q D ++ G+IL E + G
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 66/264 (25%), Positives = 105/264 (39%), Gaps = 71/264 (26%)
Query: 605 LEKKIGSGGFGVVY------YGKLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 656
L K +G G FG V K +AVK+L + + + +E+ +L I +H
Sbjct: 11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNH 70
Query: 657 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHL---------YGTLTHEQRINWIKRLEI 706
N+V LG C + G +++ EF G L L Y + +QR + +E
Sbjct: 71 LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130
Query: 707 A------------------------------------------ED-------AAKGIEYL 717
+ ED A+G+E+L
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEY 776
+ IHRDL + NILL ++ K+ DFGL++ +V R + ++ PE
Sbjct: 191 AS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247
Query: 777 YISQQLTDKSDVYSFGVILLELIS 800
+ T +SDV+SFGV+L E+ S
Sbjct: 248 IFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 711 AKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGT 768
A+G+E+L + C IHRDL + NILL ++ K+ DFGL++ +V R
Sbjct: 183 ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ ++ PE + T +SDV+SFGV+L E+ S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 37/211 (17%)
Query: 609 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 663
+GSG +G V K G +AVK L S +Q KR + E+ LL + H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 82
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 715
RS E ++ L HL G + N +K ++ +D +G++
Sbjct: 83 DVFTP-ARS---LEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 134
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YL 772
Y+H+ IIHRDLK SN+ +++ K+ DFGL A H + G V Y
Sbjct: 135 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL-------ARHTDDEMTGYVATRWYR 184
Query: 773 DPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
PE ++ +++ D++S G I+ EL++G+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 608 KIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGY 665
K+G G + VY G+ K +A+K + +G EV+LL + H N+V
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 666 CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRIN-WIKRLEIAEDAAKGIEYLHTGCV 722
E LV+E++ + LK++L G + + ++ +L +G+ Y H
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQL------LRGLNYCHR--- 122
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI-SQ 780
++HRDLK N+L+++ K++DFGL++ ++ ++ + +V T+ Y P+ + S
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGST 180
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
+ + D++ G I E+ +G+
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 54/226 (23%)
Query: 607 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIH-HRNL 659
K++G G +G+V + + + +A+K +T S KR E+ LL H+N+
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFRGHKNI 64
Query: 660 V-----------QFLG-YCQEEGRSVLVYEFMHNGT------LKEHLYGTLTHEQRINWI 701
F Y EE +++ + +G + +Y L
Sbjct: 65 TCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC-------- 116
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDG 757
G++Y+H+ V +HRDLK N+L++ K+ DFGL++ +
Sbjct: 117 -----------GLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN 162
Query: 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
A ++ V T Y PE +S Q K+ DV+S G IL EL+ +
Sbjct: 163 AGFMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQFLG 664
IG G + V +LK +I A+KV+ + E + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 665 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 715
C Q R LV E+++ G L H+ QR ++ E+ A+ +
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHM-----QRQR-------KLPEEHARFYAAEICIALN 110
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH II+RDLK N+LLD K++D+G+ K + G +S GT Y+ PE
Sbjct: 111 FLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL-GPGDTTSTFCGTPNYIAPE 166
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQ 802
++ D ++ GV++ E+++G+
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 662
K IG G FG V KLK+ ++ A+K+L + E F E +L ++ +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 663 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
Q+E LV ++ G TL L + ++ + IA D+ + Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
+HRD+K NIL+D + +++DFG ++ + SS+ GT Y+ PE I
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE--IL 175
Query: 780 QQLTD-------KSDVYSFGVILLELISGQEAISNEKF 810
Q + D + D +S GV + E++ G+ E
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIA---VKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQF 662
++IG+G FG V ++ +A VK L +N S + + EF + + H N++Q
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
LG C E +LV+E+ G LK +L H + + +A + A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--- 117
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGL--SKFAVD---GASHVSSIVRGTVGYLDPEYY 777
+H DL N L + KV D+G+ S++ D +R L E++
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 778 ---ISQQLTDKSDVYSFGVILLEL 798
I+ + T S+V++ GV L EL
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTV 769
AKG+E+L + IHRDL + NILL ++ K+ DFGL++ +V R +
Sbjct: 189 AKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
++ PE + T +SDV+SFGV+L E+ S
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 4e-08
Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 3/61 (4%)
Query: 441 SLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498
+L L L N LT IPD F G P+L+++ L N LT P + LP+LR L + N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 499 L 499
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 607 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLG 664
+K+G G + V+ G+ K + +A+K + +G EV+LL + H N+V
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ LV+E++ + LK+++ G + H +I + L +G+ Y H
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQIL-------RGLAYCHR- 122
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI- 778
++HRDLK N+L+++ K++DFGL++ +V ++ + +V T+ Y P+ +
Sbjct: 123 --RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 178
Query: 779 SQQLTDKSDVYSFGVILLELISGQ 802
S + + + D++ G I E+ SG+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-08
Identities = 57/237 (24%), Positives = 92/237 (38%), Gaps = 41/237 (17%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKV----LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+ IG GG G VY + +A+K L+ N KR F E + + + H +V
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR-FLREAKIAADLIHPGIVP 66
Query: 662 FLGYCQEEGRSVLVY---EFMHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAA 711
C + VY ++ TLK L ++ + L I
Sbjct: 67 VYSICSD---GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-------------AVDGA 758
IEY+H+ ++HRDLK NILL + D+G + F
Sbjct: 124 ATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 759 SHVS-----SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810
+ S IV GT Y+ PE + ++ +D+Y+ GVIL ++++ +K
Sbjct: 181 CYSSMTIPGKIV-GTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236
|
Length = 932 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 608 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFLG 664
K+G G + VY G+ K G+ +A+K + +G FT E +LL + H N+V
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+ LV+E++ LK+++ G + RL + + +G+ Y H
Sbjct: 71 IIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNV----RLFLFQ-LLRGLAYCHQ--- 121
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 781
++HRDLK N+L+ + K++DFGL++ A S S T+ Y P+ + S +
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 782 LTDKSDVYSFGVILLELISGQ 802
+ D++ G I E+ +G+
Sbjct: 181 YSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 6e-08
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTS---NSYQGKREFTNEVTLLSRIHHRNLVQF 662
K IG G +G+V K + +++A+K + + N KR E+ LL + H N++
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL-REIKLLRHLDHENVIAI 69
Query: 663 LGYCQEEGRSV-----LVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIE 715
R +VYE M + L + + TL+ + ++ +L +G++
Sbjct: 70 KDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQL------LRGLK 122
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
Y+H+ ++HRDLK SN+LL+ + K+ DFGL++ + ++ V T Y PE
Sbjct: 123 YIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPE 178
Query: 776 YYIS-QQLTDKSDVYSFGVILLELISGQ 802
++ + T DV+S G I EL+ +
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 8e-08
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQFL 663
IG G + V +LK + I A+KV+ + T + +H LV
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 715
Q E R V E+++ G L H+ QR ++ E+ A+ +
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHM-----QRQR-------KLPEEHARFYSAEISLALN 110
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
YLH II+RDLK N+LLD K++D+G+ K + S+ GT Y+ PE
Sbjct: 111 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE 166
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQ 802
+ D ++ GV++ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 67/274 (24%), Positives = 98/274 (35%), Gaps = 77/274 (28%)
Query: 607 KKIGSGGFGVV-YYGKLKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 662
K IG G FG V K GK A+K L + K + + E +L+ +V
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
Q+ L+ EF+ G L L Y T + + + R +AE
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-----VTRFYMAE------------ 109
Query: 721 CVPAI--------IHRDLKSSNILLDKHMRAKVSDFGLS------------------KFA 754
CV AI IHRD+K NIL+D+ K+SDFGLS K
Sbjct: 110 CVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN 169
Query: 755 VDGASHVSSIV----------------------------RGTVGYLDPEYYISQQLTDKS 786
+ + +S+ GT Y+ PE ++ Q +
Sbjct: 170 KNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229
Query: 787 DVYSFGVILLELISGQEAISNEKFGANCRNIVQW 820
D +S G I+ E + G +E R I+ W
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINW 263
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 12/102 (11%)
Query: 704 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
L + AKG+ +L + C IHRDL + NILL K+ DFGL++ D + +
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR---DIRNDSN 269
Query: 763 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+V+G V ++ PE + T +SDV+S+G++L E+ S
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQFL 663
IG G + V +LK + I A+KV+ + T + + +H LV
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 715
Q E R V EF+ G L H+ QR ++ E+ A+ +
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHM-----QRQR-------KLPEEHARFYSAEISLALN 110
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH II+RDLK N+LLD K++D+G+ K + +S GT Y+ PE
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-RPGDTTSTFCGTPNYIAPE 166
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQ 802
+ D ++ GV++ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 62/254 (24%), Positives = 97/254 (38%), Gaps = 49/254 (19%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 662
K IG G FG V + KD I A+K+L K + + E +L +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
Q++ L+ EF+ G + L TL+ E +I +A DA + +
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF---- 122
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------------------SKFAVDGAS 759
IHRD+K N+LLD K+SDFGL S F+ +
Sbjct: 123 -----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 760 -------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806
++ GT Y+ PE ++ D +S GVI+ E++ G
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 807 NEKFGANCRNIVQW 820
+E R ++ W
Sbjct: 238 SETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-07
Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 1/88 (1%)
Query: 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPS 481
LS +L+G IP + +L +L L L N+ TG IP + P L+++ L N+ +G +P
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350
Query: 482 SLMNLPNLRELYVQNNMLSGTVPSSLLS 509
+L NL L + N L+G +P L S
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
|
Length = 968 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 607 KKIGSGGFGVVYYGKLKDGK--EIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQ 661
+ +G+G FG V K+ +A+K + +++ +E +L+ I+H V
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
G ++E LV EF+ G + L +R A EYL +
Sbjct: 96 LYGSFKDESYLYLVLEFVIGG----EFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS-- 149
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
I++RDLK N+LLDK K++DFG +K VD ++ + GT Y+ PE ++
Sbjct: 150 -LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYT---LCGTPEYIAPEILLNVG 204
Query: 782 LTDKSDVYSFGVILLELISG 801
+D ++ G+ + E++ G
Sbjct: 205 HGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 63/236 (26%), Positives = 90/236 (38%), Gaps = 55/236 (23%)
Query: 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG----KREFTNEVTLLSRIHHRNLVQ 661
K +G G G V+ +LK GK A+KVL KR T E +L+ + H L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT-EQEILATLDHPFLPT 65
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 713
Q E LV ++ G L+ L + K L E+ A+
Sbjct: 66 LYASFQTETYLCLVMDYCPGG----ELFRLLQRQPG----KCLS--EEVARFYAAEVLLA 115
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR------- 766
+EYLH I++RDLK NILL + +SDF LSK + VS +R
Sbjct: 116 LEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 767 ---------------------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
GT Y+ PE D ++ G++L E++ G
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 61/254 (24%), Positives = 97/254 (38%), Gaps = 49/254 (19%)
Query: 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 662
K IG G FG V + KD G A+K+L K + + E +L +V+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
Q++ L+ EF+ G + L TLT E+ +I +A D+ + +
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF---- 122
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------------------SKFAVDGAS 759
IHRD+K N+LLD K+SDFGL S F +
Sbjct: 123 -----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 760 -------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 806
++ GT Y+ PE ++ D +S GVI+ E++ G
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 807 NEKFGANCRNIVQW 820
+E + ++ W
Sbjct: 238 SETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 12/102 (11%)
Query: 704 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
L A+G+E+L + CV HRDL + N+LL + K+ DFGL++ + +++VS
Sbjct: 240 LSFTYQVARGMEFLASKNCV----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295
Query: 763 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+G+ V ++ PE T SDV+S+G++L E+ S
Sbjct: 296 ---KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 41/213 (19%)
Query: 609 IGSGGFGVV---YYGKLKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 662
+GSG +G V Y +L+ +++AVK L S +Q R E+ LL + H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKL-SRPFQSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKE----HLYGTLTHEQRINWIKRLEIAEDAA------- 711
L F +++ +L L N +K +++++
Sbjct: 80 LDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL 127
Query: 712 -KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
+G++Y+H+ IIHRDLK SN+ +++ ++ DFGL++ A D ++ V T
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADD---EMTGYV-ATRW 180
Query: 771 YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
Y PE ++ +++ D++S G I+ EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 42/222 (18%)
Query: 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
+ +G G G+V+ D K +AVK + Q + E+ ++ R+ H N+V+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK---- 66
Query: 666 CQEEGRSVLVYEFM-HNGTLKEHLYGTLTHEQRI------------NWIKRLEIAEDAAK 712
VYE + +G+ G+LT + N +++ ++E+ A+
Sbjct: 67 ---------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 713 --------GIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSS 763
G++Y+H+ V +HRDLK +N+ ++ + + K+ DFGL++ SH
Sbjct: 118 LFMYQLLRGLKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 764 IVRGTVG--YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 802
+ G V Y P +S T D+++ G I E+++G+
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 608 KIGSGGFGVVYYGK-LKDG-KEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLV 660
+IG G +G V+ + LK+G + +A+K V +G T EV +L + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 661 QFLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
+ C E + LV+E + + L +L IK ++ +G++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLD 124
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH+ ++HRDLK NIL+ + K++DFGL++ + S +V T+ Y PE
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 179
Query: 776 YYISQQLTDKSDVYSFGVILLEL 798
+ D++S G I E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-07
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 609 IGSGGFGVVYYGKLKDGKE-IAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
IG+G FGVVY D E +A+K VL Y+ + E+ ++ ++H N++ Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-----ELLIMKNLNHINIIFLKDYY 128
Query: 667 QEEG-----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE----DAAKGIEYL 717
E +++ + M H Y + H R N L + + + + Y+
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKY--MKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
H+ I HRDLK N+L+D + K+ DFG +K + G VS I + Y PE
Sbjct: 187 HS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC--SRFYRAPEL 241
Query: 777 YI-SQQLTDKSDVYSFGVILLELISGQEAISNE 808
+ + T D++S G I+ E+I G S +
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274
|
Length = 440 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 662
K IG G FG V K+K+ ++ A+K+L + E F E +L R +
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 663 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
Q+E LV ++ G TL L + ++ + +A D+ + Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY--- 123
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYYI 778
+HRD+K N+LLDK+ +++DFG + DG S++ GT Y+ PE I
Sbjct: 124 ------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ-SNVAVGTPDYISPE--I 174
Query: 779 SQQLTD-------KSDVYSFGVILLELISGQ 802
Q + D + D +S GV + E++ G+
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 34/212 (16%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQF 662
K IG G FG V + K +++ L S KR F E +++ + +VQ
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 714
Q++ +V E+M G L +N + ++ E A+ +
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 773
+ +H+ IHRD+K N+LLDK K++DFG K +G + V GT Y+
Sbjct: 156 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 211
Query: 774 PEYYISQ----QLTDKSDVYSFGVILLELISG 801
PE SQ + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 8e-07
Identities = 50/181 (27%), Positives = 66/181 (36%), Gaps = 50/181 (27%)
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------SKF 753
R IAE IE +H IHRD+K NIL+D+ K++DFGL SK+
Sbjct: 104 RFYIAE-LTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 754 AVDGASH----------VSSIVR-----------------------GTVGYLDPEYYISQ 780
G H S I R GT Y+ PE +
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 781 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-LHIESGDIQGIIDPSLL 839
T D +S GVIL E++ GQ + ++ W LHI S Q +
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPS---QAKLSREAS 276
Query: 840 D 840
D
Sbjct: 277 D 277
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 662
K IG G FG V K+K + I A+K+L + E F E +L + +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66
Query: 663 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
Q+E LV ++ G TL L + +I + +A + + Y
Sbjct: 67 HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY--- 123
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
+HRD+K N+LLD + +++DFG + SS+ GT Y+ PE I
Sbjct: 124 ------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE--IL 175
Query: 780 QQLTD-------KSDVYSFGVILLELISGQ 802
Q + D + D +S GV + E++ G+
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 43/233 (18%)
Query: 595 LSDIEDATKMLEKKIGSGGFGVVYYGKLK----------------DGKEIAVKVLTSNSY 638
L DI ++K IG GGFG VY + + + I ++ L N+
Sbjct: 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNI 65
Query: 639 QGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE 695
+++ L IH H + ++ G C R + Y F+ L E L T E
Sbjct: 66 YDI----DKIALWKNIHNIDHLGIPKYYG-CGSFKRCRMYYRFI----LLEKLVEN-TKE 115
Query: 696 --QRI-NWIKRL--EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750
+RI K+L I +D +EY+H I H D+K NI++D + R + D+G+
Sbjct: 116 IFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGI 172
Query: 751 SKFAVDGASHVS------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLE 797
+ + H+ + RGT+ Y + + +T + D+ S G +L+
Sbjct: 173 ASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 33/102 (32%), Positives = 59/102 (57%), Gaps = 12/102 (11%)
Query: 704 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
L + A+G+++L + C IHRD+ + N+LL AK+ DFGL++ ++ +++V
Sbjct: 215 LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV- 269
Query: 763 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
V+G V ++ PE T +SDV+S+G++L E+ S
Sbjct: 270 --VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 608 KIGSGGFGVVYYGKLKDG---KEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLV-- 660
K+G G +G VY K KDG KE A+K + T S R E+ LL + H N++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR----EIALLRELKHPNVIAL 63
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEH-LYGTLT-HEQRINWIKRLEIAEDAAK------ 712
Q + + + L++++ EH L+ + H K +++ K
Sbjct: 64 QKVFLSHSDRKVWLLFDY------AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 713 --GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSI-- 764
GI YLH V +HRDLK +NIL+ + R K++D G ++ ++ +
Sbjct: 118 LDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 765 VRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
V T Y PE + ++ T D+++ G I EL++ +
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 6e-06
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 26/228 (11%)
Query: 582 LNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK 641
++D PA A + + +T+ E G GK K + IA +V +
Sbjct: 153 IDDLPAGAFGKIFICALRASTEEAEA---RRGVNSTNQGKPKCERLIAKRV--KAGSRAA 207
Query: 642 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV--------YEFMHNGTLKEHLYGTLT 693
+ NE+ L R++H N+++ + E + ++ Y FM++ L
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK 267
Query: 694 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG-LSK 752
+ I +K+L A +EY+H +IHRD+K NI L+ + + DFG
Sbjct: 268 QTRAI--MKQLLCA------VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316
Query: 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
F + + V GTV PE + +D++S G+ILL+++S
Sbjct: 317 FEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 37/150 (24%), Positives = 63/150 (42%), Gaps = 16/150 (10%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV--QFLG 664
K + G VY KD +K+ S RE EV +L + + L + L
Sbjct: 4 KLLKGGLTNRVYLLGTKDED-YVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLA 60
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
+ +G S L+ E++ TL E ++ E++ + IAE A+ + LH +
Sbjct: 61 SGESDGWSYLLMEWIEGETLDE-----VSEEEKED------IAEQLAELLAKLHQLPLLV 109
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754
+ H DL NIL+D + D+ + +
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-06
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLV 660
+++ IG G +GVV G+++A+K + + ++ + T E+ LL + H ++V
Sbjct: 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIV 62
Query: 661 Q----FLGYCQEEGRSV-LVYEFMH---------NGTL-KEH----LYGTLTHEQRINWI 701
+ L + E + + +V+E M N L EH LY L
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL--------- 113
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASH 760
+ ++Y+HT V HRDLK NIL + + K+ DFGL++ A D +
Sbjct: 114 ----------RALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160
Query: 761 V--SSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQ 802
+ + V T Y PE S + T D++S G I E+++G+
Sbjct: 161 IFWTDYV-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 7e-06
Identities = 28/80 (35%), Positives = 40/80 (50%), Gaps = 8/80 (10%)
Query: 725 IIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
IIH D+K N+L D+ R + D+GL K S GT+ Y PE I
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPE-KIKGHNY 183
Query: 784 DKS-DVYSFGVILLELISGQ 802
D S D ++ GV+ EL++G+
Sbjct: 184 DVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 608 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG-Y 665
K+G G +G VY K KDGK+ L G E+ LL + H N++ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 666 CQEEGRSV-LVYEFMHNG---TLKEHLYGTLTHEQRINWIKRL--EIAEDAAKGIEYLHT 719
R V L++++ + +K H + +++ + + + + GI YLH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFH-RASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 720 GCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLD 773
V +HRDLK +NIL+ + R K++D G ++ ++ + V T Y
Sbjct: 127 NWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 774 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
PE + ++ T D+++ G I EL++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLG 664
+G G FG V + K +I A+KV+ + + F E +LS + + Q
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
Q++ LV E+ G L L Y E + +AE + +H+
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA----QFYLAEL----VLAIHSVHQ 120
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-GTVGYLDPEYYISQQ 781
+HRD+K N+L+D+ K++DFG S + V+S + GT Y+ PE +
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 782 LTDKS------DVYSFGVILLELISGQ 802
K D +S GVI E+I G+
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 48/211 (22%), Positives = 82/211 (38%), Gaps = 30/211 (14%)
Query: 610 GSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGY 665
+V+ K K +AVK + K + E+ ++ H N++ ++
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKK-INLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 666 CQEEGRSVLVYEFMHNGT----LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 720
+ +V M G+ LK H L E I +I + D ++Y+H+ G
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-ELAIAFILK-----DVLNALDYIHSKG 121
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG------YLDP 774
IHR +K+S+ILL + +S S + + +L P
Sbjct: 122 F----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 775 EYYISQQL---TDKSDVYSFGVILLELISGQ 802
E + Q L +KSD+YS G+ EL +G
Sbjct: 178 EV-LQQNLQGYNEKSDIYSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 30/95 (31%), Positives = 56/95 (58%), Gaps = 12/95 (12%)
Query: 711 AKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT- 768
A G+E+L + CV HRDL + N+L+ + K+ DFGL++ + ++++S +G+
Sbjct: 249 ANGMEFLASKNCV----HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS---KGST 301
Query: 769 ---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ ++ PE + T SDV+SFG++L E+ +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 2/85 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ + LS N ++P ++ LS+L EL L NS+ + S +L + L +N+L
Sbjct: 186 SNLNNLDLSG-NKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKL 244
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLS 500
LP S+ NL NL L + NN +S
Sbjct: 245 E-DLPESIGNLSNLETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 609 IGSGGFGVVYYGKLKD---------GKEIAV--KVLTSNSYQGKREFTNEVTLLSRIHHR 657
+G G F +Y G L+ G+E++V KVL S+ ++ F +L+S++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-HRDSLAFFETASLMSQLSHK 61
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN----WIKRLEIAEDAAKG 713
+LV+ G C + +++V E++ G L L H ++ N W +L++A+ A
Sbjct: 62 HLVKLYGVCVRDE-NIMVEEYVKFGPLDVFL-----HREKNNVSLHW--KLDVAKQLASA 113
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKH-------MRAKVSDFGLSKFAVDGASHVSSIVR 766
+ YL ++H ++ NIL+ ++ K+SD G+ + V I
Sbjct: 114 LHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-- 168
Query: 767 GTVGYLDPEYY--ISQQLTDKSDVYSFGVILLELISGQEA 804
++ PE LT +D +SFG LLE+ S E
Sbjct: 169 ---PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-05
Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 25/195 (12%)
Query: 645 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 704
+E LL R+ H ++ L G + LV + LY L R+ +
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-----DLYTYLG--ARLRPLGLA 260
Query: 705 EIAEDAAK---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761
++ A + I+Y+H IIHRD+K+ N+L++ + DFG + FA S
Sbjct: 261 QVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFA--RGSWS 315
Query: 762 SSIVRGTVGYLD---PEYYISQQLTDKSDVYSFGVILLE-------LISGQEAISNEKFG 811
+ G G +D PE T D++S G+++ E L S +
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYD 375
Query: 812 ANCRNIVQWAKLHIE 826
A I++ A++H++
Sbjct: 376 AQILRIIRQAQVHVD 390
|
Length = 461 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-05
Identities = 27/88 (30%), Positives = 47/88 (53%), Gaps = 8/88 (9%)
Query: 605 LEKKIGSGGFGVVY------YGKLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 656
K +G+G FG V GK + +AVK+L ++++ +RE +E+ +LS + H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTL 684
+N+V LG C G +++ E+ G L
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-05
Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 28/230 (12%)
Query: 580 SSLNDAPAEAAHCFTLSDIEDATKM---LEKKIGSGGFGVVY----YGKLKDGKEIAVKV 632
S D E + SD +M + + G G V+ +G + K++ VK
Sbjct: 68 SPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKA 126
Query: 633 LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL-GYCQEEGRSVLVYEFMHNGTLKEHLYGT 691
+T G + E+ +L I HR ++ + Y + +++ ++ + G
Sbjct: 127 VT-----GGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGP 181
Query: 692 LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751
L EQ I +RL A + YLH IIHRD+K+ NI LD+ A + DFG +
Sbjct: 182 LPLEQAITIQRRLLEA------LAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA 232
Query: 752 KFAVDGASHVSSIVRGTVGYLD---PEYYISQQLTDKSDVYSFGVILLEL 798
A + G G L+ PE K+D++S G++L E+
Sbjct: 233 --CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 39/146 (26%), Positives = 60/146 (41%), Gaps = 15/146 (10%)
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 715
N+V Y E LV + G L H+ + + E W + +A DA
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
LH I+ RDL +NILLD +++ F V+ + ++ Y PE
Sbjct: 101 -LHR---EGIVCRDLNPNNILLDDRGHIQLTYFS-RWSEVEDSCDGEAVENM---YCAPE 152
Query: 776 YYISQQLTDKSDVYSFGVILLELISG 801
+ T+ D +S G IL EL++G
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 73/296 (24%), Positives = 103/296 (34%), Gaps = 105/296 (35%)
Query: 605 LEKKIGSGGFGVVYYG-----KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN- 658
L KK+G G FGVVY + K + +K + Y + NE R N
Sbjct: 136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLK--KATEYGAVEIWMNERV---RRACPNS 190
Query: 659 ----LVQFLGYCQEEGRSV--LVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEI 706
+ FL + LV+ + TL KE Y E + L
Sbjct: 191 CADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNV---EPYL-----LGK 242
Query: 707 AEDAAKGIEY------------------LH-TGCVPAIIHRDLKSSNILLDKHMRA-KVS 746
+D KG+E LH TG I+HRD+K NI+ + + K+
Sbjct: 243 VQDLPKGLERENKIIQTIMRQILFALDGLHSTG----IVHRDVKPQNIIFSEGSGSFKII 298
Query: 747 DFGLSKFAVDGASHVSSIVRGTVGY------LDP------EYYISQQ------------- 781
D G A D +R + Y LDP +Y +S Q
Sbjct: 299 DLGA---AAD--------LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 347
Query: 782 --------LTDKSDVYSFGVILLE-----LISGQEAIS-NEKFGANCRNIVQWAKL 823
L D+ D+YS G+I L+ L S I N + N ++V W KL
Sbjct: 348 SPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL 403
|
Length = 566 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 60/248 (24%), Positives = 93/248 (37%), Gaps = 61/248 (24%)
Query: 607 KKIGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 662
K +G G FG V K+ A+K L + + + E +L+ + +V+
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
Q++ V +++ G + L + + R IAE IE +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIAE-LTLAIESVHK--- 119
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGL---------SKFAVDGASHVS----------- 762
IHRD+K NIL+D K++DFGL SK+ G SH+
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG-SHIRQDSMEPSDLWD 178
Query: 763 ----------------------------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 794
S+V GT Y+ PE + + T D +S GVI
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLV-GTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 795 LLELISGQ 802
L E++ GQ
Sbjct: 238 LFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 49/191 (25%), Positives = 84/191 (43%), Gaps = 21/191 (10%)
Query: 624 DGKEIAV--KVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681
+G+E+ V KVL + F +L+S++ H +L G C +++V EF+ +
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 741
G L L + W ++ +A+ A + YL ++H ++ + NILL +
Sbjct: 101 GPLDVCLRKEKGR-VPVAW--KITVAQQLASALSYLED---KNLVHGNVCAKNILLARLG 154
Query: 742 RA-------KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGV 793
A K+SD G+S A+ V I ++ PE L+ +D +SFG
Sbjct: 155 LAEGTSPFIKLSDPGVSFTALSREERVERI-----PWIAPECVPGGNSLSTAADKWSFGT 209
Query: 794 ILLELISGQEA 804
LLE+ E
Sbjct: 210 TLLEICFDGEV 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 35/114 (30%), Positives = 58/114 (50%), Gaps = 15/114 (13%)
Query: 607 KKIGSGGFGVVY----YGKLKDGK--EIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 658
K +G+G FG V YG K +AVK+L +++ +RE +E+ +LS + +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHIN 100
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI--KRLEIAEDA 710
+V LG C G ++++ E+ G L L +R ++I K + AE A
Sbjct: 101 IVNLLGACTVGGPTLVITEYCCYGDLLNFL-----RRKRDSFICPKHEDHAEAA 149
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 33/112 (29%)
Query: 710 AAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV--- 765
A +G+ YLH G IHR++K+S+IL +S GL ++ G SH+ S+V
Sbjct: 110 ALRGLNYLHQNGY----IHRNIKASHIL--------ISGDGL--VSLSGLSHLYSLVRNG 155
Query: 766 -RGTVGYLDPEYYIS-----------QQLTD---KSDVYSFGVILLELISGQ 802
+ V Y P++ S Q L KSD+YS G+ EL +G+
Sbjct: 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 40/149 (26%), Positives = 55/149 (36%), Gaps = 51/149 (34%)
Query: 726 IHRDLKSSNILLDKHMRAKVSDFGL---------SKFAVDGASHVS-------------- 762
IHRD+K NIL+D+ K++DFGL SK+ G HV
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG-DHVRQDSMDFSNEWGDPA 181
Query: 763 -------------------------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLE 797
S+V GT Y+ PE + T D +S GVIL E
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLV-GTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 798 LISGQEAISNEKFGANCRNIVQW-AKLHI 825
++ GQ + ++ W LHI
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINWQTSLHI 269
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 929 | |||
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.58 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.55 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.5 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.47 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.32 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.17 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.16 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.14 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.14 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.06 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.98 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.93 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.93 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.88 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.82 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.81 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.8 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.75 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.73 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.71 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.71 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.7 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.7 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.69 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.65 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.64 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.58 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.55 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.55 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.55 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.51 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.48 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.41 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.4 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.37 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.35 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.3 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.27 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.24 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.23 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.18 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.1 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.07 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.06 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.99 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.96 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.95 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.91 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.89 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.89 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.87 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.87 |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-81 Score=748.89 Aligned_cols=497 Identities=24% Similarity=0.386 Sum_probs=396.0
Q ss_pred HHHHHHHhcccccCCCCceEeeCCCCCcc-ccCCCeEEccCCccccccceeeecCcccccccceeecccCC-CCcceeee
Q 002382 15 SVLILLLLDSSSAQMPGFVSLNCGGNENF-TDEIGLQWIADDHLIYGEISNISVANETRKQYMTLRHFPAD-SRKYCYKL 92 (929)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~idcg~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~tlr~fp~~-~~~~cy~~ 92 (929)
+.+++++++.++.+++++++||||++.++ +|.+|++|++|..|+.|...+...++...++|+|+|+||.. ++++||+|
T Consensus 8 ~~~~~~~~~~~~~~~~~~~~I~CGs~~~~~~d~~~~~w~~D~~~~~~~~~~~~~~~~~~~~~~t~R~F~~~~g~~~cY~~ 87 (623)
T PLN03150 8 ASALLAVLASLASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTGGIPANATRPSFIAPPLKTLRYFPLSDGPENCYNI 87 (623)
T ss_pred HHHHHHhhcccccCCCccEEEeCCCCCCcccCCCCCEEcCCcccccCccccccCcccccchhhccccCCcccccccceEe
Confidence 33444555555666789999999999987 67899999999998766555555555566889999999963 56679999
Q ss_pred eccCCceeEEeEEeeecCcCCCCCCCeeEEEECCceeeEEeeC--CCCccEEEEEEEEecCCCceEEEecCCCCCceeee
Q 002382 93 DVITRTRYLIRATFLYGNFDNNNVYPKFDISLGPTHWSTIVIS--DAATIEVRELIFLASSPKIDVCLSNATTGQPFIST 170 (929)
Q Consensus 93 ~~~~~~~yl~r~~~~yg~~d~~~~~p~fd~~~~~~~w~~v~~~--~~~~~~~~e~~~~~~~~~~~vcl~~~~~~~pfis~ 170 (929)
|+.++||||||++|+|||||+.+++|.||+++|||+|.+|+.+ ..+...++|+|+.+++++++|||++++.|.||||+
T Consensus 88 ~~~~~g~ylVRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs~ 167 (623)
T PLN03150 88 NRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILS 167 (623)
T ss_pred eecCCCcEEEEEEeecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCceeE
Confidence 9999999999999999999999999999999999999999873 34557889999999999999999999999999999
Q ss_pred eeeeecCCccccCcc--cCceeEEEEEeeccCCCC-CCCccCCCCCC--CCccccCccccccccccccCccccccccccc
Q 002382 171 LELRQFNGSVYLTPF--EDRYYLSVSARINFGADS-EAPVRYPDDPF--DRIWESDSLKKANYLVDVAAGTEKVSTKLPI 245 (929)
Q Consensus 171 le~~~l~~~~y~~~~--~~~~~l~~~~r~~~g~~~-~~~~ryp~D~~--dR~W~p~~~~~~~~~~~~~~~~~~~st~~~i 245 (929)
||||+|++++|+... +.+.+|.+++|.++|+.. ...+|||||+| ||+|+|+..+. ...+.++++...|
T Consensus 168 iEv~~l~~~~y~~~~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~-------~~~~~~~st~~~I 240 (623)
T PLN03150 168 IEILQVDDKAYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFG-------SGSDQAISTENVI 240 (623)
T ss_pred EEEEEcCcccccccccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccC-------CCccccccccccc
Confidence 999999999996442 446789999999999853 33589999999 99999975421 1124456666656
Q ss_pred CC--CCCCCChHHHHhhcccccCC--ceEEeecCCCCCCcceeEEeeccccC-CCCCcceEEEEEECCCcccccceeccc
Q 002382 246 DL--RSDELPPQKVMQTAVVGTNG--SLTYRLNLDGFPGFGWAVTYFAEIED-LDPDESRKFRLVLPGQPDVSKAIVNIQ 320 (929)
Q Consensus 246 ~~--~~~~~pP~~v~qtA~t~~~~--~l~~~~~~~~~~~~~y~~~yFae~~~-~~~~~~R~F~v~~n~~~~~~~~~~~~~ 320 (929)
.. ..++.+|++|||||.++.++ .++|.|++++. ..++++|||+|++. ....+.|+|||++||+.......+.
T Consensus 241 ~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~~v~~~-~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~-- 317 (623)
T PLN03150 241 KKASNAPNFYPESLYQSALVSTDTQPDLSYTMDVDPN-RNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIV-- 317 (623)
T ss_pred ccccCCCccChHHHhhhhccccCCCCceEEEeecCCC-CCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChh--
Confidence 53 34777899999999887663 57777775532 34467999999984 5677899999999998877665432
Q ss_pred cccCcceEEeccccccccccceeeeeecccCCCCCCCccchhccceeccCCC--CCccHHHHHHHHhhcCC---CCcccC
Q 002382 321 ENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERND--GSIDGVAIVSVISLYSS---ADWAQE 395 (929)
Q Consensus 321 ~~~~~~~~v~~~~~t~~~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~--n~~~~~~~~~l~~l~~~---~~w~~~ 395 (929)
....+.+..+...+.........++.|.+... -||+|||+|++++..... +..++.+|..+|+.... .+|
T Consensus 318 ~~~g~~~~~~~~~~~v~~~~g~l~isl~p~~~--s~pilNaiEI~~~~~~~~~t~~~~~~aL~~~k~~~~~~~~~~W--- 392 (623)
T PLN03150 318 KMSGERYTALVLNKTVAVSGRTLTIVLQPKKG--THAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGW--- 392 (623)
T ss_pred hhcCCcccceEEEeEEeecCCeEEEEEeeCCC--CcceeeeeeeeeccccccccCchHHHHHHHHHHhcCCcccCCC---
Confidence 11112221211111111112445677777654 379999999999988654 66677888888877543 267
Q ss_pred CCCCCCCC--CCceeEeCCCC---CCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEE
Q 002382 396 GGDPCLPV--PWSWLQCNSDP---QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIH 469 (929)
Q Consensus 396 ~~dpc~~~--~~~~~~c~~~~---~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~ 469 (929)
++|||.|. +|.|+.|+.+. ...++.|+|++|+|+|.+|..|++|++|+.|+|++|+|+|.+|. +++|++|+.||
T Consensus 393 ~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~Ld 472 (623)
T PLN03150 393 NGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLD 472 (623)
T ss_pred CCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 78999876 79999996432 23599999999999999999999999999999999999998885 89999999999
Q ss_pred ecCCCcCCCCCccccCCCcCccccccccccccccccccccc---ceeccccCCcccccCC
Q 002382 470 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK---NVVLNYAGNINLHEGG 526 (929)
Q Consensus 470 Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l~~~---~~~l~~~~n~~lc~~~ 526 (929)
|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+|..+... ...+.+.+|..+|+.+
T Consensus 473 Ls~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 473 LSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 99999999999999999999999999999999999987543 3467788999999764
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-61 Score=533.59 Aligned_cols=320 Identities=35% Similarity=0.564 Sum_probs=250.1
Q ss_pred eeCCCCCc---ccc-CCCeEEccCCccc-cccceeeec-----CcccccccceeecccCCCCcceeeeecc--CCceeEE
Q 002382 35 LNCGGNEN---FTD-EIGLQWIADDHLI-YGEISNISV-----ANETRKQYMTLRHFPADSRKYCYKLDVI--TRTRYLI 102 (929)
Q Consensus 35 idcg~~~~---~~~-~~~~~~~~d~~~~-~~~~~~~~~-----~~~~~~~~~tlr~fp~~~~~~cy~~~~~--~~~~yl~ 102 (929)
||||++.+ |+| .+|++|++|++|+ +|..++++. .....++|+|+|+||+|.| +||+||+. +|+||||
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~~g~r-~cY~l~~~~~~~~~yli 79 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFPEGSR-NCYTLPVTPPGGGKYLI 79 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcCCCCc-cEEEeeccCCCCceEEE
Confidence 89998866 555 6899999999999 566667732 1234578999999998877 69999998 5779999
Q ss_pred eEEeeecCcCCCC-----CCCeeEEEECCceeeEEeeCCC-CccEEEE-EEEEecCCCceEEEecCCCCC-ceeeeeeee
Q 002382 103 RATFLYGNFDNNN-----VYPKFDISLGPTHWSTIVISDA-ATIEVRE-LIFLASSPKIDVCLSNATTGQ-PFISTLELR 174 (929)
Q Consensus 103 r~~~~yg~~d~~~-----~~p~fd~~~~~~~w~~v~~~~~-~~~~~~e-~~~~~~~~~~~vcl~~~~~~~-pfis~le~~ 174 (929)
|+.|+|||||+++ +||.|||++|+|.|++|+.++. ....++| +|++.++++++|||+++++|+ ||||+||||
T Consensus 80 Rl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~ 159 (347)
T PF12819_consen 80 RLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELR 159 (347)
T ss_pred EEEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEE
Confidence 9999999999874 3788999999999999998762 2368899 555555899999999999999 999999999
Q ss_pred ecCCccccCc-ccCceeEEEEEeeccCCCCCCCccCCCCCCCCccccCccccccccccccCcccccccccccC---CCCC
Q 002382 175 QFNGSVYLTP-FEDRYYLSVSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPID---LRSD 250 (929)
Q Consensus 175 ~l~~~~y~~~-~~~~~~l~~~~r~~~g~~~~~~~ryp~D~~dR~W~p~~~~~~~~~~~~~~~~~~~st~~~i~---~~~~ 250 (929)
+|++++|+.. ...+.+|.++.|+|+|+... .||||+|+|||+|+|+.. ...|.+++++.+|+ ...+
T Consensus 160 ~lp~~ly~~~~~~~s~~L~~~~R~n~G~~~~-~iryp~D~~dR~W~~~~~---------~~~~~~ist~~~i~~~~~~~~ 229 (347)
T PF12819_consen 160 PLPDSLYPDTDANSSQALETVYRLNVGGSSS-FIRYPDDTYDRIWQPYSS---------SPGWSNISTTSNININSSNNP 229 (347)
T ss_pred ECCccceeccccCCCceeEEEEeecCCCccc-ccCCCCCcceeecccccc---------CccccccccceeeecccCCcc
Confidence 9999999533 35678999999999998654 399999999999997621 23467777776665 2358
Q ss_pred CCChHHHHhhcccccCCc--eEEeecCCCCCCcceeEEeeccccCCCCCc-ceEEEEEECCCcccccceeccccccCcce
Q 002382 251 ELPPQKVMQTAVVGTNGS--LTYRLNLDGFPGFGWAVTYFAEIEDLDPDE-SRKFRLVLPGQPDVSKAIVNIQENAQGKY 327 (929)
Q Consensus 251 ~~pP~~v~qtA~t~~~~~--l~~~~~~~~~~~~~y~~~yFae~~~~~~~~-~R~F~v~~n~~~~~~~~~~~~~~~~~~~~ 327 (929)
+.||.+|||||+++.+.+ +.+.|..++....+|++|||||++.+..+. .|+|||++||+..++..... .....+ .
T Consensus 230 ~~~P~~V~~TA~~~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~-~~~~~~-~ 307 (347)
T PF12819_consen 230 YDAPSAVYQTARTPSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPP-YLGADT-V 307 (347)
T ss_pred CcChHHHHHhhhcccccccceEEEeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcc-cccCcc-e
Confidence 999999999999998875 888998855555567799999999986444 79999999999887522211 111111 1
Q ss_pred EEeccccccccccceeeeeecccCCCCCCCccchhcccee
Q 002382 328 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKY 367 (929)
Q Consensus 328 ~v~~~~~t~~~l~~l~~l~l~~n~~s~lPP~i~~le~l~~ 367 (929)
.++..........+...++|.++..|++||+|||||++++
T Consensus 308 ~~~~d~~~~~~~~~~~~isL~~t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 308 PYYSDYVVNVPDSGFLNISLGPTPDSTLPPILNALEIYKV 347 (347)
T ss_pred EeecceEEEecCCCEEEEEEEeCCCCCcCceeEeeeeEeC
Confidence 1221111122233356778999999999999999999874
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-54 Score=551.23 Aligned_cols=510 Identities=25% Similarity=0.398 Sum_probs=370.8
Q ss_pred cccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCce-eEeCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSW-LQCNSDPQ 415 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~-~~c~~~~~ 415 (929)
.++.+..|+|+.|.++..+|. +..+..|+.|++.+|.+.......+ ....+..++.+++. ..+ +.....++
T Consensus 426 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~------l~~~~~~~~~~l 498 (968)
T PLN00113 426 KLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQ------FSGAVPRKLGSL 498 (968)
T ss_pred cCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCc------cCCccChhhhhh
Confidence 366788999999999876665 7788899999999988654221111 11222223221110 111 11112356
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
++|+.|+|++|+++|.+|..+.+|++|+.|+|++|++++.+|. +.++++|+.|||++|+++|.+|..+.++++|+.|++
T Consensus 499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l 578 (968)
T PLN00113 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578 (968)
T ss_pred hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEec
Confidence 7899999999999999999999999999999999999999986 899999999999999999999999999999999999
Q ss_pred ccccccccccccc-cccceeccccCCcccccCCC-----------CCccceeeeccccchhhhhhhhhheeeeeecCCCC
Q 002382 495 QNNMLSGTVPSSL-LSKNVVLNYAGNINLHEGGR-----------GAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKN 562 (929)
Q Consensus 495 ~~N~l~g~~P~~l-~~~~~~l~~~~n~~lc~~~~-----------~~~~~~iii~~~v~~~~~ll~~~~~~~~~~~~kk~ 562 (929)
++|+++|.+|..- +.......+.||+.+|++.. ......++++.++++++++++++++++++++ |++
T Consensus 579 s~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 657 (968)
T PLN00113 579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRG-RNN 657 (968)
T ss_pred cCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHh-hhc
Confidence 9999999999753 33445567789999997531 1111223333333333333233332222222 211
Q ss_pred cccccccccCCCCcCCCCCCCCCccccccccCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchh
Q 002382 563 NYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK 641 (929)
Q Consensus 563 ~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~ 641 (929)
...+...... .. .............++..++... ....+.||+|+||.||+|+.. +++.||||+++.....
T Consensus 658 ~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-- 729 (968)
T PLN00113 658 LELKRVENED-GT----WELQFFDSKVSKSITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-- 729 (968)
T ss_pred cccccccccc-cc----ccccccccccchhhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc--
Confidence 1111000000 00 0000000111122344444332 233568999999999999874 7899999998643322
Q ss_pred HHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCC
Q 002382 642 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721 (929)
Q Consensus 642 ~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 721 (929)
..+|++.+++++||||++++|+|.+.+..++||||+++|+|.++++ .++|.++.+++.|+++||+|||..+
T Consensus 730 --~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~ 800 (968)
T PLN00113 730 --PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRC 800 (968)
T ss_pred --cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCC
Confidence 2356889999999999999999999999999999999999999984 2789999999999999999999776
Q ss_pred CCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhC
Q 002382 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801 (929)
Q Consensus 722 ~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG 801 (929)
.++|+||||||+||+++.++.+++. ||.+...... ....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 801 ~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg 874 (968)
T PLN00113 801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG 874 (968)
T ss_pred CCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhC
Confidence 6799999999999999999988876 6665432211 123578999999999999999999999999999999999
Q ss_pred CCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc--cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 802 QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE--YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 802 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
+.||.... .....+++|++...........+|+.+... .+.++..++.+++.+|++.+|++||+|+||++.|+++.
T Consensus 875 ~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 875 KSPADAEF--GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCCCCccc--CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 99995432 233467888877666666666777776443 34567778999999999999999999999999999865
Q ss_pred h
Q 002382 880 V 880 (929)
Q Consensus 880 ~ 880 (929)
.
T Consensus 953 ~ 953 (968)
T PLN00113 953 R 953 (968)
T ss_pred c
Confidence 3
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-51 Score=456.08 Aligned_cols=288 Identities=49% Similarity=0.859 Sum_probs=254.4
Q ss_pred cccccCHHHHHHHHHHHh--ccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeee
Q 002382 589 AAHCFTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666 (929)
Q Consensus 589 ~~~~~~~~~i~~~~~~~~--~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~ 666 (929)
..+.|++.++..+|.+|. +.||+|+||.||+|...+++.||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999999996 799999999999999999999999988765433156699999999999999999999999
Q ss_pred eecC-eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEE
Q 002382 667 QEEG-RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 745 (929)
Q Consensus 667 ~~~~-~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL 745 (929)
.+.+ +.+||||||++|+|.++|+..... .++|..|++||.++|+||+|||+.+.+.||||||||+|||+|+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 599999999999999999875433 8899999999999999999999999889999999999999999999999
Q ss_pred EeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh
Q 002382 746 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 746 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
+|||+|+.......+......||.+|+|||++..+..+.|+|||||||+|+|+++|+.|.+... +....+++.|++...
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHH
Confidence 9999997554312222221179999999999999999999999999999999999999887654 444557999999999
Q ss_pred hcCCcccccCCccc-CccCH-HHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 826 ESGDIQGIIDPSLL-DEYDI-QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 826 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
.++++.+++|+.+. +.+.. +++.++..++.+|++.+|++||+|.||+++|+.+.
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999999997 66665 68899999999999999999999999999996543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=390.74 Aligned_cols=255 Identities=35% Similarity=0.572 Sum_probs=211.3
Q ss_pred HHhccccccCcEEEEEEEECCCcE-EEEEEeecCCcch--hHHHHHHHHHhcccCCCceeEEeeeeeecC-eEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGYCQEEG-RSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~~~~-vAVK~l~~~~~~~--~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~-~~~LV~E~~ 679 (929)
.+.+.||+|+||+||+|.++ |+. ||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34566999999999999998 555 9999998654322 568999999999999999999999999887 799999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCc-eecCCCCCCCeEecCCC-cEEEEeecCcccccCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-IIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDG 757 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~ 757 (929)
++|+|.++++.. ....+++..++.++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999754 467899999999999999999999998 7 99999999999999998 9999999999865443
Q ss_pred CCceeeeeecCccccCccccc--cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 758 ASHVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~--~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
. ...+...||+.|||||++. ...++.|+||||||+++|||+||+.||..... ..+...+ ...+
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~~~~~v---~~~~------- 262 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQVASAV---VVGG------- 262 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HHHHHHH---HhcC-------
Confidence 2 2223367999999999999 66999999999999999999999999987652 1112211 1111
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
.+...+..+...+..++.+||+.||+.||++.|++..|+.+...
T Consensus 263 --~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 263 --LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred --CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 12222333556788999999999999999999999999987653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=368.82 Aligned_cols=256 Identities=29% Similarity=0.400 Sum_probs=211.0
Q ss_pred cCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC-CcchhHHHHHHHHHhcccCCCceeEEeeeeeecC
Q 002382 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 670 (929)
Q Consensus 593 ~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~ 670 (929)
++..|++ ..+.||+|..|+|||++++ +++-+|+|++... .....+++.+|+++++.++||+||+++|+|...+
T Consensus 76 i~~~dle-----~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLE-----RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhh-----hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 5566665 3467999999999999998 5778999999544 3455788999999999999999999999999998
Q ss_pred -eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeec
Q 002382 671 -RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (929)
Q Consensus 671 -~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 749 (929)
...++||||.+|+|++.+.. .+++++....+|+.++++||.|||+. .+||||||||+|||++..|++||||||
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccc
Confidence 49999999999999999853 36789999999999999999999973 399999999999999999999999999
Q ss_pred CcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccc-ccccchhhHHHHHHhhhcC
Q 002382 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK-FGANCRNIVQWAKLHIESG 828 (929)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~-~~~~~~~l~~~~~~~~~~~ 828 (929)
.++...++ ......||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.... .....-.+..++-....
T Consensus 225 VS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp-- 299 (364)
T KOG0581|consen 225 VSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP-- 299 (364)
T ss_pred ccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC--
Confidence 99876554 4556779999999999999999999999999999999999999997642 11122233333222111
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 829 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
|.+..+ ..-.++..++..|+++||.+||++.|+++|
T Consensus 300 -------P~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 -------PRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -------CCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122222 233468899999999999999999999987
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=388.47 Aligned_cols=261 Identities=28% Similarity=0.447 Sum_probs=221.6
Q ss_pred HHHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 597 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 597 ~i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
+++.....+.+.||+|.||+||.|+++....||+|.++... ....+|.+|+++|++++|+|||+++|+|..++.++|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 45566667889999999999999999977799999998653 34578899999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
|||+.|+|.++|.. ..+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+...+
T Consensus 281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 99999999999975 3467788999999999999999999999 999999999999999999999999999996655
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
+.........-+..|.|||.+..+.++.|||||||||+||||+| |+.|+...... ++++ .+++|
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----ev~~----~le~G------- 420 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----EVLE----LLERG------- 420 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----HHHH----HHhcc-------
Confidence 55545555556789999999999999999999999999999999 88998776522 1222 22222
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.+-..+..++..+.+++..||+.+|++|||++.+...|+++..
T Consensus 421 --yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 421 --YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred --CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 1122344566789999999999999999999999999988754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=387.37 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=211.8
Q ss_pred HHHHHhccccccCcEEEEEEEE-CCCcEEEEEEeecC---CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~-~~~~~vAVK~l~~~---~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
.+|...+.||+|||+.||.++. ..|+.||+|++.+. .....+...+|+++.+.++|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4566788999999999999998 68999999999874 3334567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
|+|++++|.++++ ..+.+.+.++..+++||+.||.|||+. +|+|||||..|+|++++.++||+|||+|.....
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999884 467899999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
.. +...+.+|||.|+|||++.....+..+||||+||+||-||.|++||+.....+.+..|.. .+..+
T Consensus 171 ~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~------~~Y~~------ 237 (592)
T KOG0575|consen 171 DG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL------NEYSM------ 237 (592)
T ss_pred cc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh------cCccc------
Confidence 32 334567799999999999999999999999999999999999999997764444433322 11111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+........+|+.++++++|.+|||+++|+.+
T Consensus 238 ------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 ------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11122356799999999999999999999976
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=372.67 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=205.7
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc-------hhHHHHHHHHHhcccCCCceeEEeeeeeecCe
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 671 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~-------~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~ 671 (929)
...|.+.+.||+|+||.|-+|..+ +|+.||||++++.... ......+|+++|++++|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 445667899999999999999765 7999999999865321 22345799999999999999999999999999
Q ss_pred EEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC---CcEEEEee
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDF 748 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkL~DF 748 (929)
.|+||||++||+|.+.+- ..+.+.+.....++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999984 345566777788999999999999999 99999999999999866 78999999
Q ss_pred cCcccccCCCCceeeeeecCccccCccccccCcC---CCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh
Q 002382 749 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL---TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 749 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
|+|+... ....+.+.+||+.|.|||++.+... ..++|+||+|||||-+++|.+||.....+.... + ++
T Consensus 324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~---e----QI 394 (475)
T KOG0615|consen 324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK---E----QI 394 (475)
T ss_pred chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHH---H----HH
Confidence 9999765 4456677889999999999986543 347899999999999999999998765332111 1 12
Q ss_pred hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 826 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..|++.. ......+.-++..+++.+|+..||++|||+.|+++|
T Consensus 395 ~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 LKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 2222211 112233455678999999999999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=356.67 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=211.4
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEee-eeeecCe-EEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLG-YCQEEGR-SVLV 675 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g-~~~~~~~-~~LV 675 (929)
+.+.+.++||+|.||+||+++.. +|..||.|.++-. .....++...|+.+|++++|||||++++ -+.++.. +.+|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 44668899999999999999754 8999999988733 3344567889999999999999999998 4444444 8999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
||+|..|+|.+.+.....+.+.+++..+++++.|++.||.++|.+. ++ |+||||||.||+++.+|.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999887788889999999999999999999999942 24 99999999999999999999999999998
Q ss_pred ccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
+..... .....+|||.||+||.+.+..|+.+|||||+||++|||+.-++||.+...-+.+. .+.+++...+
T Consensus 178 l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~--------KI~qgd~~~~ 248 (375)
T KOG0591|consen 178 LSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCK--------KIEQGDYPPL 248 (375)
T ss_pred hcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHH--------HHHcCCCCCC
Confidence 765443 3445679999999999999999999999999999999999999998765322222 2333433222
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
-| .-....+.+|+..|+..||+.||+.-.+++.+..
T Consensus 249 p~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 PD--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cH--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11 2233468889999999999999996665555544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=366.10 Aligned_cols=198 Identities=31% Similarity=0.559 Sum_probs=177.6
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||+||+|+++ ++.+||||.+... .....+.+..|+.+|+.++|||||.+++++..++..+||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 345567999999999999987 5789999999766 4445667889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC------CcEEEEeecCccc
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH------MRAKVSDFGLSKF 753 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~------~~vkL~DFGla~~ 753 (929)
.||+|.++|+. .+.+++..+..++.|+|.||++||++ +||||||||+||||+.. -.+||+|||+|+.
T Consensus 92 ~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 92 NGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 99999999953 45799999999999999999999999 99999999999999865 4689999999998
Q ss_pred ccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccc
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~ 809 (929)
+.++ ....+.+|++-|||||+++.++|+.|+|+||+|+++|||++|+.||....
T Consensus 165 L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 165 LQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred CCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 7643 34566789999999999999999999999999999999999999998655
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=386.82 Aligned_cols=267 Identities=24% Similarity=0.439 Sum_probs=223.3
Q ss_pred HHHHHHHHHHhccccccCcEEEEEEEECC----CcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecC
Q 002382 596 SDIEDATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 670 (929)
Q Consensus 596 ~~i~~~~~~~~~~IG~G~fG~Vy~~~~~~----~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~ 670 (929)
.||......++++||.|.||+||+|+++- ...||||.++.... ...++|..|+.||.+++||||++|.|+.....
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 34555556678999999999999999872 34699999987743 44678999999999999999999999999999
Q ss_pred eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecC
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 750 (929)
..++|.|||++|+|+.+|+.+ .+++.+.+...|.++||.||.||.+. ++|||||.++|||++.+..+|++|||+
T Consensus 704 PvMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccc
Confidence 999999999999999999754 45699999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeeeee--cCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhc
Q 002382 751 SKFAVDGASHVSSIVR--GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIES 827 (929)
Q Consensus 751 a~~~~~~~~~~~~~~~--gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 827 (929)
++...++.....+... -+.+|.|||.+..++++.++||||||+||||.++ |.+|+.++..++ ++. .+
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd----VIk----aI-- 847 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----VIK----AI-- 847 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH----HHH----HH--
Confidence 9977655432222222 2579999999999999999999999999999888 999998766222 111 11
Q ss_pred CCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHhHHH
Q 002382 828 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREA 885 (929)
Q Consensus 828 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~~~~ 885 (929)
++..+-..+++++..+.+|++.||++|-.+||.+.||+..|++++.....-
T Consensus 848 -------e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL 898 (996)
T KOG0196|consen 848 -------EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL 898 (996)
T ss_pred -------HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence 112223346677889999999999999999999999999999998755433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=384.76 Aligned_cols=263 Identities=28% Similarity=0.475 Sum_probs=219.4
Q ss_pred HHHHHHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCcc-hhHHHHHHHHHhcccCCCceeEEeeeeeecC
Q 002382 598 IEDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 670 (929)
Q Consensus 598 i~~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~~-~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~ 670 (929)
+......+.+.||+|+||+||+|+.. +.+.||||.++..... ...+|++|++++..++|||||+|+|.|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 33333446788999999999999754 3457999999877655 6789999999999999999999999999999
Q ss_pred eEEEEEEeccCCchhhhhccccc------c----ccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLT------H----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 740 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~------~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~ 740 (929)
.+++|+|||..|+|.++|+.... . ...++..+.+.||.|||.||+||-++ .+|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 99999999999999999964321 1 22388899999999999999999998 99999999999999999
Q ss_pred CcEEEEeecCcccccCCCCceee-eeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhH
Q 002382 741 MRAKVSDFGLSKFAVDGASHVSS-IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIV 818 (929)
Q Consensus 741 ~~vkL~DFGla~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~ 818 (929)
..|||+|||+++.....+.+... ...-+.+|||||.+..++++.+||||||||||||+++ |+.|+.+... +..+
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn----~EVI 715 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN----QEVI 715 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch----HHHH
Confidence 99999999999977666555433 4445789999999999999999999999999999999 8899876552 2333
Q ss_pred HHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 819 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 819 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
++ ++.|.+. ..+..++.++.+|+..||+..|++||+++||...|+....
T Consensus 716 e~----i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 716 EC----IRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HH----HHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 32 2233321 2345566789999999999999999999999999998654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=332.16 Aligned_cols=270 Identities=21% Similarity=0.284 Sum_probs=205.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|+...++|+|+||+|||++++ +|+-||||++.... ..-.+-..+|+++|++++|+|+|.++++|.....++||+|||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 344467999999999999988 58999999986542 333566789999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
+..-|.++- .....++...+.+++.|+++|+.|+|++ ++|||||||+||||+.++.+||||||+|+.... ..
T Consensus 84 dhTvL~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 84 DHTVLHELE----RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred chHHHHHHH----hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 875554432 1234577888999999999999999999 999999999999999999999999999997653 23
Q ss_pred ceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHH----------hhhc-
Q 002382 760 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL----------HIES- 827 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~----------~~~~- 827 (929)
...+..+.|.+|+|||.+.+ .+|...+||||+||++.||++|.+.|.+.. +.+++....+. .+..
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S---DiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS---DIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc---hHHHHHHHHHHHcccCHHHHHHhccC
Confidence 33445568999999999988 789999999999999999999999887654 12222211111 0111
Q ss_pred C-----CcccccCCcc-cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH--HHHhHhHhHH
Q 002382 828 G-----DIQGIIDPSL-LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDAIVIERE 884 (929)
Q Consensus 828 ~-----~~~~~~d~~l-~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~--L~~~~~~~~~ 884 (929)
. .+++.-++.- ...+ .....-+++++..|++.||++|++-+|++.| ++..+.++..
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er~~~ 296 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIERELK 296 (396)
T ss_pred CceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHHHHH
Confidence 1 1111111111 1111 1222367899999999999999999999876 6666555433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.52 Aligned_cols=246 Identities=28% Similarity=0.419 Sum_probs=202.6
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.+.+.||+|+||+||.++.+ .++.+|+|++++... ...+....|..+|.+++||.||+++-.|++.+.++||+||+
T Consensus 28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~ 107 (357)
T KOG0598|consen 28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL 107 (357)
T ss_pred eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence 36789999999999999876 578899999987643 23466788999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
.||.|..+| .+++.+++..+.-++.+|+.||.|||++ +||||||||+|||+|++|+++|+|||+++..... .
T Consensus 108 ~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~ 179 (357)
T KOG0598|consen 108 NGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-G 179 (357)
T ss_pred CCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC-C
Confidence 999999998 4577899999999999999999999999 9999999999999999999999999999843332 2
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
....+.+||+.|||||++.+..|+.++|.||+|+++|||++|.+||...+.....+.+.+ +++ ...
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~--------~k~------~~~ 245 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK--------GKL------PLP 245 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc--------CcC------CCC
Confidence 334457899999999999999999999999999999999999999987663333333322 110 001
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCC----cHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRP----SISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RP----s~~eVl~~ 874 (929)
+.+ ...+..+++...++.+|++|- ++.+|.+|
T Consensus 246 p~~---ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 246 PGY---LSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred Ccc---CCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 111 112466888999999999995 56665544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=344.72 Aligned_cols=263 Identities=24% Similarity=0.308 Sum_probs=204.3
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeec--CeEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVY 676 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~--~~~~LV~ 676 (929)
.+.-.++||+|.||.||+|+.. +|+.||+|+++-+. ........+|+.||++++||||++|.+...+. +..|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 3444578999999999999865 78999999987653 34456678999999999999999999998776 7899999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
|||+. +|..++. .....+++.++..++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||+|+++..
T Consensus 198 eYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 198 EYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred ecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99976 7777764 2356789999999999999999999999 999999999999999999999999999998776
Q ss_pred CCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc-CCccccc
Q 002382 757 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES-GDIQGII 834 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~ 834 (929)
......+..+-|++|+|||++.+ ..|+.++|+||.||||.||+.|++.|.+... ..++...++..-.. .......
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE---veQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE---VEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH---HHHHHHHHHHhCCCChhccccc
Confidence 66555666778999999999987 5799999999999999999999999986551 12222222221100 0011100
Q ss_pred CC----cc--cCccCH-------HHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 835 DP----SL--LDEYDI-------QSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 835 d~----~l--~~~~~~-------~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+- .+ ...|.. .-....++|+..+|..||.+|.|+.++++.
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00 00 011111 111356789999999999999999998864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=351.46 Aligned_cols=264 Identities=28% Similarity=0.501 Sum_probs=210.2
Q ss_pred HHHHHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeE
Q 002382 595 LSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (929)
Q Consensus 595 ~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~ 672 (929)
..||......+.+.||+|.||+||+|+|. ..||||++..... +..+.|++|+..+++-+|.||+-+.|||..+..
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 34555566667899999999999999997 5799999987643 345789999999999999999999999999887
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
.+|+.+|+|.+|..+|+.. +.++...+.+.|++||++|+.|||.+ +|||||||..||++++++.|||+|||++.
T Consensus 463 AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccccee
Confidence 9999999999999999854 46788889999999999999999999 99999999999999999999999999986
Q ss_pred cccC-CCCceeeeeecCccccCcccccc---CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcC
Q 002382 753 FAVD-GASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 828 (929)
Q Consensus 753 ~~~~-~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 828 (929)
.-.. .........-|...|||||++.. .+|++.+||||||||+|||++|..||....... |+ .+...|
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq----Ii----fmVGrG 608 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ----II----FMVGRG 608 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh----eE----EEeccc
Confidence 3211 11112223347889999999974 468999999999999999999999998332111 11 112222
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 829 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.+. .|.. .....+.+++.+|+..|+..++++||.+.+|+..|++++.
T Consensus 609 ~l~--pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 609 YLM--PDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccC--ccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 111 1111 1123455678899999999999999999999999988765
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=340.86 Aligned_cols=254 Identities=25% Similarity=0.358 Sum_probs=201.0
Q ss_pred HHHhccccccCcEEEEEEEECC-CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecC--eEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~--~~~LV~E~~ 679 (929)
+...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|...... .+.+.|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 4457899999999999998874 8899999987654333567899999999999999999999854444 689999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC-CCcEEEEeecCcccccC--
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVD-- 756 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~-- 756 (929)
++|+|.+++... +..+++..+..+..|+++||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 99 ~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 99 PGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred CCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999999643 12699999999999999999999998 9999999999999999 79999999999986553
Q ss_pred CCCceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
..........||+.|||||++..+ ....++||||+||++.||+||+.||.... ....+.......+..+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~------~~~~~~~~ig~~~~~P---- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF------EEAEALLLIGREDSLP---- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc------chHHHHHHHhccCCCC----
Confidence 222233456799999999999853 33459999999999999999999997531 1122222222222111
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
..+........+++.+|++.+|++|||+.|+++|---
T Consensus 243 -----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 -----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred -----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1122233457789999999999999999999998543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=354.11 Aligned_cols=262 Identities=26% Similarity=0.413 Sum_probs=203.3
Q ss_pred HHHHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCc-chhHHHHHHHHHhccc-CCCceeEEeeeeeec-C
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-G 670 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~-~ 670 (929)
...+.+.++||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+.+++++ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 445677899999999999999752 346799999875432 3346788999999999 899999999988764 4
Q ss_pred eEEEEEEeccCCchhhhhcccccc--------------------------------------------------------
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLTH-------------------------------------------------------- 694 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~~-------------------------------------------------------- 694 (929)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999988642110
Q ss_pred --ccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc-eeeeeecCccc
Q 002382 695 --EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGY 771 (929)
Q Consensus 695 --~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y 771 (929)
...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++........ ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 13477888899999999999999998 9999999999999999999999999999754332222 12233467889
Q ss_pred cCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHH
Q 002382 772 LDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 850 (929)
Q Consensus 772 ~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 850 (929)
+|||++.+..++.++|||||||++|||++ |..||......+ .+.. ....+.... . +......+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---~~~~----~~~~~~~~~-----~----~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---EFCQ----RLKDGTRMR-----A----PENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---HHHH----HHhcCCCCC-----C----CCCCCHHH
Confidence 99999999999999999999999999997 999997644211 1111 111111110 0 11223468
Q ss_pred HHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 851 EEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 851 ~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.+++.+|++.+|++||++.|+++.|++++.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=347.98 Aligned_cols=247 Identities=26% Similarity=0.356 Sum_probs=204.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
+.|++.||+|+|++|++|+.+ .++++|||++.+.- ....+-...|-..|.+| .||.|++|+-.|.++..+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 347889999999999999876 58999999987542 22234566788889999 89999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++|+|.++|. +.+.+++....-++.||+.||+|||++ |||||||||+|||+|.||++||+|||.|+.+.+.
T Consensus 155 ~A~nGdll~~i~----K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 155 YAPNGDLLDLIK----KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ecCCCcHHHHHH----HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999995 357899999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc----------ee--eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh
Q 002382 758 ASH----------VS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 758 ~~~----------~~--~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
... .+ ...+||..|.+||++..+..+..+|+|+|||++|+|+.|++||.....--.++.|..
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~------ 301 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA------ 301 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH------
Confidence 211 11 347799999999999999999999999999999999999999987652112222222
Q ss_pred hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 826 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+|=.+...++ ..+.+|+.+.+..||.+|++..||.+|
T Consensus 302 --------l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 302 --------LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred --------hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 1111112222 467899999999999999999999988
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=378.41 Aligned_cols=266 Identities=29% Similarity=0.437 Sum_probs=217.9
Q ss_pred HHHHHHHHHhccccccCcEEEEEEEECC--Cc----EEEEEEeecC-CcchhHHHHHHHHHhcccCCCceeEEeeeeeec
Q 002382 597 DIEDATKMLEKKIGSGGFGVVYYGKLKD--GK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE 669 (929)
Q Consensus 597 ~i~~~~~~~~~~IG~G~fG~Vy~~~~~~--~~----~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~ 669 (929)
++......+.+.||+|.||.||.|...+ +. .||||.++.. +.+...+|.+|..+|++++|||||+++|+|.+.
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 3445555667899999999999998763 33 4899998766 456678999999999999999999999999999
Q ss_pred CeEEEEEEeccCCchhhhhcccc---ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEE
Q 002382 670 GRSVLVYEFMHNGTLKEHLYGTL---THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (929)
Q Consensus 670 ~~~~LV~E~~~~gsL~~~L~~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 746 (929)
+..++++|||++|+|..+|++.. .....+...+.+.++.|||+|+.||+++ ++|||||.++|+||+....+||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence 99999999999999999997542 2245688889999999999999999999 99999999999999999999999
Q ss_pred eecCcccccCCCCceeeee-ecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHh
Q 002382 747 DFGLSKFAVDGASHVSSIV-RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 824 (929)
Q Consensus 747 DFGla~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 824 (929)
|||+|+.+...+....... .-...|||||.+..+.++.|+|||||||++||++| |..||...... .+.. ..
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~----~v~~---~~ 917 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF----EVLL---DV 917 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH----HHHH---HH
Confidence 9999996555444333222 34579999999999999999999999999999999 88999765521 1111 11
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
.+.+++ +.+..+...+.+++..||+.+|++||++..+++.+..+....
T Consensus 918 ~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 918 LEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 222322 234455667889999999999999999999999998887654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=334.59 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=207.1
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcch-hHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~-~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
..|.+.+.||.|.-++||+|+.. .++.||||++.-..... .+.+.+|+..|+.++||||++++..|..+..+++||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 35667899999999999999865 67999999997654433 47899999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
|.+|++.+.++..... .+++..+..|.+++++||.|||.+ |.||||||+.||||+.+|.|||+|||.+..+.+..
T Consensus 106 Ma~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999776543 388999999999999999999999 99999999999999999999999999886544432
Q ss_pred Cc--ee-eeeecCccccCcccccc--CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 759 SH--VS-SIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 759 ~~--~~-~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
.. .. ....||+.|||||+++. ..|+.|+||||||+...||.+|..||..... ...+.. .+ ++..+..
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP---mkvLl~----tL-qn~pp~~ 252 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP---MKVLLL----TL-QNDPPTL 252 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh---HHHHHH----Hh-cCCCCCc
Confidence 21 11 44579999999999543 5799999999999999999999999986541 111111 11 1111111
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.-..+..+....-...+.+++..|++.||++|||+++++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 10011111122223478899999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=313.50 Aligned_cols=262 Identities=21% Similarity=0.296 Sum_probs=203.9
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc--hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~--~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+|...++||+|.||.||+|++. .|+.||||+++..... -.....+|++.|+.++|+||+.++++|...+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4556789999999999999865 7999999999765322 245678999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
|+. +|...+++ ....+...++..++.++++||+|||++ .|+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 83 m~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 83 MPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 975 88888864 356788899999999999999999999 99999999999999999999999999999776543
Q ss_pred CceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh--hcCC------
Q 002382 759 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI--ESGD------ 829 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~--~~~~------ 829 (929)
.... ..+-|.+|+|||.+.+ +.|+..+|+||.|||+.||+-|.+-|.+.. +.+++...+...- .+..
T Consensus 156 ~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s---DidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 156 RIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS---DIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred cccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc---hHHHHHHHHHHcCCCCcccCccccc
Confidence 3322 2257999999999986 579999999999999999999998776544 2223333222211 1110
Q ss_pred cccccCCc-----ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 IQGIIDPS-----LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 ~~~~~d~~-----l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+.+.+.-+ .....-..+....++++..++..+|.+|+++.|++++
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111100 0111112233456899999999999999999999876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=346.52 Aligned_cols=245 Identities=27% Similarity=0.415 Sum_probs=206.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
-++||+|+.|.||.|+.. +++.||||++.......++-+.+|+.+|+..+|+|||.+++.+...+.+++|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 468999999999999755 6889999999877777778889999999999999999999999999999999999999999
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeee
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (929)
.+.+. ...+++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..... ....
T Consensus 358 TDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~T 428 (550)
T KOG0578|consen 358 TDVVT-----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRST 428 (550)
T ss_pred hhhhh-----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cccc
Confidence 99884 34488999999999999999999999 999999999999999999999999999876654443 4455
Q ss_pred eecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCH
Q 002382 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844 (929)
Q Consensus 765 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 844 (929)
..||+.|||||++....|+.+.||||||++++||+.|.+||-.++. ++-.......|... + ....
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrAlyLIa~ng~P~------l--k~~~ 493 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNGTPK------L--KNPE 493 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHHHHHHhhcCCCC------c--CCcc
Confidence 6799999999999999999999999999999999999999975441 11111222222211 1 1122
Q ss_pred HHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 845 QSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 845 ~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..-..+.+++.+||+.|+++||++.|+++|
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 233468899999999999999999999987
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.12 Aligned_cols=267 Identities=20% Similarity=0.243 Sum_probs=205.8
Q ss_pred HHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccC-CCceeEEeeeeeecC-eEEE
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEG-RSVL 674 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~-~~~L 674 (929)
...+|.+.++||.|.||.||+|+.+ .++.||||.++... ...+..=.+|+..|++++ ||||+++.+.+.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 3457888899999999999999866 68899999987653 333444568999999998 999999999998888 8999
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
|||||+ .+|.++++++ ++.+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||..
T Consensus 88 VfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 999996 4899988654 67799999999999999999999999 9999999999999998889999999999976
Q ss_pred cCCCCceeeeeecCccccCccccc-cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC----
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD---- 829 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~---- 829 (929)
..... .+..+.|.+|+|||++. .+-|+.+.|+||+|||++|+.+-++.|.+...-+..-.+.+-.....++.+
T Consensus 161 ~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 161 RSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 54332 33445799999999986 467899999999999999999999999765511111111111111000000
Q ss_pred -cccccCCccc-------CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 -IQGIIDPSLL-------DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 -~~~~~d~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+...+.=++. ...-.....+..+++.+|+++||.+|||+.|.+++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0111110110 00112245678999999999999999999999987
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=342.76 Aligned_cols=239 Identities=30% Similarity=0.463 Sum_probs=200.1
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCchhh
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 686 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 686 (929)
+-||.|+-|.||+|+++ ++.||||+++.- -+.+++-|++++||||+.|.|+|.....+|+|||||..|-|.+
T Consensus 130 eWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 35899999999999998 799999987532 2357888999999999999999999999999999999999999
Q ss_pred hhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeeeee
Q 002382 687 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766 (929)
Q Consensus 687 ~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 766 (929)
.|+ .++.+.......+..+||.||.|||.+ .|||||||.-||||..+..+||+|||.++...+. .....++
T Consensus 202 VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa 272 (904)
T KOG4721|consen 202 VLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA 272 (904)
T ss_pred HHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence 995 355677777889999999999999998 9999999999999999999999999999866543 2233467
Q ss_pred cCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHH
Q 002382 767 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQS 846 (929)
Q Consensus 767 gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 846 (929)
||..|||||++...+.++|+|||||||||||||||..||.+..... +=| .+=...+.-..+..+
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----IIw-----------GVGsNsL~LpvPstc 336 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----IIW-----------GVGSNSLHLPVPSTC 336 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----eEE-----------eccCCcccccCcccC
Confidence 9999999999999999999999999999999999999997544111 111 111112222334566
Q ss_pred HHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 847 MWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 847 ~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
++.+.-|+.+||+..|..||++.+++.||+-.
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 77899999999999999999999999999743
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=348.68 Aligned_cols=246 Identities=26% Similarity=0.439 Sum_probs=203.7
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC----Cc-chhHHHHHHHHHhcccC-CCceeEEeeeeeecCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN----SY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~----~~-~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~L 674 (929)
.|.+.+.||+|.||+|+.|++. +++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++......++
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i 97 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI 97 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence 4567789999999999999776 6899999977654 12 23456778999999998 9999999999999999999
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC-CcEEEEeecCccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKF 753 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~ 753 (929)
||||+.+|+|.+++. ...++.+..+..+++|++.|++|||++ +|+||||||+|||++.+ +++||+|||++..
T Consensus 98 vmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 999999999999994 356788899999999999999999998 99999999999999999 9999999999986
Q ss_pred ccCCCCceeeeeecCccccCccccccCc-CC-CcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC--
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYISQQ-LT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD-- 829 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~-- 829 (929)
.. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++......... +..+.
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k--------i~~~~~~ 241 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK--------IRKGEFK 241 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH--------HhcCCcc
Confidence 64 3334456678999999999999877 76 689999999999999999999987542221111 22221
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+...++ -..+..++.+|+..+|.+|+++.|++++
T Consensus 242 ~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 242 IPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred CCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 111110 3468899999999999999999999944
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=341.12 Aligned_cols=245 Identities=27% Similarity=0.378 Sum_probs=208.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|.||+||||+-+ +.+.||+|.+.+... ...+.+.+|++|++.++||||+.++++|+...+.++|.||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 456678999999999999876 578899999875532 23456889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
.| +|..+| .....+++..+..++.++..||.|||+. +|+|||+||+|||++..+.+|+||||+|+.+... .
T Consensus 84 ~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t 154 (808)
T KOG0597|consen 84 VG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-T 154 (808)
T ss_pred hh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC-c
Confidence 87 999988 4577899999999999999999999999 9999999999999999999999999999976553 4
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
..-+...|||.|||||+..++.|+..+|+||+||++||+++|++||-... +.+-++....+.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-------i~~Lv~~I~~d~----------- 216 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-------ITQLVKSILKDP----------- 216 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-------HHHHHHHHhcCC-----------
Confidence 45566789999999999999999999999999999999999999996543 333333322221
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..++...-..+..++...+.+||..|.+-.+++.|
T Consensus 217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 11222444578899999999999999999999876
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.65 Aligned_cols=245 Identities=22% Similarity=0.312 Sum_probs=197.8
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcch---hHHHHHHHHHhcccCCCceeEEeeeeee----cCeEEEEEEec
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVYEFM 679 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~---~~~f~~Ev~iL~~l~HpNIv~l~g~~~~----~~~~~LV~E~~ 679 (929)
..||+|++|.||+|.+. |+.||||+++...... .+.+.+|+.+|++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 46999999999999985 8999999997653332 3567899999999999999999999876 35689999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++|+|.+++.. ...+++.....++.|++.||.|||+. .+++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999853 35688999999999999999999984 278899999999999999999999999987543321
Q ss_pred ceeeeeecCccccCcccccc--CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 760 HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+...+ ...+.. .
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~----~~~~~i---~~~~~~-----~- 241 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK----EIYDLI---INKNNS-----L- 241 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH----HHHHHH---HhcCCC-----C-
Confidence 12347899999999976 68899999999999999999999999765421 222211 111100 0
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
..+......+.+++.+||+.||++|||+.|+++.|+..
T Consensus 242 ---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 242 ---KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred ---CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11112344688999999999999999999999999875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=352.37 Aligned_cols=257 Identities=29% Similarity=0.431 Sum_probs=207.2
Q ss_pred HHHhccccccCcEEEEEEEECC--C--cE-EEEEEeecC---CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKD--G--KE-IAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~--~--~~-vAVK~l~~~---~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
..+.++||+|+||.||+|+++. + .. ||||..+.. ......+|.+|+++|++++|||||+++|++.....+++
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i 238 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML 238 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence 3456899999999999998763 2 23 899998752 34556789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
|||+|.||+|.++|... ...++..++..++.++|.||+|||++ +++||||.++|||++.++.+||+|||+++..
T Consensus 239 vmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999643 23689999999999999999999999 9999999999999999999999999998754
Q ss_pred cCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
..- ........-+..|+|||.+....++.++|||||||++||+++ |..||.+.... .+..++... + .
T Consensus 313 ~~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~~---~-~--- 380 (474)
T KOG0194|consen 313 SQY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVKN---G-Y--- 380 (474)
T ss_pred cce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHHhc---C-c---
Confidence 311 111112235789999999999999999999999999999999 89999876522 233333111 1 0
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
+-..+......+..+..+|+..+|++||+|.++.+.|+.+....
T Consensus 381 -----r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 381 -----RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred -----cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 11112234456777888999999999999999999999876543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=338.48 Aligned_cols=264 Identities=25% Similarity=0.394 Sum_probs=201.9
Q ss_pred HHHHHhccccccCcEEEEEEEECC-----------------CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLKD-----------------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQF 662 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~~-----------------~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l 662 (929)
..+.+.++||+|+||.||++.+++ +..||+|++.... .....++.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 455677899999999999998642 3369999987643 2335679999999999999999999
Q ss_pred eeeeeecCeEEEEEEeccCCchhhhhccccc---------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceec
Q 002382 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT---------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIH 727 (929)
Q Consensus 663 ~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~---------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivH 727 (929)
++++.+.+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 9999999999999999999999998854211 113467888999999999999999998 9999
Q ss_pred CCCCCCCeEecCCCcEEEEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh--CCCC
Q 002382 728 RDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEA 804 (929)
Q Consensus 728 rDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt--G~~p 804 (929)
|||||+|||++.++.+||+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999755433221 1223345789999999988899999999999999999987 5567
Q ss_pred CccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 805 ISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 805 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
|...... .+...+........... ....+......+.+++.+|++.+|++|||+.||.+.|++
T Consensus 242 ~~~~~~~----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE----QVIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH----HHHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7654322 22222222211111000 000111233568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=337.66 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=207.4
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc---hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~---~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
+...||+|+||.||+|+-+ .|+.+|+|++++.... ..+....|-.+|...++|+||+|+..|++.+++||||||++
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 5678999999999999876 5889999999876433 34557789999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC----
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD---- 756 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~---- 756 (929)
||++..+|. ..+.|++..+..++.+++.|++-||+. |+|||||||+|+|||..|++||+||||+.-...
T Consensus 225 GGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 225 GGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred CccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 999999983 467789999999999999999999998 999999999999999999999999999852110
Q ss_pred ------------------CCCc-----e-------------------eeeeecCccccCccccccCcCCCcCceeeHHHH
Q 002382 757 ------------------GASH-----V-------------------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 794 (929)
Q Consensus 757 ------------------~~~~-----~-------------------~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvv 794 (929)
.... . ....+|||.|||||++.+..|+..+|.||||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 0000 0 011359999999999999999999999999999
Q ss_pred HHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCc---HHHH
Q 002382 795 LLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEV 871 (929)
Q Consensus 795 l~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~eV 871 (929)
|||||.|.+||......+.++.|+.|-.......+. ....+..+||.+|+. ||++|-. +.||
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~--------------~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV--------------DLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC--------------cccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 999999999999998888999999996543322111 111467899999999 9999985 6666
Q ss_pred HHH
Q 002382 872 LKD 874 (929)
Q Consensus 872 l~~ 874 (929)
.+|
T Consensus 443 K~H 445 (550)
T KOG0605|consen 443 KKH 445 (550)
T ss_pred hcC
Confidence 655
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=344.06 Aligned_cols=245 Identities=24% Similarity=0.386 Sum_probs=207.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+.+++.||+|+.|.|..|++. +|+.+|||++.+... .....+++|+.+|+.+.||||+++++++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 456789999999999999876 799999999976532 2235688999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|-|.+++ ...+.+++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|.+...+
T Consensus 94 v~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 94 VPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred cCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 9999999998 3567899999999999999999999998 9999999999999999999999999999765433
Q ss_pred CceeeeeecCccccCccccccCcCC-CcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
..-.+.||++.|.+||++.+.+|. .++||||+|||||.||+|+.||++.+ .+.+.. ++..|.++
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN----ir~LLl----KV~~G~f~------ 230 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN----IRVLLL----KVQRGVFE------ 230 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc----HHHHHH----HHHcCccc------
Confidence 334556799999999999999886 68999999999999999999998654 223333 23333221
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+.....+..+|+.+|+..||++|.|++||.+|
T Consensus 231 ----MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 ----MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ----CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 122333467899999999999999999999998
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=309.44 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=214.5
Q ss_pred ccccCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeee
Q 002382 590 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGY 665 (929)
Q Consensus 590 ~~~~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~ 665 (929)
...+++.+++ +++.||+|.||.||.|+.+ ++--||+|++.+.. .+.++++.+|+++-+.++||||++++++
T Consensus 16 ~~~~~l~dfe-----igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~ 90 (281)
T KOG0580|consen 16 TKTWTLDDFE-----IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY 90 (281)
T ss_pred ccccchhhcc-----ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh
Confidence 3456666654 7899999999999999987 46679999997653 3446789999999999999999999999
Q ss_pred eeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEE
Q 002382 666 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 745 (929)
Q Consensus 666 ~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL 745 (929)
|.+....||++||..+|++...|.+. ...++++.....+..|+|.||.|+|.+ +|+||||||+|+|++.++..||
T Consensus 91 fhd~~riyLilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lki 165 (281)
T KOG0580|consen 91 FHDSKRIYLILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKI 165 (281)
T ss_pred eeccceeEEEEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeec
Confidence 99999999999999999999999643 345678888899999999999999998 9999999999999999999999
Q ss_pred EeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh
Q 002382 746 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 746 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
+|||.+.... .....+.+||..|.+||+..+...+..+|+|++|++.||++.|.+||+.....+.+..|...
T Consensus 166 AdfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~----- 237 (281)
T KOG0580|consen 166 ADFGWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV----- 237 (281)
T ss_pred cCCCceeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-----
Confidence 9999986433 34456678999999999999999999999999999999999999999876644544444331
Q ss_pred hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 826 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
+..+ +........+++.+|+..+|.+|.+..||+++-
T Consensus 238 ------~~~~-------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 238 ------DLKF-------PSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred ------cccC-------CcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 1111 122334678999999999999999999998873
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=332.88 Aligned_cols=257 Identities=22% Similarity=0.340 Sum_probs=203.9
Q ss_pred HHHHHHHhccccccCcEEEEEEEEC----CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEE
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~----~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~ 673 (929)
+...+.+.+.||+|+||.||+|+++ .+..||+|+++.... .....+.+|+..+++++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3445667889999999999999764 356899999876532 33457889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+|++|||.+..
T Consensus 83 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 999999999999998532 34688999999999999999999998 999999999999999999999999998764
Q ss_pred ccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
.............++..|+|||.+.+..++.++|||||||++||+++ |..||...... .+.... .++...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----~~~~~~----~~~~~~- 227 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----DVIKAV----EDGFRL- 227 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHH----HCCCCC-
Confidence 32221111122335678999999999999999999999999999775 99999754421 122211 111110
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
..+......+.+++.+|++.+|++||++.|+.+.|+++
T Consensus 228 --------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 --------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01122334688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=348.22 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=202.9
Q ss_pred HHHHHHhccccccCcEEEEEEEE------CCCcEEEEEEeecCC-cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCe
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 671 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~------~~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~ 671 (929)
...+.+.+.||+|+||.||+|++ ..+..||||+++... ....+.+.+|+.+++.+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 44566789999999999999974 235689999987543 23345788999999999 89999999999999999
Q ss_pred EEEEEEeccCCchhhhhccccc----------------------------------------------------------
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLT---------------------------------------------------------- 693 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 693 (929)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998854210
Q ss_pred -------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 694 -------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 694 -------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
....+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 112478888999999999999999998 9999999999999999999999999999755432221
Q ss_pred -eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 761 -VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 761 -~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
......++..|+|||++.+..++.++|||||||++|||++ |..||...... ..+.++... +... .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~~~~----~~~~--~---- 337 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKMIKE----GYRM--L---- 337 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHHHHh----CccC--C----
Confidence 1122335678999999999999999999999999999998 88888654311 122222211 1100 0
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
.+.....++.+++.+|++.+|++||++.||++.|++.
T Consensus 338 ---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 ---SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0011124688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=331.71 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=199.0
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
...+.||+|+||+||+|... +++.||||++..... .....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 34578999999999999875 689999999875432 23346788999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 83 ~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 83 NGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred CCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 999998887532 233578899999999999999999998 99999999999999999999999999997643322
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
......||..|+|||++.+..++.++|||||||++|||++|+.||...........+... .....
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----~~~~~---------- 221 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR----VKEDQ---------- 221 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH----hhccc----------
Confidence 123346899999999999999999999999999999999999999765421111111111 11100
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCc-----HHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 874 (929)
..+.......+.+++.+|++.+|++||+ ++|++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0111122346789999999999999997 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=346.31 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=203.4
Q ss_pred HHHHHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCc-chhHHHHHHHHHhccc-CCCceeEEeeeeeecC
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG 670 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~ 670 (929)
....+.+.+.||+|+||.||+|++. +++.||||+++.... .....+.+|+++++.+ +||||++++++|...+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3445667899999999999999753 235799999975432 2345688999999999 8999999999999999
Q ss_pred eEEEEEEeccCCchhhhhcccc----------------------------------------------------------
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTL---------------------------------------------------------- 692 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~---------------------------------------------------------- 692 (929)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999885321
Q ss_pred --------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc-eee
Q 002382 693 --------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSS 763 (929)
Q Consensus 693 --------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~ 763 (929)
.....+++..+++++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 0112477888999999999999999998 9999999999999999999999999998754332221 112
Q ss_pred eeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCcc
Q 002382 764 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 842 (929)
Q Consensus 764 ~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 842 (929)
...++..|+|||++.+..++.++|||||||++|||++ |+.||........ +... ...+. ......
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---~~~~----~~~~~-----~~~~~~-- 338 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---FYKM----VKRGY-----QMSRPD-- 338 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---HHHH----HHccc-----CccCCC--
Confidence 2335678999999998899999999999999999997 9999975432111 1111 11110 000001
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 843 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 843 ~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
.....+.+++.+|++.+|++||++.||++.|++++
T Consensus 339 --~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 --FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11246889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=339.23 Aligned_cols=242 Identities=24% Similarity=0.320 Sum_probs=196.3
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.||+|+||.||+++.+ +++.||||+++... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999876 68899999997542 222356778999999999999999999999999999999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 99888843 45678899999999999999999998 99999999999999999999999999987432221 222
Q ss_pred eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCcc
Q 002382 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 842 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 842 (929)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+..... .+.. .+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~~~----~~~~------~~---- 214 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELIL----MEEI------RF---- 214 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH----HHHHHHH----cCCC------CC----
Confidence 3456999999999999999999999999999999999999999754311 1111111 1110 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 843 DIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 843 ~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
+......+.+++.+|++.||++|| ++.|++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 111234578999999999999999 79999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=339.45 Aligned_cols=251 Identities=23% Similarity=0.309 Sum_probs=202.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|++++..++||||+++++++...+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 345688999999999999987 58899999997542 22345688899999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 83 VPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999843 34678889999999999999999998 999999999999999999999999999975433
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..|.... . .....++
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~---~~~~~~~-- 225 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL-Q---RPVYDDP-- 225 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc-c---CCCCCcc--
Confidence 2234468999999999999999999999999999999999999997654322222332221110 0 0000000
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.......+.+++.+|++.+|++||++.|++++
T Consensus 226 ----~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 ----RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 01223467889999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.89 Aligned_cols=272 Identities=25% Similarity=0.377 Sum_probs=222.0
Q ss_pred ccCHHHHHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcch-hHHHHHHHHHhcccCCCceeEEeeeeeecC
Q 002382 592 CFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEG 670 (929)
Q Consensus 592 ~~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~-~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~ 670 (929)
...+.|+.+....|.++||+|.||+|..+....+..||||+++...... .++|.+|+++|.+++||||+.++|+|..++
T Consensus 529 ~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 529 GPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred CcchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 3456677777778899999999999999999878999999999875544 589999999999999999999999999999
Q ss_pred eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecC
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 750 (929)
.+++|+|||++|+|.+++..+... .+.-....+|+.||+.||+||.+. ++|||||.++|||++.++++||+|||+
T Consensus 609 PicmI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgm 683 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGM 683 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccc
Confidence 999999999999999999654222 245556678999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCcee-eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh--CCCCCccccccccchhhHHHHHHhhhc
Q 002382 751 SKFAVDGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGANCRNIVQWAKLHIES 827 (929)
Q Consensus 751 a~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt--G~~p~~~~~~~~~~~~l~~~~~~~~~~ 827 (929)
++....++.+.. ....-+.+|||||.+.-++++.++|||+||+.+||+++ ...||+.... +++++-.......
T Consensus 684 sR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven~~~~~~~ 759 (807)
T KOG1094|consen 684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVENAGEFFRD 759 (807)
T ss_pred ccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHhhhhhcCC
Confidence 997777666544 34446789999999999999999999999999999876 6678875542 2333322222222
Q ss_pred CCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 828 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 828 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
..... ....+.-+..++.+++.+|++.+.++||+++++..+|++.
T Consensus 760 ~~~~~------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 760 QGRQV------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCcce------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11111 1112344556788999999999999999999999999864
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=331.53 Aligned_cols=265 Identities=21% Similarity=0.252 Sum_probs=199.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 456688999999999999987 57889999987542 223456789999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
+++.+..+.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 83 EKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9887765432 234578889999999999999999998 999999999999999999999999999986543333
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHH--------HHhhhcCCcc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA--------KLHIESGDIQ 831 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~--------~~~~~~~~~~ 831 (929)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+.... ..........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 23334568999999999998889999999999999999999999997543211111111110 0000000000
Q ss_pred cccCCcccC------ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 832 GIIDPSLLD------EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 832 ~~~d~~l~~------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....+.... .+.......+.+++.+|++.+|++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 0011123468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=326.30 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=206.1
Q ss_pred HHHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
....+.+.+.||+|+||.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 344566789999999999999998888899999987543 3356789999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999986432 34688999999999999999999998 99999999999999999999999999998654322
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
.........+..|+|||++.+..++.++||||||+++|||++ |+.||...... .+.... .....
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~----~~~~~------- 222 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVLQQV----DQGYR------- 222 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHH----HcCCC-------
Confidence 221122223468999999998899999999999999999999 99998654311 111111 11100
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
..........+.+++.+|++.+|++||++.++++.|++
T Consensus 223 --~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 --MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00111223568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.36 Aligned_cols=249 Identities=21% Similarity=0.389 Sum_probs=212.5
Q ss_pred HHHHHHHhccccccCcEEEEEEEE-CCCcEEEEEEeecCCcchhH---HHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~-~~~~~vAVK~l~~~~~~~~~---~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
.+.+|.+.+.||+|.||.|-+|.. ..|+.||||.++++...+++ .+.+|++||..++||||+.++++|+..+..++
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 456788999999999999999975 57999999999887665544 46789999999999999999999999999999
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
||||..+|.|.+++ ...+.+++.++..+++||..|+.|+|.+ +++|||||.+|||+|+++++||+|||++.++
T Consensus 131 vMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 99999999999999 4678899999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCceeeeeecCccccCccccccCcCC-CcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
.+. ..-++++|++-|.+||++.+.+|. +.+|.|||||+||-|+.|.-||++.+ ...+++. +..|.+.+
T Consensus 204 ~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D----hk~lvrQ----Is~GaYrE- 272 (668)
T KOG0611|consen 204 ADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD----HKRLVRQ----ISRGAYRE- 272 (668)
T ss_pred ccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch----HHHHHHH----hhcccccC-
Confidence 543 334567899999999999998885 68999999999999999999998755 2333332 22332221
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
++......-|+.+|+..+|++|.|+.+|..|.
T Consensus 273 ----------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 ----------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ----------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11222355789999999999999999999885
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=322.94 Aligned_cols=249 Identities=29% Similarity=0.503 Sum_probs=200.9
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.+.+.||+|+||.||+++++++..+|+|.+.... ....++.+|++++++++||||+++++++...+..++||||+++|
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG 84 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence 44568899999999999999888899999886443 33567889999999999999999999999999999999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.++..........
T Consensus 85 ~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 85 CLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred cHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999988643 23578899999999999999999998 999999999999999999999999999875433222222
Q ss_pred eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+...+.. +.. ...+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----~~~~~~i~~----~~~--~~~~~---- 224 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YEVVEMISR----GFR--LYRPK---- 224 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHC----CCC--CCCCC----
Confidence 22335678999999998889999999999999999999 8999975442 122222211 110 01111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
.....+.+++.+|++.+|++||++.|+++.|
T Consensus 225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1124688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=325.16 Aligned_cols=255 Identities=24% Similarity=0.431 Sum_probs=205.1
Q ss_pred HHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
...+.+.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 34455678999999999999998888899999886543 23567899999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++... ....+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999999998643 234578888999999999999999998 999999999999999999999999999986543322
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.......++..|+|||++....++.++|||||||++|||++ |+.||..... ..+...... +... + .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~~~----~~~~----~-~ 225 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN----SDVMSALQR----GYRM----P-R 225 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH----HHHHHHHHc----CCCC----C-C
Confidence 22222345678999999998889999999999999999998 9999965431 122222111 1100 0 0
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
.. .....+.+++.+|++.+|++||+++++.+.|++
T Consensus 226 ~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 ME----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CC----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11 122467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=334.00 Aligned_cols=240 Identities=23% Similarity=0.323 Sum_probs=193.3
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 609 IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999887 57889999987532 23345678899999999999999999999999999999999999999
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeee
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (929)
.+++.. ...+++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 998853 34688899999999999999999998 99999999999999999999999999987533222 22334
Q ss_pred eecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCH
Q 002382 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844 (929)
Q Consensus 765 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 844 (929)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....... +.. .++.
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~-------~~~~~~~-~~~----------~~~~ 214 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE-------MYRKILQ-EPL----------RFPD 214 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH-------HHHHHHc-CCC----------CCCC
Confidence 569999999999999999999999999999999999999997544211 1111111 110 0111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCc---HHHHHHH
Q 002382 845 QSMWKIEEKALMCVLPHGHMRPS---ISEVLKD 874 (929)
Q Consensus 845 ~~~~~l~~li~~Cl~~dP~~RPs---~~eVl~~ 874 (929)
.....+.+++.+|++.+|++||+ +.|++.+
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 12245789999999999999985 5666655
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=331.40 Aligned_cols=244 Identities=25% Similarity=0.388 Sum_probs=202.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc-hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCc
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~-~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gs 683 (929)
.+.||+|.||.||+|... .++.||+|++.-.... ...++.+|+.+|.+++++||.++++.+..+..++++||||.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 478999999999999876 5788999999765433 34678899999999999999999999999999999999999999
Q ss_pred hhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceee
Q 002382 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 763 (929)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 763 (929)
+.+.|.. ...+.+..+..++++++.||.|||.+ +.+|||||+.|||+..+|.+||+|||.+-......... .
T Consensus 98 v~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~ 169 (467)
T KOG0201|consen 98 VLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-K 169 (467)
T ss_pred hhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-c
Confidence 9998843 33446777778999999999999999 99999999999999999999999999997655443333 5
Q ss_pred eeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccC
Q 002382 764 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 843 (929)
Q Consensus 764 ~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 843 (929)
+.+||+.|||||++.+..|+.|+||||||++.+||.+|.+|+......... . . +..-.-|.+.+.+
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl---f-----l-----Ipk~~PP~L~~~~- 235 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL---F-----L-----IPKSAPPRLDGDF- 235 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE---E-----e-----ccCCCCCcccccc-
Confidence 677999999999999989999999999999999999999999765521100 0 0 1111223333333
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 844 IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 844 ~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
-..+.+++..|+..+|+.||++.++++|
T Consensus 236 ---S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 236 ---SPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ---CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3358899999999999999999999876
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=337.75 Aligned_cols=243 Identities=27% Similarity=0.364 Sum_probs=198.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+.+.+.||+|+||.||+|+++ +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 456789999999999999987 58899999987542 22345688999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+.+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 100 VVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred CCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 999999998853 34678888889999999999999998 99999999999999999999999999997553321
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+ ....+.+. +
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~----~i~~~~~~------~ 234 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIYE----KILAGRLK------F 234 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHHH----HHhcCCcC------C
Confidence 2346899999999999999999999999999999999999999754311 1111 11111110 0
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCc-----HHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 874 (929)
... ....+.+++.+|++.||++||+ ++|+++|
T Consensus 235 p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 PNW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111 1235779999999999999996 6888866
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.03 Aligned_cols=256 Identities=26% Similarity=0.362 Sum_probs=200.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecC-----eEEEEEEec
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVYEFM 679 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~-----~~~LV~E~~ 679 (929)
.+.+|.|+||.||+|... +++.||||+...+.. .-.+|+++|+.++|||||+++-+|.... ...+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 478999999999999877 468999998765432 2346899999999999999999885432 346899999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC-CcEEEEeecCcccccCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~~~~~~ 758 (929)
+. +|.+.++.....+++++...+.-+..||.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+....+.
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 75 89999876555677888889999999999999999997 99999999999999977 899999999999887776
Q ss_pred CceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc--C-------
Q 002382 759 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES--G------- 828 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~--~------- 828 (929)
...+.. -|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+... ..+++..++..-.. .
T Consensus 181 pniSYi--cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~---~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 181 PNISYI--CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS---VDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred CceeEE--EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH---HHHHHHHHHHhCCCCHHHHhhcCc
Confidence 665554 4899999999987 5799999999999999999999999987552 23344333322110 0
Q ss_pred CcccccCCcccCc-----cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 829 DIQGIIDPSLLDE-----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 829 ~~~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...+.-.+.+... .......+.++++.++++.+|.+|.++.|++++
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0011111222111 223344578899999999999999999999876
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=325.03 Aligned_cols=254 Identities=29% Similarity=0.436 Sum_probs=203.7
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.+.+.+.||+|+||.||+|..+ .++.||+|++.... ....++.+|+++++.++||||+++++++...+..+++|||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 3456788999999999999876 47889999987543 335678899999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++... ....+++..++.++.|+++||+|||++ +++||||||+||++++++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99999988543 234578889999999999999999998 9999999999999999999999999998765433222
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+.+.. ..+. .
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~~----~~~~---------~ 223 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELL----EKGY---------R 223 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH----HCCC---------C
Confidence 2222234678999999998899999999999999999998 99998654311 111111 1110 0
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
...+......+.+++.+|++.+|++||++.|+++.|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=324.93 Aligned_cols=252 Identities=25% Similarity=0.342 Sum_probs=198.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc--------------hhHHHHHHHHHhcccCCCceeEEeeee
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------------GKREFTNEVTLLSRIHHRNLVQFLGYC 666 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~--------------~~~~f~~Ev~iL~~l~HpNIv~l~g~~ 666 (929)
.|.+.+.||+|.||.|-+|+.. +++.||||++.+.... ..+...+|+.+|++++|||||+|+++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 4567789999999999999876 6899999999754211 124678999999999999999999998
Q ss_pred ee--cCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEE
Q 002382 667 QE--EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 744 (929)
Q Consensus 667 ~~--~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 744 (929)
.+ .+..|||+|||..|.+...= .....+.+.++++++.++..||+|||.+ +||||||||+|+||+++|++|
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred cCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence 66 45789999999998875432 1222389999999999999999999999 999999999999999999999
Q ss_pred EEeecCcccccCCCC----ceeeeeecCccccCccccccCc----CCCcCceeeHHHHHHHHHhCCCCCccccccccchh
Q 002382 745 VSDFGLSKFAVDGAS----HVSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 816 (929)
Q Consensus 745 L~DFGla~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~----~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~ 816 (929)
|+|||.+.....+.. ..-....|||.|+|||...++. .+.+.||||+||.||-|+.|+.||.+...-+.+..
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K 330 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK 330 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence 999999976533211 1122367999999999998733 34678999999999999999999976552222222
Q ss_pred hHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 817 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 817 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
| +...+.-....+.-..+.+|+.+++.+||+.|.+..+|..|.-
T Consensus 331 I----------------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 331 I----------------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred H----------------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 2 2222222222244567889999999999999999999998864
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=322.36 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=209.3
Q ss_pred HHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
...|.+.+.||+|+||.||+|...+++.+|+|++.........++.+|+.+++.++||||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34567789999999999999999889999999998766555678999999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++... ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||.+........
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999653 245678999999999999999999998 999999999999999999999999999976543322
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
. .....++..|+|||.+....++.++||||||+++|+|++ |+.||..... ..+.+.... ....
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----~~~~~~~~~---~~~~-------- 223 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN----HEVYDQITA---GYRM-------- 223 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHHHh---CCcC--------
Confidence 1 123345778999999988889999999999999999998 8999965441 122222211 1000
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
..+......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 --PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1112223467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=326.23 Aligned_cols=257 Identities=26% Similarity=0.477 Sum_probs=206.3
Q ss_pred HHHHHHhccccccCcEEEEEEEECC------CcEEEEEEeecCCcc-hhHHHHHHHHHhcccCCCceeEEeeeeeecCeE
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~~------~~~vAVK~l~~~~~~-~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~ 672 (929)
...+.+.+.||+|+||.||+|++.+ ++.||||+++..... ..+.+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3456778999999999999998743 478999998765443 457899999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhhcccc----------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc
Q 002382 673 VLVYEFMHNGTLKEHLYGTL----------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 742 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 742 (929)
++||||+++++|.+++.... .....+++..+..++.|++.||+|||++ +++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999986431 2234578889999999999999999998 9999999999999999999
Q ss_pred EEEEeecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHH
Q 002382 743 AKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQW 820 (929)
Q Consensus 743 vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~ 820 (929)
+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||..... ..++..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~----~~~~~~ 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN----EEVIEC 236 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH
Confidence 99999999875432221 11223345788999999999999999999999999999998 9999865432 122222
Q ss_pred HHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 821 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 821 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
.. .+.... .+......+.+++.+|++.+|++||++.||++.|+
T Consensus 237 ~~----~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 IT----QGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HH----cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 21 111111 11122346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=332.08 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=197.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 345688999999999999887 68899999986432 22345688999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 83 VPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999998843 34678888999999999999999998 9999999999999999999999999998755332
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +.+.+ ..+..
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----~~~~i----~~~~~-------- 215 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG----IYEKI----LAGKL-------- 215 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH----HhCCc--------
Confidence 123458999999999998889999999999999999999999997644211 11111 11111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCc-----HHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 874 (929)
.++......+.+++.+|++.||++||+ +.|++++
T Consensus 216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011111235789999999999999995 8888877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=333.67 Aligned_cols=242 Identities=25% Similarity=0.359 Sum_probs=195.8
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.||+|+||.||+++.+ +++.||||++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999876 68899999997542 223456788999999999999999999999999999999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 99888743 34688999999999999999999998 99999999999999999999999999987532221 122
Q ss_pred eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCcc
Q 002382 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 842 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 842 (929)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .... .. ..+...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----~~~~---~~~~-~~------~~~p~~- 217 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFE---LILM-ED------IKFPRT- 217 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH----HHHH---Hhcc-CC------ccCCCC-
Confidence 3456999999999999889999999999999999999999999754311 1111 1110 00 011111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 843 DIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 843 ~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
....+.+++.+|++.+|++|| ++.|++++
T Consensus 218 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 ---LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ---CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 223578899999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=328.39 Aligned_cols=264 Identities=21% Similarity=0.285 Sum_probs=197.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||+||+|+.+ +++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+.
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 456689999999999999876 68899999987543 2234567899999999999999999999999999999999997
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 87 S-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred c-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 5 888877432 33567888999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc--------CCcc
Q 002382 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES--------GDIQ 831 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~--------~~~~ 831 (929)
......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+.+........ ....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 1223457999999999875 568899999999999999999999997654222222222111100000 0000
Q ss_pred cccCCcccCcc----CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 832 GIIDPSLLDEY----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 832 ~~~d~~l~~~~----~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....+...... .........+++.+|++.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00111100000 01112357899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=334.14 Aligned_cols=242 Identities=24% Similarity=0.336 Sum_probs=195.0
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.||+|+||.||+++.+ +|+.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999876 68999999997542 223456778999999999999999999999999999999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 9988874 334688999999999999999999998 99999999999999999999999999987432221 122
Q ss_pred eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCcc
Q 002382 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 842 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 842 (929)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.... . .... .+..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~~---~-~~~~------~~p~-- 216 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELI---L-MEEI------RFPR-- 216 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHH---h-cCCC------CCCC--
Confidence 3356899999999999999999999999999999999999999754311 111110 0 0000 0111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 843 DIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 843 ~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
.....+.+++.+|++.+|++|| ++.+++++
T Consensus 217 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 --TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred --CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1234578999999999999998 89998876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=307.57 Aligned_cols=239 Identities=26% Similarity=0.373 Sum_probs=197.5
Q ss_pred cCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcch---hHHHHHHHHHhcccCCCceeEEeeeeee
Q 002382 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQE 668 (929)
Q Consensus 593 ~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~---~~~f~~Ev~iL~~l~HpNIv~l~g~~~~ 668 (929)
+++.|++ +.+.||.|+||+|.+++.+ +|..+|+|++.+...-. .+...+|..+|+.+.||+++++.+.|.+
T Consensus 41 ~~l~dfe-----~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFE-----RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhh-----heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 4555543 5678999999999999988 57789999998764332 3456789999999999999999999999
Q ss_pred cCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEee
Q 002382 669 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 748 (929)
Q Consensus 669 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 748 (929)
.+.+++||||++||.|..+|+ ..+++++..++-+|.||+.||+|||+. +|++||+||+|||+|.+|.+||+||
T Consensus 116 ~~~lymvmeyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred CCeEEEEEeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence 999999999999999999995 456899999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcC
Q 002382 749 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 828 (929)
Q Consensus 749 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 828 (929)
|.|+.... ...+.+|||.|+|||.+++..+..++|.|||||++|||+.|.+||...+.-..++.|+. +
T Consensus 189 GFAK~v~~----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~--------~ 256 (355)
T KOG0616|consen 189 GFAKRVSG----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE--------G 256 (355)
T ss_pred cceEEecC----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh--------C
Confidence 99987532 24567899999999999999999999999999999999999999987663222322222 1
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCC
Q 002382 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR 865 (929)
Q Consensus 829 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 865 (929)
++ .++.--...+.+|+...++.|-.+|
T Consensus 257 ~v----------~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 KV----------KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cc----------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 11 1121222346678888888888777
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=332.60 Aligned_cols=261 Identities=23% Similarity=0.316 Sum_probs=200.8
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.|.+.+.||+|+||.||+++.. ++..+|+|++.... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (331)
T ss_pred cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence 4556688999999999999887 57889999987542 233467899999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++.. ...+++..+..++.|++.||.|||++ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 86 DGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 99999998853 34578889999999999999999985 26999999999999999999999999998754322
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcC---Cccc----
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG---DIQG---- 832 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~---~~~~---- 832 (929)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... .+..........+ ....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK----ELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHhcccccccccCCccccCcc
Confidence 122345899999999999989999999999999999999999999654311 1111111000000 0000
Q ss_pred ---------------------------ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 833 ---------------------------IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 833 ---------------------------~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
+................+.+++.+|++.+|++|||+.|++++-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000000011234688999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=350.63 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=203.6
Q ss_pred HHHhccccccCcEEEEEEEEC-C-CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-D-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~-~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 566789999999999999765 3 57788887765554445667889999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC-
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 759 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~- 759 (929)
+|+|.+++.........+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999998865544455688899999999999999999998 999999999999999999999999999986543322
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+... ... +....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----~~~~~~---~~~-~~~~~------- 290 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----REIMQQ---VLY-GKYDP------- 290 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH---HHh-CCCCC-------
Confidence 223345699999999999999999999999999999999999999975431 111111 111 11100
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+......+.+++.+|++.+|++||++.+++++
T Consensus 291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 111122468899999999999999999998754
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=329.26 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=210.8
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCe-EEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR-SVLVYE 677 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~-~~LV~E 677 (929)
.|...+.+|+|+||.++..+++ +++.+++|.+.-.. ....+...+|+.++++++|||||.+.+.+..++. .++||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 4556789999999999999887 67889999887543 2334567899999999999999999999999888 999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
||+||++.+.+.... +.-+++..+..++.|++.|+.|||++ +|+|||||+.||+++.+..|||+|||+|+.....
T Consensus 85 Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred ecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999997543 56788999999999999999999988 9999999999999999999999999999987665
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
. .....+.||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+..+....+.+-.
T Consensus 160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~---------------- 222 (426)
T KOG0589|consen 160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL---------------- 222 (426)
T ss_pred h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc----------------
Confidence 4 24456779999999999999999999999999999999999999998766444333332210
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....+.....++..++..|++.+|+.||++.+++.+
T Consensus 223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111122233468899999999999999999999987
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.86 Aligned_cols=254 Identities=25% Similarity=0.440 Sum_probs=203.5
Q ss_pred HHHHhccccccCcEEEEEEEECC----CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~----~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
.+.+.+.||+|+||+||+|+++. ...||||+++... .....+|.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 35567899999999999998752 3579999987543 333567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++....
T Consensus 85 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 85 EYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999998542 23688999999999999999999998 999999999999999999999999999986642
Q ss_pred CCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 757 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 757 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .+..... .+...
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~----~~~~~--- 227 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ----DVIKAVE----DGYRL--- 227 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH----HHHHHHH----cCCCC---
Confidence 2221 2222335678999999998899999999999999999998 99998654311 2222211 11000
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
..+......+.+++.+|++.+|++||++.||+++|+++
T Consensus 228 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.82 Aligned_cols=248 Identities=24% Similarity=0.327 Sum_probs=196.8
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEeecCCcc---hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 609 IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~---~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
||+|+||+||++... +++.+|+|++...... ..+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999876 6889999998754222 234577899999999999999999999999999999999999999
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeee
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (929)
.+++.........+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865434456789999999999999999999998 999999999999999999999999999975543322 2233
Q ss_pred eecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCH
Q 002382 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844 (929)
Q Consensus 765 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 844 (929)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. ... .+. ..++.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~-~~~----------~~~~~ 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RIL-NDS----------VTYPD 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH---hhc-ccC----------CCCcc
Confidence 4689999999999999999999999999999999999999975431111111111 100 000 01111
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 845 QSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 845 ~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
.....+.+++.+|++.+|++|| +++|++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 2334678999999999999999 67777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=347.27 Aligned_cols=258 Identities=23% Similarity=0.323 Sum_probs=209.2
Q ss_pred HHHHhccccccCcEEEEEEEECCC-cEEEEEEeecCCcchhHHHHHHHHHhcccC-CCceeEEeee-eee------cCeE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDG-KEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGY-CQE------EGRS 672 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~-~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~-~~~------~~~~ 672 (929)
...+++.|.+|||+.||.|+...+ .++|+|++-..+....+...+|+++|++|+ |+|||.+++. ... .-+.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 345678999999999999998866 999999988777777888999999999996 9999999993 221 2367
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
+|.||||.+|.|-+++..+... .|.+.++++|+.|+++|+++||.. .++|||||||-+||||+.+++.||||||.|.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 8999999999999999766533 399999999999999999999995 5689999999999999999999999999986
Q ss_pred cccCCCCce--------eeeeecCccccCccccc---cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHH
Q 002382 753 FAVDGASHV--------SSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 821 (929)
Q Consensus 753 ~~~~~~~~~--------~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~ 821 (929)
-........ .-...-|+.|+|||++. +..+++|+|||+|||+||-|+....||+....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------- 263 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------- 263 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence 332222110 01123689999999984 67899999999999999999999999986531
Q ss_pred HHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 822 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 822 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
..+++....-.........+.+||..||+++|.+||++.||++++-++...+
T Consensus 264 ---------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 ---------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1122222211112345668999999999999999999999999999887654
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=325.71 Aligned_cols=255 Identities=27% Similarity=0.475 Sum_probs=203.4
Q ss_pred HHHhccccccCcEEEEEEEECC------CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~------~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
+.+.+.||+|+||.||+|.... .+.||+|.+.... ......+.+|++++++++||||+++++++...+..+++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 4467899999999999998653 2579999987543 23346789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhccccc------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcE
Q 002382 676 YEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 743 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 743 (929)
|||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcE
Confidence 999999999999864311 114578889999999999999999998 99999999999999999999
Q ss_pred EEEeecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHH
Q 002382 744 KVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWA 821 (929)
Q Consensus 744 kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~ 821 (929)
||+|||+++....... .......+++.|+|||++....++.++|||||||++|||++ |..||..... ..+.+.+
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~----~~~~~~i 239 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN----QEVIEMI 239 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH
Confidence 9999999975433221 12223346789999999988899999999999999999998 9999875442 1222221
Q ss_pred HHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 822 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 822 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
. .+... ..+.....++.+++.+|++.+|++||++.||+++|+.
T Consensus 240 ~----~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 R----SRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H----cCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 11111 1112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.69 Aligned_cols=250 Identities=28% Similarity=0.460 Sum_probs=200.2
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+.+.||+|+||.||+|+++++..+|+|++..... ....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 3457789999999999999988778899999864432 345788899999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 84 GCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999998643 23678999999999999999999998 99999999999999999999999999987554322221
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.... ..+. . .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~----~~~~-----~----~ 220 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----EVVESV----SAGY-----R----L 220 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----HHHHHH----HcCC-----c----C
Confidence 112224567999999998899999999999999999999 88998654311 111111 1110 0 0
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
..+......+.+++.+|++.+|++||++.|+++.|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11112344688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=330.65 Aligned_cols=257 Identities=23% Similarity=0.386 Sum_probs=201.3
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCc----EEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEE
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~----~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~ 673 (929)
...+...+.||+|+||.||+|++. +++ .||+|+++... ....+++.+|+.+++.++||||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 344566789999999999999865 333 48999987543 34456788999999999999999999999765 567
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999998643 34578888999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCce-eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 754 AVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 754 ~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
........ .....++..|+|||++.+..++.++|||||||++|||++ |..||...... .+.... ..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~----~~~~~~----~~~~~~ 230 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSIL----EKGERL 230 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH----hCCCCC
Confidence 54332221 122234678999999999999999999999999999998 99998754311 122211 111100
Q ss_pred cccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 832 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 832 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
..+......+.+++.+|++.+|++||++.++++.|..+..
T Consensus 231 ---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0011122357899999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=321.53 Aligned_cols=266 Identities=24% Similarity=0.374 Sum_probs=201.2
Q ss_pred HHhccccccCcEEEEEEEE-----CCCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeec--CeEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV 675 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~-----~~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~--~~~~LV 675 (929)
.+.+.||+|+||+||++.. .+++.||+|+++.... .....+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5678899999999988753 2577899999875532 3456788999999999999999999988653 457899
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
|||+++++|.+++.. ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999998843 3588999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCc--eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 756 DGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 756 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
..... ......++..|+|||.+....++.++|||||||++|||++|+.|+..... ....+..+.........+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPK--KFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcc--hhhhhhcccccccchhhhhhh
Confidence 33221 11222356779999999888899999999999999999999999864321 111111111100001111111
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
++.......+......+.+++.+|++.+|++||++++|++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111111122233457899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=340.07 Aligned_cols=261 Identities=24% Similarity=0.387 Sum_probs=203.5
Q ss_pred HHHHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCc-chhHHHHHHHHHhcccC-CCceeEEeeeeeecCe
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR 671 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~ 671 (929)
...+.+.+.||+|+||.||+|++. .+..||||+++.... ...+.+.+|+++++++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 345567789999999999999863 134799999975433 33457899999999996 9999999999999999
Q ss_pred EEEEEEeccCCchhhhhccccc----------------------------------------------------------
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLT---------------------------------------------------------- 693 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 693 (929)
.++||||+++|+|.++|+....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998854210
Q ss_pred ----------------------------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC
Q 002382 694 ----------------------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 739 (929)
Q Consensus 694 ----------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 739 (929)
....+++..++.++.|+++||+|||+. +|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 012477888899999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhh
Q 002382 740 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 817 (929)
Q Consensus 740 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l 817 (929)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... .+
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---~~ 349 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---TF 349 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---HH
Confidence 999999999999755332221 1222346788999999998899999999999999999997 999986543111 11
Q ss_pred HHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 818 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 818 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
.. ....+.. ...+......+.+++.+|++.+|++||++.+|.+.|+.++
T Consensus 350 ~~----~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 YN----KIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HH----HHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11 1111100 0011123346889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=330.42 Aligned_cols=242 Identities=25% Similarity=0.361 Sum_probs=194.0
Q ss_pred ccccccCcEEEEEEEEC----CCcEEEEEEeecCC----cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 607 KKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~----~~~~vAVK~l~~~~----~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+.||+|+||.||+++.. .++.||||+++... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999763 57889999987532 22234577899999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+.+++|.+++.. ...+.+..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999988843 34567788888999999999999998 99999999999999999999999999987433222
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ... ..+.. .+
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~----~~---~~~-~~~~~------~~ 219 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK----TI---DKI-LKGKL------NL 219 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH----HH---HHH-HcCCC------CC
Confidence 1 2233468999999999998889999999999999999999999997644111 11 111 11111 01
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
.. .....+.+++.+|++.+|++|| ++.+++++
T Consensus 220 ~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 PP----YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CC----CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11 1223578999999999999999 88888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.28 Aligned_cols=250 Identities=30% Similarity=0.482 Sum_probs=201.2
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.+.+.||+|+||+||+|++.++..+|+|.+.... ....++.+|++++++++||||+++++++...+..++||||+.+|
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 45668899999999999998877789999887543 33567899999999999999999999999988999999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
+|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++..........
T Consensus 85 ~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 85 CLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999988542 23578999999999999999999998 999999999999999999999999999876544322222
Q ss_pred eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
....++..|+|||++.+..++.++|||||||++|||++ |..||...... .+...+ ..+....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~----~~~~~~~--------- 221 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----ETVEKV----SQGLRLY--------- 221 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHH----hcCCCCC---------
Confidence 22335678999999988889999999999999999998 99998654411 111211 1111100
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
........+.+++.+|++.+|++||++.++++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00112357889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=332.89 Aligned_cols=262 Identities=26% Similarity=0.417 Sum_probs=203.7
Q ss_pred HHHHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCC-cchhHHHHHHHHHhccc-CCCceeEEeeeeee-cC
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE-EG 670 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~-~~ 670 (929)
...+.+.+.||+|+||.||+|... .++.||+|+++... ....+.+.+|+++++++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 456788899999999999999643 24789999987543 22345678899999999 89999999998864 45
Q ss_pred eEEEEEEeccCCchhhhhccccc---------------------------------------------------------
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLT--------------------------------------------------------- 693 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~--------------------------------------------------------- 693 (929)
..++++||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 68899999999999988853211
Q ss_pred cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce-eeeeecCcccc
Q 002382 694 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYL 772 (929)
Q Consensus 694 ~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~ 772 (929)
....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 013678999999999999999999998 99999999999999999999999999998654332222 22334677899
Q ss_pred CccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHH
Q 002382 773 DPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIE 851 (929)
Q Consensus 773 aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 851 (929)
|||++.+..++.++|||||||++|||++ |..||......+ .+.. ....+... ..+......+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~~~~---------~~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFCR----RLKEGTRM---------RAPEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHHH----HHhccCCC---------CCCccCCHHHH
Confidence 9999999999999999999999999998 999986533111 1111 11111110 00112234688
Q ss_pred HHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 852 EKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 852 ~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
+++.+|++.+|++||++.||+++|+.++.
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.39 Aligned_cols=256 Identities=25% Similarity=0.424 Sum_probs=204.1
Q ss_pred HHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
...+.+.++||+|+||.||+|++.+...||+|+++.... ....+.+|++++++++||||+++++.+.+ +..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 345778899999999999999988777899999875332 34678999999999999999999998754 5679999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++|+|.+++... ....+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999998643 234578889999999999999999998 999999999999999999999999999976544332
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.......++..|+|||+..+..++.++|||||||++|||++ |..||...... .+.. ....+..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~~~----~~~~~~~-------- 221 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLD----QVERGYR-------- 221 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HHHH----HHhcCCC--------
Confidence 22223346778999999988899999999999999999999 88888654311 1111 1111100
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
.....+....+.+++.+|++.+|++||++.++++.|++.+
T Consensus 222 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 222 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 0111233456889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.07 Aligned_cols=249 Identities=34% Similarity=0.543 Sum_probs=193.4
Q ss_pred HhccccccCcEEEEEEEEC-----CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 605 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-----~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+.+.||.|.||.||+|.+. .+..|+||+++... ....+++.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999887 25689999996543 23467899999999999999999999999988889999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.++|... ....+++..+..|+.|+++||.|||++ +++|+||+++||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999654 245688999999999999999999998 99999999999999999999999999997653222
Q ss_pred C-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 759 S-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 759 ~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
. ...........|+|||.+....++.++||||||+++|||++ |+.|+..... ..+...+ .++...
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----~~~~~~~----~~~~~~----- 224 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----EEIIEKL----KQGQRL----- 224 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----HHHHHHH----HTTEET-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccc----cccccc-----
Confidence 2 22233457789999999999899999999999999999999 7788865431 1222222 111110
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
..+......+.+++.+|++.+|++||++.|+++.|
T Consensus 225 ----~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 ----PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 01111234578999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.95 Aligned_cols=254 Identities=26% Similarity=0.443 Sum_probs=203.3
Q ss_pred HHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
...+.+.++||+|+||.||+|..+++..+|+|.++.... ..+.+.+|+.++++++|+|++++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 345677899999999999999988888999999875433 34678999999999999999999998854 5678999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++... ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 83 SKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999999998643 234578999999999999999999998 999999999999999999999999999976543322
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.......++..|+|||++.+..++.++|+||||+++|||++ |..||..... ..+.+.... ....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~~~---~~~~-------- 222 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN----REVLEQVER---GYRM-------- 222 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHc---CCCC--------
Confidence 22222335678999999988889999999999999999999 8899865431 122222111 0000
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
..+......+.+++.+|++.+|++|||+.++.+.|++
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 --PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=331.09 Aligned_cols=250 Identities=23% Similarity=0.308 Sum_probs=196.8
Q ss_pred HHhccccccCcEEEEEEEEC----CCcEEEEEEeecCC----cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~----~~~~vAVK~l~~~~----~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~L 674 (929)
.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+..|+++++.+ +||||+++++++...+..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 45688999999999999763 57899999987532 22235678899999999 59999999999999999999
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 83 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 83 ILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999998853 34588899999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+... .. .
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~---~~-~------ 225 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR---IL-K------ 225 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH---Hh-c------
Confidence 43333333345699999999999865 4788999999999999999999999654321111111111 11 1
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
.++.+... ....+.+++.+|++.||++|| ++.|++++
T Consensus 226 ~~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 CDPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11111111 223578999999999999999 77788876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=335.31 Aligned_cols=238 Identities=26% Similarity=0.367 Sum_probs=200.3
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcch---hHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEe
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~---~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
.+.++||+|.||+|+++..+ +++.+|||++++...-. .+....|.+|+... +||.++.++..|+..+++++||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 36789999999999999887 57889999999875433 34566788887777 599999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+.||++..+. ..+.+++..+.-++..|+.||.|||++ +|||||||.+|||+|.+|.+||+|||+++..- ..
T Consensus 451 ~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-~~ 521 (694)
T KOG0694|consen 451 VAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-GQ 521 (694)
T ss_pred cCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC-CC
Confidence 9999954443 356789999999999999999999999 99999999999999999999999999998432 22
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
...+.+.+||+.|||||++.+..|+.++|.|||||+|||||.|+.||.+.+..+.+.+|+. |
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~---------------d--- 583 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN---------------D--- 583 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---------------C---
Confidence 3356678899999999999999999999999999999999999999997775554444433 0
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI 868 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 868 (929)
..-|+.-...+.+.++.+.++.+|++|-.+
T Consensus 584 ~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 112344445678899999999999999966
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=324.60 Aligned_cols=262 Identities=26% Similarity=0.460 Sum_probs=207.5
Q ss_pred HHHHHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeE
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~ 672 (929)
++..+.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3445567889999999999999752 3456899998766555567799999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhhcccc---------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcE
Q 002382 673 VLVYEFMHNGTLKEHLYGTL---------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 743 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 743 (929)
++||||+++++|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999999986432 1223589999999999999999999998 99999999999999999999
Q ss_pred EEEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHH
Q 002382 744 KVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWA 821 (929)
Q Consensus 744 kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~ 821 (929)
||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||...... .+...+
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~----~~~~~i 235 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIECI 235 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH
Confidence 99999999755332211 1222335778999999998899999999999999999998 89998654311 122211
Q ss_pred HHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 822 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 822 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
..+.... .... ....+.+++.+|++.+|.+||++.||.+.|+++..
T Consensus 236 ----~~~~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 236 ----TQGRVLQ-----RPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred ----HcCCcCC-----CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1121111 0111 22468999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=324.42 Aligned_cols=264 Identities=21% Similarity=0.279 Sum_probs=193.5
Q ss_pred HHHhccccccCcEEEEEEEEC--CCcEEEEEEeecCCc--chhHHHHHHHHHhccc---CCCceeEEeeeee-----ecC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQ-----EEG 670 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~--~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l---~HpNIv~l~g~~~-----~~~ 670 (929)
|.+.+.||+|+||+||+|+.. +++.||||+++.... .....+.+|+.+++.+ +||||++++++|. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 456788999999999999874 467899999875432 2234566777776665 6999999999885 345
Q ss_pred eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecC
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 750 (929)
..++||||+. ++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 6899999996 5888888542 234578899999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCc
Q 002382 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 830 (929)
++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+.+...........
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 9754332 22334568999999999988889999999999999999999999997654222222222211100000000
Q ss_pred c------cccCCccc---CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 Q------GIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~------~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. ..+.+... ..........+.+++.+|++.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0 00000000 00001122456799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.17 Aligned_cols=259 Identities=28% Similarity=0.415 Sum_probs=196.4
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcc--cCCCceeEEeeeeeecC----eEEEEEEe
Q 002382 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQEEG----RSVLVYEF 678 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~--l~HpNIv~l~g~~~~~~----~~~LV~E~ 678 (929)
+.+.||+|.||.||||++. ++.||||++.. +.+..|..|-.|.+. ++|+||++++++-.... .++||++|
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 4578999999999999998 69999999864 345567777776554 58999999999886655 88999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCC------CCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
.+.|+|.++|. ...++|....+|+..+++||+|||+.. .++|+|||||.+||||.+|+++.|+|||+|.
T Consensus 290 h~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 290 HPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred ccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999995 446899999999999999999999843 3689999999999999999999999999998
Q ss_pred cccCCCCc-eeeeeecCccccCccccccCc-CC-----CcCceeeHHHHHHHHHhCCCCCccccccc-------------
Q 002382 753 FAVDGASH-VSSIVRGTVGYLDPEYYISQQ-LT-----DKSDVYSFGVILLELISGQEAISNEKFGA------------- 812 (929)
Q Consensus 753 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~-~s-----~~sDVwSlGvvl~elltG~~p~~~~~~~~------------- 812 (929)
.+..+... .....+||.+|||||++.+.- +. .+.||||+|.|||||++....+.....++
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 76654332 223367999999999997632 22 36899999999999999775543111010
Q ss_pred cchhhHHHHHHhhhcCCcccccCCcccCc-cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 813 NCRNIVQWAKLHIESGDIQGIIDPSLLDE-YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 813 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
..+++...+..+ ...|.+.+. .....+..+.+.+..||..||+.|.|+.=|.+.+.++..
T Consensus 445 t~e~mq~~VV~k--------K~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 445 TLEEMQELVVRK--------KQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CHHHHHHHHHhh--------ccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 111111111111 111122111 112455678899999999999999999999998887754
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=331.73 Aligned_cols=245 Identities=25% Similarity=0.378 Sum_probs=190.8
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+.||+|+||.||+|++. +++.||||++..... .....+.+|+++++.++|+||+++++++...+..++||||+++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 35678999999999999876 689999999865432 3346788999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+.. ...+..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 157 ~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 157 GSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred Ccccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 9986532 234567788999999999999998 999999999999999999999999999976543221 1
Q ss_pred eeeeecCccccCcccccc-----CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 762 SSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||...... ....+...... ...
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~----~~~------ 293 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAICM----SQP------ 293 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhc----cCC------
Confidence 233468999999998743 23446899999999999999999999743311 11111111100 000
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..........+.+++.+|++.+|++||++.|++++
T Consensus 294 ---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 ---PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111223468899999999999999999999987
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=336.85 Aligned_cols=250 Identities=24% Similarity=0.296 Sum_probs=201.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||+||+|+.. +++.||||+++... ......+.+|++++..++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 445688999999999999987 68999999997542 23345688999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 83 MPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999853 25688899999999999999999998 99999999999999999999999999997554332
Q ss_pred ----------------------------CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccc
Q 002382 759 ----------------------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (929)
Q Consensus 759 ----------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~ 810 (929)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122334689999999999999999999999999999999999999976542
Q ss_pred cccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCc-HHHHHHH
Q 002382 811 GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-ISEVLKD 874 (929)
Q Consensus 811 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~eVl~~ 874 (929)
.+....+..|... ..+. . .......+.+++.+|++ +|++||+ ++|++++
T Consensus 236 ~~~~~~i~~~~~~----~~~p--------~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYNKIINWKES----LRFP--------P--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHhccCCc----ccCC--------C--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2222222221100 0000 0 00023467889999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=327.15 Aligned_cols=201 Identities=27% Similarity=0.407 Sum_probs=173.1
Q ss_pred HHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
....|.+.++||+|+||.||++.+. +++.+|+|++.... ......+.+|++++++++||||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3456677889999999999999887 57889999887542 233467899999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999853 34578888899999999999999975 2799999999999999999999999999875432
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccc
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~ 808 (929)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2 122345899999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=318.08 Aligned_cols=256 Identities=25% Similarity=0.414 Sum_probs=205.7
Q ss_pred HHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 598 IEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 598 i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
+.+..+.+.++||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 45667788899999999999999998899999999875543 3567899999999999999999999874 456899999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+.+++|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999988543 234678899999999999999999998 9999999999999999999999999998765432
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
.........++..|+|||++....++.++||||||+++|||++ |+.||.....+ .+..... .+....
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~----~~~~~~---- 223 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP----EVIQNLE----RGYRMP---- 223 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH----HHHHHHH----cCCCCC----
Confidence 2222223345778999999998889999999999999999999 99999754421 1222111 110000
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
. ......++.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 -~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 -R----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0 11123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=324.63 Aligned_cols=259 Identities=26% Similarity=0.461 Sum_probs=207.1
Q ss_pred HHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
.+.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++||||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 3446788999999999999753 3456899998766655567899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhccccc------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcE
Q 002382 676 YEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 743 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 743 (929)
|||+++++|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999864321 223578999999999999999999998 99999999999999999999
Q ss_pred EEEeecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHH
Q 002382 744 KVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWA 821 (929)
Q Consensus 744 kL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~ 821 (929)
||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.+.
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~~- 237 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----EVIEC- 237 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH-
Confidence 9999999975443221 11223446788999999999999999999999999999999 99998654311 12221
Q ss_pred HHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 822 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 822 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
...+.... ........+.+++.+|++.+|++||++.+|++.|+++..
T Consensus 238 ---~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ---ITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---HhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11121111 011123468899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=332.46 Aligned_cols=242 Identities=24% Similarity=0.324 Sum_probs=194.7
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.||+|+||.||+++.. +++.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999875 68899999997542 223456778999999999999999999999999999999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
+|.+++. ....+++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 9988874 34468899999999999999999997 5 99999999999999999999999999987432221 12
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+. .... .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~----~~~~~i~----~~~~------~~p~~ 218 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELIL----MEEI------RFPRT 218 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH----HHHHHHh----cCCC------CCCCC
Confidence 23346999999999999999999999999999999999999999754311 1111111 0100 01111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
....+.+++.+|++.||++|+ ++.|++++
T Consensus 219 ----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 219 ----LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ----CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 223578999999999999996 89999877
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=335.14 Aligned_cols=252 Identities=23% Similarity=0.282 Sum_probs=198.2
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
..+.+.+.||+|+||.||+++.+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 34556789999999999999886 58899999997532 223345778999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 123 Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 123 EYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999998843 3467778888999999999999998 999999999999999999999999999976543
Q ss_pred CCCceeeeeecCccccCccccccC----cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
..........||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+ ........
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i-------~~~~~~~~ 267 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI-------MDHKNSLT 267 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH-------HcCCCcCC
Confidence 322223345699999999998653 4788999999999999999999999765422111111 11100000
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCC--CCcHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 874 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~eVl~~ 874 (929)
... .......+.+++.+|++.+|++ ||++.|++++
T Consensus 268 -----~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 -----FPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -----CCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 001 1112346788999999999987 9999999887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=332.82 Aligned_cols=244 Identities=23% Similarity=0.272 Sum_probs=197.5
Q ss_pred HHHHhccccccCcEEEEEEEECC--CcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~--~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
.+.+.+.||+|+||.||+|.++. +..||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 45577899999999999998653 3689999986532 223456788999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 111 Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 111 EFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999998853 34688889999999999999999998 999999999999999999999999999976432
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.+ ....+..
T Consensus 184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~~----~i~~~~~------ 245 (340)
T PTZ00426 184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----IYQ----KILEGII------ 245 (340)
T ss_pred C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH----HHH----HHhcCCC------
Confidence 2 223569999999999998889999999999999999999999997544111 111 1111110
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
.+... ....+.+++.+|++.+|++|+ +++|++++
T Consensus 246 ~~p~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 YFPKF----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCC----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00111 123567899999999999995 89999887
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=328.74 Aligned_cols=242 Identities=22% Similarity=0.342 Sum_probs=193.8
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||.||+|+.+ +++.||||+++... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999886 47899999987542 22334567788888866 799999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|...+.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 999888743 34678889999999999999999998 99999999999999999999999999987532222 12
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.+ . .+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~----~~~~~i---~-~~~~---~------- 214 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED----DLFESI---L-HDDV---L------- 214 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH----HHHHHH---H-cCCC---C-------
Confidence 23456899999999999889999999999999999999999999765421 111111 1 1110 0
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCC-------cHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRP-------SISEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RP-------s~~eVl~~ 874 (929)
.+......+.+++.+|++.+|++|| ++.+++++
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0111124678999999999999999 88888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=327.25 Aligned_cols=250 Identities=22% Similarity=0.305 Sum_probs=195.3
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||.||+|+.+ +++.+|+|+++... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999997542 22334577888888776 899999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|..++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 99988774 235688999999999999999999998 99999999999999999999999999987432221 12
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccccccc-chhhHHHHHHhhhcCCcccccCCcccC
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN-CRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 2345689999999999999999999999999999999999999964221111 11222222222222111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCc------HHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPS------ISEVLKD 874 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs------~~eVl~~ 874 (929)
..+......+.+++.+|++.||++||+ +.|+++|
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 111122345789999999999999998 5777766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=335.91 Aligned_cols=250 Identities=21% Similarity=0.290 Sum_probs=193.1
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~ 83 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (381)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence 34578999999999999876 57899999997542 223456889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC-
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA- 758 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~- 758 (929)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 84 PGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999998853 34578888899999999999999998 99999999999999999999999999975321000
Q ss_pred ---------------------------------------------CceeeeeecCccccCccccccCcCCCcCceeeHHH
Q 002382 759 ---------------------------------------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGV 793 (929)
Q Consensus 759 ---------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGv 793 (929)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012346999999999999888999999999999
Q ss_pred HHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHH--ccCCCCCCCCcHHHH
Q 002382 794 ILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEV 871 (929)
Q Consensus 794 vl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--Cl~~dP~~RPs~~eV 871 (929)
++|||++|+.||......+....+..|.. .+. +.+ ....+ ..+.+++.+ |...+|..||++.|+
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~------~~~--~~~--~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWEN------TLH--IPP--QVKLS----PEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHcccc------ccC--CCC--CCCCC----HHHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999976542221112221100 000 000 01112 245566665 556677779999999
Q ss_pred HHH
Q 002382 872 LKD 874 (929)
Q Consensus 872 l~~ 874 (929)
++|
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=314.60 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=205.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+.+.+.||+|+||.||+|+.. +++.||||.++... ......+.+|+++++.++||||+++++++...+..++|+||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 456788999999999999876 68999999876432 23345688999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++.........+++..+..++.|+++||+|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999988854333345578889999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
. ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||..... +...+.... .......
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~~~~-~~~~~~~------ 227 (267)
T cd08228 161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQKI-EQCDYPP------ 227 (267)
T ss_pred H-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHHHHH-hcCCCCC------
Confidence 1 11234588899999999988899999999999999999999999864331 111221111 1111110
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
.........+.+++.+|++.+|++||++.||++.|+++
T Consensus 228 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 --LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11112334688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=323.92 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=194.8
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.|.+.+.||+|+||.||+|+.+ +++.||||+++.... .....+.+|+.+++.++||||+++++++......++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 3556789999999999999987 688999999875432 22346778999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
. ++|.+++... ...++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 86 H-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred C-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 5 5777776432 34578888999999999999999998 99999999999999999999999999987433221
Q ss_pred ceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc---CCccc---
Q 002382 760 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---GDIQG--- 832 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~---~~~~~--- 832 (929)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .............. .....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD---IQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc---HHHHHHHHHHHhCCCChhhccchhh
Confidence 22233458999999999865 4578899999999999999999999975431 11111111111000 00000
Q ss_pred --ccCC-ccc--CccCH-------HHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 --IIDP-SLL--DEYDI-------QSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 --~~d~-~l~--~~~~~-------~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..++ ... ..... .....+.+++.+|++.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000 000 00000 011357799999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=327.53 Aligned_cols=242 Identities=26% Similarity=0.374 Sum_probs=189.7
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcc-cCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSR-IHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~-l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999886 57889999997542 1223345566666665 4899999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999988843 34688889999999999999999998 99999999999999999999999999997543322 22
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+..-+ .... + .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~----~~~~~i----~~~~------~----~ 214 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED----ELFDSI----LNDR------P----H 214 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH----HHHHHH----HcCC------C----C
Confidence 33456999999999999989999999999999999999999999754411 111111 1110 0 1
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHH-HHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~-eVl~~ 874 (929)
++......+.+++.+|++.+|++||++. ++.++
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 1111223577899999999999999875 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=326.92 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=196.4
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||.||+++++ +++.||||+++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999876 57899999997542 22335577899999888 799999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 99988874 235689999999999999999999998 9999999999999999999999999998742221 122
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccccccc-chhhHHHHHHhhhcCCcccccCCcccC
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN-CRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....||+.|+|||++.+..++.++|+|||||++|||++|+.||......+. ......+.......... .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~-- 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RI-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CC--
Confidence 2345689999999999999999999999999999999999999964321111 11122222222222211 01
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCc------HHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPS------ISEVLKD 874 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs------~~eVl~~ 874 (929)
+......+.+++.+|++.+|++||+ +.|+++|
T Consensus 225 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 --PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1112245789999999999999997 6788766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=325.20 Aligned_cols=262 Identities=25% Similarity=0.399 Sum_probs=219.7
Q ss_pred HHHHHHHHHhccccccCcEEEEEEEECC---Cc--EEEEEEeecC-CcchhHHHHHHHHHhcccCCCceeEEeeeeeecC
Q 002382 597 DIEDATKMLEKKIGSGGFGVVYYGKLKD---GK--EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 670 (929)
Q Consensus 597 ~i~~~~~~~~~~IG~G~fG~Vy~~~~~~---~~--~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~ 670 (929)
++.++...+.++||.|-||.||+|.+.+ |+ .||||..+.+ .....+.|..|..+|+.++||||++++|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 3445555567899999999999998652 33 5889998875 345577899999999999999999999999764
Q ss_pred eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecC
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 750 (929)
..++|||.++-|.|.++|... ...++......++.||+.||+|||+. .+|||||..+|||+.....+||+|||+
T Consensus 464 P~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ceeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence 679999999999999999643 45688888999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
++...+..........-+..|||||.+.-++++.++|||-|||.|||++. |..||.+....+.. .++++|+
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--------~~iEnGe 609 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--------GHIENGE 609 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--------EEecCCC
Confidence 99988877777766667889999999999999999999999999999988 99999765522211 1122222
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
+-..+..++..+..|..+||+.+|.+||.+.|+...|.+++..+
T Consensus 610 ---------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 610 ---------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred ---------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 12334566778899999999999999999999999999988743
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=333.02 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=195.2
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.|.+.+.||+|+||.||+++.. +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 4556688999999999999987 57889999986432 2234567889999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 y~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 124 YMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred CCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 9999999998843 3477888899999999999999998 9999999999999999999999999999865433
Q ss_pred CCceeeeeecCccccCccccccC----cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~----~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
.........||+.|+|||++.+. .++.++||||+||++|||++|+.||......+....+ ........
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i-------~~~~~~~~- 267 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI-------MDHKNSLN- 267 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCcccC-
Confidence 22223345699999999998754 3788999999999999999999999755421111111 11100000
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCC--CCcHHHHHHH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 874 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~eVl~~ 874 (929)
... .......+.+++..|++.++.+ ||++.|+++|
T Consensus 268 ----~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 ----FPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----CCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000 1122345678888899865543 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=315.09 Aligned_cols=247 Identities=29% Similarity=0.433 Sum_probs=195.7
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
+.||+|+||.||+|++. +++.+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999876 68899999876442 33456789999999999999999999999999999999999999999
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce-ee
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SS 763 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~ 763 (929)
.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.......... ..
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9988532 34578899999999999999999998 99999999999999999999999999987543221111 11
Q ss_pred eeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCcc
Q 002382 764 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 842 (929)
Q Consensus 764 ~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 842 (929)
....+..|+|||.+.++.++.++|||||||++|||++ |..||...... .... ...... ....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~----~~~~----~~~~~~---------~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ----QTRE----AIEQGV---------RLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH----HHHH----HHHcCC---------CCCC
Confidence 1123457999999998889999999999999999998 88888643311 1111 111110 0011
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 843 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 843 ~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
+......+.+++.+|++.+|++||++.||.+.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1122346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=335.49 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=196.2
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence 45688999999999999886 58899999997542 223456788999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 84 PGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 99999998853 34688999999999999999999998 999999999999999999999999999864322110
Q ss_pred c-------------------------------------eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCC
Q 002382 760 H-------------------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802 (929)
Q Consensus 760 ~-------------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~ 802 (929)
. ......||+.|+|||++....++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011235999999999999999999999999999999999999
Q ss_pred CCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCc---HHHHHHH
Q 002382 803 EAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEVLKD 874 (929)
Q Consensus 803 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~eVl~~ 874 (929)
.||......+....+..|.. .+. + ... ......+.+++.+|+. +|.+|++ +.|++++
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~------~~~--~----~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKE------TLQ--F----PDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCC------ccC--C----CCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99976542222222222110 000 0 000 0112356788888886 8999998 9998876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=322.28 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=204.9
Q ss_pred HHHHHHhccccccCcEEEEEEEECC------CcEEEEEEeecCC-cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCe
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 671 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~~------~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~ 671 (929)
...+.+.+.||+|+||.||++.+.. ...+|+|++.... .....++.+|+++++++ +|+||+++++++...+.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 3345567899999999999998752 3579999987542 23345688999999999 89999999999999999
Q ss_pred EEEEEEeccCCchhhhhcccc------------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC
Q 002382 672 SVLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 739 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 739 (929)
.+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 999999999999999985421 2345688999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCCce-eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhh
Q 002382 740 HMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 817 (929)
Q Consensus 740 ~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l 817 (929)
++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+ +
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~ 243 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----L 243 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----H
Confidence 9999999999998654332211 122235678999999988899999999999999999998 999987544211 1
Q ss_pred HHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 818 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 818 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
.+. ...+.. ...+......+.+++.+|++.+|++|||+.|+++.|++++
T Consensus 244 ~~~----~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKL----LKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHH----HHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111 111110 0111223346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=329.61 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=216.5
Q ss_pred HHHHHHHHHhccccccCcEEEEEEEECC-CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 597 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 597 ~i~~~~~~~~~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
|+++......++||-|.||.||.|.|+. .-.||||.++.+... .++|.+|+.+|+.++|||+|+|+|+|..+...|+|
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 3444444457899999999999999984 567999999866544 67899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
+|||..|+|.++|+... ...++-.-.+.|+.||+.||+||..+ ++|||||.++|+|+.++..+||+|||+++++.
T Consensus 342 TEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999997642 34466667788999999999999998 99999999999999999999999999999876
Q ss_pred CCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
...........-...|.|||-+....++.|+|||+|||+|||+.| |..|+.+.+... +...++.
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq--------VY~LLEk------- 481 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYGLLEK------- 481 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH--------HHHHHhc-------
Confidence 554433333445789999999999999999999999999999999 888987644211 1122222
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
..+-+.+..+..++.+|+..||++.|.+||++.|+.+.++.++..
T Consensus 482 --gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 482 --GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred --cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 222333445667899999999999999999999999999987743
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=300.97 Aligned_cols=266 Identities=20% Similarity=0.271 Sum_probs=210.5
Q ss_pred HHHHHHHhccccccCcEEEEEEEE-CCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecC-----eE
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RS 672 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~-----~~ 672 (929)
...+|.+.+.||+|||+-||.++. .+++.+|+|++.-.+.++.+...+|++..++++||||++++++...+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 345677889999999999999984 468899999998777777788999999999999999999999885443 48
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
+++++|...|+|.+.+.....++..+++.+++.|+.++++||++||+. .++++||||||.|||+.+.+.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999987766777899999999999999999999997 3469999999999999999999999999986
Q ss_pred cccCCCCc--------eeeeeecCccccCccccc---cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHH
Q 002382 753 FAVDGASH--------VSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 821 (929)
Q Consensus 753 ~~~~~~~~--------~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~ 821 (929)
...-.... ......-|..|+|||.+. +...++++|||||||+||+|+.|..||+..-..+.-..
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla----- 252 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA----- 252 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-----
Confidence 43211100 011123588999999985 45678999999999999999999999975431111000
Q ss_pred HHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 822 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 822 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
..+..+.+.-..+....+.+.+++.+|++.||.+||++.|++.+++.++
T Consensus 253 ---------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 ---------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0111112211112224457889999999999999999999999998754
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=328.64 Aligned_cols=242 Identities=26% Similarity=0.379 Sum_probs=192.7
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||+||+|+.+ +++.||||+++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999886 57899999987542 22345567788888776 699999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 999988843 34688899999999999999999998 99999999999999999999999999987532221 12
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.+ ..+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~i----~~~~~----------~ 214 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED----DLFEAI----LNDEV----------V 214 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHH----hcCCC----------C
Confidence 23456899999999999989999999999999999999999999754421 122211 11111 0
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcH------HHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~------~eVl~~ 874 (929)
.+......+.+++.+|++.||++||++ +++++|
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 011122357899999999999999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=332.46 Aligned_cols=251 Identities=22% Similarity=0.236 Sum_probs=199.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||+||+++.. +++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 345688999999999999876 688999999975422 2345688899999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 83 QPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999998542 24688889999999999999999998 99999999999999999999999999998654433
Q ss_pred CceeeeeecCccccCccccc------cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 759 SHVSSIVRGTVGYLDPEYYI------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~------~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
........||+.|+|||++. ...++.++|||||||++|||++|+.||...........+.. ......
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-------~~~~~~ 229 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN-------FQRFLK 229 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc-------CCCccC
Confidence 33334456899999999986 45677899999999999999999999975442211111111 111000
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. .. .......+.+++.+|++ +|++||++.+++++
T Consensus 230 ~-----~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 F-----PE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred C-----CC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 00 11123457789999998 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=320.56 Aligned_cols=257 Identities=22% Similarity=0.378 Sum_probs=202.0
Q ss_pred HHHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCcc-hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~~-~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~ 673 (929)
..+.+.+.||+|+||.||+|+.. +++.||+|+++..... ....+.+|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45667889999999999999864 2478999998755332 2456889999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhcccc------------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC
Q 002382 674 LVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 741 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 741 (929)
+++||+.+++|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999984321 1123578888999999999999999998 999999999999999999
Q ss_pred cEEEEeecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHH
Q 002382 742 RAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQ 819 (929)
Q Consensus 742 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~ 819 (929)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... ..+.+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~ 237 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDVIE 237 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Confidence 999999999875433221 11223345789999999988889999999999999999998 8888865431 12222
Q ss_pred HHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 820 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 820 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
... .+... ..+......+.+++..|++.+|++||+++||++.|+.
T Consensus 238 ~i~----~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIR----NRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHH----cCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 211 11111 1111233457899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.41 Aligned_cols=268 Identities=22% Similarity=0.252 Sum_probs=202.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCc-eeEEeeeeeecC------eE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEG------RS 672 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpN-Iv~l~g~~~~~~------~~ 672 (929)
+...++||+|.||+||+|+.+ +|+.||+|+++-... .......+|+.+|+.++|+| |+++++++...+ ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 334467999999999999876 688999999976533 23455689999999999999 999999998877 78
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
++|+||++. +|..++.........++...+..++.||++||+|||++ +|+||||||+||||+++|.+||+|||+|+
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHH
Confidence 999999964 88888865432224566678899999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhh---cC
Q 002382 753 FAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE---SG 828 (929)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~---~~ 828 (929)
...-. ....+..++|.+|+|||++.+. .|+...||||+||++.||++++..|.+... .+.+...+...-. +.
T Consensus 169 a~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 169 AFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCCccC
Confidence 54422 2224455689999999999876 789999999999999999999999976552 2233332222211 11
Q ss_pred Cccc--ccCC--cccCcc---C-----HHHHHHHHHHHHHccCCCCCCCCcHHHHHHH--HHHh
Q 002382 829 DIQG--IIDP--SLLDEY---D-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 878 (929)
Q Consensus 829 ~~~~--~~d~--~l~~~~---~-----~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~--L~~~ 878 (929)
+... ..+- ...... + ........+++.+|++.+|++|.|++..++| +.+.
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1100 0010 000000 0 0111367899999999999999999999987 5543
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=313.47 Aligned_cols=247 Identities=27% Similarity=0.409 Sum_probs=198.5
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCchh
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 685 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL~ 685 (929)
+.||+|+||.||+|...+++.+|+|+++.... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988889999999875533 23456889999999999999999999999999999999999999999
Q ss_pred hhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeeee
Q 002382 686 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 765 (929)
Q Consensus 686 ~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 765 (929)
+++... ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 988532 34578899999999999999999998 999999999999999999999999999875433222222223
Q ss_pred ecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCH
Q 002382 766 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844 (929)
Q Consensus 766 ~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 844 (929)
.++..|+|||++.+..++.++||||||+++||+++ |..||...... ..... ...+... ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~~~~----~~~~~~~---------~~~~ 217 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QAREQ----VEKGYRM---------SCPQ 217 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHH----HHcCCCC---------CCCC
Confidence 34678999999998899999999999999999998 99998654311 11111 1111100 1111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 845 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 845 ~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
.....+.+++.+|++.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 22356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=320.86 Aligned_cols=258 Identities=24% Similarity=0.419 Sum_probs=201.2
Q ss_pred HHHHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeE
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~ 672 (929)
...+.+.+.||+|+||.||+|.+. .+..||||++.... .....++.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 344667789999999999999764 24679999986443 23345688999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhhcccccc------ccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEE
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTH------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 746 (929)
++||||+++++|.+++...... ...+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEEC
Confidence 9999999999999998542211 23457788899999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCCce-eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHh
Q 002382 747 DFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 824 (929)
Q Consensus 747 DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 824 (929)
|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||...... .....+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~----~~~~~~--- 234 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE----QVLRFV--- 234 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH---
Confidence 999987544322211 122345788999999998889999999999999999999 78888654311 222211
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
..+.... .+......+.+++.+|++.+|++||++.|+++.|++
T Consensus 235 -~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 -MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -HcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111111 111223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=333.43 Aligned_cols=259 Identities=20% Similarity=0.278 Sum_probs=194.2
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.|.+.+.||+|+||.||++... .++.||+|... ...+.+|++++++++||||+++++++......++|+|++.
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 4666789999999999999876 57899999753 2346789999999999999999999999999999999985
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 167 -~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 167 -TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred -CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 678777742 34678899999999999999999998 9999999999999999999999999999754332222
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccc-ccccc---hhhHHHHHHh---hhcCC----
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK-FGANC---RNIVQWAKLH---IESGD---- 829 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~-~~~~~---~~l~~~~~~~---~~~~~---- 829 (929)
......||+.|+|||++.+..++.++|||||||++|||++|+.||-... ..... ..+....... ..+..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 3334569999999999999899999999999999999999998764322 11000 0111110000 00000
Q ss_pred --cccc---------cCCcccCcc--CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 --IQGI---------IDPSLLDEY--DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 --~~~~---------~d~~l~~~~--~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+... ..+...... .......+.+++.+|++.||++|||++|++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 000000000 01223468899999999999999999999875
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=320.48 Aligned_cols=256 Identities=24% Similarity=0.421 Sum_probs=201.0
Q ss_pred HHHHhccccccCcEEEEEEEEC-----CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-----~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
.+.+.+.||+|+||.||+|++. .++.+|+|.+.... ......+.+|++++++++||||+++++++......++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 3456789999999999999852 45789999987543 33346788999999999999999999999999999999
Q ss_pred EEeccCCchhhhhccccc-------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc
Q 002382 676 YEFMHNGTLKEHLYGTLT-------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 742 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 742 (929)
|||+.+++|.+++..... ....+++.+...++.|++.||+|||++ +++||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCc
Confidence 999999999998853210 123578888999999999999999998 9999999999999999999
Q ss_pred EEEEeecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHH
Q 002382 743 AKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQW 820 (929)
Q Consensus 743 vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~ 820 (929)
+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.... ...+.+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~----~~~~~~~ 238 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS----NQEVIEM 238 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC----HHHHHHH
Confidence 99999999975433221 12223335678999999988889999999999999999998 888986433 1122222
Q ss_pred HHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 821 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 821 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
+.. ..... .+......+.+++.+|++.+|++||++.+|.++|+.
T Consensus 239 ~~~----~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRK----RQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHc----CCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 211 11110 111123467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=328.24 Aligned_cols=264 Identities=20% Similarity=0.274 Sum_probs=193.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeec-----CeEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 674 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~-----~~~~L 674 (929)
|.+.+.||+|+||.||+|+.. +++.||||++... .......+.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 446789999999999999876 6899999998743 223345688999999999999999999988543 24799
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
||||+. ++|.+++. ....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 82 v~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 82 VFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 999995 68888774 234688999999999999999999998 9999999999999999999999999999754
Q ss_pred cCCCC--ceeeeeecCccccCcccccc--CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHH-------H
Q 002382 755 VDGAS--HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------L 823 (929)
Q Consensus 755 ~~~~~--~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~-------~ 823 (929)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..... .
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 12233468999999999865 6789999999999999999999999965431110000000000 0
Q ss_pred hhhcCCccccc---CCcccC---ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 824 HIESGDIQGII---DPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 824 ~~~~~~~~~~~---d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..........+ .+.... .........+.+++.+|++.+|++||+++|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 000000 0000112357899999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=320.77 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=203.0
Q ss_pred HHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
.+.+.||+|+||.||+|+.. ....+++|.+..... ....++.+|+.+++.++||||+++++.+...+..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 45688999999999999864 235789998875432 23467889999999999999999999999999999999
Q ss_pred EeccCCchhhhhcccc--------------------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeE
Q 002382 677 EFMHNGTLKEHLYGTL--------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 736 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~--------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NIL 736 (929)
||+.+++|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+|||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence 9999999999875421 1123578899999999999999999998 9999999999999
Q ss_pred ecCCCcEEEEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccc
Q 002382 737 LDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANC 814 (929)
Q Consensus 737 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~ 814 (929)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---- 235 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP---- 235 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH----
Confidence 999999999999999754332221 1222345778999999988889999999999999999998 9999865431
Q ss_pred hhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 815 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 815 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
..+..+...... ...+......+.+++.+|++.+|++||++.|+++.|++++.
T Consensus 236 ~~~~~~~~~~~~-------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFNLLKTGYR-------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHhCCCC-------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 122222211100 00111223468899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.62 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=206.6
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.+.+.+.||+|+||.||+|+.. +++.+|||.+.... .....++.+|+.+++.++||||+++++++...+..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 3556789999999999999865 78999999886532 2234578899999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++++|.+++.........+++..++.++.|+++||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998864333455689999999999999999999998 9999999999999999999999999998755432
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
.. ......|+..|+|||.+.+..++.++|+||||+++|||++|..||..... ......+... .. ..+.
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~-~~-----~~~~ 227 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIE-QC-----DYPP 227 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhhhh-cC-----CCCC
Confidence 22 12234588999999999888899999999999999999999999864331 1111111111 10 0111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
+. .......+.+++.+|++.+|++||||.+|++.++++
T Consensus 228 ~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 LP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11 112334688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=326.73 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=191.7
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHh---cccCCCceeEEeeeeeecCeEEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLL---SRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL---~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
.+.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++ +.++||||+++++++...+..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 34678999999999999876 58899999997542 12234566666554 5678999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++++|...+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 82 EYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred cCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999988774 24588999999999999999999998 999999999999999999999999999874322
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ... .+..
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~----~~~~---~i~-~~~~------ 218 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE----EVFD---SIV-NDEV------ 218 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH----HHHH---HHH-hCCC------
Confidence 21 2223456899999999999999999999999999999999999999754421 1111 111 1110
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
. ++......+.+++.+|++.+|++|| ++.+++++
T Consensus 219 ~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 R----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred C----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0 1111224578899999999999999 56777665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=314.86 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=201.6
Q ss_pred HHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
..+.+.+.||+|+||.||+|.++.+..+|+|++.... ...+.+.+|++++++++|||++++++++. .+..+++|||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4466778999999999999998877789999886543 23467889999999999999999999875 456789999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++... ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999998643 234578889999999999999999998 9999999999999999999999999999765433222
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
......++..|+|||...+..++.++|||||||++|||++ |..||...... ....+... +...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~----~~~~-------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----EVLEQVER----GYRM-------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHc----CCCC--------
Confidence 2222346778999999988889999999999999999999 89998754311 12222111 1000
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
..+......+.+++.+|++.+|++||++++|++.|++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111233568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=324.87 Aligned_cols=242 Identities=25% Similarity=0.393 Sum_probs=191.2
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcc-cCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSR-IHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~-l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||+||+|++. +++.||||+++... ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999987 47889999997542 1223445667777776 4899999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 999998843 34578888999999999999999998 999999999999999999999999999874322221 2
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.+.. .. +..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~~i~~----~~------~~~--- 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE----ELFQSIRM----DN------PCY--- 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHh----CC------CCC---
Confidence 23456899999999999989999999999999999999999999754421 22221111 10 001
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHH-HHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~-eVl~~ 874 (929)
+......+.+++.+|++.+|++||++. ++.++
T Consensus 216 -~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 216 -PRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred -CccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 111223577899999999999999997 66553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=303.60 Aligned_cols=259 Identities=22% Similarity=0.241 Sum_probs=197.5
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc--hhHHHHHHHHHhcccCCCceeEEeeeeee--cCeEEEEEEec
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFM 679 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~--~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~--~~~~~LV~E~~ 679 (929)
..++|++|.||.||+|+++ +++.||+|+++..... -.-...+|+.+|.+++|||||.+-.+... -+..++|||||
T Consensus 80 ~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~ 159 (419)
T KOG0663|consen 80 KLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV 159 (419)
T ss_pred HHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH
Confidence 5578999999999999987 6788999999755321 12345789999999999999999887754 45789999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
+. +|...+... .+++...++..++.|+++|++|||.+ .|+|||||++|+|+.+.|.+||+|||+|+.+.....
T Consensus 160 Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 160 EH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred Hh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 86 788887643 36788889999999999999999999 999999999999999999999999999997765533
Q ss_pred ceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc-CCcc-cccC-
Q 002382 760 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES-GDIQ-GIID- 835 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~-~~~~-~~~d- 835 (929)
..+..+-|.+|+|||++.+ ..|+.+.|+||+|||+.||+++++.|.+... ..++-..+...-.. +.+. ..-.
T Consensus 233 -~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE---~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 233 -PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE---IDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred -cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch---HHHHHHHHHHhCCCccccCCCcccc
Confidence 3344557999999999987 4689999999999999999999999976552 12222222221100 0000 0000
Q ss_pred -------------CcccCccCHH-HHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 -------------PSLLDEYDIQ-SMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 -------------~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..++..+... ....-.++....+..||++|.|++|.+++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0111122111 12355688889999999999999999876
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=331.99 Aligned_cols=199 Identities=26% Similarity=0.368 Sum_probs=171.2
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.+.+.||+|+||+||+++.. +++.||||+++... ......+.+|+.++.+++||||+++++.+.+....++||||+
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL 83 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence 35678999999999999876 58899999997542 222356788999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 84 PGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999998853 45688999999999999999999998 999999999999999999999999999874322100
Q ss_pred ----------------------------------ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCC
Q 002382 760 ----------------------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 805 (929)
Q Consensus 760 ----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~ 805 (929)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012346999999999999999999999999999999999999999
Q ss_pred cccc
Q 002382 806 SNEK 809 (929)
Q Consensus 806 ~~~~ 809 (929)
....
T Consensus 237 ~~~~ 240 (363)
T cd05628 237 CSET 240 (363)
T ss_pred CCCC
Confidence 7654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=313.88 Aligned_cols=246 Identities=28% Similarity=0.418 Sum_probs=195.1
Q ss_pred cccccCcEEEEEEEEC---CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 608 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 608 ~IG~G~fG~Vy~~~~~---~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
.||+|+||.||+|.++ +++.+|+|+++... ....+++.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999753 57889999986443 2235678899999999999999999998864 5678999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99998843 34678899999999999999999998 999999999999999999999999999986544332211
Q ss_pred --eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 763 --SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 763 --~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
....++..|+|||.+....++.++|+|||||++|||++ |+.||..... ..+.+.. ..+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~i----~~~~~~~------- 218 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEVTQMI----ESGERME------- 218 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH----HCCCCCC-------
Confidence 12234578999999988888999999999999999998 9999975431 1222221 1111111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
.+......+.+++.+|++.+|++||++.+|++.|++.
T Consensus 219 --~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 --CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred --CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1112234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=325.87 Aligned_cols=242 Identities=26% Similarity=0.365 Sum_probs=191.2
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||.||+|+++ +++.||+|+++... ......+..|..++... +||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999887 57899999997542 12234566777777654 899999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 999988743 34678889999999999999999998 99999999999999999999999999987432221 22
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.+.. +. +.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~----~~~~~~~~----~~------~~~~~- 217 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----ELFESIRV----DT------PHYPR- 217 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHh----CC------CCCCC-
Confidence 33456899999999999999999999999999999999999999754411 22221111 00 01111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHH-HHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~-eVl~~ 874 (929)
.....+.+++.+|++.||++||++. ++.+|
T Consensus 218 ---~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 218 ---WITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred ---CCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 1223577899999999999999984 66544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=344.38 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=201.9
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecC--------
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-------- 670 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~-------- 670 (929)
.|.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++..++|+||+++++.+...+
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 5667889999999999999865 68999999987543 233456888999999999999999988775432
Q ss_pred eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecC
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 750 (929)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 36799999999999999976544556788999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCC-CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 751 SKFAVDGA-SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 751 a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ... .+.
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~----~~~~---~~~-~~~ 261 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME----EVMH---KTL-AGR 261 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHH---HHh-cCC
Confidence 98654322 12233456999999999999999999999999999999999999999754411 1111 111 111
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... .+......+.+++.+|++.+|++||++.+++++
T Consensus 262 ~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 110 111223468899999999999999999999865
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=315.21 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=200.0
Q ss_pred HHhccccccCcEEEEEEEECC----CcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCe------
Q 002382 604 MLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------ 671 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~----~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~------ 671 (929)
.+.+.||+|+||.||+|.+.. +..||+|+++... ......+.+|++.++.++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 356889999999999998752 3679999987542 2234578899999999999999999998866554
Q ss_pred EEEEEEeccCCchhhhhccccc--cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeec
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 749 (929)
.++++||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence 7999999999999998854321 234688899999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCce-eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhc
Q 002382 750 LSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIES 827 (929)
Q Consensus 750 la~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 827 (929)
+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+.++...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~----~~~~~~~~~---- 230 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----HEIYDYLRH---- 230 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHc----
Confidence 998654332221 122335678999999988889999999999999999999 8888865431 122222211
Q ss_pred CCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 828 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 828 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
+.... .+......+.+++.+|++.+|++||++.||++.|+++
T Consensus 231 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11110 1112344688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=326.74 Aligned_cols=237 Identities=28% Similarity=0.355 Sum_probs=187.2
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHH-HhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~-iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||+||+|+.. +++.||||++..... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999986 688999999875421 22234444544 56789999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999988843 44678888999999999999999998 99999999999999999999999999987432221 22
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... +.. .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~-~~~------~~~~~ 218 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY-------DNILN-KPL------RLKPN 218 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH-------HHHHc-CCC------CCCCC
Confidence 23456899999999999999999999999999999999999999754421111 11111 110 11111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSIS 869 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 869 (929)
. ...+.+++.+|++.+|++||++.
T Consensus 219 ~----~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 I----SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C----CHHHHHHHHHHhhcCHHhCCCCC
Confidence 1 34578999999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.72 Aligned_cols=258 Identities=26% Similarity=0.377 Sum_probs=207.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 456788999999999999987 78999999886432 23356788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++.........+++.+++.++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999998865444456688999999999999999999998 99999999999999999999999999987544322
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.. .....++..|+|||.+.+..++.++|||||||++|||++|+.||.... .++.+.... ...+....
T Consensus 161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~-~~~~~~~~------ 227 (267)
T cd08224 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKK-IEKCDYPP------ 227 (267)
T ss_pred cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-----ccHHHHHhh-hhcCCCCC------
Confidence 21 223458899999999998889999999999999999999999986443 112221111 11111111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
.........+.+++.+|+..+|++||++.+|++.|+++
T Consensus 228 --~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 --LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 00112334688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=333.24 Aligned_cols=263 Identities=24% Similarity=0.401 Sum_probs=203.8
Q ss_pred HHHHHHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCcc-hhHHHHHHHHHhcccC-CCceeEEeeeeeec
Q 002382 598 IEDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIH-HRNLVQFLGYCQEE 669 (929)
Q Consensus 598 i~~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~~-~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~ 669 (929)
+....+.+.+.||+|+||.||+|++. .++.||||+++..... ..+.+.+|+++|.++. ||||++++++|...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34445557789999999999999864 2467999999754322 2346889999999997 99999999999999
Q ss_pred CeEEEEEEeccCCchhhhhccccc--------------------------------------------------------
Q 002382 670 GRSVLVYEFMHNGTLKEHLYGTLT-------------------------------------------------------- 693 (929)
Q Consensus 670 ~~~~LV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 693 (929)
+..++|+||+++|+|.++++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999999864311
Q ss_pred --------------------------------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCe
Q 002382 694 --------------------------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 735 (929)
Q Consensus 694 --------------------------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NI 735 (929)
....+++..++.++.|++.||+|||+. +++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 112366778889999999999999998 999999999999
Q ss_pred EecCCCcEEEEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCcccccccc
Q 002382 736 LLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGAN 813 (929)
Q Consensus 736 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~ 813 (929)
|+++++.+||+|||+++........ ......++..|+|||.+....++.++|||||||++|||++ |..||......+
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~- 349 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE- 349 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-
Confidence 9999999999999999754332211 1122346788999999998889999999999999999998 888986543111
Q ss_pred chhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 814 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
.+.. ....+.. ...+......+.+++.+|+..+|++||+++||++.|++++
T Consensus 350 --~~~~----~~~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 --QFYN----AIKRGYR---------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --HHHH----HHHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111 1111110 0011112346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=318.41 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=199.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|...+.||+|+||+||++... +++.||||++..... .....+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 345678999999999999876 688999999875432 2234577899999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 82 MNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999888542 234588999999999999999999998 99999999999999999999999999987643322
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
. .....|++.|+|||++.+..++.++||||+||++|||++|+.||...........+.. ......
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~----~~~~~~--------- 221 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER----RVKEDQ--------- 221 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH----Hhhhcc---------
Confidence 1 1233589999999999988899999999999999999999999976442111111111 111110
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
..+.......+.+++.+|++.||++|| ++++++++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111122334678999999999999999 88888776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=327.57 Aligned_cols=238 Identities=26% Similarity=0.344 Sum_probs=191.0
Q ss_pred ccccccCcEEEEEEEE----CCCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 607 KKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~----~~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
+.||+|+||.||+++. .+++.+|+|++..... .....+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 2578999999975432 233457789999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+|+|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999988843 34688999999999999999999998 999999999999999999999999999875433222
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..... .. ....
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----~~~~~---i~-~~~~---------- 215 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK----ETMTM---IL-KAKL---------- 215 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH----HHHHH---HH-cCCC----------
Confidence 223456899999999999888999999999999999999999999754311 11111 11 1111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISE 870 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e 870 (929)
..+......+.+++.+|++.+|++||++.+
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 011112235779999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=314.49 Aligned_cols=256 Identities=26% Similarity=0.452 Sum_probs=205.6
Q ss_pred HHHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
....+.+.+.||+|+||.||+|..++++.+|||.+..... ..+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 3445667889999999999999988888999999875433 356789999999999999999999999998999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++... ....+++..+..++.|++.||+|||++ +++|+||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999998653 234688999999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
........++..|+|||.+.+..++.++|+|||||++|||++ |+.||..... ....+...... ..
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~~~~~~~~---~~------- 223 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN----REVLEQVERGY---RM------- 223 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCC---CC-------
Confidence 221222234678999999998889999999999999999998 9999965431 11222111110 00
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
..+......+.+++.+|++.+|++||+++|+.+.|+.
T Consensus 224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 ---PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011113468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=326.10 Aligned_cols=264 Identities=24% Similarity=0.427 Sum_probs=206.0
Q ss_pred HHHHHHHHhccccccCcEEEEEEEEC--------CCcEEEEEEeecCC-cchhHHHHHHHHHhccc-CCCceeEEeeeee
Q 002382 598 IEDATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ 667 (929)
Q Consensus 598 i~~~~~~~~~~IG~G~fG~Vy~~~~~--------~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~ 667 (929)
+...++.+.+.||+|+||.||+++.. .+..||+|+++... ....+++.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 34456778899999999999999753 12368999887543 23356789999999999 7999999999999
Q ss_pred ecCeEEEEEEeccCCchhhhhcccc------------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCe
Q 002382 668 EEGRSVLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 735 (929)
Q Consensus 668 ~~~~~~LV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NI 735 (929)
..+..++++||+.+|+|.+++.... .....+++..++.++.|+++||+|||++ +++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence 9999999999999999999986431 1234578889999999999999999998 999999999999
Q ss_pred EecCCCcEEEEeecCcccccCCCCce-eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCcccccccc
Q 002382 736 LLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGAN 813 (929)
Q Consensus 736 Ll~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~ 813 (929)
+++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 243 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 243 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence 99999999999999987554322111 112224567999999999999999999999999999998 88888654311
Q ss_pred chhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 814 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
.+.... ..+.... ........+.+++.+|++.+|++||++.|+++.|+++...
T Consensus 244 --~~~~~~----~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 244 --ELFKLL----KEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred --HHHHHH----HcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 111111 1111100 1112234688999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=333.42 Aligned_cols=249 Identities=21% Similarity=0.265 Sum_probs=190.7
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.+.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++.+.+.+..++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 34678999999999999876 57889999987542 223456888999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC-
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA- 758 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~- 758 (929)
++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 84 PGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999998853 34578888889999999999999998 99999999999999999999999999975221000
Q ss_pred ---------------------------------------------CceeeeeecCccccCccccccCcCCCcCceeeHHH
Q 002382 759 ---------------------------------------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGV 793 (929)
Q Consensus 759 ---------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGv 793 (929)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012246899999999999999999999999999
Q ss_pred HHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCc---HHH
Q 002382 794 ILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISE 870 (929)
Q Consensus 794 vl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~e 870 (929)
++|||++|+.||......+....+..|... ... + ...... ..+.+++.+|+ .+|++|++ +.|
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~----~~~-----p-~~~~~s----~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTS----LHI-----P-PQAKLS----PEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCCC----cCC-----C-CcccCC----HHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 999999999999765422111122211000 000 0 001112 24556666655 49999997 888
Q ss_pred HHHH
Q 002382 871 VLKD 874 (929)
Q Consensus 871 Vl~~ 874 (929)
+++|
T Consensus 302 i~~h 305 (382)
T cd05625 302 IKAH 305 (382)
T ss_pred HhcC
Confidence 8775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=333.26 Aligned_cols=249 Identities=25% Similarity=0.318 Sum_probs=193.6
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.+.+.||+|+||+||+++.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 83 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL 83 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence 45688999999999999876 68899999986532 223456788999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 84 PGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999998853 34578888889999999999999998 999999999999999999999999999863211000
Q ss_pred ------------c----------------------------------eeeeeecCccccCccccccCcCCCcCceeeHHH
Q 002382 760 ------------H----------------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGV 793 (929)
Q Consensus 760 ------------~----------------------------------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGv 793 (929)
. ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001245999999999999999999999999999
Q ss_pred HHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCC---CCcHHH
Q 002382 794 ILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM---RPSISE 870 (929)
Q Consensus 794 vl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~---RPs~~e 870 (929)
++|||++|+.||......+....+..|... -.+ ... ......+.+++.+|++ +|.+ ||++.|
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~----~~~--------p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRET----LYF--------PDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCc----cCC--------CCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 999999999999754422222222222100 000 000 0112357789999997 6665 469999
Q ss_pred HHHH
Q 002382 871 VLKD 874 (929)
Q Consensus 871 Vl~~ 874 (929)
++++
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 9887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=325.97 Aligned_cols=245 Identities=24% Similarity=0.315 Sum_probs=193.3
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCC-CceeEEeeeeeecCeEEEEEEe
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~H-pNIv~l~g~~~~~~~~~LV~E~ 678 (929)
.+.+.||+|+||.||+|+.+ +++.||||+++... ....+.+..|.+++..++| ++|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 45688999999999999877 46789999997542 2234567789999999866 5688899999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 83 VNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999988843 34578889999999999999999998 99999999999999999999999999986432221
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+. ... .
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~----~~~------~-- 218 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----ELFQSIM----EHN------V-- 218 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHH----cCC------C--
Confidence 1223456999999999999999999999999999999999999999754421 1222111 110 0
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcH-----HHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~eVl~~ 874 (929)
.++......+.+++.+|++.+|++||+. .++.++
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 219 --SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111122457899999999999999976 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.76 Aligned_cols=264 Identities=23% Similarity=0.363 Sum_probs=201.5
Q ss_pred HHHHHhccccccCcEEEEEEEEC-----------------CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-----------------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQF 662 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-----------------~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l 662 (929)
..+.+.+.||+|+||.||++... +...+|+|+++... .....++.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 34567789999999999998543 23468999987543 3345678999999999999999999
Q ss_pred eeeeeecCeEEEEEEeccCCchhhhhccccc-------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCe
Q 002382 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 735 (929)
Q Consensus 663 ~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NI 735 (929)
++++...+..++||||+.+++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999865321 123477888999999999999999998 999999999999
Q ss_pred EecCCCcEEEEeecCcccccCCCCce-eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh--CCCCCccccccc
Q 002382 736 LLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGA 812 (929)
Q Consensus 736 Ll~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt--G~~p~~~~~~~~ 812 (929)
|++.++.++|+|||+++......... .....++..|++||...++.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999997553332211 122234678999999888889999999999999999998 678886543222
Q ss_pred cchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 813 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 813 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
.......+..... ..... ..+......+.+++.+|++.+|++||++.||++.|++
T Consensus 242 ~~~~~~~~~~~~~----~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VIENTGEFFRDQG----RQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHhhcc----ccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111110 00000 0011223578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=301.12 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=202.3
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
..|.+.+.||+|.|+.||++.+. .|+.+|+|++... ...+.+++.+|+.|.+.++||||+++.+.+.+.+..++|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 45667789999999999999765 6899999988543 34467789999999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC---CcEEEEeecCcccc
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKFA 754 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkL~DFGla~~~ 754 (929)
+|.|++|..-+- .....++..+-..++||+++|.|+|.+ +|||||+||+|+++... --+||+|||+|...
T Consensus 91 ~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 91 LVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred cccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999976653 234567777888999999999999999 99999999999999543 35899999999876
Q ss_pred cCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
. .........|||+|||||++...+|+..+|||+.||+||-|+.|+.||.+.+....++.|.+ +... +
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~--------g~yd--~ 231 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA--------GAYD--Y 231 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc--------cccC--C
Confidence 6 33445567799999999999999999999999999999999999999987553333333322 1110 1
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
++.-. ...-+...+|+.+|+..||++|.|+.|.+.|
T Consensus 232 ~~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 232 PSPEW----DTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CCccc----CcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 11111 1122357799999999999999999998754
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=320.13 Aligned_cols=266 Identities=22% Similarity=0.362 Sum_probs=200.8
Q ss_pred HHHHHHHhccccccCcEEEEEEEECC---------------CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEE
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLKD---------------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQF 662 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~~---------------~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l 662 (929)
....+.+.+.||+|+||.||+++..+ ...||+|+++... ......+.+|++++++++|||++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34556778899999999999987642 2348999987543 2334578999999999999999999
Q ss_pred eeeeeecCeEEEEEEeccCCchhhhhccccc--------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCC
Q 002382 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT--------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734 (929)
Q Consensus 663 ~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~--------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~N 734 (929)
++++...+..++||||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 9999999999999999999999998854211 112467888999999999999999998 99999999999
Q ss_pred eEecCCCcEEEEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh--CCCCCcccccc
Q 002382 735 ILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFG 811 (929)
Q Consensus 735 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt--G~~p~~~~~~~ 811 (929)
|++++++.+||+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999998754332211 1122335678999999998889999999999999999998 55677643321
Q ss_pred ccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 812 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 812 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
.++............. .....+......+.+++.+|++.+|++||+|.+|++.|++
T Consensus 240 ----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 ----QVIENTGEFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ----HHHHHHHHhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1222111111110000 0000111123478999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=319.21 Aligned_cols=262 Identities=26% Similarity=0.390 Sum_probs=199.1
Q ss_pred HHHHhccccccCcEEEEEEEEC-----CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeee--cCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-----~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~--~~~~~L 674 (929)
.+.+.+.||+|+||.||++..+ +++.||+|++........+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 3456688999999999999753 578899999876665556789999999999999999999998754 346899
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
|+||+++++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 85 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 85 VMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999998532 24578999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCce--eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccccc------cc-c-hhhHHHHHHh
Q 002382 755 VDGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG------AN-C-RNIVQWAKLH 824 (929)
Q Consensus 755 ~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~------~~-~-~~l~~~~~~~ 824 (929)
....... .....++..|+|||++.+..++.++|||||||++|||++|..++...... .. . ..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4332211 11122345699999999888999999999999999999998775432200 00 0 0000000011
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
...+ ............+.+++.+|++.+|++|||+.||++.|+.+
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111 00011112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.01 Aligned_cols=247 Identities=27% Similarity=0.436 Sum_probs=195.0
Q ss_pred cccccCcEEEEEEEEC---CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCc
Q 002382 608 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (929)
Q Consensus 608 ~IG~G~fG~Vy~~~~~---~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gs 683 (929)
.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999764 355799999875532 334678999999999999999999998864 57899999999999
Q ss_pred hhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee-
Q 002382 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS- 762 (929)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~- 762 (929)
|.+++... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99988532 34688999999999999999999998 999999999999999999999999999975433322211
Q ss_pred -eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 763 -SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 763 -~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
....++..|+|||.+....++.++|||||||++||+++ |..||...... .+... ...+.. .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~----~~~~~~---------~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----EVMSF----IEQGKR---------L 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHH----HHCCCC---------C
Confidence 11223578999999988889999999999999999996 99999754411 11111 111111 1
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
..+.....++.+++.+|++.+|++||++.+|++.|+..
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11222345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=325.01 Aligned_cols=242 Identities=26% Similarity=0.363 Sum_probs=193.9
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||+||+|+++ +++.||||+++... ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999887 47899999997542 22345567888888877 799999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 999888743 34688999999999999999999998 99999999999999999999999999986432221 12
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+ ..... .
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~----~~~~~i----~~~~~----------~ 214 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED----ELFQSI----LEDEV----------R 214 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH----HHHHHH----HcCCC----------C
Confidence 23346899999999999999999999999999999999999999754411 111111 11110 0
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcH-----HHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~eVl~~ 874 (929)
++......+.+++.+|++.+|++||++ .+++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 111123467899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=322.77 Aligned_cols=262 Identities=24% Similarity=0.433 Sum_probs=205.3
Q ss_pred HHHHHHhccccccCcEEEEEEEEC--------CCcEEEEEEeecCC-cchhHHHHHHHHHhccc-CCCceeEEeeeeeec
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE 669 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~--------~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~ 669 (929)
...+.+.+.||+|+||.||+++.. +...+|+|+++... .....++.+|+++++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 456778899999999999999763 23569999987543 23345688899999999 799999999999999
Q ss_pred CeEEEEEEeccCCchhhhhccccc------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe
Q 002382 670 GRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 737 (929)
Q Consensus 670 ~~~~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl 737 (929)
+..++||||+.+|+|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999965321 224588899999999999999999998 99999999999999
Q ss_pred cCCCcEEEEeecCcccccCCCCce-eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccch
Q 002382 738 DKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCR 815 (929)
Q Consensus 738 ~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~ 815 (929)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 999999999999987543221111 111224568999999998889999999999999999998 88888654311
Q ss_pred hhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 816 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 816 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
.+... ...+... ..+......+.+++.+|++.+|++||+|.||++.|++++..
T Consensus 250 ~~~~~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 ELFKL----LKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHH----HHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11111 1111110 11112234678899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=317.61 Aligned_cols=261 Identities=25% Similarity=0.365 Sum_probs=206.6
Q ss_pred HHHHHHhccccccCcEEEEEEEECC-----CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeee-cCeE
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRS 672 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~-~~~~ 672 (929)
...+.+.+.||+|+||.||+|.+.+ ++.|++|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4456677899999999999999875 6889999887543 3335668899999999999999999998766 5678
Q ss_pred EEEEEeccCCchhhhhcccccc----ccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEee
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTH----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 748 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 748 (929)
++++||+.+++|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998543221 25688999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCce-eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhh
Q 002382 749 GLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 826 (929)
Q Consensus 749 Gla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 826 (929)
|+++.+....... .....++..|+|||++....++.++|||||||++||+++ |+.||..... ..+..+....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~-- 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP----FEMAAYLKDG-- 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH----HHHHHHHHcC--
Confidence 9998654333221 122346778999999988889999999999999999999 9999975431 1222222211
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 827 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 827 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.... ........+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 236 -~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 236 -YRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -CCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1110 011123468899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.74 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=203.6
Q ss_pred HHHHHhccccccCcEEEEEEEECC-----------------CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLKD-----------------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQF 662 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~~-----------------~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l 662 (929)
..+.+.+.||+|+||.||+|+..+ +..||+|++.... ......+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 345677899999999999997652 2458999987553 2345678899999999999999999
Q ss_pred eeeeeecCeEEEEEEeccCCchhhhhccccc-------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCe
Q 002382 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 735 (929)
Q Consensus 663 ~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NI 735 (929)
++++..++..++++||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 9999999999999999999999999865321 123588999999999999999999998 999999999999
Q ss_pred EecCCCcEEEEeecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh--CCCCCccccccc
Q 002382 736 LLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGA 812 (929)
Q Consensus 736 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt--G~~p~~~~~~~~ 812 (929)
+++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-- 239 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence 999999999999999875433221 12233446788999999998889999999999999999998 6677764431
Q ss_pred cchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 813 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 813 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
..+.+............... ..+.....++.+++.+|++.+|++||++.||++.|+
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 12222222221111111111 111122346899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=316.94 Aligned_cols=257 Identities=25% Similarity=0.422 Sum_probs=203.8
Q ss_pred HHHHHHhccccccCcEEEEEEEECC------CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeE
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~~------~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~ 672 (929)
...+.+.+.||+|+||.||+|..++ ++.||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3455667899999999999998752 3689999986553 23345788999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhhcccccc------ccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEE
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTH------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 746 (929)
++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 9999999999999998653321 23478889999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHh
Q 002382 747 DFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 824 (929)
Q Consensus 747 DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 824 (929)
|||+++....... .......++..|+|||.+.+..++.++|||||||++||+++ |..||..... ..+..+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~~~~~-- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN----EEVLKFVI-- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH----HHHHHHHh--
Confidence 9999875543322 11223346789999999988889999999999999999998 8999865431 12222221
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
.+.... .+......+.+++.+|++.+|++|||+.|+++.|+
T Consensus 236 --~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 --DGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred --cCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111 11112457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=320.42 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=201.2
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCc--EEEEEEeecC-CcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGK--EIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~--~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV 675 (929)
..+.+.+.||+|+||.||+|.++ ++. .+|+|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 34557789999999999999875 344 4577776543 233456788999999999 899999999999999999999
Q ss_pred EEeccCCchhhhhccccc------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcE
Q 002382 676 YEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 743 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 743 (929)
+||+++++|.+++..... ....+++.+++.++.|++.||+|||++ +++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999864321 123578899999999999999999998 99999999999999999999
Q ss_pred EEEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHH
Q 002382 744 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAK 822 (929)
Q Consensus 744 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~ 822 (929)
||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||++ |..||...... ......
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~- 236 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEKL- 236 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH----HHHHHH-
Confidence 999999986321111 1111224678999999988889999999999999999998 99999654311 121111
Q ss_pred HhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 823 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 823 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
..+.. ..........+.+++.+|++.+|++||++.++++.|++++..+
T Consensus 237 ---~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 237 ---PQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred ---hcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11100 0011112345789999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=334.41 Aligned_cols=250 Identities=22% Similarity=0.279 Sum_probs=193.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||.||+++.. +++.||||++.... ......+.+|++++++++||||+++++.+.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 345688999999999999876 58899999986532 12245678899999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC-
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG- 757 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~- 757 (929)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 83 IPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999853 34577888889999999999999998 9999999999999999999999999997422100
Q ss_pred -----------------------------------------CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHH
Q 002382 758 -----------------------------------------ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 796 (929)
Q Consensus 758 -----------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ 796 (929)
.........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000011346999999999999999999999999999999
Q ss_pred HHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCC---cHHHHHH
Q 002382 797 ELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP---SISEVLK 873 (929)
Q Consensus 797 elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP---s~~eVl~ 873 (929)
||++|+.||......+....+..|.. .. . + + .... ....+.+++.+|+ .+|++|+ ++.|+++
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~------~~-~-~-~-~~~~----~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWET------TL-H-I-P-SQAK----LSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCc------cc-c-C-C-CCCC----CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999976542211111111100 00 0 0 0 0011 1234566777765 4999999 8999998
Q ss_pred H
Q 002382 874 D 874 (929)
Q Consensus 874 ~ 874 (929)
+
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.75 Aligned_cols=253 Identities=24% Similarity=0.431 Sum_probs=200.8
Q ss_pred HHHhccccccCcEEEEEEEECC-C---cEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKD-G---KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~-~---~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
+...+.||+|+||.||+|+.+. + ..+|+|.++... ....+++..|++++++++||||+++++++...+..++|||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 3456889999999999998762 3 368999887543 3335678899999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 87 YMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999988532 34678899999999999999999998 9999999999999999999999999998755433
Q ss_pred CCceee--eeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 758 ASHVSS--IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 758 ~~~~~~--~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
...... ....+..|+|||++....++.++|||||||++|||++ |+.||..... ..+...+. .....
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----~~~~~~i~---~~~~~---- 229 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----HEVMKAIN---DGFRL---- 229 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHHHHHh---cCCCC----
Confidence 222111 1223457999999998889999999999999999997 9999965431 11222111 11111
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
.........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 230 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 ------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.81 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=197.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCc----EEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~----~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
+.+.+.||+|+||+||+|.+. +++ .+++|.+..... ....++..|+..+++++||||+++++++.. ...++++
T Consensus 9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~ 87 (279)
T cd05111 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVT 87 (279)
T ss_pred ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEE
Confidence 345688999999999999875 344 477787754322 223567888889999999999999998864 4578899
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++|+|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++....
T Consensus 88 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 88 QLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999998532 34688999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 757 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 757 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
.... ......++..|+|||.+.++.++.++|||||||++|||++ |+.||...... .+.+. ...+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~----~~~~~~~~-- 231 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPDL----LEKGERLA-- 231 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH----HHCCCcCC--
Confidence 3221 2233457789999999998899999999999999999998 99998754311 11221 11221111
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.+. . ....+.+++.+|+..+|++||++.|+++.|+.+..
T Consensus 232 ~~~---~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQ---I----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCC---C----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111 1 12356788999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=321.43 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=194.2
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||+||+++.. +++.||+|+++.... ...+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 578899999986422 2335577899998888 699999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|..++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 99988874 234688999999999999999999998 99999999999999999999999999987432221 22
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+.......... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~----------~ 221 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYLFQVILEKPI----------R 221 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHHHHHHHhCCC----------C
Confidence 2345699999999999999999999999999999999999999964321111 1111222222211111 0
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCc------HHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPS------ISEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs------~~eVl~~ 874 (929)
.+......+.+++.+|++.||++||+ +.++.+|
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11112235779999999999999998 4577665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=338.85 Aligned_cols=263 Identities=22% Similarity=0.268 Sum_probs=192.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeec--------CeE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--------GRS 672 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~--------~~~ 672 (929)
.|.+.+.||+|+||.||+|... .++.||||++.... ....+|+.+++.++||||+++++++... ...
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 3556789999999999999876 57899999886432 2345799999999999999999876432 246
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC-cEEEEeecCc
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLS 751 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla 751 (929)
++||||+++ +|.+++.........+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+|
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 789999975 67776654434456788999999999999999999998 999999999999999665 7999999999
Q ss_pred ccccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh------
Q 002382 752 KFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH------ 824 (929)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~------ 824 (929)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|.+||......+....+.+.....
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 86543322 223457999999999876 468999999999999999999999997654222221222111000
Q ss_pred -----hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 825 -----IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 825 -----~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...-.+..+....+...++......+.+++.+|++.+|++|||+.|+++|
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000001111111111111223468899999999999999999999876
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.90 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=196.6
Q ss_pred HhccccccCcEEEEEEEECCCc---EEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeec------CeEE
Q 002382 605 LEKKIGSGGFGVVYYGKLKDGK---EIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 673 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~~~~---~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~------~~~~ 673 (929)
+.+.||+|+||.||+|++.+.. .+|+|.++... ....+.+.+|+++++.++||||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 4678999999999999886432 58999886542 33356788999999999999999999987432 2468
Q ss_pred EEEEeccCCchhhhhcccc--ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCc
Q 002382 674 LVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 751 (929)
+++||+.+|+|.+++.... .....+++.....++.|++.||+|||++ +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999998874221 1234578999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCce-eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 752 KFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 752 ~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
+......... .....+++.|+|||+..+..++.++|||||||++|||++ |+.||..... ..+... ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~----~~~~~ 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----SEIYDY----LRQGN 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH----HHcCC
Confidence 8654332211 122345778999999998899999999999999999999 7888865331 112221 11121
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
... ........+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 0112234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=329.57 Aligned_cols=253 Identities=22% Similarity=0.262 Sum_probs=196.2
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
..+.+.+.||+|+||.||+++++ +++.+|+|++.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 45566789999999999999987 57889999986432 223455788999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++|+|.+++.. ..++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 123 Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 123 EYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 99999999998843 3467788889999999999999998 999999999999999999999999999986543
Q ss_pred CCCceeeeeecCccccCccccccC----cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
..........||+.|+|||++... .++.++|||||||++|||++|+.||......... ...........
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~~~~~ 267 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-------SKIMNHKNSLT 267 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCCCccc
Confidence 333233445699999999998754 3788999999999999999999999765421111 11111111000
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCC--CCcHHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKDI 875 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~eVl~~L 875 (929)
..+ .......+.+++.+|++..+.+ ||++.|++++.
T Consensus 268 ~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 268 FPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 000 0112345778899999844433 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=320.61 Aligned_cols=265 Identities=23% Similarity=0.429 Sum_probs=207.3
Q ss_pred HHHHHHHHhccccccCcEEEEEEEEC--------CCcEEEEEEeecCC-cchhHHHHHHHHHhccc-CCCceeEEeeeee
Q 002382 598 IEDATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ 667 (929)
Q Consensus 598 i~~~~~~~~~~IG~G~fG~Vy~~~~~--------~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~ 667 (929)
+....+.+.+.||+|+||.||+|++. ++..||+|++.... ....+++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 33455667899999999999999742 24579999886542 33456788999999999 8999999999999
Q ss_pred ecCeEEEEEEeccCCchhhhhccccc------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCe
Q 002382 668 EEGRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 735 (929)
Q Consensus 668 ~~~~~~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NI 735 (929)
..+..++||||+.+|+|.+++..... ....+++..++.++.|+++||+|||++ +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999865321 124578889999999999999999998 999999999999
Q ss_pred EecCCCcEEEEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCcccccccc
Q 002382 736 LLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGAN 813 (929)
Q Consensus 736 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~ 813 (929)
+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-- 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 246 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence 9999999999999999865432222 1222345678999999988889999999999999999998 78888654311
Q ss_pred chhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 814 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
.+... ...+... ..+......+.+++.+|++.+|++||++.||++.|++++...
T Consensus 247 --~~~~~----~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 247 --ELFKL----LKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred --HHHHH----HHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11111 1111100 011123356889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=311.36 Aligned_cols=254 Identities=20% Similarity=0.320 Sum_probs=199.5
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
..|.+.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 34667789999999999999875 67889999997654445567889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999998843 34578889999999999999999998 999999999999999999999999999975532221
Q ss_pred ceeeeeecCccccCccccc---cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 760 HVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
......|+..|+|||.+. ...++.++|||||||++|||++|+.||......+. ...+ ..... ..+
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~---~~~~-----~~~~~---~~~ 229 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLM-----SKSNF---QPP 229 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh---heee-----ecCCC---CCC
Confidence 112345889999999884 34577899999999999999999999864331110 0000 00000 001
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
.... .......+.+++.+|++.+|++||++++++++|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1111 111234688999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=329.60 Aligned_cols=245 Identities=26% Similarity=0.390 Sum_probs=200.9
Q ss_pred cccccCcEEEEEEEECC-CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCchhh
Q 002382 608 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 686 (929)
Q Consensus 608 ~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 686 (929)
+||+|.||+||.|++.+ ...+|||-+........+.+.+|+.+.++++|+|||+++|.|.+.+..-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999875 45789999987766667788999999999999999999999999999999999999999999
Q ss_pred hhcccccccccc--chHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec-CCCcEEEEeecCcccccCCCCceee
Q 002382 687 HLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSS 763 (929)
Q Consensus 687 ~L~~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~ 763 (929)
+|+.. -+++ ++.+.--+..||++||.|||++ .|||||||-+||||+ -.|.+||+|||.++.... ......
T Consensus 662 LLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TE 734 (1226)
T KOG4279|consen 662 LLRSK---WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTE 734 (1226)
T ss_pred HHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccc
Confidence 99753 3344 5667778899999999999999 999999999999996 468999999999986532 334456
Q ss_pred eeecCccccCccccccC--cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 764 IVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 764 ~~~gt~~Y~aPE~~~~~--~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
+..||..|||||++..+ .|..++|||||||.+.||.||++||.....+....--+...+. .+.
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKv---------------HP~ 799 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKV---------------HPP 799 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceec---------------CCC
Confidence 67799999999999754 6889999999999999999999999765533221111111111 123
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+.+...+...++.+|+.++|.+||++.++++.
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 344555678899999999999999999999864
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=325.20 Aligned_cols=240 Identities=26% Similarity=0.325 Sum_probs=187.5
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHH-HHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEV-TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev-~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||+||+|++. +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999887 56789999987532 12223344444 456788999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++.. ...+.+..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 999988843 34567788888999999999999998 99999999999999999999999999987433222 12
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +..... . ... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~---~-~~~------~~~~- 217 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNIL---N-KPL------QLKP- 217 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH----HHHHHH---h-CCc------CCCC-
Confidence 234569999999999999999999999999999999999999997544221 111111 1 110 0111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVL 872 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl 872 (929)
.....+.+++.+|++.+|.+||++.+..
T Consensus 218 ---~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 218 ---NITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred ---CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 1223578999999999999999877433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.69 Aligned_cols=255 Identities=23% Similarity=0.396 Sum_probs=203.8
Q ss_pred HHHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
....+.+.+.||+|+||.||++...++..+|+|.++... .....+.+|++++++++|+||+++++.+.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 345566789999999999999998878889999887543 235678899999999999999999999887 778999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999998643 234578888999999999999999998 99999999999999999999999999987554332
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
........++..|+|||++....++.++|+|||||++||+++ |+.||..... ..+..+.. .+....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~~----~~~~~~----- 223 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRALE----RGYRMP----- 223 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHh----CCCCCC-----
Confidence 222222345678999999998889999999999999999999 8999875431 12222211 111100
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=317.02 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=199.3
Q ss_pred HHHHhccccccCcEEEEEEEECC------CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~------~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
.+.+.+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (277)
T cd05036 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI 86 (277)
T ss_pred HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEE
Confidence 34567899999999999998763 4678999876543 3334678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhccccc---cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC---cEEEEee
Q 002382 675 VYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDF 748 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkL~DF 748 (929)
||||+++++|.+++..... ....+++..++.++.||+.||+|||++ +++||||||+||+++.++ .+||+||
T Consensus 87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccC
Confidence 9999999999999864321 123588999999999999999999998 999999999999998764 5999999
Q ss_pred cCcccccCCCCce-eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhh
Q 002382 749 GLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 826 (929)
Q Consensus 749 Gla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 826 (929)
|+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||.....+ .+...+. .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~----~~~~~~~---~ 236 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----EVMEFVT---G 236 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHH---c
Confidence 9998653222111 112223568999999998999999999999999999997 99999754421 1222111 1
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 827 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 827 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
.... ..+......+.+++.+|++.+|++||++.||+++|+
T Consensus 237 ~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 GGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1110 111122346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=317.50 Aligned_cols=255 Identities=25% Similarity=0.424 Sum_probs=201.5
Q ss_pred HHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
.+.+.++||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++...+..+++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 3445789999999999999642 3567899988766555567899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhccccc-----------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEE
Q 002382 676 YEFMHNGTLKEHLYGTLT-----------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 744 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 744 (929)
+||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEE
Confidence 999999999999864321 113578899999999999999999998 999999999999999999999
Q ss_pred EEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHH
Q 002382 745 VSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAK 822 (929)
Q Consensus 745 L~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~ 822 (929)
|+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||...... ...+...
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~~~ 238 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT----EAIECIT 238 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH----HHHHHHH
Confidence 9999998754332211 1122335788999999999999999999999999999998 89998654311 1111111
Q ss_pred HhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 823 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 823 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
.+... ..+......+.+++.+|++.+|++||++.||++.|+
T Consensus 239 ----~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 ----QGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----cCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11100 001112345789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=323.24 Aligned_cols=245 Identities=24% Similarity=0.303 Sum_probs=193.5
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEe
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
.+.+.||+|+||.||+|+.. +++.||||+++.... .....+..|..++..+ +|++|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 45678999999999999877 577999999975422 2234566777887777 689999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 83 VNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999888743 34578889999999999999999998 99999999999999999999999999987432221
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+.+.. ...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~----~~~-------- 218 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIME----HNV-------- 218 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH----HHHHHHHHh----CCC--------
Confidence 122345689999999999999999999999999999999999999976442 122221111 110
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcH-----HHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~eVl~~ 874 (929)
.++......+.+++.+|++.+|++|++. .++.++
T Consensus 219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 219 --AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred --CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 1111223467899999999999999984 666554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.16 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=197.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-----chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-----~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
+.+.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|++++++++||||+++++++...+..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 345789999999999999875 588999999864421 12346888999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+++....
T Consensus 84 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 84 EYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999998843 34578888899999999999999998 999999999999999999999999999875433
Q ss_pred CCCcee--eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 757 GASHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 757 ~~~~~~--~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
...... ....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... .. .. ......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~-~~---~~~~~~----- 224 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA---AI-FK---IATQPT----- 224 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH---HH-HH---HhccCC-----
Confidence 221111 23457889999999999889999999999999999999999996543111 11 11 111100
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....+......+.+++.+|+..+|++||++.|++++
T Consensus 225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 ----NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011112233467899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.86 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=200.6
Q ss_pred HHHhccccccCcEEEEEEEECC-Cc--EEEEEEeecC-CcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~-~~--~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
+.+.+.||+|+||.||+|..++ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|+|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 4567899999999999998764 33 4788887643 233456788999999999 79999999999999999999999
Q ss_pred eccCCchhhhhccccc------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEE
Q 002382 678 FMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 745 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL 745 (929)
|+++++|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 9999999999854321 123578899999999999999999998 9999999999999999999999
Q ss_pred EeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHh
Q 002382 746 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 824 (929)
Q Consensus 746 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 824 (929)
+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||..... .++.+.
T Consensus 161 ~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~----~~~~~~---- 230 (297)
T cd05089 161 ADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC----AELYEK---- 230 (297)
T ss_pred CCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH----
Confidence 999998632211 01111223567999999998889999999999999999997 9999975442 122221
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
...+. ....+......+.+++.+|++.+|.+||++.++++.|++++...
T Consensus 231 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 LPQGY---------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11110 00011112346789999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=324.46 Aligned_cols=237 Identities=27% Similarity=0.347 Sum_probs=186.3
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHH-HHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEV-TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev-~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||.||+|+.. +++.||+|++..... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999986 578999999875421 2233445554 467889999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|..++. ....+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 99988774 245677888889999999999999998 99999999999999999999999999987432221 22
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+. .. .... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~---i~-~~~~----------~ 214 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS----QMYDN---IL-HKPL----------Q 214 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH----HHHHH---Hh-cCCC----------C
Confidence 23456899999999999889999999999999999999999999754411 11111 11 1110 1
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSIS 869 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 869 (929)
.+......+.+++.+|++.+|++||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1112234678999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=308.16 Aligned_cols=248 Identities=24% Similarity=0.387 Sum_probs=201.5
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.+.+.||+|++|.||+|+.+ +++.|++|.+... .......+.+|++++++++||||+++++++...+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 35678999999999999886 6889999998643 23345678899999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 83 NGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 99999998643 235688889999999999999999998 999999999999999999999999999876543322
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
......|++.|+|||+..+..++.++|+|||||++|||++|+.||..... ..+...+ ..+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~----~~~~~~~-------- 220 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----GALILKI----IRGVFPP-------- 220 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH----HcCCCCC--------
Confidence 22334588999999999998899999999999999999999999975441 1111211 1111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
........+.+++.+|++.+|++||++.|++++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 -VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111223468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=312.50 Aligned_cols=251 Identities=27% Similarity=0.451 Sum_probs=196.0
Q ss_pred ccccccCcEEEEEEEECC-Cc--EEEEEEeecCC-cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~-~~--~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||.||+|++++ +. .+++|.++... ......+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998864 33 46888876432 33456788999999999 899999999999999999999999999
Q ss_pred Cchhhhhcccc------------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeec
Q 002382 682 GTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (929)
Q Consensus 682 gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 749 (929)
|+|.+++.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1123578899999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcC
Q 002382 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG 828 (929)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 828 (929)
++...... ........+..|+|||++....++.++|||||||++|||++ |..||...... ...+.. ..+
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~~----~~~ 227 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEKL----PQG 227 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH----HHHHHH----hCC
Confidence 98532111 11111224567999999988889999999999999999997 99999654311 122211 111
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 829 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
... .........+.+++.+|++.+|.+||++.|+++.|++++
T Consensus 228 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 011112346789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=325.76 Aligned_cols=238 Identities=28% Similarity=0.355 Sum_probs=187.8
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHH-HhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~-iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||+||+|+.. +|+.+|+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999876 68899999987542 222344555554 56778999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|..++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 99988874 345688999999999999999999998 99999999999999999999999999987432221 22
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +.+ .... ..+ .+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----~~~---~~~~-~~~------~~~~~ 218 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE----MYD---NILH-KPL------VLRPG 218 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH----HHH---HHHc-CCc------cCCCC
Confidence 234568999999999999999999999999999999999999997544211 111 1111 111 01111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISE 870 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~e 870 (929)
....+.+++.+|++.+|++||++.+
T Consensus 219 ----~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 219 ----ASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred ----CCHHHHHHHHHHhccCHHhcCCCCC
Confidence 2235778999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=322.54 Aligned_cols=251 Identities=28% Similarity=0.398 Sum_probs=209.6
Q ss_pred HHHHHHhccccccCcEEEEEEEECC-CcEEEEEEeecCCcch---hHHHHHHHHHhcccC-CCceeEEeeeeeecCeEEE
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG---KREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~~~---~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~L 674 (929)
...|.+.+.||+|.||.||+++.+. |+.+|+|++.+..... ...+.+|+++|+++. ||||+.+.+++++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3456667899999999999999885 9999999998765433 358899999999998 9999999999999999999
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC----CcEEEEeecC
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFGL 750 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~----~~vkL~DFGl 750 (929)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+. +|+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999998644 288999999999999999999998 99999999999999643 5799999999
Q ss_pred cccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCc
Q 002382 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 830 (929)
|..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||......+....+ ..+++
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i--------~~~~~ 255 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI--------LRGDF 255 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH--------HcCCC
Confidence 987665 44556678999999999999999999999999999999999999999876633322211 12222
Q ss_pred ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.....+-...-..+.+++..|+..||.+|+++.++++|
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11112222233467899999999999999999999996
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=311.93 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=192.9
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 609 IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
||+|+||.||+++.+ +|+.+|+|++.... ....+.+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999876 58999999986432 12234566799999999999999999999999999999999999999
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeee
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (929)
.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 9887532 234578888999999999999999998 99999999999999999999999999987554322 2233
Q ss_pred eecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCH
Q 002382 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844 (929)
Q Consensus 765 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 844 (929)
..|+..|+|||++.+..++.++||||+||++|||++|+.||...........+. .... ..... . ....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~---~~~~-~~~~~----~-~~~~--- 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK---RRTL-EDEVK----F-EHQN--- 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH---HHhh-ccccc----c-cccc---
Confidence 458999999999998889999999999999999999999997533111111111 1111 11110 0 0011
Q ss_pred HHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 845 QSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 845 ~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
...++.+++.+|++.+|++||++.|+++.+
T Consensus 222 -~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 -FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred -CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 223578999999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.07 Aligned_cols=254 Identities=26% Similarity=0.477 Sum_probs=201.3
Q ss_pred HHHHhccccccCcEEEEEEEECC-C---cEEEEEEeecC-CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKD-G---KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~-~---~~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
.+.+.+.||+|+||.||+|.+.. + ..||||++... ......+|..|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 35577899999999999998763 3 36999998754 2334567999999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++++|.+++... ...+++.+++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999988542 34578899999999999999999998 999999999999999999999999999875543
Q ss_pred CCCcee--eeee--cCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 757 GASHVS--SIVR--GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 757 ~~~~~~--~~~~--gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
...... .... .+..|+|||++.+..++.++|||||||++|||++ |..||..... ..+..++... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~~~~~i~~~---~~~~ 231 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QDVINAIEQD---YRLP 231 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HHHHHHHHcC---CcCC
Confidence 322111 1111 2457999999999999999999999999999886 9999865431 1233332111 0100
Q ss_pred cccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 832 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 832 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
...+....+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 232 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 232 ----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0112234678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=306.92 Aligned_cols=250 Identities=31% Similarity=0.501 Sum_probs=203.2
Q ss_pred ccccccCcEEEEEEEECC----CcEEEEEEeecCCcch-hHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~----~~~vAVK~l~~~~~~~-~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||.||+|.... +..+++|+++...... .+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998864 7889999997654333 67889999999999999999999999999999999999999
Q ss_pred Cchhhhhcccccc-----ccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 682 GTLKEHLYGTLTH-----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 682 gsL~~~L~~~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
++|.+++...... ...+++..+..++.|+++||+|||++ +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998654211 46789999999999999999999998 999999999999999999999999999986554
Q ss_pred CCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 757 GAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 757 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
... .......++..|+|||.+....++.++|||||||++|||++ |..||..... ..+.+.... +...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~~----~~~~--- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----EEVLEYLRK----GYRL--- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHc----CCCC---
Confidence 321 12233457889999999988889999999999999999999 6999976531 122222111 1100
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
..+......+.+++.+|++.+|++||++.|++++|+
T Consensus 227 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 ------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111122356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=308.68 Aligned_cols=247 Identities=29% Similarity=0.423 Sum_probs=197.1
Q ss_pred ccccccCcEEEEEEEECC----CcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~----~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
++||+|+||.||+|++.. +..+|+|.+..... ...+++.+|+++++.++||||+++++++. .+..++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997642 26899999876543 34567899999999999999999999876 4567999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999998532 3678999999999999999999998 99999999999999999999999999998654433222
Q ss_pred e--eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 762 S--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 762 ~--~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
. ....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+..++... ...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~~~~~----~~~------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAMLESG----ERL------- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHHcC----CcC-------
Confidence 1 11223568999999998899999999999999999998 9999975441 1233322211 100
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
..+......+.+++.+|++.+|++||++.+|++.|+++
T Consensus 218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 01112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.46 Aligned_cols=259 Identities=24% Similarity=0.348 Sum_probs=195.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeee-----cCeEEEEEE
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-----EGRSVLVYE 677 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~-----~~~~~LV~E 677 (929)
.+.||+|+||.|+.+..+ +|+.||||++... .....+...+|+++|+.++|+||+.+.+.+.. -...++|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 478999999999999876 6899999998732 33445677899999999999999999998865 346799999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
+| +.+|...++ .++.+....+.-++.|+++||.|+|+. +|+|||+||+|+|++.+...||+|||+|+.....
T Consensus 107 lM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 107 LM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred HH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecccc
Confidence 99 458887774 345588889999999999999999998 9999999999999999999999999999976432
Q ss_pred -CCceeeeeecCccccCccccc-cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccccc-
Q 002382 758 -ASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII- 834 (929)
Q Consensus 758 -~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~- 834 (929)
.....+....|.+|.|||++. ...|+.+.||||.||++.||++|++-|.+.+.-....-+.+ ......+..+..+-
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~-~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILE-LLGTPSEEDLQKIRS 257 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHH-hcCCCCHHHHHHhcc
Confidence 122334556899999999986 46899999999999999999999999976542111111110 00000000000000
Q ss_pred -------C-------CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 835 -------D-------PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 835 -------d-------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. ......+ .......++|+.+|+..||.+|+|++|.++|
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0000011 1223467899999999999999999999987
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.86 Aligned_cols=250 Identities=30% Similarity=0.534 Sum_probs=200.2
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.+.+.||+|+||.||+|.+.+++.+|+|+++.... ...++.+|++++++++|||++++++++......++|+||++++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 445688999999999999988788999998865433 3467899999999999999999999999999999999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 85 ~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 85 CLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred cHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999988532 24578889999999999999999998 999999999999999999999999999875543222112
Q ss_pred eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
....++.+|+|||++.++.++.++||||||+++|||++ |+.||..... ..+.+.. ..+ .....+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~~~----~~~--~~~~~~~~--- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN----SEVVETI----NAG--FRLYKPRL--- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHH----hCC--CCCCCCCC---
Confidence 22235678999999998889999999999999999998 9999875431 1122211 111 01111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
....+.+++.+|++.+|++||++.|++++|.
T Consensus 226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1246889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=329.17 Aligned_cols=261 Identities=24% Similarity=0.313 Sum_probs=195.1
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeecC-----eEEEEE
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVY 676 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~-----~~~LV~ 676 (929)
+.+.||+|+||.||++... +++.||||++... .....+.+.+|+++++.++||||+++++++...+ ..++|+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 4678999999999999875 6899999998643 2233467889999999999999999999998776 789999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+. ++|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 84 ELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred eccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9996 57777663 245688999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHH---------------
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW--------------- 820 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~--------------- 820 (929)
..........+++.|+|||++.+. .++.++|||||||++|||++|+.||...........+.+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 333333334578999999998874 4789999999999999999999999754421111111110
Q ss_pred HHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 821 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 821 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.................+ ..........+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000000000 00111123467899999999999999999999886
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=307.55 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=199.1
Q ss_pred ccccccCcEEEEEEEECC--C--cEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLKD--G--KEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~--~--~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|++|.||+|.+.+ + ..||||.++.... ...+.+.+|++++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 2 3689999987655 556789999999999999999999999988 889999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc-
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH- 760 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 760 (929)
++|.+++..... ..+++..+..++.|+++||+|||++ +++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999865321 4688999999999999999999998 9999999999999999999999999999865442221
Q ss_pred -eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 761 -VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 761 -~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
......++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+...... ......
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~---~~~~~~------ 221 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS----QILKKIDK---EGERLE------ 221 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHh---cCCcCC------
Confidence 1122446789999999998899999999999999999999 99999654311 12221111 110000
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
.+......+.+++.+|++.+|++||++.||++.|.
T Consensus 222 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 ---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01112346889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=312.67 Aligned_cols=255 Identities=25% Similarity=0.435 Sum_probs=202.0
Q ss_pred HHHHHhccccccCcEEEEEEEEC----CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~----~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
..+.+.+.||+|+||.||+|.+. .+..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 34556789999999999999864 23479999886543 23346789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
|||+++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999998542 34578899999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceee--eeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 756 DGASHVSS--IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 756 ~~~~~~~~--~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
........ ...++..|+|||++.+..++.++|+|||||++||+++ |..||...... .+...+... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~----~~~~~~~~~---~~~-- 228 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ----DVIKAIEEG---YRL-- 228 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH----HHHHHHhCC---CcC--
Confidence 43322221 1223568999999998889999999999999999887 99998754311 122221111 000
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
.........+.+++.+|++.+|++||+|.++++.|+++
T Consensus 229 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 --------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=324.61 Aligned_cols=263 Identities=27% Similarity=0.422 Sum_probs=201.6
Q ss_pred HHHHHHHhccccccCcEEEEEEEE------CCCcEEEEEEeecCCc-chhHHHHHHHHHhccc-CCCceeEEeeeeeec-
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE- 669 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~------~~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~- 669 (929)
....+.+.+.||+|+||+||+|++ .+++.||||+++.... .....+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 345677899999999999999974 2467899999975432 2345688999999999 789999999988654
Q ss_pred CeEEEEEEeccCCchhhhhccccc--------------------------------------------------------
Q 002382 670 GRSVLVYEFMHNGTLKEHLYGTLT-------------------------------------------------------- 693 (929)
Q Consensus 670 ~~~~LV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 693 (929)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999998854210
Q ss_pred -------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc-eeeee
Q 002382 694 -------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIV 765 (929)
Q Consensus 694 -------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~ 765 (929)
....+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++........ .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 012467888899999999999999998 9999999999999999999999999998754332211 11223
Q ss_pred ecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCH
Q 002382 766 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844 (929)
Q Consensus 766 ~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 844 (929)
.++..|+|||.+.+..++.++|||||||++|||++ |..||......+ .+.. ....+.... ....
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~~~~~~-----~~~~--- 306 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCR----RLKEGTRMR-----APDY--- 306 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH---HHHH----HHhccCCCC-----CCCC---
Confidence 35678999999998899999999999999999997 899986543111 1111 111111100 0011
Q ss_pred HHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 845 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 845 ~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
....+.+++..|++.+|++||++.||+++|+.+++
T Consensus 307 -~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 -TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12357899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=315.33 Aligned_cols=263 Identities=25% Similarity=0.400 Sum_probs=201.7
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-----CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeec--Ce
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GR 671 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~--~~ 671 (929)
...+.+.+.||+|+||.||++++. +++.||+|.++... ......+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 345667789999999999999753 47789999987543 33346789999999999999999999998775 56
Q ss_pred EEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCc
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 751 (929)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence 89999999999999988532 23578999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCc--eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccc-------cc-cchhhHHHH
Q 002382 752 KFAVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-------GA-NCRNIVQWA 821 (929)
Q Consensus 752 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~-------~~-~~~~l~~~~ 821 (929)
+........ ......++..|+|||++.+..++.++|||||||++|||++++.|...... +. .......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 865433221 11234467789999999888899999999999999999998776532110 00 000111111
Q ss_pred HHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 822 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 822 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
.....+... .........+.+++.+|++.+|++||++.|+++.|+.+
T Consensus 237 -~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 -RVLEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HHHHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111110 01112335788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=318.75 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=202.3
Q ss_pred HHHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCC-cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 672 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~ 672 (929)
..+.+.+.||+|+||.||+|... .+..||||+++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 44567889999999999999752 34579999987543 23345788999999999 799999999999999999
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
++||||+.+|+|.+++.... ...+++.++..++.|++.||+|||++ +|+|+||||+|||++.++.+||+|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999985422 23378999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCc
Q 002382 753 FAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 753 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 830 (929)
........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+. +... ...+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---~~~~----~~~~~~ 262 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---FYKL----IKEGYR 262 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH---HHHH----HHcCCc
Confidence 55433221 1122335778999999998889999999999999999998 9999865442111 1111 111110
Q ss_pred ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 831 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
..........+.+++.+|+..+|++||++.|+++.|++.
T Consensus 263 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 ---------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000111234688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.31 Aligned_cols=248 Identities=30% Similarity=0.463 Sum_probs=202.5
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+.+.||+|+||.||+|... ++.||+|.++.... ..+++.+|+.+++.++|+||+++++++...+..++||||+++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 4456789999999999999876 88999999976544 467789999999999999999999999989999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
++|.+++.... ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||.++.......
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 85 GSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 99999985431 23688999999999999999999998 999999999999999999999999999976532221
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
....+..|+|||++....++.++||||||+++|||++ |..||..... ..+..... .+...
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~----~~~~~--------- 218 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPHVE----KGYRM--------- 218 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHh----cCCCC---------
Confidence 2234678999999988889999999999999999997 9999865431 12222111 11000
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
..+......+.+++.+|+..+|++||++.|+++.|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0111223568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=315.35 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=200.4
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
+|.+.+.||+|+||.||+|+.. +++.||+|.+..........+.+|+.+++.++||||+++++.+......++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 3445678999999999999865 688999999986655556778899999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 101 ~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 101 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 9999998842 3467888999999999999999998 9999999999999999999999999998754332211
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ...+..+ ...+ ... +
T Consensus 173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~---~~~~~~~----~~~~-~~~-----~-- 236 (296)
T cd06654 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLI----ATNG-TPE-----L-- 236 (296)
T ss_pred -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH---HHhHHHH----hcCC-CCC-----C--
Confidence 2234588999999999988899999999999999999999999965431 1111111 1111 000 0
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+......+.+++.+|+..+|++||++.|++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0111223457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=308.14 Aligned_cols=254 Identities=27% Similarity=0.345 Sum_probs=191.6
Q ss_pred ccccccCcEEEEEEEECC---CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 607 KKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~---~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.||+|+||.||+|.+.+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998753 4578999887553 233457889999999999999999999999999999999999999
Q ss_pred chhhhhccccc-cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 683 TLKEHLYGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 683 sL~~~L~~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
+|.+++..... .....++..+..++.|++.||+|||+. +++||||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999865322 223456777888999999999999998 99999999999999999999999999987543322211
Q ss_pred -eeeeecCccccCccccccC-------cCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 762 -SSIVRGTVGYLDPEYYISQ-------QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 762 -~~~~~gt~~Y~aPE~~~~~-------~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
.....++..|+|||++... .++.++|+|||||++|||++ |+.||...... ....+.. .+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~~~~~~~----~~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE----QVLTYTV----REQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH----HHHHHHh----hcccCC
Confidence 1234477889999998642 35789999999999999996 99999654311 1111111 011111
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
..++.+... ....+.+++.+|+ .+|++|||++||++.|+
T Consensus 230 ~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 122222211 1234677888998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=311.44 Aligned_cols=256 Identities=22% Similarity=0.353 Sum_probs=202.0
Q ss_pred HHHHHhccccccCcEEEEEEEECCC----cEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLKDG----KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~~~----~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
..+.+.+.||+|+||.||+|.+.+. ..||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 3455678999999999999987532 468999887554 3445678999999999999999999999875 456899
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999998542 23578999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
...........++..|+|||.+....++.++|||||||++||+++ |..||...... ....+.. .+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~~~----~~~~~~-- 228 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGRIE----NGERLP-- 228 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHH----cCCcCC--
Confidence 432222222334578999999988889999999999999999996 99999755421 1122111 111000
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
. .......+.+++.+|+..+|++||++.|+++.|+++..
T Consensus 229 ---~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 229 ---M----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 11223468889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=313.98 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=200.4
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCc----EEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~----~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
..+.+.++||+|+||+||+|++. +++ .||+|+++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 34456789999999999999864 444 48999987543 33456788999999999999999999999754 4679
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
++||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++..
T Consensus 86 ~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 86 VTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999988542 34688899999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCce-eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 755 VDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 755 ~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
....... .....++..|+|||...+..++.++|||||||++|||++ |..||..... ..+..+... +...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~----~~~~- 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDLLEK----GERL- 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHC----CCcC-
Confidence 4332221 112235678999999998899999999999999999998 8999865431 122222221 1100
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.........+.+++.+|++.+|++||++.|+++.|+.+..
T Consensus 231 --------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 231 --------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0011223467899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=315.56 Aligned_cols=261 Identities=23% Similarity=0.423 Sum_probs=202.2
Q ss_pred HHHHHHHhccccccCcEEEEEEEECC------CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCe
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 671 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~~------~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~ 671 (929)
...++.+.+.||+|+||.||+|..++ +..||+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34566778999999999999997642 4579999886443 2334568889999999999999999999999999
Q ss_pred EEEEEEeccCCchhhhhccccc------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEE
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLT------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 745 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL 745 (929)
.++||||+.+|+|.+++..... ......+..+..++.|++.||.|||++ +|+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964221 123345677889999999999999998 9999999999999999999999
Q ss_pred EeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHH
Q 002382 746 SDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL 823 (929)
Q Consensus 746 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~ 823 (929)
+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||..... ..+...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~----~~~~~~--- 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN----EQVLKF--- 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH---
Confidence 999998754332211 1122335678999999998899999999999999999998 7888865331 112221
Q ss_pred hhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 824 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 824 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
....+ ... .+......+.+++.+|++.+|++||++.|+++.|++.+
T Consensus 234 ~~~~~-~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGG-YLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCC-CCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111 100 01112347889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=305.42 Aligned_cols=247 Identities=32% Similarity=0.453 Sum_probs=198.0
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcc-hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCchh
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 685 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~-~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL~ 685 (929)
++||+|+||.||++...+++.||+|+++..... ....+.+|++++++++|+||+++++++......++|+||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998765443 4567899999999999999999999999999999999999999999
Q ss_pred hhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee-ee
Q 002382 686 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS-SI 764 (929)
Q Consensus 686 ~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~~ 764 (929)
+++... ...+++..+..++.+++.||+|||++ +++||||||+||+++.++.+||+|||+++.......... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 988542 23577888899999999999999998 999999999999999999999999999875432221111 11
Q ss_pred eecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccC
Q 002382 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 843 (929)
Q Consensus 765 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 843 (929)
..++..|+|||.+.++.++.++|+|||||++|||++ |..||...... ......... ... ..+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~----~~~~~~~~~---~~~----------~~~ 217 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ----QTRERIESG---YRM----------PAP 217 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH----HHHHHHhcC---CCC----------CCC
Confidence 224567999999998899999999999999999999 88888654311 111111110 000 011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 844 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 844 ~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
......+.+++.+|++.+|++||++.||++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 122346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=317.89 Aligned_cols=262 Identities=25% Similarity=0.431 Sum_probs=204.0
Q ss_pred HHHHHHHhccccccCcEEEEEEEEC--------CCcEEEEEEeecCC-cchhHHHHHHHHHhccc-CCCceeEEeeeeee
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE 668 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~--------~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~ 668 (929)
....+.+.+.||+|+||.||+++.. ....+|+|+++... ......+.+|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3445567899999999999999752 24568999987543 23345688999999999 69999999999999
Q ss_pred cCeEEEEEEeccCCchhhhhcccc------------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeE
Q 002382 669 EGRSVLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 736 (929)
Q Consensus 669 ~~~~~LV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NIL 736 (929)
.+..++||||+.+|+|.+++.... .....+++.++..++.|++.||.|||++ +++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence 999999999999999999986432 1234588899999999999999999998 9999999999999
Q ss_pred ecCCCcEEEEeecCcccccCCCCce-eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccc
Q 002382 737 LDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANC 814 (929)
Q Consensus 737 l~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~ 814 (929)
++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--- 243 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--- 243 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 9999999999999997554322111 112224567999999998889999999999999999999 88888654321
Q ss_pred hhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 815 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 815 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.+.... ..+... ..+......+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 244 -~~~~~~----~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 244 -ELFKLL----REGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -HHHHHH----HcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 122211 111111 1111223467799999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=310.12 Aligned_cols=252 Identities=31% Similarity=0.473 Sum_probs=199.5
Q ss_pred HHhccccccCcEEEEEEEECC-CcEEEEEEeecCCcchhH--HHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 604 MLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKR--EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~~~~~--~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.+.+.||+|+||+||+++... ++.+|+|++......... ...+|+.++++++||||+++++++......++|||++.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 356889999999999999884 568999999876543322 34569999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++. ....+++..++.++.|+++||++||+. +|+|+||||+||+++.++.++|+|||.+.... ....
T Consensus 82 ~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~ 153 (260)
T PF00069_consen 82 GGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNE 153 (260)
T ss_dssp TEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTS
T ss_pred ccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-cccc
Confidence 999999985 456789999999999999999999998 99999999999999999999999999987541 2223
Q ss_pred eeeeeecCccccCccccc-cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 761 VSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~-~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
......++..|+|||.+. +..++.++||||+|+++|+|++|..||...........+.+-........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 222 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS----------- 222 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH-----------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc-----------
Confidence 334456899999999998 88899999999999999999999999986521111111111110000000
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..........+.+++.+|++.+|++||++.|++++
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 223 SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000112678999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=295.96 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=198.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCc----ch----hHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEE
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY----QG----KREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~----~~----~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV 675 (929)
.+.||+|..++|.++.++ .|++.|+|++..... +. .+.-.+|+.||+++ .||+|+++.++++.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 578999999999999876 688999999864321 11 23345799999998 699999999999999999999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
+|.|+.|.|.++|. ..-.+++....+|+.|+.+|++|||.+ .||||||||+|||++++.++||+|||.|+...
T Consensus 102 Fdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 102 FDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999994 456789999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCceeeeeecCccccCcccccc------CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
++. .-...+|||+|+|||.+.. ..|+..+|+|++||+||.++.|++||.... +++. . ..+-+|.
T Consensus 175 ~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------QmlM-L-R~ImeGk 244 (411)
T KOG0599|consen 175 PGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QMLM-L-RMIMEGK 244 (411)
T ss_pred Cch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HHHH-H-HHHHhcc
Confidence 553 3345789999999999864 357788999999999999999999998655 1111 1 1122222
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.. .....-.+......+|+.+|++.||.+|.|++|+++|
T Consensus 245 yq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 245 YQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11 0111112223357799999999999999999999987
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.12 Aligned_cols=248 Identities=25% Similarity=0.341 Sum_probs=194.8
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 45678999999999999875 68899999987542 33456788999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 84 GSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 9986542 356778889999999999999998 99999999999999999999999999987543321
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||..............+........ .+.+..
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~- 222 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVLPV- 222 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCCCC-
Confidence 2234589999999999988899999999999999999999999965331111111111111111110 011100
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
......+.+++.+|++.+|++||+++|++++
T Consensus 223 --~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 --GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1122357899999999999999999999887
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=307.85 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=198.4
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.|.+.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++||||+++++++...+..++|+||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3566788999999999999887 467889998876555556678899999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|..++.. ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (282)
T cd06643 86 GGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 158 (282)
T ss_pred CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence 9999887753 234688999999999999999999998 99999999999999999999999999987543221 1
Q ss_pred eeeeeecCccccCccccc-----cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 761 VSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
......++..|+|||++. +..++.++|||||||++|||++|+.||...... ..+..... ........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~-----~~~~~~~~ 230 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM---RVLLKIAK-----SEPPTLAQ 230 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH---HHHHHHhh-----cCCCCCCC
Confidence 223345899999999984 345778999999999999999999998754311 11111111 00000000
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+......+.+++.+|++.+|++||++.+++++
T Consensus 231 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 -------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122467899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=320.47 Aligned_cols=239 Identities=23% Similarity=0.303 Sum_probs=189.7
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccC-CCceeEEeeeeeecCeEEEEEEe
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
++.+.||+|+||+||+|+.+ +++.||+|+++... ....+.+..|..+++.+. |++|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 45678999999999999876 58899999997542 222345777888888875 57888899999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.+++.. ...+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 83 VNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999988843 34688999999999999999999998 99999999999999999999999999987432221
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.+.. ...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~~----~~~-------- 218 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----ELFQSIME----HNV-------- 218 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHh----CCC--------
Confidence 1223345899999999999889999999999999999999999999765421 22221111 110
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI 868 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 868 (929)
.++......+.+++.+|++.+|++|++.
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111122357889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=309.67 Aligned_cols=248 Identities=24% Similarity=0.380 Sum_probs=199.6
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
..|...+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34556678999999999999876 57789999987443 33346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++.. ..+++..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 999999988742 4578889999999999999999998 99999999999999999999999999987554322
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.|+...... ....+ ...+. .+.+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~----~~~~~-----~~~~ 221 (277)
T cd06642 156 I-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM----RVLFL----IPKNS-----PPTL 221 (277)
T ss_pred h-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh----hHHhh----hhcCC-----CCCC
Confidence 1 122345788999999999888999999999999999999999998643311 11111 11111 1111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.......+.+++.+|++.+|++||+|.||+++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 ----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 12233568899999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=312.44 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=193.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhccc---CCCceeEEeeeeee-----cCe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQE-----EGR 671 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l---~HpNIv~l~g~~~~-----~~~ 671 (929)
|.+.+.||+|+||+||+|+.+ +++.||+|+++.... .....+.+|+++++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 345678999999999999887 588999999875422 1234566777777665 79999999998854 345
Q ss_pred EEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCc
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 751 (929)
.++|+||+.+ +|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred EEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 7999999974 888877542 234588999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
+...... ......||..|+|||++.+..++.++|||||||++|||++|++||......+....+..+...........
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 7653321 12234578999999999988999999999999999999999999965442222222222211100000000
Q ss_pred ------cccCCcc---cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 832 ------GIIDPSL---LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 832 ------~~~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....+.. ......+....+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 001111223467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=307.24 Aligned_cols=239 Identities=21% Similarity=0.376 Sum_probs=187.7
Q ss_pred ccccccCcEEEEEEEECC-------------CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEE
Q 002382 607 KKIGSGGFGVVYYGKLKD-------------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~-------------~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~ 673 (929)
+.||+|+||.||+|++.. ...|++|++..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998542 2258889876554444567888999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc-------EEEE
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-------AKVS 746 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-------vkL~ 746 (929)
+||||+++|+|..++... ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999998887532 34578889999999999999999998 9999999999999987664 8999
Q ss_pred eecCcccccCCCCceeeeeecCccccCccccc-cCcCCCcCceeeHHHHHHHHH-hCCCCCccccccccchhhHHHHHHh
Q 002382 747 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELI-SGQEAISNEKFGANCRNIVQWAKLH 824 (929)
Q Consensus 747 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~~sDVwSlGvvl~ell-tG~~p~~~~~~~~~~~~l~~~~~~~ 824 (929)
|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ .|..|+......+ ...
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~~----- 220 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE----KER----- 220 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH----HHH-----
Confidence 99998654221 2234788999999886 467889999999999999998 5888876433111 111
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
...+.. . .. ......+.+++.+|++.+|++||++.|+++.+
T Consensus 221 ~~~~~~-~-----~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 221 FYEGQC-M-----LV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHhcCc-c-----CC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 001110 0 00 11124678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=315.06 Aligned_cols=256 Identities=25% Similarity=0.439 Sum_probs=201.3
Q ss_pred HHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
.+.+.+.||+|+||.||+|..+ +++.||+|+++... ....+++.+|+.++++++||||+++++++..+...++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 4456789999999999999864 46789999987543 3335678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhcccc------------------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeE
Q 002382 675 VYEFMHNGTLKEHLYGTL------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 736 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NIL 736 (929)
|+||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil 162 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCL 162 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheE
Confidence 999999999999986421 1123478888999999999999999998 9999999999999
Q ss_pred ecCCCcEEEEeecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccc
Q 002382 737 LDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANC 814 (929)
Q Consensus 737 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~ 814 (929)
++.++.+||+|||+++....... ........+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~---- 238 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH---- 238 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999875432221 11122235678999999998899999999999999999998 8888864331
Q ss_pred hhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 815 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 815 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
..+... ...+.... .+.....++.+++.+|++.+|++||++.|+++.|++
T Consensus 239 ~~~~~~----~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 EEVIYY----VRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHH----HhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 122221 11222111 011123468899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=306.85 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=197.6
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeee-ecCeEEEEEEecc
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVYEFMH 680 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~-~~~~~~LV~E~~~ 680 (929)
.+.+.+.||+|+||.||++... ++.+|+|.++... ..+.+.+|+.++++++|+|++++++++. ..+..++|+||++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4556789999999999999876 7889999986443 2457889999999999999999999764 5567899999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 84 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999988543 233578889999999999999999998 99999999999999999999999999987543221
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
....++..|+|||++....++.++|||||||++|||++ |+.||..... ..+..+.. .+...
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~~----~~~~~-------- 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRVE----KGYKM-------- 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHh----cCCCC--------
Confidence 12235678999999998889999999999999999998 9999865431 12222221 11110
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
.........+.+++.+|++.+|++||++.++++.|++
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1111223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.53 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=198.6
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
..+.+.+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 35667789999999999999875 58899999987655444566888999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++.. ...+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999998743 34688999999999999999999998 999999999999999999999999999875433211
Q ss_pred ceeeeeecCccccCccccc---cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 760 HVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
......|+..|+|||++. ...++.++|+|||||++|||++|..||....... .+..... .... .+
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~~~~~~-----~~~~---~~ 229 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMTK-----SNFQ---PP 229 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hHHhhhc-----cCCC---CC
Confidence 122345899999999974 4568889999999999999999999986433111 1111000 0000 00
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..... ......+.+++.+|++.+|++||++++|+++
T Consensus 230 ~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 KLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 11110 0112357899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=311.83 Aligned_cols=249 Identities=27% Similarity=0.382 Sum_probs=196.9
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
..+.||+|+||.||++... +++.+|||.+..... .....+.+|+.++++++|+||+++++.+...+..++||||++
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 4578999999999999876 688999999875432 223457789999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 84 g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 84 GGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred CCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 99999988542 234588899999999999999999998 999999999999999999999999999875433221
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.................. . ......
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~---------~~~~~~ 226 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-V---------QEEYSE 226 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-h---------hhhcCc
Confidence 12345899999999999989999999999999999999999999754311111111110000 0 000111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCc-----HHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 874 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 874 (929)
. ....+.+++.+|++.+|++||| +.|++++
T Consensus 227 ~----~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 227 K----FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred c----CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 1 2235789999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=317.92 Aligned_cols=263 Identities=21% Similarity=0.299 Sum_probs=195.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 456688999999999999876 578899999875432 234467789999999999999999999999999999999997
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 88 K-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred C-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 5 777776432 34578888999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc------
Q 002382 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI------ 833 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~------ 833 (929)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+......... .....+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE-ETWPGISSNDEF 238 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH-HHHhhhcchhhh
Confidence 1223457899999999865 46789999999999999999999999765422221111111000000 000000
Q ss_pred cC---CcccC----ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 834 ID---PSLLD----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 834 ~d---~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+ +.... .........+.+++.+|++.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00 00000 0001122357899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=316.05 Aligned_cols=253 Identities=21% Similarity=0.264 Sum_probs=193.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 445688999999999999976 58899999987432 22345688899999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 83 YVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred CCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999998853 234678889999999999999999998 99999999999999999999999999987554433
Q ss_pred CceeeeeecCccccCcccccc-----CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 759 SHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.. ...........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~-------~~i~~~~~~~~- 228 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-------GKIMNHKEHFQ- 228 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH-------HHHHcCCCccc-
Confidence 333334569999999999863 45788999999999999999999999754421111 11111110000
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCC--CCCCCCcHHHHHHH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLP--HGHMRPSISEVLKD 874 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~--dP~~RPs~~eVl~~ 874 (929)
+. .. .......+.+++.+|+.. ++..||++.+++++
T Consensus 229 ~~----~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FP----PD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CC----Cc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 00 011223456677776654 44458899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=309.64 Aligned_cols=239 Identities=23% Similarity=0.377 Sum_probs=186.8
Q ss_pred cccccCcEEEEEEEECC-------------------------CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEE
Q 002382 608 KIGSGGFGVVYYGKLKD-------------------------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 662 (929)
Q Consensus 608 ~IG~G~fG~Vy~~~~~~-------------------------~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l 662 (929)
.||+|+||.||+|.+.. ...||+|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13588998865544445678889999999999999999
Q ss_pred eeeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC-
Q 002382 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM- 741 (929)
Q Consensus 663 ~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~- 741 (929)
++++.+....++||||+++|+|..++.. ....+++..+..++.|+++||+|||++ +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 9999999999999999999999988853 234678889999999999999999998 999999999999997643
Q ss_pred ------cEEEEeecCcccccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHH-hCCCCCcccccccc
Q 002382 742 ------RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELI-SGQEAISNEKFGAN 813 (929)
Q Consensus 742 ------~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~ell-tG~~p~~~~~~~~~ 813 (929)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE- 229 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence 4899999987643221 12347888999998875 56889999999999999995 6999987543111
Q ss_pred chhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 814 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
...+... .... ... ....+.+++.+|++.+|++||++.+|++.|.
T Consensus 230 ---~~~~~~~---~~~~--------~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 ---KERFYEK---KHRL--------PEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHHHh---ccCC--------CCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111111 0000 011 1135789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=309.46 Aligned_cols=247 Identities=24% Similarity=0.353 Sum_probs=207.1
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
.|.+++.||+|.|++|-+|++- .|+.||||++.+... .....+.+|++.|+.++|||||+++++......+|||.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3556789999999999999876 799999999986643 3456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec-CCCcEEEEeecCcccccCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~~~~~ 757 (929)
-.+|+|.+++-+ .+..+.+..+.+++.||+.|+.|+|+. .+|||||||+||.+- .-|-+||.|||++..+.++
T Consensus 99 GD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999954 456788999999999999999999998 999999999998765 5688999999999877665
Q ss_pred CCceeeeeecCccccCccccccCcCC-CcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
.. -.+.+|++.|-|||++.+..|+ +++||||||||||.|++|+.||+..+-.+.. ..++|.
T Consensus 173 ~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL----------------TmImDC 234 (864)
T KOG4717|consen 173 KK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL----------------TMIMDC 234 (864)
T ss_pred ch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh----------------hhhhcc
Confidence 43 3456799999999999999887 4789999999999999999999876522222 222332
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.. ..+.....++.+||..|+..||++|.+.+||+..
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 21 2234455688999999999999999999998753
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=342.76 Aligned_cols=261 Identities=21% Similarity=0.310 Sum_probs=202.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.++||+|+||.||+|+.. +++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 445689999999999999876 588999999875422 2345789999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccc-------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCc
Q 002382 679 MHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 751 (929)
+++|+|.+++..... ....+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999998854211 123456778889999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCC-----------------ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccc
Q 002382 752 KFAVDGAS-----------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 814 (929)
Q Consensus 752 ~~~~~~~~-----------------~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~ 814 (929)
+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~--- 237 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR--- 237 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh---
Confidence 75521110 0112245999999999999999999999999999999999999999753311
Q ss_pred hhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCC-cHHHHHHHHHHhHhH
Q 002382 815 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAIVI 881 (929)
Q Consensus 815 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~eVl~~L~~~~~~ 881 (929)
.+... ... .++.-. ....+....+.+++.+|++.+|++|| +++++.+.|+..+..
T Consensus 238 -ki~~~-~~i---------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 -KISYR-DVI---------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred -hhhhh-hhc---------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11110 000 000000 00112234678999999999999996 678888888877653
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=304.27 Aligned_cols=247 Identities=22% Similarity=0.356 Sum_probs=201.1
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.|...+.||+|+||.||+|.+. +++.||+|++.... ......+.+|++++++++||||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4455678999999999999876 57899999987543 334567889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++.. ..+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998842 3577888899999999999999998 999999999999999999999999999975543322
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
......++..|+|||++.+..++.++|+|||||++|||++|..||....... ... ....+ ..
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~----~~~~~---------~~ 218 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLF----LIPKN---------NP 218 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----Hhh----hhhcC---------CC
Confidence 2223457889999999988889999999999999999999999987543111 110 00111 01
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..........+.+++.+|++.+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12223345678899999999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=308.55 Aligned_cols=261 Identities=23% Similarity=0.366 Sum_probs=198.4
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhccc--CCCceeEEeeeeeecC----eEEEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI--HHRNLVQFLGYCQEEG----RSVLVYE 677 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l--~HpNIv~l~g~~~~~~----~~~LV~E 677 (929)
.+.+.||+|.||+||+|+|+ |+.||||++... +++.+.+|.+|.+.+ +|+||+.+++.-..+. .++||++
T Consensus 214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 45688999999999999998 999999998754 356678888888875 9999999999875543 6799999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhC-----CCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG-----CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-----~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
|.+.|||.|+|. ...++....++++..+|.||+|||.. ..|.|.|||||+.||||..++.+.|+|+|+|.
T Consensus 290 YHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 290 YHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred cccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 999999999994 35678889999999999999999963 34789999999999999999999999999997
Q ss_pred cccCCCCc---eeeeeecCccccCccccccCc------CCCcCceeeHHHHHHHHHhCC----------CCCccccc-cc
Q 002382 753 FAVDGASH---VSSIVRGTVGYLDPEYYISQQ------LTDKSDVYSFGVILLELISGQ----------EAISNEKF-GA 812 (929)
Q Consensus 753 ~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~------~s~~sDVwSlGvvl~elltG~----------~p~~~~~~-~~ 812 (929)
........ .....+||.+|||||++...- --..+||||||.|+||+.... .||.+.-. ..
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 65443222 234567999999999986431 123689999999999998643 44432110 00
Q ss_pred cchhhHHHHHHhhhcCCcccccCCcccC-ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 813 NCRNIVQWAKLHIESGDIQGIIDPSLLD-EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 813 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
.++++.. .+ -.+.+.|.+.. -.+.+.+..+.+++..||..+|..|-|+-.+.+.|.++.+.
T Consensus 445 s~eeMrk----VV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 445 SFEEMRK----VV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CHHHHhc----ce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 0111100 00 00111122211 12457888999999999999999999999999999988643
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=325.06 Aligned_cols=249 Identities=24% Similarity=0.353 Sum_probs=192.8
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.+.+.||+|+||.||+++.+ +++.||+|+++... ......+.+|+.++..++||||+++++.+.+.+..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 34578999999999999876 58899999997532 223456788999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 84 PGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999998843 35688889999999999999999998 999999999999999999999999999864322100
Q ss_pred ----------------------------------ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCC
Q 002382 760 ----------------------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 805 (929)
Q Consensus 760 ----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~ 805 (929)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0011346999999999999999999999999999999999999999
Q ss_pred ccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCc---HHHHHHH
Q 002382 806 SNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEVLKD 874 (929)
Q Consensus 806 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~eVl~~ 874 (929)
......+....+..|. ..+ .+.+ .. .....+.+++.+|+. +|++|++ +.|+++|
T Consensus 237 ~~~~~~~~~~~i~~~~------~~~--~~p~----~~--~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQETYRKVMNWK------ETL--VFPP----EV--PISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHHHHHHHHcCC------Cce--ecCC----CC--CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 7654222222222110 000 0110 10 112346677777664 9999985 6777766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=303.72 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=190.0
Q ss_pred ccccccCcEEEEEEEECCCc---EEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 607 KKIGSGGFGVVYYGKLKDGK---EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~---~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.||+|+||.||+|...++. .+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999765433 45667665443 334568999999999999999999999999999999999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC-Cce
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SHV 761 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~-~~~ 761 (929)
+|.+++..........++..+..++.|+++||+|||+. +++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999975433334566777889999999999999998 99999999999999999999999999986322211 112
Q ss_pred eeeeecCccccCcccccc-------CcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 762 SSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~-------~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... ..... ... +.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~~~~---~~~-~~~~~~ 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR----EVLNH---VIK-DQQVKL 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH---HHh-hccccc
Confidence 223457889999999753 245789999999999999997 56677543311 11111 111 112233
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
.++.+...+. ..+.+++.+|+ .+|++||+++||++.|.
T Consensus 230 ~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3444433333 35677888999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=310.83 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=196.3
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
..+.||+|+||+||+|.+. +++.+|+|++..... .....+.+|++++++++|+||+++.+++..++..++||||++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 3478999999999999876 688999999865432 223457889999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 84 GGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred CccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 99999888542 234689999999999999999999998 999999999999999999999999999875433221
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....|+..|+|||++.+..++.++|+|||||++|||++|..||...........+ ........ .
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~----~~~~~~~~--~-------- 222 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV----DRRVLETE--E-------- 222 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HHhhhccc--c--------
Confidence 22346899999999999889999999999999999999999999754311111111 11111110 0
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCc-----HHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 874 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 874 (929)
.+.......+.+++.+|++.+|++||+ +.|++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 111112235788999999999999999 6676665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=305.93 Aligned_cols=250 Identities=29% Similarity=0.457 Sum_probs=191.8
Q ss_pred ccccccCcEEEEEEEEC----CCcEEEEEEeecC-CcchhHHHHHHHHHhcccCCCceeEEeeeee-ecCeEEEEEEecc
Q 002382 607 KKIGSGGFGVVYYGKLK----DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVYEFMH 680 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~----~~~~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~-~~~~~~LV~E~~~ 680 (929)
+.||+|+||.||+|.+. +...+|+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 2357999988543 2334567889999999999999999999875 4556789999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+|+|.+++... ...+.+..+..++.|+++||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998542 23356777889999999999999998 9999999999999999999999999998754332111
Q ss_pred ---eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhC-CCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 761 ---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 761 ---~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
......++..|+|||.+.+..++.++|||||||++|||++| ..||..... ..+.... . .+....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~---~-~~~~~~---- 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS----FDITVYL---L-QGRRLL---- 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH---h-cCCCCC----
Confidence 11123457789999999888899999999999999999995 555654321 1222221 1 111000
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
.+......+.+++.+|++.+|++||++.||++.|+++.
T Consensus 223 -----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 -----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00111246889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=313.86 Aligned_cols=197 Identities=23% Similarity=0.379 Sum_probs=159.4
Q ss_pred hccccccCcEEEEEEEEC---CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeee--cCeEEEEEEecc
Q 002382 606 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMH 680 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~---~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~--~~~~~LV~E~~~ 680 (929)
.++||+|+||+||+|+.+ +++.+|+|.+..... ...+.+|++++++++||||+++++++.. ....++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999875 457899999864422 3457789999999999999999998854 456789999986
Q ss_pred CCchhhhhcccc-----ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe----cCCCcEEEEeecCc
Q 002382 681 NGTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLS 751 (929)
Q Consensus 681 ~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkL~DFGla 751 (929)
++|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 47777664221 1223578889999999999999999998 99999999999999 45678999999999
Q ss_pred ccccCCCCc--eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccc
Q 002382 752 KFAVDGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNE 808 (929)
Q Consensus 752 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~ 808 (929)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 865432211 1234568999999999976 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=321.56 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=205.4
Q ss_pred HHhccccccCcEEEEEEEEC--CCc--EEEEEEeecCCcc-hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 604 MLEKKIGSGGFGVVYYGKLK--DGK--EIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~--~~~--~vAVK~l~~~~~~-~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
.+.++||+|.||.|++|.|+ .|+ .||||+++..... ...+|.+|+.+|.+|+|||+++|+|+..+ ....+|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 35678999999999999887 344 5899999877554 56789999999999999999999999988 678999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
++.|+|.+.|++ .....+.......++.|||.||.||.++ +.|||||..+|+|+-....+||+|||+.+-+...+
T Consensus 192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999976 3455677888899999999999999999 99999999999999999999999999999766554
Q ss_pred Ccee--eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 759 SHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 759 ~~~~--~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
.... ....-...|+|||.+..+.++.++|||+|||.+|||++ |..||.+... ..|++ .+|
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----~qIL~-------------~iD 329 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----IQILK-------------NID 329 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----HHHHH-------------hcc
Confidence 4331 22334678999999999999999999999999999999 7889876541 12222 122
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
..-+-..+..+.+.+.+++..||..+|++||++..+.+.+
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1112223445667899999999999999999999997554
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=307.44 Aligned_cols=259 Identities=24% Similarity=0.318 Sum_probs=205.1
Q ss_pred HHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
....+.+.+.||+|+||+||++... +++.+|+|++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3456677899999999999999876 58889999886543 334577899999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++++|.+++.. .+.+++..+..++.+++.||.|||+. .+++||||||+||+++.++.++|+|||++.....
T Consensus 83 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 83 EFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred ecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 99999999988743 34578889999999999999999974 2899999999999999999999999999864422
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccccc----ccchhhHHHHHHhhhcCCccc
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG----ANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~----~~~~~l~~~~~~~~~~~~~~~ 832 (929)
.. .....|+..|+|||++.+..++.++|+|||||++|||++|+.||...... .....+..+.........
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 230 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--- 230 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC---
Confidence 21 12345899999999998888999999999999999999999999754421 111222333332221110
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
+.+. ..+....+.+++.+|++.+|++||++.|++++.
T Consensus 231 ---~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 ---PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0111 111334688999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.42 Aligned_cols=254 Identities=25% Similarity=0.328 Sum_probs=188.1
Q ss_pred ccccccCcEEEEEEEECC---CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 607 KKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~---~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+++++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997653 3468888775443 233457889999999999999999999999999999999999999
Q ss_pred chhhhhcccccc-ccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc-
Q 002382 683 TLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH- 760 (929)
Q Consensus 683 sL~~~L~~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 760 (929)
+|.+++...... ....++.....++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999998654321 23456777889999999999999998 9999999999999999999999999998643322111
Q ss_pred eeeeeecCccccCcccccc-------CcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 761 VSSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~-------~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
......++..|+|||++.. ..++.++|||||||++|||++ |..||...... ..... ...... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~~~~---~~~~~~-~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE----QVLKQ---VVREQD-IK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH----HHHHH---HhhccC-cc
Confidence 1122345678999999743 356789999999999999999 77888654311 11111 111111 11
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
..++.+.. .....+.+++..|+ .+|++||+++||++.|.
T Consensus 230 ~~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11121111 22235567778888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=308.26 Aligned_cols=251 Identities=29% Similarity=0.439 Sum_probs=197.2
Q ss_pred ccccccCcEEEEEEEECC-------CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 607 KKIGSGGFGVVYYGKLKD-------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~-------~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+.||+|+||.||+|+..+ ++.+|||.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998753 2578999876543 23456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccc---cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC-----cEEEEeecC
Q 002382 679 MHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-----RAKVSDFGL 750 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-----~vkL~DFGl 750 (929)
+++++|.+++..... ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999964322 224578899999999999999999998 999999999999999877 899999999
Q ss_pred cccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcC
Q 002382 751 SKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG 828 (929)
Q Consensus 751 a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 828 (929)
++........ ......++..|+|||++.++.++.++|||||||++|||++ |+.||..... ......+.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~~~~~~~~~---~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQHVTA---GG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----HHHHHHHhc---CC
Confidence 8754332211 1122335688999999999999999999999999999998 9999864431 112221111 11
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 829 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
.. .........+.+++.+|++.+|++||++.+|++.|++
T Consensus 231 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 1111223567899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.63 Aligned_cols=249 Identities=25% Similarity=0.390 Sum_probs=200.9
Q ss_pred HHHHhccccccCcEEEEEEEECC-CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.|.+.+.||+|+||.||+|++.+ ++.+++|.++.... ..++.+|++++++++||||+++++++......++++||+.
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 35567889999999999999875 78999999875432 5789999999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++.. ....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 82 AGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999998853 235688999999999999999999998 999999999999999999999999999876543321
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
......++..|+|||++.+..++.++|||||||++|||++|+.||....... ..... ..... +.+
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~---~~~~~-----~~~~~-----~~~-- 219 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR---AIFMI-----PNKPP-----PTL-- 219 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh---hhhhh-----ccCCC-----CCC--
Confidence 2233457899999999998899999999999999999999999997543111 11000 00000 000
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+......+.+++.+|++.+|++||++.||+++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0111222468899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.60 Aligned_cols=254 Identities=25% Similarity=0.395 Sum_probs=199.2
Q ss_pred HHhccccccCcEEEEEEEECC--CcEEEEEEeecCC----------cchhHHHHHHHHHhcc-cCCCceeEEeeeeeecC
Q 002382 604 MLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNS----------YQGKREFTNEVTLLSR-IHHRNLVQFLGYCQEEG 670 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~--~~~vAVK~l~~~~----------~~~~~~f~~Ev~iL~~-l~HpNIv~l~g~~~~~~ 670 (929)
.+.+.||+|+||.||+|.++. ++.+|+|.+.... .....++..|+.++.+ ++||||+++++++...+
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 456789999999999999875 6789999875321 1123456778887765 79999999999999999
Q ss_pred eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecC
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 750 (929)
..+++|||+++++|.+++.........+++..++.++.|++.||.|||+. .+++|+||||+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999998854434455688899999999999999999963 1899999999999999999999999999
Q ss_pred cccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCc
Q 002382 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 830 (929)
+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .... .. ..+..
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~----~~~~---~~-~~~~~ 230 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML----SLAT---KI-VEAVY 230 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH----HHHH---HH-hhccC
Confidence 97654332 223445889999999999888999999999999999999999998654311 1111 11 11111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 831 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
.... .. .....+.+++.+|++.+|++||++.||.+++++
T Consensus 231 ~~~~----~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 EPLP----EG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CcCC----cc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1100 01 122467899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=318.07 Aligned_cols=253 Identities=21% Similarity=0.255 Sum_probs=194.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||+||+++.+ +++.||+|++.... ......+.+|..++..++|+||+++++++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 345688999999999999887 57889999986532 22234578899999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 83 YVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred CCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999998532 34578888999999999999999998 99999999999999999999999999997654433
Q ss_pred CceeeeeecCccccCcccccc-----CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 759 SHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
........||+.|+|||++.+ +.++.++|||||||++|||++|+.||......+....+. . ...+. .
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~----~--~~~~~--~ 228 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----N--HEERF--Q 228 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHH----c--CCCcc--c
Confidence 333334569999999999875 467889999999999999999999997544211111110 0 00000 0
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCC--CCcHHHHHHH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 874 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~eVl~~ 874 (929)
+.+.+ ......+.+++.+|+...+++ |+++++++++
T Consensus 229 ~p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FPSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 01100 112345778888888865544 5688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.55 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=196.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcch---------hHHHHHHHHHhcccCCCceeEEeeeeeecCeE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---------KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~---------~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~ 672 (929)
+.+...||+|+||.||+|... +++.+|+|.+....... .+.+.+|+.++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 345678999999999999875 57899999886543221 24678899999999999999999999999999
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++
T Consensus 82 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999998843 34578888899999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCc-----eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc
Q 002382 753 FAVDGASH-----VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 827 (929)
Q Consensus 753 ~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 827 (929)
........ ......|+..|+|||.+.+..++.++|+|||||++|||++|+.||...... ..+.. . ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~----~-~~ 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAIFK----I-GE 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHHHH----H-hc
Confidence 55421111 111234788999999999888999999999999999999999999754311 11111 0 00
Q ss_pred CCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 828 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 828 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. ..+ ..+......+.+++.+|++.+|++||++.||+++
T Consensus 227 ~-----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 N-----ASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred c-----CCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0 111 1112233467899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.04 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=200.7
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
..|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 44556788999999999999875 68999999997665555677889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999998842 3467888999999999999999998 999999999999999999999999999875433322
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
. .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||....... .+... ...+ ...
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~---~~~~~----~~~~-~~~------- 234 (297)
T cd06656 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLI----ATNG-TPE------- 234 (297)
T ss_pred C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch---heeee----ccCC-CCC-------
Confidence 1 223458899999999998889999999999999999999999996543111 00000 0000 000
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..........+.+++.+|++.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111222457789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=305.72 Aligned_cols=250 Identities=23% Similarity=0.383 Sum_probs=194.6
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeeec------CeEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE------GRSV 673 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~------~~~~ 673 (929)
.+.+.+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +||||+++++++... ...+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 4556788999999999999876 57889999986543 3356788999999998 799999999998653 4578
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+.+++|.+++... ....+++..+..++.|++.||+|||++ +|+|+||||+||++++++.+||+|||+++.
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999988642 234678899999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeeecCccccCccccc-----cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcC
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 828 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 828 (929)
..... .......|+..|+|||++. ...++.++|||||||++|||++|+.||..... ....... ...
T Consensus 161 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~------~~~~~~~--~~~ 231 (272)
T cd06637 161 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALFLI--PRN 231 (272)
T ss_pred ccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH------HHHHHHH--hcC
Confidence 43222 1223456899999999986 34578899999999999999999999964331 1111110 011
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 829 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...... .......+.+++.+|+..+|.+||++.|++++
T Consensus 232 ~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 PAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 111111 11122467899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.98 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=200.6
Q ss_pred HHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCcc-hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~~-~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
+.+.+.||+|+||.||+|+.+ +.+.+++|.+...... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (275)
T cd05046 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMI 86 (275)
T ss_pred ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEE
Confidence 345678999999999999865 2467999988654433 356789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhcccccc-----ccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecC
Q 002382 676 YEFMHNGTLKEHLYGTLTH-----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 750 (929)
|||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||+
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccc
Confidence 9999999999998643211 12589999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
++..............++..|+|||.+.+...+.++||||||+++|||++ |..||..... ..++.... .+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~----~~~~~~~~----~~~ 235 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD----EEVLNRLQ----AGK 235 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch----HHHHHHHH----cCC
Confidence 87443322222233346788999999988888999999999999999999 7888864331 12222211 111
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
..... .......+.+++.+|++.+|++||++.|+++.|+
T Consensus 236 ~~~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 LELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11100 1112346889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=319.78 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=192.4
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeecC------e
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------R 671 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~------~ 671 (929)
..|.+.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...+ .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 34556789999999999999876 5889999998643 2233566789999999999999999999986543 4
Q ss_pred EEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCc
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 751 (929)
.++||||+.+ +|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 101 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 7999999975 5555542 2367788889999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhh--------------
Q 002382 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI-------------- 817 (929)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l-------------- 817 (929)
+..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+
T Consensus 171 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 754322 1223345899999999999999999999999999999999999999754311100000
Q ss_pred -HHHHHHhhhcC-C-----cccccCCccc---CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 818 -VQWAKLHIESG-D-----IQGIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 818 -~~~~~~~~~~~-~-----~~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
........... . ..+....... ..........+.+++.+|++.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 0 0000000000 00011123457899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.97 Aligned_cols=248 Identities=22% Similarity=0.363 Sum_probs=199.0
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+.||+|+||.||+++.. +++.+|+|.++... ....+.+.+|+.+++.++||||+++++.+...+..++||||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 45688999999999999876 68899999986432 33456788899999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
++|.+++... ....+++..+..++.|++.||.|||++ +|+|+||||+||++++++.++|+|||+++...... ..
T Consensus 83 ~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 83 GDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred CcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 9999887532 234578888999999999999999998 99999999999999999999999999987553322 12
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||...... .... ....+.... +
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~~~----~~~~~~~~~-----~--- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK----NLIL----KVCQGSYKP-----L--- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH----HHHH----HHhcCCCCC-----C---
Confidence 23345889999999999888999999999999999999999999754311 1111 111111111 1
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+......+.+++.+|++.+|++||++.|++..
T Consensus 221 -~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 -PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11122357899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.92 Aligned_cols=262 Identities=25% Similarity=0.405 Sum_probs=202.8
Q ss_pred HHHHhccccccCcEEEEEEEEC-----CCcEEEEEEeecCCcc-hhHHHHHHHHHhcccCCCceeEEeeeeee--cCeEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSV 673 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-----~~~~vAVK~l~~~~~~-~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~--~~~~~ 673 (929)
.+.+.+.||+|+||.||+|++. .++.+|||+++..... ....+.+|+++++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4456689999999999999864 3678999999765443 46789999999999999999999999877 55789
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 85 lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999998643 23588999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCce--eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccc-------hhhHHHHHHh
Q 002382 754 AVDGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC-------RNIVQWAKLH 824 (929)
Q Consensus 754 ~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~-------~~l~~~~~~~ 824 (929)
........ .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 54322211 11223566799999998888999999999999999999999998643211100 0011111111
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
...+. ....+.....++.+++.+|++.+|++||+|.||+++|+.+
T Consensus 239 ~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 0011112235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=326.12 Aligned_cols=259 Identities=21% Similarity=0.262 Sum_probs=192.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.+.+.||+|+||.||+|.+. .++.||||... ...+.+|+++|++++|+||+++++++...+..++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 445688999999999999887 47889999643 2346789999999999999999999999999999999995
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC-c
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-H 760 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 760 (929)
++|.+++... ...+++..++.++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 244 ~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 244 SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 6888877432 34689999999999999999999998 999999999999999999999999999976533221 1
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccccc---c-cchhhHHHHHHhhh-cCCcccccC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG---A-NCRNIVQWAKLHIE-SGDIQGIID 835 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~---~-~~~~l~~~~~~~~~-~~~~~~~~d 835 (929)
......||+.|+|||++.+..++.++|||||||++|||++|..++-..... . ....+.+.+..... .........
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 223456999999999999999999999999999999999988665322110 0 01112222111100 000000000
Q ss_pred Ccc------------cCccCH-------HHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSL------------LDEYDI-------QSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l------------~~~~~~-------~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.++ ...... .....+.+++.+|++.||++|||+.|++++
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 000000 111257789999999999999999999986
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=330.52 Aligned_cols=255 Identities=26% Similarity=0.390 Sum_probs=207.1
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCc----EEEEEEeecC-CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~----~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
...-.++||+|+||+||+|.|- +|+ +||+|++... ..+...++.+|+.+|.+++|||+++++|+|..+. ..||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 3344678999999999999764 443 6899998765 3455688999999999999999999999998776 7899
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
++||+.|+|.++++.. +..+.....+.|+.|||+||.|||++ +++||||.++||||..-..+||.|||+++...
T Consensus 776 tq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 9999999999999753 45677788899999999999999998 99999999999999999999999999999776
Q ss_pred CCCCcee-eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 756 DGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 756 ~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
....... ....-.+.|||-|.+....++.++|||||||.+||++| |..|+......+ +...++.++-
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------I~dlle~geR--- 918 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------IPDLLEKGER--- 918 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--------hhHHHhcccc---
Confidence 5544332 33345678999999999999999999999999999999 999998765221 1122222211
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
-..+.-+...+..++.+||..|++.||+++++...+.++..
T Consensus 919 ------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 919 ------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 11233344467888999999999999999999998887653
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=303.60 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=194.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
...||+|+||.||+|++. +++.||+|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 357999999999999866 5778999998766555667899999999999999999999999999999999999999999
Q ss_pred hhhhcccccccccc--chHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC-CCcEEEEeecCcccccCCCCce
Q 002382 685 KEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 685 ~~~L~~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~ 761 (929)
.+++.... ..+ ++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||++........ .
T Consensus 93 ~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~ 165 (268)
T cd06624 93 SALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-C 165 (268)
T ss_pred HHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-c
Confidence 99986431 223 6778888999999999999998 9999999999999976 67999999999875433221 1
Q ss_pred eeeeecCccccCccccccC--cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 762 SSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~--~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
.....|++.|+|||++... .++.++||||||+++|||++|+.||...... ....+...... . .
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~----~~~~~~~~~~~-------~----~ 230 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP----QAAMFKVGMFK-------I----H 230 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh----hhhHhhhhhhc-------c----C
Confidence 2223478999999998654 3788999999999999999999998643211 11111111000 0 0
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...+......+.+++.+|++.+|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 231 PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 11122233467899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=315.00 Aligned_cols=262 Identities=19% Similarity=0.279 Sum_probs=193.3
Q ss_pred Hhcccccc--CcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 605 LEKKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 605 ~~~~IG~G--~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
+.++||+| +|++||+++.+ +|+.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999876 689999999875432 23456778999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999985432 23478899999999999999999998 999999999999999999999999986543221111
Q ss_pred c------eeeeeecCccccCcccccc--CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhh-----
Q 002382 760 H------VSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE----- 826 (929)
Q Consensus 760 ~------~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~----- 826 (929)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ +.........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 233 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCLLDT 233 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcCCccccccc
Confidence 0 1112346778999999976 4688999999999999999999999975331110 0000000000
Q ss_pred ----cCCc-----ccccCCcc-----------------cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 827 ----SGDI-----QGIIDPSL-----------------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 827 ----~~~~-----~~~~d~~l-----------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..++ ....+... ...........+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000 00000000 001112223468899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=321.55 Aligned_cols=263 Identities=19% Similarity=0.246 Sum_probs=198.5
Q ss_pred HHHHHHHHhccccccCcEEEEEEEEC---CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 598 IEDATKMLEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 598 i~~~~~~~~~~IG~G~fG~Vy~~~~~---~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
+....|.+.+.||+|+||.||++... .++.||+|.+... +...+|++++++++||||+++++++......++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 33446777899999999999999764 3567999987543 345689999999999999999999999999999
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
|||++. ++|.+++. ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 164 v~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999985 67877772 345689999999999999999999998 9999999999999999999999999999755
Q ss_pred cCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC--cc
Q 002382 755 VDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD--IQ 831 (929)
Q Consensus 755 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~--~~ 831 (929)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....+ .+.... ..
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~ 314 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFP 314 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccC
Confidence 433221 22345699999999999999999999999999999999999999976543222112211111 110000 00
Q ss_pred cc-----------cCCcccCccC-------HHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 832 GI-----------IDPSLLDEYD-------IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 832 ~~-----------~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.. +....+..+. ......+.+++.+|++.+|++||++.|++.+
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000000 0112357789999999999999999999987
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=304.95 Aligned_cols=247 Identities=25% Similarity=0.372 Sum_probs=200.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||.|+||.||+|+.. +++.||+|++.... ......+.+|+++++.++|+||+++++++.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 556788999999999999876 58899999987543 3344678899999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++.. ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++.......
T Consensus 83 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 83 GGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred CCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 9999998853 2688999999999999999999998 999999999999999999999999999976544322
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
......++..|+|||++.+..++.++|||||||++|||++|+.||...... .... ......... +..
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~----~~~~----~~~~~~~~~-----~~~ 220 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM----RVLF----LIPKNNPPS-----LEG 220 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH----HHHH----HhhhcCCCC-----Ccc
Confidence 222345788999999999888999999999999999999999999754311 1111 111111111 111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. .....+.+++.+|+..+|++||++++++++
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 022357889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=310.89 Aligned_cols=259 Identities=23% Similarity=0.316 Sum_probs=197.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
+.+.+.||+|+||.||++.+. +++.+|+|.+.... .....++.+|++++++++||||+++++++..++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 345678999999999999876 57788999886542 2334568899999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++.. ...+++..+..++.|+++||.|||+. .+++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 154 (308)
T cd06615 83 GGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154 (308)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence 9999999853 35578888999999999999999974 289999999999999999999999999987543221
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcc---------
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ--------- 831 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~--------- 831 (929)
.....|+..|+|||.+.+..++.++|+|||||++|||++|+.||...... ....+...........
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK----ELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh----hHHHhhcCccccccccCCcccccCC
Confidence 22345889999999998888999999999999999999999998643311 1111111100000000
Q ss_pred -----------cccCCcc---cCcc-CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 832 -----------GIIDPSL---LDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 832 -----------~~~d~~l---~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+..+... .... .......+.+++.+|++.+|++||++.||+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 0000 00122358899999999999999999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=306.09 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=199.5
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
..|.+.+.||+|+||.||+|+.. +++.+++|++........+.+.+|+++++.++||||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 34667789999999999999886 47899999997666555677889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|..++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 999998877432 34578899999999999999999998 99999999999999999999999999986533221
Q ss_pred ceeeeeecCccccCccccc-----cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 760 HVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
.......++..|+|||++. ...++.++|||||||++|||++|..||...... ..+..+ . ........
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~----~-~~~~~~~~ 236 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKI----A-KSEPPTLS 236 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH---HHHHHH----h-cCCCccCC
Confidence 1223345889999999985 345678999999999999999999998654311 111111 1 11111100
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. +......+.+++.+|++.+|++||++.|++++
T Consensus 237 ~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 Q-------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred C-------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 11223357899999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=300.12 Aligned_cols=250 Identities=25% Similarity=0.299 Sum_probs=206.9
Q ss_pred HHhccccccCcEEEEEEEECC-CcEEEEEEeecCCcch---hHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~~~---~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
++.+.||+|.-|+||++.+++ +...|+|++.+..... ......|-+||+.++||.+..|+..++.++..|++||||
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC 159 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC 159 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence 466889999999999999884 5789999998764333 345677999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC---
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD--- 756 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~--- 756 (929)
+||+|...++. +.++.+++..+.-++.+++.||+|||-. |||+|||||+||||.++|++.|+||.++..+..
T Consensus 160 pGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 160 PGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred CCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 99999988754 4577899999999999999999999998 999999999999999999999999998853211
Q ss_pred ------------------------------CCC----------------------ceeeeeecCccccCccccccCcCCC
Q 002382 757 ------------------------------GAS----------------------HVSSIVRGTVGYLDPEYYISQQLTD 784 (929)
Q Consensus 757 ------------------------------~~~----------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ 784 (929)
... ..+...+||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 000 0112245999999999999999999
Q ss_pred cCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCC
Q 002382 785 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM 864 (929)
Q Consensus 785 ~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~ 864 (929)
++|.|+|||++|||+.|..||.+....+...+++.. .+.-....+....+.+||.+.+.+||++
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~----------------~l~Fp~~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ----------------PLKFPEEPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC----------------CCcCCCCCcchhHHHHHHHHHhccChhh
Confidence 999999999999999999999887755555555441 1111112245567889999999999999
Q ss_pred CCc----HHHHHHH
Q 002382 865 RPS----ISEVLKD 874 (929)
Q Consensus 865 RPs----~~eVl~~ 874 (929)
|.. +.||.+|
T Consensus 379 Rlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRH 392 (459)
T ss_pred hhccccchHHhhcC
Confidence 998 8888876
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.94 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=197.2
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEeecCCc------chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~------~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.+.+.||+|+||.||+|...+++.+|||.+..... .....+.+|++++++++|+||+++++++.+.+..++|+|
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 35678999999999999988899999998864321 123468889999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||+++.....
T Consensus 83 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 83 FVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999843 24578888899999999999999998 9999999999999999999999999998754221
Q ss_pred C-----CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 758 A-----SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 758 ~-----~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
. ........|+..|+|||++.+..++.++|||||||++|||++|+.||......+ ..... ....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~---~~~~~~~-- 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA---AMFYI---GAHRGLM-- 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH---HHHHh---hhccCCC--
Confidence 1 111223458899999999998889999999999999999999999997543111 11110 0000111
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+.+... ....+.+++.+|++.+|++||++.|++++
T Consensus 228 ---~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 228 ---PRLPDS----FSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred ---CCCCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 111122 23457899999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=316.21 Aligned_cols=253 Identities=21% Similarity=0.244 Sum_probs=193.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+.+.++||+|+||+||+++++ .++.+|+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 345688999999999999987 46789999986432 22234578899999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 83 YVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999998532 34578888999999999999999998 99999999999999999999999999987543333
Q ss_pred CceeeeeecCccccCccccc-----cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 759 SHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
........||+.|+|||++. ...++.++|||||||++|||++|+.||......+.. ...........
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~-------~~i~~~~~~~~- 228 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-------GKIMNHKERFQ- 228 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH-------HHHhCCCcccc-
Confidence 33333456999999999986 346788999999999999999999999754421111 11111110000
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCC--CCCCcHHHHHHH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHG--HMRPSISEVLKD 874 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP--~~RPs~~eVl~~ 874 (929)
+. .........+.+++.+|+..++ ..||++.|++++
T Consensus 229 ~p-----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FP-----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CC-----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 0001123456777888775544 447899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=307.48 Aligned_cols=240 Identities=24% Similarity=0.399 Sum_probs=188.7
Q ss_pred ccccccCcEEEEEEEECC--------CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 607 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~--------~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+.||+|+||.||+|..+. ..++|+|++........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998652 234888887655444456788999999999999999999999998999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc--------EEEEeecC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--------AKVSDFGL 750 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--------vkL~DFGl 750 (929)
+.+|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999998643 23578888999999999999999998 9999999999999987765 69999998
Q ss_pred cccccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCC-CCCccccccccchhhHHHHHHhhhcC
Q 002382 751 SKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ-EAISNEKFGANCRNIVQWAKLHIESG 828 (929)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~-~p~~~~~~~~~~~~l~~~~~~~~~~~ 828 (929)
+...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+..... . ..... .....
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~---~~~~~---~~~~~ 222 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-Q---KKLQF---YEDRH 222 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-H---HHHHH---HHccc
Confidence 8644321 22457889999999986 45789999999999999999995 55543221 0 11111 00000
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 829 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
..+.....++.+++.+|++.+|++|||++|+++.|+
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 ------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111112246889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=300.79 Aligned_cols=249 Identities=23% Similarity=0.382 Sum_probs=198.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeee-cCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~-~~~~~LV~E~ 678 (929)
|.+.+.||+|++|.||+++.+ +++.+|+|.+.... ....+.+.+|++++++++|+|++++++.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 456789999999999999876 57889999986543 2334568899999999999999999998764 4467899999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++... ....+++.+++.++.|++.||++||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 82 CEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999988642 234588999999999999999999998 99999999999999999999999999987653322
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
. ......+++.|+|||++.+..++.++|||||||+++||++|+.||...... ...... ..+.+.
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-------~~~~~~-~~~~~~------- 220 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN-------SLVYRI-IEGKLP------- 220 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHH-HhcCCC-------
Confidence 2 223345889999999999999999999999999999999999998754311 111111 111111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+......+.+++.+|++.+|++||++.|++++
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1112233468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=305.10 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=201.2
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
..|.+.+.||+|+||.||+|.+. +++.+|+|++..........+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 34677889999999999999876 58899999987665555677889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 85 DGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999988532 34588999999999999999999998 999999999999999999999999999865433221
Q ss_pred ceeeeeecCccccCccccc-----cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 760 HVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
......++..|+|||.+. ...++.++|+|||||++|||++|+.||...... ..+..+ ..+......
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~~~~~-----~~~~~~~~~ 229 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RVLLKI-----LKSEPPTLD 229 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HHHHHH-----hcCCCCCcC
Confidence 223345899999999975 345677999999999999999999999754311 111111 111111100
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. +......+.+++.+|++.+|++||++.+|+++
T Consensus 230 ~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 Q-------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred C-------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 11122357889999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=302.35 Aligned_cols=238 Identities=24% Similarity=0.423 Sum_probs=188.8
Q ss_pred ccccccCcEEEEEEEECCCc-----------EEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 607 KKIGSGGFGVVYYGKLKDGK-----------EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~-----------~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
+.||+|+||.||+|.+.+.. .+++|++...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999887433 5788877654333 6788999999999999999999999988 778999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC-------cEEEEee
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-------RAKVSDF 748 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-------~vkL~DF 748 (929)
+||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999998643 22678888999999999999999998 999999999999999887 7999999
Q ss_pred cCcccccCCCCceeeeeecCccccCccccccC--cCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhh
Q 002382 749 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 749 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
|+++.... .....++..|+|||++... .++.++|||||||++|||++ |..|+...... ....+..
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~----~~~~~~~--- 220 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS----EKERFYQ--- 220 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch----hHHHHHh---
Confidence 99875433 1223467789999999876 78899999999999999999 57777554311 1111111
Q ss_pred hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 826 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
..... +......+.+++.+|+..+|++||++.||++.|+
T Consensus 221 ~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQHRL------------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCCC------------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11000 0001157889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=320.69 Aligned_cols=261 Identities=22% Similarity=0.286 Sum_probs=193.2
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeec------CeE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 672 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~------~~~ 672 (929)
.|.+.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 4556789999999999999876 57889999987532 23345678899999999999999999987543 357
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
++||||+.+ +|.+.+. ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 105 YIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred EEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 999999975 6666552 2367788889999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHH------------
Q 002382 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW------------ 820 (929)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~------------ 820 (929)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+....+...
T Consensus 175 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 54332 1223345899999999999999999999999999999999999999754421111111110
Q ss_pred ---HHHhhhcC-Ccc-----cccCCcc---cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 821 ---AKLHIESG-DIQ-----GIIDPSL---LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 821 ---~~~~~~~~-~~~-----~~~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
........ ... ....... ...........+.+++.+|++.||++|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 000 0000000 000111123467899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=318.70 Aligned_cols=241 Identities=26% Similarity=0.320 Sum_probs=185.8
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEeecCCcc---hhHHHHHHHHHhccc---CCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRI---HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 609 IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~---~~~~f~~Ev~iL~~l---~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
||+|+||+||+|+.. +++.||||++...... ....+..|..++... +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 5889999998653221 123344566666655 699999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++. ....+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 99988874 345688999999999999999999998 99999999999999999999999999987533222 12
Q ss_pred eeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 762 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .+.. ....+.. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~----~~~~----~i~~~~~------~~~~ 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ----QMYR----NIAFGKV------RFPK 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH----HHHH----HHHcCCC------CCCC
Confidence 2345699999999998764 4789999999999999999999999754311 1111 1111111 0110
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCC----cHHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRP----SISEVLKD 874 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RP----s~~eVl~~ 874 (929)
. .....+.+++.+|++.+|++|| ++.|++++
T Consensus 219 ~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 219 N---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred c---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 0 1123567899999999999998 56666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=319.91 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=193.2
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeec------CeE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 672 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~------~~~ 672 (929)
.|.+.+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 4556789999999999999875 58899999987542 23345677899999999999999999988543 356
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
++||||+++ +|.+.+. ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 98 ~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 98 YLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred EEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 999999975 5655552 2467888889999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHH-------------
Q 002382 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ------------- 819 (929)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~------------- 819 (929)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+....++.
T Consensus 168 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 54322 122334689999999999998999999999999999999999999975442111111111
Q ss_pred --HHHHhhhcC-CcccccCC-----ccc---CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 820 --WAKLHIESG-DIQGIIDP-----SLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 820 --~~~~~~~~~-~~~~~~d~-----~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
......... .......+ .+. ..........+.+++.+|++.||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 00000000 000 00111123467899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=303.83 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=196.0
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeee-----ecCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ-----EEGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~-----~~~~~~L 674 (929)
.+.+.+.||+|+||.||++... +++.+|+|++.... ....++.+|+.+++.+ +||||+++++++. .++..++
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 3445688999999999999876 57899999876432 2245688899999999 6999999999874 3456899
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
||||+++++|.+++.........+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 9999999999998865444456688889999999999999999998 9999999999999999999999999998755
Q ss_pred cCCCCceeeeeecCccccCcccccc-----CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
.... .......|++.|+|||++.. ..++.++|||||||++|||++|+.||...... ..+... ....
T Consensus 175 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~~~~-----~~~~ 245 (286)
T cd06638 175 TSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---RALFKI-----PRNP 245 (286)
T ss_pred ccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---HHHhhc-----cccC
Confidence 3322 12233458999999999853 45788999999999999999999998754311 111110 0010
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
.....++. .....+.+++.+|++.+|++||++.|++++.
T Consensus 246 ~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 246 PPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 01111111 1123588999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.51 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=195.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||.||+|+.+ +++.||+|.++... ......+.+|+.+++.++||||+++++++..++..++||||+.
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 455688999999999999876 57899999987543 2234567789999999999999999999999999999999997
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
++|.+++... ...+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 88 -~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 88 -KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred -cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 5888877532 34578888999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC----
Q 002382 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID---- 835 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d---- 835 (929)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.+...... ......+++
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGILSNEEF 238 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC-hhhchhhhccccc
Confidence 1122346889999999865 3578899999999999999999999975442211111111100000 000000000
Q ss_pred -----CcccCc----cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 -----PSLLDE----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 -----~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+..... ........+.+++.+|++.+|++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 011122357899999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=303.19 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=201.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeee--cCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~--~~~~~LV~E 677 (929)
|.+.+.||.|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 345678999999999999875 67889999987542 2334568889999999999999999998754 456799999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCC--CCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
|+++++|.+++.........+++..++.++.|++.||+|||..+ ..+++|+||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 99999999998655444567899999999999999999999221 2299999999999999999999999999998654
Q ss_pred CCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
..... .....++..|+|||.+....++.++|+||||+++++|++|+.||.... ...+.+.. ..+...
T Consensus 162 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~----~~~~~~---- 228 (265)
T cd08217 162 HDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN----QLQLASKI----KEGKFR---- 228 (265)
T ss_pred CCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC----HHHHHHHH----hcCCCC----
Confidence 43321 223458999999999998889999999999999999999999997543 11222221 111111
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+......+.+++.+|++.+|++||++.||+++
T Consensus 229 -----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 -----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1112233568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=317.92 Aligned_cols=189 Identities=22% Similarity=0.346 Sum_probs=160.9
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.|.+.+.||+|+||.||+|+.. .++.||+|+.... ....|+.++++++||||+++++++...+..++|+|++.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 4667789999999999999887 4678999975432 23568999999999999999999999999999999995
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
++|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 141 -~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~ 211 (357)
T PHA03209 141 -SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--P 211 (357)
T ss_pred -CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--c
Confidence 688887743 245688999999999999999999998 9999999999999999999999999998743222 1
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 805 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~ 805 (929)
......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 222345899999999999999999999999999999999865554
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=311.64 Aligned_cols=254 Identities=25% Similarity=0.413 Sum_probs=197.4
Q ss_pred HHhccccccCcEEEEEEEEC-CCc----EEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~----~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
...+.||+|+||.||+|++. +++ .||+|++..... ....++.+|+.+++.++||||+++++++... ..++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e 88 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ 88 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence 34578999999999999875 343 478888865432 2244688999999999999999999998754 4679999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 89 LMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred hcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999988532 33578888999999999999999998 9999999999999999999999999999865433
Q ss_pred CCce-eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 758 ASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 758 ~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
.... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ...+.++.. .+....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~----~~~~~~~~~----~~~~~~--- 231 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP----TREIPDLLE----KGERLP--- 231 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHH----CCCCCC---
Confidence 2221 122335678999999998899999999999999999997 899986543 122222221 111000
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
........+.+++..|+..+|++||++.|+++.|+++...
T Consensus 232 ------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 232 ------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0011223578999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.05 Aligned_cols=265 Identities=21% Similarity=0.258 Sum_probs=199.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||.||+|.++ +++.||+|+++... ......+.+|++++++++|+||+++++++...+..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 446688999999999999887 57899999886532 233467899999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
+++.+..+.. ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 83 ERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9877766553 234478899999999999999999998 999999999999999999999999999886554433
Q ss_pred ceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh--------hcC--
Q 002382 760 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI--------ESG-- 828 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~--------~~~-- 828 (929)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||......+....+........ ...
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 233334578899999999887 889999999999999999999999975432111111111100000 000
Q ss_pred ---CcccccCCcc-cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 829 ---DIQGIIDPSL-LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 829 ---~~~~~~d~~l-~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
......++.. ...++......+.+++.+|+..+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000000 001112224678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=319.32 Aligned_cols=263 Identities=22% Similarity=0.251 Sum_probs=200.9
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccC-C-----CceeEEeeeeeecCeEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-H-----RNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-H-----pNIv~l~g~~~~~~~~~ 673 (929)
.+|.+.+.||+|.||.|-+|... +++.||||+++... .-.++-..|+.+|..++ | -|+|+++++|...+++|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 36777899999999999999766 68999999998553 33456678999999996 4 48999999999999999
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC--cEEEEeecCc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM--RAKVSDFGLS 751 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~--~vkL~DFGla 751 (929)
||+|.+. .+|.++|+.+ ....++...+..|+.||+.||.+||+. +|||+||||+||||.+.. .+||+|||.|
T Consensus 265 iVfELL~-~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhhh-hhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999884 5999999765 345588899999999999999999998 999999999999997543 7999999999
Q ss_pred ccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHH-------Hh
Q 002382 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LH 824 (929)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~-------~~ 824 (929)
+....... ...-+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+....+....|++-.. ..
T Consensus 339 c~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 339 CFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 86543221 33468899999999999999999999999999999999888876442111111111100 00
Q ss_pred -------hhc-CCcc------c----------------ccCCcccC--------ccCHHHHHHHHHHHHHccCCCCCCCC
Q 002382 825 -------IES-GDIQ------G----------------IIDPSLLD--------EYDIQSMWKIEEKALMCVLPHGHMRP 866 (929)
Q Consensus 825 -------~~~-~~~~------~----------------~~d~~l~~--------~~~~~~~~~l~~li~~Cl~~dP~~RP 866 (929)
+.. .... + ..+..... .........+.+++.+|+.+||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 000 0000 0 00100000 11124456789999999999999999
Q ss_pred cHHHHHHH
Q 002382 867 SISEVLKD 874 (929)
Q Consensus 867 s~~eVl~~ 874 (929)
|+.|.++|
T Consensus 495 tp~qal~H 502 (586)
T KOG0667|consen 495 TPAQALNH 502 (586)
T ss_pred CHHHHhcC
Confidence 99999987
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=308.49 Aligned_cols=248 Identities=24% Similarity=0.368 Sum_probs=199.7
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
|.+.+.||.|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 344578999999999999864 6899999998766555567788999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
++|.+++. ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........ .
T Consensus 101 ~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 101 GSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 99999874 23578999999999999999999998 999999999999999999999999999875433322 1
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+.. ..... ... + .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~---~~~~~----~~~~~-~~~-----~--~ 236 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYL----IATNG-TPE-----L--Q 236 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhcC-Ccc-----c--C
Confidence 22345889999999999888999999999999999999999999764411 11111 11110 000 0 0
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+......+.+++.+|++.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 011122357789999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=309.60 Aligned_cols=197 Identities=24% Similarity=0.389 Sum_probs=159.1
Q ss_pred hccccccCcEEEEEEEEC---CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeee--cCeEEEEEEecc
Q 002382 606 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMH 680 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~---~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~--~~~~~LV~E~~~ 680 (929)
..+||+|+||+||+|+.+ +++.||+|.+..... ...+.+|++++++++||||+++++++.. +...++|+||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999876 356899998865432 3457889999999999999999998853 567899999987
Q ss_pred CCchhhhhcccc-----ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe----cCCCcEEEEeecCc
Q 002382 681 NGTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLS 751 (929)
Q Consensus 681 ~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkL~DFGla 751 (929)
+ +|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 6766663211 1233578889999999999999999998 99999999999999 56679999999999
Q ss_pred ccccCCCCc--eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccc
Q 002382 752 KFAVDGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNE 808 (929)
Q Consensus 752 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~ 808 (929)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 865433221 1233468999999999876 45789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=306.98 Aligned_cols=264 Identities=23% Similarity=0.264 Sum_probs=194.6
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.+.+.||+|++|.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 35678999999999999886 68899999986432 2224668899999999999999999999999999999999997
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
++|.+++.... ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 83 -~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~ 156 (285)
T cd07861 83 -MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-R 156 (285)
T ss_pred -CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-c
Confidence 68888775432 235688999999999999999999998 99999999999999999999999999987543221 1
Q ss_pred eeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc------------
Q 002382 761 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES------------ 827 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~------------ 827 (929)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+.+........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 12223468899999988654 57889999999999999999999997543111111111100000000
Q ss_pred CCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 828 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 828 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..........+. ........++.+++.+|++.||++|||+.||+++
T Consensus 237 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 237 NTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000 0001123456799999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=305.88 Aligned_cols=265 Identities=23% Similarity=0.287 Sum_probs=199.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||.||+|++. +++.||+|++.... ......+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 446688999999999999876 68899999987653 233567899999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
+++|.+++... ...+++.++..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 82 -~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 82 -PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred -CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99999988543 25588999999999999999999998 999999999999999999999999999886544332
Q ss_pred ceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc-----CCc---
Q 002382 760 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES-----GDI--- 830 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~-----~~~--- 830 (929)
.......|+..|+|||.+.+. .++.++||||+||+++||++|.+||......+....+.......... ..+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 222334589999999998754 46889999999999999999988886443111111111100000000 000
Q ss_pred ccccCCccc----CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 QGIIDPSLL----DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+..+... .....+....+.+++.+|++.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 00001223678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=299.01 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=201.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||.||.++.. +++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 345678999999999999865 5889999988654 2344567889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++.... ...+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 82 NGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred CCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999986432 34678899999999999999999998 999999999999999999999999999876543332
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
......|++.|+|||+..+..++.++||||||+++|||++|..||......+ . ..... .+....
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----~---~~~~~-~~~~~~------- 220 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN----L---VVKIV-QGNYTP------- 220 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH----H---HHHHH-cCCCCC-------
Confidence 2233458999999999988888999999999999999999999997543111 1 11111 111111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
........+.+++.+|++.+|++||++.|+++++
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0112234688999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=300.68 Aligned_cols=249 Identities=32% Similarity=0.504 Sum_probs=199.8
Q ss_pred HhccccccCcEEEEEEEECC-----CcEEEEEEeecCCcc-hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 605 LEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~~-----~~~vAVK~l~~~~~~-~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+.+.||+|+||.||+++..+ +..||+|+++..... ..+.+.+|+++++.++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45789999999999998874 378999999765433 467899999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 83 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 83 MEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred cCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999985432 12289999999999999999999998 99999999999999999999999999998655442
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
........++..|+|||.+.+..++.++||||+|++++||++ |+.||..... ..+.+... .+....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~~----~~~~~~----- 224 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN----EEVLEYLK----KGYRLP----- 224 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHh----cCCCCC-----
Confidence 222222336789999999988889999999999999999998 7888865331 12222211 111110
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
........+.+++.+|+..+|++|||+.|+++.|
T Consensus 225 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 ----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111334688899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=305.21 Aligned_cols=256 Identities=24% Similarity=0.403 Sum_probs=202.4
Q ss_pred HHHHHhccccccCcEEEEEEEECC-Cc----EEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLKD-GK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~~-~~----~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
..+.+.+.||+|+||.||+|.+++ ++ .+|+|++..... ....++.+|++++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 445667899999999999998753 32 589998875543 345678899999999999999999999987 78899
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999998542 33588999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCcee-eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 755 VDGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 755 ~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
........ ....++..|+|||.+....++.++|+|||||++||+++ |+.||..... .++.+.+. .+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~----~~~~~- 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----VEIPDLLE----KGERL- 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH----HHHHHHHh----CCCCC-
Confidence 43322221 12224568999999988889999999999999999998 9999975441 12222221 11100
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
..+......+.+++.+|+..+|.+||++.++++.|+++..
T Consensus 231 --------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 --------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0011122357899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=302.98 Aligned_cols=264 Identities=22% Similarity=0.274 Sum_probs=197.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|++++++++|||++++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 345678999999999999987 58899999886442 223456889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 83 DHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred CccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99888877632 34588999999999999999999998 999999999999999999999999999976543321
Q ss_pred ceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhh-------cCCc-
Q 002382 760 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE-------SGDI- 830 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~-------~~~~- 830 (929)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+......... ....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 1222347889999999876 55788999999999999999999999754422111111111110000 0000
Q ss_pred ccccCCcccCccC-----HHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 QGIIDPSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.....+......+ ......+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000010000001 1113467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=298.24 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=201.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.+.+.||+|+||.||+|... +++.+++|++........+.+.+|++++++++||||+++++++...+..+++|||+.+
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 445688999999999999876 5788999999866555667899999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....... ..
T Consensus 85 ~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 85 GSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred CcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 9999987532 24688899999999999999999998 99999999999999999999999999987543321 11
Q ss_pred eeeeecCccccCccccccC---cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 762 SSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~---~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.....++..|+|||.+... .++.++|+|||||++|||++|+.||...... ....... ...+. .+.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~---~~~~~~~-----~~~~~---~~~~ 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM---RALFLIS-----KSNFP---PPKL 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH-----hccCC---Cccc
Confidence 2234578899999999776 7889999999999999999999999754311 1111110 01000 0011
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. ........+.+++.+|++.+|++||++.+|+.+
T Consensus 227 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 227 K--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred c--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1 112234568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=307.07 Aligned_cols=245 Identities=25% Similarity=0.384 Sum_probs=197.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
...||+|+||.||++... +++.||||.+........+.+.+|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 356999999999999875 5889999998765555566788999999999999999999999999999999999999999
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeee
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (929)
.+++. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........ ....
T Consensus 107 ~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 177 (292)
T cd06658 107 TDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS 177 (292)
T ss_pred HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence 98873 23578889999999999999999998 999999999999999999999999999875433222 2233
Q ss_pred eecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCH
Q 002382 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844 (929)
Q Consensus 765 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 844 (929)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...... .....+... +.+.+....
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~~---------~~~~~~~~~-- 242 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----QAMRRIRDN---------LPPRVKDSH-- 242 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhc---------CCCcccccc--
Confidence 45899999999998888999999999999999999999999754311 111111111 111111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 845 QSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 845 ~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.....+.+++.+|++.+|++|||++|++++
T Consensus 243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 122357789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=303.48 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=197.7
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC-CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
+.+.+.||+|+||.||++..+ +++.||+|.++.. .......+.+|++++++++||||+++++.+...+..++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 567789999999999999887 6899999988754 22334678899999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++.... ....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 83 AGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 999988885421 234688999999999999999999974 28999999999999999999999999998754322
Q ss_pred eeeeeecCccccCccccccCc------CCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 761 VSSIVRGTVGYLDPEYYISQQ------LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~------~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
......++..|+|||.+.+.. ++.++|+|||||++|||++|+.||....... ........ ..+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~~-~~~~~~--- 228 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN----IFAQLSAI-VDGDPP--- 228 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh----HHHHHHHH-hhcCCC---
Confidence 122334788999999986543 4789999999999999999999996543211 11111111 111111
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+......+.+++.+|++.+|++||++.+++++
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 ------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1112234467899999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=311.26 Aligned_cols=240 Identities=27% Similarity=0.436 Sum_probs=195.3
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.||.|+||.||-|++. +.+.||||++.-.. .+.-.++.+|+..|++++|||++.+-|+|..+...+||||||- |
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence 57999999999999876 57789999986443 2334678999999999999999999999999999999999996 4
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
+-.|.+.- ..+++.+.++..|+++.+.||+|||+. +.||||||+.|||+++.|.|||+|||.|....+ .
T Consensus 111 SAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----A 179 (948)
T KOG0577|consen 111 SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----A 179 (948)
T ss_pred cHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-----h
Confidence 66666642 356688889999999999999999998 999999999999999999999999999876543 3
Q ss_pred eeeecCccccCccccc---cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 763 SIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
..+.|||.|||||++. .++|+-++||||||+...||...++|+-.++- .-+..++...+. |.+.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--------MSALYHIAQNes-----PtLq 246 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNES-----PTLQ 246 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--------HHHHHHHHhcCC-----CCCC
Confidence 4467999999999985 57899999999999999999999999765440 111122222221 1111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+-...|..++..|++.-|++|||.++++.|
T Consensus 247 ---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 23344578899999999999999999988765
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=301.15 Aligned_cols=247 Identities=25% Similarity=0.385 Sum_probs=189.9
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-----chhHHHHHHHHHhcccCCCceeEEeeeeee--cCeEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLV 675 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-----~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~--~~~~~LV 675 (929)
...+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++.. ....+++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 34678999999999999875 588999998864321 223568889999999999999999998865 3567899
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
+||+++++|.+++.. ...+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 85 MEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 999999999998853 33578888899999999999999998 99999999999999999999999999987543
Q ss_pred CCC--CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 756 DGA--SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 756 ~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
... ........++..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+ .......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~---~~~----~~~~~~~----- 225 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM---AAI----FKIATQP----- 225 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH---HHH----HHHhcCC-----
Confidence 211 11112244789999999999888999999999999999999999999754311 111 1111110
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+ ..+......+.+++ +|+..+|++||+++||+++
T Consensus 226 ~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 TNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 011 11112223455565 7888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=312.38 Aligned_cols=259 Identities=23% Similarity=0.295 Sum_probs=191.3
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeec------CeE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 672 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~------~~~ 672 (929)
.|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 4566789999999999999875 67899999986532 22345677899999999999999999987543 356
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
+++++++ +++|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 96 YLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred EEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccce
Confidence 8999987 778887763 34588999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh-------
Q 002382 753 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH------- 824 (929)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~------- 824 (929)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.......
T Consensus 167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54322 223458999999999876 568899999999999999999999997543211111111110000
Q ss_pred hhcC-------CcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 825 IESG-------DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 825 ~~~~-------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.... .+...-...+.. ........+.+++.+|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred cchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000000000000 000111246799999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=306.47 Aligned_cols=245 Identities=23% Similarity=0.362 Sum_probs=197.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
...||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 357999999999999876 6889999998765545566788999999999999999999999999999999999999999
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeee
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (929)
.+++. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... .....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~ 176 (297)
T cd06659 106 TDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS 176 (297)
T ss_pred HHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccc
Confidence 88763 24578889999999999999999998 99999999999999999999999999987543322 12233
Q ss_pred eecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCH
Q 002382 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844 (929)
Q Consensus 765 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 844 (929)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...... ....... ...... ... ..
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~----~~~~~~-----~~~--~~ 241 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----QAMKRLR----DSPPPK-----LKN--AH 241 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHh----ccCCCC-----ccc--cC
Confidence 55899999999999888999999999999999999999999643311 1111111 110000 000 01
Q ss_pred HHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 845 QSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 845 ~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.....+.+++.+|++.+|++||++.|++++
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 122357889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=298.69 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=199.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||.+|+++.. +++.+|+|.+... .....+++.+|+.++++++||||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 345688999999999999876 6889999998643 2233467899999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
.+++|.+++... ....+++..+..++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 82 EGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999988532 223578888999999999999999998 999999999999999999999999999875433221
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
......|++.|+|||+..+..++.++|+|||||++++|++|+.||...... .++ .... .+...
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----~~~---~~~~-~~~~~-------- 219 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK----NLV---LKII-RGSYP-------- 219 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH----HHH---HHHh-cCCCC--------
Confidence 122345888999999999888999999999999999999999998654311 111 1111 11111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+......+.+++.+|++.+|++||+|.||+++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 -PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0111223468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.03 Aligned_cols=264 Identities=22% Similarity=0.321 Sum_probs=197.7
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 345688999999999999986 588999998764422 23456889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.++... ...+++..++.++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 83 DHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred CccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 99988876632 23478999999999999999999998 999999999999999999999999999875543322
Q ss_pred ceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh-------hcCCc-
Q 002382 760 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI-------ESGDI- 830 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~-------~~~~~- 830 (929)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+..+..... .....
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 2223447889999999875 4577899999999999999999999865442211112222111100 00000
Q ss_pred ccccCCcccCc-----cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 QGIIDPSLLDE-----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.....+..... ........+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000000 011223568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=299.79 Aligned_cols=246 Identities=29% Similarity=0.481 Sum_probs=195.8
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+.+.||+|+||.||++.. .++.||+|+++... ....+.+|+.++++++|||++++++++... ..++||||+.+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 356778999999999999975 47889999986542 245788999999999999999999998664 47999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 9999998643 234578888999999999999999998 99999999999999999999999999987543221
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....+..|+|||.+.+..++.++|+|||||++|||++ |+.||...... .+... ...+...
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~~----~~~~~~~--------- 216 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK----EVKEC----VEKGYRM--------- 216 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH----HHHHH----HhCCCCC---------
Confidence 11234578999999988889999999999999999998 99998754421 11111 1111100
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
.........+.+++.+|++.+|++||++.++++.|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0111223467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=299.69 Aligned_cols=246 Identities=27% Similarity=0.407 Sum_probs=197.1
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-----cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-----~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
...+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++......++++|
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 34578999999999999887 78999999986543 2234678899999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++++|.+++.. ...+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 83 LVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred ecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999998853 34578888999999999999999998 9999999999999999999999999998754332
Q ss_pred CCceeeeeecCccccCccccccCc-CCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
. ......|+..|++||.+.... ++.++|+|||||++|+|++|+.||..... ...+..+ .......
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~~~~----~~~~~~~----- 221 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFKI----GRSKELP----- 221 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHHHHH----HhcccCC-----
Confidence 2 223345889999999987766 89999999999999999999999965431 1111111 1101111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+......+.+++.+|++.+|++||++.|++++
T Consensus 222 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 ----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1111123457789999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=338.50 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=196.4
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeee--cCeEEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLV 675 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~--~~~~~LV 675 (929)
..|.+.+.||+|+||+||++++. .++.+|+|++.... ......+..|+.++++++||||+++++++.. ....++|
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 35667789999999999999887 46788999886542 2335678899999999999999999998854 4568999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCC----CceecCCCCCCCeEecC------------
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV----PAIIHRDLKSSNILLDK------------ 739 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~----~~ivHrDIkp~NILl~~------------ 739 (929)
|||+++|+|.++|.........+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 99999999999986544445678999999999999999999998521 25999999999999964
Q ss_pred -----CCcEEEEeecCcccccCCCCceeeeeecCccccCcccccc--CcCCCcCceeeHHHHHHHHHhCCCCCccccccc
Q 002382 740 -----HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGA 812 (929)
Q Consensus 740 -----~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~ 812 (929)
.+.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~--- 247 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN--- 247 (1021)
T ss_pred cccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC---
Confidence 2358999999997553321 2234568999999999864 458899999999999999999999996533
Q ss_pred cchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 813 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 813 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....++. . +..+.. .. ... ....+.+++..||+.+|++||++.|++++
T Consensus 248 ~~~qli~---~-lk~~p~-----lp-i~~----~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 248 NFSQLIS---E-LKRGPD-----LP-IKG----KSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred cHHHHHH---H-HhcCCC-----CC-cCC----CCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 1111111 1 111110 00 011 12457899999999999999999999854
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=299.94 Aligned_cols=248 Identities=25% Similarity=0.403 Sum_probs=199.2
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
..+.+.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34556788999999999999875 67899999886443 23346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+.+++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 84 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 999999988842 3578889999999999999999998 99999999999999999999999999987543322
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.......++..|+|||.+.+...+.++|+|||||++|||++|..||..... ...... ...... +.+
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~----~~~~~~-----~~~ 221 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----MKVLFL----IPKNNP-----PTL 221 (277)
T ss_pred -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----HHHHHH----HhcCCC-----CCC
Confidence 122234578899999999888889999999999999999999999864331 111111 111111 111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.......+.+++.+|++.+|++||++.|++++
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 ----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223467899999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=302.69 Aligned_cols=252 Identities=27% Similarity=0.384 Sum_probs=195.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeeec-----CeEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-----GRSVLV 675 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~-----~~~~LV 675 (929)
+.+.+.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++... +..++|
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 345678999999999999875 68899999986432 2245678899999998 899999999998653 358999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
+||+++++|.+++.........+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 999999999998865444456788999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCceeeeeecCccccCccccccC-----cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCc
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 830 (929)
.... ......|+..|+|||.+... .++.++|||||||++|||++|+.||...... ..+..+ ..+..
T Consensus 180 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---~~~~~~-----~~~~~ 250 (291)
T cd06639 180 STRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---KTLFKI-----PRNPP 250 (291)
T ss_pred cccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---HHHHHH-----hcCCC
Confidence 3221 12234588999999998643 3678999999999999999999999754311 111111 11111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+.+ ..+....+.+++.+|++.+|++||++.|++++
T Consensus 251 ~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 251 PTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111 11122458899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=296.56 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=201.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
+.+.+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|+|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 446788999999999999875 57889999987543 2345778999999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 83 GGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 9999999864321 24678899999999999999999998 9999999999999999999999999998755443222
Q ss_pred ---eeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 761 ---VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 761 ---~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
......|+..|+|||++... .++.++|+|||||++|||++|+.||......+ .+.+.... . .+
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~~--~--------~~ 225 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLTLQN--D--------PP 225 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHHhcC--C--------CC
Confidence 22334588999999998876 78899999999999999999999997654221 11111111 0 00
Q ss_pred cccCcc-CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+.... .......+.+++.+|++.+|++||++.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111110 11223567899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=328.54 Aligned_cols=262 Identities=19% Similarity=0.258 Sum_probs=187.1
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccC------CCceeEEeeeeeec-CeE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH------HRNLVQFLGYCQEE-GRS 672 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~------HpNIv~l~g~~~~~-~~~ 672 (929)
..|.+.+.||+|+||+||+|.+. .++.||||+++... ...+++..|+++++.++ |.+++++++++... +..
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 34566789999999999999876 57889999996432 22344566777776664 45688999988754 578
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC-----------
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----------- 741 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----------- 741 (929)
++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++ .+|+||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred EEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccccccc
Confidence 8999987 6788887743 35688999999999999999999973 2899999999999998765
Q ss_pred -----cEEEEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchh
Q 002382 742 -----RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 816 (929)
Q Consensus 742 -----~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~ 816 (929)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....
T Consensus 281 ~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999875322 122345699999999999999999999999999999999999999975441111111
Q ss_pred hHH--------HHHHh--------h-hcCCcccccCCcc----cC---ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHH
Q 002382 817 IVQ--------WAKLH--------I-ESGDIQGIIDPSL----LD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 872 (929)
Q Consensus 817 l~~--------~~~~~--------~-~~~~~~~~~d~~l----~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl 872 (929)
+.. |.... . ..+.+....++.- .. .........+.+++.+||+.||++|||++|++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 111 10000 0 0000000000000 00 00001124577999999999999999999999
Q ss_pred HH
Q 002382 873 KD 874 (929)
Q Consensus 873 ~~ 874 (929)
+|
T Consensus 437 ~H 438 (467)
T PTZ00284 437 TH 438 (467)
T ss_pred cC
Confidence 86
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=299.77 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=195.8
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc----------hhHHHHHHHHHhcccCCCceeEEeeeeeecCeE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ----------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~----------~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~ 672 (929)
...+.||+|+||.||+|... +++.+|+|.++..... ..+.+.+|+.++++++|||++++++++...+..
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 45678999999999999865 6889999987532111 123578899999999999999999999999999
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
++|+||+.+++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred EEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999988543 4678888999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCc-eeeeeecCccccCccccccCc--CCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 753 FAVDGASH-VSSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 753 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~--~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
........ ......|+..|+|||.+.... ++.++|+||||+++||+++|..||..... ...... ... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~-~~~-~~ 228 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFK-LGN-KR 228 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHH-hhc-cc
Confidence 54322111 123345889999999987654 78999999999999999999999964331 111111 111 11
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....++.... .+....+.+++.+|++.+|++||++.||+++
T Consensus 229 ~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIPPDVS----MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCCcccc----ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111111111 1233568899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=301.58 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=197.0
Q ss_pred HHhccccccCcEEEEEEEEC----CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecC------e
Q 002382 604 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------R 671 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~----~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~------~ 671 (929)
.+.+.||+|+||.||+|.+. .++.||||++.... ....+++.+|++++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 35678999999999999864 36789999987542 233567889999999999999999999886432 2
Q ss_pred EEEEEEeccCCchhhhhccccc--cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeec
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 749 (929)
.++++||+.+|+|.+++..... ....+++...+.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence 4788999999999888743221 223578888999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhc
Q 002382 750 LSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIES 827 (929)
Q Consensus 750 la~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 827 (929)
+++........ ......++..|++||.+....++.++|||||||++|||++ |+.||..... ..+..+... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~---~ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEIYNYLIK---G 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHHHHHHHc---C
Confidence 98865432211 1122335678999999988889999999999999999999 8888865431 122222111 1
Q ss_pred CCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 828 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 828 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
.... ........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 232 ~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 0112234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=298.48 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=199.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc--hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~--~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||.||+|... +++.+++|+++..... ..+.+.+|+++++.++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 445688999999999999876 6889999998765442 5678899999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++.. ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 82 SGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999998853 34578888999999999999999998 999999999999999999999999999876544332
Q ss_pred ceee---eeecCccccCccccccCc---CCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 760 HVSS---IVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 760 ~~~~---~~~gt~~Y~aPE~~~~~~---~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
.... ...++..|+|||++.+.. .+.++||||||+++||+++|+.||...... ..+..... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~~~~~~~----~~~---- 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQIMFHVG----AGH---- 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HHHHHHHh----cCC----
Confidence 2211 345788999999998766 889999999999999999999999654211 01111100 010
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+.+... ......+.+++.+|++.+|++||++.|++.+
T Consensus 224 -~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 224 -KPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred -CCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0111111 1123457799999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.01 Aligned_cols=251 Identities=23% Similarity=0.389 Sum_probs=197.5
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc------chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~------~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
...+.||+|+||.||+|... +++.+|+|++..... ...+.+.+|++++++++|+||+++++++.+.+..++|+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 34578999999999999864 688999999864321 12457889999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC-cEEEEeecCccccc
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAV 755 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~ 755 (929)
||+++++|.+++.. ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++ .+||+|||.+....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 83 EWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred eccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999998853 34678889999999999999999998 999999999999998776 59999999987554
Q ss_pred CCCC---ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 756 DGAS---HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 756 ~~~~---~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
.... .......|+..|+|||.+.+..++.++||||+||++++|++|..||......... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~--- 228 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL----ALIFKIASATT--- 228 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH----HHHHHHhccCC---
Confidence 3211 1122345789999999998888999999999999999999999999654321111 11111110000
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....+......+.+++.+|++.+|++||++.|++++
T Consensus 229 ------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 ------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 111222333568899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=302.26 Aligned_cols=251 Identities=26% Similarity=0.389 Sum_probs=192.6
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHH-hcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTL-LSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~i-L~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.+.+.||+|+||.||+++++ +|+.||+|+++... .....++..|+.+ ++..+||||+++++++..++..+++|||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 35678999999999999887 68999999987543 2334456666665 566789999999999999999999999996
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
|+|.+++.........+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||+++......
T Consensus 84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (283)
T cd06617 84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-- 158 (283)
T ss_pred -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccc--
Confidence 6888877654444567899999999999999999999852 89999999999999999999999999987553221
Q ss_pred eeeeeecCccccCcccccc----CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 761 VSSIVRGTVGYLDPEYYIS----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~----~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||.... .....+... .. +.. +
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~----~~-~~~-----~ 226 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK--TPFQQLKQV----VE-EPS-----P 226 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc--cCHHHHHHH----Hh-cCC-----C
Confidence 1222457889999998865 456889999999999999999999996432 111122111 11 100 1
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+.. ......+.+++.+|++.+|++||++.|++++
T Consensus 227 ~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 227 QLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1110 0122458899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=304.91 Aligned_cols=264 Identities=20% Similarity=0.255 Sum_probs=192.6
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||.||+|+.. +|+.+|+|+++.... .....+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 345678999999999999886 688999999865422 22356788999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
. ++|.+++... ...+++..++.++.||++||.|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 82 D-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred C-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 7 4777776432 34588999999999999999999998 999999999999999999999999999875433221
Q ss_pred ceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCcccc-ccccchhhHH---------HHHHhh-hc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEK-FGANCRNIVQ---------WAKLHI-ES 827 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~-~~~~~~~l~~---------~~~~~~-~~ 827 (929)
......++..|+|||.+.+. .++.++|||||||++|||++|..|+.... ..+....+.+ |..... ..
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 11223478899999998764 46889999999999999999998864322 1111111111 100000 00
Q ss_pred CCcccccCCccc-CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 828 GDIQGIIDPSLL-DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 828 ~~~~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
............ ..........+.+++.+|++.+|++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000000000 00111123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=296.92 Aligned_cols=251 Identities=28% Similarity=0.400 Sum_probs=200.5
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+.||+|+||.||++.++ +++.+|+|++.... ....+++.+|++++++++||||+++++.+...+..++++||+.+
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 45678999999999999887 58899999987653 34456789999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
++|.+++.... ..+++..+..++.|+++||+|||+ . +++|+||||+||++++++.++|+|||.+.........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 84 GSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred CcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 99999885431 567888889999999999999999 7 9999999999999999999999999998754322111
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .....+.......... +.+..
T Consensus 158 ---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~------~~~~~ 226 (265)
T cd06605 158 ---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEPP------PRLPS 226 (265)
T ss_pred ---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCCC------CCCCh
Confidence 155889999999999989999999999999999999999999654211 1112222222211110 01111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. .....+.+++.+|+..+|++||++.|++++
T Consensus 227 ~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 227 G---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred h---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1 133468899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.45 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=198.1
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeeecC------eE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG------RS 672 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~------~~ 672 (929)
..|.+.+.||+|+||.||+|..+ +++.+++|++..... ...++.+|+.+++++ +|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 34567789999999999999986 578899999875543 346789999999999 7999999999997644 48
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
++||||+++++|.+++.........+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccce
Confidence 999999999999998865433356788999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCceeeeeecCccccCcccccc-----CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc
Q 002382 753 FAVDGASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 827 (929)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 827 (929)
....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.||...... ..+.+ ...
T Consensus 162 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~-----~~~ 232 (275)
T cd06608 162 QLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALFK-----IPR 232 (275)
T ss_pred ecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHHH-----hhc
Confidence 5433221 2223458899999998753 34678899999999999999999999643311 11111 111
Q ss_pred CCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 828 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 828 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+.... +. ........+.+++.+|+..||++|||+.|++++
T Consensus 233 ~~~~~-----~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 NPPPT-----LK--SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred cCCCC-----CC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11111 11 111233468899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=301.09 Aligned_cols=265 Identities=21% Similarity=0.223 Sum_probs=196.9
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc--hhHHHHHHHHHhcccCCCceeEEeeeeeec--CeEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVY 676 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~--~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~--~~~~LV~ 676 (929)
.|.+.+.||+|+||.||+|..+ +++.+|+|.++..... ....+.+|+.++++++||||+++++++... +..++|+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 4556789999999999999987 5788999998754322 234567899999999999999999999877 8899999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+. ++|.+.+... ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 86 EYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred hhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 9997 4888877532 23588999999999999999999998 999999999999999999999999999876544
Q ss_pred CCCceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh-----------
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH----------- 824 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~----------- 824 (929)
.... .....+++.|+|||.+.+. .++.++|+||||+++|||++|+.||...........+.......
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 159 PLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred Cccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 3211 1233478899999998764 46889999999999999999999997544222222221111000
Q ss_pred --hhcCCcccccCCcccCccCHH-HHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 825 --IESGDIQGIIDPSLLDEYDIQ-SMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 825 --~~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.............+...+... ....+.+++.+|++.+|++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000011111111111111 24467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=315.78 Aligned_cols=246 Identities=28% Similarity=0.432 Sum_probs=192.6
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEee--c--CCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCe--EEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLT--S--NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR--SVLVY 676 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~--~--~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~--~~LV~ 676 (929)
.+...||+|+|-+||+|.+. +|.+||=-.++ . .+......|..|+.+|+.|+||||++++.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45678999999999999876 46676532221 1 123334779999999999999999999999977655 78899
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC-CcEEEEeecCccccc
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAV 755 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~~~ 755 (929)
|.+..|+|..++. +.++++...+..|++||++||.|||++ .|+|||||||.+||+|+.+ |.|||+|+|+|....
T Consensus 123 EL~TSGtLr~Y~k----k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRK----KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHH----HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 9999999999985 456677888999999999999999997 5799999999999999865 899999999998654
Q ss_pred CCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
.. ....+.|||.|||||+.. ..|++.+||||||++|+||+|+..||.... +-.+. ......|.-+..+.
T Consensus 198 ~s---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~------n~AQI-YKKV~SGiKP~sl~ 266 (632)
T KOG0584|consen 198 KS---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT------NPAQI-YKKVTSGIKPAALS 266 (632)
T ss_pred cc---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC------CHHHH-HHHHHcCCCHHHhh
Confidence 32 233477999999999987 789999999999999999999999997544 22221 11222222111111
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... ..++.++|.+|+.. .++|||+.|++++
T Consensus 267 -----kV~---dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 267 -----KVK---DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----ccC---CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 111 13577899999999 8899999999875
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=294.72 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=198.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||.||++... +++.+|||.+.... ......+.+|++++++++||||+++++.+...+..++|+||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 345678999999999999875 67889999987542 233567889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC-CcEEEEeecCcccccCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~~~~~~ 758 (929)
++++|.+++... ....+++..+..++.|+++||+|||++ +++|+||||+||+++.+ +.+||+|||.+.......
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 82 PGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999998542 234578889999999999999999998 99999999999999865 468999999987654322
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........ +....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----~~~~~~~~----~~~~~------ 220 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----ALVLKIMS----GTFAP------ 220 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH----HHHHHHHh----cCCCC------
Confidence 122345889999999999888999999999999999999999999754421 12211111 11111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
........+.+++.+|++.+|++|||+.|++++
T Consensus 221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.60 Aligned_cols=263 Identities=21% Similarity=0.257 Sum_probs=196.9
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc-----hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~-----~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.+.+.||+|+||.||+|... +++.||||.++..... ....+..|++++++++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 45678999999999999876 6889999999765332 23456789999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+ +++|.+++... ...+++..+..++.|+++||+|||++ +|+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 83 FM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred cc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 99 89999988542 13688999999999999999999998 9999999999999999999999999999765433
Q ss_pred CCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc-----CCcc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES-----GDIQ 831 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~-----~~~~ 831 (929)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|..||......+....+.......... ....
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 221 122346788999998864 457889999999999999999988776543211111111111000000 0000
Q ss_pred cccCCcccCccC-----HHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 832 GIIDPSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 832 ~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...........+ ......+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 111000011111 1223568899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=297.99 Aligned_cols=247 Identities=25% Similarity=0.351 Sum_probs=191.1
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-----cchhHHHHHHHHHhcccCCCceeEEeeeeeec--CeEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV 675 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-----~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~--~~~~LV 675 (929)
.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++||||+++++++.+. ...+++
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 35688999999999999876 58899999886331 12235678899999999999999999988663 467899
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
|||+++++|.+++.. ...+++.....++.|++.||+|||++ +++|+||||+||+++.++.++|+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 85 MEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 999999999998843 23467888899999999999999998 99999999999999999999999999987543
Q ss_pred CCCC--ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 756 DGAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 756 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
.... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||....... .+.+ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~----~~~~~----- 225 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---AIFK----IATQP----- 225 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH---HHHH----HhcCC-----
Confidence 2111 11223458899999999988889999999999999999999999996543111 1111 11000
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. ....+......+.+++.+|+. +|++||+++||+++
T Consensus 226 ~----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 T----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred C----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0 111122333467788888884 89999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=296.51 Aligned_cols=257 Identities=24% Similarity=0.318 Sum_probs=200.3
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeee--cCeEEEEEEecc
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMH 680 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~--~~~~~LV~E~~~ 680 (929)
..+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||+++++++.. .+..++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 3578999999999999986 578899999875432 345678999999999999999999998854 346899999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++.........++...+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 160 (287)
T cd06621 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA- 160 (287)
T ss_pred CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence 9999988765444456688889999999999999999998 999999999999999999999999999865432211
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccccc-ccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG-ANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
....++..|+|||.+.+..++.++|||||||++|||++|+.||.....+ .....+..+..... ... +.....
T Consensus 161 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~ 233 (287)
T cd06621 161 --GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP----NPE-LKDEPG 233 (287)
T ss_pred --ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC----chh-hccCCC
Confidence 2334788999999999889999999999999999999999999765321 11122333322210 000 110100
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
........+.+++.+|++.+|++|||+.||+++
T Consensus 234 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 234 --NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred --CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 011223568899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=306.78 Aligned_cols=250 Identities=24% Similarity=0.292 Sum_probs=197.2
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc---hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~---~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.+.+.||+|+||.||+|... +++.+|+|.+...... ..+.+.+|+++++.++||||+++++.+......++||||+
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC 83 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence 44578999999999999887 4889999999765332 3456889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
.+++|.+++... ....+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 84 PGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred CCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999988532 235688899999999999999999998 999999999999999999999999999864422111
Q ss_pred c----------------------------eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccccc
Q 002382 760 H----------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (929)
Q Consensus 760 ~----------------------------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~ 811 (929)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 111235788999999999888999999999999999999999999755421
Q ss_pred ccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCc----HHHHHHH
Q 002382 812 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS----ISEVLKD 874 (929)
Q Consensus 812 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs----~~eVl~~ 874 (929)
.....+ .. .... ... .......+.+++.+|++.+|++||+ +.|++++
T Consensus 239 ~~~~~~-------~~-~~~~------~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 ETFSNI-------LK-KEVT------FPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHH-------hc-CCcc------CCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 111110 00 0000 000 1113457889999999999999999 6666554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=301.24 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=199.8
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.+.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 4556788999999999999865 678999999875544455678899999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++.. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 100 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 9999998843 3467888899999999999999998 999999999999999999999999998875443322
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
......|++.|+|||.+....++.++|+|||||++||+++|+.||........ +... ...+. . . .
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~---~~~~----~~~~~-~-----~--~ 235 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLI----ATNGT-P-----E--L 235 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh---eeeh----hcCCC-C-----C--C
Confidence 22234588899999999888899999999999999999999999975431111 1000 00000 0 0 0
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.........+.+++.+|++.+|++||++.|++.+
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223467899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=298.51 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=192.6
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeee------cCeEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE------EGRSV 673 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~------~~~~~ 673 (929)
.+.+.+.||+|+||.||+|++. +++.+|+|++.... ....++..|+.+++++ +||||+++++++.. ....+
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 4556789999999999999885 57889999986543 2345688899999998 79999999999853 45789
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
++|||+.+|+|.+++.... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||++..
T Consensus 96 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 9999999999999885432 34577888889999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeeecCccccCccccc-----cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcC
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 828 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 828 (929)
...... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....... .+.. ....
T Consensus 171 ~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~---~~~~-----~~~~ 241 (282)
T cd06636 171 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR---ALFL-----IPRN 241 (282)
T ss_pred hhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh---hhhh-----HhhC
Confidence 432211 122345889999999975 3467889999999999999999999996533111 1100 0000
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 829 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.. +.+. .......+.+++.+|++.+|++||++.|++++
T Consensus 242 ~~-----~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 242 PP-----PKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred CC-----CCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00 1110 01123468899999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=302.82 Aligned_cols=263 Identities=21% Similarity=0.269 Sum_probs=194.7
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
...+.||+|++|.||+|+.. +++.||||+++... ......+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 34578999999999999876 68899999886442 2233578899999999999999999999999999999999995
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
++|.+++... ....+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||+++........
T Consensus 83 -~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 83 -QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred -cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 6888877542 235688999999999999999999998 9999999999999999999999999998754332211
Q ss_pred eeeeeecCccccCccccccCc-CCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhh------------c
Q 002382 761 VSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE------------S 827 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~-~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~------------~ 827 (929)
.....++..|+|||++.+.. ++.++|||||||++|||++|+.||...........+.++...... .
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 12234688999999887644 588999999999999999999999654321111111111110000 0
Q ss_pred CCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 828 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 828 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..........+.. ........+.+++.+|++.||++||+++|++++
T Consensus 236 ~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 236 PSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000000 001112356789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=301.78 Aligned_cols=261 Identities=21% Similarity=0.302 Sum_probs=192.6
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|++|.||+|+.+ +++.||||.+..... .....+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 345678999999999999876 688999999875432 223457789999999999999999999999999999999997
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+ +|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 87 ~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~ 158 (291)
T cd07844 87 T-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-K 158 (291)
T ss_pred C-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-c
Confidence 5 898887533 23578889999999999999999998 99999999999999999999999999986432211 1
Q ss_pred eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc---CCccc----
Q 002382 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---GDIQG---- 832 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~---~~~~~---- 832 (929)
......++..|+|||++.+ ..++.++||||+||++|||++|+.||....... ............ .....
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE---DQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH---HHHHHHHHhcCCCChhhhhhhhhc
Confidence 1122346889999999875 457889999999999999999999996543110 011100000000 00000
Q ss_pred ----------ccCCcccCcc-CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 ----------IIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 ----------~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.....+.... .......+.+++.+|++.+|++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000000 01112467799999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=296.52 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=196.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccC---CCceeEEeeeeeecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~---HpNIv~l~g~~~~~~~~~LV~E 677 (929)
|.+.+.||+|+||.||+|.+. +++.+|+|+++... .....++.+|+.++++++ |||++++++++......++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 445678999999999999875 68899999987542 333467888999999986 9999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 83 YAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred cCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 9999999988743 2678899999999999999999998 9999999999999999999999999998765443
Q ss_pred CCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 758 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
... .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||....... +... ..... .+
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~~~~-~~~~~-----~~ 220 (277)
T cd06917 155 SSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AMML-IPKSK-----PP 220 (277)
T ss_pred ccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------hhhc-cccCC-----CC
Confidence 322 233458899999999875 446889999999999999999999997543111 1100 01111 11
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+... .....+.+++.+|++.+|++||++.|++++
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11111 123468899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=301.64 Aligned_cols=243 Identities=26% Similarity=0.358 Sum_probs=197.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||.||++.+. +++.+|+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 345688999999999999876 58899999987542 22345688999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++.. ...+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 83 VPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999998853 35688899999999999999999998 9999999999999999999999999998765433
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.....|++.|+|||.+.+...+.++||||||+++|+|++|+.||...... ...+. ...+.. .+
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~----~~~~~~------~~ 217 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----QIYEK----ILEGKV------RF 217 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----HhcCCc------cC
Confidence 22345889999999998888899999999999999999999999754411 11111 111111 01
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
... ....+.+++.+|++.+|++|| +++|++++
T Consensus 218 ~~~----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 218 PSF----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred Ccc----CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 111 134678999999999999999 77777765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=297.91 Aligned_cols=245 Identities=24% Similarity=0.337 Sum_probs=197.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
.+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 468999999999999875 6889999998755555566788999999999999999999999999999999999999999
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeee
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (929)
.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+....... .....
T Consensus 104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~ 174 (285)
T cd06648 104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKS 174 (285)
T ss_pred HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-ccccc
Confidence 998853 4578889999999999999999998 99999999999999999999999999886543322 12223
Q ss_pred eecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCH
Q 002382 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844 (929)
Q Consensus 765 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 844 (929)
..|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ...+ .. ...... .... ..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~----~~~~---~~-~~~~~~-----~~~~--~~ 239 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL----QAMK---RI-RDNLPP-----KLKN--LH 239 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH----HHHH---HH-HhcCCC-----CCcc--cc
Confidence 45889999999998888999999999999999999999998654311 1111 11 111110 0100 11
Q ss_pred HHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 845 QSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 845 ~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.....+.+++.+|++.+|++||++.|++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 123468899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=292.93 Aligned_cols=249 Identities=29% Similarity=0.400 Sum_probs=203.5
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+.||+|++|.||+|+.. +++.|+||++..... .....+.+|+..+++++|+||+++++++...+..++|+||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 45688999999999999887 489999999876543 4467899999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
++|.+++.. ...+++..++.++.|+++||+|||+ . +++||||+|+||+++.++.++|+|||.+.........
T Consensus 84 ~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 84 GSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999853 2568889999999999999999999 8 9999999999999999999999999998765433222
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||..... .....+..+... ... +.
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~----~~~-----~~--- 222 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAICD----GPP-----PS--- 222 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHHHHhc----CCC-----CC---
Confidence 2234578999999999988899999999999999999999999976542 112222222221 111 01
Q ss_pred ccCHH-HHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 841 EYDIQ-SMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 841 ~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+.. ....+.+++.+|++.+|++||++.|++++
T Consensus 223 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 -LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111 33578899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=301.30 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=195.9
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.+.+.||+|+||.||++.+. .++.||+|.+..... .....+.+|+++++.++||||+++++.+..++..++||||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV 83 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence 35678999999999999887 578899999875532 23456789999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC-
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA- 758 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~- 758 (929)
++++|.+++.. ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 84 EGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999843 34578888999999999999999998 99999999999999999999999999986321100
Q ss_pred -------------CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh
Q 002382 759 -------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 759 -------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
........++..|+|||.+....++.++|+|||||++|||++|..||...... .+.+ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----~~~~---~~~ 229 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----ELFG---QVI 229 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH---HHH
Confidence 00111235788999999998888999999999999999999999999754311 1111 111
Q ss_pred hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 826 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
. +.. ..+.... .....+.+++.+|++.+|++||++.++.+.|+.
T Consensus 230 ~-~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 S-DDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred h-ccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1 110 0011011 122357899999999999999997666666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=300.19 Aligned_cols=245 Identities=26% Similarity=0.381 Sum_probs=193.4
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.|.+.+.||+|+||.||+|+.. +++.||+|++..... ...+++.+|+++++.++||||+++++++...+..++|+|
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 3566789999999999999876 688999999864422 233568899999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+. |++.+.+... ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 96 ~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 96 YCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred hhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 997 5666665321 34588999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCceeeeeecCccccCccccc---cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
....++..|+|||++. ...++.++||||||+++|||++|+.||....... .... ........
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~----~~~~----~~~~~~~~-- 233 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYH----IAQNDSPT-- 233 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH----HHHH----HhcCCCCC--
Confidence 2235788999999884 4568889999999999999999999986543111 1110 11111100
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+. .......+.+++.+|++.+|++||++.+|+++
T Consensus 234 ---~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 ---LS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---CC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 11233468899999999999999999999886
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=290.38 Aligned_cols=248 Identities=30% Similarity=0.485 Sum_probs=201.7
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
.+.+.||+|++|.||++... +++.+++|++..........+.+|++++++++|+|++++++++......++++||++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 34578999999999999986 68899999997665545678999999999999999999999999999999999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
+|.+++... ...+++..+..++.|+++||.+||+. +++||||+|+||++++++.++|+|||.+........ .
T Consensus 83 ~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 83 SLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred cHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999988543 25688999999999999999999998 999999999999999999999999999876544332 3
Q ss_pred eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCcc
Q 002382 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 842 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 842 (929)
....++..|+|||.+.+..++.++||||||+++++|++|+.||...... ..+.. ... .......+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~-~~~----~~~~~~~~------- 219 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFK-IAT----NGPPGLRN------- 219 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHH-HHh----cCCCCcCc-------
Confidence 3456889999999998888999999999999999999999999754311 11111 110 11111110
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 843 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 843 ~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.......+.+++.+|++.+|++|||+.|++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01113468899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=299.49 Aligned_cols=262 Identities=23% Similarity=0.270 Sum_probs=194.6
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.+.||+|++|.||+|... +|+.||+|++.... ......+.+|++++++++|||++++++++.+.+..+++|||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 4578999999999999876 68999999987543 2223568889999999999999999999999999999999995
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
++|.+++.... ...+++..++.++.|+++||+|||++ +++||||+|+||+++.++.++|+|||+++........
T Consensus 82 ~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 82 LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 68988875432 24688999999999999999999998 9999999999999999999999999998754322211
Q ss_pred eeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcC------------
Q 002382 762 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG------------ 828 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~------------ 828 (929)
.....++..|+|||++.+. .++.++|+||||+++|||++|+.||...........+.++........
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 1222468899999988764 568899999999999999999999975432111111111110000000
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 829 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.......... ..........+.+++.+|++.+|++||+++|++++
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 236 TFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 00011122467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=322.76 Aligned_cols=271 Identities=19% Similarity=0.263 Sum_probs=187.3
Q ss_pred HHHHHHhccccccCcEEEEEEEECC--CcEEEEEEe--------------ec---CCcchhHHHHHHHHHhcccCCCcee
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLKD--GKEIAVKVL--------------TS---NSYQGKREFTNEVTLLSRIHHRNLV 660 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~~--~~~vAVK~l--------------~~---~~~~~~~~f~~Ev~iL~~l~HpNIv 660 (929)
...|.+.+.||+|+||+||++.++. +...++|.+ .+ ........+.+|+++|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3467778899999999999987642 222222211 00 1112245688999999999999999
Q ss_pred EEeeeeeecCeEEEEEEeccCCchhhhhcccc-ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC
Q 002382 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL-THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 739 (929)
Q Consensus 661 ~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 739 (929)
++++++...+..++|++++. ++|.+++.... ..........+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 99999999999999999985 56766664321 1122234556778999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHH
Q 002382 740 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (929)
Q Consensus 740 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~ 819 (929)
++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|..++...........+.+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999986654433333445699999999999999999999999999999999998754322221111112222
Q ss_pred HHHHhh-hcCCcc-------cccCCccc----Ccc-----CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 820 WAKLHI-ESGDIQ-------GIIDPSLL----DEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 820 ~~~~~~-~~~~~~-------~~~d~~l~----~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...... ...++. +.++.... ... .......+.+++.+|++.||++|||+.|++++
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111100 000000 00000000 000 00112346778999999999999999999986
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=303.27 Aligned_cols=268 Identities=21% Similarity=0.255 Sum_probs=195.2
Q ss_pred HHHhccccccCcEEEEEEEECC---CcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeec--CeEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVL 674 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~---~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~--~~~~L 674 (929)
|.+.+.||+|+||.||+|.... ++.||+|.+.... ......+.+|+.++++++||||+++++++... ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 3456789999999999998764 7899999997643 23345678899999999999999999999888 78999
Q ss_pred EEEeccCCchhhhhcccccc-ccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC----CCcEEEEeec
Q 002382 675 VYEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK----HMRAKVSDFG 749 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~----~~~vkL~DFG 749 (929)
||||+++ +|.+.+...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 666665433222 23688899999999999999999998 9999999999999999 8999999999
Q ss_pred CcccccCCCC--ceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCcccccccc------chhhHHH
Q 002382 750 LSKFAVDGAS--HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGAN------CRNIVQW 820 (929)
Q Consensus 750 la~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~------~~~l~~~ 820 (929)
+++....... .......++..|+|||++.+. .++.++|||||||+++||++|+.||........ ...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9986543222 112334578999999988764 578999999999999999999999975442210 0011111
Q ss_pred HHHhhh-----------cCCcccccCCcccCccC---------H--HHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 821 AKLHIE-----------SGDIQGIIDPSLLDEYD---------I--QSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 821 ~~~~~~-----------~~~~~~~~d~~l~~~~~---------~--~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+..... ..+.....+......++ . .....+.+++.+|++.+|++|||+.|++++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 110000 00000000000000011 0 223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=299.00 Aligned_cols=262 Identities=23% Similarity=0.297 Sum_probs=197.0
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeec--CeEEEEEEec
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEFM 679 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~--~~~~LV~E~~ 679 (929)
+.+.||+|+||.||+|+.. +++.+|+|++.... ......+.+|++++++++|||++++++++... +..++|+||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 4578999999999999887 47899999998653 33345688999999999999999999999887 8899999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++ +|.+++... ...+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 83 DH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 75 888877532 24688999999999999999999998 999999999999999999999999999986544332
Q ss_pred ceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc------
Q 002382 760 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG------ 832 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~------ 832 (929)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+........ ......
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPT-DENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc-hhhccccccchh
Confidence 22233446889999998765 4578999999999999999999999976542222112211110000 000000
Q ss_pred --------ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 --------IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 --------~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.....+...+.......+.+++.+|++.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000011111124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=297.87 Aligned_cols=264 Identities=21% Similarity=0.286 Sum_probs=197.2
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.++||+|++|.||+|+.. +++.||||+++.... .....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK 82 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence 34678999999999999986 588999999875532 2345677899999999999999999999999999999999985
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
+|.+++.... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........ .
T Consensus 83 -~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 83 -DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred -cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 8888775432 234689999999999999999999998 999999999999999999999999999875433211 1
Q ss_pred eeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhh--------c----C
Q 002382 762 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE--------S----G 828 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~--------~----~ 828 (929)
.....++..|++||.+.+. .++.++|||||||++|||++|+.||......+....+.+....... . .
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 1223478899999998664 5688999999999999999999999765433222222221110000 0 0
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 829 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
......+... ..........+.+++.+|++.+|++||++.|++++
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 237 TFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000000 00111223467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=290.78 Aligned_cols=250 Identities=26% Similarity=0.434 Sum_probs=203.9
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.+.+.||+|+||.||++... +++.+++|++..... ...+.+.+|+++++.++|||++++++.+...+..++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 34678999999999999886 588999999876533 445678899999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++.........+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 158 (258)
T cd08215 83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-D 158 (258)
T ss_pred CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-c
Confidence 9999999865433456789999999999999999999998 99999999999999999999999999987654432 2
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
......|++.|+|||...+..++.++|+||+|+++++|++|+.||...... .+.. ... .....
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~---~~~-~~~~~--------- 221 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL----ELAL---KIL-KGQYP--------- 221 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH----HHHH---HHh-cCCCC---------
Confidence 233346889999999998888999999999999999999999999654421 1111 111 11111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+......+.+++.+|+..+|++||++.|++++
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111223468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=299.64 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=194.1
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.+...+.||+|+||.||+|+.. +++.+|+|++..... .....+.+|++++++++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3556778999999999999875 688999999875422 223568889999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+. |+|.+.+.. ....+++.++..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 997 477776642 234588999999999999999999998 9999999999999999999999999998654322
Q ss_pred CCceeeeeecCccccCccccc---cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||....... .+..+.. .+. .
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~----~~~-~--- 242 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQ----NES-P--- 242 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHh----ccC-C---
Confidence 2235788999999974 4568899999999999999999999986533111 1111111 110 0
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
..........+.+++.+|++.+|++||++.||++++-
T Consensus 243 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 243 -----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred -----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 0001122345789999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=291.80 Aligned_cols=242 Identities=22% Similarity=0.299 Sum_probs=194.2
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 609 IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
||+|+||.||+++.. +++.+|+|++..... ...+.+.+|+++++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999987 488999999875432 3346789999999999999999999999999999999999999999
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeee
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (929)
.+++.. ...+++..+..++.|+++||+|||++ +++|+||||+||+++.++.++|+|||+++...... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 999853 23478889999999999999999998 99999999999999999999999999998654432 2223
Q ss_pred eecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCH
Q 002382 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844 (929)
Q Consensus 765 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 844 (929)
..|+..|++||.+....++.++|+||||+++|||++|..||..... +..+......... ....++.
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~---------~~~~~~~ 217 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGN---------GKLEFPN 217 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccC---------CCCCCCc
Confidence 4578999999999888899999999999999999999999975441 1111111111100 0111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCc-----HHHHHH
Q 002382 845 QSMWKIEEKALMCVLPHGHMRPS-----ISEVLK 873 (929)
Q Consensus 845 ~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~ 873 (929)
.....+.+++.+|++.+|++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 22456889999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-33 Score=307.04 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=203.1
Q ss_pred HHHHhccccccCcEEEEEEEECCCcE-EEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~-vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
-+++...||-|+||.||+|..++... .|.|++...+.+...+|.-|++||..++||+||+|++.|.-.+.+++..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 45566779999999999999885443 46688877777777889999999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
||-++..+-. -+..+.+.++..++.|++.||.|||++ .|||||||+.|||++-+|.++|+|||.+...... ..
T Consensus 113 GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~q 185 (1187)
T KOG0579|consen 113 GGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQ 185 (1187)
T ss_pred CchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-Hh
Confidence 9999887743 356788999999999999999999999 9999999999999999999999999997532221 22
Q ss_pred eeeeeecCccccCccccc-----cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 761 VSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
....+.|||+|||||+.. ..+|+.++||||||+.|.||..+.+|-.... ..+.++. +...+.+.++.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln---pMRVllK-----iaKSePPTLlq 257 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN---PMRVLLK-----IAKSEPPTLLQ 257 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc---hHHHHHH-----HhhcCCCcccC
Confidence 344567999999999975 4679999999999999999999999875433 1112222 22223333333
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
|. .-...+.++..+|+..+|+.||++.++++|
T Consensus 258 PS-------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 PS-------HWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cc-------hhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 22 223468899999999999999999999875
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=296.34 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=192.7
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccC-CCceeEEeeeeeecCeEEEEEEeccC
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||+..
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 4578999999999999876 57899999987543 234567889999999996 99999999999999999999999864
Q ss_pred Cchhhhhcc-ccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 682 GTLKEHLYG-TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 682 gsL~~~L~~-~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
++.++... .......+++..+..++.|+++||+|||+. .+++||||||+||+++.++.+||+|||+++.......
T Consensus 88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 163 (288)
T cd06616 88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA- 163 (288)
T ss_pred -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc-
Confidence 55443311 111235688999999999999999999974 2899999999999999999999999999875433221
Q ss_pred eeeeeecCccccCccccccC---cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 761 VSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~---~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
.....|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ........... +. .+.
T Consensus 164 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~-~~-----~~~ 230 (288)
T cd06616 164 -KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVK-GD-----PPI 230 (288)
T ss_pred -cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcC-CC-----CCc
Confidence 1223578999999998765 68899999999999999999999996543 11111111111 11 111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+...........+.+++.+|++.+|++||++.||+++
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111112234468899999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=300.04 Aligned_cols=253 Identities=28% Similarity=0.345 Sum_probs=200.2
Q ss_pred HHHHHHHhccccccCcEEEEEEEECCCcEEEEEEeec--CCcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEE
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTS--NSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~--~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV 675 (929)
....|.+.++||+||.+.||++...+.+.+|+|++.. .+.+...-|.+|+..|.++ .|.+|+++++|-..++.+++|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 4556778899999999999999998888888887643 3445567799999999999 599999999999999999999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
||+- ..+|..+|.+.. ..++...+..+..||+.++.++|.. ||||.||||.|+|+-. |.+||+|||+|....
T Consensus 439 mE~G-d~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eecc-cccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 9975 568999886432 2233236788999999999999998 9999999999999865 689999999998765
Q ss_pred CCCC-ceeeeeecCccccCccccccCc-----------CCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHH
Q 002382 756 DGAS-HVSSIVRGTVGYLDPEYYISQQ-----------LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL 823 (929)
Q Consensus 756 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~-----------~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~ 823 (929)
.... -.....+||+.||+||.+.... .+.++||||||||||+|+.|+.||.... + .|.+.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------n--~~aKl 582 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------N--QIAKL 582 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------H--HHHHH
Confidence 5443 3455677999999999985432 5578999999999999999999996432 2 23332
Q ss_pred hhhcCCcccccCCcccCccC-HHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 824 HIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 824 ~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+.|+.-.-+|+ ....+++++++..|+++||.+||+..|++++
T Consensus 583 -------~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 583 -------HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -------HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2334443222222 2223348999999999999999999999987
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=295.73 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=200.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.+.+.||+|+||.||+|.++ +++.+++|++..... ....+.+|+++++.++|+|++++++++...+..++|+||+++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence 445578999999999999987 688999999976544 466788999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........ .
T Consensus 100 ~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 100 GSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred CcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 99999985431 3788999999999999999999998 999999999999999999999999998865433221 1
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....++..|++||.+.+..++.++|+|||||++|+|++|+.||...... ...... .. ....... .
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~~~----~~-~~~~~~~-----~- 238 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALFLI----TT-KGIPPLK-----N- 238 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH----Hh-cCCCCCc-----c-
Confidence 22334788999999998888999999999999999999999998754311 111111 11 1111100 0
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.......+.+++.+|++.+|.+||++.+++++
T Consensus 239 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 -PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11123468899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=293.57 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=201.9
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.+.+.||+|+||.||+++.+ +++.+|+|.+.... ......+.+|++++++++|+||+++++++......++|+||++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 45678999999999999866 67899999987542 2334567889999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++.....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999865443446688999999999999999999998 9999999999999999999999999999765443
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
......++..|++||.+.+..++.++|+||||+++|||++|+.||...... .+... ...+...
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~~----~~~~~~~--------- 219 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----DLRYK----VQRGKYP--------- 219 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----HhcCCCC---------
Confidence 122234788999999999988999999999999999999999999754411 11111 1111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.........+.+++.+|++.+|++||++.|++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1112334568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=302.13 Aligned_cols=260 Identities=21% Similarity=0.280 Sum_probs=192.7
Q ss_pred cccccc--CcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G--~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
..||+| +||+||++++. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999875 689999999875432 2346788999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
++|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999886532 23578888899999999999999998 99999999999999999999999998653222111100
Q ss_pred ------eeeeecCccccCccccccC--cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh---------
Q 002382 762 ------SSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH--------- 824 (929)
Q Consensus 762 ------~~~~~gt~~Y~aPE~~~~~--~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~--------- 824 (929)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||........ +.......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM---LLQKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH---HHHHhcCCCCCCccccc
Confidence 1112356679999999763 478899999999999999999999975431111 11110000
Q ss_pred --------------h---------hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 825 --------------I---------ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 825 --------------~---------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. .......+.+..+...........+.+++.+|++.+|++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 0000001111112222223345678999999999999999999999876
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-33 Score=288.73 Aligned_cols=248 Identities=21% Similarity=0.352 Sum_probs=203.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
..+.++||+|+||.||+|.++ .|+.||||.+... .+.+++.+|+.+|++++.|++|+++|.+-....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 445678999999999999887 5899999998654 3457889999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+..+.++. +.+.+.+.++..++..-++||+|||.. .-||||||+.|||++.+|.+||+|||.|-.+.+.. ..
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AK 185 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AK 185 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-Hh
Confidence 999999863 467899999999999999999999997 78999999999999999999999999986544332 23
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
..++.||+.|||||++..-.|..++||||||+...||..|++|+.+-..-. .+. ++.-... |.+ .
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---AIF-----MIPT~PP-----PTF--~ 250 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---AIF-----MIPTKPP-----PTF--K 250 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---eeE-----eccCCCC-----CCC--C
Confidence 355779999999999999999999999999999999999999997543100 000 0110110 111 1
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+.+-...+.+++..|+-..|++|-|+.++++|
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 122333478999999999999999999999886
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=306.86 Aligned_cols=262 Identities=22% Similarity=0.298 Sum_probs=194.5
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeec------Ce
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GR 671 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~------~~ 671 (929)
..|...+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 34555688999999999999876 6889999998643 223345677899999999999999999988543 35
Q ss_pred EEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCc
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 751 (929)
.++||||+. ++|.+.+.. .++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred EEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 799999996 477776632 277888889999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHH-----------
Q 002382 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW----------- 820 (929)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~----------- 820 (929)
+....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 76533221 22345789999999999999999999999999999999999999754321111111110
Q ss_pred ----HHHhhhcC------CcccccCCcc----cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 821 ----AKLHIESG------DIQGIIDPSL----LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 821 ----~~~~~~~~------~~~~~~d~~l----~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
........ .+.......+ ...........+.+++.+|++.||++||++.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0001111111 111112234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=293.77 Aligned_cols=244 Identities=27% Similarity=0.367 Sum_probs=191.1
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 609 IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
||+|+||+||++..+ +++.+|+|++.... ......+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999866 68899999987542 22244567899999999999999999999999999999999999999
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeee
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (929)
.+++.... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||.+....... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 99886432 24688999999999999999999998 99999999999999999999999999987543321 1223
Q ss_pred eecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCH
Q 002382 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844 (929)
Q Consensus 765 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 844 (929)
..++..|+|||++.+..++.++|||||||++|+|++|+.||...........+... .. . .. ...+.
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~-~------~~----~~~~~ 219 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR---TL-E------MA----VEYPD 219 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc---cc-c------cc----ccCCc
Confidence 35788999999998888999999999999999999999999754421111111110 00 0 00 01111
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----cHHHHHH
Q 002382 845 QSMWKIEEKALMCVLPHGHMRP-----SISEVLK 873 (929)
Q Consensus 845 ~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~ 873 (929)
.....+.+++.+|++.+|++|| ++.++++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 1234578999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=293.79 Aligned_cols=246 Identities=24% Similarity=0.305 Sum_probs=198.1
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++.+......++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 45688999999999999887 588999999975432 33567899999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
.+++|.+++.. ...+++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+|||.+.......
T Consensus 83 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 83 LGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999998843 24678889999999999999999998 99999999999999999999999999987554332
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... ....+. ...... .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~----~~~~~~----------~ 218 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIR----AKQETA----------D 218 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHH----HHhccc----------c
Confidence 223345888999999999888999999999999999999999999765421 111111 111100 0
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcH--HHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSI--SEVLK 873 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~--~eVl~ 873 (929)
...+......+.+++.+|++.+|.+||++ +|+++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 11111223578899999999999999999 66543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=298.04 Aligned_cols=266 Identities=21% Similarity=0.207 Sum_probs=193.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccC-CCceeEEeeeeeecCe-----EE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR-----SV 673 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~-----~~ 673 (929)
|.+.+.||+|+||.||+|.+. +++.||+|+++.... .....+.+|+.+++.++ ||||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 345678999999999999876 688999998765422 22356888999999994 6999999999877665 89
Q ss_pred EEEEeccCCchhhhhcccccc-ccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC-CCcEEEEeecCc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLS 751 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla 751 (929)
+||||+++ +|.+++...... ...+++..++.++.||++||+|||++ +|+||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 788887543222 34688999999999999999999998 9999999999999998 889999999998
Q ss_pred ccccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCc
Q 002382 752 KFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 830 (929)
+....... ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||......+....+.+..... .....
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 236 (295)
T cd07837 159 RAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP-TEQVW 236 (295)
T ss_pred eecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC-ChhhC
Confidence 75432211 1122346889999998865 457899999999999999999999997543221111111111000 00000
Q ss_pred ccccC-------Cccc----CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 QGIID-------PSLL----DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~~d-------~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....+ +... ..........+.+++.+|++.+|++||++.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0000 00001123468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=293.80 Aligned_cols=242 Identities=25% Similarity=0.317 Sum_probs=186.0
Q ss_pred cccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhc---ccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 608 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLS---RIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 608 ~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~---~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..+++ ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999876 588999999875422 12233445544433 3479999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 9999988843 34689999999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
....|+..|+|||.+.. ..++.++|||||||++|||++|..||....... ...+.+. ... .+..+
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~---~~~-------~~~~~- 218 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRM---TLT-------VNVEL- 218 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-HHHHHHH---hhc-------CCcCC-
Confidence 22358999999999864 567899999999999999999999997543111 1111110 000 11111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
+......+.+++.+|++.+|++|| +++|++++
T Consensus 219 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 ---PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 112234678999999999999999 59999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=294.55 Aligned_cols=262 Identities=21% Similarity=0.289 Sum_probs=191.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc-hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~-~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.+++.++|+||+++++++..++..++|+||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 445688999999999999875 6889999998754322 23467889999999999999999999999999999999996
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
++|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++++||+|||+++.......
T Consensus 87 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 87 -TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred -CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence 6776665322 23467778889999999999999998 999999999999999999999999999875432211
Q ss_pred eeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh--hh----------c
Q 002382 761 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH--IE----------S 827 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~--~~----------~ 827 (929)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .+.+.+..... .. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 12233478999999998754 5788999999999999999999999754311 11111100000 00 0
Q ss_pred CCcccccCCcccCcc-----CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 828 GDIQGIIDPSLLDEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 828 ~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
............... .......+.+++.+|++.+|++|||+.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000000000000 00113467799999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=292.49 Aligned_cols=248 Identities=28% Similarity=0.418 Sum_probs=197.8
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.+.+.||+|+||.||+|..+ +++.+|+|.+.... ....+.+.+|+++++.++|+||+++++.+...+..++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 45678999999999999887 57899999986542 2334578899999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC-cEEEEeecCcccccCCCC
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~~~ 759 (929)
+++|.+++... ....+++..+..++.|+++||+|||+. +++|+||||+||++++++ .+||+|||.+........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 83 GGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999988542 233578899999999999999999998 999999999999999886 469999999876543322
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
......|++.|+|||+..+..++.++|+||||++++||++|+.||..... .++...... +.... .
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~~~-----~- 222 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQ-GYFAP-----I- 222 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhc-ccCCC-----C-
Confidence 22334588999999999888899999999999999999999999865431 112221111 11111 0
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.......+.+++.+|++.+|++||++.|++++
T Consensus 223 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ---SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122368899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=294.49 Aligned_cols=261 Identities=20% Similarity=0.231 Sum_probs=191.1
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccC-CCceeEEeeeeeec--CeEEEEEEe
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEE--GRSVLVYEF 678 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~--~~~~LV~E~ 678 (929)
.+.+.||+|+||.||+|... +++.+|+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 34678999999999999876 68899999987542 222334457888888885 99999999999887 889999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+. ++|.+.+... ...+++.++..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++......
T Consensus 82 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 82 MD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred CC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 97 5777777432 24688999999999999999999998 9999999999999999 999999999997553322
Q ss_pred CceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHH-------HhhhcCCc
Q 002382 759 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LHIESGDI 830 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~-------~~~~~~~~ 830 (929)
.. ....++..|+|||++.. ..++.++|||||||++|||++|..||...+..+....+..... ........
T Consensus 154 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 154 PY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred Cc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 21 22347889999997654 5578899999999999999999999976442211111111000 00000000
Q ss_pred ccccCCcccC----ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 QGIIDPSLLD----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.....+.... .........+.+++.+|++.+|++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000 0011234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=295.97 Aligned_cols=245 Identities=25% Similarity=0.359 Sum_probs=196.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
..+||+|+||.||++..+ +++.||||++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 367999999999999875 6889999998655555566789999999999999999999999999999999999999999
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeee
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (929)
.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... .....
T Consensus 105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~ 175 (292)
T cd06657 105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 175 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence 987732 3478888999999999999999998 99999999999999999999999999887543322 12233
Q ss_pred eecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCH
Q 002382 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844 (929)
Q Consensus 765 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 844 (929)
..|+..|+|||.+.+..++.++|+||+||++|||++|..||..... ........... .+.+.. ..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~----~~~~~~~~~~~---------~~~~~~--~~ 240 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMKMIRDNL---------PPKLKN--LH 240 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhhC---------CcccCC--cc
Confidence 4588999999999888889999999999999999999999875331 11111111111 011100 01
Q ss_pred HHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 845 QSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 845 ~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.....+.+++.+|++.+|.+||++.|++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 122357789999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=292.21 Aligned_cols=245 Identities=26% Similarity=0.361 Sum_probs=195.2
Q ss_pred ccccCcEEEEEEEECC-CcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 609 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 609 IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
||+|+||.||++...+ ++.+++|++..... .....+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999874 89999999875533 3456788999999999999999999999999999999999999999
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC-----
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS----- 759 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~----- 759 (929)
.+++.. ...+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 998853 23688999999999999999999998 999999999999999999999999999875433211
Q ss_pred --ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 760 --HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 760 --~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
.......++..|+|||.......+.++||||||+++||+++|..||...... .+..... .+....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~----~~~~~~----- 220 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE----EIFQNIL----NGKIEW----- 220 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHh----cCCcCC-----
Confidence 1223345788999999998888899999999999999999999999754411 1111111 111100
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
.. .......+.+++.+|++.+|++||++.++.+.|+
T Consensus 221 -~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 -PE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -Cc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 0001356789999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=286.64 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=200.4
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeec--CeEEEEEEec
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEFM 679 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~--~~~~LV~E~~ 679 (929)
..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+... ...++|+||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 4578999999999999987 688999999876542 3457789999999999999999999999888 8899999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 84 ~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 84 SGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999988532 3788999999999999999999998 999999999999999999999999999876544322
Q ss_pred c-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 760 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 760 ~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
. ......++..|+|||.+.+...+.++||||||+++++|++|..||.... ..............
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~--------- 221 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKIGSSGE--------- 221 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhccccCC---------
Confidence 1 1233458899999999988889999999999999999999999997544 01111111110001
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....+......+.+++.+|++.+|++||++.|++++
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111112224578899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=288.56 Aligned_cols=244 Identities=22% Similarity=0.267 Sum_probs=187.4
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc---hhHHHHHHHHH-hcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTL-LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~---~~~~f~~Ev~i-L~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||.||+|... +++.||||+++..... ....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999875 5889999998754321 12334445444 3455899999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999998843 34578889999999999999999998 999999999999999999999999999875332
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....++..|+|||.+.+..++.++||||||+++|||++|..||...... .+.. .. ..+... ......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~---~~-~~~~~~--~~~~~~-- 217 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD----AVFD---NI-LSRRIN--WPEEVK-- 217 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHH---HH-HhcccC--CCCccc--
Confidence 12335788999999998888899999999999999999999999754311 1111 11 011100 000011
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
......+.+++.+|++.+|++||++.++.+.|.
T Consensus 218 --~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 --EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred --ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 112346889999999999999998766655444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=294.37 Aligned_cols=248 Identities=26% Similarity=0.352 Sum_probs=200.7
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecC---CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
-++||+|+||.||-++.+ +|+.+|.|.+.+. ..+++....+|-++|++++.+.||.+--+|+..+.+|||+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 468999999999999876 5889999988654 234456678899999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.-||+..- ...+++..++-++.+|+.||++||+. +||+||+||+|||+|+.|+++|+|.|+|..+..+....
T Consensus 270 GDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~ 344 (591)
T KOG0986|consen 270 GDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR 344 (591)
T ss_pred CceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence 99999997653 36789999999999999999999999 99999999999999999999999999999877665443
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
. .+||.+|||||++....|+...|.||+||++|||+.|+.||........-+.+-+.+... ..+
T Consensus 345 ~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~--------------~~e 408 (591)
T KOG0986|consen 345 G--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED--------------PEE 408 (591)
T ss_pred c--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc--------------hhh
Confidence 3 369999999999999999999999999999999999999997654211111111111110 112
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
++..-.++..++....++.||++|- .+.||.+|
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 2222234566788888999999987 45566655
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=295.23 Aligned_cols=264 Identities=22% Similarity=0.259 Sum_probs=191.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
+.+.+.||+|++|+||+|..+ +++.||+|++..... ...+.+.+|++++++++||||+++++++......++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 345678999999999999876 688999998864422 22456889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC-CCcEEEEeecCcccccCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~~ 758 (929)
+ ++|.+++... ....+++..+..++.||+.||+|||++ +++||||||+||+++. ++.+||+|||++.......
T Consensus 84 ~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 84 D-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred c-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 6 5777776432 223356778889999999999999998 9999999999999985 5579999999997543321
Q ss_pred CceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcC-----Cccc
Q 002382 759 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG-----DIQG 832 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~-----~~~~ 832 (929)
. ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+..+........ .+..
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1 1122346889999998866 4578899999999999999999999975442221111111111000000 0000
Q ss_pred c-------cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 I-------IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 ~-------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. ....+. .........+.+++.+|++.+|++||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 237 YKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000 0011122457899999999999999999999875
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=283.06 Aligned_cols=247 Identities=24% Similarity=0.405 Sum_probs=200.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|++|.||+++.. +++.+++|.+..... .....+.+|++++++++|||++++++++...+..++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 345688999999999999876 578999999976643 34567899999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 82 ENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999998843 35688999999999999999999998 999999999999999999999999999986544332
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
. .....++..|+|||...+..++.++||||+|+++|+|++|+.||..... .... |... .....
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~--~~~~---~~~~~-------- 217 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAAL--FRIV---QDDHP-------- 217 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHH--HHHh---ccCCC--------
Confidence 2 2334588999999999888889999999999999999999999875431 0011 1111 01110
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+......+.+++.+|+..+|++||++.|++.+
T Consensus 218 -~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 218 -PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred -CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 1111223467899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=301.13 Aligned_cols=261 Identities=21% Similarity=0.214 Sum_probs=193.6
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcch--------------hHHHHHHHHHhcccCCCceeEEeeeeee
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG--------------KREFTNEVTLLSRIHHRNLVQFLGYCQE 668 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~--------------~~~f~~Ev~iL~~l~HpNIv~l~g~~~~ 668 (929)
.+.+.||+|+||+||+|... +++.||||+++...... ...+.+|+++++.++||||+++++++..
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 45678999999999999876 68899999986542221 1257789999999999999999999999
Q ss_pred cCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEee
Q 002382 669 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 748 (929)
Q Consensus 669 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 748 (929)
.+..++||||+. |+|.+++. ....+++.....++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence 999999999996 68888874 234578889999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCC-------------CceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccc
Q 002382 749 GLSKFAVDGA-------------SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANC 814 (929)
Q Consensus 749 Gla~~~~~~~-------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~ 814 (929)
|+++...... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||......+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9987554110 0111123468899999998764 4688999999999999999999999765422211
Q ss_pred hhhHHHHHHhhhcCCcccc--------cC----CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 815 RNIVQWAKLHIESGDIQGI--------ID----PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 815 ~~l~~~~~~~~~~~~~~~~--------~d----~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+.......... ..... .. +..... .......+.+++.+|++.+|++||+++|++.+
T Consensus 244 ~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNED-NWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchh-hCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1222211100000 00000 00 000000 01123467899999999999999999999875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=295.79 Aligned_cols=264 Identities=23% Similarity=0.250 Sum_probs=193.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc--hhHHHHHHHHHhcccCCCceeEEeeeeeec--CeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~--~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~--~~~~LV~E 677 (929)
+.+.+.||+|+||.||+|... +++.||+|+++..... ....+.+|+.++++++|+||+++++++... +..++|||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 445678999999999999886 5899999998744322 233567899999999999999999998654 56899999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+.+ +|.+++... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 89 ~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 89 YCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred cCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9964 787777532 25688999999999999999999998 9999999999999999999999999999765432
Q ss_pred CCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc-------CC
Q 002382 758 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES-------GD 829 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~-------~~ 829 (929)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.++....... ..
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 21 1222335788999999875 457899999999999999999999997554222222222211100000 00
Q ss_pred ccccc--CCcccCcc---CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 IQGII--DPSLLDEY---DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 ~~~~~--d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....+ ........ .......+.+++.+|++.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 00000000 00123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=305.76 Aligned_cols=270 Identities=23% Similarity=0.379 Sum_probs=203.9
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecC------eEEEEE
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSVLVY 676 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~------~~~LV~ 676 (929)
..+.||+|+||.||+|+++ .|+.||||.++... ....+...+|+++|++++|||||+++++-++.. ...+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 3578999999999999976 69999999998654 333456788999999999999999999875543 568999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec--CCC--cEEEEeecCcc
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHM--RAKVSDFGLSK 752 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~--~~~--~vkL~DFGla~ 752 (929)
|||.+|||...|.+. .....|++.+.+.+..++..||.|||++ +|+||||||.||++- .+| .-||+|||.|+
T Consensus 97 EyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 999999999999765 3456799999999999999999999998 999999999999984 334 36999999999
Q ss_pred cccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 753 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
...++. .....+||..|++||+... +.|+..+|.|||||++||+.||..||.....+..-. -+.|....-......
T Consensus 173 el~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~-~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 173 ELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK-EIMWHIITKKPSGVA 249 (732)
T ss_pred cCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc-hhhhhhhccCCCcee
Confidence 765543 5566789999999999984 889999999999999999999999997544332111 112222111111111
Q ss_pred cccCCcccC------------ccCHHHHHHHHHHHHHccCCCCCCCC--cHHHHHHHHHHhHhH
Q 002382 832 GIIDPSLLD------------EYDIQSMWKIEEKALMCVLPHGHMRP--SISEVLKDIQDAIVI 881 (929)
Q Consensus 832 ~~~d~~l~~------------~~~~~~~~~l~~li~~Cl~~dP~~RP--s~~eVl~~L~~~~~~ 881 (929)
..+++...+ .........+-.+...++..+|++|- ...+.-+.+..++..
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 112221111 11123334566777888889999998 777777777666654
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=294.14 Aligned_cols=266 Identities=23% Similarity=0.278 Sum_probs=195.3
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecC------
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------ 670 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~------ 670 (929)
...+.+.+.||+|+||.||+|.++ +++.||+|+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 345667789999999999999987 588999999875432 23356778999999999999999999987654
Q ss_pred ----eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEE
Q 002382 671 ----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (929)
Q Consensus 671 ----~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 746 (929)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 666665432 34688999999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh
Q 002382 747 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 747 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.+......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999997654333222223346788999998865 4578899999999999999999999975432111111111111000
Q ss_pred hcCCcccc--------cCC------cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 826 ESGDIQGI--------IDP------SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 826 ~~~~~~~~--------~d~------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. .....+ .++ ....... .....+.+++.+|++.+|++||++.+++++
T Consensus 239 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 239 P-AVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred h-hhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 000000 000 0000000 123468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=292.63 Aligned_cols=250 Identities=24% Similarity=0.327 Sum_probs=194.4
Q ss_pred HHhccccccCcEEEEEEEEC----CCcEEEEEEeecCCc----chhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY----QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~----~~~~vAVK~l~~~~~----~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~L 674 (929)
.+.+.||+|+||.||+++.. +|+.||+|+++.... ...+.+.+|+++++++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 35678999999999999863 688999999875422 2346678899999999 69999999999999999999
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
|+||+++++|.+++.. ...+++..+..++.|+++||.|||+. +++||||||+|||++.++.+||+|||+++..
T Consensus 83 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 83 ILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999998853 34577888889999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCceeeeeecCccccCccccccC--cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
............|+..|+|||.+.+. .++.++||||||+++|+|++|+.||........ ...+........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~~~~~~~~---- 228 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS---QAEISRRILKSE---- 228 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc---HHHHHHHhhccC----
Confidence 43322222334588999999998753 467899999999999999999999964331111 111211111111
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
+ .++......+.+++.+|++.+|++|| ++.+++++
T Consensus 229 ---~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ---P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 01111234678999999999999997 77777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=304.91 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=191.8
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeec-----CeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~-----~~~~L 674 (929)
.|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 3456789999999999999876 68899999986432 23345678899999999999999999987544 35799
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
|+||+.+ +|.+.+. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 86 VQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred Eehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 9999964 7776663 34588889999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCCc--eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc---C
Q 002382 755 VDGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---G 828 (929)
Q Consensus 755 ~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~---~ 828 (929)
...... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ........... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~----~~~~~~~~~~~~~~~ 232 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH----QLNLILGVLGTPSQE 232 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHcCCCCHH
Confidence 332211 1123458899999998754 568899999999999999999999996543111 11111110000 0
Q ss_pred CcccccCCcc-------c--Ccc-----CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 829 DIQGIIDPSL-------L--DEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 829 ~~~~~~d~~l-------~--~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....+.+... . ... .......+.+++.+|++.+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 0 000 01123468899999999999999999999988
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=295.51 Aligned_cols=264 Identities=20% Similarity=0.254 Sum_probs=190.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecC--------e
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--------R 671 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~--------~ 671 (929)
|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++...+ .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 556788999999999999876 688999998865422 22345678999999999999999999986654 4
Q ss_pred EEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCc
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 751 (929)
.++||||+.+ +|.+.+.. ....+++.+++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 94 ~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 94 FYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred EEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 5999999964 77776643 233688999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCc---eeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc
Q 002382 752 KFAVDGASH---VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 827 (929)
Q Consensus 752 ~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 827 (929)
......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||......... ..+.........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~-~~~~~~~~~~~~ 245 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL-TLISQLCGSITP 245 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCh
Confidence 755432211 11233478899999988664 4688999999999999999999998654321111 111111100000
Q ss_pred CCccc-----ccCC-cccCcc---------CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 828 GDIQG-----IIDP-SLLDEY---------DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 828 ~~~~~-----~~d~-~l~~~~---------~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..... ..+. .+.... .......+.+++.+|++.+|++||+++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000 0000 000000 00012356789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=292.42 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=197.2
Q ss_pred HHhccccccCcEEEEEEEEC----CCcEEEEEEeecCC----cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~----~~~~vAVK~l~~~~----~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~L 674 (929)
.+.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|++++.++ +||||+++++.+......++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 35678999999999999753 56789999987532 22345688899999999 69999999999999999999
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
||||+.+|+|.+++.. ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 83 ILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999988843 34578888999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCceeeeeecCccccCccccccCc--CCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
............|+..|+|||.+.+.. .+.++||||||+++|||++|..||......... ....+......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~---- 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ---SEISRRILKSK---- 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH---HHHHHHHHccC----
Confidence 443322223345889999999987654 788999999999999999999999643211111 11111111110
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
+..... ....+.+++.+|++.+|++|||+.++.+.|+..
T Consensus 229 ---~~~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 ---PPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ---CCCCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 111111 223577899999999999999999888877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=288.05 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=192.7
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC-----CcchhHHHHHHHHHhcccCCCceeEEeeeeeec--CeEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-----SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVL 674 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~-----~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~--~~~~L 674 (929)
+.+.+.||+|+||.||+|... +++.||+|++... .......+.+|++++++++|+||+++++++.+. +..++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 345789999999999999875 5889999987532 122345788999999999999999999998654 46789
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
++||+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 84 FVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 9999999999998843 23477888899999999999999998 9999999999999999999999999998754
Q ss_pred cCCC--CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 755 VDGA--SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 755 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
.... ........|+..|+|||++.+..++.++|+|||||++|||++|+.||...... ..+.+ ..... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~----~~~~~-~-- 226 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AAIFK----IATQP-T-- 226 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HHHHH----HHcCC-C--
Confidence 3211 11112345889999999999888999999999999999999999999754311 11111 11111 0
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....+......+.+++.+|++ +|..||+..+++.|
T Consensus 227 ------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 227 ------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 011122233568899999999 47999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=301.82 Aligned_cols=267 Identities=23% Similarity=0.300 Sum_probs=200.6
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecC-----eEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVL 674 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~-----~~~L 674 (929)
|.+.+.||+|+||.||+|+.. +++.+|||++.... ....+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 345688999999999999986 48899999987543 334567889999999999999999999997765 7899
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
||||+. ++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 82 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 82 VTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred Eecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 999997 478887743 33788999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCC--ceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc----
Q 002382 755 VDGAS--HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---- 827 (929)
Q Consensus 755 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~---- 827 (929)
..... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+.+.......+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 44321 112234578899999999887 78999999999999999999999997654222222222211100000
Q ss_pred ---CCcccccCCc-cc-----CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH--HHH
Q 002382 828 ---GDIQGIIDPS-LL-----DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQD 877 (929)
Q Consensus 828 ---~~~~~~~d~~-l~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~--L~~ 877 (929)
......+... .. ..........+.+++.+|++.+|++||++.+++++ +++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0000000000 00 00011123467899999999999999999999986 544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=294.28 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=194.1
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC---CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
..++...+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 344555678999999999999976 5788999988643 222345678899999999999999999999999999999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
+||+. |++.+.+... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 94 MEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99996 5777766422 34578889999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCceeeeeecCccccCccccc---cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
.. ....++..|+|||.+. ...++.++|||||||++|||++|+.||......+ .+..+ ..+....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~-----~~~~~~~ 233 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHI-----AQNESPA 233 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHHHH-----hhcCCCC
Confidence 22 2234788999999975 3567889999999999999999999986543110 11111 1111110
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
.. .......+.+++.+|++.+|++||++.+|+++-.
T Consensus 234 -----~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 234 -----LQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -----cC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 00 1122345789999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=293.77 Aligned_cols=259 Identities=19% Similarity=0.223 Sum_probs=182.0
Q ss_pred HHHHHHHHhccccccCcEEEEEEEECCC----cEEEEEEeecCCcch--h---------HHHHHHHHHhcccCCCceeEE
Q 002382 598 IEDATKMLEKKIGSGGFGVVYYGKLKDG----KEIAVKVLTSNSYQG--K---------REFTNEVTLLSRIHHRNLVQF 662 (929)
Q Consensus 598 i~~~~~~~~~~IG~G~fG~Vy~~~~~~~----~~vAVK~l~~~~~~~--~---------~~f~~Ev~iL~~l~HpNIv~l 662 (929)
+....|.+.+.||+|+||+||+|.+.++ ..+|+|+........ + .....+...+..+.|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3334567788999999999999987643 456666543222111 0 112233445667789999999
Q ss_pred eeeeeecC----eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec
Q 002382 663 LGYCQEEG----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (929)
Q Consensus 663 ~g~~~~~~----~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~ 738 (929)
++++.... ..+++++++.. ++.+.+.. ....++..+..++.|+++||+|||++ +|+||||||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 99775543 34667776643 45444421 22346777889999999999999998 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCc------eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccc
Q 002382 739 KHMRAKVSDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 812 (929)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~ 812 (929)
.++.++|+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 9999999999999765322111 1122459999999999999999999999999999999999999997653221
Q ss_pred cchhh--HHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHH
Q 002382 813 NCRNI--VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 813 ~~~~l--~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
..... .++... +..+.+ . .......+.+++..|++.+|++||++.++++.|+
T Consensus 241 ~~~~~~~~~~~~~-~~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 NLIHAAKCDFIKR-LHEGKI--------K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHhHHHHHHH-hhhhhh--------c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111 111111 111111 0 0112356889999999999999999999998763
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=288.64 Aligned_cols=262 Identities=22% Similarity=0.283 Sum_probs=193.4
Q ss_pred HhccccccCcEEEEEEEECC-CcEEEEEEeecCCc--chhHHHHHHHHHhccc---CCCceeEEeeeeeecCe-----EE
Q 002382 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQEEGR-----SV 673 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l---~HpNIv~l~g~~~~~~~-----~~ 673 (929)
+.+.||+|+||.||+|+++. ++.+|+|+++.... .....+.+|+.+++++ +|||++++++++...+. .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 45789999999999999874 89999999874322 2234566787777665 69999999999988776 89
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
++|||+.+ +|.+++.... ...+++..++.++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++..
T Consensus 83 l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 83 LVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred EEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 99999974 7888775422 23588999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc-
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG- 832 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~- 832 (929)
...... .....++..|+|||++.+..++.++|+|||||++|||++|+.||......+....+.+.............
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 533221 12234788999999999888999999999999999999999998765422222222221110000000000
Q ss_pred -----ccCCccc---CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 -----IIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 -----~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....... .....+....+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000000 01111233567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=297.04 Aligned_cols=265 Identities=24% Similarity=0.348 Sum_probs=193.7
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhccc-CCCceeEEeeeeeec--CeEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE--GRSVL 674 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~--~~~~L 674 (929)
..+.+.+.||+|+||.||+|... +++.+|||++... .......+.+|+.+++++ +||||+++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 35667789999999999999876 5788999988543 223345677899999999 999999999998653 46799
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
||||+. ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 87 v~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 87 VFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred Eecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 999997 588887743 2677888899999999999999998 9999999999999999999999999999755
Q ss_pred cCCCCc----eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHH------
Q 002382 755 VDGASH----VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL------ 823 (929)
Q Consensus 755 ~~~~~~----~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~------ 823 (929)
...... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 433211 2223458899999998865 45788999999999999999999999654321111111111000
Q ss_pred -hhhcCCcccccCC----cc--cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 824 -HIESGDIQGIIDP----SL--LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 824 -~~~~~~~~~~~d~----~l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.........+++. .. ...........+.+++.+|++.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000 00 000001123468899999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=289.41 Aligned_cols=261 Identities=22% Similarity=0.265 Sum_probs=196.8
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.+.||+|++|.||+|... +++.+++|++..... .....+.+|++++++++|+||+++++++..++..++|+||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 4578999999999999876 688899999875432 2356788899999999999999999999999999999999975
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
+|.+++... ...+++..+..++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||.+....... ..
T Consensus 83 -~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 83 -DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred -CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 887777432 25688999999999999999999998 99999999999999999999999999987654432 11
Q ss_pred eeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC-----
Q 002382 762 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID----- 835 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d----- 835 (929)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+.+...... ........+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPD-PEVWPKFTSLARNY 233 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCc-hHhcccchhhhhhh
Confidence 1223478899999998876 788999999999999999999999965442111111111000000 000000000
Q ss_pred -Ccc-------cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 -PSL-------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 -~~l-------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... ..........++.+++.+|++.+|.+||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 001112234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=292.95 Aligned_cols=261 Identities=18% Similarity=0.256 Sum_probs=192.2
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+++++.++||||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445556666666666655 5899999998754 2344567999999999999999999999999999999999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC---
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--- 759 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~--- 759 (929)
+|.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999986432 23578888899999999999999998 999999999999999999999999998864432111
Q ss_pred ---ceeeeeecCccccCcccccc--CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh----h----
Q 002382 760 ---HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI----E---- 826 (929)
Q Consensus 760 ---~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~----~---- 826 (929)
.......++..|+|||++.. ..++.++|+|||||++|||++|+.||...... ..+.+...... .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT---QMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCccccccCch
Confidence 11122346788999999875 45888999999999999999999999754311 11111111000 0
Q ss_pred ---cCCccc----ccCCcc----cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 827 ---SGDIQG----IIDPSL----LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 827 ---~~~~~~----~~d~~l----~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...... ..++.. ...........+.+++.+|++.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 000000 011112233568899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=288.49 Aligned_cols=263 Identities=21% Similarity=0.274 Sum_probs=195.0
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-chhHHHHHHHHHhcccC-CCceeEEeeeeeecCeEEEEEEecc
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.+.+.||+|+||+||+|+.. +++.|+||++..... .......+|+..+++++ ||||+++++++...+..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 35678999999999999986 478899999865432 22334567899999998 999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+|+|.+++.... ...+++..++.++.|++.+|.|||++ +++|+||||+||++++++.++|+|||+++........
T Consensus 81 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 889988875432 34688999999999999999999998 9999999999999999999999999999755432221
Q ss_pred eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHH---------HHHHhhhcCCc
Q 002382 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDI 830 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~---------~~~~~~~~~~~ 830 (929)
....++..|+|||++.. ..++.++|+||||++++||++|+.||......+....+.. |..........
T Consensus 156 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 156 --TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred --CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 22347889999998854 5578999999999999999999999965442111111111 11110000001
Q ss_pred ccccCCccc---CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 QGIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...+..... ..........+.+++.+|++.+|++||+++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000 00001113568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=288.92 Aligned_cols=242 Identities=26% Similarity=0.339 Sum_probs=186.3
Q ss_pred cccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHH---HhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 608 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVT---LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 608 ~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~---iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.||+|+||.||+|... +++.||+|++..... .....+..|.. +++..+||||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 578999999875432 11223444443 3444579999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999988742 34689999999999999999999998 99999999999999999999999999987543222
Q ss_pred eeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 761 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
.....|+..|+|||++.++ .++.++||||+||++|||++|+.||........ ..+ . .... . .+..+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~-~--~~~~-~------~~~~~~ 219 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEI-D--RMTL-T------MAVELP 219 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHH-H--HHhh-c------cCCCCC
Confidence 1234589999999998754 688999999999999999999999976431111 111 0 0000 0 011111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
.. ....+.+++.+|+..+|++|| ++.|++++
T Consensus 220 ~~----~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 DS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred Cc----CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11 234688999999999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=301.97 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=193.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeec-----CeEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 674 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~-----~~~~L 674 (929)
|.+.+.||+|+||+||+|+.. +++.||||.+... .......+.+|+.+++.++||||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 445678999999999999876 6889999998653 223345677899999999999999999988644 35799
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
|+||+. ++|.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 87 v~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 87 VYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 999996 67877774 235688999999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh-------h
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI-------E 826 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~-------~ 826 (929)
.... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||......+....+.+...... .
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 4322 22223457889999998865 4688999999999999999999999975432111111111100000 0
Q ss_pred cCCc-------ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 827 SGDI-------QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 827 ~~~~-------~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.... ....++.... ........+.+++.+|++.+|++||+++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred chhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000 0000000000 011233467899999999999999999999988
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=299.73 Aligned_cols=245 Identities=24% Similarity=0.421 Sum_probs=202.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc--hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~--~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+...||+|.|++|..|++. .+.+||||++.+.... ....+.+|+++|..++|||||+++.+...+..+++||||+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 445689999999999999877 6899999999876432 2345889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
.+|.+.+++.. ..+..+..+..++.|+.+|++|||++ .|+|||||++|||++.+.++||+|||++..+.. .
T Consensus 138 ~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~ 208 (596)
T KOG0586|consen 138 SGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY--G 208 (596)
T ss_pred cCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc--c
Confidence 99999999953 45556688889999999999999999 999999999999999999999999999987653 3
Q ss_pred ceeeeeecCccccCccccccCcC-CCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
......+|++.|.|||++.+.++ .+++|+||+|+++|-|+.|..||++....+.....+. ..+
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~----------------gk~ 272 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR----------------GKY 272 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee----------------eee
Confidence 44566789999999999998776 4789999999999999999999987664332221111 111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+-.+.. -..+.+++++++-.+|.+|++++++.++
T Consensus 273 rIp~~m--s~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 RIPFYM--SCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccccee--echhHHHHHHhhccCccccCCHHHhhhh
Confidence 111111 1245688999999999999999999876
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=288.41 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=195.2
Q ss_pred HHHhccccccCcEEEEEEEECC-CcEEEEEEeecCC-----cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~-----~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
|.+.+.||+|+||.||++.... +..+++|+++... .....++..|+.++++++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 4567899999999999998763 4456666655321 223345778999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++++|.+++.........+++..++.++.|+++||.|||+. +++|+||||+||+++. +.+||+|||+++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998865444456789999999999999999999998 9999999999999975 5699999999876543
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
.. .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........ .+...
T Consensus 158 ~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~~~~~~-~~~~~----- 223 (260)
T cd08222 158 SC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LSVVLRIV-EGPTP----- 223 (260)
T ss_pred Cc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHH-cCCCC-----
Confidence 22 222334578899999999888889999999999999999999999864331 11111111 11111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. .+......+.+++.+|++.+|++||++.|++++
T Consensus 224 ~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 S----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred C----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1 112233468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=299.64 Aligned_cols=265 Identities=19% Similarity=0.279 Sum_probs=194.1
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeee----cCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~----~~~~~L 674 (929)
.|.+.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 3445678999999999999876 58999999987542 2334567789999999999999999998753 356899
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
|+||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 86 VMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 999996 588888743 34588999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCCc---eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHH-------
Q 002382 755 VDGASH---VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL------- 823 (929)
Q Consensus 755 ~~~~~~---~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~------- 823 (929)
...... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 332211 1123468899999999865 46889999999999999999999999754321111000000000
Q ss_pred hhhcCCcccccCC-cccCcc-----CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 824 HIESGDIQGIIDP-SLLDEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 824 ~~~~~~~~~~~d~-~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
......+....+. ...... .......+.+++.+|++.+|++||++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000000 000000 11224568899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=275.35 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=198.6
Q ss_pred HHHHhccccccCcEEEEEEE-ECCCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEec
Q 002382 602 TKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~-~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
+..-.+.||+|+|+.|--+. ..+|.++|||++.+..........+|++++.+. .|+||++++++|+++...|||||.|
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm 158 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM 158 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence 33346789999999998885 457999999999988777788899999999998 5999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC---cEEEEeecCccccc-
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKFAV- 755 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkL~DFGla~~~~- 755 (929)
.||+|..++. +..-+++.++.++..+|+.||.|||.+ ||.|||+||+|||-.... -+||+||.+..-..
T Consensus 159 ~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 159 RGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred cCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 9999999995 456688999999999999999999999 999999999999986543 48999998874221
Q ss_pred -----CCCCceeeeeecCccccCccccc-----cCcCCCcCceeeHHHHHHHHHhCCCCCcccc-------ccccchhhH
Q 002382 756 -----DGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEK-------FGANCRNIV 818 (929)
Q Consensus 756 -----~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvl~elltG~~p~~~~~-------~~~~~~~l~ 818 (929)
......-.+.+|+..|||||+.. ...|+.+.|.||||||+|-|++|.+||.+.- .++.++.-.
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 11111223456899999999973 3468889999999999999999999996533 223332211
Q ss_pred HHHHHhhhcCCcccccCCcccCccCHHH----HHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 819 QWAKLHIESGDIQGIIDPSLLDEYDIQS----MWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 819 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~----~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+..-..+.+|.. +++.++ ..+..+++...+..++..|-++.+++.+
T Consensus 312 ~~LFesIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 312 NKLFESIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHHHHHHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 111122233322 222222 2355678888888999999999998874
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=290.87 Aligned_cols=244 Identities=25% Similarity=0.402 Sum_probs=190.7
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+...+.||+|+||+||+|+.. +++.|++|++..... .....+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 334567999999999999875 588999999875422 2235678899999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+. |++.+.+.. ....+++.++..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 577766642 234588999999999999999999998 999999999999999999999999998864321
Q ss_pred CceeeeeecCccccCccccc---cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 759 SHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
.....|+..|+|||++. ...++.++|||||||++|||++|..||...... ...... .. .......
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~----~~~~~~---~~-~~~~~~~- 241 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHI---AQ-NDSPTLQ- 241 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHH---Hh-cCCCCCC-
Confidence 12345889999999984 456888999999999999999999998654311 111111 11 1111111
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... ....+.+++.+|++.+|++||++.+++++
T Consensus 242 ---~~~----~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 ---SNE----WTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---ccc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 12357889999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=289.04 Aligned_cols=262 Identities=24% Similarity=0.298 Sum_probs=197.1
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.+.||+|+||.||+|+.. +++.+|+|++.... ....+.+..|+.++++++|+|++++++++...+..++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 3467999999999999887 48999999987653 2234667889999999999999999999999999999999997
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
++|.+++... ...+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+|||+++....... .
T Consensus 82 ~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 82 MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 5899988542 14688999999999999999999998 999999999999999999999999999875543322 1
Q ss_pred eeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcC--Ccccc--cCC
Q 002382 762 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG--DIQGI--IDP 836 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~--~d~ 836 (929)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.+......... ..... .+.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 1223457889999998776 788999999999999999999999976542222222222111000000 00000 000
Q ss_pred cccC-------ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLD-------EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.... .........+.+++.+|++.+|++||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000 0001113468999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=290.20 Aligned_cols=247 Identities=25% Similarity=0.337 Sum_probs=198.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccC-CCceeEEeeeeeecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~LV~E 677 (929)
|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++ ||||+++++++...+..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 345678999999999999876 68999999987532 233467888999999998 9999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
++++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 83 YAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999998853 34689999999999999999999998 9999999999999999999999999998755432
Q ss_pred CC-------------------ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhH
Q 002382 758 AS-------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 818 (929)
Q Consensus 758 ~~-------------------~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~ 818 (929)
.. .......++..|+|||......++.++|+||||++++++++|+.||...... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~ 231 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----LTF 231 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH----HHH
Confidence 21 1122345788999999998888999999999999999999999999755411 111
Q ss_pred HHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcH----HHHHHH
Q 002382 819 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI----SEVLKD 874 (929)
Q Consensus 819 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~----~eVl~~ 874 (929)
+.. .... ...+......+.+++.+|++.+|++||++ +|++++
T Consensus 232 ~~~---~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 232 QKI---LKLE-----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHH---HhcC-----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 111 1000 01111123468899999999999999999 777654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=326.73 Aligned_cols=245 Identities=25% Similarity=0.394 Sum_probs=193.5
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
...||.|.||.||-|... +|+-.|+|-++-.. ....+...+|..++..++|||+|+.+|+-...+..++.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 357999999999999765 57788999776442 333467889999999999999999999999999999999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce-
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV- 761 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~- 761 (929)
+|.+.+. .++-.++.-...+..|++.|++|||+. |||||||||.||+++.+|.+|++|||.|..........
T Consensus 1320 sLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1320 SLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred cHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999884 334456666677899999999999999 99999999999999999999999999998765543221
Q ss_pred --eeeeecCccccCccccccC---cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHH-hhhcCCcccccC
Q 002382 762 --SSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-HIESGDIQGIID 835 (929)
Q Consensus 762 --~~~~~gt~~Y~aPE~~~~~---~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~d 835 (929)
-....||+.|||||++.+. ....++||||+|||+.||+||+.||...+. .|+.. +...|..
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--------e~aIMy~V~~gh~----- 1459 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--------EWAIMYHVAAGHK----- 1459 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--------hhHHHhHHhccCC-----
Confidence 1345699999999999763 345689999999999999999999976541 12221 1222221
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
++.+...-.+-.+++.+|+..||++|.++.|++++
T Consensus 1460 ----Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 ----PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 12222233355688999999999999988877665
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=317.96 Aligned_cols=265 Identities=27% Similarity=0.432 Sum_probs=210.0
Q ss_pred HHHHHHHHHhccccccCcEEEEEEEEC----C----CcEEEEEEeecCCc-chhHHHHHHHHHhccc-CCCceeEEeeee
Q 002382 597 DIEDATKMLEKKIGSGGFGVVYYGKLK----D----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYC 666 (929)
Q Consensus 597 ~i~~~~~~~~~~IG~G~fG~Vy~~~~~----~----~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~ 666 (929)
++.+....+.+.||+|.||.|++|... . ...||||+++.... ...+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 333343456679999999999999754 1 34699999986533 4467899999999999 699999999999
Q ss_pred eecCeEEEEEEeccCCchhhhhcccc----------ccc--cccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCC
Q 002382 667 QEEGRSVLVYEFMHNGTLKEHLYGTL----------THE--QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734 (929)
Q Consensus 667 ~~~~~~~LV~E~~~~gsL~~~L~~~~----------~~~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~N 734 (929)
...+..++|+||+..|+|.++|+... ... ..+.....+.++.|||.|++||++. +++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence 99999999999999999999997544 011 2388899999999999999999998 99999999999
Q ss_pred eEecCCCcEEEEeecCcccccCCCCceeeeeec--CccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCcccccc
Q 002382 735 ILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 811 (929)
Q Consensus 735 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~ 811 (929)
||+..+..+||+|||+|+...+..........| +..|||||.+....++.++|||||||+||||+| |..|+.+...
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~- 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP- 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence 999999999999999998655544443232223 456999999999999999999999999999999 8888865221
Q ss_pred ccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 812 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 812 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
...+.++ +++|.- .+.+..+..++.+++..||+.+|++||++.|+.+.++..+.
T Consensus 528 --~~~l~~~----l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 --TEELLEF----LKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred --HHHHHHH----HhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1233332 222211 12233345578899999999999999999999999998643
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=281.56 Aligned_cols=235 Identities=20% Similarity=0.311 Sum_probs=182.0
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEeccCCchhh
Q 002382 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 686 (929)
Q Consensus 609 IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 686 (929)
||+|+||.||+++.+ +++.+|+|++....... . |+.....+ +||||+++++.+...+..++||||+++++|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 599999999999876 67889999986432211 1 22222222 79999999999999999999999999999999
Q ss_pred hhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC-cEEEEeecCcccccCCCCceeeee
Q 002382 687 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIV 765 (929)
Q Consensus 687 ~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~ 765 (929)
++.. ...+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||+++...... ..
T Consensus 99 ~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~~ 166 (267)
T PHA03390 99 LLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----CY 166 (267)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----cC
Confidence 9853 23789999999999999999999998 999999999999999998 99999999987543221 23
Q ss_pred ecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHH
Q 002382 766 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ 845 (929)
Q Consensus 766 ~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 845 (929)
.++..|+|||++.+..++.++|||||||++|||++|+.||....... .....+..... ... . .. ..
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~--~~~-~-----~~----~~ 232 (267)
T PHA03390 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQQ--KKL-P-----FI----KN 232 (267)
T ss_pred CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhhc--ccC-C-----cc----cc
Confidence 47899999999998889999999999999999999999997443111 11222221110 000 0 01 12
Q ss_pred HHHHHHHHHHHccCCCCCCCCc-HHHHHHH
Q 002382 846 SMWKIEEKALMCVLPHGHMRPS-ISEVLKD 874 (929)
Q Consensus 846 ~~~~l~~li~~Cl~~dP~~RPs-~~eVl~~ 874 (929)
....+.+++.+|++.+|++||+ ++|++++
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 233 VSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred cCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 2346789999999999999995 6888764
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=275.32 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=200.4
Q ss_pred ccCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHH---HHHHHHHhcccCCCceeEEeeeee
Q 002382 592 CFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLGYCQ 667 (929)
Q Consensus 592 ~~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~---f~~Ev~iL~~l~HpNIv~l~g~~~ 667 (929)
..++.+++ +.+.||+|.||+|-+++-+ .++.+|+|++++...-.+.+ -..|-++|+..+||.+..+--.|+
T Consensus 164 kvTm~dFd-----fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 164 KVTMEDFD-----FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred eeccchhh-----HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence 34555543 6789999999999999877 68899999998765443333 356889999999999999999999
Q ss_pred ecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEe
Q 002382 668 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 747 (929)
Q Consensus 668 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 747 (929)
..+++|+||||+.||.|.-+| +..+.+++....-+..+|..||.|||++ +||.||+|.+|.|+|.+|++||+|
T Consensus 239 t~drlCFVMeyanGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitD 311 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITD 311 (516)
T ss_pred cCceEEEEEEEccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeee
Confidence 999999999999999998888 4567788888888999999999999998 999999999999999999999999
Q ss_pred ecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc
Q 002382 748 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 827 (929)
Q Consensus 748 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 827 (929)
||+++.-- .......+.+|||.|+|||++....|..++|.|.+|||||||++|+.||...+-...++-|.. ++
T Consensus 312 FGLCKE~I-~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~------ed 384 (516)
T KOG0690|consen 312 FGLCKEEI-KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM------ED 384 (516)
T ss_pred cccchhcc-cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh------hh
Confidence 99987422 223445678899999999999999999999999999999999999999986553222221111 11
Q ss_pred CCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 828 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 828 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
-+. +.....+...|....+..||.+|. .+.||.++
T Consensus 385 ~kF------------Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 385 LKF------------PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ccC------------CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 111 111122456777788999999997 35555443
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=292.82 Aligned_cols=266 Identities=21% Similarity=0.274 Sum_probs=190.6
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc--hhHHHHHHHHHhcccCCCceeEEeeeeeec--------C
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEE--------G 670 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~--~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~--------~ 670 (929)
.|.+.+.||+|+||.||+|+.+ +++.+|||++...... ....+.+|++++++++||||+++++++... .
T Consensus 9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 3456788999999999999876 5889999988654322 234577899999999999999999987543 3
Q ss_pred eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecC
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 750 (929)
..++|+||+.+ +|.+.+.. ....+++..+..++.|+++||+|||++ +|+|+||||+||++++++.+||+|||+
T Consensus 89 ~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 89 SVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred eEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 46999999975 56665542 234689999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCc----------eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHH
Q 002382 751 SKFAVDGASH----------VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (929)
Q Consensus 751 a~~~~~~~~~----------~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~ 819 (929)
++........ ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9754322111 1123457889999998865 4578999999999999999999999975442111111111
Q ss_pred HHHHhhh-----cCCcccccCCcccCccC-------HHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 820 WAKLHIE-----SGDIQGIIDPSLLDEYD-------IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 820 ~~~~~~~-----~~~~~~~~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....... ...+....+.......+ ......+.+++.+|++.+|++|||+.|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1000000 00000100000000000 1112467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=287.39 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=190.0
Q ss_pred HHHhccccccCcEEEEEEEECC-CcEEEEEEeecCCc-chhHHHHHHHHHhcccC-CCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
+.+.+.||+|+||.||+|.+++ ++.||||+++.... .....+..|+.++.+.. ||||+++++++.+....+++|||+
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 4567899999999999999875 88999999875432 23455667777776664 999999999999999999999998
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
. +++.+++... ...+++..+..++.|++.||+|||+. .+|+||||+|+||++++++.+||+|||++........
T Consensus 97 ~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 97 S-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred C-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 5 4666655321 23688889999999999999999973 2899999999999999999999999999875543222
Q ss_pred ceeeeeecCccccCccccccCc----CCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~----~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
. ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... ..+.+... .... ...
T Consensus 171 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~----~~~~-~~~--- 238 (296)
T cd06618 171 K--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKI----LQEE-PPS--- 238 (296)
T ss_pred c--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHH----hcCC-CCC---
Confidence 1 2234788999999987553 78899999999999999999999965321 11111111 1111 000
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... ......++.+++.+|++.+|++||++.+++++
T Consensus 239 --~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 --LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 00123468899999999999999999999877
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=284.32 Aligned_cols=261 Identities=24% Similarity=0.326 Sum_probs=207.2
Q ss_pred HHHHHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecC-CcchhHHHHHHHHHhcccCCCceeEEeeeeeec-C
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-G 670 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~-~ 670 (929)
.+.+..+...+-+|.||+||+|.|. +.++|.||.++.. +.-....+..|..++..+.|||+.++.+++.++ .
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 3444445667899999999999665 3456788877654 333456688899999999999999999998654 4
Q ss_pred eEEEEEEeccCCchhhhhcc----ccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEE
Q 002382 671 RSVLVYEFMHNGTLKEHLYG----TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~----~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 746 (929)
..+++|.++.-|+|..+|.. .....+.+...+...++.|++.|++|||+. +|||.||.++|++|++..++||+
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEec
Confidence 66888999999999999962 112345678888999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCCce-eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHh
Q 002382 747 DFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 824 (929)
Q Consensus 747 DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 824 (929)
|=.+++...+.+.+. ......+..||+||.+....|+.++|||||||+||||+| |+.|+..-+.. .+..+.+
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf----Em~~ylk-- 512 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF----EMEHYLK-- 512 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH----HHHHHHh--
Confidence 999999776665553 334446789999999999999999999999999999999 89998654411 1112211
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
+| .+-..+..++.++..++.-||+..|++||+.+|++.-|.+.-
T Consensus 513 --dG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 513 --DG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred --cc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 11 112234556778999999999999999999999999998754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=278.47 Aligned_cols=236 Identities=29% Similarity=0.355 Sum_probs=191.1
Q ss_pred ccccCcEEEEEEEEC-CCcEEEEEEeecCCcc---hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 609 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 609 IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~---~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
||+|+||.||++... +++.+|+|++...... ....+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999886 5889999998765322 345788999999999999999999999999999999999999999
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeee
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (929)
.+++.. ...+++..+..++.|+++||.|||+. +++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 998853 33578999999999999999999998 99999999999999999999999999987654332 12233
Q ss_pred eecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCH
Q 002382 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844 (929)
Q Consensus 765 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 844 (929)
..++..|++||...+...+.++|+||||+++||+++|+.||..... ..+.+.+.. ... ..+.
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~----~~~----------~~~~ 214 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILK----DPL----------RFPE 214 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhc----CCC----------CCCC
Confidence 4578899999999888889999999999999999999999965431 111121111 100 0111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCcHHH
Q 002382 845 QSMWKIEEKALMCVLPHGHMRPSISE 870 (929)
Q Consensus 845 ~~~~~l~~li~~Cl~~dP~~RPs~~e 870 (929)
.....+.+++.+|+..+|++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11346789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=293.47 Aligned_cols=264 Identities=20% Similarity=0.258 Sum_probs=190.3
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeec-----------
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE----------- 669 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~----------- 669 (929)
+|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 3455688999999999999876 5889999998766555567788999999999999999999876543
Q ss_pred ---CeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC-CCcEEE
Q 002382 670 ---GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKV 745 (929)
Q Consensus 670 ---~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL 745 (929)
...++|+||+. ++|.+++. ...+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 58877763 23578889999999999999999998 9999999999999974 567899
Q ss_pred EeecCcccccCCCCce--eeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHH
Q 002382 746 SDFGLSKFAVDGASHV--SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 822 (929)
Q Consensus 746 ~DFGla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~ 822 (929)
+|||+++......... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+..-..
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999987543221111 122347889999998754 5678899999999999999999999975431111111110000
Q ss_pred Hhh--hcCCcccccCCcc-----cCcc-----CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 823 LHI--ESGDIQGIIDPSL-----LDEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 823 ~~~--~~~~~~~~~d~~l-----~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... ............+ .... .......+.+++.+|++.+|++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 0000000000000 0000 01122467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=290.42 Aligned_cols=262 Identities=21% Similarity=0.298 Sum_probs=190.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeec------CeEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 673 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~------~~~~ 673 (929)
+.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++... ...+
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence 334678999999999999875 68999999986532 22235678999999999999999999998654 3468
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+|+||+.. +|..++ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 97 lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 97 LVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 99999864 665544 23578888999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHH-------Hhh
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LHI 825 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~-------~~~ 825 (929)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..... ...
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 4221 122357889999999876 4688999999999999999999999975432111111111000 000
Q ss_pred hcCC-------cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH--HHHhH
Q 002382 826 ESGD-------IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDAI 879 (929)
Q Consensus 826 ~~~~-------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~--L~~~~ 879 (929)
.... ........+...+ ......+.+++.+|++.+|++||++.|++++ ++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000 0000000000000 0122357899999999999999999999977 66653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=287.84 Aligned_cols=245 Identities=25% Similarity=0.381 Sum_probs=196.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
++.||+|.||+||-|+++ +|+.||||++.+- ....+.++.+|+.||++++||.||.+-..|+..++.++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 689999999999999886 6999999999764 344567899999999999999999999999999999999999955
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC---CcEEEEeecCcccccCCCC
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkL~DFGla~~~~~~~~ 759 (929)
+..+.+.. .+.+++++....-+..||+.||.|||.+ +|+|+||||+|||+... .++||||||.|+.....
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 55555432 3467788888888999999999999998 99999999999999754 47999999999987543
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
.....+.||+.|+|||++..+.|...-|+||.||++|--++|..||+... ++.+.++-+.-+ +.+.
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE---dIndQIQNAaFM---------yPp~-- 786 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE---DINDQIQNAAFM---------YPPN-- 786 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc---chhHHhhccccc---------cCCC--
Confidence 34456789999999999999999999999999999999999999997543 222222211111 1111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.-.+.-...+++|...++..-++|-+.++-+.+
T Consensus 787 --PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 787 --PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred --chhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 111223356788888889888899988876654
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=288.91 Aligned_cols=259 Identities=19% Similarity=0.271 Sum_probs=190.6
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeee-cCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~-~~~~~LV~E~ 678 (929)
|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.. ....++++||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 445689999999999999876 7899999987643 22234678889999999999999999998865 5578999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+ +++|.+++. ...+++.....++.|+++||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 92 ~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 92 L-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred h-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 8 568887774 23467777888999999999999998 9999999999999999999999999998743221
Q ss_pred CceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHH--------HHhhhcCC
Q 002382 759 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA--------KLHIESGD 829 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~--------~~~~~~~~ 829 (929)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.++. ........
T Consensus 162 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 162 ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred ---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 122346889999998866 568899999999999999999999996543211111111110 00000000
Q ss_pred cccccCCcccCccCH-----HHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 IQGIIDPSLLDEYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~-----~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..-...-......+. .....+.+++.+|++.+|++||++.|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000011111 123578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=291.19 Aligned_cols=263 Identities=22% Similarity=0.267 Sum_probs=188.9
Q ss_pred HHhccccccCcEEEEEEEEC-C--CcEEEEEEeecCC--cchhHHHHHHHHHhccc-CCCceeEEeeeeeec----CeEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-D--GKEIAVKVLTSNS--YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE----GRSV 673 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~--~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~----~~~~ 673 (929)
.+.+.||+|+||.||+++.. . ++.||+|++.... ....+.+.+|+++++++ +||||+++++.+... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 45678999999999999876 3 6789999986432 22345678899999999 599999999875432 4567
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+++|++. ++|.+++. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 83 ~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 83 LYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 8888885 68888774 345688999999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCCc---eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh-----
Q 002382 754 AVDGASH---VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH----- 824 (929)
Q Consensus 754 ~~~~~~~---~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~----- 824 (929)
....... ......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||......+....++......
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4332211 1123458999999998765 468899999999999999999999997544211111111110000
Q ss_pred --hhcCCccc---ccCCc---ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 825 --IESGDIQG---IIDPS---LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 825 --~~~~~~~~---~~d~~---l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
........ ..... ............+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000 00000 0000001123468899999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=308.13 Aligned_cols=246 Identities=24% Similarity=0.362 Sum_probs=182.2
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeec--------------
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-------------- 669 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~-------------- 669 (929)
.+.||+||||.||+++.+ ||+.+|||++.... ......+.+|+.+|.+++|||||+++..+.+.
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 357999999999999988 89999999997653 33345688999999999999999987432100
Q ss_pred --------------------------------------------------------------------------------
Q 002382 670 -------------------------------------------------------------------------------- 669 (929)
Q Consensus 670 -------------------------------------------------------------------------------- 669 (929)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred -------------------------CeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCc
Q 002382 670 -------------------------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724 (929)
Q Consensus 670 -------------------------~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 724 (929)
..+|+-||||+..++.++++...-.. .....++++++|++||+|+|++ |
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH~~---g 717 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIHDQ---G 717 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHHhC---c
Confidence 12356788888877777765432111 3456789999999999999999 9
Q ss_pred eecCCCCCCCeEecCCCcEEEEeecCccccc----C-------------CCCceeeeeecCccccCccccccC---cCCC
Q 002382 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAV----D-------------GASHVSSIVRGTVGYLDPEYYISQ---QLTD 784 (929)
Q Consensus 725 ivHrDIkp~NILl~~~~~vkL~DFGla~~~~----~-------------~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ 784 (929)
||||||||.||+++++..|||+|||+|+... . ......+...||.-|+|||++.+. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998621 0 111123446699999999999754 5999
Q ss_pred cCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCC
Q 002382 785 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM 864 (929)
Q Consensus 785 ~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~ 864 (929)
|+|+||||||++||+. ||.-.. +.. -+...++.+.++.- ..+..+.+..-..++.+++++||.+
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsM-----ERa--~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSM-----ERA--SILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchH-----HHH--HHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCcc
Confidence 9999999999999986 454221 111 11122334444332 1223334445568999999999999
Q ss_pred CCcHHHHHH
Q 002382 865 RPSISEVLK 873 (929)
Q Consensus 865 RPs~~eVl~ 873 (929)
|||+.|++.
T Consensus 862 RPtA~eLL~ 870 (1351)
T KOG1035|consen 862 RPTATELLN 870 (1351)
T ss_pred CCCHHHHhh
Confidence 999999885
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=289.93 Aligned_cols=258 Identities=21% Similarity=0.270 Sum_probs=190.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecC------eEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV 673 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~------~~~ 673 (929)
|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.... ..+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence 445678999999999999865 68899999986432 223456789999999999999999999886543 458
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 97 lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 97 LVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred EEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 999998 678887774 24578899999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHH--------HHHh
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW--------AKLH 824 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~--------~~~~ 824 (929)
..... ....+++.|+|||.+.+ ..++.++|+|||||++|++++|+.||...........+... ....
T Consensus 168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 168 TDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 43221 22347889999999876 45788999999999999999999999754321111111110 0000
Q ss_pred hhc------CCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 825 IES------GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 825 ~~~------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... ..+.......+ ..........+.+++.+|++.+|++|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000000000 00001122357899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=272.48 Aligned_cols=202 Identities=25% Similarity=0.368 Sum_probs=167.8
Q ss_pred HHHHhccccccCcEEEEEEEEC---C--CcEEEEEEeecCCcc--hhHHHHHHHHHhcccCCCceeEEeeeeee-cCeEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK---D--GKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSV 673 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~---~--~~~vAVK~l~~~~~~--~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~-~~~~~ 673 (929)
.|+....||+|.||.||+|.-+ + .+.+|+|+++..+.. -.....+|+.+++.++||||+.+..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 4556678999999999999544 2 337899998755322 23457789999999999999999999977 78899
Q ss_pred EEEEeccCCchhhhhccc-cccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC----CcEEEEee
Q 002382 674 LVYEFMHNGTLKEHLYGT-LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDF 748 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~----~~vkL~DF 748 (929)
+++||.+. +|.+.++-. ......++...+..|+.||+.|+.|||++ -|+||||||.|||+..+ |.|||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999986 777777432 23446789999999999999999999999 89999999999999887 89999999
Q ss_pred cCcccccCCCCce--eeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCcc
Q 002382 749 GLSKFAVDGASHV--SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISN 807 (929)
Q Consensus 749 Gla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~ 807 (929)
|+++.+.+.-... ...++-|.+|+|||++.+ ..|+.+.|||+.||++.||++-.+.|..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999776543332 345678999999999987 5789999999999999999999887754
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=264.27 Aligned_cols=248 Identities=24% Similarity=0.357 Sum_probs=190.7
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccC-CCceeEEeeeeeecCeEEEEEEeccC
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+...||.|.-|.|++++++ .|..+|||.+.... .+..+.+...+.++.+.+ +|.||+.+|+|......++.||.|..
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 3457999999999999987 47889999997653 344566777777776664 89999999999999888999998743
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
.++.++... .+.+++.-+-++...+.+||.||.++ .+|+|||+||+|||+|+.|++|+||||++-.+.++..+
T Consensus 176 -C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh- 248 (391)
T KOG0983|consen 176 -CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH- 248 (391)
T ss_pred -HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence 344444321 34577777788999999999999998 49999999999999999999999999999876654433
Q ss_pred eeeeecCccccCcccccc---CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 762 SSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~---~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
+...|.+.|||||.+.- ..|+.++||||||+.++||.||+.||...+. +++ ....+.. +....++...
T Consensus 249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe-~ltkvln-----~ePP~L~~~~ 319 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFE-VLTKVLN-----EEPPLLPGHM 319 (391)
T ss_pred -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cHH-HHHHHHh-----cCCCCCCccc
Confidence 34568999999999964 4688899999999999999999999986441 121 1121111 1112222211
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. +. ..+.+++..|+++|+.+||...++++|
T Consensus 320 g--FS----p~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 320 G--FS----PDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred C--cC----HHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1 22 358899999999999999999999886
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=308.82 Aligned_cols=253 Identities=23% Similarity=0.268 Sum_probs=202.2
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC---CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
...+.+.+.||+|+||.|...+++ .++.+|+|++.+. ......-|.+|-.+|..-+.+-|+.++-+|.+..++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 344567899999999999999987 5778999999763 233456688999999999999999999999999999999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
||||+||+|..+|.. ...+++.-+.-++..|..||.-||+. |+|||||||+|||||..|++||+|||.+-.+.
T Consensus 154 MdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 999999999999843 34788888999999999999999998 99999999999999999999999999887666
Q ss_pred CCCCceeeeeecCccccCcccccc-----CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCc
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 830 (929)
......+...+|||.|++||++.. +.|+..+|.||+||++|||+.|..||.....-+.+..|...-.. -.+
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~----l~F 302 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES----LSF 302 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh----cCC
Confidence 555556667789999999999863 56889999999999999999999999876644444443332000 001
Q ss_pred ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCc---HHHHHHH
Q 002382 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEVLKD 874 (929)
Q Consensus 831 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~eVl~~ 874 (929)
++ ..+......+||.+-+. +|+.|-. ++++..|
T Consensus 303 P~----------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 303 PD----------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred Cc----------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 10 12233456677666554 5566776 8888776
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=290.86 Aligned_cols=258 Identities=22% Similarity=0.290 Sum_probs=188.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeec------CeEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 673 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~------~~~~ 673 (929)
|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (345)
T cd07877 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 98 (345)
T ss_pred eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEE
Confidence 344678999999999999865 68899999986532 22345678899999999999999999988543 3467
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
++++++ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 99 lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 99 LVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred EEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 888876 778887763 23578899999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh-------h
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------I 825 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~-------~ 825 (929)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.+..... .
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 170 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred cccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 4321 223457889999999866 567889999999999999999999996543211111111111000 0
Q ss_pred hcCC-------cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 826 ESGD-------IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 826 ~~~~-------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.... +......... .........+.+++.+|++.+|++||++.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred ccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 0000000000 0000122357899999999999999999999877
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=292.86 Aligned_cols=259 Identities=22% Similarity=0.304 Sum_probs=191.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCe------EE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------SV 673 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~------~~ 673 (929)
|.+.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++...+. .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 345688999999999999986 5789999988643 22234567789999999999999999998866554 89
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 97 lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 97 LVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 999998 6689888742 4588999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh-------h
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------I 825 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~-------~ 825 (929)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.+..... .
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 4322 223357889999999865 467889999999999999999999997543211111111110000 0
Q ss_pred hcCCcccc---cCCcccCcc---CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 826 ESGDIQGI---IDPSLLDEY---DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 826 ~~~~~~~~---~d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
........ +...-...+ .......+.+++.+|++.+|++|||+.||+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000 000000000 00113468899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=274.03 Aligned_cols=265 Identities=24% Similarity=0.335 Sum_probs=202.9
Q ss_pred cCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcch-------hHHHHHHHHHhcccCCCceeEEee
Q 002382 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIHHRNLVQFLG 664 (929)
Q Consensus 593 ~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~-------~~~f~~Ev~iL~~l~HpNIv~l~g 664 (929)
|.-......+|.+.+.||+|||+.||+|.+- ..+.||||+-.-+..+. .+...+|..|.+.+.||.||++++
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 3333345667888899999999999999754 67889999875443222 234678999999999999999999
Q ss_pred eee-ecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC---C
Q 002382 665 YCQ-EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---H 740 (929)
Q Consensus 665 ~~~-~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~ 740 (929)
++. +.+..|-|+|||+|.+|+-+|. ..+.+++.++..|+.||+.||.||.+. .++|||-||||.|||+.. -
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gtac 609 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTAC 609 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccc
Confidence 995 4567899999999999999884 456789999999999999999999986 468999999999999954 4
Q ss_pred CcEEEEeecCcccccCCCC------ceeeeeecCccccCcccccc----CcCCCcCceeeHHHHHHHHHhCCCCCccccc
Q 002382 741 MRAKVSDFGLSKFAVDGAS------HVSSIVRGTVGYLDPEYYIS----QQLTDKSDVYSFGVILLELISGQEAISNEKF 810 (929)
Q Consensus 741 ~~vkL~DFGla~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~----~~~s~~sDVwSlGvvl~elltG~~p~~~~~~ 810 (929)
|.+||.|||+++.+.+... .......||.+|++||.+.- .+++.|+||||.||++|+++.|+.||....
T Consensus 610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq- 688 (775)
T KOG1151|consen 610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ- 688 (775)
T ss_pred ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch-
Confidence 7899999999997765432 23345679999999999863 357889999999999999999999998654
Q ss_pred cccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 811 GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 811 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..++|++... +.....-.+ ...+....+...++.+|++..-++|....++..+
T Consensus 689 --sQQdILqeNT-------IlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 689 --SQQDILQENT-------ILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred --hHHHHHhhhc-------hhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 2334444211 111111011 1112233456789999999999999887777653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=271.82 Aligned_cols=221 Identities=21% Similarity=0.172 Sum_probs=174.9
Q ss_pred cCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCchhhhhcc
Q 002382 612 GGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG 690 (929)
Q Consensus 612 G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~ 690 (929)
|.||.||+++.. +++.+|+|+++... .+..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999876 68899999987543 233455555556799999999999999999999999999999998843
Q ss_pred ccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeeeeecCcc
Q 002382 691 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770 (929)
Q Consensus 691 ~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 770 (929)
...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 33588999999999999999999998 9999999999999999999999999987654322 122345778
Q ss_pred ccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHH
Q 002382 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 850 (929)
Q Consensus 771 Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 850 (929)
|+|||.+.+..++.++||||+||++|||++|..|+...... + . ......+... ....+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-~------------~~~~~~~~~~----~~~~~ 205 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-N------------THTTLNIPEW----VSEEA 205 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-c------------cccccCCccc----CCHHH
Confidence 99999998888899999999999999999999887532200 0 0 0000001111 22457
Q ss_pred HHHHHHccCCCCCCCCcHHH
Q 002382 851 EEKALMCVLPHGHMRPSISE 870 (929)
Q Consensus 851 ~~li~~Cl~~dP~~RPs~~e 870 (929)
.+++.+|++.||++||++.+
T Consensus 206 ~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHHccCCHHHhcCCCc
Confidence 88999999999999999733
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=309.00 Aligned_cols=143 Identities=31% Similarity=0.419 Sum_probs=126.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.++||+|+||+||+|.+. +++.||||+++.... .....+..|+.+++.++||||+++++++...+..++||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 345688999999999999987 688999999975432 2236788899999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
+.+++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999998853 34577888899999999999999998 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=290.02 Aligned_cols=239 Identities=21% Similarity=0.331 Sum_probs=190.3
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEe
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
..|.+...+|.|+|+.|-++.+. +++..+||++.+.. .+-.+|+.++... +||||+++.+.+.+..+.++|||.
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 34566778999999999999766 68889999997652 2344567665555 799999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe-cCCCcEEEEeecCcccccCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL-DKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl-~~~~~vkL~DFGla~~~~~~ 757 (929)
+.++-+.+.+... .....++..|+.+|+.|+.|||++ ||||||+||+|||+ ++.++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999887777432 222256677999999999999998 99999999999999 58899999999999865443
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
....+-|..|.|||+.....+++++|+||||++||+|++|+.||.....+ .++.. .+..++
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~----~i~~~~-------- 530 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHT----RIQMPK-------- 530 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHH----hhcCCc--------
Confidence 12234588999999999999999999999999999999999999765422 12222 122221
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+....-....+|+.+|++.||.+||+|.|+..+
T Consensus 531 ----~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 531 ----FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ----cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 222333467899999999999999999999876
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-31 Score=267.16 Aligned_cols=265 Identities=27% Similarity=0.368 Sum_probs=197.8
Q ss_pred cccccCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-chhHHHHHHHHHhccc-CCCceeEEeee
Q 002382 589 AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGY 665 (929)
Q Consensus 589 ~~~~~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l-~HpNIv~l~g~ 665 (929)
..+.|+-.++++. ..||.|+||+|+|..++ .|+..|||+++.... ..++++..|.+...+- +.||||+++|+
T Consensus 57 ~~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 57 HLHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 3455665555432 46899999999999887 689999999987654 4466788888765544 78999999999
Q ss_pred eeecCeEEEEEEeccCCchhhhhc-cccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEE
Q 002382 666 CQEEGRSVLVYEFMHNGTLKEHLY-GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 744 (929)
Q Consensus 666 ~~~~~~~~LV~E~~~~gsL~~~L~-~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 744 (929)
+-.++..++.||.|. -||+.+-. -...+...+++.-.-.|..-...||.||.+. ..|||||+||+|||++..|.+|
T Consensus 132 ~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 132 LFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEe
Confidence 999999999999995 45544321 1123456678877778888889999999987 5899999999999999999999
Q ss_pred EEeecCcccccCCCCceeeeeecCccccCcccccc--CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHH
Q 002382 745 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 822 (929)
Q Consensus 745 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~ 822 (929)
|||||++-.+.++ ...+.-.|...|||||.+.. ..|+.+|||||||+.|+|+.||+.|+.... ..++++.+
T Consensus 209 LCDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~--svfeql~~--- 281 (361)
T KOG1006|consen 209 LCDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD--SVFEQLCQ--- 281 (361)
T ss_pred eecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH--HHHHHHHH---
Confidence 9999998654432 22233458889999999964 358899999999999999999999987654 12222222
Q ss_pred HhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 823 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 823 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. -.|+...+.. +....+....+...+..|+.+|-.+||...++.++
T Consensus 282 -V-v~gdpp~l~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 282 -V-VIGDPPILLF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -H-HcCCCCeecC----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 1222222111 11122334567888999999999999999998765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=276.26 Aligned_cols=243 Identities=25% Similarity=0.312 Sum_probs=194.2
Q ss_pred HHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHH---HHHHHHHhccc-CCCceeEEeeeeeecCeE
Q 002382 598 IEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 672 (929)
Q Consensus 598 i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~---f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~ 672 (929)
+.....+|...||+|+||.|-+|.-+ ..+.+|||+++++..-...+ -..|-++|... +-|.+++++.+++.-+++
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 33445568899999999999999766 45679999998774433222 23466666665 568999999999999999
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
++||||+.||+|.-++. +-+++.+..+.-+|.+||-||-+||++ +||+||||.+|||++.+|++||+|||+++
T Consensus 426 yFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccc
Confidence 99999999999988873 456677888889999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
.-.- ......+.+||+.|+|||++..++|+.++|.|||||+||||+.|++||++.+..+.++.|.+.
T Consensus 499 Eni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh------------ 565 (683)
T KOG0696|consen 499 ENIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH------------ 565 (683)
T ss_pred cccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc------------
Confidence 4222 233455678999999999999999999999999999999999999999987644444444331
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCC
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP 866 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 866 (929)
.-.|+..-..+...+...-+...|.+|.
T Consensus 566 ------nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 ------NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ------cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 0123333334567777888889998886
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=290.94 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=202.2
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeee-----cCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE-----EGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~-----~~~~~L 674 (929)
+..|.+.||+|.+|.||+++.. +++..|+|++..... .+.+.+.|.++|+.. +|||++.++|++.. ++.++|
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 3456789999999999999876 588899999875543 356788899999887 79999999999853 578999
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
|||||.+||..|+++..+ +.++.|..+.-|+++++.||.|||.+ .++|||||-.|||++.++.+||+|||.+...
T Consensus 99 VMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred EeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 999999999999998775 77899999999999999999999999 9999999999999999999999999998755
Q ss_pred cCCCCceeeeeecCccccCccccccC-----cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
..+ .....+..||+.|||||++... .|+.++|+||||++..||.-|.+|+-++..- .+.-.+....
T Consensus 174 dsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------raLF~IpRNP 244 (953)
T KOG0587|consen 174 DST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------RALFLIPRNP 244 (953)
T ss_pred ecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------hhhccCCCCC
Confidence 433 2334456799999999999643 4677899999999999999999998665410 0111111111
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.. .-..+..--.++.+.|..|+..|-+.||++.++++|
T Consensus 245 PP-------kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 245 PP-------KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred Cc-------cccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11 111223344579999999999999999999998865
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=261.08 Aligned_cols=243 Identities=24% Similarity=0.274 Sum_probs=191.0
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeee----cCeEEEEEEec
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE----EGRSVLVYEFM 679 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~----~~~~~LV~E~~ 679 (929)
.++||-|-.|.|-.+.++ .++++|+|++... ....+|+++.-.. .|||||.+++++.. ...+.+|||.|
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 478999999999999877 6889999998632 3456788876555 69999999998854 45778999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC---CCcEEEEeecCcccccC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DFGla~~~~~ 756 (929)
+||.|...+.+. ..+.+.+.++..|+.||+.|+.|||+. +|.||||||+|+|... +..+||+|||+|+....
T Consensus 142 eGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 142 EGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred cchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 999999988653 345689999999999999999999998 9999999999999975 45699999999986433
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
.....+.+-|+.|.|||++-..+|+...|+||+||+||-|++|.+||...... .+.--.+..+..|..
T Consensus 217 --~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~----aispgMk~rI~~gqy------ 284 (400)
T KOG0604|consen 217 --PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKRRIRTGQY------ 284 (400)
T ss_pred --CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc----cCChhHHhHhhccCc------
Confidence 22234456799999999999999999999999999999999999999754411 111111222222211
Q ss_pred cccCccCH----HHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDI----QSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~----~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+++. ...+...+++...++.+|.+|.|+.|+.++
T Consensus 285 ----~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 ----EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ----cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 2222 233456789999999999999999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-31 Score=262.39 Aligned_cols=261 Identities=20% Similarity=0.297 Sum_probs=192.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeec-CC-cchhHHHHHHHHHhcccCCCceeEEeeeeee--------cCe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTS-NS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--------EGR 671 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~-~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~--------~~~ 671 (929)
|.-..+||+|.||+||+|+.+ .++.||+|++-- +. ..-.....+|+.+|+.++|+|++.+++.|.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 333468999999999999877 577889986532 22 2223456789999999999999999998843 235
Q ss_pred EEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCc
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 751 (929)
.++|+.+|+. +|...|.. ...+++..++.+++.++..||.|+|+. .|+|||+||.|+||+.++.+||+|||++
T Consensus 99 ~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 7999999976 77777643 246788889999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCC---CceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh---
Q 002382 752 KFAVDGA---SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH--- 824 (929)
Q Consensus 752 ~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~--- 824 (929)
+.+.... ....+..+-|.+|++||.+.+ +.|+++.|||..||||.||+++.+-+.+.... ..+..+...
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq----qql~~Is~LcGs 247 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ----QQLHLISQLCGS 247 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH----HHHHHHHHHhcc
Confidence 7554322 122344557999999999986 57999999999999999999999888765421 111222211
Q ss_pred --------hhcCCcccccCCc-c-cCccC--HHHHH------HHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 825 --------IESGDIQGIIDPS-L-LDEYD--IQSMW------KIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 825 --------~~~~~~~~~~d~~-l-~~~~~--~~~~~------~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+.+-++...+.-. + .+.+. .+.++ ...+|+..++..||.+|+++.+++.+
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1111111111100 1 11110 11122 56789999999999999999999865
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=238.53 Aligned_cols=258 Identities=20% Similarity=0.280 Sum_probs=190.3
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
.++||+|.||+||+|+.. .++-||+|.++-+. ........+|+-+|+.++|+|||++++....+..+.+|+|||..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 368999999999999876 46779999987543 23345678999999999999999999999999999999999954
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
+|..+... -.+.++...+..++.|+++||.|+|++ ++.|||+||.|.||+.+|+.|++|||+++.++-.....
T Consensus 86 dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrcy- 158 (292)
T KOG0662|consen 86 DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY- 158 (292)
T ss_pred HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEee-
Confidence 66665532 245677888899999999999999998 99999999999999999999999999998665433222
Q ss_pred eeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHh--hhcCC---cccccC
Q 002382 763 SIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH--IESGD---IQGIID 835 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~--~~~~~---~~~~~d 835 (929)
....-|.+|.+|.++.+. -|+...|+||.||++.|+.. |++.|.+.+. ..++.+.++.. ..++. +..+-|
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv---ddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH---HHHHHHHHHHhCCCccccCCccccCCC
Confidence 233469999999999875 47888999999999999998 6666665442 22333333221 11111 111122
Q ss_pred CcccCccCH-----HHH----HHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSLLDEYDI-----QSM----WKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~-----~~~----~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
-...+.++. +.. ..=.++....+.-+|..|.++++.+++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111222221 111 123467777788899999999887765
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=263.12 Aligned_cols=238 Identities=27% Similarity=0.424 Sum_probs=192.6
Q ss_pred CcEEEEEEEECC-CcEEEEEEeecCCcch-hHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCchhhhhcc
Q 002382 613 GFGVVYYGKLKD-GKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG 690 (929)
Q Consensus 613 ~fG~Vy~~~~~~-~~~vAVK~l~~~~~~~-~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~ 690 (929)
+||.||+|...+ ++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999874 8999999997665444 67899999999999999999999999999999999999999999998853
Q ss_pred ccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeeeeecCcc
Q 002382 691 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770 (929)
Q Consensus 691 ~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 770 (929)
. ..+++..+..++.++++++.+||+. +++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 2 2278889999999999999999998 99999999999999999999999999997654432 2233457889
Q ss_pred ccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHH
Q 002382 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 850 (929)
Q Consensus 771 Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 850 (929)
|++||......++.++||||||++++++++|..||.... ....+.++... +.... ..........+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~---~~~~~~~~~~~----~~~~~-------~~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD---QLLELFKKIGK----PKPPF-------PPPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhc----cCCCC-------ccccccCCHHH
Confidence 999999988889999999999999999999999986522 11222232221 11100 00000023468
Q ss_pred HHHHHHccCCCCCCCCcHHHHHH
Q 002382 851 EEKALMCVLPHGHMRPSISEVLK 873 (929)
Q Consensus 851 ~~li~~Cl~~dP~~RPs~~eVl~ 873 (929)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 89999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=243.83 Aligned_cols=199 Identities=27% Similarity=0.404 Sum_probs=168.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcc-cCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSR-IHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~-l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
...||+|++|.|-+-++. +|+..|+|.++..- .+..++...|+.+..+ ..+|.+|.++|...+.+..++.||.|. .
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-T 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-h
Confidence 467999999999988876 68899999997653 3445667788877555 479999999999999999999999995 4
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
||+.+-.+....++.+++.-+-+|+..+.+||.|||++ ..++|||+||+|||++.+|++|+||||++-.+.++-. .
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA--k 205 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA--K 205 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH--H
Confidence 88777666667788899999999999999999999998 5899999999999999999999999999976654322 2
Q ss_pred eeeecCccccCcccccc----CcCCCcCceeeHHHHHHHHHhCCCCCcccc
Q 002382 763 SIVRGTVGYLDPEYYIS----QQLTDKSDVYSFGVILLELISGQEAISNEK 809 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~~~----~~~s~~sDVwSlGvvl~elltG~~p~~~~~ 809 (929)
+.-.|...|||||.+.. ..|+-++||||||+.+.||.+++.|++...
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 22357889999999853 478899999999999999999999997654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=292.79 Aligned_cols=259 Identities=24% Similarity=0.271 Sum_probs=167.5
Q ss_pred HHHhccccccCcEEEEEEEECC-----CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeee------eeecCe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY------CQEEGR 671 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~-----~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~------~~~~~~ 671 (929)
+.+.+.||+|+||.||+|++.+ ++.||||++...... +....| .+....+.++..++.. +.....
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence 4567899999999999999864 689999987643211 111111 1122222222222221 245667
Q ss_pred EEEEEEeccCCchhhhhccccc----------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCe
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLT----------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 735 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NI 735 (929)
.++|+||+.+++|.+++..... .........+..++.|++.||+|||++ +|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHE
Confidence 8999999999999998853210 001112334567999999999999998 999999999999
Q ss_pred EecC-CCcEEEEeecCcccccCCCCceeeeeecCccccCccccccC----------------------cCCCcCceeeHH
Q 002382 736 LLDK-HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ----------------------QLTDKSDVYSFG 792 (929)
Q Consensus 736 Ll~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~s~~sDVwSlG 792 (929)
|++. ++.+||+|||+|+..............+++.|+|||.+... .+..++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9986 57999999999986544444444456789999999965322 234567999999
Q ss_pred HHHHHHHhCCCCCccccc------cccchhhHHHHHHhhhcCCcccccCCcccCccC--HHHHHHHHHHHHHccCCCCCC
Q 002382 793 VILLELISGQEAISNEKF------GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD--IQSMWKIEEKALMCVLPHGHM 864 (929)
Q Consensus 793 vvl~elltG~~p~~~~~~------~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~li~~Cl~~dP~~ 864 (929)
|++|||+++..+++.... ......+..|....... ..+.+...+. ........+++.+|++.||++
T Consensus 367 viL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 367 LIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999998766542210 00001122222211100 0000000000 001123458999999999999
Q ss_pred CCcHHHHHHH
Q 002382 865 RPSISEVLKD 874 (929)
Q Consensus 865 RPs~~eVl~~ 874 (929)
|||+.|+++|
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999987
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=266.07 Aligned_cols=273 Identities=20% Similarity=0.257 Sum_probs=206.2
Q ss_pred cccCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCC--C----ceeEEe
Q 002382 591 HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--R----NLVQFL 663 (929)
Q Consensus 591 ~~~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~H--p----NIv~l~ 663 (929)
-.+..+|....+|.+...+|+|.||.|-.+.+. .+..||||+++..... .+...-|+++|+++.+ | -++.+.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 456778888889999999999999999999766 4688999999754332 3455679999999942 3 367888
Q ss_pred eeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec-----
Q 002382 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD----- 738 (929)
Q Consensus 664 g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~----- 738 (929)
+||.-.++.|+|+|.+ |-|+.++|..+ ....++...+..|+.|++++++|||+. +++|-||||+|||+.
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence 9999999999999988 66999999653 466788899999999999999999998 999999999999983
Q ss_pred ---------------CCCcEEEEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCC
Q 002382 739 ---------------KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 803 (929)
Q Consensus 739 ---------------~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~ 803 (929)
.+..+||+|||.|+...... ...+.|..|.|||++.+-.++..+||||+||||.|+++|..
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 13458999999998543222 44568999999999999999999999999999999999999
Q ss_pred CCccccccc-----------cchhhHHHH--HHhhhcCCcc-----------cccCCcc----cCccCHHHHHHHHHHHH
Q 002382 804 AISNEKFGA-----------NCRNIVQWA--KLHIESGDIQ-----------GIIDPSL----LDEYDIQSMWKIEEKAL 855 (929)
Q Consensus 804 p~~~~~~~~-----------~~~~l~~~~--~~~~~~~~~~-----------~~~d~~l----~~~~~~~~~~~l~~li~ 855 (929)
.|..-..-+ ....++... ......+.+. .+.++.. .-.....+..++.+|+.
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 886432111 111111111 0111111111 1111110 01123456678999999
Q ss_pred HccCCCCCCCCcHHHHHHH
Q 002382 856 MCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 856 ~Cl~~dP~~RPs~~eVl~~ 874 (929)
.|+..||.+|+|+.|+++|
T Consensus 388 ~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHccCccccccHHHHhcC
Confidence 9999999999999999876
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=283.10 Aligned_cols=259 Identities=22% Similarity=0.347 Sum_probs=177.6
Q ss_pred HHHhccccccCcEEEEEEEE-----------------CCCcEEEEEEeecCCcchhHHH--------------HHHHHHh
Q 002382 603 KMLEKKIGSGGFGVVYYGKL-----------------KDGKEIAVKVLTSNSYQGKREF--------------TNEVTLL 651 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~-----------------~~~~~vAVK~l~~~~~~~~~~f--------------~~Ev~iL 651 (929)
+.+.++||+|+||+||+|.+ .+++.||||++........++| ..|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 44678999999999999964 2356799999875433222333 3466677
Q ss_pred cccCCCce-----eEEeeeeee--------cCeEEEEEEeccCCchhhhhccccc--------------------ccccc
Q 002382 652 SRIHHRNL-----VQFLGYCQE--------EGRSVLVYEFMHNGTLKEHLYGTLT--------------------HEQRI 698 (929)
Q Consensus 652 ~~l~HpNI-----v~l~g~~~~--------~~~~~LV~E~~~~gsL~~~L~~~~~--------------------~~~~l 698 (929)
.+++|.++ ++++++|.. .+..+|||||+++++|.++++.... ....+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 77766554 677787753 3568999999999999999864211 11234
Q ss_pred chHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeeeeecCccccCccccc
Q 002382 699 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778 (929)
Q Consensus 699 ~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 778 (929)
++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++..............+++.|+|||.+.
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 6777889999999999999998 9999999999999999999999999999754433222222233578999999975
Q ss_pred cCcC----------------------CCcCceeeHHHHHHHHHhCCC-CCccccc-----cccchhhHHHHHHhhhcCCc
Q 002382 779 SQQL----------------------TDKSDVYSFGVILLELISGQE-AISNEKF-----GANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 779 ~~~~----------------------s~~sDVwSlGvvl~elltG~~-p~~~~~~-----~~~~~~l~~~~~~~~~~~~~ 830 (929)
.... ..+.||||+||+++||++|.. |+..... ......+..|.... ...
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~--~~~- 460 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK--GQK- 460 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc--ccC-
Confidence 4321 134699999999999999875 6643221 00111222232111 111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHHHccCCCC---CCCCcHHHHHHH
Q 002382 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHG---HMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP---~~RPs~~eVl~~ 874 (929)
.+-... ........+++.+++..+| .+|+|+.|+++|
T Consensus 461 ---~~~~~~----d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 ---YDFSLL----DRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ---CCcccc----cccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111111 1122456788889998765 689999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-29 Score=285.19 Aligned_cols=244 Identities=27% Similarity=0.391 Sum_probs=188.0
Q ss_pred hccccccCcE-EEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEeccCCc
Q 002382 606 EKKIGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (929)
Q Consensus 606 ~~~IG~G~fG-~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~~~gs 683 (929)
.+.+|.|+.| .||+|... |++||||++-.. ......+|+..|+.- +|||||++++.-.++...|+..|.|. .+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS 588 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence 4678999998 57999997 899999987533 234567899999988 69999999999999999999999995 59
Q ss_pred hhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC---C--CcEEEEeecCcccccCCC
Q 002382 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---H--MRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~--~~vkL~DFGla~~~~~~~ 758 (929)
|++++.....+.....-...+.+..|++.||+|||+. +||||||||.||||+. + ..++|+|||+++....+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9999976311111112245577899999999999997 9999999999999975 3 479999999999776655
Q ss_pred Ccee--eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhC-CCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 759 SHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 759 ~~~~--~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
.... ....||-+|+|||++....-+.++||||+|||+|+.++| .+||.+.- +...+|+.- +..+..
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~------~~~L~~--- 734 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTG------NYTLVH--- 734 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcC------ccceee---
Confidence 4433 456799999999999988888899999999999999995 89997543 111122221 001100
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+... .++ +..+||.+|+.++|..||++.+|+.|
T Consensus 735 --L~~~--~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 --LEPL--PDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred --eccC--chH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1111 111 67899999999999999999999865
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-29 Score=270.78 Aligned_cols=244 Identities=22% Similarity=0.277 Sum_probs=199.2
Q ss_pred hccccccCcEEEEEEEECCCc-EEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 606 EKKIGSGGFGVVYYGKLKDGK-EIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~~~~-~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
...||-|+||.|=+.+.+... .+|+|++++.. ...++....|-.+|..++.|.||+++.-|.++...|+.||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 457999999999999887433 37889887653 23345567899999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|.|...|+ ..+.++.....-++.-+++|++|||++ +||+|||||+|++++.+|-+||.|||.|+....+. .
T Consensus 505 GElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--K 575 (732)
T KOG0614|consen 505 GELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--K 575 (732)
T ss_pred chhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC--c
Confidence 99999985 456778888888999999999999999 99999999999999999999999999999776543 3
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.-+.+||+.|.|||++..+..+.++|.||||+++|||++|.+||...+.-..+..|..-+.. -.
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~----------------i~ 639 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK----------------IE 639 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----------------hh
Confidence 44678999999999999999999999999999999999999999876622222222221111 12
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCc-----HHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 874 (929)
++....+...+++.+.++.+|.+|.. +.||.+|
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 23334456778999999999999985 6777666
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=266.87 Aligned_cols=208 Identities=25% Similarity=0.383 Sum_probs=175.0
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc---hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~---~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.||-|+||+|.+++.. ....+|.|.+++.+.- .....+.|-.||...+.+-||+|+-.|.+.+.+|+||+|++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 56999999999999755 4566899998766432 2344677999999999999999999999999999999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcc---------c
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK---------F 753 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~---------~ 753 (929)
++..+|.. -+-+.+..+..++.+++.|+++.|.. |+|||||||+|||||.+|++||+||||+. +
T Consensus 715 DmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 715 DMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 99998853 34567777788899999999999998 99999999999999999999999999984 1
Q ss_pred ccCCCCce---------------------------------eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh
Q 002382 754 AVDGASHV---------------------------------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800 (929)
Q Consensus 754 ~~~~~~~~---------------------------------~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt 800 (929)
+..+. +. ....+||+.|+|||++....++..+|.||.|||||||+.
T Consensus 788 Yq~gd-H~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 788 YQEGD-HHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred ccCCC-ccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 11111 10 012349999999999999999999999999999999999
Q ss_pred CCCCCccccccccchhhHHHHH
Q 002382 801 GQEAISNEKFGANCRNIVQWAK 822 (929)
Q Consensus 801 G~~p~~~~~~~~~~~~l~~~~~ 822 (929)
|+.||......+.+..++.|-.
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhh
Confidence 9999998887777778888844
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=258.45 Aligned_cols=276 Identities=21% Similarity=0.344 Sum_probs=205.7
Q ss_pred cccccCHHHHHH-HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccC-----C---Cc
Q 002382 589 AAHCFTLSDIED-ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----H---RN 658 (929)
Q Consensus 589 ~~~~~~~~~i~~-~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-----H---pN 658 (929)
..|....+|... .+|.+.++||-|.|++||++.+. ..+.||+|+.+..... .+....|+++|++++ | ..
T Consensus 65 GYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~ 143 (590)
T KOG1290|consen 65 GYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKC 143 (590)
T ss_pred CCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCce
Confidence 346666677666 88889999999999999999876 5678999998755332 455678999999983 3 46
Q ss_pred eeEEeeeeee----cCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCC
Q 002382 659 LVQFLGYCQE----EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734 (929)
Q Consensus 659 Iv~l~g~~~~----~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~N 734 (929)
||+|+++|.. +.+.|+|+|++ |.+|..+|... ..+.++...+.+|+.||+.||.|||++| +|||-||||+|
T Consensus 144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPEN 218 (590)
T KOG1290|consen 144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPEN 218 (590)
T ss_pred eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcce
Confidence 9999999964 45889999998 66777777543 4667889999999999999999999998 99999999999
Q ss_pred eEec----------------------------------------------------------------------------
Q 002382 735 ILLD---------------------------------------------------------------------------- 738 (929)
Q Consensus 735 ILl~---------------------------------------------------------------------------- 738 (929)
||+.
T Consensus 219 vLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~ 298 (590)
T KOG1290|consen 219 VLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEP 298 (590)
T ss_pred eeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccc
Confidence 9990
Q ss_pred ---------------------------------------C----------------------------------------
Q 002382 739 ---------------------------------------K---------------------------------------- 739 (929)
Q Consensus 739 ---------------------------------------~---------------------------------------- 739 (929)
.
T Consensus 299 ~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~ 378 (590)
T KOG1290|consen 299 NQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNP 378 (590)
T ss_pred cccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccc
Confidence 0
Q ss_pred -----------CCcEEEEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccc
Q 002382 740 -----------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (929)
Q Consensus 740 -----------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~ 808 (929)
+.+|||+|||-|+.... ..+.-..|..|+|||++.+..|+..+||||++|+++||+||...|+..
T Consensus 379 ~v~p~~~~~~~di~vKIaDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePh 454 (590)
T KOG1290|consen 379 LVNPDIPLPECDIRVKIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPH 454 (590)
T ss_pred ccCCCCCCCccceeEEEeeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCC
Confidence 01256666666654321 111222588999999999999999999999999999999999888643
Q ss_pred c---ccccchhhHHHHHHh-------hhc-----------CCcccccCCc-------ccC--ccCHHHHHHHHHHHHHcc
Q 002382 809 K---FGANCRNIVQWAKLH-------IES-----------GDIQGIIDPS-------LLD--EYDIQSMWKIEEKALMCV 858 (929)
Q Consensus 809 ~---~~~~~~~l~~~~~~~-------~~~-----------~~~~~~~d~~-------l~~--~~~~~~~~~l~~li~~Cl 858 (929)
. +..+..+|...+... ... |++..+-.-. |.. +++.++..++.+++.-|+
T Consensus 455 sG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmL 534 (590)
T KOG1290|consen 455 SGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPML 534 (590)
T ss_pred CCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHH
Confidence 2 333444444433321 111 2222111111 111 245778889999999999
Q ss_pred CCCCCCCCcHHHHHHH
Q 002382 859 LPHGHMRPSISEVLKD 874 (929)
Q Consensus 859 ~~dP~~RPs~~eVl~~ 874 (929)
+.+|++|||+.+.+++
T Consensus 535 ef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 535 EFDPEKRPTAAQCLKH 550 (590)
T ss_pred hcCccccccHHHHhcC
Confidence 9999999999999876
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=248.24 Aligned_cols=244 Identities=22% Similarity=0.291 Sum_probs=188.3
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEec
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
+.+.||+|+|++|-.++++ ..+-+|+|++++.- .+...-...|-.+..+. +||.+|.++.+|..+.++++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 4578999999999999887 56789999987642 22223344555555554 7999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
+||+|.-++ .+.+++++..+.-+..+|..||.|||++ |||.||+|..|||+|..|++||.|+|+.+.-. ...
T Consensus 334 ~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l-~~g 405 (593)
T KOG0695|consen 334 NGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-GPG 405 (593)
T ss_pred cCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC-CCC
Confidence 999998777 4567899999999999999999999999 99999999999999999999999999987432 334
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
....+.+||+.|+|||.+.+..|...+|.|++||+|+||+.|+.||+-.......++--++.-..+-+. .++
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek--------qir 477 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK--------QIR 477 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh--------ccc
Confidence 455677899999999999999999999999999999999999999975433222223333322222111 111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCC
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRP 866 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RP 866 (929)
- +.....+...+...-+.+||.+|.
T Consensus 478 i--prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 I--PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred c--cceeehhhHHHHHHhhcCCcHHhc
Confidence 1 111112344566677889998875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-28 Score=249.30 Aligned_cols=261 Identities=23% Similarity=0.304 Sum_probs=193.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeecC-----eEEEEEE
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVYE 677 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~-----~~~LV~E 677 (929)
++.||.|+||.||..++. +|+.||.|++... .....+.+.+|+++|..++|.|++..+++..... +.++++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 467999999999999876 7999999988643 2334577889999999999999999988775543 4567777
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
.|. .+|...+ ...+.++-..+..+..||++||.|||+. +|.||||||.|.|++.+...||||||+++.....
T Consensus 138 LmQ-SDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LMQ-SDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHH-hhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 774 3555544 4566788888899999999999999998 9999999999999999999999999999976655
Q ss_pred CCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccc---------------hhhHHHH
Q 002382 758 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANC---------------RNIVQWA 821 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~---------------~~l~~~~ 821 (929)
+...++...-|..|+|||.+++ +.|+.+.||||.||++.|++..+..|.....-+.. +...+-+
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 5555566667999999999987 57999999999999999999988887643311110 0111112
Q ss_pred HHhhhcCCcccccCCcccCcc----CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 822 KLHIESGDIQGIIDPSLLDEY----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 822 ~~~~~~~~~~~~~d~~l~~~~----~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
+.++-.+... .+.+..-| ....-.+.+.+.++++..+|++|.+.++.+.++..
T Consensus 290 k~H~LR~~~k---~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 290 KNHVLRAGLR---APDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HHHhhccCCC---CCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 2222111110 01111101 01112245677888999999999999999888653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=233.92 Aligned_cols=211 Identities=35% Similarity=0.609 Sum_probs=182.6
Q ss_pred ccccCcEEEEEEEECC-CcEEEEEEeecCCcc-hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCchhh
Q 002382 609 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 686 (929)
Q Consensus 609 IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~~-~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 686 (929)
||+|.+|.||++...+ ++.+++|++...... ....+.+|++.++.++|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999874 899999998765432 34678999999999999999999999999999999999999999999
Q ss_pred hhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC-CCcEEEEeecCcccccCCCCceeeee
Q 002382 687 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSIV 765 (929)
Q Consensus 687 ~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~ 765 (929)
++.... ..+++..+..++.++++++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 885321 4578889999999999999999998 9999999999999999 89999999999875543321 12234
Q ss_pred ecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCH
Q 002382 766 RGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844 (929)
Q Consensus 766 ~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 844 (929)
.+...|++||..... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 478899999999877 788999999999999999
Q ss_pred HHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 845 QSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 845 ~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
..+.+++..|++.+|++||++.++++++
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3577899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=229.48 Aligned_cols=256 Identities=20% Similarity=0.324 Sum_probs=194.2
Q ss_pred HHHHhccccccCcEEEEEEEE-CCCcEEEEEEeecCCcchhHHHHHHHHHhcccC-CCceeEEeeeeeec--CeEEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEE--GRSVLVYE 677 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~--~~~~LV~E 677 (929)
.|.+.+++|+|.|++||.|.. .+.++++||+++.. ..+.+.+|+.+|+.+. ||||+++++...++ ....||+|
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 466789999999999999974 46789999999743 3567899999999996 99999999998765 45689999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC-CcEEEEeecCcccccC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVD 756 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~~~~ 756 (929)
|+.+.+.... .+.+....+..++.++++||.|+|+. ||+|||+||.|++||.. ...+|+|+|+|.+..+
T Consensus 116 ~v~n~Dfk~l-------y~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 116 YVNNTDFKQL-------YPTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhccccHHHH-------hhhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 9998776543 24567778888999999999999998 99999999999999975 4699999999987655
Q ss_pred CCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc------CC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES------GD 829 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~------~~ 829 (929)
+... .....+..|..||.+.. ..|+..-|+|||||++..|+..+.||-... +..++++..++-.-.. .+
T Consensus 186 ~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~--dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 186 GKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH--DNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred Ccee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC--CCHHHHHHHHHHhChHHHHHHHHH
Confidence 4332 23446888999999875 567788899999999999999999985433 2334555544422110 00
Q ss_pred cccccCCcccC---cc-------------CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 IQGIIDPSLLD---EY-------------DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 ~~~~~d~~l~~---~~-------------~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..--+|+...+ .. ..-...+.++++.+.+.-|-++|||++|...|
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11112322211 11 01112467899999999999999999999877
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-27 Score=255.07 Aligned_cols=280 Identities=18% Similarity=0.284 Sum_probs=211.3
Q ss_pred ccccccccCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccC------CCc
Q 002382 586 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH------HRN 658 (929)
Q Consensus 586 ~~~~~~~~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~------HpN 658 (929)
..+..-.+.++|+.+.+|.+....|+|-|++|.+|... .|+.||||+++.+... .+.=+.|+++|++|+ --+
T Consensus 417 DaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 417 DAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred cccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhH
Confidence 34556677889999999999999999999999999876 5789999999876543 344567999999995 347
Q ss_pred eeEEeeeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec
Q 002382 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (929)
Q Consensus 659 Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~ 738 (929)
+++++..|...+++|||+|-+ ..+|.+.|... .....|....+..++.|+.-||..|... +|+|.||||.|||++
T Consensus 496 clrl~r~F~hknHLClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVN 570 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVN 570 (752)
T ss_pred HHHHHHHhhhcceeEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEec
Confidence 899999999999999999977 56888888654 4556688889999999999999999998 999999999999999
Q ss_pred CCC-cEEEEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccch--
Q 002382 739 KHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR-- 815 (929)
Q Consensus 739 ~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~-- 815 (929)
+.- .+||||||.|.......... ..-+..|.|||++.+..|+...|+||.||.||||.||+..|.+.....+..
T Consensus 571 E~k~iLKLCDfGSA~~~~eneitP---YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENEITP---YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF 647 (752)
T ss_pred cCcceeeeccCccccccccccccH---HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence 764 68999999987654432211 123568999999999999999999999999999999999997654221111
Q ss_pred ---------hhHH---HHHHhhhcC---------C--------cccccCC------ccc-----CccCHHHHHHHHHHHH
Q 002382 816 ---------NIVQ---WAKLHIESG---------D--------IQGIIDP------SLL-----DEYDIQSMWKIEEKAL 855 (929)
Q Consensus 816 ---------~l~~---~~~~~~~~~---------~--------~~~~~d~------~l~-----~~~~~~~~~~l~~li~ 855 (929)
.+++ +...++... . +...+.| .+. .+-.......+.+|+.
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 0000 111111110 0 0011111 011 1112344557889999
Q ss_pred HccCCCCCCCCcHHHHHHH
Q 002382 856 MCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 856 ~Cl~~dP~~RPs~~eVl~~ 874 (929)
.|+..||++|.|..|.++|
T Consensus 728 kml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHhccChhhcCCHHHHhcC
Confidence 9999999999999998875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=231.91 Aligned_cols=197 Identities=35% Similarity=0.543 Sum_probs=170.2
Q ss_pred HhccccccCcEEEEEEEECC-CcEEEEEEeecCCcc-hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~~-~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++|++.++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45789999999999999875 889999999866544 5678899999999999999999999999999999999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
+|.+++.... ..+++..+..++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+...........
T Consensus 83 ~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 83 DLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999885431 1178889999999999999999998 999999999999999999999999999886544321122
Q ss_pred eeeecCccccCcccc-ccCcCCCcCceeeHHHHHHHHHhCCCCCcc
Q 002382 763 SIVRGTVGYLDPEYY-ISQQLTDKSDVYSFGVILLELISGQEAISN 807 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~-~~~~~s~~sDVwSlGvvl~elltG~~p~~~ 807 (929)
....++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 334578899999998 667778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-26 Score=236.25 Aligned_cols=249 Identities=25% Similarity=0.341 Sum_probs=186.6
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeecC------eEEEEEE
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSVLVYE 677 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~------~~~LV~E 677 (929)
+.+|.|.- .|..+.+. .++.||+|++... .....+...+|..++..++|+||++++.++.... ..++|||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 46777777 55555443 5889999987543 2334566788999999999999999999986543 5689999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
+|. ++|.+.+. ..++-.....|..|++.|+.|||+. +|+||||||+||++..++.+||.|||+|+.....
T Consensus 102 ~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 102 LMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc
Confidence 995 57877764 3356667788999999999999998 9999999999999999999999999999754322
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC--------
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD-------- 829 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~-------- 829 (929)
-..+....|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.. .+-+|.+....-|.
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d------~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD------HIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch------HHHHHHHHHHHhcCCCHHHHHH
Confidence 33445568899999999999899999999999999999999999887533 33344332211111
Q ss_pred -------------------cccccCCcc-cC--ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 -------------------IQGIIDPSL-LD--EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 -------------------~~~~~d~~l-~~--~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+.+...+ .. +.+.-......+++.+|+..+|++|-+++++++|
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 011111100 00 1111223457799999999999999999999987
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-26 Score=249.69 Aligned_cols=194 Identities=22% Similarity=0.410 Sum_probs=164.3
Q ss_pred HHHhccccccCcEEEEEEEECC-CcEEEEEEeecCCcch--------hHHHHHHHHHhcccC---CCceeEEeeeeeecC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG--------KREFTNEVTLLSRIH---HRNLVQFLGYCQEEG 670 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~~~--------~~~f~~Ev~iL~~l~---HpNIv~l~g~~~~~~ 670 (929)
|...+.+|+|+||.|+.|.++. ..+|+||.+.+...-. ......|++||..++ |+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 3345789999999999999884 5689999987643211 123567999999997 999999999999999
Q ss_pred eEEEEEEec-cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeec
Q 002382 671 RSVLVYEFM-HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (929)
Q Consensus 671 ~~~LV~E~~-~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 749 (929)
.++|+||-. ++-+|.+++ .....+++.++..|+.|++.|+++||+. +|||||||-+||.++.+|-+||+|||
T Consensus 643 ~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred eeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence 999999975 445777777 3467789999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCceeeeeecCccccCccccccCcCCC-cCceeeHHHHHHHHHhCCCCCc
Q 002382 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-KSDVYSFGVILLELISGQEAIS 806 (929)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~-~sDVwSlGvvl~elltG~~p~~ 806 (929)
.|.+...+. ....+||..|.|||++.+.+|-- .-|||++|++||.++....||.
T Consensus 716 saa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998765543 34567999999999999887754 5699999999999998888874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=220.17 Aligned_cols=255 Identities=20% Similarity=0.303 Sum_probs=186.9
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEee-eeeecCeEEEEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLG-YCQEEGRSVLVYE 677 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g-~~~~~~~~~LV~E 677 (929)
..|.+.+.+|+|.||.+-++.++ ..+.+++|-+... ....++|.+|..---.+ .|.||+.-++ .|+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 35678899999999999999988 4678899987643 34467899988765455 6899998776 4678889999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec-C-CCcEEEEeecCccccc
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-K-HMRAKVSDFGLSKFAV 755 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-~-~~~vkL~DFGla~~~~ 755 (929)
|++.|+|.+-+. ...+.+....+++.|++.||.|||++ .+||||||.+||||- . ..++||||||+++..+
T Consensus 103 ~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999988773 34567788889999999999999999 999999999999984 3 3489999999987542
Q ss_pred CCCCceeeeeecCccccCccccccC-----cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCc
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 830 (929)
. ......-+..|.+||..... ...+.+|+|.||++++.++||+.||.... .......+|.... .+..
T Consensus 175 ~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~--~~d~~Y~~~~~w~--~rk~ 246 (378)
T KOG1345|consen 175 T----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS--IMDKPYWEWEQWL--KRKN 246 (378)
T ss_pred c----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh--ccCchHHHHHHHh--cccC
Confidence 2 12223356789999987542 35678899999999999999999998433 1223444443332 2211
Q ss_pred ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 831 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
.. -|+.-..+. .+++.+-.+-+.++|++|-...++.++..+.
T Consensus 247 ~~--~P~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 247 PA--LPKKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred cc--CchhhcccC----HHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 11 111111222 2455666778889999997777777665543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=252.29 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=197.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
|.+.+++|.|.||.|||++.+ .++..|||+++-.......-..+|+-+++..+||||+.++|.+...+..++.||||.+
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg 96 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG 96 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence 445678999999999999876 6888999999876666666778899999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|++.-+. -..+++.++..++++.++||+|||+. +=+|||||-.|||+++.|.+|++|||.+-.+... ...
T Consensus 97 gslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~K 168 (829)
T KOG0576|consen 97 GSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAK 168 (829)
T ss_pred Ccccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh-hhh
Confidence 999986543 35688889999999999999999998 8899999999999999999999999988543322 122
Q ss_pred eeeeecCccccCccccc---cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 762 SSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.....||+.|||||+.. .+.|...+|||++|+...|+-.-+.|..+... .+.+.-..+..++. +.+
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---mr~l~LmTkS~~qp--------p~l 237 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---MRALFLMTKSGFQP--------PTL 237 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---HHHHHHhhccCCCC--------Ccc
Confidence 34456999999999974 46788999999999999999888777543220 11111111111111 111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+. ..--..+-+++..|+..+|++||+++.+++|
T Consensus 238 kDk--~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 238 KDK--TKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred cCC--ccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 111 1122357799999999999999999988764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=269.76 Aligned_cols=196 Identities=18% Similarity=0.270 Sum_probs=138.3
Q ss_pred ccCC-CceeEEeeee-------eecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCc
Q 002382 653 RIHH-RNLVQFLGYC-------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724 (929)
Q Consensus 653 ~l~H-pNIv~l~g~~-------~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 724 (929)
.++| +||++++++| ......++++|++ +++|.++|... ...+++.+++.++.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 3455 6888888877 2334567788877 66999999532 35589999999999999999999998 9
Q ss_pred eecCCCCCCCeEecCC-------------------CcEEEEeecCcccccCCCC---------------ceeeeeecCcc
Q 002382 725 IIHRDLKSSNILLDKH-------------------MRAKVSDFGLSKFAVDGAS---------------HVSSIVRGTVG 770 (929)
Q Consensus 725 ivHrDIkp~NILl~~~-------------------~~vkL~DFGla~~~~~~~~---------------~~~~~~~gt~~ 770 (929)
|+||||||+||||+.. +.+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4455666666543211000 00111347889
Q ss_pred ccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHH
Q 002382 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 850 (929)
Q Consensus 771 Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 850 (929)
|||||++.+..++.++|||||||+||||++|..|+.... ..+...... .+.+.. .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~---------~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR---------VLPPQI-----LLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh---------hcChhh-----hhcCHHH
Confidence 999999999999999999999999999999988865321 011111000 011100 1112345
Q ss_pred HHHHHHccCCCCCCCCcHHHHHHH
Q 002382 851 EEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 851 ~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+++.+|++++|.+||+|.|++++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 678889999999999999999764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=226.20 Aligned_cols=258 Identities=22% Similarity=0.332 Sum_probs=188.4
Q ss_pred HHHhccccccCcEEEEEEEEC----CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~----~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
+...++||+|.|++||++.+. ..+.||+|.+...+. ...+..|+++|..+ .+.||+++.+++...+..++|+|
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 345689999999999999754 357899998865433 34588999999999 59999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC-CcEEEEeecCcccccC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVD 756 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~~~~ 756 (929)
|++.....++.. .++...+..+++.+..||.++|.+ |||||||||+|+|.+.. +.-.|+|||+|.....
T Consensus 116 ~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 116 YFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred ccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHh
Confidence 999988877763 356778889999999999999999 99999999999999864 5789999999961100
Q ss_pred ------CCC-------------------------------------ceeeeeecCccccCcccccc-CcCCCcCceeeHH
Q 002382 757 ------GAS-------------------------------------HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFG 792 (929)
Q Consensus 757 ------~~~-------------------------------------~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlG 792 (929)
... .......||+||.|||++.. ...+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 000 00112459999999999875 5678899999999
Q ss_pred HHHHHHHhCCCCCccccccccchhhHHHHHH---------hhhcCC--ccc---------------ccC-CcccC-cc--
Q 002382 793 VILLELISGQEAISNEKFGANCRNIVQWAKL---------HIESGD--IQG---------------IID-PSLLD-EY-- 842 (929)
Q Consensus 793 vvl~elltG~~p~~~~~~~~~~~~l~~~~~~---------~~~~~~--~~~---------------~~d-~~l~~-~~-- 842 (929)
||++-+++++.||-... .+...+.+.+.. ..-.|. +.+ -++ +.+.. +.
T Consensus 266 VI~Lslls~~~PFf~a~--dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAK--DDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ceeehhhccccccccCc--cccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 99999999999995432 111222221110 001111 111 000 00100 00
Q ss_pred -----CHH-HHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 843 -----DIQ-SMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 843 -----~~~-~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+ ....++++..+|+..+|.+|.|++|.++|
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 011 11257899999999999999999999987
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.1e-23 Score=207.19 Aligned_cols=168 Identities=20% Similarity=0.167 Sum_probs=126.1
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++... ...+++.+++.++.|+++||+|||++ + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6888888532 45689999999999999999999997 4 999999999999999 99987654322
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+..+..... .. ++... .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~-~~------~~~~~-~ 130 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMP-AD------DPRDR-S 130 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhc-cC------Ccccc-c
Confidence 24899999999999999999999999999999999999999654311 111111111111 10 00000 0
Q ss_pred cCHHHH--HHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 842 YDIQSM--WKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 842 ~~~~~~--~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
...... ..+.+++.+|++.+|++||++.|+++++....
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 011111 25899999999999999999999999997764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=216.66 Aligned_cols=161 Identities=19% Similarity=0.179 Sum_probs=124.7
Q ss_pred HHHHhccccccCcEEEEEEEEC--CCcEEEEEEeecCC-----cchhHHHHHHHHHhcccCCCceeE-EeeeeeecCeEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQ-FLGYCQEEGRSV 673 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~--~~~~vAVK~l~~~~-----~~~~~~f~~Ev~iL~~l~HpNIv~-l~g~~~~~~~~~ 673 (929)
.|.+.+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|+++|++++|+|+++ ++++ +..+
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~ 94 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDG 94 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcE
Confidence 3556789999999999999875 46778999875331 123456899999999999999985 4432 4679
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCC-CCCCeEecCCCcEEEEeecCcc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL-KSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDI-kp~NILl~~~~~vkL~DFGla~ 752 (929)
+||||+++++|.. +. ... ...++.|++++|.|||+. +|+|||| ||+|||++.++++||+|||+|+
T Consensus 95 LVmE~~~G~~L~~-~~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 95 LVRGWTEGVPLHL-AR----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred EEEEccCCCCHHH-hC----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 9999999999963 21 111 135788999999999998 9999999 9999999999999999999998
Q ss_pred cccCCCCce-------eeeeecCccccCccccccC
Q 002382 753 FAVDGASHV-------SSIVRGTVGYLDPEYYISQ 780 (929)
Q Consensus 753 ~~~~~~~~~-------~~~~~gt~~Y~aPE~~~~~ 780 (929)
......... -....+++.|+|||++...
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 654332111 1345688899999999643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.1e-21 Score=211.60 Aligned_cols=261 Identities=21% Similarity=0.242 Sum_probs=194.6
Q ss_pred HHHHhccccccCcEEEEEEEECCC--cEEEEEEeecCCcchhHHHHHHHHHhcccCC----CceeEEeeee-eecCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDG--KEIAVKVLTSNSYQGKREFTNEVTLLSRIHH----RNLVQFLGYC-QEEGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~--~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~H----pNIv~l~g~~-~~~~~~~L 674 (929)
.+.+.++||+|+||.||++..... ..+|+|+...........+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 566789999999999999997753 4789998765533333367888888888863 6888888888 57778899
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC-----CcEEEEeec
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-----MRAKVSDFG 749 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-----~~vkL~DFG 749 (929)
||+.+ |.+|.++..... .+.++..+.+.|+.|++.+|.+||+. |++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99977 779988764332 57889999999999999999999998 99999999999999865 469999999
Q ss_pred Ccc--cccCCCC----ce---eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHH
Q 002382 750 LSK--FAVDGAS----HV---SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 820 (929)
Q Consensus 750 la~--~~~~~~~----~~---~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~ 820 (929)
+++ ....... .. .....||..|.+++...+...+.+.|+||++.++.|++.|..||...........+.+
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~- 251 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK- 251 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH-
Confidence 998 3221111 11 1235599999999999999999999999999999999999999965442211111111
Q ss_pred HHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 821 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 821 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
...... ... ........+.++...+-..+..++|....+...|++....
T Consensus 252 ---~~~~~~----~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 252 ---DPRKLL----TDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred ---Hhhhhc----ccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 111110 100 1111223455666666668999999999999998877653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=197.96 Aligned_cols=250 Identities=21% Similarity=0.327 Sum_probs=189.2
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
++..+|.+...|+.|+|+|+ |..+++|++.... ....++|.+|.-.|+.+.||||+.++|.|..+....++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 45667899999999999998 6778888876442 33357899999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|...|++. ..-..+..++.+++.++|+|++|||+. .+-|..--+....++||++.+++|. .+-+++...
T Consensus 272 gslynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsfq----- 342 (448)
T KOG0195|consen 272 GSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ----- 342 (448)
T ss_pred hHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeeee-----
Confidence 9999999864 344567788999999999999999996 3334444688999999999988874 111111100
Q ss_pred eeeeecCccccCccccccCcCC---CcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLT---DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s---~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.....-.+.||+||.++..+-+ .++|+|||++++||+.|...||.+...-+.- .+ +.-+.+
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------mk----------ialegl 406 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------MK----------IALEGL 406 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------hh----------hhhccc
Confidence 0112246889999999876543 5789999999999999999999765411110 01 111122
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
+...++.....+.+++.-|+..||.+||.+..|+-.||++.
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 33333344456778888899999999999999999998763
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-19 Score=198.60 Aligned_cols=260 Identities=28% Similarity=0.416 Sum_probs=196.1
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEeecCCcc---hhHHHHHHHHHhcccCCC-ceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHR-NLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~---~~~~f~~Ev~iL~~l~Hp-NIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.+.+.||.|+||.||++... +.+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......+++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 34578999999999999987 88999998765332 367799999999999988 7999999997777789999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC-cEEEEeecCcccccCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~~ 758 (929)
.++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 81 ~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 81 DGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999666432111 3678888999999999999999998 899999999999999998 79999999997544333
Q ss_pred Cc-----eeeeeecCccccCcccccc---CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCc
Q 002382 759 SH-----VSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 759 ~~-----~~~~~~gt~~Y~aPE~~~~---~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 830 (929)
.. ......|+..|+|||.+.+ .......|+||+|++++++++|..||...............+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 22 2355679999999999987 578889999999999999999999976543110011222221111110
Q ss_pred ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000001111012223467889999999999999999988776
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.3e-20 Score=218.59 Aligned_cols=250 Identities=22% Similarity=0.275 Sum_probs=182.6
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecC--Ccchh----HHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGK----REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~----~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
....+|.|++|.|+..... ..+..+.|..+.. ..... ..+..|+.+=..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3578999999988777544 3333444433210 11111 225567778888899999988888777666666699
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
||+. +|...+.. ...+...++..++.|+..|+.|||+. ||.|||+|++|+++..+|.+||+|||.+....-.
T Consensus 402 ~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 99888732 34677888899999999999999998 9999999999999999999999999998744322
Q ss_pred -C--CceeeeeecCccccCccccccCcCCCc-CceeeHHHHHHHHHhCCCCCccccccccch---hhHHHHHHhhhcCCc
Q 002382 758 -A--SHVSSIVRGTVGYLDPEYYISQQLTDK-SDVYSFGVILLELISGQEAISNEKFGANCR---NIVQWAKLHIESGDI 830 (929)
Q Consensus 758 -~--~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDVwSlGvvl~elltG~~p~~~~~~~~~~~---~l~~~~~~~~~~~~~ 830 (929)
. ........|+..|+|||++.+..|.+. .||||.|+++..|.+|+.||......+... +...|....
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~------ 547 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIF------ 547 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccc------
Confidence 2 255666789999999999999999875 699999999999999999997655222110 000000000
Q ss_pred ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.-..........+...++.++++++|.+|-||++|++.
T Consensus 548 ------~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 548 ------EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ------cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00001112334467789999999999999999999863
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.4e-19 Score=183.08 Aligned_cols=139 Identities=19% Similarity=0.178 Sum_probs=107.2
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeecCCcc--h-------h-----------------HHHHHHHHHhcccCCCce
Q 002382 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--G-------K-----------------REFTNEVTLLSRIHHRNL 659 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~--~-------~-----------------~~f~~Ev~iL~~l~HpNI 659 (929)
...||+|+||.||+|...+|+.||||+++..... . . .....|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999999754211 1 0 122349999999987776
Q ss_pred eEEeeeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHH-HhCCCCceecCCCCCCCeEec
Q 002382 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCVPAIIHRDLKSSNILLD 738 (929)
Q Consensus 660 v~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrDIkp~NILl~ 738 (929)
.....+.. ...++||||++++++..... ....++......++.|++.+|.++ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 43322221 23389999999877654431 234678888999999999999999 677 999999999999998
Q ss_pred CCCcEEEEeecCcccc
Q 002382 739 KHMRAKVSDFGLSKFA 754 (929)
Q Consensus 739 ~~~~vkL~DFGla~~~ 754 (929)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.5e-19 Score=184.14 Aligned_cols=261 Identities=20% Similarity=0.270 Sum_probs=189.6
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEec
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
-|.+.++||+|.||+++.|+.- +++.||||.-...+ ...++..|.+..+.+ ..++|...+-+-.++.+..||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 3567899999999999999744 78999999754332 235677888888888 4699999988888888999999987
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC-----CcEEEEeecCcccc
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-----MRAKVSDFGLSKFA 754 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-----~~vkL~DFGla~~~ 754 (929)
|-+|.|+.. --+++++..+++.+|.|++.-++|+|++ .+|.|||||+|+||... ..+.|+|||+|+.+
T Consensus 107 -GPSLEDLFD---~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLFD---LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHHH---HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 668877652 1356799999999999999999999999 99999999999999754 35899999999976
Q ss_pred cCCCCc--e----eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcC
Q 002382 755 VDGASH--V----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 828 (929)
Q Consensus 755 ~~~~~~--~----~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 828 (929)
.+.... . .....||.+||+-....++..+.+.|+-|||-++.+.|-|..||.+..-+..-+ .+ ..+.+.
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~---kY--eKIGe~ 254 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE---KY--EKIGET 254 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH---HH--HHhccc
Confidence 554322 1 123459999999999999999999999999999999999999998755221111 11 011111
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 829 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
+-..-++.-+ .. -+++....+..+ -..+-.+-|..+-+...+..++..
T Consensus 255 Kr~T~i~~Lc-~g-~P~efa~Yl~yv---R~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 255 KRSTPIEVLC-EG-FPEEFATYLRYV---RRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred cccCCHHHHH-hc-CHHHHHHHHHHH---HhcCcccCCCHHHHHHHHHHHHHh
Confidence 0000010000 11 123333333333 234556778888888887777755
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-19 Score=178.97 Aligned_cols=261 Identities=22% Similarity=0.308 Sum_probs=191.1
Q ss_pred HHHHHHhccccccCcEEEEEEEE-CCCcEEEEEEeecCCcchhHHHHHHHHHhcccCC-CceeEEeeeeeecCeEEEEEE
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~-~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~H-pNIv~l~g~~~~~~~~~LV~E 677 (929)
...|.+.++||.|+||.+|.|.. .+|++||||+-+.... ..++..|..+...++| ..|..+..+..+..+-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 34566789999999999999975 4799999998654432 3567788999998875 677778888888899999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC---CcEEEEeecCcccc
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKFA 754 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkL~DFGla~~~ 754 (929)
.. |-+|.++.. --.+.++..+++.++.|++.-++|+|.+ ++|||||||+|+|..-+ ..+.++|||+|+.+
T Consensus 92 LL-GPsLEdLfn---fC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFN---FCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHH---HHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 87 678887763 1245678889999999999999999999 99999999999998643 46899999999876
Q ss_pred cCCCC--ce----eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcC
Q 002382 755 VDGAS--HV----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 828 (929)
Q Consensus 755 ~~~~~--~~----~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 828 (929)
.+... +. .....||.+|.+-....+...+.+.|+-|+|.+|..+.-|..||.+..-..-.+. .+ .+.+.
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK-yE----kI~Ek 239 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK-YE----KISEK 239 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH-HH----HHHHh
Confidence 55332 21 2345699999998887777888899999999999999999999987552111111 11 11111
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 829 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
++...+. .+-..++ .++...+.-|-...-++-|...-+-+.++-+.
T Consensus 240 K~s~~ie-~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 240 KMSTPIE-VLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred hcCCCHH-HHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 1111111 1112222 24666667788888888888777766665444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.4e-19 Score=185.57 Aligned_cols=174 Identities=14% Similarity=0.171 Sum_probs=133.5
Q ss_pred HHHHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHH---------HHHHHHHhcccCCCceeEEeeee
Q 002382 596 SDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---------FTNEVTLLSRIHHRNLVQFLGYC 666 (929)
Q Consensus 596 ~~i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~---------f~~Ev~iL~~l~HpNIv~l~g~~ 666 (929)
.++-...+...+.+|.|+||.||.... +++.+|||+++......++. +.+|+..+.++.||+|..+..++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 345556667788999999999999765 57789999997654333322 68899999999999999998886
Q ss_pred eec--------CeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec
Q 002382 667 QEE--------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (929)
Q Consensus 667 ~~~--------~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~ 738 (929)
... +..++||||++|.+|.++.. ++. ....+++.+|..+|+. +++|||+||+||+++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~ 169 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS 169 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence 533 35789999999999977631 111 2456999999999998 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHH
Q 002382 739 KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 799 (929)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ell 799 (929)
.++ ++|+|||..+........ ..+.....+..++|+||||+.+....
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999987643211110 01344556778999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.2e-18 Score=176.18 Aligned_cols=140 Identities=20% Similarity=0.203 Sum_probs=109.7
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeecCCcch--------------------------hHHHHHHHHHhcccCCCce
Q 002382 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--------------------------KREFTNEVTLLSRIHHRNL 659 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~--------------------------~~~f~~Ev~iL~~l~HpNI 659 (929)
...||+|+||.||+|+..+|+.||||+++...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999998889999999998652110 1123578899999999987
Q ss_pred eEEeeeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCeEec
Q 002382 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLD 738 (929)
Q Consensus 660 v~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~ 738 (929)
.....+... ..++||||++++++..... ....++......++.|++.++.+||+ . +|+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 544443332 2489999999885543321 12346677889999999999999999 7 999999999999999
Q ss_pred CCCcEEEEeecCccccc
Q 002382 739 KHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 739 ~~~~vkL~DFGla~~~~ 755 (929)
+++++|+|||+++...
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-19 Score=212.29 Aligned_cols=249 Identities=21% Similarity=0.276 Sum_probs=179.1
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCC-cchhHHHHHHHHH--hcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS-YQGKREFTNEVTL--LSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~-~~~~~~f~~Ev~i--L~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
..+.+.||++.|=+|.+|++++|. |+||++-+.. .-.-+.|.++++- ...++|||.+++.-+-......+||-+|.
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 345688999999999999999777 9999986554 3334445444333 44558999999988877777778888888
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
.+ +|.|.| ..+..+...+.+.|+.|++.||..+|.. +|+|||||.+||||+.-.-+.|+||..-+...-..+
T Consensus 104 kh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 104 KH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred hh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 54 666666 5667788888999999999999999998 999999999999999999999999986553322211
Q ss_pred ce------eeeeecCccccCccccccC-----------cCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHH
Q 002382 760 HV------SSIVRGTVGYLDPEYYISQ-----------QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWA 821 (929)
Q Consensus 760 ~~------~~~~~gt~~Y~aPE~~~~~-----------~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~ 821 (929)
.. ..+...-..|+|||.+... ..+++.||||+||++.||++ |+++|.-.+ +..+-
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-------L~aYr 248 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-------LLAYR 248 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-------HHhHh
Confidence 11 1222234579999998541 15678899999999999998 688886432 22221
Q ss_pred HHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 822 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 822 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
.+. .......+ .+.+. ..+.+++..|++.||++|-+++++++.-++
T Consensus 249 -----~~~-~~~~e~~L-e~Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 249 -----SGN-ADDPEQLL-EKIED---VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred -----ccC-ccCHHHHH-HhCcC---ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 110 00000000 00000 147789999999999999999999988443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-18 Score=195.70 Aligned_cols=218 Identities=24% Similarity=0.379 Sum_probs=167.2
Q ss_pred hcccCCCceeEEeeeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCC
Q 002382 651 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL 730 (929)
Q Consensus 651 L~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDI 730 (929)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.....+.+++++||+|||.. +--.|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence 4678999999999999999999999999999999999964 467789999999999999999999997 22399999
Q ss_pred CCCCeEecCCCcEEEEeecCcccccCC-CCceeeeeecCccccCccccccC-------cCCCcCceeeHHHHHHHHHhCC
Q 002382 731 KSSNILLDKHMRAKVSDFGLSKFAVDG-ASHVSSIVRGTVGYLDPEYYISQ-------QLTDKSDVYSFGVILLELISGQ 802 (929)
Q Consensus 731 kp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~-------~~s~~sDVwSlGvvl~elltG~ 802 (929)
+++|++++....+||+|||+....... .........-..-|.|||.+... ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998765321 01111112234679999998753 1466799999999999999999
Q ss_pred CCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 803 EAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 803 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.||...........++.+++.. -...+.|.+.... +....+..++..||..+|++||++++|-..++.+..
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~-----~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKG-----GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred CccccccccCChHHHHHHHHhc-----CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9998765444334555554441 1111222222111 333468899999999999999999999887776543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-16 Score=192.97 Aligned_cols=91 Identities=31% Similarity=0.468 Sum_probs=80.9
Q ss_pred CCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCC-CcCcc
Q 002382 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNL-PNLRE 491 (929)
Q Consensus 414 ~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l-~~L~~ 491 (929)
.+++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|+ +++|++|+.|+|++|+|+|.+|..++++ .++..
T Consensus 440 ~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~ 519 (623)
T PLN03150 440 KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRAS 519 (623)
T ss_pred CCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCce
Confidence 356899999999999999999999999999999999999999886 8999999999999999999999999875 46778
Q ss_pred ccccccccccccc
Q 002382 492 LYVQNNMLSGTVP 504 (929)
Q Consensus 492 L~l~~N~l~g~~P 504 (929)
+++++|......|
T Consensus 520 l~~~~N~~lc~~p 532 (623)
T PLN03150 520 FNFTDNAGLCGIP 532 (623)
T ss_pred EEecCCccccCCC
Confidence 8999998543333
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.9e-17 Score=168.86 Aligned_cols=185 Identities=14% Similarity=0.138 Sum_probs=138.4
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeecCCcchh----HHHHHHHHHhcccC-CCceeEEeeeeeecCeEEEEEEecc
Q 002382 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK----REFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~----~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
...|++|+||+||.+.. .+.+++.+.+........ ..+.+|+++|++++ |+++.+++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46799999999997766 578888777765543221 25789999999995 5889999886 45699999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCC-CCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL-KSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDI-kp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
|.+|.+.+. . ....++.|++++|.++|++ ||+|||| ||+|||++.++.++|+|||+|........
T Consensus 82 G~~L~~~~~----~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 82 GAAMYQRPP----R-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred CccHHhhhh----h-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 988865431 1 1134778999999999998 9999999 79999999999999999999985433221
Q ss_pred c----e--------eeeeecCccccCccccccC-cCC-CcCceeeHHHHHHHHHhCCCCCcccc
Q 002382 760 H----V--------SSIVRGTVGYLDPEYYISQ-QLT-DKSDVYSFGVILLELISGQEAISNEK 809 (929)
Q Consensus 760 ~----~--------~~~~~gt~~Y~aPE~~~~~-~~s-~~sDVwSlGvvl~elltG~~p~~~~~ 809 (929)
. . ......++.|++|+...-. ..+ .+.+.++-|+-+|.++|+..+.-.+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0 1112367788888765322 222 45688899999999999998865443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.2e-18 Score=195.30 Aligned_cols=225 Identities=25% Similarity=0.313 Sum_probs=174.8
Q ss_pred cccccCcEEEEEEE----ECCCcEEEEEEeecCCcch--hHHHHHHHHHhcccC-CCceeEEeeeeeecCeEEEEEEecc
Q 002382 608 KIGSGGFGVVYYGK----LKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 608 ~IG~G~fG~Vy~~~----~~~~~~vAVK~l~~~~~~~--~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.+|+|.||.|+..+ .+.++-+|+|++++..... ......|..++..++ ||.++++...+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999763 3357778999887553211 124456778888886 9999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+|.|...+. ....+.+.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++........
T Consensus 81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 999988774 455667777788889999999999998 9999999999999999999999999999866543332
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
+||..|||||++. ....++|.||||++++||++|..||.... ...|.. . .-
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~----~~~Il~---~---------------~~ 204 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT----MKRILK---A---------------EL 204 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH----HHHHhh---h---------------cc
Confidence 7999999999998 56788999999999999999999997511 111111 0 01
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSI 868 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 868 (929)
..+.+......++...+...+|..|--.
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 2233334455667777777888877754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.3e-17 Score=174.83 Aligned_cols=230 Identities=18% Similarity=0.202 Sum_probs=146.4
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCC----------CceeEEeeee-----
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHH----------RNLVQFLGYC----- 666 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~H----------pNIv~l~g~~----- 666 (929)
.+.||.|+++.||.+++. +++++|||+...... ...+++++|.-....+.+ -.++..++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 568999999999999988 489999998864432 234567777655555322 1222222211
Q ss_pred ----eec---C-----eEEEEEEeccCCchhhhhcc---ccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCC
Q 002382 667 ----QEE---G-----RSVLVYEFMHNGTLKEHLYG---TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 731 (929)
Q Consensus 667 ----~~~---~-----~~~LV~E~~~~gsL~~~L~~---~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIk 731 (929)
... . ..+++|+-+ .++|.+++.. .......+....++.+..|+.+.+++||+. |++|+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 111 1 236778877 5688777532 212233455666778889999999999999 99999999
Q ss_pred CCCeEecCCCcEEEEeecCcccccCCCCceeeeeecCccccCccccccC--------cCCCcCceeeHHHHHHHHHhCCC
Q 002382 732 SSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ--------QLTDKSDVYSFGVILLELISGQE 803 (929)
Q Consensus 732 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--------~~s~~sDVwSlGvvl~elltG~~ 803 (929)
|+|++++.+|.++|+||+.....+. .......+..|.+||..... .++.+.|.|++|+++|.|++|..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999999999999987654321 11112356789999987542 46788999999999999999999
Q ss_pred CCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCC
Q 002382 804 AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR 865 (929)
Q Consensus 804 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 865 (929)
||........... ....+. +..+.+..|+..+++++|++|
T Consensus 249 Pf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9986542111100 111222 555678899999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.6e-17 Score=167.04 Aligned_cols=134 Identities=18% Similarity=0.258 Sum_probs=104.5
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhccc-----CCCceeEEeeeeeecC---e-EEEEE
Q 002382 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-----HHRNLVQFLGYCQEEG---R-SVLVY 676 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-----~HpNIv~l~g~~~~~~---~-~~LV~ 676 (929)
.+.||+|+||.||. +.+....+||++........+.+.+|+.+++.+ .||||++++|++.++. . ..+|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 36899999999996 443333479988765455567899999999999 5799999999998863 3 33789
Q ss_pred Ee--ccCCchhhhhccccccccccchHHHHHHHHHHHHHH-HHHHhCCCCceecCCCCCCCeEecC----CCcEEEEeec
Q 002382 677 EF--MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI-EYLHTGCVPAIIHRDLKSSNILLDK----HMRAKVSDFG 749 (929)
Q Consensus 677 E~--~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~~~~~ivHrDIkp~NILl~~----~~~vkL~DFG 749 (929)
|| +.+|+|.+++... .+++. ..++.|++.++ +|||++ +|+||||||+|||++. +++++|+||+
T Consensus 85 e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred cCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 99 5579999999432 24443 35677888777 999998 9999999999999974 3479999954
Q ss_pred Cc
Q 002382 750 LS 751 (929)
Q Consensus 750 la 751 (929)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.1e-17 Score=194.75 Aligned_cols=254 Identities=19% Similarity=0.206 Sum_probs=182.9
Q ss_pred HHHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccC---CCceeEEeeeeeecCeEE
Q 002382 597 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 597 ~i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~---HpNIv~l~g~~~~~~~~~ 673 (929)
++....+.+.+.||+|+||.||+|...+|+.||+|+-+....+.. .-=.+++.+|+ -+.|..+..+..-.+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 444455667889999999999999999999999999877665531 11112233333 244555555556667789
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC-------CCcEEEE
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------HMRAKVS 746 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-------~~~vkL~ 746 (929)
||+||.+.|+|.+++. ..+.++|.-.+.+..|++..+++||.. +|||+||||+|+||.. ...++|+
T Consensus 771 lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence 9999999999999995 456788999999999999999999998 9999999999999942 3458999
Q ss_pred eecCcccccCC-CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh
Q 002382 747 DFGLSKFAVDG-ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 747 DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
|||.+-.+..- +.......++|-.+-.+|+..++.++..+|.|.++-+++-||.|+.-- .
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------------------~ 904 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------------------V 904 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------------------h
Confidence 99998643221 223455677899999999999999999999999999999999997421 0
Q ss_pred hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHhH
Q 002382 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 883 (929)
Q Consensus 826 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~~ 883 (929)
..| -...++..+..-...+.+-++.+++ |.++-..=|...++...|++++....
T Consensus 905 ~~g-~~~~~~~~~~Ry~~~~~W~~~F~~l---LN~~~~~~p~l~~lr~~~~~~~~~~~ 958 (974)
T KOG1166|consen 905 KNG-SSWMVKTNFPRYWKRDMWNKFFDLL---LNPDCDTLPNLQELRTELEEVLAEHF 958 (974)
T ss_pred cCC-cceeccccchhhhhHHHHHHHHHHH---hCcCcccchhHHHHHHHHHHHHHHHH
Confidence 011 1112222222222233333444444 44666667788888888888776543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.9e-16 Score=164.04 Aligned_cols=140 Identities=22% Similarity=0.252 Sum_probs=108.3
Q ss_pred HHHhccccccCcEEEEEEE--ECCCcEEEEEEeecCCcc------------------------hhHHHHHHHHHhcccCC
Q 002382 603 KMLEKKIGSGGFGVVYYGK--LKDGKEIAVKVLTSNSYQ------------------------GKREFTNEVTLLSRIHH 656 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~--~~~~~~vAVK~l~~~~~~------------------------~~~~f~~Ev~iL~~l~H 656 (929)
+.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4567899999999999998 457999999998754210 01235689999999975
Q ss_pred Cc--eeEEeeeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCc-eecCCCCCC
Q 002382 657 RN--LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-IIHRDLKSS 733 (929)
Q Consensus 657 pN--Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-ivHrDIkp~ 733 (929)
.. +.+.+++ ...++||||+.+++|...... ...+.......++.|++.++.+||+. + ++||||||+
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 33 3444443 235899999999888765421 22344556678999999999999998 8 999999999
Q ss_pred CeEecCCCcEEEEeecCcccc
Q 002382 734 NILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 734 NILl~~~~~vkL~DFGla~~~ 754 (929)
||+++ ++.++|+|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999998743
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.1e-16 Score=160.47 Aligned_cols=134 Identities=25% Similarity=0.427 Sum_probs=112.5
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcc--------hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~--------~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+.||+|++|.||+|.+ .+..+++|+....... ....+.+|++++..++|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999988 5788999987643221 124577899999999999988777777777888999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
++|++|.+.+... .. .+..++.+++.+|.+||+. +++|||++|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887432 11 6788999999999999998 999999999999999 78999999998764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-15 Score=156.23 Aligned_cols=136 Identities=21% Similarity=0.216 Sum_probs=107.4
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcc----------------------hhHHHHHHHHHhcccCCCc-
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ----------------------GKREFTNEVTLLSRIHHRN- 658 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~----------------------~~~~f~~Ev~iL~~l~HpN- 658 (929)
.+.+.+.||+|+||.||++..++|+.||||+++..... ....+..|+.++.++.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 35667899999999999999888999999987643210 0123567888999888774
Q ss_pred -eeEEeeeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe
Q 002382 659 -LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 737 (929)
Q Consensus 659 -Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl 737 (929)
+...++ ....++||||+++++|...... .....++.+++.++.++|+. +|+||||||+||++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill 158 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV 158 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence 444443 2455899999999998765420 23456889999999999998 99999999999999
Q ss_pred cCCCcEEEEeecCcccc
Q 002382 738 DKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 738 ~~~~~vkL~DFGla~~~ 754 (929)
+++++++|+|||++...
T Consensus 159 ~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 159 DDDEKIYIIDWPQMVST 175 (198)
T ss_pred cCCCcEEEEECCccccC
Confidence 99999999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-15 Score=157.03 Aligned_cols=130 Identities=26% Similarity=0.450 Sum_probs=105.8
Q ss_pred cccccCcEEEEEEEECCCcEEEEEEeecCCcc--------hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 608 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 608 ~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~--------~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.||+|+||.||+|.+. ++.+++|+....... ....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999964 788999986543211 1245778999999999887665555556666779999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+|++|.+.+... .. .++.+++++|.+||+. +++|||++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998877321 10 6899999999999998 999999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.6e-15 Score=158.53 Aligned_cols=197 Identities=19% Similarity=0.227 Sum_probs=135.6
Q ss_pred CCCceeEEeeeeee---------------------------cCeEEEEEEeccCCchhhhhccccccccccchHHHHHHH
Q 002382 655 HHRNLVQFLGYCQE---------------------------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA 707 (929)
Q Consensus 655 ~HpNIv~l~g~~~~---------------------------~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~ 707 (929)
+|||||++.++|.+ ...+++||.... .+|.+++.. +..+......|.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999887743 235678887664 488888853 234556677899
Q ss_pred HHHHHHHHHHHhCCCCceecCCCCCCCeEec--CCC--cEEEEeecCcccccCCC-----CceeeeeecCccccCccccc
Q 002382 708 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHM--RAKVSDFGLSKFAVDGA-----SHVSSIVRGTVGYLDPEYYI 778 (929)
Q Consensus 708 ~qia~gL~yLH~~~~~~ivHrDIkp~NILl~--~~~--~vkL~DFGla~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~ 778 (929)
.|+++|+.|||.+ ||.|||+|.+|||+. +|+ ...|+|||++--..... ....-...|.-.-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999998 999999999999984 343 57899999874221100 01111234777899999986
Q ss_pred cCc------CCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHH
Q 002382 779 SQQ------LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEE 852 (929)
Q Consensus 779 ~~~------~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 852 (929)
..+ .-.|+|.|+.|.+.||+++...||.... +..-+...+ ++..+ |.+ +..+...+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG--em~L~~r~Y-----qe~qL-----Pal----p~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG--EMLLDTRTY-----QESQL-----PAL----PSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc--hheechhhh-----hhhhC-----CCC----cccCChHHHH
Confidence 532 2358999999999999999999997632 211111111 11111 112 2223345778
Q ss_pred HHHHccCCCCCCCCcHHHHHHHHH
Q 002382 853 KALMCVLPHGHMRPSISEVLKDIQ 876 (929)
Q Consensus 853 li~~Cl~~dP~~RPs~~eVl~~L~ 876 (929)
++...++.||.+||+..-....|.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 889999999999999766555544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.1e-15 Score=176.59 Aligned_cols=132 Identities=23% Similarity=0.331 Sum_probs=108.5
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEeecCC--c------chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--Y------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~--~------~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
..+.||+|+||+||+|.+... .+++|+..... . .....+.+|+++++.++|++++....++......++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 467899999999999988744 44444432211 1 11345789999999999999998888887777889999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
||+++++|.+++. ....++.+++++|.+||+. +++||||||+|||+ .++.++|+|||+++.
T Consensus 416 E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 416 EYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999988773 3467899999999999998 99999999999999 678999999999875
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.4e-17 Score=154.18 Aligned_cols=163 Identities=23% Similarity=0.332 Sum_probs=133.1
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (929)
+++.++.|.|++|.++.+||-|..+.+|++|++.+|+++. .+.++.++..++.++...+ .....+-.++.++.
T Consensus 31 ~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~-lp~~issl~klr~lnvgmn------rl~~lprgfgs~p~ 103 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMN------RLNILPRGFGSFPA 103 (264)
T ss_pred chhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhh-cChhhhhchhhhheecchh------hhhcCccccCCCch
Confidence 3556688899999999999999999999999999999876 2333444433333321100 01111123456789
Q ss_pred eeEEEecCCCCC-ccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccc
Q 002382 418 ITVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (929)
Q Consensus 418 l~~L~L~~n~l~-g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 496 (929)
|+.|||+.|+|+ ..+|..|..|+.|+-|+|+.|.+.-++|++++|++|+.|.|..|.|- .+|.+++.|++|++|++++
T Consensus 104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 999999999996 47999999999999999999999999999999999999999999999 8999999999999999999
Q ss_pred ccccccccccccc
Q 002382 497 NMLSGTVPSSLLS 509 (929)
Q Consensus 497 N~l~g~~P~~l~~ 509 (929)
|+++ .+|+++.+
T Consensus 183 nrl~-vlppel~~ 194 (264)
T KOG0617|consen 183 NRLT-VLPPELAN 194 (264)
T ss_pred ceee-ecChhhhh
Confidence 9999 99998853
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.1e-16 Score=174.83 Aligned_cols=176 Identities=28% Similarity=0.369 Sum_probs=129.8
Q ss_pred CeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeec
Q 002382 670 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (929)
Q Consensus 670 ~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 749 (929)
.+.++.|++|...+|.++|.... .....++...+.++.|++.|++| + +.+|+|+||.||+...+.++||+|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence 35789999999999999996543 23445777889999999999999 5 89999999999999999999999999
Q ss_pred CcccccCCC-----CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHH
Q 002382 750 LSKFAVDGA-----SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL 823 (929)
Q Consensus 750 la~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~ 823 (929)
+........ ....+...||..||+||.+.+..|+.++||||||++|+|++. -..+++... +..
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-----------t~~ 470 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-----------TLT 470 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-----------hhh
Confidence 987554433 122344569999999999999999999999999999999998 333332111 000
Q ss_pred hhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHH
Q 002382 824 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 872 (929)
Q Consensus 824 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl 872 (929)
-++.+. +++....+++. =..+..+++.+.|.+||++.++.
T Consensus 471 d~r~g~----ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 471 DIRDGI----IPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hhhcCC----CChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHHh
Confidence 111121 22222223332 34788899999999999555443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.5e-15 Score=178.09 Aligned_cols=202 Identities=25% Similarity=0.312 Sum_probs=139.9
Q ss_pred hccccccCcEEEEEEEECC-CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 606 EKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
.+.|..|+||.||..+++. .+..|+|+=+.+ .+.+- ++.....|.+| |+=
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee---------------------chh
Confidence 5789999999999999884 567888542211 11110 33333444443 222
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC-------
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG------- 757 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~------- 757 (929)
...+. .-+.++. +++.+++|||+. +|+|||+||+|.+|+.-|++|+.|||+++.....
T Consensus 139 ~tllk----~~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 139 ATLLK----NIGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred hhhcc----cCCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 22221 1122222 237889999998 9999999999999999999999999998732211
Q ss_pred -------CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCc
Q 002382 758 -------ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 758 -------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 830 (929)
.......++||+.|+|||++..+.|...+|.|++|+|+||.+.|+.||.++...+.+..++.......++
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~--- 280 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE--- 280 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc---
Confidence 0112234689999999999999999999999999999999999999998877555554444422221111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCC
Q 002382 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP 866 (929)
Q Consensus 831 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 866 (929)
+.....+..+++.+.++.+|..|-
T Consensus 281 ------------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 281 ------------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ------------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 122223567888888999999887
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.7e-14 Score=145.37 Aligned_cols=136 Identities=22% Similarity=0.277 Sum_probs=97.0
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeecCCcch--hHH----------------------HHHHHHHhcccCCCc--e
Q 002382 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KRE----------------------FTNEVTLLSRIHHRN--L 659 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~--~~~----------------------f~~Ev~iL~~l~HpN--I 659 (929)
.+.||+|+||+||+|...+++.||||+++...... ... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987542211 111 134555555554332 3
Q ss_pred eEEeeeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCeEec
Q 002382 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLD 738 (929)
Q Consensus 660 v~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~ 738 (929)
.+.++. ...++||||++++.+........ ... .....++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444433 24589999999965432211100 001 4567899999999999999 7 999999999999999
Q ss_pred CCCcEEEEeecCcccc
Q 002382 739 KHMRAKVSDFGLSKFA 754 (929)
Q Consensus 739 ~~~~vkL~DFGla~~~ 754 (929)
++.++|+|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 889999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.6e-14 Score=136.01 Aligned_cols=134 Identities=25% Similarity=0.296 Sum_probs=113.5
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCC--CceeEEeeeeeecCeEEEEEEeccCCc
Q 002382 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~H--pNIv~l~g~~~~~~~~~LV~E~~~~gs 683 (929)
.+.||+|.++.||++...+ +.+++|....... ...+.+|+.+++.++| .++.+++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 3679999999999999874 7899999865433 4678899999999976 589999998888888999999999877
Q ss_pred hhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+... +......++.+++++|++||.....+++|+|++|+||+++..+.++++|||.++.
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7543 3455667899999999999996445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-15 Score=170.22 Aligned_cols=160 Identities=23% Similarity=0.270 Sum_probs=115.5
Q ss_pred cccccccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCC
Q 002382 334 YTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSD 413 (929)
Q Consensus 334 ~t~~~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~ 413 (929)
.-.+.|+.|..|+|++|.+.+|||.+.+|..||.|.|++|.+....+..|.++.++.-+..++..-. ...++-+.+
T Consensus 144 ~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT----l~N~Ptsld 219 (1255)
T KOG0444|consen 144 SLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT----LDNIPTSLD 219 (1255)
T ss_pred hHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch----hhcCCCchh
Confidence 3467789999999999999999999999999999999999998877777777766655544332221 122233345
Q ss_pred CCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccc
Q 002382 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (929)
Q Consensus 414 ~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 493 (929)
.+.+|..+|||.|+|. .+|+.+.+|.+|+.|+||+|+|+.+--....-.+|++|+||+|+|+ .+|+.++.|+.|+.|+
T Consensus 220 ~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy 297 (1255)
T KOG0444|consen 220 DLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLY 297 (1255)
T ss_pred hhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHH
Confidence 5667777888888888 7888888888888888888877765555555566666666666666 5666666666666555
Q ss_pred cccccc
Q 002382 494 VQNNML 499 (929)
Q Consensus 494 l~~N~l 499 (929)
+.+|+|
T Consensus 298 ~n~NkL 303 (1255)
T KOG0444|consen 298 ANNNKL 303 (1255)
T ss_pred hccCcc
Confidence 555554
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.7e-14 Score=181.83 Aligned_cols=178 Identities=24% Similarity=0.327 Sum_probs=125.1
Q ss_pred cceeeeeecccCCC-CCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 340 PFVLSFKFGKTYDS-SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 340 ~~l~~l~l~~n~~s-~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
++|+.|+|..|.++ .+|+.+..+..|+.|+++.|.+.......+..+..+..++.+++. ..+.........+|
T Consensus 404 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~------~~~~~p~~~~~~~L 477 (968)
T PLN00113 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK------FFGGLPDSFGSKRL 477 (968)
T ss_pred CCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCce------eeeecCcccccccc
Confidence 34555555555554 333345555555556665555543222222222222222211100 00000011123589
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
+.|+|++|+++|.+|..|.+|++|+.|+|++|++++.+|. +.++++|++|+|++|+++|.+|..++++++|+.|+|++|
T Consensus 478 ~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 557 (968)
T PLN00113 478 ENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQN 557 (968)
T ss_pred eEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCC
Confidence 9999999999999999999999999999999999998885 899999999999999999999999999999999999999
Q ss_pred ccccccccccc--ccceeccccCCcccc
Q 002382 498 MLSGTVPSSLL--SKNVVLNYAGNINLH 523 (929)
Q Consensus 498 ~l~g~~P~~l~--~~~~~l~~~~n~~lc 523 (929)
+++|.+|..+. ..+..+++.+|...+
T Consensus 558 ~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 558 QLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred cccccCChhHhcCcccCEEeccCCccee
Confidence 99999999874 345667777776443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.1e-13 Score=143.09 Aligned_cols=135 Identities=18% Similarity=0.224 Sum_probs=104.4
Q ss_pred hcccc-ccCcEEEEEEEECCCcEEEEEEeecCC-------------cchhHHHHHHHHHhcccCCCce--eEEeeeeeec
Q 002382 606 EKKIG-SGGFGVVYYGKLKDGKEIAVKVLTSNS-------------YQGKREFTNEVTLLSRIHHRNL--VQFLGYCQEE 669 (929)
Q Consensus 606 ~~~IG-~G~fG~Vy~~~~~~~~~vAVK~l~~~~-------------~~~~~~f~~Ev~iL~~l~HpNI--v~l~g~~~~~ 669 (929)
...|| .|+.|+||..... +..++||.+.... ......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 8999999999886 7889999875321 1223457889999999998875 6777765432
Q ss_pred C----eEEEEEEeccC-CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEE
Q 002382 670 G----RSVLVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 744 (929)
Q Consensus 670 ~----~~~LV~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 744 (929)
. ..++|+|++++ .+|.+++.. ..++.. .+.+++++|.+||+. ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 688887742 223332 367899999999998 999999999999999999999
Q ss_pred EEeecCccc
Q 002382 745 VSDFGLSKF 753 (929)
Q Consensus 745 L~DFGla~~ 753 (929)
|+|||.++.
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3e-14 Score=169.63 Aligned_cols=253 Identities=20% Similarity=0.272 Sum_probs=182.6
Q ss_pred HHhccccccCcEEEEEEEECC--CcEEEEEEeecCC--cchhHHHHHHHHHhcccC-CCceeEEeeeeeecCeEEEEEEe
Q 002382 604 MLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNS--YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~--~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
.+.+.||+|.|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++.....+..+++.++
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 345669999999998887643 3445666654432 222233445777777776 99999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHH-hCCCCceecCCCCCCCeEecCCC-cEEEEeecCcccccC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD 756 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~ 756 (929)
..++++.+.+.. ......+....-.+..|+..++.|+| .. ++.|+||||+|.+++..+ ..+++|||+|.....
T Consensus 103 s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 103 SDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999887731 11213455566778999999999999 76 999999999999999999 999999999986555
Q ss_pred --CCCceeeeeec-CccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 757 --GASHVSSIVRG-TVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 757 --~~~~~~~~~~g-t~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... .....|.... +...
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~---~~~~- 251 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNK---GRFT- 251 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeecccc---cccc-
Confidence 33444455668 9999999999884 45678899999999999999999987654221 1222222221 0000
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..... .......++..+++..+|..|.+.+++...
T Consensus 252 ---~~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 252 ---QLPWN----SISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ---cCccc----cCChhhhhcccccccCCchhcccccccccc
Confidence 00011 112245677778888999999999887654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.1e-13 Score=140.94 Aligned_cols=203 Identities=23% Similarity=0.320 Sum_probs=143.9
Q ss_pred HhcccCCCceeEEeeeeeec-----CeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCc
Q 002382 650 LLSRIHHRNLVQFLGYCQEE-----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724 (929)
Q Consensus 650 iL~~l~HpNIv~l~g~~~~~-----~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ 724 (929)
-|-++.|.||++++.|+.+. .+..++.|||..|++.++|+........+......+++.||..||.|||+ |.|.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 34456799999999998553 45789999999999999998877777788888999999999999999999 6789
Q ss_pred eecCCCCCCCeEecCCCcEEEEeecCccccc---CCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhC
Q 002382 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAV---DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801 (929)
Q Consensus 725 ivHrDIkp~NILl~~~~~vkL~DFGla~~~~---~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG 801 (929)
|+|+++..+-|++..+|-+|++--.-..... ...........+-++|.+||+-.....+.++|||+||+..+||.-|
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999999988874211110000 0011111122367899999998887888899999999999999887
Q ss_pred CCCCcc-ccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 802 QEAISN-EKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 802 ~~p~~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..--.. ...-+...++..- ... +.+. .=...+..|++..|..||+|++++.|
T Consensus 279 Eiq~tnseS~~~~ee~ia~~-i~~-------------len~-------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANV-IIG-------------LENG-------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeccCCCcceeehhhhhhhh-eee-------------ccCc-------cccCcCcccccCCCCCCcchhhhhcC
Confidence 643211 1100111111110 000 0000 01245678999999999999998866
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.1e-12 Score=146.99 Aligned_cols=139 Identities=23% Similarity=0.287 Sum_probs=99.2
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcch----------------------------------------hHHHHH
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG----------------------------------------KREFTN 646 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~----------------------------------------~~~f~~ 646 (929)
+.||.|++|.||+|++++|+.||||+.+...... +-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999999999999986542110 013455
Q ss_pred HHHHhcccC-----CCceeEEeeee-eecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHH-HHHHHHh
Q 002382 647 EVTLLSRIH-----HRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-GIEYLHT 719 (929)
Q Consensus 647 Ev~iL~~l~-----HpNIv~l~g~~-~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~-gL~yLH~ 719 (929)
|++.+.+++ ++++ .+-..+ ...+..+|||||++|++|.+..... .... ....++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCC---CHHHHHHHHHHHHHHHHHh
Confidence 666555552 3333 332222 2344579999999999998876321 1111 23456666666 4678898
Q ss_pred CCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 720 ~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
. |++|+|+||.||+++.+++++++|||++....
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 7 99999999999999999999999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.5e-13 Score=151.48 Aligned_cols=164 Identities=20% Similarity=0.127 Sum_probs=110.6
Q ss_pred cccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (929)
++.+|..|.|++|.+|+||+. +.+|..|+.|+|..|++..+.-..++++.+++++....++--.- -.|+- -.+.
T Consensus 195 ~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL--~DG~F---y~l~ 269 (873)
T KOG4194|consen 195 SLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKL--DDGAF---YGLE 269 (873)
T ss_pred ccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccc--cCcce---eeec
Confidence 455889999999999999999 66799999999999998765434444444433332211111100 01110 1234
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 495 (929)
.+++|+|+.|+++..-..++.+|+.|+.|+||+|.|..+.++ +.-+++|++||||+|+|+..-+++|..|.+|+.|.|+
T Consensus 270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs 349 (873)
T KOG4194|consen 270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLS 349 (873)
T ss_pred ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccc
Confidence 677888888888755566777888888888888888777665 6777788888888888885555567777667666666
Q ss_pred cccccccccccc
Q 002382 496 NNMLSGTVPSSL 507 (929)
Q Consensus 496 ~N~l~g~~P~~l 507 (929)
+|.++ .+-+..
T Consensus 350 ~Nsi~-~l~e~a 360 (873)
T KOG4194|consen 350 HNSID-HLAEGA 360 (873)
T ss_pred ccchH-HHHhhH
Confidence 66666 554443
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.2e-12 Score=144.36 Aligned_cols=178 Identities=20% Similarity=0.270 Sum_probs=137.4
Q ss_pred ccceeeeeecccC--CCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCC
Q 002382 339 LPFVLSFKFGKTY--DSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (929)
Q Consensus 339 l~~l~~l~l~~n~--~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (929)
+++|..|.++++. +..+|+.|..|.+|..++++.|.+.. -++.+-++..+..++++++. .+-++...+.-.
T Consensus 196 mtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~-vPecly~l~~LrrLNLS~N~------iteL~~~~~~W~ 268 (1255)
T KOG0444|consen 196 MTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPI-VPECLYKLRNLRRLNLSGNK------ITELNMTEGEWE 268 (1255)
T ss_pred chhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCc-chHHHhhhhhhheeccCcCc------eeeeeccHHHHh
Confidence 4455555555544 66788888888888888888888754 34555555555555443211 111221112224
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCC--CCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~--~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
+|++|+||.|+|+ .+|+.+++|+.|+.|++.+|+|+ |+|..++.|.+|+++++++|+|. ..|+.++.+..|+.|.|
T Consensus 269 ~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L 346 (1255)
T KOG0444|consen 269 NLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKL 346 (1255)
T ss_pred hhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcc
Confidence 7999999999999 99999999999999999999875 66667999999999999999999 99999999999999999
Q ss_pred ccccccccccccc--cccceeccccCCcccccCC
Q 002382 495 QNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 526 (929)
Q Consensus 495 ~~N~l~g~~P~~l--~~~~~~l~~~~n~~lc~~~ 526 (929)
+.|+|- ++|+.+ +..+..|.+..|+++.-.+
T Consensus 347 ~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 347 DHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred ccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 999999 999986 6667788888888886554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.9e-11 Score=139.45 Aligned_cols=253 Identities=21% Similarity=0.205 Sum_probs=181.6
Q ss_pred HHHHHHHHHhccccc--cCcEEEEEEEE--C-CCcEEEEEEeecC--CcchhHHHHHHHHHhccc-CCCceeEEeeeeee
Q 002382 597 DIEDATKMLEKKIGS--GGFGVVYYGKL--K-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE 668 (929)
Q Consensus 597 ~i~~~~~~~~~~IG~--G~fG~Vy~~~~--~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~ 668 (929)
+..+....+.+.+|. |.+|.||.+.. . ++..+|+|.-+.. .......=.+|+.-..++ .|+|.++....+..
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 444555566788999 99999999987 3 5788999874332 222222334566666666 49999999999999
Q ss_pred cCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHH----HHHHHHhCCCCceecCCCCCCCeEecCC-CcE
Q 002382 669 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----GIEYLHTGCVPAIIHRDLKSSNILLDKH-MRA 743 (929)
Q Consensus 669 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~----gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~v 743 (929)
.+..++-+|.+. .+|.++.+.. ...++....+....+..+ ||.++|.. .++|-|+||.||+...+ ..+
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred CCcceeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccccee
Confidence 999999999885 6887776532 334566667777888888 99999998 99999999999999999 889
Q ss_pred EEEeecCcccccCCCCce----eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHH
Q 002382 744 KVSDFGLSKFAVDGASHV----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (929)
Q Consensus 744 kL~DFGla~~~~~~~~~~----~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~ 819 (929)
+++|||+...+.+..... .....|...|++||...+ .++.++|+|++|.+..+..++..+....... .
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~ 334 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS-------S 334 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC-------C
Confidence 999999988776554221 222357889999998754 5688999999999999999988765433100 1
Q ss_pred HHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 820 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 820 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
|.. .+.+- +..++....-.++...+.++++.+|..|++..++..+
T Consensus 335 W~~--~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 335 WSQ--LRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccc--ccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 110 11110 1222222222345558889999999999998887654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=9.6e-11 Score=117.81 Aligned_cols=129 Identities=20% Similarity=0.165 Sum_probs=96.1
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCcee-EEeeeeeecCeEEEEEEeccCCchh
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV-QFLGYCQEEGRSVLVYEFMHNGTLK 685 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv-~l~g~~~~~~~~~LV~E~~~~gsL~ 685 (929)
+.|+.|.++.||+++.. ++.+++|+...... ....+..|+++++.+.+.+++ +++.+.. ...++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 56889999999999876 78899998754432 234567899999988665544 4444432 3457999999998875
Q ss_pred hhhccccccccccchHHHHHHHHHHHHHHHHHHhCC--CCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 686 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 686 ~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
+.. .....++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 420 011235678999999999972 12369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.9e-12 Score=144.56 Aligned_cols=92 Identities=29% Similarity=0.402 Sum_probs=55.2
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCc---cccCCCcCccc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPS---SLMNLPNLREL 492 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~---~l~~l~~L~~L 492 (929)
+|+.|+|++|+|+..-+.+|..|.+|+.|+|++|+|..+-.. |..+++|+.|||++|.|++.+-+ .|..|+.|+.|
T Consensus 318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL 397 (873)
T KOG4194|consen 318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL 397 (873)
T ss_pred cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence 677777777777755555666666666666666666655543 55566666666666665543332 34455666666
Q ss_pred ccccccccccccccccc
Q 002382 493 YVQNNMLSGTVPSSLLS 509 (929)
Q Consensus 493 ~l~~N~l~g~~P~~l~~ 509 (929)
.|.+|+|. +||..-+.
T Consensus 398 ~l~gNqlk-~I~krAfs 413 (873)
T KOG4194|consen 398 RLTGNQLK-SIPKRAFS 413 (873)
T ss_pred eecCceee-ecchhhhc
Confidence 66666666 55554433
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.3e-12 Score=138.38 Aligned_cols=163 Identities=20% Similarity=0.194 Sum_probs=111.4
Q ss_pred eeeeecccCCCCCCCccchhccceeccCCCCCccH-----HHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCC
Q 002382 343 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDG-----VAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (929)
Q Consensus 343 ~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~-----~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (929)
..|+..+|+++++|+.+..+..|..|.+.+|.+.. ++|..||++ |||.. -.+-++-..+++.+
T Consensus 140 ~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~l-----------d~~~N-~L~tlP~~lg~l~~ 207 (565)
T KOG0472|consen 140 EDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHL-----------DCNSN-LLETLPPELGGLES 207 (565)
T ss_pred hhhhccccccccCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhc-----------ccchh-hhhcCChhhcchhh
Confidence 33444455555555555555555555555554322 233333333 22210 01112223345667
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCC-CCCCCCcEEEecCCCcCCCCCccccCCCcCccccccc
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~-~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 496 (929)
|.-|+|..|+|. .+| +|.++..|++|+++.|+|.-.+.+. .+|.+|.+|||..|+|+ ..|..+.-|.+|..||+++
T Consensus 208 L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSN 284 (565)
T KOG0472|consen 208 LELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSN 284 (565)
T ss_pred hHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccC
Confidence 888888889888 888 7888888999999999888776664 57999999999999999 8999999999999999999
Q ss_pred cccccccccccccc-ceeccccCCcc
Q 002382 497 NMLSGTVPSSLLSK-NVVLNYAGNIN 521 (929)
Q Consensus 497 N~l~g~~P~~l~~~-~~~l~~~~n~~ 521 (929)
|.|+ .+|.++.+. +..+...||+.
T Consensus 285 N~is-~Lp~sLgnlhL~~L~leGNPl 309 (565)
T KOG0472|consen 285 NDIS-SLPYSLGNLHLKFLALEGNPL 309 (565)
T ss_pred Cccc-cCCcccccceeeehhhcCCch
Confidence 9999 888888543 45667788864
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.5e-11 Score=139.96 Aligned_cols=139 Identities=19% Similarity=0.232 Sum_probs=91.4
Q ss_pred ccccccCcEEEEEEEECC-CcEEEEEEeecCCcch----------------------------------------hHHHH
Q 002382 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG----------------------------------------KREFT 645 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~~~----------------------------------------~~~f~ 645 (929)
+.||+|++|.||+|++++ |++||||+++..-... +-+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 9999999997542100 11244
Q ss_pred HHHHHhcccC----CCceeEEeeeeee-cCeEEEEEEeccCCchhhhh--ccccccccccchHHHHHHHHHHHHHHHHHH
Q 002382 646 NEVTLLSRIH----HRNLVQFLGYCQE-EGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718 (929)
Q Consensus 646 ~Ev~iL~~l~----HpNIv~l~g~~~~-~~~~~LV~E~~~~gsL~~~L--~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 718 (929)
+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+.- .........+....+..++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 4555554442 3333333333322 45678999999999997742 1110111123333333334443 3
Q ss_pred hCCCCceecCCCCCCCeEecCCC----cEEEEeecCccccc
Q 002382 719 TGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGLSKFAV 755 (929)
Q Consensus 719 ~~~~~~ivHrDIkp~NILl~~~~----~vkL~DFGla~~~~ 755 (929)
.. |++|+|+||.||+++.++ +++++|||++....
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 44 999999999999999988 99999999987553
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.8e-12 Score=139.22 Aligned_cols=91 Identities=27% Similarity=0.401 Sum_probs=85.4
Q ss_pred CeeEEEecCCCCCccCChhhh-ccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccc
Q 002382 417 SITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~-~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 495 (929)
.|++|+++.|+|+ .+|.+.+ +|.+|..|||..|++++.|.+++-|++|+.||||+|.|+ .+|.++|+| .|+.|-+.
T Consensus 229 ~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~le 305 (565)
T KOG0472|consen 229 LLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALE 305 (565)
T ss_pred HHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhc
Confidence 7999999999999 9999888 899999999999999999999999999999999999999 799999999 99999999
Q ss_pred cccccccccccccccc
Q 002382 496 NNMLSGTVPSSLLSKN 511 (929)
Q Consensus 496 ~N~l~g~~P~~l~~~~ 511 (929)
+|++. ++-.++.++.
T Consensus 306 GNPlr-TiRr~ii~~g 320 (565)
T KOG0472|consen 306 GNPLR-TIRREIISKG 320 (565)
T ss_pred CCchH-HHHHHHHccc
Confidence 99998 7877776654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.4e-09 Score=125.32 Aligned_cols=166 Identities=19% Similarity=0.241 Sum_probs=124.7
Q ss_pred ECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCchhhhhccccccccccchH
Q 002382 622 LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 701 (929)
Q Consensus 622 ~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~ 701 (929)
..++.+|.|+..+...........+-++.|+.++||||++++.....++..|+|+|.+. .|..++.. +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 34688999988876655445567788899999999999999999999999999999885 45555532 2245
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeeeeecCccccCccccccCc
Q 002382 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781 (929)
Q Consensus 702 ~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 781 (929)
.....+.||+.||.|||+.| +++|++|.-.-|+|+..|+.||++|.++........ ......--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 56667899999999999775 899999999999999999999999988753322111 011111123456666543222
Q ss_pred CCCcCceeeHHHHHHHHHhC
Q 002382 782 LTDKSDVYSFGVILLELISG 801 (929)
Q Consensus 782 ~s~~sDVwSlGvvl~elltG 801 (929)
-..|.|-|||+++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-09 Score=110.98 Aligned_cols=135 Identities=19% Similarity=0.194 Sum_probs=96.7
Q ss_pred ccccccCcEEEEEEEECC-------CcEEEEEEeecCCc----------------------chhHHH----HHHHHHhcc
Q 002382 607 KKIGSGGFGVVYYGKLKD-------GKEIAVKVLTSNSY----------------------QGKREF----TNEVTLLSR 653 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~-------~~~vAVK~l~~~~~----------------------~~~~~f----~~Ev~iL~~ 653 (929)
..||.|--+.||.|...+ +..+|||+.+.... ...+.+ ++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999997653 47999998753210 001122 379999999
Q ss_pred cCC--CceeEEeeeeeecCeEEEEEEeccCCchhh-hhccccccccccchHHHHHHHHHHHHHHHHH-HhCCCCceecCC
Q 002382 654 IHH--RNLVQFLGYCQEEGRSVLVYEFMHNGTLKE-HLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCVPAIIHRD 729 (929)
Q Consensus 654 l~H--pNIv~l~g~~~~~~~~~LV~E~~~~gsL~~-~L~~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~ivHrD 729 (929)
+.. -++.+.+++ ...++||||+.+..+.. .+. ...++..+...+..+++.+|..| |+. +++|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 853 455666654 46789999997653321 121 12233445567789999999999 777 999999
Q ss_pred CCCCCeEecCCCcEEEEeecCcccc
Q 002382 730 LKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 730 Ikp~NILl~~~~~vkL~DFGla~~~ 754 (929)
|++.||+++ ++.+.|+|||.+...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 468999999988644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.6e-09 Score=110.28 Aligned_cols=142 Identities=18% Similarity=0.335 Sum_probs=108.1
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCc-chhHHHHHHHHHhcccCC--CceeEEeeeeeec---CeEEEEEEecc
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHH--RNLVQFLGYCQEE---GRSVLVYEFMH 680 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~H--pNIv~l~g~~~~~---~~~~LV~E~~~ 680 (929)
+.|+.|.++.||++...+|+.+++|+...... .....+..|+++++.+++ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999887778999999764432 134578899999999965 4456777777654 35689999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--------------------------------------- 721 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--------------------------------------- 721 (929)
+.++.+.+.. ..++..+...++.+++++|..||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888775521 23556666777888888888887521
Q ss_pred --------------CCceecCCCCCCCeEecC--CCcEEEEeecCccc
Q 002382 722 --------------VPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKF 753 (929)
Q Consensus 722 --------------~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~ 753 (929)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246899999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.4e-09 Score=102.45 Aligned_cols=131 Identities=24% Similarity=0.404 Sum_probs=101.0
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcc--------hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~--------~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
..+++|+-+.+|.+.+. |.++++|.-.+.... ....-.+|+.++.+++--.|...+-+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999876 445666654322211 123456799999999766666666666777888999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
++|..|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888432 245677888888999999 999999999999998765 99999999863
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.8e-11 Score=114.70 Aligned_cols=149 Identities=23% Similarity=0.306 Sum_probs=103.6
Q ss_pred cchhccceeccCCCCCccHH--HHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeEEEecCCCCCccCChhh
Q 002382 359 LNAMEINKYLERNDGSIDGV--AIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDL 436 (929)
Q Consensus 359 i~~le~l~~L~l~~n~~~~~--~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~L~L~~n~l~g~~p~~l 436 (929)
+-.+++..-|.|+.|++.++ .+..|+++..+.-|+.. .+-++.+...++.|+.|+++-|+|. .+|..|
T Consensus 29 Lf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnq---------ie~lp~~issl~klr~lnvgmnrl~-~lprgf 98 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQ---------IEELPTSISSLPKLRILNVGMNRLN-ILPRGF 98 (264)
T ss_pred ccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccch---------hhhcChhhhhchhhhheecchhhhh-cCcccc
Confidence 44567778889999998763 34555555444445221 2222233445677888888888887 778888
Q ss_pred hccccCceeeccCCcCCC-CCC-CCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccccccccccccc--cccce
Q 002382 437 TKLSSLVELWLDGNSLTG-PIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNV 512 (929)
Q Consensus 437 ~~L~~L~~L~Ls~N~l~~-~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l--~~~~~ 512 (929)
+.++.|+.|||.+|++.+ .+| .|..++.|+.|.|++|.+. .+|..+++|++|+.|.+..|.+- ++|.++ +..+.
T Consensus 99 gs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lr 176 (264)
T KOG0617|consen 99 GSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLR 176 (264)
T ss_pred CCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHH
Confidence 888888888888887775 344 3777778888888888888 78888888888888888888887 788776 33344
Q ss_pred eccccCC
Q 002382 513 VLNYAGN 519 (929)
Q Consensus 513 ~l~~~~n 519 (929)
.+...||
T Consensus 177 elhiqgn 183 (264)
T KOG0617|consen 177 ELHIQGN 183 (264)
T ss_pred HHhcccc
Confidence 5555555
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.8e-10 Score=135.58 Aligned_cols=172 Identities=27% Similarity=0.371 Sum_probs=126.2
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHH-------------------------------HHHHHHhh
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGV-------------------------------AIVSVISL 386 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~-------------------------------~~~~l~~l 386 (929)
..+++..|....|.++-+||.+..+..|+.|+|..|.+... .+..|..+
T Consensus 285 ~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~L 364 (1081)
T KOG0618|consen 285 RITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQEL 364 (1081)
T ss_pred hhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHH
Confidence 35667777777888888888887777788777777765331 11111111
Q ss_pred cCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeEEEecCCCCCccCCh-hhhccccCceeeccCCcCCCCCCCCCCCCCC
Q 002382 387 YSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPDFSGCPDL 465 (929)
Q Consensus 387 ~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~L~L~~n~l~g~~p~-~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L 465 (929)
+.-.+ .-+|-| |+-+. +.++|+.|+|++|+|. .+|+ .+.+|..|++|+||||+|+.++..+.+++.|
T Consensus 365 ylanN---~Ltd~c----~p~l~----~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L 432 (1081)
T KOG0618|consen 365 YLANN---HLTDSC----FPVLV----NFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRL 432 (1081)
T ss_pred HHhcC---cccccc----hhhhc----cccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhh
Confidence 11111 124445 33333 3568999999999999 6665 6888999999999999999888779999999
Q ss_pred cEEEecCCCcCCCCCccccCCCcCccccccccccc-cccccccc-ccceeccccCCcccc
Q 002382 466 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS-GTVPSSLL-SKNVVLNYAGNINLH 523 (929)
Q Consensus 466 ~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~-g~~P~~l~-~~~~~l~~~~n~~lc 523 (929)
++|...+|+|. .+| .+..+++|+.+||+.|+|+ +.+|..+- ..+..|++.||..+.
T Consensus 433 ~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~ 490 (1081)
T KOG0618|consen 433 HTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLV 490 (1081)
T ss_pred HHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccc
Confidence 99999999999 888 8999999999999999996 34455444 556778889997653
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.3e-08 Score=100.10 Aligned_cols=140 Identities=26% Similarity=0.305 Sum_probs=104.3
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCc--------chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~--------~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
..|-+|+-+.|+++.+. |+...||.-..... -..+...+|+++|.+++--.|.-..-++.+.....++|||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 56889999999999987 77777775332211 1245677899999998766665555566677777899999
Q ss_pred ccC-CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC---cEEEEeecCcc
Q 002382 679 MHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSK 752 (929)
Q Consensus 679 ~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkL~DFGla~ 752 (929)
+++ .++.+++....... ........++.+|-+.+.-||.+ +|+|+||..+||++..++ .+.++|||++.
T Consensus 92 ~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred ccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 976 47777776543221 22222367888999999999999 999999999999997665 35899999975
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.1e-09 Score=130.33 Aligned_cols=154 Identities=23% Similarity=0.207 Sum_probs=84.5
Q ss_pred cceeeeeecccCCCCCCCccchhccceeccCCCCCccHHH--HHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCC
Q 002382 340 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVA--IVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~--~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (929)
+.|+.|+|..|.++.+|..+ ..|+.|++++|++.... +..|+.+ ...+ |. ...++. .+.+
T Consensus 282 ~~L~~L~Ls~N~Lt~LP~~p---~~L~~LdLS~N~L~~Lp~lp~~L~~L------~Ls~---N~---L~~LP~---lp~~ 343 (788)
T PRK15387 282 SGLCKLWIFGNQLTSLPVLP---PGLQELSVSDNQLASLPALPSELCKL------WAYN---NQ---LTSLPT---LPSG 343 (788)
T ss_pred hhcCEEECcCCccccccccc---cccceeECCCCccccCCCCccccccc------cccc---Cc---cccccc---cccc
Confidence 45667777777777777643 45777777777765421 1111111 0000 00 000100 0124
Q ss_pred eeEEEecCCCCCccCChhhhc-----------------cccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCC
Q 002382 418 ITVIHLSSKNLTGNIPSDLTK-----------------LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP 480 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~-----------------L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P 480 (929)
|+.|+|++|+|+ .+|....+ +.+|+.|+|++|+|+++++. .++|+.|+|++|+|+ .+|
T Consensus 344 Lq~LdLS~N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~Ls-sIP 418 (788)
T PRK15387 344 LQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVL---PSELKELMVSGNRLT-SLP 418 (788)
T ss_pred cceEecCCCccC-CCCCCCcccceehhhccccccCcccccccceEEecCCcccCCCCc---ccCCCEEEccCCcCC-CCC
Confidence 445555555554 23321111 23567777777777754432 256777888888887 466
Q ss_pred ccccCCCcCccccccccccccccccccc--ccceeccccCCc
Q 002382 481 SSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNI 520 (929)
Q Consensus 481 ~~l~~l~~L~~L~l~~N~l~g~~P~~l~--~~~~~l~~~~n~ 520 (929)
... .+|+.|+|++|+|+ .+|.++. ..+..+.+.+|+
T Consensus 419 ~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~ 456 (788)
T PRK15387 419 MLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 456 (788)
T ss_pred cch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCC
Confidence 533 35777888888888 8888764 344566667775
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=8.6e-09 Score=125.05 Aligned_cols=35 Identities=11% Similarity=-0.087 Sum_probs=26.2
Q ss_pred cceeeeeecccCCCCCCCccchhccceeccCCCCCccH
Q 002382 340 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDG 377 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~ 377 (929)
++|+.|+|..|.++.+|+.+ ..|+.|++..|.+..
T Consensus 242 ~~Lk~LdLs~N~LtsLP~lp---~sL~~L~Ls~N~L~~ 276 (788)
T PRK15387 242 PELRTLEVSGNQLTSLPVLP---PGLLELSIFSNPLTH 276 (788)
T ss_pred CCCcEEEecCCccCcccCcc---cccceeeccCCchhh
Confidence 46788888888888888764 356777888887654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.9e-09 Score=127.09 Aligned_cols=158 Identities=21% Similarity=0.251 Sum_probs=86.6
Q ss_pred ceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeE
Q 002382 341 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITV 420 (929)
Q Consensus 341 ~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~ 420 (929)
.|+.|+|..|.++.+|..+. ..|+.|++++|.+..+. ..+.. .+..++.++ +. ...++- .-..+|+.
T Consensus 221 nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~~LP-~~l~s--~L~~L~Ls~---N~---L~~LP~--~l~~sL~~ 287 (754)
T PRK15370 221 NIKTLYANSNQLTSIPATLP--DTIQEMELSINRITELP-ERLPS--ALQSLDLFH---NK---ISCLPE--NLPEELRY 287 (754)
T ss_pred CCCEEECCCCccccCChhhh--ccccEEECcCCccCcCC-hhHhC--CCCEEECcC---Cc---cCcccc--ccCCCCcE
Confidence 45666666666666665432 24666666666654321 11111 122221110 00 011110 01135666
Q ss_pred EEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccccc
Q 002382 421 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 500 (929)
Q Consensus 421 L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~ 500 (929)
|+|++|+|+ .+|..+. ++|+.|+|++|+|+..++.+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+
T Consensus 288 L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 288 LSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT 359 (754)
T ss_pred EECCCCccc-cCcccch--hhHHHHHhcCCccccCCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCC
Confidence 777777766 4555443 356666777777765444332 56777777777777 4676664 57777888888877
Q ss_pred ccccccccccceeccccCCc
Q 002382 501 GTVPSSLLSKNVVLNYAGNI 520 (929)
Q Consensus 501 g~~P~~l~~~~~~l~~~~n~ 520 (929)
.+|..+...+..|.+.+|.
T Consensus 360 -~LP~~lp~~L~~LdLs~N~ 378 (754)
T PRK15370 360 -VLPETLPPTITTLDVSRNA 378 (754)
T ss_pred -cCChhhcCCcCEEECCCCc
Confidence 6777666666666666653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4e-09 Score=120.74 Aligned_cols=242 Identities=21% Similarity=0.195 Sum_probs=167.7
Q ss_pred HhccccccCcEEEEEEEEC--CCcEEEEEEeecCCcchh--HHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEec
Q 002382 605 LEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~--~~~~vAVK~l~~~~~~~~--~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
+...||.|.|+.|++...+ ++..+++|.+.+...... ..-..|+.+...+ .|.+++.....+..-...++--|||
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 3568999999999988644 567889998766543322 2234566666655 5888888777776666677889999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC-CcEEEEeecCcccccCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~~~~~~ 758 (929)
+++++...+ .-...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||++..+.-.
T Consensus 349 ~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~- 420 (524)
T KOG0601|consen 349 EGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS- 420 (524)
T ss_pred cCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee-
Confidence 999887665 2345567778889999999999999997 99999999999999886 78899999998632111
Q ss_pred CceeeeeecCccc-cCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 759 SHVSSIVRGTVGY-LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 759 ~~~~~~~~gt~~Y-~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
.......+..| .+++......+..+.|++|||.-+.|..++..--... ++|.. +..+.+.
T Consensus 421 --~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---------~~~~~--i~~~~~p------ 481 (524)
T KOG0601|consen 421 --SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---------VQSLT--IRSGDTP------ 481 (524)
T ss_pred --cccccccccccccchhhccccccccccccccccccccccccCcccCccc---------cccee--eeccccc------
Confidence 00111123334 3555555677888999999999999999886533221 11111 0111110
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
.. +. ....+..++..++.+++..||.+.++..+.+.
T Consensus 482 --~~-~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 482 --NL-PG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred --CC-Cc-hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 00 11 11456778888999999999999988776654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.1e-08 Score=124.82 Aligned_cols=159 Identities=20% Similarity=0.233 Sum_probs=115.1
Q ss_pred cceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCee
Q 002382 340 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~ 419 (929)
..|+.|+|+.|.++.+|+.+. ..|+.|+++.|++... ...+. ..+..+..++ |. ...++ ..-...|+
T Consensus 241 ~~L~~L~Ls~N~L~~LP~~l~--s~L~~L~Ls~N~L~~L-P~~l~--~sL~~L~Ls~---N~---Lt~LP--~~lp~sL~ 307 (754)
T PRK15370 241 DTIQEMELSINRITELPERLP--SALQSLDLFHNKISCL-PENLP--EELRYLSVYD---NS---IRTLP--AHLPSGIT 307 (754)
T ss_pred ccccEEECcCCccCcCChhHh--CCCCEEECcCCccCcc-ccccC--CCCcEEECCC---Cc---cccCc--ccchhhHH
Confidence 367899999999999998765 5799999999988742 11111 1233332211 10 11111 00123689
Q ss_pred EEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccccc
Q 002382 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 499 (929)
Q Consensus 420 ~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l 499 (929)
.|+|++|+|+ .+|..+. ++|+.|++++|+|++++..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|
T Consensus 308 ~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~L 379 (754)
T PRK15370 308 HLNVQSNSLT-ALPETLP--PGLKTLEAGENALTSLPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNAL 379 (754)
T ss_pred HHHhcCCccc-cCCcccc--ccceeccccCCccccCChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcC
Confidence 9999999999 6787654 689999999999998665554 79999999999999 7888774 6899999999999
Q ss_pred cccccccccccceeccccCCc
Q 002382 500 SGTVPSSLLSKNVVLNYAGNI 520 (929)
Q Consensus 500 ~g~~P~~l~~~~~~l~~~~n~ 520 (929)
+ .+|..+...+..+.+.+|.
T Consensus 380 t-~LP~~l~~sL~~LdLs~N~ 399 (754)
T PRK15370 380 T-NLPENLPAALQIMQASRNN 399 (754)
T ss_pred C-CCCHhHHHHHHHHhhccCC
Confidence 9 8998876666666666664
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=4.4e-09 Score=113.57 Aligned_cols=91 Identities=24% Similarity=0.255 Sum_probs=77.4
Q ss_pred hhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccccccccccccccccc--
Q 002382 435 DLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN-- 511 (929)
Q Consensus 435 ~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l~~~~-- 511 (929)
.|..|++|+.|+|++|+|+++-+. |.++.+|+.|.|..|+|.-.--..|.+|..|+.|+|.+|+|+ .+-...|+..
T Consensus 269 cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it-~~~~~aF~~~~~ 347 (498)
T KOG4237|consen 269 CFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQIT-TVAPGAFQTLFS 347 (498)
T ss_pred HHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeE-EEecccccccce
Confidence 578899999999999999998885 899999999999999998555567889999999999999999 7766666654
Q ss_pred -eeccccCCcccccCC
Q 002382 512 -VVLNYAGNINLHEGG 526 (929)
Q Consensus 512 -~~l~~~~n~~lc~~~ 526 (929)
..+++.+|+..|+..
T Consensus 348 l~~l~l~~Np~~CnC~ 363 (498)
T KOG4237|consen 348 LSTLNLLSNPFNCNCR 363 (498)
T ss_pred eeeeehccCcccCccc
Confidence 566778999888764
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.2e-10 Score=123.52 Aligned_cols=160 Identities=19% Similarity=0.196 Sum_probs=82.9
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccH--HHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDG--VAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQ 415 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~--~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~ 415 (929)
.|+.....+|+.|..+.+|....++-.|+.|.|+.|.+.. +++..|..++ -.+.+.++--. ..---|..
T Consensus 73 ~ltdt~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r~ip~~i~~L~~lt---~l~ls~NqlS~---lp~~lC~l--- 143 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFSELPEEACAFVSLESLILYHNCIRTIPEAICNLEALT---FLDLSSNQLSH---LPDGLCDL--- 143 (722)
T ss_pred cccchhhhhccccccccCchHHHHHHHHHHHHHHhccceecchhhhhhhHHH---Hhhhccchhhc---CChhhhcC---
Confidence 3444455667778888888777777777777777666443 2333333331 11111000000 00001221
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCc----------------------EEEecCC
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLR----------------------IIHLEDN 473 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~----------------------~L~Ls~N 473 (929)
-|+.|-+++|+|+ .+|++|+.+..|..||.+.|.|...++.+++|.+|+ .||+|.|
T Consensus 144 -pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScN 221 (722)
T KOG0532|consen 144 -PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCN 221 (722)
T ss_pred -cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccC
Confidence 3555666666666 566666655666666666666655555555555554 4555555
Q ss_pred CcCCCCCccccCCCcCccccccccccccccccccccc
Q 002382 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510 (929)
Q Consensus 474 ~l~g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l~~~ 510 (929)
+++ .||-.|.+|+.|++|-|.+|.|+ +-|..++.+
T Consensus 222 kis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~k 256 (722)
T KOG0532|consen 222 KIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEK 256 (722)
T ss_pred cee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhc
Confidence 555 55555555555555555555555 445444433
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.2e-07 Score=96.82 Aligned_cols=125 Identities=26% Similarity=0.323 Sum_probs=81.9
Q ss_pred EEEEEEECCCcEEEEEEeecCCc-------------c-------------hhHHHHHHHHHhcccCCC--ceeEEeeeee
Q 002382 616 VVYYGKLKDGKEIAVKVLTSNSY-------------Q-------------GKREFTNEVTLLSRIHHR--NLVQFLGYCQ 667 (929)
Q Consensus 616 ~Vy~~~~~~~~~vAVK~l~~~~~-------------~-------------~~~~f~~Ev~iL~~l~Hp--NIv~l~g~~~ 667 (929)
.||.|...+|..+|||+.+.... . ......+|++.|.++... ++.+.+.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998899999998764210 0 012356799999999765 455666442
Q ss_pred ecCeEEEEEEecc--CCchhhhhccccccccccchHHHHHHHHHHHHHHHH-HHhCCCCceecCCCCCCCeEecCCCcEE
Q 002382 668 EEGRSVLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY-LHTGCVPAIIHRDLKSSNILLDKHMRAK 744 (929)
Q Consensus 668 ~~~~~~LV~E~~~--~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~y-LH~~~~~~ivHrDIkp~NILl~~~~~vk 744 (929)
..++||||++ |..+..+.. ..++......++.+++..+.. +|.. ||+|+|+.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~------~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD------VDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH------CGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHh------ccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 4579999998 555544321 111233456678888886666 4676 99999999999999988 999
Q ss_pred EEeecCcccc
Q 002382 745 VSDFGLSKFA 754 (929)
Q Consensus 745 L~DFGla~~~ 754 (929)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.70 E-value=6.6e-09 Score=104.33 Aligned_cols=82 Identities=26% Similarity=0.402 Sum_probs=27.5
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCC-CCCCCCcEEEecCCCcCCC-CCccccCCCcCccccc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGP-LPSSLMNLPNLRELYV 494 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~-~~l~~L~~L~Ls~N~l~g~-~P~~l~~l~~L~~L~l 494 (929)
+|+.|||++|+|+ .++ .|..|+.|++|+|++|+|+...+.+ ..+++|+.|+|++|+|... --..+..+++|+.|+|
T Consensus 43 ~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L 120 (175)
T PF14580_consen 43 KLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSL 120 (175)
T ss_dssp T--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-
T ss_pred CCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeec
Confidence 5666666666666 444 2556666666666666666544333 2456666666666666521 0124455566666666
Q ss_pred cccccc
Q 002382 495 QNNMLS 500 (929)
Q Consensus 495 ~~N~l~ 500 (929)
.+|+++
T Consensus 121 ~~NPv~ 126 (175)
T PF14580_consen 121 EGNPVC 126 (175)
T ss_dssp TT-GGG
T ss_pred cCCccc
Confidence 666665
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.70 E-value=7.6e-10 Score=124.17 Aligned_cols=82 Identities=22% Similarity=0.351 Sum_probs=64.2
Q ss_pred CCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCc---Cc
Q 002382 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPN---LR 490 (929)
Q Consensus 414 ~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~---L~ 490 (929)
.+.+|+.|++..|++. .+|.++..| .|..||+|+|+++.+|-.|.+|+.|++|-|.+|-|+ ..|..|+..-. -+
T Consensus 187 ~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFK 263 (722)
T KOG0532|consen 187 YLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFK 263 (722)
T ss_pred hHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeee
Confidence 3445666777777777 677777743 578899999999988889999999999999999999 78887765433 46
Q ss_pred cccccccc
Q 002382 491 ELYVQNNM 498 (929)
Q Consensus 491 ~L~l~~N~ 498 (929)
+|+.+-++
T Consensus 264 yL~~qA~q 271 (722)
T KOG0532|consen 264 YLSTQACQ 271 (722)
T ss_pred eecchhcc
Confidence 77777775
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=7.2e-10 Score=130.63 Aligned_cols=177 Identities=18% Similarity=0.168 Sum_probs=128.9
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHH--HHHHHhhc-------CCCCccc-----------CCCC
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVA--IVSVISLY-------SSADWAQ-----------EGGD 398 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~--~~~l~~l~-------~~~~w~~-----------~~~d 398 (929)
+..|+.+....|.++.+|..|..+..|+.|....|.+.-+. ++.++.+- .++++-. .-+.
T Consensus 263 ~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~ 342 (1081)
T KOG0618|consen 263 CANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNV 342 (1081)
T ss_pred cccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhh
Confidence 45677888899999999999999999999998888765421 12222221 1111100 0011
Q ss_pred CCCCCCCceeEeC-CCCCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcC
Q 002382 399 PCLPVPWSWLQCN-SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLT 476 (929)
Q Consensus 399 pc~~~~~~~~~c~-~~~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~ 476 (929)
-|.. .+-..|. ....+.|+.|.|.+|.|+...=+.|.+.+.|+.|+|++|+|...+.+ +.++..|+.|+||+|+|+
T Consensus 343 s~n~--l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~ 420 (1081)
T KOG0618|consen 343 SSNK--LSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT 420 (1081)
T ss_pred hhcc--ccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh
Confidence 1111 1112232 23456899999999999988777899999999999999999977775 899999999999999999
Q ss_pred CCCCccccCCCcCcccccccccccccccccc-cccceeccccCC
Q 002382 477 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGN 519 (929)
Q Consensus 477 g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l-~~~~~~l~~~~n 519 (929)
.+|..+.++.+|+.|...+|+|. .+|+.. +..+..+..+.|
T Consensus 421 -~Lp~tva~~~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N 462 (1081)
T KOG0618|consen 421 -TLPDTVANLGRLHTLRAHSNQLL-SFPELAQLPQLKVLDLSCN 462 (1081)
T ss_pred -hhhHHHHhhhhhHHHhhcCCcee-echhhhhcCcceEEecccc
Confidence 89999999999999999999999 999433 223345555544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.8e-07 Score=104.81 Aligned_cols=170 Identities=21% Similarity=0.305 Sum_probs=129.7
Q ss_pred cEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeee----ecCeEEEEEEeccC-Cchhhh
Q 002382 614 FGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ----EEGRSVLVYEFMHN-GTLKEH 687 (929)
Q Consensus 614 fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~----~~~~~~LV~E~~~~-gsL~~~ 687 (929)
-.+.||+... ||..+++|+++.+..+.......-++.++++.|+|+|++.+++. .+..+++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578999876 89999999996554443333445678899999999999999886 34578999999876 567665
Q ss_pred hccc-----------cccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 688 LYGT-----------LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 688 L~~~-----------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
-... ...+..+++..++.++.|++.||.++|+. |+.-+-|.+++|+++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4322 12345578889999999999999999998 999999999999999999999988887654433
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 804 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p 804 (929)
... |.+.+. .+-|.=.||.+++.|.||..-
T Consensus 446 d~~---------------~~le~~---Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLESQ---QQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhHH---hhhhHHHHHHHHHHHhhcccc
Confidence 220 112221 256888899999999999754
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.3e-08 Score=84.00 Aligned_cols=59 Identities=37% Similarity=0.573 Sum_probs=35.3
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQL 475 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l 475 (929)
+|+.|+|++|+|+..-+..|.+|++|++|+|++|+|+...|. |.++++|++|+|++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 566666666666633334555666666666666666655553 56666666666666654
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.9e-08 Score=81.97 Aligned_cols=60 Identities=45% Similarity=0.608 Sum_probs=55.7
Q ss_pred ccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccccc
Q 002382 440 SSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 499 (929)
Q Consensus 440 ~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l 499 (929)
++|+.|+|++|+|+.++++ |.++++|++|+|++|+|+...|..|.+|++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4799999999999998885 89999999999999999977778999999999999999986
|
... |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.7e-08 Score=99.89 Aligned_cols=101 Identities=33% Similarity=0.526 Sum_probs=38.4
Q ss_pred CCeeEEEecCCCCCccCChhhh-ccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccc-cCCCcCcccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSL-MNLPNLRELY 493 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~-~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l-~~l~~L~~L~ 493 (929)
.++++|+|.+|+|+ .|. .++ .|++|+.|+|++|+|+. ++.+..|++|++|+|++|+|+ .+++.+ ..+++|+.|+
T Consensus 19 ~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 19 VKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 37899999999999 665 476 68999999999999996 567999999999999999999 666555 4689999999
Q ss_pred cccccccccccc----cccccceeccccCCcc
Q 002382 494 VQNNMLSGTVPS----SLLSKNVVLNYAGNIN 521 (929)
Q Consensus 494 l~~N~l~g~~P~----~l~~~~~~l~~~~n~~ 521 (929)
|++|+|. .+-. .-+.++..+...||+-
T Consensus 95 L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 95 LSNNKIS-DLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp -TTS----SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred CcCCcCC-ChHHhHHHHcCCCcceeeccCCcc
Confidence 9999997 4322 2245567788888864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.4e-06 Score=92.46 Aligned_cols=257 Identities=12% Similarity=0.137 Sum_probs=155.6
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeee------eee-cCeEEEEEE
Q 002382 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGY------CQE-EGRSVLVYE 677 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~------~~~-~~~~~LV~E 677 (929)
.+.||+|+-+.+|--- +-...+.|+.+......+.+.. +.|... .||-+-.-+.| -.+ +...-+.|.
T Consensus 16 gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecc--hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 5679999999999432 2223356777655443333222 223333 45543321111 111 223567777
Q ss_pred eccCCchhhhhcccc---ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 678 FMHNGTLKEHLYGTL---THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
.+.+.---..++... .......|...++.++.++.+.+.||+. |.+-+|+.++|+|+.+++.+.|.|=..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence 776642222222211 2234468999999999999999999998 9999999999999999999999985433222
Q ss_pred cCCCCceeeeeecCccccCccccc-----cCcCCCcCceeeHHHHHHHHHhC-CCCCcccccc----ccch-hhHHHHHH
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISG-QEAISNEKFG----ANCR-NIVQWAKL 823 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvl~elltG-~~p~~~~~~~----~~~~-~l~~~~~~ 823 (929)
.. ........|...|.+||... +-.-+...|.|.||+++++++.| ++||.+-... .-.+ .|..
T Consensus 168 ~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~---- 241 (637)
T COG4248 168 AN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH---- 241 (637)
T ss_pred cC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc----
Confidence 22 22233345889999999865 23456778999999999999986 9999754321 1111 1211
Q ss_pred hhhcCCcccccCCcc-----cCccCHH-HHHHHHHHHHHccCC--CCCCCCcHHHHHHHHHHhHh
Q 002382 824 HIESGDIQGIIDPSL-----LDEYDIQ-SMWKIEEKALMCVLP--HGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 824 ~~~~~~~~~~~d~~l-----~~~~~~~-~~~~l~~li~~Cl~~--dP~~RPs~~eVl~~L~~~~~ 880 (929)
+.+...-|.+. ....+.+ -...+..+-.+|+.. .+.-||+++-++..|..+..
T Consensus 242 ----g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 242 ----GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred ----ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 11100011000 0011111 112455666778874 46789999999998887643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.1e-08 Score=122.48 Aligned_cols=242 Identities=18% Similarity=0.183 Sum_probs=157.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+-+|.++.++.+.-. .|.-.++|+...... ...+....+-.++-..+||-++...--+.......|+++|..+
T Consensus 809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 347888999999877543 233334443322111 1112222233333334567777666555667788999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc---CCC
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV---DGA 758 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~---~~~ 758 (929)
++|...|+..- ..+..-.......+.+++++||.. .+.|+|++|.|+++..++..++.|||...... +..
T Consensus 889 ~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 889 GDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred CCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 99988886432 233333344566778899999997 68999999999999999999999998432110 000
Q ss_pred ---------------------C------ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccccc
Q 002382 759 ---------------------S------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG 811 (929)
Q Consensus 759 ---------------------~------~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~ 811 (929)
. .......||+.|.+||...+......+|.|+.|++++|.++|..||......
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0 0012245899999999999999999999999999999999999999877755
Q ss_pred ccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHH
Q 002382 812 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS 869 (929)
Q Consensus 812 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 869 (929)
..++++....-.. .....+......+++..-+..+|.+|-.|.
T Consensus 1042 ~~f~ni~~~~~~~---------------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 QIFENILNRDIPW---------------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhccccCCCCC---------------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 4444443311000 000111112344566666777777777666
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=6.4e-07 Score=96.81 Aligned_cols=140 Identities=14% Similarity=0.107 Sum_probs=98.0
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcc-----------hhHHHHHHHHHhcccCCCce--eEEeeeeee-----
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-----------GKREFTNEVTLLSRIHHRNL--VQFLGYCQE----- 668 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~-----------~~~~f~~Ev~iL~~l~HpNI--v~l~g~~~~----- 668 (929)
+.+-.-....|.+..+. |+.+.||........ ....+.+|...+.++...+| ...+++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 34444444557777664 788999976432211 11247789998888854333 344555433
Q ss_pred cCeEEEEEEeccCC-chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC-------C
Q 002382 669 EGRSVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------H 740 (929)
Q Consensus 669 ~~~~~LV~E~~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-------~ 740 (929)
....++|+|++++- +|.+++.... ....+......++.+++..+.-||.. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23578999999885 7888874221 12334556678999999999999999 9999999999999975 4
Q ss_pred CcEEEEeecCcc
Q 002382 741 MRAKVSDFGLSK 752 (929)
Q Consensus 741 ~~vkL~DFGla~ 752 (929)
..+.++||+.++
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 689999999875
|
|
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.9e-07 Score=93.08 Aligned_cols=134 Identities=25% Similarity=0.436 Sum_probs=75.6
Q ss_pred eEeeCCCCCccccCCCeEEccCCccccccce--------------eeecCcc-cccccceeecccCCCCcceeeeeccCC
Q 002382 33 VSLNCGGNENFTDEIGLQWIADDHLIYGEIS--------------NISVANE-TRKQYMTLRHFPADSRKYCYKLDVITR 97 (929)
Q Consensus 33 ~~idcg~~~~~~~~~~~~~~~d~~~~~~~~~--------------~~~~~~~-~~~~~~tlr~fp~~~~~~cy~~~~~~~ 97 (929)
+.|+||++.. +|..++.|.+|..|..|... ....... ..+.|+|-|+=| ....|.+|+.++
T Consensus 3 ~~IN~Gg~~~-~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~---~~f~Y~ip~~~~ 78 (174)
T PF11721_consen 3 LRINAGGPAY-TDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGP---SSFSYDIPVVPN 78 (174)
T ss_dssp EEEEETSSSE-EETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----S---SSEEEEEE--S-
T ss_pred EEEECCCCcc-cCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCC---CceEEEEecCCC
Confidence 4799999998 88899999999999866551 0111111 114678999933 357999999999
Q ss_pred ceeEEeEEe---eecCcCCCCCCC---eeEEEECCce-eeEEeeC-CC--Cc-cEEEEE-EEEecCCCceEEEec-----
Q 002382 98 TRYLIRATF---LYGNFDNNNVYP---KFDISLGPTH-WSTIVIS-DA--AT-IEVREL-IFLASSPKIDVCLSN----- 160 (929)
Q Consensus 98 ~~yl~r~~~---~yg~~d~~~~~p---~fd~~~~~~~-w~~v~~~-~~--~~-~~~~e~-~~~~~~~~~~vcl~~----- 160 (929)
|.|-||+.| +++. ++....| +||+.++|+. ...+++- .+ .. ....+. -+.+.+..+.++|..
T Consensus 79 G~Y~V~L~FaE~~~~~-~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~~~ 157 (174)
T PF11721_consen 79 GTYTVRLHFAELYFGA-SGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGKGT 157 (174)
T ss_dssp EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--SE
T ss_pred cEEEEEEEeccccccc-cccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCCCc
Confidence 999999999 3333 3333344 8999999963 2222221 11 11 233333 234578889999985
Q ss_pred ------CCCCCceeeee
Q 002382 161 ------ATTGQPFISTL 171 (929)
Q Consensus 161 ------~~~~~pfis~l 171 (929)
...|.|.||+|
T Consensus 158 ~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 158 LCIPFIGSYGNPLISAI 174 (174)
T ss_dssp EEEEEESSSSSSSEEEE
T ss_pred EEeeccccCCCcEEeeC
Confidence 55667998886
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=6.4e-07 Score=93.96 Aligned_cols=135 Identities=21% Similarity=0.251 Sum_probs=98.1
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCc----------------------chhHHHHHHHHHhcccCCC--
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----------------------QGKREFTNEVTLLSRIHHR-- 657 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~----------------------~~~~~f~~Ev~iL~~l~Hp-- 657 (929)
-+.+...||.|.-+.||.|...+|.++|||.-+.... ......++|.++|+++.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3456789999999999999999999999996442110 0123457899999998644
Q ss_pred ceeEEeeeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe
Q 002382 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 737 (929)
Q Consensus 658 NIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl 737 (929)
.|.+.+++ ++.++|||++++-.|...- ++......++..|++-+..+-.. ||||+|+.+-||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEE
Confidence 56666554 5678999999986654321 12233344555555555555555 99999999999999
Q ss_pred cCCCcEEEEeecCcc
Q 002382 738 DKHMRAKVSDFGLSK 752 (929)
Q Consensus 738 ~~~~~vkL~DFGla~ 752 (929)
+++|.+.++||-.+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999997654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.4e-08 Score=105.76 Aligned_cols=129 Identities=19% Similarity=0.194 Sum_probs=106.2
Q ss_pred ceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeE
Q 002382 341 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITV 420 (929)
Q Consensus 341 ~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~ 420 (929)
.|+.++|+.|.++.+-..+--+..++.|+++.|.+.++. +...+++|+.
T Consensus 285 ~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v~-------------------------------nLa~L~~L~~ 333 (490)
T KOG1259|consen 285 ELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTVQ-------------------------------NLAELPQLQL 333 (490)
T ss_pred hhhhccccccchhhhhhhhhhccceeEEeccccceeeeh-------------------------------hhhhcccceE
Confidence 456788899999999888888888999999999876521 0123568999
Q ss_pred EEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCC--ccccCCCcCccccccccc
Q 002382 421 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 421 L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P--~~l~~l~~L~~L~l~~N~ 498 (929)
||||+|.|+ .+..+=.+|-+.++|.|++|.|. .+..+..|-+|..||+++|+|. .+- ..||+|++|+.|.|-+|+
T Consensus 334 LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~LSGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 334 LDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-TLSGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred eecccchhH-hhhhhHhhhcCEeeeehhhhhHh-hhhhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCC
Confidence 999999999 78888888999999999999886 3455777888999999999998 333 479999999999999999
Q ss_pred cccccc
Q 002382 499 LSGTVP 504 (929)
Q Consensus 499 l~g~~P 504 (929)
|. .+|
T Consensus 411 l~-~~v 415 (490)
T KOG1259|consen 411 LA-GSV 415 (490)
T ss_pred cc-ccc
Confidence 99 444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.1e-07 Score=109.46 Aligned_cols=169 Identities=26% Similarity=0.345 Sum_probs=125.5
Q ss_pred cceeeeeecccCCCCCCCccchhc-cceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 340 PFVLSFKFGKTYDSSRGPLLNAME-INKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~i~~le-~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
+.+..|.+..|.++.+||.+..+. .|+.|+++.|++.... ..+..+..+..+.....+ +..+.-....++.|
T Consensus 116 ~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~-~~~~~l~~L~~L~l~~N~------l~~l~~~~~~~~~L 188 (394)
T COG4886 116 TNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLP-SPLRNLPNLKNLDLSFND------LSDLPKLLSNLSNL 188 (394)
T ss_pred cceeEEecCCcccccCccccccchhhcccccccccchhhhh-hhhhccccccccccCCch------hhhhhhhhhhhhhh
Confidence 567889999999999999999995 9999999999987641 334444444444322221 11111111145688
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
+.|++++|+++ .+|..+..+..|++|++++|.+...+..+.++++|..|.+++|++. .+|..++.+++|+.|++++|+
T Consensus 189 ~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~ 266 (394)
T COG4886 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ 266 (394)
T ss_pred hheeccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccchhccccccceecccccc
Confidence 99999999999 8998888888899999999987777777888888888889999988 568888999999999999999
Q ss_pred ccccccccc--cccceeccccCC
Q 002382 499 LSGTVPSSL--LSKNVVLNYAGN 519 (929)
Q Consensus 499 l~g~~P~~l--~~~~~~l~~~~n 519 (929)
++ .++. + +..+..+.+.+|
T Consensus 267 i~-~i~~-~~~~~~l~~L~~s~n 287 (394)
T COG4886 267 IS-SISS-LGSLTNLRELDLSGN 287 (394)
T ss_pred cc-cccc-ccccCccCEEeccCc
Confidence 98 6765 2 233345555555
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.41 E-value=6.3e-07 Score=116.46 Aligned_cols=60 Identities=32% Similarity=0.419 Sum_probs=43.1
Q ss_pred CCCcEEEecCCCcCCCCCccccCCCcCcccccccccccccccccc-cccceeccccCCccc
Q 002382 463 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGNINL 522 (929)
Q Consensus 463 ~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l-~~~~~~l~~~~n~~l 522 (929)
++|+.|+|++|...+.+|.++++|++|+.|+|++|..-+.+|..+ +..+..+.+.+|..+
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L 838 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRL 838 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcc
Confidence 477888888887777888888888888888888875444788765 344455666665433
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.40 E-value=1e-07 Score=106.03 Aligned_cols=139 Identities=18% Similarity=0.220 Sum_probs=87.3
Q ss_pred ccceeeeeecccCCCC-CCCccchhcc---ceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCC
Q 002382 339 LPFVLSFKFGKTYDSS-RGPLLNAMEI---NKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDP 414 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~-lPP~i~~le~---l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~ 414 (929)
++.++.|+|..|.+.. .++.+.++.. |+.|++..|.+...++..+...... .
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~------------------------~ 135 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKD------------------------L 135 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHh------------------------C
Confidence 4567777777777763 4444666665 7788887777765444333222000 0
Q ss_pred CCCeeEEEecCCCCCc----cCChhhhccccCceeeccCCcCCCC-----CCCCCCCCCCcEEEecCCCcCCC----CCc
Q 002382 415 QPSITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGP-----IPDFSGCPDLRIIHLEDNQLTGP----LPS 481 (929)
Q Consensus 415 ~~~l~~L~L~~n~l~g----~~p~~l~~L~~L~~L~Ls~N~l~~~-----~p~~~~l~~L~~L~Ls~N~l~g~----~P~ 481 (929)
.++|+.|+|++|.+++ .++..+..+++|+.|+|++|.+++. .+.+..+++|++|+|++|.+++. ++.
T Consensus 136 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~ 215 (319)
T cd00116 136 PPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAE 215 (319)
T ss_pred CCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHH
Confidence 1367778888887773 2344556667788888888877742 11244556788888888877632 334
Q ss_pred cccCCCcCcccccccccccc
Q 002382 482 SLMNLPNLRELYVQNNMLSG 501 (929)
Q Consensus 482 ~l~~l~~L~~L~l~~N~l~g 501 (929)
.+..+++|+.|++++|++++
T Consensus 216 ~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 216 TLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HhcccCCCCEEecCCCcCch
Confidence 55667778888888887774
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.2e-06 Score=102.49 Aligned_cols=143 Identities=23% Similarity=0.270 Sum_probs=93.8
Q ss_pred HHh-ccccccCcEEEEEEEECCCcEEEEEEeecCCcch----------------------------------------hH
Q 002382 604 MLE-KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG----------------------------------------KR 642 (929)
Q Consensus 604 ~~~-~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~----------------------------------------~~ 642 (929)
.|. +.|+.++-|.||+|++++|++||||+.+.+-... +-
T Consensus 127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 443 6799999999999999999999999987542110 01
Q ss_pred HHHHHHHHhcccC-----CCceeEEeeeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHH-HHH
Q 002382 643 EFTNEVTLLSRIH-----HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG-IEY 716 (929)
Q Consensus 643 ~f~~Ev~iL~~l~-----HpNIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~g-L~y 716 (929)
++..|...+.+++ .+++.----|.+-.+..+|+|||++|-.+.+...-. ...++. ..++..++++ +..
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~---k~ia~~~~~~f~~q 280 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDR---KELAELLVRAFLRQ 280 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCH---HHHHHHHHHHHHHH
Confidence 2344555555542 344332222333456779999999998888774211 122332 2233333333 222
Q ss_pred HHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 717 LH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
+-.. |++|.|.+|.||+++.+|++.+.|||+.....
T Consensus 281 ~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 281 LLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHhc---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 2233 89999999999999999999999999986543
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.4e-06 Score=113.23 Aligned_cols=155 Identities=15% Similarity=0.133 Sum_probs=101.1
Q ss_pred ceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeE
Q 002382 341 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITV 420 (929)
Q Consensus 341 ~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~ 420 (929)
.|..|.+..+.+..+|+.+ ..+.|+.|++..|++... ...++.+..++..+.+........+ +...+++|+.
T Consensus 590 ~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~~L-~~~~~~l~~Lk~L~Ls~~~~l~~ip------~ls~l~~Le~ 661 (1153)
T PLN03210 590 KLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLEKL-WDGVHSLTGLRNIDLRGSKNLKEIP------DLSMATNLET 661 (1153)
T ss_pred ccEEEEecCCCCCCCCCcC-CccCCcEEECcCcccccc-ccccccCCCCCEEECCCCCCcCcCC------ccccCCcccE
Confidence 4677888888888888877 468888888888876541 1223334444443322111110001 1234568889
Q ss_pred EEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccccc
Q 002382 421 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 500 (929)
Q Consensus 421 L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~ 500 (929)
|+|++|.....+|..|.+|++|+.|+|++|...+.+|...++++|+.|+|++|...+.+|.. .++|+.|+|++|.++
T Consensus 662 L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~ 738 (1153)
T PLN03210 662 LKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE 738 (1153)
T ss_pred EEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc
Confidence 99988776668888899999999999988754455555447888888888887655566643 345677777777776
Q ss_pred ccccccc
Q 002382 501 GTVPSSL 507 (929)
Q Consensus 501 g~~P~~l 507 (929)
.+|..+
T Consensus 739 -~lP~~~ 744 (1153)
T PLN03210 739 -EFPSNL 744 (1153)
T ss_pred -cccccc
Confidence 666543
|
syringae 6; Provisional |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.2e-07 Score=107.91 Aligned_cols=150 Identities=19% Similarity=0.343 Sum_probs=102.0
Q ss_pred HHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC--------CceeeeeecCccccCcccccc
Q 002382 708 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA--------SHVSSIVRGTVGYLDPEYYIS 779 (929)
Q Consensus 708 ~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~--------~~~~~~~~gt~~Y~aPE~~~~ 779 (929)
.+++.||.|+|.. .++||++|.|++|.++..+..||+.|+.+....... ........-...|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455899999998 599999999999999999999999998775332211 111112234578999999999
Q ss_pred CcCCCcCceeeHHHHHHHHHhCCCC-CccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHcc
Q 002382 780 QQLTDKSDVYSFGVILLELISGQEA-ISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCV 858 (929)
Q Consensus 780 ~~~s~~sDVwSlGvvl~elltG~~p-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl 858 (929)
...+.++|+||+||++|-+..|..+ +.... ......... ..+..-...+..+...++.+=+.+.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~-~~~~~~~~~-------------~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANG-GLLSYSFSR-------------NLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccC-Ccchhhhhh-------------cccccccccccccCcHHHHHHHHHHh
Confidence 8889999999999999999954444 33222 111111111 11111111223344456777788889
Q ss_pred CCCCCCCCcHHHHHH
Q 002382 859 LPHGHMRPSISEVLK 873 (929)
Q Consensus 859 ~~dP~~RPs~~eVl~ 873 (929)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998777654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.27 E-value=5.1e-06 Score=86.68 Aligned_cols=106 Identities=26% Similarity=0.312 Sum_probs=81.0
Q ss_pred hHHHHHHHHHhcccCCC--ceeEEeeeeeec----CeEEEEEEeccCC-chhhhhccccccccccchHHHHHHHHHHHHH
Q 002382 641 KREFTNEVTLLSRIHHR--NLVQFLGYCQEE----GRSVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713 (929)
Q Consensus 641 ~~~f~~Ev~iL~~l~Hp--NIv~l~g~~~~~----~~~~LV~E~~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~qia~g 713 (929)
.....+|...+..+... .+.+.+++.... ...++|+|++++. +|.+++.... ..+......++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 44577888888777533 344556655442 2458999999874 7888875321 14455667899999999
Q ss_pred HHHHHhCCCCceecCCCCCCCeEecCCC---cEEEEeecCccc
Q 002382 714 IEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKF 753 (929)
Q Consensus 714 L~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkL~DFGla~~ 753 (929)
++-||+. ||+|+|+++.|||++.+. .+.++||+.++.
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.24 E-value=6e-07 Score=103.38 Aligned_cols=156 Identities=22% Similarity=0.262 Sum_probs=119.3
Q ss_pred ceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHH-hhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCee
Q 002382 341 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVI-SLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (929)
Q Consensus 341 ~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~-~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~ 419 (929)
.++.|++..|.+..+|..+..+..|+.|+++.|++....-. . .+..+.....+++. ..-+.+....+..|.
T Consensus 141 nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~~l~~~--~~~~~~L~~L~ls~N~------i~~l~~~~~~~~~L~ 212 (394)
T COG4886 141 NLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSDLPKL--LSNLSNLNNLDLSGNK------ISDLPPEIELLSALE 212 (394)
T ss_pred hcccccccccchhhhhhhhhccccccccccCCchhhhhhhh--hhhhhhhhheeccCCc------cccCchhhhhhhhhh
Confidence 68889999999999998899999999999999998763222 1 22222222111111 112222222344699
Q ss_pred EEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccccc
Q 002382 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 499 (929)
Q Consensus 420 ~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l 499 (929)
+|.+++|.+. .++..+.++++|..|.+++|++...+..++.++.|+.|++++|+++ .++. ++.+.+|+.|++++|.+
T Consensus 213 ~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~ 289 (394)
T COG4886 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSL 289 (394)
T ss_pred hhhhcCCcce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccc-cccc-ccccCccCEEeccCccc
Confidence 9999999876 7888899999999999999999987667899999999999999999 6666 99999999999999999
Q ss_pred cccccccc
Q 002382 500 SGTVPSSL 507 (929)
Q Consensus 500 ~g~~P~~l 507 (929)
+..+|...
T Consensus 290 ~~~~~~~~ 297 (394)
T COG4886 290 SNALPLIA 297 (394)
T ss_pred cccchhhh
Confidence 95555444
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.8e-05 Score=81.55 Aligned_cols=137 Identities=18% Similarity=0.176 Sum_probs=100.9
Q ss_pred ccccCcEEEEEEEECCCcEEEEEEeecC---C---cchhHHHHHHHHHhcccCCC--ceeEEeeeee-e----cCeEEEE
Q 002382 609 IGSGGFGVVYYGKLKDGKEIAVKVLTSN---S---YQGKREFTNEVTLLSRIHHR--NLVQFLGYCQ-E----EGRSVLV 675 (929)
Q Consensus 609 IG~G~fG~Vy~~~~~~~~~vAVK~l~~~---~---~~~~~~f~~Ev~iL~~l~Hp--NIv~l~g~~~-~----~~~~~LV 675 (929)
-|+||-+-|++-.+. |+.+-+|.-... + +.+...|.+|+..|+++... .+.+.+ ++. . .-..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 477999999998776 557888875421 1 34567899999999998532 244444 332 1 1246899
Q ss_pred EEeccC-CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc--EEEEeecCcc
Q 002382 676 YEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--AKVSDFGLSK 752 (929)
Q Consensus 676 ~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--vkL~DFGla~ 752 (929)
+|-+.+ .+|.+++.+.. -.+.+...+..+..++++.+.-||+. |+.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997764 57887774321 22345666778999999999999998 9999999999999986666 9999998765
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.18 E-value=6.4e-07 Score=99.68 Aligned_cols=104 Identities=29% Similarity=0.346 Sum_probs=76.5
Q ss_pred CCeeEEEecCCCCCc----cCChhhhcc-ccCceeeccCCcCCCCCC-----CCCCCCCCcEEEecCCCcCC----CCCc
Q 002382 416 PSITVIHLSSKNLTG----NIPSDLTKL-SSLVELWLDGNSLTGPIP-----DFSGCPDLRIIHLEDNQLTG----PLPS 481 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g----~~p~~l~~L-~~L~~L~Ls~N~l~~~~p-----~~~~l~~L~~L~Ls~N~l~g----~~P~ 481 (929)
++|+.|+|++|++++ .+...+..+ ++|+.|+|++|.+++... .+..+++|+.|+|++|.+++ .++.
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 187 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE 187 (319)
T ss_pred CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHH
Confidence 469999999999983 445566777 899999999999995322 36778899999999999984 2445
Q ss_pred cccCCCcCcccccccccccccccccc------cccceeccccCC
Q 002382 482 SLMNLPNLRELYVQNNMLSGTVPSSL------LSKNVVLNYAGN 519 (929)
Q Consensus 482 ~l~~l~~L~~L~l~~N~l~g~~P~~l------~~~~~~l~~~~n 519 (929)
.+..+++|+.|+|++|.+++.-...+ +.++..+.+.+|
T Consensus 188 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n 231 (319)
T cd00116 188 GLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDN 231 (319)
T ss_pred HHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCC
Confidence 56677899999999999974333222 223455555555
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=6e-07 Score=97.39 Aligned_cols=114 Identities=24% Similarity=0.383 Sum_probs=89.6
Q ss_pred CCCCCCCCCC--ceeEeCCCCC--------CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCC
Q 002382 396 GGDPCLPVPW--SWLQCNSDPQ--------PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPD 464 (929)
Q Consensus 396 ~~dpc~~~~~--~~~~c~~~~~--------~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~ 464 (929)
-..||.-..- ..|.|+..++ +..+.|+|..|+|+..-|.+|+.|++|+.||||+|+|+.+-|+ |.+|.+
T Consensus 37 CP~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~ 116 (498)
T KOG4237|consen 37 CPAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLAS 116 (498)
T ss_pred CCCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHh
Confidence 3556654332 2377876654 4568999999999944455899999999999999999999886 999999
Q ss_pred CcEEEe-cCCCcCCCCC-ccccCCCcCcccccccccccccccccccccc
Q 002382 465 LRIIHL-EDNQLTGPLP-SSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511 (929)
Q Consensus 465 L~~L~L-s~N~l~g~~P-~~l~~l~~L~~L~l~~N~l~g~~P~~l~~~~ 511 (929)
|..|-| ++|+|+ .+| ..|++|..|+.|.+.-|++. .++...+..+
T Consensus 117 l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~i~-Cir~~al~dL 163 (498)
T KOG4237|consen 117 LLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANHIN-CIRQDALRDL 163 (498)
T ss_pred hhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhhhc-chhHHHHHHh
Confidence 866555 459999 666 48999999999999999999 8887776554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.5e-05 Score=81.53 Aligned_cols=139 Identities=15% Similarity=0.218 Sum_probs=84.7
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCc--eeEEeeeeeecCeEEEEEEeccCCc-
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGYCQEEGRSVLVYEFMHNGT- 683 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpN--Iv~l~g~~~~~~~~~LV~E~~~~gs- 683 (929)
..||+|..+.||+. .+..+++|..+... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47899999999984 25567888876433 3345688999998886433 4667777777777889999999863
Q ss_pred hhhhh---------------------ccccccccccchHHHHHHHH----------HHHH-HHHHHHhC-CCCceecCCC
Q 002382 684 LKEHL---------------------YGTLTHEQRINWIKRLEIAE----------DAAK-GIEYLHTG-CVPAIIHRDL 730 (929)
Q Consensus 684 L~~~L---------------------~~~~~~~~~l~~~~~~~i~~----------qia~-gL~yLH~~-~~~~ivHrDI 730 (929)
+...+ |........+... ...+.. .+.+ ...+|... ..+.++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 1100000011000 000000 0011 12222211 1236789999
Q ss_pred CCCCeEecCCCcEEEEeecCcc
Q 002382 731 KSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 731 kp~NILl~~~~~vkL~DFGla~ 752 (929)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.9e-07 Score=105.10 Aligned_cols=164 Identities=26% Similarity=0.311 Sum_probs=114.6
Q ss_pred ccchhccceeccCCCCCccH-HHHHHH----Hhhc---CC---CC-cccCCCCCCCCCCCce---eEeCCC---------
Q 002382 358 LLNAMEINKYLERNDGSIDG-VAIVSV----ISLY---SS---AD-WAQEGGDPCLPVPWSW---LQCNSD--------- 413 (929)
Q Consensus 358 ~i~~le~l~~L~l~~n~~~~-~~~~~l----~~l~---~~---~~-w~~~~~dpc~~~~~~~---~~c~~~--------- 413 (929)
.|.-+..|+.|++....+.- ..++.| .++. .+ .+ ...-.||-|....|.- +.|+.+
T Consensus 104 ~ifpF~sLr~LElrg~~L~~~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~~mD~SL 183 (1096)
T KOG1859|consen 104 SIFPFRSLRVLELRGCDLSTAKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLVLMDESL 183 (1096)
T ss_pred eeccccceeeEEecCcchhhhhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHHhHHHHH
Confidence 37777778888887665433 222222 2221 11 11 1112577776655654 345432
Q ss_pred -CCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCC-CCCCCCCCcEEEecCCCcCCCCCccccCCCcCcc
Q 002382 414 -PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 491 (929)
Q Consensus 414 -~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~ 491 (929)
-++.|+.|||++|+++ ... .|..|+.|++|||++|.|+..+- ...+++ |+.|.|+||-++ .+ -.+.+|.+|+.
T Consensus 184 qll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~-tL-~gie~LksL~~ 258 (1096)
T KOG1859|consen 184 QLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALT-TL-RGIENLKSLYG 258 (1096)
T ss_pred HHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhccccccchhhhh-heeeeecccHHH-hh-hhHHhhhhhhc
Confidence 2567899999999999 444 78999999999999999986554 345566 999999999998 33 35889999999
Q ss_pred ccccccccccc---ccccccccceeccccCCcccccCC
Q 002382 492 LYVQNNMLSGT---VPSSLLSKNVVLNYAGNINLHEGG 526 (929)
Q Consensus 492 L~l~~N~l~g~---~P~~l~~~~~~l~~~~n~~lc~~~ 526 (929)
|||+.|-|.+. .|-+.+..+..|.+.||+-.|...
T Consensus 259 LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 259 LDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred cchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 99999998753 355556666778889999998764
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.8e-05 Score=90.64 Aligned_cols=139 Identities=19% Similarity=0.199 Sum_probs=89.2
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcch-------------------------------------hHHHHHHHH
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-------------------------------------KREFTNEVT 649 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~-------------------------------------~~~f~~Ev~ 649 (929)
+.||..+.|.||+|++++|+.||||+-+..-... +-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999976532110 112444554
Q ss_pred Hhccc----CCCc------eeEEeeeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHh
Q 002382 650 LLSRI----HHRN------LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719 (929)
Q Consensus 650 iL~~l----~HpN------Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 719 (929)
-..++ .|-+ |.+++- .-.....|+||||+|..+.+.-.- ....++... ++..+.++... .
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~---i~~~l~~~~~~--q 316 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHD---ILNKLVEAYLE--Q 316 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH---HHcCCCHHH---HHHHHHHHHHH--H
Confidence 44333 3444 222222 223567999999999988776321 122344333 33333333222 1
Q ss_pred CCCCceecCCCCCCCeEecC----CCcEEEEeecCccccc
Q 002382 720 GCVPAIIHRDLKSSNILLDK----HMRAKVSDFGLSKFAV 755 (929)
Q Consensus 720 ~~~~~ivHrDIkp~NILl~~----~~~vkL~DFGla~~~~ 755 (929)
-...|++|+|-+|.||++.. ++++.+-|||+.....
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 11128999999999999984 6789999999986543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.2e-06 Score=98.44 Aligned_cols=183 Identities=16% Similarity=0.172 Sum_probs=134.9
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCc-eeEEeeeeeecCeEEEEEEeccCC-
Q 002382 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEGRSVLVYEFMHNG- 682 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpN-Iv~l~g~~~~~~~~~LV~E~~~~g- 682 (929)
+-+-+++|++++++|.+....+....+.+... ....-++++|.+++||| .+..++-+..+...+++++++.++
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 34567899999999988664455555554322 34556889999999999 777777777788899999999887
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
+-..-. ...+..+...+...+...-++++++||+. .=+|+| ||+..+ +..|..||+....+.... ..
T Consensus 321 s~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~ 387 (829)
T KOG0576|consen 321 SSALEM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KP 387 (829)
T ss_pred cccccC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cc
Confidence 222111 12233445555666778888999999986 347888 777765 678999999876544332 23
Q ss_pred eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCC
Q 002382 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 805 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~ 805 (929)
....+++.++|||+.....+....|+|++|+--.++--|-+|-
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 4456899999999999999999999999998777777777664
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.96 E-value=7.5e-05 Score=78.00 Aligned_cols=137 Identities=22% Similarity=0.255 Sum_probs=92.1
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcchh------------------------HHHHHHHHHhcccC--CCcee
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK------------------------REFTNEVTLLSRIH--HRNLV 660 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~------------------------~~f~~Ev~iL~~l~--HpNIv 660 (929)
-.|+.|.-+.||+|...++..+|||+.+......+ ....+|+..|.++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 35778888999999988899999999875422111 11345777777663 33333
Q ss_pred EEeeeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC
Q 002382 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 740 (929)
Q Consensus 661 ~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~ 740 (929)
+-+++. ...|||||+..... -...+ ....+.......+..++++.+.-|-..+ ++||+||..-|||+. +
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~---pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGL---PAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-D 202 (268)
T ss_pred Cceeec----CCeEEEEeccCCCC---CCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-C
Confidence 444433 34799999865311 11111 1122222256677888888888887742 899999999999999 8
Q ss_pred CcEEEEeecCcccc
Q 002382 741 MRAKVSDFGLSKFA 754 (929)
Q Consensus 741 ~~vkL~DFGla~~~ 754 (929)
+.+.|+|||.|...
T Consensus 203 ~~p~iID~~QaV~~ 216 (268)
T COG1718 203 GEPYIIDVSQAVTI 216 (268)
T ss_pred CeEEEEECcccccc
Confidence 89999999988643
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.95 E-value=5.6e-06 Score=63.22 Aligned_cols=36 Identities=33% Similarity=0.557 Sum_probs=19.8
Q ss_pred cCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcC
Q 002382 441 SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 476 (929)
Q Consensus 441 ~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~ 476 (929)
+|++|+|++|+|+..+|.+++|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCcccCchHhCCCCCCEEEecCCCCC
Confidence 455666666666654444556666666666666555
|
... |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.91 E-value=6.6e-06 Score=62.84 Aligned_cols=36 Identities=47% Similarity=0.720 Sum_probs=17.2
Q ss_pred CCcEEEecCCCcCCCCCccccCCCcCccccccccccc
Q 002382 464 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 500 (929)
Q Consensus 464 ~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~ 500 (929)
+|++|+|++|+|+ .+|+.|++|++|+.|++++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4455555555555 34444555555555555555554
|
... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00011 Score=78.58 Aligned_cols=140 Identities=18% Similarity=0.159 Sum_probs=85.2
Q ss_pred ccccCc-EEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccC-CCceeEEeeeeeecCeEEEEEEeccCCchhh
Q 002382 609 IGSGGF-GVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 686 (929)
Q Consensus 609 IG~G~f-G~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 686 (929)
|-.|.. ..||+.... +..+.||+..... ..++.+|+++++.+. +--+.+++++....+..++|||+++|.++.+
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 789999765 4788888875443 345678898888883 4446677887776677899999999887764
Q ss_pred hh-------------------ccccccccccc-h-HHHHHHHH--------------------HHHHHHHHHHh----CC
Q 002382 687 HL-------------------YGTLTHEQRIN-W-IKRLEIAE--------------------DAAKGIEYLHT----GC 721 (929)
Q Consensus 687 ~L-------------------~~~~~~~~~l~-~-~~~~~i~~--------------------qia~gL~yLH~----~~ 721 (929)
.. +........+. . ........ .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 11000000000 0 00000000 01111222211 11
Q ss_pred CCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 722 ~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2469999999999999998778999999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.89 E-value=1.7e-06 Score=81.17 Aligned_cols=89 Identities=24% Similarity=0.330 Sum_probs=60.1
Q ss_pred CeeEEEecCCCCCccCChhhhcc-ccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKL-SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L-~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 495 (929)
.|+.++|++|++. ..|+.|... +.++.|+|++|.|+..|.++..++.|+.|+++.|.|. ..|.-+..|.+|..|+..
T Consensus 54 el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~ 131 (177)
T KOG4579|consen 54 ELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSP 131 (177)
T ss_pred eEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCC
Confidence 5666677777777 566655543 4667777777777766666777777777777777777 666666667777777777
Q ss_pred ccccccccccccc
Q 002382 496 NNMLSGTVPSSLL 508 (929)
Q Consensus 496 ~N~l~g~~P~~l~ 508 (929)
+|.+. .+|-.++
T Consensus 132 ~na~~-eid~dl~ 143 (177)
T KOG4579|consen 132 ENARA-EIDVDLF 143 (177)
T ss_pred CCccc-cCcHHHh
Confidence 77766 6665543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.87 E-value=9.8e-05 Score=77.77 Aligned_cols=143 Identities=19% Similarity=0.234 Sum_probs=84.3
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCC--ceeEEeeeee---ecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR--NLVQFLGYCQ---EEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~Hp--NIv~l~g~~~---~~~~~~LV~E~~~~ 681 (929)
+.|+.|..+.||+....+ +.+++|+.... .....+.+|..+++.+... .+.+++.++. .....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568999999999999986 69999997544 4456788899998888533 3456666442 33456899999999
Q ss_pred Cchhh----------------hh---ccccccccccch-H--------HHHH------------HHHHHHH-HHHHHHh-
Q 002382 682 GTLKE----------------HL---YGTLTHEQRINW-I--------KRLE------------IAEDAAK-GIEYLHT- 719 (929)
Q Consensus 682 gsL~~----------------~L---~~~~~~~~~l~~-~--------~~~~------------i~~qia~-gL~yLH~- 719 (929)
..+.. .+ +........... . .... ....+.+ .++.+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88777 11 111000000000 0 0000 0112222 3333332
Q ss_pred ---CCCCceecCCCCCCCeEec-CCCcEEEEeecCcc
Q 002382 720 ---GCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSK 752 (929)
Q Consensus 720 ---~~~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~ 752 (929)
.....++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1234799999999999999 66667899999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.87 E-value=2.9e-06 Score=88.82 Aligned_cols=82 Identities=22% Similarity=0.326 Sum_probs=58.4
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 495 (929)
..|++||||+|.|+ .+..++.-++.++.|+||+|+|...- ++..|.+|+.||||+|.|+ .+-..-..|-+++.|.|+
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeeeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 35777888888877 77777777777888888888776433 3777777888888888777 455555556666677777
Q ss_pred ccccc
Q 002382 496 NNMLS 500 (929)
Q Consensus 496 ~N~l~ 500 (929)
+|.|.
T Consensus 361 ~N~iE 365 (490)
T KOG1259|consen 361 QNKIE 365 (490)
T ss_pred hhhHh
Confidence 77665
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 929 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-57 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-56 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-48 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-32 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-32 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-31 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-26 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-26 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-26 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-26 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-26 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-26 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-26 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-26 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-26 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-26 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-26 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-25 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-25 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-25 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-25 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-25 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-25 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-25 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-25 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-24 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-24 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-24 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-24 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-24 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-24 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-24 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-23 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-23 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-22 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 5e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 6e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 7e-06 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 448 bits (1154), Expect = e-151
Identities = 122/312 (39%), Positives = 187/312 (59%), Gaps = 7/312 (2%)
Query: 577 RPVSSLNDAPAEAAHCFTLSDIEDATKMLEKK--IGSGGFGVVYYGKLKDGKEIAVKVLT 634
S + ++ L D+E+AT + K IG G FG VY G L+DG ++A+K T
Sbjct: 13 NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT 72
Query: 635 SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH 694
S QG EF E+ LS H +LV +G+C E +L+Y++M NG LK HLYG+
Sbjct: 73 PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132
Query: 695 EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-F 753
++W +RLEI AA+G+ YLHT IIHRD+KS NILLD++ K++DFG+SK
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189
Query: 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 813
+H+S++V+GT+GY+DPEY+I +LT+KSDVYSFGV+L E++ + AI +
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPRE 248
Query: 814 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 873
N+ +WA +G ++ I+DP+L D+ +S+ K + A+ C+ RPS+ +VL
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
Query: 874 DIQDAIVIEREA 885
++ A+ ++
Sbjct: 309 KLEYALRLQESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 376 bits (969), Expect = e-124
Identities = 103/288 (35%), Positives = 168/288 (58%), Gaps = 4/288 (1%)
Query: 590 AHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTN 646
F+L +++ A+ + +G GGFG VY G+L DG +AVK L QG + +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 647 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 706
EV ++S HRNL++ G+C +LVY +M NG++ L + ++W KR I
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 707 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766
A +A+G+ YLH C P IIHRD+K++NILLD+ A V DFGL+K +HV++ VR
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 767 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-GANCRNIVQWAKLHI 825
GT+G++ PEY + + ++K+DV+ +GV+LLELI+GQ A + + ++ W K +
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 873
+ ++ ++D L Y + + ++ + AL+C RP +SEV++
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 356 bits (917), Expect = e-116
Identities = 97/305 (31%), Positives = 166/305 (54%), Gaps = 27/305 (8%)
Query: 591 HCFTLSDIEDATK--------MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTS----NSY 638
H F+ ++++ T + K+G GGFGVVY G + + +AVK L + +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 639 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 698
+ K++F E+ ++++ H NLV+ LG+ + LVY +M NG+L + L L +
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPL 130
Query: 699 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDG 757
+W R +IA+ AA GI +LH IHRD+KS+NILLD+ AK+SDFGL++
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817
+ ++S + GT Y+ PE + ++T KSD+YSFGV+LLE+I+G A+ + + +
Sbjct: 188 QTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR---EPQLL 243
Query: 818 VQWAK-LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV---LK 873
+ + + E I+ ID +++ D S+ + A C+ + RP I +V L+
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 874 DIQDA 878
++ +
Sbjct: 303 EMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 2e-75
Identities = 77/310 (24%), Positives = 124/310 (40%), Gaps = 33/310 (10%)
Query: 593 FTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTL 650
++ + L+ + G FG V+ +L + +AVK+ Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 651 LSRIHHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 706
L + H N++QF+G + L+ F G+L + L ++W + I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHI 126
Query: 707 AEDAAKGIEYLHT-------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759
AE A+G+ YLH G PAI HRD+KS N+LL ++ A ++DFGL+ G S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 760 HVSSIVR-GTVGYLDPEY-----YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 813
+ + GT Y+ PE + + D+Y+ G++L EL S A
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP-VDEY 245
Query: 814 CRNIVQWAKLHIESGDIQGII-----DPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPS 867
+ H D+Q ++ P L D + M + E C R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 868 ISEVLKDIQD 877
V + I
Sbjct: 306 AGCVGERITQ 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 3e-70
Identities = 82/240 (34%), Positives = 125/240 (52%), Gaps = 6/240 (2%)
Query: 566 KEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDG 625
K H H + + + + A DI +++KIG+G FG V+ + G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-G 60
Query: 626 KEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683
++AVK+L + + EF EV ++ R+ H N+V F+G + +V E++ G+
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 743
L L+ + EQ ++ +RL +A D AKG+ YLH P I+HR+LKS N+L+DK
Sbjct: 121 LYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTV 178
Query: 744 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 803
KV DFGLS+ S GT ++ PE + +KSDVYSFGVIL EL + Q+
Sbjct: 179 KVCDFGLSRLKASTFLSSKS-AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 9e-63
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLV 660
LE+ IG GGFG VY G E+AVK + + E L + + H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
G C +E LV EF G L L +RI + A A+G+ YLH
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 721 CVPAIIHRDLKSSNILLDK--------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
+ IIHRDLKSSNIL+ + + K++DFGL++ + S G ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAA-GAYAWM 181
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELISGQE 803
PE + + SDV+S+GV+L EL++G+
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEV 212
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-62
Identities = 80/338 (23%), Positives = 141/338 (41%), Gaps = 59/338 (17%)
Query: 595 LSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI 654
+IE +E+ +G G FGVV K + K++A+K + S S ++ F E+ LSR+
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQLSRV 58
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
+H N+V+ G C LV E+ G+L L+G + ++G+
Sbjct: 59 NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGV 115
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMR-AKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
YLH+ A+IHRDLK N+LL K+ DFG + + +G+ ++
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMA 171
Query: 774 PEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833
PE + ++K DV+S+G+IL E+I+ ++ + ++ + I
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKP---------------FDEIGGPAFRIMWA 216
Query: 834 ID----PSLLDEYD------IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 883
+ P L+ + W + P RPS+ E++K + + R
Sbjct: 217 VHNGTRPPLIKNLPKPIESLMTRCWSKD--------P--SQRPSMEEIVKIMTH---LMR 263
Query: 884 EAAAARDGNSDDMSRNSLHSSLNVGSFGGTENFLSLDE 921
+D+ + SL G G E ++ E
Sbjct: 264 YFP-----GADEPLQYPCQHSLPPGEDGRVEPYVDFAE 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-62
Identities = 85/291 (29%), Positives = 137/291 (47%), Gaps = 45/291 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK-------REFTNEVTLLSRIHH 656
EK+IG GGFG+V+ G+L D +A+K L +G+ +EF EV ++S ++H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
N+V+ G +V EF+ G L L I W +L + D A GIEY
Sbjct: 83 PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEY 137
Query: 717 LHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
+ P I+HRDL+S NI L + AKV+DFGLS+ + H S + G +
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQW 192
Query: 772 LDPEYYISQQL--TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG- 828
+ PE +++ T+K+D YSF +IL +++G+ +G +++ + E G
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGL 247
Query: 829 --DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877
I P L + I+ W + P RP S ++K++ +
Sbjct: 248 RPTIPEDCPPRLRNV--IELCWSGD--------P--KKRPHFSYIVKELSE 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 4e-62
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 23/209 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 662
K+ G ++ G+ + G +I VKVL + + R+F E L H N++
Sbjct: 14 FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 663 LGYCQE--EGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYL 717
LG CQ L+ +M G+L L HE ++ + ++ A D A+G+ +L
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNVL-----HEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 777
HT P I L S ++++D+ M A++S + ++ PE
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG------RMYAPAWVAPEAL 180
Query: 778 ISQQL---TDKSDVYSFGVILLELISGQE 803
+ +D++SF V+L EL++ +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREV 209
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-61
Identities = 71/322 (22%), Positives = 122/322 (37%), Gaps = 46/322 (14%)
Query: 593 FTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--V 648
S+ L+ + IG G +G VY G L D + +AVKV + + Q F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRINWIKR 703
+ + H N+ +F+ + LV E+ NG+L ++L +W+
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSS 113
Query: 704 LEIAEDAAKGIEYLHT------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---- 753
+A +G+ YLHT PAI HRDL S N+L+ +SDFGLS
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 754 ---AVDGASHVSSIVRGTVGYLDPEY-------YISQQLTDKSDVYSFGVILLELISGQE 803
+ + GT+ Y+ PE + + D+Y+ G+I E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 804 AISNEKFGANCRNIVQW-AKLHIESGDIQGIID-----PSLLDEYDIQSMWKIEEKALM- 856
+ + + Q H D+Q ++ P + + S+ K +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 857 -CVLPHGHMRPSISEVLKDIQD 877
C R + + + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAE 315
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 3e-60
Identities = 70/205 (34%), Positives = 114/205 (55%), Gaps = 15/205 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 662
+ ++IGSG FG VY GK ++AVK+L + + + F NEV +L + H N++ F
Sbjct: 28 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+GY ++ V ++ +L HL+ E + K ++IA A+G++YLH
Sbjct: 86 MGYSTAPQLAI-VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA--- 138
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPE---YYI 778
+IIHRDLKS+NI L + K+ DFGL+ + SH + G++ ++ PE
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 779 SQQLTDKSDVYSFGVILLELISGQE 803
S + +SDVY+FG++L EL++GQ
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQL 223
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 7e-60
Identities = 61/290 (21%), Positives = 111/290 (38%), Gaps = 44/290 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 662
+ + IG G FG VY+G+ E+A++++ + F EV + H N+V F
Sbjct: 37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+G C ++ TL + + ++ K +IA++ KG+ YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA--- 148
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF----AVDGASHVSSIVRGTVGYLDPEYYI 778
I+H+DLKS N+ D + ++DFGL I G + +L PE
Sbjct: 149 KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 779 SQQL---------TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829
+ SDV++ G I EL + + + A + W + +G
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-----IIWQ---MGTGM 259
Query: 830 IQGIIDPSLLDEYD--IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877
+ + E + W E RP+ ++++ ++
Sbjct: 260 KPNLSQIGMGKEISDILLFCWAFE--------Q--EERPTFTKLMDMLEK 299
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-59
Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +G G FG ++ G+ + +K L + +R F EV ++ + H N+++F+
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
G ++ R + E++ GTL+ + + + + W +R+ A+D A G+ YLH+
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHS---M 127
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-------------VRGTVG 770
IIHRDL S N L+ ++ V+DFGL++ VD + + V G
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 804
++ PE + +K DV+SFG++L E+I A
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-55
Identities = 69/303 (22%), Positives = 126/303 (41%), Gaps = 45/303 (14%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 662
+ K+IG G +G V+ GK + G+++AVKV + + + E + + H N++ F
Sbjct: 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGF 96
Query: 663 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ + S L+ ++ NG+L ++L ++ L++A + G+ +LH
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 719 T-----GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVG 770
T PAI HRDLKS NIL+ K+ ++D GL+ + + V + GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 771 YLDPE------YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 824
Y+ PE Q +D+YSFG+IL E+ + + + + +
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 825 IESGDIQGIID--------PSLLDEYDIQSMWK--IEEKALMCVLPHGHMRPSISEVLKD 874
E D++ I+ P+ + + E C + R + V K
Sbjct: 272 YE--DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE----CWAHNPASRLTALRVKKT 325
Query: 875 IQD 877
+
Sbjct: 326 LAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-54
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 662
L + +G G +G V+ G + G+ +AVK+ +S + ++ + E + + H N++ F
Sbjct: 12 LLECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGF 67
Query: 663 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ S L+ + G+L ++L ++ + L I A G+ +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 719 T-----GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG--- 770
PAI HRDLKS NIL+ K+ + ++D GL+ + + VG
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 771 YLDPE------YYISQQLTDKSDVYSFGVILLELISG 801
Y+ PE + D+++FG++L E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 2e-52
Identities = 65/303 (21%), Positives = 128/303 (42%), Gaps = 45/303 (14%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 662
L++ IG G FG V+ GK + G+E+AVK+ +S + +R + E + + H N++ F
Sbjct: 46 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGF 101
Query: 663 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ ++ + LV ++ +G+L ++L + + +++A A G+ +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 156
Query: 719 -----TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVG 770
T PAI HRDLKS NIL+ K+ ++D GL+ + + GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 771 YLDPE------YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 824
Y+ PE + ++D+Y+ G++ E+ + + +
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 825 IESGDIQGI---------IDPSLLDEYDIQSMWK-IEEKALMCVLPHGHMRPSISEVLKD 874
+E +++ + I ++ M K + E C +G R + + K
Sbjct: 277 VE--EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE----CWYANGAARLTALRIKKT 330
Query: 875 IQD 877
+
Sbjct: 331 LSQ 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-42
Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 40/282 (14%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+ +IG G F VY G + E+A + ++ F E +L + H N+V+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 662 FLGY----CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 715
F + + VLV E M +GTLK +L + + + +W + +I + G++
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR--QILK----GLQ 143
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
+LHT P IIHRDLK NI + K+ D GL+ + AS +++ GT ++ P
Sbjct: 144 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT--LKRASFAKAVI-GTPEFMAP 199
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834
E Y ++ + DVY+FG+ +LE+ + E + C+N Q + + SG
Sbjct: 200 EMY-EEKYDESVDVYAFGMCMLEMATS------EYPYSECQNAAQIYRR-VTSGVKPASF 251
Query: 835 DPSLLDEYDIQSMWKIEEKA--LMCVLPHGHMRPSISEVLKD 874
+ E K C+ + R SI ++L
Sbjct: 252 -DKVAIP---------EVKEIIEGCIRQNKDERYSIKDLLNH 283
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-40
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGK-EIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 662
L ++IG G FG V+ G+L+ +AVK + K +F E +L + H N+V+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+G C ++ +V E + G L T R+ L++ DAA G+EYL + C
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-----VRGTVGYLDPEYY 777
IHRDL + N L+ + K+SDFG+S+ DG S V+ T PE
Sbjct: 235 ---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA----PEAL 287
Query: 778 ISQQLTDKSDVYSFGVILLELIS 800
+ + +SDV+SFG++L E S
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-38
Identities = 66/280 (23%), Positives = 121/280 (43%), Gaps = 46/280 (16%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+KIG G FG K +DG++ +K ++ S + + E EV +L+ + H N+VQ+
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 719
+E G +V ++ G L + + G L E +I +W ++ ++++H
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------CLALKHVHD 143
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
I+HRD+KS NI L K ++ DFG+++ + + GT YL PE +
Sbjct: 144 ---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICEN 199
Query: 780 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839
+ +KSD+++ G +L EL + + A I+ G P +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--------GSF-----PPVS 246
Query: 840 DEYD------IQSMWKIEEKALMCVLPHGHMRPSISEVLK 873
Y + ++K RPS++ +L+
Sbjct: 247 LHYSYDLRSLVSQLFKRNP----------RDRPSVNSILE 276
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-38
Identities = 73/262 (27%), Positives = 114/262 (43%), Gaps = 52/262 (19%)
Query: 568 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSD---IEDATKMLEKKIGSGGFGVVYYGKL-- 622
H H P + F D E+ +++G G FG V +
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDP 64
Query: 623 ---KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV--LVYE 677
G+ +AVK L ++ + R+F E+ +L + H N+V++ G C GR L+ E
Sbjct: 65 LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124
Query: 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNIL 736
++ G+L+++L H++RI+ IK L+ KG+EYL T IHRDL + NIL
Sbjct: 125 YLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKRY----IHRDLATRNIL 177
Query: 737 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-------------- 782
++ R K+ DFGL+K D EYY ++
Sbjct: 178 VENENRVKIGDFGLTKVLPQ----------------DKEYYKVKEPGESPIFWYAPESLT 221
Query: 783 ----TDKSDVYSFGVILLELIS 800
+ SDV+SFGV+L EL +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-38
Identities = 65/315 (20%), Positives = 118/315 (37%), Gaps = 40/315 (12%)
Query: 571 HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIA 629
S +Q P + + + KKIG G F VY L DG +A
Sbjct: 4 QSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIE--KKIGRGQFSEVYRAACLLDGVPVA 61
Query: 630 VK---VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 686
+K + + + + E+ LL +++H N++++ E+ +V E G L
Sbjct: 62 LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 121
Query: 687 HL-----YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 740
+ L E+ + + +L +E++H+ ++HRD+K +N+ +
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQL------CSALEHMHS---RRVMHRDIKPANVFITAT 172
Query: 741 MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
K+ D GL +F + S+V GT Y+ PE KSD++S G +L E+ +
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231
Query: 801 GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD--IQSMWKIEEKALMCV 858
Q F + N+ IE D + +E + +
Sbjct: 232 LQSP-----FYGDKMNLYS-LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP------ 279
Query: 859 LPHGHMRPSISEVLK 873
RP ++ V
Sbjct: 280 ----EKRPDVTYVYD 290
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 47/286 (16%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
IG+G +G + DGK + K S + K+ +EV LL + H N+V++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 664 GYCQEEGRSVL--VYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+ + L V E+ G L + E+ + L + ++
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-----LRVMTQLTLALKE 126
Query: 717 LHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
H ++HRDLK +N+ LD K+ DFGL++ S + V GT Y+ P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSP 185
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834
E +KSD++S G +L EL + F A + + A I G
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPP-----FTAF--SQKELAGK-IREGKF---- 233
Query: 835 DPSLLDEYD------IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
+ Y I M +++ + RPS+ E+L++
Sbjct: 234 -RRIPYRYSDELNEIITRMLNLKD----------YHRPSVEEILEN 268
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 49/222 (22%)
Query: 605 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 659
+++G G FG V + G+ +AVK L ++ + R+F E+ +L + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 660 VQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
V++ G C GR L+ E++ G+L+++L H++RI+ IK L+ KG+EYL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 718 HT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
T IHRDL + NIL++ R K+ DFGL+K D E+
Sbjct: 131 GTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQ----------------DKEF 170
Query: 777 YISQQ------------------LTDKSDVYSFGVILLELIS 800
+ ++ + SDV+SFGV+L EL +
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-37
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
LE K+G G FG V+ G +A+K L + F E ++ ++ H LVQ
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCVP 723
EE +V E+M G+L + L + + + +++A A G+ Y+
Sbjct: 247 VVSEEPI-YIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVERMN-- 300
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 301 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 784 DKSDVYSFGVILLELIS 800
KSDV+SFG++L EL +
Sbjct: 360 IKSDVWSFGILLTELTT 376
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 15/200 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
++IGSG FG+V+ G + ++A+K + + + +F E ++ ++ H LVQ G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
C E+ LV EFM +G L ++L T L + D +G+ YL CV
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEACV-- 125
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 780
IHRDL + N L+ ++ KVSDFG+++F +D +S + V+ PE +
Sbjct: 126 -IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS----PEVFSFS 180
Query: 781 QLTDKSDVYSFGVILLELIS 800
+ + KSDV+SFGV++ E+ S
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-37
Identities = 60/293 (20%), Positives = 108/293 (36%), Gaps = 44/293 (15%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+K+G GGF V + L DG A+K + + Q + E E + +H N+++ +
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 664 GYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
YC E + L+ F GTL + + + L + +G+E +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--------GTVGY 771
HRDLK +NILL + + D G A + T+ Y
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 772 LDPE---YYISQQLTDKSDVYSFGVILLELISGQ-----EAISNEKFGANCRNIVQWAKL 823
PE + +++DV+S G +L ++ G+ + +N + +
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQS 269
Query: 824 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876
S + ++ ++M V P H RP I +L ++
Sbjct: 270 PRHSSALWQLL------------------NSMMTVDP--HQRPHIPLLLSQLE 302
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 15/200 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
K++G+G FGVV YGK + ++A+K++ S + EF E ++ + H LVQ G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
C ++ ++ E+M NG L +L R + LE+ +D + +EYL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESKQF-- 141
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 780
+HRDL + N L++ KVSDFGLS++ +D +S S VR + PE +
Sbjct: 142 -LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEVLMYS 196
Query: 781 QLTDKSDVYSFGVILLELIS 800
+ + KSD+++FGV++ E+ S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 65/298 (21%), Positives = 106/298 (35%), Gaps = 58/298 (19%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
+ +G GGFGVV+ K K D A+K + N + + EV L+++ H +V++
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 665 YCQEEG---------RSVLVY---EFMHNGTLKEHL----YGTLTHEQRINWIKRLEIAE 708
E+ V +Y + LK+ + L I
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC-----LHIFL 125
Query: 709 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-----------FAVDG 757
A+ +E+LH+ ++HRDLK SNI KV DFGL
Sbjct: 126 QIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817
A + GT Y+ PE + K D++S G+IL EL+ F +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--------PFSTQMERV 234
Query: 818 VQWAKLHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
+ + + EY +Q M + P RP ++++
Sbjct: 235 RTLTD--VRNLKFPPLFTQKYPCEYVMVQDM--------LSPSP--MERPEAINIIEN 280
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-36
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
LE K+G G FG V+ G +A+K L + F E ++ ++ H LVQ
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCVP 723
EE +V E+M G+L + L + + + +++A A G+ Y+
Sbjct: 330 VVSEEPI-YIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVERMN-- 383
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 384 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 784 DKSDVYSFGVILLELIS 800
KSDV+SFG++L EL +
Sbjct: 443 IKSDVWSFGILLTELTT 459
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 65/200 (32%), Positives = 112/200 (56%), Gaps = 15/200 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L K++GSG FGVV GK K ++AVK++ S + EF E + ++ H LV+F G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
C +E +V E++ NG L +L +H + + + LE+ D +G+ +L +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQF-- 125
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 780
IHRDL + N L+D+ + KVSDFG++++ +D +S + V+ + PE +
Sbjct: 126 -IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA----PEVFHYF 180
Query: 781 QLTDKSDVYSFGVILLELIS 800
+ + KSDV++FG+++ E+ S
Sbjct: 181 KYSSKSDVWAFGILMWEVFS 200
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 22/226 (9%)
Query: 584 DAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNS 637
+AP +A +++ K +GSG FG VY G E +A+K L + S
Sbjct: 2 EAPNQALLRI----LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57
Query: 638 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 697
+ +E +E +++ + + ++ + LG C L+ + M G L +++ H+
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV---REHKDN 113
Query: 698 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757
I L AKG+ YL ++HRDL + N+L+ K++DFGL+K
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 758 ASHVSSIVRGT---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ G + ++ E + + T +SDV+S+GV + EL++
Sbjct: 171 EKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 50/223 (22%)
Query: 605 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRN 658
+ +G G FG V + G+++AVK L + + E+ +L ++H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 659 LVQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+V++ G C E+G + L+ EF+ +G+LKE+L ++ +IN ++L+ A KG++Y
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDY 141
Query: 717 LHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
L + +HRDL + N+L++ + K+ DFGL+K D E
Sbjct: 142 LGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAI----------------ETDKE 181
Query: 776 YYISQQL------------------TDKSDVYSFGVILLELIS 800
YY + SDV+SFGV L EL++
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 599 EDATKMLEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRI 654
D + + ++G G FG V G + K+ +A+KVL E E ++ ++
Sbjct: 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 67
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
+ +V+ +G CQ E +LV E G L + L + + I E+ + G+
Sbjct: 68 DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGM 123
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYL 772
+YL +HRDL + N+LL AK+SDFGLSK S+ ++ G + +
Sbjct: 124 KYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELIS 800
PE ++ + +SDV+S+GV + E +S
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 49/222 (22%)
Query: 605 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 659
++G G FG V + G +AVK L + +R+F E+ +L +H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 660 VQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
V++ G GR LV E++ +G L++ L H R++ + L + KG+EYL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYL 143
Query: 718 HT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
+ C +HRDL + NIL++ K++DFGL+K D +Y
Sbjct: 144 GSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPL----------------DKDY 183
Query: 777 YISQQL------------------TDKSDVYSFGVILLELIS 800
Y+ ++ + +SDV+SFGV+L EL +
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-36
Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
++ K+G G +G VY G K +AVK L ++ + EF E ++ I H NLVQ L
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 282
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCV 722
G C E ++ EFM G L ++L Q ++ + L +A + +EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKN- 338
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
IHR+L + N L+ ++ KV+DFGLS+ + + + + PE +
Sbjct: 339 --FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 783 TDKSDVYSFGVILLELIS 800
+ KSDV++FGV+L E+ +
Sbjct: 397 SIKSDVWAFGVLLWEIAT 414
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 7e-36
Identities = 72/341 (21%), Positives = 126/341 (36%), Gaps = 24/341 (7%)
Query: 466 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG 525
I + + P + L L V+ L L + + A N +
Sbjct: 212 LISQDKAGKYCIPEGTKFDTLWQL----VEYLKLKADGLIYCLKEACPNSSASNASGAAA 267
Query: 526 GRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDA 585
H + + L +P+ V +
Sbjct: 268 PTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSP-------DKPRPMPMDTSVFESPFS 320
Query: 586 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGK 641
E L D + + ++G G FG V G + K+ +A+KVL
Sbjct: 321 DPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT 380
Query: 642 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 701
E E ++ ++ + +V+ +G CQ E +LV E G L + L + + I
Sbjct: 381 EEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL---VGKREEIPVS 436
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761
E+ + G++YL +HR+L + N+LL AK+SDFGLSK S+
Sbjct: 437 NVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493
Query: 762 SSIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
++ G + + PE ++ + +SDV+S+GV + E +S
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-35
Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 15/199 (7%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
L + IG G FG V G + G ++AVK + +++ + F E ++++++ H NLVQ L
Sbjct: 196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLL 252
Query: 664 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
G +E+G +V E+M G+L ++L + L+ + D + +EYL
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN- 309
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQ 781
+HRDL + N+L+ + AKVSDFGL+K + V+ T PE ++
Sbjct: 310 --FVHRDLAARNVLVSEDNVAKVSDFGLTKE-ASSTQDTGKLPVKWTA----PEALREKK 362
Query: 782 LTDKSDVYSFGVILLELIS 800
+ KSDV+SFG++L E+ S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 63/261 (24%), Positives = 101/261 (38%), Gaps = 58/261 (22%)
Query: 567 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--- 623
H H + L P + + + +G G FG V
Sbjct: 3 HHHHHHHHHHGALEVLFQGPGDP------TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTN 56
Query: 624 DGKEI--AVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV--LVYEF 678
DG AVK L Q + + E+ +L ++H +++++ G C++ G + LV E+
Sbjct: 57 DGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116
Query: 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILL 737
+ G+L+++L I + L A+ +G+ YLH IHRDL + N+LL
Sbjct: 117 VPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQHY----IHRDLAARNVLL 167
Query: 738 DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL--------------- 782
D K+ DFGL+K EYY ++
Sbjct: 168 DNDRLVKIGDFGLAKAV----------------PEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 783 ---TDKSDVYSFGVILLELIS 800
SDV+SFGV L EL++
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 46/221 (20%)
Query: 604 MLEKKIGSGGFGVVYYGKLK--DGKEI--AVKVL---TSNSYQGKREFTNEVTLLSRIHH 656
L +K+G G FGVV G+ GK + AVK L + + +F EV + + H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
RNL++ G +V E G+L + L H+ A A+G+ Y
Sbjct: 81 RNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGY 136
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
L + IHRDL + N+LL K+ DFGL + + D Y
Sbjct: 137 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA---------------LPQNDDHY 178
Query: 777 YISQ-----------------QLTDKSDVYSFGVILLELIS 800
+ + + SD + FGV L E+ +
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 66/254 (25%), Positives = 120/254 (47%), Gaps = 29/254 (11%)
Query: 564 YDKEQHRHS-LPVQR---PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 619
Y H +P ++ P +A FT ++I + +K IG+G FG VY
Sbjct: 4 YHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLKFT-TEIHPSCVTRQKVIGAGEFGEVYK 62
Query: 620 GKLKDGKE-----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673
G LK +A+K L + + + + +F E ++ + H N+++ G + +
Sbjct: 63 GMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122
Query: 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 732
++ E+M NG L + L + + ++ + + A G++YL +HRDL +
Sbjct: 123 IITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANMNY----VHRDLAA 175
Query: 733 SNILLDKHMRAKVSDFGLSKFAVDG-----ASHVSSI-VRGTVGYLDPEYYISQQLTDKS 786
NIL++ ++ KVSDFGLS+ D + I +R T PE ++ T S
Sbjct: 176 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA----PEAISYRKFTSAS 231
Query: 787 DVYSFGVILLELIS 800
DV+SFG+++ E+++
Sbjct: 232 DVWSFGIVMWEVMT 245
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 603 KMLEKKIGSGGFGVVYYGKLKDGK---EIAVKVL--TSNSYQGKREFTNEVTLLSRIHHR 657
+ +K++GSG FG V G + K +AVK+L +N K E E ++ ++ +
Sbjct: 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 78
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
+V+ +G C+ E +LV E G L ++L + + +E+ + G++YL
Sbjct: 79 YIVRMIGICEAESW-MLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPE 775
+HRDL + N+LL AK+SDFGLSK ++ + G V + PE
Sbjct: 134 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 776 YYISQQLTDKSDVYSFGVILLELIS 800
+ + KSDV+SFGV++ E S
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 58/289 (20%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
+ IGSGGFG V+ K DGK +K + N + EV L+++ H N+V + G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGC 72
Query: 666 CQEEGRSVLVYEFMHNGTLKEHLY--------GTLTHEQRINWIKR-----------LEI 706
+ + + L+ GTL WI++ LE+
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ-----WIEKRRGEKLDKVLALEL 127
Query: 707 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766
E KG++Y+H+ +I+RDLK SNI L + K+ DFGL + S
Sbjct: 128 FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-- 182
Query: 767 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE-AISNEKFGANCRNIVQWAKLHI 825
GT+ Y+ PE SQ + D+Y+ G+IL EL+ + A KF + R+ +
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIF-- 240
Query: 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
+ ++ + L+ P RP+ SE+L+
Sbjct: 241 -DKKEKTLL------------------QKLLSKKP--EDRPNTSEILRT 268
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 67/269 (24%), Positives = 122/269 (45%), Gaps = 48/269 (17%)
Query: 557 HKGKKNNYDKEQHRHSLPVQRPV--SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGF 614
H + + + LP + + P A FT +IE + +EK IGSG
Sbjct: 4 HHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFT-REIEASRIHIEKIIGSGDS 62
Query: 615 GVVYYGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE 669
G V YG+L+ +++ A+K L + + + +R+F +E +++ + H N+++ G
Sbjct: 63 GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122
Query: 670 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRD 729
+++V E+M NG+L L TH+ + ++ + + G+ YL +HRD
Sbjct: 123 RLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---VHRD 176
Query: 730 LKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ-------- 781
L + N+L+D ++ KVSDFGLS+ D DP+ +
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRVLED----------------DPDAAYTTTGGKIPIRW 220
Query: 782 ----------LTDKSDVYSFGVILLELIS 800
+ SDV+SFGV++ E+++
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-35
Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 7/196 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
LEKK+G+G FG V+ ++AVK + F E ++ + H LV+
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
+E + + EFM G+L + L + K ++ + A+G+ ++
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN--- 304
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
IHRDL+++NIL+ + K++DFGL++ D + + + PE T
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 785 KSDVYSFGVILLELIS 800
KSDV+SFG++L+E+++
Sbjct: 365 KSDVWSFGILLMEIVT 380
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-35
Identities = 70/250 (28%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 565 DKEQHRHSLPVQRP-VSSLND-----APAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY 618
+K H + ++ P + + D P + H F +++ ++K +G+G FG V
Sbjct: 4 EKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVC 62
Query: 619 YGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673
G+LK KEI A+K L + + +R+F E +++ + H N+++ G + +
Sbjct: 63 SGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122
Query: 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 732
+V E+M NG+L L H+ + I+ + + A G++YL G V HRDL +
Sbjct: 123 IVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV----HRDLAA 175
Query: 733 SNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYISQQLTDKSDVYS 790
NIL++ ++ KVSDFGL + D + G + + PE ++ T SDV+S
Sbjct: 176 RNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWS 235
Query: 791 FGVILLELIS 800
+G++L E++S
Sbjct: 236 YGIVLWEVMS 245
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 659
L + +G G FG VY G G++I AVK + + K +F +E ++ + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
V+ +G +EE + ++ E G L +L ++ + + + + K + YL +
Sbjct: 76 VKLIGIIEEE-PTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 720 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL-----D 773
C +HRD+ NIL+ K+ DFGLS++ D + +V L
Sbjct: 132 INC----VHRDIAVRNILVASPECVKLGDFGLSRYIED-----EDYYKASVTRLPIKWMS 182
Query: 774 PEYYISQQLTDKSDVYSFGVILLELIS 800
PE ++ T SDV+ F V + E++S
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L +++G+G FG V+ G ++AVK L S F E L+ ++ H+ LV+
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
+E + + E+M NG+L + L ++ K L++A A+G+ ++
Sbjct: 76 VVTQEPIYI-ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERNY-- 130
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 780
IHRDL+++NIL+ + K++DFGL++ D A + ++ T PE
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYG 185
Query: 781 QLTDKSDVYSFGVILLELIS 800
T KSDV+SFG++L E+++
Sbjct: 186 TFTIKSDVWSFGILLTEIVT 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
++ K+G G +G VY G K +AVK L ++ + EF E ++ I H NLVQ L
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
G C E ++ EFM G L ++L + Q ++ + L +A + +EYL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKNF- 132
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
IHRDL + N L+ ++ KV+DFGLS+ + + + + PE + +
Sbjct: 133 --IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 784 DKSDVYSFGVILLELIS 800
KSDV++FGV+L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 659
L + IG G FG V+ G + +A+K + S + +F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
V+ +G E ++ E G L+ L + ++ + A + + YL +
Sbjct: 79 VKLIGVITEN-PVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 720 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
+HRD+ + N+L+ + K+ DFGLS++ D + +S + + ++ PE
Sbjct: 135 KRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190
Query: 779 SQQLTDKSDVYSFGVILLELIS 800
++ T SDV+ FGV + E++
Sbjct: 191 FRRFTSASDVWMFGVCMWEILM 212
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 60/275 (21%), Positives = 105/275 (38%), Gaps = 41/275 (14%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQF 662
++G G +G V+ + K DG+ AVK S + + EV ++ H V+
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+E G L E +L++H +G E ++ D + +LH+
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQV-----WGYLRDTLLALAHLHS- 175
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
++H D+K +NI L R K+ DFGL + A G Y+ PE +
Sbjct: 176 --QGLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQE-GDPRYMAPE-LLQG 230
Query: 781 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840
+DV+S G+ +LE+ E + W +L QG + P
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQL------RQGYLPPEFTA 275
Query: 841 EY--DIQSMWKIEEKALMCVLPHGHMRPSISEVLK 873
+++S+ M + P +R + +L
Sbjct: 276 GLSSELRSVLV------MMLEPDPKLRATAEALLA 304
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 64/199 (32%), Positives = 106/199 (53%), Gaps = 17/199 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L + IG G FG V G + G ++AVK + +++ + F E ++++++ H NLVQ LG
Sbjct: 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 81
Query: 665 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCV 722
+E+G +V E+M G+L ++L + L+ + D + +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 138
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQ 781
+HRDL + N+L+ + AKVSDFGL+K A + V+ T PE ++
Sbjct: 139 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASS-TQDTGKLPVKWTA----PEALREKK 190
Query: 782 LTDKSDVYSFGVILLELIS 800
+ KSDV+SFG++L E+ S
Sbjct: 191 FSTKSDVWSFGILLWEIYS 209
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 22/226 (9%)
Query: 584 DAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNS 637
+AP +A +++ K +GSG FG VY G E +A+K L + S
Sbjct: 2 EAPNQALLRI----LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57
Query: 638 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 697
+ +E +E +++ + + ++ + LG C L+ + M G L +++ H+
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV---REHKDN 113
Query: 698 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757
I L AKG+ YL ++HRDL + N+L+ K++DFGL+K
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 758 ASHVSSIVRGT---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
+ G + ++ E + + T +SDV+S+GV + EL++
Sbjct: 171 EKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-34
Identities = 74/284 (26%), Positives = 121/284 (42%), Gaps = 26/284 (9%)
Query: 529 AKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAE 588
A + + GS + + + + L+ G +N Y + + + + S+LN +
Sbjct: 22 AAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDL----SALNPELVQ 77
Query: 589 AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKRE 643
A + + IG G FG VY+G L D AVK L +
Sbjct: 78 AVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 136
Query: 644 FTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 702
F E ++ H N++ LG C + EG ++V +M +G L+ +
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKD 193
Query: 703 RLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761
+ AKG+++L + V HRDL + N +LD+ KV+DFGL++ D
Sbjct: 194 LIGFGLQVAKGMKFLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD- 248
Query: 762 SSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
S+ T L E +Q+ T KSDV+SFGV+L EL++
Sbjct: 249 -SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 659
+ K+G GG VY + ++A+K + + K E F EV S++ H+N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKRFEREVHNSSQLSHQNI 73
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
V + +E+ LV E++ TL E++ ++ + GI++ H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
I+HRD+K NIL+D + K+ DFG++K + + ++ V GTV Y PE
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 780 QQLTDKSDVYSFGVILLELISGQ 802
+ + +D+YS G++L E++ G+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGE 209
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 18/231 (7%)
Query: 580 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTS 635
S+LN +A + + IG G FG VY+G L D AVK L
Sbjct: 5 SALNPELVQAVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63
Query: 636 N-SYQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLT 693
+F E ++ H N++ LG C + EG ++V +M +G L+ +
Sbjct: 64 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RN 120
Query: 694 HEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
+ AKG++YL + V HRDL + N +LD+ KV+DFGL++
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLASKKFV----HRDLAARNCMLDEKFTVKVADFGLAR 176
Query: 753 FAVDG---ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
D + H + + V ++ E +Q+ T KSDV+SFGV+L EL++
Sbjct: 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 18/206 (8%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNSYQGKREFTNEVTLLSRIHHR 657
K +GSG FG V+ G E + +KV+ + Q + T+ + + + H
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
++V+ LG C LV +++ G+L +H+ H + L AKG+ YL
Sbjct: 76 HIVRLLGLCPGS-SLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT---VGYLDP 774
++HR+L + N+LL + +V+DFG++ + + ++
Sbjct: 132 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMAL 186
Query: 775 EYYISQQLTDKSDVYSFGVILLELIS 800
E + T +SDV+S+GV + EL++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 51/216 (23%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGK--------EIAVKVLTSNSYQGKREFTNEVTLLSRIH 655
+ + +G G F ++ G ++ E+ +KVL F +++S++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 656 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
H++LV G C ++LV EF+ G+L +L ++ IN + +LE+A+ A +
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMH 127
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMR--------AKVSDFGLSKFAVDGASHVSSIVRG 767
+L + IH ++ + NILL + K+SD G+S + I++
Sbjct: 128 FLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-----KDILQE 179
Query: 768 TVGYLDPE---YYISQQLTDKSDVYSFGVILLELIS 800
+ ++ PE + L +D +SFG L E+ S
Sbjct: 180 RIPWVPPECIENP--KNLNLATDKWSFGTTLWEICS 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 659
++ IG G FGVVY+G+ D + A+K L+ Q F E L+ ++H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 660 VQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ +G EG ++ +M +G L + + + ++ + A+G+EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 719 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT---VGYLDP 774
+HRDL + N +LD+ KV+DFGL++ +D + R V +
Sbjct: 142 EQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 775 EYYISQQLTDKSDVYSFGVILLELIS 800
E + + T KSDV+SFGV+L EL++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 59/257 (22%), Positives = 110/257 (42%), Gaps = 43/257 (16%)
Query: 578 PVSSLNDAPAEAAHCFTLS-DIEDATKMLE-----KKIGSGGFGVVYYGKLKDGKEIAVK 631
P+ S+ D + ++ L+ +++ K + + + G F + + KD K A+K
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALK 60
Query: 632 VLTSNSYQGKREFT-----------------NEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674
+ + KR+FT NE+ +++ I + + G +
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYI 120
Query: 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAII 726
+YE+M N ++ + + ++ I K Y+H I
Sbjct: 121 IYEYMENDSILKFD----EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NIC 174
Query: 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 784
HRD+K SNIL+DK+ R K+SDFG S++ VD S RGT ++ PE++ ++ +
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---RGTYEFMPPEFFSNESSYNGA 231
Query: 785 KSDVYSFGVILLELISG 801
K D++S G+ L +
Sbjct: 232 KVDIWSLGICLYVMFYN 248
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-33
Identities = 63/299 (21%), Positives = 103/299 (34%), Gaps = 53/299 (17%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 662
+ + + GGF VY + + G+E A+K L SN + R EV + ++ H N+VQF
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 663 LGYC-------QEEGRSVLVYEFMHNGTLKEHLYGTLTH----EQRINWIKRLEIAEDAA 711
L+ + G L E L + + L+I
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV-----LKIFYQTC 146
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI------- 764
+ ++++H P IIHRDLK N+LL K+ DFG + + S
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 765 ----VRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817
T Y PE Y + + +K D+++ G IL L Q +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265
Query: 818 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876
+ +I + + R SI+EV+ +Q
Sbjct: 266 YSIPPHDTQYTVFHSLIR--------------------AMLQVNPEERLSIAEVVHQLQ 304
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 659
L + +G GG V+ + L+D +++AVKVL ++ F E + ++H +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAI 74
Query: 660 VQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
V + E + +V E++ TL++ + E + + +E+ DA + +
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALN 130
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLD 773
+ H IIHRD+K +NI++ KV DFG+++ D + V ++ V GT YL
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 774 PEYYISQQLTDKSDVYSFGVILLELISGQ 802
PE + +SDVYS G +L E+++G+
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 67/306 (21%), Positives = 113/306 (36%), Gaps = 67/306 (21%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+G G FG V + D + A+K + ++ + +EV LL+ ++H+ +V++
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 664 GYCQEEGRSV-------------LVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIA 707
E V + E+ NGTL + + + +I
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR--QIL 126
Query: 708 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR- 766
E + Y+H+ IIHRDLK NI +D+ K+ DFGL+K + +
Sbjct: 127 E----ALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 767 ------------GTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISGQEAISNE 808
GT Y+ E +Y +K D+YS G+I E+I
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYP------- 227
Query: 809 KFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI 868
R + K + S I+ P D+ ++ KI L+ P + RP
Sbjct: 228 FSTGMERVNI-LKK--LRSVSIE---FPPDFDDNKMKVEKKIIRL-LIDHDP--NKRPGA 278
Query: 869 SEVLKD 874
+L
Sbjct: 279 RTLLNS 284
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 60/232 (25%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNL 659
+ IG G FG V ++K A+K + S R+F E+ +L ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLEIA 707
+ LG C+ G L E+ +G L + L + ++ + L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 708 EDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766
D A+G++YL IHRDL + NIL+ ++ AK++DFGLS+
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR-------------- 190
Query: 767 GTVGYLDPEYYISQQL------------------TDKSDVYSFGVILLELIS 800
E Y+ + + T SDV+S+GV+L E++S
Sbjct: 191 ------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 3e-32
Identities = 51/229 (22%), Positives = 97/229 (42%), Gaps = 19/229 (8%)
Query: 578 PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVL 633
P+ + IE L + IG G FG V+ G + +A+K
Sbjct: 372 DEEDTYTMPSTRDYEIQRERIE-----LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC 426
Query: 634 TSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL 692
+ S + +F E + + H ++V+ +G E ++ E G L+ L
Sbjct: 427 KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL---Q 482
Query: 693 THEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751
+ ++ + A + + YL + V HRD+ + N+L+ + K+ DFGLS
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESKRFV----HRDIAARNVLVSSNDCVKLGDFGLS 538
Query: 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 800
++ D + +S + + ++ PE ++ T SDV+ FGV + E++
Sbjct: 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-32
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 658
L+ ++G G FG V+ + + +AVK L S +++F E LL+ + H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-----------YGTLTHEQRINWIKRLEIA 707
+V+F G C E ++V+E+M +G L L G + + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 708 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 767
A G+ YL +HRDL + N L+ + + K+ DFG+S+ + G
Sbjct: 165 SQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----RVG 217
Query: 768 TVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
L PE + ++ T +SDV+SFGV+L E+ +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL---TSNSYQGKREFTNEV 648
+ L D E + + +G G FG VY + K +A+KVL + + EV
Sbjct: 6 WALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 708
+ S + H N+++ GY + R L+ E+ GT+ Y L + + +
Sbjct: 61 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYIT 116
Query: 709 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-- 766
+ A + Y H+ +IHRD+K N+LL K++DFG S H S R
Sbjct: 117 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV-------HAPSSRRTD 166
Query: 767 --GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
GT+ YL PE + +K D++S GV+ E + G
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 657
+ +++G G FG+VY G K + +A+K + S + + EF NE +++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------YGTLTHEQRINWIKRLEIAEDAA 711
++V+ LG + ++++ E M G LK +L + K +++A + A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
G+ YL+ +HRDL + N ++ + K+ DFG+++ + +G G
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET----DYYRKGGKGL 201
Query: 772 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
L PE T SDV+SFGV+L E+ +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 658
L++++G G FG V+ + + +AVK L + +++F E LL+ + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLEI 706
+V+F G C + ++V+E+M +G L + L + + + L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 707 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766
A A G+ YL + +HRDL + N L+ ++ K+ DFG+S+ +
Sbjct: 139 ASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RV 191
Query: 767 GTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
G L PE + ++ T +SDV+SFGVIL E+ +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 19/232 (8%)
Query: 580 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY 638
S + + D E +G G +G+VY G+ L + IA+K +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 639 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTL-TH 694
+ + E+ L + H+N+VQ+LG E G + E + G+L +G L +
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 695 EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKF 753
EQ I + + +I E G++YLH I+HRD+K N+L++ + K+SDFG SK
Sbjct: 121 EQTIGFYTK-QILE----GLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKR 172
Query: 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISGQ 802
+ GT+ Y+ PE I + +D++S G ++E+ +G+
Sbjct: 173 LAGINPCTET-FTGTLQYMAPE-IIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVL--TSNSYQGKREFTNEVTLLSRIHHRN 658
L K +G G FG V G LK +AVK + ++S + EF +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 659 LVQFLGYCQEEG-----RSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAA 711
+++ LG C E + +++ FM G L +L T + I L+ D A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
G+EYL +HRDL + N +L M V+DFGLSK G + +G +
Sbjct: 158 LGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAK 210
Query: 772 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
+ E + T KSDV++FGV + E+ +
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 29/216 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL--V 660
+ K+IGSGG V+ + + A+K L Q + NE+ L+++ + +
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ Y + +V E N L L ++ +R ++ K + E + +H
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLE----AVHTIH 144
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE-- 775
I+H DLK +N L+ M K+ DFG++ D S V GTV Y+ PE
Sbjct: 145 QH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 776 ---------YYISQQLTDKSDVYSFGVILLELISGQ 802
+++ KSDV+S G IL + G+
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 26/215 (12%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN--SYQGKREFTNEVTLLSRIHHRN 658
L + +G G FG V +LK +AVK+L ++ + EF E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 659 LVQFLGYCQEEGRSV------LVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDA 710
+ + +G ++ FM +G L L + + + D
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
A G+EYL + IHRDL + N +L + M V+DFGLS+ G + +G
Sbjct: 147 ACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCAS 199
Query: 771 YL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
L E T SDV++FGV + E+++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 657
L + +G G FG VY G++ ++AVK L S Q + +F E ++S+ +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGI 714
N+V+ +G + ++ E M G LK L + + + L +A D A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
+YL IHRD+ + N LL AK+ DFG+++ S +G
Sbjct: 154 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCAM 206
Query: 772 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
L PE ++ T K+D +SFGV+L E+ S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 35/221 (15%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL---TSNSYQGKREFTNEV 648
FT+ D + + + +G G FG VY + K +A+KVL + + E+
Sbjct: 11 FTIDDFD-----IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 65
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 708
+ S + H N+++ Y + R L+ EF G L Y L R + E
Sbjct: 66 EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFD--------E 113
Query: 709 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760
+ + Y H V IHRD+K N+L+ K++DFG S A
Sbjct: 114 QRSATFMEELADALHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170
Query: 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
GT+ YL PE + +K D++ GV+ E + G
Sbjct: 171 TMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 70/292 (23%), Positives = 117/292 (40%), Gaps = 52/292 (17%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRI--HHRNLV 660
+ K+IGSGG V+ + + A+K L Q + NE+ L+++ H ++
Sbjct: 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ Y + +V E N L L ++ +R ++ K + + + +H
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM------LEAVHTIH 125
Query: 719 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE- 775
G I+H DLK +N L+ M K+ DFG++ D S V GTV Y+ PE
Sbjct: 126 QHG----IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 776 ----------YYISQQLTDKSDVYSFGVILLELISGQ---EAISNEKFGANCRNIVQWAK 822
+++ KSDV+S G IL + G+ + I N+ + I+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAIID-PN 237
Query: 823 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
IE I + L D ++ K + K R SI E+L
Sbjct: 238 HEIE---FPDIPEKDLQDV--LKCCLKRDPK----------QRISIPELLAH 274
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-31
Identities = 67/267 (25%), Positives = 109/267 (40%), Gaps = 28/267 (10%)
Query: 555 FMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSD---IEDATKMLEKKIGS 611
F E L ++ N A ++SD + L + +G
Sbjct: 22 FQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGH 81
Query: 612 GGFGVVYYGKLKDGK------EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLG 664
G FG VY G++ ++AVK L S Q + +F E ++S+ +H+N+V+ +G
Sbjct: 82 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 141
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
+ ++ E M G LK L + + + L +A D A G +YL
Sbjct: 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 201
Query: 722 VPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL-----D 773
IHRD+ + N LL AK+ DFG+++ +G L
Sbjct: 202 ---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----GYYRKGGCAMLPVKWMP 254
Query: 774 PEYYISQQLTDKSDVYSFGVILLELIS 800
PE ++ T K+D +SFGV+L E+ S
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 51/234 (21%), Positives = 88/234 (37%), Gaps = 59/234 (25%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 657
+++G FG VY G L +A+K L + EF +E L +R+ H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLE 705
N+V LG ++ +++ + +G L E L T + + +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 706 IAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764
+ A G+EYL + V H+DL + N+L+ + K+SD GL +
Sbjct: 133 LVAQIAAGMEYLSSHHVV----HKDLATRNVLVYDKLNVKISDLGLFREVYAA------- 181
Query: 765 VRGTVGYLDPEYYISQQL------------------TDKSDVYSFGVILLELIS 800
+YY + SD++S+GV+L E+ S
Sbjct: 182 ----------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 60/262 (22%), Positives = 105/262 (40%), Gaps = 34/262 (12%)
Query: 560 KKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 619
K+ K + +H + A + A C + ++ + K+IGSGG V+
Sbjct: 18 KETAAAKFERQHMDSPDLGTDDDDKASSSANECIS---VKGRIYSILKQIGSGGSSKVFQ 74
Query: 620 GKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL--VQFLGYCQEEGRSVLV 675
+ + A+K L Q + NE+ L+++ + ++ Y + +V
Sbjct: 75 VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134
Query: 676 YEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 732
E N L L ++ +R ++ K + E + +H G I+H DLK
Sbjct: 135 MEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLE----AVHTIHQHG----IVHSDLKP 183
Query: 733 SNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE-----------YYISQ 780
+N L+ M K+ DFG++ D S V G V Y+ PE
Sbjct: 184 ANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
+++ KSDV+S G IL + G+
Sbjct: 243 KISPKSDVWSLGCILYYMTYGK 264
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFL 663
+ +G G G + Y + D +++AVK + + EV LL H N++++
Sbjct: 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRY- 83
Query: 664 GYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 720
+C E+ R + E TL+E++ + ++ + + + G+ +LH+
Sbjct: 84 -FCTEKDRQFQYIAIELC-AATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 721 CVPAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLD 773
I+HRDLK NIL+ ++A +SDFGL K G S V GT G++
Sbjct: 139 ----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 774 PEYY---ISQQLTDKSDVYSFGVILLELISG 801
PE + T D++S G + +IS
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 43/208 (20%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSN-----SYQGKREFTNEVTLLSRIHHRN 658
L + +G GG G VY + + +A+K+++ ++ + E R+ +
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR--MQREARTAGRLQEPH 95
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+V + + +G+ + ++ L L G L + + I ++
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRA------VAIVRQIGSALDA 149
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDP 774
H HRD+K NIL+ A + DFG++ A + + V GT+ Y+ P
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTV-GTLYYMAP 204
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQ 802
E + T ++D+Y+ +L E ++G
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGS 232
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 56/223 (25%), Positives = 105/223 (47%), Gaps = 34/223 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE--------IAVKVLTSN-SYQGKREFTNEVTLLSRI- 654
L K +G G FG V + + +AVK+L + + + + +E+ ++ I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 702
H+N++ LG C ++G ++ E+ G L+E+L E+++ +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
+ A+G+EYL + IHRDL + N+L+ ++ K++DFGL++ +
Sbjct: 159 LVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNI----D 211
Query: 763 SIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
+ T G L PE + T +SDV+SFGV++ E+ +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-30
Identities = 70/300 (23%), Positives = 117/300 (39%), Gaps = 54/300 (18%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFL 663
EK +G G G V + G+ +AVK + + E+ LL+ H N++++
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRY- 74
Query: 664 GYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYLH 718
YC E + E N L++ + ++ + K A G+ +LH
Sbjct: 75 -YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 719 TGCVPAIIHRDLKSSNILLD-------------KHMRAKVSDFGLSKFAVDGASHVSSIV 765
+ IIHRDLK NIL+ +++R +SDFGL K G S + +
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 766 R---GTVGYLDPE-------YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 815
GT G+ PE ++LT D++S G + ++S FG
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK----GKHPFGDKYS 245
Query: 816 NIVQWAKLHIESGDIQGIIDPSLLDE-YD-IQSMWKIEEKALMCVLPHGHMRPSISEVLK 873
+ +++ + D SL+ E D I M + P RP+ +VL+
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQM--------IDHDP--LKRPTAMKVLR 295
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 656
L K +G G FG V + +AVK+L ++ R +E+ +L I HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 657 RNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHL------------YGTLTHEQRINWIKR 703
N+V LG C + G ++V EF G L +L ++ +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 704 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 763
+ + AKG+E+L + IHRDL + NILL + K+ DFGL++
Sbjct: 151 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PD 203
Query: 764 IVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
VR L PE + T +SDV+SFGV+L E+ S
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 36/224 (16%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 656
K +G+G FG V + +AVK+L + + +E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------YGTLTHEQRINWIK 702
N+V LG C G ++++ E+ G L L E ++
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 703 RLEIAEDAAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761
L + AKG+ +L C IHRDL + NILL K+ DFGL++ +
Sbjct: 147 LLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKND---- 198
Query: 762 SSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
S+ V L PE + T +SDV+S+G+ L EL S
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 62/249 (24%), Positives = 108/249 (43%), Gaps = 13/249 (5%)
Query: 556 MHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFG 615
MH ++ + +L Q V + A D K IG G G
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVK-IGEGSTG 59
Query: 616 VVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674
+V + G+++AVK++ Q + NEV ++ H N+V+ +
Sbjct: 60 IVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119
Query: 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734
+ EF+ G L + + +E++I + + + YLH +IHRD+KS +
Sbjct: 120 LMEFLQGGALTDIVSQVRLNEEQIATVCE-----AVLQALAYLHA---QGVIHRDIKSDS 171
Query: 735 ILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-KSDVYSFGV 793
ILL R K+SDFG S+V GT ++ PE IS+ L + D++S G+
Sbjct: 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPE-VISRSLYATEVDIWSLGI 229
Query: 794 ILLELISGQ 802
+++E++ G+
Sbjct: 230 MVIEMVDGE 238
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 45/231 (19%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 657
L K +G G FG V K +AVK+L N S R+ +E +L +++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------------YGTLTHEQR 697
++++ G C ++G +L+ E+ G+L+ L E+
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 698 INWIKRLEIAEDAAKGIEYL---HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754
+ + A ++G++YL ++HRDL + NIL+ + + K+SDFGLS+
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMK------LVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 755 VDGASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
+ S V+ + G + E T +SDV+SFGV+L E+++
Sbjct: 201 YEE----DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 28/217 (12%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
L +G G V+ G+ K G A+KV + S+ + E +L +++H+N+V+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 663 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYL 717
+E VL+ EF G+L L + E D G+ +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 718 HTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
I+HR++K NI+ D K++DFG ++ D VS GT YL
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLH 183
Query: 774 PEYY--------ISQQLTDKSDVYSFGVILLELISGQ 802
P+ Y ++ D++S GV +G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLV 660
+ +G GGF + + A K++ + + + E+++ + H+++V
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
F G+ ++ +V E +L E LT + +++++ G +YLH
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------VLGCQYLH 132
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYY 777
V IHRDLK N+ L++ + K+ DFGL+ K DG GT Y+ PE
Sbjct: 133 RNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE-V 186
Query: 778 ISQQLTD-KSDVYSFGVILLELISG 801
+S++ + DV+S G I+ L+ G
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVG 211
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 34/223 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGK--------EIAVKVLTSN-SYQGKREFTNEVTLLSRI- 654
L K +G G FG V + ++AVK+L S+ + + + +E+ ++ I
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 702
H+N++ LG C ++G ++ E+ G L+E+L + E++++
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++
Sbjct: 193 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----D 245
Query: 763 SIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
+ T G L PE + T +SDV+SFGV+L E+ +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLV 660
+ +G GGF + + A K++ + + + E+++ + H+++V
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
F G+ ++ +V E +L E LT + +++++ G +YLH
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------VLGCQYLH 158
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYY 777
V IHRDLK N+ L++ + K+ DFGL+ K DG GT Y+ PE
Sbjct: 159 RNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE-V 212
Query: 778 ISQQLTD-KSDVYSFGVILLELISG 801
+S++ + DV+S G I+ L+ G
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVG 237
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-29
Identities = 45/207 (21%), Positives = 84/207 (40%), Gaps = 26/207 (12%)
Query: 605 LEKKIGSGGFGVVYYGK--LKDGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
++ I GG G +Y +G+ + +K L S + + E L+ + H ++VQ
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 662 FLGYCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+ + R +V E++ +LK L + I + + Y
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI------AYLLEILPALSY 197
Query: 717 LHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
LH+ G +++ DLK NI+L + + K+ D G ++ ++ GT G+ PE
Sbjct: 198 LHSIG----LVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY----GTPGFQAPE 247
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQ 802
+ T +D+Y+ G L L
Sbjct: 248 I-VRTGPTVATDIYTVGRTLAALTLDL 273
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 32/220 (14%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 656
K +G+G FG V + +AVK+L S K +E+ ++S + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------YGTLTHEQRINWIKRLEI 706
N+V LG C G +++ E+ G L L + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 707 AEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 765
+ A+G+ +L + C IHRD+ + N+LL AK+ DFGL++ ++ S+ +
Sbjct: 170 SSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMND----SNYI 221
Query: 766 RGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
L PE T +SDV+S+G++L E+ S
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLV 660
+ +G G F VY + + G E+A+K++ + + NEV + ++ H +++
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
+ Y ++ LV E HNG + +L + + +++ ++ G+ YL
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------ITGMLYL 128
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEY 776
H+ + +HRDL SN+LL ++M K++DFGL+ + + H + GT Y+ PE
Sbjct: 129 HSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPEI 183
Query: 777 YISQQLTDKSDVYSFGVILLELISG 801
+SDV+S G + L+ G
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-29
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 28/217 (12%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
L +G G V+ G+ K G A+KV + S+ + E +L +++H+N+V+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 663 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYL 717
+E VL+ EF G+L L + E D G+ +L
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 718 HTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
I+HR++K NI+ D K++DFG ++ D VS GT YL
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLH 183
Query: 774 PEYY--------ISQQLTDKSDVYSFGVILLELISGQ 802
P+ Y ++ D++S GV +G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-29
Identities = 56/226 (24%), Positives = 104/226 (46%), Gaps = 40/226 (17%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE--------IAVKVLTSN-SYQGKREFTNEVTLLSRI- 654
L K +G G FG V + + +AVK+L + + + + +E+ ++ I
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 702
H+N++ LG C ++G ++ E+ G L+E+L E+++ +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 703 RLEIAEDAAKGIEYL---HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759
+ A+G+EYL IHRDL + N+L+ ++ K++DFGL++ +
Sbjct: 205 LVSCTYQLARGMEYLASQK------CIHRDLAARNVLVTENNVMKIADFGLARDINNI-- 256
Query: 760 HVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
+ T G L PE + T +SDV+SFGV++ E+ +
Sbjct: 257 --DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
++G G FG V+ K + G + AVK + ++ E+ + + +V G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 666 CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
+E + E + G+L + + G L E R + A +G+EYLHT
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLP-EDRALYYLG-----QALEGLEYLHTRR-- 170
Query: 724 AIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSI----VRGTVGYLDPEYYI 778
I+H D+K+ N+LL RA + DFG + S + + GT ++ PE +
Sbjct: 171 -ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 779 SQQLTDKSDVYSFGVILLELISGQ 802
+ K D++S ++L +++G
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 39/228 (17%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 656
K +GSG FG V + +AVK+L + +E+ +++++ H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-------------YGTLTHEQRINWIKR 703
N+V LG C G L++E+ G L +L Y + +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 704 L------EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757
L A AKG+E+L +HRDL + N+L+ K+ DFGL++ +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 758 ASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
S+ V L PE T KSDV+S+G++L E+ S
Sbjct: 226 ----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-28
Identities = 27/271 (9%), Positives = 67/271 (24%), Gaps = 41/271 (15%)
Query: 566 KEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD- 624
+E + + V++ +L + L + + G VV+ + +
Sbjct: 27 EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVER 86
Query: 625 GKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLGYCQEEGRS--------- 672
++ A+KV T + + E +R+ + + + S
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 673 -----------------VLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
+L+ L L + + +
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
L + ++H N+ + R + D V Y
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW----KVGTRGPASSVPVTYAP 259
Query: 774 PEYYISQ--QLTDKSDVYSFGVILLELISGQ 802
E+ + T + + G+ + +
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 41/229 (17%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 657
+ IG G FG V+ + +AVK+L S + +F E L++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------------YGTLTHEQR 697
N+V+ LG C L++E+M G L E L +
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 698 INWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756
++ ++L IA A G+ YL V HRDL + N L+ ++M K++DFGLS+
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFV----HRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 757 GASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 800
+ PE + T +SDV+++GV+L E+ S
Sbjct: 227 A----DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
+++++G+GGFG V +D G+++A+K RE + E+ ++ +++H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 663 L------GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKG 713
+L E+ G L+++L + +K I D +
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL----NQFENCCGLKEGPIRTLLSDISSA 133
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
+ YLH IIHRDLK NI+L + + K+ D G +K G + V GT+
Sbjct: 134 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQ 188
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
YL PE ++ T D +SFG + E I+G
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 12/212 (5%)
Query: 594 TLSDIEDATKMLEK--KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTL 650
++ + D K + KIG G G VY + G+E+A++ + K NE+ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 651 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 710
+ + N+V +L +V E++ G+L + + T E +I + R +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----EC 125
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
+ +E+LH+ +IHRD+KS NILL K++DFG S S++V GT
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY 181
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
++ PE + K D++S G++ +E+I G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 63/338 (18%), Positives = 111/338 (32%), Gaps = 91/338 (26%)
Query: 606 EKKIGSGGFGVVYYGKLK-DGKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +G GGFGVV+ K K D A+K + N + + EV L+++ H +V++
Sbjct: 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 70
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI------------------------- 698
E E E L+ +
Sbjct: 71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130
Query: 699 -------------------NWIKR------------LEIAEDAAKGIEYLHTGCVPAIIH 727
+W+ R L I A+ +E+LH+ ++H
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMH 187
Query: 728 RDLKSSNILLDKHMRAKVSDFGLSK---FAVDGASHVSSIVR--------GTVGYLDPEY 776
RDLK SNI KV DFGL + + ++ + GT Y+ PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 777 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836
+ K D++S G+IL EL+ F + +
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYS--------FSTQMERVRIITDVR------NLKFPL 293
Query: 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
+Y + M + + ++ P RP ++++++
Sbjct: 294 LFTQKYPQEHMM-V--QDMLSPSP--TERPEATDIIEN 326
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-28
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 33/212 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLV 660
++ +G G FG V K K G+E AVKV++ + K + EV LL ++ H N++
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------- 712
+ + +++G LV E G L + I I R +E A
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFD----------EI--ISRKRFSEVDAARIIRQVLS 137
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
GI Y+H I+HRDLK N+LL K ++ DFGLS I GT
Sbjct: 138 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTA 192
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
Y+ PE + +K DV+S GVIL L+SG
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-28
Identities = 40/217 (18%), Positives = 69/217 (31%), Gaps = 22/217 (10%)
Query: 605 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 658
+ +G G F VY D ++ +KV + T + L
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
++F + SVLV E GTL + T E+ + + A IE +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRA-----------KVSDFGLSKFA-VDGASHVSSIV 765
H IIH D+K N +L + D G S + + +
Sbjct: 189 HDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 766 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
T G+ E ++ + D + + ++ G
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 61/295 (20%), Positives = 116/295 (39%), Gaps = 56/295 (18%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
++K+GSG FG V+ + + G E +K + + Q E E+ +L + H N+++
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 663 LGYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
++ +V E G L + L+ +K++ + Y
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM------MNALAY 139
Query: 717 LHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
H+ ++H+DLK NIL H K+ DFGL++ H ++ GT Y+
Sbjct: 140 FHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAA-GTALYM 193
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832
PE + +T K D++S GV++ L++G F ++
Sbjct: 194 APE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP-----F---------TGT------SLEE 232
Query: 833 IIDPSLLDEYDIQSMWK-IEEKA------LMCVLPHGHMRPSISEVLKD--IQDA 878
+ + E + + + +A ++ P RPS ++VL + A
Sbjct: 233 VQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDP--ERRPSAAQVLHHEWFKQA 285
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-28
Identities = 68/250 (27%), Positives = 103/250 (41%), Gaps = 34/250 (13%)
Query: 568 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGKLK-D 624
H H R F S ++M KK+GSG +G V + K
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 625 GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682
E A+K++ S EV +L + H N+++ + +++ LV E G
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSN 734
L + I I R++ E A G+ YLH I+HRDLK N
Sbjct: 122 ELFD----------EI--IHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPEN 166
Query: 735 ILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 791
+LL +K K+ DFGLS + + GT Y+ PE + ++ +K DV+S
Sbjct: 167 LLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPE-VLRKKYDEKCDVWSI 223
Query: 792 GVILLELISG 801
GVIL L++G
Sbjct: 224 GVILFILLAG 233
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +GSG F V+ K + GK A+K + + NE+ +L +I H N+V
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GIE 715
+ LV + + G L + RI ++R E DA+ ++
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFD----------RI--LERGVYTEKDASLVIQQVLSAVK 120
Query: 716 YLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
YLH G I+HRDLK N+L +++ + ++DFGLSK +G +S+ GT GY
Sbjct: 121 YLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGY 173
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISG 801
+ PE + + D +S GVI L+ G
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 27/213 (12%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 658
L + IG G F VV ++ G++ AVK+ TS+ + E ++ + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAK 712
+V+ L +G +V+EFM L + + ++++++ +
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI------LE 141
Query: 713 GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 768
+ Y H IIHRD+K +LL + K+ FG++ + V GT
Sbjct: 142 ALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
++ PE + DV+ GVIL L+SG
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 58/226 (25%), Positives = 107/226 (47%), Gaps = 20/226 (8%)
Query: 586 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF 644
E H D + +++ + +G G FG VY K + G A KV+ + S + ++
Sbjct: 5 SREYEHVRRDLDPNEVWEIVGE-LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY 63
Query: 645 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWI 701
E+ +L+ H +V+ LG +G+ ++ EF G + L LT E +I +
Sbjct: 64 IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT-EPQIQVV 122
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761
R + + +LH+ IIHRDLK+ N+L+ +++DFG+S +
Sbjct: 123 CR-----QMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174
Query: 762 SSIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 802
S + GT ++ PE + + + D K+D++S G+ L+E+ +
Sbjct: 175 DSFI-GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-27
Identities = 68/212 (32%), Positives = 97/212 (45%), Gaps = 34/212 (16%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 661
+ +G G FG V K + +E AVKV+ S + K EV LL ++ H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------G 713
++ +V E G L + I IKR +E DAA+ G
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFD----------EI--IKRKRFSEHDAARIIKQVFSG 133
Query: 714 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
I Y+H I+HRDLK NILL +K K+ DFGLS + + + GT
Sbjct: 134 ITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTA 187
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
Y+ PE + +K DV+S GVIL L+SG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 43/308 (13%), Positives = 86/308 (27%), Gaps = 61/308 (19%)
Query: 567 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDG 625
VS+ + + T + +G + G
Sbjct: 39 TSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETG 98
Query: 626 KEIAVKVLTSNSYQG-------KRE---------------------FTNEVTLLSRIHHR 657
+ V V K E F L+ +
Sbjct: 99 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158
Query: 658 NLVQFLGYCQEEGRS--VLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
+++ ++ +Y M T E L + + + RL++ +
Sbjct: 159 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 218
Query: 714 IEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
+ LH G ++H L+ +I+LD+ ++ F DGA VS + G+
Sbjct: 219 LASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR--DGARVVS---SVSRGFE 269
Query: 773 DPEYYISQQL-----------TDKSDVYSFGVILLELISGQ-------EAISNEKFGANC 814
PE + T D ++ G+++ + +E +C
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC 329
Query: 815 RNIVQWAK 822
+NI Q +
Sbjct: 330 KNIPQPVR 337
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 56/246 (22%), Positives = 99/246 (40%), Gaps = 37/246 (15%)
Query: 572 SLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AV 630
+ P S + P D + K +G G F V + A+
Sbjct: 6 AEPRPGAGSLQHAQPPPQPRKKRPEDFK-----FGKILGEGSFSTVVLARELATSREYAI 60
Query: 631 KVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH 687
K+L + + E ++SR+ H V+ Q++ + + NG L ++
Sbjct: 61 KILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 120
Query: 688 LYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDK 739
+ + E + +EYLH IIHRDLK NILL++
Sbjct: 121 IR----KIGSFD--------ETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNE 165
Query: 740 HMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILL 796
M +++DFG +K + +S V GT Y+ PE ++++ KS D+++ G I+
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPE-LLTEKSACKSSDLWALGCIIY 223
Query: 797 ELISGQ 802
+L++G
Sbjct: 224 QLVAGL 229
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 2/94 (2%)
Query: 416 PSITVIHLSSKN-LTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDN 473
P + +++ N L G IP + KL+ L L++ +++G IPDF S L + N
Sbjct: 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
L+G LP S+ +LPNL + N +SG +P S
Sbjct: 136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-26
Identities = 29/107 (27%), Positives = 44/107 (41%), Gaps = 1/107 (0%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 476
++ + LS L G+ + ++ L NSL + +L + L +N++
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY 257
Query: 477 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGNINL 522
G LP L L L L V N L G +P L + V YA N L
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 40/145 (27%), Positives = 64/145 (44%), Gaps = 9/145 (6%)
Query: 382 SVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP-SITVIHLSSKNLTG--NIPSDLTK 438
+ + + + W C W + C++D Q + + LS NL IPS L
Sbjct: 17 DLGNPTTLSSWL--PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN 74
Query: 439 LSSLVELWL-DGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496
L L L++ N+L GPIP + L +++ ++G +P L + L L
Sbjct: 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134
Query: 497 NMLSGTVPSSL--LSKNVVLNYAGN 519
N LSGT+P S+ L V + + GN
Sbjct: 135 NALSGTLPPSISSLPNLVGITFDGN 159
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 28/109 (25%), Positives = 55/109 (50%), Gaps = 12/109 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ 474
+ ++++ N++G IP L+++ +LV L N+L+G +P S P+L I + N+
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 475 LTGPLPSSLMNLPNLRE-LYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 522
++G +P S + L + + N L+G +P + N+NL
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF----------ANLNL 199
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 21/91 (23%), Positives = 37/91 (40%), Gaps = 1/91 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVE-LWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 474
P++ I ++G IP S L + + N LTG IP +L + L N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM 208
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 505
L G + N +++++ N L+ +
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 2/68 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ + L + + G +P LT+L L L + N+L G IP + +N+
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 476 T--GPLPS 481
PLP+
Sbjct: 304 LCGSPLPA 311
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-FTNEVT- 649
D+E ++G G +GVV + G+ +AVK + + +++ ++
Sbjct: 4 VKADDLEP-----IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI 58
Query: 650 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIA 707
+ + V F G EG + E M + +L + + Q I + + + IA
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IA 115
Query: 708 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 767
K +E+LH+ ++IHRD+K SN+L++ + K+ DFG+S + VD + G
Sbjct: 116 VSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--G 171
Query: 768 TVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 802
Y+ PE I+ +L KSD++S G+ ++EL +
Sbjct: 172 CKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 45/223 (20%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-------------TSNSYQGKREFTNEVTL 650
+K+GSG +G V K K E A+KV+ N + E NE++L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 651 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 710
L + H N+++ +++ LV EF G L E +I I R + E
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE----------QI--INRHKFDECD 147
Query: 711 AK--------GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGA 758
A GI YLH I+HRD+K NILL + + K+ DFGLS F
Sbjct: 148 AANIMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD- 202
Query: 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
+ + GT Y+ PE + ++ +K DV+S GVI+ L+ G
Sbjct: 203 YKLRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 49/210 (23%), Positives = 78/210 (37%), Gaps = 32/210 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
LE IG G +G V K A K + + F E+ ++ + H N+++
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 715
++ LV E G L E R+ + + E A +
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFE----------RV--VHKRVFRESDAARIMKDVLSAVA 120
Query: 716 YLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
Y H + HRDLK N L K+ DFGL+ G + + V GT Y
Sbjct: 121 YCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKV-GTPYY 174
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISG 801
+ P+ + + D +S GV++ L+ G
Sbjct: 175 VSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-26
Identities = 22/118 (18%), Positives = 50/118 (42%), Gaps = 4/118 (3%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG 461
W+ + + + +S ++G++ +++ +L L + N+ + IP
Sbjct: 166 ANVVGWVLSDGCG--ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGD 221
Query: 462 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
C L+ + + N+L+G ++ L+ L + +N G +P L L+ A N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAEN 279
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-25
Identities = 39/111 (35%), Positives = 54/111 (48%), Gaps = 4/111 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+ +HLS L+G IPS L LS L +L L N L G IP L + L+ N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLH 523
LTG +PS L N NL + + NN L+G +P + L +L + N +
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN-SFS 527
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-24
Identities = 37/121 (30%), Positives = 57/121 (47%), Gaps = 6/121 (4%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFS 460
P+ + Q P+ ++ ++L + TG IP L+ S LV L L N L+G IP
Sbjct: 383 PILPNLCQN---PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 461 GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAG 518
LR + L N L G +P LM + L L + N L+G +PS L + ++ +
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 519 N 519
N
Sbjct: 500 N 500
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-24
Identities = 31/128 (24%), Positives = 58/128 (45%), Gaps = 3/128 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ 474
++ + L +LTG IPS L+ ++L + L N LTG IP +L I+ L +N
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGGRGAKHL 532
+G +P+ L + +L L + N+ +GT+P+++ S + N+
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK 585
Query: 533 NIIIGSSV 540
++
Sbjct: 586 ECHGAGNL 593
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-23
Identities = 39/95 (41%), Positives = 54/95 (56%), Gaps = 3/95 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 472
S+ + LSS N +G I +L ++L EL+L N TG IP S C +L +HL
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
N L+G +PSSL +L LR+L + NML G +P L
Sbjct: 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-23
Identities = 38/124 (30%), Positives = 57/124 (45%), Gaps = 13/124 (10%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPD-F 459
P+P L S+ + L+ TG IP L+ +L L L GN G +P F
Sbjct: 262 PIPPLPL-------KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314
Query: 460 SGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYVQNNMLSGTVPSSL--LSKN-VVLN 515
C L + L N +G LP +L+ + L+ L + N SG +P SL LS + + L+
Sbjct: 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 374
Query: 516 YAGN 519
+ N
Sbjct: 375 LSSN 378
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-22
Identities = 31/97 (31%), Positives = 42/97 (43%), Gaps = 4/97 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG--CPDLRIIHLEDN 473
+ ++++SS G IP L SL L L N TG IPDF C L + L N
Sbjct: 247 TELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
G +P + L L + +N SG +P L K
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-20
Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ + LSS N +G +P D L K+ L L L N +G +P+ + L + L
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 473 NQLTGPLPSSLMN--LPNLRELYVQNNMLSGTVPSSL 507
N +GP+ +L L+ELY+QNN +G +P +L
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 7e-20
Identities = 36/128 (28%), Positives = 53/128 (41%), Gaps = 16/128 (12%)
Query: 390 ADWAQEGGDPCLPVPWSWL--QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVE 444
DW +PC ++ C D +T I LSSK L + S L L+ L
Sbjct: 31 PDW-SSNKNPC-----TFDGVTCRDD---KVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81
Query: 445 LWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS--SLMNLPNLRELYVQNNMLSGT 502
L+L + + G + F L + L N L+GP+ + SL + L+ L V +N L
Sbjct: 82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFP 141
Query: 503 VPSSLLSK 510
S K
Sbjct: 142 GKVSGGLK 149
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-19
Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 7/111 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTG--PIPDFSGCPDLRIIHLE 471
S+T + LS +L+G + + L S L L + N+L + L ++ L
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159
Query: 472 DNQLTGPLPSSLM---NLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
N ++G + L+ L + N +SG V S L+ + N
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSN 210
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-18
Identities = 32/108 (29%), Positives = 50/108 (46%), Gaps = 2/108 (1%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQL 475
S+ + +S L+G IP ++ + L L L N ++G IPD L I+ L N+L
Sbjct: 633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 692
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSS-LLSKNVVLNYAGNINL 522
G +P ++ L L E+ + NN LSG +P + N L
Sbjct: 693 DGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGL 740
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-16
Identities = 18/97 (18%), Positives = 37/97 (38%), Gaps = 1/97 (1%)
Query: 412 SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHL 470
+D + G L +LS+ + G F + + +
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639
Query: 471 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
N L+G +P + ++P L L + +N +SG++P +
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-13
Identities = 17/102 (16%), Positives = 33/102 (32%), Gaps = 5/102 (4%)
Query: 423 LSSKNLTGNIPSDLTKLSSLVELWLDGN--SLTGPIP-DFSGCPDLRIIHLEDNQLTGPL 479
+++ + G + E GN G + ++ G
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 480 PSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
+ N ++ L + NMLSG +P + + +LN N
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-04
Identities = 14/56 (25%), Positives = 26/56 (46%), Gaps = 4/56 (7%)
Query: 468 IHLEDNQLT---GPLPSSLMNLPNLRELYVQNNMLSGTVPS-SLLSKNVVLNYAGN 519
I L L + SSL++L L L++ N+ ++G+V + L+ + N
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRN 110
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-26
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 664
+G GGFG V+ ++K ++ A K L + ++ + E +L+++H R +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LA 251
Query: 665 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 715
Y + + LV M+ G ++ H+Y E A G+E
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ--------EPRAIFYTAQIVSGLE 303
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH II+RDLK N+LLD ++SD GL+ G + GT G++ PE
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQ 802
+ ++ D ++ GV L E+I+ +
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 18/230 (7%)
Query: 576 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 634
QR + D E ++G+G GVV+ K + A K++
Sbjct: 13 QRKRLEAFLTQKQKVGELKDDDFE-----KISELGAGNGGVVFKVSHKPSGLVMARKLIH 67
Query: 635 SNSYQGKREF-TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-YGTL 692
R E+ +L + +V F G +G + E M G+L + L
Sbjct: 68 LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR 127
Query: 693 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
EQ + +++ KG+ YL I+HRD+K SNIL++ K+ DFG+S
Sbjct: 128 IPEQILG-----KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
+D S +S V GT Y+ PE + +SD++S G+ L+E+ G+
Sbjct: 181 QLID--SMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-26
Identities = 47/206 (22%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +++GSG FGVV+ K G+ K + + K NE+++++++HH L+
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 664 GYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
+++ VL+ EF+ G L +++ + + IN+++ + E G++++
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKM---SEAEVINYMR--QACE----GLKHM 165
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
H +I+H D+K NI+ + + K+ DFGL+ + + T + PE
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPE 220
Query: 776 YYISQQLTDKSDVYSFGVILLELISG 801
+ + +D+++ GV+ L+SG
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV--------LTSNSYQGKRE-FTNEVTLLSRI 654
++ +G G VV K KE AVK+ ++ Q RE EV +L ++
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 655 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 712
H N++Q + LV++ M G L + + +++ ++E +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD----------YL--TEKVTLSEKETRK 128
Query: 713 -------GIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764
I LH I+HRDLK NILLD M K++DFG S +D + +
Sbjct: 129 IMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGEKLREV 183
Query: 765 VRGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISG 801
GT YL PE + D++S GVI+ L++G
Sbjct: 184 C-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 66/212 (31%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 661
+ +G G FG V K + +E AVKV+ S + K EV LL ++ H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 713
++ +V E G L + I IKR +E A G
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFD----------EI--IKRKRFSEHDAARIIKQVFSG 133
Query: 714 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
I Y+H I+HRDLK NILL +K K+ DFGLS + + + GT
Sbjct: 134 ITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTA 187
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
Y+ PE + +K DV+S GVIL L+SG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 58/201 (28%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
+KIG G FG V+ G + K +A+K++ + + E E+T+LS+ + ++
Sbjct: 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
G ++ + ++ E++ G+ + L E +I I R + KG++YLH+
Sbjct: 86 YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE-- 138
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
IHRD+K++N+LL +H K++DFG++ D ++ V GT ++ PE I Q
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE-VIKQSA 195
Query: 783 TD-KSDVYSFGVILLELISGQ 802
D K+D++S G+ +EL G+
Sbjct: 196 YDSKADIWSLGITAIELARGE 216
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 71/310 (22%), Positives = 114/310 (36%), Gaps = 54/310 (17%)
Query: 596 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRI 654
ED ++ E +G G V +E AVK++ + EV +L +
Sbjct: 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQC 67
Query: 655 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK 712
HRN+++ + + +EE R LV+E M G++ I KR E +A+
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS----------HI--HKRRHFNELEASV 115
Query: 713 -------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVS 762
+++LH I HRDLK NIL ++ K+ DF L
Sbjct: 116 VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 763 SIVR------GTVGYLDPE----YYISQQLTDKS-DVYSFGVILLELISGQEAISNEKFG 811
G+ Y+ PE + + DK D++S GVIL L+SG F
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP-----FV 227
Query: 812 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQS-MWK-IEEKA------LMCVLPHGH 863
C + W + + + +Y+ W I A L+
Sbjct: 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDA--K 285
Query: 864 MRPSISEVLK 873
R S ++VL+
Sbjct: 286 QRLSAAQVLQ 295
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-26
Identities = 56/258 (21%), Positives = 112/258 (43%), Gaps = 24/258 (9%)
Query: 557 HKGKKNNYDKEQHRHSLPVQRPVSSLNDAP-AEAAHCFTLSDIEDATK------MLEKKI 609
+ ++ YD ++ + + VSS D + + +E + +++
Sbjct: 106 ERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEEL 165
Query: 610 GSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE 668
G+G FGVV+ + G A K + + K E+ +S + H LV ++
Sbjct: 166 GTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED 225
Query: 669 EGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 725
+ V++YEFM G L E + + ++ ++ + +++ ++ + G+ ++H
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR--QVCK----GLCHMHEN---NY 276
Query: 726 IHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
+H DLK NI+ K+ DFGL+ +D V GT + PE + +
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTT-GTAEFAAPEVAEGKPVG 334
Query: 784 DKSDVYSFGVILLELISG 801
+D++S GV+ L+SG
Sbjct: 335 YYTDMWSVGVLSYILLSG 352
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 22/225 (9%)
Query: 588 EAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREF 644
E FT D++ +IG G +G V K G+ +AVK T + + K+
Sbjct: 14 EQHWDFTAEDLK-----DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL 68
Query: 645 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIK 702
+ ++ +VQF G EG + E M K + Y + I +
Sbjct: 69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
+ I K + +L IIHRD+K SNILLD+ K+ DFG+S VD +
Sbjct: 129 K--ITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184
Query: 763 SIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 802
G Y+ PE I + +SDV+S G+ L EL +G+
Sbjct: 185 DA--GCRPYMAPE-RIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 52/296 (17%), Positives = 109/296 (36%), Gaps = 62/296 (20%)
Query: 607 KKIGSGGFGVVYYG-KLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 662
+KIGSG FG V+ K DG A+K ++ EV + + H ++V++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
E+ ++ E+ + G+L + + + ++ +G+ Y+H+
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--- 133
Query: 723 PAIIHRDLKSSNILLDKH-------------------MRAKVSDFGLSKFAVDGASHVSS 763
+++H D+K SNI + + + K+ D G + +SS
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH-------VTRISS 186
Query: 764 --IVRGTVGYLDPEYYISQQL--TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
+ G +L E + + K+D+++ + ++ + N Q
Sbjct: 187 PQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---------Q 236
Query: 820 WAKLHIESGDIQGIIDPSLLDEY--DIQSMWKIEEKALMCVLPHGHMRPSISEVLK 873
W + I G + P + + + K + + P RPS ++K
Sbjct: 237 WHE--IRQGRL-----PRIPQVLSQEFTELLK------VMIHPDPERRPSAMALVK 279
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 55/247 (22%), Positives = 83/247 (33%), Gaps = 54/247 (21%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 658
L+ IG G +GVV A+K+ + + + EV L+ ++HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------------------------YG 690
+ + ++E LV E H G L + L
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 691 TLTHEQRINWIKRLEIAEDAAK--------GIEYLHT-GCVPAIIHRDLKSSNILL--DK 739
E + YLH G I HRD+K N L +K
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTNK 205
Query: 740 HMRAKVSDFGLSKFAVDGASHVSSIVR---GTVGYLDPE--YYISQQLTDKSDVYSFGVI 794
K+ DFGLSK + + GT ++ PE ++ K D +S GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 795 LLELISG 801
L L+ G
Sbjct: 266 LHLLLMG 272
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 30/239 (12%)
Query: 583 NDAPAEAAHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQ 639
+D+PA + LS + D + L + +G+G +G VY G+ +K G+ A+KV+
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-D 62
Query: 640 GKREFTNEVTLLSRI-HHRNLVQFLG-YCQEEGRSV-----LVYEFMHNGT----LKEHL 688
+ E E+ +L + HHRN+ + G + ++ + LV EF G+ +K
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 689 YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 748
TL E+ I +I R + +G+ +LH V IHRD+K N+LL ++ K+ DF
Sbjct: 123 GNTLK-EEWIAYICR-----EILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDF 173
Query: 749 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 802
G+S ++ + GT ++ PE + D KSD++S G+ +E+ G
Sbjct: 174 GVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 25/219 (11%)
Query: 596 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEV 648
S +ED + + +++GSG F +V + K GKE A K + +S + E EV
Sbjct: 1 SMVEDHYE-MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEI 706
+L I H N++ + + VL+ E + G L + L +LT ++ ++K +I
Sbjct: 60 NILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK--QI 117
Query: 707 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVS 762
+ G+ YLH+ I H DLK NI+L + R K+ DFG++ ++ +
Sbjct: 118 LD----GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFK 169
Query: 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
+I GT ++ PE + L ++D++S GVI L+SG
Sbjct: 170 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 657
+ +++GSG F +V + K G E A K + S + E EV++L ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 715
N++ + VL+ E + G L + L +L+ E+ ++IK +I + G+
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--QILD----GVN 129
Query: 716 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
YLHT I H DLK NI+L K+ DFGL+ ++ +I GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEF 184
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISG 801
+ PE + L ++D++S GVI L+SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 609 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 664
+G GGFG V +++ ++ A K L + ++ NE +L +++ R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 250
Query: 665 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTH---EQRINWIKRLEIAEDAAKGIEYLHTG 720
Y + + LV M+ G LK H+Y E R AE G+E LH
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA----VFYAAE-ICCGLEDLHRE 305
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I++RDLK NILLD H ++SD GL+ +G + + V GTVGY+ PE ++
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 360
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
+ T D ++ G +L E+I+GQ
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQ 382
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 596 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLS 652
+ + + K++G G F VV K G+E A K L + E +E+ +L
Sbjct: 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE 83
Query: 653 RI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIA 707
++ + +L+ E+ G + L ++ I IK +I
Sbjct: 84 LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK--QIL 141
Query: 708 EDAAKGIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 763
E G+ YLH I+H DLK NILL K+ DFG+S+ + A +
Sbjct: 142 E----GVYYLHQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHACELRE 192
Query: 764 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
I+ GT YL PE +T +D+++ G+I L++
Sbjct: 193 IM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 28/235 (11%), Positives = 59/235 (25%), Gaps = 43/235 (18%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIH--- 655
+G + G+ V V K E L +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 656 ---------------HRNLVQFLGYCQEEGRSVLVYEF-------MHNGTLKEHLYGTLT 693
+ + +E ++ F + T E L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 694 HEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
+ + RL++ + + LH G ++H L+ +I+LD+ ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQ-----LTDKSDVYSFGVILLELISGQ 802
A Q +T D ++ G+ + +
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 657
+ +++GSG F +V + K G E A K + S + E EV++L ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 715
N++ + VL+ E + G L + L +L+ E+ ++IK +I + G+
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--QILD----GVN 129
Query: 716 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
YLHT I H DLK NI+L K+ DFGL+ ++ +I GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEF 184
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISG 801
+ PE + L ++D++S GVI L+SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 604 MLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 662
+ +K+G G +G VY + G+ +A+K + +E E++++ + ++V++
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKY 89
Query: 663 LGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
G + +V E+ G++ TLT E I I + KG+EYLH
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT-EDEIATILQ-----STLKGLEYLHF 143
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
IHRD+K+ NILL+ AK++DFG++ D + ++++ GT ++ PE
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQE 199
Query: 780 QQLTDKSDVYSFGVILLELISGQ 802
+D++S G+ +E+ G+
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGK 222
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-25
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIH---HRNL 659
+ IG GGFG VY + D ++ A+K L + K+ T NE +LS + +
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 660 VQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEY 716
V + Y + + + M+ G L HL G + E + R AE G+E+
Sbjct: 255 VC-MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADM----RFYAAE-IILGLEH 307
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
+H +++RDLK +NILLD+H ++SD GL+ H + V GT GY+ PE
Sbjct: 308 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEV 361
Query: 777 YISQQLTDKS-DVYSFGVILLELISGQ 802
D S D +S G +L +L+ G
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 63/252 (25%), Positives = 111/252 (44%), Gaps = 30/252 (11%)
Query: 566 KEQHRHSLPVQRPVSSLNDAPAEAA---HCFTLS---DIEDATKMLEKK-IGSGGFGVVY 618
R + +R + D PA A H + + + + + +G G FG V+
Sbjct: 47 DLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVH 106
Query: 619 YGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677
+ G ++A K++ + + K E NE+++++++ H NL+Q + + VLV E
Sbjct: 107 KCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166
Query: 678 FMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 731
++ G L + + T I ++K +I E GI ++H I+H DLK
Sbjct: 167 YVDGGELFDRIIDESYNL---TELDTILFMK--QICE----GIRHMHQM---YILHLDLK 214
Query: 732 SSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVY 789
NIL K+ DFGL++ + GT +L PE ++ +D++
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARR-YKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMW 272
Query: 790 SFGVILLELISG 801
S GVI L+SG
Sbjct: 273 SVGVIAYMLLSG 284
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
L++ IGSG VV +++A+K + Q + E+ +S+ HH N+V +
Sbjct: 19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78
Query: 663 LGYCQEEGRSVLVYEFMHNGTL----------KEHLYGTLTHEQRINWIKRLEIAEDAAK 712
+ LV + + G++ EH G L E I I R + +
Sbjct: 79 YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILR-----EVLE 132
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VG- 770
G+EYLH IHRD+K+ NILL + +++DFG+S F G + VR T VG
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 771 --YLDPEYYISQQLTD---KSDVYSFGVILLELISGQ 802
++ PE + +Q+ K+D++SFG+ +EL +G
Sbjct: 190 PCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 21/218 (9%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE-FTNEV-T 649
++D+E ++GSG G V+ + + + AVK + + + + + ++
Sbjct: 22 AEINDLE-----NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV 76
Query: 650 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 709
+L +VQ G + E M K L + + + +
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGK--MTVA 132
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
K + YL +IHRD+K SNILLD+ + K+ DFG+S VD + S G
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCA 188
Query: 770 GYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 802
Y+ PE T ++DV+S G+ L+EL +GQ
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 43/222 (19%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 655
+ IG G VV + G E AVK++ + + E E +L ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 656 -HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 712
H +++ + + LV++ M G L + + +++ ++E +
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFD----------YL--TEKVALSEKETRSI 205
Query: 713 ------GIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 765
+ +LH I+HRDLK NILLD +M+ ++SDFG S G + +
Sbjct: 206 MRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELC 260
Query: 766 RGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISG 801
GT GYL PE + D+++ GVIL L++G
Sbjct: 261 -GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 31/211 (14%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 661
+++++G G F VV K G E A K++ + + E + ++ H N+V+
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KG 713
QEE LV++ + G L E I + R +E A +
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFE----------DI--VAREFYSEADASHCIQQILES 117
Query: 714 IEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
I Y H+ I+HR+LK N+LL K K++DFGL+ D GT G
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFA-GTPG 172
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELISG 801
YL PE + D+++ GVIL L+ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-25
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLV 660
+ + IG G FG V + D K++ A+K + + E N E+ ++ + H LV
Sbjct: 19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 661 QFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYL 717
L Y Q+E +V + + G L+ HL E+ + +L I E ++YL
Sbjct: 79 N-LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-EETV----KLFICE-LVMALDYL 131
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 777
IIHRD+K NILLD+H ++DF ++ + + GT Y+ PE +
Sbjct: 132 QNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMF 186
Query: 778 ISQQLT--DKS-DVYSFGVILLELISGQ 802
S++ + D +S GV EL+ G+
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 62/291 (21%), Positives = 110/291 (37%), Gaps = 55/291 (18%)
Query: 567 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKM-----LEKKIGSGGFGVVYYGK 621
H H + AP H L+ ++ + + +GSGGFG VY G
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63
Query: 622 -LKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIHHR--NLVQFLGYCQEEGRS 672
+ D +A+K + + E N EV LL ++ +++ L + +
Sbjct: 64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123
Query: 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPA 724
VL+ E ++ L+ +T + E+ A+ + + H V
Sbjct: 124 VLILERPEPV--QD-LFDFITERGALQ--------EELARSFFWQVLEAVRHCHNCGV-- 170
Query: 725 IIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
+HRD+K NIL+D K+ DFG D GT Y PE +I
Sbjct: 171 -LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPE-WIRYHRY 225
Query: 784 D--KSDVYSFGVILLELISG------QEAISNEKFG------ANCRNIVQW 820
+ V+S G++L +++ G E I + + C+++++W
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 40/219 (18%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH-- 655
L +G GGFG V+ G L D ++A+KV+ N G ++ EV LL ++
Sbjct: 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 656 --HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 712
H +++ L + + + +LV E + L+ +T + + E ++
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLG--------EGPSRC 143
Query: 713 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSI 764
I++ H+ V +HRD+K NIL+D AK+ DFG D
Sbjct: 144 FFGQVVAAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199
Query: 765 VRGTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
GT Y PE +IS+ + V+S G++L +++ G
Sbjct: 200 --GTRVYSPPE-WISRHQYHALPATVWSLGILLYDMVCG 235
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 37/214 (17%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 658
L + +G G +G V + +AVK++ K+E + + ++H N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHEN 66
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------ 712
+V+F G+ +E L E+ G L + + + + E A+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQL 114
Query: 713 --GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTV 769
G+ YLH I HRD+K N+LLD+ K+SDFGL+ + + + GT+
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 770 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
Y+ PE + ++ DV+S G++L +++G
Sbjct: 172 PYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 657
+++GSG F VV + K G + A K + +S + + EV++L I H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 715
N++ + + +L+ E + G L + L +LT E+ ++K +I G+
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK--QILN----GVY 128
Query: 716 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
YLH+ I H DLK NI+L R K+ DFGL+ +D + +I GT +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIF-GTPEF 183
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISG 801
+ PE + L ++D++S GVI L+SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 655
+ K +GSG G V + K++A+++++ + E+ +L +++
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 656 HRNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 712
H +++ + E +V E M G L + ++ + + E K
Sbjct: 199 HPCIIKIKNFFDAE--DYYIVLELMEGGELFD----------KV--VGNKRLKEATCKLY 244
Query: 713 ------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 763
++YLH IIHRDLK N+LL ++ K++DFG SK + S + +
Sbjct: 245 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRT 300
Query: 764 IVRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISG 801
+ GT YL PE + D +S GVIL +SG
Sbjct: 301 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 37/203 (18%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ + +G G FG+V+ K K + + E+++L+ HRN++
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ V+++EF+ + E + L + ++++ ++ E +++LH+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH--QVCE----ALQFLHSH 121
Query: 721 CVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
I H D++ NI+ + K+ +FG ++ + + + Y PE +
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLF-TAPEYYAPEVHQ 176
Query: 779 SQQLTDKSDVYSFGVILLELISG 801
++ +D++S G ++ L+SG
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSG 199
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 31/211 (14%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 661
+++++G G F VV K G E A K++ + + E + ++ H N+V+
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KG 713
QEE LV++ + G L E I + R +E A +
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFE----------DI--VAREFYSEADASHCIQQILES 140
Query: 714 IEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
I Y H+ I+HR+LK N+LL K K++DFGL+ V+ + GT G
Sbjct: 141 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGFA-GTPG 195
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELISG 801
YL PE + D+++ GVIL L+ G
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 45/216 (20%), Positives = 82/216 (37%), Gaps = 28/216 (12%)
Query: 605 LEKKIGSG--GFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL 659
L IG G V + G+ + V+ L + S + E+ + +H N+
Sbjct: 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGT----LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
V + + +V FM G+ + H + E I +I + K ++
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN-ELAIAYILQ-----GVLKALD 142
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR------GTV 769
Y+H +HR +K+S+IL+ + +S + + + +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 770 GYLDPEYYISQQL---TDKSDVYSFGVILLELISGQ 802
+L PE + Q L KSD+YS G+ EL +G
Sbjct: 200 PWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 32/212 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 661
L +++G G F VV G+E A ++ + + E + + H N+V+
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------G 713
EEG L+++ + G L E I + R +E DA+
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFE----------DI--VAREYYSEADASHCIQQILEA 122
Query: 714 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
+ + H G ++HR+LK N+LL K K++DFGL+ GT
Sbjct: 123 VLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTP 177
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
GYL PE D+++ GVIL L+ G
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 66/240 (27%), Positives = 106/240 (44%), Gaps = 26/240 (10%)
Query: 572 SLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAV 630
+P SL D + A F D E L + IG G FG VY+ + +++ + +A+
Sbjct: 28 PMPAGGRAGSLKDP--DVAELFFKDDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAI 84
Query: 631 KVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG--TLK 685
K ++ + Q ++ EV L ++ H N +Q+ G E + LV E+ L
Sbjct: 85 KKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLL 144
Query: 686 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 745
E L E I + A +G+ YLH+ +IHRD+K+ NILL + K+
Sbjct: 145 EVHKKPLQ-EVEIAAVTH-----GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 195
Query: 746 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISGQ 802
DFG + S V GT ++ PE ++ K DV+S G+ +EL +
Sbjct: 196 GDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 37/214 (17%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 658
L + +G G +G V + +AVK++ K+E + + ++H N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHEN 66
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------ 712
+V+F G+ +E L E+ G L + + + + E A+
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQL 114
Query: 713 --GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTV 769
G+ YLH I HRD+K N+LLD+ K+SDFGL+ + + + GT+
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 770 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
Y+ PE + ++ DV+S G++L +++G
Sbjct: 172 PYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 69/267 (25%), Positives = 108/267 (40%), Gaps = 42/267 (15%)
Query: 556 MHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCF--------TLSDIEDATKMLEK 607
MH ++ + +L Q S A A + D + +E
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFE-VES 59
Query: 608 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 666
++G G +VY K K K A+KVL K+ E+ +L R+ H N+++
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GIEYLH 718
+ LV E + G L + RI +++ +E DAA + YLH
Sbjct: 118 ETPTEISLVLELVTGGELFD----------RI--VEKGYYSERDAADAVKQILEAVAYLH 165
Query: 719 T-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
G I+HRDLK N+L K++DFGLSK V+ + ++ GT GY P
Sbjct: 166 ENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC-GTPGYCAP 219
Query: 775 EYYISQQLTDKSDVYSFGVILLELISG 801
E + D++S G+I L+ G
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 38/217 (17%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--------TSNSYQGKREFTNEVTLLSRIH 655
+GSG FG V+ + KE+ VK + + T E+ +LSR+
Sbjct: 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87
Query: 656 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--- 712
H N+++ L + +G LV E +G L+ + R++ E A
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLD--------EPLASYIF 136
Query: 713 -----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVR 766
+ YL IIHRD+K NI++ + K+ DFG + + G +
Sbjct: 137 RQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--- 190
Query: 767 GTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
GT+ Y PE + + +++S GV L L+
Sbjct: 191 GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 655
+ K +GSG G V + K++A+K+++ + E+ +L +++
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 656 HRNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 712
H +++ + E +V E M G L + ++ + + E K
Sbjct: 74 HPCIIKIKNFFDAE--DYYIVLELMEGGELFD----------KV--VGNKRLKEATCKLY 119
Query: 713 ------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 763
++YLH IIHRDLK N+LL ++ K++DFG SK + S + +
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRT 175
Query: 764 IVRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISG 801
+ GT YL PE + D +S GVIL +SG
Sbjct: 176 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-23
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 596 SDIEDATKM--LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLS 652
S + +K +G G F + K + AVK+++ + E+T L
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALK 60
Query: 653 RI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DA 710
H N+V+ ++ + LV E ++ G L E RI K+ +E +A
Sbjct: 61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE----------RI--KKKKHFSETEA 108
Query: 711 AK-------GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGAS 759
+ + ++H G ++HRDLK N+L + ++ K+ DFG ++
Sbjct: 109 SYIMRKLVSAVSHMHDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 760 HVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 801
+ + T+ Y PE ++Q D+S D++S GVIL ++SG
Sbjct: 165 PLKTPC-FTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 46/222 (20%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--------TSNSYQGKREFTNEVTLLSRIH 655
+ +G G +G V + AVK+L + K+E + LL R+
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE----IQLLRRLR 64
Query: 656 HRNLVQFLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 712
H+N++Q + E + +V E+ G ++E + ++ KR A
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQE-MLDSVPE-------KRFP--VCQAHG 113
Query: 713 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS----KFAVDGASHV 761
G+EYLH+ I+H+D+K N+LL K+S G++ FA D
Sbjct: 114 YFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 762 SSIVRGTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
S G+ + PE K D++S GV L + +G
Sbjct: 171 SQ---GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 38/213 (17%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSR-IHHRNLVQF 662
+++ IG G + V K E AVK++ + E + +L R H N++
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITL 81
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GI 714
+ +V E M G L + +I +++ +E +A+ +
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLD----------KI--LRQKFFSEREASAVLFTITKTV 129
Query: 715 EYLHT-GCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
EYLH G ++HRDLK SNIL ++ DFG +K + + T
Sbjct: 130 EYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTA 184
Query: 770 GYLDPEYYISQQLTDKS-DVYSFGVILLELISG 801
++ PE + +Q D + D++S GV+L +++G
Sbjct: 185 NFVAPE-VLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 38/213 (17%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHRNLV 660
K IGSG FGV + + +AVK + + +RE + + H N+V
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIV 79
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------- 712
+F ++ E+ G L E + +ED A+
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERI------------CNAGRFSEDEARFFFQQLLS 127
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGASHVSSIVRGTVG 770
G+ Y H+ + HRDLK N LLD R K+ DFG SK +V + S++ GT
Sbjct: 128 GVSYCHSMQI---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPA 182
Query: 771 YLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
Y+ PE + +Q D +DV+S GV L ++ G
Sbjct: 183 YIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-22
Identities = 58/211 (27%), Positives = 85/211 (40%), Gaps = 25/211 (11%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 662
K IG G F V K+K ++ A+K++ + E F E +L R + Q
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ- 125
Query: 663 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
L + Q+E LV E+ G L L +G + R +AE I+ +H
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA----RFYLAE-IVMAIDSVHR 180
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 778
+HRD+K NILLD+ +++DFG DG V GT YL PE
Sbjct: 181 L---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQ 236
Query: 779 SQQLTDKSDVY-------SFGVILLELISGQ 802
+ + Y + GV E+ GQ
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 656
L +G G FG V G+ G ++AVK+L + KRE + L H
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRH 70
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 712
++++ +V E++ G L +++ K + E A+
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYI------------CKHGRVEEMEARRLFQ 118
Query: 713 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 768
++Y H ++HRDLK N+LLD HM AK++DFGLS DG +S G+
Sbjct: 119 QILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GS 173
Query: 769 VGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
Y PE IS +L + D++S GVIL L+ G
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-21
Identities = 66/243 (27%), Positives = 104/243 (42%), Gaps = 30/243 (12%)
Query: 574 PVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVK-V 632
P+ N A + + K IG+G FGVV+ KL + E+A+K V
Sbjct: 13 VKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV 72
Query: 633 LTSNSYQGKREFTN-EVTLLSRIHHRNLVQFLGYCQEEGRSV------LVYEFMHNGTLK 685
L Q KR F N E+ ++ + H N+V + G LV E++ T+
Sbjct: 73 L-----QDKR-FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVY 125
Query: 686 EHLYGTLTHEQRI--NWIKRL--EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 741
+Q + IK ++ + + Y+H+ I HRD+K N+LLD
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQL----LRSLAYIHSI---GICHRDIKPQNLLLDPPS 178
Query: 742 RA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELI 799
K+ DFG +K + G +VS I + Y PE + T D++S G ++ EL+
Sbjct: 179 GVLKLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236
Query: 800 SGQ 802
GQ
Sbjct: 237 QGQ 239
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 39/214 (18%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 657
L K IG G F V + + G+E+A+K++ ++ + RE V ++ ++H
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFRE----VRIMKILNHP 74
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 712
N+V+ + E L+ E+ G + ++L + + E A+
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYL------------VAHGRMKEKEARSKFRQ 122
Query: 713 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
++Y H I+HRDLK+ N+LLD M K++DFG S G + + G
Sbjct: 123 IVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAP 177
Query: 770 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
Y PE + D + DV+S GVIL L+SG
Sbjct: 178 PYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSG 210
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-21
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 33/214 (15%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 662
K IG G FG V KLK+ ++ A+K+L + E F E +L + +
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT- 138
Query: 663 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 713
L Y Q++ LV ++ G L L E R+ E+ A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLS---KFEDRLP--------EEMARFYLAEMVIA 187
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
I+ +H +HRD+K NIL+D + +++DFG ++ + SS+ GT Y+
Sbjct: 188 IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 774 PEYYISQQLTDKS-----DVYSFGVILLELISGQ 802
PE + + D +S GV + E++ G+
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 62/307 (20%), Positives = 111/307 (36%), Gaps = 70/307 (22%)
Query: 596 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSR 653
+ D ++ ++ +G G G V + G++ A+K+L EV +
Sbjct: 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY------DSPKARQEVDHHWQ 77
Query: 654 I-HHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA- 707
++V L + ++ E M G L RI +R + A
Sbjct: 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS----------RI--QERGDQAF 125
Query: 708 --EDAAK-------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAV 755
+AA+ I++LH+ I HRD+K N+L +K K++DFG +K
Sbjct: 126 TEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 815
A + + T Y+ PE ++ D++S GVI+ L+ G F +N
Sbjct: 183 QNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP-----FYSNTG 234
Query: 816 NIVQWAKLH-IESGDIQGIIDPSLLDEYDIQSMW-KIEEKA------LMCVLPHGHMRPS 867
+ I G + W ++ E A L+ P R +
Sbjct: 235 QAISPGMKRRIRLGQY------GFPNPE-----WSEVSEDAKQLIRLLLKTDP--TERLT 281
Query: 868 ISEVLKD 874
I++ +
Sbjct: 282 ITQFMNH 288
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 58/255 (22%), Positives = 99/255 (38%), Gaps = 47/255 (18%)
Query: 569 HRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKE 627
H + P P ++ + I D K+ + +G G G V K ++
Sbjct: 30 HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89
Query: 628 IAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV----LVYEFMHN 681
A+K+L EV L R ++V+ + + +V E +
Sbjct: 90 FALKMLQ------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143
Query: 682 GTLKEHLYGTLTHEQRINWIKRLEIA---EDAA-------KGIEYLHT-GCVPAIIHRDL 730
G L RI R + A +A+ + I+YLH+ I HRD+
Sbjct: 144 GELFS----------RI--QDRGDQAFTEREASEIMKSIGEAIQYLHSIN----IAHRDV 187
Query: 731 KSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS- 786
K N+L + K++DFG +K + +++ T Y+ PE + + DKS
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPC-YTPYYVAPE-VLGPEKYDKSC 244
Query: 787 DVYSFGVILLELISG 801
D++S GVI+ L+ G
Sbjct: 245 DMWSLGVIMYILLCG 259
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 38/223 (17%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEV 648
L + K +G+G FG V K K+ A+K+L ++ NE
Sbjct: 38 AQLDQFD-----RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 708
+L ++ LV+ ++ +V E++ G + HL R + E
Sbjct: 93 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFS--------E 140
Query: 709 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760
A+ EYLH+ +I+RDLK N+L+D+ +V+DFG +K
Sbjct: 141 PHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193
Query: 761 VSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
+ + GT L PE I + +K+ D ++ GV++ E+ +G
Sbjct: 194 RTWTLCGTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 5e-21
Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 38/223 (17%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEV 648
++L D + + + +G+G FG V+ + + A+KVL ++ +E
Sbjct: 3 YSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 57
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 708
+LS + H +++ G Q+ + ++ +++ G L L QR
Sbjct: 58 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFP--------N 105
Query: 709 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760
AK +EYLH+ II+RDLK NILLDK+ K++DFG +K+ D
Sbjct: 106 PVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 160
Query: 761 VSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
+ GT Y+ PE +S + +KS D +SFG+++ E+++G
Sbjct: 161 --YTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 6e-21
Identities = 68/251 (27%), Positives = 103/251 (41%), Gaps = 23/251 (9%)
Query: 560 KKNNYDKEQHRHSLPVQRP-VSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY 618
KK + R P + + A+ H T+++ E K +G G FG V
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFE-----YLKLLGKGTFGKVI 165
Query: 619 YGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLGYC-QEEGRSV 673
K K A+K+L K E + E +L H L L Y Q R
Sbjct: 166 LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA-LKYSFQTHDRLC 224
Query: 674 LVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 731
V E+ + G L HL + E R R AE ++YLH+ +++RDLK
Sbjct: 225 FVMEYANGGELFFHLSRERVFS-EDRA----RFYGAE-IVSALDYLHSEK--NVVYRDLK 276
Query: 732 SSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 791
N++LDK K++DFGL K + + + + GT YL PE D +
Sbjct: 277 LENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGL 335
Query: 792 GVILLELISGQ 802
GV++ E++ G+
Sbjct: 336 GVVMYEMMCGR 346
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 7e-21
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 656
L +G G FG V GK G ++AVK+L + +RE + L H
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE----IQNLKLFRH 75
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 712
++++ +V E++ G L +++ K + E ++
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYI------------CKNGRLDEKESRRLFQ 123
Query: 713 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 768
G++Y H V +HRDLK N+LLD HM AK++DFGLS DG +S G+
Sbjct: 124 QILSGVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GS 178
Query: 769 VGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
Y PE IS +L + D++S GVIL L+ G
Sbjct: 179 PNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCG 212
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 71/245 (28%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------------------TSNSYQGKREF 644
L+ +IG G +GVV D A+KVL T + G +
Sbjct: 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 645 TN-------EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-------- 689
E+ +L ++ H N+V+ + E + + ++HLY
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVK-------------LVEVLDDPN-EDHLYMVFELVNQ 122
Query: 690 GTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHM 741
G + + ++ED A+ GIEYLH IIHRD+K SN+L+ +
Sbjct: 123 GPV-----MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDG 174
Query: 742 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD----KSDVYSFGVILLE 797
K++DFG+S + +S+ V GT ++ PE +S+ DV++ GV L
Sbjct: 175 HIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYC 232
Query: 798 LISGQ 802
+ GQ
Sbjct: 233 FVFGQ 237
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 33/218 (15%)
Query: 604 MLEKKIGSGGFGVVYYGKLKD-GKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+E+ G G FG V GK K G +A+K V+ ++ RE + L+ +HH N+VQ
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-NRELQ-IMQDLAVLHHPNIVQ 83
Query: 662 FLGYCQEEGRS-------VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 712
Y G +V E++ TL R + +++ K
Sbjct: 84 LQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCC--------RNYYRRQVAPPPILIKVF 134
Query: 713 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIV 765
I LH V + HRD+K N+L+++ K+ DFG +K +V+ I
Sbjct: 135 LFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 766 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
+ Y PE +Q T D++S G I E++ G+
Sbjct: 194 --SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 73/247 (29%), Positives = 109/247 (44%), Gaps = 27/247 (10%)
Query: 565 DKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD 624
+ + + P P +N P+ H SD K IG G FG V + K
Sbjct: 8 PELMNANPAPPPAPSQQINLGPSSNPH-AKPSDFH-----FLKVIGKGSFGKVLLARHKA 61
Query: 625 GKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQFLGYC-QEEGRSVLVYEF 678
+ AVKVL + K+E + ++ LL + H LV L + Q + V ++
Sbjct: 62 EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG-LHFSFQTADKLYFVLDY 120
Query: 679 MHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 736
++ G L HL E R R AE A + YLH+ I++RDLK NIL
Sbjct: 121 INGGELFYHLQRERCFL-EPRA----RFYAAE-IASALGYLHSL---NIVYRDLKPENIL 171
Query: 737 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVIL 795
LD ++DFGL K ++ S S+ GT YL PE + +Q D++ D + G +L
Sbjct: 172 LDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPE-VLHKQPYDRTVDWWCLGAVL 229
Query: 796 LELISGQ 802
E++ G
Sbjct: 230 YEMLYGL 236
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-20
Identities = 68/218 (31%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 604 MLEKKIGSGGFGVVYYGKLKD-GKEIAVK-VLTSNSYQGKREFTN-EVTLLSRIHHRNLV 660
K IG+G FGVVY KL D G+ +A+K VL Q KR F N E+ ++ ++ H N+V
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKR-FKNRELQIMRKLDHCNIV 110
Query: 661 QFLGYCQEEGRSV------LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 712
+ + G LV +++ E +Y H R + K
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAK----QTLPVIYVKLY 161
Query: 713 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIV 765
+ Y+H+ I HRD+K N+LLD K+ DFG +K V G +VS I
Sbjct: 162 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 766 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
+ Y PE + T DV+S G +L EL+ GQ
Sbjct: 219 --SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-20
Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 34/213 (15%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 662
K IG G FG V + K +++ A+K+L+ + + F E +++ + +VQ
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ- 133
Query: 663 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 713
L Y Q++ +V E+M G L + ++ E A+
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM-------------SNYDVPEKWARFYTAEVVLA 180
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
++ +H+ IHRD+K N+LLDK K++DFG GT Y+
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 774 PEYYISQQLT---DKS-DVYSFGVILLELISGQ 802
PE SQ + D +S GV L E++ G
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 43/216 (19%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 656
+ + +G G FG V K +++A+K + + + +RE ++ L + H
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRH 68
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 712
++++ V+V E+ G L +++ +++ + ED +
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYI------------VEKKRMTEDEGRRFFQ 115
Query: 713 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRG 767
IEY H I+HRDLK N+LLD ++ K++DFGLS DG S G
Sbjct: 116 QIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---G 169
Query: 768 TVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 801
+ Y PE I+ +L + DV+S G++L ++ G
Sbjct: 170 SPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVG 204
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 24/203 (11%), Positives = 56/203 (27%), Gaps = 43/203 (21%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLV 660
L G + +++A+ + +E + LSRI +
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-T 719
+ L ++V E++ G+L+E + + + + A + H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA------IRAMQSLAAAADAAHRA 148
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
G + S + + ++ T+ +P+
Sbjct: 149 G----VALSIDHPSRVRVSIDGDVVLAYP------------------ATMPDANPQ---- 182
Query: 780 QQLTDKSDVYSFGVILLELISGQ 802
D+ G L L+ +
Sbjct: 183 ------DDIRGIGASLYALLVNR 199
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 70/232 (30%), Positives = 116/232 (50%), Gaps = 27/232 (11%)
Query: 581 SLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSN 636
++ E S E L K +G G FG V+ D +++ A+KVL
Sbjct: 9 AITHHVKEGHEKADPSQFE-----LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA 63
Query: 637 SYQGKREF--TNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GT 691
+ + + E +L ++H +V+ L Y Q EG+ L+ +F+ G L L
Sbjct: 64 TLKVRDRVRTKMERDILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 122
Query: 692 LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751
T E+ + + +AE A +++LH+ II+RDLK NILLD+ K++DFGLS
Sbjct: 123 FT-EEDV----KFYLAE-LALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLS 173
Query: 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
K ++D S GTV Y+ PE ++++ +S D +SFGV++ E+++G
Sbjct: 174 KESIDHEKKAYSFC-GTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 32/210 (15%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 662
K +G G FG V + K A+K+L K E + E +L H L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA- 69
Query: 663 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 713
L Y Q R V E+ + G L HL E+ E+ A+
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFT--------EERARFYGAEIVSA 117
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
+EYLH+ +++RD+K N++LDK K++DFGL K + + + + GT YL
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLA 173
Query: 774 PEYYISQQLTDKS-DVYSFGVILLELISGQ 802
PE + ++ D + GV++ E++ G+
Sbjct: 174 PE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-19
Identities = 24/108 (22%), Positives = 42/108 (38%), Gaps = 4/108 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
++ + +S + LSSL L + GNS F+ +L + L
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN--VVLNYAGN 519
QL P++ +L +L+ L + +N N VL+Y+ N
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-18
Identities = 22/109 (20%), Positives = 39/109 (35%), Gaps = 5/109 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 473
S+ V+ ++ + N D T+L +L L L L P F+ L+++++ N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS---LLSKNVVLNYAGN 519
L +L+ L N + + S LN N
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 8e-18
Identities = 23/96 (23%), Positives = 36/96 (37%), Gaps = 1/96 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
P + V+ LS + LS L L L GN + FSG L+ + +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
L + +L L+EL V +N++ S
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-17
Identities = 20/106 (18%), Positives = 37/106 (34%), Gaps = 2/106 (1%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCP 463
++L ++T + LS L P+ LSSL L + N+ +
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518
Query: 464 DLRIIHLEDNQLTGPLPSSLMNLP-NLRELYVQNNMLSGTVPSSLL 508
L+++ N + L + P +L L + N + T
Sbjct: 519 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 564
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-17
Identities = 14/97 (14%), Positives = 29/97 (29%), Gaps = 3/97 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
S+ + LS + + S+ L L L ++L F +L + +
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
L +L L + N + ++
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-15
Identities = 27/109 (24%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 416 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 473
PS+ + LS L+ G +SL L L N + +F G L + + +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 474 QLTGPLPSS-LMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
L S ++L NL L + + LS VL AGN
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 7/111 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLEDN 473
S+ + NL + L +L EL + N + +P+ FS +L + L N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 474 QLTGPLPSSLMNLPNLR----ELYVQNNMLSGTVPSSLLSKN-VVLNYAGN 519
++ + L L + L + N ++ P + L N
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-14
Identities = 20/93 (21%), Positives = 34/93 (36%), Gaps = 5/93 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ 474
P+IT N IP +L S L L N L F P+L+++ L +
Sbjct: 8 PNITY-QCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
+ + +L +L L + N + +
Sbjct: 64 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF 96
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-12
Identities = 23/107 (21%), Positives = 37/107 (34%), Gaps = 4/107 (3%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPD-FSGCPDLRIIH 469
++ L+ + G L SL L L N L+ G G L+ +
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 470 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
L N + + S+ + L L L Q++ L S+ L Y
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-10
Identities = 16/102 (15%), Positives = 31/102 (30%), Gaps = 5/102 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSL----VELWLDGNSLTGPIPDFSGCPDLRIIHLE 471
++ + LSS + +DL L + + L L N + P L + L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 472 DNQLTGPLPS-SLMNLPNLRELYVQNNMLSGTVPSSLLSKNV 512
+N + + + L L + K+
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 7e-10
Identities = 15/125 (12%), Positives = 36/125 (28%), Gaps = 11/125 (8%)
Query: 406 SWLQCNSDPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG----PIPDFS 460
+++Q + + + + L + + N+ + L+ L L D S
Sbjct: 190 NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249
Query: 461 GCPDLRIIHLEDNQLT------GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 514
L + +E+ +L + L N+ + + + S L
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL 309
Query: 515 NYAGN 519
Sbjct: 310 ELVNC 314
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 8e-08
Identities = 22/130 (16%), Positives = 43/130 (33%), Gaps = 25/130 (19%)
Query: 414 PQPSITVIHLSSKNLTGN-IPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 472
+I L+ + + I L+++ L ++ + DFS + + L +
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVN 313
Query: 473 NQLT-------------------GPLPSSLMNLPNLRELYVQNNMLS--GTVPSSL--LS 509
+ G S ++LP+L L + N LS G S +
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 510 KNVVLNYAGN 519
L+ + N
Sbjct: 374 SLKYLDLSFN 383
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 16/100 (16%), Positives = 25/100 (25%), Gaps = 28/100 (28%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPD-LRIIHLEDN 473
S+ V+++S N L+SL L N + P L ++L N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 474 QLTG--------------------------PLPSSLMNLP 487
PS +P
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 36/214 (16%)
Query: 607 KKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSNSYQGKREFT----NEVTLLSRIHHRN 658
+ +G GG+G V+ + +I A+KVL + T E +L + H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 659 LVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 712
+V L Y Q G+ L+ E++ G L L E ED A
Sbjct: 83 IVD-LIYAFQTGGKLYLILEYLSGGELFMQLE----REGIFM--------EDTACFYLAE 129
Query: 713 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
+ +LH II+RDLK NI+L+ K++DFGL K ++ + + GT+
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTI 185
Query: 770 GYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
Y+ PE + + +++ D +S G ++ ++++G
Sbjct: 186 EYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 9e-19
Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLG 664
+K+G G + V+ + + +++ VK+L K++ E+ +L + N++
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 98
Query: 665 --YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
LV+E ++N K LY TLT ++ + K ++Y H+
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFK-QLYQTLTDYDIRFYMYEI------LKALDYCHSM-- 149
Query: 723 PAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
I+HRD+K N+++D R ++ D+GL++F G + + + + PE + Q
Sbjct: 150 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVDYQ 206
Query: 782 LTDKS-DVYSFGVILLELISGQEAI 805
+ D S D++S G +L +I +E
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 661
+K+G G +GVVY K G+ +A+K + ++ + E T E++LL +HH N+V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVS 83
Query: 662 FLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+ E LV+EFM + + L Q ++ +L +G+ + H
Sbjct: 84 LIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL------LRGVAHCHQ 137
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 778
I+HRDLK N+L++ K++DFGL++ F + S+ +V T+ Y P+ +
Sbjct: 138 HR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLM 192
Query: 779 -SQQLTDKSDVYSFGVILLELISGQ 802
S++ + D++S G I E+I+G+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 604 MLEK-----KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN--EVTLLSRIH 655
M+EK KIG G +GVV+ + +D G+ +A+K + + E+ +L ++
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 656 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIAEDAAK 712
H NLV L + + R LV+E+ + T+ L Y E + + + +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQT------LQ 113
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 771
+ + H IHRD+K NIL+ KH K+ DFG ++ + + T Y
Sbjct: 114 AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA--TRWY 168
Query: 772 LDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
PE + DV++ G + EL+SG
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-18
Identities = 63/243 (25%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 576 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 634
+ N +++ + + E + +G G FG V ++K+ ++ AVKVL
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFE-----FIRVLGKGSFGKVMLARVKETGDLYAVKVL- 56
Query: 635 SNSYQGKREF---TNEVT--------LLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNG 682
K++ ++V L +H L Q L C Q R V EF++ G
Sbjct: 57 ------KKDVILQDDDVECTMTEKRILSLARNHPFLTQ-LFCCFQTPDRLFFVMEFVNGG 109
Query: 683 TLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 740
L H+ E R R AE + +LH II+RDLK N+LLD
Sbjct: 110 DLMFHIQKSRRFD-EARA----RFYAAE-IISALMFLHDK---GIIYRDLKLDNVLLDHE 160
Query: 741 MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELI 799
K++DFG+ K + ++ GT Y+ PE + + L + D ++ GV+L E++
Sbjct: 161 GHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEML 218
Query: 800 SGQ 802
G
Sbjct: 219 CGH 221
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-18
Identities = 24/96 (25%), Positives = 41/96 (42%), Gaps = 2/96 (2%)
Query: 417 SITVIHLSSKNL-TGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
I +I++ NL T + + L K+ L L N L G +P F L ++L NQ+
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQI 365
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511
T + + L +N L +P+ +K+
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKS 400
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-16
Identities = 15/111 (13%), Positives = 32/111 (28%), Gaps = 8/111 (7%)
Query: 401 LPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-F 459
PV S + + ++ L G +P+ L L L N +T +
Sbjct: 320 FPVETSLQKM-----KKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFC 373
Query: 460 SGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
+ + N+L P ++ + + N + +
Sbjct: 374 GFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-15
Identities = 25/119 (21%), Positives = 40/119 (33%), Gaps = 14/119 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG--------PIPDFSGCPDLRI 467
+++ I+LS+ ++ + S L + L GN LT +F L
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 468 IHLEDNQLTGPLPSSLM--NLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINL 522
I L N+LT L LP L + + N S P+ S +
Sbjct: 493 IDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDA 549
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-15
Identities = 25/116 (21%), Positives = 42/116 (36%), Gaps = 10/116 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED- 472
+T I L LT + D T L LV + L NS + L+ + +
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQ 546
Query: 473 -----NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
N+ P + P+L +L + +N + V + VL+ N N+
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDNPNIS 601
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-14
Identities = 19/115 (16%), Positives = 39/115 (33%), Gaps = 13/115 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEL------WLDGNSLTGPIPD-FSGCPDLRII 468
P + I LS + + P+ S+L GN P+ + CP L +
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNIN 521
+ N + + + PN+ L +++N S + + + +
Sbjct: 572 QIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-14
Identities = 12/104 (11%), Positives = 32/104 (30%), Gaps = 10/104 (9%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 472
+ + L L ++ + +P P++++I++
Sbjct: 223 ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVAC 282
Query: 473 NQLT--------GPLPSSLMNLPNLRELYVQNNML-SGTVPSSL 507
N+ + ++ +Y+ N L + V +SL
Sbjct: 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-14
Identities = 16/128 (12%), Positives = 36/128 (28%), Gaps = 22/128 (17%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP------------------- 457
T I S N+T + + +L+ L + ++ +
Sbjct: 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED 242
Query: 458 -DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+ DL + + + LP+ L LP ++ + V N + +
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADA 301
Query: 517 AGNINLHE 524
+
Sbjct: 302 PVGEKIQI 309
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-13
Identities = 21/163 (12%), Positives = 52/163 (31%), Gaps = 19/163 (11%)
Query: 376 DGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ--CNSDPQPSITV--------IHLSS 425
D +A+ + + +W+Q+G W++ + QP +++ + L
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEG 90
Query: 426 KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-----SGCPDLRIIHLEDNQLTGPLP 480
+G +P + +L+ L L L + F S
Sbjct: 91 FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150
Query: 481 SSLM--NLPNLRELYVQNNMLSGTVPSS--LLSKNVVLNYAGN 519
+ +L + + ++ ++ S + K+ + N
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSN 193
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-13
Identities = 13/92 (14%), Positives = 27/92 (29%), Gaps = 4/92 (4%)
Query: 421 IHLSSKNLTGNIPSDLTKL--SSLVELWLDGNSLTGPIPDFSG-CPDLRIIHLEDNQLTG 477
+ + S L++ ++ + I S I N +T
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
Query: 478 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
+ ++M L LR+ Y+ N+
Sbjct: 198 -VSKAVMRLTKLRQFYMGNSPFVAENICEAWE 228
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-13
Identities = 15/102 (14%), Positives = 31/102 (30%), Gaps = 11/102 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 472
+ ++L+ +T + + L N L IP+ + I
Sbjct: 353 IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSY 411
Query: 473 NQLTG-------PLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
N++ PL + N+ + + NN +S
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELF 453
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-12
Identities = 17/124 (13%), Positives = 37/124 (29%), Gaps = 21/124 (16%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 476
+ ++S +I ++ N++T LR ++ ++
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 477 GP-------------------LPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLN 515
NL +L ++ V N +P+ L L + ++N
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279
Query: 516 YAGN 519
A N
Sbjct: 280 VACN 283
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-12
Identities = 18/109 (16%), Positives = 37/109 (33%), Gaps = 11/109 (10%)
Query: 416 PSITVIHLSSKNLTGNIPS--DLTKLSSLVELWLDGNSLTGPI--------PDFSGCPDL 465
+ + + L IP+ D +S + + N + P ++
Sbjct: 377 EQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
Query: 466 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 514
I+L +NQ++ L + + NML+ +SL +N
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-08
Identities = 14/113 (12%), Positives = 32/113 (28%), Gaps = 10/113 (8%)
Query: 416 PSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIPDFSG---CPDLRII 468
+ V+ L S N P ++ S + D+ DL
Sbjct: 105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKD 164
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
+ + + S ++ +N ++ V ++ L+K +
Sbjct: 165 CINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNS 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTN--EVTLLSRIHHRNLVQF 662
+G G +G+V + KD I A+K L S+ + + E+ LL ++ H NLV
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRHENLVNL 89
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 719
L C+++ R LV+EF+ + T+ + L + Q + ++ ++ GI + H+
Sbjct: 90 LEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQI------INGIGFCHS 142
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 778
IIHRD+K NIL+ + K+ DFG ++ A G + + T Y PE +
Sbjct: 143 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYRAPELLV 197
Query: 779 -SQQLTDKSDVYSFGVILLELISGQ 802
+ DV++ G ++ E+ G+
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-18
Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 41/230 (17%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSNSYQGKREFT--- 645
+ + E L K +G+G +G V+ D ++ A+KVL + K + T
Sbjct: 51 VGIENFE-----LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 105
Query: 646 -NEVTLLSRI-HHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 702
E +L I LV L Y Q E + L+ ++++ G L HL +R
Sbjct: 106 RTERQVLEHIRQSPFLVT-LHYAFQTETKLHLILDYINGGELFTHLS----QRERFT--- 157
Query: 703 RLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754
E + +E+LH II+RD+K NILLD + ++DFGLSK
Sbjct: 158 -----EHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209
Query: 755 VDGASHVSSIVRGTVGYLDPE-YYISQQLTDKS-DVYSFGVILLELISGQ 802
V + + GT+ Y+ P+ DK+ D +S GV++ EL++G
Sbjct: 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 661
+ IG G + V +LK I A+KV+ + T +H LV
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 662 FLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
L C Q E R V E+++ G L H+ L E+ R AE + + YLH
Sbjct: 75 -LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHA----RFYSAE-ISLALNYLH 127
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
II+RDLK N+LLD K++D+G+ K + S+ GT Y+ PE +
Sbjct: 128 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE-IL 182
Query: 779 SQQLTDKS-DVYSFGVILLELISGQ 802
+ S D ++ GV++ E+++G+
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 7e-18
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 608 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQF 662
KIG G +GVVY + G+ A+K + + E T E+++L + H N+V+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELKHSNIVKL 65
Query: 663 LGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ R VLV+E + L + G L +++ +L GI Y H
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL------LNGIAYCHDR 119
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI- 778
++HRDLK N+L+++ K++DFGL++ F + + IV T+ Y P+ +
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMG 174
Query: 779 SQQLTDKSDVYSFGVILLELISGQ 802
S++ + D++S G I E+++G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 608 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGK-----REFTNEVTLLSRIHHRNLVQ 661
K+G+G + VY G K A+K + +S +G RE ++L+ + H N+V+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKHENIVR 67
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEH-LYGTLTHEQRINWIKRLEIAEDAA------KGI 714
E + LV+EFM ++ L + N + LE+ +G+
Sbjct: 68 LYDVIHTENKLTLVFEFM------DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLD 773
+ H I+HRDLK N+L++K + K+ DFGL++ F + + S +V T+ Y
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRA 176
Query: 774 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
P+ + S+ + D++S G IL E+I+G+
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 9e-18
Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 661
+G G FG V + K E+ AVK+L + + + L L Q
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 662 FLGYC-QEEGRSVLVYEFMHNGTLKEHLYGT-LTHEQRINWIKRLEIAEDAAKGIEYLHT 719
L C Q R V E+++ G L H+ E AE A G+ +L +
Sbjct: 407 -LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA----VFYAAE-IAIGLFFLQS 460
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
II+RDLK N++LD K++DFG+ K + + GT Y+ PE I+
Sbjct: 461 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPE-IIA 515
Query: 780 QQLTDKS-DVYSFGVILLELISGQ 802
Q KS D ++FGV+L E+++GQ
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 57/235 (24%), Positives = 98/235 (41%), Gaps = 49/235 (20%)
Query: 598 IEDATKMLEKKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNSYQGKREFTN--EVTLLS 652
+ED + K+G G +G VY K KD K+ A+K + + E+ LL
Sbjct: 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLR 73
Query: 653 RIHHRNLVQFLGYCQEEG-RSV-LVYEFMHNGTLKEH-LYGTL-THEQRINWIKRLEIAE 708
+ H N++ R V L++++ EH L+ + H K +++
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKKPVQLPR 127
Query: 709 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKF--- 753
K GI YLH ++HRDLK +NIL+ + R K++D G ++
Sbjct: 128 GMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 754 AVDGASHVSSIVRGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISGQ 802
+ + + +V T Y PE +Y T D+++ G I EL++ +
Sbjct: 185 PLKPLADLDPVVV-TFWYRAPELLLGARHY-----TKAIDIWAIGCIFAELLTSE 233
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 26/236 (11%)
Query: 576 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 634
+ + +A+ L D + L + IG G + V +LK I A++V+
Sbjct: 32 EEKEAMNTRESGKASSSLGLQDFD-----LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVK 86
Query: 635 SNSYQGKREFTNEVT----LLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY 689
+ T +H LV L C Q E R V E+++ G L H+
Sbjct: 87 KELVNDDEDIDWVQTEKHVFEQASNHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQ 145
Query: 690 --GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 747
L E+ R AE + + YLH II+RDLK N+LLD K++D
Sbjct: 146 RQRKLP-EEHA----RFYSAE-ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196
Query: 748 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
+G+ K + S+ GT Y+ PE + + S D ++ GV++ E+++G+
Sbjct: 197 YGMCKEGLRPGDTTSTFC-GTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 35/212 (16%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF---TNEVT--------LLSRI 654
+G G FG V + K E+ AVK+L K++ ++V L
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKIL-------KKDVVIQDDDVECTMVEKRVLALPG 78
Query: 655 HHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAA 711
L Q L C Q R V E+++ G L H+ G E AE A
Sbjct: 79 KPPFLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-EPHA----VFYAAE-IA 131
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
G+ +L + II+RDLK N++LD K++DFG+ K + + GT Y
Sbjct: 132 IGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDY 187
Query: 772 LDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
+ PE I+ Q KS D ++FGV+L E+++GQ
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 608 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 661
KIG G +G V+ K ++ EI A+K + + E + E+ LL + H+N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVR 65
Query: 662 FLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
+ + LV+EF + G L E +++ +L KG+ + H+
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL------LKGLGFCHS 119
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 778
++HRDLK N+L++++ K+++FGL++ F + + + +V T+ Y P+
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLF 174
Query: 779 -SQQLTDKSDVYSFGVILLELISGQEAI 805
++ + D++S G I EL + +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-17
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 607 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 661
K +G G FG V+ + K + A+K L + + + L H L
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 662 FLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ Q + V E+++ G L H+ + AE G+++LH
Sbjct: 83 -MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-----TFYAAE-IILGLQFLH 135
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 778
+ I++RDLK NILLDK K++DFG+ K + G + ++ GT Y+ PE +
Sbjct: 136 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE-IL 190
Query: 779 SQQLTDKS-DVYSFGVILLELISGQ 802
Q + S D +SFGV+L E++ GQ
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 7e-17
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLV 660
+G G F VY + + +A+K + ++ T E+ LL + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 661 QFLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
L + LV++FM + + LT ++ +G+EYLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT------LQGLEYLH 129
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEY- 776
I+HRDLK +N+LLD++ K++DFGL+K F ++ +V T Y PE
Sbjct: 130 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--TRWYRAPELL 184
Query: 777 YISQQLTDKSDVYSFGVILLELISGQ 802
+ ++ D+++ G IL EL+
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 24/157 (15%)
Query: 608 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTN--EVTLLSRIHHRNLVQFL 663
KIG G FG V+ + + + A+K VL N +G T E+ +L + H N+V +
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLI 82
Query: 664 GYCQEEGRSV--------LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
C+ + LV++F + L ++ T + ++ L G
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML------LNG 136
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750
+ Y+H I+HRD+K++N+L+ + K++DFGL
Sbjct: 137 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGK-----REFTNEVTLLSRIHHRNLV 660
K+G G + VY GK K +A+K + +G RE V+LL + H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANIV 63
Query: 661 QFLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
E LV+E++ + + ++ +L +G+ Y H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL------LRGLAYCH 117
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 777
++HRDLK N+L+++ K++DFGL++ ++ ++ + +V T+ Y P+
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDIL 172
Query: 778 I-SQQLTDKSDVYSFGVILLELISGQ 802
+ S + + D++ G I E+ +G+
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-16
Identities = 26/109 (23%), Positives = 43/109 (39%), Gaps = 5/109 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
P + V++L L+ ++L EL L NS+ + F +L + L N
Sbjct: 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKNVVLNYAGN 519
L+ + + L NL+EL + NN + L S L + N
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-16
Identities = 25/107 (23%), Positives = 41/107 (38%), Gaps = 3/107 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+T + + ++ P KL L L L N L+ F+ C +L +HL N
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
+ + + NL L + +N LS T + L L + N
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-16
Identities = 19/97 (19%), Positives = 35/97 (36%), Gaps = 3/97 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 472
++ + LS L+ +L +L EL L N + + L+ + L
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
NQ+ P + L L++ N L ++ L
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-15
Identities = 20/112 (17%), Positives = 45/112 (40%), Gaps = 6/112 (5%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLE 471
+ +++L+ ++ + L L L L N + + + G ++ I+L
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 472 DNQLTGPLPSSLMNLPNLRELYVQNNMLSG--TVPSSL--LSKNVVLNYAGN 519
N+ +S +P+L+ L ++ L + PS L +L+ + N
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-15
Identities = 26/116 (22%), Positives = 40/116 (34%), Gaps = 12/116 (10%)
Query: 416 PSITVIHLSSKNLT--------GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLR 466
+ ++ L NL G L LS L L L+ N + F +L+
Sbjct: 504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563
Query: 467 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 519
II L N L S N +L+ L +Q N+++ L+ N
Sbjct: 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-15
Identities = 25/100 (25%), Positives = 40/100 (40%), Gaps = 8/100 (8%)
Query: 409 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRI 467
+C S V S LT +P DL +++ L L N L +F+ L
Sbjct: 1 KCTV----SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTS 53
Query: 468 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
+ + N ++ P LP L+ L +Q+N LS +
Sbjct: 54 LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTF 93
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-15
Identities = 24/112 (21%), Positives = 39/112 (34%), Gaps = 4/112 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 472
+I I+LS + + SL L L +L F +L I+ L +
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
N + L L L L +Q+N L+ + + G +LH
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLA-RLWKHANPGGPIYFLKGLSHLHI 540
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-14
Identities = 15/106 (14%), Positives = 36/106 (33%), Gaps = 5/106 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG---PIPDFSGCP--DLRIIHL 470
+ +++ ++ G + T L +L L L + + F L I++L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 471 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
N+++ + L +L L + N + + +
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-13
Identities = 27/104 (25%), Positives = 43/104 (41%), Gaps = 3/104 (2%)
Query: 410 CNSDPQPSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDGNSLTGPIPD-FSGCPDLR 466
C SI + LS+ L+ + K ++L L L N+L D F+ P L
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275
Query: 467 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
LE N + SL L N+R L ++ + ++ + L K
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK 319
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-13
Identities = 20/100 (20%), Positives = 38/100 (38%), Gaps = 6/100 (6%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIH 469
S+ + LSS + P + L L+L+ L + + +R +
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228
Query: 470 LEDNQLTGPLPSSLMNL--PNLRELYVQNNMLSGTVPSSL 507
L ++QL+ ++ + L NL L + N L+ S
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-13
Identities = 20/110 (18%), Positives = 38/110 (34%), Gaps = 10/110 (9%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD----------FSGCPDL 465
P + L N+ L L ++ L L + I F L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 466 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 515
+++EDN + G + L NL+ L + N+ S ++ ++ +
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-06
Identities = 15/69 (21%), Positives = 24/69 (34%), Gaps = 2/69 (2%)
Query: 441 SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 500
S LT +PD ++ +++L NQL ++ L L V N +S
Sbjct: 5 SHEVADCSHLKLTQ-VPDDLP-TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 501 GTVPSSLLS 509
P
Sbjct: 63 KLEPELCQK 71
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 3e-16
Identities = 60/272 (22%), Positives = 95/272 (34%), Gaps = 83/272 (30%)
Query: 605 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQG-KREFTNEVTLLSRI-HH 656
L K +G G FG V + +AVK+L + R +E+ +L I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 657 RN--------------------------LVQFL-------------GYCQEEGRSVLVYE 677
N L +L G +G+ +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 678 FMH----------------NGTLKEHLYGTLTHEQRINWIKR--------LEIAEDAAKG 713
+ +G ++E + E+ + + + + AKG
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
+E+L + IHRDL + NILL + K+ DFGL++ VR L
Sbjct: 206 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDYVRKGDARLP 258
Query: 774 -----PEYYISQQLTDKSDVYSFGVILLELIS 800
PE + T +SDV+SFGV+L E+ S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 51/227 (22%), Positives = 82/227 (36%), Gaps = 66/227 (29%)
Query: 596 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSR 653
+ I D K+ + +G G G V K ++ A+K+L EV L R
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWR 66
Query: 654 I-HHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA- 707
++V+ + + +V E + G L RI R + A
Sbjct: 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS----------RI--QDRGDQAF 114
Query: 708 --EDAA-------KGIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFA 754
+A+ + I+YLH+ I HRD+K N+L + K++DFG +K
Sbjct: 115 TEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 168
Query: 755 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 801
G Y D D++S GVI+ L+ G
Sbjct: 169 ---------ETTGE-KY-DKS----------CDMWSLGVIMYILLCG 194
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 662
K IGSG G+V + +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 89
Query: 663 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
L EE + V +V E M L + + L HE+ + ++ GI++
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQM------LCGIKH 142
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
LH+ + IHRDLK SNI++ K+ DFGL++ A +V T Y PE
Sbjct: 143 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEV 197
Query: 777 YISQQLTDKSDVYSFGVILLELISGQ 802
+ + D++S G I+ E+I G
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 47/254 (18%), Positives = 94/254 (37%), Gaps = 65/254 (25%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN-EVTLLSRI 654
+ L K +G+G FG+V + GK A+K + + + N E+ ++ +
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVL 57
Query: 655 HHRNLVQFLGYCQEEGRSV--------------------------------------LVY 676
H N+++ + Y G ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE------DAAKGIEYLHTGCVPAIIHRDL 730
E++ + L+ L R + + + + + ++H+ I HRD+
Sbjct: 118 EYV-----PDTLHKVLKSFIRSG--RSIPMNLISIYIYQLFRAVGFIHSL---GICHRDI 167
Query: 731 KSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDV 788
K N+L++ K+ DFG +K + V+ I + Y PE + + + T D+
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDL 225
Query: 789 YSFGVILLELISGQ 802
+S G + ELI G+
Sbjct: 226 WSIGCVFGELILGK 239
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 608 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 661
K+G G +G VY + +A+K + + + E T EV+LL + HRN+++
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNIIE 97
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
R L++E+ N LK+++ ++ +++ +L G+ + H+
Sbjct: 98 LKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL------INGVNFCHS 150
Query: 720 GCVPAIIHRDLKSSNILLDKHMRA-----KVSDFGLSK-FAVDGASHVSSIVRGTVGYLD 773
+HRDLK N+LL + K+ DFGL++ F + I+ T+ Y
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWYRP 205
Query: 774 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 802
PE + S+ + D++S I E++
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 1e-15
Identities = 22/116 (18%), Positives = 37/116 (31%), Gaps = 13/116 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI----------PDFSGCPDL 465
+T + L + +P L L L L + N D P +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 466 RIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPS-SLLSKNVVLNYAGN 519
+I ++ N L P +SL + L L +N + + + K L N
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYN 605
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 19/113 (16%), Positives = 34/113 (30%), Gaps = 10/113 (8%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 472
+ N + L L ++ L +PD P+L+ +++
Sbjct: 465 IAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC 524
Query: 473 NQLTGP---------LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
N+ L P ++ Y+ N L S+ L K V L
Sbjct: 525 NRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGL 577
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 3e-14
Identities = 23/120 (19%), Positives = 38/120 (31%), Gaps = 16/120 (13%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---------FSGCPDLRI 467
+ + + LS + S + + L N +T IP+ + L
Sbjct: 674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS-IPENSLKPKDGNYKNTYLLTT 732
Query: 468 IHLEDNQLTGPLPSSLM--NLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLH 523
I L N+LT L LP L + V N S + P+ S+ +
Sbjct: 733 IDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAE 790
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 4e-14
Identities = 24/117 (20%), Positives = 44/117 (37%), Gaps = 12/117 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLE- 471
+T I L LT + D T L L + + N + P L+ +
Sbjct: 728 YLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRH 785
Query: 472 -----DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
N++ P+ + P+L +L + +N + V L + +L+ A N N+
Sbjct: 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADNPNIS 841
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 4e-13
Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 5/98 (5%)
Query: 416 PSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 474
P I + ++ NL + L K+ L L N + + F L + L+ NQ
Sbjct: 548 PKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYNQ 606
Query: 475 LTGPLPSSLM-NLPNLRELYVQNNMLSGTVPSSLLSKN 511
+ +P + L +N L +P+ +K+
Sbjct: 607 IEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 17/110 (15%), Positives = 30/110 (27%), Gaps = 20/110 (18%)
Query: 422 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--------------------FSG 461
+ N I + +L+ L ++ + T +S
Sbjct: 430 IGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSN 489
Query: 462 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511
DL + L + LP L +LP L+ L + N
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 5e-12
Identities = 21/115 (18%), Positives = 39/115 (33%), Gaps = 15/115 (13%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEL------WLDGNSLTGPIPD-FSGCPDLRII 468
P ++ + +S + P+ S L +GN + P + CP L +
Sbjct: 753 PYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS----GTVPSSLLSKNVVLNYAGN 519
+ N + + L P L L + +N +V + + VL Y
Sbjct: 812 QIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 5e-11
Identities = 13/102 (12%), Positives = 33/102 (32%), Gaps = 10/102 (9%)
Query: 416 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIPDFSGCPD------LRI 467
+ + S L IP+ + + + N + + S D
Sbjct: 619 DQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677
Query: 468 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
+ L N++ + + + NN+++ ++P + L
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLK 718
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 20/118 (16%), Positives = 35/118 (29%), Gaps = 21/118 (17%)
Query: 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP---- 478
++ I D ++ N +T L+II+ ++ T
Sbjct: 408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV 467
Query: 479 ---------------LPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
S NL +L ++ + N +P L L + LN A N
Sbjct: 468 DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 13/120 (10%), Positives = 38/120 (31%), Gaps = 4/120 (3%)
Query: 398 DPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP 457
+ + + ++ +T + L+ G +P + +L+ L L +S T
Sbjct: 307 ELDMWGDQPGVDLDN--NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGR 364
Query: 458 DFSG-CPDLRIIHLEDNQLTGPLPS-SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 515
F + +++ L L + + ++ + K+ ++
Sbjct: 365 LFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRIS 424
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 17/122 (13%), Positives = 41/122 (33%), Gaps = 11/122 (9%)
Query: 412 SDPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHL 470
D + + + + + L L L +++ P+ I L
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISL 425
Query: 471 ED-------NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
+D N++T + ++ L L+ +Y N+ + ++ ++ +YA
Sbjct: 426 KDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTY-DNIAVDWEDANSDYAKQYENE 483
Query: 524 EG 525
E
Sbjct: 484 EL 485
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 9/62 (14%), Positives = 22/62 (35%), Gaps = 3/62 (4%)
Query: 465 LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS---LLSKNVVLNYAGNIN 521
+ + L G +P ++ L L+ L + + + L+ ++ I
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384
Query: 522 LH 523
+H
Sbjct: 385 MH 386
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-15
Identities = 18/108 (16%), Positives = 34/108 (31%), Gaps = 4/108 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 473
S+ + ++ + N S+ ++L L L L F L+++++ N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
L S L +L L N + + N N
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-14
Identities = 15/101 (14%), Positives = 30/101 (29%), Gaps = 3/101 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDN 473
S+ + LS + ++ L L L ++L F L + +
Sbjct: 376 NSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 514
+ L +L L + N S++ + L
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL 475
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-14
Identities = 20/96 (20%), Positives = 33/96 (34%), Gaps = 1/96 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+ + LS + L L L L GN + P FSG L + + +
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
L + L L++L V +N + + S
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-14
Identities = 18/99 (18%), Positives = 32/99 (32%), Gaps = 4/99 (4%)
Query: 410 CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRII 468
+ L+ +P D+ SS + L N L FS +L+ +
Sbjct: 5 NPCIEVVPNITYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWL 61
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
L ++ + L +L L + N + P S
Sbjct: 62 DLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSF 100
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-13
Identities = 14/86 (16%), Positives = 28/86 (32%), Gaps = 1/86 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
++T + LS L L L L + N+L ++ L + N+
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLS 500
+ +L + NN ++
Sbjct: 533 IETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-11
Identities = 21/116 (18%), Positives = 37/116 (31%), Gaps = 7/116 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLEDN 473
S+ + L + +L +L +L + N + +P FS +L + L N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163
Query: 474 QLTGPLPSSLMNLPNLR----ELYVQNNMLSGTVPSSL-LSKNVVLNYAGNINLHE 524
+ + L L L + N + + K L GN N
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSN 219
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-11
Identities = 24/109 (22%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 416 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 473
PS++ + LS L+ G +SL L L N +F G +L+ + + +
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHS 409
Query: 474 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
L S+ ++L L L + L+ L AGN
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-10
Identities = 20/106 (18%), Positives = 39/106 (36%), Gaps = 4/106 (3%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 473
+I L+ N + L+++ + L G S+ + D + + +
Sbjct: 259 CDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRC 317
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
QL P+ +LP L+ L + N S + L L+ + N
Sbjct: 318 QLKQ-FPTL--DLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRN 360
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 5e-07
Identities = 20/108 (18%), Positives = 35/108 (32%), Gaps = 9/108 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + L DL L L L N + P L + L N L
Sbjct: 307 FKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGSI-SFKKVALPSLSYLDLSRNAL 362
Query: 476 T--GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
+ G S + +LR L + N + ++ L + L++ +
Sbjct: 363 SFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHS 409
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-06
Identities = 14/114 (12%), Positives = 24/114 (21%), Gaps = 10/114 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG-------PIPDFSGCPDLRI 467
+ + L + NI L L+ L L G D+ I
Sbjct: 204 IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263
Query: 468 IHLED--NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
L N+ + + + K L+
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRC 317
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 14/102 (13%), Positives = 30/102 (29%), Gaps = 5/102 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLS----SLVELWLDGNSLTGPIPDFSGCPDLRIIHLE 471
++ + LS + +DL L + L + N + L + L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212
Query: 472 DNQLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNV 512
N + + + L NL L + + ++
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 4e-15
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 662
K IGSG G+V + +A+K L+ N KR + E+ L+ ++H+N++
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 126
Query: 663 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
L EE + V LV E M L + + L HE+ + ++ GI++
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQM------LCGIKH 179
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
LH+ + IHRDLK SNI++ K+ DFGL++ + ++ V T Y PE
Sbjct: 180 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYV-VTRYYRAPEV 234
Query: 777 YISQQLTDKSDVYSFGVILLELISGQ 802
+ + D++S G I+ E++ +
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 48/233 (20%), Positives = 87/233 (37%), Gaps = 62/233 (26%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVK--VLTSNSYQGKREFTN---------EVTLLSR 653
+++ I SG +G V G +G +A+K T + + ++ E+ LL+
Sbjct: 26 VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85
Query: 654 IHHRNLVQ----FLGYCQEEGRSV-LVYEFM----------HNGTLKEH-----LYGTLT 693
HH N++ F+ + + + LV E M + +Y L
Sbjct: 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHIL- 144
Query: 694 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753
G+ LH V +HRDL NILL + + DF L++
Sbjct: 145 ------------------LGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLARE 183
Query: 754 AVDGAS---HVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
A+ +V+ Y PE + + K D++S G ++ E+ + +
Sbjct: 184 DTADANKTHYVT-----HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-15
Identities = 14/98 (14%), Positives = 31/98 (31%), Gaps = 5/98 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 472
S+ + LS + + S+ L L L ++L + + F +L + +
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISH 430
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
L +L L + N + ++
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-14
Identities = 26/110 (23%), Positives = 45/110 (40%), Gaps = 6/110 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
++ + +S + LSSL L + GNS F+ +L + L
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
QL P++ +L +L+ L + +N L +VP + + L I LH
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQK---IWLH 526
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 7e-12
Identities = 19/97 (19%), Positives = 33/97 (34%), Gaps = 5/97 (5%)
Query: 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTG 477
N IP +L S L L N L F P+L+++ L ++
Sbjct: 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 478 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 514
+ +L +L L + N + ++ S L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSL 102
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 21/104 (20%), Positives = 37/104 (35%), Gaps = 4/104 (3%)
Query: 416 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 473
PS+ + LS L+ G +SL L L N + +F G L + + +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 474 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
L S ++L NL L + + + + + L
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEV 449
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-11
Identities = 19/89 (21%), Positives = 39/89 (43%), Gaps = 2/89 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 473
S+ V+ ++ + N D T+L +L L L L P F+ L+++++ N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGT 502
QL L +L+++++ N +
Sbjct: 505 QLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 20/115 (17%), Positives = 40/115 (34%), Gaps = 8/115 (6%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLE 471
++ + L+ + + LSSL +L +L L+ +++
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 472 DNQLT-GPLPSSLMNLPNLRELYVQNNMLSGTVP------SSLLSKNVVLNYAGN 519
N + LP NL NL L + +N + + N+ L+ + N
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 22/86 (25%), Positives = 36/86 (41%), Gaps = 1/86 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 474
P + V+ LS + LS L L L GN + + FSG L+ + +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLS 500
L + +L L+EL V +N++
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 7/111 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-GPIPD-FSGCPDLRIIHLEDN 473
S+ + NL + L +L EL + N + +P+ FS +L + L N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 474 QLTGPLPSSLMNLPNLR----ELYVQNNMLSGTVPSSLLSKN-VVLNYAGN 519
++ + L L + L + N ++ P + L N
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 20/73 (27%), Positives = 29/73 (39%), Gaps = 3/73 (4%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGC 462
++L ++T + LS L P+ LSSL L + N L +PD F
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VPDGIFDRL 517
Query: 463 PDLRIIHLEDNQL 475
L+ I L N
Sbjct: 518 TSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 17/107 (15%), Positives = 38/107 (35%), Gaps = 5/107 (4%)
Query: 414 PQPSITVIHLSSKNLTGN-IPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 472
+I L+ + + I L+++ L ++ + DFS + + L +
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVN 313
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ P+ + L +L+ L +N L L+ + N
Sbjct: 314 CKFGQ-FPT--LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRN 357
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-15
Identities = 20/96 (20%), Positives = 33/96 (34%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 473
+ S+ I+L + S L EL L L+ G L+ + L N
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSAN 311
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
+ S N P+L L ++ N + + L
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-15
Identities = 23/109 (21%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIHLE 471
+ V++LS L + L +L L L GN L I+ L
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 472 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGN 519
L+ + +L + + + +N L+ + +L K + LN A N
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASN 533
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-14
Identities = 20/107 (18%), Positives = 32/107 (29%), Gaps = 3/107 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
S + S L + ++L +L L L + D F L + L N
Sbjct: 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
L ++L L+ L+ +S L L N
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-14
Identities = 19/109 (17%), Positives = 37/109 (33%), Gaps = 5/109 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+ + L++ L + L+ +L L+ ++ L ++L N
Sbjct: 81 HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS----KNVVLNYAGN 519
++ L+ L QNN + + S N+ LN GN
Sbjct: 141 ISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-14
Identities = 21/123 (17%), Positives = 45/123 (36%), Gaps = 4/123 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
++ + ++ L +L L+L N ++ L+++ ++N
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164
Query: 475 LTGPLPSSLMNLPNLR--ELYVQNNMLSGTVPSSLLSKNV-VLNYAGNINLHEGGRGAKH 531
+ + +L L + N ++G P + S LN+ G NL +G K+
Sbjct: 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224
Query: 532 LNI 534
I
Sbjct: 225 STI 227
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-14
Identities = 16/94 (17%), Positives = 27/94 (28%), Gaps = 2/94 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+ ++LS + L L L L F L++++L +
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
L LP L+ L +Q N
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-13
Identities = 18/99 (18%), Positives = 30/99 (30%), Gaps = 4/99 (4%)
Query: 410 CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRII 468
+ + + L IP L +S L N L FS +L +
Sbjct: 6 QKCIEKEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFL 62
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
L Q+ + + L L + N L ++L
Sbjct: 63 DLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETAL 101
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-12
Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 4/105 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLE 471
PS+T + + + + L L +L EL L + + L+ ++L
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 472 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
N+ + P L L + L S +L
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-11
Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 2/88 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+ ++ LS +L+ T L + + L N LT + S + + +L N
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYL-NLASNH 534
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGT 502
++ LPS L L R + ++ N L T
Sbjct: 535 ISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-09
Identities = 21/121 (17%), Positives = 41/121 (33%), Gaps = 8/121 (6%)
Query: 406 SWLQCNSDPQPSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPD-FSGC 462
+ ++ + ++ I L + + SL + P F G
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 463 PD--LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAG 518
+ + I+L+ + ++ L+EL + LS +PS L LS L +
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 519 N 519
N
Sbjct: 311 N 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 608 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFTN----EVTLLSRIH---HRN 658
+IG G +G VY + G +A+K V N G EV LL R+ H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 659 LVQFL-----GYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAEDA 710
+V+ + E + LV+E + L + L E + +++
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF------ 129
Query: 711 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGA-SHVSSIVRGT 768
+G+++LH C I+HRDLK NIL+ K++DFGL++ ++ A + V +V T
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV--VV--T 182
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
+ Y PE + D++S G I E+ +
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 662
+GSG +G V + G+++A+K L+ + KR + E+ LL + H N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGL 88
Query: 663 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
L LV FM L++ + + E+ + ++ KG++Y
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQML------KGLKY 141
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLD 773
+H+ ++HRDLK N+ +++ K+ DFGL A H + + G V Y
Sbjct: 142 IHSA---GVVHRDLKPGNLAVNEDCELKILDFGL-------ARHADAEMTGYVVTRWYRA 191
Query: 774 PEYYISQQLTDKS-DVYSFGVILLELISGQ 802
PE +S +++ D++S G I+ E+++G+
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 53/252 (21%), Positives = 92/252 (36%), Gaps = 68/252 (26%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 660
++ IG G +G VY K +A+K + + KR E+T+L+R+ ++
Sbjct: 30 IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLKSDYII 88
Query: 661 Q----FLGYCQEEGRSV-LVYEFM---------HNGTLK-EH----LYGTLTHEQRINWI 701
+ + + + +V E L EH LY L
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLL--------- 139
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASH 760
G ++H IIHRDLK +N LL++ KV DFGL+ + ++
Sbjct: 140 ----------LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 761 VSSIVRGTVGYLDPEYYISQQLTD--------------------KS-DVYSFGVILLELI 799
+ + + + +QLT KS D++S G I EL+
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 800 SGQEAISNEKFG 811
+ ++ N+
Sbjct: 247 NMLQSHINDPTN 258
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 55/229 (24%), Positives = 87/229 (37%), Gaps = 54/229 (23%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ 661
L+ +G G +GVV G+ +A+K + R E+ +L H N++
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHENIIT 73
Query: 662 ----FLGYCQEEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKR 703
E V ++ E M L +H +Y TL
Sbjct: 74 IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL----------- 122
Query: 704 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 763
+ ++ LH V IHRDLK SN+L++ + KV DFGL++ + A+ S
Sbjct: 123 --------RAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 764 IVRGTVG---------YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
G Y PE ++ ++ DV+S G IL EL +
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 14/97 (14%), Positives = 29/97 (29%), Gaps = 3/97 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDN 473
S+ + LS + + S+ L L L ++L F +L + +
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
L +L L + N + ++
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 25/104 (24%), Positives = 38/104 (36%), Gaps = 4/104 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG---PIPDFSGCPDLRIIHLED 472
S T + L S L KL+ L +L L N L+ G L+ + L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
N + + S+ + L L L Q++ L S+ L Y
Sbjct: 88 NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 130
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 19/97 (19%), Positives = 39/97 (40%), Gaps = 5/97 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
++ + +S + + LSSL L + GNS F+ +L + L
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
QL P++ +L +L+ L + +N ++ +
Sbjct: 185 CQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK 220
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
S+ V+ ++ + N D T+L +L L L L + F+ L+++++
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSH 208
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
N L +L+ L N + T L
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQ 244
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 20/97 (20%), Positives = 36/97 (37%), Gaps = 4/97 (4%)
Query: 416 PSITVIHLSSKNLT-GNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 473
+T + LSS L+ S +SL L L N + +F G L + + +
Sbjct: 52 TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 111
Query: 474 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
L S ++L NL L + + + + +
Sbjct: 112 NLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFN 147
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 17/89 (19%), Positives = 33/89 (37%), Gaps = 6/89 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
++T + LS L + LSSL L + N+ + + L+++
Sbjct: 175 RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSL 232
Query: 473 NQLTGPLPSSLMNLP-NLRELYVQNNMLS 500
N + L + P +L L + N +
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 5e-14
Identities = 21/104 (20%), Positives = 44/104 (42%), Gaps = 3/104 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T + + + ++ + + L+ L L + N ++ I + L + L +NQL
Sbjct: 243 SQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQL 299
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ L NL L++ N ++ P + LSK ++A
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 5/107 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
SIT + ++ + + +I + L++L L L+GN +T I S L +++ N++
Sbjct: 44 ESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI 100
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 522
T S+L NL NLRELY+ + +S P + L+K LN N NL
Sbjct: 101 TDI--SALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGANHNL 145
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 5e-12
Identities = 18/86 (20%), Positives = 35/86 (40%), Gaps = 5/86 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+ ++++ S ++ S L LS L L+L+ N L + G +L + L N
Sbjct: 265 TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLS 500
+T L +L + N ++
Sbjct: 323 ITDI--RPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 8e-12
Identities = 22/104 (21%), Positives = 46/104 (44%), Gaps = 4/104 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T +++ + +T S L L++L EL+L+ ++++ I + + ++L N
Sbjct: 88 VKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHN 144
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
S L N+ L L V + + P + L+ L+ N
Sbjct: 145 LS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYN 187
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 9e-12
Identities = 25/104 (24%), Positives = 41/104 (39%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + L+ + P L L+SL N +T I + L + + +N++
Sbjct: 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKI 233
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T S L NL L L + N +S L+K +LN N
Sbjct: 234 TDL--SPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSN 275
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 1e-10
Identities = 21/104 (20%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + ++ + P + L+ L L L+ N + I + L NQ+
Sbjct: 155 TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQI 211
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T + + N+ L L + NN ++ P + LS+ L N
Sbjct: 212 TDI--TPVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTN 253
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 1e-10
Identities = 15/86 (17%), Positives = 36/86 (41%), Gaps = 4/86 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ ++L+ N++ S L L+ + L L N + S L + + ++++
Sbjct: 110 TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV 167
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSG 501
+ + NL +L L + N +
Sbjct: 168 KD--VTPIANLTDLYSLSLNYNQIED 191
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 7e-08
Identities = 15/86 (17%), Positives = 28/86 (32%), Gaps = 3/86 (3%)
Query: 434 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493
L+ + L S+T + + + + ++ + L NL L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLN 72
Query: 494 VQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ N ++ P S L K L N
Sbjct: 73 LNGNQITDISPLSNLVKLTNLYIGTN 98
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 38/216 (17%)
Query: 608 KIGSGGFGVVYYGK-LKDGKEI-AVK-VLTSNSYQGK-----REFTNEVTLL---SRIHH 656
+IG G +G V+ + LK+G A+K V +G RE V +L H
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE----VAVLRHLETFEH 73
Query: 657 RNLVQFL-----GYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAE 708
N+V+ E + LV+E + L + + E + + +L
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL---- 129
Query: 709 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGA-SHVSSIVR 766
+G+++LH+ ++HRDLK NIL+ + K++DFGL++ ++ A + V +V
Sbjct: 130 --LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VV- 181
Query: 767 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
T+ Y PE + D++S G I E+ +
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 26/104 (25%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ + L+ L L L++L +L L N ++ + SG L + L NQ+
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI 277
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ S L L L L + N L P S L L N
Sbjct: 278 SNI--SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 319
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-13
Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++T + L++ ++ P L+ L+ L EL L N ++ I +G L + L +NQL
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQL 299
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
S + NL NL L + N +S P S L+K L + N
Sbjct: 300 EDI--SPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNN 341
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-13
Identities = 17/106 (16%), Positives = 45/106 (42%), Gaps = 6/106 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++T + L N++ P ++ L+ L L+ N ++ + + ++ + NQ+
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQI 365
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 521
+ + L NL + +L + + + P + + + N N+
Sbjct: 366 SDL--TPLANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVT 408
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-12
Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T + L + ++ P L L++L L L+ N L I S +L + L N +
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNI 321
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ P + +L L+ L+ NN +S + L+ L+ N
Sbjct: 322 SDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHN 363
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-11
Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T + + + L++L ++ N LT I L I + +NQ+
Sbjct: 46 DQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQI 102
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ L NL NL L + NN ++ P L+ L + N
Sbjct: 103 AD--ITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN 144
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 24/104 (23%), Positives = 44/104 (42%), Gaps = 6/104 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
S+ + + +T P L L++L L + N ++ I + +L + +NQ+
Sbjct: 156 TSLQQLSFGN-QVTDLKP--LANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQI 211
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ + L L NL EL + N L + L+ L+ A N
Sbjct: 212 SDI--TPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANN 253
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 7e-11
Identities = 28/105 (26%), Positives = 50/105 (47%), Gaps = 5/105 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++T I+ S+ LT P L L+ LV++ ++ N + I + +L + L +NQ+
Sbjct: 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQI 124
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 520
T L NL NL L + +N +S S L+ L++ +
Sbjct: 125 TDI--DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV 167
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 6e-10
Identities = 29/104 (27%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ + LSS ++ S L+ L+SL +L GN +T P + L + + N++
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP-LANLTTLERLDISSNKV 189
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ S L L NL L NN +S P +L+ L+ GN
Sbjct: 190 SDI--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGN 231
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 19/101 (18%), Positives = 38/101 (37%), Gaps = 7/101 (6%)
Query: 423 LSSKNLTGNIP----SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP 478
L S +T + P T L+ ++ L ++T + + + + + +
Sbjct: 3 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI 61
Query: 479 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ L NL ++ NN L+ P L+K V + N
Sbjct: 62 --DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNN 100
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 12/104 (11%), Positives = 30/104 (28%), Gaps = 3/104 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + + ++ S L L+++ L N ++ + + + + L D
Sbjct: 331 TKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQAW 387
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T + N+ + L S + N
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWN 431
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 49/221 (22%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ-- 661
IG G +G+V + +A+K ++ + +R E+ +L R H N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGIN 91
Query: 662 --FLGYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHEQRINWIKRLE 705
E+ + V +V + M L +H LY L
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL------------- 138
Query: 706 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI- 764
+G++Y+H+ V +HRDLK SN+LL+ K+ DFGL++ A H +
Sbjct: 139 ------RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 765 --VRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
V T Y PE ++ + KS D++S G IL E++S +
Sbjct: 190 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 64/239 (26%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIH-HRNL 659
L KK+G G +G+V+ + G+ +AVK + NS +R F E+ +L+ + H N+
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENI 71
Query: 660 VQFLGYCQ-EEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKRL 704
V L + + R V LV+++M L+ H +Y +
Sbjct: 72 VNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLI------------ 119
Query: 705 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764
K I+YLH+G + +HRD+K SNILL+ KV+DFGLS+ V+ ++I
Sbjct: 120 -------KVIKYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 765 VRGTVGYLDPEYYISQQLTD---------------------KSDVYSFGVILLELISGQ 802
+ LTD D++S G IL E++ G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 51/271 (18%), Positives = 109/271 (40%), Gaps = 64/271 (23%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIH------- 655
+K+G G F V+ K + + +A+K++ + + E + LL R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----IKLLQRVNDADNTKE 80
Query: 656 ----HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH-----------LYGTL--THEQRI 698
++++ L + F H G H L + + I
Sbjct: 81 DSMGANHILKLLDH------------FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 128
Query: 699 N--WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA------KVSDFGL 750
++K+ I++ G++Y+H C IIH D+K N+L++ K++D G
Sbjct: 129 PLIYVKQ--ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184
Query: 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 810
+ + + H ++ ++ T Y PE + +D++S ++ ELI+G ++
Sbjct: 185 ACWYDE---HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240
Query: 811 GANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841
+ ++ A+ I ++ G + LL
Sbjct: 241 HSYTKDDDHIAQ--II--ELLGELPSYLLRN 267
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 48/250 (19%), Positives = 90/250 (36%), Gaps = 73/250 (29%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 660
+ IG+G +G V + + +A+K + + KR E+ +L+R++H ++V
Sbjct: 57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDHVV 115
Query: 661 Q----FLGYCQEEGRSV-LVYEFMH---------NGTLK-EH----LYGTLTHEQRINWI 701
+ + E+ + +V E L H LY L
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLL--------- 166
Query: 702 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS------KFAV 755
G++Y+H+ + +HRDLK +N L+++ KV DFGL+ +
Sbjct: 167 ----------VGVKYVHSAGI---LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 756 DGASHVSSIVRGTVGYLDPEYYISQQLTD--------------------KS-DVYSFGVI 794
+ + +QLT ++ DV+S G I
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273
Query: 795 LLELISGQEA 804
EL++ +
Sbjct: 274 FAELLNMIKE 283
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 57/223 (25%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 662
+ +GSG +G V + G ++A+K L + KR + E+ LL + H N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIGL 89
Query: 663 L-----GYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHEQRINWIKR 703
L ++ LV FM + L ++ +Y L
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML----------- 138
Query: 704 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 763
KG+ Y+H IIHRDLK N+ +++ K+ DFGL A S
Sbjct: 139 --------KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL-------ARQADS 180
Query: 764 IVRGTVG---YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
+ G V Y PE ++ ++ D++S G I+ E+I+G+
Sbjct: 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 19/86 (22%), Positives = 35/86 (40%), Gaps = 2/86 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 474
PS+ + L I L +L L L ++ +P+ + L + + N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNH 229
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLS 500
P S L +L++L+V N+ +S
Sbjct: 230 FPEIRPGSFHGLSSLKKLWVMNSQVS 255
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 26/96 (27%), Positives = 41/96 (42%), Gaps = 4/96 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+ ++L N+ L L L L NS+ I F+G L + L DN
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFDN 133
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
LT + L LREL+++NN + ++PS +
Sbjct: 134 WLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 25/95 (26%), Positives = 49/95 (51%), Gaps = 4/95 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
++ ++L N+ ++P +LT L L EL + GN P F G L+ + + ++Q
Sbjct: 196 FNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
++ ++ L +L EL + +N LS ++P L +
Sbjct: 254 VSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFT 287
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 21/85 (24%), Positives = 33/85 (38%), Gaps = 5/85 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ V+ L ++ I L+SL L L N LT IP F LR + L +
Sbjct: 99 HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRN 156
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNN 497
N + + +P+L L +
Sbjct: 157 NPIESIPSYAFNRVPSLMRLDLGEL 181
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 5/87 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ + +S + I LSSL +LW+ + ++ I F G L ++L
Sbjct: 218 VGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAH 275
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNML 499
N L+ L L EL++ +N
Sbjct: 276 NNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 57/223 (25%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 662
+GSG +G V K G +AVK L+ + KR + E+ LL + H N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGL 93
Query: 663 L-----GYCQEEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKR 703
L EE V LV M L +H +Y L
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----------- 142
Query: 704 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 763
+G++Y+H+ IIHRDLK SN+ +++ K+ DFGL A H +
Sbjct: 143 --------RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL-------ARHTAD 184
Query: 764 IVRGTVG---YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 802
+ G V Y PE ++ +++ D++S G I+ EL++G+
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 38/170 (22%), Positives = 65/170 (38%), Gaps = 30/170 (17%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 662
+ KKIG G FG + GK L + +A+K+ S + E ++ + Q
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 715
+ + +V E + G E L+ + R L IA +E
Sbjct: 71 YYFGPCGKYNAMVLELL--GPSLEDLF---------DLCDRTFSLKTVLMIAIQLISRME 119
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVS-----DFGLSKFAVDGASH 760
Y+H+ +I+RD+K N L+ + DF L+K +D +
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 58/232 (25%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHRNLVQF 662
K +G GG G+V+ K +A+K + ++ K E+ ++ R+ H N+V+
Sbjct: 15 DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKV 73
Query: 663 L-------------GYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHE 695
E SV +V E+M G L +EH +Y L
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL--- 130
Query: 696 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFA 754
+G++Y+H+ V +HRDLK +N+ ++ + + K+ DFGL++
Sbjct: 131 ----------------RGLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 755 VDGASHVSSI---VRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 802
SH + + T Y P +S T D+++ G I E+++G+
Sbjct: 172 DPHYSHKGHLSEGL-VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 5e-13
Identities = 19/101 (18%), Positives = 37/101 (36%), Gaps = 3/101 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ ++L + ++ + + L L L N L P+F + I L +N+L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+ +L NL ++ N SKN +
Sbjct: 227 VL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT 266
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 19/86 (22%), Positives = 34/86 (39%), Gaps = 3/86 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+ ++ +L + S ++ EL L GN L+ + L +++L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLS 500
L L +L LR L + NN +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 5e-11
Identities = 18/107 (16%), Positives = 41/107 (38%), Gaps = 7/107 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
PSI +H ++ N++ + ++L N +T + D ++ + L+ N
Sbjct: 99 PSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLN 154
Query: 474 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
++ + L L +Q N + + +K L+ + N
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSN 201
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 15/82 (18%), Positives = 30/82 (36%), Gaps = 1/82 (1%)
Query: 439 LSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497
+ + +SL + +++ + L N L+ + L L L + +N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 498 MLSGTVPSSLLSKNVVLNYAGN 519
+L T+ LS L+ N
Sbjct: 69 VLYETLDLESLSTLRTLDLNNN 90
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 14/84 (16%), Positives = 32/84 (38%), Gaps = 4/84 (4%)
Query: 427 NLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN 485
+L N +L S+ L N+++ G + I+L +N++T
Sbjct: 86 DLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQG---KKNIYLANNKITMLRDLDEGC 142
Query: 486 LPNLRELYVQNNMLSGTVPSSLLS 509
++ L ++ N + + L +
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAA 166
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 14/108 (12%), Positives = 28/108 (25%), Gaps = 2/108 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T I L + L I L +L L GN + R+ + +
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
+ + +P+ + + L + L
Sbjct: 273 KKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLS 319
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 12/96 (12%), Positives = 22/96 (22%), Gaps = 3/96 (3%)
Query: 422 HLSSKNLTGNIPSDLTKL--SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPL 479
++L L L L G+ + R I Q +
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352
Query: 480 PSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 515
+ L + L S+ + L+
Sbjct: 353 DQVTLRKQAKITLEQKKKALD-EQVSNGRRAHAELD 387
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 25/188 (13%), Positives = 59/188 (31%), Gaps = 46/188 (24%)
Query: 605 LEKKIGSGGFGVVYYGK---------LKDGKEIAVKVLTSNS----------YQGKREFT 645
L+ G++Y ++ ++K+ + K
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 646 NEVTLLSRIHHRNLVQFLGYCQEEGR-SVLVYEFMHNGTLKEHLYGT-LTHEQRINWIKR 703
N+ L + +G+ + + LV G L + ++ +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP----------SLGRSL--QSALDVSPK 153
Query: 704 --------LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKF 753
L++A +E+LH +H ++ + NI +D +++V + +G +
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
Query: 754 AVDGASHV 761
HV
Sbjct: 211 YCPSGKHV 218
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 9e-13
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 3/96 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ ++L + ++ + L L L N L P+F + I L +N+L
Sbjct: 169 DTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511
+ +L NL ++ N SKN
Sbjct: 227 VL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 18/106 (16%), Positives = 40/106 (37%), Gaps = 5/106 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 474
PSI +H ++ N++ + ++L N +T D ++ + L+ N+
Sbjct: 99 PSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
Query: 475 LTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ + L L +Q N + + +K L+ + N
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSN 201
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 20/86 (23%), Positives = 35/86 (40%), Gaps = 3/86 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 474
+ ++ +L + S ++ EL L GN L+ D + L +++L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLS 500
L L +L LR L + NN +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 16/89 (17%), Positives = 31/89 (34%), Gaps = 1/89 (1%)
Query: 432 IPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 490
I + + +SL + +++ + L N L+ + L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 491 ELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
L + +N+L T+ LS L+ N
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNN 90
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 14/85 (16%), Positives = 32/85 (37%), Gaps = 4/85 (4%)
Query: 427 NLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN 485
+L N +L S+ L N+++ G + I+L +N++T
Sbjct: 86 DLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQG---KKNIYLANNKITMLRDLDEGC 142
Query: 486 LPNLRELYVQNNMLSGTVPSSLLSK 510
++ L ++ N + + L +
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAAS 167
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 15/77 (19%), Positives = 24/77 (31%), Gaps = 9/77 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T I L + L I L +L L GN C LR ++ ++
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH--------CGTLRDFFSKNQRV 264
Query: 476 TGPLPSSLMNLPNLREL 492
++ L E
Sbjct: 265 QTVAKQTVKKLTGQNEE 281
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 21/86 (24%), Positives = 36/86 (41%), Gaps = 2/86 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 474
PS+ + L I LS+L L L +L IP+ + L + L N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNH 218
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLS 500
L+ P S L +L++L++ + +
Sbjct: 219 LSAIRPGSFQGLMHLQKLWMIQSQIQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 23/96 (23%), Positives = 44/96 (45%), Gaps = 4/96 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+ +++L + + L L L L N + I F+G +L + L DN
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDN 122
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
+LT + + L L+EL+++NN + ++PS +
Sbjct: 123 RLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 30/109 (27%), Positives = 52/109 (47%), Gaps = 9/109 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
++ ++L+ NL IP +LT L L EL L GN L+ I F G L+ + + +
Sbjct: 185 SNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQS 241
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 519
Q+ ++ NL +L E+ + +N L+ +P L L ++ N
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 22/89 (24%), Positives = 38/89 (42%), Gaps = 6/89 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ ++ LS ++ I L++L L L N LT IP+ F L+ + L +
Sbjct: 88 RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRN 145
Query: 473 NQLTGPLPSSLMNLPNLRELYVQ-NNMLS 500
N + + +P+LR L + LS
Sbjct: 146 NPIESIPSYAFNRIPSLRRLDLGELKRLS 174
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 19/87 (21%), Positives = 33/87 (37%), Gaps = 5/87 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ + LS +L+ I L L +LW+ + + I F L I+L
Sbjct: 207 IKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAH 264
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNML 499
N LT L +L +++ +N
Sbjct: 265 NNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 20/98 (20%), Positives = 38/98 (38%), Gaps = 6/98 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ +HL L + L++L L+L N+L +PD F +L + L
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHG 162
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
N+++ + L +L L + N ++ V
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 29/112 (25%), Positives = 52/112 (46%), Gaps = 9/112 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
++ ++L L +P D L +L L+L GN ++ +P+ F G L + L
Sbjct: 129 AALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQ 186
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
N++ P + +L L LY+ N LS +P+ L+ L Y + L++
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQY---LRLND 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 21/102 (20%), Positives = 41/102 (40%), Gaps = 5/102 (4%)
Query: 409 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRI 467
C +P +T + L +P + ++ ++L GN ++ P F C +L I
Sbjct: 5 ACVCYNEPKVTT-SCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTI 60
Query: 468 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
+ L N L ++ L L +L + +N +V +
Sbjct: 61 LWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 23/98 (23%), Positives = 35/98 (35%), Gaps = 5/98 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+ I L ++ + +L LWL N L I F+G L + L DN
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDN 90
Query: 474 -QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
QL P++ L L L++ L + L
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRG 127
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 19/85 (22%), Positives = 35/85 (41%), Gaps = 5/85 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
++T + L ++ ++P L SL L L N + + F L ++L
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFA 210
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNN 497
N L+ +L L L+ L + +N
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDN 235
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 42/224 (18%), Positives = 84/224 (37%), Gaps = 48/224 (21%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 662
+ ++IG G FGV++ G L + +++A+K S + +E + +
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 715
+ QE +VLV + + G E L + R A+ ++
Sbjct: 72 YYFGQEGLHNVLVIDLL--GPSLEDLL---------DLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAK-----VSDFGLSKFAVDGASHV------SSI 764
+H +++RD+K N L+ + V DFG+ KF D +
Sbjct: 121 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177
Query: 765 VRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQ 802
+ GT Y+S ++ + + D+ + G + + + G
Sbjct: 178 LSGTA------RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 662
L +KIGSG FG +Y G + G+E+A+K+ + + E + + +
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTI 70
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
E +V+V E + G E L+ + + + + L +A+ IEY+H+
Sbjct: 71 RWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTV--LLLADQMISRIEYIHSKN- 125
Query: 723 PAIIHRDLKSSNILLDKHMRAK---VSDFGLSKFAVDGASHV------SSIVRGTVGYLD 773
IHRD+K N L+ + + DFGL+K D +H + + GT Y
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 774 PEYYISQQLTDKSDVYSFGVILLELISGQ 802
++ + + + D+ S G +L+ G
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
++ I ++ N+T IP L SL EL LDGN +T + G +L + L N
Sbjct: 171 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFN 226
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
++ SL N P+LREL++ NN L VP L
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 22/105 (20%), Positives = 43/105 (40%), Gaps = 9/105 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLT-GPIPD--FSGCPDLRIIHLE 471
++ + + +T + L+ ++ + L N L I + F G L I +
Sbjct: 121 KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179
Query: 472 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
D +T +P L P+L EL++ N ++ V ++ L L
Sbjct: 180 DTNITT-IPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAK 220
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 28/114 (24%), Positives = 43/114 (37%), Gaps = 8/114 (7%)
Query: 399 PCLPVPWSW-LQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP 457
P +P C Q + V+ S L +P DL L L N +T I
Sbjct: 13 PEVPEIEPMGPVCPFRCQCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITE-IK 68
Query: 458 --DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
DF +L + L +N+++ P + L L LY+ N L +P +
Sbjct: 69 DGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK 121
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 14/115 (12%), Positives = 40/115 (34%), Gaps = 12/115 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 474
++ + LS +++ + + L L EL L+ N L + +++++L +N
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274
Query: 475 LTG------PLPSSLMNLPNLRELYVQNNMLSGT-VPSSL---LSKNVVLNYAGN 519
++ P + + + +N + + S + +
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 21/108 (19%), Positives = 36/108 (33%), Gaps = 24/108 (22%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
P ++ L + +T D L +L L L N ++ I F+ L ++L N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLSKN 110
Query: 474 QLT---GPLPSSLM------------------NLPNLRELYVQNNMLS 500
QL +P +L L + + + N L
Sbjct: 111 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 158
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 24/109 (22%), Positives = 43/109 (39%), Gaps = 7/109 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+ V+ +S + + +L L + +LT +P LR ++L N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYN 258
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 519
++ S L L L+E+ + L+ V L+ VLN +GN
Sbjct: 259 PISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGN 306
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 20/97 (20%), Positives = 38/97 (39%), Gaps = 6/97 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
++T + +S + + + L +L L + N L I FSG L + LE
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEK 161
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
LT +L +L L L +++ ++ +
Sbjct: 162 CNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFK 197
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 24/104 (23%), Positives = 45/104 (43%), Gaps = 6/104 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
S+ + L NLT +IP++ L+ L L+ L L ++ I D F L+++ +
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISH 209
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+ + + NL L + + L+ VP + V L +
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRF 252
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 6/97 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
P + + L+ ++ + L +L L L N L IP F+G +L + + +
Sbjct: 56 PHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISE 113
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
N++ L +L NL+ L V +N L + S
Sbjct: 114 NKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFS 149
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 20/96 (20%), Positives = 38/96 (39%), Gaps = 5/96 (5%)
Query: 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDN 473
+ K +P + + L L N + +F+ P L + L +N
Sbjct: 10 SAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
++ P + NL NLR L +++N L +P + +
Sbjct: 67 IVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFT 101
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 24/88 (27%), Positives = 41/88 (46%), Gaps = 5/88 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ ++LS ++ I L +L L E+ L G L + F G LR++++
Sbjct: 248 VYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAV-VEPYAFRGLNYLRVLNVSG 305
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLS 500
NQLT S ++ NL L + +N L+
Sbjct: 306 NQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 32/122 (26%), Positives = 44/122 (36%), Gaps = 24/122 (19%)
Query: 410 CNSDPQPSITVIHLSSKNLT---GNIPSDLTKL------------------SSLVELWLD 448
C S ++ +NLT ++P D T L + L +L LD
Sbjct: 4 CEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 449 GNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL 508
LT + P L + L NQL LP LP L L V N L+ ++P L
Sbjct: 64 RAELTK-LQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120
Query: 509 SK 510
Sbjct: 121 RG 122
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 5/100 (5%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHL 470
P + + LS L ++P L +L L + N LT +P G +L+ ++L
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYL 131
Query: 471 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
+ N+L P L P L +L + NN L+ +P+ LL+
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNG 170
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 6/92 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
P++TV+ +S LT ++P L L EL+L GN L +P + P L + L +
Sbjct: 100 PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLAN 157
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 504
N LT L L NL L +Q N L T+P
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 4e-12
Identities = 23/105 (21%), Positives = 38/105 (36%), Gaps = 4/105 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 474
P + + LS L I K+ L L++ N L P L+++ L N
Sbjct: 254 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNH 312
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
L + + L LY+ +N + T+ S L + N
Sbjct: 313 LLH-VERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 22/107 (20%), Positives = 44/107 (41%), Gaps = 6/107 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+I +++ + +P + + L L L+ N L+ +P F P L + + +
Sbjct: 99 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 156
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
N L + +L+ L + +N L+ V SL+ N + N
Sbjct: 157 NNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYN 202
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 2e-11
Identities = 21/109 (19%), Positives = 39/109 (35%), Gaps = 7/109 (6%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 472
++ + S ++ + + L L L N+LT P L + L
Sbjct: 208 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSY 263
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
N+L + + + L LY+ NN L + + VL+ + N
Sbjct: 264 NELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 311
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 17/102 (16%), Positives = 40/102 (39%), Gaps = 6/102 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ ++ + + +P+ L + L L+ + I F+ ++ +++
Sbjct: 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 108
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 514
N + P N+P L L ++ N LS ++P + L
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKL 149
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 26/88 (29%), Positives = 42/88 (47%), Gaps = 8/88 (9%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
P +TV+ L +L+ ++P + L L + N+L I D F L+ + L
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 180
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLS 500
N+LT + SL +P+L V N+LS
Sbjct: 181 NRLTH-VDLSL--IPSLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 16/104 (15%), Positives = 33/104 (31%), Gaps = 4/104 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ +++S+ L + + +L L L N L + L ++L+ N +
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSI 336
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
L S L+ L + +N +L
Sbjct: 337 V-TLKLS--THHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDA 377
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 7/86 (8%), Positives = 30/86 (34%), Gaps = 2/86 (2%)
Query: 432 IPSDLTKLSSLVELWLDGNSLTGP-IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 490
I S+L ++ +D + + + +I+ +++ + + L + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 491 ELYVQNNMLSGTVPSSLLSKNVVLNY 516
L + + + + + + +
Sbjct: 79 LLNLNDLQIE-EIDTYAFAYAHTIQK 103
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 22/107 (20%), Positives = 43/107 (40%), Gaps = 6/107 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+I +++ + +P + L L L+ N L+ +P F P L + + +
Sbjct: 93 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 150
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
N L + +L+ L + +N L+ V SL+ N + N
Sbjct: 151 NNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYN 196
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-12
Identities = 18/88 (20%), Positives = 32/88 (36%), Gaps = 4/88 (4%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 472
++ + S ++ + + L L L N+LT P L + L
Sbjct: 202 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSY 257
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLS 500
N+L + + + L LY+ NN L
Sbjct: 258 NELEKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 18/110 (16%), Positives = 43/110 (39%), Gaps = 9/110 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ ++ + + +P+ L + L L+ + I F+ ++ +++
Sbjct: 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 102
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN---VVLNYAGN 519
N + P N+P L L ++ N LS ++P + L+ + N
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNN 151
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 23/95 (24%), Positives = 38/95 (40%), Gaps = 5/95 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 474
+T++ L NLT + L LVE+ L N L F L +++ +N+
Sbjct: 226 VELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
L L +P L+ L + +N L V +
Sbjct: 284 LVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 8/88 (9%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
P +TV+ L +L+ ++P + L L + N+L I D F L+ + L
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 174
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLS 500
N+LT + S +P+L V N+LS
Sbjct: 175 NRLTH-VDLS--LIPSLFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 11/100 (11%), Positives = 34/100 (34%), Gaps = 6/100 (6%)
Query: 415 QPSITVIHLSSKNLTGNIPSDLTK--LSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHL 470
Q + T ++ L++ + +++ +P + +++L
Sbjct: 18 QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNL 76
Query: 471 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
D Q+ + +++LY+ N + +P +
Sbjct: 77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQN 115
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 22/97 (22%), Positives = 39/97 (40%), Gaps = 7/97 (7%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 473
P P++ V+ LS +L ++ + + L L+LD NS+ + S L+ + L N
Sbjct: 293 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHN 349
Query: 474 QLTGPLPSSLMNLP-NLRELYVQNNMLSGTVPSSLLS 509
+SL L N+ V + + L
Sbjct: 350 DWD---CNSLRALFRNVARPAVDDADQHCKIDYQLEH 383
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-12
Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 8/104 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++T + + ++T ++ + KL+ L +L N++T D S +L + + N+L
Sbjct: 42 ATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITTL--DLSQNTNLTYLACDSNKL 97
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T L + L L L N L+ + S LN A N
Sbjct: 98 TN-LD--VTPLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARN 137
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 23/104 (22%), Positives = 39/104 (37%), Gaps = 9/104 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T + S +T D+++ L L D N++T D + L + N+L
Sbjct: 170 TQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK--LDLNQNIQLTFLDCSSNKL 224
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T + + L L N L+ + S LSK L+
Sbjct: 225 TE-IDVT--PLTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQT 264
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 22/109 (20%), Positives = 37/109 (33%), Gaps = 9/109 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ ++ + N+T + DL + L L N LT D + L N L
Sbjct: 191 KLLNRLNCDTNNIT-KL--DLNQNIQLTFLDCSSNKLTEI--DVTPLTQLTYFDCSVNPL 245
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
T L S L L L+ L + + ++ + G + E
Sbjct: 246 T-ELDVS--TLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKIKE 290
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 19/99 (19%), Positives = 34/99 (34%), Gaps = 5/99 (5%)
Query: 421 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP 480
I+ ++ D+T + L L +T + D S P L ++L + +LT L
Sbjct: 278 IYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELTE-LD 334
Query: 481 SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
S + L+ L N + + A
Sbjct: 335 VS--HNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEG 371
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 9e-10
Identities = 16/105 (15%), Positives = 42/105 (40%), Gaps = 7/105 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ ++ + +T + DL++ LV L+L+ LT + D S L+ + + +
Sbjct: 297 TQLYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNTELTE-L-DVSHNTKLKSLSCVNAHI 351
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 520
S + +P L + +L + ++ + + ++
Sbjct: 352 QD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 20/97 (20%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSS 482
++ + +L++L L +S+T + L + N +T L S
Sbjct: 25 AAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNITT-LDLS 82
Query: 483 LMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
NL L +N L+ + + L+K LN N
Sbjct: 83 --QNTNLTYLACDSNKLT-NLDVTPLTKLTYLNCDTN 116
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 27/104 (25%), Positives = 43/104 (41%), Gaps = 8/104 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++T + S LT N+ +T L+ L L D N LT D S P L ++ N L
Sbjct: 85 TNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL--DVSQNPLLTYLNCARNTL 139
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T + S + L EL N + + ++ L+ + N
Sbjct: 140 T-EIDVS--HNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFN 180
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 19/104 (18%), Positives = 38/104 (36%), Gaps = 8/104 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
P +T ++ + LT I D++ + L EL N D + L + N++
Sbjct: 127 PLLTYLNCARNTLT-EI--DVSHNTQLTELDCHLNKKI-TKLDVTPQTQLTTLDCSFNKI 182
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T + L L N ++ + + + L+ + N
Sbjct: 183 TE---LDVSQNKLLNRLNCDTNNIT-KLDLNQNIQLTFLDCSSN 222
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 25/123 (20%), Positives = 35/123 (28%), Gaps = 25/123 (20%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T + SS LT I D+T L+ L N LT D S L +H L
Sbjct: 212 IQLTFLDCSSNKLT-EI--DVTPLTQLTYFDCSVNPLT--ELDVSTLSKLTTLHCIQTDL 266
Query: 476 T----GPLPS---------------SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+ + L L Q ++ + S K V L
Sbjct: 267 LEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELDLSQNPKLVYLYL 325
Query: 517 AGN 519
Sbjct: 326 NNT 328
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 18/106 (16%), Positives = 37/106 (34%), Gaps = 8/106 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
P + ++L++ LT + D++ + L L + P L + Q
Sbjct: 318 PKLVYLYLNNTELT-EL--DVSHNTKLKSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQT 373
Query: 476 TGPLPSSLMNLPNLRELYVQNNML--SGTVPSSLLSKNVVLNYAGN 519
+P + +L + V ++L G + V + A N
Sbjct: 374 IT-MPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDGGVYDQATN 417
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-12
Identities = 23/96 (23%), Positives = 46/96 (47%), Gaps = 5/96 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 474
+ V S++ T +IPS L +++ L L N +T D C +L+++ L+ ++
Sbjct: 5 DASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
+ + +L +L L + +N LS ++ SS
Sbjct: 62 INTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGP 96
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 22/97 (22%), Positives = 36/97 (37%), Gaps = 3/97 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
++ + LS +T DL ++L L L + + I F L + L DN
Sbjct: 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDN 84
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
L+ S L +L+ L + N +SL
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 19/111 (17%), Positives = 39/111 (35%), Gaps = 5/111 (4%)
Query: 416 PSITVIHLSSKNLTGNIP-SDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
++ + + + I D L+SL EL + SL D+ + L
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQSQSLKSIRDIHHLTLHL 181
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
++ L L ++R L +++ L+ S L + V + +
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFR 231
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-10
Identities = 21/82 (25%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ V+ +S+ NL + L L EL++ N L +PD S P L ++ + NQL
Sbjct: 431 QTLEVLDVSNNNLD-SFSLFLP---RLQELYISRNKLKT-LPDASLFPVLLVMKISRNQL 485
Query: 476 TGPLPSSLMNLPNLRELYVQNN 497
L +L+++++ N
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 21/124 (16%)
Query: 416 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 473
PS+ + LS +L L L +L L + N+ +R ++L
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSST 420
Query: 474 QLT---GPLPSSL--------------MNLPNLRELYVQNNMLSGTVPSSLLSKN-VVLN 515
+ +P +L + LP L+ELY+ N L T+P + L +V+
Sbjct: 421 GIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDASLFPVLLVMK 479
Query: 516 YAGN 519
+ N
Sbjct: 480 ISRN 483
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 6e-09
Identities = 18/108 (16%), Positives = 38/108 (35%), Gaps = 7/108 (6%)
Query: 403 VPWSWLQCNSDPQPSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIP--DF 459
+ SW P S+ ++L + S L++L L + I DF
Sbjct: 89 LSSSWFG----PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144
Query: 460 SGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
+G L + ++ L SL ++ ++ L + + + +
Sbjct: 145 AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 13/88 (14%), Positives = 33/88 (37%), Gaps = 4/88 (4%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQL 475
+I +H+ L ++ + + L + + ++ + + P L + L +N +
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
Query: 476 T---GPLPSSLMNLPNLRELYVQNNMLS 500
+ P+L+ L + N L
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 23/104 (22%), Positives = 37/104 (35%), Gaps = 4/104 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
++ V+ L S + L SL L L N L+ + F L+ ++L N
Sbjct: 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGN 108
Query: 474 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+ S NL NL+ L + N + + LN
Sbjct: 109 PYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNE 152
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 7e-08
Identities = 21/107 (19%), Positives = 43/107 (40%), Gaps = 12/107 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ ++LSS + + + + +L L + N+L P L+ +++ N+L
Sbjct: 410 EKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDS-FS--LFLPRLQELYISRNKL 463
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 519
LP + P L + + N L +VP + L+ + N
Sbjct: 464 KT-LPDA-SLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 13/109 (11%), Positives = 38/109 (34%), Gaps = 8/109 (7%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQL 475
+ + S ++ + + ++ L + L + +S ++ I +E++++
Sbjct: 265 GLGDFNPSESDVVSELGK--VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSG-----TVPSSLLSKNVVLNYAGN 519
S +L +L L + N++ + L + N
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 11/89 (12%), Positives = 22/89 (24%), Gaps = 1/89 (1%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLE 471
I + L + LSS+ L L +L +
Sbjct: 169 KSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL 228
Query: 472 DNQLTGPLPSSLMNLPNLRELYVQNNMLS 500
+ + S L L ++ + +
Sbjct: 229 AFRGSVLTDESFNELLKLLRYILELSEVE 257
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 19/109 (17%), Positives = 49/109 (44%), Gaps = 5/109 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
S+T I L++ N+T ++ + + ++ +L ++ T SG +L + + +
Sbjct: 44 NSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDV 100
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINL 522
T +L L +L L + ++ ++ + + L K ++ + N +
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 15/86 (17%), Positives = 37/86 (43%), Gaps = 2/86 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
S+T++ +S +I + + L + + L N I P+L+ ++++ + +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSG 501
+ + P L +LY + + G
Sbjct: 172 HD--YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 19/105 (18%), Positives = 40/105 (38%), Gaps = 2/105 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 474
++ + + K++T + +L+ L+SL L + ++ + + P + I L N
Sbjct: 88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ L LP L+ L +Q + + K L
Sbjct: 148 AITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQ 191
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 33/179 (18%), Positives = 64/179 (35%), Gaps = 28/179 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEI------AVKVLTSNSYQGKREFTNEVTLLSRIHHRN 658
+ IG GGFG +Y + + + VKV S++ E ++
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTEL-KFYQRAAKPEQIQ 97
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEH------LYGT-LTHEQRINWIKR-------L 704
+ G +H+ K + +G+ L ++ + L
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDL--QKIYEANAKRFSRKTVL 155
Query: 705 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKFAVDGASHV 761
+++ +EY+H +H D+K+SN+LL+ +V D+GL+ H
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 33/93 (35%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQ 474
+ + +S LT IP DL +L EL LD N + I L + L NQ
Sbjct: 173 KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQ 228
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
+ SL LP LREL++ NN LS VP+ L
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 26/113 (23%), Positives = 46/113 (40%), Gaps = 7/113 (6%)
Query: 409 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLR 466
C + V+ S L +P +++ L L N ++ + DF G L
Sbjct: 26 MCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISE-LRKDDFKGLQHLY 81
Query: 467 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ L +N+++ + L L++LY+ N L +P +L S V L N
Sbjct: 82 ALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDN 133
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 17/91 (18%), Positives = 36/91 (39%), Gaps = 10/91 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-------GPIPDFSGCPDLRII 468
P++ +HL + L+ +P+ L L L ++L N++T P+ I
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299
Query: 469 HLEDNQLTGPL--PSSLMNLPNLRELYVQNN 497
L +N + P++ + + + N
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 24/110 (21%), Positives = 41/110 (37%), Gaps = 24/110 (21%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
P T++ L + +++ D L L L L N ++ I + FS L+ +++ N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKN 112
Query: 474 QLT---GPLPSSL------------------MNLPNLRELYVQNNMLSGT 502
L LPSSL L N+ + + N L +
Sbjct: 113 HLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS 162
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 17/92 (18%), Positives = 33/92 (35%), Gaps = 8/92 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 474
+ + L + I + L+ L +L EL LD N L+ L++++L N
Sbjct: 217 SKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNN 275
Query: 475 LTG------PLPSSLMNLPNLRELYVQNNMLS 500
+T + + + NN +
Sbjct: 276 ITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 31/111 (27%), Positives = 46/111 (41%), Gaps = 4/111 (3%)
Query: 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 473
QP + L S L P +LS L + +D L +PD L + L N
Sbjct: 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARN 137
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
L LP+S+ +L LREL ++ +P L S + + G +NL
Sbjct: 138 PLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQS 187
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 22/112 (19%), Positives = 46/112 (41%), Gaps = 7/112 (6%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED-NQL 475
++ + L + ++P+ + L +L L + + L+ P P L + L L
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTAL 242
Query: 476 TGPLPSSLMNLPNLRELYVQN-NMLSGTVPSSL--LSKNVVLNYAGNINLHE 524
P L+ L +++ + L T+P + L++ L+ G +NL
Sbjct: 243 RN-YPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSR 292
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 18/95 (18%), Positives = 29/95 (30%), Gaps = 4/95 (4%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWL-DGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
+ + L N P + L L L D ++L +P L + L
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCV 288
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
LPS + LP + V + L +
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPH-LQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 18/119 (15%), Positives = 40/119 (33%), Gaps = 12/119 (10%)
Query: 417 SITVIHLSSKNLTGNIPSDL---------TKLSSLVELWLDGNSLTGPIPDFSGCPDLRI 467
+ + + + +P L L +L L L+ + + +L+
Sbjct: 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKS 210
Query: 468 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHE 524
+ + ++ L+ L ++ +LP L EL ++ P + L NL
Sbjct: 211 LKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 9e-10
Identities = 26/124 (20%), Positives = 46/124 (37%), Gaps = 12/124 (9%)
Query: 406 SWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSS--LVELWLDGNSLTGPIPD-FSGC 462
+W Q NS+ + + + + L L + V L L L PD
Sbjct: 49 AWRQANSN---NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRL 103
Query: 463 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI 520
L+ + ++ L LP ++ L L + N L +P+S+ L++ L+
Sbjct: 104 SHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161
Query: 521 NLHE 524
L E
Sbjct: 162 ELTE 165
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 20/115 (17%), Positives = 42/115 (36%), Gaps = 15/115 (13%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED-NQ 474
+ + + + L +P + + + L L L N L +P + LR + + +
Sbjct: 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPE 162
Query: 475 LT--------GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 519
LT L NL+ L ++ + ++P+S+ L L +
Sbjct: 163 LTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 34/216 (15%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV-QF 662
L +KIGSG FG +Y G ++ +E+A+K+ + + E + + +
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNV 68
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 715
+ E +VLV + + G E L+ N+ R L +A+ +E
Sbjct: 69 RWFGVEGDYNVLVMDLL--GPSLEDLF---------NFCSRKLSLKTVLMLADQMINRVE 117
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAK---VSDFGLSKFAVDGASHV------SSIVR 766
++H+ +HRD+K N L+ RA + DFGL+K D ++H + +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 767 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
GT Y ++ + + + D+ S G +L+ + G
Sbjct: 175 GTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.7 bits (159), Expect = 2e-11
Identities = 38/268 (14%), Positives = 73/268 (27%), Gaps = 68/268 (25%)
Query: 590 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--------TSNSYQGK 641
+HC ++ +KIG G FG V+ +A+K++ + +
Sbjct: 14 SHCLPTEKLQRC-----EKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTF 67
Query: 642 REFTNEVTLLSRIH---------HRNLVQFLGYCQEEGRS-------------------- 672
E E+ + + + +G
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 673 ----------VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+V EF G E + + + I +
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLTASLAVAEA--S 180
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
HRDL N+LL K K+ K + + + V +D Y +S+
Sbjct: 181 LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGL------QVSIID--YTLSRLE 232
Query: 783 TDKSDVYSFGVILLELISGQEAISNEKF 810
D V+ + +L +G + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIY 260
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 23/99 (23%), Positives = 43/99 (43%), Gaps = 6/99 (6%)
Query: 419 TVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 475
+ LS +L I S+ + +L L L N L + + FS L ++ L +N +
Sbjct: 67 HSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHI 124
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 514
++ ++ L++LY+ N +S P L+ L
Sbjct: 125 VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKL 162
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 7/99 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLE 471
++ LS NL+ + ++ T+L++L L L N L I F P+LR + L
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLS 96
Query: 472 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
N L +L L L + NN + V +
Sbjct: 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFED 134
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 12/116 (10%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
P++ + LSS +L + + L +L L L N + + F L+ ++L
Sbjct: 88 PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQ 145
Query: 473 NQLTGPLP----SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
NQ++ P LP L L + +N L +P + L K G + LH
Sbjct: 146 NQISR-FPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNG-LYLHN 198
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 36/185 (19%), Positives = 64/185 (34%), Gaps = 43/185 (23%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLL--SRIHHRNLVQ 661
L KKIGSGGFG++Y ++ A V+ K E+ L + + R
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVV-------KVEYQENGPLFSELKFYQR---- 89
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-----------------INWIKR- 703
+ + + + + G + G + R
Sbjct: 90 -VAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTF 148
Query: 704 -----LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKFAVD 756
L++ +EY+H +H D+K++N+LL +V +D+GLS
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205
Query: 757 GASHV 761
+H
Sbjct: 206 NGNHK 210
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 5e-11
Identities = 25/112 (22%), Positives = 48/112 (42%), Gaps = 9/112 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIPD------FSGCPDLRI 467
P + ++ L+ + + D ++ SL +L+L N L F G L++
Sbjct: 426 PHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484
Query: 468 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
++L N L P +L LR L + +N L+ + L + +L+ + N
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRN 536
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 9e-11
Identities = 22/104 (21%), Positives = 34/104 (32%), Gaps = 3/104 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+ + LS + S L L L L I F P+LRI+ L +
Sbjct: 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLS-GTVPSSLLSKNVVLNY 516
++ P + L +L EL + LS + L
Sbjct: 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 2/97 (2%)
Query: 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLED 472
+ S+ + LS + L L L L N + F G +L++++L
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
N L S+ LP + + +Q N ++ +
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFK 359
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 5e-09
Identities = 19/99 (19%), Positives = 34/99 (34%), Gaps = 7/99 (7%)
Query: 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGP 478
+ NLT +P L ++ L L N + F L+++ L
Sbjct: 8 IAFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 479 L-PSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+ + NLPNLR L + ++ + + L
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFE 101
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 30/110 (27%), Positives = 42/110 (38%), Gaps = 9/110 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTK-----LSSLVELWLDGNSLTG-PIPDFSGCPDLRIIH 469
PS+ + L L ++L LS L L+L+ N L P FS LR +
Sbjct: 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLS 510
Query: 470 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
L N+LT + L NL L + N L + VL+ N
Sbjct: 511 LNSNRLTVLSHNDL--PANLEILDISRNQLL-APNPDVFVSLSVLDITHN 557
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 23/120 (19%), Positives = 48/120 (40%), Gaps = 2/120 (1%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 474
+ V++L+ + L +L L L N L +F G P + I L+ N
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNI 534
+ + L L+ L +++N L+ T+ ++ L+ + L + A +++
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALT-TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHL 408
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 22/115 (19%), Positives = 33/115 (28%), Gaps = 9/115 (7%)
Query: 416 PSITVIHLSSKNLTGNI--PSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLE 471
+ + L L+ + L +L L L N + P F L+ I
Sbjct: 97 FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS 156
Query: 472 DNQLTGPLPSSLMNL--PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
NQ+ L L L + N L V +N N+ L
Sbjct: 157 SNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGK---CMNPFRNMVLEI 208
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 23/100 (23%), Positives = 43/100 (43%), Gaps = 9/100 (9%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + L LT + + S+ +++L GN L +P + +IHL +N+L
Sbjct: 362 EKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVT-LPKIN--LTANLIHLSENRL 413
Query: 476 TG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 514
+ L+ +P+L+ L + N S S+N L
Sbjct: 414 ENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL 453
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 15/116 (12%), Positives = 36/116 (31%), Gaps = 22/116 (18%)
Query: 415 QPSITVIHLSSKNLTGNIPSDLTKLS------SLVELWLDGNSLTGPIPD---------- 458
+++ L++ +L + D K L L + GN T I
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 459 ---FSGCPDLRIIHLEDNQLTGPLPSSLMNLP--NLRELYVQNNMLSGTVPSSLLS 509
+ + + P ++ L ++R L + + + ++ S +
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFE 287
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 24/106 (22%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ + + + ++ ++ + L LS L L D N ++ I + P+L +HL++NQ+
Sbjct: 151 TNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQI 207
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 521
+ S L N NL + + N ++ P + VV N +
Sbjct: 208 SDV--SPLANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPS 250
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 29/104 (27%), Positives = 50/104 (48%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
SI + L+S +T P L LS+L L+LD N +T I +G +L+ + + + Q+
Sbjct: 107 QSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQV 163
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ + L NL L L +N +S P + L + ++ N
Sbjct: 164 SDL--TPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNN 205
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 25/104 (24%), Positives = 51/104 (49%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ V++L +T NI S L L++L L + ++ + + L + +DN++
Sbjct: 129 SNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKI 185
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ S L +LPNL E++++NN +S P + S ++
Sbjct: 186 SDI--SPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQ 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 22/104 (21%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
IT + +T I + L++L+ L L N +T + + + L N L
Sbjct: 41 DGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPL 97
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
S++ L +++ L + + ++ P + LS VL N
Sbjct: 98 KNV--SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 14/86 (16%), Positives = 35/86 (40%), Gaps = 3/86 (3%)
Query: 434 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493
L++ +++ +++T + + + + +T + L NL L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLE 69
Query: 494 VQNNMLSGTVPSSLLSKNVVLNYAGN 519
+++N ++ P L+K L +GN
Sbjct: 70 LKDNQITDLAPLKNLTKITELELSGN 95
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 17/100 (17%), Positives = 39/100 (39%), Gaps = 5/100 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T + ++ +I S L L +L+E+ L N ++ + + +L I+ L + +
Sbjct: 173 SKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQTI 229
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 515
T NL V+ + P+++ +
Sbjct: 230 TNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYAS 267
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 27/114 (23%), Positives = 44/114 (38%), Gaps = 6/114 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
++ + LS+ +T SDL + +L L L N + I + FS L + L N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYN 110
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNINLHE 524
L+ S L +L L + N +SL L+K +L +
Sbjct: 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK 164
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 24/132 (18%), Positives = 40/132 (30%), Gaps = 30/132 (22%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLT------------------ 453
S+ + LS L+ N+ S LSSL L L GN
Sbjct: 97 SSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155
Query: 454 -------GPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 504
I F+G L + ++ + L P SL ++ N+ L + +
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLL 214
Query: 505 SSLLSKNVVLNY 516
+ +
Sbjct: 215 EIFVDVTSSVEC 226
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 16/114 (14%), Positives = 35/114 (30%), Gaps = 3/114 (2%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHL 470
+ ++ + + + I L+ L EL +D + L ++ + L
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205
Query: 471 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
Q L + ++ L +++ L T S LS +
Sbjct: 206 HMKQHILLLEIFVDVTSSVECLELRDTDLD-TFHFSELSTGETNSLIKKFTFRN 258
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 15/93 (16%), Positives = 31/93 (33%), Gaps = 7/93 (7%)
Query: 407 WLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLR 466
L+ + H S L+ + L K + + + SL + + L
Sbjct: 228 ELRDTD-----LDTFHFSE--LSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLL 280
Query: 467 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 499
+ NQL L +L+++++ N
Sbjct: 281 ELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 20/107 (18%), Positives = 32/107 (29%), Gaps = 13/107 (12%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSL---------TGPIPDFSGC 462
+++ + L K + SS+ L L L TG
Sbjct: 195 KSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253
Query: 463 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
R + + D L + L + L EL N L +VP +
Sbjct: 254 FTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFD 298
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 23/117 (19%), Positives = 42/117 (35%), Gaps = 10/117 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
PS + L +L IPS + L ++ +++ + + F + I + +
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 473 NQ-LTGPLPSSLMNLPNLRELYVQNNMLSGTVPS----SLLSKNVVLNYAGNINLHE 524
+ LT P +L LP L+ L + N L P +L N +
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTS 145
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 22/111 (19%), Positives = 42/111 (37%), Gaps = 13/111 (11%)
Query: 409 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLR 466
+C+ + ++ K++ IPS S L L L IP FS P++
Sbjct: 9 ECHQE-----EDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLRT-IPSHAFSNLPNIS 58
Query: 467 IIHLEDN-QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
I++ + L S NL + + ++N + L + +L +
Sbjct: 59 RIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 21/113 (18%), Positives = 40/113 (35%), Gaps = 9/113 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSS-LVELWLDGNSLTGPIPD--FSGCPDLRIIHLE 471
++ ++ +IP + L + + L L N T + F+G L ++L
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNG-TKLDAVYLN 187
Query: 472 DNQ-LTGPLPSSLMNLPN-LRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 522
N+ LT + + + L V ++ +PS L L L
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWTL 239
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 19/102 (18%), Positives = 36/102 (35%), Gaps = 5/102 (4%)
Query: 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTG 477
++ S L ++P DL+ L + N ++ D LRI+ + N++
Sbjct: 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 478 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
S L L + +N L + L+ + N
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLV-KISCHPTVNLKHLDLSFN 100
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 22/93 (23%), Positives = 44/93 (47%), Gaps = 4/93 (4%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLE 471
S+ + +S +++ + + SL+ L + N LT I P ++++ L
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR-CLPPRIKVLDLH 429
Query: 472 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 504
N++ +P ++ L L+EL V +N L +VP
Sbjct: 430 SNKIKS-IPKQVVKLEALQELNVASNQLK-SVP 460
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 20/109 (18%), Positives = 40/109 (36%), Gaps = 6/109 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD----LRIIHLE 471
+ S+ LT + + L+ L L L N L + + L+ + +
Sbjct: 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDIS 382
Query: 472 DNQLTGPLPSSL-MNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
N ++ +L L + +N+L+ T+ L + VL+ N
Sbjct: 383 QNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSN 431
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 19/102 (18%), Positives = 35/102 (34%), Gaps = 4/102 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
T++++S ++ SD+ LS L L + N + F +L + L N+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
L + NL+ L + N L +
Sbjct: 81 LVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKF 119
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 12/85 (14%), Positives = 27/85 (31%), Gaps = 1/85 (1%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQL 475
++++ + S S++ + + S + +N L
Sbjct: 277 ALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLL 336
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLS 500
T + + +L L L +Q N L
Sbjct: 337 TDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 7e-07
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 9/96 (9%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG 461
SW S+ +++SS LT I L + L L N +
Sbjct: 392 KGDCSWT-------KSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVK 442
Query: 462 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497
L+ +++ NQL L +L+++++ N
Sbjct: 443 LEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 16/105 (15%), Positives = 27/105 (25%), Gaps = 5/105 (4%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHL 470
+ + LS L I +L L L N+ +F L+ + L
Sbjct: 66 KFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGL 122
Query: 471 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 515
L + +L + L V L +
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTES 167
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 23/88 (26%), Positives = 37/88 (42%), Gaps = 5/88 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
P + V+ LS + I LS L L L GN + + FSG L+ + +
Sbjct: 52 PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVE 109
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLS 500
L + +L L+EL V +N++
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 18/92 (19%), Positives = 37/92 (40%), Gaps = 8/92 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLED 472
S+ + NL ++ + L +L EL + N + +P+ FS +L + L
Sbjct: 100 SSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 473 NQLTGPLPSSLMNLPNLR----ELYVQNNMLS 500
N++ + L L + L + N ++
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 19/115 (16%), Positives = 42/115 (36%), Gaps = 13/115 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLE- 471
++ ++++ + + + L++L L L N + D + +++L
Sbjct: 124 KTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 472 ---DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
N + + L+EL + N L +VP + + L I LH
Sbjct: 183 DLSLNPMNF-IQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQK---IWLH 232
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 5e-05
Identities = 19/89 (21%), Positives = 37/89 (41%), Gaps = 10/89 (11%)
Query: 416 PSITVIHLSSKNLTGNIPSD----LTKLSSL-VELWLDGNSLTGPIPD--FSGCPDLRII 468
++ + LSS + +I L ++ L + L L N + I F L+ +
Sbjct: 149 TNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKE-IRLKEL 205
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNN 497
L+ NQL L +L+++++ N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 14/93 (15%), Positives = 32/93 (34%), Gaps = 4/93 (4%)
Query: 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLT 476
+ + + + L +L EL+++ + G +LR + + + L
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 477 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
P + P L L + N L ++ +
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQ 101
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 26/115 (22%), Positives = 45/115 (39%), Gaps = 15/115 (13%)
Query: 398 DPCLPVPWSWLQCNSD----------PQPSITVIHLSSKNLTGNIPS-DLTKLSSLVELW 446
D C P S L+C D ++T +++ ++ ++ DL L L L
Sbjct: 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 447 LDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 499
+ + L + F P L ++L N L L + +L+EL + N L
Sbjct: 63 IVKSGLR-FVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 28/111 (25%), Positives = 45/111 (40%), Gaps = 9/111 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ + L+ + I + L+ L++L L N L I F L ++ L
Sbjct: 299 TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSY 356
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
N + S + LPNL+EL + N L +VP + + L I LH
Sbjct: 357 NHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQK---IWLH 403
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 6e-10
Identities = 19/104 (18%), Positives = 36/104 (34%), Gaps = 3/104 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+ + LS ++ + ++L L L ++ + I + F G L I+ L+ N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNML-SGTVPSSLLSKNVVLNY 516
Q + L NL L + L + + L
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM 133
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 23/85 (27%), Positives = 40/85 (47%), Gaps = 5/85 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 472
+ ++LS N G+I S + L L L L N + + D F G P+L+ + L+
Sbjct: 323 THLLKLNLSQ-NFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDT 380
Query: 473 NQLTGPLPSSLMNLPNLRELYVQNN 497
NQL L +L+++++ N
Sbjct: 381 NQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 8e-06
Identities = 22/118 (18%), Positives = 43/118 (36%), Gaps = 7/118 (5%)
Query: 413 DPQPSITVIHLSSKNLTG-NIPSDL-TKLSSLVELWLDGNSLT--GPIPDFSGCPDLRII 468
+ ++ V+ L+ NL G + + L+SL L L N++ P F ++
Sbjct: 100 NGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVL 159
Query: 469 HLEDNQLTGPLPSSLMNLP--NLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
L N++ L+N + L + + L + L N N ++
Sbjct: 160 DLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ-DMNEYWLGWEKCGNPFKNTSITT 216
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 51/262 (19%), Positives = 92/262 (35%), Gaps = 80/262 (30%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 665
+K+G G F V+ ++ K +A+KV+ S + + +E+ LL + + +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDP------ 95
Query: 666 CQEEGRSVLVY---EFMHNGTLKEH-------LYGTLTHEQRINWIKRL------EIAED 709
+ R ++V +F +G H L L + + L +I +
Sbjct: 96 -NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILL-------------------------------- 737
+G++YLHT C IIH D+K NILL
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 738 -----------------DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
+ ++ K++D G A H + ++ T Y E I
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGN---ACWVHKHFTEDIQ-TRQYRSLEVLIGS 268
Query: 781 QLTDKSDVYSFGVILLELISGQ 802
+D++S + EL +G
Sbjct: 269 GYNTPADIWSTACMAFELATGD 290
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 5e-10
Identities = 29/109 (26%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + +S LT ++P + L EL + GN LT +P L + + NQL
Sbjct: 221 SGLKELIVSGNRLT-SLPVLPS---ELKELMVSGNRLTS-LPM--LPSGLLSLSVYRNQL 273
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
T LP SL++L + + ++ N LS +L Y+G I +
Sbjct: 274 TR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFD 321
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 25/89 (28%), Positives = 38/89 (42%), Gaps = 8/89 (8%)
Query: 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP 478
V+++ LT +P L + + L + N+LT +P P+LR + + NQLT
Sbjct: 43 AVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPA--LPPELRTLEVSGNQLTS- 95
Query: 479 LPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
LP L L L +PS L
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLP-ALPSGL 123
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 22/92 (23%), Positives = 39/92 (42%), Gaps = 12/92 (13%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + + LT ++P + L EL + N L +P +L + +N+L
Sbjct: 161 SELCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQLAS-LPTLPS--ELYKLWAYNNRL 213
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
T LP+ L+EL V N L+ ++P
Sbjct: 214 T-SLPALP---SGLKELIVSGNRLT-SLPVLP 240
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 30/120 (25%), Positives = 48/120 (40%), Gaps = 33/120 (27%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD 458
P + + +S LT ++P L S L +LW+ GN LT +P
Sbjct: 81 PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTS-LPV 138
Query: 459 FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-------LSKN 511
L+ + + DNQL LP+ L +L+ NN L+ ++P +S N
Sbjct: 139 LPP--GLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLT-SLPMLPSGLQELSVSDN 191
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 14/100 (14%), Positives = 27/100 (27%), Gaps = 9/100 (9%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + + LT +P L LSS + L+GN L+ ++ +
Sbjct: 261 SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA--LREITSAPGYSGPI 317
Query: 476 T------GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
P L ++ P+
Sbjct: 318 IRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWH 357
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 61.7 bits (149), Expect = 7e-10
Identities = 27/104 (25%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + L ++ +I + L L L L+L N +T I S L + LEDNQ+
Sbjct: 109 KKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 165
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ L L L+ LY+ N +S + L VL
Sbjct: 166 SDI--VPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQ 207
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 4e-09
Identities = 26/104 (25%), Positives = 48/104 (46%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ + L + ++ S L L L L L+ N ++ I P L ++L +N++
Sbjct: 87 KNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKI 143
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T + L L L L +++N +S VP + L+K L + N
Sbjct: 144 TDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN 185
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 2e-07
Identities = 25/106 (23%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
P + ++L + +T +I + L++L+ L L L+ N ++ I +G L+ ++L N +
Sbjct: 131 PQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI 187
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 521
+ +L L NL L + + + S VV N N +
Sbjct: 188 SDL--RALAGLKNLDVLELFSQECLNKPINH-QSNLVVPNTVKNTD 230
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 2e-07
Identities = 21/104 (20%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+L K++T + +L+S+ ++ + + + + P++ + L N+L
Sbjct: 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKL 77
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T L NL NL L++ N + L K L+ N
Sbjct: 78 TDI--KPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHN 119
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 14/86 (16%), Positives = 30/86 (34%), Gaps = 3/86 (3%)
Query: 434 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493
+ ++ L S+T + + I ++ + + LPN+ +L+
Sbjct: 15 FPDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLF 71
Query: 494 VQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ N L+ P + L L N
Sbjct: 72 LNGNKLTDIKPLTNLKNLGWLFLDEN 97
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 22/107 (20%), Positives = 39/107 (36%), Gaps = 16/107 (14%)
Query: 409 QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCP 463
+C + T + S++ L +IP EL L+ N T F P
Sbjct: 8 KCRCEG----TTVDCSNQKLNKIPEHIPQYTA------ELRLNNNEFTVLEATGIFKKLP 57
Query: 464 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
LR I+ +N++T + + E+ + +N L V +
Sbjct: 58 QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKG 103
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 23/91 (25%), Positives = 41/91 (45%), Gaps = 4/91 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDN 473
P + I+ S+ +T +I S + E+ L N L F G L+ + L N
Sbjct: 57 PQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSN 115
Query: 474 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 504
++T S + L ++R L + +N ++ TV
Sbjct: 116 RITCVGNDSFIGLSSVRLLSLYDNQIT-TVA 145
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 5/88 (5%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 469
+ + I L+S L N+ + L SL L L N +T + + F G +R++
Sbjct: 78 EGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLS 135
Query: 470 LEDNQLTGPLPSSLMNLPNLRELYVQNN 497
L DNQ+T P + L +L L + N
Sbjct: 136 LYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 24/111 (21%), Positives = 41/111 (36%), Gaps = 26/111 (23%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ +I + + +L +P SL + N L +P+ P L I+ ++N L
Sbjct: 153 SFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSL 207
Query: 476 TGPLPSSLMNL-------------------PNLRELYVQNNMLSGTVPSSL 507
LP ++L P L +Y NN+L T+P
Sbjct: 208 KK-LPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLP 256
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 28/130 (21%), Positives = 42/130 (32%), Gaps = 40/130 (30%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD 458
P + + S +LT +P L L L + N L +P+
Sbjct: 91 PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LPE 148
Query: 459 FSGCPDLRIIHLEDNQLTGPLPSSLMNL-------------------PNLRELYVQNNML 499
L+II +++N L LP +L P L +Y NN L
Sbjct: 149 LQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSL 207
Query: 500 SGTVPSSLLS 509
+P LS
Sbjct: 208 K-KLPDLPLS 216
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 27/99 (27%), Positives = 40/99 (40%), Gaps = 11/99 (11%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 476
S+ I + L +L L L ++ D N L +PD P L +++ DN LT
Sbjct: 216 SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKT-LPD--LPPSLEALNVRDNYLT 270
Query: 477 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKN 511
LP +L L + LS +P +L S N
Sbjct: 271 D-LPELPQSLTFLDVSENIFSGLS-ELPPNLYYLNASSN 307
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 12/92 (13%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
P++ ++ SS + ++ SL EL + N L +P + P L + N L
Sbjct: 297 PNLYYLNASSNEIR-SLCD---LPPSLEELNVSNNKLIE-LP--ALPPRLERLIASFNHL 349
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
+P NL++L+V+ N L P
Sbjct: 350 AE-VPEL---PQNLKQLHVEYNPLR-EFPDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 24/113 (21%), Positives = 36/113 (31%), Gaps = 22/113 (19%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLS-------------SLVELWLDGNSLTGPIPDFSGC 462
S T + + N P + EL L+ L+ +P+
Sbjct: 34 KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL--P 90
Query: 463 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKN 511
P L + N LT LP +L +L LS +P L +S N
Sbjct: 91 PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSD-LPPLLEYLGVSNN 141
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 26/109 (23%), Positives = 46/109 (42%), Gaps = 23/109 (21%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
PS+ +++S+ L +P+ +L L N L +P +L+ +H+E N L
Sbjct: 317 PSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAE-VP--ELPQNLKQLHVEYNPL 369
Query: 476 TG--PLPSSLMNL-------------PNLRELYVQNNMLSGTVPSSLLS 509
+P S+ +L NL++L+V+ N L P S
Sbjct: 370 REFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPES 417
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 19/99 (19%), Positives = 31/99 (31%), Gaps = 20/99 (20%)
Query: 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG--------------CPDLRII 468
S NLT +P + + S E + + P +G +
Sbjct: 18 RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHEL 76
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
L + L+ LP P+L L N L+ +P
Sbjct: 77 ELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP 110
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 10/79 (12%), Positives = 26/79 (32%), Gaps = 6/79 (7%)
Query: 422 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS 481
L + +P +L +L ++ N L PD + + + ++ P
Sbjct: 381 DLRMNSHLAEVPE---LPQNLKQLHVETNPLRE-FPDIPE--SVEDLRMNSERVVDPYEF 434
Query: 482 SLMNLPNLRELYVQNNMLS 500
+ L + +++
Sbjct: 435 AHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 26/106 (24%), Positives = 38/106 (35%), Gaps = 20/106 (18%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
P +T I+ + L +P SL L + N LT L + + L
Sbjct: 237 PFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 292
Query: 476 TGPLPSSLMNL--------------PNLRELYVQNNMLSGTVPSSL 507
+ LP +L L P+L EL V NN L +P+
Sbjct: 293 S-ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP 336
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 27/104 (25%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + L ++ +I + L L L L+L N +T I S L + LEDNQ+
Sbjct: 112 KKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 168
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ L L L+ LY+ N +S + L VL
Sbjct: 169 SDI--VPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQ 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 26/106 (24%), Positives = 50/106 (47%), Gaps = 6/106 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
P + ++L + +T +I + L++L+ L L L+ N ++ I +G L+ ++L N +
Sbjct: 134 PQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI 190
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 521
+ +L L NL L + + P + S VV N N +
Sbjct: 191 SDL--RALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNTD 233
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 21/104 (20%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+L K++T + +L+S+ ++ + + + + P++ + L N+L
Sbjct: 24 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKL 80
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
T L NL NL L++ N + L K L+ N
Sbjct: 81 TDI--KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 22/85 (25%), Positives = 47/85 (55%), Gaps = 5/85 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
SI I ++ ++ ++ + L ++ +L+L+GN LT I + +L + L++N++
Sbjct: 46 NSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKV 102
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLS 500
SSL +L L+ L +++N +S
Sbjct: 103 KDL--SSLKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 18/101 (17%), Positives = 36/101 (35%), Gaps = 7/101 (6%)
Query: 423 LSSKNLTGNIP----SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP 478
L S+ +T P + ++ L S+T + + I ++ +
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKS- 60
Query: 479 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ LPN+ +L++ N L+ P + L L N
Sbjct: 61 -VQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDEN 100
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 2e-09
Identities = 23/86 (26%), Positives = 36/86 (41%), Gaps = 3/86 (3%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+T + LS L +P L L L L N+L + + P L+ + L +N+L
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRL 520
Query: 476 TG-PLPSSLMNLPNLRELYVQNNMLS 500
L++ P L L +Q N L
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 3e-08
Identities = 31/115 (26%), Positives = 48/115 (41%), Gaps = 9/115 (7%)
Query: 409 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRII 468
+ V+HL+ K+LT + L +L + L L N L P + L ++
Sbjct: 434 SVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVL 491
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS----SLLSKNVVLNYAGN 519
DN L + + NLP L+EL + NN L + + V+LN GN
Sbjct: 492 QASDNALEN-VD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 21/82 (25%), Positives = 33/82 (40%), Gaps = 7/82 (8%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGP--IPDFSGCPDLRIIHLEDN 473
+ V+ S L N+ + L L EL L N L I CP L +++L+ N
Sbjct: 486 RCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
Query: 474 QLTG--PLPSSLMN-LPNLREL 492
L + L LP++ +
Sbjct: 544 SLCQEEGIQERLAEMLPSVSSI 565
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 32/211 (15%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHR----- 657
K IG G FG V K + +A+K++ + Q E+ +L + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNT 158
Query: 658 -NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
N++ L + +E + +K++ + + + +++ A +
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFS----LPLVRK--FAHSILQC 212
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGY 771
++ LH IIH DLK NILL + R+ KV DFG S + V + ++ + Y
Sbjct: 213 LDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQ-SRFY 265
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
PE + + D++S G IL EL++G
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 30/129 (23%), Positives = 52/129 (40%), Gaps = 16/129 (12%)
Query: 407 WLQCNS---------DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTG-P 455
L+ N+ P + I LS+ ++ + D L SL L L GN +T P
Sbjct: 38 RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELP 96
Query: 456 IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 515
F G L+++ L N++ + +L NL L + +N L T+ S +
Sbjct: 97 KSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQ 155
Query: 516 YAGNINLHE 524
++L +
Sbjct: 156 T---MHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 27/92 (29%), Positives = 42/92 (45%), Gaps = 13/92 (14%)
Query: 424 SSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGP 478
K LT N+P +T E+ L+ N++ IP FS LR I L +NQ++
Sbjct: 19 RGKGLTEIPTNLPETIT------EIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISEL 71
Query: 479 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
P + L +L L + N ++ +P SL
Sbjct: 72 APDAFQGLRSLNSLVLYGNKIT-ELPKSLFEG 102
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 22/88 (25%), Positives = 37/88 (42%), Gaps = 5/88 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+IT I L + P + L + L N ++ + F G L + L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGN 90
Query: 474 QLTGPLPSSLM-NLPNLRELYVQNNMLS 500
++T LP SL L +L+ L + N ++
Sbjct: 91 KITE-LPKSLFEGLFSLQLLLLNANKIN 117
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 19/88 (21%), Positives = 36/88 (40%), Gaps = 5/88 (5%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 469
S+ + L +T +P L L SL L L+ N + + F +L ++
Sbjct: 77 QGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLS 134
Query: 470 LEDNQLTGPLPSSLMNLPNLRELYVQNN 497
L DN+L + L ++ +++ N
Sbjct: 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-09
Identities = 18/76 (23%), Positives = 30/76 (39%), Gaps = 1/76 (1%)
Query: 425 SKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 484
S++ G + + L L LT I + L+ + L DN+++G L
Sbjct: 27 SRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSDNRVSGGLEVLAE 85
Query: 485 NLPNLRELYVQNNMLS 500
PNL L + N +
Sbjct: 86 KCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 23/89 (25%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 411 NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFS-GCPDLRIIH 469
+D + + + LT +I ++L KL+ L +L L N ++G + + CP+L ++
Sbjct: 37 LTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94
Query: 470 LEDNQLTGPL-PSSLMNLPNLRELYVQNN 497
L N++ L L NL+ L + N
Sbjct: 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 17/106 (16%), Positives = 35/106 (33%), Gaps = 6/106 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
++ + L + L + L L +L L + N L I L ++ L N++
Sbjct: 106 ACLSRLFLDNNELR-DT-DSLIHLKNLEILSIRNNKLKS-IVMLGFLSKLEVLDLHGNEI 162
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 521
T L L + + + P + + N + +
Sbjct: 163 TNT--GGLTRLKKVNWIDLTGQKCV-NEPVKYQPELYITNTVKDPD 205
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 427 NLTGNIPSDLTKLS--SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 484
++ N +L + L L+LD N L +L I+ + +N+L L
Sbjct: 91 SVNRNRLKNLNGIPSACLSRLFLDNNELRD-TDSLIHLKNLEILSIRNNKLKSI--VMLG 147
Query: 485 NLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
L L L + N ++ T + L K ++ G
Sbjct: 148 FLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 27/123 (21%), Positives = 49/123 (39%), Gaps = 22/123 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
+ + + N+ ++ + + ++L EL L N ++ + L + + N+L
Sbjct: 41 SGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQISD-LSPLKDLTKLEELSVNRNRL 97
Query: 476 TG--PLP-----------------SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+P SL++L NL L ++NN L V LSK VL+
Sbjct: 98 KNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDL 157
Query: 517 AGN 519
GN
Sbjct: 158 HGN 160
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 16/86 (18%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 434 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493
L++ V+ L S+T + ++ + +++ + + + NL+EL+
Sbjct: 13 FPDPGLANAVKQNLGKQSVTD-LVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELH 69
Query: 494 VQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ +N +S P L+K L+ N
Sbjct: 70 LSHNQISDLSPLKDLTKLEELSVNRN 95
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 30/211 (14%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHR----- 657
IG G FG V + + +A+K++ + Q + EV LL ++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMK 115
Query: 658 -NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
+V + LV+E + L+ + ++ +N ++ A+
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS----LNLTRK--FAQQMCTA 169
Query: 714 IEYLHTGCVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
+ +L T + +IIH DLK NILL K K+ DFG S + ++ + Y
Sbjct: 170 LLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQ-SRFY 224
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
PE + D++S G IL+E+ +G+
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 17/101 (16%), Positives = 27/101 (26%), Gaps = 21/101 (20%)
Query: 422 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLT--- 476
+ + +G + L L L NSL L ++L L
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVP 269
Query: 477 GPLPSSL----------------MNLPNLRELYVQNNMLSG 501
LP+ L LP + L ++ N
Sbjct: 270 KGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 18/109 (16%), Positives = 36/109 (33%), Gaps = 8/109 (7%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPD----LRIIHL 470
P + V+ ++ + + +L L L N G + CP L+++ L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 471 EDNQLT---GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+ + G + L+ L + +N L + LN
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 22/115 (19%), Positives = 42/115 (36%), Gaps = 4/115 (3%)
Query: 398 DPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP 457
+PC S SDP+P + + L L +D + G
Sbjct: 4 EPCELDEESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYL-LKRVDTEADLGQFT 62
Query: 458 DFSGCPDLRIIHLEDNQLTGPLPSS---LMNLPNLRELYVQNNMLSGTVPSSLLS 509
D L+ + + ++ + ++ + L+EL ++N ++GT P LL
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE 117
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 24/139 (17%), Positives = 47/139 (33%), Gaps = 25/139 (17%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD- 458
+ I+ + LT +P T L SL L + N L +P
Sbjct: 141 LLEYINADNNQLT-MLPELPTSLEVLSVRNNQLTFLPELPESLEALDVSTNLLES-LPAV 198
Query: 459 FSGCPDLR----IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 514
+N++T +P ++++L + +++N LS + SL +
Sbjct: 199 PVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQP 257
Query: 515 NYAGNINLHEGGRGAKHLN 533
+Y G G ++
Sbjct: 258 DYHGPRIYFSMSDGQQNTL 276
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 30/109 (27%), Positives = 46/109 (42%), Gaps = 26/109 (23%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD 458
P ITV+ ++ L ++P L +SL L +D N LT +P+
Sbjct: 80 PQITVLEITQNALI-SLPELPASLEYLDACDNRLSTLPELPASLKHLDVDNNQLTM-LPE 137
Query: 459 FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
L I+ ++NQLT LP +L L V+NN L+ +P
Sbjct: 138 LPA--LLEYINADNNQLTM-LPEL---PTSLEVLSVRNNQLT-FLPELP 179
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 22/91 (24%), Positives = 41/91 (45%), Gaps = 11/91 (12%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 476
+ + L+ NL+ ++P +L + L + N+L +P+ L + DN+L+
Sbjct: 60 QFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA--SLEYLDACDNRLS 113
Query: 477 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
LP +L+ L V NN L+ +P
Sbjct: 114 T-LPEL---PASLKHLDVDNNQLT-MLPELP 139
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 21/87 (24%), Positives = 35/87 (40%), Gaps = 9/87 (10%)
Query: 425 SKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSS 482
S L ++ EL L+ +L+ +PD + P + ++ + N L LP
Sbjct: 42 PGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPD-NLPPQITVLEITQNALI-SLPEL 98
Query: 483 LMNLPNLRELYVQNNMLSGTVPSSLLS 509
+L L +N LS T+P S
Sbjct: 99 ---PASLEYLDACDNRLS-TLPELPAS 121
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 27/85 (31%), Positives = 39/85 (45%), Gaps = 9/85 (10%)
Query: 419 TVIHLSSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
TV+ S+K L IP D+T EL+LDGN T + S L +I L +N++
Sbjct: 13 TVVRCSNKGLKVLPKGIPRDVT------ELYLDGNQFTLVPKELSNYKHLTLIDLSNNRI 66
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLS 500
+ S N+ L L + N L
Sbjct: 67 STLSNQSFSNMTQLLTLILSYNRLR 91
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 1/76 (1%)
Query: 425 SKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 484
K+ G I + +L L L L + + P L+ + L +N++ G L
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSENRIFGGLDMLAE 92
Query: 485 NLPNLRELYVQNNMLS 500
LPNL L + N L
Sbjct: 93 KLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 4/89 (4%)
Query: 411 NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG-CPDLRIIH 469
+ ++ + L + L ++ S+L KL L +L L N + G + + P+L ++
Sbjct: 44 LTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101
Query: 470 LEDNQLTGPLP-SSLMNLPNLRELYVQNN 497
L N+L L L L+ L + N
Sbjct: 102 LSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 34/115 (29%), Positives = 48/115 (41%), Gaps = 30/115 (26%)
Query: 410 CNSDPQPSITVIHLSSKNLT---GNIPSDLTKL------------------SSLVELWLD 448
CN++ +V SSK LT NIP+D KL + L L+L+
Sbjct: 14 CNNNKN---SV-DCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLN 69
Query: 449 GNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLM-NLPNLRELYVQNNMLS 500
N L +P F +L + + DN+L LP + L NL EL + N L
Sbjct: 70 DNKLQT-LPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK 122
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 25/101 (24%), Positives = 37/101 (36%), Gaps = 6/101 (5%)
Query: 419 TVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 475
+ L L ++P + L+ L L L N L +P F L+ + L +NQL
Sbjct: 112 AELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQL 169
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 516
+ L L+ L + NN L VP L
Sbjct: 170 KRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKM 209
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 25/82 (30%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 419 TVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 475
T + L L ++P + KL+SL EL L N L +P+ F +L+ + L++NQL
Sbjct: 136 TYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQL 193
Query: 476 TGPLPSSLMNLPNLRELYVQNN 497
+ +L L+ L +Q N
Sbjct: 194 KRVPEGAFDSLEKLKMLQLQEN 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 20/116 (17%), Positives = 36/116 (31%), Gaps = 6/116 (5%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSD-LTKLSS-LVELWLDGNSLTGPIPD--FSGCPDLRII 468
++ + I + LS V LWL+ N + I + F+G +
Sbjct: 125 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELN 183
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 524
++N L L + + ++PS L L NL +
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKK 238
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 17/99 (17%), Positives = 39/99 (39%), Gaps = 5/99 (5%)
Query: 416 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWL-DGNSLTGPIPD--FSGCPDLRIIHLE 471
+ I +S ++ I +D + L L E+ + N+L I F P+L+ + +
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY-INPEAFQNLPNLQYLLIS 112
Query: 472 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
+ + ++ L +Q+N+ T+ +
Sbjct: 113 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 17/84 (20%), Positives = 26/84 (30%), Gaps = 9/84 (10%)
Query: 417 SITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
+ + NL +P+D S V L + + +P LR
Sbjct: 179 LDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--Y 234
Query: 474 QLTGPLPSSLMNLPNLRELYVQNN 497
L LP+ L L L E +
Sbjct: 235 NLKK-LPT-LEKLVALMEASLTYP 256
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 23/89 (25%), Positives = 44/89 (49%), Gaps = 4/89 (4%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKL-SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
S+ + +S +L + S++ L L N LTG + P ++++ L +N++
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNNRI 462
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVP 504
+P + +L L+EL V +N L +VP
Sbjct: 463 MS-IPKDVTHLQALQELNVASNQLK-SVP 489
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 24/144 (16%), Positives = 43/144 (29%), Gaps = 25/144 (17%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 473
P + LS +++ D++ LS L L L N + + F DL + + N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHN 110
Query: 474 QLTG----------------------PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511
+L P+ NL L L + + +
Sbjct: 111 RLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170
Query: 512 VVLNYAGNINLHEGGRGAKHLNII 535
+ ++ H G + L I
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIP 194
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 38/272 (13%), Positives = 80/272 (29%), Gaps = 21/272 (7%)
Query: 254 PQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVS 313
+ + V + + L L + L
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263
Query: 314 KAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERND 372
K V + + + V NL++ + + +++ L + ++ +L +
Sbjct: 264 KCSVKLFQFFWPRP-VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 373 GSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNI 432
A +++ L S P + + C S T ++ + T ++
Sbjct: 323 ALYSVFAEMNIKMLSIS-------DTPFIHMV-----C-PPSPSSFTFLNFTQNVFTDSV 369
Query: 433 PSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD-LRIIHLEDNQLT----GPLPSSLMNLP 487
+ L L L L N L + + + D L +
Sbjct: 370 FQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428
Query: 488 NLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
++ L + +NML+G+V L K VL+ N
Sbjct: 429 SILVLNLSSNMLTGSVFRCLPPKVKVLDLHNN 460
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 21/82 (25%), Positives = 38/82 (46%), Gaps = 2/82 (2%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 475
SI V++LSS LTG++ L + L L N + D + L+ +++ NQL
Sbjct: 428 ESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQL 485
Query: 476 TGPLPSSLMNLPNLRELYVQNN 497
L +L+ +++ +N
Sbjct: 486 KSVPDGVFDRLTSLQYIWLHDN 507
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 2e-06
Identities = 99/672 (14%), Positives = 204/672 (30%), Gaps = 195/672 (29%)
Query: 324 QGKYR----VYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVA 379
Q +Y+ V+E FV +F D + +L+ EI+ + D ++ G
Sbjct: 15 QYQYKDILSVFED-------AFVDNFDCKDVQDMPK-SILSKEEIDHIIMSKD-AVSGTL 65
Query: 380 IVSVISLYSSADWAQEGGDPCLPVPWSWL------QCNSDPQPS-ITVIHLSSKNLTGNI 432
+ L + Q+ + L + + +L + QPS +T +++ ++ N
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR---QPSMMTRMYIEQRDRLYND 122
Query: 433 PSDLTKLS------------SLVEL------WLDG------NSLTGPIPDFSGCPDLRII 468
K + +L+EL +DG + C ++
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVAL-----DVCLSYKVQ 177
Query: 469 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRG 528
D ++ +NL N P ++L L Y + N
Sbjct: 178 CKMDFKI------FWLNLKNCNS------------PETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 529 AKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAE 588
+ ++ + I S + + L K + + L V V + A
Sbjct: 220 SSNIKLRIHS--------IQAELRRLLKSK---------PYENCLLVLLNVQNAKAWNAF 262
Query: 589 AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEV 648
C K+L + T ++ T+ +
Sbjct: 263 NLSC----------KIL--------------------------LTTRF-----KQVTDFL 281
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA 707
+ + H + +E +S+L+ Y L + T+ +R++ I I
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV--LTTNPRRLSIIAES-IR 338
Query: 708 EDAAKGIEYLHTGCVPAIIHRDLKSS-NILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 766
+ A + H C + ++SS N+L R + F +H+ +I+
Sbjct: 339 DGLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRKMFDRLSV--FPPS--AHIPTILL 392
Query: 767 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS----NEKFGANCRNIVQWAK 822
+ + D + +K YS L+E + IS + N
Sbjct: 393 SLI-WFDVIKSDVMVVVNKLHKYS----LVEKQPKESTISIPSIYLELKVKLENEYA--- 444
Query: 823 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCV-------LPHGHMRPS-------- 867
LH S++D Y+I + ++ + + H H++
Sbjct: 445 LHR-----------SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-HLKNIEHPERMTL 492
Query: 868 ISEVLKD---IQDAIVIEREAAAARDGNSDD----------MSRNSLHSSLNVGSFGGTE 914
V D ++ I + A A + + N V +
Sbjct: 493 FRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAI---L 549
Query: 915 NFL-SLDESIVR 925
+FL ++E+++
Sbjct: 550 DFLPKIEENLIC 561
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 3e-05
Identities = 73/619 (11%), Positives = 171/619 (27%), Gaps = 225/619 (36%)
Query: 22 LDSSSAQM------------PGFVS-LNCGGNENFTDEIGLQWIAD---DHLIYGEISNI 65
+D + + FV +C ++ I ++ DH I +
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSI----LSKEEIDH-IIMSKDAV 61
Query: 66 SVANETR--------KQYMTLRHFPADSRKYCY-----KLDVITRTRYLIRATFLYGN-- 110
+ T KQ ++ F + + Y + R ++ ++
Sbjct: 62 ---SGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 111 -FDNNNVYPKFDISLGPTHWSTIVISDAATIEVRE-LIFLASSPKI-------------- 154
+++N V+ K+++S + ++R+ L+ L + +
Sbjct: 119 LYNDNQVFAKYNVSRLQPYL-----------KLRQALLELRPAKNVLIDGVLGSGKTWVA 167
Query: 155 -DVCLSNATTGQPFISTLELRQFNGSVY-------------LTPFEDRYYL--------- 191
DVCLS + + ++ L + Y
Sbjct: 168 LDVCLSYKV----------QCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 192 --SVSARINFGADSEAPVR------YP------DDPFD-RIWES---------------- 220
S + ++ + R Y + + + W +
Sbjct: 218 DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV 277
Query: 221 -DSLKKANY----LVDVAAG-TEKVSTKL---PIDLRSDELPPQKV----MQTAVVGT-- 265
D L A L + T L +D R +LP + + + +++
Sbjct: 278 TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI 337
Query: 266 -NGSLTY----RLNLDGFPGFGWAVTYFAE--IEDLDPDESRK-FRL--VLPGQPDV--- 312
+G T+ +N D +T E + L+P E RK F V P P
Sbjct: 338 RDGLATWDNWKHVNCD-------KLTTIIESSLNVLEPAEYRKMFDRLSVFP--PSAHIP 388
Query: 313 ------------------------SKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFG 348
++V ++ + + S+ L K
Sbjct: 389 TILLSLIWFDVIKSDVMVVVNKLHKYSLVE-KQPKESTISIP-------SIYLELKVKLE 440
Query: 349 KTYDSSRGPLLNAMEINKYLERNDGS---IDGVAIVSVISLY--SSADWAQEGGD-PCLP 402
Y R +++ I K + +D +D S I + + + + +
Sbjct: 441 NEYALHR-SIVDHYNIPKTFDSDDLIPPYLDQY-FYSHIG-HHLKNIEHPERMTLFRMVF 497
Query: 403 VPWSWLQ-----------CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNS 451
+ + +L+ + ++ + + N P ++++++
Sbjct: 498 LDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF------ 551
Query: 452 LTGPIPDFSGCPDLRIIHL 470
L + ++ +
Sbjct: 552 LPKIEENLICSKYTDLLRI 570
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 19/113 (16%), Positives = 42/113 (37%), Gaps = 10/113 (8%)
Query: 407 WLQCNS-------DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF 459
L N+ ++ ++ L + I + +L ELW+ N + +
Sbjct: 54 ALSTNNIEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGI 111
Query: 460 SGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511
+LR++++ +N++T L L L +L + N L + +
Sbjct: 112 EKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 18/79 (22%), Positives = 34/79 (43%), Gaps = 3/79 (3%)
Query: 422 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS 481
H + + + L+ L + L L N++ I SG +LRI+ L N + + +
Sbjct: 31 HGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIKK-IEN 87
Query: 482 SLMNLPNLRELYVQNNMLS 500
L EL++ N ++
Sbjct: 88 LDAVADTLEELWISYNQIA 106
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 25/97 (25%), Positives = 39/97 (40%), Gaps = 16/97 (16%)
Query: 409 QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPD 464
QC+ T + SK IP++ L +L N +T P F +
Sbjct: 16 QCSCSG----TTVDCRSKRHASVPAGIPTNAQIL------YLHDNQITKLEPGVFDSLIN 65
Query: 465 LRIIHLEDNQLTGPLPSSLMN-LPNLRELYVQNNMLS 500
L+ ++L NQL LP + + L L L + N L+
Sbjct: 66 LKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 13/62 (20%), Positives = 24/62 (38%), Gaps = 1/62 (1%)
Query: 439 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498
L + N + + F L+ + + +N++ LP+L EL + NN
Sbjct: 41 LDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 99
Query: 499 LS 500
L
Sbjct: 100 LV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 18/82 (21%), Positives = 30/82 (36%), Gaps = 7/82 (8%)
Query: 422 HLSSKNLTGN-IPS--DLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLT 476
+ + + N I L L L ++ N + I + PDL + L +N L
Sbjct: 43 QFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSLV 101
Query: 477 GPLP-SSLMNLPNLRELYVQNN 497
L +L +L L + N
Sbjct: 102 ELGDLDPLASLKSLTYLCILRN 123
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 27/165 (16%), Positives = 48/165 (29%), Gaps = 28/165 (16%)
Query: 35 LNCGGNENFTDEIGLQWIADDHLI-------YGEISNISVANETRKQ-YMTLRHFPADSR 86
+N GG D G+ + D YG I +N + Y T R+
Sbjct: 10 VNAGGES-HVDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNEDS-- 66
Query: 87 KYCYKLDVITRTRYLIRATFLYGNFDNNN------------VYPKFDISLGPTHWSTIVI 134
+ Y + + Y++ F F + V DI H +
Sbjct: 67 -FGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDE 125
Query: 135 SDAATIEVRELIF----LASSPKIDVCLSNATTGQPFISTLELRQ 175
+I+ +L + K+ V P + L + +
Sbjct: 126 IIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMK 170
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 28/111 (25%)
Query: 419 TVIHLSSKNLT---GNIPSDLT-------------------KLSSLVELWLDGNSLTGPI 456
T + + + L +IP T +L LV+L L N LTG I
Sbjct: 11 TTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-I 69
Query: 457 PD--FSGCPDLRIIHLEDNQLTGPLPSSLMN-LPNLRELYVQNNMLSGTVP 504
F G ++ + L +N++ + + + L L+ L + +N +S V
Sbjct: 70 EPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 5/88 (5%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 469
P + + L LT I + S + EL L N + I + F G L+ ++
Sbjct: 51 GRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLN 108
Query: 470 LEDNQLTGPLPSSLMNLPNLRELYVQNN 497
L DNQ++ +P S +L +L L + +N
Sbjct: 109 LYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 24/83 (28%), Positives = 34/83 (40%), Gaps = 3/83 (3%)
Query: 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTG 477
+ L S L + L+ L L LD N L F +L + L +NQL
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 478 PLPSSLM-NLPNLRELYVQNNML 499
LP + +L L +LY+ N L
Sbjct: 98 -LPLGVFDHLTQLDKLYLGGNQL 119
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 25/86 (29%), Positives = 37/86 (43%), Gaps = 7/86 (8%)
Query: 419 TVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 475
T ++L L + + + L+ L L L N L +P F L ++L NQL
Sbjct: 62 TWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQL 119
Query: 476 TGPLPSSLM-NLPNLRELYVQNNMLS 500
LPS + L L+EL + N L
Sbjct: 120 KS-LPSGVFDRLTKLKELRLNTNQLQ 144
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 5/88 (5%)
Query: 413 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 469
D + ++L L +PS + +L+ L EL L+ N L IP F +L+ +
Sbjct: 104 DHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLS 161
Query: 470 LEDNQLTGPLPSSLMNLPNLRELYVQNN 497
L NQL + L L+ + + N
Sbjct: 162 LSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 49/229 (21%), Positives = 83/229 (36%), Gaps = 50/229 (21%)
Query: 607 KKIGSGGFGVVY--YGKLKDGKEIAVKVLTSN-SY--QGKREFTNEVTLLSRIHHR---- 657
+G G FG V + ++A+K++ + Y + E + +L +I +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKEN 80
Query: 658 --NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAK 712
V + G + +E + T LKE+ + ++ +A
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPH----VRH--MAYQLCH 134
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILL-------------------DKHMRAKVSDFGLSKF 753
+ +LH + H DLK NIL K+ +V+DFG + F
Sbjct: 135 ALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
+ H ++IV T Y PE + DV+S G IL E G
Sbjct: 192 DHE---HHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 59/238 (24%), Positives = 90/238 (37%), Gaps = 64/238 (26%)
Query: 607 KKIGSGGFG-VVYYGKLKDGKEIAVKVLTSN-SY--QGKREFTNEVTLLSRI-----HHR 657
+K+G G FG V+ + + K AVKV+ + Y K E +L +I ++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNN 96
Query: 658 NLVQFLGYCQEEGRSVLV--------YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 709
N+V++ G L+ YE + + Y E IK +
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGPSLYEI-----ITRNNYNGFHIED----IKL--YCIE 145
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILL-------------------------DKHMRAK 744
K + YL ++ H DLK NILL K K
Sbjct: 146 ILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 745 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
+ DFG + F D + SI+ T Y PE ++ SD++SFG +L EL +G
Sbjct: 203 LIDFGCATFKSD---YHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 22/65 (33%), Positives = 35/65 (53%), Gaps = 5/65 (7%)
Query: 438 KLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMN-LPNLRELYV 494
+L++L L L GN L +P+ F +L+ + L +NQL LP + + L NL L +
Sbjct: 83 ELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNL 140
Query: 495 QNNML 499
+N L
Sbjct: 141 AHNQL 145
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 17/92 (18%), Positives = 40/92 (43%), Gaps = 12/92 (13%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 476
+L K++T + + +L+S+ ++ + + + + P++R + L N+L
Sbjct: 20 ETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQGIQYLPNVRYLALGGNKLH 76
Query: 477 GPLPSSLM---NLPNLRELYVQNNMLSGTVPS 505
+ L NL L + N L ++P+
Sbjct: 77 -----DISALKELTNLTYLILTGNQLQ-SLPN 102
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 30/114 (26%), Positives = 46/114 (40%), Gaps = 28/114 (24%)
Query: 409 QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKL------------------SSLVELWL 447
+C+ T + S+ T IP+ T L +SL +L+L
Sbjct: 4 RCSCSG----TTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYL 59
Query: 448 DGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN-LPNLRELYVQNNML 499
GN L P F+ L ++L NQL LP+ + + L L+EL + N L
Sbjct: 60 GGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQL 112
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 929 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.72 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.62 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.56 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.56 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.56 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.56 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.55 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.55 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.55 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.54 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.54 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.54 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.54 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.53 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.53 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.52 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.52 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.5 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.5 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.5 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.49 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.49 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.49 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.48 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.48 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.46 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.46 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.46 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.46 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.45 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.43 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.43 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.43 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.43 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.42 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.42 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.42 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.42 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.41 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.4 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.4 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.4 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.4 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.39 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.38 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.38 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.38 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.38 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.37 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.37 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.37 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.37 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.37 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.37 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.37 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.36 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.36 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.36 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.36 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.36 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.36 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.36 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.35 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.35 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.34 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.34 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.33 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.33 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.33 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.33 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.32 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.31 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.31 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.31 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.31 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.31 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.31 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.31 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.31 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.31 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.3 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.3 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.3 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.3 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.3 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.29 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.29 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.29 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.29 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.29 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.26 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.26 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.26 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.26 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.25 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.25 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.25 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.24 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.24 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.24 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.23 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.23 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.22 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.22 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.21 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.21 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.19 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.19 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.19 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.18 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.18 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.18 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.17 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.17 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.16 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.16 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.15 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.12 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.12 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.09 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.08 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.05 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.05 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.04 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.03 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.03 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.01 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.98 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.97 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.96 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.89 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.82 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.81 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.79 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.78 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.75 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.67 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.64 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.62 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.57 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 98.54 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.5 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.31 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.3 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.25 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.24 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.15 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.09 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.08 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.06 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.01 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.97 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.96 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.91 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.84 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.8 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.67 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.63 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.45 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.43 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.42 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.37 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.28 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.22 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.99 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.88 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.84 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.79 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.7 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.61 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.59 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.55 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.42 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.37 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.37 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.0 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.54 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.49 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.9 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 93.47 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.43 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 93.25 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.1 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 92.95 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 91.94 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 90.79 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 90.53 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 90.38 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 88.38 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.58 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=442.62 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=206.0
Q ss_pred HHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.+.++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++|||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35688999999999999875 467899999987766667889999999999999999999999999999999999
Q ss_pred eccCCchhhhhccccc-----------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEE
Q 002382 678 FMHNGTLKEHLYGTLT-----------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 746 (929)
||++|+|.++|+.... ....++|.+++.|+.||++||+|||++ +||||||||+||||++++++||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence 9999999999965321 234689999999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHh
Q 002382 747 DFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 824 (929)
Q Consensus 747 DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 824 (929)
|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||...... .+...+.
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~~i~-- 274 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT----EAIDCIT-- 274 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH----HHHHHHH--
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH----HHHHHHH--
Confidence 9999986544332 23345679999999999999999999999999999999999 89999765421 2222221
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.+... ..+......+.+++.+||+.||++||||.||+++|+.+.+
T Consensus 275 --~g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 275 --QGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp --HTCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --cCCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11110 1112233468899999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=439.64 Aligned_cols=257 Identities=26% Similarity=0.472 Sum_probs=211.6
Q ss_pred HHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++|||
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 95 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 95 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 46789999999999999874 467899999987766667889999999999999999999999999999999999
Q ss_pred eccCCchhhhhcccc---------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEee
Q 002382 678 FMHNGTLKEHLYGTL---------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 748 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 748 (929)
||++|+|.++|+... .....++|.+++.|+.||++||+|||++ +|+||||||+|||+++++++||+||
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DF 172 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDF 172 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCc
Confidence 999999999996532 2235689999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhh
Q 002382 749 GLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 826 (929)
Q Consensus 749 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 826 (929)
|+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...... .+...+.
T Consensus 173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~~i~---- 244 (299)
T 4asz_A 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIECIT---- 244 (299)
T ss_dssp SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHHHHH----
T ss_pred ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHH----
Confidence 999865443322 2334569999999999999999999999999999999999 89999765421 2222222
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 827 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 827 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.+... ..+.....++.+++.+||+.||++||||.||++.|+++..
T Consensus 245 ~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 245 QGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22111 1112233468899999999999999999999999988643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=445.88 Aligned_cols=257 Identities=21% Similarity=0.370 Sum_probs=210.5
Q ss_pred HHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
...+.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3456789999999999999873 46789999997543 3345789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhcccc------------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc
Q 002382 675 VYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 742 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 742 (929)
|||||++|+|.++|.... .....++|.+++.|+.|||+||+|||++ +||||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 999999999999996432 1234689999999999999999999998 9999999999999999999
Q ss_pred EEEEeecCcccccCCC-CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHH
Q 002382 743 AKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQW 820 (929)
Q Consensus 743 vkL~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~ 820 (929)
+||+|||+|+...... ........||+.|||||++.++.++.++|||||||++|||+| |+.||..... ..+.+.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~----~~~~~~ 259 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDVVEM 259 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH----HHHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence 9999999998654332 223345679999999999999999999999999999999998 8999976542 233333
Q ss_pred HHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 821 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 821 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
+. .+.... .+..+...+.+++.+||+.||++||||.||+++|+..
T Consensus 260 i~----~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 260 IR----NRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HH----TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HH----cCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22 222111 1222345688999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=429.21 Aligned_cols=254 Identities=31% Similarity=0.524 Sum_probs=199.3
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.++||+|+||+||+|+++ ..||||+++... ....+.|.+|+++|++++|||||+++|+|.+ +..++|||||++
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g 115 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG 115 (307)
T ss_dssp CEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred EEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence 46789999999999999876 369999987543 3345779999999999999999999999865 568999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC-Cc
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SH 760 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~-~~ 760 (929)
|+|.++|+.. ...+++.+++.|+.|||+||+|||++ +||||||||+|||+++++++||+|||+|+...... ..
T Consensus 116 GsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 116 SSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999642 45689999999999999999999998 99999999999999999999999999998654322 22
Q ss_pred eeeeeecCccccCcccccc---CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 761 VSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~---~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
......||+.|||||++.+ +.++.++|||||||++|||+||+.||...... ..+... ...+.. .+.
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~---~~~~~~----~~~~~~----~p~ 258 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR---DQIIFM----VGRGYA----SPD 258 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHH----HHTTCC----CCC
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---HHHHHH----HhcCCC----CCC
Confidence 3345679999999999964 45889999999999999999999999754411 111111 111111 111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
+ ......+...+.+++.+||+.+|++||||.||+++|+.+
T Consensus 259 ~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 259 L-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp S-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred c-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 111223345688999999999999999999999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=428.38 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=204.4
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
.+.++||+|+||+||+|+++ +|+.||||+++.... ..+|+.+|++++|||||++++++.+++..++|||||++|
T Consensus 61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 35678999999999999987 689999999975432 247999999999999999999999999999999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC-cEEEEeecCcccccCCCCc-
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASH- 760 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~~~~- 760 (929)
+|.++|. ....+++..+..++.||+.||+|||++ +|+||||||+||||+.++ ++||+|||+|+........
T Consensus 136 ~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 136 SLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp BHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 9999995 345789999999999999999999998 999999999999999988 6999999999866443211
Q ss_pred ---eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 761 ---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 761 ---~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
.....+||+.|||||++.+..++.++|||||||++|||++|+.||......+....+.. .....
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-------~~~~~------ 275 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-------EPPPI------ 275 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH-------SCCGG------
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc-------CCCCc------
Confidence 22345799999999999999999999999999999999999999986553333322222 11000
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
...+......+.+++.+|++.||++|||+.|++++|...+.
T Consensus 276 --~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 276 --REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp --GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 01112223467899999999999999999999999988764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=430.79 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=206.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
|.+.++||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 344578999999999999987 6899999999866555567789999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+...... ..
T Consensus 156 g~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 226 (346)
T 4fih_A 156 GALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 226 (346)
T ss_dssp EEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred CcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence 99999884 34589999999999999999999998 99999999999999999999999999998664432 23
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .+...+.... .+.+..
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~~~~---------~~~~~~- 292 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIRDNL---------PPRLKN- 292 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHSS---------CCCCSC-
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHHHcCC---------CCCCCc-
Confidence 34567999999999999999999999999999999999999999765421 2222211110 011110
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.......+.+++.+||+.||++|||+.|+++|
T Consensus 293 -~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 293 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11122467899999999999999999999876
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=432.91 Aligned_cols=265 Identities=26% Similarity=0.395 Sum_probs=213.2
Q ss_pred HHHHHHHHhccccccCcEEEEEEEECC------CcEEEEEEeecCCc-chhHHHHHHHHHhcccCC-CceeEEeeeeeec
Q 002382 598 IEDATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHH-RNLVQFLGYCQEE 669 (929)
Q Consensus 598 i~~~~~~~~~~IG~G~fG~Vy~~~~~~------~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~H-pNIv~l~g~~~~~ 669 (929)
|....+.+.+.||+|+||+||+|++.. ++.||||+++.... ...+.|.+|+++|.+++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 444556678899999999999998752 35799999976543 335679999999999965 9999999999764
Q ss_pred -CeEEEEEEeccCCchhhhhccccc------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeE
Q 002382 670 -GRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 736 (929)
Q Consensus 670 -~~~~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NIL 736 (929)
+..++|||||++|+|.++|+.... ....+++.+++.++.|||+||+|||++ +||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcccee
Confidence 568999999999999999965321 134589999999999999999999998 9999999999999
Q ss_pred ecCCCcEEEEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccc
Q 002382 737 LDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANC 814 (929)
Q Consensus 737 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~ 814 (929)
+++++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||......+
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-- 295 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 295 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--
Confidence 999999999999999866544333 3445679999999999999999999999999999999998 999997654221
Q ss_pred hhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 815 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 815 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
.+... +..+... ..+.....++.+++.+||+.||++|||+.||+++|+++++.
T Consensus 296 -~~~~~----i~~g~~~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 296 -EFCRR----LKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp -HHHHH----HHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHH----HHcCCCC---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 12222 2222111 11112234678999999999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=430.72 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=199.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 556789999999999999986 68999999997653 233567899999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++|+|.++|... ....+++.+++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+..... .
T Consensus 106 ~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~ 179 (350)
T 4b9d_A 106 EGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-V 179 (350)
T ss_dssp TTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-H
T ss_pred CCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-c
Confidence 999999999542 234578889999999999999999998 9999999999999999999999999999865322 1
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||......+ +... .. .+.... +.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~---i~-~~~~~~-----~~ 246 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN----LVLK---II-SGSFPP-----VS 246 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHH---HH-HTCCCC-----CC
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHH---HH-cCCCCC-----CC
Confidence 22344679999999999999999999999999999999999999997654221 2211 11 111111 11
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+ ...+.+++.+||+.||++|||+.|++++
T Consensus 247 ~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 247 LHY----SYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122 2357899999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=411.34 Aligned_cols=247 Identities=28% Similarity=0.437 Sum_probs=196.7
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeee----cCeEEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVY 676 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~----~~~~~LV~ 676 (929)
.+.++||+|+||+||+|++. +++.||||++.... ....+.|.+|+++|++++|||||++++++.+ ++..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 35678999999999999987 58899999997542 3335679999999999999999999999865 34679999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC-CCcEEEEeecCccccc
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAV 755 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~ 755 (929)
|||++|+|.+++. ....+++..+..++.||+.||+|||++. ++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999995 3457899999999999999999999971 13999999999999984 7999999999998543
Q ss_pred CCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
. ......+||+.|||||++.+ .++.++|||||||++|||+||+.||..... ...+.+. ...+.....++
T Consensus 184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~---~~~~~~~----i~~~~~~~~~~ 252 (290)
T 3fpq_A 184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIYRR----VTSGVKPASFD 252 (290)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---HHHHHHH----HTTTCCCGGGG
T ss_pred C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc---HHHHHHH----HHcCCCCCCCC
Confidence 2 23345679999999998865 699999999999999999999999975431 1112221 11111111111
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.. ...++.+++.+|++.||++|||+.|+++|
T Consensus 253 ----~~----~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 ----KV----AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----GC----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----cc----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 12357899999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=416.73 Aligned_cols=266 Identities=23% Similarity=0.335 Sum_probs=202.1
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecC----eEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~----~~~LV~E~~ 679 (929)
.+.++||+|+||+||+|+++ |+.||||+++.... ....++.|+..+.+++|||||+++++|.+++ ..+||||||
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 45789999999999999985 89999999965432 2233455777778899999999999998764 579999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCC-----CCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-----VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
++|+|.++|+. ..++|..+.+++.|+++||+|||+++ .++|+||||||+|||++.++++||+|||+|+..
T Consensus 84 ~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 84 EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999953 45889999999999999999999863 358999999999999999999999999999876
Q ss_pred cCCCCce---eeeeecCccccCccccccC------cCCCcCceeeHHHHHHHHHhCCCCCcccccccc-ch------hhH
Q 002382 755 VDGASHV---SSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGAN-CR------NIV 818 (929)
Q Consensus 755 ~~~~~~~---~~~~~gt~~Y~aPE~~~~~------~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~-~~------~l~ 818 (929)
....... .....||+.|||||++.+. .++.++|||||||++|||+||+.|+......+. +. ...
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 5443322 2345799999999998754 467899999999999999999888754321110 00 001
Q ss_pred HHHHHhhhcCCcccccCCcccCc-cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 819 QWAKLHIESGDIQGIIDPSLLDE-YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 819 ~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
......... ..+++.+... ...+....+.+++.+||+.||++||||.||++.|+++..
T Consensus 239 ~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 239 EEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111111111 1122333222 234566788999999999999999999999999998754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=422.41 Aligned_cols=246 Identities=22% Similarity=0.344 Sum_probs=205.6
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||+||+|+++ +++.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 567899999999999999986 68999999997542 23346789999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
|++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 114 ~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 114 AKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred CCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 99999999995 345789999999999999999999998 99999999999999999999999999998765432
Q ss_pred -CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 759 -SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 759 -~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+..+....+.. +++ .
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~--------~~~------~ 252 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--------LEY------D 252 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------TCC------C
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--------CCC------C
Confidence 2334566899999999999999999999999999999999999999976542222222211 111 1
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 873 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~ 873 (929)
+.... ..++.+++.+|++.||++|||++|+..
T Consensus 253 ~p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 253 FPEKF----FPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp CCTTC----CHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CCccc----CHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 11122 235789999999999999999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=431.88 Aligned_cols=248 Identities=24% Similarity=0.329 Sum_probs=206.7
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
|.+.++||+|+||+||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++|||||++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 345678999999999999987 6899999999876666667899999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++. ...+++.++..++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+....... .
T Consensus 233 G~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 303 (423)
T 4fie_A 233 GALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 303 (423)
T ss_dssp EEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred CcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence 99999884 34589999999999999999999998 999999999999999999999999999986644332 3
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .+...+.. +.. +.+..
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~~----~~~-----~~~~~- 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIRD----NLP-----PRLKN- 369 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHH----SCC-----CCCSC-
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHHHc----CCC-----CCCcc-
Confidence 34567999999999999999999999999999999999999999765421 22222111 110 11110
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.......+.+++.+||+.||++|||+.|+++|
T Consensus 370 -~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 370 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01122357899999999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=407.86 Aligned_cols=245 Identities=23% Similarity=0.388 Sum_probs=190.0
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.|.+.+.||+|+||+||+|++. +++.||||++++.. ......+.+|+++|++++|||||++++++.+++..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3567789999999999999876 68999999997543 2234678999999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+ +|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+.....
T Consensus 94 y~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 94 YA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp CC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred CC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 99 689998884 345799999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCceeeeeecCccccCccccccCcC-CCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
. .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||......+ +.+.+. .+...
T Consensus 166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~----~~~~i~----~~~~~----- 230 (275)
T 3hyh_A 166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV----LFKNIS----NGVYT----- 230 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHH----HTCCC-----
T ss_pred C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHH----cCCCC-----
Confidence 2 2344679999999999998876 579999999999999999999997654222 222111 11110
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+.... ...+.+++.+|++.||++|||++|+++|
T Consensus 231 -~p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 231 -LPKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -CCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -CCCCC----CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11112 2357899999999999999999999885
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=413.78 Aligned_cols=246 Identities=26% Similarity=0.334 Sum_probs=194.7
Q ss_pred HHHhccccccCcEEEEEEEEC----CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~----~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
|.+.+.||+|+||+||+|+.. .++.||||+++... ......+.+|+++|++++|||||++++++.+++..++||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 567789999999999999863 46789999997543 223446889999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
|||++|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 106 Ey~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 106 DFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp CCCTTCEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EcCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 9999999999985 345789999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
... .....+||+.|||||++.+..++.++|||||||++|||++|+.||...+..+ +...+. .+..
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~i~----~~~~------ 243 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE----TMTMIL----KAKL------ 243 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHH----HCCC------
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH----HHHHHH----cCCC------
Confidence 322 2344679999999999999999999999999999999999999998654222 222111 1111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCc-----HHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 874 (929)
.+... ....+.+++.+|++.||++||| ++|+++|
T Consensus 244 ~~p~~----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 GMPQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp CCCTT----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred CCCCc----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 01111 2235789999999999999998 4677654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=396.89 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=186.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecC----------
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG---------- 670 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~---------- 670 (929)
|.+.+.||+|+||+||+|+++ +++.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 455789999999999999986 689999999975543 33567899999999999999999999987654
Q ss_pred --eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEee
Q 002382 671 --RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 748 (929)
Q Consensus 671 --~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 748 (929)
..++|||||++|+|.+++.... ......+..++.++.||++||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccC
Confidence 3689999999999999996432 222345566889999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCc-----------eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhh
Q 002382 749 GLSKFAVDGASH-----------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (929)
Q Consensus 749 Gla~~~~~~~~~-----------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l 817 (929)
|+|+........ .....+||+.|||||++.+..|+.++|||||||++|||++ ||.... ...
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~ 234 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERV 234 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHH
Confidence 999865443211 1233569999999999999999999999999999999996 775322 111
Q ss_pred HHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 818 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 818 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.... ......... ...+......+++.+|++.||++|||+.|++++
T Consensus 235 -~~~~-~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 235 -RTLT-DVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp -HHHH-HHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHH-HHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111 111111110 111222346789999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=385.38 Aligned_cols=274 Identities=42% Similarity=0.744 Sum_probs=240.1
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCc
Q 002382 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gs 683 (929)
.+.+.||+|+||.||+|++++++.||||++........+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 42 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 121 (321)
T 2qkw_B 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121 (321)
T ss_dssp SCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCB
T ss_pred CccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCc
Confidence 34678999999999999988899999999887666667789999999999999999999999999999999999999999
Q ss_pred hhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC-CCcee
Q 002382 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG-ASHVS 762 (929)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~ 762 (929)
|.+++.........+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 122 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 198 (321)
T 2qkw_B 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198 (321)
T ss_dssp TGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred HHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9999976544445689999999999999999999998 9999999999999999999999999999754332 22223
Q ss_pred eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCcc
Q 002382 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 842 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 842 (929)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... +.....+..|.......+.+...+++.+....
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL-PREMVNLAEWAVESHNNGQLEQIVDPNLADKI 277 (321)
T ss_dssp CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS-SSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCS
T ss_pred cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC-cHHHHHHHHHhhhccccccHHHhcChhhcccc
Confidence 44568999999999999999999999999999999999999997655 33344667777777777788888888888888
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 843 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 843 ~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
..+....+.+++.+|++.+|++|||+.||+++|+.++..
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 888899999999999999999999999999999988753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=386.15 Aligned_cols=288 Identities=35% Similarity=0.657 Sum_probs=247.7
Q ss_pred cccCHHHHHHHHH--HHhccccccCcEEEEEEEECCCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeee
Q 002382 591 HCFTLSDIEDATK--MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQ 667 (929)
Q Consensus 591 ~~~~~~~i~~~~~--~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~ 667 (929)
..++..++..... .+.+.||+|+||.||+|++++++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 3456666654443 44689999999999999988899999999876532 23447899999999999999999999999
Q ss_pred ecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEe
Q 002382 668 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 747 (929)
Q Consensus 668 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 747 (929)
..+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+++.++|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999977655566699999999999999999999998767999999999999999999999999
Q ss_pred ecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccc-cccchhhHHHHHHhhh
Q 002382 748 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-GANCRNIVQWAKLHIE 826 (929)
Q Consensus 748 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~-~~~~~~l~~~~~~~~~ 826 (929)
||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..|......
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 999987655555555556699999999999988999999999999999999999999975432 2334467778888888
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 827 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 827 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
...+....+..+...+..+....+.+++.+|++.+|++|||+.||+++|++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 8888888898888888899999999999999999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=394.57 Aligned_cols=263 Identities=20% Similarity=0.285 Sum_probs=198.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeee------cCeEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRSV 673 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~------~~~~~ 673 (929)
|.+.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+..+
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 556789999999999999986 68999999997543 2334678899999999999999999998754 36789
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+|||||+ |+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 136 ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 136 VVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 9999995 68988884 346789999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCC---CceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 754 AVDGA---SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 754 ~~~~~---~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
..... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||......+....+......... ..
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~-~~ 286 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP-AV 286 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG-GG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh-HH
Confidence 54321 2233456799999999998875 5689999999999999999999999765422222222221100000 00
Q ss_pred cccccCC-------ccc--CccCH-----HHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 IQGIIDP-------SLL--DEYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 ~~~~~d~-------~l~--~~~~~-----~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....-.. .+. ...+. .....+.+|+.+||+.||++|||+.|+++|
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 000 00000 112357899999999999999999999886
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=384.90 Aligned_cols=194 Identities=25% Similarity=0.376 Sum_probs=165.6
Q ss_pred HHHhccccccCcEEEEEEEEC----CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~----~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
|.+.+.||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|+.+ +||||+++++++.+.++.++|||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 556789999999999999864 46789999986543 245678999999988 69999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC-CcEEEEeecCcccccC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVD 756 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~~~~ 756 (929)
|+++|+|.+++. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+...+
T Consensus 101 ~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 101 YLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp CCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 999999999883 378889999999999999999998 99999999999999877 7999999999975433
Q ss_pred CCC---------------------------ceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccc
Q 002382 757 GAS---------------------------HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNE 808 (929)
Q Consensus 757 ~~~---------------------------~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~ 808 (929)
... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 211 112234699999999999875 5899999999999999999999999543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=408.20 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=206.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
|.+.+.||+|+||+||+|+++ +|+.||||++........+.+.+|+++|+.++|||||++++++.+.+..++|||||++
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g 238 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 556789999999999999987 6899999999876666667889999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC--CcEEEEeecCcccccCCCC
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~--~~vkL~DFGla~~~~~~~~ 759 (929)
|+|.++|.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 239 g~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 239 GELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 999998853 245689999999999999999999998 99999999999999854 89999999999876443
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||......+ +...+. .... .++....
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~----~~~~i~----~~~~--~~~~~~~ 380 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----TLRNVK----SCDW--NMDDSAF 380 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHH----TTCC--CCCSGGG
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHH----hCCC--CCCcccc
Confidence 23345579999999999999999999999999999999999999997654221 222111 1110 0111111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... ...+.+++.+||+.||++|||+.|+++|
T Consensus 381 ~~~----s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 381 SGI----SEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112 2357799999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=398.87 Aligned_cols=246 Identities=24% Similarity=0.314 Sum_probs=196.7
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHH---HHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFT---NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~---~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
.+.+.||+|+||+||+|+.+ +|+.||||++.+... .....+. .++.+++.++|||||++++++.+.+.+++||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm 271 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL 271 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence 34678999999999999987 689999999975321 1122233 3466778889999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
|||+||+|.++|. ....+++..+..++.||+.||+|||++ +||||||||+||||+.+|++||+|||+|+....
T Consensus 272 Ey~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 272 DLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp CCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 9999999999995 346789999999999999999999998 999999999999999999999999999986644
Q ss_pred CCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
.. ....+||+.|||||++.. ..|+.++|+|||||++|||++|+.||....... ...+.+.... ...
T Consensus 345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~----~~~----- 411 (689)
T 3v5w_A 345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLT----MAV----- 411 (689)
T ss_dssp CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHH----CCC-----
T ss_pred CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcC----CCC-----
Confidence 32 234579999999999975 579999999999999999999999997654221 1122221111 111
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCc-----HHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 874 (929)
.+.... ...+.+++.+|++.||++|++ +.||.+|
T Consensus 412 -~~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 412 -ELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -CCCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -CCCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 111122 235789999999999999998 7888776
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=363.53 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=209.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.+.+.||+|+||+||+|++. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 91 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG 91 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCC
Confidence 345789999999999999986 5889999998776666678899999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 92 GTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999998642 45689999999999999999999998 99999999999999999999999999998654332211
Q ss_pred -------------eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccccccc--chhhHHHHHHhhh
Q 002382 762 -------------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN--CRNIVQWAKLHIE 826 (929)
Q Consensus 762 -------------~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~--~~~l~~~~~~~~~ 826 (929)
.....||+.|+|||.+.+..++.++|||||||++|||++|..|+........ ...........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~-- 243 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY-- 243 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT--
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc--
Confidence 1145699999999999999999999999999999999999999865432111 11111111110
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 827 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 827 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
. +......+.+++.+|++.+|++|||+.|+++.|+.+...
T Consensus 244 -----------~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 244 -----------C----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp -----------C----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 111123578999999999999999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=362.18 Aligned_cols=258 Identities=31% Similarity=0.479 Sum_probs=201.1
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.+.+.+.||+|+||+||+|++. ++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECC
T ss_pred HceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecC
Confidence 4456789999999999999885 88999999976542 33467889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
++|+|.+++.... ....+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+++.....
T Consensus 117 ~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 117 SRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp TTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 9999999986431 233588999999999999999999998 7 999999999999999999999999999754332
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+...+........
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~----~~~~~~~~~~~~~~-------- 259 (309)
T 3p86_A 193 F-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA----QVVAAVGFKCKRLE-------- 259 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH----HHHHHHHHSCCCCC--------
T ss_pred c-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCCCC--------
Confidence 1 2233456999999999999999999999999999999999999999765411 22222111111111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
.+......+.+++.+|++.+|++|||+.|+++.|+.++..
T Consensus 260 ----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 260 ----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1112224688999999999999999999999999988754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=358.25 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=204.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
|.+.+.||+|+||+||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 101 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence 445688999999999999875 6899999999866655667889999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 102 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 172 (297)
T 3fxz_A 102 GSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (297)
T ss_dssp CBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence 999998843 3588899999999999999999998 999999999999999999999999999986544332 2
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+... ...+.. .. .
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~----~~~~~~-~~-------~ 237 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLI----ATNGTP-EL-------Q 237 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH----HHHCSC-CC-------S
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----HhCCCC-CC-------C
Confidence 334569999999999999999999999999999999999999997544111 11111 111110 00 0
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+......+.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111223457899999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=370.20 Aligned_cols=260 Identities=25% Similarity=0.438 Sum_probs=208.4
Q ss_pred HHHHHHHhccccccCcEEEEEEEEC----CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEE
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~----~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~ 673 (929)
....+.+.+.||+|+||.||+|++. .+..||||+++... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3445566789999999999999985 34569999997653 334567999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 127 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999998532 34688999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCc--eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCc
Q 002382 754 AVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 754 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 830 (929)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .+...+... ...
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~~~~~~---~~~ 273 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR----DVISSVEEG---YRL 273 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HHHHHHHTT---CCC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHHcC---CCC
Confidence 5443222 2223346788999999998999999999999999999999 99999765421 222211111 010
Q ss_pred ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 831 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
..+......+.+++.+|++.+|++||++.||++.|+.++..
T Consensus 274 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 274 ----------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 11122334688999999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=354.50 Aligned_cols=256 Identities=29% Similarity=0.461 Sum_probs=210.0
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+.+.||+|+||.||+|+++++..||||+++.... ..+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN 87 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred heeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence 3456789999999999999999888999999976543 356789999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 88 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 88 GCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999998532 34589999999999999999999998 99999999999999999999999999998665444333
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... ...+.. ...+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~----~~~~~~--~~~~---- 227 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS----EVVLK----VSQGHR--LYRP---- 227 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHHH----HHTTCC--CCCC----
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH----HHHHH----HHcCCC--CCCC----
Confidence 344456788999999999899999999999999999999 99999754421 11111 111110 0001
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
......+.+++.+|++.+|++|||+.|++++|+.+...
T Consensus 228 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 228 ---HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ---CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11123588999999999999999999999999988654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.70 Aligned_cols=281 Identities=35% Similarity=0.585 Sum_probs=226.7
Q ss_pred ccccCHHHHHHHHHHHh--------ccccccCcEEEEEEEECCCcEEEEEEeecCC----cchhHHHHHHHHHhcccCCC
Q 002382 590 AHCFTLSDIEDATKMLE--------KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHR 657 (929)
Q Consensus 590 ~~~~~~~~i~~~~~~~~--------~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~----~~~~~~f~~Ev~iL~~l~Hp 657 (929)
.+.|++.++...+..+. +.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 35678889988887774 5699999999999987 48899999987532 23356789999999999999
Q ss_pred ceeEEeeeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe
Q 002382 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 737 (929)
Q Consensus 658 NIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl 737 (929)
||+++++++...+..++||||+++++|.+++... .....+++..++.++.|++.||.|||++ +|+||||||+||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 9999999999999999999999999999998643 2345689999999999999999999998 99999999999999
Q ss_pred cCCCcEEEEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchh
Q 002382 738 DKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 816 (929)
Q Consensus 738 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~ 816 (929)
+.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++|||||||++|||++|+.||...........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 99999999999999865433222 2334568999999998765 588999999999999999999999987654333333
Q ss_pred hHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 817 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 817 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
+.+... .....+.+.+++.+ ..........+.+++.+|++.+|++||++.||+++|+++.
T Consensus 246 ~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIE--DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHH--TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhh--hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 322211 11223344444443 2345667778999999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=353.46 Aligned_cols=254 Identities=28% Similarity=0.466 Sum_probs=208.6
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.+.+.||+|+||.||+|++.+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 90 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred ceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence 445789999999999999998899999999975543 3567999999999999999999999999999999999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
+|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 91 ~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 91 CLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp BHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred cHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999998532 34588999999999999999999998 999999999999999999999999999986543322223
Q ss_pred eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+...... +. ....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~----~~~~~~~~----~~--~~~~------ 228 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDIST----GF--RLYK------ 228 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHT----TC--CCCC------
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH----HHHHHHhc----Cc--cCCC------
Confidence 33446788999999998999999999999999999999 99999765421 12221111 10 0000
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
+......+.+++.+|++.+|++||++.|++++|+++..
T Consensus 229 -~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 -PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 11112458899999999999999999999999998864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=370.39 Aligned_cols=261 Identities=24% Similarity=0.430 Sum_probs=210.1
Q ss_pred HHHHhccccccCcEEEEEEEEC--------CCcEEEEEEeecCCc-chhHHHHHHHHHhccc-CCCceeEEeeeeeecCe
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 671 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~--------~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~ 671 (929)
.+.+.+.||+|+||.||+|++. ++..||||+++.... ...+.+.+|+++++++ +||||+++++++...+.
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 3456789999999999999863 345799999976533 3346789999999999 89999999999999999
Q ss_pred EEEEEEeccCCchhhhhccccc------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 739 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 739 (929)
.++||||+++|+|.+++..... ....+++..++.++.||++||+|||++ +|+||||||+|||++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECC
Confidence 9999999999999999965321 134578999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhh
Q 002382 740 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 817 (929)
Q Consensus 740 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l 817 (929)
++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~----~~ 314 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----EL 314 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GH
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH----HH
Confidence 999999999999865433221 2233457889999999999999999999999999999999 99999765422 22
Q ss_pred HHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 818 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 818 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
...+. .+.. ...+......+.+++.+|++.+|++||++.|++++|++++...
T Consensus 315 ~~~~~----~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 315 FKLLK----EGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHHH----TTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHh----cCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 22211 1111 0111222346889999999999999999999999999988654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=355.92 Aligned_cols=260 Identities=23% Similarity=0.358 Sum_probs=211.4
Q ss_pred cccCHHHHHHHHHH------------HhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCC
Q 002382 591 HCFTLSDIEDATKM------------LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 657 (929)
Q Consensus 591 ~~~~~~~i~~~~~~------------~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~Hp 657 (929)
..++..++..++.. ..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34677777766643 2458999999999999987 6999999999876666677899999999999999
Q ss_pred ceeEEeeeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe
Q 002382 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 737 (929)
Q Consensus 658 NIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl 737 (929)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999998842 4588999999999999999999998 99999999999999
Q ss_pred cCCCcEEEEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhh
Q 002382 738 DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 817 (929)
Q Consensus 738 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l 817 (929)
+.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~----~~ 249 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----QA 249 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HH
T ss_pred CCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HH
Confidence 9999999999999976543322 223456999999999999999999999999999999999999999754311 11
Q ss_pred HHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 818 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 818 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...... ... +.+.. .......+.+++.+|++.+|++|||+.|++++
T Consensus 250 ~~~~~~----~~~-----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 MKRLRD----SPP-----PKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHH----SSC-----CCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhc----CCC-----CCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 111 11110 11122457899999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=372.74 Aligned_cols=257 Identities=24% Similarity=0.423 Sum_probs=197.8
Q ss_pred HHHHhccccccCcEEEEEEEEC----CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~----~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
.+.+.+.||+|+||.||+|++. ++..||||+++... ....+.|.+|+.++++++||||+++++++.+.+..++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 4456789999999999999875 46789999997653 334567999999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++|+|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 126 e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 126 EYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp ECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred eCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999642 34688999999999999999999998 999999999999999999999999999986544
Q ss_pred CCCce--eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 757 GASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 757 ~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
..... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+...+....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~----~~~~~~i~~~~-------- 267 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDVIKAVDEGY-------- 267 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH----HHHHHHHHTTE--------
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCC--------
Confidence 32221 122335778999999999999999999999999999998 9999975441 12222211110
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
....+......+.+++.+|++.+|++||++.||++.|+.++..
T Consensus 268 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 268 -----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0111122335688999999999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=353.49 Aligned_cols=256 Identities=28% Similarity=0.458 Sum_probs=206.9
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+.+.||+|+||+||+|++.+++.||||+++.... ..+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 103 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCC
Confidence 4556789999999999999999888999999976543 356789999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 104 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 104 GCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred CcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 9999998642 35689999999999999999999998 99999999999999999999999999998654332222
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+. .+. ..
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~~----~~~-----~~---- 240 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ETAEHIA----QGL-----RL---- 240 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHHHHH----TTC-----CC----
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh----HHHHHHh----ccc-----CC----
Confidence 233446788999999998899999999999999999998 99999765421 1111111 110 00
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
..+......+.+++.+|++.+|++|||+.|++++|++++..
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 00111124688999999999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=349.67 Aligned_cols=272 Identities=21% Similarity=0.286 Sum_probs=211.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecC--eEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~--~~~LV~E~ 678 (929)
|.+.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 456789999999999999987 48999999997543 233567889999999999999999999997755 78999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe----cCCCcEEEEeecCcccc
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkL~DFGla~~~ 754 (929)
+++++|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 91 ~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 91 CPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999999996532 223489999999999999999999998 99999999999999 78888999999999865
Q ss_pred cCCCCceeeeeecCccccCccccc--------cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhh
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYI--------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 826 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 826 (929)
..... .....||+.|+|||++. +..++.++|||||||++|||++|+.||...........+...+.....
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 44332 23356999999999986 467899999999999999999999999754433322233222222111
Q ss_pred cCCccccc-----------CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 827 SGDIQGII-----------DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 827 ~~~~~~~~-----------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
......+. +-.............+.+++.+|++.||++|||++|++++..+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 11111100 0011123345667788999999999999999999999999987643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=359.97 Aligned_cols=245 Identities=24% Similarity=0.402 Sum_probs=201.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 456789999999999999985 78999999997542 233567889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 97 SGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp TTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 99999999843 45688999999999999999999998 99999999999999999999999999998654332
Q ss_pred ceeeeeecCccccCccccccCcCC-CcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
......||+.|+|||++.+..+. .++|||||||++|||++|+.||...... .+...+ ..+...
T Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i----~~~~~~------- 232 (328)
T 3fe3_A 169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK----ELRERV----LRGKYR------- 232 (328)
T ss_dssp -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH----HHCCCC-------
T ss_pred -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH----HHHHHH----HhCCCC-------
Confidence 23345699999999999887765 7899999999999999999999765422 122211 111110
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+......+.+++.+|++.||++|||++|++++
T Consensus 233 ---~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 ---IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011122357899999999999999999999886
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=358.23 Aligned_cols=266 Identities=27% Similarity=0.353 Sum_probs=204.8
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecC----eEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~----~~~LV~E~ 678 (929)
+.+.+.||+|+||+||+|++. ++.||||++.... .....+..|+.++++++||||+++++++.... ..++||||
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~ 103 (322)
T 3soc_A 26 LQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103 (322)
T ss_dssp EEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred chhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence 456789999999999999987 7999999996543 23445667999999999999999999998754 36999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCC-------CCceecCCCCCCCeEecCCCcEEEEeecCc
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-------VPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------~~~ivHrDIkp~NILl~~~~~vkL~DFGla 751 (929)
+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 104 HEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp CTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 999999999853 35889999999999999999999852 238999999999999999999999999999
Q ss_pred ccccCCCCc-eeeeeecCccccCcccccc-----CcCCCcCceeeHHHHHHHHHhCCCCCccccccccch---------h
Q 002382 752 KFAVDGASH-VSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR---------N 816 (929)
Q Consensus 752 ~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~---------~ 816 (929)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... .
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 865443222 2233569999999999986 356678899999999999999999997543111000 1
Q ss_pred hHHHHHHhhhcCCcccccCCcccCc-cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 817 IVQWAKLHIESGDIQGIIDPSLLDE-YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 817 l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
...+....... . ..+.+... ........+.+++.+|++.||++|||+.||++.|+++..
T Consensus 259 ~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 259 LEDMQEVVVHK-K----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHHHHHTTS-C----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhhhhcc-c----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111111111 1 11111111 123455679999999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=353.29 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=203.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.|.+.+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 3456789999999999999876 688999999865432 234678899999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 92 ~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 92 YIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999843 35689999999999999999999998 9999999999999999999999999999866544
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
.........||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .......... .. .
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~-~~-----~ 231 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQDS-VP-----N 231 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHSSC-CC-----C
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhcc-CC-----C
Confidence 333344566999999999999999999999999999999999999999765411 1111111111 10 0
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCC-cHHHHHHHHHHhHh
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAIV 880 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~eVl~~L~~~~~ 880 (929)
............+.+++.+|++.+|++|| ++.++.+.|+.++.
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 01111122234688999999999999999 89999999987653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=358.30 Aligned_cols=265 Identities=27% Similarity=0.395 Sum_probs=204.8
Q ss_pred HHHHHhccccccCcEEEEEEEEC-----CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeee--cCeEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSV 673 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-----~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~--~~~~~ 673 (929)
..+.+.+.||+|+||+||+|++. +++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 34556789999999999999852 578999999987666666789999999999999999999999854 45689
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 90 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999998643 34588999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCc--eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccccc--------ccchhhHHHHHH
Q 002382 754 AVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG--------ANCRNIVQWAKL 823 (929)
Q Consensus 754 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~--------~~~~~l~~~~~~ 823 (929)
....... ......++..|+|||.+.+..++.++|||||||++|||++|..|+...... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 5433221 222344778899999999999999999999999999999999998643210 000011111111
Q ss_pred hhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 824 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 824 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
....+.. ...+......+.+++.+|++.+|++|||+.|+++.|+++..
T Consensus 244 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 244 LLKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCc---------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1111111 11122233568899999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=369.17 Aligned_cols=255 Identities=29% Similarity=0.432 Sum_probs=206.7
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
+.+.+.||+|+||.||+|++. +++.||||+++... ......|.+|++++++++||||+++++++...+..++||||++
T Consensus 116 ~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 195 (377)
T 3cbl_A 116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 195 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCC
Confidence 446789999999999999987 68999999987543 2334578899999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 196 ~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 196 GGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp TCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 9999999853 234688999999999999999999998 9999999999999999999999999999754332111
Q ss_pred ee-eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 761 VS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 761 ~~-~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.. ....+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .+.+.+ ..+...
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~----~~~~~~----~~~~~~------- 334 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ----QTREFV----EKGGRL------- 334 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----HHHHHH----HTTCCC-------
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----HcCCCC-------
Confidence 11 12335778999999998899999999999999999998 99999765411 122221 111100
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
..+......+.+++.+|++.+|++|||+.||++.|+++..
T Consensus 335 --~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 335 --PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 0111123468899999999999999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=356.46 Aligned_cols=246 Identities=23% Similarity=0.311 Sum_probs=201.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+.+.+.||+|+||+||+|+.+ +++.||||++++.. ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence 345689999999999999987 68999999997542 22345688999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 87 ANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 99999999884 345688999999999999999999998 99999999999999999999999999997533222
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.+. . +.. .+
T Consensus 160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~---~-~~~------~~ 224 (337)
T 1o6l_A 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELIL---M-EEI------RF 224 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH---H-CCC------CC
T ss_pred -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH----HHHHHHH---c-CCC------CC
Confidence 2234457999999999999999999999999999999999999999754421 1211111 1 111 01
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
... ....+.+++.+|++.+|++|| ++.|+++|
T Consensus 225 p~~----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 PRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCC----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 111 224678999999999999999 89999887
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=360.95 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=202.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc------hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~------~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
|.+.+.||+|+||+||+|+.+ +|+.||||+++..... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 456789999999999999987 5899999999765322 246789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC----cEEEEeecCc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGLS 751 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkL~DFGla 751 (929)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||++
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 94 LELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999843 45689999999999999999999998 999999999999998877 7999999999
Q ss_pred ccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|..||......+ +...+ ..+...
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~----~~~~i----~~~~~~ 236 (361)
T 2yab_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANI----TAVSYD 236 (361)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHH----HTTCCC
T ss_pred eEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH----HhcCCC
Confidence 8654432 2234569999999999999899999999999999999999999997654211 11111 111100
Q ss_pred cccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 832 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 832 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+++..... ....+.+++.+|++.||++|||+.|+++|
T Consensus 237 --~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 237 --FDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp --CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --CCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01111111 12357899999999999999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=354.26 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=203.8
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc------hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~------~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~ 673 (929)
..|.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++||||+++++++...+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45667889999999999999987 5899999999754322 3567899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC----cEEEEeec
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFG 749 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkL~DFG 749 (929)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999843 45689999999999999999999998 999999999999999887 89999999
Q ss_pred CcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+... ...
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~~~~~--~~~ 235 (326)
T 2y0a_A 164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANVSAV--NYE 235 (326)
T ss_dssp TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHHT--CCC
T ss_pred CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----HHHHHHhc--CCC
Confidence 998654332 2234569999999999998999999999999999999999999997544211 11111110 000
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. ...........+.+++.+|++.||++|||+.|++++
T Consensus 236 ~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 F--------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C--------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred c--------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 000001122457899999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=360.25 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=204.7
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-----cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEE
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-----~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~ 673 (929)
...|.+.+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 346677899999999999999886 68999999986431 223567899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc---EEEEeecC
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFGL 750 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkL~DFGl 750 (929)
+||||+++++|.+.+.........+++..+..++.||++||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988865433344588999999999999999999998 9999999999999987654 99999999
Q ss_pred cccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCc
Q 002382 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 830 (929)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+...+. .+..
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~i~----~~~~ 249 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-----ERLFEGII----KGKY 249 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-----HHHHHHHH----HTCC
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-----HHHHHHHH----cCCC
Confidence 98654432 22334569999999999999999999999999999999999999997543 11111111 1111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. .++..... ....+.+++.+|++.||++|||+.|++++
T Consensus 250 ~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 K--MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp C--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C--CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00000011 12467899999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=354.67 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=209.7
Q ss_pred HHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
.+.+.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|++++++++||||+++++++...+..++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 103 (314)
T 2ivs_A 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL 103 (314)
T ss_dssp GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence 3456789999999999999862 35789999997553 3345678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhccccc--------------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCC
Q 002382 675 VYEFMHNGTLKEHLYGTLT--------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~N 734 (929)
||||+++++|.+++..... ....+++..++.++.|+++||+|||++ +|+||||||+|
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~N 180 (314)
T 2ivs_A 104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN 180 (314)
T ss_dssp EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchhe
Confidence 9999999999999965322 124588999999999999999999998 99999999999
Q ss_pred eEecCCCcEEEEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccc
Q 002382 735 ILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGA 812 (929)
Q Consensus 735 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~ 812 (929)
|+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~- 259 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE- 259 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 99999999999999999865443322 2233457889999999999899999999999999999999 99999765421
Q ss_pred cchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 813 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 813 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
.+...... +... ..+......+.+++.+|++.+|++||++.|++++|++++..
T Consensus 260 ---~~~~~~~~----~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 260 ---RLFNLLKT----GHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp ---GHHHHHHT----TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---HHHHHhhc----CCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 22222111 1110 11112234688999999999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=362.19 Aligned_cols=262 Identities=27% Similarity=0.416 Sum_probs=207.5
Q ss_pred HHHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCc-chhHHHHHHHHHhccc-CCCceeEEeeeeeecC-e
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG-R 671 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~-~ 671 (929)
..+.+.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+++++++ +||||+++++++...+ .
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 44556789999999999999742 457899999976533 3346799999999999 7999999999998755 4
Q ss_pred EEEEEEeccCCchhhhhcccccc---------------------------------------------------------
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLTH--------------------------------------------------------- 694 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~~--------------------------------------------------------- 694 (929)
.++||||+++|+|.+++......
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 89999999999999999654211
Q ss_pred -----ccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC-ceeeeeecC
Q 002382 695 -----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGT 768 (929)
Q Consensus 695 -----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt 768 (929)
...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 11288999999999999999999998 999999999999999999999999999986543322 233455689
Q ss_pred ccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHH
Q 002382 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSM 847 (929)
Q Consensus 769 ~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 847 (929)
+.|+|||++.+..++.++|||||||++|||++ |+.||......+ .+..... .+.... .... ..
T Consensus 259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~----~~~~~~-----~~~~----~~ 322 (359)
T 3vhe_A 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRRLK----EGTRMR-----APDY----TT 322 (359)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHHHHH----HTCCCC-----CCTT----CC
T ss_pred ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH---HHHHHHH----cCCCCC-----CCCC----CC
Confidence 99999999999999999999999999999998 999997654221 1111111 111100 1111 22
Q ss_pred HHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 848 WKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 848 ~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
..+.+++.+|++.+|++|||+.||+++|++++..
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 3588999999999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=351.52 Aligned_cols=263 Identities=21% Similarity=0.264 Sum_probs=199.2
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||+||+|++.+++.||||++..... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence 445789999999999999998899999999975432 224678899999999999999999999999999999999998
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+ +|.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 103 ~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 103 K-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp E-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred C-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 5 77777753 234588999999999999999999998 999999999999999999999999999986543322
Q ss_pred eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc-------
Q 002382 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG------- 832 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~------- 832 (929)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+......... .....
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~ 253 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNP-REWPQVQELPLW 253 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCT-TTSGGGTTSHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCCh-HHhhhhhccchh
Confidence 2233468999999999876 56899999999999999999999999765533222222221111000 00000
Q ss_pred ------ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 ------IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 ------~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+.............++.+++.+|++.||++|||+.|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000000011122467899999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=347.31 Aligned_cols=257 Identities=22% Similarity=0.363 Sum_probs=197.6
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcc--cCCCceeEEeeeeee----cCeEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQE----EGRSVLVY 676 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~--l~HpNIv~l~g~~~~----~~~~~LV~ 676 (929)
+.+.+.||+|+||+||+|++ +++.||||++... ....+..|.+++.. ++||||+++++++.. ....++||
T Consensus 10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 45678999999999999998 4899999998643 23455566666655 799999999998754 34579999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHH--------hCCCCceecCCCCCCCeEecCCCcEEEEee
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--------TGCVPAIIHRDLKSSNILLDKHMRAKVSDF 748 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 748 (929)
||+++|+|.+++. ...+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||+||
T Consensus 86 e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 86 HYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp CCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCC
T ss_pred hhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeC
Confidence 9999999999984 346889999999999999999999 76 9999999999999999999999999
Q ss_pred cCcccccCCCCce---eeeeecCccccCccccccC------cCCCcCceeeHHHHHHHHHhC----------CCCCcccc
Q 002382 749 GLSKFAVDGASHV---SSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISG----------QEAISNEK 809 (929)
Q Consensus 749 Gla~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~------~~s~~sDVwSlGvvl~elltG----------~~p~~~~~ 809 (929)
|+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9997655433322 2234699999999999876 455789999999999999999 77775433
Q ss_pred ccccchhhHHHHHHhhhcCCcccccCCccc-CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 810 FGANCRNIVQWAKLHIESGDIQGIIDPSLL-DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 810 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
..... ............. .+.+. ..........+.+++.+|++.||++|||+.||++.|+++
T Consensus 238 ~~~~~--~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PNDPS--FEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSCC--HHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcc--hhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 22111 1111111111111 11111 112334667899999999999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=372.98 Aligned_cols=255 Identities=23% Similarity=0.386 Sum_probs=207.7
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.+|++++||||+++++++. .+..++||||+++
T Consensus 189 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~ 266 (454)
T 1qcf_A 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAK 266 (454)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCC
Confidence 345678999999999999999988999999997654 34678999999999999999999999987 5678999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 267 g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 267 GSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp CBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred CcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 9999999643 234578889999999999999999998 99999999999999999999999999998654322222
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....+|..|+|||++....++.++|||||||++|||++ |+.||...... .+.+.+... ..+
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~----~~~~~i~~~---~~~---------- 404 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRALERG---YRM---------- 404 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHHHHT---CCC----------
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcC---CCC----------
Confidence 233446789999999998999999999999999999999 99999765422 222221111 111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
..+......+.+++.+|++.+|++|||+.+|++.|+++..
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 0111223468899999999999999999999999998753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=358.76 Aligned_cols=264 Identities=25% Similarity=0.376 Sum_probs=206.8
Q ss_pred HHHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCC-cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 672 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~ 672 (929)
..+.+.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 44566789999999999999862 45689999997542 33456789999999999 899999999999999999
Q ss_pred EEEEEeccCCchhhhhcccccc-------------------ccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCC
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTH-------------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS 733 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~-------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~ 733 (929)
++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence 9999999999999999653211 13478999999999999999999998 9999999999
Q ss_pred CeEecCCCcEEEEeecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCcccccc
Q 002382 734 NILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG 811 (929)
Q Consensus 734 NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~ 811 (929)
|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 99999999999999999986544332 22334567899999999999899999999999999999998 99999765422
Q ss_pred ccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHhH
Q 002382 812 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 883 (929)
Q Consensus 812 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~~ 883 (929)
. .+..... .+.. ...+......+.+++.+|++.+|++||++.||+++|+.++...+
T Consensus 282 ~---~~~~~~~----~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 282 A---NFYKLIQ----NGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp H---HHHHHHH----TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred H---HHHHHHh----cCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 1 1112111 1100 01111223468899999999999999999999999998876443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=346.57 Aligned_cols=257 Identities=21% Similarity=0.334 Sum_probs=195.8
Q ss_pred HHHHhccccccCcEEEEEEEECC----CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~----~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
.|.+.+.||+|+||.||+|++.. +..||+|+++... ....+.+.+|+.++++++||||+++++++. .+..++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 94 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 94 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence 45567899999999999998753 4569999987543 333567899999999999999999999985 45689999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 95 ELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp ECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999998532 34588999999999999999999998 999999999999999999999999999986654
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
..........+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... .+...+. .+...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~----~~~~~i~----~~~~~---- 236 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIE----NGERL---- 236 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHH----TTCCC----
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH----HHHHHHH----cCCCC----
Confidence 43333344457889999999998899999999999999999997 99999765422 2222211 11110
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
..+......+.+++.+|++.+|++||++.|++++|++++..+
T Consensus 237 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 237 -----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 011122346889999999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=364.24 Aligned_cols=262 Identities=25% Similarity=0.428 Sum_probs=211.2
Q ss_pred HHHHHhccccccCcEEEEEEEEC--------CCcEEEEEEeecCCc-chhHHHHHHHHHhccc-CCCceeEEeeeeeecC
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG 670 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~--------~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~ 670 (929)
..+.+.+.||+|+||+||+|++. .++.||||+++.... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 34567789999999999999863 235799999976533 3346789999999999 9999999999999999
Q ss_pred eEEEEEEeccCCchhhhhccccc------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~ 738 (929)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEc
Confidence 99999999999999999965421 124589999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchh
Q 002382 739 KHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRN 816 (929)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~ 816 (929)
.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~----~~ 301 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----EE 301 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HH
Confidence 999999999999986543322 22233457889999999999999999999999999999999 9999975442 12
Q ss_pred hHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 817 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 817 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
+.+.+.. +... ..+......+.+++.+|++.+|++||++.||+++|++++...
T Consensus 302 ~~~~~~~----~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 302 LFKLLKE----GHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHHHT----TCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHc----CCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 2222211 1110 011122346889999999999999999999999999987643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=346.16 Aligned_cols=264 Identities=21% Similarity=0.279 Sum_probs=197.7
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||+||+|+..+++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 345688999999999999998899999999975432 224678899999999999999999999999999999999997
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+ +|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 84 ~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (288)
T 1ob3_A 84 Q-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (288)
T ss_dssp E-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred C-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-c
Confidence 5 888887532 35688899999999999999999998 99999999999999999999999999997654322 1
Q ss_pred eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC--c--ccccC
Q 002382 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD--I--QGIID 835 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~--~--~~~~d 835 (929)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.+.......... . ....+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 2233458999999999976 45899999999999999999999999765422211122111100000000 0 00011
Q ss_pred Cccc-------CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSLL-------DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+... ..........+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1110 01111223467899999999999999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=347.10 Aligned_cols=247 Identities=25% Similarity=0.344 Sum_probs=193.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc--------------------------hhHHHHHHHHHhcccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------------------------GKREFTNEVTLLSRIH 655 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~--------------------------~~~~f~~Ev~iL~~l~ 655 (929)
|.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 456789999999999999876 5889999998754311 1256889999999999
Q ss_pred CCceeEEeeeeee--cCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCC
Q 002382 656 HRNLVQFLGYCQE--EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS 733 (929)
Q Consensus 656 HpNIv~l~g~~~~--~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~ 733 (929)
||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.|+++||+|||++ +|+||||||+
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 166 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS 166 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 9999999999986 568899999999999988653 34689999999999999999999998 9999999999
Q ss_pred CeEecCCCcEEEEeecCcccccCCCCceeeeeecCccccCccccccCc---CCCcCceeeHHHHHHHHHhCCCCCccccc
Q 002382 734 NILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNEKF 810 (929)
Q Consensus 734 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~~sDVwSlGvvl~elltG~~p~~~~~~ 810 (929)
|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999986544322 233456999999999997654 36789999999999999999999975431
Q ss_pred cccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 811 GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 811 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. .+... ........ ..... ....+.+++.+|++.||++||++.|+++|
T Consensus 246 ~----~~~~~----~~~~~~~~----~~~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 M----CLHSK----IKSQALEF----PDQPD----IAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp H----HHHHH----HHHCCCCC----CSSSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred H----HHHHH----HhcccCCC----CCccc----cCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 1 11111 11111100 00111 22358899999999999999999999865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=352.90 Aligned_cols=249 Identities=18% Similarity=0.293 Sum_probs=202.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
|.+.+.||+|+||.||+|++. +++.+|+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 85 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence 446788999999999999987 57889999987443 3456788999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC--CCcEEEEeecCcccccCCCC
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~~~~~~~ 759 (929)
|+|.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 86 ~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 86 LDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 999999853 234688999999999999999999998 9999999999999987 7899999999998664432
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... .+...+.. +... .+....
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~----~~~~--~~~~~~ 227 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----QIIENIMN----AEYT--FDEEAF 227 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHH----TCCC--CCHHHH
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH----HHHHHHHc----CCCC--CChhhh
Confidence 234456999999999999888999999999999999999999999765421 11111111 1100 000000
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. .....+.+++.+|++.||++|||+.|++++
T Consensus 228 ~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 228 K----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 122467899999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=360.38 Aligned_cols=247 Identities=25% Similarity=0.351 Sum_probs=197.7
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
.+.+.+.||+|+||+||+|+++ +++.||||+++... ......+.+|..+++.+ +||||+++++++.+.+..++||
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~ 103 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence 3456789999999999999987 58899999997542 22345677899999988 7999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 104 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 104 EFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999998843 45689999999999999999999998 999999999999999999999999999975332
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. +..
T Consensus 177 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--------~~~------ 241 (353)
T 3txo_A 177 N-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--------DEV------ 241 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------CCC------
T ss_pred C-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc--------CCC------
Confidence 2 2233445799999999999999999999999999999999999999976542222111111 111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcH------HHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~------~eVl~~ 874 (929)
.++......+.+++.+|++.+|++||++ .|+++|
T Consensus 242 ----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 242 ----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 0111122357899999999999999998 778775
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=364.36 Aligned_cols=261 Identities=26% Similarity=0.399 Sum_probs=207.9
Q ss_pred HHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecC-CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
.+.+.+.||+|+||+||+|++. +++.||||+++.. .......+.+|+.++++++||||+++++++...+..++
T Consensus 72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 151 (367)
T 3l9p_A 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151 (367)
T ss_dssp GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEE
Confidence 3456789999999999999854 4668999999754 33445678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhcccc---ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC---cEEEEee
Q 002382 675 VYEFMHNGTLKEHLYGTL---THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDF 748 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkL~DF 748 (929)
||||+++|+|.+++.... .....+++..++.++.|+++||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCC
Confidence 999999999999996532 2234588999999999999999999998 999999999999999555 5999999
Q ss_pred cCcccccCC-CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhh
Q 002382 749 GLSKFAVDG-ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 826 (929)
Q Consensus 749 Gla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 826 (929)
|+++..... .........||+.|+|||++.+..++.++|||||||++|||++ |..||..... ..+...+..
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~----~~~~~~i~~--- 301 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----QEVLEFVTS--- 301 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHHT---
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHc---
Confidence 999754322 1122233457899999999999999999999999999999998 9999976541 122222111
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 827 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 827 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
+... ..+......+.+++.+|++.+|++||++.||+++|+.+....
T Consensus 302 -~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 302 -GGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp -TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -CCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 1100 111122345889999999999999999999999999876543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=364.88 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=202.4
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
..|.+.+.||+|+||+||+|... +++.+|+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 45667889999999999999876 688999999976542 234668899999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec---CCCcEEEEeecCcccc
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFA 754 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~---~~~~vkL~DFGla~~~ 754 (929)
|+.+|+|.+.+.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++..
T Consensus 91 ~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 91 LVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred eCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999998853 35688999999999999999999998 999999999999998 4578999999999765
Q ss_pred cCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .+.+.+. .+... .
T Consensus 164 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~----~~~~~i~----~~~~~--~ 232 (444)
T 3soa_A 164 EGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH----RLYQQIK----AGAYD--F 232 (444)
T ss_dssp CTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHH----HTCCC--C
T ss_pred cCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH----HHHHHHH----hCCCC--C
Confidence 44322 223456999999999999989999999999999999999999999765421 2222111 11110 0
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....... ....+.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~~----~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 PSPEWDT----VTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CTTTTTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Ccccccc----CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000111 22467899999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=348.95 Aligned_cols=259 Identities=27% Similarity=0.418 Sum_probs=213.7
Q ss_pred HHHHHhccccccCcEEEEEEEECC-CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
..+.+.+.||+|+||.||+|.+.. ++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 91 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence 345567899999999999999874 7889999997543 34577899999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 92 ~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 92 TYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp TTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred CCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 999999998643 235588999999999999999999998 999999999999999999999999999987655444
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... .+.+.......
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~----~~~~~~~~~~~------------ 230 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLEKDYR------------ 230 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHHHTTCC------------
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHhccCC------------
Confidence 44445567889999999998999999999999999999999 99999765422 22222111100
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
...+......+.+++.+|++.+|++||++.|+++.|+.+....
T Consensus 231 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 231 -MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0111122346889999999999999999999999999987654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.58 Aligned_cols=251 Identities=30% Similarity=0.430 Sum_probs=191.6
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCc----chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~----~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+.+.+.||+|+||.||+|++. ++.||||+++.... ...+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred eeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence 345689999999999999986 89999999875432 2246788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC--------CCcEEEEeecC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--------HMRAKVSDFGL 750 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~--------~~~vkL~DFGl 750 (929)
+++++|.+++. ...+++..++.++.|+++||+|||++...+|+||||||+||+++. ++.+||+|||+
T Consensus 88 ~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 88 ARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp CTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred CCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999884 346889999999999999999999982222999999999999986 77899999999
Q ss_pred cccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCc
Q 002382 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 830 (929)
++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... . .....
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~---~-~~~~~ 231 (271)
T 3dtc_A 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----AVAYG---V-AMNKL 231 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH----HHHHH---H-HTSCC
T ss_pred cccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHh---h-hcCCC
Confidence 97554322 22346899999999999989999999999999999999999999764411 11111 1 11111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 831 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
. ...+......+.+++.+|++.+|++|||+.|++++|+.+
T Consensus 232 ~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 232 A--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0 111122234688999999999999999999999999853
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=355.56 Aligned_cols=256 Identities=23% Similarity=0.367 Sum_probs=199.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCc----EEEEEEeecC-CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~----~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
.|.+.+.||+|+||+||+|++. +++ +||+|.++.. .....+.+.+|+.++++++||||++++++|.... .++|
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v 94 (327)
T 3poz_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEE
T ss_pred HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEE
Confidence 3456789999999999999875 344 3588877543 2344578999999999999999999999998754 7899
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
+||+.+|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 95 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 95 TQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999998642 35688999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 756 DGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 756 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...... +..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~~~----~~~--- 237 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEK----GER--- 237 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHHT----TCC---
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH----HHHHHHHc----CCC---
Confidence 43322 2233457889999999999999999999999999999999 99999765422 22222111 110
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
...+......+.+++.+|++.+|++||++.|++++|+.+...
T Consensus 238 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 238 ------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 011112234688999999999999999999999999988654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=357.58 Aligned_cols=265 Identities=25% Similarity=0.366 Sum_probs=208.3
Q ss_pred HHHHhccccccCcEEEEEEEE-----CCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeee--ecCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ--EEGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~-----~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~--~~~~~~L 674 (929)
.+.+.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 455678999999999999985 357899999998776666678999999999999999999999886 4567899
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
||||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 104 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999998532 34589999999999999999999998 9999999999999999999999999999866
Q ss_pred cCCCCc--eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccccc--------ccchhhHHHHHHh
Q 002382 755 VDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG--------ANCRNIVQWAKLH 824 (929)
Q Consensus 755 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~--------~~~~~l~~~~~~~ 824 (929)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ......... ...
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL-LEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH-HHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH-HHH
Confidence 443322 223345888899999999988999999999999999999999998653311 000011111 111
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
...+ .....+......+.+++.+|++.+|++|||+.|++++|+.+....
T Consensus 257 ~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 LEEG---------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hhcc---------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 1111 111112233356889999999999999999999999999886543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=353.77 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=199.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||+||+|++. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 345789999999999999987 688999999875432 334678899999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC-C
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-S 759 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~-~ 759 (929)
+|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 89 ~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 89 GGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp TEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999884 345689999999999999999999998 99999999999999999999999999997553322 1
Q ss_pred ceeeeeecCccccCccccccCcC-CCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ......|..... . ..
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~~~---~----~~--- 229 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWKEKKT---Y----LN--- 229 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT--SHHHHHHHTTCT---T----ST---
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHhcccc---c----CC---
Confidence 22334569999999999987765 77899999999999999999999764411 112222211110 0 00
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
........+.+++.+|++.||++|||+.|++++
T Consensus 230 ---~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 ---PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 001122457799999999999999999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=353.99 Aligned_cols=256 Identities=23% Similarity=0.387 Sum_probs=200.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcE----EEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKE----IAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~----vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
+.+.+.||+|+||+||+|++. +++. ||+|++.... ......+.+|+.++++++||||+++++++. .+..++||
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 93 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT 93 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence 345689999999999999876 3443 7888875443 333456788999999999999999999986 45689999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+.+|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 94 QYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp ECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999998642 45688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 757 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 757 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
.... ......||..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+..... .+....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~----~~~~~~-- 237 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----EVPDLLE----KGERLA-- 237 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT----HHHHHHH----TTCBCC--
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH----HHHHHHH----cCCCCC--
Confidence 3322 2344568889999999999999999999999999999999 99999765422 2222211 111000
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
.+......+.+++.+|++.+|++||++.|++++|+.+....
T Consensus 238 -------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 238 -------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp -------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred -------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 00011124678999999999999999999999999886543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=343.14 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=207.9
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+.+.||+|+||.||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 91 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCC
Confidence 345678999999999999999888899999997554 335678999999999999999999999864 568999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
++|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 92 ~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 92 GSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp CBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 9999998542 233688999999999999999999998 99999999999999999999999999998665443333
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.+... .+.. ..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~~~----~~~~-----~~--- 230 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----EVIQNLE----RGYR-----MV--- 230 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHHHH----TTCC-----CC---
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH----HHHHHHh----cccC-----CC---
Confidence 334457889999999998889999999999999999999 99999754421 1222111 1100 00
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
.+......+.+++.+|++.+|++|||+.++++.|+++...
T Consensus 231 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 1112234688999999999999999999999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=352.25 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=194.8
Q ss_pred HHHHHhccccccCcEEEEEEEECCCc----EEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeE--
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLKDGK----EIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS-- 672 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~~~~----~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~-- 672 (929)
..|.+.+.||+|+||+||+|++.... .||||+++.. .....+.+.+|++++++++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 34567789999999999999876432 7999998754 334457799999999999999999999999876655
Q ss_pred ----EEEEEeccCCchhhhhccccc--cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEE
Q 002382 673 ----VLVYEFMHNGTLKEHLYGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (929)
Q Consensus 673 ----~LV~E~~~~gsL~~~L~~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 746 (929)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEe
Confidence 999999999999999854321 122588999999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHh
Q 002382 747 DFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 824 (929)
Q Consensus 747 DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 824 (929)
|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ +.....
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----~~~~~~-- 253 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE----IYNYLI-- 253 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHH--
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH----HHHHHh--
Confidence 99999865443221 2233457889999999999999999999999999999999 999997654221 222111
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
..... ..+......+.+++.+|++.||++|||+.|+++.|++++...
T Consensus 254 -~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 254 -GGNRL----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -TTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -cCCCC----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11100 111122346889999999999999999999999999987643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.93 Aligned_cols=254 Identities=28% Similarity=0.447 Sum_probs=207.5
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.+.+.||+|+||.||+|++.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG 88 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence 445688999999999999998889999999976543 3467899999999999999999999999999999999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
+|.+++... ...+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 89 ~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 89 CLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp BHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred cHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999998532 34578999999999999999999998 999999999999999999999999999976543222222
Q ss_pred eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+...+. .+.. ..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~i~----~~~~-----~~---- 225 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVEDIS----TGFR-----LY---- 225 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHH----TTCC-----CC----
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH----HHHHHHh----cCCc-----CC----
Confidence 23447789999999998889999999999999999999 89999764421 1222111 1100 00
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.+......+.+++.+|++.+|++||++.|++++|+++..
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011122467899999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=375.83 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=210.0
Q ss_pred HHHhccccccCcEEEEEEEECC-CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.+.+.||+|+||.||+|+++. ++.||||+++.... ..++|.+|+.+|++++||||++++++|...+..++||||+++
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~ 300 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 300 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCC
Confidence 4567899999999999999884 78999999976543 357799999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 301 g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 301 GNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp CBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred CCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 9999999643 234588999999999999999999998 99999999999999999999999999998654433222
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.+.+.. +. ..
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~----~~~~~~~~----~~---------~~ 438 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLEK----DY---------RM 438 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHHHT----TC---------CC
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHc----CC---------CC
Confidence 333446789999999999999999999999999999999 99999765422 22222111 10 01
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
..+......+.+++.+|++.+|++|||+.||++.|+.++.
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1112233468899999999999999999999999998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=356.72 Aligned_cols=260 Identities=25% Similarity=0.428 Sum_probs=207.9
Q ss_pred HHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
.+.+.+.||+|+||.||+|++. +++.||||+++... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 127 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence 3456789999999999999885 34789999997653 3335678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhcccccc--------------------ccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCC
Q 002382 675 VYEFMHNGTLKEHLYGTLTH--------------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~--------------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~N 734 (929)
||||+++|+|.+++...... ...+++.+++.++.||++||.|||++ +|+||||||+|
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~N 204 (343)
T 1luf_A 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 204 (343)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcce
Confidence 99999999999998653211 25688999999999999999999998 99999999999
Q ss_pred eEecCCCcEEEEeecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccc
Q 002382 735 ILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGA 812 (929)
Q Consensus 735 ILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~ 812 (929)
||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-- 282 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-- 282 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh--
Confidence 9999999999999999975433221 22234458899999999998899999999999999999999 9999975441
Q ss_pred cchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 813 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 813 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
..+... ...+.... .+......+.+++.+|++.+|++||++.||+++|+++...
T Consensus 283 --~~~~~~----~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 283 --EEVIYY----VRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp --HHHHHH----HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred --HHHHHH----HhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 122221 11221111 1112234688999999999999999999999999988653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=355.89 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=203.4
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
...|.+.+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 345667889999999999999986 589999999976532 33467889999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC---cEEEEeecCccc
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKF 753 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkL~DFGla~~ 753 (929)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 108 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999998843 35688999999999999999999998 999999999999998654 599999999986
Q ss_pred ccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+.. +...
T Consensus 181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----~~~~~i~~----~~~~-- 248 (362)
T 2bdw_A 181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQIKA----GAYD-- 248 (362)
T ss_dssp CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH----TCCC--
T ss_pred ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHh----CCCC--
Confidence 54332 223456999999999999989999999999999999999999999764421 22221111 1110
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....... .....+.+++.+|++.||++||++.|++++
T Consensus 249 ~~~~~~~----~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 YPSPEWD----TVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCTTGGG----GSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000011 123467899999999999999999999876
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=356.25 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=197.1
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
.+.||+|+||.||+|+.. +++.||+|+++.......+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999876 6899999999877666677899999999999999999999999999999999999999999
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe--cCCCcEEEEeecCcccccCCCCcee
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl--~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
.+++.. ....+++..++.++.|+++||+|||++ +|+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 998853 234688999999999999999999998 99999999999999 5678999999999986544322 2
Q ss_pred eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCcc
Q 002382 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 842 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 842 (929)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. .. ... .......
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~---~~---~~~----~~~~~~~- 314 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA---CR---WDL----EDEEFQD- 314 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---TC---CCS----CSGGGTT-
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cc---CCC----Chhhhcc-
Confidence 334699999999999988999999999999999999999999976542211111111 10 000 0111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 843 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 843 ~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....+.+++.+|++.+|++||++.|++++
T Consensus 315 ---~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 315 ---ISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp ---SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 22468899999999999999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=357.57 Aligned_cols=251 Identities=21% Similarity=0.327 Sum_probs=205.0
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.|.+.+.||+|+||.||+|... +++.||+|++..........+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 3556789999999999999887 688999999987665556789999999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC--CCcEEEEeecCcccccCCC
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~~~~~~ 758 (929)
+|+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++......
T Consensus 132 gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 132 GGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 9999998853 234689999999999999999999998 9999999999999974 4789999999998654332
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.. ... ..++..
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~i~~----~~~--~~~~~~ 273 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKR----CDW--EFDEDA 273 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHH----CCC--CCCSST
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH----HHHHHHHh----CCC--CCCccc
Confidence 233456999999999999999999999999999999999999999764411 11111111 110 011111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... ....+.+++.+|++.||++|||+.|++++
T Consensus 274 ~~~----~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 FSS----VSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccc----CCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 112 22467899999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=350.60 Aligned_cols=259 Identities=17% Similarity=0.209 Sum_probs=206.6
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||+||+|+.. +++.||||++..... ...+.+|+++++++ +||||+++++++...+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~- 87 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence 345689999999999999975 688999999875432 35688999999999 9999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc-----EEEEeecCccccc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-----AKVSDFGLSKFAV 755 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-----vkL~DFGla~~~~ 755 (929)
+++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++...
T Consensus 88 ~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 88 GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999998542 35789999999999999999999998 9999999999999999887 9999999998654
Q ss_pred CCCCc------eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 756 DGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 756 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA-TP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-SC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-CC
Confidence 43221 123456999999999999999999999999999999999999999865422221111111111110 00
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
.. ....... .+.+++..|++.+|++||++.+|.+.|+++...
T Consensus 241 ~~---------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 241 IE---------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HH---------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HH---------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 00 0000112 788999999999999999999999999987654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=347.93 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=209.4
Q ss_pred HHHHhccccccCcEEEEEEEE------CCCcEEEEEEeecCCc-chhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~------~~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~ 673 (929)
.+.+.+.||+|+||.||+|++ .+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++...+..+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 103 (313)
T 1t46_A 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (313)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence 455678999999999999985 2467899999976543 3356789999999999 9999999999999999999
Q ss_pred EEEEeccCCchhhhhccccc--------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC
Q 002382 674 LVYEFMHNGTLKEHLYGTLT--------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 739 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 739 (929)
+||||+++|+|.+++..... ....+++..++.++.|+++||+|||++ +|+||||||+||+++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH 180 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEET
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcC
Confidence 99999999999999864321 123588999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhh
Q 002382 740 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 817 (929)
Q Consensus 740 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l 817 (929)
++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... .+
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~ 257 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---KF 257 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---HH
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh---HH
Confidence 999999999999865544322 2334557889999999999999999999999999999999 999997654221 11
Q ss_pred HHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 818 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 818 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
......... . ..+......+.+++.+|++.+|++|||+.|++++|++++.
T Consensus 258 ~~~~~~~~~---------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 258 YKMIKEGFR---------M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp HHHHHHTCC---------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhccCCC---------C----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 111111100 0 0011123468899999999999999999999999998875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=342.97 Aligned_cols=263 Identities=20% Similarity=0.248 Sum_probs=196.7
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||+||+|++. +++.||||+++.... .....+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 345688999999999999987 588999999975532 23467889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++ ++.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 84 DQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp SE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred CC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 76 55555432 245689999999999999999999998 99999999999999999999999999998654332
Q ss_pred ceeeeeecCccccCccccccCc-CCCcCceeeHHHHHHHHHhCCCCCcccc-ccccchhhHHHHHHhhhcCCcccc---c
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEK-FGANCRNIVQWAKLHIESGDIQGI---I 834 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDVwSlGvvl~elltG~~p~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~---~ 834 (929)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..|+.... ..+....+.+..... ........ .
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~ 234 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP-TEEQWPSMTKLP 234 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC-CTTTCTTGGGST
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC-Chhhhhhhcccc
Confidence 2223446899999999998765 7999999999999999999888864322 111111111110000 00000000 0
Q ss_pred C---------CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 835 D---------PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 835 d---------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+ ..............+.+++.+|++.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000001111233467899999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=352.89 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=206.4
Q ss_pred HHhccccccCcEEEEEEEEC-----CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeec--CeEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV 675 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-----~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~--~~~~LV 675 (929)
.+.+.||+|+||+||++.++ +++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 56789999999999998754 57889999998653 23456789999999999999999999999874 678999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 114 ~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp ECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999843 3488999999999999999999998 99999999999999999999999999998665
Q ss_pred CCCCc--eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccc--------cchhhHHHHHHhh
Q 002382 756 DGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA--------NCRNIVQWAKLHI 825 (929)
Q Consensus 756 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~--------~~~~l~~~~~~~~ 825 (929)
..... ......+|..|+|||.+.+..++.++|||||||++|||++|+.||....... ....... .....
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-LTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH-HHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH-HHHHH
Confidence 44322 2233457889999999999899999999999999999999999986533110 0000111 11111
Q ss_pred hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 826 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
..+ .....+......+.+++.+|++.+|++|||+.|+++.|+.+....
T Consensus 265 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 265 ERG---------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hcc---------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 111 111112223356889999999999999999999999999887654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=347.51 Aligned_cols=267 Identities=22% Similarity=0.286 Sum_probs=191.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.|.+.+.||+|+||.||+|+.+ +++.||||+++.... .....+.+|++++++++||||+++++++..++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 4566789999999999999876 589999999975532 23467889999999999999999999999999999999999
Q ss_pred cCCchhhhhcccc--ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 680 HNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 680 ~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
+ |+|.+++.... .....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 8 58988885432 1224588899999999999999999998 9999999999999999999999999999865432
Q ss_pred CCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc----
Q 002382 758 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG---- 832 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~---- 832 (929)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.+...... ......
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~ 239 (317)
T 2pmi_A 162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN-ESLWPSVTKL 239 (317)
T ss_dssp CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC-TTTCGGGGGC
T ss_pred cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-hhHhhhhhhh
Confidence 22 2233468999999999976 4689999999999999999999999976542222222221111000 000000
Q ss_pred -ccCCcc------------cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 -IIDPSL------------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 -~~d~~l------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...+.+ ...........+.+++.+|++.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000 000001122468899999999999999999999876
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=366.32 Aligned_cols=249 Identities=28% Similarity=0.428 Sum_probs=203.1
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecC-eEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-RSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~-~~~LV~E~~~~ 681 (929)
+.+.+.||+|+||.||+|.++ ++.||||+++... ..+.|.+|+++|++++||||+++++++.... ..++||||+++
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~ 271 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred eEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence 345689999999999999987 7899999997653 4567999999999999999999999987665 78999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++... ....+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 272 g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 342 (450)
T 1k9a_A 272 GSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 342 (450)
T ss_dssp CBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence 9999999643 223468889999999999999999998 9999999999999999999999999999854322
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...+ ..+.. .
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----~~~~~i----~~~~~---------~ 405 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRV----EKGYK---------M 405 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT----THHHHH----HTTCC---------C
T ss_pred ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----HcCCC---------C
Confidence 122357889999999999999999999999999999998 99999765422 222211 11110 0
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
..+......+.+++.+|++.+|++|||+.|+++.|+.+..
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1112233568899999999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=350.38 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=195.9
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecC---------
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--------- 670 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~--------- 670 (929)
.|.+.+.||+|+||.||+|+++ +++.||||+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 3456789999999999999987 78999999997543 334577999999999999999999999986543
Q ss_pred ------------------------------------------------eEEEEEEeccCCchhhhhccccccccccchHH
Q 002382 671 ------------------------------------------------RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 702 (929)
Q Consensus 671 ------------------------------------------------~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~ 702 (929)
..++||||+++++|.+++.... ......+..
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~ 165 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHGV 165 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhHH
Confidence 3799999999999999996542 233456667
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC-----------ceeeeeecCccc
Q 002382 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-----------HVSSIVRGTVGY 771 (929)
Q Consensus 703 ~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~-----------~~~~~~~gt~~Y 771 (929)
++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 889999999999999998 999999999999999999999999999986554321 112334699999
Q ss_pred cCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHH
Q 002382 772 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIE 851 (929)
Q Consensus 772 ~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 851 (929)
+|||.+.+..++.++|||||||++|||++|..|+.... .+... ...... ..........+.
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~------~~~~~----~~~~~~---------~~~~~~~~~~~~ 303 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV------RIITD----VRNLKF---------PLLFTQKYPQEH 303 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH------HHHHH----HHTTCC---------CHHHHHHCHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH------HHHHH----hhccCC---------CcccccCChhHH
Confidence 99999999999999999999999999999987653221 11111 111111 011122334678
Q ss_pred HHHHHccCCCCCCCCcHHHHHHH
Q 002382 852 EKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 852 ~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+++.+|++.||++|||+.|++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=350.73 Aligned_cols=263 Identities=24% Similarity=0.374 Sum_probs=209.3
Q ss_pred HHHHhccccccCcEEEEEEEECC------CcEEEEEEeecCCc-chhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~------~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~ 673 (929)
.+.+.+.||+|+||.||+|++.. .+.||+|++..... ...+.+.+|+.+++++ +||||+++++++...+..+
T Consensus 47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 126 (333)
T 2i1m_A 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126 (333)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceE
Confidence 44567899999999999998752 24799999976533 3456789999999999 8999999999999999999
Q ss_pred EEEEeccCCchhhhhccccc----------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcE
Q 002382 674 LVYEFMHNGTLKEHLYGTLT----------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 743 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 743 (929)
+||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+
T Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEE
T ss_pred EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeE
Confidence 99999999999999864321 123578899999999999999999998 99999999999999999999
Q ss_pred EEEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHH
Q 002382 744 KVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWA 821 (929)
Q Consensus 744 kL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~ 821 (929)
||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |..||....... .+....
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~ 280 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---KFYKLV 280 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH---HHHHHH
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH---HHHHHH
Confidence 99999999865433222 2334557889999999999899999999999999999999 999997644221 111211
Q ss_pred HHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHhH
Q 002382 822 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 883 (929)
Q Consensus 822 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~~ 883 (929)
..... . ..+......+.+++.+|++.+|++|||+.||+++|+++....+
T Consensus 281 ~~~~~---------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 281 KDGYQ---------M----AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp HHTCC---------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hcCCC---------C----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 11110 0 0011122468899999999999999999999999998876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=350.53 Aligned_cols=263 Identities=22% Similarity=0.260 Sum_probs=200.6
Q ss_pred CHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC-----CcchhHHHHHHHHHhcccCCCceeEEeeeee
Q 002382 594 TLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-----SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 667 (929)
Q Consensus 594 ~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~-----~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~ 667 (929)
+..++. ..|.+.+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 20 ~~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 20 SLLELQ-KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp CHHHHH-HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhh-hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 344443 45667899999999999999886 6789999998653 2334567899999999999999999999999
Q ss_pred ecCeEEEEEEeccCCchhhhhccccc------------------------------------cccccchHHHHHHHHHHH
Q 002382 668 EEGRSVLVYEFMHNGTLKEHLYGTLT------------------------------------HEQRINWIKRLEIAEDAA 711 (929)
Q Consensus 668 ~~~~~~LV~E~~~~gsL~~~L~~~~~------------------------------------~~~~l~~~~~~~i~~qia 711 (929)
+.+..++||||+++|+|.+++..... ....+++..+..++.|++
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 99999999999999999998852111 122346778889999999
Q ss_pred HHHHHHHhCCCCceecCCCCCCCeEecCCC--cEEEEeecCcccccCCCC---ceeeeeecCccccCcccccc--CcCCC
Q 002382 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHM--RAKVSDFGLSKFAVDGAS---HVSSIVRGTVGYLDPEYYIS--QQLTD 784 (929)
Q Consensus 712 ~gL~yLH~~~~~~ivHrDIkp~NILl~~~~--~vkL~DFGla~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~--~~~s~ 784 (929)
+||+|||++ +|+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.
T Consensus 179 ~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 999999998 999999999999998776 899999999986533221 12344569999999999975 67889
Q ss_pred cCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCC
Q 002382 785 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM 864 (929)
Q Consensus 785 ~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~ 864 (929)
++|||||||++|||++|+.||......+.. .+ ....... .. ..........+.+++.+|++.+|++
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~----~~~~~~~---~~----~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTI---SQ----VLNKKLC---FE----NPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HH----HHHCCCC---TT----SGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChHHHH---HH----HHhcccc---cC----CcccccCCHHHHHHHHHHcCCChhH
Confidence 999999999999999999999765422111 11 1111100 00 0001112346889999999999999
Q ss_pred CCcHHHHHHH
Q 002382 865 RPSISEVLKD 874 (929)
Q Consensus 865 RPs~~eVl~~ 874 (929)
||++.|++++
T Consensus 322 Rps~~~~l~h 331 (345)
T 3hko_A 322 RFDAMRALQH 331 (345)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhcC
Confidence 9999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=365.52 Aligned_cols=252 Identities=22% Similarity=0.286 Sum_probs=204.1
Q ss_pred HHhccccccCcEEEEEEEECC-CcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.+.++||+|+||+||+|+++. ++.||||++++... .....+.+|..++..++||||+++++++.+.+..++||||+
T Consensus 77 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~ 156 (437)
T 4aw2_A 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY 156 (437)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecC
Confidence 346789999999999999874 78899999975321 22344889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 157 ~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 157 VGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 999999999642 45689999999999999999999998 999999999999999999999999999986655444
Q ss_pred ceeeeeecCccccCccccc-----cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 760 HVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
......+||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+..+... -.....
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----~~~p~~- 305 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER----FQFPTQ- 305 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----CCCCSS-
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc----ccCCcc-
Confidence 4445567999999999997 467899999999999999999999999865533333333322111 111110
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCC--CCcHHHHHHH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 874 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~eVl~~ 874 (929)
.... ...+.+++.+|++.+|++ ||+++|+++|
T Consensus 306 ----~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 306 ----VTDV----SENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ----CCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ----cccC----CHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0111 235788999999988888 9999999987
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=341.57 Aligned_cols=260 Identities=16% Similarity=0.218 Sum_probs=207.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+|+.+++++ +|+|++++++++......++||||+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 88 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 88 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence 456789999999999999974 68899999986543 235688999999999 7999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc-----EEEEeecCccccc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-----AKVSDFGLSKFAV 755 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-----vkL~DFGla~~~~ 755 (929)
+++|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++...
T Consensus 89 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 89 GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999998532 34589999999999999999999998 9999999999999987776 9999999998655
Q ss_pred CCCCc------eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 756 DGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 756 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .....+........
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QKYERIGEKKQSTP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-HHHHHHHHHHHHSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-HHHHHHHhhccCcc
Confidence 43221 224456999999999999999999999999999999999999999765422211 11111111111111
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
... ........+.+++.+|++.+|++||++.+|++.|++++..
T Consensus 242 ~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 242 LRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 110 0111234688999999999999999999999999998753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=364.21 Aligned_cols=249 Identities=22% Similarity=0.269 Sum_probs=202.1
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.+.+.||+|+||+||+|+++ +++.||+|++++.. ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 72 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~ 151 (410)
T 3v8s_A 72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151 (410)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 34578999999999999987 58899999997532 122345889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 152 ~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 152 PGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp TTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 99999998843 3578899999999999999999998 999999999999999999999999999986654443
Q ss_pred ceeeeeecCccccCccccccCc----CCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~----~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+....+..+.... ....
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~----~~p~--- 296 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL----TFPD--- 296 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC----CCCT---
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc----cCCC---
Confidence 3444567999999999998655 7899999999999999999999998655333332332221110 0100
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCC--CCcHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~eVl~~ 874 (929)
... ....+.+++.+|++.+|++ ||+++||++|
T Consensus 297 ---~~~----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 297 ---DND----ISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---TCC----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---ccc----ccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 001 1235789999999999988 9999999987
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=356.12 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=199.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
+.+.+.||+|+||+||+|+++ +++.||||++++... .....+..|..++.++ +||||+++++++.+.+..++|||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E 133 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence 446789999999999999987 578899999976432 2234578899999887 89999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 134 ~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 134 YVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp CCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred cCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 999999999884 345689999999999999999999998 9999999999999999999999999999853322
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccccccc-chhhHHHHHHhhhcCCcccccCC
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN-CRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ......+.........+
T Consensus 207 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 279 (396)
T 4dc2_A 207 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 279 (396)
T ss_dssp -TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred -CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence 2233456799999999999999999999999999999999999999964331111 01111111111111111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcH------HHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~------~eVl~~ 874 (929)
.++......+.+++.+|++.||++||++ .|+++|
T Consensus 280 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 280 ----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 0111122357899999999999999985 666665
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=370.32 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=202.6
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+.+.||+|+||.||+|+++++..||||+++.... ..++|.+|+++|++++||||+++++++.+ +..++||||+++
T Consensus 185 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~ 262 (452)
T 1fmk_A 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 262 (452)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence 3456789999999999999999888899999976543 35679999999999999999999999876 678999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 263 gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 263 GSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp CBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 9999999532 234588999999999999999999998 99999999999999999999999999998654433223
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...+ ..+.. .
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----~~~~~i----~~~~~---------~ 400 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQV----ERGYR---------M 400 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHHH----HTTCC---------C
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----HcCCC---------C
Confidence 334457889999999999999999999999999999999 99999754411 122211 11110 0
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
..+......+.+++.+|++.+|++|||+.+|++.|+.+..
T Consensus 401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 1112233468899999999999999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=348.89 Aligned_cols=243 Identities=24% Similarity=0.387 Sum_probs=200.6
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+.+.+.||+|+||+||+|+.+ +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 345689999999999999987 68999999997542 22345678899999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 88 IEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 999999999853 35688999999999999999999998 9999999999999999999999999999865332
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. . +.. .+
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-------~-~~~------~~ 222 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL-------N-AEL------RF 222 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-------H-CCC------CC
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-------h-CCC------CC
Confidence 234569999999999999999999999999999999999999997644211111111 1 111 01
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
...+ ...+.+++.+|++.+|++|| +++|+++|
T Consensus 223 p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 223 PPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1112 23578999999999999999 89999876
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=351.76 Aligned_cols=263 Identities=25% Similarity=0.383 Sum_probs=204.0
Q ss_pred HHHHhccccccCcEEEEEEEE-----CCCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeec--CeEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSV 673 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~-----~~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~--~~~~ 673 (929)
.+.+.+.||+|+||.||+|++ .+++.||||+++... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 355678999999999999984 358899999997543 33456789999999999999999999999876 6689
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 102 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999998532 34588999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCc--eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccc-------cccchhhHHHHHHh
Q 002382 754 AVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-------GANCRNIVQWAKLH 824 (929)
Q Consensus 754 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~-------~~~~~~l~~~~~~~ 824 (929)
....... ......||..|+|||.+.+..++.++|||||||++|||++|+.|+..... +.....-.......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6543321 22344578889999999999999999999999999999999998753210 00000011111111
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
...+.. ...+......+.+++.+|++.+|++|||+.|+++.|++++
T Consensus 256 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 LKEGKR---------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCC---------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111 1111222346889999999999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=337.70 Aligned_cols=249 Identities=21% Similarity=0.309 Sum_probs=200.9
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeec--CeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~--~~~~LV~E~ 678 (929)
+.+.+.||+|+||.||+|+++ ++.||||+++... ....+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred hHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 446789999999999999986 8999999997653 33356799999999999999999999999877 788999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
+++|+|.+++... ....+++..++.++.|+++||+|||++ + |+||||||+||+++.++.++|+|||++.....
T Consensus 91 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 91 MPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp CTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999643 233589999999999999999999998 7 99999999999999999999999998754221
Q ss_pred CCCceeeeeecCccccCccccccCcCCC---cCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~---~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
....||+.|+|||.+.+...+. ++|||||||++|||++|+.||......+ ... .....+.
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~---~~~~~~~---- 228 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME----IGM---KVALEGL---- 228 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH----HHH---HHHHSCC----
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH----HHH---HHHhcCC----
Confidence 2235899999999998766555 7999999999999999999997644111 111 1111111
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
.+.+.. .....+.+++.+|++.+|++|||+.|+++.|+++.
T Consensus 229 -~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 229 -RPTIPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp -CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -CCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111111 22346889999999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=340.18 Aligned_cols=259 Identities=23% Similarity=0.367 Sum_probs=204.0
Q ss_pred HHHhccccccCcEEEEEEEECC----CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~----~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
+.+.+.||+|+||.||+|++.. +..||||++.... ....+.+.+|+.++++++||||+++++++.++ ..++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEe
Confidence 4467899999999999998653 2359999987653 33457789999999999999999999998754 5689999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 93 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 93 LYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp CCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred cCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 99999999998532 34588999999999999999999998 9999999999999999999999999999865544
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
.........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...... +....
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~----~~~~~~~~----~~~~~---- 234 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK----DVIGVLEK----GDRLP---- 234 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG----GHHHHHHH----TCCCC----
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH----HHHHHHhc----CCCCC----
Confidence 3333344557889999999998899999999999999999998 99999754422 12221111 11000
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHhHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREA 885 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~~~~ 885 (929)
.+......+.+++.+|++.+|++||++.|++++|+++...+.+.
T Consensus 235 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~i 278 (281)
T 3cc6_A 235 -----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDI 278 (281)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhhh
Confidence 01112245889999999999999999999999999998776543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=346.11 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=194.7
Q ss_pred HHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhccc-CCCceeEEeeeeeecCe
Q 002382 596 SDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 671 (929)
Q Consensus 596 ~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~ 671 (929)
.++....+.+.++||+|+||+||+|++. +++.||||++..... .....+..|+..+.++ +||||+++++++.+.+.
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 3455566777889999999999999987 689999999865432 2234455566665555 89999999999999999
Q ss_pred EEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCc
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 751 (929)
.++||||+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred EEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceee
Confidence 99999999 67898887532 34689999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 752 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
+..... .......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... . |. ....+..
T Consensus 205 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------~---~~--~~~~~~~- 269 (311)
T 3p1a_A 205 VELGTA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------G---WQ--QLRQGYL- 269 (311)
T ss_dssp EECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------H---HH--HHTTTCC-
T ss_pred eecccC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------H---HH--HHhccCC-
Confidence 765432 22334559999999998876 78999999999999999999977664322 0 10 1111111
Q ss_pred cccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 832 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 832 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. ..........+.+++.+|++.+|++|||+.|++++
T Consensus 270 ---~----~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 270 ---P----PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ---C----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---C----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 0 11111123468899999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=352.46 Aligned_cols=244 Identities=22% Similarity=0.344 Sum_probs=199.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 456789999999999999985 68999999987532 12245788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+ +|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 91 A-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp C-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred C-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9 7888888743 45689999999999999999999998 99999999999999999999999999998654332
Q ss_pred CceeeeeecCccccCccccccCcC-CCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...........+. .+.
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~--------~~~-------- 224 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN--------SCV-------- 224 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC--------SSC--------
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH--------cCC--------
Confidence 2234569999999999988776 679999999999999999999997654322221110 000
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...+......+.+++.+|++.||++|||+.|++++
T Consensus 225 --~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 --YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00111122457899999999999999999999876
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=348.70 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=180.1
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccC-CCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
+.||+|+||+||+|+++ +++.||||++... ....+.+|+.+++.+. ||||+++++++.+.+..++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 67999999999999987 5889999998643 3456788999999997 99999999999999999999999999999
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC---cEEEEeecCcccccCCCCce
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkL~DFGla~~~~~~~~~~ 761 (929)
.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++....... .
T Consensus 94 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~ 165 (325)
T 3kn6_A 94 FERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-P 165 (325)
T ss_dssp HHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-c
Confidence 999853 45689999999999999999999998 999999999999998765 899999999986543322 2
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.............+... .+..+... ....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~i~~~~~~------~~~~ 238 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK-KIKKGDFS------FEGE 238 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH-HHTTTCCC------CCSH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH-HHHcCCCC------CCcc
Confidence 2345689999999999999999999999999999999999999976542222222222211 12222110 0011
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
........+.+++.+|++.||++|||+.|++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 001123468899999999999999999998765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=355.64 Aligned_cols=246 Identities=24% Similarity=0.375 Sum_probs=199.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
+.+.+.||+|+||+||+|+++ +++.||||+++... ......+..|..++..+ +||||+++++++.+.+..++|||
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E 98 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 98 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 446789999999999999987 58899999997542 22345677899999877 99999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 99 YLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999999999853 35688999999999999999999998 9999999999999999999999999999754322
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.+.. +.. .
T Consensus 172 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~----~~~------~ 236 (345)
T 1xjd_A 172 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIRM----DNP------F 236 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH----CCC------C
T ss_pred C-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHHh----CCC------C
Confidence 2 2234557999999999999999999999999999999999999999765422 22221111 110 1
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHH-HHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-eVl~~ 874 (929)
.... ....+.+++.+|++.+|++||++. |+.+|
T Consensus 237 ~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 237 YPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp CCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 1111 224678999999999999999997 77654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=348.78 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=191.9
Q ss_pred HHHHhccccccCcEEEEEEEE----CCCcEEEEEEeecCC----cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~----~~~~~vAVK~l~~~~----~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~ 673 (929)
.|.+.+.||+|+||.||+++. .+++.||+|+++... ......+.+|+.++++++||||+++++++...+..+
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 97 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY 97 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence 345678999999999999987 468999999997642 223456788999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 98 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 98 LILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999998843 45678889999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +...+.. ...
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~----~~~--- 238 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK----TIDKILK----CKL--- 238 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHH----TCC---
T ss_pred cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHh----CCC---
Confidence 43222 22234569999999999999899999999999999999999999997654221 1111111 110
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
.+.. .....+.+++.+|++.+|++|| ++.|+++|
T Consensus 239 ---~~p~----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 ---NLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---CCCT----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---CCCC----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0111 1224678999999999999999 78888876
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=339.25 Aligned_cols=250 Identities=32% Similarity=0.544 Sum_probs=198.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcch-------hHHHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~-------~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
+.+.+.||+|+||+||+|++. +++.||||++....... .+.+.+|++++++++||||+++++++.+.. ++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l 98 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM 98 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence 456789999999999999985 68899999986543221 167889999999999999999999997665 69
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCeEecCCCc-----EEEEe
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMR-----AKVSD 747 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDIkp~NILl~~~~~-----vkL~D 747 (929)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ + |+||||||+|||++.++. +||+|
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred EEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 9999999999888853 245689999999999999999999998 7 999999999999988776 99999
Q ss_pred ecCcccccCCCCceeeeeecCccccCccccc--cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh
Q 002382 748 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 748 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
||+++.... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||........ ..... ..
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~---~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI--KFINM---IR 243 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH--HHHHH---HH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH--HHHHH---Hh
Confidence 999974332 233456899999999984 45678899999999999999999999976542111 11111 11
Q ss_pred hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 826 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
..+. .+.+ +......+.+++.+|++.||++|||+.|+++.|+++
T Consensus 244 ~~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEGL-----RPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSCC-----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCC-----CCCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111 1111 112234688999999999999999999999999863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=337.04 Aligned_cols=250 Identities=21% Similarity=0.270 Sum_probs=202.5
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
..|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 35667889999999999999987 46789999998765566778999999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe---cCCCcEEEEeecCcccccC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~~~~ 756 (929)
++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++.....
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 89 TGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999998843 45688999999999999999999998 99999999999999 7889999999999976543
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
.. ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+ +... ...+....
T Consensus 162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~----~~~~~~~~---- 226 (277)
T 3f3z_A 162 GK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE----VMLK----IREGTFTF---- 226 (277)
T ss_dssp TS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHHCCCCC----
T ss_pred cc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH----HHHH----HHhCCCCC----
Confidence 32 22344689999999988654 8999999999999999999999997644211 1111 11111100
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...........+.+++.+|++.+|++||++.|++++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 227 --PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp --CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000122468899999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=348.76 Aligned_cols=263 Identities=24% Similarity=0.428 Sum_probs=209.7
Q ss_pred HHHHHhccccccCcEEEEEEEEC--------CCcEEEEEEeecCCc-chhHHHHHHHHHhccc-CCCceeEEeeeeeecC
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG 670 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~--------~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~ 670 (929)
..+.+.+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 45567789999999999999873 467899999976532 3356788999999999 8999999999999999
Q ss_pred eEEEEEEeccCCchhhhhccccc------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~ 738 (929)
..++||||+++|+|.+++..... ....+++..++.++.|+++||+|||++ +|+||||||+||+++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 191 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEc
Confidence 99999999999999999965421 123588999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchh
Q 002382 739 KHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRN 816 (929)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~ 816 (929)
.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~ 267 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----E 267 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----H
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH----H
Confidence 9999999999999865443221 2233457889999999998889999999999999999999 99999754421 2
Q ss_pred hHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHhH
Q 002382 817 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 883 (929)
Q Consensus 817 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~~ 883 (929)
+...... +... ..+......+.+++.+|++.+|++||++.|++++|++++....
T Consensus 268 ~~~~~~~----~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 268 LFKLLKE----GHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHHHH----TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHhc----CCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 2222111 1110 0111223468899999999999999999999999999987543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.77 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=204.8
Q ss_pred ccccccCcEEEEEEEEC---CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 607 KKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~---~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 48999999999999864 57789999997653 33456789999999999999999999999 556789999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce-
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV- 761 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~- 761 (929)
+|.+++.. ....+++..++.++.|+++||.|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 95 ~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 168 (287)
T 1u59_A 95 PLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168 (287)
T ss_dssp EHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred CHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceee
Confidence 99999853 245688999999999999999999998 99999999999999999999999999998664433221
Q ss_pred -eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 762 -SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 762 -~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
.....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...+. .+...
T Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~i~----~~~~~-------- 232 (287)
T 1u59_A 169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFIE----QGKRM-------- 232 (287)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHHHHH----TTCCC--------
T ss_pred ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHh----cCCcC--------
Confidence 123346889999999998889999999999999999998 99999765421 2222211 11110
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
..+......+.+++.+|++.+|++||++.|++++|+.+....
T Consensus 233 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 233 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111222346889999999999999999999999999987644
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=351.75 Aligned_cols=243 Identities=23% Similarity=0.294 Sum_probs=200.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+.+.+.||+|+||.||+|+++ +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 122 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 345688999999999999987 68999999997542 22345688999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 123 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 123 VAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp CTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 999999999853 34688999999999999999999998 9999999999999999999999999999865332
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +.+.+ ..+.. .+
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i----~~~~~------~~ 257 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYEKI----VSGKV------RF 257 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH----HHCCC------CC
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH----HHHHH----HcCCC------CC
Confidence 234569999999999999999999999999999999999999997654211 11111 11111 01
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCc-----HHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 874 (929)
... ....+.+++.+|++.||++||+ ++||++|
T Consensus 258 p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 258 PSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCC----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 111 2245789999999999999998 8888876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=353.03 Aligned_cols=266 Identities=16% Similarity=0.240 Sum_probs=203.7
Q ss_pred HHHHhccccccCcEEEEEEEECC------CcEEEEEEeecCCcch-----------hHHHHHHHHHhcccCCCceeEEee
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQG-----------KREFTNEVTLLSRIHHRNLVQFLG 664 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~------~~~vAVK~l~~~~~~~-----------~~~f~~Ev~iL~~l~HpNIv~l~g 664 (929)
.|.+.+.||+|+||.||+|++.. ++.||||++....... ...+..|+..+..++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 45567899999999999998874 4789999987654221 122345666778889999999999
Q ss_pred eeeec----CeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec--
Q 002382 665 YCQEE----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-- 738 (929)
Q Consensus 665 ~~~~~----~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-- 738 (929)
++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 98764 4589999999 9999999853 235689999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCc------eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccc
Q 002382 739 KHMRAKVSDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 812 (929)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~ 812 (929)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~- 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD- 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-
Confidence 8899999999999765432211 112345999999999999999999999999999999999999999854311
Q ss_pred cchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 813 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 813 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
.....+...... ..+..++++.+... .....+.+++..|++.+|++||++.+|++.|++++..
T Consensus 268 --~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 268 --PKYVRDSKIRYR-ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp --HHHHHHHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHHHhh-hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 122222222111 12223333322211 1224688999999999999999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=353.82 Aligned_cols=273 Identities=21% Similarity=0.279 Sum_probs=211.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecC--eEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~--~~~LV~E~ 678 (929)
|.+.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 456789999999999999987 48999999997543 233567789999999999999999999998755 77999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe----cCCCcEEEEeecCcccc
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkL~DFGla~~~ 754 (929)
+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 91 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 91 CPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred CCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999999996532 223389999999999999999999998 99999999999999 77888999999999865
Q ss_pred cCCCCceeeeeecCccccCcccccc--------CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhh
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYIS--------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 826 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 826 (929)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....+.....+...+.....
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred cCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 4322 2233569999999999865 56788999999999999999999999754432222222222111111
Q ss_pred cCCccccc-----------CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 827 SGDIQGII-----------DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 827 ~~~~~~~~-----------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
...+.... +..............+.+++.+|++.||++||++.|+++.+++++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11111000 00111223456677889999999999999999999999999988764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=344.31 Aligned_cols=250 Identities=24% Similarity=0.427 Sum_probs=200.4
Q ss_pred HHHHhccccccCcEEEEEEEECC-C-------cEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKD-G-------KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~-~-------~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~ 673 (929)
.+.+.+.||+|+||+||+|++.. + +.||+|++........+.+.+|++++++++||||+++++++...+..+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (289)
T 4fvq_A 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI 88 (289)
T ss_dssp GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence 34567899999999999998763 3 479999997766666778999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc--------EEE
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--------AKV 745 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--------vkL 745 (929)
+||||+++|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++. +||
T Consensus 89 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999642 34488999999999999999999998 9999999999999998887 999
Q ss_pred EeecCcccccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCC-CccccccccchhhHHHHHH
Q 002382 746 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEA-ISNEKFGANCRNIVQWAKL 823 (929)
Q Consensus 746 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p-~~~~~~~~~~~~l~~~~~~ 823 (929)
+|||++..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|..| +.... . ........
T Consensus 163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-~---~~~~~~~~- 232 (289)
T 4fvq_A 163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-S---QRKLQFYE- 232 (289)
T ss_dssp CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-H---HHHHHHHH-
T ss_pred ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-h---HHHHHHhh-
Confidence 99999864422 123458999999999987 7789999999999999999996544 43322 1 11111111
Q ss_pred hhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 824 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 824 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
....... .. ...+.+++.+|++.+|++|||+.|++++|++++..
T Consensus 233 --~~~~~~~--------~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 233 --DRHQLPA--------PK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp --TTCCCCC--------CS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred --ccCCCCC--------CC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 1111111 11 12477899999999999999999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=351.39 Aligned_cols=246 Identities=24% Similarity=0.304 Sum_probs=199.8
Q ss_pred HHHhccccccCcEEEEEEEECC-CcEEEEEEeecCC---cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
+.+.+.||+|+||+||+|+.+. ++.||||+++... ......+..|..++..+ +||||+++++++.+.+..++|||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E 101 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 101 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence 4457899999999999999874 7889999997542 22345678899999888 89999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 102 YVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 9999999999853 35688999999999999999999998 9999999999999999999999999999753322
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +.+.+. . +.. .
T Consensus 175 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~~i~---~-~~~------~ 239 (353)
T 2i0e_A 175 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQSIM---E-HNV------A 239 (353)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHH---H-CCC------C
T ss_pred C-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH----HHHHHH---h-CCC------C
Confidence 2 22344579999999999999999999999999999999999999997654222 222111 1 111 0
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCc-----HHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 874 (929)
++......+.+++.+|++.+|++||+ +.|+++|
T Consensus 240 ----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 ----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11112246789999999999999994 6788766
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=353.70 Aligned_cols=251 Identities=26% Similarity=0.318 Sum_probs=192.9
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.|.+.+.||+|+||+||+++.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 3556789999999999999987 688999999975433 24668899999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc--EEEEeecCcccccCCC
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--AKVSDFGLSKFAVDGA 758 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--vkL~DFGla~~~~~~~ 758 (929)
+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++.....
T Consensus 100 ~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 100 GGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 9999998843 45689999999999999999999998 9999999999999987765 999999999743222
Q ss_pred CceeeeeecCccccCccccccCcCCCc-CceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDK-SDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||...........+.+..... .....
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~------ 242 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV--KYSIP------ 242 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT--CCCCC------
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC--CCCCC------
Confidence 12233469999999999988877655 899999999999999999998655333333333221111 00000
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. .......+.+++.+|++.+|++|||+.|+++|
T Consensus 243 --~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 --D--DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --T--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --C--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 00112457899999999999999999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=344.49 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=204.0
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc------hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~------~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~ 673 (929)
..|.+.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45667899999999999999987 5889999999764322 3567899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC----cEEEEeec
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFG 749 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkL~DFG 749 (929)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 92 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999853 45688999999999999999999998 999999999999999888 79999999
Q ss_pred CcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ....... ...
T Consensus 165 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~i~----~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANIT----SVS 234 (321)
T ss_dssp TCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHH----TTC
T ss_pred cceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHH----hcc
Confidence 998654432 223446899999999999999999999999999999999999999754411 1111111 110
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. ..++..... ....+.+++.+|++.||++|||+.|++++
T Consensus 235 ~--~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 Y--DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C--CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c--ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 011111111 12357899999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=340.25 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=199.8
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.|.+.+.||+|+||.||+|... +++.||||+++... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 3567789999999999999875 68999999997532 2335678899999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++++|.+++.........+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999865434456688999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... +....... ..........
T Consensus 190 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~-~~~~~~~~~~--- 259 (310)
T 2wqm_A 190 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKK-IEQCDYPPLP--- 259 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHHH-HHTTCSCCCC---
T ss_pred Cc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHHH-hhcccCCCCc---
Confidence 22 22334589999999999998999999999999999999999999975431 11111111 1111111111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
... ....+.+++.+|++.||++||++.||++.|+++....
T Consensus 260 -~~~----~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 260 -SDH----YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp -TTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -ccc----cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 111 2236889999999999999999999999999987654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=341.19 Aligned_cols=254 Identities=28% Similarity=0.460 Sum_probs=195.8
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 682 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~g 682 (929)
+.+.+.||+|+||+||+|++. ++.||||++... ...+.+.+|++++++++||||+++++++.+ ..++||||+++|
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~ 84 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG 84 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred eeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence 345789999999999999986 789999998643 345678999999999999999999999874 478999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc-EEEEeecCcccccCCCCce
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-AKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~-vkL~DFGla~~~~~~~~~~ 761 (929)
+|.+++.... ....+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.....
T Consensus 85 ~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 85 SLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp BHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 9999996432 2234678889999999999999999932238999999999999998886 799999999754322
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..|.. ..+... .....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~-~~~~~---~~~~~~-----~~~~~ 228 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FR-IMWAV---HNGTRP-----PLIKN 228 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--HH-HHHHH---HTTCCC-----CCBTT
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--HH-HHHHH---hcCCCC-----Ccccc
Confidence 223458999999999999999999999999999999999999997543111 11 11111 111111 11112
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
. ...+.+++.+|++.+|++|||+.|++++|+.+...
T Consensus 229 ~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 229 L----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred c----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 2 23578999999999999999999999999987643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=348.15 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=199.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
+.+.+.||+|+||.||+|+++ +++.||||+++.... ...+.+.+|..+++++ +||||+++++++.+.+..++|||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 345689999999999999987 578999999976532 2345678899999887 89999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.....
T Consensus 91 ~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 91 YVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 9999999998843 35688999999999999999999998 9999999999999999999999999999753322
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccc-hhhHHHHHHhhhcCCcccccCC
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC-RNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ................
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 2 2234457999999999999999999999999999999999999999653211110 0111111111111111
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcH------HHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~------~eVl~~ 874 (929)
.+ +......+.+++.+|++.||++||++ .|+++|
T Consensus 237 ~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 RI----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CC----CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 01 11122457899999999999999985 666665
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=341.71 Aligned_cols=268 Identities=24% Similarity=0.361 Sum_probs=200.5
Q ss_pred HHHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcc--cCCCceeEEeeeeeec----C
Q 002382 597 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQEE----G 670 (929)
Q Consensus 597 ~i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~--l~HpNIv~l~g~~~~~----~ 670 (929)
......|.+.+.||+|+||.||+|++. ++.||||++.... ...+..|.+++.. ++||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 334456777899999999999999987 8999999986432 2334455555544 4999999999999877 7
Q ss_pred eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCC-----CCceecCCCCCCCeEecCCCcEEE
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-----VPAIIHRDLKSSNILLDKHMRAKV 745 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDIkp~NILl~~~~~vkL 745 (929)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+++ .++|+||||||+|||++.++.+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 88999999999999999843 35889999999999999999999852 238999999999999999999999
Q ss_pred EeecCcccccCCCCce---eeeeecCccccCccccccCcCCCc------CceeeHHHHHHHHHhC----------CCCCc
Q 002382 746 SDFGLSKFAVDGASHV---SSIVRGTVGYLDPEYYISQQLTDK------SDVYSFGVILLELISG----------QEAIS 806 (929)
Q Consensus 746 ~DFGla~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~s~~------sDVwSlGvvl~elltG----------~~p~~ 806 (929)
+|||+++......... .....||+.|+|||++.+.....+ +|||||||++|||++| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999997554332221 123469999999999988776665 9999999999999999 55554
Q ss_pred cccccccchhhHHHHHHhhhcCCcccccCCcccCcc-CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 807 NEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 807 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
........ . ........... ..+...... ..+....+.+++.+|++.||++|||+.||+++|+.+..
T Consensus 264 ~~~~~~~~--~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 264 DLVPSDPS--Y-EDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TTSCSSCC--H-HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCCCCc--h-hhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 33211111 1 11111111111 111111111 22566789999999999999999999999999998865
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=344.46 Aligned_cols=262 Identities=27% Similarity=0.421 Sum_probs=208.0
Q ss_pred HHHHHhccccccCcEEEEEEEE------CCCcEEEEEEeecCCc-chhHHHHHHHHHhccc-CCCceeEEeeeeeecC-e
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG-R 671 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~------~~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~-~ 671 (929)
..|.+.+.||+|+||+||+|++ .+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++...+ .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 3455678999999999999985 2467899999976543 3346789999999999 7999999999987754 5
Q ss_pred EEEEEEeccCCchhhhhcccccc------------ccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLTH------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 739 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~~------------~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 739 (929)
.++||||+++|+|.+++...... ...+++..++.++.|+++||.|||++ +|+||||||+||+++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 183 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECC
Confidence 89999999999999999654321 12388999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhh
Q 002382 740 HMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 817 (929)
Q Consensus 740 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l 817 (929)
++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+ .+
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~ 260 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EF 260 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---HH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH---HH
Confidence 99999999999986544332 22334568899999999999999999999999999999998 999997644221 11
Q ss_pred HHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 818 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 818 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
..... .+... ..... ....+.+++.+|++.+|++|||+.||+++|+.++..
T Consensus 261 ~~~~~----~~~~~-----~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 261 CRRLK----EGTRM-----RAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp HHHHH----HTCCC-----CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhc----cCccC-----CCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 11111 11110 01111 223588999999999999999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.60 Aligned_cols=269 Identities=22% Similarity=0.294 Sum_probs=199.3
Q ss_pred HHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-----chhHHHHHHHHHhcccC---CCceeEEeeeee
Q 002382 597 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIH---HRNLVQFLGYCQ 667 (929)
Q Consensus 597 ~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-----~~~~~f~~Ev~iL~~l~---HpNIv~l~g~~~ 667 (929)
++....|.+.+.||+|+||+||+|++. +++.||||+++.... .....+.+|++++++++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 334456677899999999999999975 688999999874321 12346778888877775 999999999997
Q ss_pred ecC-----eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc
Q 002382 668 EEG-----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 742 (929)
Q Consensus 668 ~~~-----~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 742 (929)
... ..++||||+. ++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 755 5799999997 5999988643 233489999999999999999999998 9999999999999999999
Q ss_pred EEEEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHH
Q 002382 743 AKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 822 (929)
Q Consensus 743 vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~ 822 (929)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.+...
T Consensus 159 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 159 VKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp EEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999998654322 22345689999999999999999999999999999999999999976542222222222111
Q ss_pred HhhhcCCcccccC---Cccc-------CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 823 LHIESGDIQGIID---PSLL-------DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 823 ~~~~~~~~~~~~d---~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..... ....... .... .....+....+.+++.+|++.||++|||+.|+++|
T Consensus 237 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 237 LPPED-DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCTT-TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChh-hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 11010 0000000 0000 00011223468899999999999999999999876
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=360.09 Aligned_cols=251 Identities=23% Similarity=0.260 Sum_probs=201.4
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.+.+.||+|+||+||+++.+ +++.||||++++... .....+.+|..++..++||||+++++++.+.+..++||||+
T Consensus 64 ~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~ 143 (412)
T 2vd5_A 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYY 143 (412)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCC
Confidence 34678999999999999986 689999999975321 22345889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.......
T Consensus 144 ~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 144 VGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp CSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 999999999532 34688999999999999999999998 999999999999999999999999999986654433
Q ss_pred ceeeeeecCccccCccccc-------cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYI-------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~-------~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
......+||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+..+... ...
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~----~~~-- 291 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH----LSL-- 291 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH----CCC--
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC----cCC--
Confidence 3344567999999999997 357899999999999999999999999765533333333322111 011
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCC---CcHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR---PSISEVLKD 874 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R---Ps~~eVl~~ 874 (929)
+..... ....+.+++.+|++ +|++| |+++|+++|
T Consensus 292 ---p~~~~~----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 292 ---PLVDEG----VPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ---C----C----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ---CccccC----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 001111 22367899999999 99988 689999876
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=348.22 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=192.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCe----EE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR----SV 673 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~----~~ 673 (929)
.|.+.+.||+|+||.||+|++. +++.||||+++.... .....+.+|++++++++||||+++++++..... .+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 3456789999999999999975 688999999976532 224578899999999999999999999876543 49
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 99999999999999853 35688999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCC--ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 754 AVDGAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 754 ~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ............
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~~ 238 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVREDPIP 238 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCCCC
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHhcCCCCC
Confidence 543322 12233568999999999999999999999999999999999999997644111 111111111110
Q ss_pred cccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHH-HHHHHh
Q 002382 832 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL-KDIQDA 878 (929)
Q Consensus 832 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl-~~L~~~ 878 (929)
. ..........+.+++.+|++.||++||++.+++ +.|...
T Consensus 239 ~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 239 P-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp H-------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred c-------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0 000111224678999999999999999766655 445443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=363.82 Aligned_cols=246 Identities=23% Similarity=0.303 Sum_probs=192.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC---CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
+.+.+.||+|+||.||+|+.. +++.||||+++.. .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence 456789999999999999976 6889999999753 223345678899999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
+++|+|.+++. ....+++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||+++.....
T Consensus 230 ~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 230 ANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp CSSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999884 34568899999999999999999998 7 9999999999999999999999999999754332
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+.. ....+
T Consensus 303 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~--~~~~~------- 368 (446)
T 4ejn_A 303 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILM--EEIRF------- 368 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH--CCCCC-------
T ss_pred C-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHHHh--CCCCC-------
Confidence 2 2233456999999999999999999999999999999999999999765421 12221111 11111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
... ....+.+++.+|++.||++|| ++.|+++|
T Consensus 369 -p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 369 -PRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -CTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -Ccc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 111 224678999999999999999 99999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=352.28 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=193.3
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCc--chhHHHHHHHHHhcccCC--CceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~H--pNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||.||++...+++.||||++..... ...+.+.+|+.++++++| |||+++++++...+..++|||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 89 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 89 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence 446789999999999999998899999999975432 334678999999999976 999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+.+++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++......
T Consensus 90 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 90 CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 568899999853 45688999999999999999999998 999999999999997 6789999999998654432
Q ss_pred Cc-eeeeeecCccccCcccccc-----------CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhh
Q 002382 759 SH-VSSIVRGTVGYLDPEYYIS-----------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 826 (929)
Q Consensus 759 ~~-~~~~~~gt~~Y~aPE~~~~-----------~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 826 (929)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+ ........
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~-~~~~~~~~ 235 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQI-SKLHAIID 235 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHH-HHHHHHHC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHH-HHHHHHhc
Confidence 22 2334569999999999865 678889999999999999999999996532 111 11111111
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 827 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 827 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
+.....++......+.+++.+|++.||++|||+.|++++-
T Consensus 236 ---------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 236 ---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp ---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1111111111224678999999999999999999999873
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=338.30 Aligned_cols=258 Identities=17% Similarity=0.272 Sum_probs=197.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL 115 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence 456789999999999999986 688999999875432 2246788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 116 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 116 INGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp CCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 999999999853 34688999999999999999999998 99999999999999999999999999997654433
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .+.. ....... . +
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~----~~~~~~~-~---~-- 254 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMGA----HINQAIP-R---P-- 254 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHHH----HHHSCCC-C---G--
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHHH----HhccCCC-C---c--
Confidence 33334456899999999999999999999999999999999999999764411 1111 1111100 0 0
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCC-cHHHHHHHHHHhHhHh
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAIVIE 882 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~eVl~~L~~~~~~~ 882 (929)
..........+.+++.+|++.+|++|| +++++++.|+..+...
T Consensus 255 -~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 255 -STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 011111223578999999999999999 9999999999876543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=347.15 Aligned_cols=257 Identities=25% Similarity=0.413 Sum_probs=200.3
Q ss_pred HHHhccccccCcEEEEEEEECC-----CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~-----~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
+.+.+.||+|+||.||+|++.. +..||||+++... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 46 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 125 (333)
T 1mqb_A 46 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 125 (333)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEE
Confidence 3446789999999999998753 2359999997653 233557899999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 126 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 126 EYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp ECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred eCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999998532 35688999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCc--eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 757 GASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 757 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
.... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...+ ..+..
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----~~~~~~----~~~~~--- 268 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----EVMKAI----NDGFR--- 268 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHH----HTTCC---
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH----HHHHHH----HCCCc---
Confidence 3221 1222346789999999998899999999999999999999 99999754411 222211 11110
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
...+......+.+++.+|++.+|++||++.|++++|++++...
T Consensus 269 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 269 ------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp ------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0011122346889999999999999999999999999987543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=351.71 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=200.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 96 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL 96 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 456789999999999999987 57899999987542 22346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+.+|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 97 LLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp CTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 999999999853 45688999999999999999999998 9999999999999999999999999999865433
Q ss_pred CceeeeeecCccccCcccccc---CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 759 SHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ....+....... ..
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~----~~----- 237 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-SSKEIVHTFETT----VV----- 237 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-CHHHHHHHHHHC----CC-----
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhhc----cc-----
Confidence 22344569999999999974 45889999999999999999999999754421 112222221111 00
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCc-HHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-ISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~eVl~~ 874 (929)
.++......+.+++.+|++.+|++||+ +.+|.++
T Consensus 238 -----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 238 -----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred -----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 111112346889999999999999998 7777654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=346.10 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=203.3
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeee----cCeEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVY 676 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~----~~~~~LV~ 676 (929)
.|.+.+.||+|+||.||+++.. +++.||||++........+.+.+|++++++++||||+++++++.. ....++||
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 4556789999999999999984 689999999977666667789999999999999999999999863 34789999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++|+|.+++.........+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999999976544456789999999999999999999998 999999999999999999999999999875421
Q ss_pred CCCc--------eeeeeecCccccCccccccCc---CCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh
Q 002382 757 GASH--------VSSIVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 757 ~~~~--------~~~~~~gt~~Y~aPE~~~~~~---~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
.... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||........ .+......
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~-- 262 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--SVALAVQN-- 262 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--CHHHHHHC--
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--hhhHHhhc--
Confidence 1100 011234799999999987543 68899999999999999999999965321111 11111111
Q ss_pred hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 826 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
.... .........+.+++.+|++.+|++||++.|++++|+.+.
T Consensus 263 -~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 263 -QLSI----------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp -C--C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred -cCCC----------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0000 001112246889999999999999999999999998763
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=349.23 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=198.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCc----EEEEEEeecC-CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~----~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
|.+.+.||+|+||+||+|++. +++ +||+|.+... .....+.+.+|+.++++++||||+++++++.... .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence 456789999999999999875 344 3577777543 3345678999999999999999999999998765 78999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+.+|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 96 QLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp CCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999998643 34688999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 757 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 757 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
.... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+..... .+..
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~~~~----~~~~---- 237 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILE----KGER---- 237 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHH----TTCC----
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHHHHH----cCCC----
Confidence 3222 2233446889999999999999999999999999999999 99999765422 2222211 1110
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
...+......+.+++.+|++.+|++||++.|+++.|+++....
T Consensus 238 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 238 -----LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred -----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 0011112335889999999999999999999999999987543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=341.95 Aligned_cols=270 Identities=23% Similarity=0.382 Sum_probs=210.3
Q ss_pred cCHHHHHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcc--cCCCceeEEeeeeeecC
Q 002382 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQEEG 670 (929)
Q Consensus 593 ~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~--l~HpNIv~l~g~~~~~~ 670 (929)
+...+.....+.+.+.||+|+||.||+|++. ++.||||++... ....+.+|++++.. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3345555667778899999999999999985 899999998643 34567788888877 78999999999998776
Q ss_pred ----eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHH--------hCCCCceecCCCCCCCeEec
Q 002382 671 ----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--------TGCVPAIIHRDLKSSNILLD 738 (929)
Q Consensus 671 ----~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~ivHrDIkp~NILl~ 738 (929)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +. +|+||||||+|||++
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK 181 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence 78999999999999999853 35889999999999999999999 66 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCc---eeeeeecCccccCccccccC------cCCCcCceeeHHHHHHHHHhC--------
Q 002382 739 KHMRAKVSDFGLSKFAVDGASH---VSSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISG-------- 801 (929)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~------~~s~~sDVwSlGvvl~elltG-------- 801 (929)
.++.+||+|||+++........ ......||+.|+|||.+.+. .++.++|||||||++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999865544322 12344699999999999765 334689999999999999999
Q ss_pred --CCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc-cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 802 --QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE-YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 802 --~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
..||........ ....+...... .. ..+.+... ...+....+.+++.+|++.+|++|||+.||+++|+++
T Consensus 262 ~~~~p~~~~~~~~~--~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 262 DYQLPYYDLVPSDP--SVEEMRKVVCE-QK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCTTTTTSCSSC--CHHHHHHHHTT-SC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCccccCcCcc--cHHHHHHHHHH-HH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 677765432111 11112111111 11 11222211 2345667899999999999999999999999999998
Q ss_pred HhH
Q 002382 879 IVI 881 (929)
Q Consensus 879 ~~~ 881 (929)
...
T Consensus 335 ~~~ 337 (342)
T 1b6c_B 335 SQQ 337 (342)
T ss_dssp HHT
T ss_pred HHH
Confidence 653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=338.47 Aligned_cols=253 Identities=22% Similarity=0.365 Sum_probs=199.0
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
..|.+.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 35667899999999999999886 58899999987653 33457789999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe---cCCCcEEEEeecCccccc
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~~~ 755 (929)
+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999865444456789999999999999999999998 99999999999999 456789999999997654
Q ss_pred CCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
... ......||+.|+|||.+. ..++.++|||||||++|||++|+.||...... .+....... ..... ..
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~----~~~~~~~~~--~~~~~--~~ 247 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE----EVQQKATYK--EPNYA--VE 247 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHC--CCCCC--C-
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH----HHHhhhccC--Ccccc--cc
Confidence 322 233456899999999875 56889999999999999999999999765421 111111111 00000 00
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... ....+.+++.+|++.||++|||+.|++++
T Consensus 248 ---~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 248 ---CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ---cCc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001 12357799999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=341.78 Aligned_cols=261 Identities=32% Similarity=0.538 Sum_probs=194.7
Q ss_pred HHHHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 598 IEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 598 i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
+....+.+.+.||+|+||+||+|++. ..||||+++... ....+.+.+|++++++++||||+++++++ .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 33445667789999999999999875 469999997553 23346789999999999999999999966 45568999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
|||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999988532 45688999999999999999999998 99999999999999999999999999997543
Q ss_pred CCC-CceeeeeecCccccCccccc---cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 756 DGA-SHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 756 ~~~-~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
... ........||+.|+|||.+. +..++.++|||||||++|||++|+.||...... ..+...... +...
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~----~~~~ 244 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIEMVGR----GSLS 244 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH---HHHHHHHHH----TSCC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH---HHHHHHhcc----cccC
Confidence 321 22233456899999999986 566788999999999999999999999764411 122222211 1111
Q ss_pred cccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 832 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 832 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
.... .........+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 245 ~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1110 111122346889999999999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=340.92 Aligned_cols=264 Identities=22% Similarity=0.275 Sum_probs=196.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||+||+|++. +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 345688999999999999987 589999999865432 22466889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 85 DHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp SEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 99999887742 35588999999999999999999998 999999999999999999999999999986543222
Q ss_pred ceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHH-------hhhcCCcc
Q 002382 760 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HIESGDIQ 831 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~-------~~~~~~~~ 831 (929)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+...... ........
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 2234468999999999976 67899999999999999999999999765422111111111000 00000000
Q ss_pred ---cccCCcccCc---cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 832 ---GIIDPSLLDE---YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 832 ---~~~d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...++.-... ........+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000 001223457899999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=338.10 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=204.9
Q ss_pred HHhc-cccccCcEEEEEEEEC---CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 604 MLEK-KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 604 ~~~~-~IG~G~fG~Vy~~~~~---~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.+.+ .||+|+||.||+|.+. .++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 19 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 97 (291)
T 1xbb_A 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVME 97 (291)
T ss_dssp EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEE
Confidence 3445 8999999999999653 46789999997543 22356799999999999999999999999 5677899999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 98 MAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp CCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred eCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 9999999999853 34588999999999999999999998 9999999999999999999999999999865444
Q ss_pred CCcee--eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 758 ASHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 758 ~~~~~--~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
..... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+...+. .+...
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~~----~~~~~--- 239 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLE----KGERM--- 239 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHH----TTCCC---
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHH----cCCCC---
Confidence 33221 22346789999999998889999999999999999999 9999976441 12222211 11111
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHhHHHH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAA 886 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~~~~~ 886 (929)
..+......+.+++.+|++.+|++||++.||++.|+++........
T Consensus 240 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 285 (291)
T 1xbb_A 240 ------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285 (291)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence 1111223468899999999999999999999999999987665443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=349.75 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=185.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
|.+.+.||+|+||.||+|++. +++.||||+++... ..+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 132 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence 456789999999999999987 57899999997543 345688999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC---CCcEEEEeecCcccccCCC
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DFGla~~~~~~~ 758 (929)
|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 133 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 133 GELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp CBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 999998853 34588999999999999999999998 9999999999999975 889999999999865332
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+.+. ....... .. ...
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~----i~~~~~~-~~-~~~ 274 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD---QFMFRR----ILNCEYY-FI-SPW 274 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH---HHHHHH----HHTTCCC-CC-TTT
T ss_pred -cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc---HHHHHH----HHhCCCc-cC-Cch
Confidence 2223456899999999999999999999999999999999999999654311 111111 1111110 00 001
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. ......+.+++.+|++.||++|||+.|++++
T Consensus 275 ~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 275 W----DEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp T----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h----hhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1223467899999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=335.90 Aligned_cols=262 Identities=22% Similarity=0.322 Sum_probs=203.5
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeee-eecCeEEEEEEe
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEF 678 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~-~~~~~~~LV~E~ 678 (929)
..|.+.+.||+|+||+||+|++. +++.||||++..... ...+.+|+++++.++|++++..++++ ...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 34567889999999999999974 688999998765432 34688999999999888777666655 667788999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe---cCCCcEEEEeecCccccc
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~~~ 755 (929)
+ +++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 87 L-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp C-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred c-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9 99999998532 34589999999999999999999998 99999999999999 788999999999998654
Q ss_pred CCCCc------eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 756 DGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 756 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.......... .
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-P 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-C
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-h
Confidence 43221 2234569999999999999999999999999999999999999998654332222222222211111 0
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
.. .+...+ ...+.+++.+|++.+|++||++.||++.|+++...
T Consensus 239 ~~-----~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 239 IE-----VLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HH-----HHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hh-----hhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 00 000111 24688999999999999999999999999998754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=348.57 Aligned_cols=255 Identities=25% Similarity=0.312 Sum_probs=187.0
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccC-CCceeEEeeeee--------ecCe
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQ--------EEGR 671 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~--------~~~~ 671 (929)
.|.+.+.||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++. ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 4556789999999999999976 68999999997776666778999999999996 999999999984 3445
Q ss_pred EEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCeEecCCCcEEEEeec
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFG 749 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDIkp~NILl~~~~~vkL~DFG 749 (929)
.++||||+. |+|.+++.... ....+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred EEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCc
Confidence 799999995 79988885432 244689999999999999999999998 7 9999999999999999999999999
Q ss_pred CcccccCCCCce-----------eeeeecCccccCcccc---ccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccch
Q 002382 750 LSKFAVDGASHV-----------SSIVRGTVGYLDPEYY---ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 815 (929)
Q Consensus 750 la~~~~~~~~~~-----------~~~~~gt~~Y~aPE~~---~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~ 815 (929)
+++......... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---- 259 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL---- 259 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH----
Confidence 998654332211 1134589999999998 5667888999999999999999999999754311
Q ss_pred hhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 816 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 816 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
.+.. . ... ...... ....+.+++.+|++.+|++||++.|++++|+.+...
T Consensus 260 ~~~~---~-----~~~----~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 260 RIVN---G-----KYS----IPPHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp --------------CC----CCTTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Hhhc---C-----ccc----CCcccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111 0 000 000011 112377899999999999999999999999988653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=352.31 Aligned_cols=272 Identities=18% Similarity=0.253 Sum_probs=203.2
Q ss_pred HHHHhcccccc--CcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 602 TKMLEKKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 602 ~~~~~~~IG~G--~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
.|.+.+.||+| +||+||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 35567899999 99999999987 68999999997553 233467888999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++|+|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+.....
T Consensus 106 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 106 SFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp ECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999998643 234588999999999999999999998 999999999999999999999999999864322
Q ss_pred CCC------ceeeeeecCccccCcccccc--CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh-hh-
Q 002382 757 GAS------HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-IE- 826 (929)
Q Consensus 757 ~~~------~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~-~~- 826 (929)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....... ..
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 111 11122468999999999987 678999999999999999999999997644222111111100000 00
Q ss_pred ----cCC-------------cccccCCcc---------cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH--HHHh
Q 002382 827 ----SGD-------------IQGIIDPSL---------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 878 (929)
Q Consensus 827 ----~~~-------------~~~~~d~~l---------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~--L~~~ 878 (929)
... ..+.+.... ...........+.+++.+|++.||++|||+.|++++ ++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 000 000000000 000111223468899999999999999999999987 5544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=334.42 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=200.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 87 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 87 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence 445789999999999999887 58899999997543 233467889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc---EEEEeecCcccccC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFGLSKFAVD 756 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkL~DFGla~~~~~ 756 (929)
++++|.+.+.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++.....
T Consensus 88 ~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 88 TGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999888743 45688999999999999999999998 9999999999999987655 99999999976543
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .+...... +.... ..+
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~----~~~~~-~~~ 229 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQIKA----GAYDY-PSP 229 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH----TCCCC-CTT
T ss_pred Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh----HHHHHHHh----ccccC-Cch
Confidence 322 23356899999999999999999999999999999999999999764421 11111111 11100 000
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.... ....+.+++.+|++.+|++|||+.|++++
T Consensus 230 -~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 230 -EWDT----VTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -TTTT----SCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -hhcc----cCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0111 22457899999999999999999999886
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=375.59 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=206.9
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+.+.||+|+||.||+|++++++.||||+++.... ..++|.+|+++|++++||||+++++++.+ +..++||||+++
T Consensus 268 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~ 345 (535)
T 2h8h_A 268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 345 (535)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred hhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcC
Confidence 3456789999999999999999888999999986543 35679999999999999999999999876 678999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++... ....+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 346 gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 346 GSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp EEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred CcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 9999999542 234588999999999999999999998 99999999999999999999999999998654321112
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....++..|+|||.+....++.++|||||||++|||++ |+.||...... .+.+.+ ..+.. .
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~----~~~~~i----~~~~~---------~ 483 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQV----ERGYR---------M 483 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH----HHHHHH----HTTCC---------C
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----HcCCC---------C
Confidence 223346789999999999999999999999999999999 99999754411 222221 11110 0
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
..+......+.+++.+|++.+|++|||+.+|++.|+.+..
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 1111223468899999999999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=352.47 Aligned_cols=242 Identities=26% Similarity=0.327 Sum_probs=189.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHH-hcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTL-LSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~i-L~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
+.+.+.||+|+||+||+|+.+ +++.||||++++... .....+..|..+ ++.++||||+++++++.+.+..++|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 456789999999999999987 578899999976532 223456667776 577899999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 120 YINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999998843 45678889999999999999999998 9999999999999999999999999999854332
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
. ......+||+.|+|||++.+..++.++|+|||||++|||++|+.||......+....+.. +.. .
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--------~~~------~ 257 (373)
T 2r5t_A 193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--------KPL------Q 257 (373)
T ss_dssp C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH--------SCC------C
T ss_pred C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------ccc------C
Confidence 2 223445799999999999999999999999999999999999999976542222222211 111 0
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISE 870 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e 870 (929)
+.... ...+.+++.+|++.||++||++.+
T Consensus 258 ~~~~~----~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 258 LKPNI----TNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CCSSS----CHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CCCCC----CHHHHHHHHHHcccCHHhCCCCCC
Confidence 11112 235789999999999999999853
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=335.69 Aligned_cols=244 Identities=24% Similarity=0.390 Sum_probs=197.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||.||+|++. +++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 345789999999999999887 56789999986542 22246788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 91 APLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp CTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence 999999998843 35688999999999999999999998 9999999999999999999999999998643322
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ..... .....
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~----~~~~~-------- 224 (279)
T 3fdn_A 163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----TYKRI----SRVEF-------- 224 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHH----HHTCC--------
T ss_pred --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH----HHHHH----HhCCC--------
Confidence 2234468999999999999999999999999999999999999997654221 11111 11100
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+......+.+++.+|++.+|++||++.|++++
T Consensus 225 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0111122457899999999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=355.41 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=193.6
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCC--cchhHHHHHHHHHhcccC--CCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~--HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||+||+|...+++.||||++.... ....+.+.+|+++|++++ ||||+++++++...+..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 55678999999999999998889999999997543 334567899999999996 5999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+.+++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++......
T Consensus 137 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 137 CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 678899999853 34678889999999999999999998 999999999999995 5899999999998654332
Q ss_pred Cc-eeeeeecCccccCcccccc-----------CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhh
Q 002382 759 SH-VSSIVRGTVGYLDPEYYIS-----------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 826 (929)
Q Consensus 759 ~~-~~~~~~gt~~Y~aPE~~~~-----------~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 826 (929)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~------~~~~~~~~~~~ 282 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------NQISKLHAIID 282 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC------CHHHHHHHHHC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh------HHHHHHHHHhC
Confidence 22 2344569999999999865 368889999999999999999999996532 11111111111
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 827 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 827 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. .....++......+.+++.+|++.||++||++.|++++
T Consensus 283 ~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 283 P---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp T---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred c---------cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1 11111111112467899999999999999999999976
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=342.69 Aligned_cols=261 Identities=22% Similarity=0.294 Sum_probs=203.4
Q ss_pred cCHHHHHHHHHHHh-ccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhccc-CCCceeEEeeeee
Q 002382 593 FTLSDIEDATKMLE-KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ 667 (929)
Q Consensus 593 ~~~~~i~~~~~~~~-~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~ 667 (929)
+...+.....|.+. +.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++++ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 44444444555554 88999999999999887 58999999987542 33356789999999999 5699999999999
Q ss_pred ecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC---CCcEE
Q 002382 668 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAK 744 (929)
Q Consensus 668 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vk 744 (929)
..+..++||||+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 999999999999999999988542 245688999999999999999999998 9999999999999998 78999
Q ss_pred EEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh
Q 002382 745 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 824 (929)
Q Consensus 745 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~ 824 (929)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ...
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i----~~~ 248 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI----SQV 248 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHT
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH----Hhc
Confidence 99999998654322 223356999999999999999999999999999999999999999765421111111 110
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.... ...........+.+++.+|++.+|++|||++|++++
T Consensus 249 --~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 --NVDY--------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --CCCC--------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --cccc--------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0000 011111223467899999999999999999999876
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=338.99 Aligned_cols=256 Identities=24% Similarity=0.341 Sum_probs=194.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEeccCCc
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~~~gs 683 (929)
.+.||+|+||+||+|+.. +++.||||++..........+.+|++++.++ +||||+++++++.+.+..++||||+++|+
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 367999999999999875 6899999999876655567889999999885 79999999999999999999999999999
Q ss_pred hhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc---EEEEeecCcccccCCC--
Q 002382 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFGLSKFAVDGA-- 758 (929)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkL~DFGla~~~~~~~-- 758 (929)
|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+++......
T Consensus 98 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 98 ILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp HHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 9999853 35688999999999999999999998 9999999999999998776 9999999987543211
Q ss_pred ----CceeeeeecCccccCcccccc-----CcCCCcCceeeHHHHHHHHHhCCCCCcccccccc-------chhhHHHHH
Q 002382 759 ----SHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGAN-------CRNIVQWAK 822 (929)
Q Consensus 759 ----~~~~~~~~gt~~Y~aPE~~~~-----~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~-------~~~l~~~~~ 822 (929)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. .........
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence 111223459999999999875 5688999999999999999999999976432110 000000011
Q ss_pred HhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 823 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 823 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.....+... +...... .....+.+++.+|++.||++|||+.|++++
T Consensus 251 ~~i~~~~~~--~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 251 ESIQEGKYE--FPDKDWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHCCCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhccCcc--cCchhcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111111110 0000000 122468899999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=333.78 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=203.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeee-eecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~-~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||.||+|++. +++.||||++..... ...+.+|+.+++.++|++++..+.++ ...+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 445789999999999999974 789999999875432 34688999999999988766666655 6677889999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe---cCCCcEEEEeecCcccccCC
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~~~~~ 757 (929)
+++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 88 ~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 88 GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999998532 34689999999999999999999998 99999999999999 48889999999999865543
Q ss_pred CCc------eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 758 ASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 758 ~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.......... ...
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 240 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-chH
Confidence 321 1234569999999999999999999999999999999999999998654222222222221111110 000
Q ss_pred cccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 832 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 832 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
.+... ....+.+++.+|++.+|++||++.||++.|+++...
T Consensus 241 -----~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 241 -----VLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp -----HHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----HHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 00111 124688999999999999999999999999988653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=352.63 Aligned_cols=254 Identities=30% Similarity=0.472 Sum_probs=192.6
Q ss_pred HHhccccccCcEEEEEEEEC--CC--cEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeee-ecCeEEEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK--DG--KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVYE 677 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~--~~--~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~-~~~~~~LV~E 677 (929)
.+.+.||+|+||+||+|++. ++ ..||||+++... ....+.+.+|+.++++++||||+++++++. ..+..++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 34678999999999999864 22 358999986543 344577999999999999999999999875 4567899999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++|+|.+++.. ....+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 172 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 172 YMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999953 234578889999999999999999998 9999999999999999999999999999855432
Q ss_pred CCc---eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 758 ASH---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 758 ~~~---~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... .+..... .+...
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~----~~~~~~~----~~~~~-- 315 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYLL----QGRRL-- 315 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS----CHHHHHH----TTCCC--
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH----HHHHHHH----cCCCC--
Confidence 211 1233457889999999999999999999999999999999 67777654422 1222111 11100
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.. +......+.+++.+|++.+|++||++.|++++|++++.
T Consensus 316 ~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 316 LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 11122468899999999999999999999999998865
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=334.21 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=200.3
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc------hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~------~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~ 673 (929)
..|.+.+.||+|+||.||+|+.. +++.||+|+++..... ..+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 34667889999999999999987 6899999998754321 3567899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC----cEEEEeec
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFG 749 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkL~DFG 749 (929)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999843 45688999999999999999999998 999999999999998877 89999999
Q ss_pred CcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
+++...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ...... ....
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~----~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ----ETLTNI----SAVN 227 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHH----HTTC
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH----HHHHHh----Hhcc
Confidence 997654322 223345899999999999889999999999999999999999999764411 111111 1110
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. ..+.... ......+.+++.+|++.+|++||++.|++++
T Consensus 228 ~--~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 228 Y--DFDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp C--CCCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred c--CCcchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0 0000001 1122468899999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=333.47 Aligned_cols=247 Identities=23% Similarity=0.368 Sum_probs=180.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 445688999999999999985 689999999975421 2236788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 93 CHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp CTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred CCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999998532 35688999999999999999999998 99999999999999999999999999997654322
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ . .. +...
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~-~~------~~~~ 231 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV-------V-LA------DYEM 231 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C-------C-SS------CCCC
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH-------h-hc------ccCC
Confidence 1 222356899999999999888999999999999999999999999764422111000 0 00 0011
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... ....+.+++.+|++.||++||++.|++++
T Consensus 232 ~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 232 PSF----LSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccc----cCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 111 22467899999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=338.63 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=200.5
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
..|.+.+.||+|+||.||+++.. +++.||+|+++.........+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 45667889999999999999986 68999999998665555567899999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe---cCCCcEEEEeecCcccccC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~~~~ 756 (929)
++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++....
T Consensus 89 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 89 SGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999998843 34688999999999999999999998 99999999999999 7889999999999875432
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+...+. .+... ...
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~i~----~~~~~--~~~ 228 (304)
T 2jam_A 162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES----KLFEKIK----EGYYE--FES 228 (304)
T ss_dssp B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHH----HCCCC--CCT
T ss_pred C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHH----cCCCC--CCc
Confidence 2 122345899999999999989999999999999999999999999754421 1211111 11110 011
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..... ....+.+++.+|++.||++||++.|++++
T Consensus 229 ~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 229 PFWDD----ISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTTTT----SCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111 23468899999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=345.17 Aligned_cols=256 Identities=28% Similarity=0.448 Sum_probs=202.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcE--EEEEEeecC-CcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKE--IAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~--vAVK~l~~~-~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
+.+.+.||+|+||.||+|++. +++. +|||+++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 106 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 106 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence 456789999999999999876 4554 499988754 233456789999999999 89999999999999999999999
Q ss_pred eccCCchhhhhcccc------------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEE
Q 002382 678 FMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 745 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL 745 (929)
|+++|+|.+++.... .....+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEE
Confidence 999999999996542 2234689999999999999999999998 9999999999999999999999
Q ss_pred EeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHh
Q 002382 746 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 824 (929)
Q Consensus 746 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 824 (929)
+|||+++..... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...
T Consensus 184 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----~~~~~---- 253 (327)
T 1fvr_A 184 ADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEK---- 253 (327)
T ss_dssp CCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHH----
T ss_pred cccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH----HHHHH----
Confidence 999998743211 11223447889999999998889999999999999999998 99999765421 11111
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
...+.. . ..+......+.+++.+|++.+|++||++.|++++|+.++.
T Consensus 254 ~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 254 LPQGYR-----L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp GGGTCC-----C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCCC-----C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111110 0 1111223468899999999999999999999999998875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=338.39 Aligned_cols=255 Identities=30% Similarity=0.472 Sum_probs=198.6
Q ss_pred HHHhccccccCcEEEEEEEECC----CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeee-eecCeEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVY 676 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~----~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~-~~~~~~~LV~ 676 (929)
+.+.+.||+|+||+||+|++.+ ...+|+|++.... ....+.+.+|+.++++++||||+++++++ ..++..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 3456899999999999998753 2358999987543 33456789999999999999999999986 4556789999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 107 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 107 PYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp ECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred eCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 99999999999953 245578899999999999999999998 999999999999999999999999999975543
Q ss_pred CCC---ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 757 GAS---HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 757 ~~~---~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
... .......+|+.|+|||.+.+..++.++|||||||++|||++ |.+||...... .+...... +...
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~----~~~~~~~~----~~~~- 251 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYLLQ----GRRL- 251 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT----THHHHHHT----TCCC-
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH----HHHHHHhc----CCCC-
Confidence 221 12233457889999999999999999999999999999999 55566543311 11111111 1100
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.. +......+.+++.+|++.+|++||++.|+++.|++++.
T Consensus 252 -~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 252 -LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp -CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CC-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 11112368899999999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=371.40 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=200.2
Q ss_pred cccccCcEEEEEEEEC---CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCc
Q 002382 608 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (929)
Q Consensus 608 ~IG~G~fG~Vy~~~~~---~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gs 683 (929)
.||+|+||.||+|.++ ++..||||+++... ....+++.+|+++|++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 45679999997653 3346789999999999999999999999976 56899999999999
Q ss_pred hhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce--
Q 002382 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-- 761 (929)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-- 761 (929)
|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99998542 45689999999999999999999998 99999999999999999999999999998654332221
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...+ ..+.. .
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~~~~~i----~~~~~---------~ 558 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFI----EQGKR---------M 558 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH----HHHHHH----HTTCC---------C
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHHHH----HcCCC---------C
Confidence 122345689999999999999999999999999999998 99999765422 222221 11211 1
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
..+......+.+++.+|++.+|++||++.+|++.|+.+...
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 11122335688999999999999999999999999987643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=343.05 Aligned_cols=268 Identities=24% Similarity=0.381 Sum_probs=194.0
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHH--HHHHhcccCCCceeEEeeeeee-----cCeEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTN--EVTLLSRIHHRNLVQFLGYCQE-----EGRSVLV 675 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~--Ev~iL~~l~HpNIv~l~g~~~~-----~~~~~LV 675 (929)
+.+.+.||+|+||.||+|+.. ++.||||++.... ...+.. |+..+..++||||+++++.+.. ....++|
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred hheeeecccCCCeEEEEEEEC-CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 345789999999999999874 8999999997443 233334 4444556899999999985532 3367899
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCC------CCceecCCCCCCCeEecCCCcEEEEeec
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------VPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~~ivHrDIkp~NILl~~~~~vkL~DFG 749 (929)
|||+++|+|.+++.. ...++..++.++.|+++||+|||+.+ .++|+||||||+|||++.++.+||+|||
T Consensus 91 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 999999999999843 33478889999999999999999863 2389999999999999999999999999
Q ss_pred CcccccCCC-------CceeeeeecCccccCcccccc-------CcCCCcCceeeHHHHHHHHHhCCCCCccccccccch
Q 002382 750 LSKFAVDGA-------SHVSSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 815 (929)
Q Consensus 750 la~~~~~~~-------~~~~~~~~gt~~Y~aPE~~~~-------~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~ 815 (929)
+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+..........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 998654321 111223459999999999976 456778999999999999999987764332111111
Q ss_pred hhHH----------HHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 816 NIVQ----------WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 816 ~l~~----------~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
.... ..............+.... .........+.+++.+|++.||++|||+.|+++.|++++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 1100 0001111111111111100 11233556799999999999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=344.10 Aligned_cols=260 Identities=23% Similarity=0.404 Sum_probs=207.6
Q ss_pred HHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
.|.+.+.||+|+||.||+|++. .++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 105 (322)
T 1p4o_A 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 105 (322)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence 4556789999999999999765 367899999975533 334578899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhccccc------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEee
Q 002382 675 VYEFMHNGTLKEHLYGTLT------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 748 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 748 (929)
||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Df 182 (322)
T 1p4o_A 106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 182 (322)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcC
Confidence 9999999999999864321 113468889999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhh
Q 002382 749 GLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE 826 (929)
Q Consensus 749 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 826 (929)
|+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+...+ .
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~----~ 254 (322)
T 1p4o_A 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----EQVLRFV----M 254 (322)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----HHHHHHH----H
T ss_pred ccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH----HHHHHHH----H
Confidence 999755432221 2223457889999999998899999999999999999999 8899875441 1222211 1
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 827 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 827 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
.+.... .+......+.+++.+|++.+|++||++.|++++|++.+..
T Consensus 255 ~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 255 EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 111111 1112234688999999999999999999999999987653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=331.85 Aligned_cols=252 Identities=28% Similarity=0.435 Sum_probs=204.8
Q ss_pred HHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeee-------
Q 002382 597 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------- 668 (929)
Q Consensus 597 ~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~------- 668 (929)
+.....|.+.+.||+|+||.||+|++. +++.||+|+++... ..+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 334455667889999999999999987 78999999997543 457789999999999999999998854
Q ss_pred ---------cCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC
Q 002382 669 ---------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 739 (929)
Q Consensus 669 ---------~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 739 (929)
....++||||+++++|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+||+++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD 157 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence 45579999999999999999643 235688999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHH
Q 002382 740 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (929)
Q Consensus 740 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~ 819 (929)
++.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|..|+.... ....
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------~~~~ 229 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS------KFFT 229 (284)
T ss_dssp TTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH------HHHH
T ss_pred CCCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH------HHHH
Confidence 9999999999998654432 2233458999999999999999999999999999999999998875322 1111
Q ss_pred HHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 820 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 820 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
....+.+. ..++ ..+.+++.+|++.+|++||++.|++++|+.+...
T Consensus 230 ----~~~~~~~~--------~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 ----DLRDGIIS--------DIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp ----HHHTTCCC--------TTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ----Hhhccccc--------ccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 11111111 1222 3477899999999999999999999999987543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=350.22 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=201.1
Q ss_pred HHHhccccccCcEEEEEEEE----CCCcEEEEEEeecCC----cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~----~~~~~vAVK~l~~~~----~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~ 673 (929)
|.+.+.||+|+||.||+|+. .+++.||||+++... ......+.+|+++++++ +||||+++++++...+..+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 45678999999999999988 368999999986532 22345677899999999 6999999999999999999
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 136 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999853 34688999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeeeeecCccccCcccccc--CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.+.. ....
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~~--- 282 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---LKSE--- 282 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH---HHCC---
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH---hccC---
Confidence 54433333444569999999999985 347889999999999999999999997544222222222211 1110
Q ss_pred cccCCcccCccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHHH
Q 002382 832 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKDI 875 (929)
Q Consensus 832 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~L 875 (929)
+ .++......+.+++.+|++.||++|| ++.|++++.
T Consensus 283 ----~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ----P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----C----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0 11112234578999999999999999 999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=344.65 Aligned_cols=251 Identities=23% Similarity=0.328 Sum_probs=198.5
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEe
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
..|.+.+.||+|+||+||+|+++ +++.||||++..... ...+|++++.++ +||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 34567789999999999999987 588999999975532 345688888887 799999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC----CcEEEEeecCcccc
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKFA 754 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~----~~vkL~DFGla~~~ 754 (929)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+.++ +.+||+|||+++..
T Consensus 98 ~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999998853 35688999999999999999999998 99999999999998543 35999999999865
Q ss_pred cCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......+...+ ..+...
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~~~~~i----~~~~~~--- 241 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP-DDTPEEILARI----GSGKFS--- 241 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST-TSCHHHHHHHH----HHCCCC---
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC-cCCHHHHHHHH----ccCCcc---
Confidence 44322 2234568999999999988889999999999999999999999997533 11122222221 122111
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+...+.......+.+++.+|++.||++||++.|+++|
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111111223467899999999999999999999876
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=359.64 Aligned_cols=245 Identities=24% Similarity=0.392 Sum_probs=201.6
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||.||+|++. +|+.||||++..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 456789999999999999987 789999999975422 2245788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 98 VSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp CSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999853 45689999999999999999999998 99999999999999999999999999998654432
Q ss_pred CceeeeeecCccccCccccccCcC-CCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .+...+ ..+...
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i----~~~~~~------ 234 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP----TLFKKI----CDGIFY------ 234 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH----HHHHHH----HTTCCC------
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH----HHHHHH----hcCCcC------
Confidence 2234569999999999988765 67999999999999999999999765422 121111 111110
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.... ....+.+++.+|++.||++|||+.|++++
T Consensus 235 ~p~~----~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 235 TPQY----LNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCcc----CCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0011 12357899999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=337.05 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=200.4
Q ss_pred HhccccccCcEEEEEEEECC-C---cEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeE-EEEEEe
Q 002382 605 LEKKIGSGGFGVVYYGKLKD-G---KEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS-VLVYEF 678 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~~-~---~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~-~LV~E~ 678 (929)
+.+.||+|+||+||+|++.+ + ..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|+||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 35789999999999998642 2 3799999875433 3456789999999999999999999999876655 999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+.+|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 105 MCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp CTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred ccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999854 245678899999999999999999998 99999999999999999999999999997543321
Q ss_pred ---CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 759 ---SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 759 ---~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
........+|+.|+|||.+.+..++.++|||||||++|||++|..|+...... ..+........ ..
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~~~~---~~----- 247 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLTHFLAQGR---RL----- 247 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG---GGHHHHHHTTC---CC-----
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH---HHHHHHhhcCC---CC-----
Confidence 11223345789999999999999999999999999999999966554332211 12222211111 00
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
..+......+.+++.+|++.+|++|||+.|+++.|++++..
T Consensus 248 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 248 -----PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00111224688999999999999999999999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=345.33 Aligned_cols=245 Identities=24% Similarity=0.385 Sum_probs=196.7
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc---hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~---~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.+.+.+.||+|+||+||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 3455688999999999999975 6889999999754322 23568899999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+. |+|.+++.. ....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 135 ~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 135 YCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp CCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred cCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 997 678777743 235688999999999999999999998 9999999999999999999999999999765332
Q ss_pred CCceeeeeecCccccCccccc---cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
....||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+ ....... .....
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~---~~----~~~~~~~-~~~~~ 274 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---AL----YHIAQNE-SPALQ 274 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH----HHHHHSC-CCCCC
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HH----HHHHhcC-CCCCC
Confidence 2346899999999985 5678999999999999999999999997544111 11 1111111 11111
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...+ ...+.+++.+|++.+|++|||+.|++++
T Consensus 275 ----~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 ----SGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCCC----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1111 2357899999999999999999999876
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=343.13 Aligned_cols=252 Identities=18% Similarity=0.163 Sum_probs=201.9
Q ss_pred HHHHhccccccCcEEEEEEE------ECCCcEEEEEEeecCCcchhHHHHHHHHHhcccC---CCceeEEeeeeeecCeE
Q 002382 602 TKMLEKKIGSGGFGVVYYGK------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRS 672 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~------~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~---HpNIv~l~g~~~~~~~~ 672 (929)
.|.+.+.||+|+||+||+|. ..+++.||||+++... ..++..|+++++.++ |+||+++++++...+..
T Consensus 66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 34567899999999999994 3468899999997543 446777777777775 99999999999999999
Q ss_pred EEEEEeccCCchhhhhccccc-cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC-----------C
Q 002382 673 VLVYEFMHNGTLKEHLYGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-----------H 740 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-----------~ 740 (929)
++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999964322 345689999999999999999999998 9999999999999998 8
Q ss_pred CcEEEEeecCcccccC-CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHH
Q 002382 741 MRAKVSDFGLSKFAVD-GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819 (929)
Q Consensus 741 ~~vkL~DFGla~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~ 819 (929)
+.+||+|||+|+.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------ 293 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------ 293 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------
Confidence 9999999999975432 223334556799999999999999999999999999999999999999965431100
Q ss_pred HHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCC-CcHHHHHHHHHHhHhH
Q 002382 820 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR-PSISEVLKDIQDAIVI 881 (929)
Q Consensus 820 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R-Ps~~eVl~~L~~~~~~ 881 (929)
.++..+..... ...+.+++..|++.+|.+| |++.++.+.|++.+..
T Consensus 294 -------------~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 -------------KPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -------------EECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -------------eechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 01111111111 2356688889999999988 5889999999988764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=331.31 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=201.8
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence 4556789999999999999987 68999999987543 334567899999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 88 SGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp TTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999998843 45688999999999999999999998 999999999999999999999999999975433221
Q ss_pred -ceeeeeecCccccCccccccCcC-CCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 760 -HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 760 -~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
.......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||...... ...+..|.... ... .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~---~~~----~-- 229 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWKEKK---TYL----N-- 229 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT--SHHHHHHHTTC---TTS----T--
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHhhhcc---ccc----C--
Confidence 22234568999999999987665 67899999999999999999999764411 11222221110 000 0
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... .....+.+++.+|++.+|++|||+.|++++
T Consensus 230 ~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 PWK----KIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TGG----GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred chh----hcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 001 122357899999999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=343.84 Aligned_cols=241 Identities=23% Similarity=0.342 Sum_probs=199.0
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc--------hhHHHHHHHHHhcccCCCceeEEeeeeeecCe
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 671 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~--------~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~ 671 (929)
..|.+.+.||+|+||+||+|++. +++.||||+++..... ....+.+|+.++++++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 45566789999999999999876 6889999999765321 23467789999999999999999999999999
Q ss_pred EEEEEEeccCC-chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecC
Q 002382 672 SVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (929)
Q Consensus 672 ~~LV~E~~~~g-sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 750 (929)
.++||||+.+| +|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 99999999777 99988843 44689999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeeeeecCccccCccccccCcC-CCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ..
T Consensus 177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~----------- 237 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TV----------- 237 (335)
T ss_dssp CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GT-----------
T ss_pred ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HH-----------
Confidence 986544322 234569999999999988776 7889999999999999999999965320 00
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...... +......+.+++.+|++.+|++|||+.|++++
T Consensus 238 -----~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 -----EAAIHP--PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TTCCCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----hhccCC--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00112358899999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=373.52 Aligned_cols=249 Identities=27% Similarity=0.417 Sum_probs=198.9
Q ss_pred ccccccCcEEEEEEEEC---CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~---~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.||+|+||+||+|.+. .++.||||+++.... ...+++.+|+++|++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999664 457899999976432 335789999999999999999999999964 568899999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc-
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH- 760 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 760 (929)
|+|.+++. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999994 345688999999999999999999998 9999999999999999999999999999865443321
Q ss_pred -eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 761 -VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 761 -~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.+. +..+...
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~~~~~----i~~~~~~------- 591 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAM----LEKGERM------- 591 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHH----HHTTCCC-------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH----HHcCCCC-------
Confidence 2233457889999999999999999999999999999998 99999765421 12221 1122111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
..+......+.+++.+|++.+|++||++.+|++.|+++..
T Consensus 592 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 592 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1112233568899999999999999999999999998764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=347.21 Aligned_cols=264 Identities=27% Similarity=0.399 Sum_probs=206.8
Q ss_pred HHHHhccccccCcEEEEEEEE-----CCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecC--eEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~-----~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~--~~~L 674 (929)
.+.+.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..++
T Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 121 (326)
T 2w1i_A 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121 (326)
T ss_dssp GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence 345678999999999999985 258899999998766666678999999999999999999999986644 6799
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
||||+++++|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 122 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 122 IMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999998542 34588999999999999999999998 9999999999999999999999999999866
Q ss_pred cCCCCce--eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccc--------cccchhhHHHHHHh
Q 002382 755 VDGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF--------GANCRNIVQWAKLH 824 (929)
Q Consensus 755 ~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~--------~~~~~~l~~~~~~~ 824 (929)
....... .....++..|+|||.+.+..++.++|||||||++|||++|..|+..... ..............
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 5433221 2234477889999999988899999999999999999999998864320 00000111111111
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
...+.. ...+......+.+++.+|++.+|++||++.||++.|+.+..
T Consensus 276 ~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 276 LKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhcCCC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111110 01112223468899999999999999999999999998764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.75 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=202.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeee--ecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQ--EEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~--~~~~~~LV~E 677 (929)
|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++. ..+..++|||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence 345689999999999999987 68999999997543 234567899999999999999999999884 4678899999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCc-----eecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-----IIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~-----ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
|+++++|.+++.........+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999999965433445589999999999999999999998 6 9999999999999999999999999997
Q ss_pred cccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+... ...+....
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~----i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELAGK----IREGKFRR 235 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH----HHHTCCCC
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH----HHHHHH----Hhhccccc
Confidence 6543221 12234589999999999988899999999999999999999999976541 122221 11121111
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
+... ....+.+++.+|++.+|++||++.||++++..
T Consensus 236 -----~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 -----IPYR----YSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -----CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----CCcc----cCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1112 22468899999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=340.34 Aligned_cols=261 Identities=27% Similarity=0.407 Sum_probs=197.0
Q ss_pred HHHHHhccccccCcEEEEEEEEC----CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecC----
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG---- 670 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~----~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~---- 670 (929)
..+.+.+.||+|+||.||+|++. .++.||||+++... ....+.+.+|+.++++++||||+++++++...+
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 34556789999999999999765 24579999987543 233467899999999999999999999997655
Q ss_pred -eEEEEEEeccCCchhhhhcccc--ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEe
Q 002382 671 -RSVLVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 747 (929)
Q Consensus 671 -~~~LV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 747 (929)
..++||||+++|+|.+++.... .....+++..++.++.|+++||.|||++ +|+||||||+||+++.++.+||+|
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECS
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEee
Confidence 3599999999999999984322 2345689999999999999999999998 999999999999999999999999
Q ss_pred ecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhh
Q 002382 748 FGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 748 FGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .+......
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~~~~-- 264 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH----EMYDYLLH-- 264 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHHHT--
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH----HHHHHHHc--
Confidence 999976543322 12233457889999999999999999999999999999999 88998765422 22221111
Q ss_pred hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 826 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
+... ..+......+.+++.+|++.+|++||++.|++++|++++..
T Consensus 265 --~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 265 --GHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp --TCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1100 01112234688999999999999999999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=344.73 Aligned_cols=263 Identities=19% Similarity=0.212 Sum_probs=190.4
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc--hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~--~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
.|.+.+.||+|+||+||+|+.. +++.||||+++..... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 3556789999999999999876 6889999999754322 245678999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe-----cCCCcEEEEeecCccc
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKF 753 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl-----~~~~~vkL~DFGla~~ 753 (929)
++ |+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 115 ~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 115 AE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp CS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred CC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 97 599888843 34588999999999999999999998 99999999999999 4556699999999986
Q ss_pred ccCCCCceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCc--
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI-- 830 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~-- 830 (929)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+.+..... .....
T Consensus 187 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~ 264 (329)
T 3gbz_A 187 FGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP-DDTTWPG 264 (329)
T ss_dssp HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC-CTTTSTT
T ss_pred cCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC-chhhhhh
Confidence 543222 22334589999999999874 48999999999999999999999997654221111111110000 00000
Q ss_pred -----------ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 -----------QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 -----------~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.......+...........+.+++.+|++.||++|||+.|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00000000000011122467899999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=334.29 Aligned_cols=246 Identities=19% Similarity=0.301 Sum_probs=197.9
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
..|.+.+.||+|+||+||+|++. +++.||||++.... .....++.+|+..+..+ +||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 44566789999999999999987 78999999997642 33456788999999999 9999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC----------------
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---------------- 740 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---------------- 740 (929)
||+++++|.+++.........+++..++.++.|++.||+|||++ +|+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999965433335689999999999999999999998 99999999999999844
Q ss_pred ---CcEEEEeecCcccccCCCCceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchh
Q 002382 741 ---MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 816 (929)
Q Consensus 741 ---~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~ 816 (929)
..+||+|||.++...... ...||+.|+|||.+.+. .++.++|||||||++|||++|..++.... .
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------~ 236 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------Q 236 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------H
T ss_pred CCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------H
Confidence 479999999998654322 23489999999999765 56679999999999999999998764332 1
Q ss_pred hHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 817 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 817 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... ...+... .+.... ...+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~-----~~~~~~~-----~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 WHE-----IRQGRLP-----RIPQVL----SQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHH-----HHTTCCC-----CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHH-----HHcCCCC-----CCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 1111111 111122 2468899999999999999999999876
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=344.90 Aligned_cols=263 Identities=19% Similarity=0.214 Sum_probs=196.0
Q ss_pred HHHHHhccccccCcEEEEEEEEC----CCcEEEEEEeecCCcc-----------hhHHHHHHHHHhcccCCCceeEEeee
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQ-----------GKREFTNEVTLLSRIHHRNLVQFLGY 665 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~----~~~~vAVK~l~~~~~~-----------~~~~f~~Ev~iL~~l~HpNIv~l~g~ 665 (929)
..|.+.+.||+|+||.||+|++. .+..+|||++...... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 34567789999999999999986 4678999998765322 12346678889999999999999999
Q ss_pred eee----cCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC
Q 002382 666 CQE----EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 741 (929)
Q Consensus 666 ~~~----~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 741 (929)
+.. ....++||||+ +++|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 987 67889999999 9999999853 33789999999999999999999998 999999999999999887
Q ss_pred --cEEEEeecCcccccCCCC------ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccccccc
Q 002382 742 --RAKVSDFGLSKFAVDGAS------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 813 (929)
Q Consensus 742 --~vkL~DFGla~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~ 813 (929)
.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP- 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence 999999999976533211 11134569999999999999899999999999999999999999996432111
Q ss_pred chhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 814 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
..+ ......... .+...+..... .......+.+++.+|++.+|++||++.||++.|++.
T Consensus 268 -~~~-~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 -VAV-QTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp -HHH-HHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred -HHH-HHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 111 111111111 01110000000 001234688999999999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=346.49 Aligned_cols=247 Identities=21% Similarity=0.245 Sum_probs=188.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcc-cCCCceeEEeeeeee----cCeEEEEEEec
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR-IHHRNLVQFLGYCQE----EGRSVLVYEFM 679 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~-l~HpNIv~l~g~~~~----~~~~~LV~E~~ 679 (929)
.+.||+|+||+||+|++. +++.||||+++. ...+.+|++++.+ .+||||+++++++.. .+..++||||+
T Consensus 67 ~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred cceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 368999999999999987 588999999863 2456788888744 589999999999875 56789999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC---CCcEEEEeecCcccccC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DFGla~~~~~ 756 (929)
++|+|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 142 ~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 142 DGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred CCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 999999999643 234689999999999999999999998 9999999999999998 78999999999986533
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+. .+.... ..
T Consensus 217 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~~~--~~ 288 (400)
T 1nxk_A 217 HN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQYEF--PN 288 (400)
T ss_dssp ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCCCC--CT
T ss_pred CC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcccC--CC
Confidence 22 22345689999999999999999999999999999999999999976542222112222111 111100 00
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.... .....+.+++.+|++.||++|||+.|++++
T Consensus 289 ~~~~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 289 PEWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0001 122468899999999999999999999987
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=362.78 Aligned_cols=250 Identities=28% Similarity=0.371 Sum_probs=203.7
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.+.+.||+|+||.||+|+++ +|+.||||++.... ......+.+|+.+|++++||||+++++++.+.+..++||||+
T Consensus 187 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~ 266 (576)
T 2acx_A 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 266 (576)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcC
Confidence 35678999999999999986 68999999997542 223456889999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 267 ~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~- 340 (576)
T 2acx_A 267 NGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 340 (576)
T ss_dssp CSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc-
Confidence 999999998643 234588999999999999999999998 99999999999999999999999999998654432
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.+.+... . .
T Consensus 341 -~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----~------~--- 406 (576)
T 2acx_A 341 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----P------E--- 406 (576)
T ss_dssp -CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----C------C---
T ss_pred -cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc----c------c---
Confidence 2233579999999999999999999999999999999999999997654222222222222111 1 0
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
.++......+.+++.+|++.||++|| ++.||++|
T Consensus 407 -~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 -EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11111224678999999999999999 78999877
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=344.53 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=198.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 106 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence 455789999999999999987 488999999865533 23456789999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 107 ~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 107 DHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp SEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 9999988763 234588999999999999999999998 99999999999999999999999999997554322
Q ss_pred ceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHH-------hhh-cCCc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HIE-SGDI 830 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~-------~~~-~~~~ 830 (929)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+...... ... ....
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 222344689999999999875 7899999999999999999999999765422211111111000 000 0000
Q ss_pred ccccCCcccCcc-----CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 QGIIDPSLLDEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.....+.+.... .......+.+++.+|++.||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111111111111 11223568899999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=344.98 Aligned_cols=264 Identities=23% Similarity=0.298 Sum_probs=199.8
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccC-----CCceeEEeeeeeecCeEE
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----HRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-----HpNIv~l~g~~~~~~~~~ 673 (929)
...|.+.++||+|+||+||+|++. +++.||||+++.. ....+.+..|+.+++.++ ||||+++++++...+..+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~ 112 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC 112 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence 345667889999999999999985 6889999998743 233556778999999886 999999999999999999
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC--------------
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------------- 739 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-------------- 739 (929)
+||||+ +++|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 113 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred EEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccc
Confidence 999999 89999998643 233588899999999999999999998 9999999999999975
Q ss_pred -----------CCcEEEEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccc
Q 002382 740 -----------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (929)
Q Consensus 740 -----------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~ 808 (929)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 789999999999864332 23456899999999999999999999999999999999999999764
Q ss_pred cccccchhhHHHHHH-------hhhcCCcccccCC-ccc----C----------------ccCHHHHHHHHHHHHHccCC
Q 002382 809 KFGANCRNIVQWAKL-------HIESGDIQGIIDP-SLL----D----------------EYDIQSMWKIEEKALMCVLP 860 (929)
Q Consensus 809 ~~~~~~~~l~~~~~~-------~~~~~~~~~~~d~-~l~----~----------------~~~~~~~~~l~~li~~Cl~~ 860 (929)
...+....+...... ..........++. .+. . .........+.+++.+|++.
T Consensus 263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 422111111110000 0000000000000 000 0 00000114677999999999
Q ss_pred CCCCCCcHHHHHHH
Q 002382 861 HGHMRPSISEVLKD 874 (929)
Q Consensus 861 dP~~RPs~~eVl~~ 874 (929)
||++|||+.|++++
T Consensus 343 dP~~Rpta~elL~h 356 (360)
T 3llt_A 343 DPTLRPSPAELLKH 356 (360)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=335.06 Aligned_cols=250 Identities=30% Similarity=0.444 Sum_probs=196.2
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeec-CeEEEEEEecc
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-GRSVLVYEFMH 680 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~-~~~~LV~E~~~ 680 (929)
.+.+.+.||+|+||.||+|+++ ++.||||+++... ..+.+.+|++++++++||||+++++++... +..++||||++
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 3456789999999999999986 8899999987543 356789999999999999999999987544 57899999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 99 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 99 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp TEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 99999998532 123478889999999999999999998 9999999999999999999999999998754322
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+...+ ..+.. ..
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~~~~----~~~~~-----~~-- 234 (278)
T 1byg_A 171 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRV----EKGYK-----MD-- 234 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHHHH----TTTCC-----CC--
T ss_pred -ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----hcCCC-----CC--
Confidence 123357889999999998899999999999999999998 99999765422 222211 11110 11
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.+......+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 235 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 235 --APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 111223468899999999999999999999999998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=353.88 Aligned_cols=263 Identities=24% Similarity=0.373 Sum_probs=188.0
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccC-CCceeEEeeeeeecC--eEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEG--RSVLV 675 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~--~~~LV 675 (929)
.|.+.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.+++++. ||||+++++++...+ ..++|
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 4556789999999999999876 6899999998644 2334566789999999997 999999999997544 68999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
|||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+...
T Consensus 90 ~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 90 FDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred ecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99997 588888743 4678889999999999999999998 99999999999999999999999999998543
Q ss_pred CCC--------------------CceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccc
Q 002382 756 DGA--------------------SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 814 (929)
Q Consensus 756 ~~~--------------------~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~ 814 (929)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 211 112234569999999999986 67899999999999999999999999765422211
Q ss_pred hhhHHHHHHhhhcCCccccc------------------CCcccCcc------------CHHHHHHHHHHHHHccCCCCCC
Q 002382 815 RNIVQWAKLHIESGDIQGII------------------DPSLLDEY------------DIQSMWKIEEKALMCVLPHGHM 864 (929)
Q Consensus 815 ~~l~~~~~~~~~~~~~~~~~------------------d~~l~~~~------------~~~~~~~l~~li~~Cl~~dP~~ 864 (929)
..+....... ....+..+- .......+ .......+.+++.+|++.||++
T Consensus 241 ~~i~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 241 ERIIGVIDFP-SNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHCCC-CHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHhcCCC-CHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 1221110000 000000000 00000000 0012246889999999999999
Q ss_pred CCcHHHHHHH
Q 002382 865 RPSISEVLKD 874 (929)
Q Consensus 865 RPs~~eVl~~ 874 (929)
|||+.|+++|
T Consensus 320 R~t~~e~l~H 329 (388)
T 3oz6_A 320 RISANDALKH 329 (388)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhCC
Confidence 9999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=357.10 Aligned_cols=260 Identities=22% Similarity=0.292 Sum_probs=192.6
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeec------CeEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV 673 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~------~~~~ 673 (929)
|.+.+.||+|+||+||+|++. +++.||||++... .....+.+.+|+.+++.++||||+++++++... ...+
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 143 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence 456789999999999999876 5889999999754 233456788999999999999999999999654 4579
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||++++ |.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 144 lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 144 LVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 999999764 555552 2378889999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHH-----------
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK----------- 822 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~----------- 822 (929)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+++...
T Consensus 214 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 5432 223445699999999999999999999999999999999999999976542221111111100
Q ss_pred ----HhhhcC------CcccccCCcccC---ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 823 ----LHIESG------DIQGIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 823 ----~~~~~~------~~~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...... .....+...+.. .........+.+++.+|++.||++|||++|+++|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000000000 0011124568999999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=360.93 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=202.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.||+|+||.||+|+++ +|+.||||++..... .....+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 467999999999999986 689999999975422 2345688999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++.........+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~-~ 345 (543)
T 3c4z_A 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-K 345 (543)
T ss_dssp CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-C
T ss_pred CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc-c
Confidence 999999875544455789999999999999999999998 999999999999999999999999999986544322 2
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.+.+. . ... .
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~---~-~~~----------~ 411 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL---E-QAV----------T 411 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH---H-CCC----------C
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh---h-ccc----------C
Confidence 2334799999999999999999999999999999999999999976542212222222111 1 110 0
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcH-----HHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~eVl~~ 874 (929)
++......+.+++.+|++.+|++||++ .|+++|
T Consensus 412 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 111223467899999999999999965 666654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=335.01 Aligned_cols=246 Identities=21% Similarity=0.339 Sum_probs=201.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 445789999999999999987 57889999987542 23356788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++. ....+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 97 CRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp CTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999874 245688999999999999999999998 99999999999999999999999999998654322
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ... . ...+.. .+
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~---~-~~~~~~------~~ 234 (294)
T 2rku_A 170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYL---R-IKKNEY------SI 234 (294)
T ss_dssp C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH---H-HHTTCC------CC
T ss_pred c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH---H-HhhccC------CC
Confidence 2 2234568999999999998889999999999999999999999997654211 111 1 111111 01
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.... ...+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 PKHI----NPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccc----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1112 2357899999999999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=350.16 Aligned_cols=263 Identities=20% Similarity=0.229 Sum_probs=197.0
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeee------------
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------------ 668 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~------------ 668 (929)
.|.+.+.||+|+||+||+|++. +++.||||++..... ...+|+++++.++||||+++++++..
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 3556789999999999999875 689999999875432 23479999999999999999999844
Q ss_pred --------------------------cCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCC
Q 002382 669 --------------------------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722 (929)
Q Consensus 669 --------------------------~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~ 722 (929)
....++||||++ |+|.+.+.........+++..+..++.|+++||+|||++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 160 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-- 160 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 334789999998 588888765545567799999999999999999999998
Q ss_pred CceecCCCCCCCeEec-CCCcEEEEeecCcccccCCCCceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHh
Q 002382 723 PAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELIS 800 (929)
Q Consensus 723 ~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~ellt 800 (929)
+|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||+||++|||++
T Consensus 161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 999999999999998 688999999999986544322 2334589999999998764 58999999999999999999
Q ss_pred CCCCCccccccccchhhHHHHHH--------h---hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHH
Q 002382 801 GQEAISNEKFGANCRNIVQWAKL--------H---IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS 869 (929)
Q Consensus 801 G~~p~~~~~~~~~~~~l~~~~~~--------~---~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 869 (929)
|+.||......+....+++.... . ..................+......+.+++.+|++.+|++|||+.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 99999865422222222211000 0 000011111111111111222334688999999999999999999
Q ss_pred HHHHH
Q 002382 870 EVLKD 874 (929)
Q Consensus 870 eVl~~ 874 (929)
|+++|
T Consensus 318 e~l~h 322 (383)
T 3eb0_A 318 EAMAH 322 (383)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99976
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=329.27 Aligned_cols=246 Identities=28% Similarity=0.433 Sum_probs=195.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeee----cCeEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLV 675 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~----~~~~~LV 675 (929)
+.+.+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 345678999999999999886 57889999987543 3345678999999999999999999998865 3568999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCeEec-CCCcEEEEeecCcc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLD-KHMRAKVSDFGLSK 752 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~--ivHrDIkp~NILl~-~~~~vkL~DFGla~ 752 (929)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. + |+||||||+|||++ .++.+||+|||++.
T Consensus 108 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 108 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999843 35688899999999999999999998 7 99999999999998 78999999999997
Q ss_pred cccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
..... ......||+.|+|||.+. +.++.++|||||||++|||++|+.||..... ...+.. . ...+....
T Consensus 181 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~---~-~~~~~~~~ 249 (290)
T 1t4h_A 181 LKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIYR---R-VTSGVKPA 249 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---HHHHHH---H-HTTTCCCG
T ss_pred ccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc---HHHHHH---H-HhccCCcc
Confidence 54332 223456899999999876 4589999999999999999999999975431 111111 1 11111111
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+......+.+++.+|++.+|++|||+.|++++
T Consensus 250 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 --------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111112358899999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=341.73 Aligned_cols=247 Identities=21% Similarity=0.330 Sum_probs=201.7
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.|.+.+.||+|+||.||++++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 121 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence 3456789999999999999987 47889999987542 2345678899999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++++|.+++.. ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 122 ~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 122 LCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp CCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred cCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999998742 45688999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..... ..+.. .
T Consensus 195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~----~~~~~------~ 259 (335)
T 2owb_A 195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYLRI----KKNEY------S 259 (335)
T ss_dssp TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHH----HHTCC------C
T ss_pred cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH----HHHHH----hcCCC------C
Confidence 22 2234568999999999999889999999999999999999999997544211 11111 11111 0
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+.... ...+.+++.+|++.||++||++.|++++
T Consensus 260 ~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 260 IPKHI----NPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112 2357889999999999999999999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=343.92 Aligned_cols=263 Identities=21% Similarity=0.291 Sum_probs=192.7
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc-hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~-~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||+||+|+.. +++.||||+++..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 345688999999999999987 6889999998754322 22345679999999999999999999999999999999997
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 84 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~ 155 (324)
T 3mtl_A 84 -KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 155 (324)
T ss_dssp -EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred -cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-c
Confidence 5888887532 34588899999999999999999998 99999999999999999999999999997543322 2
Q ss_pred eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC---
Q 002382 761 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP--- 836 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~--- 836 (929)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.+..... ...........
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTP-TEETWPGILSNEEF 234 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTTTSTTGGGCHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-ChHhchhhhcchhh
Confidence 2233468999999999876 568999999999999999999999997654222211221111100 00011111000
Q ss_pred ------ccc----CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 ------SLL----DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ------~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... ..........+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 00011122467899999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=342.19 Aligned_cols=262 Identities=14% Similarity=0.194 Sum_probs=203.5
Q ss_pred HHHHhccccccCcEEEEEEEECC---------CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeE-----------
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKD---------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ----------- 661 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~---------~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~----------- 661 (929)
.|.+.+.||+|+||.||+|+... ++.||||++... ..+.+|++++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 35567899999999999999874 788999998744 46889999999999999988
Q ss_pred ----Eeeeeee-cCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeE
Q 002382 662 ----FLGYCQE-EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 736 (929)
Q Consensus 662 ----l~g~~~~-~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NIL 736 (929)
+++++.. .+..++||||+ +++|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl 191 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF 191 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence 5667765 67889999999 99999999643 246789999999999999999999998 9999999999999
Q ss_pred ecCCC--cEEEEeecCcccccCCCCc------eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccc
Q 002382 737 LDKHM--RAKVSDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 808 (929)
Q Consensus 737 l~~~~--~vkL~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~ 808 (929)
++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 8999999999755432211 113346999999999999989999999999999999999999999765
Q ss_pred cccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 809 KFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 809 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
... ...+......... ......+...... .....+.+++.+|++.+|++||++.||++.|++++..
T Consensus 272 ~~~--~~~~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 272 LPN--TEDIMKQKQKFVD--KPGPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp TTC--HHHHHHHHHHHHH--SCCCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CcC--HHHHHHHHHhccC--ChhhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 311 1122222221111 1111111111100 1124688999999999999999999999999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=341.89 Aligned_cols=266 Identities=21% Similarity=0.231 Sum_probs=196.9
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc-----hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~-----~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
..|.+.+.||+|+||.||+|++. +++.||||++...... ..+.+.+|++++++++||||+++++++...+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 35667789999999999999986 5899999998753221 13468899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
||||+++ +|.+++.. ....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 90 v~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999986 88887753 234678889999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcC-----
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG----- 828 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~----- 828 (929)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|..||......+....+...........
T Consensus 163 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 163 GSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred cCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 4332 223345689999999998764 578899999999999999999999976542221112211110000000
Q ss_pred CcccccCCcccCccC-----HHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 829 DIQGIIDPSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 829 ~~~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...+.+........+ ......+.+++.+|++.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000000000011 1122568899999999999999999999886
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=352.20 Aligned_cols=241 Identities=13% Similarity=0.123 Sum_probs=186.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC---CcchhHHHHHHH---HHhcccCCCceeEEe-------eeeee
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEV---TLLSRIHHRNLVQFL-------GYCQE 668 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~---~~~~~~~f~~Ev---~iL~~l~HpNIv~l~-------g~~~~ 668 (929)
+.+.+.||+|+||+||+|++. +++.||||++... .....+.+.+|+ +++++++||||++++ +++..
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 345688999999999999975 6899999999743 233457788999 555566899999998 55554
Q ss_pred cC-----------------eEEEEEEeccCCchhhhhcccc---ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecC
Q 002382 669 EG-----------------RSVLVYEFMHNGTLKEHLYGTL---THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHR 728 (929)
Q Consensus 669 ~~-----------------~~~LV~E~~~~gsL~~~L~~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHr 728 (929)
.+ ..++||||+ +|+|.+++.... .....+++..++.++.||+.||+|||++ +|+||
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHr 230 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT 230 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 43 278999999 689999986421 1123455688889999999999999998 99999
Q ss_pred CCCCCCeEecCCCcEEEEeecCcccccCCCCceeeeeecCccccCccccccC-----------cCCCcCceeeHHHHHHH
Q 002382 729 DLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-----------QLTDKSDVYSFGVILLE 797 (929)
Q Consensus 729 DIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~~sDVwSlGvvl~e 797 (929)
||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||++||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 999999999999999999999998532 23334557 999999999887 89999999999999999
Q ss_pred HHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 798 LISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 798 lltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
|++|+.||...........+ ... .... ...+.+++.+|++.||++||++.|++++
T Consensus 306 lltg~~Pf~~~~~~~~~~~~----------------~~~--~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 306 IWCADLPITKDAALGGSEWI----------------FRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHSSCCC------CCSGGG----------------GSS--CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHCCCCCcccccccchhhh----------------hhh--ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999754422111111 000 0112 2468899999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=329.96 Aligned_cols=248 Identities=24% Similarity=0.397 Sum_probs=195.2
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCchh
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 685 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL~ 685 (929)
..||+|+||.||+|++. +++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 48999999999999975 67899999998766555678999999999999999999999999999999999999999999
Q ss_pred hhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC-CCcEEEEeecCcccccCCCCceeee
Q 002382 686 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSI 764 (929)
Q Consensus 686 ~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~ 764 (929)
+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+++...... .....
T Consensus 108 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 182 (295)
T 2clq_A 108 ALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTET 182 (295)
T ss_dssp HHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Ccccc
Confidence 9986432 223456888889999999999999998 9999999999999987 8999999999997654322 12234
Q ss_pred eecCccccCccccccCc--CCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCcc
Q 002382 765 VRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 842 (929)
Q Consensus 765 ~~gt~~Y~aPE~~~~~~--~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 842 (929)
..||+.|+|||++.+.. ++.++||||||+++|||++|+.||....... ..+.. ..... ..+.+...
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~---~~~~~------~~~~~~~~- 250 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--AAMFK---VGMFK------VHPEIPES- 250 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--HHHHH---HHHHC------CCCCCCTT-
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--HHHHh---hcccc------cccccccc-
Confidence 46899999999997643 7889999999999999999999997543111 01111 10000 01111112
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 843 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 843 ~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....+.+++.+|++.+|++||++.|++++
T Consensus 251 ---~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 251 ---MSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ---SCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ---CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22467899999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.56 Aligned_cols=244 Identities=24% Similarity=0.353 Sum_probs=200.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 95 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence 456789999999999999987 57789999986532 22246788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++.. ...+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 96 APRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 999999998853 34688999999999999999999998 99999999999999999999999999987543321
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ... . ..... ..+
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~---~-~~~~~------~~~ 231 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE----THR---R-IVNVD------LKF 231 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH---H-HHTTC------CCC
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH----HHH---H-Hhccc------cCC
Confidence 233568999999999999999999999999999999999999997544111 111 1 11111 011
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... ....+.+++.+|++.+|++||++.|++++
T Consensus 232 ~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 232 PPF----LSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CCc----CCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 111 22457899999999999999999999876
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=350.61 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=189.7
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--------chhHHHHHHHHHhcccCCCceeEEeeeeeecCe
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 671 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--------~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~ 671 (929)
..|.+.+.||+|+||+||+|... +++.||||++..... .....+.+|+++|++++||||+++++++.. +.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 34567789999999999999886 578999999875421 122358899999999999999999999854 55
Q ss_pred EEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC---cEEEEee
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDF 748 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkL~DF 748 (929)
.++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+||
T Consensus 214 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp EEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred eEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeec
Confidence 799999999999998884 345689999999999999999999998 999999999999997544 5999999
Q ss_pred cCcccccCCCCceeeeeecCccccCcccccc---CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh
Q 002382 749 GLSKFAVDGASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 749 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
|+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+....
T Consensus 287 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~~~~~i---- 357 (419)
T 3i6u_A 287 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQI---- 357 (419)
T ss_dssp STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC---CHHHHH----
T ss_pred ccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH---HHHHHH----
Confidence 999865432 22344569999999999863 567889999999999999999999997543221 121211
Q ss_pred hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 826 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+.... .+... ......+.+++.+|++.+|++||++.|+++|
T Consensus 358 ~~~~~~~--~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 TSGKYNF--IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HTTCCCC--CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCCC--Cchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111100 00000 1123468899999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=332.52 Aligned_cols=247 Identities=25% Similarity=0.411 Sum_probs=203.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 445688999999999999876 68899999997553 3345778999999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+++|.+++. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....... .
T Consensus 104 ~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 174 (303)
T 3a7i_A 104 GGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 174 (303)
T ss_dssp TEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred CCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence 999999884 24688999999999999999999998 99999999999999999999999999997654332 1
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... ..+.. +.+..
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~----~~~~~-----~~~~~ 241 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM----KVLFLI----PKNNP-----PTLEG 241 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHH----HHSCC-----CCCCS
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH----HHHHHh----hcCCC-----CCCcc
Confidence 223456899999999999999999999999999999999999999754311 111111 11111 11122
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
.++ ..+.+++.+|++.+|++|||+.|++++.
T Consensus 242 ~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 242 NYS----KPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp SCC----HHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ccC----HHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 222 3588999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=341.83 Aligned_cols=263 Identities=25% Similarity=0.396 Sum_probs=204.4
Q ss_pred HHHHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeE
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 672 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~ 672 (929)
...|.+.+.||+|+||.||+|++. +++.||||++.... .....++.+|+.++++++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 344567789999999999999842 46789999997543 34456789999999999999999999999999999
Q ss_pred EEEEEeccCCchhhhhccccc---cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC---CCcEEEE
Q 002382 673 VLVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVS 746 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~ 746 (929)
++||||+++++|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999965321 224588999999999999999999998 9999999999999984 4469999
Q ss_pred eecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHh
Q 002382 747 DFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH 824 (929)
Q Consensus 747 DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 824 (929)
|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+...+..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~~~~- 260 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----QEVLEFVTS- 260 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHHHHHHT-
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH----HHHHHHHhc-
Confidence 9999975433222 12233457899999999998899999999999999999998 9999975441 122222211
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
+... ..+......+.+++.+|++.+|++||++.|++++|+.+....
T Consensus 261 ---~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 261 ---GGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp ---TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ---CCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 1110 011122346889999999999999999999999999876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=355.02 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=197.4
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
..|.+.+.||+|+||+||+|+.+ +++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45667899999999999999987 68899999997653 3335678999999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC---CcEEEEeecCcccc
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKFA 754 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkL~DFGla~~~ 754 (929)
|+++|+|.+.+.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.. +.+||+|||+++..
T Consensus 117 ~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 117 CYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999988843 45688999999999999999999998 99999999999999764 55999999999865
Q ss_pred cCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||...... .+...+. .+... .
T Consensus 190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~----~~~~~--~ 256 (494)
T 3lij_A 190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ----EILRKVE----KGKYT--F 256 (494)
T ss_dssp BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH----HTCCC--C
T ss_pred CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH----hCCCC--C
Confidence 4332 233456999999999876 56899999999999999999999999765421 2222111 11110 0
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+...... ....+.+++.+|++.+|++|||+.|++++
T Consensus 257 ~~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 DSPEWKN----VSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CSGGGTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred Cchhccc----CCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0000111 22357899999999999999999999976
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=350.92 Aligned_cols=259 Identities=23% Similarity=0.264 Sum_probs=193.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeec------CeEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSVLV 675 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~------~~~~LV 675 (929)
|.+.+.||+|+||+||+|++. +++.||||++.... +...+|+++|++++||||+++++++... ...++|
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 445688999999999999986 58999999986542 2334799999999999999999988542 236799
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC-CcEEEEeecCcccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFA 754 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~~ 754 (929)
|||+++ +|.+.+.........+++..+..++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||+++..
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999975 66666544333456789999999999999999999998 99999999999999965 57899999999865
Q ss_pred cCCCCceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh--------
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI-------- 825 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~-------- 825 (929)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+.+.++...
T Consensus 208 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 208 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHHHH
T ss_pred ccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHH
Confidence 44322 2234689999999999764 78999999999999999999999997654221 2222221100
Q ss_pred -hcCCcccccCCcccC-----ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 826 -ESGDIQGIIDPSLLD-----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 826 -~~~~~~~~~d~~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
......+..-+.+.. .+.......+.+|+.+|++.||++||++.|+++|
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000111111111110 0111223568899999999999999999999976
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=356.19 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=203.4
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
...|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 456777899999999999999987 68999999997543 23456789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe---cCCCcEEEEeecCcc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSK 752 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~ 752 (929)
|||+.+|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999998853 45689999999999999999999998 99999999999999 567899999999998
Q ss_pred cccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .+...+. .+....
T Consensus 178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~----~~~~~~ 246 (484)
T 3nyv_A 178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY----DILKKVE----KGKYTF 246 (484)
T ss_dssp HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH----HCCCCC
T ss_pred Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHH----cCCCCC
Confidence 6544322 233459999999999876 6899999999999999999999999765421 2222211 111110
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.. .........+.+++.+|++.+|++|||+.|+++|
T Consensus 247 --~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 247 --EL----PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --CS----GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CC----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00 0001123467899999999999999999999876
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=354.48 Aligned_cols=251 Identities=27% Similarity=0.364 Sum_probs=200.6
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
...|.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 356777899999999999999987 68999999986432 234567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec---CCCcEEEEeecCccc
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKF 753 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~---~~~~vkL~DFGla~~ 753 (929)
||+.+|+|.+.+.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999988843 45688999999999999999999998 999999999999995 456799999999986
Q ss_pred ccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .+...+. .+....
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~----~~~~~~- 241 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----DILKRVE----TGKYAF- 241 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH----HTCCCS-
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH----hCCCCC-
Confidence 54332 2234569999999999875 5899999999999999999999999765421 1222111 111110
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+.... ......+.+++.+|++.+|++|||+.|++++
T Consensus 242 -~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 -DLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -CSGGG----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -CCccc----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 1122457899999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=343.55 Aligned_cols=264 Identities=22% Similarity=0.287 Sum_probs=199.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
.|.+.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 113 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence 3445678999999999999987 68899999997653 334567899999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++++|.+++.. ...+++..+..++.|++.||+|||+++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 ~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 114 DGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 99999999853 346889999999999999999999841 7999999999999999999999999999754322
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh---------------
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH--------------- 824 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~--------------- 824 (929)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.......
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 1233468999999999999999999999999999999999999997543211100000000000
Q ss_pred -------hhcCCcccccC----CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 825 -------IESGDIQGIID----PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 825 -------~~~~~~~~~~d----~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.......+.++ ..............+.+++.+|++.||++|||+.|+++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000000 000000001122368899999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=346.59 Aligned_cols=262 Identities=21% Similarity=0.260 Sum_probs=194.0
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCe------EEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------SVLVY 676 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~------~~LV~ 676 (929)
|.+.+.||+|+||+||+|++..+..||+|++..... ...+|+++++.++||||+++++++...+. .++||
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 556789999999999999998778899998865432 22369999999999999999999965443 78999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec-CCCcEEEEeecCccccc
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~~~ 755 (929)
||++++.+ +.+.........+++..+..++.|+++||+|||++ +|+||||||+|||++ .++.+||+|||+++...
T Consensus 118 e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 118 EYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp ECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 99987544 33332223356788999999999999999999998 999999999999999 78999999999998654
Q ss_pred CCCCceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHH-----------H
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-----------L 823 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~-----------~ 823 (929)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+..... .
T Consensus 194 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 194 AGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp TTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred CCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 4332 2234589999999998764 589999999999999999999999976542222222221100 0
Q ss_pred hhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 824 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 824 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..................+.......+.+++.+|++.||++|||+.|+++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000011111111111111112233478899999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=338.71 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=199.1
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc--------hhHHHHHHHHHhccc-CCCceeEEeeeeeecCe
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 671 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~--------~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~ 671 (929)
.|.+.+.||+|+||.||+|++. +|+.||||+++..... ..+.+.+|+.+++++ +||||+++++++...+.
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 3445689999999999999986 6899999999755321 134678899999999 79999999999999999
Q ss_pred EEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCc
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 751 (929)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 175 ~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp EEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 9999999999999999853 45688999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecCccccCcccccc------CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh
Q 002382 752 KFAVDGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .+...+.
T Consensus 248 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----~~~~~i~--- 318 (365)
T 2y7j_A 248 CHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI----LMLRMIM--- 318 (365)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH---
T ss_pred cccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHH---
Confidence 8654332 2234569999999999863 35788999999999999999999999754311 1111111
Q ss_pred hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 826 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+.... ....... ....+.+++.+|++.+|++||++.|++++
T Consensus 319 -~~~~~~--~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 319 -EGQYQF--SSPEWDD----RSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -HTCCCC--CHHHHSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -hCCCCC--CCccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111100 0000011 12358899999999999999999999875
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=327.69 Aligned_cols=245 Identities=24% Similarity=0.416 Sum_probs=192.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence 456789999999999999987 68999999987542 22345788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 93 VSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred cCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999999853 34688999999999999999999998 99999999999999999999999999997654322
Q ss_pred CceeeeeecCccccCccccccCcC-CCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... .+.+.+. .+.. .
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~----~~~~------~ 229 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP----TLFKKIR----GGVF------Y 229 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH----HCCC------C
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----HHHHHhh----cCcc------c
Confidence 2233458999999999987765 57999999999999999999999754421 1222111 1110 0
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+... ....+.+++.+|++.+|++|||+.|++++
T Consensus 230 ~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 IPEY----LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cchh----cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111 12357899999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=339.30 Aligned_cols=265 Identities=19% Similarity=0.268 Sum_probs=197.4
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeee--------cC
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQE--------EG 670 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~--------~~ 670 (929)
.|.+.+.||+|+||+||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++.. .+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 4556789999999999999985 689999999865432 224578899999999999999999999977 45
Q ss_pred eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecC
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 750 (929)
..++||||+++ +|.+.+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 68999999975 776666432 34588999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCC---CceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhh
Q 002382 751 SKFAVDGA---SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 826 (929)
Q Consensus 751 a~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 826 (929)
++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.+.... ..
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~ 249 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-IT 249 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CC
Confidence 98654221 122234568999999999876 45799999999999999999999999865422211122111110 00
Q ss_pred cCCcccc--------cCCcccCccCH-HH------HHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 827 SGDIQGI--------IDPSLLDEYDI-QS------MWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 827 ~~~~~~~--------~d~~l~~~~~~-~~------~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....... +.......... +. ...+.+++.+|++.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000 00000000011 11 2357899999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=332.61 Aligned_cols=256 Identities=26% Similarity=0.376 Sum_probs=194.4
Q ss_pred HHHHhccccccCcEEEEEEEEC--CCc--EEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK--DGK--EIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~--~~~--~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
.|.+.+.||+|+||+||+|++. +++ .||||+++... ....+.+.+|++++++++||||+++++++.... .++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 3456789999999999999864 233 68999987542 234567899999999999999999999998765 789
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
|+||+++++|.+++... ...+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 98 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999998532 35688999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCc--eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 755 VDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 755 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
...... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+..... ......
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~~---~~~~~~ 244 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKID---KEGERL 244 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHH---TSCCCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH----HHHHHHH---ccCCCC
Confidence 443322 1233457889999999998889999999999999999999 99999765421 2222111 111100
Q ss_pred cccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 832 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 832 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.........+.+++.+|++.+|++||++.|++++|+++..
T Consensus 245 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 245 ---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ---------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 0111223468899999999999999999999999998654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=353.36 Aligned_cols=192 Identities=24% Similarity=0.362 Sum_probs=150.9
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeee-----cCeEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-----EGRSV 673 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~-----~~~~~ 673 (929)
.|.+.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|+++|++++||||+++++++.. ....+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 3556789999999999999876 68899999986542 3345678899999999999999999999844 35789
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+ +++|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 134 lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 999998 578888874 345689999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCC--------------------------ceeeeeecCccccCcccc-ccCcCCCcCceeeHHHHHHHHHhC
Q 002382 754 AVDGAS--------------------------HVSSIVRGTVGYLDPEYY-ISQQLTDKSDVYSFGVILLELISG 801 (929)
Q Consensus 754 ~~~~~~--------------------------~~~~~~~gt~~Y~aPE~~-~~~~~s~~sDVwSlGvvl~elltG 801 (929)
...... .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 542211 112345689999999986 456799999999999999999993
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.41 Aligned_cols=261 Identities=24% Similarity=0.388 Sum_probs=183.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||||++
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 96 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96 (303)
T ss_dssp CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence 456789999999999999865 68899999986543 2335678899999999999999999999999999999999999
Q ss_pred CCchhhhhcccc----ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 681 NGTLKEHLYGTL----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 681 ~gsL~~~L~~~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
+++|.+++.... .....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence 999999985321 1234588999999999999999999998 999999999999999999999999999875543
Q ss_pred CCC----ceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 757 GAS----HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 757 ~~~----~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...............
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK----VLMLTLQNDPPSLET 249 (303)
T ss_dssp --------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HHHHHHTSSCCCTTC
T ss_pred CCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh----HHHHHhccCCCcccc
Confidence 211 11233468999999999876 568999999999999999999999997644211 111111100000001
Q ss_pred cccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 832 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 832 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...++.....++ ..+.+++.+|++.||++||++.|++++
T Consensus 250 ~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 250 GVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 111111222222 357899999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=330.97 Aligned_cols=251 Identities=21% Similarity=0.336 Sum_probs=198.2
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
...|.+.+.||+|+||.||+|.+. +++.||||++.... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 344556789999999999999987 58999999997543 346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++++|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 106 ~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 106 CGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999998852 245688999999999999999999998 99999999999999999999999999997654332
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .... .. ..........
T Consensus 180 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~---~~-~~~~~~~~~~--- 247 (314)
T 3com_A 180 A-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM----RAIF---MI-PTNPPPTFRK--- 247 (314)
T ss_dssp S-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHH---HH-HHSCCCCCSS---
T ss_pred c-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH----HHHH---HH-hcCCCcccCC---
Confidence 2 223446899999999999989999999999999999999999999754311 1111 11 1111100000
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+......+.+++.+|++.+|++||++.|++++
T Consensus 248 ----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 248 ----PELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11122468899999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=347.92 Aligned_cols=197 Identities=24% Similarity=0.353 Sum_probs=163.7
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeec-----CeEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSV 673 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~-----~~~~ 673 (929)
.|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+++|++++||||+++++++... ...+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 3556789999999999999987 57889999997542 23456788999999999999999999999766 5789
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+. ++|.+++.. ...+++..+..++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 9999986 599988843 45689999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCc---------------------eeeeeecCccccCcccc-ccCcCCCcCceeeHHHHHHHHHhCCCCCc
Q 002382 754 AVDGASH---------------------VSSIVRGTVGYLDPEYY-ISQQLTDKSDVYSFGVILLELISGQEAIS 806 (929)
Q Consensus 754 ~~~~~~~---------------------~~~~~~gt~~Y~aPE~~-~~~~~s~~sDVwSlGvvl~elltG~~p~~ 806 (929)
....... ......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 5432211 12445689999999986 45679999999999999999998666553
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=340.30 Aligned_cols=258 Identities=21% Similarity=0.285 Sum_probs=191.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecC------eEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV 673 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~------~~~ 673 (929)
|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 456688999999999999986 68999999986532 233467889999999999999999999997653 459
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+ +++|.+++.. ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 999999 8899998843 4588899999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh-------h
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------I 825 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~-------~ 825 (929)
.... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+....... .
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 5332 233468999999999987 679999999999999999999999997654211111111100000 0
Q ss_pred hcC-------CcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 826 ESG-------DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 826 ~~~-------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... .+...-...+. .........+.+++.+|++.||++|||+.|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000 00000000000 1111223468899999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=333.59 Aligned_cols=252 Identities=24% Similarity=0.312 Sum_probs=185.7
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc-h-hHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-G-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~-~-~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
+.+.+.||+|+||+||+|+.. +++.||||+++..... . .+.+.++...++.++||||+++++++.+.+..++||||+
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM 88 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECC
T ss_pred hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehh
Confidence 446789999999999999985 6889999999755322 2 233455556688889999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
+ |+|.+++.........+++..++.++.|++.||+|||++ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 164 (290)
T 3fme_A 89 D-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV- 164 (290)
T ss_dssp S-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred c-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccc-
Confidence 7 588888765444566799999999999999999999985 289999999999999999999999999997654332
Q ss_pred ceeeeeecCccccCcccc----ccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 760 HVSSIVRGTVGYLDPEYY----ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~----~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
......||+.|+|||.+ .+..++.++|||||||++|||++|+.||..... ....+... ...... .
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~----~~~~~~-~--- 233 (290)
T 3fme_A 165 -AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQLKQV----VEEPSP-Q--- 233 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHHHHH----HHSCCC-C---
T ss_pred -cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHHHHH----hccCCC-C---
Confidence 22234589999999996 456788899999999999999999999975321 11111111 111110 0
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.. .......+.+++.+|++.+|++|||+.|++++
T Consensus 234 --~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 234 --LP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp --CC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --cc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 00 11122458899999999999999999999885
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.74 Aligned_cols=250 Identities=21% Similarity=0.356 Sum_probs=195.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
|.+.+.||+|+||.||+|++. +++.||+|++........+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence 456788999999999999987 5889999999766656667899999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
++|.+++... ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...... ...
T Consensus 101 ~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 173 (302)
T 2j7t_A 101 GAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQK 173 (302)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC
T ss_pred CcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccc
Confidence 9999988532 35588999999999999999999998 9999999999999999999999999987532211 111
Q ss_pred eeeeecCccccCccccc-----cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 762 SSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+... .. ........
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~-~~~~~~~~- 244 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKI----AK-SDPPTLLT- 244 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH----HH-SCCCCCSS-
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHHH----hc-cCCcccCC-
Confidence 22345899999999984 5678899999999999999999999997544111 11111 11 11111100
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+......+.+++.+|++.+|++|||+.|++++
T Consensus 245 ------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 245 ------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ------ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11122468899999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.60 Aligned_cols=256 Identities=19% Similarity=0.299 Sum_probs=196.3
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccC-CCceeEEeeeeee--cCeEEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQE--EGRSVLVYE 677 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~--~~~~~LV~E 677 (929)
.|.+.+.||+|+||+||+|+.. +++.||||+++.. ..+.+.+|++++++++ ||||+++++++.. ....++|||
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred ceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 3556789999999999999875 6889999998743 3467899999999997 9999999999987 667899999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC-cEEEEeecCcccccC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD 756 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~ 756 (929)
|+.+++|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++....
T Consensus 114 ~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 114 HVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999988873 377888999999999999999998 999999999999999777 899999999986544
Q ss_pred CCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh--------hhc
Q 002382 757 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH--------IES 827 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~--------~~~ 827 (929)
... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+....... ...
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHHHHHHHhcCCchhhhHHHH
Confidence 322 233468999999999987 67899999999999999999999999543211 11111111100 000
Q ss_pred CC--c------------ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 828 GD--I------------QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 828 ~~--~------------~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.. . ...................+.+++.+|++.||++|||++|+++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0 00000000111111133568899999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=367.24 Aligned_cols=246 Identities=24% Similarity=0.308 Sum_probs=200.6
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
+.+.+.||+|+||+||+|+++ +++.||||+++... ......+..|..++..+ +||||+++++++.+.+..++|||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E 422 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence 445689999999999999987 57889999997542 22345677899999887 79999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.....
T Consensus 423 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 423 YVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred CcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 9999999999853 35689999999999999999999998 9999999999999999999999999999853322
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +.+. ... +.+
T Consensus 496 ~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~----~~~~---i~~-~~~------- 559 (674)
T 3pfq_A 496 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQS---IME-HNV------- 559 (674)
T ss_dssp T-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH---HHS-SCC-------
T ss_pred C-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH----HHHH---HHh-CCC-------
Confidence 2 23345679999999999999999999999999999999999999997654221 2221 111 111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcH-----HHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~eVl~~ 874 (929)
.++......+.+++.+|++.||++||++ +||++|
T Consensus 560 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 560 ---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ---CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1111223468899999999999999997 777765
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=348.72 Aligned_cols=260 Identities=20% Similarity=0.333 Sum_probs=204.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCC-CceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~H-pNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.++||+|+||.||+|++. +++.||||++..... ..++..|+++++.++| +++..+..++...+..++||||+
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~- 85 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence 456789999999999999975 689999999875433 3468899999999976 56666777778888999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe---cCCCcEEEEeecCcccccCC
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl---~~~~~vkL~DFGla~~~~~~ 757 (929)
+++|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++.....
T Consensus 86 g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 86 GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999998532 35689999999999999999999998 99999999999999 68899999999999866543
Q ss_pred CCc------eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 758 ASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 758 ~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~ 238 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-TSIE 238 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-SCHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-ccHH
Confidence 321 122456999999999999999999999999999999999999999865422222222221111111 1110
Q ss_pred cccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 832 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 832 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
. +...+ ..++.+++..|++.+|++||++.+|++.|++++..
T Consensus 239 ~-----l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 239 A-----LCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp H-----HHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred H-----HhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 0 00111 24688999999999999999999999999998764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=327.73 Aligned_cols=249 Identities=26% Similarity=0.294 Sum_probs=198.7
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---------chhHHHHHHHHHhcccC-CCceeEEeeeeeecCe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---------QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR 671 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---------~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~ 671 (929)
|.+.+.||+|+||.||+|+++ +++.||||++..... ...+.+.+|+++++++. ||||+++++++...+.
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence 445789999999999999987 588999999975431 12356789999999995 9999999999999999
Q ss_pred EEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCc
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 751 (929)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 99 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 99 FFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccch
Confidence 9999999999999999853 35688999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecCccccCccccc------cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh
Q 002382 752 KFAVDGASHVSSIVRGTVGYLDPEYYI------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
........ .....|++.|+|||++. ...++.++||||||+++|||++|+.||...... .+.....
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~--- 242 (298)
T 1phk_A 172 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM----LMLRMIM--- 242 (298)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH---
T ss_pred hhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH----HHHHHHh---
Confidence 86543322 23346899999999985 456788999999999999999999999754411 1111111
Q ss_pred hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 826 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+.... .. .........+.+++.+|++.+|++||++.|++++
T Consensus 243 -~~~~~~--~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 243 -SGNYQF--GS----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp -HTCCCC--CT----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -cCCccc--Cc----ccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 111100 00 0001223468899999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=333.02 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=195.3
Q ss_pred HHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--------chhHHHHHHHHHhcccCCCceeEEeeeeeecC
Q 002382 600 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG 670 (929)
Q Consensus 600 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--------~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~ 670 (929)
...|.+.+.||+|+||.||+|++. +++.||||++..... .....+.+|++++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 345677899999999999999886 578999999865321 12345889999999999999999999987655
Q ss_pred eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc---EEEEe
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSD 747 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkL~D 747 (929)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 8999999999999998843 45688999999999999999999998 9999999999999987664 99999
Q ss_pred ecCcccccCCCCceeeeeecCccccCccccc---cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh
Q 002382 748 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 824 (929)
Q Consensus 748 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~ 824 (929)
||+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+...+.
T Consensus 161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~-- 233 (322)
T 2ycf_A 161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKDQIT-- 233 (322)
T ss_dssp CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS---CHHHHHH--
T ss_pred Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH---HHHHHHH--
Confidence 9999865332 2223346899999999974 4678899999999999999999999997544221 1222111
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+... ..+.... .....+.+++.+|++.||++||++.|++++
T Consensus 234 --~~~~~--~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 --SGKYN--FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp --HTCCC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --hCccc--cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 11110 0000011 123468899999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=343.51 Aligned_cols=252 Identities=11% Similarity=0.027 Sum_probs=177.7
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhccc--CCCceeEEe-------eeeeec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI--HHRNLVQFL-------GYCQEE 669 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l--~HpNIv~l~-------g~~~~~ 669 (929)
+.+.+.||+|+||+||+|++. +++.||||++..... ...+.+.+|+.+++.+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 345689999999999999976 688999999987543 2345677785544444 699988855 344332
Q ss_pred -----------------CeEEEEEEeccCCchhhhhccccccccccchHHH------HHHHHHHHHHHHHHHhCCCCcee
Q 002382 670 -----------------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR------LEIAEDAAKGIEYLHTGCVPAII 726 (929)
Q Consensus 670 -----------------~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~------~~i~~qia~gL~yLH~~~~~~iv 726 (929)
...++||||++ |+|.+++... ...+.+..+ ..++.||++||+|||++ +|+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 33799999998 8999999643 223444555 67889999999999998 999
Q ss_pred cCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeeeeecCccccCcccccc--CcCCCcCceeeHHHHHHHHHhCCCC
Q 002382 727 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEA 804 (929)
Q Consensus 727 HrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvl~elltG~~p 804 (929)
||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999985432 1213457799999999987 7799999999999999999999999
Q ss_pred CccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 805 ISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 805 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
|....... ... | ........................+.+++.+|++.||++|||+.|++++
T Consensus 293 f~~~~~~~-~~~---~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 293 FGLVTPGI-KGS---W-----KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TTBCCTTC-TTC---C-----CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCcCccc-ccc---h-----hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 97654110 000 0 0000000001111111111223468899999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=353.43 Aligned_cols=249 Identities=28% Similarity=0.408 Sum_probs=197.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-------------chhHHHHHHHHHhcccCCCceeEEeeeee
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-------------QGKREFTNEVTLLSRIHHRNLVQFLGYCQ 667 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-------------~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~ 667 (929)
.|.+.++||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 116 (504)
T 3q5i_A 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116 (504)
T ss_dssp TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4556789999999999999987 578999999975431 22467889999999999999999999999
Q ss_pred ecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC---cEE
Q 002382 668 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAK 744 (929)
Q Consensus 668 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vk 744 (929)
+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+|
T Consensus 117 ~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 117 DKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEE
T ss_pred cCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999998843 45689999999999999999999998 999999999999998776 699
Q ss_pred EEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh
Q 002382 745 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 824 (929)
Q Consensus 745 L~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~ 824 (929)
|+|||+++...... ......||+.|+|||++. +.++.++||||+||++|+|++|..||...... .+...+
T Consensus 190 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i--- 259 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ----DIIKKV--- 259 (504)
T ss_dssp ECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH---
T ss_pred EEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH---
Confidence 99999998654332 223456999999999986 46899999999999999999999999765421 222211
Q ss_pred hhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 825 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 825 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+.... +...... ....+.+++.+|++.+|++|||+.|++++
T Consensus 260 -~~~~~~~--~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 260 -EKGKYYF--DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp -HHCCCCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HcCCCCC--CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111100 0000011 12468899999999999999999999876
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=342.42 Aligned_cols=262 Identities=19% Similarity=0.226 Sum_probs=191.2
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcc-----------hhHHHHHHHHHhcccCCCceeEEeeeeee---
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-----------GKREFTNEVTLLSRIHHRNLVQFLGYCQE--- 668 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~-----------~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~--- 668 (929)
|.+.+.||+|+||.||+|...+++.||||++...... ..+.+.+|++++++++||||+++++++..
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 103 (362)
T 3pg1_A 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE 103 (362)
T ss_dssp CEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCT
T ss_pred eEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccC
Confidence 3456899999999999999988999999998643221 12678999999999999999999999844
Q ss_pred --cCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEE
Q 002382 669 --EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (929)
Q Consensus 669 --~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 746 (929)
....++||||+. |+|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 104 ~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 104 PAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp TTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEE
Confidence 346899999997 688887753 244689999999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh
Q 002382 747 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 747 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+........
T Consensus 177 Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 177 DFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp CTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999744322 22234568999999999876 6789999999999999999999999976542222222222111000
Q ss_pred ---------------hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 826 ---------------ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 826 ---------------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....... ................+.+++.+|++.||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSN-VPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCC-CCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hHHhhhccchhhhHHHHhhccc-CChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0000000 00000001111223468899999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=337.63 Aligned_cols=260 Identities=22% Similarity=0.295 Sum_probs=189.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecC------eEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV 673 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~------~~~ 673 (929)
|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence 456789999999999999876 68899999997542 233467889999999999999999999997654 789
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+++ +|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 107 IVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred EEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 99999974 7777763 3478888999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHH--------------
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ-------------- 819 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~-------------- 819 (929)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.+
T Consensus 177 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 177 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 5332 122345689999999999999999999999999999999999999976442111111110
Q ss_pred -HHHHhhhcCC------cccccCCcccC---ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 820 -WAKLHIESGD------IQGIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 820 -~~~~~~~~~~------~~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.......... +...+...... .........+.+++.+|++.||++|||++|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000000000 00000000000 0112234578999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=335.74 Aligned_cols=263 Identities=21% Similarity=0.278 Sum_probs=198.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeec-----CeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~-----~~~~L 674 (929)
.|.+.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 3556789999999999999876 678899999975432 3346788999999999999999999998654 46899
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
||||+. |+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~-~~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 108 VQDLME-TDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEECCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEcccC-cCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 999997 58888874 34588999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCce--eeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 755 VDGASHV--SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 755 ~~~~~~~--~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.........+ .+.
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~ 257 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE-DLN 257 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH-HHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH-HHH
Confidence 4322211 234569999999998764 458999999999999999999999997655333222222211000000 000
Q ss_pred c------------ccCCcc--cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 832 G------------IIDPSL--LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 832 ~------------~~d~~l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. ...+.. ...........+.+++.+|++.||++|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000 000001122468899999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=343.98 Aligned_cols=272 Identities=21% Similarity=0.280 Sum_probs=202.8
Q ss_pred cCHHHHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccC--------CCceeEEe
Q 002382 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH--------HRNLVQFL 663 (929)
Q Consensus 593 ~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~--------HpNIv~l~ 663 (929)
+..+++....|.+.+.||+|+||+||+|+.. +++.||||+++.. ....+.+.+|++++++++ |+||++++
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 3344444456677889999999999999876 5789999999743 233567889999999985 78899999
Q ss_pred eeee----ecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC
Q 002382 664 GYCQ----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 739 (929)
Q Consensus 664 g~~~----~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 739 (929)
+++. .....++||||+ +++|.+.+... ....+++..++.++.||+.||+|||+++ +|+||||||+|||++.
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~ 182 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSV 182 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECC
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEec
Confidence 9987 556789999999 55666655432 2356889999999999999999999953 8999999999999997
Q ss_pred CC-------------------------------------------------cEEEEeecCcccccCCCCceeeeeecCcc
Q 002382 740 HM-------------------------------------------------RAKVSDFGLSKFAVDGASHVSSIVRGTVG 770 (929)
Q Consensus 740 ~~-------------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 770 (929)
++ .+||+|||+++..... .....||+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~ 258 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQ 258 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGG
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCc
Confidence 75 7999999999865432 233468999
Q ss_pred ccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhh--HHHHHHhhhc-------------------CC
Q 002382 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI--VQWAKLHIES-------------------GD 829 (929)
Q Consensus 771 Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l--~~~~~~~~~~-------------------~~ 829 (929)
|+|||++.+..++.++|||||||++|||++|+.||......+..... .......... +.
T Consensus 259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 99999999999999999999999999999999999764422211111 1111110000 00
Q ss_pred cccccCCcc---------cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 IQGIIDPSL---------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 ~~~~~d~~l---------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...+.+... ....+.+....+.+++.+|++.||++|||+.|+++|
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000000000 012345666789999999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=347.63 Aligned_cols=197 Identities=25% Similarity=0.339 Sum_probs=168.7
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc------CCCceeEEeeeeeecCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI------HHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l------~HpNIv~l~g~~~~~~~~~L 674 (929)
.|.+.+.||+|+||+||+|+.. +++.||||+++.. ....+++.+|+++++.+ +|+||+++++++...+..++
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 3556789999999999999877 5789999999754 23345677888888777 57799999999999999999
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc--EEEEeecCcc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--AKVSDFGLSK 752 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~--vkL~DFGla~ 752 (929)
||||+. ++|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+++
T Consensus 177 v~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 999996 6898888543 234588999999999999999999998 9999999999999999987 9999999997
Q ss_pred cccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccc
Q 002382 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (929)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~ 809 (929)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 54322 223468999999999999999999999999999999999999997654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=334.25 Aligned_cols=256 Identities=22% Similarity=0.288 Sum_probs=200.8
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcch-----------------hHHHHHHHHHhcccCCCceeEEeee
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-----------------KREFTNEVTLLSRIHHRNLVQFLGY 665 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~-----------------~~~f~~Ev~iL~~l~HpNIv~l~g~ 665 (929)
|.+.+.||+|+||.||+|+. +++.||||++....... .+.+.+|++++++++||||++++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 45678999999999999999 79999999987542211 1789999999999999999999999
Q ss_pred eeecCeEEEEEEeccCCchhhh------hccccccccccchHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCeEec
Q 002382 666 CQEEGRSVLVYEFMHNGTLKEH------LYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLD 738 (929)
Q Consensus 666 ~~~~~~~~LV~E~~~~gsL~~~------L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~ 738 (929)
+.+.+..++||||+++|+|.++ +.. .....+++..++.++.|++.||+|||+ + +|+||||||+||+++
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMD 186 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEEC
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEc
Confidence 9999999999999999999998 432 125678999999999999999999999 7 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCCceeeeeecCccccCccccccC-cCCC-cCceeeHHHHHHHHHhCCCCCccccccccchh
Q 002382 739 KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRN 816 (929)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~-~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~ 816 (929)
.++.+||+|||+++..... ......||+.|+|||.+.+. .++. ++|||||||++|||++|+.||...... ..
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~ 260 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---VE 260 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---HH
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---HH
Confidence 9999999999999865432 33445689999999999877 5666 999999999999999999999765421 12
Q ss_pred hHHHHHHhhhcCCccccc------CCcc---cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 817 IVQWAKLHIESGDIQGII------DPSL---LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 817 l~~~~~~~~~~~~~~~~~------d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+.+.+. .+...... .+.. ...........+.+++.+|++.+|++||++.|++++
T Consensus 261 ~~~~i~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 LFNNIR----TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHT----SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHh----ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 222211 11110000 0000 000002223468899999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=363.92 Aligned_cols=258 Identities=21% Similarity=0.328 Sum_probs=203.4
Q ss_pred HHHHHhccccccCcEEEEEEEECC----CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~~----~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
..+.+.+.||+|+||.||+|++.. +..||||+++... ....+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence 445567899999999999998752 4579999987543 333467899999999999999999999985 4568999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
|||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 469 ~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 469 MELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999998532 34588999999999999999999998 99999999999999999999999999998665
Q ss_pred CCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
...........+|+.|+|||++.+..++.++|||||||++|||++ |..||...... .+...+.. +...
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----~~~~~i~~----~~~~--- 611 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIEN----GERL--- 611 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHH----TCCC---
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHc----CCCC---
Confidence 443333344557889999999998899999999999999999997 99999765421 22222111 1110
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
..+......+.+++.+|++.+|++||++.||++.|+.++..+
T Consensus 612 ------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 612 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 011122346889999999999999999999999999987543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=327.91 Aligned_cols=248 Identities=22% Similarity=0.315 Sum_probs=194.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC----cchhHHHHHHHHHhcccCCCceeEEeeee--eecCeEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRNLVQFLGYC--QEEGRSVLV 675 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~----~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~--~~~~~~~LV 675 (929)
|.+.+.||+|+||.||++... +++.||||+++... ......+.+|++++++++||||+++++++ .+....++|
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 446789999999999999986 68899999997542 23456789999999999999999999998 455688999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
|||++++ |.+++... ....+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 87 ~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 9999876 66666432 245688999999999999999999998 99999999999999999999999999998654
Q ss_pred CCC-CceeeeeecCccccCccccccCc--CCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 756 DGA-SHVSSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 756 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~--~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
... ........||+.|+|||++.+.. .+.++|||||||++|||++|+.||...... .+.+. ...+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~----i~~~~~-- 230 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY----KLFEN----IGKGSY-- 230 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHH----HHHCCC--
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH----HHHHH----HhcCCC--
Confidence 322 22333456899999999987643 367999999999999999999999764421 11111 111111
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+... ....+.+++.+|++.||++||++.|++++
T Consensus 231 ----~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ----AIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----CCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----CCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11112 22467899999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=330.50 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=192.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeee------cCeEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE------EGRSVL 674 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~------~~~~~L 674 (929)
|.+.+.||+|+||.||+|++. +++.||||++.... .....+.+|+.+++++ +||||+++++++.. .+..++
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 446789999999999999985 68899999987543 3356788999999999 89999999999976 467899
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
||||+++|+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 99999999999998643 235688899999999999999999998 9999999999999999999999999998755
Q ss_pred cCCCCceeeeeecCccccCccccc-----cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
.... .......||+.|+|||++. +..++.++|||||||++|||++|+.||...... ..... .....
T Consensus 180 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~----~~~~~ 250 (326)
T 2x7f_A 180 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALFL----IPRNP 250 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH----HHHSC
T ss_pred CcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----HHHHH----hhcCc
Confidence 3321 1223346899999999987 567889999999999999999999999654311 11111 11111
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..... ...+ ...+.+++.+|++.+|++||++.|++++
T Consensus 251 ~~~~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 251 APRLK----SKKW----SKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp CCCCS----CSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccCC----cccc----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111 1112 2368899999999999999999999885
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=338.08 Aligned_cols=266 Identities=21% Similarity=0.248 Sum_probs=187.7
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCe-------EE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR-------SV 673 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~-------~~ 673 (929)
.|.+.+.||+|+||+||+|++. +++.||||++...... ...+.+|++.++.++||||+++++++...+. .+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp TEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence 4556789999999999999986 6899999998654322 3456678888899999999999999966443 78
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHH--hCCCCceecCCCCCCCeEecC-CCcEEEEeecC
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--TGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGL 750 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGl 750 (929)
+||||+.+ +|.+.+.........+++..+..++.|++.||.||| ++ +|+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 103 VVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred EEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 99999986 555555433345567888899999999999999999 77 9999999999999997 89999999999
Q ss_pred cccccCCCCceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHH------
Q 002382 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL------ 823 (929)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~------ 823 (929)
++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.+....
T Consensus 179 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 986544322 2334589999999998765 4899999999999999999999999865532222222221100
Q ss_pred --hhhcCCcccccCCc------ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 824 --HIESGDIQGIIDPS------LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 824 --~~~~~~~~~~~d~~------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...........+.. ............+.+++.+|++.||++|||+.|+++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000000 0011112234678999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=322.31 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=190.0
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeee------------
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------------ 668 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~------------ 668 (929)
.|.+.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 4556789999999999999986 6899999998643 2335678899999999999999999998855
Q ss_pred -cCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEe
Q 002382 669 -EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 747 (929)
Q Consensus 669 -~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 747 (929)
.+..++||||+++|+|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred cCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence 45679999999999999999642 34577888999999999999999998 999999999999999999999999
Q ss_pred ecCcccccCCC-------------CceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCcccccccc
Q 002382 748 FGLSKFAVDGA-------------SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGAN 813 (929)
Q Consensus 748 FGla~~~~~~~-------------~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~ 813 (929)
||+++...... ........||+.|+|||.+.+. .++.++|||||||++|||++ ||.... .
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---~ 233 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---E 233 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---H
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---h
Confidence 99997553221 1122345689999999999764 68999999999999999998 443211 0
Q ss_pred chhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 814 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
...+..... .. ...+...........+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~----~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVNILKKLR----SV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHH----ST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhcc----cc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111111 11 0111122233334567899999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=340.37 Aligned_cols=262 Identities=20% Similarity=0.277 Sum_probs=180.5
Q ss_pred hccccccCcEEEEEEEEC---CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeee--cCeEEEEEEecc
Q 002382 606 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMH 680 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~---~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~--~~~~~LV~E~~~ 680 (929)
.++||+|+||+||+|+++ +++.||||++..... ...+.+|+++|++++||||+++++++.. ....++||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 468999999999999976 478899999875432 3568899999999999999999999954 678999999996
Q ss_pred CCchhhhhcccc-----ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe----cCCCcEEEEeecCc
Q 002382 681 NGTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLS 751 (929)
Q Consensus 681 ~gsL~~~L~~~~-----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkL~DFGla 751 (929)
|+|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 47777764221 1223488999999999999999999998 99999999999999 67789999999999
Q ss_pred ccccCCCC--ceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccc------cchhhHHHHH
Q 002382 752 KFAVDGAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGA------NCRNIVQWAK 822 (929)
Q Consensus 752 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~------~~~~l~~~~~ 822 (929)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+...+.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 86543221 22234568999999999987 458999999999999999999999996543110 0011111111
Q ss_pred HhhhcC---Cccccc------------CCcccCccC---------HHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 823 LHIESG---DIQGII------------DPSLLDEYD---------IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 823 ~~~~~~---~~~~~~------------d~~l~~~~~---------~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+... ....+. ......... ......+.+++.+|++.||++|||+.|+++|
T Consensus 260 -~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 260 -VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp -HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11000 000000 000000000 0012357899999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=337.63 Aligned_cols=259 Identities=22% Similarity=0.306 Sum_probs=180.7
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeec------CeE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS 672 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~------~~~ 672 (929)
.|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++++.++||||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 3456789999999999999876 68899999986542 23456788999999999999999999998654 567
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
++|+|++ +++|.+++.. ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 110 ~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp EEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred EEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 9999999 7899888742 4688999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 753 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.+..... ....+.
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p-~~~~~~ 255 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP-GAELLK 255 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC-CHHHHT
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-CHHHHH
Confidence 64322 233568999999999887 678999999999999999999999997654211111111110000 000000
Q ss_pred cccCC-------cc--cCccC-----HHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 832 GIIDP-------SL--LDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 832 ~~~d~-------~l--~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+... .+ ..... ......+.+++.+|++.||++|||+.|+++|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000 00 00000 1112467899999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=337.18 Aligned_cols=263 Identities=22% Similarity=0.283 Sum_probs=194.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeec-----CeEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVLV 675 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~-----~~~~LV 675 (929)
|.+.+.||+|+||.||+|++. +++.||||++.... ......+.+|++++++++||||+++++++... ...++|
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 345789999999999999987 68899999997543 23356788999999999999999999988654 678999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
|||+. ++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 93 QELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp ECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99997 688888742 4688999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCc---------eeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh
Q 002382 756 DGASH---------VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 756 ~~~~~---------~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 32111 1123468999999998764 6788999999999999999999999976542111111111000000
Q ss_pred hcCCcccccCCc-------c-------cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 826 ESGDIQGIIDPS-------L-------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 826 ~~~~~~~~~d~~-------l-------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
............ + ...........+.+++.+|++.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000000 0 000001223467899999999999999999999885
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=329.99 Aligned_cols=264 Identities=21% Similarity=0.290 Sum_probs=197.2
Q ss_pred HHHhccccccCcEEEEEEEEC--CCcEEEEEEeecCCc--chhHHHHHHHHHhccc---CCCceeEEeeeee-----ecC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQ-----EEG 670 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~--~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l---~HpNIv~l~g~~~-----~~~ 670 (929)
|.+.+.||+|+||.||+|++. +++.||||+++.... .....+.+|+.+++.+ +||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 456789999999999999983 578899999875422 2234577888887776 8999999999987 556
Q ss_pred eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecC
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 750 (929)
..++||||+. |+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred eEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcc
Confidence 7899999997 6999988543 233488999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCc
Q 002382 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 830 (929)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.............
T Consensus 167 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 167 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred cccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 9754322 12234568999999999999899999999999999999999999997654222111222111100000000
Q ss_pred ccc------cC---CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 QGI------ID---PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~------~d---~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... .. ..............+.+++.+|++.+|++||++.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00 000011112233467899999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.83 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=195.4
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
+.+.+.||+|+||.||+|+++. .+|+|+++... ....+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence 4467899999999999999863 49999987542 2234567889999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC--
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-- 758 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~-- 758 (929)
+++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++ ++.+||+|||+++......
T Consensus 113 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 113 GRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp SEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 99999998542 34688999999999999999999998 999999999999998 6799999999987543211
Q ss_pred --CceeeeeecCccccCcccccc---------CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc
Q 002382 759 --SHVSSIVRGTVGYLDPEYYIS---------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 827 (929)
Q Consensus 759 --~~~~~~~~gt~~Y~aPE~~~~---------~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 827 (929)
........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... .+... ...
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~----~~~ 257 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE----AIIWQ----MGT 257 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH----HHHHH----HHT
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----hcc
Confidence 112233458999999999874 34688999999999999999999999754411 11111 111
Q ss_pred CCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 828 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 828 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
+....... ... ...+.+++.+|++.+|++|||+.|+++.|+++...
T Consensus 258 ~~~~~~~~----~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 258 GMKPNLSQ----IGM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp TCCCCCCC----SSC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCCCCCCc----CCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11111111 111 12478999999999999999999999999988654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=325.57 Aligned_cols=262 Identities=21% Similarity=0.260 Sum_probs=190.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeee--------------
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-------------- 667 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~-------------- 667 (929)
|.+.+.||+|+||.||+|+.. +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 92 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92 (320)
T ss_dssp EEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence 445688999999999999987 48899999998766666678999999999999999999999873
Q ss_pred ecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec-CCCcEEEE
Q 002382 668 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVS 746 (929)
Q Consensus 668 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkL~ 746 (929)
.....++||||++ |+|.+++. ...+++..+..++.|+++||+|||++ +|+||||||+||+++ +++.+||+
T Consensus 93 ~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 93 ELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp SCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999997 69999884 24578889999999999999999998 999999999999997 56799999
Q ss_pred eecCcccccCCCC--ceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHH-
Q 002382 747 DFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK- 822 (929)
Q Consensus 747 DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~- 822 (929)
|||+++....... .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999986543211 11233457899999998865 6788999999999999999999999976542211111111000
Q ss_pred ------HhhhcCCcccccCCccc------CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 823 ------LHIESGDIQGIIDPSLL------DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 823 ------~~~~~~~~~~~~d~~l~------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.... ..+...+..... ..........+.+++.+|++.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 244 VHEEDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCHHHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred Cchhhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000 000000000000 00011123468899999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=329.66 Aligned_cols=250 Identities=23% Similarity=0.309 Sum_probs=192.3
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCC--cchhHHHHHHHHHhcccC--CCceeEEeeeeeecCeEEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~--HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.|.+.+.||+|+||.||+++..+++.||||++.... ......+.+|++++++++ ||||+++++++...+..++|||
T Consensus 29 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e 108 (313)
T 3cek_A 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 108 (313)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe
Confidence 355678999999999999999889999999997543 234567899999999997 5999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
+.+++|.+++.. ...+++..++.++.|+++||.|||++ +|+||||||+|||+++ +.+||+|||+++.....
T Consensus 109 -~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 109 -CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp -CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred -cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 668899999853 34678889999999999999999998 9999999999999964 89999999999865433
Q ss_pred CCc-eeeeeecCccccCcccccc-----------CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh
Q 002382 758 ASH-VSSIVRGTVGYLDPEYYIS-----------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 758 ~~~-~~~~~~gt~~Y~aPE~~~~-----------~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..... .. .......
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~-~~~~~~~ 253 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QI-SKLHAII 253 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HH-HHHHHHH
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HH-HHHHHHH
Confidence 221 2234568999999999875 4678899999999999999999999965331 11 1111111
Q ss_pred hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHH
Q 002382 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875 (929)
Q Consensus 826 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L 875 (929)
... .....+......+.+++.+|++.+|++||++.|++++-
T Consensus 254 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 254 DPN---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp CTT---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred hcc---------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 111 11111111124688999999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=320.51 Aligned_cols=252 Identities=27% Similarity=0.366 Sum_probs=200.6
Q ss_pred HHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
....|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3456677899999999999999987 68999999987543 23456789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC---CcEEEEeecCcc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSK 752 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkL~DFGla~ 752 (929)
+||+++++|.+.+.. ...+++..++.++.|++.||.|||++ +|+||||||+||+++.+ +.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999988843 34688999999999999999999998 99999999999999764 479999999997
Q ss_pred cccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
....... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...... .+... ...+....
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~----~~~~~~~~ 241 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----DILKR----VETGKYAF 241 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----HHHCCCCC
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH----HHHHH----HHcCCCCC
Confidence 6543321 223458999999998865 4889999999999999999999999764411 12111 11111110
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+...... ....+.+++.+|++.+|++|||+.|++++
T Consensus 242 --~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 --DLPQWRT----ISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp --CSGGGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --Cchhhhh----cCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0000011 12468899999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=326.54 Aligned_cols=262 Identities=20% Similarity=0.266 Sum_probs=199.3
Q ss_pred HHHHhccccccCcEEEEEEEE-C-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCc------eeEEeeeeeecCeEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKL-K-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN------LVQFLGYCQEEGRSV 673 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~-~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpN------Iv~l~g~~~~~~~~~ 673 (929)
.|.+.+.||+|+||+||+|.. . +++.||||+++.. ....+.+.+|+++++.++|++ ++++++++...+..+
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 456678999999999999987 3 5789999999743 233567889999999887654 999999999999999
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC--------------
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------------- 739 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-------------- 739 (929)
+||||+ +++|.+++... ....+++..+..++.|+++||+|||++ +|+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 999999 88999988543 223578899999999999999999998 9999999999999987
Q ss_pred -----CCcEEEEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccc
Q 002382 740 -----HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC 814 (929)
Q Consensus 740 -----~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~ 814 (929)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 668999999999764332 22346899999999999999999999999999999999999999764422111
Q ss_pred hhhHHHHHHh----hhcCCcccccC--------------------Ccc--cCccCHHHHHHHHHHHHHccCCCCCCCCcH
Q 002382 815 RNIVQWAKLH----IESGDIQGIID--------------------PSL--LDEYDIQSMWKIEEKALMCVLPHGHMRPSI 868 (929)
Q Consensus 815 ~~l~~~~~~~----~~~~~~~~~~d--------------------~~l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 868 (929)
..+....... ........... ..+ ...........+.+++.+|++.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 1111100000 00000000000 000 001123445678999999999999999999
Q ss_pred HHHHHH
Q 002382 869 SEVLKD 874 (929)
Q Consensus 869 ~eVl~~ 874 (929)
.|++++
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999876
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=333.54 Aligned_cols=258 Identities=20% Similarity=0.289 Sum_probs=193.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeE------E
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS------V 673 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~------~ 673 (929)
|.+.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|+.+++.++||||+++++++...+.. +
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 123 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence 445788999999999999876 688999999975432 2356788999999999999999999999877654 9
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+. ++|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 124 lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp EEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 9999997 68877762 3488999999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc--CCc
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES--GDI 830 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~--~~~ 830 (929)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.........+ ..+
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 4322 233458999999999987 788999999999999999999999997654222222221110000000 000
Q ss_pred c--------cccCCcccC---ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 Q--------GIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~--------~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. ..+...... .........+.+++.+|++.||++|||+.|++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 000000000 0011123468899999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=329.73 Aligned_cols=199 Identities=25% Similarity=0.299 Sum_probs=166.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccC-CC-----ceeEEeeeeeecCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HR-----NLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-Hp-----NIv~l~g~~~~~~~~~L 674 (929)
.|.+.+.||+|+||+||+|+.. +++.||||+++.. .....++..|+.+++.++ |+ +|+++++++...+..++
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 4556789999999999999887 5788999999743 233456778888888874 44 49999999999999999
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec--CCCcEEEEeecCcc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSK 752 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~--~~~~vkL~DFGla~ 752 (929)
||||+. ++|.+++... ....+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||+++
T Consensus 134 v~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 999996 5999988643 224588999999999999999999952 12899999999999995 47789999999998
Q ss_pred cccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccc
Q 002382 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809 (929)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~ 809 (929)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 210 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 210 QLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 65332 223468999999999999999999999999999999999999998654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=337.86 Aligned_cols=250 Identities=23% Similarity=0.302 Sum_probs=185.6
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEeccCCc
Q 002382 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~~~gs 683 (929)
..+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++||||+. |+
T Consensus 19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs 94 (434)
T 2rio_A 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN 94 (434)
T ss_dssp EEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence 35789999999998776677999999998653 234678899999876 89999999999999999999999995 69
Q ss_pred hhhhhccccccccc---cchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC-------------CcEEEEe
Q 002382 684 LKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-------------MRAKVSD 747 (929)
Q Consensus 684 L~~~L~~~~~~~~~---l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-------------~~vkL~D 747 (929)
|.+++......... ..+..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 99998653221111 23445678999999999999998 99999999999999754 4899999
Q ss_pred ecCcccccCCCCc---eeeeeecCccccCcccccc-------CcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchh
Q 002382 748 FGLSKFAVDGASH---VSSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRN 816 (929)
Q Consensus 748 FGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~-------~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~ 816 (929)
||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----- 246 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR----- 246 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-----
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-----
Confidence 9999866543322 1234569999999999975 678899999999999999999 99999654311
Q ss_pred hHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 817 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 817 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.......... .. .............+.+++.+|++.||++|||+.||+++
T Consensus 247 ~~~i~~~~~~---~~-----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 247 ESNIIRGIFS---LD-----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHHHHTCCC---CC-----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHhcCCCC---cc-----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 1111111110 10 11111233455678999999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=329.05 Aligned_cols=257 Identities=20% Similarity=0.301 Sum_probs=192.6
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCe------EE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------SV 673 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~------~~ 673 (929)
|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+. .+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 445688999999999999986 68899999997543 2234678899999999999999999999977654 49
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+. ++|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 106 lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp EEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 9999997 68887763 2488899999999999999999998 999999999999999999999999999975
Q ss_pred ccCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh-------h
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------I 825 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~-------~ 825 (929)
.... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....... .
T Consensus 176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 251 (353)
T 3coi_A 176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence 4322 233468999999999877 678999999999999999999999997654222111111110000 0
Q ss_pred hc-------CCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 826 ES-------GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 826 ~~-------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.. ..+.......+ ..........+.+++.+|++.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 252 NDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp SCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 00000000000 01111233568899999999999999999999876
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=325.59 Aligned_cols=254 Identities=26% Similarity=0.320 Sum_probs=175.4
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-chhHHHHHHHH-HhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~f~~Ev~-iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.+.+.||+|+||.||+|... +++.||||+++.... ....++..|+. +++.++||||+++++++...+..++||||+.
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (327)
T 3aln_A 25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS 104 (327)
T ss_dssp EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence 34678999999999999986 688999999976532 23345556665 7788899999999999999999999999998
Q ss_pred CCchhhhhcccc-ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 681 NGTLKEHLYGTL-THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 681 ~gsL~~~L~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
+ +|.+++.... .....+++..+..++.|++.||.|||++ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 105 ~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 180 (327)
T 3aln_A 105 T-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI- 180 (327)
T ss_dssp E-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred C-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-
Confidence 5 7777764221 1245688999999999999999999995 289999999999999999999999999997654322
Q ss_pred ceeeeeecCccccCcccc----ccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 760 HVSSIVRGTVGYLDPEYY----ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~----~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
......||+.|+|||++ .+..++.++|||||||++|||++|+.||...... ....... ..+..
T Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~-~~~~~----- 247 (327)
T 3aln_A 181 -AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV------FDQLTQV-VKGDP----- 247 (327)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCC-CCSCC-----
T ss_pred -ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH------HHHHHHH-hcCCC-----
Confidence 12233589999999998 4567899999999999999999999999753310 0000000 00110
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+.+...........+.+++.+|++.+|++||++.|++++
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 111111111223468899999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=326.38 Aligned_cols=244 Identities=25% Similarity=0.389 Sum_probs=190.1
Q ss_pred HHHHHHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc------hhHHHHHHHHHhccc----CCCceeEEeee
Q 002382 597 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRI----HHRNLVQFLGY 665 (929)
Q Consensus 597 ~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~------~~~~f~~Ev~iL~~l----~HpNIv~l~g~ 665 (929)
+.....|.+.+.||+|+||.||+|++. +++.||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344556777899999999999999875 6889999999755321 234466789999888 89999999999
Q ss_pred eeecCeEEEEEEe-ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec-CCCcE
Q 002382 666 CQEEGRSVLVYEF-MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRA 743 (929)
Q Consensus 666 ~~~~~~~~LV~E~-~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~v 743 (929)
+...+..++|+|+ +.+++|.+++.. ...+++..++.++.|+++||+|||++ +|+||||||+||+++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9999999999999 789999999853 34688999999999999999999998 999999999999999 88999
Q ss_pred EEEeecCcccccCCCCceeeeeecCccccCccccccCcCC-CcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHH
Q 002382 744 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 822 (929)
Q Consensus 744 kL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~ 822 (929)
||+|||+++...... .....||..|+|||++.+..+. .++|||||||++|||++|+.||.... .+..
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~--- 247 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILE--- 247 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH---
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhh---
Confidence 999999998654332 2344589999999999876664 48999999999999999999996432 1111
Q ss_pred HhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 823 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 823 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... .+... ....+.+++.+|++.+|++||++.|++++
T Consensus 248 -----~~~------~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 248 -----AEL------HFPAH----VSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -----TCC------CCCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----hcc------CCccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 01111 22357899999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=326.97 Aligned_cols=263 Identities=20% Similarity=0.252 Sum_probs=197.2
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CC-cEEEEEEeecCCcchhHHHHHHHHHhcccCCCc------eeEEeeeeeecCeE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DG-KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN------LVQFLGYCQEEGRS 672 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~-~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpN------Iv~l~g~~~~~~~~ 672 (929)
..|.+.+.||+|+||+||+|+.. ++ +.||||+++.. ......+.+|+.++++++|++ ++.+++++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 45667789999999999999886 34 68999999743 233567888999999997766 99999999999999
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEe---------------
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL--------------- 737 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl--------------- 737 (929)
++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 9999999 56666666432 234688999999999999999999998 99999999999999
Q ss_pred ----cCCCcEEEEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCcccccccc
Q 002382 738 ----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 813 (929)
Q Consensus 738 ----~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~ 813 (929)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999764332 2334689999999999999999999999999999999999999976442111
Q ss_pred chhhHHHHHHh----hhcCCcccc-------cCC-------------cc--cCccCHHHHHHHHHHHHHccCCCCCCCCc
Q 002382 814 CRNIVQWAKLH----IESGDIQGI-------IDP-------------SL--LDEYDIQSMWKIEEKALMCVLPHGHMRPS 867 (929)
Q Consensus 814 ~~~l~~~~~~~----~~~~~~~~~-------~d~-------------~l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPs 867 (929)
...+....... ......... .+. .+ ...........+.+++.+|++.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 11111100000 000000000 000 00 00112234457889999999999999999
Q ss_pred HHHHHHH
Q 002382 868 ISEVLKD 874 (929)
Q Consensus 868 ~~eVl~~ 874 (929)
+.|++++
T Consensus 328 ~~e~l~h 334 (355)
T 2eu9_A 328 LAEALLH 334 (355)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.80 Aligned_cols=247 Identities=20% Similarity=0.252 Sum_probs=167.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeee----cCeEEEEEEecc
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVYEFMH 680 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~----~~~~~LV~E~~~ 680 (929)
.+.||+|+||+||+|++. +++.||||++.... ....+....++.++||||+++++++.. ....++||||++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 457999999999999987 68999999986431 222223334566799999999999876 455899999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC---CCcEEEEeecCcccccCC
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DFGla~~~~~~ 757 (929)
+|+|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 110 gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~ 184 (336)
T 3fhr_A 110 GGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184 (336)
T ss_dssp TEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc
Confidence 99999999643 234689999999999999999999998 9999999999999986 455999999999754322
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
......||+.|+|||++.+..++.++|||||||++|||++|+.||............... ...+.. .
T Consensus 185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~~~~~------~ 251 (336)
T 3fhr_A 185 ---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR----IRLGQY------G 251 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------C
T ss_pred ---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh----hhcccc------c
Confidence 223456899999999998888999999999999999999999999754422111111110 000000 0
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
............+.+++.+|++.+|++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000011223468899999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=329.39 Aligned_cols=263 Identities=20% Similarity=0.339 Sum_probs=196.8
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccC-----------CCceeEEeeeeeec
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----------HRNLVQFLGYCQEE 669 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-----------HpNIv~l~g~~~~~ 669 (929)
.|.+.+.||+|+||+||+|+.. +++.||||++... ......+.+|+.++++++ ||||+++++++...
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 4567789999999999999975 6889999999743 233567888999998886 89999999999765
Q ss_pred C----eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec------C
Q 002382 670 G----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD------K 739 (929)
Q Consensus 670 ~----~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~------~ 739 (929)
+ ..++|||++ +++|.+++... ....+++..+..++.||+.||+|||+++ +|+||||||+|||++ .
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 4 789999999 89999988543 2345889999999999999999999952 899999999999994 4
Q ss_pred CCcEEEEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccc---cchh
Q 002382 740 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA---NCRN 816 (929)
Q Consensus 740 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~---~~~~ 816 (929)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 458999999999865432 223468999999999999999999999999999999999999997543111 1111
Q ss_pred hHHHHHHh-----------------hhcCCcccccCC-cc---------cCccCHHHHHHHHHHHHHccCCCCCCCCcHH
Q 002382 817 IVQWAKLH-----------------IESGDIQGIIDP-SL---------LDEYDIQSMWKIEEKALMCVLPHGHMRPSIS 869 (929)
Q Consensus 817 l~~~~~~~-----------------~~~~~~~~~~d~-~l---------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 869 (929)
+.+..... .........+.. .. ....+......+.+++.+|++.||++|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 11111100 000000000000 00 1123456677899999999999999999999
Q ss_pred HHHHH
Q 002382 870 EVLKD 874 (929)
Q Consensus 870 eVl~~ 874 (929)
|++++
T Consensus 330 ell~h 334 (373)
T 1q8y_A 330 GLVNH 334 (373)
T ss_dssp HHHTC
T ss_pred HHhhC
Confidence 99885
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.73 Aligned_cols=245 Identities=22% Similarity=0.378 Sum_probs=197.9
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc------hhHHHHHHHHHhcccC--CCceeEEeeeeeecCe
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGR 671 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~------~~~~f~~Ev~iL~~l~--HpNIv~l~g~~~~~~~ 671 (929)
..|.+.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++ ||||+++++++...+.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 34566789999999999999875 6889999999754322 2345778999999996 5999999999999999
Q ss_pred EEEEEEeccC-CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec-CCCcEEEEeec
Q 002382 672 SVLVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFG 749 (929)
Q Consensus 672 ~~LV~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkL~DFG 749 (929)
.++|+|++.+ ++|.+++.. ...+++..++.++.|+++||+|||++ +|+||||||+|||++ +++.+||+|||
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 9999999986 899998843 45688999999999999999999998 999999999999999 78999999999
Q ss_pred CcccccCCCCceeeeeecCccccCccccccCcC-CCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcC
Q 002382 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 828 (929)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 828 (929)
+++..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+.. +
T Consensus 196 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~--------~ 258 (320)
T 3a99_A 196 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--------G 258 (320)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--------C
T ss_pred cccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhc--------c
Confidence 99865432 2233458999999999987665 678899999999999999999996532 1110 0
Q ss_pred CcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH--HHHhH
Q 002382 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDAI 879 (929)
Q Consensus 829 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~--L~~~~ 879 (929)
.. ...... ...+.+++.+|++.+|++||++.|++++ +++..
T Consensus 259 ~~------~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 259 QV------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CC------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred cc------cccccC----CHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 00 011112 2367899999999999999999999986 44443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=333.36 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=183.8
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
+.+.+.||+|+||+||.....+++.||||++..... ..+.+|+++|+++ +||||+++++++.+.+..++||||+.
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 344678999999997665566799999999865432 3456899999999 79999999999999999999999996
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC-----CCcEEEEeecCcccccC
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-----~~~vkL~DFGla~~~~~ 756 (929)
|+|.+++... ...+.+..++.++.||++||+|||++ +|+||||||+|||++. ...+||+|||+++....
T Consensus 102 g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 102 ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 6999988643 22344556678999999999999998 9999999999999953 33688999999986543
Q ss_pred CCC--ceeeeeecCccccCccccc---cCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCc
Q 002382 757 GAS--HVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 757 ~~~--~~~~~~~gt~~Y~aPE~~~---~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 830 (929)
... .......||+.|+|||++. ...++.++|||||||++|||++ |..||..... .... ........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-----~~~~---~~~~~~~~ 247 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-----RQAN---ILLGACSL 247 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----HHHH---HHTTCCCC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----HHHH---HHhccCCc
Confidence 321 2233456999999999997 4567889999999999999999 9999864331 1111 11111111
Q ss_pred ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... .........+.+++.+|++.||++|||+.||++|
T Consensus 248 -~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 -DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp -TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 000 0112234457899999999999999999999965
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=345.83 Aligned_cols=240 Identities=19% Similarity=0.281 Sum_probs=192.9
Q ss_pred HHHHHhccccccCcEEEEEEEEC--CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCe-----E
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR-----S 672 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~--~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~-----~ 672 (929)
..|.+.+.||+|+||+||+|++. +++.||||++.... ......+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 34567789999999999999986 58899999986543 3345678899999999999999999999987665 7
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
++||||+++++|.+++.. .+++..++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||+++
T Consensus 160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 999999999999887632 688999999999999999999998 99999999999999986 89999999998
Q ss_pred cccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 753 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 753 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
..... ....||+.|+|||++.+.. +.++|||||||++|||++|..|+.........
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------ 285 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------ 285 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------------------
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc------------------
Confidence 65432 3346999999999987654 88999999999999999999887643211000
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCC-cHHHHHHHHHHhHh
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAIV 880 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~eVl~~L~~~~~ 880 (929)
...........+.+++.+|++.||++|| +++++.+.|..++.
T Consensus 286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0000112234688999999999999999 56777777777654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=314.56 Aligned_cols=249 Identities=24% Similarity=0.302 Sum_probs=175.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc-h-hHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-G-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~-~-~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||.||+|++. +++.||||++...... . .+.+.++..+++.++||||+++++++...+..++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (318)
T 2dyl_A 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM 106 (318)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence 345678999999999999986 6899999999765332 2 233445556788889999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
++.+..+... ....+++..+..++.|+++||.|||+ . +|+||||||+||+++.++.+||+|||+++......
T Consensus 107 -~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 107 -GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp -SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred -CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 4444444321 23568899999999999999999998 4 89999999999999999999999999997554322
Q ss_pred CceeeeeecCccccCccccc-----cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 759 SHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
......||+.|+|||.+. ...++.++|||||||++|||++|+.||...... ..... ...... ...
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~---~~~~~~-~~~- 249 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD---FEVLT---KVLQEE-PPL- 249 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHH---HHHHSC-CCC-
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---HHHHH---HHhccC-CCC-
Confidence 223346899999999984 456888999999999999999999999753311 11111 111111 000
Q ss_pred cCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 834 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+... ......+.+++.+|++.||++||++.|++++
T Consensus 250 ----~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 ----LPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ----CCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----CCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0000 0122357899999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=343.22 Aligned_cols=268 Identities=22% Similarity=0.322 Sum_probs=201.8
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecC-CcchhHHHHHHHHHhcccCCCceeEEeeeeee------cCeE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRS 672 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~------~~~~ 672 (929)
..|.+.+.||+|+||.||+|.+. +++.||||+++.. .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 45778899999999999999875 5889999998754 33345678999999999999999999998765 6778
Q ss_pred EEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCc---EEEEeec
Q 002382 673 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFG 749 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~---vkL~DFG 749 (929)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999986532 234588899999999999999999998 9999999999999997764 9999999
Q ss_pred CcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...|.........
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~------~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ------PVQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH------HHHSSTTCC----
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc------hhhhhhhhhcccc
Confidence 998654432 22345689999999999999999999999999999999999999965421 1111111111100
Q ss_pred cccccC----C------c--ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHH-----HHHHHHHhHh
Q 002382 830 IQGIID----P------S--LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISE-----VLKDIQDAIV 880 (929)
Q Consensus 830 ~~~~~d----~------~--l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e-----Vl~~L~~~~~ 880 (929)
...... . . ............+.+++.+|++.||++|||+.| +.+.++.++.
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000000 0 0 011233445678999999999999999999988 4455555543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=310.84 Aligned_cols=233 Identities=14% Similarity=0.119 Sum_probs=181.7
Q ss_pred HHHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc---hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~---~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
..|.+.+.||+|+||.||+|++. +++.||||++...... ..+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 45667889999999999999987 4899999999765332 2367899999999999999999999999999999999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++++|.+++... ....++..++.|++.||+|||++ +|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999998432 24456788999999999999998 99999999999999999999997443
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
|++| ++.++|||||||++|||++|+.||......+....... ... +..
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~----~~~-~~~------ 222 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER----DTA-GQP------ 222 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB----CTT-SCB------
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH----Hhc-cCC------
Confidence 3333 67899999999999999999999986542211100000 000 000
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
.............+.+++.+|++.||++| |+.|+++.|+++....
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 00001111223468899999999999999 9999999999876543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=322.31 Aligned_cols=239 Identities=13% Similarity=0.096 Sum_probs=178.3
Q ss_pred HhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCC-CceeE------------------
Q 002382 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHH-RNLVQ------------------ 661 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~H-pNIv~------------------ 661 (929)
+.+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+.+++.++| +|...
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 3578999999999999966 689999999874332 225678999999999977 32211
Q ss_pred ---Eeeeeee-----cCeEEEEEEeccCCchhhhhccc---cccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCC
Q 002382 662 ---FLGYCQE-----EGRSVLVYEFMHNGTLKEHLYGT---LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL 730 (929)
Q Consensus 662 ---l~g~~~~-----~~~~~LV~E~~~~gsL~~~L~~~---~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDI 730 (929)
++.++.. ....+++|+.+ +++|.+++... ......+++..++.++.|+++||+|||++ +|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence 1111111 22456677755 68999887421 22355688999999999999999999998 9999999
Q ss_pred CCCCeEecCCCcEEEEeecCcccccCCCCceeeeeecCccccCcccc----------ccCcCCCcCceeeHHHHHHHHHh
Q 002382 731 KSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY----------ISQQLTDKSDVYSFGVILLELIS 800 (929)
Q Consensus 731 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~s~~sDVwSlGvvl~ellt 800 (929)
||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999998754322 334557 999999999 55568889999999999999999
Q ss_pred CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 801 GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 801 G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
|+.||......+....+ +... ... ...+.+++.+|++.+|++||++.|++++
T Consensus 313 g~~Pf~~~~~~~~~~~~----------------~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWI----------------FRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp SSCCCCTTGGGSCSGGG----------------GSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCcchhhhHHHH----------------Hhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 99999765422211111 1100 111 2468899999999999999999998765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-33 Score=314.77 Aligned_cols=245 Identities=18% Similarity=0.187 Sum_probs=184.5
Q ss_pred HHHHHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCc--------chhHHHHHHHHHhcccC---------CCceeE
Q 002382 599 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIH---------HRNLVQ 661 (929)
Q Consensus 599 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~--------~~~~~f~~Ev~iL~~l~---------HpNIv~ 661 (929)
....|.+.+.||+|+||+||+|++ +++.||||+++.... ...+.+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 345678889999999999999998 589999999976532 22367889999988886 666666
Q ss_pred Eeeee-----------------ee-------------cCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHH
Q 002382 662 FLGYC-----------------QE-------------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 711 (929)
Q Consensus 662 l~g~~-----------------~~-------------~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia 711 (929)
+.+.+ .+ .+..++||||+++|++.+.+.. ..+++..+..++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 66543 32 6789999999999987766632 4578999999999999
Q ss_pred HHHHHHH-hCCCCceecCCCCCCCeEecCCC--------------------cEEEEeecCcccccCCCCceeeeeecCcc
Q 002382 712 KGIEYLH-TGCVPAIIHRDLKSSNILLDKHM--------------------RAKVSDFGLSKFAVDGASHVSSIVRGTVG 770 (929)
Q Consensus 712 ~gL~yLH-~~~~~~ivHrDIkp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~ 770 (929)
.||+||| ++ +|+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 88 999999999999999887 8999999999865432 3469999
Q ss_pred ccCccccccCcCCCcCceeeHHHH-HHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHH
Q 002382 771 YLDPEYYISQQLTDKSDVYSFGVI-LLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWK 849 (929)
Q Consensus 771 Y~aPE~~~~~~~s~~sDVwSlGvv-l~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 849 (929)
|+|||++.+.. +.++||||+|++ .+++++|..||...... ..+.+. ....... ...............
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~---~~~~~~---~~~~~~~----~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL---HYLTDK---MLKQMTF----KTKCNTPAMKQIKRK 311 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH---HHHHHH---HHHTCCC----SSCCCSHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh---hHHHHh---hhhhhcc----CcccchhhhhhcCHH
Confidence 99999998766 889999998777 78899999998542100 001111 1101000 011111122345567
Q ss_pred HHHHHHHccCCCCCCCCcHHHHH-HH
Q 002382 850 IEEKALMCVLPHGHMRPSISEVL-KD 874 (929)
Q Consensus 850 l~~li~~Cl~~dP~~RPs~~eVl-~~ 874 (929)
+.+++.+|++.+ |+.|++ +|
T Consensus 312 ~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHhccC-----CHHHHHhcC
Confidence 999999999976 999888 54
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=298.98 Aligned_cols=222 Identities=22% Similarity=0.271 Sum_probs=173.8
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHh-cccCCCceeEEeeeeee----cCeEEEEEEec
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLL-SRIHHRNLVQFLGYCQE----EGRSVLVYEFM 679 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL-~~l~HpNIv~l~g~~~~----~~~~~LV~E~~ 679 (929)
.+.||+|+||.||+|... +++.||||+++. ...+.+|++++ +..+||||+++++++.. ....++||||+
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred CcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 367999999999999885 688999999863 24567888887 55699999999999977 67789999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC---CCcEEEEeecCcccccC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DFGla~~~~~ 756 (929)
++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||++....
T Consensus 98 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 98 DGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp CSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 999999998643 234689999999999999999999998 9999999999999998 7899999999986432
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
+..++.++|||||||++|||++|+.||...........+ ...+...
T Consensus 172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~------------~~~~~~~ 217 (299)
T 3m2w_A 172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------------KTRIRMG 217 (299)
T ss_dssp ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS------------CCSSCTT
T ss_pred ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH------------HHHHhhc
Confidence 234677899999999999999999999754311100000 0000000
Q ss_pred cccCccC----HHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYD----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~----~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
. ...+ ......+.+++.+|++.+|++|||+.|++++
T Consensus 218 ~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 218 Q--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp C--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred c--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 0011 1123468899999999999999999999986
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-27 Score=284.80 Aligned_cols=186 Identities=16% Similarity=0.109 Sum_probs=130.4
Q ss_pred cccccCcEEEEEEEEC-CCcEEEEEEeecCCc----------chhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEE
Q 002382 608 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY----------QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 608 ~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~----------~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV 675 (929)
..+.|++|.+..++.. -|+.+|||++..... ...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4566777766665432 488999999975421 1235699999999999 799999999999999999999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
|||++|++|.+.|.. ...++. .+|+.||+.||+|||++ |||||||||+|||+++++++||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~----~~~l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA----GEEIDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHT----TCCCCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHh----CCCCCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999953 334544 35899999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCC
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 805 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~ 805 (929)
... ......+||++|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 391 ~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 332 22344569999999999875 4677899999999999887776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-24 Score=255.63 Aligned_cols=182 Identities=18% Similarity=0.227 Sum_probs=144.6
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeecCCcc--------hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~--------~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.+.||+|+||+||+|+.. ++.+++|+....... ..+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 578999999999999554 788999987543221 13458899999999999999976666667778899999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. ++||+|||+++.....
T Consensus 420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 9999999999853 457999999999999998 9999999999999999 9999999999876443
Q ss_pred CCce------eeeeecCccccCcccccc--CcCCCcCceeeHHHHHHHHHhCCCCC
Q 002382 758 ASHV------SSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAI 805 (929)
Q Consensus 758 ~~~~------~~~~~gt~~Y~aPE~~~~--~~~s~~sDVwSlGvvl~elltG~~p~ 805 (929)
.... .....||+.|||||++.. ..|+..+|+||..+-..+.+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211 234579999999999986 67888899999988888887776655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.2e-21 Score=211.03 Aligned_cols=141 Identities=17% Similarity=0.096 Sum_probs=114.4
Q ss_pred hccccccCcEEEEEEEECCCcEEEEEEeecCCc------------------chhHHHHHHHHHhcccCCCceeEEeeeee
Q 002382 606 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY------------------QGKREFTNEVTLLSRIHHRNLVQFLGYCQ 667 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~------------------~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~ 667 (929)
.+.||+|+||.||+|++.+|+.||||+++.... .....+.+|++++++++| +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEEe
Confidence 488999999999999997799999999964321 124568899999999984 55555543
Q ss_pred ecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEe
Q 002382 668 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 747 (929)
Q Consensus 668 ~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 747 (929)
. +..++||||+++++|.+ +.. .....++.|+++||.|||+. +|+||||||+|||++ ++.+||+|
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECC
T ss_pred c-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEE
Confidence 3 55699999999999988 421 12346999999999999998 999999999999999 99999999
Q ss_pred ecCcccccCCCCceeeeeecCccccCcccccc
Q 002382 748 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779 (929)
Q Consensus 748 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 779 (929)
||+|+. +..++|||++.+
T Consensus 236 FG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 236 FPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp CTTCEE--------------TTSTTHHHHHHH
T ss_pred CCCCeE--------------CCCCCHHHHHHH
Confidence 999862 455789998754
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.3e-18 Score=213.20 Aligned_cols=114 Identities=29% Similarity=0.443 Sum_probs=105.8
Q ss_pred CCCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcc
Q 002382 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 491 (929)
Q Consensus 413 ~~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~ 491 (929)
..+++|+.|||++|+|+|.+|.+|++|++|+.|+|++|+|+|.+|. |+++++|+.|||++|+|+|.+|..+++|+.|+.
T Consensus 629 ~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~ 708 (768)
T 3rgz_A 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE 708 (768)
T ss_dssp SSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSE
T ss_pred hccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCE
Confidence 3467899999999999999999999999999999999999999985 999999999999999999999999999999999
Q ss_pred cccccccccccccccc-cccceeccccCCcccccCC
Q 002382 492 LYVQNNMLSGTVPSSL-LSKNVVLNYAGNINLHEGG 526 (929)
Q Consensus 492 L~l~~N~l~g~~P~~l-~~~~~~l~~~~n~~lc~~~ 526 (929)
|+|++|+|+|.+|..- +......+|.||+++|+.+
T Consensus 709 L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~ 744 (768)
T 3rgz_A 709 IDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744 (768)
T ss_dssp EECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred EECcCCcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence 9999999999999763 5666778899999999765
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=8e-18 Score=180.44 Aligned_cols=134 Identities=24% Similarity=0.270 Sum_probs=102.8
Q ss_pred HhccccccCcEEEEEEEE-CCCcE--EEEEEeecCCcc------------------------hhHHHHHHHHHhcccCCC
Q 002382 605 LEKKIGSGGFGVVYYGKL-KDGKE--IAVKVLTSNSYQ------------------------GKREFTNEVTLLSRIHHR 657 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~-~~~~~--vAVK~l~~~~~~------------------------~~~~f~~Ev~iL~~l~Hp 657 (929)
+.+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|+.+|.+++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 457899999999999998 57888 999997543111 113578899999999887
Q ss_pred ce--eEEeeeeeecCeEEEEEEeccC-C----chhhhhccccccccccchHHHHHHHHHHHHHHHHHH-hCCCCceecCC
Q 002382 658 NL--VQFLGYCQEEGRSVLVYEFMHN-G----TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAIIHRD 729 (929)
Q Consensus 658 NI--v~l~g~~~~~~~~~LV~E~~~~-g----sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~ivHrD 729 (929)
++ ...+++ +..++||||+.+ | +|.+... ..++..+..++.|++.||.||| +. +|+|||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 64 334432 356899999942 4 4444331 1234567789999999999999 87 999999
Q ss_pred CCCCCeEecCCCcEEEEeecCcccc
Q 002382 730 LKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 730 Ikp~NILl~~~~~vkL~DFGla~~~ 754 (929)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999753
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.62 E-value=6.5e-17 Score=178.40 Aligned_cols=182 Identities=20% Similarity=0.178 Sum_probs=140.9
Q ss_pred cccceeeeeecccCCC-CCCCccchhccceeccCCCCCccHHHHHHHHhhc-CCCCcccCCCCCCCCCCCcee-EeCCCC
Q 002382 338 SLPFVLSFKFGKTYDS-SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY-SSADWAQEGGDPCLPVPWSWL-QCNSDP 414 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s-~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~-~~~~w~~~~~dpc~~~~~~~~-~c~~~~ 414 (929)
.++.|+.|+|+.|.++ .+|..+..+..|+.|+++.|++.......+.++. .+..+...++. ..+. .-....
T Consensus 123 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~------l~~~~~~~~~~ 196 (313)
T 1ogq_A 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR------LTGKIPPTFAN 196 (313)
T ss_dssp GCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSE------EEEECCGGGGG
T ss_pred CCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCe------eeccCChHHhC
Confidence 3567788888888888 5666788888888888888887643333344443 33333221110 1110 111122
Q ss_pred CCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 415 ~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
+. |+.|+|++|++++.+|..|.++++|+.|+|++|++++.+|.+..+++|++|+|++|+|++.+|..+.++++|+.|+|
T Consensus 197 l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 275 (313)
T 1ogq_A 197 LN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275 (313)
T ss_dssp CC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEEC
T ss_pred Cc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEEC
Confidence 33 99999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccc-cccceeccccCCcccccCC
Q 002382 495 QNNMLSGTVPSSL-LSKNVVLNYAGNINLHEGG 526 (929)
Q Consensus 495 ~~N~l~g~~P~~l-~~~~~~l~~~~n~~lc~~~ 526 (929)
++|+|+|.+|..- +..+..+.+.+|+.+|+.+
T Consensus 276 s~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 276 SFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp CSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred cCCcccccCCCCccccccChHHhcCCCCccCCC
Confidence 9999999999862 3455778889999999865
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.60 E-value=8.5e-16 Score=170.62 Aligned_cols=182 Identities=15% Similarity=0.174 Sum_probs=139.2
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCC--CCCCCCceeE--eCCCC
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDP--CLPVPWSWLQ--CNSDP 414 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dp--c~~~~~~~~~--c~~~~ 414 (929)
++.|+.|+|..|.++.+|..+..+..|+.|+++.|.+... ...+..+..+..+..++..- ..|....... ....+
T Consensus 103 l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~l-p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~ 181 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181 (328)
T ss_dssp GTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCC-CGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEE
T ss_pred CCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccC-cHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhcc
Confidence 6678888999999999988899999999999988887632 33455555555443321110 0111111000 01123
Q ss_pred CCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 415 ~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
+++|+.|+|++|+|+ .+|..|++|++|+.|+|++|++++.++.+.++++|++|+|++|++.+.+|..++++++|+.|+|
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 260 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence 678999999999999 8999999999999999999999998888999999999999999999999999999999999999
Q ss_pred cccccccccccccc--ccceeccccCCccc
Q 002382 495 QNNMLSGTVPSSLL--SKNVVLNYAGNINL 522 (929)
Q Consensus 495 ~~N~l~g~~P~~l~--~~~~~l~~~~n~~l 522 (929)
++|++.+.+|..+. ..+..+.+.+|...
T Consensus 261 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp TTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred CCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence 99999999998873 44567777777543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.2e-15 Score=170.86 Aligned_cols=135 Identities=15% Similarity=0.143 Sum_probs=96.7
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEeecCCc-----c---------hhHH--------HHHHHHHhcccCCCceeE
Q 002382 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-----Q---------GKRE--------FTNEVTLLSRIHHRNLVQ 661 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~-----~---------~~~~--------f~~Ev~iL~~l~HpNIv~ 661 (929)
.+.++||+|+||.||+|...+|+.||||+++.... . .... ..+|...|.++.+.++..
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v 177 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV 177 (397)
T ss_dssp EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 45678999999999999999999999999764210 0 0011 234566666665444321
Q ss_pred EeeeeeecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC
Q 002382 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 741 (929)
Q Consensus 662 l~g~~~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~ 741 (929)
..-+.. ...+|||||+++++|.+... ......++.|++.+|.+||+. +||||||||.|||+++++
T Consensus 178 p~p~~~--~~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 178 PEPIAQ--SRHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCEEEE--ETTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred Ceeeec--cCceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence 111111 23479999999988866542 112356889999999999998 999999999999998876
Q ss_pred ----------cEEEEeecCccc
Q 002382 742 ----------RAKVSDFGLSKF 753 (929)
Q Consensus 742 ----------~vkL~DFGla~~ 753 (929)
.+.|+||+.+..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 389999997753
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.56 E-value=3.7e-15 Score=162.47 Aligned_cols=112 Identities=31% Similarity=0.388 Sum_probs=97.0
Q ss_pred CCCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcc
Q 002382 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 491 (929)
Q Consensus 413 ~~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~ 491 (929)
..+++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++..+..+..+++|+.
T Consensus 97 ~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~ 176 (290)
T 1p9a_G 97 QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176 (290)
T ss_dssp TTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCE
T ss_pred ccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCE
Confidence 4567899999999999976667899999999999999999998886 788999999999999999555556788999999
Q ss_pred ccccccccccccccccccc--ceeccccCCcccccC
Q 002382 492 LYVQNNMLSGTVPSSLLSK--NVVLNYAGNINLHEG 525 (929)
Q Consensus 492 L~l~~N~l~g~~P~~l~~~--~~~l~~~~n~~lc~~ 525 (929)
|+|++|+|+ .+|..++.. +..+.+.+|+..|..
T Consensus 177 L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp EECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred EECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 999999999 899988665 466778899988865
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.9e-14 Score=153.18 Aligned_cols=155 Identities=19% Similarity=0.220 Sum_probs=126.5
Q ss_pred cceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
+.++.|+|..|.++.++|. +..+..|+.|+++.|++... .+- ....+++|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-------------------~~~----------~~~~l~~L 85 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTL-------------------SAG----------VFDDLTEL 85 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCC-------------------CTT----------TTTTCTTC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCcc-------------------CHh----------HhccCCcC
Confidence 4578889999999999885 89999999999999987631 000 11345689
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
+.|+|++|+|++..+..|..+++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|+.+++|+.|+|++|
T Consensus 86 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 165 (251)
T 3m19_A 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTN 165 (251)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCC
Confidence 9999999999977777889999999999999999988886 688999999999999999766668999999999999999
Q ss_pred ccccccccccc---ccceeccccCCccccc
Q 002382 498 MLSGTVPSSLL---SKNVVLNYAGNINLHE 524 (929)
Q Consensus 498 ~l~g~~P~~l~---~~~~~l~~~~n~~lc~ 524 (929)
+|+ .+|...+ ..+..+.+.+|+..|.
T Consensus 166 ~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 166 QLQ-SVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCS-CCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cCC-ccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 999 5555443 3456778888887775
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=8.4e-15 Score=157.74 Aligned_cols=179 Identities=19% Similarity=0.139 Sum_probs=126.3
Q ss_pred ceeeeeecccCCCCCCC-ccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeE-eCCCCCCCe
Q 002382 341 FVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQPSI 418 (929)
Q Consensus 341 ~l~~l~l~~n~~s~lPP-~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~-c~~~~~~~l 418 (929)
.++.|+|..|.++.+|+ .+..+..|+.|+++.|++.......+..+..+..+...++. ...+. .....+++|
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l~~L 111 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK------LQALPIGVFDQLVNL 111 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSC------CCCCCTTTTTTCSSC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCc------CCcCCHhHcccccCC
Confidence 34556666666666665 36666666666666665543222222222223322221100 01111 112456799
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 112 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (270)
T 2o6q_A 112 AELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191 (270)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCC
Confidence 9999999999977777899999999999999999998886 889999999999999999766677999999999999999
Q ss_pred cccccccccccc---cceeccccCCcccccCC
Q 002382 498 MLSGTVPSSLLS---KNVVLNYAGNINLHEGG 526 (929)
Q Consensus 498 ~l~g~~P~~l~~---~~~~l~~~~n~~lc~~~ 526 (929)
+|+ .+|...+. .+..+.+.+|+..|...
T Consensus 192 ~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 192 QLK-RVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CCS-CCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred cCC-cCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 999 67776543 45678889998877653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=2.1e-15 Score=186.73 Aligned_cols=82 Identities=27% Similarity=0.429 Sum_probs=57.6
Q ss_pred cccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccccccccccccc--ccceecc
Q 002382 439 LSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLN 515 (929)
Q Consensus 439 L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l~--~~~~~l~ 515 (929)
+++|+.|+|++|+++|.+|. ++++++|+.|+|++|+|+|.+|..|++|++|+.|+|++|+++|.+|..+. ..+..++
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 45667777777777777664 77777777777777777777777777777777777777777777777663 3445556
Q ss_pred ccCCc
Q 002382 516 YAGNI 520 (929)
Q Consensus 516 ~~~n~ 520 (929)
++.|.
T Consensus 711 ls~N~ 715 (768)
T 3rgz_A 711 LSNNN 715 (768)
T ss_dssp CCSSE
T ss_pred CcCCc
Confidence 66653
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.55 E-value=5.6e-16 Score=181.56 Aligned_cols=171 Identities=13% Similarity=0.099 Sum_probs=92.9
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeC------
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN------ 411 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~------ 411 (929)
.++.|+.|+|+.|.++.++| +..+..|+.|++++|.+.... ....+..+..++ | .+.++.|.
T Consensus 56 ~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L~~---N---~l~~~~~~~l~~L~ 123 (487)
T 3oja_A 56 PFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAAN---N---NISRVSCSRGQGKK 123 (487)
T ss_dssp TCTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCS---S---CCCCEEECCCSSCE
T ss_pred CCCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCC-----CCCCcCEEECcC---C---cCCCCCccccCCCC
Confidence 34567777777777777766 777777777777777765311 011122221110 1 12222221
Q ss_pred ----------------CCCCCCeeEEEecCCCCCccCChhhh-ccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCC
Q 002382 412 ----------------SDPQPSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 474 (929)
Q Consensus 412 ----------------~~~~~~l~~L~L~~n~l~g~~p~~l~-~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~ 474 (929)
...+++|+.|+|++|.|++.+|..+. .|++|+.|+|++|.|++. |.+..+++|+.|+|++|+
T Consensus 124 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~Ls~N~ 202 (487)
T 3oja_A 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNK 202 (487)
T ss_dssp EEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSC
T ss_pred EEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cccccCCCCCEEECCCCC
Confidence 12234555555555555555555554 455555555555555554 223346666666666666
Q ss_pred cCCCCCccccCCCcCccccccccccccccccccc--ccceeccccCCcccc
Q 002382 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNINLH 523 (929)
Q Consensus 475 l~g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l~--~~~~~l~~~~n~~lc 523 (929)
|++ +|..++.+++|+.|+|++|+|+ .+|..+. ..+..+.+.+|+..|
T Consensus 203 l~~-~~~~~~~l~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 203 LAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp CCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCBCH
T ss_pred CCC-CCHhHcCCCCccEEEecCCcCc-ccchhhccCCCCCEEEcCCCCCcC
Confidence 663 4444666666666666666666 4555542 234555566665554
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.4e-15 Score=168.93 Aligned_cols=165 Identities=15% Similarity=0.123 Sum_probs=129.2
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHH---------hhcCCCCcccCCCCCCCCCCCcee
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVI---------SLYSSADWAQEGGDPCLPVPWSWL 408 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~---------~l~~~~~w~~~~~dpc~~~~~~~~ 408 (929)
.++.|+.|+|..|.++.+|+.+..+..|+.|+++.|.........+. .+..+..+.... |. ...+
T Consensus 125 ~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~---n~---l~~l 198 (328)
T 4fcg_A 125 QFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW---TG---IRSL 198 (328)
T ss_dssp GGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEE---EC---CCCC
T ss_pred ccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcC---CC---cCcc
Confidence 46778999999999999999999999999999987654321111111 122222222111 00 1111
Q ss_pred EeCCCCCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCC
Q 002382 409 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLP 487 (929)
Q Consensus 409 ~c~~~~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~ 487 (929)
......+++|+.|+|++|+++ .+|+.+.+|++|+.|+|++|++.+.+|. +.++++|+.|+|++|++.+.+|..+++++
T Consensus 199 p~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~ 277 (328)
T 4fcg_A 199 PASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277 (328)
T ss_dssp CGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCT
T ss_pred hHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCC
Confidence 112345679999999999999 5888899999999999999999999886 89999999999999999999999999999
Q ss_pred cCcccccccccccccccccccc
Q 002382 488 NLRELYVQNNMLSGTVPSSLLS 509 (929)
Q Consensus 488 ~L~~L~l~~N~l~g~~P~~l~~ 509 (929)
+|+.|+|++|++.|.+|..+..
T Consensus 278 ~L~~L~L~~n~~~~~iP~~l~~ 299 (328)
T 4fcg_A 278 QLEKLDLRGCVNLSRLPSLIAQ 299 (328)
T ss_dssp TCCEEECTTCTTCCCCCGGGGG
T ss_pred CCCEEeCCCCCchhhccHHHhh
Confidence 9999999999999999998844
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.8e-14 Score=155.42 Aligned_cols=179 Identities=17% Similarity=0.103 Sum_probs=129.1
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeC-CCCCCC
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN-SDPQPS 417 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~-~~~~~~ 417 (929)
++.++.|.+..|.++.++ .+..+..|+.|++..|.+... ..+..+..+..+..++ | ....+... ...+++
T Consensus 40 l~~L~~L~l~~~~i~~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~---n---~l~~~~~~~~~~l~~ 110 (272)
T 3rfs_A 40 LNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTG---N---QLQSLPNGVFDKLTN 110 (272)
T ss_dssp HTTCCEEECTTSCCCCCT-TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTT---S---CCCCCCTTTTTTCTT
T ss_pred ccceeeeeeCCCCccccc-ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCC---C---ccCccChhHhcCCcC
Confidence 455666777777766654 366677777777777766542 2333444444332211 1 01122211 245679
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccc
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 496 (929)
|+.|+|++|++++..|..|.+|++|+.|+|++|+|++.++. +.++++|+.|+|++|+|++..|..++.+++|+.|+|++
T Consensus 111 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 190 (272)
T 3rfs_A 111 LKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQ 190 (272)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCC
Confidence 99999999999977777789999999999999999998886 68999999999999999977777789999999999999
Q ss_pred ccccccccccc--cccceeccccCCcccccCC
Q 002382 497 NMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 526 (929)
Q Consensus 497 N~l~g~~P~~l--~~~~~~l~~~~n~~lc~~~ 526 (929)
|+|++..|..+ +..+..+.+.+|+..|..+
T Consensus 191 N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 191 NQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 99995444333 3455778888998776554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.54 E-value=8.6e-15 Score=149.43 Aligned_cols=154 Identities=18% Similarity=0.171 Sum_probs=124.9
Q ss_pred eeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeEEE
Q 002382 343 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 422 (929)
Q Consensus 343 ~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~L~ 422 (929)
+.++++.|.++.+|..+.. .++.|++..|.+... .+- + ....+++|+.|+
T Consensus 11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~-------------------~~~------~---~~~~l~~L~~L~ 60 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRI-------------------SSD------G---LFGRLPHLVKLE 60 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSB-------------------CCS------C---SGGGCTTCCEEE
T ss_pred CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCcc-------------------CCc------c---ccccCCCCCEEE
Confidence 4678899999999997755 789999999987641 000 0 013467999999
Q ss_pred ecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccccccc
Q 002382 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 501 (929)
Q Consensus 423 L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g 501 (929)
|++|+|++..|..|.+|++|+.|+|++|+|++.++. |.++++|++|+|++|+|++..|..+..+++|+.|+|++|++++
T Consensus 61 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 140 (192)
T 1w8a_A 61 LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence 999999988899999999999999999999999987 8999999999999999999999999999999999999999998
Q ss_pred ccccccccc-ceeccccCCcccccCC
Q 002382 502 TVPSSLLSK-NVVLNYAGNINLHEGG 526 (929)
Q Consensus 502 ~~P~~l~~~-~~~l~~~~n~~lc~~~ 526 (929)
..+...+.. +....+.++...|..+
T Consensus 141 ~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 141 NCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred cCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 877543322 2223445555666655
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-14 Score=157.87 Aligned_cols=170 Identities=21% Similarity=0.234 Sum_probs=124.5
Q ss_pred cceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCee
Q 002382 340 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~ 419 (929)
++++.+++..+.++.+|+.+. ..++.|++..|.+.......+..+..+..+..+++ ....+... ..+++|+
T Consensus 10 ~~l~~l~~~~~~l~~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n------~l~~~~~~-~~l~~L~ 80 (290)
T 1p9a_G 10 ASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA------ELTKLQVD-GTLPVLG 80 (290)
T ss_dssp TTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTS------CCCEEECC-SCCTTCC
T ss_pred CCccEEECCCCCCCcCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCC------ccCcccCC-CCCCcCC
Confidence 345556666666666666554 45666666666655433333444444443332211 12222222 4577999
Q ss_pred EEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 420 ~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++. |.++++|++|+|++|+|++..|..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 9999999999 8999999999999999999999999886 8999999999999999997777778999999999999999
Q ss_pred ccccccccccc---cceeccccCCc
Q 002382 499 LSGTVPSSLLS---KNVVLNYAGNI 520 (929)
Q Consensus 499 l~g~~P~~l~~---~~~~l~~~~n~ 520 (929)
|+ .+|...+. .+..+.+.+|.
T Consensus 160 l~-~l~~~~~~~l~~L~~L~L~~N~ 183 (290)
T 1p9a_G 160 LT-ELPAGLLNGLENLDTLLLQENS 183 (290)
T ss_dssp CS-CCCTTTTTTCTTCCEEECCSSC
T ss_pred CC-ccCHHHhcCcCCCCEEECCCCc
Confidence 99 88887754 44666777774
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.54 E-value=3e-14 Score=148.66 Aligned_cols=150 Identities=21% Similarity=0.219 Sum_probs=119.2
Q ss_pred eeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeEEEe
Q 002382 344 SFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL 423 (929)
Q Consensus 344 ~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~L~L 423 (929)
.+++..+.++.+|+.+. +.++.|++.+|++..+ .+ -....+++|+.|+|
T Consensus 15 ~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~i-------------------~~----------~~~~~l~~L~~L~L 63 (220)
T 2v9t_B 15 IVDCRGKGLTEIPTNLP--ETITEIRLEQNTIKVI-------------------PP----------GAFSPYKKLRRIDL 63 (220)
T ss_dssp EEECTTSCCSSCCSSCC--TTCCEEECCSSCCCEE-------------------CT----------TSSTTCTTCCEEEC
T ss_pred EEEcCCCCcCcCCCccC--cCCCEEECCCCcCCCc-------------------CH----------hHhhCCCCCCEEEC
Confidence 45677888889988765 6788899998887641 00 01234568999999
Q ss_pred cCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccccccc
Q 002382 424 SSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT 502 (929)
Q Consensus 424 ~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~ 502 (929)
++|+|++..|..|.+|++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+ .
T Consensus 64 s~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~ 142 (220)
T 2v9t_B 64 SNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-T 142 (220)
T ss_dssp CSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-C
T ss_pred CCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC-E
Confidence 99999988888999999999999999999988876 688999999999999999888888999999999999999999 5
Q ss_pred cccccc---ccceeccccCCcccccC
Q 002382 503 VPSSLL---SKNVVLNYAGNINLHEG 525 (929)
Q Consensus 503 ~P~~l~---~~~~~l~~~~n~~lc~~ 525 (929)
+|...+ ..+..+.+.+|+..|..
T Consensus 143 ~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 143 IAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred ECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 555443 34467778888877754
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=2e-14 Score=150.09 Aligned_cols=109 Identities=23% Similarity=0.305 Sum_probs=57.7
Q ss_pred CCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccc
Q 002382 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (929)
Q Consensus 415 ~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 493 (929)
+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.++. |.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus 56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 135 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence 34555555555555544444555555555555555555555554 55555555555555555555555555555555555
Q ss_pred cccccccccccccc--cccceeccccCCcccc
Q 002382 494 VQNNMLSGTVPSSL--LSKNVVLNYAGNINLH 523 (929)
Q Consensus 494 l~~N~l~g~~P~~l--~~~~~~l~~~~n~~lc 523 (929)
|++|+|++..|..+ +..+..+.+.+|+..|
T Consensus 136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp CTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 55555553333333 2223444455555444
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=8.7e-15 Score=158.76 Aligned_cols=180 Identities=17% Similarity=0.177 Sum_probs=130.8
Q ss_pred ccceeeeeecccCCCCCCC-ccchhccceeccCCCCC-ccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeE-eCCCCC
Q 002382 339 LPFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGS-IDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQ 415 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP-~i~~le~l~~L~l~~n~-~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~-c~~~~~ 415 (929)
++.|+.|+|..|.++.++| .+..+..|+.|+++.|+ +.......+..+..+..+...+.. ...+. .....+
T Consensus 55 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l 128 (285)
T 1ozn_A 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG------LQELGPGLFRGL 128 (285)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSC------CCCCCTTTTTTC
T ss_pred CCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCc------CCEECHhHhhCC
Confidence 4567777777777777744 47777778888887775 544333334444444443321111 11111 123456
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
++|+.|+|++|++++..+..|.++++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..+.++++|+.|+|
T Consensus 129 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 208 (285)
T 1ozn_A 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208 (285)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeC
Confidence 7899999999999966666789999999999999999988885 888999999999999999888999999999999999
Q ss_pred ccccccccccccc---cccceeccccCCcccccC
Q 002382 495 QNNMLSGTVPSSL---LSKNVVLNYAGNINLHEG 525 (929)
Q Consensus 495 ~~N~l~g~~P~~l---~~~~~~l~~~~n~~lc~~ 525 (929)
++|+|+ .+|... +..+..+.+.+|+..|..
T Consensus 209 ~~n~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~~ 241 (285)
T 1ozn_A 209 FANNLS-ALPTEALAPLRALQYLRLNDNPWVCDC 241 (285)
T ss_dssp CSSCCS-CCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred CCCcCC-cCCHHHcccCcccCEEeccCCCccCCC
Confidence 999999 455443 334567788889877754
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=1e-14 Score=168.61 Aligned_cols=181 Identities=19% Similarity=0.173 Sum_probs=145.3
Q ss_pred cccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEe-CCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQ 415 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~ 415 (929)
.+++|+.|+|..|.++.+|+. +..+..|+.|+++.|++.......+..+..+..+...+.. ....+.- ...++
T Consensus 110 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~-----~l~~i~~~~~~~l 184 (440)
T 3zyj_A 110 GLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELK-----RLSYISEGAFEGL 184 (440)
T ss_dssp TCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCT-----TCCEECTTTTTTC
T ss_pred CCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCC-----CcceeCcchhhcc
Confidence 367889999999999999985 9999999999999999876444444555555544332111 0111221 24567
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
++|+.|+|++|+|+ .+|. +..+++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|.++++|+.|+|
T Consensus 185 ~~L~~L~L~~n~l~-~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 262 (440)
T 3zyj_A 185 SNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINL 262 (440)
T ss_dssp SSCCEEECTTSCCS-SCCC-CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEEC
T ss_pred cccCeecCCCCcCc-cccc-cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEEC
Confidence 89999999999999 7774 99999999999999999999875 899999999999999999888999999999999999
Q ss_pred ccccccccccccccc---cceeccccCCcccccCC
Q 002382 495 QNNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 526 (929)
Q Consensus 495 ~~N~l~g~~P~~l~~---~~~~l~~~~n~~lc~~~ 526 (929)
++|+|+ .+|...+. .+..+.+.+|+..|...
T Consensus 263 ~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 263 AHNNLT-LLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp TTSCCC-CCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred CCCCCC-ccChhHhccccCCCEEEcCCCCccCCCC
Confidence 999999 77776654 45678889999888654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.52 E-value=3.4e-15 Score=164.57 Aligned_cols=175 Identities=25% Similarity=0.221 Sum_probs=130.9
Q ss_pred cccceeeeeecccCCC-CCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCce-eEeCCCCC
Q 002382 338 SLPFVLSFKFGKTYDS-SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSW-LQCNSDPQ 415 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s-~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~-~~c~~~~~ 415 (929)
.++.|+.|+|..|.++ .+|..+..+..|+.|+++.|++.......+..+..+..+...++. ..+ +......+
T Consensus 99 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~------l~~~~p~~l~~l 172 (313)
T 1ogq_A 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR------ISGAIPDSYGSF 172 (313)
T ss_dssp GCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC------CEEECCGGGGCC
T ss_pred cCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc------ccCcCCHHHhhh
Confidence 4678899999999998 777779999999999999999875334455555555555332111 111 11122334
Q ss_pred C-CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccc
Q 002382 416 P-SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (929)
Q Consensus 416 ~-~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 493 (929)
+ +|+.|+|++|+++|.+|..+..++ |+.|+|++|++++.+|. |.++++|+.|+|++|++++.+|. +..+++|+.|+
T Consensus 173 ~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~ 250 (313)
T 1ogq_A 173 SKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLD 250 (313)
T ss_dssp CTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEE
T ss_pred hhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEE
Confidence 4 788888888888888888888887 88888888888887775 78888888888888888866655 78888888888
Q ss_pred ccccccccccccccc--ccceeccccCCc
Q 002382 494 VQNNMLSGTVPSSLL--SKNVVLNYAGNI 520 (929)
Q Consensus 494 l~~N~l~g~~P~~l~--~~~~~l~~~~n~ 520 (929)
|++|+|+|.+|..+. ..+..+.+.+|.
T Consensus 251 Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 279 (313)
T 1ogq_A 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279 (313)
T ss_dssp CCSSCCEECCCGGGGGCTTCCEEECCSSE
T ss_pred CcCCcccCcCChHHhcCcCCCEEECcCCc
Confidence 888888888887763 345666677664
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.50 E-value=7.7e-15 Score=160.83 Aligned_cols=182 Identities=14% Similarity=0.065 Sum_probs=136.0
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHH-HHHHhhcCCCCcccCCCCCCCCCCCceeE-eCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAI-VSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQ 415 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~-~~l~~l~~~~~w~~~~~dpc~~~~~~~~~-c~~~~~ 415 (929)
.+++|+.|+|+.|.++.+|+.+..+..|+.|+++.|.+..... ..+..+..+..+...+.. ...+. .....+
T Consensus 76 ~~~~L~~L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l 149 (306)
T 2z66_A 76 GTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH------TRVAFNGIFNGL 149 (306)
T ss_dssp SCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSC------CEECSTTTTTTC
T ss_pred cccccCEEECCCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCc------CCccchhhcccC
Confidence 3567788888888888888888888888888888887654321 233344444443221110 11111 123456
Q ss_pred CCeeEEEecCCCCCc-cCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccc
Q 002382 416 PSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g-~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 493 (929)
++|+.|+|++|++++ .+|..+..+++|+.|+|++|++++.+|. +.++++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 150 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 229 (306)
T 2z66_A 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 229 (306)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEE
T ss_pred cCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeE
Confidence 789999999999987 6888999999999999999999998775 88899999999999999976667899999999999
Q ss_pred cccccccccccccccc---cceeccccCCcccccC
Q 002382 494 VQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEG 525 (929)
Q Consensus 494 l~~N~l~g~~P~~l~~---~~~~l~~~~n~~lc~~ 525 (929)
|++|++++..|..+.. .+..+.+.+|+..|..
T Consensus 230 L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 230 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp CTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred CCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 9999999777777643 4567788888776643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=5e-14 Score=147.04 Aligned_cols=137 Identities=19% Similarity=0.236 Sum_probs=118.2
Q ss_pred ceeeeeecccCCCCCCCc--cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 341 FVLSFKFGKTYDSSRGPL--LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 341 ~l~~l~l~~n~~s~lPP~--i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
.++.|+|..|.++.++|. +..+..|+.|+++.|++..+ .+ -...++++|
T Consensus 33 ~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i-------------------~~----------~~~~~l~~L 83 (220)
T 2v70_A 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDI-------------------EE----------GAFEGASGV 83 (220)
T ss_dssp TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEE-------------------CT----------TTTTTCTTC
T ss_pred CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEE-------------------CH----------HHhCCCCCC
Confidence 346788999999999664 89999999999999987641 00 012346799
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
+.|+|++|+|++..|..|.+|++|+.|+|++|+|++.+|. |.++++|++|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 84 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 163 (220)
T 2v70_A 84 NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163 (220)
T ss_dssp CEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred CEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCc
Confidence 9999999999977777899999999999999999999875 899999999999999999888999999999999999999
Q ss_pred ccccccccc
Q 002382 498 MLSGTVPSS 506 (929)
Q Consensus 498 ~l~g~~P~~ 506 (929)
++++..+..
T Consensus 164 ~l~c~c~l~ 172 (220)
T 2v70_A 164 PFNCNCYLA 172 (220)
T ss_dssp CEECSGGGH
T ss_pred CCcCCCchH
Confidence 999766643
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.1e-13 Score=145.21 Aligned_cols=150 Identities=21% Similarity=0.186 Sum_probs=114.9
Q ss_pred eeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeEEE
Q 002382 343 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 422 (929)
Q Consensus 343 ~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~L~ 422 (929)
+.+++..+.++.+|+.+. ..|+.|+++.|++... .|- ....+++|+.|+
T Consensus 22 ~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~-------------------~~~----------~~~~l~~L~~L~ 70 (229)
T 3e6j_A 22 TTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKL-------------------EPG----------VFDSLINLKELY 70 (229)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCC-------------------CTT----------TTTTCTTCCEEE
T ss_pred CEeEccCCCcCccCCCCC--CCCCEEEcCCCccCcc-------------------CHH----------HhhCccCCcEEE
Confidence 346677888888888765 7788889988887640 000 113456889999
Q ss_pred ecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccccccc
Q 002382 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 501 (929)
Q Consensus 423 L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g 501 (929)
|++|+|++..+..|.+|++|+.|+|++|+|++.++. |..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+
T Consensus 71 L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~- 148 (229)
T 3e6j_A 71 LGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK- 148 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCC-
T ss_pred CCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCC-
Confidence 999999854445678899999999999999988876 688999999999999998 78888889999999999999998
Q ss_pred cccccccc---cceeccccCCcccccC
Q 002382 502 TVPSSLLS---KNVVLNYAGNINLHEG 525 (929)
Q Consensus 502 ~~P~~l~~---~~~~l~~~~n~~lc~~ 525 (929)
.+|...+. .+..+.+.+|+..|..
T Consensus 149 ~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 149 SIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred ccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 66655443 4466777888776654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.49 E-value=2.1e-14 Score=166.50 Aligned_cols=181 Identities=18% Similarity=0.190 Sum_probs=143.8
Q ss_pred cccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEe-CCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQ 415 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~ 415 (929)
.+++|+.|+|..|.++.+|+. +..+..|+.|+++.|++.......+..+..+..+...+ |. ....+.- ...++
T Consensus 121 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~---~~--~l~~i~~~~~~~l 195 (452)
T 3zyi_A 121 GLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGE---LK--KLEYISEGAFEGL 195 (452)
T ss_dssp TCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCC---CT--TCCEECTTTTTTC
T ss_pred CcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCC---CC--CccccChhhccCC
Confidence 367889999999999999987 88899999999999988754433444454454443321 10 0112221 23467
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..|..|.++++|+.|+|
T Consensus 196 ~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 273 (452)
T 3zyi_A 196 FNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNL 273 (452)
T ss_dssp TTCCEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEEC
Confidence 89999999999999 566 599999999999999999999885 899999999999999999888999999999999999
Q ss_pred ccccccccccccccc---cceeccccCCcccccCC
Q 002382 495 QNNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 526 (929)
Q Consensus 495 ~~N~l~g~~P~~l~~---~~~~l~~~~n~~lc~~~ 526 (929)
++|+|+ .+|...+. .+..+.+.+|+..|...
T Consensus 274 ~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 274 AHNNLS-SLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CSSCCS-CCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred CCCcCC-ccChHHhccccCCCEEEccCCCcCCCCC
Confidence 999999 77776644 45678889999888654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.49 E-value=4.9e-14 Score=151.95 Aligned_cols=159 Identities=20% Similarity=0.189 Sum_probs=109.8
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEe-CCCCCCC
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQPS 417 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~~~ 417 (929)
++.|+.|+|..|.++.+ +.+..+..|+.|++..|.+.......+..+..+..++..++. ...+.. ....+++
T Consensus 62 l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~------l~~~~~~~~~~l~~ 134 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQ------LQSLPDGVFDKLTN 134 (272)
T ss_dssp CTTCCEEECTTSCCCCC-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC------CCCCCTTTTTTCTT
T ss_pred CCCCcEEECCCCCCCCc-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCc------CCccCHHHhccCCC
Confidence 34455555555555554 245555555555555555443222222333333322221100 111111 1245679
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccc
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 496 (929)
|+.|+|++|+|++..+..+.++++|+.|+|++|+|++.++. +.++++|++|+|++|+|++..|..+..+++|+.|+|++
T Consensus 135 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 214 (272)
T 3rfs_A 135 LTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHD 214 (272)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccC
Confidence 99999999999977677789999999999999999998886 68899999999999999988888899999999999999
Q ss_pred cccccccc
Q 002382 497 NMLSGTVP 504 (929)
Q Consensus 497 N~l~g~~P 504 (929)
|++.+..|
T Consensus 215 N~~~~~~~ 222 (272)
T 3rfs_A 215 NPWDCTCP 222 (272)
T ss_dssp SCBCCCTT
T ss_pred CCccccCc
Confidence 99997766
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=3.8e-14 Score=153.72 Aligned_cols=176 Identities=15% Similarity=0.127 Sum_probs=132.1
Q ss_pred cceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeE-eCCCCCCC
Q 002382 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQPS 417 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~-c~~~~~~~ 417 (929)
+.++.|+|..|.++.+|+. +..+..|+.|++..|.+.......+..+..+..++.+++.- ...+. -....+++
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~-----l~~~~~~~~~~l~~ 106 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ-----LRSVDPATFHGLGR 106 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT-----CCCCCTTTTTTCTT
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCC-----ccccCHHHhcCCcC
Confidence 4678899999999999976 99999999999999988764444555555555543322110 01110 12345678
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccc
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 496 (929)
|+.|+|++|++++..|..|.++++|+.|+|++|++++.++. |.++++|++|+|++|+|++..+..+..+++|+.|+|++
T Consensus 107 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 186 (285)
T 1ozn_A 107 LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186 (285)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCC
Confidence 99999999999977788888899999999999999888876 78899999999999999865556788899999999999
Q ss_pred cccccccccccc--ccceeccccCCc
Q 002382 497 NMLSGTVPSSLL--SKNVVLNYAGNI 520 (929)
Q Consensus 497 N~l~g~~P~~l~--~~~~~l~~~~n~ 520 (929)
|++++..|..+. ..+..+.+.+|.
T Consensus 187 n~l~~~~~~~~~~l~~L~~L~l~~n~ 212 (285)
T 1ozn_A 187 NRVAHVHPHAFRDLGRLMTLYLFANN 212 (285)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CcccccCHhHccCcccccEeeCCCCc
Confidence 999866666653 345666666663
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1.2e-13 Score=146.89 Aligned_cols=136 Identities=15% Similarity=0.153 Sum_probs=118.1
Q ss_pred cccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (929)
.++.|+.|+|..|.++.++|. +..+..|+.|+++.|++... .+. ....++
T Consensus 57 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-------------------~~~----------~~~~l~ 107 (251)
T 3m19_A 57 GLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASL-------------------PLG----------VFDHLT 107 (251)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCC-------------------CTT----------TTTTCT
T ss_pred CcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCccccc-------------------Chh----------HhcccC
Confidence 357889999999999999987 89999999999999987630 000 113457
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 495 (929)
+|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.++. |.++++|++|+|++|+|++..|..+..+++|+.|+|+
T Consensus 108 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 187 (251)
T 3m19_A 108 QLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF 187 (251)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEee
Confidence 999999999999966666689999999999999999999985 8999999999999999998777799999999999999
Q ss_pred ccccccc
Q 002382 496 NNMLSGT 502 (929)
Q Consensus 496 ~N~l~g~ 502 (929)
+|++++.
T Consensus 188 ~N~~~c~ 194 (251)
T 3m19_A 188 GNQFDCS 194 (251)
T ss_dssp SCCBCTT
T ss_pred CCceeCC
Confidence 9999865
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.48 E-value=6.7e-14 Score=139.19 Aligned_cols=136 Identities=20% Similarity=0.166 Sum_probs=118.5
Q ss_pred ccceeeeeecccCCC--CCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCC
Q 002382 339 LPFVLSFKFGKTYDS--SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (929)
Q Consensus 339 l~~l~~l~l~~n~~s--~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (929)
.+.++.|+|..|.++ .+|+.+..+..|+.|++..|.+... .....++
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-------------------------------~~~~~l~ 71 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-------------------------------SNLPKLP 71 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-------------------------------SSCCCCS
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-------------------------------hhhccCC
Confidence 467899999999999 9999999999999999999987640 0123456
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCC--CCCCCCCCCcEEEecCCCcCCCCC---ccccCCCcCcc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI--PDFSGCPDLRIIHLEDNQLTGPLP---SSLMNLPNLRE 491 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~--p~~~~l~~L~~L~Ls~N~l~g~~P---~~l~~l~~L~~ 491 (929)
+|+.|+|++|++++.+|..+.++++|+.|+|++|+|++.+ +.+..+++|++|+|++|.|++..+ ..+..+++|+.
T Consensus 72 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~ 151 (168)
T 2ell_A 72 KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTY 151 (168)
T ss_dssp SCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCE
T ss_pred CCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcE
Confidence 9999999999999879998889999999999999999975 569999999999999999995444 48999999999
Q ss_pred ccccccccccccccc
Q 002382 492 LYVQNNMLSGTVPSS 506 (929)
Q Consensus 492 L~l~~N~l~g~~P~~ 506 (929)
|++++|.++ .+|..
T Consensus 152 L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 152 LDGYDREDQ-EAPDS 165 (168)
T ss_dssp ETTEETTSC-BCCSS
T ss_pred ecCCCCChh-hcccc
Confidence 999999998 77754
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=2.2e-13 Score=157.71 Aligned_cols=186 Identities=13% Similarity=0.084 Sum_probs=122.2
Q ss_pred cceeeeeecccCCCCCCCc---------cchhccceeccCCCCCccHHHHHHHHhhcC---CCCcccCCC----------
Q 002382 340 PFVLSFKFGKTYDSSRGPL---------LNAMEINKYLERNDGSIDGVAIVSVISLYS---SADWAQEGG---------- 397 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~---------i~~le~l~~L~l~~n~~~~~~~~~l~~l~~---~~~w~~~~~---------- 397 (929)
..++.|++..|.+..+++. +..+..|+.|+++.|++.......+..... +..+...+.
T Consensus 180 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~ 259 (455)
T 3v47_A 180 KHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259 (455)
T ss_dssp CEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCC
T ss_pred ccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchh
Confidence 4556666666666666654 224467999999999998877777766521 111111000
Q ss_pred -----CC-----CCCCCCceeE-----------eCCCCCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCC
Q 002382 398 -----DP-----CLPVPWSWLQ-----------CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI 456 (929)
Q Consensus 398 -----dp-----c~~~~~~~~~-----------c~~~~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~ 456 (929)
.+ +.......+. -....+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++.+
T Consensus 260 ~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 339 (455)
T 3v47_A 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSID 339 (455)
T ss_dssp SSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred hhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcC
Confidence 00 0000011111 01234667888888888888777778888888888888888887776
Q ss_pred CC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccccccccccccc---ccceeccccCCcccccCC
Q 002382 457 PD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG 526 (929)
Q Consensus 457 p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l~---~~~~~l~~~~n~~lc~~~ 526 (929)
|. |.++++|++|+|++|+|++..|..+.++++|+.|+|++|+|+ .+|...+ ..+..+.+.+|+..|..+
T Consensus 340 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 340 SRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp GGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccc-cCCHhHhccCCcccEEEccCCCcccCCC
Confidence 64 677888888888888888777788888888888888888888 5666553 344666777887666554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.4e-13 Score=140.19 Aligned_cols=136 Identities=19% Similarity=0.180 Sum_probs=102.1
Q ss_pred cceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
+.++.|+|..|.++.+|+. +..+..|+.|++..|++... .+. ....+++|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-------------------~~~----------~~~~l~~L 78 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSL-------------------PNG----------VFNKLTSL 78 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC-------------------CTT----------TTTTCTTC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCcc-------------------Chh----------hcCCCCCc
Confidence 4577888889999988886 68888899999988876531 000 01235678
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
+.|+|++|+|++..+..|.++++|+.|+|++|+|++.++. |.++++|++|+|++|+|++..+..+..+++|+.|+|++|
T Consensus 79 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 158 (208)
T 2o6s_A 79 TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158 (208)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSC
T ss_pred CEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCC
Confidence 8888888888855555577888888888888888877775 677888888888888888655556788888888888888
Q ss_pred ccccccc
Q 002382 498 MLSGTVP 504 (929)
Q Consensus 498 ~l~g~~P 504 (929)
++.+..|
T Consensus 159 ~~~~~~~ 165 (208)
T 2o6s_A 159 PWDCTCP 165 (208)
T ss_dssp CBCCCTT
T ss_pred CeecCCC
Confidence 8776554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1.4e-13 Score=143.57 Aligned_cols=133 Identities=17% Similarity=0.185 Sum_probs=114.7
Q ss_pred cceeeeeecccCCCCCCC-ccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 340 PFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP-~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
+.++.|+|..|.++.+|+ .+..+..|+.|+|+.|++... .| -...++++|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~-------------------~~----------~~~~~l~~L 82 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISEL-------------------AP----------DAFQGLRSL 82 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEE-------------------CT----------TTTTTCSSC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCc-------------------CH----------HHhhCCcCC
Confidence 467889999999999999 499999999999999988641 00 012346799
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
+.|+|++|+|++..+..|.+|++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 83 ~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 162 (220)
T 2v9t_B 83 NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162 (220)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCC
Confidence 9999999999954445578999999999999999999885 899999999999999999877778999999999999999
Q ss_pred cccc
Q 002382 498 MLSG 501 (929)
Q Consensus 498 ~l~g 501 (929)
++..
T Consensus 163 ~~~c 166 (220)
T 2v9t_B 163 PFIC 166 (220)
T ss_dssp CEEC
T ss_pred CcCC
Confidence 9974
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.2e-13 Score=142.93 Aligned_cols=136 Identities=18% Similarity=0.149 Sum_probs=116.8
Q ss_pred cceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
+.++.|+|+.|.++.++|. +..+..|+.|+|++|++... .+. ....+++|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i-------------------~~~----------~~~~l~~L 90 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL-------------------PVG----------VFDSLTQL 90 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC-------------------CTT----------TTTTCTTC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCc-------------------Chh----------hcccCCCc
Confidence 5788999999999999665 89999999999999987531 000 12346799
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
+.|+|++|+|++..+..|..|++|+.|+|++|+|+..++.+.++++|++|+|++|+|++..+..+..+++|+.|+|++|+
T Consensus 91 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 170 (229)
T 3e6j_A 91 TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170 (229)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred CEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCC
Confidence 99999999999666667899999999999999999877789999999999999999997666789999999999999999
Q ss_pred cccccc
Q 002382 499 LSGTVP 504 (929)
Q Consensus 499 l~g~~P 504 (929)
+++..+
T Consensus 171 ~~c~c~ 176 (229)
T 3e6j_A 171 WDCECR 176 (229)
T ss_dssp BCTTBG
T ss_pred ccCCcc
Confidence 986554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=3.3e-14 Score=170.91 Aligned_cols=182 Identities=13% Similarity=0.016 Sum_probs=141.5
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHH-HHHHhhcCCCCcccCCCCCCCCCCCcee-EeCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAI-VSVISLYSSADWAQEGGDPCLPVPWSWL-QCNSDPQ 415 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~-~~l~~l~~~~~w~~~~~dpc~~~~~~~~-~c~~~~~ 415 (929)
.++.|+.|+|..|.++.+|+.+..+..|+.|+++.|++..... ..+..+..+..+..++.. .... ......+
T Consensus 374 ~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l 447 (606)
T 3vq2_A 374 GTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTN------TKIDFDGIFLGL 447 (606)
T ss_dssp CCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSC------CEECCTTTTTTC
T ss_pred cCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCC------CCccchhhhcCC
Confidence 4567888888888888888888888899999998888765322 334444444444322111 1111 1123456
Q ss_pred CCeeEEEecCCCCCc-cCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccc
Q 002382 416 PSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g-~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 493 (929)
++|+.|+|++|++++ .+|..|..+++|+.|+|++|++++.+|. +.++++|++|+|++|+|++..|..++++++|+.|+
T Consensus 448 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 527 (606)
T 3vq2_A 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLD 527 (606)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEE
Confidence 799999999999997 4788999999999999999999998886 89999999999999999988899999999999999
Q ss_pred cccccccccccccccc---cceeccccCCcccccCC
Q 002382 494 VQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 526 (929)
Q Consensus 494 l~~N~l~g~~P~~l~~---~~~~l~~~~n~~lc~~~ 526 (929)
|++|+|+ .+|..+.. .+..+.+.+|+..|..+
T Consensus 528 l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 528 CSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 9999999 89988543 35677889998887654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.43 E-value=5.4e-14 Score=154.07 Aligned_cols=183 Identities=15% Similarity=0.090 Sum_probs=137.3
Q ss_pred cccceeeeeecccCCCCCCC--ccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCce--eEeCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGP--LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSW--LQCNSD 413 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP--~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~--~~c~~~ 413 (929)
.++.|+.|+|..|.++.+|+ .+..+..|+.|+++.|.+.......+..+..+..+...+.. ... +.-...
T Consensus 99 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~ 172 (306)
T 2z66_A 99 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS------FQENFLPDIFT 172 (306)
T ss_dssp TCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCE------EGGGEECSCCT
T ss_pred CCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCc------cccccchhHHh
Confidence 36678889999999999886 58888999999999888765433344444444444322110 111 222345
Q ss_pred CCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCC-CCCCCCCCcEEEecCCCcCCCCCccccCCC-cCcc
Q 002382 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLP-NLRE 491 (929)
Q Consensus 414 ~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~-~L~~ 491 (929)
.+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++.++ .+.++++|+.|+|++|+|++..|..+..++ +|+.
T Consensus 173 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~ 252 (306)
T 2z66_A 173 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 252 (306)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCE
T ss_pred hCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCE
Confidence 67899999999999998889999999999999999999999888 489999999999999999999999999995 9999
Q ss_pred ccccccccccccccc----ccccceeccccCCcccccCC
Q 002382 492 LYVQNNMLSGTVPSS----LLSKNVVLNYAGNINLHEGG 526 (929)
Q Consensus 492 L~l~~N~l~g~~P~~----l~~~~~~l~~~~n~~lc~~~ 526 (929)
|+|++|++++..+.. ++.....+....+...|..+
T Consensus 253 L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p 291 (306)
T 2z66_A 253 LNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 291 (306)
T ss_dssp EECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEES
T ss_pred EEccCCCeecccChHHHHHHHHhhhhhhccccccccCCc
Confidence 999999998654422 12222333344555566554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=6.7e-14 Score=150.97 Aligned_cols=180 Identities=13% Similarity=0.115 Sum_probs=125.8
Q ss_pred ccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeE-eCCCCCC
Q 002382 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQP 416 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~-c~~~~~~ 416 (929)
++.|+.|+|..|.++.+++. +..+..|+.|+++.|++.......+..+..+......+.. ...+. -....++
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l~ 124 (276)
T 2z62_A 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN------LASLENFPIGHLK 124 (276)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSC------CCCSTTCCCTTCT
T ss_pred ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCC------ccccCchhcccCC
Confidence 45677788888888888774 7778888888888887665433344444444433221111 01111 0134567
Q ss_pred CeeEEEecCCCCCc-cCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCc----EEEecCCCcCCCCCccccCCCcCc
Q 002382 417 SITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLR----IIHLEDNQLTGPLPSSLMNLPNLR 490 (929)
Q Consensus 417 ~l~~L~L~~n~l~g-~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~----~L~Ls~N~l~g~~P~~l~~l~~L~ 490 (929)
+|+.|+|++|++++ .+|..|.+|++|+.|+|++|++++.++. +..+++|+ .|+|++|+|++ +|.......+|+
T Consensus 125 ~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~-~~~~~~~~~~L~ 203 (276)
T 2z62_A 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLK 203 (276)
T ss_dssp TCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCE-ECTTSSCSCCEE
T ss_pred CCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccc-cCccccCCCccc
Confidence 89999999999986 3688999999999999999999988764 65555555 89999999995 444444556899
Q ss_pred ccccccccccccccccccc---cceeccccCCcccccCC
Q 002382 491 ELYVQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG 526 (929)
Q Consensus 491 ~L~l~~N~l~g~~P~~l~~---~~~~l~~~~n~~lc~~~ 526 (929)
.|+|++|+|+ .+|..++. .+..+.+.+|+..|..+
T Consensus 204 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 204 ELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp EEECCSSCCS-CCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred EEECCCCcee-ecCHhHhcccccccEEEccCCcccccCC
Confidence 9999999999 67776644 44667788898777553
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.4e-13 Score=154.69 Aligned_cols=154 Identities=20% Similarity=0.174 Sum_probs=122.2
Q ss_pred ceeeeeecccCCCCCCCc-cc-hhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 341 FVLSFKFGKTYDSSRGPL-LN-AMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 341 ~l~~l~l~~n~~s~lPP~-i~-~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
.++.|+|+.|.++.+|+. +. .+..|+.|+|+.|++..+ .+ -...++++|
T Consensus 40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i-------------------~~----------~~~~~l~~L 90 (361)
T 2xot_A 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFI-------------------SS----------EAFVPVPNL 90 (361)
T ss_dssp TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEE-------------------CT----------TTTTTCTTC
T ss_pred CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCcc-------------------Ch----------hhccCCCCC
Confidence 356788999999999887 44 889999999999987641 00 012346789
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccc----cCCCcCcccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSL----MNLPNLRELY 493 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l----~~l~~L~~L~ 493 (929)
+.|+|++|+|++..+..|.+|++|+.|+|++|+|++..|. |.++++|+.|+|++|+|+ .+|..+ ..+++|+.|+
T Consensus 91 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~ 169 (361)
T 2xot_A 91 RYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLD 169 (361)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCCEEE
T ss_pred CEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCCEEE
Confidence 9999999999977777899999999999999999998775 899999999999999999 466554 6799999999
Q ss_pred cccccccccccccccccc-----eeccccCCcccccC
Q 002382 494 VQNNMLSGTVPSSLLSKN-----VVLNYAGNINLHEG 525 (929)
Q Consensus 494 l~~N~l~g~~P~~l~~~~-----~~l~~~~n~~lc~~ 525 (929)
|++|+|+ .+|...+..+ ..+.+.+|+..|..
T Consensus 170 L~~N~l~-~l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 170 LSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp CCSSCCC-CCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred CCCCCCC-ccCHHHhhhccHhhcceEEecCCCccCCc
Confidence 9999999 7776544433 34677889887754
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.3e-13 Score=163.39 Aligned_cols=183 Identities=17% Similarity=0.125 Sum_probs=129.8
Q ss_pred cceeeeeecccCCCCCCCc-cc-------hhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEe-
Q 002382 340 PFVLSFKFGKTYDSSRGPL-LN-------AMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC- 410 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~-i~-------~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c- 410 (929)
+.|+.|+|+.|.++...|. |. .+..|+.|+++.|++.......++.+..+..+..+++.-. ..+-.....
T Consensus 402 ~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~ 480 (636)
T 4eco_A 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDE 480 (636)
T ss_dssp SCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEET
T ss_pred CccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccc
Confidence 3556666666666554333 44 4556666666666665433333333444443322211100 000000010
Q ss_pred --CCCCCCCeeEEEecCCCCCccCChhhh--ccccCceeeccCCcCCCCCCCCCCCCCCcEEEe------cCCCcCCCCC
Q 002382 411 --NSDPQPSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHL------EDNQLTGPLP 480 (929)
Q Consensus 411 --~~~~~~~l~~L~L~~n~l~g~~p~~l~--~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L------s~N~l~g~~P 480 (929)
...++++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++.++.+.++++|+.|+| ++|++.+.+|
T Consensus 481 ~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p 559 (636)
T 4eco_A 481 NENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWP 559 (636)
T ss_dssp TEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCBCTTCCBCCCCCC
T ss_pred cccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCcccccCcccccCh
Confidence 0122348999999999999 8999998 999999999999999995556899999999999 5688999999
Q ss_pred ccccCCCcCcccccccccccccccccccccceeccccCCcccccC
Q 002382 481 SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG 525 (929)
Q Consensus 481 ~~l~~l~~L~~L~l~~N~l~g~~P~~l~~~~~~l~~~~n~~lc~~ 525 (929)
..++++++|+.|+|++|+| +.+|..+...+..+.+.+|+..|..
T Consensus 560 ~~l~~l~~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 560 EGITLCPSLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNISID 603 (636)
T ss_dssp TTGGGCSSCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCEEE
T ss_pred HHHhcCCCCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCcccc
Confidence 9999999999999999999 5999999988889999999877643
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.42 E-value=7.7e-14 Score=158.38 Aligned_cols=181 Identities=17% Similarity=0.145 Sum_probs=92.3
Q ss_pred cccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCC---CCCCCCceeEeC--
Q 002382 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDP---CLPVPWSWLQCN-- 411 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dp---c~~~~~~~~~c~-- 411 (929)
.++.|+.|+|+.|.++.++|. +..+..|+.|+++.|++....+..+.++ .......+.. ..+.....+..+
T Consensus 139 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L---~~L~l~~n~l~~~~~~~~L~~L~l~~n 215 (390)
T 3o6n_A 139 NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSL---FHANVSYNLLSTLAIPIAVEELDASHN 215 (390)
T ss_dssp TCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTC---SEEECCSSCCSEEECCSSCSEEECCSS
T ss_pred CCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcccccccccc---ceeecccccccccCCCCcceEEECCCC
Confidence 356777888888888877765 7777888888888777655332222222 1110000000 000001111100
Q ss_pred ----------------------------CCCCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCC
Q 002382 412 ----------------------------SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCP 463 (929)
Q Consensus 412 ----------------------------~~~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~ 463 (929)
...+++|+.|+|++|++++..|..|.++++|+.|+|++|++++.++.+..++
T Consensus 216 ~l~~~~~~~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~ 295 (390)
T 3o6n_A 216 SINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIP 295 (390)
T ss_dssp CCCEEECCCCSSCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCT
T ss_pred eeeeccccccccccEEECCCCCCcccHHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCC
Confidence 1123445555555555555555555555555555555555555444445555
Q ss_pred CCcEEEecCCCcCCCCCccccCCCcCcccccccccccccccccccccceeccccCCcccc
Q 002382 464 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523 (929)
Q Consensus 464 ~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l~~~~~~l~~~~n~~lc 523 (929)
+|++|+|++|+|+ .+|..++.+++|+.|+|++|+|+ .+|...+..+..+.+.+|+..|
T Consensus 296 ~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp TCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC-CCCCCTTCCCSEEECCSSCEEH
T ss_pred CCCEEECCCCcce-ecCccccccCcCCEEECCCCccc-eeCchhhccCCEEEcCCCCccc
Confidence 5555555555555 44555555555555555555555 4444444444555555554443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=6e-13 Score=147.39 Aligned_cols=171 Identities=18% Similarity=0.224 Sum_probs=112.9
Q ss_pred ceeeeeecccCCCCCCCc-cchhccceeccCCCCCccH--HHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCC
Q 002382 341 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDG--VAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (929)
Q Consensus 341 ~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~--~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (929)
.|+.|++..|.++.+++. +..+..|+.|+++.|.+.. .....+..+..+..+...+.. ...+. ..-.++
T Consensus 122 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~------l~~l~--~~~~~~ 193 (330)
T 1xku_A 122 TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN------ITTIP--QGLPPS 193 (330)
T ss_dssp TCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC------CCSCC--SSCCTT
T ss_pred cccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCc------cccCC--cccccc
Confidence 455555555555555554 5555555555555555432 112223333333322211100 00111 011258
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCC-CCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccc
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 496 (929)
|+.|+|++|++++..|..|.++++|+.|+|++|++++.++ .+.++++|+.|+|++|+|+ .+|..+..+++|+.|+|++
T Consensus 194 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~ 272 (330)
T 1xku_A 194 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 272 (330)
T ss_dssp CSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCS
T ss_pred CCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCC
Confidence 8999999999998888899999999999999999998887 4888999999999999999 8899999999999999999
Q ss_pred ccccccccccccc---------cceeccccCCcc
Q 002382 497 NMLSGTVPSSLLS---------KNVVLNYAGNIN 521 (929)
Q Consensus 497 N~l~g~~P~~l~~---------~~~~l~~~~n~~ 521 (929)
|+|+ .+|...+. ....+.+.+|+.
T Consensus 273 N~i~-~~~~~~f~~~~~~~~~~~l~~l~l~~N~~ 305 (330)
T 1xku_A 273 NNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPV 305 (330)
T ss_dssp SCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred CcCC-ccChhhcCCcccccccccccceEeecCcc
Confidence 9999 66655542 123455666654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.42 E-value=3.2e-13 Score=145.36 Aligned_cols=158 Identities=20% Similarity=0.174 Sum_probs=119.0
Q ss_pred ccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeE-eCCCCCC
Q 002382 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQP 416 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~-c~~~~~~ 416 (929)
++.|+.|+|..|.++.+|+. +..+..|+.|+++.|++.......+..+..+..+...++. ...+. .....++
T Consensus 60 l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l~ 133 (270)
T 2o6q_A 60 LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQ------LKSLPPRVFDSLT 133 (270)
T ss_dssp CTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSC------CCCCCTTTTTTCT
T ss_pred CCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCc------cCeeCHHHhCcCc
Confidence 55677788888888888776 4677888888888777665333333444444443322111 11111 1134678
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 495 (929)
+|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.++. |.++++|++|+|++|+|++..+..+..+++|+.|+|+
T Consensus 134 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 213 (270)
T 2o6q_A 134 KLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213 (270)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEec
Confidence 999999999999965556689999999999999999998886 8999999999999999997666679999999999999
Q ss_pred ccccccc
Q 002382 496 NNMLSGT 502 (929)
Q Consensus 496 ~N~l~g~ 502 (929)
+|++...
T Consensus 214 ~N~~~c~ 220 (270)
T 2o6q_A 214 ENPWDCT 220 (270)
T ss_dssp SSCBCCS
T ss_pred CCCeeCC
Confidence 9999744
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.3e-13 Score=139.29 Aligned_cols=148 Identities=16% Similarity=0.130 Sum_probs=113.0
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (929)
.++.++.|++..|.++.+| .+..+..|+.|++..|.+... . ....+++
T Consensus 42 ~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~~-----------~--------------------~l~~l~~ 89 (197)
T 4ezg_A 42 QMNSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATNY-----------N--------------------PISGLSN 89 (197)
T ss_dssp HHHTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSCC-----------G--------------------GGTTCTT
T ss_pred hcCCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCcc-----------h--------------------hhhcCCC
Confidence 4567889999999999998 689999999999998865420 0 0123568
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCC-cCCCCCccccCCCcCcccccc
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ-LTGPLPSSLMNLPNLRELYVQ 495 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~-l~g~~P~~l~~l~~L~~L~l~ 495 (929)
|+.|+|++|++++..|..|.+|++|+.|+|++|++++..|. +.++++|++|+|++|+ ++ .+| .+..+++|+.|+++
T Consensus 90 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~ 167 (197)
T 4ezg_A 90 LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQ 167 (197)
T ss_dssp CCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECT
T ss_pred CCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECC
Confidence 88888888888877888888888889999988888875554 7888888888998888 55 666 68888888888888
Q ss_pred ccccccccc-ccccccceeccccCCc
Q 002382 496 NNMLSGTVP-SSLLSKNVVLNYAGNI 520 (929)
Q Consensus 496 ~N~l~g~~P-~~l~~~~~~l~~~~n~ 520 (929)
+|+++ .+| -.-+.++..+.+.+|.
T Consensus 168 ~n~i~-~~~~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 168 FDGVH-DYRGIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp TBCCC-CCTTGGGCSSCCEEEECBC-
T ss_pred CCCCc-ChHHhccCCCCCEEEeeCcc
Confidence 88888 454 2224455666666664
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.41 E-value=8.2e-14 Score=167.43 Aligned_cols=181 Identities=17% Similarity=0.145 Sum_probs=97.2
Q ss_pred cccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCC---CCCCCCceeEeC--
Q 002382 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDP---CLPVPWSWLQCN-- 411 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dp---c~~~~~~~~~c~-- 411 (929)
.++.|+.|+|+.|.++.+||. |..+..|+.|++++|.+....+..+.++ ..+....+.. ..+.....+.++
T Consensus 145 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L---~~L~l~~n~l~~l~~~~~L~~L~ls~n 221 (597)
T 3oja_B 145 NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSL---FHANVSYNLLSTLAIPIAVEELDASHN 221 (597)
T ss_dssp TCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTC---SEEECCSSCCSEEECCTTCSEEECCSS
T ss_pred cCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhh---hhhhcccCccccccCCchhheeeccCC
Confidence 356777777777777777775 7777778888887777654322222222 1110000000 000000111100
Q ss_pred ----------------------------CCCCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCC
Q 002382 412 ----------------------------SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCP 463 (929)
Q Consensus 412 ----------------------------~~~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~ 463 (929)
...+++|+.|+|++|.|++.+|..|++|++|+.|+|++|+|++.++.+..++
T Consensus 222 ~l~~~~~~~~~~L~~L~L~~n~l~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~ 301 (597)
T 3oja_B 222 SINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIP 301 (597)
T ss_dssp CCCEEECSCCSCCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCT
T ss_pred cccccccccCCCCCEEECCCCCCCCChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCC
Confidence 1123455666666666665556666666666666666666665544455566
Q ss_pred CCcEEEecCCCcCCCCCccccCCCcCcccccccccccccccccccccceeccccCCcccc
Q 002382 464 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523 (929)
Q Consensus 464 ~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l~~~~~~l~~~~n~~lc 523 (929)
+|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|+ .+|...+..+..+.+.+|+..|
T Consensus 302 ~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~L~~L~l~~N~~~~ 359 (597)
T 3oja_B 302 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDC 359 (597)
T ss_dssp TCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC-CCCCCTTCCCSEEECCSSCEEH
T ss_pred CCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCC-CcChhhcCCCCEEEeeCCCCCC
Confidence 6666666666666 45555666666666666666665 4454445555555566665444
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.40 E-value=2e-13 Score=169.41 Aligned_cols=140 Identities=19% Similarity=0.244 Sum_probs=117.8
Q ss_pred cHHHHHHHHhhcCCCCcccCC----CCC--CCCCCC------------ceeEeCCCCCCCeeEEEecCCCCCccCChhhh
Q 002382 376 DGVAIVSVISLYSSADWAQEG----GDP--CLPVPW------------SWLQCNSDPQPSITVIHLSSKNLTGNIPSDLT 437 (929)
Q Consensus 376 ~~~~~~~l~~l~~~~~w~~~~----~dp--c~~~~~------------~~~~c~~~~~~~l~~L~L~~n~l~g~~p~~l~ 437 (929)
|..|+.++|+....++|+... .+| | .| .||.|+.. .+++.|+|++|+|+|.+|++|+
T Consensus 270 d~~ALl~~k~~l~~~~W~~~~~~~~~~~~~C---~W~~~~~~~~w~~~~GV~C~~~--~~V~~L~Ls~~~L~G~ip~~l~ 344 (876)
T 4ecn_A 270 DYKALKAIWEALDGKNWRYYSGTINNTIHSL---NWNFNKELDMWGDQPGVDLDNN--GRVTGLSLAGFGAKGRVPDAIG 344 (876)
T ss_dssp HHHHHHHHHHHTTGGGCCCCCSSCSSCCCCC---SCCCSSCGGGTTCCTTEEECTT--SCEEEEECTTTCCEEEECGGGG
T ss_pred HHHHHHHHHHHcCCCCCCcCCCcccccCCcc---ccccccccccccCcCceEecCC--CCEEEEECccCCCCCcCchHHh
Confidence 567888898887766897654 467 7 58 99999753 5899999999999999999999
Q ss_pred ccccCceeec-cCCcCCCC-------------------------------------------------------------
Q 002382 438 KLSSLVELWL-DGNSLTGP------------------------------------------------------------- 455 (929)
Q Consensus 438 ~L~~L~~L~L-s~N~l~~~------------------------------------------------------------- 455 (929)
+|++|+.|+| ++|.++|.
T Consensus 345 ~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~ 424 (876)
T 4ecn_A 345 QLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRIS 424 (876)
T ss_dssp GCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCC
T ss_pred ccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccccc
Confidence 9999999999 77755443
Q ss_pred ---------------CC-CCCCCCCCcEEEecCCCcCC-----------------CCCcccc--CCCcCccccccccccc
Q 002382 456 ---------------IP-DFSGCPDLRIIHLEDNQLTG-----------------PLPSSLM--NLPNLRELYVQNNMLS 500 (929)
Q Consensus 456 ---------------~p-~~~~l~~L~~L~Ls~N~l~g-----------------~~P~~l~--~l~~L~~L~l~~N~l~ 500 (929)
+| .|++|++|++|+|++|+|+| .+|..++ +|++|+.|+|++|++.
T Consensus 425 l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~ 504 (876)
T 4ecn_A 425 LKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNM 504 (876)
T ss_dssp CCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTC
T ss_pred hhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCC
Confidence 45 48899999999999999998 3999988 9999999999999999
Q ss_pred cccccccc--ccceeccccCCc
Q 002382 501 GTVPSSLL--SKNVVLNYAGNI 520 (929)
Q Consensus 501 g~~P~~l~--~~~~~l~~~~n~ 520 (929)
|.+|..+. ..+..|.+.+|.
T Consensus 505 ~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 505 TQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CSCCGGGGGCSSCCEEECTTCT
T ss_pred ccChHHHhCCCCCCEEECcCCC
Confidence 99998774 456777777775
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.40 E-value=8.5e-14 Score=153.19 Aligned_cols=173 Identities=18% Similarity=0.126 Sum_probs=93.3
Q ss_pred ccceeeeeecccCCC-CCCCcc--chhccceeccCCCCCccHHHHHHHHhh-----cCCCCcccCCCCCCCCCCCceeEe
Q 002382 339 LPFVLSFKFGKTYDS-SRGPLL--NAMEINKYLERNDGSIDGVAIVSVISL-----YSSADWAQEGGDPCLPVPWSWLQC 410 (929)
Q Consensus 339 l~~l~~l~l~~n~~s-~lPP~i--~~le~l~~L~l~~n~~~~~~~~~l~~l-----~~~~~w~~~~~dpc~~~~~~~~~c 410 (929)
++.|+.|+|..|.++ .+|+.+ ..+..|+.|+++.|++... ...+..+ ..++.+..+++. ...+.+
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~------l~~~~~ 166 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAH------SLNFSC 166 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCS------CCCCCT
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCC------CccchH
Confidence 455666666666665 345544 6666666666666665543 2233333 223322211110 111111
Q ss_pred -CCCCCCCeeEEEecCCCCCcc--CChhh--hccccCceeeccCCcCCCCC--C-C-CCCCCCCcEEEecCCCcCCCCC-
Q 002382 411 -NSDPQPSITVIHLSSKNLTGN--IPSDL--TKLSSLVELWLDGNSLTGPI--P-D-FSGCPDLRIIHLEDNQLTGPLP- 480 (929)
Q Consensus 411 -~~~~~~~l~~L~L~~n~l~g~--~p~~l--~~L~~L~~L~Ls~N~l~~~~--p-~-~~~l~~L~~L~Ls~N~l~g~~P- 480 (929)
....+++|+.|+|++|++.|. +|..+ .++++|+.|+|++|+|++.. + . +.++++|++|+|++|+|++..|
T Consensus 167 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 246 (312)
T 1wwl_A 167 EQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246 (312)
T ss_dssp TTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCC
T ss_pred HHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccch
Confidence 123455666677766666654 23344 66666666666666666422 1 2 3456666666666666665554
Q ss_pred ccccCCCcCcccccccccccccccccccccceeccccCC
Q 002382 481 SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519 (929)
Q Consensus 481 ~~l~~l~~L~~L~l~~N~l~g~~P~~l~~~~~~l~~~~n 519 (929)
..+..+++|+.|+|++|+|+ .+|..+...+..+.+.+|
T Consensus 247 ~~~~~l~~L~~L~Ls~N~l~-~ip~~~~~~L~~L~Ls~N 284 (312)
T 1wwl_A 247 PSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYN 284 (312)
T ss_dssp SCCCCCTTCCEEECTTSCCS-SCCSSCCSEEEEEECCSS
T ss_pred hhhhhcCCCCEEECCCCccC-hhhhhccCCceEEECCCC
Confidence 34555666666666666666 666666644555555555
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.6e-12 Score=134.01 Aligned_cols=150 Identities=21% Similarity=0.194 Sum_probs=120.6
Q ss_pred eeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeEEEe
Q 002382 344 SFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL 423 (929)
Q Consensus 344 ~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~L~L 423 (929)
.+++..+.++.+|..+. +.++.|++..|++... ... ....+++|+.|+|
T Consensus 11 ~v~c~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~----------~~~-------------------~~~~l~~L~~L~l 59 (208)
T 2o6s_A 11 TVECYSQGRTSVPTGIP--AQTTYLDLETNSLKSL----------PNG-------------------VFDELTSLTQLYL 59 (208)
T ss_dssp EEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCC----------CTT-------------------TTTTCTTCSEEEC
T ss_pred EEEecCCCccCCCCCCC--CCCcEEEcCCCccCcC----------Chh-------------------hhcccccCcEEEC
Confidence 45567888889987764 5799999999987530 000 0134568999999
Q ss_pred cCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccccccc
Q 002382 424 SSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT 502 (929)
Q Consensus 424 ~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~ 502 (929)
++|+|++..+..|.++++|++|+|++|+|++.++. |.++++|++|+|++|+|++..+..+..+++|+.|+|++|+|+ .
T Consensus 60 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~ 138 (208)
T 2o6s_A 60 GGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-S 138 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-C
T ss_pred CCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc-e
Confidence 99999966566689999999999999999998886 789999999999999999766677899999999999999999 6
Q ss_pred cccccc---ccceeccccCCcccccC
Q 002382 503 VPSSLL---SKNVVLNYAGNINLHEG 525 (929)
Q Consensus 503 ~P~~l~---~~~~~l~~~~n~~lc~~ 525 (929)
+|...+ .++..+.+.+|+..|..
T Consensus 139 ~~~~~~~~l~~L~~L~l~~N~~~~~~ 164 (208)
T 2o6s_A 139 VPDGVFDRLTSLQYIWLHDNPWDCTC 164 (208)
T ss_dssp CCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred eCHHHhccCCCccEEEecCCCeecCC
Confidence 666643 34567788888766544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.40 E-value=3.5e-13 Score=156.24 Aligned_cols=176 Identities=18% Similarity=0.158 Sum_probs=130.4
Q ss_pred cccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEe-CCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQ 415 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~ 415 (929)
.++.|+.|+|..|.++.++|. +..+..|+.|+|+.|++.......+..+..+..++.+++. ...+.. ....+
T Consensus 97 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~------l~~~~~~~~~~l 170 (452)
T 3zyi_A 97 HLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNP------IESIPSYAFNRV 170 (452)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCC------CCEECTTTTTTC
T ss_pred CCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCC------cceeCHhHHhcC
Confidence 467889999999999999876 8999999999999998876443344444445544332111 222221 24567
Q ss_pred CCeeEEEecCCCCCccCCh-hhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 416 PSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~-~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
++|+.|+|++|+..+.+|. .|.+|++|+.|+|++|+|++. |.+..+++|+.|+|++|+|++..|..|.++++|+.|+|
T Consensus 171 ~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 249 (452)
T 3zyi_A 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWV 249 (452)
T ss_dssp TTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEEC
T ss_pred CcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcCcccCcccccCccCCCEEEe
Confidence 7899999988443335554 688899999999999999875 67888999999999999999888889999999999999
Q ss_pred ccccccccccccc--cccceeccccCCc
Q 002382 495 QNNMLSGTVPSSL--LSKNVVLNYAGNI 520 (929)
Q Consensus 495 ~~N~l~g~~P~~l--~~~~~~l~~~~n~ 520 (929)
++|+|++..|..+ +..+..+.+.+|.
T Consensus 250 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 277 (452)
T 3zyi_A 250 MNSQVSLIERNAFDGLASLVELNLAHNN 277 (452)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCcCceECHHHhcCCCCCCEEECCCCc
Confidence 9999995555444 2345666777774
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.39 E-value=3.4e-13 Score=148.17 Aligned_cols=168 Identities=18% Similarity=0.265 Sum_probs=119.7
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
++.|+.|+|+.|.++.+|+ +..+..|+.|+++.|++... ..+..+..+..+..++ |. ...+.. ...+++|
T Consensus 62 l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~---n~---l~~~~~-l~~l~~L 131 (308)
T 1h6u_A 62 LNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTS---TQ---ITDVTP-LAGLSNL 131 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTT---SC---CCCCGG-GTTCTTC
T ss_pred cCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCC---CC---CCCchh-hcCCCCC
Confidence 5678889999999999998 89999999999999987652 2344444454443321 11 111111 3456788
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
+.|+|++|++++ ++. +..+++|+.|+|++|++++.++ +.++++|+.|+|++|+|++ +|. +..+++|+.|+|++|+
T Consensus 132 ~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~N~ 206 (308)
T 1h6u_A 132 QVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQ 206 (308)
T ss_dssp CEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSC
T ss_pred CEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCc-Chh-hcCCCCCCEEEccCCc
Confidence 888888888884 444 8888888888888888887666 8888888888888888884 443 7888888888888888
Q ss_pred ccccccccccccceeccccCCcc
Q 002382 499 LSGTVPSSLLSKNVVLNYAGNIN 521 (929)
Q Consensus 499 l~g~~P~~l~~~~~~l~~~~n~~ 521 (929)
+++..|-.-+..+..+.+.+|..
T Consensus 207 l~~~~~l~~l~~L~~L~l~~N~i 229 (308)
T 1h6u_A 207 ISDVSPLANTSNLFIVTLTNQTI 229 (308)
T ss_dssp CCBCGGGTTCTTCCEEEEEEEEE
T ss_pred cCccccccCCCCCCEEEccCCee
Confidence 88444322234455666666653
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=6.9e-13 Score=135.41 Aligned_cols=125 Identities=18% Similarity=0.190 Sum_probs=73.6
Q ss_pred eeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeEEEe
Q 002382 344 SFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL 423 (929)
Q Consensus 344 ~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~L~L 423 (929)
.+++..|.++.+|+.+. ..++.|++.+|++..+ .. ....+++|+.|+|
T Consensus 14 ~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~~i-----------p~-------------------~~~~l~~L~~L~L 61 (193)
T 2wfh_A 14 VVRCSNKGLKVLPKGIP--RDVTELYLDGNQFTLV-----------PK-------------------ELSNYKHLTLIDL 61 (193)
T ss_dssp EEECTTSCCSSCCSCCC--TTCCEEECCSSCCCSC-----------CG-------------------GGGGCTTCCEEEC
T ss_pred EEEcCCCCCCcCCCCCC--CCCCEEECCCCcCchh-----------HH-------------------HhhcccCCCEEEC
Confidence 35566777777776543 3566666666655420 00 0122345666666
Q ss_pred cCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccccc
Q 002382 424 SSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 500 (929)
Q Consensus 424 ~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~ 500 (929)
++|+|++..+..|.+|++|+.|+|++|+|++.+|. |.++++|++|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus 62 s~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 62 SNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 66666655555566666666666666666666653 666666666666666666433345666666666666666665
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=5.7e-13 Score=160.30 Aligned_cols=139 Identities=15% Similarity=0.149 Sum_probs=119.4
Q ss_pred cceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
+.++.|+|+.|.++.+||. |.++..|+.|+|+.|++..+ .|- ...++++|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i-------------------~~~----------~f~~L~~L 102 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI-------------------EDG----------AYQSLSHL 102 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEE-------------------CTT----------TTTTCTTC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCc-------------------Chh----------HhcCCCCC
Confidence 3678999999999999986 99999999999999987641 000 12456799
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCC-CCCccccCCCcCccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQN 496 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g-~~P~~l~~l~~L~~L~l~~ 496 (929)
++|+|++|+|++..+..|.+|++|++|+|++|+|++.++. |++|++|++|+|++|+|++ .+|..++.+++|+.|+|++
T Consensus 103 ~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~ 182 (635)
T 4g8a_A 103 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 182 (635)
T ss_dssp CEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCS
T ss_pred CEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccC
Confidence 9999999999966667899999999999999999998885 8999999999999999985 4688999999999999999
Q ss_pred ccccccccccc
Q 002382 497 NMLSGTVPSSL 507 (929)
Q Consensus 497 N~l~g~~P~~l 507 (929)
|+|++..|..+
T Consensus 183 N~l~~~~~~~l 193 (635)
T 4g8a_A 183 NKIQSIYCTDL 193 (635)
T ss_dssp SCCCEECGGGG
T ss_pred ccccccccccc
Confidence 99995555544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.7e-12 Score=130.14 Aligned_cols=131 Identities=18% Similarity=0.215 Sum_probs=104.5
Q ss_pred eeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeEEE
Q 002382 343 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 422 (929)
Q Consensus 343 ~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~L~ 422 (929)
+.+++..+.++.+|..+. +.|+.|++..|++... .+. ....+++|+.|+
T Consensus 10 ~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~-------------------~~~----------~~~~l~~L~~L~ 58 (177)
T 2o6r_A 10 TEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSL-------------------PHG----------VFDKLTQLTKLS 58 (177)
T ss_dssp TEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCC-------------------CTT----------TTTTCTTCSEEE
T ss_pred CEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEe-------------------CHH----------HhcCcccccEEE
Confidence 456778888999987654 6788999998877530 000 113456899999
Q ss_pred ecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccccccc
Q 002382 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 501 (929)
Q Consensus 423 L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g 501 (929)
|++|+|++..+..|.++++|+.|+|++|+|++.++. +.++++|++|+|++|+|++..+..+..+++|+.|+|++|++++
T Consensus 59 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 59 LSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 999999965566678999999999999999998886 7889999999999999996555567889999999999999997
Q ss_pred ccc
Q 002382 502 TVP 504 (929)
Q Consensus 502 ~~P 504 (929)
..|
T Consensus 139 ~~~ 141 (177)
T 2o6r_A 139 SCP 141 (177)
T ss_dssp CHH
T ss_pred cCc
Confidence 666
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.38 E-value=9.3e-13 Score=163.37 Aligned_cols=106 Identities=21% Similarity=0.292 Sum_probs=95.4
Q ss_pred CCCeeEEEecCCCCCccCChhhh--ccccCceeeccCCcCCCCCCCCCCCCCCcEEEecC------CCcCCCCCccccCC
Q 002382 415 QPSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED------NQLTGPLPSSLMNL 486 (929)
Q Consensus 415 ~~~l~~L~L~~n~l~g~~p~~l~--~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~------N~l~g~~P~~l~~l 486 (929)
+++|+.|+|++|+|+ .+|..+. .|++|+.|+|++|+|++.++.+.++++|+.|+|++ |++.+.+|..|++|
T Consensus 727 l~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L 805 (876)
T 4ecn_A 727 TYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTC 805 (876)
T ss_dssp GGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGC
T ss_pred cCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCCCcccccccccChHHHhcC
Confidence 348999999999999 8999998 99999999999999999656789999999999976 88899999999999
Q ss_pred CcCcccccccccccccccccccccceeccccCCccc
Q 002382 487 PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 522 (929)
Q Consensus 487 ~~L~~L~l~~N~l~g~~P~~l~~~~~~l~~~~n~~l 522 (929)
++|+.|+|++|+| +.+|..+.+.+..+.+.+|+..
T Consensus 806 ~~L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~ 840 (876)
T 4ecn_A 806 PSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNI 840 (876)
T ss_dssp SSCCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTC
T ss_pred CCCCEEECCCCCC-CccCHhhcCCCCEEECCCCCCC
Confidence 9999999999999 5999999888888888888643
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=2.3e-13 Score=146.75 Aligned_cols=136 Identities=15% Similarity=0.139 Sum_probs=108.4
Q ss_pred cceeeeeecccCCCCCCC-ccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 340 PFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP-~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
+.++.|+|+.|.++.+|+ .+..+..|+.|++..|++...... ....+++|
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-----------------------------~~~~l~~L 78 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG-----------------------------AYQSLSHL 78 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTT-----------------------------TTTTCTTC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHH-----------------------------HccCCcCC
Confidence 357899999999999999 599999999999999987541000 11335678
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCC-CCCCCCCCcEEEecCCCcCC-CCCccccCCCcCccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQN 496 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g-~~P~~l~~l~~L~~L~l~~ 496 (929)
+.|+|++|+|++..|..|.+|++|+.|+|++|++++..+ .+.++++|++|+|++|++++ .+|..++++++|+.|+|++
T Consensus 79 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~ 158 (276)
T 2z62_A 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158 (276)
T ss_dssp CEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCS
T ss_pred CEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCC
Confidence 888888888887777788888888888888888888777 47888888888888888885 3688888888888888888
Q ss_pred ccccccccc
Q 002382 497 NMLSGTVPS 505 (929)
Q Consensus 497 N~l~g~~P~ 505 (929)
|+++ .+|.
T Consensus 159 N~l~-~~~~ 166 (276)
T 2z62_A 159 NKIQ-SIYC 166 (276)
T ss_dssp SCCC-EECG
T ss_pred CCCC-cCCH
Confidence 8888 4443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=2.4e-13 Score=158.61 Aligned_cols=180 Identities=21% Similarity=0.121 Sum_probs=129.8
Q ss_pred ccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCC
Q 002382 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (929)
+++|+.|+|..|.++.+|+. +..+..|+.|++..|.+.......+..+..+..+...+. +. ...+.-......+
T Consensus 151 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~-~~----~~~~~~~~~~~~~ 225 (477)
T 2id5_A 151 LNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW-PY----LDTMTPNCLYGLN 225 (477)
T ss_dssp CTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECC-TT----CCEECTTTTTTCC
T ss_pred CCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCC-cc----ccccCcccccCcc
Confidence 45667777777777777765 677777777777777665432222223323332221110 00 0111111122348
Q ss_pred eeEEEecCCCCCccCC-hhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccc
Q 002382 418 ITVIHLSSKNLTGNIP-SDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p-~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 495 (929)
|+.|+|++|+|+ .+| ..|.++++|+.|+|++|.|++.++. |.++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 226 L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 304 (477)
T 2id5_A 226 LTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304 (477)
T ss_dssp CSEEEEESSCCC-SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECC
T ss_pred ccEEECcCCccc-ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECC
Confidence 999999999999 555 6899999999999999999998886 8999999999999999999889999999999999999
Q ss_pred cccccccccccccc---cceeccccCCcccccC
Q 002382 496 NNMLSGTVPSSLLS---KNVVLNYAGNINLHEG 525 (929)
Q Consensus 496 ~N~l~g~~P~~l~~---~~~~l~~~~n~~lc~~ 525 (929)
+|+|+ .+|...+. .+..+.+.+|+..|..
T Consensus 305 ~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 305 GNQLT-TLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp SSCCS-CCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred CCcCc-eeCHhHcCCCcccCEEEccCCCccCcc
Confidence 99999 67776644 4567788999877754
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=3.7e-14 Score=158.83 Aligned_cols=181 Identities=13% Similarity=0.092 Sum_probs=127.5
Q ss_pred ccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHH-HHHHhhcCCCCcccCCCCCCCCCCCceeE-eCCCCC
Q 002382 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAI-VSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQ 415 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~-~~l~~l~~~~~w~~~~~dpc~~~~~~~~~-c~~~~~ 415 (929)
++.|+.|+|+.|.++.+|+. +..+..|+.|++++|++..... ..+..+..+..+...+++. ...+. ....++
T Consensus 99 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~-----~~~~~~~~~~~l 173 (353)
T 2z80_A 99 LGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT-----FTKIQRKDFAGL 173 (353)
T ss_dssp CTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSS-----CCEECTTTTTTC
T ss_pred CCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcc-----ccccCHHHccCC
Confidence 46677888888888888877 7778888888888887654211 1233333333332211100 11111 123456
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCC----------------
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGP---------------- 478 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~---------------- 478 (929)
++|+.|+|++|++++..|..|.++++|+.|+|++|+++..++. +..+++|+.|+|++|++++.
T Consensus 174 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~ 253 (353)
T 2z80_A 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253 (353)
T ss_dssp CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCE
T ss_pred CCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhc
Confidence 7899999999999988888899999999999999998766555 45588999999999998863
Q ss_pred ---------------CCccccCCCcCcccccccccccccccccccc---cceeccccCCcccccC
Q 002382 479 ---------------LPSSLMNLPNLRELYVQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEG 525 (929)
Q Consensus 479 ---------------~P~~l~~l~~L~~L~l~~N~l~g~~P~~l~~---~~~~l~~~~n~~lc~~ 525 (929)
+|..+..+++|+.|+|++|+|+ .+|..++. .+..+.+.+|+..|..
T Consensus 254 l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 254 FTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp EEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 3445778899999999999999 89988754 4467778888776643
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.37 E-value=1.3e-12 Score=133.26 Aligned_cols=110 Identities=26% Similarity=0.341 Sum_probs=96.1
Q ss_pred CCeeEEEecCCCCCccCCh-hhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccc
Q 002382 416 PSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~-~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 493 (929)
.+|+.|+|++|+|++..+. .|.+|++|+.|+|++|+|++.+|. |.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus 29 ~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 108 (192)
T 1w8a_A 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence 3799999999999965554 499999999999999999999875 99999999999999999988888899999999999
Q ss_pred cccccccccccccc--cccceeccccCCcccccC
Q 002382 494 VQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEG 525 (929)
Q Consensus 494 l~~N~l~g~~P~~l--~~~~~~l~~~~n~~lc~~ 525 (929)
|++|+|++..|..+ +..+..+.+.+|+..|..
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 99999997777766 345677888899876644
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.37 E-value=6.4e-13 Score=160.80 Aligned_cols=163 Identities=12% Similarity=0.093 Sum_probs=126.0
Q ss_pred cccceeeeeecccCCC-CCCCccchhccceeccCCCCC-ccH-HHHHHHHhh------cCCCCcccCCCCCCCCCCCcee
Q 002382 338 SLPFVLSFKFGKTYDS-SRGPLLNAMEINKYLERNDGS-IDG-VAIVSVISL------YSSADWAQEGGDPCLPVPWSWL 408 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s-~lPP~i~~le~l~~L~l~~n~-~~~-~~~~~l~~l------~~~~~w~~~~~dpc~~~~~~~~ 408 (929)
.++.|+.|+|..|.++ .+|+.|..+..|+.|+++.|+ +.. ..+..+..+ ..+..+...+.. ...+
T Consensus 247 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~------l~~i 320 (636)
T 4eco_A 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN------LKTF 320 (636)
T ss_dssp GCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSC------CSSC
T ss_pred ccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCc------CCcc
Confidence 4778999999999854 577779999999999999998 887 566677765 556655432211 1122
Q ss_pred Ee--CCCCCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCC-CcEEEecCCCcCCCCCccccC
Q 002382 409 QC--NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD-LRIIHLEDNQLTGPLPSSLMN 485 (929)
Q Consensus 409 ~c--~~~~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~-L~~L~Ls~N~l~g~~P~~l~~ 485 (929)
.- ....+++|+.|+|++|+++|.+| .|.++++|+.|+|++|+++..++.+.++++ |++|+|++|+|+ .+|..++.
T Consensus 321 p~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~ 398 (636)
T 4eco_A 321 PVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDA 398 (636)
T ss_dssp CCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCT
T ss_pred CchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhh
Confidence 22 23456788899999999988888 888888899999999988865556888888 888999888888 78888777
Q ss_pred CC--cCccccccccccccccccccc
Q 002382 486 LP--NLRELYVQNNMLSGTVPSSLL 508 (929)
Q Consensus 486 l~--~L~~L~l~~N~l~g~~P~~l~ 508 (929)
++ +|+.|+|++|+++|.+|..+.
T Consensus 399 ~~l~~L~~L~Ls~N~l~~~~p~~l~ 423 (636)
T 4eco_A 399 KSVSVMSAIDFSYNEIGSVDGKNFD 423 (636)
T ss_dssp TCSSCEEEEECCSSCTTTTTTCSSC
T ss_pred cccCccCEEECcCCcCCCcchhhhc
Confidence 65 788888888888888777664
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=5.4e-13 Score=154.07 Aligned_cols=176 Identities=18% Similarity=0.174 Sum_probs=130.4
Q ss_pred cccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEe-CCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQ 415 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~ 415 (929)
.++.|+.|+|..|.++.+++. +..+..|+.|+|..|++.......+..+..+..++.+++. ...+.. ....+
T Consensus 86 ~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~------i~~~~~~~~~~l 159 (440)
T 3zyj_A 86 HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNP------IESIPSYAFNRI 159 (440)
T ss_dssp SCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCC------CCEECTTTTTTC
T ss_pred CCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCc------ccccCHHHhhhC
Confidence 467789999999999999876 8999999999999998876433344444445544332111 222221 24467
Q ss_pred CCeeEEEecCCCCCccCCh-hhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 416 PSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~-~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
++|+.|+|++|+..+.++. .|.+|++|+.|+|++|+|+. +|.+..+++|+.|+|++|+|++..|..|.++++|+.|+|
T Consensus 160 ~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 238 (440)
T 3zyj_A 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238 (440)
T ss_dssp TTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-ccccCCCcccCEEECCCCccCccChhhhccCccCCEEEC
Confidence 7899999998544335554 78889999999999999985 467889999999999999999888889999999999999
Q ss_pred ccccccccccccc--cccceeccccCCc
Q 002382 495 QNNMLSGTVPSSL--LSKNVVLNYAGNI 520 (929)
Q Consensus 495 ~~N~l~g~~P~~l--~~~~~~l~~~~n~ 520 (929)
++|+|++..|..+ +..+..+.+.+|.
T Consensus 239 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 266 (440)
T 3zyj_A 239 IQSQIQVIERNAFDNLQSLVEINLAHNN 266 (440)
T ss_dssp TTCCCCEECTTSSTTCTTCCEEECTTSC
T ss_pred CCCceeEEChhhhcCCCCCCEEECCCCC
Confidence 9999994444433 2345666777774
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-12 Score=157.60 Aligned_cols=156 Identities=19% Similarity=0.214 Sum_probs=127.5
Q ss_pred cccccccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCC
Q 002382 334 YTNLSLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNS 412 (929)
Q Consensus 334 ~t~~~l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~ 412 (929)
.+.+.++.+..|++..|.++.+|+. +..+..|+.|++..|.+... .|- ..
T Consensus 45 ~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~-------------------~~~----------~~ 95 (597)
T 3oja_B 45 FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI-------------------DTY----------AF 95 (597)
T ss_dssp CSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEE-------------------CTT----------TT
T ss_pred cccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCC-------------------ChH----------Hh
Confidence 3466778889999999999999998 68899999999999987641 000 12
Q ss_pred CCCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcc
Q 002382 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 491 (929)
Q Consensus 413 ~~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~ 491 (929)
..+++|+.|+|++|.|++..|..|++|++|+.|+|++|.|++.++. |.++++|++|+|++|+|++..|..|+.+++|+.
T Consensus 96 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 175 (597)
T 3oja_B 96 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 175 (597)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCE
T ss_pred cCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcE
Confidence 3456899999999999987777889999999999999999988887 688999999999999999888888999999999
Q ss_pred cccccccccccccccccccceeccccCC
Q 002382 492 LYVQNNMLSGTVPSSLLSKNVVLNYAGN 519 (929)
Q Consensus 492 L~l~~N~l~g~~P~~l~~~~~~l~~~~n 519 (929)
|+|++|+|+ .+|...+..+..+.+.+|
T Consensus 176 L~L~~N~l~-~~~~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 176 LQLSSNRLT-HVDLSLIPSLFHANVSYN 202 (597)
T ss_dssp EECTTSCCS-BCCGGGCTTCSEEECCSS
T ss_pred EECcCCCCC-CcChhhhhhhhhhhcccC
Confidence 999999998 566666666666666655
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.9e-12 Score=132.09 Aligned_cols=108 Identities=23% Similarity=0.283 Sum_probs=97.6
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
++|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++.++. |.++++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus 31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence 47999999999999 8999999999999999999999999886 999999999999999999887889999999999999
Q ss_pred ccccccccccccccc---cceeccccCCcccccC
Q 002382 495 QNNMLSGTVPSSLLS---KNVVLNYAGNINLHEG 525 (929)
Q Consensus 495 ~~N~l~g~~P~~l~~---~~~~l~~~~n~~lc~~ 525 (929)
++|+|+ .+|...+. .+..+.+.+|+..|..
T Consensus 110 ~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 110 HGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CSSCCC-BCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCCCCC-eeChhhhhcCccccEEEeCCCCeecCC
Confidence 999999 78876544 4577788999887754
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-12 Score=148.22 Aligned_cols=156 Identities=19% Similarity=0.214 Sum_probs=131.1
Q ss_pred cccccccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCC
Q 002382 334 YTNLSLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNS 412 (929)
Q Consensus 334 ~t~~~l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~ 412 (929)
...+.+..++.|++..+.++.+|+. +..+..|+.|++..|.+... .+ -..
T Consensus 39 ~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~-------------------~~----------~~~ 89 (390)
T 3o6n_A 39 FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI-------------------DT----------YAF 89 (390)
T ss_dssp CSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEE-------------------CT----------TTT
T ss_pred ccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCccccc-------------------Ch----------hhc
Confidence 4467788899999999999999998 68999999999999987641 00 012
Q ss_pred CCCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcc
Q 002382 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 491 (929)
Q Consensus 413 ~~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~ 491 (929)
..+++|+.|+|++|++++..|..|.++++|++|+|++|+|++.++. |.++++|++|+|++|+|++..|..++.+++|+.
T Consensus 90 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 169 (390)
T 3o6n_A 90 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN 169 (390)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCE
T ss_pred cCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCE
Confidence 3467899999999999987788899999999999999999988877 688999999999999999877888999999999
Q ss_pred cccccccccccccccccccceeccccCC
Q 002382 492 LYVQNNMLSGTVPSSLLSKNVVLNYAGN 519 (929)
Q Consensus 492 L~l~~N~l~g~~P~~l~~~~~~l~~~~n 519 (929)
|+|++|+++ .++...+..+..+.+.+|
T Consensus 170 L~l~~n~l~-~~~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 170 LQLSSNRLT-HVDLSLIPSLFHANVSYN 196 (390)
T ss_dssp EECCSSCCS-BCCGGGCTTCSEEECCSS
T ss_pred EECCCCcCC-ccccccccccceeecccc
Confidence 999999999 567666677666666666
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.36 E-value=2.5e-13 Score=143.20 Aligned_cols=149 Identities=17% Similarity=0.098 Sum_probs=101.0
Q ss_pred ccceeeeeecc-cCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCC
Q 002382 339 LPFVLSFKFGK-TYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (929)
Q Consensus 339 l~~l~~l~l~~-n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (929)
++.|+.|+|.. |.++.+|+. +..+..|+.|++..|++.. ..+ ...++
T Consensus 79 l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-----------lp~--------------------~~~l~ 127 (239)
T 2xwt_C 79 LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-----------FPD--------------------LTKVY 127 (239)
T ss_dssp CTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-----------CCC--------------------CTTCC
T ss_pred CcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-----------ccc--------------------ccccc
Confidence 34555666665 666666553 5556666666666555432 000 11223
Q ss_pred C---eeEEEecCC-CCCccCChhhhccccCc-eeeccCCcCCCCCCCCCCCCCCcEEEecCCC-cCCCCCccccCC-CcC
Q 002382 417 S---ITVIHLSSK-NLTGNIPSDLTKLSSLV-ELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ-LTGPLPSSLMNL-PNL 489 (929)
Q Consensus 417 ~---l~~L~L~~n-~l~g~~p~~l~~L~~L~-~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~-l~g~~P~~l~~l-~~L 489 (929)
+ |+.|+|++| ++++..+..|.++++|+ .|+|++|+++..++.....++|+.|+|++|+ |++..+..|..+ ++|
T Consensus 128 ~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L 207 (239)
T 2xwt_C 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207 (239)
T ss_dssp BCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCC
T ss_pred ccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCC
Confidence 3 448888888 88865556688888888 8888888888666653333788888888884 885556678888 888
Q ss_pred cccccccccccccccccccccceeccccCC
Q 002382 490 RELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519 (929)
Q Consensus 490 ~~L~l~~N~l~g~~P~~l~~~~~~l~~~~n 519 (929)
+.|+|++|+|+ .+|...+..+..+...++
T Consensus 208 ~~L~l~~N~l~-~l~~~~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 208 SLLDVSQTSVT-ALPSKGLEHLKELIARNT 236 (239)
T ss_dssp SEEECTTCCCC-CCCCTTCTTCSEEECTTC
T ss_pred cEEECCCCccc-cCChhHhccCceeeccCc
Confidence 88888888888 777777666666665544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.36 E-value=3.8e-13 Score=130.85 Aligned_cols=127 Identities=17% Similarity=0.189 Sum_probs=107.6
Q ss_pred ccceeeeeecccCCC--CCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCC
Q 002382 339 LPFVLSFKFGKTYDS--SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (929)
Q Consensus 339 l~~l~~l~l~~n~~s--~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (929)
.+.++.|++..|.++ .+|+.+..+..|+.|+++.|.+... . ....++
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-----------~--------------------~~~~l~ 64 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-----------A--------------------NLPKLN 64 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-----------T--------------------TCCCCT
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-----------h--------------------hhhcCC
Confidence 467789999999998 8999999999999999999987641 0 113456
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCC--CCCCCCCCCcEEEecCCCcCCCCC---ccccCCCcCcc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI--PDFSGCPDLRIIHLEDNQLTGPLP---SSLMNLPNLRE 491 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~--p~~~~l~~L~~L~Ls~N~l~g~~P---~~l~~l~~L~~ 491 (929)
+|+.|+|++|++++.+|..+.++++|+.|+|++|++++.+ +.+.++++|++|+|++|++++..+ ..+..+++|+.
T Consensus 65 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~ 144 (149)
T 2je0_A 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTY 144 (149)
T ss_dssp TCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCE
T ss_pred CCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCccc
Confidence 8999999999999778988888999999999999999864 568999999999999999996554 47899999999
Q ss_pred ccccc
Q 002382 492 LYVQN 496 (929)
Q Consensus 492 L~l~~ 496 (929)
|++++
T Consensus 145 L~l~d 149 (149)
T 2je0_A 145 LDGYD 149 (149)
T ss_dssp ETTBC
T ss_pred ccCCC
Confidence 99864
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-13 Score=151.75 Aligned_cols=103 Identities=23% Similarity=0.206 Sum_probs=81.8
Q ss_pred CCCCCeeEEEecCCCCCc--cCC-hhhhccccCceeeccCCcCCCCCC--CCCCCCCCcEEEecCCCcCCCCCccccCCC
Q 002382 413 DPQPSITVIHLSSKNLTG--NIP-SDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPSSLMNLP 487 (929)
Q Consensus 413 ~~~~~l~~L~L~~n~l~g--~~p-~~l~~L~~L~~L~Ls~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~ 487 (929)
..+++|+.|+|++|+|++ .++ ..+.++++|+.|+|++|+|++.+| .+..+++|++|+|++|+|+ .+|..+. +
T Consensus 198 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~ 274 (312)
T 1wwl_A 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--A 274 (312)
T ss_dssp TSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--S
T ss_pred ccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--C
Confidence 356789999999999983 233 334578999999999999999875 4677999999999999999 8898887 8
Q ss_pred cCcccccccccccccccccc--cccceeccccCCc
Q 002382 488 NLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI 520 (929)
Q Consensus 488 ~L~~L~l~~N~l~g~~P~~l--~~~~~~l~~~~n~ 520 (929)
+|+.|+|++|+|++ +|. + +..+..+.+.+|+
T Consensus 275 ~L~~L~Ls~N~l~~-~p~-~~~l~~L~~L~L~~N~ 307 (312)
T 1wwl_A 275 KLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNP 307 (312)
T ss_dssp EEEEEECCSSCCCS-CCC-TTTSCEEEEEECTTCT
T ss_pred CceEEECCCCCCCC-Chh-HhhCCCCCEEeccCCC
Confidence 99999999999994 466 3 2334566677775
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.5e-12 Score=146.35 Aligned_cols=146 Identities=19% Similarity=0.257 Sum_probs=122.1
Q ss_pred eeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCC-CCCCeeEE
Q 002382 343 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSD-PQPSITVI 421 (929)
Q Consensus 343 ~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~-~~~~l~~L 421 (929)
..+++..+.++.+|..+.. .++.|+|+.|++... ...+ .. ++++|+.|
T Consensus 21 ~~l~c~~~~l~~iP~~~~~--~l~~L~Ls~N~l~~l----------~~~~-------------------~~~~l~~L~~L 69 (361)
T 2xot_A 21 NILSCSKQQLPNVPQSLPS--YTALLDLSHNNLSRL----------RAEW-------------------TPTRLTNLHSL 69 (361)
T ss_dssp TEEECCSSCCSSCCSSCCT--TCSEEECCSSCCCEE----------CTTS-------------------SSSCCTTCCEE
T ss_pred CEEEeCCCCcCccCccCCC--CCCEEECCCCCCCcc----------Chhh-------------------hhhcccccCEE
Confidence 3577889999999987654 488999999987641 0011 11 46799999
Q ss_pred EecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccccc
Q 002382 422 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 500 (929)
Q Consensus 422 ~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~ 500 (929)
+|++|+|++..|..|.+|++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+
T Consensus 70 ~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 149 (361)
T 2xot_A 70 LLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149 (361)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC
Confidence 9999999977778899999999999999999998886 899999999999999999888899999999999999999999
Q ss_pred cccccccc------ccceeccccCCc
Q 002382 501 GTVPSSLL------SKNVVLNYAGNI 520 (929)
Q Consensus 501 g~~P~~l~------~~~~~l~~~~n~ 520 (929)
.+|..++ ..+..+.+.+|.
T Consensus 150 -~l~~~~~~~~~~l~~L~~L~L~~N~ 174 (361)
T 2xot_A 150 -RFPVELIKDGNKLPKLMLLDLSSNK 174 (361)
T ss_dssp -SCCGGGTC----CTTCCEEECCSSC
T ss_pred -eeCHHHhcCcccCCcCCEEECCCCC
Confidence 7888774 344566677764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.7e-13 Score=163.06 Aligned_cols=175 Identities=21% Similarity=0.194 Sum_probs=99.3
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCC-------------ccH---HHHHHHHhhcCCCCcccCCCCC-C
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGS-------------IDG---VAIVSVISLYSSADWAQEGGDP-C 400 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~-------------~~~---~~~~~l~~l~~~~~w~~~~~dp-c 400 (929)
..++++.|+|+.|.++.||+.|+.+..|+.|++++|. ... ..+..+.++..+.... .+.. -
T Consensus 347 ~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~--~n~~~~ 424 (567)
T 1dce_A 347 TDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMR--AAYLDD 424 (567)
T ss_dssp TTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGG--HHHHHH
T ss_pred cCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchh--hcccch
Confidence 3556778999999999999999999999999987663 111 1222222221111000 0000 0
Q ss_pred CCCCC-c--eeEeCCCCCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCC
Q 002382 401 LPVPW-S--WLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTG 477 (929)
Q Consensus 401 ~~~~~-~--~~~c~~~~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g 477 (929)
.+.-+ . .+.. -....|+.|+|++|+|++ +|. |++|++|+.|+|++|+|+.+++.|++|++|+.|+|++|+|++
T Consensus 425 L~~l~l~~n~i~~--l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~ 500 (567)
T 1dce_A 425 LRSKFLLENSVLK--MEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN 500 (567)
T ss_dssp HHHHHHHHHHHHH--HHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC
T ss_pred hhhhhhhcccccc--cCccCceEEEecCCCCCC-CcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC
Confidence 00000 0 0000 001146667777777763 565 666777777777777776444456667777777777777764
Q ss_pred CCCccccCCCcCcccccccccccccc-cccc--cccceeccccCCc
Q 002382 478 PLPSSLMNLPNLRELYVQNNMLSGTV-PSSL--LSKNVVLNYAGNI 520 (929)
Q Consensus 478 ~~P~~l~~l~~L~~L~l~~N~l~g~~-P~~l--~~~~~~l~~~~n~ 520 (929)
+| .+++|++|+.|+|++|+|++.. |..+ +..+..+.+.+|.
T Consensus 501 -lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~ 544 (567)
T 1dce_A 501 -VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544 (567)
T ss_dssp -CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred -Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCc
Confidence 55 6666777777777777776443 5555 2344555555554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=5.6e-13 Score=160.19 Aligned_cols=180 Identities=18% Similarity=0.111 Sum_probs=106.6
Q ss_pred ccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHH-HHHHhhcCCCCcccCCCCCCCCCCCcee-EeCCCCC
Q 002382 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAI-VSVISLYSSADWAQEGGDPCLPVPWSWL-QCNSDPQ 415 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~-~~l~~l~~~~~w~~~~~dpc~~~~~~~~-~c~~~~~ 415 (929)
++.|+.|++..|.++.++|. +..+..|+.|+++.|++..... ..+..+..+..+..++ |. .... ......+
T Consensus 375 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~---n~---l~~~~~~~~~~l 448 (606)
T 3t6q_A 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSH---SL---LDISSEQLFDGL 448 (606)
T ss_dssp CTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTT---CC---CBTTCTTTTTTC
T ss_pred CCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCC---Cc---cCCcCHHHHhCC
Confidence 34555555555555555443 5555556666665555432111 1122222222222111 00 0000 0112345
Q ss_pred CCeeEEEecCCCCCcc---CChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcc
Q 002382 416 PSITVIHLSSKNLTGN---IPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 491 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~---~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~ 491 (929)
++|+.|+|++|++++. .+..+..+++|+.|+|++|++++.+|. |.++++|+.|+|++|+|++..|..+.++++| .
T Consensus 449 ~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~ 527 (606)
T 3t6q_A 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-Y 527 (606)
T ss_dssp TTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-E
T ss_pred CCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-E
Confidence 6778888888877752 235677778888888888888877664 7778888888888888887777788888888 8
Q ss_pred cccccccccccccccc--cccceeccccCCcccccC
Q 002382 492 LYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEG 525 (929)
Q Consensus 492 L~l~~N~l~g~~P~~l--~~~~~~l~~~~n~~lc~~ 525 (929)
|+|++|++++..|..+ +..+..+.+.+|+..|..
T Consensus 528 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 528 LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp EECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred EECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 8888888885444433 344566777788777644
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.35 E-value=4.9e-13 Score=148.30 Aligned_cols=172 Identities=16% Similarity=0.169 Sum_probs=120.8
Q ss_pred cceeeeeecccCCCCCCCc-cchhccceeccCCCCCccH--HHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCC
Q 002382 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDG--VAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~--~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (929)
++|+.|++..|.++.+|+. +..+..|+.|+++.|.+.. .....+..+ .+....... |. ...+.. .-.+
T Consensus 123 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~---n~---l~~l~~--~~~~ 193 (332)
T 2ft3_A 123 SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISE---AK---LTGIPK--DLPE 193 (332)
T ss_dssp TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCS---SB---CSSCCS--SSCS
T ss_pred ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcC---CC---CCccCc--cccC
Confidence 5677777888888877775 7778888888888777653 111111111 222221110 00 111111 1125
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 495 (929)
+|+.|+|++|++++..|..|.++++|+.|+|++|++++.++. +..+++|+.|+|++|+|+ .+|..+..+++|+.|+|+
T Consensus 194 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~ 272 (332)
T 2ft3_A 194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272 (332)
T ss_dssp SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECC
T ss_pred CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECC
Confidence 899999999999977778899999999999999999998885 888999999999999999 889999999999999999
Q ss_pred ccccccccccccccc---------ceeccccCCccc
Q 002382 496 NNMLSGTVPSSLLSK---------NVVLNYAGNINL 522 (929)
Q Consensus 496 ~N~l~g~~P~~l~~~---------~~~l~~~~n~~l 522 (929)
+|+|+ .+|...+.. +..+.+.+|+..
T Consensus 273 ~N~l~-~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 273 TNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp SSCCC-BCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred CCCCC-ccChhHccccccccccccccceEeecCccc
Confidence 99999 666544322 234566677543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.5e-12 Score=142.95 Aligned_cols=168 Identities=23% Similarity=0.263 Sum_probs=128.0
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (929)
.++.++.|++..+.++.+| .+..+..|+.|+++.|.+..... +..+..++.+..+++. ...+. ....+++
T Consensus 39 ~l~~L~~L~l~~~~i~~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~------l~~~~-~~~~l~~ 108 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP------LKNVS-AIAGLQS 108 (308)
T ss_dssp HHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC------CSCCG-GGTTCTT
T ss_pred HcCCcCEEEeeCCCccCch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCc------CCCch-hhcCCCC
Confidence 4678899999999999997 68999999999999999876332 5555556555432211 11111 2345778
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
|+.|+|++|+|++ +|. +..|++|+.|+|++|++++.++ +.++++|+.|+|++|+|++ +|. +..+++|+.|+|++|
T Consensus 109 L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n 183 (308)
T 1h6u_A 109 IKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDN 183 (308)
T ss_dssp CCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSS
T ss_pred CCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCC
Confidence 9999999999995 554 9999999999999999998766 8889999999999999995 554 899999999999999
Q ss_pred cccccccccccccceeccccCCc
Q 002382 498 MLSGTVPSSLLSKNVVLNYAGNI 520 (929)
Q Consensus 498 ~l~g~~P~~l~~~~~~l~~~~n~ 520 (929)
++++..|-.-+..+..+.+.+|.
T Consensus 184 ~l~~~~~l~~l~~L~~L~L~~N~ 206 (308)
T 1h6u_A 184 KISDISPLASLPNLIEVHLKNNQ 206 (308)
T ss_dssp CCCCCGGGGGCTTCCEEECTTSC
T ss_pred ccCcChhhcCCCCCCEEEccCCc
Confidence 99944332234455667777764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=3.8e-13 Score=147.83 Aligned_cols=176 Identities=16% Similarity=0.088 Sum_probs=122.9
Q ss_pred cccceeeeeecccCCCCCCCc-c--chhccceeccCCCCCccHH----HHHHHHhhcCCCCcccCCCCCCCCCCCceeEe
Q 002382 338 SLPFVLSFKFGKTYDSSRGPL-L--NAMEINKYLERNDGSIDGV----AIVSVISLYSSADWAQEGGDPCLPVPWSWLQC 410 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~-i--~~le~l~~L~l~~n~~~~~----~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c 410 (929)
.++.++.|+|..|.++..+|. + ..+..|+.|+++.|++... ....+..+..++.++.+++. ...+.+
T Consensus 89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~------l~~~~~ 162 (310)
T 4glp_A 89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAH------SPAFSC 162 (310)
T ss_dssp HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCS------SCCCCT
T ss_pred ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCC------cchhhH
Confidence 345688999999998866555 5 8899999999999987641 11222233344444332111 122222
Q ss_pred -CCCCCCCeeEEEecCCCCCcc--CC--hhhhccccCceeeccCCcCCCCCCC----CCCCCCCcEEEecCCCcCCCCCc
Q 002382 411 -NSDPQPSITVIHLSSKNLTGN--IP--SDLTKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIHLEDNQLTGPLPS 481 (929)
Q Consensus 411 -~~~~~~~l~~L~L~~n~l~g~--~p--~~l~~L~~L~~L~Ls~N~l~~~~p~----~~~l~~L~~L~Ls~N~l~g~~P~ 481 (929)
....+++|+.|+|++|++.+. ++ ..+.++++|++|+|++|+|+...+. +.++++|++|||++|+|++..|.
T Consensus 163 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~ 242 (310)
T 4glp_A 163 EQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNP 242 (310)
T ss_dssp TSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCS
T ss_pred HHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchh
Confidence 234567888899998888752 32 2346788888888888888754442 46788889999999999877788
Q ss_pred cccCC---CcCcccccccccccccccccccccceeccccCCc
Q 002382 482 SLMNL---PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 520 (929)
Q Consensus 482 ~l~~l---~~L~~L~l~~N~l~g~~P~~l~~~~~~l~~~~n~ 520 (929)
.++.+ ++|+.|+|++|+|+ .+|..+...+..+.+.+|.
T Consensus 243 ~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~ 283 (310)
T 4glp_A 243 SAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNR 283 (310)
T ss_dssp CCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCC
T ss_pred hHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCc
Confidence 77777 58889999999998 8888887777777777774
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=2.2e-12 Score=149.16 Aligned_cols=140 Identities=19% Similarity=0.155 Sum_probs=120.9
Q ss_pred ccccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCC
Q 002382 337 LSLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQ 415 (929)
Q Consensus 337 ~~l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~ 415 (929)
...++++.|+|..|.++.++|. +..+..|+.|+++.|++... .|. ....+
T Consensus 272 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-------------------~~~----------~~~~l 322 (455)
T 3v47_A 272 LEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKI-------------------DDN----------AFWGL 322 (455)
T ss_dssp GTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEE-------------------CTT----------TTTTC
T ss_pred ccccCceEEEecCccccccchhhcccCCCCCEEECCCCccccc-------------------Chh----------HhcCc
Confidence 3446789999999999998776 89999999999999987641 110 12345
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
++|+.|+|++|+|++..|..|.++++|+.|+|++|++++.+|. |.++++|++|+|++|+|++..+..+..+++|+.|+|
T Consensus 323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 402 (455)
T 3v47_A 323 THLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWL 402 (455)
T ss_dssp TTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred ccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEc
Confidence 6999999999999988899999999999999999999999775 899999999999999999766667899999999999
Q ss_pred ccccccccccc
Q 002382 495 QNNMLSGTVPS 505 (929)
Q Consensus 495 ~~N~l~g~~P~ 505 (929)
++|++++..|.
T Consensus 403 ~~N~l~~~~~~ 413 (455)
T 3v47_A 403 HTNPWDCSCPR 413 (455)
T ss_dssp CSSCBCCCTTT
T ss_pred cCCCcccCCCc
Confidence 99999988883
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=1.2e-12 Score=155.93 Aligned_cols=114 Identities=20% Similarity=0.187 Sum_probs=93.7
Q ss_pred CCCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCC-CCCC-CCCCCCCCcEEEecCCCcCCCCCccccCCCcCc
Q 002382 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-GPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 490 (929)
Q Consensus 413 ~~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~-~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~ 490 (929)
..+++|+.|+|++|++++.+|..+.++++|+.|+|++|+++ +.+| .+..+++|+.|+|++|++++..|..+.++++|+
T Consensus 418 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 497 (570)
T 2z63_A 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497 (570)
T ss_dssp TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred hcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCC
Confidence 35678999999999999888889999999999999999997 4555 588899999999999999988888999999999
Q ss_pred ccccccccccccccccc--cccceeccccCCcccccCC
Q 002382 491 ELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGG 526 (929)
Q Consensus 491 ~L~l~~N~l~g~~P~~l--~~~~~~l~~~~n~~lc~~~ 526 (929)
.|+|++|++++..|..+ +..+..+.+.+|+..|..+
T Consensus 498 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred EEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 99999999995444433 3445677888888777554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.33 E-value=1.3e-12 Score=142.30 Aligned_cols=125 Identities=25% Similarity=0.391 Sum_probs=72.7
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
++.|+.|+|+.|.++.+++ +..+..|+.|+++.|.+... ..+.. +++|
T Consensus 67 l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~--~~l~~-----------------------------l~~L 114 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDL--SSLKD-----------------------------LKKL 114 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCG--GGGTT-----------------------------CTTC
T ss_pred CCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCC--hhhcc-----------------------------CCCC
Confidence 5678889999999999988 89999999999999987651 12222 2344
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
+.|+|++|+|++ + +.+..|++|+.|+|++|++++. +.+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+
T Consensus 115 ~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 115 KSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH 189 (291)
T ss_dssp CEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred CEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence 555555555542 2 2344455555555555555443 334445555555555555543222 4444555555555555
Q ss_pred cc
Q 002382 499 LS 500 (929)
Q Consensus 499 l~ 500 (929)
|+
T Consensus 190 i~ 191 (291)
T 1h6t_A 190 IS 191 (291)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=7.1e-13 Score=154.52 Aligned_cols=155 Identities=17% Similarity=0.132 Sum_probs=100.6
Q ss_pred ceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEe-CCCCCCCe
Q 002382 341 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQPSI 418 (929)
Q Consensus 341 ~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~~~l 418 (929)
.++.|+|..|.++.++|. +..+..|+.|++..|.+.......+.++..++.++.+++. ...+.. ...++++|
T Consensus 33 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~------l~~~~~~~~~~l~~L 106 (477)
T 2id5_A 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR------LKLIPLGVFTGLSNL 106 (477)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC------CCSCCTTSSTTCTTC
T ss_pred CCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc------CCccCcccccCCCCC
Confidence 456677777777777653 7777777777777777655333344444444433321110 111111 12345677
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
+.|+|++|++++..|..|.+|++|+.|+|++|++++..+. |.++++|+.|+|++|+|++..+..+.++++|+.|+|++|
T Consensus 107 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n 186 (477)
T 2id5_A 107 TKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL 186 (477)
T ss_dssp CEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESC
T ss_pred CEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCC
Confidence 7777777777777777777777777777777777777663 777777777777777777555556777777777777777
Q ss_pred cccc
Q 002382 498 MLSG 501 (929)
Q Consensus 498 ~l~g 501 (929)
++++
T Consensus 187 ~i~~ 190 (477)
T 2id5_A 187 NINA 190 (477)
T ss_dssp CCCE
T ss_pred cCcE
Confidence 7773
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.6e-13 Score=151.88 Aligned_cols=139 Identities=23% Similarity=0.135 Sum_probs=86.7
Q ss_pred cceeeeeecccCCCCCCC-ccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 340 PFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP-~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
+.++.|+|..|.++.+|+ .+..+..|+.|+++.|++....... ..++++|
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-----------------------------~~~l~~L 102 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDS-----------------------------FSSLGSL 102 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTT-----------------------------TTTCTTC
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhh-----------------------------cCCCCCC
Confidence 356788888888888888 5888888888888888775411111 1234466
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCC--CCCCCCCCcEEEecCC-CcCCCCCccccCCCcCcccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDN-QLTGPLPSSLMNLPNLRELYVQ 495 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p--~~~~l~~L~~L~Ls~N-~l~g~~P~~l~~l~~L~~L~l~ 495 (929)
+.|+|++|+|++..+..|.++++|++|+|++|++++.++ .+.++++|++|+|++| .+++..|..++++++|+.|+++
T Consensus 103 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 182 (353)
T 2z80_A 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182 (353)
T ss_dssp CEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred CEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECC
Confidence 666666666663222236666666666666666665555 3566666666666666 3554445566666666666666
Q ss_pred cccccccccccc
Q 002382 496 NNMLSGTVPSSL 507 (929)
Q Consensus 496 ~N~l~g~~P~~l 507 (929)
+|++++..|..+
T Consensus 183 ~n~l~~~~~~~l 194 (353)
T 2z80_A 183 ASDLQSYEPKSL 194 (353)
T ss_dssp ETTCCEECTTTT
T ss_pred CCCcCccCHHHH
Confidence 666664445444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.32 E-value=8.4e-13 Score=145.58 Aligned_cols=105 Identities=15% Similarity=0.137 Sum_probs=55.5
Q ss_pred CCeeEEEecCCCCCccCChhhh-ccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~-~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
++|+.|+|++|++++..|..+. .+++|+.|+|++|+|++. +....+++|++|+|++|+|+ .+|..+..+++|+.|+|
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L 221 (317)
T 3o53_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221 (317)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEEC
T ss_pred CCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCC-cchhhhcccCcccEEEC
Confidence 4455555555555544444442 455555555555555544 22333556666666666666 34444666666666666
Q ss_pred cccccccccccccc--ccceeccccCCcccc
Q 002382 495 QNNMLSGTVPSSLL--SKNVVLNYAGNINLH 523 (929)
Q Consensus 495 ~~N~l~g~~P~~l~--~~~~~l~~~~n~~lc 523 (929)
++|+|+ .+|..+. ..+..+.+.+|+..|
T Consensus 222 ~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp TTSCCC-EECTTCCCCTTCCEEECTTCCCBH
T ss_pred cCCccc-chhhHhhcCCCCCEEEccCCCccC
Confidence 666666 5555442 233455555555444
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=2.2e-12 Score=155.00 Aligned_cols=178 Identities=20% Similarity=0.185 Sum_probs=117.2
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeE-eCCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQP 416 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~-c~~~~~~ 416 (929)
.++.|+.|+|..|.++.+|+.+..+..|+.|++..|++.......+..+..+..+...+..-.. .+. -....++
T Consensus 276 ~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~-----~~~~~~~~~l~ 350 (606)
T 3t6q_A 276 CFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRL-----ELGTGCLENLE 350 (606)
T ss_dssp TCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCC-----BCCSSTTTTCT
T ss_pred cccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCccc-----ccchhhhhccC
Confidence 3567888999999999999999999999999999988776444455555555544332111000 000 0123456
Q ss_pred CeeEEEecCCCCCccC--ChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCcc-ccCCCcCccc
Q 002382 417 SITVIHLSSKNLTGNI--PSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSS-LMNLPNLREL 492 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~--p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~-l~~l~~L~~L 492 (929)
+|+.|+|++|++++.. |..+.++++|+.|+|++|++++.+|. |.++++|+.|+|++|++++..|.. +.++++|+.|
T Consensus 351 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 430 (606)
T 3t6q_A 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430 (606)
T ss_dssp TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEE
T ss_pred cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEE
Confidence 7777777777777554 66677777777777777777776664 677777777777777777665543 7777777777
Q ss_pred ccccccccccccccc--cccceeccccCCc
Q 002382 493 YVQNNMLSGTVPSSL--LSKNVVLNYAGNI 520 (929)
Q Consensus 493 ~l~~N~l~g~~P~~l--~~~~~~l~~~~n~ 520 (929)
++++|++++..|..+ +..+..+.+.+|.
T Consensus 431 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 460 (606)
T 3t6q_A 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNH 460 (606)
T ss_dssp ECTTCCCBTTCTTTTTTCTTCCEEECTTCB
T ss_pred ECCCCccCCcCHHHHhCCCCCCEEECCCCC
Confidence 777777775555544 3344555555553
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.31 E-value=3.5e-12 Score=152.79 Aligned_cols=101 Identities=27% Similarity=0.402 Sum_probs=67.9
Q ss_pred CCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccc
Q 002382 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (929)
Q Consensus 414 ~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 493 (929)
.+++|+.|+|++|+|++ + +.+..|++|+.|+|++|+|++. +.+..|++|+.|+|++|+|++..| +..|++|+.|+
T Consensus 107 ~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 181 (605)
T 1m9s_A 107 DLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 181 (605)
T ss_dssp TCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred cCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEE
Confidence 45677777777777774 3 3477777777777777777765 567777777777777777775444 77777777777
Q ss_pred cccccccccccc-cccccceeccccCCc
Q 002382 494 VQNNMLSGTVPS-SLLSKNVVLNYAGNI 520 (929)
Q Consensus 494 l~~N~l~g~~P~-~l~~~~~~l~~~~n~ 520 (929)
|++|+|+ .+|. .-+..+..|.+.+|.
T Consensus 182 Ls~N~i~-~l~~l~~l~~L~~L~L~~N~ 208 (605)
T 1m9s_A 182 LSKNHIS-DLRALAGLKNLDVLELFSQE 208 (605)
T ss_dssp CCSSCCC-BCGGGTTCTTCSEEECCSEE
T ss_pred CcCCCCC-CChHHccCCCCCEEEccCCc
Confidence 7777777 3442 113344555555554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=2.3e-12 Score=152.74 Aligned_cols=176 Identities=12% Similarity=0.014 Sum_probs=109.0
Q ss_pred cceeeeeecccCCCCCCCcc-chhccceeccCCCCCccHHHHHH---HHhhcCCCCcccCCCCCCCCCCCceeE---eCC
Q 002382 340 PFVLSFKFGKTYDSSRGPLL-NAMEINKYLERNDGSIDGVAIVS---VISLYSSADWAQEGGDPCLPVPWSWLQ---CNS 412 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~i-~~le~l~~L~l~~n~~~~~~~~~---l~~l~~~~~w~~~~~dpc~~~~~~~~~---c~~ 412 (929)
..++.|++..|.++.+|+.+ ..+..|+.|+++.|++....+.. +..+..+..+..++ |. ...+. -..
T Consensus 310 ~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~---N~---l~~~~~~~~~~ 383 (549)
T 2z81_A 310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ---NH---LRSMQKTGEIL 383 (549)
T ss_dssp TTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTT---SC---CCCHHHHHHHG
T ss_pred ccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccC---Cc---ccccccchhhh
Confidence 45677777778887777775 46777888888877776644332 22333333332221 10 11110 012
Q ss_pred CCCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCC------------------CCCCCCcEEEecCCC
Q 002382 413 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF------------------SGCPDLRIIHLEDNQ 474 (929)
Q Consensus 413 ~~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~------------------~~l~~L~~L~Ls~N~ 474 (929)
..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+..+ .++++|++|+|++|+
T Consensus 384 ~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~ 462 (549)
T 2z81_A 384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNK 462 (549)
T ss_dssp GGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSC
T ss_pred hcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhhhcccCChhcEEECCCCc
Confidence 33556777777777777 66777777777777777777666543322 257778888888888
Q ss_pred cCCCCCccccCCCcCcccccccccccccccccc--cccceeccccCCccccc
Q 002382 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHE 524 (929)
Q Consensus 475 l~g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l--~~~~~~l~~~~n~~lc~ 524 (929)
|+ .+|. ...+++|+.|+|++|+|++..|..+ +..+..+.+.+|+..|.
T Consensus 463 l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 463 LK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp CS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred cC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence 87 6776 4667888888888888885444433 33456677777876553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.31 E-value=2.2e-12 Score=140.50 Aligned_cols=146 Identities=21% Similarity=0.227 Sum_probs=120.2
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (929)
.++.++.|++..|.++.+|. +..+..|+.|+++.|++... .+ ...+++
T Consensus 44 ~l~~L~~L~l~~~~i~~~~~-~~~l~~L~~L~L~~n~l~~~-------------------~~------------l~~l~~ 91 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTDI-------------------KP------------LANLKN 91 (291)
T ss_dssp HHHTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCCC-------------------GG------------GTTCTT
T ss_pred hcCcccEEEccCCCcccChh-HhcCCCCCEEEccCCccCCC-------------------cc------------cccCCC
Confidence 46778899999999999964 88899999999999987630 00 134569
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
|+.|+|++|+|++ +|. +.+|++|+.|+|++|+|++. +.+..+++|+.|+|++|+|++. ..++.+++|+.|+|++|
T Consensus 92 L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N 166 (291)
T 1h6t_A 92 LGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDN 166 (291)
T ss_dssp CCEEECCSSCCCC-GGG-GTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSS
T ss_pred CCEEECCCCcCCC-Chh-hccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCC
Confidence 9999999999995 554 99999999999999999985 7799999999999999999954 68999999999999999
Q ss_pred cccccccccccccceeccccCCc
Q 002382 498 MLSGTVPSSLLSKNVVLNYAGNI 520 (929)
Q Consensus 498 ~l~g~~P~~l~~~~~~l~~~~n~ 520 (929)
+|++..|-.-+..+..+.+.+|.
T Consensus 167 ~l~~~~~l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 167 QISDIVPLAGLTKLQNLYLSKNH 189 (291)
T ss_dssp CCCCCGGGTTCTTCCEEECCSSC
T ss_pred ccccchhhcCCCccCEEECCCCc
Confidence 99955552224455667777774
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.31 E-value=5e-12 Score=126.20 Aligned_cols=85 Identities=28% Similarity=0.339 Sum_probs=62.4
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 495 (929)
+|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++.++. |.++++|++|+|++|+|++..|..|..+++|+.|+|+
T Consensus 31 ~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 110 (170)
T 3g39_A 31 TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLL 110 (170)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeC
Confidence 567777777777766677777777777777777777777765 5677777777777777775555567777777777777
Q ss_pred cccccc
Q 002382 496 NNMLSG 501 (929)
Q Consensus 496 ~N~l~g 501 (929)
+|+++.
T Consensus 111 ~N~~~c 116 (170)
T 3g39_A 111 NNPWDC 116 (170)
T ss_dssp SSCBCT
T ss_pred CCCCCC
Confidence 777763
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.31 E-value=3.2e-12 Score=152.32 Aligned_cols=157 Identities=17% Similarity=0.203 Sum_probs=114.8
Q ss_pred cccceeeeeecccCCCC-CCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSS-RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~-lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (929)
.+++++.|+|+.|.++. +|+.+..+..|+.|+++.|++.... .+.-....++
T Consensus 351 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---------------------------~~~~~~~~l~ 403 (562)
T 3a79_B 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFF---------------------------KVALMTKNMS 403 (562)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTT---------------------------HHHHTTTTCT
T ss_pred CCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcc---------------------------cchhhhcCCC
Confidence 45677888888888887 4556888888888888888776310 0000123456
Q ss_pred CeeEEEecCCCCCccCChh-hhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 417 SITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~-l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
+|+.|+|++|++++.+|.. +..+++|+.|+|++|+|++.+|. +. ++|+.|+|++|+|+ .+|..+..+++|+.|+|
T Consensus 404 ~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L 480 (562)
T 3a79_B 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNV 480 (562)
T ss_dssp TCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEEC
T ss_pred CCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEEC
Confidence 7888888888888756654 77788888888888888876664 33 68888888888888 78887778888888888
Q ss_pred cccccccccccccc---ccceeccccCCcccccC
Q 002382 495 QNNMLSGTVPSSLL---SKNVVLNYAGNINLHEG 525 (929)
Q Consensus 495 ~~N~l~g~~P~~l~---~~~~~l~~~~n~~lc~~ 525 (929)
++|+|+ .+|...+ ..+..+.+.+|+..|..
T Consensus 481 ~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 481 ASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp CSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred CCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence 888888 7887743 33456677788766643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=3.8e-12 Score=152.90 Aligned_cols=139 Identities=14% Similarity=0.148 Sum_probs=112.1
Q ss_pred cceeeeeecccCCCCCCC-ccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 340 PFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP-~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
+.++.|+|+.|.++.+|+ .+..+..|+.|+++.|.+... .|- ...++++|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i-------------------~~~----------~~~~l~~L 82 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI-------------------EDK----------AWHGLHHL 82 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEE-------------------CTT----------TTTTCTTC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCccccc-------------------CHH----------Hhhchhhc
Confidence 567889999999999998 599999999999999987541 000 12345688
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCC-CCCCCCCCcEEEecCCCcCC-CCCccccCCCcCccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQN 496 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g-~~P~~l~~l~~L~~L~l~~ 496 (929)
+.|+|++|+|++..|..|++|++|++|+|++|++++.++ .++++++|++|+|++|++++ .+|..++++++|+.|+|++
T Consensus 83 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~ 162 (606)
T 3vq2_A 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162 (606)
T ss_dssp CEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCS
T ss_pred CEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccC
Confidence 899999999887778888889999999999999888775 48888999999999998885 5788888899999999999
Q ss_pred ccccccccccc
Q 002382 497 NMLSGTVPSSL 507 (929)
Q Consensus 497 N~l~g~~P~~l 507 (929)
|++++..|..+
T Consensus 163 n~l~~~~~~~~ 173 (606)
T 3vq2_A 163 NYIQTITVNDL 173 (606)
T ss_dssp SCCCEECTTTT
T ss_pred CcceecChhhh
Confidence 98885444443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.31 E-value=5e-13 Score=163.86 Aligned_cols=138 Identities=16% Similarity=0.145 Sum_probs=76.5
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
++.|+.|+|+.|.++.+|+.+..+..|+.|+|+.|.+.. +.. ....+++|
T Consensus 223 l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~~-----------lp~-------------------~~~~l~~L 272 (727)
T 4b8c_D 223 DQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLTE-----------LPA-------------------EIKNLSNL 272 (727)
T ss_dssp CCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCSC-----------CCG-------------------GGGGGTTC
T ss_pred CCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCcc-----------cCh-------------------hhhCCCCC
Confidence 344555666666666666655566666666666555432 000 01123456
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCc-Ccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPN-LRELYVQNN 497 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~-L~~L~l~~N 497 (929)
+.|+|++|+|+ .+|..|++|++|+.|+|++|.|+.+++.|++|++|++|+|++|+|++.+|..+..+.. +..|+|++|
T Consensus 273 ~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N 351 (727)
T 4b8c_D 273 RVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDN 351 (727)
T ss_dssp CEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHC
T ss_pred CEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccC
Confidence 66666666666 5566666666666666666666544445666666666666666666655555544322 123556666
Q ss_pred cccccccccc
Q 002382 498 MLSGTVPSSL 507 (929)
Q Consensus 498 ~l~g~~P~~l 507 (929)
.++|.+|..+
T Consensus 352 ~l~~~~p~~l 361 (727)
T 4b8c_D 352 RPEIPLPHER 361 (727)
T ss_dssp CCCCCCCCC-
T ss_pred cccCcCcccc
Confidence 6666666544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.31 E-value=1.9e-12 Score=136.42 Aligned_cols=148 Identities=18% Similarity=0.128 Sum_probs=113.8
Q ss_pred ceeeeeecccCCCCCCC-ccchhccceeccCCCCC-ccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 341 FVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGS-IDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 341 ~l~~l~l~~n~~s~lPP-~i~~le~l~~L~l~~n~-~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
.++.|+|..|.++.+|+ .+..+..|+.|++..|. +..+ .+. ...++++|
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i-------------------~~~----------~f~~l~~L 82 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQL-------------------ESH----------SFYNLSKV 82 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEE-------------------CTT----------TEESCTTC
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCccee-------------------CHh----------HcCCCcCC
Confidence 67889999999999999 58899999999999886 6531 000 01234588
Q ss_pred eEEEecC-CCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCc---EEEecCC-CcCCCCCccccCCCcCc-cc
Q 002382 419 TVIHLSS-KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLR---IIHLEDN-QLTGPLPSSLMNLPNLR-EL 492 (929)
Q Consensus 419 ~~L~L~~-n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~---~L~Ls~N-~l~g~~P~~l~~l~~L~-~L 492 (929)
+.|+|++ |+|++..+..|.++++|+.|+|++|++++ +|.+.++++|+ +|+|++| +|++..+..|.++++|+ .|
T Consensus 83 ~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L 161 (239)
T 2xwt_C 83 THIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161 (239)
T ss_dssp CEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCCCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEE
T ss_pred cEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccccccccccccccEEECCCCcchhhcCcccccchhcceeEE
Confidence 8899988 88886556678888899999999998888 44477788887 8999998 88865556788888898 89
Q ss_pred cccccccccccccccccc--ceeccccCC
Q 002382 493 YVQNNMLSGTVPSSLLSK--NVVLNYAGN 519 (929)
Q Consensus 493 ~l~~N~l~g~~P~~l~~~--~~~l~~~~n 519 (929)
++++|+++ .+|...+.. +..+.+.+|
T Consensus 162 ~l~~n~l~-~i~~~~~~~~~L~~L~L~~n 189 (239)
T 2xwt_C 162 KLYNNGFT-SVQGYAFNGTKLDAVYLNKN 189 (239)
T ss_dssp ECCSCCCC-EECTTTTTTCEEEEEECTTC
T ss_pred EcCCCCCc-ccCHhhcCCCCCCEEEcCCC
Confidence 99999888 888776544 345556666
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.30 E-value=6.2e-12 Score=126.09 Aligned_cols=84 Identities=25% Similarity=0.364 Sum_probs=41.5
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 495 (929)
+|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++.++. |.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 34 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~ 113 (174)
T 2r9u_A 34 DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLY 113 (174)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECC
T ss_pred CCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeC
Confidence 344555555555544444455555555555555555554443 3445555555555555553322335555555555555
Q ss_pred ccccc
Q 002382 496 NNMLS 500 (929)
Q Consensus 496 ~N~l~ 500 (929)
+|++.
T Consensus 114 ~N~~~ 118 (174)
T 2r9u_A 114 NNPWD 118 (174)
T ss_dssp SSCBC
T ss_pred CCCcc
Confidence 55554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.6e-12 Score=131.36 Aligned_cols=131 Identities=13% Similarity=0.201 Sum_probs=107.4
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
++.|+.|++..|.++.++ .+..+..|+.|+++.|++... .+. ....+++|
T Consensus 65 l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~n~l~~~-------------------~~~----------~l~~l~~L 114 (197)
T 4ezg_A 65 AHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTSD-------------------KIP----------NLSGLTSL 114 (197)
T ss_dssp CTTCSEEEEESCCCSCCG-GGTTCTTCCEEEEECTTCBGG-------------------GSC----------CCTTCTTC
T ss_pred CCCCCEEEccCCCCCcch-hhhcCCCCCEEEeECCccCcc-------------------cCh----------hhcCCCCC
Confidence 457889999999877664 788899999999999987641 000 11345799
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
+.|+|++|++++..|..+.+|++|+.|+|++|.+.+.+|.+.++++|+.|+|++|+|++ ++ .+..+++|+.|++++|+
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 99999999999889999999999999999999844445689999999999999999995 55 79999999999999999
Q ss_pred ccc
Q 002382 499 LSG 501 (929)
Q Consensus 499 l~g 501 (929)
+.+
T Consensus 193 i~~ 195 (197)
T 4ezg_A 193 IGG 195 (197)
T ss_dssp ---
T ss_pred cCC
Confidence 873
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.30 E-value=8.4e-12 Score=125.13 Aligned_cols=120 Identities=24% Similarity=0.276 Sum_probs=100.8
Q ss_pred CCceeEeCCCC--------CCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCC
Q 002382 404 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474 (929)
Q Consensus 404 ~~~~~~c~~~~--------~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~ 474 (929)
.|..+.|+..+ .++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.++. |.++++|++|+|++|+
T Consensus 8 ~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 87 (177)
T 2o6r_A 8 SGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87 (177)
T ss_dssp ETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence 36677775433 35799999999999976666789999999999999999998886 7899999999999999
Q ss_pred cCCCCCccccCCCcCcccccccccccccccccccc---cceeccccCCccccc
Q 002382 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS---KNVVLNYAGNINLHE 524 (929)
Q Consensus 475 l~g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l~~---~~~~l~~~~n~~lc~ 524 (929)
|++..|..+..+++|+.|+|++|+|+ .+|...+. .+..+.+.+|+..|.
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 88 LQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeecc
Confidence 99777777899999999999999999 77777644 456777888876653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.6e-12 Score=137.75 Aligned_cols=152 Identities=15% Similarity=0.137 Sum_probs=83.5
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
++.++.|++..|.++.+| .+..+..|+.|++++|++..... +..+..+..++.+++.-. ....+ .. ++|
T Consensus 40 l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~---~l~~~----~~-~~L 108 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK---NLNGI----PS-ACL 108 (263)
T ss_dssp HTTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCS---CCTTC----CC-SSC
T ss_pred cCcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccC---CcCcc----cc-Ccc
Confidence 445566666666666665 45666666666666666543211 222222222211110000 00000 01 466
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
+.|+|++|+|++ +| .+.+|++|+.|+|++|+|++. +.+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+
T Consensus 109 ~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~ 183 (263)
T 1xeu_A 109 SRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQK 183 (263)
T ss_dssp CEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEE
T ss_pred cEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCc
Confidence 777777777763 33 466777777777777777665 3566677777777777777643 556667777777777777
Q ss_pred ccccccccc
Q 002382 499 LSGTVPSSL 507 (929)
Q Consensus 499 l~g~~P~~l 507 (929)
++ ..|...
T Consensus 184 ~~-~~~~~~ 191 (263)
T 1xeu_A 184 CV-NEPVKY 191 (263)
T ss_dssp EE-CCCEEC
T ss_pred cc-CCcccc
Confidence 66 334443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.7e-12 Score=142.94 Aligned_cols=169 Identities=17% Similarity=0.215 Sum_probs=116.6
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
++.|+.|++..|.++.+++ +..+..|+.|++..|.+..... +..+..+......+ |. ...+.. ...+++|
T Consensus 176 l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~---n~---l~~~~~-~~~l~~L 245 (347)
T 4fmz_A 176 LTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGN---NK---ITDLSP-LANLSQL 245 (347)
T ss_dssp CTTCSEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCS---SC---CCCCGG-GTTCTTC
T ss_pred CCCCCEEEccCCccccccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccC---Cc---cCCCcc-hhcCCCC
Confidence 4566777777777777776 6777777777777777654221 33333344332211 10 111111 3456788
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
+.|+|++|++++ + +.+..+++|+.|+|++|++++. +.+..+++|+.|+|++|++++..|..++.+++|+.|+|++|+
T Consensus 246 ~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 322 (347)
T 4fmz_A 246 TWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322 (347)
T ss_dssp CEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSS
T ss_pred CEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCc
Confidence 888888888884 4 4688888888888888888875 567888888888888888887777888888888888888888
Q ss_pred ccccccccccccceeccccCCc
Q 002382 499 LSGTVPSSLLSKNVVLNYAGNI 520 (929)
Q Consensus 499 l~g~~P~~l~~~~~~l~~~~n~ 520 (929)
+++..|-.-+..+..+.+.+|.
T Consensus 323 l~~~~~~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 323 ITDIRPLASLSKMDSADFANQV 344 (347)
T ss_dssp CCCCGGGGGCTTCSEESSSCC-
T ss_pred cccccChhhhhccceeehhhhc
Confidence 8866664445566667777664
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=5.1e-12 Score=138.72 Aligned_cols=154 Identities=19% Similarity=0.200 Sum_probs=112.5
Q ss_pred cccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (929)
.++.|+.|+|+.|.++.+||. +..+..|+.|+++.|++.... .+.. .-| ...++
T Consensus 143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~------------~~~-----------~~~l~ 197 (310)
T 4glp_A 143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGER--GLMA------------ALC-----------PHKFP 197 (310)
T ss_dssp BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHH--HHHT------------TSC-----------TTSSC
T ss_pred hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccch--hhhH------------HHh-----------hhcCC
Confidence 467889999999999999975 899999999999999865311 0100 001 12345
Q ss_pred CeeEEEecCCCCCccCCh----hhhccccCceeeccCCcCCCCCC-CCCCC---CCCcEEEecCCCcCCCCCccccCCCc
Q 002382 417 SITVIHLSSKNLTGNIPS----DLTKLSSLVELWLDGNSLTGPIP-DFSGC---PDLRIIHLEDNQLTGPLPSSLMNLPN 488 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~----~l~~L~~L~~L~Ls~N~l~~~~p-~~~~l---~~L~~L~Ls~N~l~g~~P~~l~~l~~ 488 (929)
+|+.|+|++|+|+ .+|. .+.++++|++|+|++|+|++..| .+..+ ++|++|+|++|+|+ .+|..+. ++
T Consensus 198 ~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~ 273 (310)
T 4glp_A 198 AIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AK 273 (310)
T ss_dssp CCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SC
T ss_pred CCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CC
Confidence 7888899999887 4444 25678899999999999988854 45555 68999999999998 7788775 68
Q ss_pred Ccccccccccccccccc-cccccceeccccCCcc
Q 002382 489 LRELYVQNNMLSGTVPS-SLLSKNVVLNYAGNIN 521 (929)
Q Consensus 489 L~~L~l~~N~l~g~~P~-~l~~~~~~l~~~~n~~ 521 (929)
|+.|+|++|+|++ +|. .-+..+..+.+.+|+.
T Consensus 274 L~~L~Ls~N~l~~-~~~~~~l~~L~~L~L~~N~l 306 (310)
T 4glp_A 274 LRVLDLSSNRLNR-APQPDELPEVDNLTLDGNPF 306 (310)
T ss_dssp CSCEECCSCCCCS-CCCTTSCCCCSCEECSSTTT
T ss_pred CCEEECCCCcCCC-CchhhhCCCccEEECcCCCC
Confidence 8999999999984 333 2234556667777753
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=5.5e-12 Score=148.60 Aligned_cols=154 Identities=17% Similarity=0.220 Sum_probs=110.1
Q ss_pred cccceeeeeecccCCCC-CCCccchhccceeccCCCCCccHHH--HHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCC
Q 002382 338 SLPFVLSFKFGKTYDSS-RGPLLNAMEINKYLERNDGSIDGVA--IVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDP 414 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~-lPP~i~~le~l~~L~l~~n~~~~~~--~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~ 414 (929)
.++.++.|+|+.|.++. +|+.+..+..|+.|+++.|++.... ...+ ..
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~-----------------------------~~ 372 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMT-----------------------------TQ 372 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHH-----------------------------TT
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHH-----------------------------hh
Confidence 46678889999999888 5666889999999999998886421 1112 22
Q ss_pred CCCeeEEEecCCCCCccCChh-hhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccc
Q 002382 415 QPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 492 (929)
Q Consensus 415 ~~~l~~L~L~~n~l~g~~p~~-l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 492 (929)
+++|+.|+|++|++++.+|.. +..+++|+.|+|++|++++..|. +. ++|+.|+|++|+|+ .+|..+..+++|+.|
T Consensus 373 l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L 449 (520)
T 2z7x_B 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQEL 449 (520)
T ss_dssp CTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEE
T ss_pred CCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEE
Confidence 457777888888887656654 67777888888888887766653 32 67788888888887 777777777888888
Q ss_pred cccccccccccccccc---ccceeccccCCccccc
Q 002382 493 YVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHE 524 (929)
Q Consensus 493 ~l~~N~l~g~~P~~l~---~~~~~l~~~~n~~lc~ 524 (929)
+|++|+|+ .+|...+ ..+..+.+.+|+..|.
T Consensus 450 ~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 450 NVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp ECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ECCCCcCC-ccCHHHhccCCcccEEECcCCCCccc
Confidence 88888887 6777633 3345666677766553
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.29 E-value=3e-12 Score=153.27 Aligned_cols=157 Identities=21% Similarity=0.259 Sum_probs=123.8
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (929)
.++.|+.|+|+.|.++.+|| +..+..|+.|+|+.|.+.. +..+..+..+..+..+++. ...+. ....+++
T Consensus 63 ~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~--l~~l~~l~~L~~L~Ls~N~------l~~l~-~l~~l~~ 132 (605)
T 1m9s_A 63 YLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIKD--LSSLKDLKKLKSLSLEHNG------ISDIN-GLVHLPQ 132 (605)
T ss_dssp GCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCC--CTTSTTCTTCCEEECTTSC------CCCCG-GGGGCTT
T ss_pred cCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCCC--ChhhccCCCCCEEEecCCC------CCCCc-cccCCCc
Confidence 36778899999999999988 8899999999999998765 2244444445544332211 11111 1335679
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
|+.|+|++|+|++. +.|..|++|+.|+|++|+|++.+| +..|++|+.|+|++|+|++ +| .|..|++|+.|+|++|
T Consensus 133 L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N 207 (605)
T 1m9s_A 133 LESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQ 207 (605)
T ss_dssp CSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSE
T ss_pred cCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCC
Confidence 99999999999954 679999999999999999999888 9999999999999999995 54 6999999999999999
Q ss_pred ccccccccccccc
Q 002382 498 MLSGTVPSSLLSK 510 (929)
Q Consensus 498 ~l~g~~P~~l~~~ 510 (929)
+++ ..|...+..
T Consensus 208 ~l~-~~p~~~~~~ 219 (605)
T 1m9s_A 208 ECL-NKPINHQSN 219 (605)
T ss_dssp EEE-CCCCCCCSS
T ss_pred cCc-CCccccccc
Confidence 999 556554443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.29 E-value=1e-12 Score=161.02 Aligned_cols=135 Identities=24% Similarity=0.177 Sum_probs=101.5
Q ss_pred eeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeEEE
Q 002382 343 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 422 (929)
Q Consensus 343 ~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~L~ 422 (929)
..+.+..|.+...|..+..+..|+.|+|+.|.+..+ . + ....+++|+.|+
T Consensus 204 ~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~l-----------~--------~-----------~~~~l~~L~~L~ 253 (727)
T 4b8c_D 204 DEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIFNI-----------S--------A-----------NIFKYDFLTRLY 253 (727)
T ss_dssp ------------------CCCCCCEEECTTSCCSCC-----------C--------G-----------GGGGCCSCSCCB
T ss_pred cCccccccceecChhhhccCCCCcEEECCCCCCCCC-----------C--------h-----------hhcCCCCCCEEE
Confidence 445556667776666688889999999998876530 0 0 011356899999
Q ss_pred ecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccccccc
Q 002382 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT 502 (929)
Q Consensus 423 L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~ 502 (929)
|++|+|+ .+|..|++|++|+.|+|++|+|+.+++.|++|++|++|+|++|+|+ .+|..|++|++|+.|+|++|+|+|.
T Consensus 254 Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~ 331 (727)
T 4b8c_D 254 LNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQ 331 (727)
T ss_dssp CTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSH
T ss_pred eeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCC
Confidence 9999999 9999999999999999999999976667999999999999999998 8999999999999999999999988
Q ss_pred ccccccc
Q 002382 503 VPSSLLS 509 (929)
Q Consensus 503 ~P~~l~~ 509 (929)
+|..+..
T Consensus 332 ~p~~~~~ 338 (727)
T 4b8c_D 332 FLKILTE 338 (727)
T ss_dssp HHHHHHH
T ss_pred ChHHHhh
Confidence 8877743
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=1.7e-12 Score=156.12 Aligned_cols=183 Identities=14% Similarity=0.068 Sum_probs=132.3
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHH-HHHHHHhhcCCCCcccCCCCCCCCCCCceeE-eCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGV-AIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQ 415 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~-~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~-c~~~~~ 415 (929)
.+.++..|++..+....+++.+..++.|+.+++..+..... ....+..+..+.....+. + ....+. .....+
T Consensus 395 ~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~---n---~l~~~~~~~~~~~ 468 (635)
T 4g8a_A 395 GTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH---T---HTRVAFNGIFNGL 468 (635)
T ss_dssp SCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTT---S---CCEECCTTTTTTC
T ss_pred hhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccc---c---ccccccccccccc
Confidence 34566777777777777777777888888888776553321 111111221111111100 0 011111 123456
Q ss_pred CCeeEEEecCCCC-CccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccc
Q 002382 416 PSITVIHLSSKNL-TGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (929)
Q Consensus 416 ~~l~~L~L~~n~l-~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 493 (929)
+.++.|+|++|++ .+.+|..|..|++|+.|+|++|+|++.+|. |.++++|++|+|++|+|++..|..|.+|++|+.|+
T Consensus 469 ~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 548 (635)
T 4g8a_A 469 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 548 (635)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEE
T ss_pred hhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEE
Confidence 7899999999975 456788999999999999999999999886 89999999999999999988888999999999999
Q ss_pred ccccccccccccccc---ccceeccccCCcccccCC
Q 002382 494 VQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG 526 (929)
Q Consensus 494 l~~N~l~g~~P~~l~---~~~~~l~~~~n~~lc~~~ 526 (929)
|++|+|++..|..+. ..+..+.+.+|+..|.+.
T Consensus 549 Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 549 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999976676653 345778889999888654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=6.6e-12 Score=153.03 Aligned_cols=161 Identities=14% Similarity=0.083 Sum_probs=104.8
Q ss_pred cceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEe-CCCCCCC
Q 002382 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQPS 417 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~~~ 417 (929)
+.++.|+|+.|.++.+|+. +..+..|+.|+++.|.+.......+.++..++.++.++.. ...+.. ...++++
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~------l~~l~~~~~~~l~~ 98 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE------LSQLSDKTFAFCTN 98 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSC------CCCCCTTTTTTCTT
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCc------cCccChhhhccCCC
Confidence 4678899999999999986 9999999999999998776444555555555544332110 111111 1334556
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCcccc--CCCcCccccc
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLM--NLPNLRELYV 494 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~--~l~~L~~L~l 494 (929)
|++|+|++|++++..|..|++|++|++|+|++|++++.+|. +.++++|++|+|++|++++..|..+. .+++|+.|++
T Consensus 99 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 178 (680)
T 1ziw_A 99 LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178 (680)
T ss_dssp CSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEEC
T ss_pred CCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEEC
Confidence 77777777777655556677777777777777777766654 66677777777777777755555443 4466777777
Q ss_pred cccccccccccc
Q 002382 495 QNNMLSGTVPSS 506 (929)
Q Consensus 495 ~~N~l~g~~P~~ 506 (929)
++|++++..|..
T Consensus 179 ~~n~l~~~~~~~ 190 (680)
T 1ziw_A 179 SSNQIKEFSPGC 190 (680)
T ss_dssp TTCCCCCBCTTG
T ss_pred CCCcccccChhh
Confidence 777776444443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=7.5e-12 Score=156.47 Aligned_cols=162 Identities=16% Similarity=0.086 Sum_probs=80.7
Q ss_pred ccceeeeeecccCCCCCCCc-cchhccceeccCCCCCcc-HHHHHHHHhhcCCCCcccCCCCCCCCCCCceeE-eCCCCC
Q 002382 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSID-GVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQ 415 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~-~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~-c~~~~~ 415 (929)
.+.++.|+|+.|.++.++|. +..+..|+.|+++.|... .+...++.++..++.++.+++. ...+. -...++
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~------l~~~~p~~~~~l 96 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK------IYFLHPDAFQGL 96 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCC------CCEECTTSSCSC
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCc------CcccCHhHccCC
Confidence 35678889999999988654 899999999999887432 1111222222222222211100 11110 112234
Q ss_pred CCeeEEEecCCCCCccCChh--hhccccCceeeccCCcCCCCCC--CCCCCCCCcEEEecCCCcCCCCCccccCC--CcC
Q 002382 416 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPSSLMNL--PNL 489 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~--l~~L~~L~~L~Ls~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l--~~L 489 (929)
++|+.|+|++|+|++.+|.. |.+|++|+.|+|++|.+++..+ .|++|++|++|+|++|++++..|..++.+ ++|
T Consensus 97 ~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L 176 (844)
T 3j0a_A 97 FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTL 176 (844)
T ss_dssp SSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSS
T ss_pred cccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCcc
Confidence 44555555555554444433 4445555555555555544433 24445555555555555554444444444 445
Q ss_pred ccccccccccccccccc
Q 002382 490 RELYVQNNMLSGTVPSS 506 (929)
Q Consensus 490 ~~L~l~~N~l~g~~P~~ 506 (929)
+.|+|++|.+++..|..
T Consensus 177 ~~L~L~~n~l~~~~~~~ 193 (844)
T 3j0a_A 177 SFFSLAANSLYSRVSVD 193 (844)
T ss_dssp CCCEECCSBSCCCCCCC
T ss_pred ceEECCCCccccccccc
Confidence 55555555554444443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.3e-11 Score=136.65 Aligned_cols=171 Identities=16% Similarity=0.138 Sum_probs=90.5
Q ss_pred cccceeeeeecccCCCCCCC-ccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEe-CCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQ 415 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP-~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~ 415 (929)
.++.|+.|+|..|.++.++| .+..+..|+.|+++.|++........ ..+..+...+ | ....+.. ...++
T Consensus 74 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~---~~L~~L~l~~---n---~l~~~~~~~~~~l 144 (330)
T 1xku_A 74 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMP---KTLQELRVHE---N---EITKVRKSVFNGL 144 (330)
T ss_dssp TCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCC---TTCCEEECCS---S---CCCBBCHHHHTTC
T ss_pred cCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChhhc---ccccEEECCC---C---cccccCHhHhcCC
Confidence 35667777777777777744 47777777777777776543110000 0111111100 0 0011110 01234
Q ss_pred CCeeEEEecCCCCC--ccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccc
Q 002382 416 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (929)
Q Consensus 416 ~~l~~L~L~~n~l~--g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 493 (929)
++|+.|+|++|.++ +..+..+.++++|+.|+|++|++++.+..+. ++|++|+|++|+|++..|..+..+++|+.|+
T Consensus 145 ~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 222 (330)
T 1xku_A 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLG 222 (330)
T ss_dssp TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEE
T ss_pred ccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence 56666666666664 2555566666666666666666665444332 5666666666666655556666666666666
Q ss_pred cccccccccccccc--cccceeccccCC
Q 002382 494 VQNNMLSGTVPSSL--LSKNVVLNYAGN 519 (929)
Q Consensus 494 l~~N~l~g~~P~~l--~~~~~~l~~~~n 519 (929)
|++|++++..|..+ +..+..+.+.+|
T Consensus 223 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N 250 (330)
T 1xku_A 223 LSFNSISAVDNGSLANTPHLRELHLNNN 250 (330)
T ss_dssp CCSSCCCEECTTTGGGSTTCCEEECCSS
T ss_pred CCCCcCceeChhhccCCCCCCEEECCCC
Confidence 66666663333233 123344444444
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.26 E-value=6.4e-12 Score=139.24 Aligned_cols=84 Identities=23% Similarity=0.320 Sum_probs=41.5
Q ss_pred CCCCeeEEEecCCCCC--ccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcc
Q 002382 414 PQPSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 491 (929)
Q Consensus 414 ~~~~l~~L~L~~n~l~--g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~ 491 (929)
.+++|+.|+|++|.++ +..|..+..+ +|+.|+|++|++++.+..+. ++|+.|+|++|++++..|..+.++++|+.
T Consensus 145 ~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~ 221 (332)
T 2ft3_A 145 GLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYR 221 (332)
T ss_dssp SCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSC
T ss_pred CCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCE
Confidence 3455666666666664 2444444444 44444444444443322221 34555555555555444455555555555
Q ss_pred ccccccccc
Q 002382 492 LYVQNNMLS 500 (929)
Q Consensus 492 L~l~~N~l~ 500 (929)
|+|++|+++
T Consensus 222 L~L~~N~l~ 230 (332)
T 2ft3_A 222 LGLGHNQIR 230 (332)
T ss_dssp CBCCSSCCC
T ss_pred EECCCCcCC
Confidence 555555555
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.25 E-value=5.3e-12 Score=126.60 Aligned_cols=132 Identities=14% Similarity=0.072 Sum_probs=104.8
Q ss_pred ccccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCC
Q 002382 337 LSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (929)
Q Consensus 337 ~~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (929)
.....++.|+|..|.++.+|........|+.|+++.|.+... . ....++
T Consensus 16 ~~~~~L~~L~l~~n~l~~i~~~~~~~~~L~~L~Ls~N~l~~~-----------~--------------------~l~~l~ 64 (176)
T 1a9n_A 16 TNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL-----------D--------------------GFPLLR 64 (176)
T ss_dssp ECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE-----------C--------------------CCCCCS
T ss_pred CCcCCceEEEeeCCCCchhHHhhhcCCCCCEEECCCCCCCcc-----------c--------------------ccccCC
Confidence 345678899999999999965444334899999999987640 0 113456
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCC--CCCCCCCCcEEEecCCCcCCCCCcc----ccCCCcCc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPSS----LMNLPNLR 490 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~g~~P~~----l~~l~~L~ 490 (929)
+|+.|+|++|+|++..|..+..+++|+.|+|++|+|+..++ .+.++++|+.|+|++|.++ .+|.. +..+++|+
T Consensus 65 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~ 143 (176)
T 1a9n_A 65 RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVR 143 (176)
T ss_dssp SCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCS
T ss_pred CCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccc
Confidence 89999999999995434445899999999999999987665 5888999999999999998 67775 88999999
Q ss_pred cccccccccc
Q 002382 491 ELYVQNNMLS 500 (929)
Q Consensus 491 ~L~l~~N~l~ 500 (929)
.|++++|.+.
T Consensus 144 ~Ld~~~n~~~ 153 (176)
T 1a9n_A 144 VLDFQKVKLK 153 (176)
T ss_dssp EETTEECCHH
T ss_pred eeCCCcCCHH
Confidence 9999999886
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.2e-11 Score=147.16 Aligned_cols=139 Identities=15% Similarity=0.158 Sum_probs=114.2
Q ss_pred cceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
+.++.|+|+.|.++.+++. +..+..|+.|+++.|++... .|- ...++++|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i-------------------~~~----------~~~~l~~L 78 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI-------------------EDG----------AYQSLSHL 78 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEE-------------------CTT----------TTTTCTTC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCcc-------------------Ccc----------cccCchhC
Confidence 3578899999999999885 99999999999999987541 000 12345689
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCC-CCCCCCCCcEEEecCCCcCC-CCCccccCCCcCccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQN 496 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g-~~P~~l~~l~~L~~L~l~~ 496 (929)
+.|+|++|++++..|..|.+|++|++|+|++|++++.++ .++++++|++|+|++|++++ .+|..|+++++|+.|++++
T Consensus 79 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~ 158 (570)
T 2z63_A 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158 (570)
T ss_dssp CEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTT
T ss_pred CEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcC
Confidence 999999999997777889999999999999999998877 48899999999999999986 4789999999999999999
Q ss_pred ccccccccccc
Q 002382 497 NMLSGTVPSSL 507 (929)
Q Consensus 497 N~l~g~~P~~l 507 (929)
|++++..|..+
T Consensus 159 n~l~~~~~~~~ 169 (570)
T 2z63_A 159 NKIQSIYCTDL 169 (570)
T ss_dssp SCCCEECGGGG
T ss_pred CccceecHHHc
Confidence 99985444443
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=2.3e-11 Score=121.76 Aligned_cols=139 Identities=18% Similarity=0.221 Sum_probs=95.2
Q ss_pred eEeeCCCCCccccCCCeEEccCCccc-cccceeee----cC--c-ccccccceeecccCCCCcceeeeeccCCceeEEeE
Q 002382 33 VSLNCGGNENFTDEIGLQWIADDHLI-YGEISNIS----VA--N-ETRKQYMTLRHFPADSRKYCYKLDVITRTRYLIRA 104 (929)
Q Consensus 33 ~~idcg~~~~~~~~~~~~~~~d~~~~-~~~~~~~~----~~--~-~~~~~~~tlr~fp~~~~~~cy~~~~~~~~~yl~r~ 104 (929)
+.||||++.. +|..+++|.+|..|. .|..+... .. . ...+.|+|-|.||. +.+|.+|+.++|+|+||.
T Consensus 8 ~~INcGg~~~-~d~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~~---~~tY~f~v~~~G~Y~VrL 83 (174)
T 2jwp_A 8 WAVNAGGESH-VDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNED---SFGYDIPIKEEGEYVLVL 83 (174)
T ss_dssp EEEEETSSSE-EETTTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCCS---CEEEEEECCSCEEEEEEE
T ss_pred EEEECCCCCc-cCCCCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCCC---CeEEEEEeCCCeEEEEEE
Confidence 4799998875 567899999998886 34322111 11 1 11247899999995 579999999999999999
Q ss_pred EeeecCcCCCCCCCeeEEEECCcee-eEEeeC---CCCccEEEEEEEEe-------------cCCCceEEEecCCCCCce
Q 002382 105 TFLYGNFDNNNVYPKFDISLGPTHW-STIVIS---DAATIEVRELIFLA-------------SSPKIDVCLSNATTGQPF 167 (929)
Q Consensus 105 ~~~yg~~d~~~~~p~fd~~~~~~~w-~~v~~~---~~~~~~~~e~~~~~-------------~~~~~~vcl~~~~~~~pf 167 (929)
.|.--.|.. ....+||++|+|..- .-.+.. ....+.+.|..+.+ .+..+.|.|.....+.||
T Consensus 84 hF~ei~~~~-~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~~a~ 162 (174)
T 2jwp_A 84 KFAEVYFAQ-SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPK 162 (174)
T ss_dssp EEECCSCCC-SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSCSSS
T ss_pred EEeccccCC-CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCCCcE
Confidence 998776654 455689999999532 112221 12234455555542 455688888764456799
Q ss_pred eeeeeeeec
Q 002382 168 ISTLELRQF 176 (929)
Q Consensus 168 is~le~~~l 176 (929)
||+||+.+-
T Consensus 163 inaIEI~~~ 171 (174)
T 2jwp_A 163 VCALFIMKG 171 (174)
T ss_dssp EEEEEEESS
T ss_pred EEEEEEEeC
Confidence 999999863
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.24 E-value=2e-12 Score=151.36 Aligned_cols=175 Identities=13% Similarity=0.004 Sum_probs=109.2
Q ss_pred ccceeeeeecccCCCCCCC-ccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCC-----CCCCCCCceeEeCC
Q 002382 339 LPFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGD-----PCLPVPWSWLQCNS 412 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP-~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~d-----pc~~~~~~~~~c~~ 412 (929)
.+.|+.|+|+.|.++.+|| .|..+..|+.|+|+.|.+..... +..+..+..++.+++. ++ .....+..+.
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~--~~L~~L~L~~ 108 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG--PSIETLHAAN 108 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC--TTCCEEECCS
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC--CCcCEEECcC
Confidence 3478999999999999987 49999999999999999864211 4444445444332111 00 0112222222
Q ss_pred CC--------CCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CC-CCCCCcEEEecCCCcCCCCCcc
Q 002382 413 DP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FS-GCPDLRIIHLEDNQLTGPLPSS 482 (929)
Q Consensus 413 ~~--------~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~-~l~~L~~L~Ls~N~l~g~~P~~ 482 (929)
.. +++|+.|+|++|+|++..|..|+++++|+.|+|++|.|++.+|. +. .+++|+.|+|++|+|++. |.
T Consensus 109 N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~- 186 (487)
T 3oja_A 109 NNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG- 186 (487)
T ss_dssp SCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-
T ss_pred CcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-
Confidence 11 34567777777777766666777777777777777777776553 43 577777777777777743 32
Q ss_pred ccCCCcCccccccccccccccccccc--ccceeccccCCc
Q 002382 483 LMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNI 520 (929)
Q Consensus 483 l~~l~~L~~L~l~~N~l~g~~P~~l~--~~~~~l~~~~n~ 520 (929)
+..+++|+.|+|++|+|+ .+|+.+. ..+..+.+.+|.
T Consensus 187 ~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~Ls~N~ 225 (487)
T 3oja_A 187 QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225 (487)
T ss_dssp CCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSC
T ss_pred cccCCCCCEEECCCCCCC-CCCHhHcCCCCccEEEecCCc
Confidence 335677777777777777 3444442 234455555553
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.24 E-value=4.5e-12 Score=150.31 Aligned_cols=147 Identities=18% Similarity=0.145 Sum_probs=95.5
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
++.|+.|+|+.|.++.+|+ +.. .|+.|++++|++..+.. .+..+..++.+++. ..+++. .+++|
T Consensus 99 l~~L~~L~Ls~N~l~~ip~-l~~--~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~------l~~lp~---~l~~L 162 (571)
T 3cvr_A 99 PASLEYLDACDNRLSTLPE-LPA--SLKHLDVDNNQLTMLPE----LPALLEYINADNNQ------LTMLPE---LPTSL 162 (571)
T ss_dssp CTTCCEEECCSSCCSCCCC-CCT--TCCEEECCSSCCSCCCC----CCTTCCEEECCSSC------CSCCCC---CCTTC
T ss_pred cCCCCEEEccCCCCCCcch-hhc--CCCEEECCCCcCCCCCC----cCccccEEeCCCCc------cCcCCC---cCCCc
Confidence 3567888888888888888 555 78888888887764111 12222222221110 111221 34577
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCC-------cEEEecCCCcCCCCCccccCCCcCcc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDL-------RIIHLEDNQLTGPLPSSLMNLPNLRE 491 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L-------~~L~Ls~N~l~g~~P~~l~~l~~L~~ 491 (929)
+.|+|++|+|++ +|. |. ++|+.|+|++|+|+.+++ +.. +| +.|+|++|+|+ .+|..+.++++|+.
T Consensus 163 ~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~ 234 (571)
T 3cvr_A 163 EVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCT 234 (571)
T ss_dssp CEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEE
T ss_pred CEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCE
Confidence 888888888874 776 55 778888888888875555 544 55 88888888887 67777777888888
Q ss_pred cccccccccccccccccc
Q 002382 492 LYVQNNMLSGTVPSSLLS 509 (929)
Q Consensus 492 L~l~~N~l~g~~P~~l~~ 509 (929)
|+|++|+|+|.+|..+..
T Consensus 235 L~L~~N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 235 IILEDNPLSSRIRESLSQ 252 (571)
T ss_dssp EECCSSSCCHHHHHHHHH
T ss_pred EEeeCCcCCCcCHHHHHH
Confidence 888888887777776643
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.24 E-value=7.6e-12 Score=147.43 Aligned_cols=125 Identities=15% Similarity=0.079 Sum_probs=73.3
Q ss_pred eeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeEEE
Q 002382 343 LSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIH 422 (929)
Q Consensus 343 ~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~L~ 422 (929)
+.|+++.|.++.+|+.+. +.++.|+++.|.+.......+. ++++|+.|+
T Consensus 3 ~~l~ls~n~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~-----------------------------~l~~L~~L~ 51 (520)
T 2z7x_B 3 FLVDRSKNGLIHVPKDLS--QKTTILNISQNYISELWTSDIL-----------------------------SLSKLRILI 51 (520)
T ss_dssp CEEECTTSCCSSCCCSCC--TTCSEEECCSSCCCCCCHHHHT-----------------------------TCTTCCEEE
T ss_pred ceEecCCCCccccccccc--ccccEEECCCCcccccChhhcc-----------------------------ccccccEEe
Confidence 356677777777777665 6777777777776542222221 233556666
Q ss_pred ecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCC-CCCccccCCCcCccccccccccc
Q 002382 423 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLS 500 (929)
Q Consensus 423 L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g-~~P~~l~~l~~L~~L~l~~N~l~ 500 (929)
|++|+|++..|..|.+|++|++|+|++|+|++.++. .+++|++|+|++|+|++ .+|..|+++++|+.|+|++|+|+
T Consensus 52 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~ 128 (520)
T 2z7x_B 52 ISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128 (520)
T ss_dssp CCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCC
T ss_pred cCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccc
Confidence 666666655555566666666666666666543333 55666666666666654 34555666666666666666655
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=8.6e-12 Score=152.01 Aligned_cols=92 Identities=28% Similarity=0.378 Sum_probs=52.1
Q ss_pred CCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCC---------CCCCCCCCcEEEecCCCcCCCCC-ccc
Q 002382 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP---------DFSGCPDLRIIHLEDNQLTGPLP-SSL 483 (929)
Q Consensus 414 ~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p---------~~~~l~~L~~L~Ls~N~l~g~~P-~~l 483 (929)
.+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+ .|.++++|+.|+|++|+|+ .+| ..|
T Consensus 478 ~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~ 556 (680)
T 1ziw_A 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVF 556 (680)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTT
T ss_pred cCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHc
Confidence 34566666666666665444556666666666666666654311 1455566666666666665 333 245
Q ss_pred cCCCcCcccccccccccccccccc
Q 002382 484 MNLPNLRELYVQNNMLSGTVPSSL 507 (929)
Q Consensus 484 ~~l~~L~~L~l~~N~l~g~~P~~l 507 (929)
.++++|+.|+|++|+|+ .+|...
T Consensus 557 ~~l~~L~~L~Ls~N~l~-~l~~~~ 579 (680)
T 1ziw_A 557 KDLFELKIIDLGLNNLN-TLPASV 579 (680)
T ss_dssp TTCTTCCEEECCSSCCC-CCCTTT
T ss_pred ccccCcceeECCCCCCC-cCCHhH
Confidence 55666666666666665 455444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.23 E-value=3.6e-12 Score=136.71 Aligned_cols=167 Identities=16% Similarity=0.207 Sum_probs=103.1
Q ss_pred ccccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCC
Q 002382 337 LSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (929)
Q Consensus 337 ~~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (929)
..+..+..+.+..+.++.++ .+..+..|+.|++.+|.+... ..+..+..+..+..+++. ...+.. ...++
T Consensus 16 ~~l~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~~l--~~l~~l~~L~~L~L~~N~------i~~~~~-l~~l~ 85 (263)
T 1xeu_A 16 PGLANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHLSHNQ------ISDLSP-LKDLT 85 (263)
T ss_dssp HHHHHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCCCC--TTGGGCTTCCEEECCSSC------CCCCGG-GTTCS
T ss_pred HHHHHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcccc--hHHhhCCCCCEEECCCCc------cCCChh-hccCC
Confidence 34566778889999999998 689999999999999987652 234444444444332111 111111 33456
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 496 (929)
+|+.|+|++|+|++ +|. +.. ++|+.|+|++|+|++. +.+.++++|+.|+|++|+|++ +| .++.+++|+.|+|++
T Consensus 86 ~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~-~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~ 159 (263)
T 1xeu_A 86 KLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT-DSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHG 159 (263)
T ss_dssp SCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS-GGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTT
T ss_pred CCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCCC-hhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCC
Confidence 67777777777763 444 222 6677777777777664 456677777777777777773 34 566777777777777
Q ss_pred ccccccccccc--cccceeccccCCcc
Q 002382 497 NMLSGTVPSSL--LSKNVVLNYAGNIN 521 (929)
Q Consensus 497 N~l~g~~P~~l--~~~~~~l~~~~n~~ 521 (929)
|+|++. ..+ +..+..+.+.+|..
T Consensus 160 N~i~~~--~~l~~l~~L~~L~l~~N~~ 184 (263)
T 1xeu_A 160 NEITNT--GGLTRLKKVNWIDLTGQKC 184 (263)
T ss_dssp SCCCBC--TTSTTCCCCCEEEEEEEEE
T ss_pred CcCcch--HHhccCCCCCEEeCCCCcc
Confidence 777643 222 23334455555543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=2.1e-12 Score=153.21 Aligned_cols=139 Identities=20% Similarity=0.143 Sum_probs=80.4
Q ss_pred cceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
+.++.|+|+.|.++.++|. +..+..|+.|+++.|++......++ .++++|
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~-----------------------------~~l~~L 76 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF-----------------------------YSLGSL 76 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTT-----------------------------TTCTTC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhc-----------------------------cccccC
Confidence 4567788888888887654 7888888888888887654211111 223455
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCC--CCCCCCCCCCcEEEecCCCcCCCCC-ccccCCCcCcccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGP--IPDFSGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYVQ 495 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~--~p~~~~l~~L~~L~Ls~N~l~g~~P-~~l~~l~~L~~L~l~ 495 (929)
++|+|++|+|++..|..|++|++|++|+|++|++++. ++.+.++++|++|+|++|++.+.+| ..+.++++|+.|+++
T Consensus 77 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~ 156 (549)
T 2z81_A 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156 (549)
T ss_dssp CEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred CEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeecc
Confidence 5556665555544444455555566666665555542 2235555555555555555333443 355555555555555
Q ss_pred cccccccccccc
Q 002382 496 NNMLSGTVPSSL 507 (929)
Q Consensus 496 ~N~l~g~~P~~l 507 (929)
+|++++.+|..+
T Consensus 157 ~n~l~~~~~~~l 168 (549)
T 2z81_A 157 ALSLRNYQSQSL 168 (549)
T ss_dssp ETTCCEECTTTT
T ss_pred CCcccccChhhh
Confidence 555555455444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.22 E-value=3.2e-12 Score=140.90 Aligned_cols=138 Identities=17% Similarity=0.181 Sum_probs=107.0
Q ss_pred ccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCC
Q 002382 339 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (929)
+++|+.|+|+.|.++.++|. +..+..|+.|+++.|.+...... .+ ...+++
T Consensus 119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~---------~~-------------------~~~l~~ 170 (317)
T 3o53_A 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA---------EL-------------------AASSDT 170 (317)
T ss_dssp CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGG---------GG-------------------GGGTTT
T ss_pred cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHH---------HH-------------------hhccCc
Confidence 45678888888888888774 77888888888888876531000 00 013458
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
|+.|+|++|+|++ +|. ...+++|+.|+|++|+|++.++.+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|
T Consensus 171 L~~L~L~~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N 247 (317)
T 3o53_A 171 LEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247 (317)
T ss_dssp CCEEECTTSCCCE-EEC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTC
T ss_pred CCEEECCCCcCcc-ccc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCC
Confidence 9999999999984 443 44589999999999999988888888999999999999999 68888999999999999999
Q ss_pred ccc-ccccccc
Q 002382 498 MLS-GTVPSSL 507 (929)
Q Consensus 498 ~l~-g~~P~~l 507 (929)
+++ +.+|..+
T Consensus 248 ~~~~~~~~~~~ 258 (317)
T 3o53_A 248 GFHCGTLRDFF 258 (317)
T ss_dssp CCBHHHHHHHH
T ss_pred CccCcCHHHHH
Confidence 998 6666554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.8e-11 Score=153.11 Aligned_cols=104 Identities=21% Similarity=0.255 Sum_probs=79.0
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
++|+.|+|++|.+++..|..|..+++|+.|+|++|++++.+|. |.++++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus 266 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 345 (844)
T 3j0a_A 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345 (844)
T ss_dssp SCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEEC
T ss_pred CCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEEC
Confidence 5688888888888877778888888888888888888887774 788888888888888888777888888888888888
Q ss_pred cccccccccccccc---ccceeccccCCc
Q 002382 495 QNNMLSGTVPSSLL---SKNVVLNYAGNI 520 (929)
Q Consensus 495 ~~N~l~g~~P~~l~---~~~~~l~~~~n~ 520 (929)
++|+|+ .+|...+ .++..+.+.+|.
T Consensus 346 ~~N~i~-~~~~~~~~~l~~L~~L~Ls~N~ 373 (844)
T 3j0a_A 346 QKNHIA-IIQDQTFKFLEKLQTLDLRDNA 373 (844)
T ss_dssp CSCCCC-CCCSSCSCSCCCCCEEEEETCC
T ss_pred CCCCCC-ccChhhhcCCCCCCEEECCCCC
Confidence 888887 4544432 334455555553
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.21 E-value=2.6e-11 Score=120.95 Aligned_cols=105 Identities=24% Similarity=0.298 Sum_probs=90.8
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 495 (929)
..+.|++++|+|+ .+|..+. ++|+.|+|++|+|++.+|. |.++++|++|+|++|+|++..|..|.++++|+.|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3568999999999 7998774 8999999999999999886 8999999999999999997666678999999999999
Q ss_pred ccccccccccccc---ccceeccccCCcccccC
Q 002382 496 NNMLSGTVPSSLL---SKNVVLNYAGNINLHEG 525 (929)
Q Consensus 496 ~N~l~g~~P~~l~---~~~~~l~~~~n~~lc~~ 525 (929)
+|+|+ .+|...+ ..+..+.+.+|+..|..
T Consensus 87 ~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 87 DNQLK-SIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SSCCC-CCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CCccC-EeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 99999 6776644 45577888999877754
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.19 E-value=3.9e-11 Score=139.16 Aligned_cols=157 Identities=18% Similarity=0.184 Sum_probs=98.7
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
++.|+.|+|+.|.++.+| +..+..|+.|+++.|++.... +..+..+..+........ ..+ ....+++|
T Consensus 105 l~~L~~L~L~~N~l~~l~--~~~l~~L~~L~l~~N~l~~l~---l~~l~~L~~L~l~~n~~~-----~~~--~~~~l~~L 172 (457)
T 3bz5_A 105 LTKLTYLNCDTNKLTKLD--VSQNPLLTYLNCARNTLTEID---VSHNTQLTELDCHLNKKI-----TKL--DVTPQTQL 172 (457)
T ss_dssp CTTCCEEECCSSCCSCCC--CTTCTTCCEEECTTSCCSCCC---CTTCTTCCEEECTTCSCC-----CCC--CCTTCTTC
T ss_pred CCcCCEEECCCCcCCeec--CCCCCcCCEEECCCCccceec---cccCCcCCEEECCCCCcc-----ccc--ccccCCcC
Confidence 455666777777777664 666677777777776665421 222222332222111000 001 23346678
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
+.|+|++|+|++ +| +..+++|+.|+|++|+|++. ++..+++|+.|+|++|+|++ +| ++.+++|+.|++++|+
T Consensus 173 ~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~ 244 (457)
T 3bz5_A 173 TTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNP 244 (457)
T ss_dssp CEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSC
T ss_pred CEEECCCCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCc
Confidence 888888888884 55 77788888888888888776 47778888888888888885 56 7778888888888888
Q ss_pred ccccccccccccceeccc
Q 002382 499 LSGTVPSSLLSKNVVLNY 516 (929)
Q Consensus 499 l~g~~P~~l~~~~~~l~~ 516 (929)
|++ +|..-+..+..+..
T Consensus 245 l~~-~~~~~l~~L~~L~l 261 (457)
T 3bz5_A 245 LTE-LDVSTLSKLTTLHC 261 (457)
T ss_dssp CSC-CCCTTCTTCCEEEC
T ss_pred CCC-cCHHHCCCCCEEec
Confidence 884 45444444444433
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.19 E-value=3.5e-11 Score=120.52 Aligned_cols=104 Identities=21% Similarity=0.332 Sum_probs=89.7
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccc
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 496 (929)
-+.|++++|+|+ .+|..+. ++|+.|+|++|+|++.+|. |.++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 368999999998 8998775 8999999999999999885 89999999999999999965555679999999999999
Q ss_pred cccccccccccc---ccceeccccCCcccccC
Q 002382 497 NMLSGTVPSSLL---SKNVVLNYAGNINLHEG 525 (929)
Q Consensus 497 N~l~g~~P~~l~---~~~~~l~~~~n~~lc~~ 525 (929)
|+|+ .+|...+ ..+..+.+.+|+..|..
T Consensus 91 N~l~-~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 91 NHLK-SIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp SCCC-CCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred Cccc-eeCHHHhccccCCCEEEeCCCCccccc
Confidence 9999 7777644 45577788899877654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.19 E-value=2.2e-11 Score=144.48 Aligned_cols=154 Identities=18% Similarity=0.181 Sum_probs=110.9
Q ss_pred cceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCee
Q 002382 340 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~ 419 (929)
++|+.|+|+.|.++.+| ..+..|+.|++++|++..+.. +.. .+..++.+++. ..+++- .+++|+
T Consensus 80 ~~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~ip~--l~~--~L~~L~Ls~N~------l~~lp~---~l~~L~ 143 (571)
T 3cvr_A 80 PQITVLEITQNALISLP---ELPASLEYLDACDNRLSTLPE--LPA--SLKHLDVDNNQ------LTMLPE---LPALLE 143 (571)
T ss_dssp TTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCC--CCT--TCCEEECCSSC------CSCCCC---CCTTCC
T ss_pred CCCCEEECcCCCCcccc---cccCCCCEEEccCCCCCCcch--hhc--CCCEEECCCCc------CCCCCC---cCcccc
Confidence 46789999999999998 557889999999998875211 221 33333222111 111111 456899
Q ss_pred EEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcC-------ccc
Q 002382 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNL-------REL 492 (929)
Q Consensus 420 ~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L-------~~L 492 (929)
.|+|++|+|++ +|. .+++|+.|+|++|+|++.++ |. ++|+.|+|++|+|+ .+|. |.. +| +.|
T Consensus 144 ~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L 212 (571)
T 3cvr_A 144 YINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFF 212 (571)
T ss_dssp EEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEE
T ss_pred EEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEE
Confidence 99999999995 776 67899999999999998555 65 89999999999999 7887 665 77 999
Q ss_pred ccccccccccccccccc--cceeccccCCcc
Q 002382 493 YVQNNMLSGTVPSSLLS--KNVVLNYAGNIN 521 (929)
Q Consensus 493 ~l~~N~l~g~~P~~l~~--~~~~l~~~~n~~ 521 (929)
+|++|+|+ .+|..++. .+..+.+.+|..
T Consensus 213 ~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l 242 (571)
T 3cvr_A 213 RCRENRIT-HIPENILSLDPTCTIILEDNPL 242 (571)
T ss_dssp ECCSSCCC-CCCGGGGGSCTTEEEECCSSSC
T ss_pred ecCCCcce-ecCHHHhcCCCCCEEEeeCCcC
Confidence 99999999 78987754 446677777754
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.18 E-value=2.8e-11 Score=134.63 Aligned_cols=168 Identities=17% Similarity=0.205 Sum_probs=118.2
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (929)
.++.|+.|++..|.++.+++ +..+..|+.|++..|.+..... +..+..+....... |. ...+.. ...+++
T Consensus 153 ~l~~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~---n~---l~~~~~-~~~~~~ 222 (347)
T 4fmz_A 153 NMTGLNYLTVTESKVKDVTP-IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYV---NQ---ITDITP-VANMTR 222 (347)
T ss_dssp TCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCS---SC---CCCCGG-GGGCTT
T ss_pred hCCCCcEEEecCCCcCCchh-hccCCCCCEEEccCCccccccc--ccCCCccceeeccc---CC---CCCCch-hhcCCc
Confidence 35667788888888888877 7788888888888887654221 33333333332211 11 111111 234568
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
|+.|+|++|+++ .+|. +..+++|+.|+|++|++++. +.+..+++|+.|+|++|++++ + +.+..+++|+.|+|++|
T Consensus 223 L~~L~l~~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n 297 (347)
T 4fmz_A 223 LNSLKIGNNKIT-DLSP-LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNN 297 (347)
T ss_dssp CCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSS
T ss_pred CCEEEccCCccC-CCcc-hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCC
Confidence 899999999998 4554 88899999999999988875 668888999999999999885 4 45888899999999999
Q ss_pred cccccccccc--cccceeccccCCc
Q 002382 498 MLSGTVPSSL--LSKNVVLNYAGNI 520 (929)
Q Consensus 498 ~l~g~~P~~l--~~~~~~l~~~~n~ 520 (929)
++++..|..+ +..+..+.+.+|.
T Consensus 298 ~l~~~~~~~l~~l~~L~~L~L~~n~ 322 (347)
T 4fmz_A 298 QLGNEDMEVIGGLTNLTTLFLSQNH 322 (347)
T ss_dssp CCCGGGHHHHHTCTTCSEEECCSSS
T ss_pred cCCCcChhHhhccccCCEEEccCCc
Confidence 9986666555 3445667777774
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.18 E-value=2.7e-11 Score=120.21 Aligned_cols=104 Identities=22% Similarity=0.266 Sum_probs=85.1
Q ss_pred CCCeeEEEecCCCCC-ccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccc
Q 002382 415 QPSITVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (929)
Q Consensus 415 ~~~l~~L~L~~n~l~-g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 493 (929)
+++|+.|+|++|+++ +.+|..+..+++|+.|+|++|+|++. +.+..+++|++|+|++|+|++.+|..+.++++|+.|+
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 457899999999998 78888889999999999999999887 7788899999999999999977888888899999999
Q ss_pred ccccccccccc--ccc--cccceeccccCCc
Q 002382 494 VQNNMLSGTVP--SSL--LSKNVVLNYAGNI 520 (929)
Q Consensus 494 l~~N~l~g~~P--~~l--~~~~~~l~~~~n~ 520 (929)
|++|+|+ .+| ..+ +..+..+.+.+|.
T Consensus 102 Ls~N~l~-~~~~~~~l~~l~~L~~L~l~~N~ 131 (168)
T 2ell_A 102 LSGNKLK-DISTLEPLKKLECLKSLDLFNCE 131 (168)
T ss_dssp CBSSSCC-SSGGGGGGSSCSCCCEEECCSSG
T ss_pred ccCCccC-cchhHHHHhcCCCCCEEEeeCCc
Confidence 9999998 554 333 3344566666663
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.18 E-value=3.5e-11 Score=139.89 Aligned_cols=167 Identities=20% Similarity=0.197 Sum_probs=93.4
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
++.|+.|++..|.++.++ .+..+..|+.|+++.|.+..... +..+..+..+...+ |. ...+.. ...+++|
T Consensus 220 l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~---n~---l~~~~~-~~~l~~L 289 (466)
T 1o6v_A 220 LTNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA---NQ---ISNISP-LAGLTAL 289 (466)
T ss_dssp CTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCS---SC---CCCCGG-GTTCTTC
T ss_pred cCCCCEEECCCCCcccch-hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCC---Cc---cCcccc-ccCCCcc
Confidence 344555555555555542 34555555555555555443211 22222233222111 10 011111 2345567
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
+.|+|++|++++..| +..+++|+.|+|++|++++.+| +..+++|+.|+|++|++++. ..+.++++|+.|++++|+
T Consensus 290 ~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~ 364 (466)
T 1o6v_A 290 TNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQ 364 (466)
T ss_dssp SEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSC
T ss_pred CeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCc
Confidence 777777777774333 6777777777777777777665 66777777777777777753 457777777777777777
Q ss_pred ccccccccccccceeccccCCc
Q 002382 499 LSGTVPSSLLSKNVVLNYAGNI 520 (929)
Q Consensus 499 l~g~~P~~l~~~~~~l~~~~n~ 520 (929)
+++..|..-+..+..+...+|.
T Consensus 365 l~~~~~~~~l~~L~~L~l~~n~ 386 (466)
T 1o6v_A 365 ISDLTPLANLTRITQLGLNDQA 386 (466)
T ss_dssp CCBCGGGTTCTTCCEEECCCEE
T ss_pred cCccchhhcCCCCCEEeccCCc
Confidence 7766663334444555555554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.17 E-value=2e-11 Score=118.63 Aligned_cols=103 Identities=19% Similarity=0.238 Sum_probs=82.0
Q ss_pred CCeeEEEecCCCCC-ccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 416 PSITVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 416 ~~l~~L~L~~n~l~-g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
++|+.|+|++|+++ +.+|..+..+++|+.|+|++|+|++. +.+.++++|++|+|++|+|++.+|..+..+++|+.|++
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 47888888888888 78888888888899999988888887 77888888888999888888778888888888888888
Q ss_pred cccccccccc--ccc--cccceeccccCCc
Q 002382 495 QNNMLSGTVP--SSL--LSKNVVLNYAGNI 520 (929)
Q Consensus 495 ~~N~l~g~~P--~~l--~~~~~~l~~~~n~ 520 (929)
++|++++ +| ..+ +..+..+.+.+|.
T Consensus 96 s~N~i~~-~~~~~~~~~l~~L~~L~l~~N~ 124 (149)
T 2je0_A 96 SGNKIKD-LSTIEPLKKLENLKSLDLFNCE 124 (149)
T ss_dssp TTSCCCS-HHHHGGGGGCTTCCEEECTTCG
T ss_pred CCCcCCC-hHHHHHHhhCCCCCEEeCcCCc
Confidence 8888884 33 444 3344566666663
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.17 E-value=1.3e-12 Score=148.10 Aligned_cols=179 Identities=14% Similarity=0.146 Sum_probs=130.2
Q ss_pred cccceeeeeecccCCCC-----CCCccchhccceeccCCCCCccHHHHHHHHhh-------------cCCCCcccCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSS-----RGPLLNAMEINKYLERNDGSIDGVAIVSVISL-------------YSSADWAQEGGDP 399 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~-----lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l-------------~~~~~w~~~~~dp 399 (929)
.++.|+.|+|+.|.++. +|+.+..+..|+.|+++.|.+....+..+... ..+..+..+++.
T Consensus 92 ~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~- 170 (386)
T 2ca6_A 92 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR- 170 (386)
T ss_dssp TCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC-
T ss_pred hCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC-
Confidence 45788999999999998 78889999999999999999976555544443 455555432111
Q ss_pred CCCCCCceeE---eCCCCCCCeeEEEecCCCCC--c---cCChhhhccccCceeeccCCcCC----CCCC-CCCCCCCCc
Q 002382 400 CLPVPWSWLQ---CNSDPQPSITVIHLSSKNLT--G---NIPSDLTKLSSLVELWLDGNSLT----GPIP-DFSGCPDLR 466 (929)
Q Consensus 400 c~~~~~~~~~---c~~~~~~~l~~L~L~~n~l~--g---~~p~~l~~L~~L~~L~Ls~N~l~----~~~p-~~~~l~~L~ 466 (929)
- ...++. -....+++|+.|+|++|+|+ | .+|..+.++++|+.|+|++|.|+ +.+| .+..+++|+
T Consensus 171 l---~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~ 247 (386)
T 2ca6_A 171 L---ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 247 (386)
T ss_dssp C---TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCC
T ss_pred C---CcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcC
Confidence 1 001111 01123458999999999988 3 35557888999999999999985 4444 478889999
Q ss_pred EEEecCCCcCCC----CCccc--cCCCcCcccccccccccc----cccccc---cccceeccccCCc
Q 002382 467 IIHLEDNQLTGP----LPSSL--MNLPNLRELYVQNNMLSG----TVPSSL---LSKNVVLNYAGNI 520 (929)
Q Consensus 467 ~L~Ls~N~l~g~----~P~~l--~~l~~L~~L~l~~N~l~g----~~P~~l---~~~~~~l~~~~n~ 520 (929)
.|+|++|+|++. +|..+ +.+++|+.|+|++|+|++ .+|..+ +..+..+.+.+|.
T Consensus 248 ~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 248 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314 (386)
T ss_dssp EEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred EEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCc
Confidence 999999998865 56676 448899999999999986 488877 4556777777774
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.5e-11 Score=146.51 Aligned_cols=136 Identities=15% Similarity=0.113 Sum_probs=77.7
Q ss_pred cceeeeeecccCCCCCCC-ccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 340 PFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP-~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
+.++.|+|..|.++.+|| .+..+..|+.|+++.|++.......+..+..++.++.+++. ...++.. .+++|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~------l~~lp~~--~l~~L 123 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR------LQNISCC--PMASL 123 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSC------CCEECSC--CCTTC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCc------CCccCcc--ccccC
Confidence 467888889999999987 48889999999999888765333334444333333221110 1111111 34556
Q ss_pred eEEEecCCCCCc-cCChhhhccccCceeeccCCcCCCCCCCCCCCCCC--cEEEecCCCc--CCCCCccccC
Q 002382 419 TVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDL--RIIHLEDNQL--TGPLPSSLMN 485 (929)
Q Consensus 419 ~~L~L~~n~l~g-~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L--~~L~Ls~N~l--~g~~P~~l~~ 485 (929)
+.|+|++|+|++ .+|..|++|++|+.|+|++|+|++ ..+..+++| +.|+|++|++ ++..|..+..
T Consensus 124 ~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~--~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~ 193 (562)
T 3a79_B 124 RHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ--LDLLPVAHLHLSCILLDLVSYHIKGGETESLQI 193 (562)
T ss_dssp SEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT--TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEE
T ss_pred CEEECCCCCccccCchHhhcccCcccEEecCCCcccc--CchhhhhhceeeEEEeecccccccccCcccccc
Confidence 666666666654 234556666666666666666654 223333333 6666666665 5555554444
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.16 E-value=4.4e-11 Score=139.06 Aligned_cols=166 Identities=23% Similarity=0.259 Sum_probs=92.1
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
++.|+.|++..|.++.+++ +..+..|+.|+++.|.+..... +..+..+..+..++ |. ...+. ....+++|
T Consensus 176 l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~---n~---l~~~~-~l~~l~~L 245 (466)
T 1o6v_A 176 LTTLERLDISSNKVSDISV-LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNG---NQ---LKDIG-TLASLTNL 245 (466)
T ss_dssp CTTCCEEECCSSCCCCCGG-GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCS---SC---CCCCG-GGGGCTTC
T ss_pred CCCCCEEECcCCcCCCChh-hccCCCCCEEEecCCccccccc--ccccCCCCEEECCC---CC---cccch-hhhcCCCC
Confidence 4456666666666666543 5666666666666666543211 22222333332211 10 00010 11234567
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
+.|+|++|++++..| +..+++|+.|+|++|++++.++ +..+++|+.|+|++|++++..| ++.+++|+.|+|++|+
T Consensus 246 ~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~ 320 (466)
T 1o6v_A 246 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNN 320 (466)
T ss_dssp SEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSC
T ss_pred CEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCc
Confidence 777777777764333 6667777777777777766555 6667777777777777764332 6666777777777777
Q ss_pred ccccccccccccceeccccCC
Q 002382 499 LSGTVPSSLLSKNVVLNYAGN 519 (929)
Q Consensus 499 l~g~~P~~l~~~~~~l~~~~n 519 (929)
+++..|..-+..+..+.+.+|
T Consensus 321 l~~~~~~~~l~~L~~L~l~~n 341 (466)
T 1o6v_A 321 ISDISPVSSLTKLQRLFFYNN 341 (466)
T ss_dssp CSCCGGGGGCTTCCEEECCSS
T ss_pred CCCchhhccCccCCEeECCCC
Confidence 765555444444555555555
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.15 E-value=7.2e-11 Score=136.94 Aligned_cols=161 Identities=17% Similarity=0.080 Sum_probs=89.9
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
++.++.|+|..|.++.+| .+..+..|+.|+++.|++.... +..+..+..++.++ |. ..++. ...+++|
T Consensus 41 l~~L~~L~Ls~n~l~~~~-~l~~l~~L~~L~Ls~n~l~~~~---~~~l~~L~~L~Ls~---N~---l~~~~--~~~l~~L 108 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDMT-GIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLACDS---NK---LTNLD--VTPLTKL 108 (457)
T ss_dssp HTTCCEEECCSSCCCCCT-TGGGCTTCSEEECCSSCCSCCC---CTTCTTCSEEECCS---SC---CSCCC--CTTCTTC
T ss_pred cCCCCEEEccCCCcccCh-hhcccCCCCEEEccCCcCCeEc---cccCCCCCEEECcC---CC---Cceee--cCCCCcC
Confidence 556677777777777764 5677777777777777665531 23333333332211 10 11111 3345566
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
+.|+|++|+|++ +| ++++++|+.|+|++|+|++. +++++++|++|+|++|+..+.+ .++.+++|+.|++++|+
T Consensus 109 ~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l--~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~ 181 (457)
T 3bz5_A 109 TYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI--DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNK 181 (457)
T ss_dssp CEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC--CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSC
T ss_pred CEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee--ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCc
Confidence 777777777664 44 66666777777777766664 2566666666666666544444 35566666666666666
Q ss_pred ccccccccccccceeccccCC
Q 002382 499 LSGTVPSSLLSKNVVLNYAGN 519 (929)
Q Consensus 499 l~g~~P~~l~~~~~~l~~~~n 519 (929)
|+ .+|-.-+..+..+...+|
T Consensus 182 l~-~l~l~~l~~L~~L~l~~N 201 (457)
T 3bz5_A 182 IT-ELDVSQNKLLNRLNCDTN 201 (457)
T ss_dssp CC-CCCCTTCTTCCEEECCSS
T ss_pred cc-eeccccCCCCCEEECcCC
Confidence 66 355332333344444443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.3e-10 Score=139.34 Aligned_cols=84 Identities=31% Similarity=0.354 Sum_probs=58.9
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ 495 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~ 495 (929)
++|+.|+|++|+|+ .+| ..+++|+.|+|++|+|+++++ .+++|+.|+|++|+|+ .+|..|.++++|+.|+|+
T Consensus 221 ~~L~~L~Ls~N~L~-~lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 221 SGLKELIVSGNRLT-SLP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCCEEEccCCccC-cCC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 46777777777777 355 445677777777777775444 5667777777777777 677777777777777777
Q ss_pred cccccccccccc
Q 002382 496 NNMLSGTVPSSL 507 (929)
Q Consensus 496 ~N~l~g~~P~~l 507 (929)
+|+|+|.+|..+
T Consensus 293 ~N~l~~~~~~~l 304 (622)
T 3g06_A 293 GNPLSERTLQAL 304 (622)
T ss_dssp SCCCCHHHHHHH
T ss_pred CCCCCCcCHHHH
Confidence 777776666554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.12 E-value=5.2e-11 Score=132.69 Aligned_cols=100 Identities=19% Similarity=0.227 Sum_probs=56.5
Q ss_pred EEecCC-CCCccCChhhhccccCceeeccC-CcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 421 IHLSSK-NLTGNIPSDLTKLSSLVELWLDG-NSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 421 L~L~~n-~l~g~~p~~l~~L~~L~~L~Ls~-N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
++++++ +|+ .+|. |..+++|+.|+|++ |+|+++++. |.+|++|+.|+|++|+|++..|..|.+|++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 344554 555 4555 66666666666664 666665553 556666666666666666555555666666666666666
Q ss_pred ccccccccccccc--ceeccccCCcccc
Q 002382 498 MLSGTVPSSLLSK--NVVLNYAGNINLH 523 (929)
Q Consensus 498 ~l~g~~P~~l~~~--~~~l~~~~n~~lc 523 (929)
+|+ .+|..++.. +..|.+.+|...|
T Consensus 91 ~l~-~~~~~~~~~~~L~~l~l~~N~~~c 117 (347)
T 2ifg_A 91 ALE-SLSWKTVQGLSLQELVLSGNPLHC 117 (347)
T ss_dssp CCS-CCCSTTTCSCCCCEEECCSSCCCC
T ss_pred ccc-eeCHHHcccCCceEEEeeCCCccC
Confidence 666 455544433 3444445555444
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=1.3e-10 Score=123.97 Aligned_cols=138 Identities=18% Similarity=0.112 Sum_probs=108.2
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccC-CCceeEEeeeeeecCeEEEEEEeccCCc
Q 002382 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~LV~E~~~~gs 683 (929)
+...++.|+.+.||+.... ++.+++|+...........+.+|+++++.+. |..+.++++++...+..++||||++|.+
T Consensus 18 ~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 96 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL 96 (263)
T ss_dssp EEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred eEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence 4566788888999999865 7899999987532233456889999999884 6778899999998899999999999999
Q ss_pred hhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 002382 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------------------------------------------ 721 (929)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------------ 721 (929)
|.+.+. +......++.+++++|+.||+..
T Consensus 97 l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 97 CSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp HHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred hhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 876531 11223468889999999999810
Q ss_pred --------------CCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 722 --------------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 722 --------------~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1369999999999999876566799999764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=7.4e-11 Score=140.34 Aligned_cols=89 Identities=26% Similarity=0.297 Sum_probs=82.3
Q ss_pred CCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCC-CccccCCCcCccc
Q 002382 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPL-PSSLMNLPNLREL 492 (929)
Q Consensus 414 ~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~-P~~l~~l~~L~~L 492 (929)
.+++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|+++ |.+++|++|+.|+|++|+|++.. |..|+.|++|+.|
T Consensus 461 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~l-p~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 461 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred ccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCCC-cccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 3568999999999999 9999999999999999999999985 58999999999999999999776 9999999999999
Q ss_pred cccccccccccc
Q 002382 493 YVQNNMLSGTVP 504 (929)
Q Consensus 493 ~l~~N~l~g~~P 504 (929)
+|++|+|++..|
T Consensus 539 ~L~~N~l~~~~~ 550 (567)
T 1dce_A 539 NLQGNSLCQEEG 550 (567)
T ss_dssp ECTTSGGGGSSS
T ss_pred EecCCcCCCCcc
Confidence 999999995444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.08 E-value=5.5e-10 Score=133.98 Aligned_cols=92 Identities=32% Similarity=0.391 Sum_probs=54.9
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 496 (929)
+|+.|+|++|.|+ .+|.. +++|+.|+|++|+|++.+ ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++
T Consensus 202 ~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~ 270 (622)
T 3g06_A 202 ELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYR 270 (622)
T ss_dssp TCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCS
T ss_pred hhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCC
Confidence 3444444444444 33321 256677777777776643 44567777777777777 5665 456677777777
Q ss_pred cccccccccccc--ccceeccccCCc
Q 002382 497 NMLSGTVPSSLL--SKNVVLNYAGNI 520 (929)
Q Consensus 497 N~l~g~~P~~l~--~~~~~l~~~~n~ 520 (929)
|+|+ .+|..+. ..+..+.+.+|+
T Consensus 271 N~L~-~lp~~l~~l~~L~~L~L~~N~ 295 (622)
T 3g06_A 271 NQLT-RLPESLIHLSSETTVNLEGNP 295 (622)
T ss_dssp SCCC-SCCGGGGGSCTTCEEECCSCC
T ss_pred CCCC-cCCHHHhhccccCEEEecCCC
Confidence 7777 6776653 233555556664
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.05 E-value=5.6e-10 Score=129.27 Aligned_cols=137 Identities=28% Similarity=0.379 Sum_probs=94.1
Q ss_pred cceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCee
Q 002382 340 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~ 419 (929)
+.++.|+|+.|.++.+| .+..+..|+.|+++.|++... | ....+|+
T Consensus 131 ~~L~~L~L~~n~l~~lp-~~~~l~~L~~L~l~~N~l~~l--------------------p-------------~~~~~L~ 176 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEKLP-ELQNSSFLKIIDVDNNSLKKL--------------------P-------------DLPPSLE 176 (454)
T ss_dssp TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSCC--------------------C-------------CCCTTCC
T ss_pred CCCCEEECcCCCCCCCc-ccCCCCCCCEEECCCCcCccc--------------------C-------------CCccccc
Confidence 46677777888887776 477777788888877766420 0 0113678
Q ss_pred EEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccccc
Q 002382 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 499 (929)
Q Consensus 420 ~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l 499 (929)
.|+|++|++++ +| .+++|++|+.|+|++|++++.+.. .++|+.|+|++|+++ .+|. ++.+++|+.|++++|++
T Consensus 177 ~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l 249 (454)
T 1jl5_A 177 FIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDL---PLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLL 249 (454)
T ss_dssp EEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCC
T ss_pred EEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCC---cCcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcC
Confidence 88888888874 66 577888888888888888764332 247778888888877 6773 77788888888888888
Q ss_pred cccccccccccceeccccCC
Q 002382 500 SGTVPSSLLSKNVVLNYAGN 519 (929)
Q Consensus 500 ~g~~P~~l~~~~~~l~~~~n 519 (929)
+ .+|.. ...+..+.+.+|
T Consensus 250 ~-~l~~~-~~~L~~L~l~~N 267 (454)
T 1jl5_A 250 K-TLPDL-PPSLEALNVRDN 267 (454)
T ss_dssp S-SCCSC-CTTCCEEECCSS
T ss_pred C-ccccc-ccccCEEECCCC
Confidence 7 46643 344555555555
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.05 E-value=1.4e-11 Score=136.37 Aligned_cols=157 Identities=15% Similarity=0.165 Sum_probs=87.8
Q ss_pred ccceeeeeecccCCCC--CCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCC
Q 002382 339 LPFVLSFKFGKTYDSS--RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP 416 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~--lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~ 416 (929)
++.|+.|+|..|.++. +|..+..+..|+.|++..|.+....+..+.++..++.+...+ |......++......++
T Consensus 92 ~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~---~~~l~~~~l~~~~~~~~ 168 (336)
T 2ast_B 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG---CSGFSEFALQTLLSSCS 168 (336)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT---CBSCCHHHHHHHHHHCT
T ss_pred CCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCC---CCCCCHHHHHHHHhcCC
Confidence 4556666666666653 555666666777777776666655555555555555443321 11000001110112244
Q ss_pred CeeEEEecCC-CCCcc-CChhhhccc-cCceeeccCC--cCC-CCCCC-CCCCCCCcEEEecCCC-cCCCCCccccCCCc
Q 002382 417 SITVIHLSSK-NLTGN-IPSDLTKLS-SLVELWLDGN--SLT-GPIPD-FSGCPDLRIIHLEDNQ-LTGPLPSSLMNLPN 488 (929)
Q Consensus 417 ~l~~L~L~~n-~l~g~-~p~~l~~L~-~L~~L~Ls~N--~l~-~~~p~-~~~l~~L~~L~Ls~N~-l~g~~P~~l~~l~~ 488 (929)
+|+.|+|++| ++++. ++..+..++ +|+.|+|++| .++ +.+|. +.++++|+.|+|++|. +++..+..+.++++
T Consensus 169 ~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~ 248 (336)
T 2ast_B 169 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 248 (336)
T ss_dssp TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred CCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCC
Confidence 6666666666 66643 555666666 6666666666 343 23332 4556666666666666 55555666666666
Q ss_pred Cccccccccc
Q 002382 489 LRELYVQNNM 498 (929)
Q Consensus 489 L~~L~l~~N~ 498 (929)
|+.|+|++|.
T Consensus 249 L~~L~l~~~~ 258 (336)
T 2ast_B 249 LQHLSLSRCY 258 (336)
T ss_dssp CCEEECTTCT
T ss_pred CCEeeCCCCC
Confidence 6666666664
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.04 E-value=3.8e-10 Score=130.75 Aligned_cols=85 Identities=29% Similarity=0.411 Sum_probs=42.6
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCC--CCCccccCC-------
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTG--PLPSSLMNL------- 486 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g--~~P~~l~~l------- 486 (929)
++|+.|+|++|+|++ +|.. +++|+.|+|++|++++.++ .+++|++|+|++|++++ .+|.+++.|
T Consensus 317 ~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~ 389 (454)
T 1jl5_A 317 PSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAEVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLA 389 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC---
T ss_pred CcCCEEECCCCcccc-cccc---CCcCCEEECCCCccccccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhccccc
Confidence 367777777777774 5553 4667777777777775433 46677777777777776 566666666
Q ss_pred ------CcCcccccccccccc--cccccc
Q 002382 487 ------PNLRELYVQNNMLSG--TVPSSL 507 (929)
Q Consensus 487 ------~~L~~L~l~~N~l~g--~~P~~l 507 (929)
++|+.|++++|+++| .+|.++
T Consensus 390 ~i~~~~~~L~~L~ls~N~l~~~~~iP~sl 418 (454)
T 1jl5_A 390 EVPELPQNLKQLHVETNPLREFPDIPESV 418 (454)
T ss_dssp -----------------------------
T ss_pred ccccccCcCCEEECCCCcCCccccchhhH
Confidence 667777777777765 566554
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.03 E-value=6.1e-11 Score=134.26 Aligned_cols=176 Identities=17% Similarity=0.166 Sum_probs=130.8
Q ss_pred ccceeeeeecccCCCCC----CCcc-------chhccceeccCCCCCccHH----HHHHHHhhcCCCCcccCCCCCCCCC
Q 002382 339 LPFVLSFKFGKTYDSSR----GPLL-------NAMEINKYLERNDGSIDGV----AIVSVISLYSSADWAQEGGDPCLPV 403 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~l----PP~i-------~~le~l~~L~l~~n~~~~~----~~~~l~~l~~~~~w~~~~~dpc~~~ 403 (929)
++.|+.|+|+.|.+..+ |+.+ ..+..|+.|+++.|.+... ....+..+..+..++.++ |.
T Consensus 59 ~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~---n~-- 133 (386)
T 2ca6_A 59 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHN---NG-- 133 (386)
T ss_dssp CTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCS---SC--
T ss_pred CCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcC---CC--
Confidence 56788999988766643 4444 5778899999999998773 344666666676664422 21
Q ss_pred CCce-----eEeCCCCC---------CCeeEEEecCCCCC-ccCC---hhhhccccCceeeccCCcCC--C---CCC-CC
Q 002382 404 PWSW-----LQCNSDPQ---------PSITVIHLSSKNLT-GNIP---SDLTKLSSLVELWLDGNSLT--G---PIP-DF 459 (929)
Q Consensus 404 ~~~~-----~~c~~~~~---------~~l~~L~L~~n~l~-g~~p---~~l~~L~~L~~L~Ls~N~l~--~---~~p-~~ 459 (929)
... +......+ ++|+.|+|++|+|+ +.+| ..|..+++|+.|+|++|+|+ | ..| .+
T Consensus 134 -l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l 212 (386)
T 2ca6_A 134 -LGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGL 212 (386)
T ss_dssp -CHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTG
T ss_pred -CCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHh
Confidence 110 00000011 68999999999998 5666 57888999999999999998 3 456 78
Q ss_pred CCCCCCcEEEecCCCcC----CCCCccccCCCcCccccccccccccc----ccccc----cccceeccccCCc
Q 002382 460 SGCPDLRIIHLEDNQLT----GPLPSSLMNLPNLRELYVQNNMLSGT----VPSSL----LSKNVVLNYAGNI 520 (929)
Q Consensus 460 ~~l~~L~~L~Ls~N~l~----g~~P~~l~~l~~L~~L~l~~N~l~g~----~P~~l----~~~~~~l~~~~n~ 520 (929)
.++++|+.|+|++|+|+ +.+|..+..+++|+.|+|++|+|++. +|..+ +..+..+.+.+|.
T Consensus 213 ~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~ 285 (386)
T 2ca6_A 213 AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNE 285 (386)
T ss_dssp GGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSC
T ss_pred hcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCc
Confidence 99999999999999996 67899999999999999999999865 56655 4556677777774
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.03 E-value=5.9e-11 Score=132.68 Aligned_cols=175 Identities=15% Similarity=0.147 Sum_probs=109.3
Q ss_pred cceeeeeecccCCCCCCCc-cchhccceeccCCCCCc-cHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEe-CCCCCC
Q 002382 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSI-DGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQP 416 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~-~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~~ 416 (929)
+.++.|+|+.|.++.+|+. +.++..|+.|+|+.|++ +.+....+..+..+..+...+.. ....+.- ....++
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N-----~l~~l~~~~f~~l~ 104 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN-----NLLYINPEAFQNLP 104 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEET-----TCCEECTTSBCCCT
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCC-----cccccCchhhhhcc
Confidence 4567889999999999985 89999999999998875 32211222222221111000000 0111110 112344
Q ss_pred CeeEEEecCCCCCc-------------------------cCChhhhccc-cCceeeccCCcCCCCCCCCCCCCCCcEEEe
Q 002382 417 SITVIHLSSKNLTG-------------------------NIPSDLTKLS-SLVELWLDGNSLTGPIPDFSGCPDLRIIHL 470 (929)
Q Consensus 417 ~l~~L~L~~n~l~g-------------------------~~p~~l~~L~-~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L 470 (929)
+|+.|+|++|+|++ ..+..|..+. .|+.|+|++|+|+++++......+|+.|+|
T Consensus 105 ~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l 184 (350)
T 4ay9_X 105 NLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNL 184 (350)
T ss_dssp TCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEEC
T ss_pred ccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhh
Confidence 55555555555442 2222344443 577888888888887777666778888888
Q ss_pred cC-CCcCCCCCc-cccCCCcCcccccccccccccccccccccceeccccCCcc
Q 002382 471 ED-NQLTGPLPS-SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 521 (929)
Q Consensus 471 s~-N~l~g~~P~-~l~~l~~L~~L~l~~N~l~g~~P~~l~~~~~~l~~~~n~~ 521 (929)
++ |+++ .+|. .|..+++|+.|+|++|+|+ .+|...+..+..+....+.+
T Consensus 185 ~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~~~L~~L~~l~~~~ 235 (350)
T 4ay9_X 185 SDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYN 235 (350)
T ss_dssp TTCTTCC-CCCTTTTTTEECCSEEECTTSCCC-CCCSSSCTTCCEEECTTCTT
T ss_pred ccCCccc-CCCHHHhccCcccchhhcCCCCcC-ccChhhhccchHhhhccCCC
Confidence 75 5666 5664 6788999999999999998 88888887776666555443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.01 E-value=3.9e-10 Score=112.90 Aligned_cols=103 Identities=18% Similarity=0.156 Sum_probs=80.5
Q ss_pred CCCeeEEEecCCCCCccCChhhhccc-cCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccc
Q 002382 415 QPSITVIHLSSKNLTGNIPSDLTKLS-SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (929)
Q Consensus 415 ~~~l~~L~L~~n~l~g~~p~~l~~L~-~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 493 (929)
+.+|+.|+|++|+|+ .+|. +..+. +|+.|+|++|+|++. +.+.++++|++|+|++|+|++..|..+..+++|+.|+
T Consensus 18 ~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 18 AVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 347899999999999 5665 66655 999999999999987 7788999999999999999954334458899999999
Q ss_pred cccccccccccc--cc--cccceeccccCCcc
Q 002382 494 VQNNMLSGTVPS--SL--LSKNVVLNYAGNIN 521 (929)
Q Consensus 494 l~~N~l~g~~P~--~l--~~~~~~l~~~~n~~ 521 (929)
|++|+|+ .+|. .+ +..+..+.+.+|+.
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i 125 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPV 125 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGG
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCC
Confidence 9999997 7776 44 33456667777753
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.00 E-value=3.3e-10 Score=126.11 Aligned_cols=86 Identities=26% Similarity=0.257 Sum_probs=76.1
Q ss_pred CCCeeEEEecC-CCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccc
Q 002382 415 QPSITVIHLSS-KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 492 (929)
Q Consensus 415 ~~~l~~L~L~~-n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 492 (929)
+.+|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++.+|. |.+|++|+.|||++|+|++..|..+..++ |+.|
T Consensus 30 ~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l 108 (347)
T 2ifg_A 30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQEL 108 (347)
T ss_dssp CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEE
T ss_pred CCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEE
Confidence 45799999996 999977778999999999999999999999996 89999999999999999965445555555 9999
Q ss_pred ccccccccc
Q 002382 493 YVQNNMLSG 501 (929)
Q Consensus 493 ~l~~N~l~g 501 (929)
+|++|+|..
T Consensus 109 ~l~~N~~~c 117 (347)
T 2ifg_A 109 VLSGNPLHC 117 (347)
T ss_dssp ECCSSCCCC
T ss_pred EeeCCCccC
Confidence 999999983
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.98 E-value=9.8e-10 Score=116.53 Aligned_cols=130 Identities=19% Similarity=0.119 Sum_probs=97.9
Q ss_pred ccc-ccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCc--eeEEeeeeeecCeEEEEEEeccCCch
Q 002382 608 KIG-SGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 608 ~IG-~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpN--Iv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
.++ .|..+.||+....+|+.+++|+.... ....+..|+++++.+.+.+ +.+++++...++..++||||++|.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 55569999998777888999997643 2356788999999986544 45688888888889999999999888
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------------------------------------------- 721 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------------- 721 (929)
. ... . ....++.++++.|..||+..
T Consensus 103 ~--~~~-------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 103 L--SSH-------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp T--TSC-------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred C--cCc-------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 4 211 0 11256777888888888742
Q ss_pred ------------CCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 722 ------------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 722 ------------~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
...++|+|++|.||++++++.+.|+|||.+.
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877667799999875
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.97 E-value=5.2e-12 Score=129.21 Aligned_cols=123 Identities=17% Similarity=0.258 Sum_probs=101.5
Q ss_pred ccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeEEEecCCCC
Q 002382 349 KTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNL 428 (929)
Q Consensus 349 ~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~L~L~~n~l 428 (929)
.+.++.+|..+..+..|+.|+++.|.+... | ....+++|+.|+|++|+|
T Consensus 34 ~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l--------------------~-----------~~~~l~~L~~L~l~~n~l 82 (198)
T 1ds9_A 34 IPPIEKMDATLSTLKACKHLALSTNNIEKI--------------------S-----------SLSGMENLRILSLGRNLI 82 (198)
T ss_dssp CTTCCCCHHHHHHTTTCSEEECSEEEESCC--------------------C-----------CHHHHTTCCEEEEEEEEE
T ss_pred cCcHhhhhHHHhcCCCCCEEECCCCCCccc--------------------c-----------ccccCCCCCEEECCCCCc
Confidence 346677777899999999999998877530 0 012245899999999999
Q ss_pred CccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCC--ccccCCCcCcccccccccccccccc
Q 002382 429 TGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLRELYVQNNMLSGTVPS 505 (929)
Q Consensus 429 ~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P--~~l~~l~~L~~L~l~~N~l~g~~P~ 505 (929)
+ .+|..+..+++|+.|+|++|+|++. |.+.++++|++|+|++|+|++ +| ..+..+++|+.|++++|++++.+|.
T Consensus 83 ~-~l~~~~~~~~~L~~L~L~~N~l~~l-~~~~~l~~L~~L~l~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 83 K-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp C-SCSSHHHHHHHCSEEEEEEEECCCH-HHHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred c-cccchhhcCCcCCEEECcCCcCCcC-CccccCCCCCEEECCCCcCCc-hhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 9 7899899999999999999999985 478889999999999999994 44 4789999999999999999877665
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.96 E-value=6.1e-11 Score=131.23 Aligned_cols=175 Identities=14% Similarity=0.091 Sum_probs=133.1
Q ss_pred cceeeeeecccCCCCCCCccchhccceeccCCCCCccHH-HHHHHHhhcCCCCcccCCCCCCCCCCCcee-EeCCCCCCC
Q 002382 340 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGV-AIVSVISLYSSADWAQEGGDPCLPVPWSWL-QCNSDPQPS 417 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~-~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~-~c~~~~~~~ 417 (929)
..+..|++..|.++..++.+..+..|+.|+++.|.+... ....+.++..+..+...+ |. .... .-....+++
T Consensus 70 ~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~---~~---l~~~~~~~l~~~~~ 143 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG---LR---LSDPIVNTLAKNSN 143 (336)
T ss_dssp TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT---CB---CCHHHHHHHTTCTT
T ss_pred ccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcC---cc---cCHHHHHHHhcCCC
Confidence 567888999999999999999999999999999998875 334566666666664422 21 1110 011234679
Q ss_pred eeEEEecCC-CCCc-cCChhhhccccCceeeccCC-cCCCC-CCC-CCCCC-CCcEEEecCC--CcC-CCCCccccCCCc
Q 002382 418 ITVIHLSSK-NLTG-NIPSDLTKLSSLVELWLDGN-SLTGP-IPD-FSGCP-DLRIIHLEDN--QLT-GPLPSSLMNLPN 488 (929)
Q Consensus 418 l~~L~L~~n-~l~g-~~p~~l~~L~~L~~L~Ls~N-~l~~~-~p~-~~~l~-~L~~L~Ls~N--~l~-g~~P~~l~~l~~ 488 (929)
|+.|+|++| .+++ .++..+.++++|+.|+|++| ++++. ++. +..++ +|++|+|++| .++ +.+|..+..+++
T Consensus 144 L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~ 223 (336)
T 2ast_B 144 LVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN 223 (336)
T ss_dssp CSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTT
T ss_pred CCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCC
Confidence 999999999 7886 37888999999999999999 99864 444 77899 9999999999 555 467888889999
Q ss_pred Cccccccccc-cccccccccc--ccceeccccCCc
Q 002382 489 LRELYVQNNM-LSGTVPSSLL--SKNVVLNYAGNI 520 (929)
Q Consensus 489 L~~L~l~~N~-l~g~~P~~l~--~~~~~l~~~~n~ 520 (929)
|+.|+|++|. +++..+..+. ..+..+.+.+|.
T Consensus 224 L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 224 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp CSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred CCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 9999999999 7767776663 345666777764
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.89 E-value=8.1e-11 Score=132.15 Aligned_cols=175 Identities=18% Similarity=0.164 Sum_probs=115.8
Q ss_pred cceeeeeecccCCCCCCC-----ccchhc-cceeccCCCCCccHHHHHHHHhh-----cCCCCcccCCCCCCCCCCCcee
Q 002382 340 PFVLSFKFGKTYDSSRGP-----LLNAME-INKYLERNDGSIDGVAIVSVISL-----YSSADWAQEGGDPCLPVPWSWL 408 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP-----~i~~le-~l~~L~l~~n~~~~~~~~~l~~l-----~~~~~w~~~~~dpc~~~~~~~~ 408 (929)
+.++.|+|+.|.++..++ .+..+. .|+.|+++.|.+.......+..+ ..++.++.++.. ....
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~------l~~~ 95 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNF------LSYK 95 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSC------GGGS
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCc------CChH
Confidence 347889999999999886 355666 79999999999887666666665 445555432211 1111
Q ss_pred EeC-----CCCC-CCeeEEEecCCCCCccCChhhhc-----cccCceeeccCCcCCCCCC-----CCCCCC-CCcEEEec
Q 002382 409 QCN-----SDPQ-PSITVIHLSSKNLTGNIPSDLTK-----LSSLVELWLDGNSLTGPIP-----DFSGCP-DLRIIHLE 471 (929)
Q Consensus 409 ~c~-----~~~~-~~l~~L~L~~n~l~g~~p~~l~~-----L~~L~~L~Ls~N~l~~~~p-----~~~~l~-~L~~L~Ls 471 (929)
.+. .... ++|+.|+|++|+|++..+..+.. .++|++|+|++|+|++... .+..++ +|++|+|+
T Consensus 96 ~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls 175 (362)
T 3goz_A 96 SSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLR 175 (362)
T ss_dssp CHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECT
T ss_pred HHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeec
Confidence 110 1112 57888899988888665555544 2688889999888885333 244554 88889999
Q ss_pred CCCcCCCCCcccc----CC-CcCccccccccccccc----ccccccc---cceeccccCCc
Q 002382 472 DNQLTGPLPSSLM----NL-PNLRELYVQNNMLSGT----VPSSLLS---KNVVLNYAGNI 520 (929)
Q Consensus 472 ~N~l~g~~P~~l~----~l-~~L~~L~l~~N~l~g~----~P~~l~~---~~~~l~~~~n~ 520 (929)
+|+|++..+..+. .+ ++|+.|+|++|+|++. +|..+.. .+..+.+.+|.
T Consensus 176 ~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 236 (362)
T 3goz_A 176 GNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC 236 (362)
T ss_dssp TSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSC
T ss_pred CCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCC
Confidence 9988876665444 34 5888899999988842 5555532 45666666663
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.82 E-value=2.2e-11 Score=124.57 Aligned_cols=128 Identities=17% Similarity=0.213 Sum_probs=106.6
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (929)
.++.++.|+|+.|.++.+| .+..+..|+.|+++.|.+.. +... ...+++
T Consensus 46 ~l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~~-----------l~~~-------------------~~~~~~ 94 (198)
T 1ds9_A 46 TLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIKK-----------IENL-------------------DAVADT 94 (198)
T ss_dssp HTTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEECS-----------CSSH-------------------HHHHHH
T ss_pred cCCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCccc-----------ccch-------------------hhcCCc
Confidence 3667899999999999998 99999999999999997753 0110 011348
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCC--CCCCCCCCcEEEecCCCcCCCCCcc----------ccC
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPSS----------LMN 485 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~g~~P~~----------l~~ 485 (929)
|+.|+|++|+|++ +| .+..+++|+.|+|++|+|++..+ .+..+++|++|+|++|.+++.+|.. +..
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~ 172 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKR 172 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHh
Confidence 9999999999995 66 69999999999999999998655 5899999999999999999776653 888
Q ss_pred CCcCccccccccccc
Q 002382 486 LPNLRELYVQNNMLS 500 (929)
Q Consensus 486 l~~L~~L~l~~N~l~ 500 (929)
+++|+.|+ +|.++
T Consensus 173 l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 173 LPNLKKLD--GMPVD 185 (198)
T ss_dssp CSSCSEEC--CGGGT
T ss_pred CCCcEEEC--CcccC
Confidence 99999886 77776
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.81 E-value=8e-09 Score=115.63 Aligned_cols=140 Identities=16% Similarity=0.311 Sum_probs=105.2
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEee--cCC-cchhHHHHHHHHHhcccC--CCceeEEeeeeeec---CeEEEEEEe
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLT--SNS-YQGKREFTNEVTLLSRIH--HRNLVQFLGYCQEE---GRSVLVYEF 678 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~--~~~-~~~~~~f~~Ev~iL~~l~--HpNIv~l~g~~~~~---~~~~LV~E~ 678 (929)
+.|+.|.++.||+.... ++.+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 46899999999999876 4678888775 332 123457889999999986 45678889888776 457999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------------------------------------- 721 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------- 721 (929)
++|..+.+... ..++..++..++.++++.|+.||+..
T Consensus 123 v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 123 VSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred cCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99988754221 23566777889999999999999731
Q ss_pred ------------------CCceecCCCCCCCeEecCCCc--EEEEeecCccc
Q 002382 722 ------------------VPAIIHRDLKSSNILLDKHMR--AKVSDFGLSKF 753 (929)
Q Consensus 722 ------------------~~~ivHrDIkp~NILl~~~~~--vkL~DFGla~~ 753 (929)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998864
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.79 E-value=3e-10 Score=127.51 Aligned_cols=175 Identities=17% Similarity=0.134 Sum_probs=114.3
Q ss_pred eeecccCCCCCCCccc-hhccceeccCCCCCccHHHH----HHHHhhc-CCCCcccCCCCCCCCCCCcee-EeCCCCCCC
Q 002382 345 FKFGKTYDSSRGPLLN-AMEINKYLERNDGSIDGVAI----VSVISLY-SSADWAQEGGDPCLPVPWSWL-QCNSDPQPS 417 (929)
Q Consensus 345 l~l~~n~~s~lPP~i~-~le~l~~L~l~~n~~~~~~~----~~l~~l~-~~~~w~~~~~dpc~~~~~~~~-~c~~~~~~~ 417 (929)
+.|+.|.++.+.|.+- ....|+.|+++.|.+..... ..++.+. .+..++.+++.-. ...+..+ .+-....++
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~-~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLG-FKNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGG-GSCHHHHHHHHHTSCTT
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCC-HHHHHHHHHHHhccCCC
Confidence 4567888887777744 44559999999999887655 5566555 5655544221100 0000000 000011258
Q ss_pred eeEEEecCCCCCccCChhhhcc-----ccCceeeccCCcCCCCCCC-----CCC-CCCCcEEEecCCCcCCCC----Ccc
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKL-----SSLVELWLDGNSLTGPIPD-----FSG-CPDLRIIHLEDNQLTGPL----PSS 482 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L-----~~L~~L~Ls~N~l~~~~p~-----~~~-l~~L~~L~Ls~N~l~g~~----P~~ 482 (929)
|+.|+|++|+|++..+..+..+ ++|+.|+|++|+|++..+. +.. .++|++|+|++|+|++.. +..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999987666655554 8899999999999877663 344 368999999999988533 344
Q ss_pred ccCCC-cCccccccccccccccccccc-------ccceeccccCCc
Q 002382 483 LMNLP-NLRELYVQNNMLSGTVPSSLL-------SKNVVLNYAGNI 520 (929)
Q Consensus 483 l~~l~-~L~~L~l~~N~l~g~~P~~l~-------~~~~~l~~~~n~ 520 (929)
+..++ +|+.|+|++|+|++..+..+. ..+..+.+.+|.
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 207 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANL 207 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCC
Confidence 45565 899999999999866655442 244566666663
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.78 E-value=5.9e-10 Score=128.87 Aligned_cols=138 Identities=20% Similarity=0.194 Sum_probs=98.6
Q ss_pred cceeeeeecccCCCC-----CCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCC
Q 002382 340 PFVLSFKFGKTYDSS-----RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDP 414 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~-----lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~ 414 (929)
+.++.|+|..|.++. +|..+..+..|+.|+++.|.+....+..+..... ..
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~------------------------~~ 311 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLL------------------------EP 311 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHT------------------------ST
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhc------------------------cC
Confidence 445555555555555 4444555555555555555555444444433310 11
Q ss_pred CCCeeEEEecCCCCCcc----CChhhhccccCceeeccCCcCCCCCCC-CC----C-CCCCcEEEecCCCcCC----CCC
Q 002382 415 QPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIPD-FS----G-CPDLRIIHLEDNQLTG----PLP 480 (929)
Q Consensus 415 ~~~l~~L~L~~n~l~g~----~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~----~-l~~L~~L~Ls~N~l~g----~~P 480 (929)
.++|+.|+|++|++++. ++..+..+++|+.|+|++|++++..+. +. . .++|+.|+|++|+|++ .+|
T Consensus 312 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~ 391 (461)
T 1z7x_W 312 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLA 391 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred CccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHH
Confidence 24899999999999865 677888889999999999999875432 32 2 7799999999999996 788
Q ss_pred ccccCCCcCcccccccccccc
Q 002382 481 SSLMNLPNLRELYVQNNMLSG 501 (929)
Q Consensus 481 ~~l~~l~~L~~L~l~~N~l~g 501 (929)
..+..+++|+.|+|++|++++
T Consensus 392 ~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 392 ATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp HHHHHCCCCCEEECCSSSCCH
T ss_pred HHHHhCCCccEEECCCCCCCH
Confidence 889999999999999999984
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.75 E-value=1.1e-09 Score=126.71 Aligned_cols=157 Identities=22% Similarity=0.210 Sum_probs=102.1
Q ss_pred ccceeeeeecccCCC-----CCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCC
Q 002382 339 LPFVLSFKFGKTYDS-----SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSD 413 (929)
Q Consensus 339 l~~l~~l~l~~n~~s-----~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~ 413 (929)
++.++.|+|..|.++ .+|..+..+..|+.|++++|.+....+..+..... .
T Consensus 27 ~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~------------------------~ 82 (461)
T 1z7x_W 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ------------------------T 82 (461)
T ss_dssp HTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC------------------------S
T ss_pred cCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh------------------------h
Confidence 345666777777766 44555666677777777777766554444433210 0
Q ss_pred CCCCeeEEEecCCCCCc----cCChhhhccccCceeeccCCcCCCCCCC------CCCCCCCcEEEecCCCcCCC----C
Q 002382 414 PQPSITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGPIPD------FSGCPDLRIIHLEDNQLTGP----L 479 (929)
Q Consensus 414 ~~~~l~~L~L~~n~l~g----~~p~~l~~L~~L~~L~Ls~N~l~~~~p~------~~~l~~L~~L~Ls~N~l~g~----~ 479 (929)
...+|+.|+|++|+++. .+|..|.++++|+.|+|++|.+++..+. ...+++|++|+|++|++++. +
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 01268888888888883 5678888888888888888888754331 23366788888888888853 3
Q ss_pred CccccCCCcCcccccccccccccccccccc-------cceeccccCC
Q 002382 480 PSSLMNLPNLRELYVQNNMLSGTVPSSLLS-------KNVVLNYAGN 519 (929)
Q Consensus 480 P~~l~~l~~L~~L~l~~N~l~g~~P~~l~~-------~~~~l~~~~n 519 (929)
+..+..+++|+.|+|++|++++..+..+.. .+..+.+.+|
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n 209 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESC 209 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTS
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCC
Confidence 566667788888888888887544443322 4455555555
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.67 E-value=5.9e-09 Score=113.87 Aligned_cols=186 Identities=21% Similarity=0.253 Sum_probs=119.8
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccC-CCc--eeEEeeeeeecC---eEEEEEEecc
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRN--LVQFLGYCQEEG---RSVLVYEFMH 680 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-HpN--Iv~l~g~~~~~~---~~~LV~E~~~ 680 (929)
+.++.|....||+.. +.+++|+.... .....+.+|+++|+.+. +.. +.+.+......+ ..++||++++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 458899999999863 56889985432 33567889999998873 322 344555443333 3478999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG---------------------------------------- 720 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~---------------------------------------- 720 (929)
|.+|.+... ..++..++..++.++++.|+.||+.
T Consensus 100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 988865332 2345566677788888888888851
Q ss_pred ---------------CCCceecCCCCCCCeEecC--CCcEEEEeecCcccccCCCCceeeeee--------------cCc
Q 002382 721 ---------------CVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGASHVSSIVR--------------GTV 769 (929)
Q Consensus 721 ---------------~~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~~--------------gt~ 769 (929)
..+.++|+|++|.||++++ ...+.|+||+.+...... ........ ...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHc
Confidence 1136899999999999998 456889999988643221 11100000 000
Q ss_pred cccC-ccccccCcCCCcCceeeHHHHHHHHHhCCCCCcc
Q 002382 770 GYLD-PEYYISQQLTDKSDVYSFGVILLELISGQEAISN 807 (929)
Q Consensus 770 ~Y~a-PE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~ 807 (929)
+... |+.... .....+.|+++.++|++.+|+.+|..
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 1111 222111 11225889999999999999987743
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.64 E-value=3.5e-09 Score=119.23 Aligned_cols=138 Identities=20% Similarity=0.122 Sum_probs=103.1
Q ss_pred cceeeeeecccCCCCC--CCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCC
Q 002382 340 PFVLSFKFGKTYDSSR--GPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~l--PP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (929)
+.|+.|+|+.|.++.. ..+..++..|+.|+|+.|.+....+..|..... . ..++
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~---------~---------------~~~~ 156 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL---------H---------------DQCQ 156 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH---------S---------------TTCC
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH---------h---------------cCCc
Confidence 4677888888877653 333566777888888888887766666655421 0 1137
Q ss_pred eeEEEecCCCCCc----cCChhhhccccCceeeccCCcCCCCC----C-CCCCCCCCcEEEecCCCcCC----CCCcccc
Q 002382 418 ITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGPI----P-DFSGCPDLRIIHLEDNQLTG----PLPSSLM 484 (929)
Q Consensus 418 l~~L~L~~n~l~g----~~p~~l~~L~~L~~L~Ls~N~l~~~~----p-~~~~l~~L~~L~Ls~N~l~g----~~P~~l~ 484 (929)
|+.|+|++|+|+. .++..+..+++|++|+|++|.|+..- . .+..+++|+.|+|++|+|+. .++..+.
T Consensus 157 L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~ 236 (372)
T 3un9_A 157 ITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAR 236 (372)
T ss_dssp CCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHH
T ss_pred cceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHH
Confidence 9999999999974 35666788999999999999998632 2 36778899999999999984 2445566
Q ss_pred CCCcCcccccccccccc
Q 002382 485 NLPNLRELYVQNNMLSG 501 (929)
Q Consensus 485 ~l~~L~~L~l~~N~l~g 501 (929)
..++|+.|+|++|+|++
T Consensus 237 ~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 237 EHPSLELLHLYFNELSS 253 (372)
T ss_dssp HCSSCCEEECTTSSCCH
T ss_pred hCCCCCEEeccCCCCCH
Confidence 67899999999999984
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.62 E-value=4.1e-08 Score=109.46 Aligned_cols=101 Identities=21% Similarity=0.282 Sum_probs=83.4
Q ss_pred CceeEeCCCC--------CCCeeEEEecCCCCCccCC-hhhhccccCceeeccCCcCCCCCCC--CCCCCCCcE-EEecC
Q 002382 405 WSWLQCNSDP--------QPSITVIHLSSKNLTGNIP-SDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRI-IHLED 472 (929)
Q Consensus 405 ~~~~~c~~~~--------~~~l~~L~L~~n~l~g~~p-~~l~~L~~L~~L~Ls~N~l~~~~p~--~~~l~~L~~-L~Ls~ 472 (929)
+..|.|+..+ +++++.|+|++|+|+ .+| ..|.+|++|+.|+|++|++.+.+|. |.++++|+. ++++.
T Consensus 11 ~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 11 NRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp TTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred CCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 4567786433 246899999999999 565 5799999999999999999887763 789998865 77788
Q ss_pred CCcCCCCCccccCCCcCcccccccccccccccccc
Q 002382 473 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507 (929)
Q Consensus 473 N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l 507 (929)
|+|+...|..|..+++|+.|++++|+|+ .+|...
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~-~~~~~~ 123 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVH 123 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCS-SCCCCT
T ss_pred CcccccCchhhhhccccccccccccccc-cCCchh
Confidence 9999777889999999999999999999 555443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.57 E-value=3.6e-08 Score=108.85 Aligned_cols=94 Identities=21% Similarity=0.281 Sum_probs=80.5
Q ss_pred CCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCc-EEEecCCCcCCCCCccccCCCcCccc
Q 002382 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLR-IIHLEDNQLTGPLPSSLMNLPNLREL 492 (929)
Q Consensus 415 ~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~-~L~Ls~N~l~g~~P~~l~~l~~L~~L 492 (929)
+++|+.|+|++|+++..-+..|.+|++|+.|+|++| ++.+.+. |.+|++|+ .|+|.+ +++..-+..|.++++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 468999999999999444457999999999999998 7776664 99999999 999999 7774556799999999999
Q ss_pred ccccccccccccccccccc
Q 002382 493 YVQNNMLSGTVPSSLLSKN 511 (929)
Q Consensus 493 ~l~~N~l~g~~P~~l~~~~ 511 (929)
++++|+++ .++...|...
T Consensus 303 ~l~~n~i~-~I~~~aF~~~ 320 (329)
T 3sb4_A 303 LATGDKIT-TLGDELFGNG 320 (329)
T ss_dssp EECSSCCC-EECTTTTCTT
T ss_pred EeCCCccC-ccchhhhcCC
Confidence 99999999 8888776654
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=9e-08 Score=95.55 Aligned_cols=155 Identities=18% Similarity=0.120 Sum_probs=89.4
Q ss_pred EEEeeccCCCCCCCccCCCCCCCCccccCccccccccccccCcccccccccccCCCCCCCChHHHHhhcccccCCceEEe
Q 002382 193 VSARINFGADSEAPVRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYR 272 (929)
Q Consensus 193 ~~~r~~~g~~~~~~~ryp~D~~dR~W~p~~~~~~~~~~~~~~~~~~~st~~~i~~~~~~~pP~~v~qtA~t~~~~~l~~~ 272 (929)
.+.|.|||+.. +. |..+|.|++|.......... .... .+.....+..|..|+|||=... .+++|.
T Consensus 6 ~~~~INcGg~~---~~---d~~gr~w~~D~~~~~~g~~~------~~~~--~~~~~~~~~~~~~lY~TaR~~~-~~~tY~ 70 (174)
T 2jwp_A 6 VIWAVNAGGES---HV---DVHGIHYRKDPLEGRVGRAS------DYGM--KLPILRSNPEDQVLYQTERYNE-DSFGYD 70 (174)
T ss_dssp EEEEEEETSSS---EE---ETTTEEECSSCSSTTCCCCC------CCCT--TSCCSSSCHHHHHTTTCCCCCC-SCEEEE
T ss_pred EEEEEECCCCC---cc---CCCCCEEcCCcCcccCCccc------cccc--ceEecccCCCCchhhhhhccCC-CCeEEE
Confidence 35699999843 22 67899999985432111000 0001 1111223456889999997743 467888
Q ss_pred ecCCCCCCcceeEEeeccccCCCCCcceEEEEEECCCcccccceeccccccCcc-eEEecccccc---------ccccce
Q 002382 273 LNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGK-YRVYEPGYTN---------LSLPFV 342 (929)
Q Consensus 273 ~~~~~~~~~~y~~~yFae~~~~~~~~~R~F~v~~n~~~~~~~~~~~~~~~~~~~-~~v~~~~~t~---------~~l~~l 342 (929)
.+++.. ..+.+-|||+|+.. ...+.|+|||++||+...++..+.-....... +.-+....++ ..-...
T Consensus 71 f~v~~~-G~Y~VrLhF~ei~~-~~~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~ 148 (174)
T 2jwp_A 71 IPIKEE-GEYVLVLKFAEVYF-AQSQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGK 148 (174)
T ss_dssp EECCSC-EEEEEEEEEECCSC-CCSSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSE
T ss_pred EEeCCC-eEEEEEEEEecccc-CCCCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCe
Confidence 887643 34456899999974 45789999999999988776554322211111 1111111000 011233
Q ss_pred eeeeecccCCCCCCCccchhccce
Q 002382 343 LSFKFGKTYDSSRGPLLNAMEINK 366 (929)
Q Consensus 343 ~~l~l~~n~~s~lPP~i~~le~l~ 366 (929)
..+.+.+. +.-.|.||++|+++
T Consensus 149 L~I~f~p~--~~~~a~inaIEI~~ 170 (174)
T 2jwp_A 149 LSVEFVKG--YYDNPKVCALFIMK 170 (174)
T ss_dssp EEEEEECS--SSCSSSEEEEEEES
T ss_pred EEEEEecc--CCCCcEEEEEEEEe
Confidence 45555542 34568999999875
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.50 E-value=9.5e-09 Score=115.66 Aligned_cols=154 Identities=16% Similarity=0.138 Sum_probs=110.3
Q ss_pred ccceeeeeecccCCCCCCCc-cchh-----ccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCC
Q 002382 339 LPFVLSFKFGKTYDSSRGPL-LNAM-----EINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNS 412 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~-i~~l-----e~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~ 412 (929)
++.++.|+|+.|.++..... |..+ ..|+.|+|+.|.+....+..+...
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~-------------------------- 124 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPV-------------------------- 124 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHH--------------------------
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHH--------------------------
Confidence 45677888888888765443 3333 578888888888876555544332
Q ss_pred CCCCCeeEEEecCCCCCccCChhhh-----ccccCceeeccCCcCCCC----CC-CCCCCCCCcEEEecCCCcCC----C
Q 002382 413 DPQPSITVIHLSSKNLTGNIPSDLT-----KLSSLVELWLDGNSLTGP----IP-DFSGCPDLRIIHLEDNQLTG----P 478 (929)
Q Consensus 413 ~~~~~l~~L~L~~n~l~g~~p~~l~-----~L~~L~~L~Ls~N~l~~~----~p-~~~~l~~L~~L~Ls~N~l~g----~ 478 (929)
+.+|+.|+|++|+|+..-...|. ..++|+.|+|++|.|+.. ++ .+..+++|++|||++|+|+. .
T Consensus 125 --L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~ 202 (372)
T 3un9_A 125 --FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLEL 202 (372)
T ss_dssp --HHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHH
T ss_pred --HHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHH
Confidence 12689999999999855444443 468899999999999762 22 35778999999999999984 2
Q ss_pred CCccccCCCcCccccccccccccc----ccccc--cccceeccccCCc
Q 002382 479 LPSSLMNLPNLRELYVQNNMLSGT----VPSSL--LSKNVVLNYAGNI 520 (929)
Q Consensus 479 ~P~~l~~l~~L~~L~l~~N~l~g~----~P~~l--~~~~~~l~~~~n~ 520 (929)
++..+..+++|+.|+|++|+|++. ++..+ ...+..+++.+|.
T Consensus 203 L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~ 250 (372)
T 3un9_A 203 LAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNE 250 (372)
T ss_dssp HHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSS
T ss_pred HHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCC
Confidence 356777888999999999999843 22222 2345667777774
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.31 E-value=2.5e-07 Score=98.55 Aligned_cols=77 Identities=26% Similarity=0.357 Sum_probs=43.0
Q ss_pred CCCeeEEEecCCCCCc--cCChhhhccccCceeeccCCcCCCCC--CCCCCCCCCcEEEecCCCcCCCCCc-------cc
Q 002382 415 QPSITVIHLSSKNLTG--NIPSDLTKLSSLVELWLDGNSLTGPI--PDFSGCPDLRIIHLEDNQLTGPLPS-------SL 483 (929)
Q Consensus 415 ~~~l~~L~L~~n~l~g--~~p~~l~~L~~L~~L~Ls~N~l~~~~--p~~~~l~~L~~L~Ls~N~l~g~~P~-------~l 483 (929)
+++|+.|+|++|+|++ .+|..+..|++|+.|+|++|+|++.. ..+..+ +|++|+|++|.|.+.+|. .+
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl~~~~~~~~~y~~~il 247 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLCDTFRDQSTYISAIR 247 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTTGGGCSSHHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcCccccCcchhHHHHHH
Confidence 3456666666666665 44455566666666666666666541 123333 666666666666655542 24
Q ss_pred cCCCcCccc
Q 002382 484 MNLPNLREL 492 (929)
Q Consensus 484 ~~l~~L~~L 492 (929)
..+++|+.|
T Consensus 248 ~~~P~L~~L 256 (267)
T 3rw6_A 248 ERFPKLLRL 256 (267)
T ss_dssp HHCTTCCEE
T ss_pred HHCcccCeE
Confidence 455555554
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.30 E-value=3.3e-08 Score=117.99 Aligned_cols=163 Identities=15% Similarity=0.100 Sum_probs=96.3
Q ss_pred ccceeeeeec-----------ccCCCC--CCCccchhccceeccCCCCCccHHHHHHHHh-hcCCCCcccCCCCCCCCCC
Q 002382 339 LPFVLSFKFG-----------KTYDSS--RGPLLNAMEINKYLERNDGSIDGVAIVSVIS-LYSSADWAQEGGDPCLPVP 404 (929)
Q Consensus 339 l~~l~~l~l~-----------~n~~s~--lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~-l~~~~~w~~~~~dpc~~~~ 404 (929)
++.|+.|+|. .|.++. ++..+..+..|+.|+++.|.+....+..+.+ +..+..+.....+-|....
T Consensus 341 ~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~ 420 (592)
T 3ogk_B 341 CKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERIT 420 (592)
T ss_dssp CTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCS
T ss_pred CCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCcccc
Confidence 4567777777 244442 3333556777888888777777777777665 4444444332111121111
Q ss_pred C----ceeEeCCCCCCCeeEEEecCC--CCCccCChhhhc-cccCceeeccCCcCCC-CCCC-CCCCCCCcEEEecCCCc
Q 002382 405 W----SWLQCNSDPQPSITVIHLSSK--NLTGNIPSDLTK-LSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLEDNQL 475 (929)
Q Consensus 405 ~----~~~~c~~~~~~~l~~L~L~~n--~l~g~~p~~l~~-L~~L~~L~Ls~N~l~~-~~p~-~~~l~~L~~L~Ls~N~l 475 (929)
. .++.....++++|+.|+|+++ .+++..+..+.. +++|+.|+|++|++++ .++. +.++++|+.|+|++|.|
T Consensus 421 ~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l 500 (592)
T 3ogk_B 421 DLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF 500 (592)
T ss_dssp SCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCC
T ss_pred CchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCC
Confidence 0 011110112457788888643 366655555554 7778888888887775 3333 46677888888888877
Q ss_pred CCC-CCccccCCCcCcccccccccccc
Q 002382 476 TGP-LPSSLMNLPNLRELYVQNNMLSG 501 (929)
Q Consensus 476 ~g~-~P~~l~~l~~L~~L~l~~N~l~g 501 (929)
++. ++..+..+++|+.|+|++|++++
T Consensus 501 ~~~~~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 501 SERAIAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp BHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred cHHHHHHHHHhcCccCeeECcCCcCCH
Confidence 643 34445567778888888888774
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.15 E-value=2.5e-06 Score=94.02 Aligned_cols=69 Identities=19% Similarity=0.098 Sum_probs=49.5
Q ss_pred cccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCc-cccccccccccccccccccc
Q 002382 439 LSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR-ELYVQNNMLSGTVPSSLLSK 510 (929)
Q Consensus 439 L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~-~L~l~~N~l~g~~P~~l~~~ 510 (929)
+++|+.|+|++|+++.+++. |.+|++|+.|+|++| ++..-+..|.++++|+ .|++.+ +++ .|+...|..
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~ 295 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMG 295 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTT
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhC
Confidence 67788888888887776664 777888888888777 6644445777888887 787776 666 666665543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.09 E-value=4.8e-07 Score=96.30 Aligned_cols=82 Identities=23% Similarity=0.371 Sum_probs=64.3
Q ss_pred EEecCCCCCccCCh----hhhccccCceeeccCCcCCCC--CCC-CCCCCCCcEEEecCCCcCCCCCccccCCC--cCcc
Q 002382 421 IHLSSKNLTGNIPS----DLTKLSSLVELWLDGNSLTGP--IPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLP--NLRE 491 (929)
Q Consensus 421 L~L~~n~l~g~~p~----~l~~L~~L~~L~Ls~N~l~~~--~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~--~L~~ 491 (929)
++++.|.+. .++. ...+|++|+.|+|++|+|+++ +|. +..+++|+.|+|++|+|++. ..+..+. +|+.
T Consensus 148 l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~ 224 (267)
T 3rw6_A 148 IDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEE 224 (267)
T ss_dssp CCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSE
T ss_pred ccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcce
Confidence 566777543 3333 335789999999999999994 445 57899999999999999964 4455555 9999
Q ss_pred cccccccccccccc
Q 002382 492 LYVQNNMLSGTVPS 505 (929)
Q Consensus 492 L~l~~N~l~g~~P~ 505 (929)
|+|++|++++.+|.
T Consensus 225 L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 225 LWLDGNSLCDTFRD 238 (267)
T ss_dssp EECTTSTTGGGCSS
T ss_pred EEccCCcCccccCc
Confidence 99999999987773
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.2e-05 Score=87.72 Aligned_cols=135 Identities=20% Similarity=0.245 Sum_probs=89.7
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCC---ceeEEeeeee-ecCeEEEEEEeccCC
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR---NLVQFLGYCQ-EEGRSVLVYEFMHNG 682 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~Hp---NIv~l~g~~~-~~~~~~LV~E~~~~g 682 (929)
+.++.|....||+. ++.+++|+-. .......+..|+++|+.+.+. .+.+.+.++. ..+..++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888999988 5778888842 223346788999999998642 3556666664 445678999999998
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG------------------------------------------ 720 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------------------------------------------ 720 (929)
++.+.... .++..+...++.++++.|+.||+.
T Consensus 99 ~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88653211 112223333444444444444431
Q ss_pred ---------------CCCceecCCCCCCCeEecC---CCc-EEEEeecCccc
Q 002382 721 ---------------CVPAIIHRDLKSSNILLDK---HMR-AKVSDFGLSKF 753 (929)
Q Consensus 721 ---------------~~~~ivHrDIkp~NILl~~---~~~-vkL~DFGla~~ 753 (929)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2236799999999999987 455 48999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=1.8e-05 Score=84.14 Aligned_cols=134 Identities=17% Similarity=0.120 Sum_probs=94.4
Q ss_pred cccccCcE-EEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccC-CCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 608 KIGSGGFG-VVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 608 ~IG~G~fG-~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
.+..|..| .||+.... ++..+++|+-... ...++..|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 44556555 68987765 4567899986532 3456888999988874 33467788999999999999999999887
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------------------------------------------- 721 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------------- 721 (929)
.+..... ......++.++++.|..||+..
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 6643211 1122345555666666666421
Q ss_pred ------------CCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 722 ------------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 722 ------------~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
.+.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1248999999999999987777799999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=8.9e-06 Score=90.53 Aligned_cols=80 Identities=4% Similarity=0.048 Sum_probs=56.4
Q ss_pred ccc-cccCcEEEEEEEEC-------CCcEEEEEEeecCC---cchhHHHHHHHHHhcccC-C--CceeEEeeeeeec---
Q 002382 607 KKI-GSGGFGVVYYGKLK-------DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIH-H--RNLVQFLGYCQEE--- 669 (929)
Q Consensus 607 ~~I-G~G~fG~Vy~~~~~-------~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~-H--pNIv~l~g~~~~~--- 669 (929)
+.| +.|....+|+.... +++.+++|+..... ......+..|+.+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78888999988764 26778898865332 112356788999988884 3 3567788877655
Q ss_pred CeEEEEEEeccCCchhh
Q 002382 670 GRSVLVYEFMHNGTLKE 686 (929)
Q Consensus 670 ~~~~LV~E~~~~gsL~~ 686 (929)
+..++|||+++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.96 E-value=1.7e-06 Score=87.23 Aligned_cols=118 Identities=10% Similarity=0.094 Sum_probs=90.5
Q ss_pred ccchhccceeccCCCC-CccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeEEEecCCCCCc----cC
Q 002382 358 LLNAMEINKYLERNDG-SIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTG----NI 432 (929)
Q Consensus 358 ~i~~le~l~~L~l~~n-~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~L~L~~n~l~g----~~ 432 (929)
.+.....|+.|+|+.| .+....+..|..... ..++|++|+|++|+|.. .+
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~-------------------------~~~~L~~L~Ls~n~i~~~g~~~l 85 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALK-------------------------TNTYVKKFSIVGTRSNDPVAFAL 85 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHT-------------------------TCCSCCEEECTTSCCCHHHHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHH-------------------------hCCCcCEEECcCCCCChHHHHHH
Confidence 3555677889999998 898877777766521 11368999999999974 24
Q ss_pred ChhhhccccCceeeccCCcCCCC-----CCCCCCCCCCcEEEe--cCCCcCCC----CCccccCCCcCccccccccccc
Q 002382 433 PSDLTKLSSLVELWLDGNSLTGP-----IPDFSGCPDLRIIHL--EDNQLTGP----LPSSLMNLPNLRELYVQNNMLS 500 (929)
Q Consensus 433 p~~l~~L~~L~~L~Ls~N~l~~~-----~p~~~~l~~L~~L~L--s~N~l~g~----~P~~l~~l~~L~~L~l~~N~l~ 500 (929)
...+...+.|++|+|++|+|+.. ...+...+.|++|+| ++|.|+.. +...+...++|+.|+|++|.+.
T Consensus 86 ~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 86 AEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 55666778999999999999863 334777889999999 88998843 3455666689999999999986
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.96 E-value=1.3e-06 Score=104.15 Aligned_cols=134 Identities=13% Similarity=0.104 Sum_probs=65.7
Q ss_pred cccceeeeeecccCCCCCCCc-cchh--ccceeccCCCCC-ccHHHHHHHH-hhcCCCCcccCCCCCCCCCCCceeEeCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPL-LNAM--EINKYLERNDGS-IDGVAIVSVI-SLYSSADWAQEGGDPCLPVPWSWLQCNS 412 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~-i~~l--e~l~~L~l~~n~-~~~~~~~~l~-~l~~~~~w~~~~~dpc~~~~~~~~~c~~ 412 (929)
.++.|+.|+|..+.++...+. +..+ ..|+.|++..+. +....+..+. .+..++.+...... -...+..|+..-.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~-~~~~~~~~l~~~~ 188 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESS-FSEKDGKWLHELA 188 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCE-EECCCSHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECcccc-ccCcchhHHHHHH
Confidence 355677777777765543222 4443 337777776655 3433444332 33344444321110 0000011111111
Q ss_pred CCCCCeeEEEecCCCCC----ccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecC
Q 002382 413 DPQPSITVIHLSSKNLT----GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 472 (929)
Q Consensus 413 ~~~~~l~~L~L~~n~l~----g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~ 472 (929)
..+++|+.|+|++|+++ +.++..+.++++|+.|+|++|.+.+.+..+.++++|+.|++++
T Consensus 189 ~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 189 QHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp HHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEECB
T ss_pred hcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhcccc
Confidence 12456677777777665 3444455566677777777766665433344455555555543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.91 E-value=3.5e-07 Score=109.07 Aligned_cols=179 Identities=15% Similarity=0.042 Sum_probs=89.9
Q ss_pred ccceeeeeecccCCCC--CCCccchhccceeccCCCCCccHHHHHHHHh-hcCCCCcccCCC-----CCCCCCCCceeEe
Q 002382 339 LPFVLSFKFGKTYDSS--RGPLLNAMEINKYLERNDGSIDGVAIVSVIS-LYSSADWAQEGG-----DPCLPVPWSWLQC 410 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~--lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~-l~~~~~w~~~~~-----dpc~~~~~~~~~c 410 (929)
++.|+.|+|..|.++. ++..+..+..|+.|++.+| +....+..+.. +..++.+..+.. ..|......++..
T Consensus 288 ~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~ 366 (594)
T 2p1m_B 288 CSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVS 366 (594)
T ss_dssp HTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHH
T ss_pred hCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHH
Confidence 5677888888877554 2233567777888888777 44444554443 344444422111 1121111111100
Q ss_pred CCCCCCCeeEEEecCCCCCccCChhhh-ccccCceeecc--C----CcCCCCCCC------CCCCCCCcEEEecCCCcCC
Q 002382 411 NSDPQPSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLD--G----NSLTGPIPD------FSGCPDLRIIHLEDNQLTG 477 (929)
Q Consensus 411 ~~~~~~~l~~L~L~~n~l~g~~p~~l~-~L~~L~~L~Ls--~----N~l~~~~p~------~~~l~~L~~L~Ls~N~l~g 477 (929)
-...+++|+.|+++.|++++..+..+. .+++|+.|+|+ + |++++.+.+ +.++++|+.|+|++ ++++
T Consensus 367 l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~ 445 (594)
T 2p1m_B 367 VSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTD 445 (594)
T ss_dssp HHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCH
T ss_pred HHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccH
Confidence 001134666666666776655555554 36677777776 3 455532221 34455666666655 4444
Q ss_pred CCCccccC-CCcCcccccccccccccccccc---cccceeccccCC
Q 002382 478 PLPSSLMN-LPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 519 (929)
Q Consensus 478 ~~P~~l~~-l~~L~~L~l~~N~l~g~~P~~l---~~~~~~l~~~~n 519 (929)
..+..++. +++|+.|+|++|.+++..+..+ +..+..+.+.+|
T Consensus 446 ~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n 491 (594)
T 2p1m_B 446 KVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDC 491 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESC
T ss_pred HHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCC
Confidence 43444443 5556666666666654433333 233344444444
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.84 E-value=2.6e-06 Score=95.23 Aligned_cols=44 Identities=20% Similarity=0.246 Sum_probs=31.9
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHH
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVI 384 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~ 384 (929)
.+.|+.|.|..+....+|+ +. +..|+.|.+..+.+....+..+.
T Consensus 171 ~P~L~~L~L~g~~~l~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~ 214 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNLSIGK-KP-RPNLKSLEIISGGLPDSVVEDIL 214 (362)
T ss_dssp CTTCCEEEEECCBTCBCCS-CB-CTTCSEEEEECSBCCHHHHHHHH
T ss_pred CCCCcEEEEeCCCCceecc-cc-CCCCcEEEEecCCCChHHHHHHH
Confidence 4577888887775456777 43 77888888888888776666665
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.80 E-value=7.5e-07 Score=106.12 Aligned_cols=65 Identities=14% Similarity=0.130 Sum_probs=32.5
Q ss_pred hhccccCceeeccCCcCCCCCC-CCCC-CCCCcEEEecCCCcCCCCCccc-cCCCcCcccccccccccc
Q 002382 436 LTKLSSLVELWLDGNSLTGPIP-DFSG-CPDLRIIHLEDNQLTGPLPSSL-MNLPNLRELYVQNNMLSG 501 (929)
Q Consensus 436 l~~L~~L~~L~Ls~N~l~~~~p-~~~~-l~~L~~L~Ls~N~l~g~~P~~l-~~l~~L~~L~l~~N~l~g 501 (929)
+.++++|+.|+|++ .+++... .+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++
T Consensus 428 ~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~ 495 (594)
T 2p1m_B 428 VEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD 495 (594)
T ss_dssp HHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred HhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence 44555566666644 3333222 2333 5556666666665554333333 445556666666665543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00013 Score=80.17 Aligned_cols=140 Identities=15% Similarity=0.206 Sum_probs=79.5
Q ss_pred cccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCC--CceeEEee------eeeecCeEEEEEEec
Q 002382 608 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--RNLVQFLG------YCQEEGRSVLVYEFM 679 (929)
Q Consensus 608 ~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~H--pNIv~l~g------~~~~~~~~~LV~E~~ 679 (929)
.|+.|..+.||+....++ .+++|+.... ...+..|+.+++.+.. -.+.+++. +....+..+++|+|+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 455577899999987644 5899988642 2334456666655531 12333332 123466789999999
Q ss_pred cCCchhh--------------hhccccc----c-c-----cccchHH-------------------------------HH
Q 002382 680 HNGTLKE--------------HLYGTLT----H-E-----QRINWIK-------------------------------RL 704 (929)
Q Consensus 680 ~~gsL~~--------------~L~~~~~----~-~-----~~l~~~~-------------------------------~~ 704 (929)
+|..+.. .+|.... . . ..-.|.. ..
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 9865530 1111100 0 0 0011111 01
Q ss_pred HHHHHHHHHHHHHHh----------CCCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 705 EIAEDAAKGIEYLHT----------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 705 ~i~~qia~gL~yLH~----------~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
.+..++..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 112234445666653 012489999999999999888899999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00013 Score=82.34 Aligned_cols=74 Identities=15% Similarity=0.119 Sum_probs=48.7
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-------chhHHHHHHHHHhcccCC--Cc-eeEEeeeeeecCeEEEE
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-------QGKREFTNEVTLLSRIHH--RN-LVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-------~~~~~f~~Ev~iL~~l~H--pN-Iv~l~g~~~~~~~~~LV 675 (929)
+.||.|..+.||+++.. +++.++||....... .....+..|.++++.+.. +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 56899999999999765 468899998653211 123456778888887742 33 3455544 34456899
Q ss_pred EEeccCC
Q 002382 676 YEFMHNG 682 (929)
Q Consensus 676 ~E~~~~g 682 (929)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.45 E-value=2.5e-05 Score=78.51 Aligned_cols=113 Identities=12% Similarity=0.101 Sum_probs=87.0
Q ss_pred ccceeeeeeccc-CCCC-----CCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCC
Q 002382 339 LPFVLSFKFGKT-YDSS-----RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNS 412 (929)
Q Consensus 339 l~~l~~l~l~~n-~~s~-----lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~ 412 (929)
.+.++.|+|..| .+.. +...+.....|+.|+|+.|.+.......|.....
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~------------------------ 90 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLK------------------------ 90 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHH------------------------
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHH------------------------
Confidence 456788999998 7764 3344555578999999999999877777766521
Q ss_pred CCCCCeeEEEecCCCCCcc----CChhhhccccCceeec--cCCcCCCCC-----CCCCCCCCCcEEEecCCCcC
Q 002382 413 DPQPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWL--DGNSLTGPI-----PDFSGCPDLRIIHLEDNQLT 476 (929)
Q Consensus 413 ~~~~~l~~L~L~~n~l~g~----~p~~l~~L~~L~~L~L--s~N~l~~~~-----p~~~~l~~L~~L~Ls~N~l~ 476 (929)
..+.|+.|+|++|+|+.. +...+...++|+.|+| ++|.|+..- ..+...+.|+.|+|++|.+.
T Consensus 91 -~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 91 -VNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp -HCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred -hCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 012689999999999853 5667888899999999 889998632 23566789999999999986
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00013 Score=82.68 Aligned_cols=159 Identities=12% Similarity=0.037 Sum_probs=88.2
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEe-CCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQP 416 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c-~~~~~~ 416 (929)
..++|+.++|..|.++.+|+..-....|+.+.+..+ +..+.-.++.....+....... ....++- ...+ .
T Consensus 178 ~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~-------~l~~I~~~aF~~-~ 248 (401)
T 4fdw_A 178 YCYNLKKADLSKTKITKLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPE-------NVSTIGQEAFRE-S 248 (401)
T ss_dssp TCTTCCEEECTTSCCSEECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCT-------TCCEECTTTTTT-C
T ss_pred CcccCCeeecCCCcceEechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCC-------CccCcccccccc-C
Confidence 345677778888888888887444677777777643 3222222222222222221100 0111110 0111 3
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCC-----CCCC-CCCCCCCCcEEEecCCCcCCCCCccccCCCcCc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-----GPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 490 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~-----~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~ 490 (929)
+|+.|+| .++++..-+..|.++++|+.|+|.+|.+. .+.+ .|.+|++|+.++|. |+++..-...|.++++|+
T Consensus 249 ~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~ 326 (401)
T 4fdw_A 249 GITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVT 326 (401)
T ss_dssp CCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCC
T ss_pred CccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCcc
Confidence 5777777 45566344557777777777777777665 2333 27777777777777 346633345677777777
Q ss_pred ccccccccccccccccccc
Q 002382 491 ELYVQNNMLSGTVPSSLLS 509 (929)
Q Consensus 491 ~L~l~~N~l~g~~P~~l~~ 509 (929)
.|.|.+| ++ .++...|.
T Consensus 327 ~l~lp~~-l~-~I~~~aF~ 343 (401)
T 4fdw_A 327 QLTIPAN-VT-QINFSAFN 343 (401)
T ss_dssp EEEECTT-CC-EECTTSSS
T ss_pred EEEECcc-cc-EEcHHhCC
Confidence 7777443 55 56555544
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00061 Score=74.25 Aligned_cols=74 Identities=19% Similarity=0.242 Sum_probs=59.3
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccC---CCceeEEeeeeeecCeEEEEEEeccCCc
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~---HpNIv~l~g~~~~~~~~~LV~E~~~~gs 683 (929)
+.|+.|....+|+.... ++.+++|+.... ....+..|++.|+.+. ...+.+.+.++...+..++|||++++..
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 45888999999998864 778899987642 3566888999998884 3567888888888888999999999876
Q ss_pred h
Q 002382 684 L 684 (929)
Q Consensus 684 L 684 (929)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.37 E-value=3.6e-05 Score=85.83 Aligned_cols=105 Identities=18% Similarity=0.297 Sum_probs=68.4
Q ss_pred CCCeeEEEecCCCCCccCChhhh--ccccCceeeccC--CcCCCC------CCCC--CCCCCCcEEEecCCCcCCCCCcc
Q 002382 415 QPSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDG--NSLTGP------IPDF--SGCPDLRIIHLEDNQLTGPLPSS 482 (929)
Q Consensus 415 ~~~l~~L~L~~n~l~g~~p~~l~--~L~~L~~L~Ls~--N~l~~~------~p~~--~~l~~L~~L~Ls~N~l~g~~P~~ 482 (929)
+++|+.|+|..++++...-..+. .|++|+.|+|+. |...+. -+.+ ..+++|++|+|++|++.+..+..
T Consensus 192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~ 271 (362)
T 2ra8_A 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271 (362)
T ss_dssp CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence 35899999998888754444555 688999998853 222221 1223 35889999999999887544333
Q ss_pred cc---CCCcCccccccccccccc----ccccc--cccceeccccCC
Q 002382 483 LM---NLPNLRELYVQNNMLSGT----VPSSL--LSKNVVLNYAGN 519 (929)
Q Consensus 483 l~---~l~~L~~L~l~~N~l~g~----~P~~l--~~~~~~l~~~~n 519 (929)
+. .+++|+.|+|+.|.|++. ++..+ +..+..+.+..|
T Consensus 272 la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n 317 (362)
T 2ra8_A 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317 (362)
T ss_dssp HHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSB
T ss_pred HHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCC
Confidence 33 578999999999999853 33332 233445555444
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00024 Score=80.35 Aligned_cols=155 Identities=11% Similarity=0.022 Sum_probs=101.7
Q ss_pred cceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeE-eCCCCCCC
Q 002382 340 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQPS 417 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~-c~~~~~~~ 417 (929)
++|+.+.|. +.++.+++. +..+..|+.+.+..| +..+...++.. ..+..... |.....++ ....++.+
T Consensus 203 ~~L~~l~lp-~~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-------p~~i~~I~~~aF~~c~~ 272 (401)
T 4fdw_A 203 AGIEEVLLP-VTLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-------PNGVTNIASRAFYYCPE 272 (401)
T ss_dssp CCCSEEECC-TTCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-------ETTCCEECTTTTTTCTT
T ss_pred cccCEEEeC-CchheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-------CCCccEEChhHhhCCCC
Confidence 345566665 447777776 777788888888754 22111111111 11111110 00011111 12334568
Q ss_pred eeEEEecCCCCC-----ccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcc
Q 002382 418 ITVIHLSSKNLT-----GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE 491 (929)
Q Consensus 418 l~~L~L~~n~l~-----g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~ 491 (929)
|+.|+|.+|.+. ..-+..|.+|++|+.|.|. |+++.+... |.+|++|+.|+|.+| ++..-+..|.++ +|+.
T Consensus 273 L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~ 349 (401)
T 4fdw_A 273 LAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKE 349 (401)
T ss_dssp CCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCE
T ss_pred CCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCE
Confidence 999999998775 3455689999999999999 557776664 999999999999665 664556789999 9999
Q ss_pred ccccccccccccccccc
Q 002382 492 LYVQNNMLSGTVPSSLL 508 (929)
Q Consensus 492 L~l~~N~l~g~~P~~l~ 508 (929)
|++++|.+. .++...+
T Consensus 350 l~l~~n~~~-~l~~~~F 365 (401)
T 4fdw_A 350 VKVEGTTPP-QVFEKVW 365 (401)
T ss_dssp EEECCSSCC-BCCCSSC
T ss_pred EEEcCCCCc-ccccccc
Confidence 999999988 6665544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00071 Score=72.65 Aligned_cols=74 Identities=20% Similarity=0.212 Sum_probs=54.7
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCC---CceeEEeeeeeecCeEEEEEEeccCCc
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH---RNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~H---pNIv~l~g~~~~~~~~~LV~E~~~~gs 683 (929)
+.+|.|..+.||+.+..+|+.+++|+-..........|..|++.|+.+.- --+.+.+++. ..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 56899999999999999999999998765544445668899999888742 1234445432 2378999988764
Q ss_pred h
Q 002382 684 L 684 (929)
Q Consensus 684 L 684 (929)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0015 Score=74.26 Aligned_cols=77 Identities=16% Similarity=0.198 Sum_probs=45.9
Q ss_pred CceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeeee-ecCccccCccccccCc---CCCcCceeeHHHHHHHH
Q 002382 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV-RGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLEL 798 (929)
Q Consensus 723 ~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~---~s~~sDVwSlGvvl~el 798 (929)
..++|+|+++.|||++.++ ++|+||+.+......- ...... .-...|++|+...... .....++.+....+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4899999999999999876 9999999886432111 111000 0113456665543111 11123445677777777
Q ss_pred HhC
Q 002382 799 ISG 801 (929)
Q Consensus 799 ltG 801 (929)
+.+
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0023 Score=69.67 Aligned_cols=143 Identities=15% Similarity=0.188 Sum_probs=79.9
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCc--eeEEeee------eeecCeEEEEEEe
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGY------CQEEGRSVLVYEF 678 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpN--Iv~l~g~------~~~~~~~~LV~E~ 678 (929)
+.|+.|....+|+....++ .+++|+.... .....+..|+.+++.+...+ +.+++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3467788889999987755 6889987652 12345667888777774222 2333321 1234567899999
Q ss_pred ccCCchhhh--------------hcccc---ccc-----cccchHHHHH------------HHHHHHHHHHHHHhC----
Q 002382 679 MHNGTLKEH--------------LYGTL---THE-----QRINWIKRLE------------IAEDAAKGIEYLHTG---- 720 (929)
Q Consensus 679 ~~~gsL~~~--------------L~~~~---~~~-----~~l~~~~~~~------------i~~qia~gL~yLH~~---- 720 (929)
++|..+... ++... ... ....|..... +...+.+.++++++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 998654220 11110 000 0011221100 011234455555532
Q ss_pred CCCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 721 ~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
...+++|+|+++.|||++.+..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 12479999999999999987666899999765
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.84 E-value=0.00017 Score=71.48 Aligned_cols=85 Identities=12% Similarity=0.092 Sum_probs=66.1
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCc-CCCC-CCCCCCC----CCCcEEEecCCC-cCCCCCccccCCCc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNS-LTGP-IPDFSGC----PDLRIIHLEDNQ-LTGPLPSSLMNLPN 488 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~-l~~~-~p~~~~l----~~L~~L~Ls~N~-l~g~~P~~l~~l~~ 488 (929)
.+|+.|||+++.|+..=-..|.+|++|+.|+|+++. |+.. +..++.+ ++|++|+|+++. ||..--..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 379999999999886544568899999999999995 6642 2335554 479999999974 87543356788999
Q ss_pred Cccccccccc-cc
Q 002382 489 LRELYVQNNM-LS 500 (929)
Q Consensus 489 L~~L~l~~N~-l~ 500 (929)
|+.|+|+++. ++
T Consensus 141 L~~L~L~~c~~It 153 (176)
T 3e4g_A 141 LKYLFLSDLPGVK 153 (176)
T ss_dssp CCEEEEESCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 9999999986 55
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0031 Score=69.05 Aligned_cols=141 Identities=14% Similarity=0.121 Sum_probs=71.8
Q ss_pred cccccCcEE-EEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCC--CceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 608 KIGSGGFGV-VYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 608 ~IG~G~fG~-Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~H--pNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
.|+.|.... +|+....+++.+++|...... ..++..|+.+++.+.. -.+.+++.+..+.+ +++||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 455554444 667665446777777654321 1345567777776642 23455666544333 789999877665
Q ss_pred hhhhcccc---------------------cc-ccccchHHH---------------H-----HHHHHHHHHHHHHH---h
Q 002382 685 KEHLYGTL---------------------TH-EQRINWIKR---------------L-----EIAEDAAKGIEYLH---T 719 (929)
Q Consensus 685 ~~~L~~~~---------------------~~-~~~l~~~~~---------------~-----~i~~qia~gL~yLH---~ 719 (929)
.+.+.... .. ...++.... . .....+...++.+. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 44332110 00 000100000 0 00011122222221 1
Q ss_pred CCCCceecCCCCCCCeEecCC----CcEEEEeecCccc
Q 002382 720 GCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKF 753 (929)
Q Consensus 720 ~~~~~ivHrDIkp~NILl~~~----~~vkL~DFGla~~ 753 (929)
.....++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123489999999999999875 6899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0048 Score=67.27 Aligned_cols=142 Identities=13% Similarity=0.122 Sum_probs=80.9
Q ss_pred cccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCc--eeEEeee-----eeecCeEEEEEEecc
Q 002382 608 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGY-----CQEEGRSVLVYEFMH 680 (929)
Q Consensus 608 ~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpN--Iv~l~g~-----~~~~~~~~LV~E~~~ 680 (929)
.++ |....||+....+|+.+++|+..... .....+..|..+++.+.... +.+++.. ....+..++++++++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 355 77789998877777789999986432 23456777888887774222 3334432 123456688999998
Q ss_pred CCchhh----h----------hccccc-----cccccchHHH----H---------------HHHHHHHHHHHHHHhC--
Q 002382 681 NGTLKE----H----------LYGTLT-----HEQRINWIKR----L---------------EIAEDAAKGIEYLHTG-- 720 (929)
Q Consensus 681 ~gsL~~----~----------L~~~~~-----~~~~l~~~~~----~---------------~i~~qia~gL~yLH~~-- 720 (929)
|..+.. . ++.... .....++... . .+...+.+.++.+.+.
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 865431 0 111000 0011111100 0 0011111222333221
Q ss_pred --CCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 721 --CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 721 --~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 224789999999999999 4 899999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0043 Score=70.76 Aligned_cols=72 Identities=14% Similarity=0.316 Sum_probs=49.4
Q ss_pred ccccccCcEEEEEEEECC--------CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCce-eEEeeeeeecCeEEEEEE
Q 002382 607 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~--------~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNI-v~l~g~~~~~~~~~LV~E 677 (929)
+.|+.|....+|+....+ ++.+++|+.... .....+..|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 457788889999998763 578999987432 111455679998888853333 566666542 38999
Q ss_pred eccCCch
Q 002382 678 FMHNGTL 684 (929)
Q Consensus 678 ~~~~gsL 684 (929)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0023 Score=60.14 Aligned_cols=55 Identities=31% Similarity=0.514 Sum_probs=27.5
Q ss_pred EEEecCCCCC-ccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcC
Q 002382 420 VIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLT 476 (929)
Q Consensus 420 ~L~L~~n~l~-g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~ 476 (929)
.++.++++|+ ..+|..|. .+|+.|+|++|+|+.+++. |..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5566666665 34553322 2455555555555554443 444555555555555443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.55 E-value=0.004 Score=67.15 Aligned_cols=71 Identities=11% Similarity=0.137 Sum_probs=44.3
Q ss_pred ccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCce-eEEeeeeeecCeEEEEEEec-cCCch
Q 002382 607 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYEFM-HNGTL 684 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNI-v~l~g~~~~~~~~~LV~E~~-~~gsL 684 (929)
+.|+.|....+|+. +.+++|+....... ......|+.+++.+...++ .++++++ .+.-++++||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 56888999999998 56888887643211 1234568877777743222 4555543 33346899999 66555
Q ss_pred h
Q 002382 685 K 685 (929)
Q Consensus 685 ~ 685 (929)
.
T Consensus 96 ~ 96 (301)
T 3dxq_A 96 S 96 (301)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0033 Score=59.05 Aligned_cols=56 Identities=27% Similarity=0.215 Sum_probs=46.1
Q ss_pred ceeeccCCcCC--CCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccccc
Q 002382 443 VELWLDGNSLT--GPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 500 (929)
Q Consensus 443 ~~L~Ls~N~l~--~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~ 500 (929)
..++.++++|+ ..+..+. ++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 47899999998 6554442 46899999999999554557889999999999999985
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0084 Score=67.00 Aligned_cols=141 Identities=16% Similarity=0.199 Sum_probs=80.8
Q ss_pred ccccccCcEEEEEEEEC--------CCcEEEEEEeecCCcchhHHHHHHHHHhcccC-CCceeEEeeeeeecCeEEEEEE
Q 002382 607 KKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~--------~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~LV~E 677 (929)
+.|..|-...+|+.... +++.+++|+.... ......+.+|.++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 34666777889998875 2478999985322 223456678999988884 3223566666643 28999
Q ss_pred eccCCchhhh-h----------------ccccc-ccccc--chHHHHHHHHHHHH-------------------HHHHH-
Q 002382 678 FMHNGTLKEH-L----------------YGTLT-HEQRI--NWIKRLEIAEDAAK-------------------GIEYL- 717 (929)
Q Consensus 678 ~~~~gsL~~~-L----------------~~~~~-~~~~l--~~~~~~~i~~qia~-------------------gL~yL- 717 (929)
|++|.+|..- + |.... ..... -+.++.++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665421 1 11100 01111 13334444433321 12333
Q ss_pred ---HhC-CCCceecCCCCCCCeEecCC----CcEEEEeecCcc
Q 002382 718 ---HTG-CVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSK 752 (929)
Q Consensus 718 ---H~~-~~~~ivHrDIkp~NILl~~~----~~vkL~DFGla~ 752 (929)
... ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 221 12378999999999999876 789999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.37 E-value=0.013 Score=67.08 Aligned_cols=74 Identities=12% Similarity=0.125 Sum_probs=48.1
Q ss_pred ccccccCcEEEEEEEECC-CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCce-eEEeeeeeecCeEEEEEEeccCCch
Q 002382 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNI-v~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
+.|+.|-...+|+....+ ++.+++|+..... ...-+...|..+++.+...++ .++++.+. + .+|+||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 467888889999998875 4788899874332 111123578888888864444 46777663 2 259999988655
Q ss_pred h
Q 002382 685 K 685 (929)
Q Consensus 685 ~ 685 (929)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.00 E-value=0.011 Score=65.67 Aligned_cols=73 Identities=15% Similarity=0.150 Sum_probs=44.3
Q ss_pred ccccccCcEEEEEEEECC---------CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCc-eeEEeeeeeecCeEEEEE
Q 002382 607 KKIGSGGFGVVYYGKLKD---------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~---------~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpN-Iv~l~g~~~~~~~~~LV~ 676 (929)
+.|+.|....+|+....+ ++.+++|+...... ...+...|.++++.+...+ +.++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457778888999998764 26888888654321 1123467888888775333 34566544 2 26899
Q ss_pred EeccCCch
Q 002382 677 EFMHNGTL 684 (929)
Q Consensus 677 E~~~~gsL 684 (929)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.54 E-value=0.0042 Score=62.50 Aligned_cols=113 Identities=12% Similarity=0.077 Sum_probs=68.0
Q ss_pred ccceeccCCCC-CccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeEEEecCCCCCc----cCChhhh
Q 002382 363 EINKYLERNDG-SIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTG----NIPSDLT 437 (929)
Q Consensus 363 e~l~~L~l~~n-~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~L~L~~n~l~g----~~p~~l~ 437 (929)
..|+.|+|+.| ++.....+.|...... -..|+.|+|++|+|.. .|...|.
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~-------------------------N~~L~~L~L~~n~igd~ga~alA~aL~ 95 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACN-------------------------SKHIEKFSLANTAISDSEARGLIELIE 95 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTT-------------------------CSCCCEEECTTSCCBHHHHTTHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhh-------------------------CCCcCEEEccCCCCChHHHHHHHHHHh
Confidence 34677777764 7776666666555220 0267888888888873 2333444
Q ss_pred ccccCceeeccCCcCCCC-----CCCCCCCCCCcEEEecCCCc---CC----CCCccccCCCcCccccccccccc
Q 002382 438 KLSSLVELWLDGNSLTGP-----IPDFSGCPDLRIIHLEDNQL---TG----PLPSSLMNLPNLRELYVQNNMLS 500 (929)
Q Consensus 438 ~L~~L~~L~Ls~N~l~~~-----~p~~~~l~~L~~L~Ls~N~l---~g----~~P~~l~~l~~L~~L~l~~N~l~ 500 (929)
.=+.|+.|+|++|.|+.. ...+..=+.|+.|+|++|.. .. .+-+.+..-+.|+.|+++.|.+.
T Consensus 96 ~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 96 TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred cCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 557788888888888752 11355555688888876532 21 12233444466777777666543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.49 E-value=0.066 Score=58.73 Aligned_cols=68 Identities=12% Similarity=0.189 Sum_probs=43.5
Q ss_pred cccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccC---CCceeEEeee------eeecCeEEEEEEecc
Q 002382 610 GSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGY------CQEEGRSVLVYEFMH 680 (929)
Q Consensus 610 G~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~---HpNIv~l~g~------~~~~~~~~LV~E~~~ 680 (929)
|.|....||+....+| .+++|+...... ..|+.+++.+. -|.+.+.+.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3444679999987766 899998765432 34555555552 1224444432 233567899999999
Q ss_pred CCch
Q 002382 681 NGTL 684 (929)
Q Consensus 681 ~gsL 684 (929)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8766
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=93.47 E-value=0.11 Score=58.07 Aligned_cols=80 Identities=19% Similarity=0.156 Sum_probs=58.2
Q ss_pred CCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCC-CCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccc
Q 002382 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (929)
Q Consensus 415 ~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 493 (929)
..+|+.+.+.++ ++..-...|.++++|+.++|.++ ++.+.. .|.+|++|+.++|..| ++..-...|.++++|+.++
T Consensus 296 ~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ 372 (394)
T 4fs7_A 296 CSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVE 372 (394)
T ss_dssp CTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEE
T ss_pred cccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEE
Confidence 457888888654 66333457888899999999754 665555 3888999999999877 6634445788888999888
Q ss_pred cccc
Q 002382 494 VQNN 497 (929)
Q Consensus 494 l~~N 497 (929)
|..|
T Consensus 373 lp~~ 376 (394)
T 4fs7_A 373 LPKR 376 (394)
T ss_dssp EEGG
T ss_pred ECCC
Confidence 7544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.43 E-value=0.13 Score=58.11 Aligned_cols=73 Identities=14% Similarity=0.140 Sum_probs=47.5
Q ss_pred ccccccCcEEEEEEEECC--------CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCc-eeEEeeeeeecCeEEEEEE
Q 002382 607 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~--------~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpN-Iv~l~g~~~~~~~~~LV~E 677 (929)
+.+..|-...+|+....+ ++.+++|+..... ....+..+|..+++.+...+ ..++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 456678888999998763 5789999864332 21223467888888774222 345555332 268999
Q ss_pred eccCCch
Q 002382 678 FMHNGTL 684 (929)
Q Consensus 678 ~~~~gsL 684 (929)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998765
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=93.25 E-value=0.015 Score=58.41 Aligned_cols=82 Identities=15% Similarity=0.243 Sum_probs=61.0
Q ss_pred CCeeEEEecCC-CCCc----cCChhhhccccCceeeccCCcCCCCC----C-CCCCCCCCcEEEecCCCcCCC----CCc
Q 002382 416 PSITVIHLSSK-NLTG----NIPSDLTKLSSLVELWLDGNSLTGPI----P-DFSGCPDLRIIHLEDNQLTGP----LPS 481 (929)
Q Consensus 416 ~~l~~L~L~~n-~l~g----~~p~~l~~L~~L~~L~Ls~N~l~~~~----p-~~~~l~~L~~L~Ls~N~l~g~----~P~ 481 (929)
+.|+.|+|++| +|.. .+-..+..=+.|+.|+|++|+|...- . .+..=+.|+.|+|++|+|... +-+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 37899999986 7753 24456666789999999999997422 1 244567899999999999842 334
Q ss_pred cccCCCcCcccccccc
Q 002382 482 SLMNLPNLRELYVQNN 497 (929)
Q Consensus 482 ~l~~l~~L~~L~l~~N 497 (929)
.+..-+.|+.|+|++|
T Consensus 121 aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQ 136 (197)
T ss_dssp HTTTTCCCSEEECCCC
T ss_pred HHhhCCceeEEECCCC
Confidence 5556677999999865
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.10 E-value=0.3 Score=49.56 Aligned_cols=104 Identities=13% Similarity=0.061 Sum_probs=65.8
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
.-+|.+.|.. .+.++++.+++.++.|.+++|.-+-.+.. . ..+=+-|..|++..+|.|...+ +.+.
T Consensus 32 ~vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 32 ALSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc--------
Confidence 3478888853 46789999999999999999877622100 1 1222346889999999887653 1110
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 804 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p 804 (929)
.....+.|||... ...+.+.=|||||+++|..+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123466888763 3456778899999999999874444
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=92.95 E-value=0.17 Score=56.03 Aligned_cols=89 Identities=15% Similarity=0.204 Sum_probs=63.3
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
..|+.+.+.++ ++..-...|.++++|+.+.+.+|.++.+.+. |.++.+|+.++|..| ++..-..+|.++++|+.+.+
T Consensus 263 ~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 263 TALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISY 340 (379)
T ss_dssp TTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCC
T ss_pred ehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEE
Confidence 46777887543 6633445788889999999988888876664 888999999999765 55233457888888998877
Q ss_pred cccccccccccccc
Q 002382 495 QNNMLSGTVPSSLL 508 (929)
Q Consensus 495 ~~N~l~g~~P~~l~ 508 (929)
..+ ++ .|....|
T Consensus 341 p~~-v~-~I~~~aF 352 (379)
T 4h09_A 341 PKS-IT-LIESGAF 352 (379)
T ss_dssp CTT-CC-EECTTTT
T ss_pred CCc-cC-EEchhHh
Confidence 544 55 4544444
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=91.94 E-value=0.034 Score=54.81 Aligned_cols=70 Identities=10% Similarity=0.119 Sum_probs=51.3
Q ss_pred cCChhhhccccCceeeccCCcCCCC-CCCCCCCCCCcEEEecCCC-cCCCCCccccCC----CcCccccccccc-cc
Q 002382 431 NIPSDLTKLSSLVELWLDGNSLTGP-IPDFSGCPDLRIIHLEDNQ-LTGPLPSSLMNL----PNLRELYVQNNM-LS 500 (929)
Q Consensus 431 ~~p~~l~~L~~L~~L~Ls~N~l~~~-~p~~~~l~~L~~L~Ls~N~-l~g~~P~~l~~l----~~L~~L~l~~N~-l~ 500 (929)
.+|.....--+|+.|||+++.|+.. +..+.++++|+.|+|+++. |+..--..|+.+ ++|+.|+|++|. ||
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT 128 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT 128 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence 3454332334799999999998753 4457899999999999985 774333446664 379999999985 77
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=90.79 E-value=0.37 Score=53.64 Aligned_cols=82 Identities=21% Similarity=0.255 Sum_probs=57.0
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCC-CCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
..|+.+.+. ++++..-...|.++++|+.+.|..| ++.+.. .|.+|++|+.+.|..| ++..-...|.++++|+.+++
T Consensus 288 ~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~ 364 (394)
T 4gt6_A 288 PALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEY 364 (394)
T ss_dssp TTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEE
T ss_pred cccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEE
Confidence 467777775 4566333457778888888888754 555444 3888888888888654 66233457888888888888
Q ss_pred cccccc
Q 002382 495 QNNMLS 500 (929)
Q Consensus 495 ~~N~l~ 500 (929)
.+|...
T Consensus 365 ~~~~~~ 370 (394)
T 4gt6_A 365 SGSRSQ 370 (394)
T ss_dssp SSCHHH
T ss_pred CCceee
Confidence 776543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=90.53 E-value=0.39 Score=53.02 Aligned_cols=90 Identities=16% Similarity=0.200 Sum_probs=68.8
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCC-CCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
..|+.+.+..+ ++..-...+.++.+|+.+.+..+ ++.... .|.++++|+.++|.+|.++..-...|.++.+|+.+.|
T Consensus 240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred ccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEc
Confidence 47888888765 66344567888999999999755 555544 3899999999999999988444568999999999998
Q ss_pred ccccccccccccccc
Q 002382 495 QNNMLSGTVPSSLLS 509 (929)
Q Consensus 495 ~~N~l~g~~P~~l~~ 509 (929)
..+ ++ .|+...|.
T Consensus 318 p~~-l~-~I~~~aF~ 330 (379)
T 4h09_A 318 PTA-LK-TIQVYAFK 330 (379)
T ss_dssp CTT-CC-EECTTTTT
T ss_pred Ccc-cc-EEHHHHhh
Confidence 654 66 66666544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=90.38 E-value=0.43 Score=53.16 Aligned_cols=100 Identities=15% Similarity=0.326 Sum_probs=72.6
Q ss_pred CCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccc
Q 002382 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (929)
Q Consensus 415 ~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 493 (929)
...|+.+.+.++-.+ .-...|.++++|+.+.+. +.++.+... |.++.+|+.++|..| ++..-...|.++++|+.+.
T Consensus 264 c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ 340 (394)
T 4gt6_A 264 CAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIA 340 (394)
T ss_dssp CSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred cccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEE
Confidence 347888888766554 556678899999999996 566666554 999999999999865 5533446899999999999
Q ss_pred ccccccccccccccccc---ceeccccCC
Q 002382 494 VQNNMLSGTVPSSLLSK---NVVLNYAGN 519 (929)
Q Consensus 494 l~~N~l~g~~P~~l~~~---~~~l~~~~n 519 (929)
|..+ ++ .|....|.. +..+.+.++
T Consensus 341 ip~s-v~-~I~~~aF~~C~~L~~i~~~~~ 367 (394)
T 4gt6_A 341 IPSS-VT-KIPESAFSNCTALNNIEYSGS 367 (394)
T ss_dssp ECTT-CC-BCCGGGGTTCTTCCEEEESSC
T ss_pred ECcc-cC-EEhHhHhhCCCCCCEEEECCc
Confidence 8644 77 777766543 344444444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=88.38 E-value=0.86 Score=50.65 Aligned_cols=87 Identities=16% Similarity=0.118 Sum_probs=60.1
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
..++.+.+..+.+ ....+..+.+|+.+.+.+| ++.+... |.++++|+.++|.++ ++..-..+|.++++|+.+.|
T Consensus 276 ~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~l 350 (394)
T 4fs7_A 276 SGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINF 350 (394)
T ss_dssp TTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECC
T ss_pred cccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEE
Confidence 3556666655432 2346778889999998765 6555443 888999999999754 66333467888999999988
Q ss_pred ccccccccccccccc
Q 002382 495 QNNMLSGTVPSSLLS 509 (929)
Q Consensus 495 ~~N~l~g~~P~~l~~ 509 (929)
..| ++ .|+...|.
T Consensus 351 p~~-l~-~I~~~aF~ 363 (394)
T 4fs7_A 351 PLS-LR-KIGANAFQ 363 (394)
T ss_dssp CTT-CC-EECTTTBT
T ss_pred Ccc-cc-EehHHHhh
Confidence 766 66 66665543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.58 E-value=1.7 Score=48.55 Aligned_cols=29 Identities=31% Similarity=0.484 Sum_probs=24.6
Q ss_pred ceecCCCCCCCeEe------cCCCcEEEEeecCcc
Q 002382 724 AIIHRDLKSSNILL------DKHMRAKVSDFGLSK 752 (929)
Q Consensus 724 ~ivHrDIkp~NILl------~~~~~vkL~DFGla~ 752 (929)
.++|+|+.+.|||+ +++..++++||..|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46799999999999 456679999999875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 929 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 6e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 4e-65
Identities = 80/276 (28%), Positives = 134/276 (48%), Gaps = 23/276 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
+ ++IGSG FG VY GK + + +T+ + Q + F NEV +L + H N++ F+G
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
Y +V ++ +L HL+ E + IK ++IA A+G++YLH +
Sbjct: 72 YSTAPQL-AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA---KS 124
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYISQQ-- 781
IIHRDLKS+NI L + + K+ DFGL+ + SH + G++ ++ PE Q
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 782 -LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840
+ +SDVY+FG++L EL++GQ SN N + +G + P L
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNI-------NNRDQIIFMVG----RGYLSPD-LS 232
Query: 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876
+ ++ C+ RP ++L I+
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 4e-63
Identities = 75/274 (27%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
K++G+G FGVV YGK + ++A+K++ + EF E ++ + H LVQ G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
C ++ ++ E+M NG L +L R + LE+ +D + +EYL +
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESKQ--- 120
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
+HRDL + N L++ KVSDFGLS++ +D S + V + PE + + +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 785 KSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 843
KSD+++FGV++ E+ S G+ +I Q +L+ P L E
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------RPHLASE-- 228
Query: 844 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877
K+ C RP+ +L +I D
Sbjct: 229 -----KVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 4e-62
Identities = 69/273 (25%), Positives = 123/273 (45%), Gaps = 23/273 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
++IGSG FG+V+ G + ++A+K + + +F E ++ ++ H LVQ G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
C E+ LV+EFM +G L ++ T L + D +G+ YL C
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 121
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
+IHRDL + N L+ ++ KVSDFG+++F +D S+ + V + PE + + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 785 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844
KSDV+SFGV++ E+ S + + + + + P L
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------LYKPRLAST--- 229
Query: 845 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877
+ + C RP+ S +L+ + +
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-61
Identities = 65/273 (23%), Positives = 123/273 (45%), Gaps = 23/273 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
L +++G+G FG V+ G ++AVK L F E L+ ++ H+ LV+
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
+E ++ E+M NG+L + L ++ K L++A A+G+ ++
Sbjct: 76 VVTQEPI-YIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
IHRDL+++NIL+ + K++DFGL++ D + + + PE T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 785 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844
KSDV+SFG++L E+++ G ++Q ++E G ++ P E
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYP---GMTNPEVIQ----NLERG--YRMVRPDNCPE--- 237
Query: 845 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877
++ + +C RP+ + ++D
Sbjct: 238 ----ELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 3e-60
Identities = 62/295 (21%), Positives = 126/295 (42%), Gaps = 29/295 (9%)
Query: 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+L++ IG G FG V+ GK + G+E+AVK+ +S + E+ + H N++ F+
Sbjct: 6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFI 63
Query: 664 GYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
++ + LV ++ +G+L ++L + + +++A A G+ +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 720 GCV-----PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---AVDGASHVSSIVRGTVGY 771
V PAI HRDLKS NIL+ K+ ++D GL+ A D + GT Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 772 LDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGANC---RNIVQWAK 822
+ PE + ++D+Y+ G++ E+ + +
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 823 LHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876
+ + + P++ + + +++ + + C +G R + + K +
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-56
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
++G+G GVV+ K G +A K++ R E+ +L + +V F
Sbjct: 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
G +G + E M G+L + L RI +++ KG+ YL
Sbjct: 70 YGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH- 124
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
I+HRD+K SNIL++ K+ DFG+S +D +++ GT Y+ PE
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHY 180
Query: 783 TDKSDVYSFGVILLELISGQ 802
+ +SD++S G+ L+E+ G+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGR 200
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-56
Identities = 62/273 (22%), Positives = 114/273 (41%), Gaps = 23/273 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 664
LE K+G G FG V+ G +A+K L F E ++ ++ H LVQ
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 665 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 724
EE +V E+M G+L + L G + + + +++A A G+ Y+
Sbjct: 80 VVSEEPI-YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 725 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 784
+HRDL+++NIL+ +++ KV+DFGL++ D + + + PE + + T
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 785 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 844
KSDV+SFG++L EL + + ++ ++
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGM----------------VNREVLDQVERGYRMPCPP 237
Query: 845 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877
+ + + C RP+ + ++D
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 5e-56
Identities = 63/277 (22%), Positives = 109/277 (39%), Gaps = 25/277 (9%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+ IG+G +G + K DGK + K L S + K+ +EV LL + H N+V+
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 662 FLGYCQEE--GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH- 718
+ + +V E+ G L + Q ++ L + ++ H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 719 -TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 777
+ ++HRDLK +N+ LD K+ DFGL++ S + GT Y+ PE
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQM 186
Query: 778 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837
+KSD++S G +L EL + + I + I
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR-----YSDE 241
Query: 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
L + I M +++ RPS+ E+L++
Sbjct: 242 LNE--IITRMLNLKDY----------HRPSVEEILEN 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 7e-56
Identities = 67/278 (24%), Positives = 115/278 (41%), Gaps = 32/278 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+ +IG G F VY G + E+A L + ++ F E +L + H N+V+
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 662 FLGYCQEEGRS----VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
F + + VLV E M +GTLK +L + + KG+++L
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 128
Query: 718 HTGCVPAIIHRDLKSSNILL-DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
HT P IIHRDLK NI + K+ D GL+ + + V GT ++ PE
Sbjct: 129 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM 184
Query: 777 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836
++ + DVY+FG+ +LE+ + + S + N I + ++ + P
Sbjct: 185 -YEEKYDESVDVYAFGMCMLEMATSEYPYSECQ---NAAQIYRRVTSGVKPASFDKVAIP 240
Query: 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
+ + I+ + + R SI ++L
Sbjct: 241 EVKEI--IEGCIRQNKDE----------RYSIKDLLNH 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (490), Expect = 7e-56
Identities = 72/307 (23%), Positives = 137/307 (44%), Gaps = 42/307 (13%)
Query: 593 FTLSDIEDATK-----------MLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN- 636
FT D +A + +E+ IG+G FG V G LK + +A+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 637 SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQ 696
+ + +R+F +E +++ + H N++ G + +++ EFM NG+L L ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDG 123
Query: 697 RINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756
+ I+ + + A G++YL +HRDL + NIL++ ++ KVSDFGLS+F D
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 757 GASHVSSI----VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 812
S + + + + PE ++ T SDV+S+G+++ E++S E +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD---- 236
Query: 813 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 872
+ + D+ I+ + + + L C + RP +++
Sbjct: 237 ------------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 873 KDIQDAI 879
+ I
Sbjct: 285 NTLDKMI 291
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 192 bits (489), Expect = 8e-56
Identities = 70/274 (25%), Positives = 120/274 (43%), Gaps = 23/274 (8%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
++ K+G G +G VY G K +AVK L ++ + EF E ++ I H NLVQ L
Sbjct: 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 79
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
G C E ++ EFM G L ++L + Q ++ + L +A + +EYL
Sbjct: 80 GVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK---K 134
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
IHRDL + N L+ ++ KV+DFGLS+ + + + + PE + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 784 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 843
KSDV++FGV+L E+ + + + + +++ E
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYELLEKDYRMERP 238
Query: 844 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877
K+ E C + RPS +E+ + +
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (489), Expect = 2e-55
Identities = 66/285 (23%), Positives = 123/285 (43%), Gaps = 37/285 (12%)
Query: 599 EDATKMLE--KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK---REFTNEVTLLS 652
+D K+ ++IG G FG VY+ + +++ + +A+K ++ + Q ++ EV L
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 653 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 712
++ H N +Q+ G E + LV E+ H++ + ++ + A +
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQ 126
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
G+ YLH+ +IHRD+K+ NILL + K+ DFG + S V GT ++
Sbjct: 127 GLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWM 178
Query: 773 DPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829
PE ++ Q K DV+S G+ +EL + + N + +I Q ++SG
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238
Query: 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
+ + S + + RP+ +LK
Sbjct: 239 ----WSEYFRNF--VDSCLQKIPQD----------RPTSEVLLKH 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-55
Identities = 61/284 (21%), Positives = 114/284 (40%), Gaps = 29/284 (10%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 655
+ ED +++ ++G G FG VY + K+ A KV+ + S + ++ E+ +L+
Sbjct: 9 NPEDFWEII-GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 656 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
H N+V+ L E ++ EF G + + E+ + + + + +
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALN 124
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
YLH IIHRDLK+ NIL K++DFG+S S + GT ++ PE
Sbjct: 125 YLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPE 180
Query: 776 YYISQQLTD-----KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 830
+ + D K+DV+S G+ L+E+ + I + +
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS- 239
Query: 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
+ D ++ + A R + S++L+
Sbjct: 240 --RWSSNFKDF--LKKCLEKNVDA----------RWTTSQLLQH 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 8e-55
Identities = 60/271 (22%), Positives = 115/271 (42%), Gaps = 25/271 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+KIG G G VY + G+E+A++ + K NE+ ++ + N+V +L
Sbjct: 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
+V E++ G+L + + E ++ + + + + +E+LH+
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 724 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 783
+IHRD+KS NILL K++DFG S S++V GT ++ PE +
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 784 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 843
K D++S G++ +E+I G+ NE I +++ + + D
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE---KLSAIFRDF-- 249
Query: 844 IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
+ ++ + R S E+L+
Sbjct: 250 LNRCLDMDVE----------KRGSAKELLQH 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-54
Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 37/286 (12%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK---REFTNEV 648
+ L D E + + +G G FG VY + K +A+KVL + + EV
Sbjct: 3 WALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 708
+ S + H N+++ GY + R L+ E+ GT+ L + + +
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYIT 113
Query: 709 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 768
+ A + Y H+ +IHRD+K N+LL K++DFG S A + GT
Sbjct: 114 ELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGT 167
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 828
+ YL PE + +K D++S GV+ E + G+ + + I +
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEF 221
Query: 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
+ D I + K RP + EVL+
Sbjct: 222 TFPDFVTEGARDL--ISRLLKHNPSQ----------RPMLREVLEH 255
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 4e-54
Identities = 74/286 (25%), Positives = 131/286 (45%), Gaps = 34/286 (11%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 652
+ +++ L + IG G FG V G + G ++AVK + +++ + F E ++++
Sbjct: 4 LNMKELK-----LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMT 55
Query: 653 RIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 711
++ H NLVQ LG +E+G +V E+M G+L ++L + L+ + D
Sbjct: 56 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVC 113
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
+ +EYL +HRDL + N+L+ + AKVSDFGL+K A S + V +
Sbjct: 114 EAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKW 166
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831
PE ++ + KSDV+SFG++L E+ S +++V +E G
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVP----RVEKGYKM 219
Query: 832 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877
D Y++ C MRPS ++ + ++
Sbjct: 220 DAPDGCPPAVYEV---------MKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 7e-54
Identities = 79/308 (25%), Positives = 127/308 (41%), Gaps = 32/308 (10%)
Query: 579 VSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGK----EIAVKVLT 634
+S+LN +A + + IG G FG VY+G L D AVK L
Sbjct: 6 LSALNPELVQAVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64
Query: 635 SNSYQGK-REFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEFMHNGTLKEHLYGTL 692
+ G+ +F E ++ H N++ LG C EG ++V +M +G L+ +
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--- 121
Query: 693 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
+ AKG + +HRDL + N +LD+ KV+DFGL++
Sbjct: 122 NETHNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 753 FAVDG---ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 809
D + H + + V ++ E +Q+ T KSDV+SFGV+L EL++ +
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
Query: 810 FGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS 869
N ++ L EY ++++ L C P MRPS S
Sbjct: 239 ------NTFDITVYLLQG-------RRLLQPEYCPDPLYEV---MLKCWHPKAEMRPSFS 282
Query: 870 EVLKDIQD 877
E++ I
Sbjct: 283 ELVSRISA 290
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-53
Identities = 69/280 (24%), Positives = 123/280 (43%), Gaps = 33/280 (11%)
Query: 606 EKKIGSGGFGVVYYGKLKD---GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLV 660
+K++GSG FG V G + K +AVK+L +N K E E ++ ++ + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ +G C+ E +LV E G L ++L + + +E+ + G++YL
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS--IVRGTVGYLDPEYYI 778
+HRDL + N+LL AK+SDFGLSK ++ + + V + PE
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 779 SQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837
+ + KSDV+SFGV++ E S GQ+ K + + ++ +G
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG-----CPRE 238
Query: 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877
+ D + W + + RP + V +++
Sbjct: 239 MYDL--MNLCWTYDVE----------NRPGFAAVELRLRN 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (474), Expect = 1e-53
Identities = 67/300 (22%), Positives = 120/300 (40%), Gaps = 47/300 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHR 657
+ IG G FG V+ + +AVK+L + + +F E L++ +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH--------------------EQR 697
N+V+ LG C L++E+M G L E L H
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 698 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757
++ ++L IA A G+ YL +HRDL + N L+ ++M K++DFGLS+
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 758 -ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 816
+ ++ PE + T +SDV+++GV+L E+ S +G
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY---YGMAHEE 250
Query: 817 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876
++ + + G+I + L+ Y++ +C RPS + + +Q
Sbjct: 251 VIYY----VRDGNILACPENCPLELYNL---------MRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-53
Identities = 59/274 (21%), Positives = 113/274 (41%), Gaps = 26/274 (9%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 662
L + +G G +G V + + +AVK++ + E+ + ++H N+V+F
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
G+ +E L E+ G L + + + + G+ YLH
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG--- 121
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
I HRD+K N+LLD+ K+SDFGL+ F + + + + GT+ Y+ PE ++
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 782 L-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840
+ DV+S G++L +++G+ + + K ++ ID + L
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK---KIDSAPLA 238
Query: 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
+ + A R +I ++ KD
Sbjct: 239 --LLHKILVENPSA----------RITIPDIKKD 260
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-53
Identities = 66/283 (23%), Positives = 129/283 (45%), Gaps = 30/283 (10%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE-----IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRN 658
+K IG+G FG VY G LK +A+K L + + +R +F E ++ + H N
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+++ G + +++ E+M NG L + L + + ++ + + A G++YL
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVGYLDPEY 776
+HRDL + NIL++ ++ KVSDFGLS+ D A++ +S + + + PE
Sbjct: 128 N---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 777 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836
++ T SDV+SFG+++ E+++ E E + + ++ I+
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----------------LSNHEVMKAIND 228
Query: 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879
+ I + + C RP ++++ + I
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 4e-53
Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 31/282 (10%)
Query: 603 KMLEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRN 658
+ + ++G G FG V G + ++A+KVL + + E E ++ ++ +
Sbjct: 11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 70
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+V+ +G CQ E +LV E G L + L G + I E+ + G++YL
Sbjct: 71 IVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE 126
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRGTVGYLDPEY 776
+HRDL + N+LL AK+SDFGLSK A D S + + + PE
Sbjct: 127 E---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 777 YISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835
++ + +SDV+S+GV + E +S GQ+ K I Q ++
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE-----CP 238
Query: 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877
P L Y + C + RP V + ++
Sbjct: 239 PEL---YAL---------MSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 6e-52
Identities = 67/298 (22%), Positives = 119/298 (39%), Gaps = 41/298 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 656
K +G+G FG V +AVK+L +++ +RE +E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--------------TLTHEQRINWIK 702
N+V LG C G ++++ E+ G L L E ++
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-V 761
L + AKG+ +L + IHRDL + NILL K+ DFGL++ + +++ V
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 821
R V ++ PE + T +SDV+S+G+ L EL S +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS---------------PY 248
Query: 822 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879
+I + ++ + C RP+ ++++ I+ I
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 4e-51
Identities = 65/297 (21%), Positives = 117/297 (39%), Gaps = 46/297 (15%)
Query: 605 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 656
K +GSG FG V ++AVK+L + +RE +E+ +++++ H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 657 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-------------------EQR 697
N+V LG C G L++E+ G L +L
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 698 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757
+ + L A AKG+E+L + +HRDL + N+L+ K+ DFGL++ +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 758 ASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 816
+++V R V ++ PE T KSDV+S+G++L E+ S
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP----------- 266
Query: 817 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 873
+ + +++ + +I + + +I C RPS +
Sbjct: 267 ---YPGIPVDA-NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-50
Identities = 59/285 (20%), Positives = 114/285 (40%), Gaps = 30/285 (10%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 659
L + IG G FG V+ G + +A+K + + RE F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
V+ +G E ++ E G L+ L + ++ + A + + YL +
Sbjct: 71 VKLIGVI-TENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 126
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
+HRD+ + N+L+ + K+ DFGLS++ D + +S + + ++ PE
Sbjct: 127 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 780 QQLTDKSDVYSFGVILLELI-SGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838
++ T SDV+ FGV + E++ G + K I +L + P+L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN-----CPPTL 238
Query: 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 883
+ W + RP +E+ + + E+
Sbjct: 239 YSL--MTKCWAYDPS----------RRPRFTELKAQLSTILEEEK 271
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (451), Expect = 6e-50
Identities = 60/273 (21%), Positives = 108/273 (39%), Gaps = 25/273 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +++G+G FGVV+ G A K + + K E+ +S + H LV
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
+++ V++YEFM G L E + +++ + +E KG+ ++H
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 724 AIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
+H DLK NI+ + K+ DFGL+ S GT + PE +
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEGKP 201
Query: 782 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841
+ +D++S GV+ L+SG E RN+ +++ G I D
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-DWNMDDSAFSG-ISEDGKDF 259
Query: 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
I+ + + R +I + L+
Sbjct: 260 --IRKLLLADPNT----------RMTIHQALEH 280
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-49
Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 38/292 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLKDG---KEIAVKVL-TSNSYQGKREFTNEVTLLSRI-HHRNL 659
+ IG G FG V ++K + A+K + S R+F E+ +L ++ HH N+
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE------------QRINWIKRLEIA 707
+ LG C+ G L E+ +G L + L + E ++ + L A
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133
Query: 708 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 767
D A+G++YL IHRDL + NIL+ ++ AK++DFGLS+ R
Sbjct: 134 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM--GRL 188
Query: 768 TVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 827
V ++ E T SDV+S+GV+L E++S G C + +
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC---GMTCAELYEK------- 238
Query: 828 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879
+ E + ++ + C + RPS +++L + +
Sbjct: 239 ------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-48
Identities = 64/283 (22%), Positives = 106/283 (37%), Gaps = 31/283 (10%)
Query: 605 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHR 657
L +K+G G FGVV G+ +AVK L + + +F EV + + HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
NL++ G +V E G+L + L H+ A A+G+ YL
Sbjct: 72 NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPE 775
+ IHRDL + N+LL K+ DFGL + H + + + PE
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835
++ + SD + FGV L E+ + + N Q + G+ +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG------LNGSQILHKIDKEGERLPRPE 238
Query: 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878
D Y++ + C RP+ + + +A
Sbjct: 239 DCPQDIYNV---------MVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (440), Expect = 2e-48
Identities = 55/273 (20%), Positives = 121/273 (44%), Gaps = 25/273 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ +++GSG FGVV+ G+ K + + K NE+++++++HH L+
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
+++ VL+ EF+ G L + + + +++ + + A +G++++H
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHE---H 146
Query: 724 AIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
+I+H D+K NI+ + K K+ DFGL+ + + T + PE +
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREP 204
Query: 782 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841
+ +D+++ GV+ L+SG + E +N+ + E D + P D
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE--DAFSSVSPEAKDF 262
Query: 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
I+++ + E + R ++ + L+
Sbjct: 263 --IKNLLQKEPRK----------RLTVHDALEH 283
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 5e-48
Identities = 57/279 (20%), Positives = 116/279 (41%), Gaps = 30/279 (10%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 658
K +GSG FG VY G +G+++ + V + S + +E +E +++ + + +
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 659 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 718
+ + LG C L+ + M G L +++ H+ I L AKG+ YL
Sbjct: 73 VCRLLGICLTSTV-QLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYL- 127
Query: 719 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYY 777
++HRDL + N+L+ K++DFGL+K + + + + + ++ E
Sbjct: 128 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 778 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837
+ + T +SDV+S+GV + EL++ + + +I I++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----------------PASEISSILEKG 229
Query: 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 876
+ + C + RP E++ +
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-47
Identities = 57/274 (20%), Positives = 104/274 (37%), Gaps = 30/274 (10%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHRNLV 660
K +G G F V + L +E A+K+L T E ++SR+ H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
+ Q++ + + NG L +++ + + +EYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG- 126
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYIS 779
IIHRDLK NILL++ M +++DFG +K + + ++ GT Y+ PE
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 780 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839
+ SD+++ G I+ +L++G + I++ D P
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK------LEYDFPEKFFPKAR 238
Query: 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 873
D ++ + ++ R E+
Sbjct: 239 DL--VEKLLVLDATK----------RLGCEEMEG 260
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-47
Identities = 63/289 (21%), Positives = 122/289 (42%), Gaps = 33/289 (11%)
Query: 605 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 657
+ +++G G FG+VY G K +A+K + + S + + EF NE +++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------GTLTHEQRINWIKRLEIAEDAA 711
++V+ LG + ++++ E M G LK +L + K +++A + A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG-ASHVSSIVRGTVG 770
G+ YL+ +HRDL + N ++ + K+ DFG+++ + V
Sbjct: 144 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 771 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 830
++ PE T SDV+SFGV+L E+ + E + + G +
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVLRFVMEGGL 253
Query: 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879
D +++ MC + MRPS E++ I++ +
Sbjct: 254 LDKPDNCPDMLFEL---------MRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 5e-47
Identities = 72/297 (24%), Positives = 121/297 (40%), Gaps = 40/297 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRI-HH 656
L K +G G FG V + +AVK+L + R +E+ +L I HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 657 RNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYG------------TLTHEQRINWIKR 703
N+V LG C + G + ++ EF G L +L ++ +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 704 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-S 762
+ + AKG+E+L + IHRDL + NILL + K+ DFGL++ +V
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 822
R + ++ PE + T +SDV+SFGV+L E+ S + I +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV------KIDEEFC 247
Query: 823 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879
++ G D + + Y L C RP+ SE+++ + + +
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQT---------MLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-45
Identities = 50/273 (18%), Positives = 107/273 (39%), Gaps = 26/273 (9%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ + +G G FG+V+ K K + + E+++L+ HRN++
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
+ V+++EF+ + E + T +N + + + +++LH+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---H 121
Query: 724 AIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
I H D++ NI+ + K+ +FG ++ G + ++ Y PE +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDV 179
Query: 782 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841
++ +D++S G ++ L+SG E NI+ A+ + + I +D
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN-AEYTFDEEAFKE-ISIEAMDF 237
Query: 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
+ + E K R + SE L+
Sbjct: 238 --VDRLLVKERK----------SRMTASEALQH 258
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (412), Expect = 4e-45
Identities = 68/283 (24%), Positives = 114/283 (40%), Gaps = 29/283 (10%)
Query: 597 DIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 654
DI D +G+G F V + + K +A+K + + +GK NE+ +L +I
Sbjct: 6 DIRDIYD-FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI 64
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
H N+V + G L+ + + G L + + + + +
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAV 120
Query: 715 EYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 771
+YLH I+HRDLK N+L D+ + +SDFGLSK G V S GT GY
Sbjct: 121 KYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGY 175
Query: 772 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831
+ PE + + D +S GVI L+ G +E I++ A+ +S
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK-AEYEFDSPYWD 234
Query: 832 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
I S D I+ + + + + R + + L+
Sbjct: 235 D-ISDSAKDF--IRHLMEKDPEK----------RFTCEQALQH 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 7e-45
Identities = 62/298 (20%), Positives = 127/298 (42%), Gaps = 42/298 (14%)
Query: 605 LEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRI- 654
L K +G G FG V + ++AVK+L S++ + + +E+ ++ I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------------GTLTHEQRINWIK 702
H+N++ LG C ++G ++ E+ G L+E+L + E++++
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 703 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762
+ A A+G+EYL + IHRDL + N+L+ + K++DFGL++ +
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 763 SIV-RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 821
+ R V ++ PE + T +SDV+SFGV+L E+ + +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------------ 241
Query: 822 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879
++ ++ + ++ C RP+ ++++D+ +
Sbjct: 242 ----PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (405), Expect = 4e-44
Identities = 58/285 (20%), Positives = 118/285 (41%), Gaps = 33/285 (11%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVL---TSNSYQGKREFTNEV 648
++L D + + + +G+G FG V+ + + +G+ A+KVL + +E
Sbjct: 1 YSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 55
Query: 649 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 708
+LS + H +++ G Q+ + ++ +++ G L L + + E+
Sbjct: 56 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 115
Query: 709 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 768
L II+RDLK NILLDK+ K++DFG +K+ D + GT
Sbjct: 116 -------ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGT 164
Query: 769 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 828
Y+ PE ++ D +SFG+++ E+++G + I+ A+L
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-AELRFPPF 223
Query: 829 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 873
+ + D + + + + G+++ +V
Sbjct: 224 -----FNEDVKDL--LSRLITRDLSQRL-----GNLQNGTEDVKN 256
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (394), Expect = 4e-43
Identities = 57/225 (25%), Positives = 108/225 (48%), Gaps = 17/225 (7%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK---REFTNEVTLLSRIHHRNLV 660
L + +G GG V+ + L+ +++AVKVL ++ + F E + ++H +V
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 661 QFLGYCQEE----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+ E +V E++ TL++ ++ E + + +E+ DA + + +
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNF 126
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLDP 774
H IIHRD+K +NI++ KV DFG+++ D + V ++ V GT YL P
Sbjct: 127 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 775 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 819
E + +SDVYS G +L E+++G+ + + + V+
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (390), Expect = 1e-42
Identities = 66/287 (22%), Positives = 108/287 (37%), Gaps = 40/287 (13%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---------TSNSYQGKREFTNEVTLLSRI 654
++ +G G VV KE AVK++ + + EV +L ++
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 655 H-HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
H N++Q + LV++ M G L ++L T + ++ + +I +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEV 122
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
I LH I+HRDLK NILLD M K++DFG S G V GT YL
Sbjct: 123 ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLA 177
Query: 774 PEYYISQQL------TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 827
PE + D++S GVI+ L++G + K R I+ S
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-NYQFGS 236
Query: 828 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
+ ++ D + ++ + R + E L
Sbjct: 237 PEWDD-YSDTVKDL--VSRFLVVQPQK----------RYTAEEALAH 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 153 bits (388), Expect = 2e-41
Identities = 65/277 (23%), Positives = 108/277 (38%), Gaps = 28/277 (10%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEV---TLLSRIHHR 657
+ + IG GGFG VY + D GK A+K L QG+ NE +L+S
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 658 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
+V + + + M+ G L HL + + A + G+E++
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHM 123
Query: 718 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 777
H +++RDLK +NILLD+H ++SD GL+ H GT GY+ PE
Sbjct: 124 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVL 177
Query: 778 ISQQLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836
D +D +S G +L +L+ G K + +E + P
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE---LPDSFSP 234
Query: 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 873
L ++ + + + + G + EV +
Sbjct: 235 ELRSL--LEGLLQRDVNRRL-----GCLGRGAQEVKE 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-41
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 659
L K +G G FG V+ + K + A+K L + + + L H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 660 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 719
Q + V E+++ G L H+ + + + A + G+++LH+
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 720 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
I++RDLK NILLDK K++DFG+ K + G + ++ GT Y+ PE +
Sbjct: 122 KG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLG 177
Query: 780 QQLTDKSDVYSFGVILLELISGQ 802
Q+ D +SFGV+L E++ GQ
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 1e-40
Identities = 54/288 (18%), Positives = 104/288 (36%), Gaps = 34/288 (11%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
L +KIGSG FG +Y G + G+E+A+K+ + + E + + + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTI 68
Query: 664 GYCQEEGRS-VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+C EG V+V E + + ++ + L +A+ IEY+H+
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKN- 123
Query: 723 PAIIHRDLKSSNIL---LDKHMRAKVSDFGLSKFAVDGASHV------SSIVRGTVGYLD 773
IHRD+K N L K + DFGL+K D +H + + GT Y
Sbjct: 124 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 774 PEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA--KLHIESGDIQ 831
++ + + + D+ S G +L+ G K + + + K+ +
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 832 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879
+ + +P S + + ++
Sbjct: 242 KGYPSEFATY--LNFCRSLRFDD----------KPDYSYLRQLFRNLF 277
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-40
Identities = 58/276 (21%), Positives = 104/276 (37%), Gaps = 27/276 (9%)
Query: 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-----FTNEVTLLSRIHHRNLV 660
+G G F VY + K + +A+K + ++ E+ LL + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 661 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
L + LV++FM + + +G+EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 721 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 780
I+HRDLK +N+LLD++ K++DFGL+K + V T Y PE
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 781 QLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839
++ D+++ G IL EL+ + + I + + P+
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI------------FETLGTPTEE 223
Query: 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875
D+ S+ +P H+ + + L D+
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (375), Expect = 2e-40
Identities = 52/283 (18%), Positives = 97/283 (34%), Gaps = 20/283 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQF 662
+KIG G +GVVY + G+ A+K + E+++L + H N+V+
Sbjct: 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+ R VLV+E + K E + + GI Y H
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
++HRDLK N+L+++ K++DFGL++ + + S++
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 783 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQGI 833
+ D++S G I E+++G I + W +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 834 IDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 874
L L+ + + R + + L+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 65/293 (22%), Positives = 115/293 (39%), Gaps = 35/293 (11%)
Query: 593 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVL------TSNSYQGKREFT 645
F +++D +++GSG F VV + K G + A K + +S + +
Sbjct: 3 FRQENVDDYYDTG-EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 646 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE 705
EV++L I H N++ + + +L+ E + G L + L ++ + + E
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATE 117
Query: 706 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKFAVDGASHV 761
+ G+ YLH+ I H DLK NI+L R K+ DFGL+ G
Sbjct: 118 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 173
Query: 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 821
+ GT ++ PE + L ++D++S GVI L+SG + N+
Sbjct: 174 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV- 231
Query: 822 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
E + D I+ + + K R +I + L+
Sbjct: 232 NYEFED-EYFSNTSALAKDF--IRRLLVKDPK----------KRMTIQDSLQH 271
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 5e-40
Identities = 57/291 (19%), Positives = 104/291 (35%), Gaps = 29/291 (9%)
Query: 605 LEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRI---HHR 657
+IG G +G V+ + G+ +A+K + + + EV +L + H
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70
Query: 658 NLVQFLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 712
N+V+ C E + LV+E + E + ++ +
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLR 127
Query: 713 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 772
G+++LH+ ++HRDLK NIL+ + K++DFGL++ + S V T+ Y
Sbjct: 128 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLWYR 182
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832
PE + D++S G I E+ + I+ L E +
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 833 IIDPSLLDEYDIQSMWKI-------EEKALM--CVLPHGHMRPSISEVLKD 874
+ P + K L+ C+ + R S L
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-40
Identities = 54/284 (19%), Positives = 106/284 (37%), Gaps = 20/284 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+KIG G +GVVY + K G+ +A+K + + + E++LL ++H N+V+
Sbjct: 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 65
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
L E + LV+EF+H K + I +G+ + H+
Sbjct: 66 LLDVIHTENKLYLVFEFLHQDLKKFMD---ASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
++HRDLK N+L++ K++DFGL++ + V +
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 782 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQG 832
+ D++S G I E+++ + + I + W +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 833 IIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 874
+ D + + ++L+ + + R S L
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 6e-40
Identities = 55/288 (19%), Positives = 107/288 (37%), Gaps = 22/288 (7%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 662
IG G +G+V + +A+K ++ +Q + E+ +L R H N++
Sbjct: 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 71
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
+ + ++ L L Q ++ +G++Y+H+
Sbjct: 72 NDIIRAPTIEQMKDVYLVTH-LMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 129
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLDPEYYISQ 780
++HRDLK SN+LL+ K+ DFGL++ A H + T Y PE ++
Sbjct: 130 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 781 QLTDKS-DVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839
+ KS D++S G IL E++S + + + +I+ + I +
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 840 DEYDIQSMWKIEEKALM-------------CVLPHGHMRPSISEVLKD 874
+ K+ L + + H R + + L
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 6e-39
Identities = 55/284 (19%), Positives = 107/284 (37%), Gaps = 37/284 (13%)
Query: 603 KMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLV 660
K+ + +G G G V + ++ A+K+L Q + EV L R ++V
Sbjct: 14 KVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIV 68
Query: 661 QFLGYCQ----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 716
+ + + ++V E + G L + +Q + EI + + I+Y
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQY 126
Query: 717 LHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 773
LH+ I HRD+K N+L K++DFG +K S + T Y+
Sbjct: 127 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVA 181
Query: 774 PEYYISQQLTDKSDVYSFGVILLELISGQ---EAISNEKFGANCRNIVQWAKLHIESGDI 830
PE ++ D++S GVI+ L+ G + + ++ + + +
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
+ + I+++ K E R +I+E +
Sbjct: 242 SE-VSEEVKML--IRNLLKTEPT----------QRMTITEFMNH 272
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 9e-39
Identities = 62/289 (21%), Positives = 108/289 (37%), Gaps = 28/289 (9%)
Query: 605 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
K IG+G FGVVY KL D G+ +A+K + Q KR E+ ++ ++ H N+V+
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 664 GYCQEEGRS------VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 717
+ G LV +++ + + +Q + I + + Y+
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 718 HTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 776
H+ I HRD+K N+LLD K+ DFG +K V G S +
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 194
Query: 777 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIES 827
+ + T DV+S G +L EL+ GQ + I++ +++
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 828 GDIQGIIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 874
+ + + + E AL + R + E
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (362), Expect = 1e-38
Identities = 44/289 (15%), Positives = 105/289 (36%), Gaps = 34/289 (11%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 663
+ ++IG G FGV++ G L + +++A+K S + +E + + +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 664 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 723
Y +EG ++ + +L++ L ++ + A+ ++ +H
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 121
Query: 724 AIIHRDLKSSNILLDKHMR-----AKVSDFGLSKFAVDGASHVSSI------VRGTVGYL 772
+++RD+K N L+ + V DFG+ KF D + + GT Y+
Sbjct: 122 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 773 DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832
++ ++ + + D+ + G + + + G K A + + +S ++
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK-AATNKQKYERIGEKKQSTPLRE 239
Query: 833 IID--PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879
+ P +Y + + A P + +
Sbjct: 240 LCAGFPEEFYKY-MHYARNLAFDA----------TPDYDYLQGLFSKVL 277
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-38
Identities = 52/281 (18%), Positives = 98/281 (34%), Gaps = 44/281 (15%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE------FTNEVTLLSRIH-- 655
+ +GSGGFG VY G + D +A+K + + E EV LL ++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 656 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
+++ L + + VL+ E +T + + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDF---ITERGALQEELARSFFWQVLEAVR 124
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 774
+ H ++HRD+K NIL+D + K+ DFG D V + GT Y P
Sbjct: 125 HCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPP 178
Query: 775 EYYISQQLTDKS-DVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833
E+ + +S V+S G++L +++ G ++ + ++
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EEIIRGQVFFRQR----- 226
Query: 834 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874
+ I+ + RP+ E+
Sbjct: 227 VSSECQHL--IRWCLALRPSD----------RPTFEEIQNH 255
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 50/285 (17%), Positives = 104/285 (36%), Gaps = 22/285 (7%)
Query: 605 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+KIG G +G V+ K + + +A+K + + E+ LL + H+N+V+
Sbjct: 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 65
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
+ + LV+EF K ++ KG+ + H+
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
++HRDLK N+L++++ K+++FGL++ S+ V + ++
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 782 LTDKSDVYSFGVILLELISG----------QEAISNEKFGANCRNIVQWAKLHIESGDIQ 831
+ D++S G I EL + + + QW +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 832 GIIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 874
+ P+ ++ + L+ + + R S E L+
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-37
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 17/213 (7%)
Query: 594 TLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVT 649
T++D + K +G G FG V + K G+ A+K+L K E E
Sbjct: 3 TMNDFD-----YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 650 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 709
+L H L Q R V E+ + G L HL R
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-------SRERVFTEERARFY 110
Query: 710 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 769
A+ + L +++RD+K N++LDK K++DFGL K + + + + GT
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTP 169
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 802
YL PE D + GV++ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-36
Identities = 55/286 (19%), Positives = 103/286 (36%), Gaps = 22/286 (7%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+ +GSG +G V + G ++A+K L S + E+ LL + H N++
Sbjct: 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 81
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
L + +F G L +++ + + KG+ Y+H
Sbjct: 82 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 141
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
IIHRDLK N+ +++ K+ DFGL++ A S ++ V +
Sbjct: 142 ---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWMR 195
Query: 782 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQG 832
T D++S G I+ E+I+G+ + I++ +L +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 833 IIDPSLLDEYDIQSMWKIEEKAL----MCVLPHGHMRPSISEVLKD 874
P L + + A+ ++ R + E L
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 9e-36
Identities = 53/300 (17%), Positives = 110/300 (36%), Gaps = 38/300 (12%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 661
KIG G FG V+ + K G+++A+K + + + E+ +L + H N+V
Sbjct: 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 73
Query: 662 FLGYCQE--------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 713
+ C+ +G LV++F + + EI
Sbjct: 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-------NVLVKFTLSEIKRVMQML 126
Query: 714 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---AVDGASHVSSIVRGTVG 770
+ L+ I+HRD+K++N+L+ + K++DFGL++ A + + + T+
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 771 YLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829
Y PE + ++ D++ G I+ E+ + + I Q I
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ-LCGSITPEV 245
Query: 830 IQGIIDPSLLDEYDIQSMWKIEEKALM---------------CVLPHGHMRPSISEVLKD 874
+ + L ++ ++ K + K + ++ R + L
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (341), Expect = 3e-35
Identities = 58/290 (20%), Positives = 113/290 (38%), Gaps = 33/290 (11%)
Query: 607 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 662
K +G+G FG V K + G A+K+L ++ NE +L ++ LV+
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 663 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 722
++ +V E++ G + HL R + A EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD- 161
Query: 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 782
+I+RDLK N+L+D+ +V+DFG +K + GT L PE +S+
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEIILSKGY 215
Query: 783 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 842
D ++ GV++ E+ +G ++ IV L D
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------KVRFPSHFSSDLKD-- 267
Query: 843 DIQSMWKIEEKALMCVLPHGHMRPSISEVL-----KDIQDAIVIEREAAA 887
++++ +++ G+++ ++++ + +R+ A
Sbjct: 268 LLRNLLQVDLTKRF-----GNLKNGVNDIKNHKWFATTDWIAIYQRKVEA 312
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (326), Expect = 2e-33
Identities = 52/277 (18%), Positives = 114/277 (41%), Gaps = 23/277 (8%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 662
L +K+G G + V+ + + +++ VK+L K++ E+ +L + N++
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITL 95
Query: 663 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 720
++ LV+E ++N K+ Q + + K ++Y H+
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM 148
Query: 721 CVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 779
I+HRD+K N+++D +H + ++ D+GL++F G + + + + PE +
Sbjct: 149 G---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVD 203
Query: 780 QQLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838
Q+ D D++S G +L +I +E + N +V+ AK+ I ++
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGH--DNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 875
+ + + H + +S D
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-31
Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 18/209 (8%)
Query: 605 LEKKIGSGGFGVVYYGKL----KDGKEIAVKVL----TSNSYQGKREFTNEVTLLSRI-H 655
L K +G+G +G V+ + GK A+KVL + E +L I
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 656 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
LV Q E + L+ ++++ G L HL + I EI
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL------- 140
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
L II+RD+K NILLD + ++DFGLSK V + + GT+ Y+ P+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 776 YYISQQ--LTDKSDVYSFGVILLELISGQ 802
D +S GV++ EL++G
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 3e-30
Identities = 56/276 (20%), Positives = 104/276 (37%), Gaps = 22/276 (7%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
+GSG +G V K G +AVK L S + E+ LL + H N++
Sbjct: 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 662 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 721
L + L + Q++ + +G++Y+H+
Sbjct: 82 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 722 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 781
IIHRDLK SN+ +++ K+ DFGL++ + T Y PE ++
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEIMLNWM 194
Query: 782 LTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840
+ D++S G I+ EL++G+ + I++ + G LL
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR----------LVGTPGAELLK 244
Query: 841 EYDIQSMWK-IEEKALMCVLPHGHMRPSISEVLKDI 875
+ +S I+ M + ++ + + D+
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 280
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (300), Expect = 6e-30
Identities = 50/225 (22%), Positives = 92/225 (40%), Gaps = 21/225 (9%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 661
K IGSG G+V + +A+K L + + E+ L+ ++H+N++
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 662 FLGYC------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 715
L +E LV E M + + ++ + + GI+
Sbjct: 81 LLNVFTPQKTLEEFQDVYLVMELMDANLCQ-------VIQMELDHERMSYLLYQMLCGIK 133
Query: 716 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 775
+LH+ IIHRDLK SNI++ K+ DFGL++ G S + + T Y PE
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 188
Query: 776 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 820
+ + D++S G I+ E++ + + +++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (288), Expect = 2e-28
Identities = 42/241 (17%), Positives = 97/241 (40%), Gaps = 18/241 (7%)
Query: 605 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL---- 659
L +K+G G F V+ K + + +A+K++ +E+ LL R++ +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 660 -------VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAA 711
++ L + +G + + + + L +E R + + +I++
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 712 KGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVS-SIVRGTV 769
G++Y+H C IIH D+K N+L++ + ++ + T
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 770 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829
Y PE + +D++S ++ ELI+G ++ + ++ A++ G+
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253
Query: 830 I 830
+
Sbjct: 254 L 254
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.3 bits (231), Expect = 3e-22
Identities = 29/158 (18%), Positives = 48/158 (30%), Gaps = 21/158 (13%)
Query: 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVL----------TSNSYQGKREFTNEVTLLSRI 654
+ K +G G V+ + E VK G F+ +R
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 655 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 714
R L + G VY + N L E R+ E+ + + +
Sbjct: 64 EFRALQKLQGLAV-----PKVYAWEGNAVLME--LIDAKELYRVRVENPDEVLDMILEEV 116
Query: 715 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752
+ I+H DL N+L+ + + DF S
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQSV 150
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.1 bits (178), Expect = 3e-14
Identities = 15/93 (16%), Positives = 36/93 (38%), Gaps = 5/93 (5%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 464
++T + L N++ P ++ L+ L L+ N ++ + +
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SSLANLTN 352
Query: 465 LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497
+ + NQ++ P L NL + +L + +
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.9 bits (162), Expect = 4e-12
Identities = 21/81 (25%), Positives = 37/81 (45%), Gaps = 3/81 (3%)
Query: 439 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498
L +L L L N+++ P S L+ + +N+++ SSL NL N+ L +N
Sbjct: 306 LKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQ 362
Query: 499 LSGTVPSSLLSKNVVLNYAGN 519
+S P + L++ L
Sbjct: 363 ISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 7e-07
Identities = 36/131 (27%), Positives = 52/131 (39%), Gaps = 24/131 (18%)
Query: 412 SDPQPSITVIHLSSKNLTGNI---PSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRII 468
SD P + +L +L GN L L++L +L L N ++ P SG L +
Sbjct: 210 SDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP-LSGLTKLTEL 268
Query: 469 HLEDNQLTGPLP--------------------SSLMNLPNLRELYVQNNMLSGTVPSSLL 508
L NQ++ P S + NL NL L + N +S P S L
Sbjct: 269 KLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSL 328
Query: 509 SKNVVLNYAGN 519
+K L +A N
Sbjct: 329 TKLQRLFFANN 339
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 1e-05
Identities = 13/78 (16%), Positives = 30/78 (38%), Gaps = 3/78 (3%)
Query: 439 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498
L+ ++ L ++T + + + + + + + L NL ++ NN
Sbjct: 21 LAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQ 77
Query: 499 LSGTVPSSLLSKNVVLNY 516
L+ P L+K V +
Sbjct: 78 LTDITPLKNLTKLVDILM 95
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 1e-05
Identities = 24/78 (30%), Positives = 36/78 (46%), Gaps = 3/78 (3%)
Query: 438 KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497
KL++L L N ++ P +L + L NQL +L +L NL +L + NN
Sbjct: 195 KLTNLESLIATNNQISDITPLGI-LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANN 251
Query: 498 MLSGTVPSSLLSKNVVLN 515
+S P S L+K L
Sbjct: 252 QISNLAPLSGLTKLTELK 269
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.8 bits (169), Expect = 2e-13
Identities = 19/79 (24%), Positives = 34/79 (43%), Gaps = 2/79 (2%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 464
++ ++ + L + + G +P LT+L L L + N+L G IP
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR 292
Query: 465 LRIIHLEDNQ-LTG-PLPS 481
+ +N+ L G PLP+
Sbjct: 293 FDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 21/62 (33%), Positives = 28/62 (45%), Gaps = 1/62 (1%)
Query: 462 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGNI 520
+L + L +N++ G LP L L L L V N L G +P L + V YA N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 521 NL 522
L
Sbjct: 303 CL 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 5e-09
Identities = 15/58 (25%), Positives = 22/58 (37%), Gaps = 3/58 (5%)
Query: 446 WLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN-MLSG 501
L N + G +P + L +++ N L G +P NL NN L G
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCG 306
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 63.1 bits (152), Expect = 3e-11
Identities = 25/104 (24%), Positives = 39/104 (37%), Gaps = 5/104 (4%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 475
+ V+ S L +P DL L L N +T DF +L + L +N++
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 476 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 519
+ P + L L LY+ N L +P + L N
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHEN 110
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 24/93 (25%), Positives = 38/93 (40%), Gaps = 4/93 (4%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474
P ++ L + +T D L +L L L N ++ P F+ L ++L NQ
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
L LP + L+EL V N ++ S
Sbjct: 91 LKE-LPEKMPK--TLQELRVHENEITKVRKSVF 120
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 46.6 bits (109), Expect = 7e-06
Identities = 16/128 (12%), Positives = 38/128 (29%), Gaps = 25/128 (19%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG--------------------- 454
++ + L + ++ P L L L+L N L
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114
Query: 455 ---PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511
+ + + + + +G + + L + + + ++ T+P L
Sbjct: 115 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSL 173
Query: 512 VVLNYAGN 519
L+ GN
Sbjct: 174 TELHLDGN 181
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.0 bits (92), Expect = 8e-04
Identities = 17/115 (14%), Positives = 38/115 (33%), Gaps = 30/115 (26%)
Query: 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLD------------------------GNS 451
PS+T +HL +T + L L++L +L L N
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230
Query: 452 LTGPIPDFSGCPDLRIIHLEDNQLTG------PLPSSLMNLPNLRELYVQNNMLS 500
L + +++++L +N ++ P + + + +N +
Sbjct: 231 LVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.6 bits (91), Expect = 0.001
Identities = 19/71 (26%), Positives = 31/71 (43%), Gaps = 4/71 (5%)
Query: 438 KLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496
+VEL + +G F G L I + D +T +P L P+L EL++
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 180
Query: 497 NMLSGTVPSSL 507
N ++ +SL
Sbjct: 181 NKITKVDAASL 191
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 55.5 bits (133), Expect = 6e-10
Identities = 24/105 (22%), Positives = 38/105 (36%), Gaps = 25/105 (23%)
Query: 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDL-------------- 465
V+HL+ K+LT + L +L + L L N L P + L
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 466 --------RIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSG 501
+ + L +N+L L++ P L L +Q N L
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 8e-04
Identities = 11/40 (27%), Positives = 17/40 (42%), Gaps = 2/40 (5%)
Query: 466 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 505
R++HL LT L L + L + +N L P+
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA 38
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 5e-08
Identities = 25/97 (25%), Positives = 43/97 (44%), Gaps = 3/97 (3%)
Query: 400 CLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF 459
L + + + S + +LS N + + L LS L L D N ++ I
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPL 191
Query: 460 SGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496
+ P+L +HL++NQ++ P L N NL + + N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 15/59 (25%), Positives = 30/59 (50%), Gaps = 2/59 (3%)
Query: 457 PDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 515
+ L + +DN+++ P L +LPNL E++++NN +S P + S ++
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVT 223
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 8/61 (13%), Positives = 26/61 (42%), Gaps = 3/61 (4%)
Query: 439 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498
L++ +++ +++T + + + + +T + L NL L +++N
Sbjct: 18 LANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74
Query: 499 L 499
+
Sbjct: 75 I 75
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 23/118 (19%), Positives = 37/118 (31%), Gaps = 9/118 (7%)
Query: 392 WAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNS 451
P + + + I S SL EL + N
Sbjct: 236 LTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNK 295
Query: 452 LTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG--TVPSSL 507
L +P + P L + N L +P NL++L+V+ N L +P S+
Sbjct: 296 LIE-LP--ALPPRLERLIASFNHLAE-VPEL---PQNLKQLHVEYNPLREFPDIPESV 346
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 15/75 (20%), Positives = 28/75 (37%), Gaps = 6/75 (8%)
Query: 441 SLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDNQLTG----PLPSSLMNLPNLRELYV 494
+ L + L+ +++ L+D LT + S+L P L EL +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 495 QNNMLSGTVPSSLLS 509
++N L +L
Sbjct: 63 RSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 7e-06
Identities = 20/103 (19%), Positives = 34/103 (33%), Gaps = 14/103 (13%)
Query: 404 PWSWLQCNSDPQPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIPD- 458
Q P + V+ L+ +++ + + + L SL EL L N L
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416
Query: 459 -----FSGCPDLRIIHLEDNQLTGPLPSSLMNL----PNLREL 492
L + L D + + L L P+LR +
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 6e-04
Identities = 14/55 (25%), Positives = 24/55 (43%), Gaps = 4/55 (7%)
Query: 459 FSGCPDLRIIHLEDNQLTG----PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 509
LR++ L D ++ L ++L+ +LREL + NN L L+
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.2 bits (108), Expect = 7e-06
Identities = 18/64 (28%), Positives = 32/64 (50%), Gaps = 2/64 (3%)
Query: 435 DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494
+++K++S +E+ D +LT PD D I+HL +N L ++LM L +L +
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 495 QNNM 498
Sbjct: 63 DRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 16/100 (16%), Positives = 30/100 (30%), Gaps = 3/100 (3%)
Query: 400 CLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDG-NSLTGPIPD 458
+ L + N +P L + +E N+LT
Sbjct: 107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG 166
Query: 459 -FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497
+G +L + L++N L +P L ++ N
Sbjct: 167 LLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (104), Expect = 2e-05
Identities = 22/107 (20%), Positives = 40/107 (37%), Gaps = 8/107 (7%)
Query: 402 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FS 460
P + L + +HL L P L++L L+L N+L D F
Sbjct: 98 PATFHGLGR-------LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 461 GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 507
+L + L N+++ + L +L L + N ++ P +
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 4e-05
Identities = 12/76 (15%), Positives = 28/76 (36%), Gaps = 2/76 (2%)
Query: 425 SKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDNQLTGPLPSS 482
++ ++ + + L + + S C L+ + LE +L+ P+ ++
Sbjct: 31 PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90
Query: 483 LMNLPNLRELYVQNNM 498
L NL L +
Sbjct: 91 LAKNSNLVRLNLSGCS 106
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 12/73 (16%), Positives = 29/73 (39%), Gaps = 3/73 (4%)
Query: 437 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496
+ ++ L S+T + + + I ++ + + LPN+ +L++
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQ-NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 497 NMLSGTVPSSLLS 509
N L+ P + L
Sbjct: 78 NKLTDIKPLANLK 90
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 10/41 (24%), Positives = 19/41 (46%), Gaps = 2/41 (4%)
Query: 456 IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496
I +G L+ ++L N ++ +L L NL L + +
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 11/66 (16%), Positives = 25/66 (37%), Gaps = 3/66 (4%)
Query: 405 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 464
+ + L ++ +P L L+ L L+L N ++ + +G +
Sbjct: 145 KITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRALAGLKN 201
Query: 465 LRIIHL 470
L ++ L
Sbjct: 202 LDVLEL 207
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 3e-04
Identities = 16/72 (22%), Positives = 27/72 (37%), Gaps = 2/72 (2%)
Query: 431 NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTG--PLPSSLMNLPN 488
DL + V L + P+L ++L +N+L + S + PN
Sbjct: 33 RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPN 92
Query: 489 LRELYVQNNMLS 500
L+ L + N L
Sbjct: 93 LKILNLSGNELK 104
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.003
Identities = 16/90 (17%), Positives = 30/90 (33%), Gaps = 3/90 (3%)
Query: 422 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS 481
L + + + ++K + LD L PD +++ + L
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRS-DPDLVAQNIDVVLNRRSSMAAT-LRI 59
Query: 482 SLMNLPNLRELYVQNNMLSGTVPSSLLSKN 511
N+P L L + NN L S + +
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQK 89
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 11/51 (21%), Positives = 17/51 (33%), Gaps = 3/51 (5%)
Query: 455 PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 505
P F G I+ + ++ L NL LR N +P+
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.004
Identities = 14/88 (15%), Positives = 24/88 (27%), Gaps = 12/88 (13%)
Query: 404 PWSWLQCNSDPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSG 461
+ + + ++LS N +P+D S V L + +
Sbjct: 164 GIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 223
Query: 462 CPDLRIIHLEDNQLTGPLPSSLMNLPNL 489
LR +L LP L
Sbjct: 224 LKKLRARST----------YNLKKLPTL 241
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 3e-04
Identities = 16/109 (14%), Positives = 35/109 (32%), Gaps = 3/109 (2%)
Query: 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQ 474
+ + + + L +L EL+++ + G +LR + + +
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 523
L P + P L L + N L ++ ++ LH
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 10/65 (15%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 437 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496
T L+ ++ L ++T + + + + + + + L NL ++ N
Sbjct: 15 TALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71
Query: 497 NMLSG 501
N L+
Sbjct: 72 NQLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 11/47 (23%), Positives = 18/47 (38%), Gaps = 3/47 (6%)
Query: 446 WLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 492
N +T P + L + + N+++ S L L NL L
Sbjct: 156 NFSSNQVTDLKP-LANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 6/55 (10%), Positives = 17/55 (30%), Gaps = 1/55 (1%)
Query: 456 IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 510
++ R + L ++ + + L + +N + LL +
Sbjct: 11 AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFPLLRR 64
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 929 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.59 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.52 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.51 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.47 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.38 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.33 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.31 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.29 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.28 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.21 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.18 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.13 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.12 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.12 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.12 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.09 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.09 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.09 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.03 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.02 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.01 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.99 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.91 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.82 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.77 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.71 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.53 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.36 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.19 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.08 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.06 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.0 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.83 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.76 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.75 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.75 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.74 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.63 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.59 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.5 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.83 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.69 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.37 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.03 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.2 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.71 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.25 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 92.97 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=414.47 Aligned_cols=253 Identities=27% Similarity=0.470 Sum_probs=198.3
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCc
Q 002382 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gs 683 (929)
.+.+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++||||++++|+|..++..++||||+++|+
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 3568899999999999999988999999997543 345789999999999999999999999999999999999999999
Q ss_pred hhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceee
Q 002382 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 763 (929)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 763 (929)
|.+++... ...+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++...........
T Consensus 87 L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 87 LSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp HHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred HHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99988542 45688999999999999999999998 9999999999999999999999999999876554444444
Q ss_pred eeecCccccCccccccCcCCCcCceeeHHHHHHHHHhC-CCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCcc
Q 002382 764 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 842 (929)
Q Consensus 764 ~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 842 (929)
...||+.|+|||++.+..++.++|||||||++|||+|+ ++|+.... ...+.+.+.... +. ..+
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~----~~~~~~~i~~~~---~~---~~p------ 224 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSEVVEDISTGF---RL---YKP------ 224 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC----HHHHHHHHHHTC---CC---CCC------
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC----HHHHHHHHHhcC---CC---CCc------
Confidence 56799999999999999999999999999999999995 55554333 122333222211 10 111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 843 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 843 ~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.....++.+++.+|++.+|++||||+||+++|+++.+
T Consensus 225 -~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 -RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1122467899999999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=413.31 Aligned_cols=256 Identities=24% Similarity=0.391 Sum_probs=208.0
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+.+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||||+++
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 345678999999999999999988899999997554 345679999999999999999999998865 567899999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++... ....+++..++.|+.||++||.|||++ +|+||||||+||||++++.+||+|||+|+.........
T Consensus 92 g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 92 GSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp CBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 9999987543 344689999999999999999999998 99999999999999999999999999999776554444
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.++.++.++|||||||++|||+||..|+.... ....+.+.+. .+.. +..
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~---~~~~~~~~i~----~~~~-----~~~--- 231 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLE----RGYR-----MVR--- 231 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHH----TTCC-----CCC---
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC---CHHHHHHHHH----hcCC-----CCC---
Confidence 455678999999999999999999999999999999999665543322 1112222221 1110 011
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
+......+.+++.+|++.+|++||||+||++.|++...
T Consensus 232 -p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11223468899999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-47 Score=415.76 Aligned_cols=253 Identities=26% Similarity=0.466 Sum_probs=196.8
Q ss_pred HhccccccCcEEEEEEEECC-C---cEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 605 LEKKIGSGGFGVVYYGKLKD-G---KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~~-~---~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
+.+.||+|+||+||+|+++. + ..||||++.... ....+.|.+|+++|++++|||||+++|+|..++..++|||||
T Consensus 30 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~ 109 (299)
T d1jpaa_ 30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFM 109 (299)
T ss_dssp EEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEec
Confidence 35789999999999999863 3 258899886543 334567999999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
++|+|.+++.. ....+++.+++.++.||++||+|||++ +|+||||||+|||++.++++||+|||+|+.......
T Consensus 110 ~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 110 ENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp TTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 99999998853 245689999999999999999999998 999999999999999999999999999986654322
Q ss_pred ce----eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 760 HV----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 760 ~~----~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
.. .....||+.|||||.+.++.++.++|||||||++|||+| |+.||..... ..+...+... .++
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~----~~~~~~i~~~---~~~---- 252 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN----QDVINAIEQD---YRL---- 252 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHHHTT---CCC----
T ss_pred cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH----HHHHHHHHcC---CCC----
Confidence 11 122457999999999999999999999999999999998 8999976542 2233322211 111
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
..+.+....+.+++.+||+.+|++||||.||++.|++++.
T Consensus 253 ------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 253 ------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1122234568899999999999999999999999998864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=403.23 Aligned_cols=249 Identities=29% Similarity=0.492 Sum_probs=209.5
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
+.++||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++||||++++|+|.+++..++||||+++|+|
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 5689999999999999999888999999986543 457899999999999999999999999999999999999999999
Q ss_pred hhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCceeee
Q 002382 685 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 764 (929)
Q Consensus 685 ~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 764 (929)
.+++.. ....+++..+.+++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++............
T Consensus 87 ~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 87 LNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp HHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred HHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 998753 345678899999999999999999998 99999999999999999999999999998665544444445
Q ss_pred eecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCccC
Q 002382 765 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 843 (929)
Q Consensus 765 ~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 843 (929)
..||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ +... +..+.. ... +
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~----~~~~----i~~~~~--~~~-------p 223 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAEH----IAQGLR--LYR-------P 223 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH----HHHH----HHTTCC--CCC-------C
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH----HHHH----HHhCCC--CCC-------c
Confidence 668999999999999999999999999999999998 899997655222 2221 111110 011 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 844 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 844 ~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
......+.+++.+||+.+|++|||+.|++++|.+
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1222468899999999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-48 Score=418.10 Aligned_cols=257 Identities=27% Similarity=0.391 Sum_probs=211.8
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.+.+.+.||+|+||+||+|+++ +++.||||+++.... ..++|.+|+++|++++|||||+++++|.+++..++||||++
T Consensus 18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence 4456789999999999999987 588999999875543 35679999999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+|+|.+++... ....+++..++.++.||++||+|||++ +|+||||||+|||+++++++||+|||+|+........
T Consensus 97 ~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 97 YGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp TCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred CcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 99999998643 345789999999999999999999998 9999999999999999999999999999876655555
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
......|++.|+|||++.+..++.++|||||||++|||++|..|+.... ....+.+.+. .+. ..
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~---~~~~~~~~i~----~~~---------~~ 235 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLE----KDY---------RM 235 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHHHHH----TTC---------CC
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc---hHHHHHHHHh----cCC---------CC
Confidence 5555678999999999999999999999999999999999777664322 1122222221 111 11
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
..+......+.+++.+|++.||++||||.||++.|+.+..
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1112223468899999999999999999999999987643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=408.49 Aligned_cols=256 Identities=32% Similarity=0.533 Sum_probs=199.4
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecC--CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~--~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
+.+.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|+++|++++||||+++++++.+ +..++||||++
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~ 86 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE 86 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence 345689999999999999875 46999998754 33445789999999999999999999998865 56799999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC-
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 759 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~- 759 (929)
+|+|.+++... ...+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 87 ~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 87 GSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999998642 35689999999999999999999998 999999999999999999999999999986544322
Q ss_pred ceeeeeecCccccCcccccc---CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 760 HVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
.......||+.|||||++.+ ..++.++|||||||++|||+||+.||....... .+...+ ..+.. .+
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~~~~----~~~~~----~p 229 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIFMV----GRGYL----SP 229 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHH----HHTSC----CC
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHHHHH----hcCCC----CC
Confidence 23345679999999999864 357889999999999999999999997644111 111111 11111 11
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
.+ ..........+.+++.+|++.+|++||||.||+++|+.+.
T Consensus 230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11 1112223356889999999999999999999999998765
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=404.17 Aligned_cols=250 Identities=22% Similarity=0.353 Sum_probs=199.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+++|++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 345689999999999999986 68999999997553 2335678999999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC-
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 759 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~- 759 (929)
+|+|.+++. ....+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 87 gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 87 GGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp TEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999984 345789999999999999999999998 999999999999999999999999999986544322
Q ss_pred ceeeeeecCccccCccccccCcC-CCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
......+||+.|||||++.+..+ +.++|||||||++|||++|+.||...... ......+ .......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~~~~~----~~~~~~~------- 226 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDW----KEKKTYL------- 226 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT--SHHHHHH----HTTCTTS-------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH--HHHHHHH----hcCCCCC-------
Confidence 23345679999999999988776 57899999999999999999999754411 1111111 1111000
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.........+.+++.+|++.||++|||++|+++|
T Consensus 227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 227 --NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0001112357789999999999999999999764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=407.81 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=205.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
|.+.+.||+|+||+||+|++. +|+.||||+++.......+.+.+|+++|++++||||+++++++.+++..++||||+++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 455688999999999999875 6899999999866555567899999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+....... .
T Consensus 102 g~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 102 GSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp CBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 99998764 34588999999999999999999998 999999999999999999999999999987654332 2
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... ....+.. . + .
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~---~~~~~~~-~-----~--~ 237 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYL---IATNGTP-E-----L--Q 237 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH---HHHHCSC-C-----C--S
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH----HHHHH---HHhCCCC-C-----C--C
Confidence 34456999999999999999999999999999999999999999754411 11111 1111111 0 0 0
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+......+.+++.+|++.||++|||+.|+++|
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111122467899999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=403.29 Aligned_cols=244 Identities=25% Similarity=0.410 Sum_probs=203.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 456789999999999999986 68899999987532 23356788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.+++. ....+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 88 ~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 88 APLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp CTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred cCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 99999999984 345689999999999999999999998 9999999999999999999999999999765432
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... ...++. .+
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~----i~~~~~------~~ 223 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKR----ISRVEF------TF 223 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHH----HHTTCC------CC
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH----HHHHH----HHcCCC------CC
Confidence 223456999999999999999999999999999999999999999765421 12111 111111 11
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... ....+.+++.+|++.||++|||++|+++|
T Consensus 224 p~~----~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 224 PDF----VTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred Ccc----CCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 111 22457899999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-47 Score=406.79 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=194.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeee--cCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~--~~~~~LV~E 677 (929)
|.+.+.||+|+||+||+|+.+ +|+.||||++..... ...+.+.+|+++|++++||||+++++++.+ .+..++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 446789999999999999886 688999999976532 334668899999999999999999999864 456899999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCC--CCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
||++|+|.+++.........+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 99999999998765445667999999999999999999999862 1249999999999999999999999999998765
Q ss_pred CCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... +..+....
T Consensus 166 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~----~~~~~----i~~~~~~~--- 233 (269)
T d2java1 166 HDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----ELAGK----IREGKFRR--- 233 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHH----HHHTCCCC---
T ss_pred cCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH----HHHHH----HHcCCCCC---
Confidence 4322 234467999999999999999999999999999999999999999765421 22221 11222211
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+...++ ..+.+++.+|++.||++|||+.|+++|
T Consensus 234 --~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 234 --IPYRYS----DELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCcccC----HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111222 358899999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=405.69 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=203.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
|.+.+.||+|+||+||+|++. +++.||||+++.......+.+.+|+++|++++|||||++++++.+++..++|||||++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 455688999999999999986 6889999999877666678899999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++.. ....+++..+..++.||++||.|||++ +|+||||||+|||++.++++||+|||+|+...... ..
T Consensus 94 g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 94 GAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 999998753 235689999999999999999999998 99999999999999999999999999997543221 12
Q ss_pred eeeeecCccccCccccc-----cCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 762 SSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~-----~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+. .+......
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~--------~~~~~~~~-- 236 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA--------KSEPPTLA-- 236 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH--------HSCCCCCS--
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH--------cCCCCCCC--
Confidence 23456999999999984 4568899999999999999999999997654222111111 11111100
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+......+.+++.+|++.||++|||+.|+++|
T Consensus 237 -----~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 237 -----QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -----SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----ccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223467899999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=402.94 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=199.6
Q ss_pred ccccccCcEEEEEEEECC---CcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 607 KKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~---~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
++||+|+||+||+|.+++ ++.||||+++... ....++|.+|+++|++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998753 4679999997542 3335679999999999999999999999965 457899999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++. ....+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.........
T Consensus 92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999885 345689999999999999999999998 99999999999999999999999999998665443332
Q ss_pred --eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 762 --SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 762 --~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.....||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...+ ..+...
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~----~~~~~i----~~~~~~------- 229 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAML----EKGERM------- 229 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHHH----HTTCCC-------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH----HHHHHH----HcCCCC-------
Confidence 234568999999999999999999999999999999998 89999765421 222222 222111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
..+......+.+++.+|++.||++|||++||++.|+...
T Consensus 230 --~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 230 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 111122346889999999999999999999999998765
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=399.77 Aligned_cols=249 Identities=26% Similarity=0.413 Sum_probs=203.4
Q ss_pred cccccCcEEEEEEEEC---CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccCCc
Q 002382 608 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 683 (929)
Q Consensus 608 ~IG~G~fG~Vy~~~~~---~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~gs 683 (929)
+||+|+||+||+|.++ ++..||||+++... ....++|.+|+++|++++|||||+++|++.. +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999875 34579999997653 3345789999999999999999999999865 46899999999999
Q ss_pred hhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce--
Q 002382 684 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-- 761 (929)
Q Consensus 684 L~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-- 761 (929)
|.+++.. ....+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+|+.........
T Consensus 95 L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (285)
T d1u59a_ 95 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168 (285)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred HHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccccc
Confidence 9998753 245689999999999999999999998 99999999999999999999999999998765443322
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccC
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 840 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 840 (929)
.....||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+...+ ..+...+
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~----~~~~~i----~~~~~~~-------- 232 (285)
T d1u59a_ 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAFI----EQGKRME-------- 232 (285)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHHHH----HTTCCCC--------
T ss_pred ccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH----HHHHHH----HcCCCCC--------
Confidence 233458999999999999999999999999999999998 99999765422 222221 2222111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 841 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 841 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.+......+.+++.+||+.+|++||||.+|++.|+.+..
T Consensus 233 -~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 233 -CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112223468899999999999999999999999987654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=406.71 Aligned_cols=256 Identities=25% Similarity=0.404 Sum_probs=199.0
Q ss_pred HHhccccccCcEEEEEEEECCC-----cEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLKDG-----KEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~~-----~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.+.+.||+|+||+||+|.++.. ..||||+++.... ....+|.+|++++++++|||||+++|++.+.+..++|||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 3568899999999999987632 3699999975533 334578999999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+.++++.+.+.. ....+++.+++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 90 ~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 90 YMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp CCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 9999999887753 245689999999999999999999998 9999999999999999999999999999865443
Q ss_pred CC--ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 758 AS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 758 ~~--~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..|+..... ...+.+.+. .+.
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~---~~~~~~~i~----~~~------ 230 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHEVMKAIN----DGF------ 230 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHH----TTC------
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC---HHHHHHHHh----ccC------
Confidence 22 222345689999999999999999999999999999999997666543221 122222221 111
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
+...+......+.+++.+||+.+|++||||.||++.|++++..
T Consensus 231 ---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 ---RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ---CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111222335688999999999999999999999999987753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=412.28 Aligned_cols=263 Identities=22% Similarity=0.293 Sum_probs=200.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||+||+|++. +|+.||+|+++... ......+.+|+.+|++++|||||+++++|.+++..++||||++
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~ 87 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 87 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 456689999999999999986 68899999997653 3345678999999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
+|+|.+++.. ...+++..+..++.|+++||.|||+++ +|+||||||+|||++.++++||+|||+|+.....
T Consensus 88 gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 158 (322)
T d1s9ja_ 88 GGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158 (322)
T ss_dssp TEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence 9999999853 456899999999999999999999731 7999999999999999999999999999865432
Q ss_pred eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc--------CC--c
Q 002382 761 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES--------GD--I 830 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~--------~~--~ 830 (929)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...................... .. .
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 2234579999999999999999999999999999999999999997543211100000000000000 00 0
Q ss_pred ccccCCcc---------------cCcc-CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 QGIIDPSL---------------LDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~~d~~l---------------~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....+... .... ......++.+++.+|++.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000000 0000 00112357899999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=394.31 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=195.5
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeee----cCeEEEEE
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVY 676 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~----~~~~~LV~ 676 (929)
.+.++||+|+||+||+|++. +++.||+|++.... ....+.+.+|+++|++++||||+++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45678999999999999987 58899999987543 2334678999999999999999999999865 34579999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec-CCCcEEEEeecCccccc
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~~~ 755 (929)
||+++|+|.+++. ....+++..+..++.||++||+|||++. ++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHh----ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999984 3456889999999999999999999971 1399999999999997 57899999999998543
Q ss_pred CCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
. .......||+.|||||++.+ .++.++|||||||++|||++|+.||..... ...+.+. +..+.....+
T Consensus 167 ~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~---~~~~~~~----i~~~~~~~~~- 234 (270)
T d1t4ha_ 167 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIYRR----VTSGVKPASF- 234 (270)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---HHHHHHH----HTTTCCCGGG-
T ss_pred C---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc---HHHHHHH----HHcCCCCccc-
Confidence 2 22345679999999998865 699999999999999999999999975431 1112221 1111111111
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+.....++.+++.+|++.||++|||++|+++|
T Consensus 235 -------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 235 -------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11122357899999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=410.50 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=204.6
Q ss_pred HHHHhccccccCcEEEEEEEECC-C-----cEEEEEEeecC-CcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKD-G-----KEIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~-~-----~~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~ 673 (929)
.+.+.+.||+|+||+||+|++.. + ..||||++... .......+.+|+.+|.++ +|||||++++++.+.+..+
T Consensus 38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (325)
T d1rjba_ 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117 (325)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence 34577899999999999998752 2 36999998654 333456789999999998 8999999999999999999
Q ss_pred EEEEeccCCchhhhhccccc-------------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCC
Q 002382 674 LVYEFMHNGTLKEHLYGTLT-------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 734 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~-------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~N 734 (929)
+|||||++|+|.++|+.... ....+++..++.++.||++||+|||++ +|+||||||+|
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~N 194 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN 194 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhc
Confidence 99999999999999965321 124588999999999999999999998 99999999999
Q ss_pred eEecCCCcEEEEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccc
Q 002382 735 ILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGA 812 (929)
Q Consensus 735 ILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~ 812 (929)
||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||++ |+.||......+
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999865544333 3345668999999999999999999999999999999998 899997654222
Q ss_pred cchhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHH
Q 002382 813 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 877 (929)
Q Consensus 813 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~ 877 (929)
.+.+.+. .+. ....+......+.+++.+|++.+|++||||+||+++|..
T Consensus 275 ---~~~~~~~----~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 275 ---NFYKLIQ----NGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp ---HHHHHHH----TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHHHHh----cCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1222111 111 011112223468899999999999999999999999964
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=401.71 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=201.6
Q ss_pred HHHHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
.+.+.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|+|.+ +..++||||+++
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 356788999999999999999988899999997543 345789999999999999999999999965 567899999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCce
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 761 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 761 (929)
|+|.+++... ....++|.+++.++.||++||+|||++ +|+||||||+||||+.++++||+|||+|+.........
T Consensus 96 g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 96 GSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred Cchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 9999888643 244689999999999999999999998 99999999999999999999999999998765554444
Q ss_pred eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 762 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 762 ~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
.....||+.|+|||++..+.++.++|||||||++|||++|..|+.... ....+...+.... + . .
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~---~~~~~~~~i~~~~---~------~----~ 234 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGY---R------M----P 234 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTC---C------C----C
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC---CHHHHHHHHHhcC---C------C----C
Confidence 455679999999999999999999999999999999999766654332 1122333322111 0 1 1
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
.+.....++.+++.+|++.+|++||+|++|++.|++..
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 11222346889999999999999999999999998765
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=401.87 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=201.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|+++|++++||||+++++++.+++..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 557789999999999999986 68999999997532 22346789999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 90 ~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 90 AKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 99999999874 345789999999999999999999998 99999999999999999999999999998665432
Q ss_pred -CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 759 -SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 759 -~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+ +.+. +..++. .
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~----i~~~~~------~ 228 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----IFQK----IIKLEY------D 228 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHTTCC------C
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH----HHHH----HHcCCC------C
Confidence 223345679999999999999999999999999999999999999997654211 1111 111111 0
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+.... ...+.+++.+|++.||++|||++|++++
T Consensus 229 ~p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 229 FPEKF----FPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CCTTC----CHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCccC----CHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11122 2357899999999999999999997654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.5e-45 Score=405.16 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=206.8
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.|.+.+.||+|+||+||+|++. +|+.||||++........+.+.+|+.+|++++||||+++++++.+++..++|||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 3567789999999999999986 689999999987666666789999999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC--CCcEEEEeecCcccccCCC
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~~~~~~ 758 (929)
+|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+|+.....
T Consensus 107 gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 107 GGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp SCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 9999998853 245689999999999999999999998 9999999999999964 578999999999866443
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.......||+.|||||++.+..++.++|||||||++|||++|+.||......+....+.. . .... +...
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~----~--~~~~----~~~~ 248 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS----C--DWNM----DDSA 248 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----T--CCCS----CCGG
T ss_pred -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHh----C--CCCC----Cccc
Confidence 233456799999999999999999999999999999999999999976542221111111 0 0111 1111
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.. .....+.+++.+|++.||++|||++|+++|
T Consensus 249 ~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 FS----GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GG----GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cc----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 122457899999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-45 Score=401.89 Aligned_cols=249 Identities=23% Similarity=0.355 Sum_probs=188.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||+||+|+++ +++.||||++..... .....+.+|+.+|++++||||+++++++.+++..++|||||+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~ 90 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 567789999999999999986 688999999976532 234568899999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec---CCCcEEEEeecCcccccCC
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~---~~~~vkL~DFGla~~~~~~ 757 (929)
+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+|+.....
T Consensus 91 gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 91 GGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp SCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred CCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999853 45789999999999999999999998 999999999999995 5789999999999865433
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||...... .+...+.. +... ....
T Consensus 164 ~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~i~~----~~~~--~~~~ 231 (307)
T d1a06a_ 164 S--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA----KLFEQILK----AEYE--FDSP 231 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHT----TCCC--CCTT
T ss_pred C--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHhc----cCCC--CCCc
Confidence 2 233456999999999999999999999999999999999999999765422 12221111 1110 1111
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.... ....+.+++.+|++.||++|||+.|+++|
T Consensus 232 ~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 232 YWDD----ISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccC----CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1112 22457899999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=395.83 Aligned_cols=257 Identities=21% Similarity=0.334 Sum_probs=197.0
Q ss_pred HHHHhccccccCcEEEEEEEECC----CcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~----~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
.+.+.+.||+|+||+||+|++.. +..||||+++... ....+.|.+|+++|++++||||+++++++. .+..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 45567899999999999998753 3468899886543 333567999999999999999999999996 46789999
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
||+++|+|.+++.. ....+++..++.++.||++||.|||++ +|+||||||+||+++.++.+||+|||+|+....
T Consensus 87 E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 87 ELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp ECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence 99999999988753 245689999999999999999999998 999999999999999999999999999987655
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
..........||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+...+. .+....
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~----~~~~~i~----~~~~~~--- 229 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIE----NGERLP--- 229 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHH----TTCCCC---
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH----HHHHHHH----cCCCCC---
Confidence 44444555678999999999999999999999999999999998 89999765522 2222221 111111
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhHh
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE 882 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~~ 882 (929)
.+......+.+++.+|++.||++|||+.||+++|+.+++.+
T Consensus 230 ------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 230 ------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11122346889999999999999999999999999987543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-45 Score=398.44 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=199.0
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc---hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~---~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
.|...+.||+|+||+||+|++. +++.||||+++..... ..+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 3555788999999999999976 6888999999765432 23568899999999999999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
||.+|+|..++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999999976653 345789999999999999999999998 9999999999999999999999999999864332
Q ss_pred CCceeeeeecCccccCcccccc---CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~---~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
....||+.|||||++.+ ..++.++|||||||++|||++|+.||......+ ... .... +......
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~----~~~---~i~~-~~~~~~~ 235 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALY---HIAQ-NESPALQ 235 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHH---HHHH-SCCCCCS
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH----HHH---HHHh-CCCCCCC
Confidence 23569999999999864 468999999999999999999999997544111 111 1111 1111111
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
+ ..+ ...+.+++.+|++.||++|||+.|+++|
T Consensus 236 ~----~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 236 S----GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp C----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C----CCC----CHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1 112 2368899999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-44 Score=403.45 Aligned_cols=250 Identities=21% Similarity=0.341 Sum_probs=206.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
|.+.+.||+|+||+||+|++. +|+.||||+++.........+.+|+++|++++||||+++++++.+++..++|||||++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 567789999999999999986 6899999999876656667889999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec--CCCcEEEEeecCcccccCCCC
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~--~~~~vkL~DFGla~~~~~~~~ 759 (929)
|+|.+++.. ....+++.+++.++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.....
T Consensus 111 g~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 111 GELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred ChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 999887743 245689999999999999999999998 999999999999998 5789999999999876543
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+.. +... ......
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~i~~----~~~~--~~~~~~ 252 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKR----CDWE--FDEDAF 252 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHH----CCCC--CCSSTT
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHh----CCCC--CCcccc
Confidence 2344567999999999999999999999999999999999999999765421 12221111 1110 111111
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.. ....+.+++.+|++.||++|||+.|+++|
T Consensus 253 ~~----~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 253 SS----VSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 22457899999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=393.56 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=203.3
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc------chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~------~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
.|.+.+.||+|+||+||+|+++ +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4567789999999999999986 689999999975422 235679999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC----cEEEEeecC
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGL 750 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkL~DFGl 750 (929)
|||||++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 91 v~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 91 ILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999853 45789999999999999999999998 999999999999998776 599999999
Q ss_pred cccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCc
Q 002382 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 830 (929)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 830 (929)
|+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +...+ ..+..
T Consensus 164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i----~~~~~ 233 (293)
T d1jksa_ 164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANV----SAVNY 233 (293)
T ss_dssp CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH----HTTCC
T ss_pred hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH----HHHHH----HhcCC
Confidence 98654332 2334568999999999999999999999999999999999999997654211 11111 11110
Q ss_pred ccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 831 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 831 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.............+.+++.+|++.||++|||++|+++|
T Consensus 234 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 ------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001111122357899999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=384.96 Aligned_cols=248 Identities=29% Similarity=0.448 Sum_probs=196.8
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeee-cCeEEEEEEeccCC
Q 002382 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEFMHNG 682 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~-~~~~~LV~E~~~~g 682 (929)
.+.+.||+|+||.||+|+++ |+.||||+++... ..+.|.+|++++++++||||++++|+|.+ .+..++||||+++|
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 35688999999999999996 7899999996543 34679999999999999999999999855 45689999999999
Q ss_pred chhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCcee
Q 002382 683 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 762 (929)
Q Consensus 683 sL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 762 (929)
+|.++|... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 87 ~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~ 157 (262)
T d1byga_ 87 SLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 157 (262)
T ss_dssp EHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----C
Confidence 999999642 234589999999999999999999998 9999999999999999999999999999864332 2
Q ss_pred eeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCcccccCCcccCc
Q 002382 763 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 841 (929)
Q Consensus 763 ~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 841 (929)
....+|+.|+|||++.++.++.++|||||||++|||+| |+.||..... .++..++.. +.. ..
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~----~~~~~~i~~----~~~---------~~ 220 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRVEK----GYK---------MD 220 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHHHHHTT----TCC---------CC
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH----HHHHHHHHc----CCC---------CC
Confidence 33458999999999999999999999999999999998 6887765442 233333221 111 11
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 842 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 842 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.+.....++.+++.+|++.||++||||.||+++|+++..
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 122223468899999999999999999999999998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=394.75 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=197.0
Q ss_pred HHHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCC-cchhHHHHHHHHHhccc-CCCceeEEeeeeeec-Ce
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-GR 671 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~-~~ 671 (929)
..+.+.+.||+|+||+||+|++. +++.||||+++... ....+.+.+|+.++.++ +|+||+.+++++... ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 34567789999999999999864 24689999997543 33456678888888777 789999999998654 46
Q ss_pred EEEEEEeccCCchhhhhccccc------------cccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 739 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 739 (929)
.++|||||++|+|.++++.... ....+++..++.++.||++||+|||++ +|+||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 8999999999999999964321 134588999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCC-CCCccccccccchhh
Q 002382 740 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFGANCRNI 817 (929)
Q Consensus 740 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~-~p~~~~~~~~~~~~l 817 (929)
++++||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|. .||......+ .+
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~---~~ 246 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EF 246 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---HH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH---HH
Confidence 999999999999865443332 334567999999999999999999999999999999999975 5776544221 12
Q ss_pred HHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 818 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 818 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
... ...+.... . +......+.+++.+|++.||++|||+.||+++|+++++
T Consensus 247 ~~~----~~~~~~~~-----~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 247 CRR----LKEGTRMR-----A----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHH----HHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----HhcCCCCC-----C----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 221 12221111 1 11123468899999999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=393.51 Aligned_cols=246 Identities=23% Similarity=0.313 Sum_probs=203.6
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||+||+|+.+ +|+.||||++++.. ....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 446789999999999999986 68999999997542 22346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
|++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.+|.+||+|||+|+......
T Consensus 87 ~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 87 ANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp CTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999884 356788999999999999999999998 99999999999999999999999999998654322
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+.+.. ..+.+ .+
T Consensus 160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~----~~~~~i----~~~~~------~~ 224 (337)
T d1o6la_ 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELI----LMEEI------RF 224 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH----HHCCC------CC
T ss_pred -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH----HHHHHH----hcCCC------CC
Confidence 2334567999999999999999999999999999999999999999865522 222211 11111 11
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCCc-----HHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 874 (929)
.... ...+.+++.+|++.||++||+ +.|+++|
T Consensus 225 p~~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 225 PRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CccC----CHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1122 235789999999999999995 8888876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=393.34 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=200.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCc----EEEEEEeecC-CcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 676 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~----~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~ 676 (929)
|.+.+.||+|+||+||+|++. +|+ +||||+++.. .....++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 445689999999999999876 343 5899988654 344567899999999999999999999999865 567889
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
|++.+|+|.+++.. ....+++..++.++.||++||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 90 e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 90 QLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp ECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 99999999988753 345689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 757 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 757 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
.... ......||+.|+|||++.++.++.++|||||||++|||+| |..||...... .+...+.. +..
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~----~~~~~i~~----~~~---- 231 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILEK----GER---- 231 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG----GHHHHHHH----TCC----
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH----HHHHHHHc----CCC----
Confidence 4333 2334568999999999999999999999999999999998 78888765422 22222211 110
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
...+......+.+++.+|++.+|++|||+.||+++|+.+..
T Consensus 232 -----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 232 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 01112223468899999999999999999999999988754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-44 Score=391.52 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=205.9
Q ss_pred HHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCc-chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
+.+.+.||+|+||+||+|+++ +++.||||+++.... ...++|.+|+++|++++||||++++++|...+..++|
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 346789999999999999874 357899999975533 3356799999999999999999999999999999999
Q ss_pred EEeccCCchhhhhcccc--------------------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCe
Q 002382 676 YEFMHNGTLKEHLYGTL--------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 735 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~--------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NI 735 (929)
|||+++|+|.++++... .....+++..++.++.|++.||+|||++ +|+||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence 99999999999985421 1223478999999999999999999998 999999999999
Q ss_pred EecCCCcEEEEeecCcccccCCC-CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCC-CCCcccccccc
Q 002382 736 LLDKHMRAKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFGAN 813 (929)
Q Consensus 736 Ll~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~-~p~~~~~~~~~ 813 (929)
|++.++.+||+|||+|+...... ........||+.|+|||.+.+..++.++|||||||++|||++|. +||.....
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~--- 248 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH--- 248 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH---
Confidence 99999999999999998554332 22334556899999999999999999999999999999999986 56765442
Q ss_pred chhhHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhH
Q 002382 814 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 879 (929)
Q Consensus 814 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~ 879 (929)
..+...+ ..+.... .+......+.+++.+||+.+|++||||.||++.|+++.
T Consensus 249 -~e~~~~v----~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 -EEVIYYV----RDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp -HHHHHHH----HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -HHHHHHH----HcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1222222 2222211 11122346889999999999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=388.40 Aligned_cols=254 Identities=29% Similarity=0.447 Sum_probs=202.2
Q ss_pred HhccccccCcEEEEEEEECCC----cEEEEEEeecC-CcchhHHHHHHHHHhcccCCCceeEEeeeeee-cCeEEEEEEe
Q 002382 605 LEKKIGSGGFGVVYYGKLKDG----KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEF 678 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~~~----~~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~-~~~~~LV~E~ 678 (929)
+.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++||||++++|++.. ++..++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 357899999999999998642 25899999754 33445779999999999999999999999876 4688999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
|++|+|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred eecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999988643 44567888999999999999999998 99999999999999999999999999998654432
Q ss_pred Cc---eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC
Q 002382 759 SH---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 835 (929)
Q Consensus 759 ~~---~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 835 (929)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|..||...... .++..++. .+... ..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~---~~~~~~i~----~g~~~--~~ 255 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYLL----QGRRL--LQ 255 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHHH----TTCCC--CC
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH---HHHHHHHH----cCCCC--CC
Confidence 22 223356899999999999999999999999999999999988887643311 12233222 11111 11
Q ss_pred CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 836 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 836 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
+......+.+++.+||+.||++||+|.||+++|+.+..
T Consensus 256 -------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 256 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11123468899999999999999999999999998864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-43 Score=390.18 Aligned_cols=243 Identities=24% Similarity=0.379 Sum_probs=201.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 446789999999999999986 68999999997542 23356788999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+++|+|..++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 ~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 86 IEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred cCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 99999988874 345677888889999999999999998 9999999999999999999999999999865432
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. .+.. .+
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~--------~~~~------~~ 220 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--------NAEL------RF 220 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--------HCCC------CC
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH--------cCCC------CC
Confidence 234579999999999999999999999999999999999999997654222111111 1111 01
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
... ....+.+++.+|++.||++|| |++|+++|
T Consensus 221 p~~----~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 221 PPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCC----CCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111 223578999999999999996 89999887
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=387.08 Aligned_cols=267 Identities=22% Similarity=0.337 Sum_probs=201.0
Q ss_pred HHhccccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecC----eEEEEEEec
Q 002382 604 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVYEFM 679 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~----~~~LV~E~~ 679 (929)
.+.+.||+|+||+||+|+++ |+.||||+++.... .....+.|+..+.+++||||++++++|.+.+ ..++|||||
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 35688999999999999985 89999999864422 1222344666667889999999999997654 579999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCC-----CCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-----VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
++|+|.++|+. ..++|..++.++.|++.||+|||+.+ .++|+||||||+||||+.++++||+|||+++..
T Consensus 84 ~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 84 EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred cCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 99999999953 35889999999999999999999731 249999999999999999999999999999876
Q ss_pred cCCCCc---eeeeeecCccccCccccccC------cCCCcCceeeHHHHHHHHHhCCCCCccccccc-cch------hhH
Q 002382 755 VDGASH---VSSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGA-NCR------NIV 818 (929)
Q Consensus 755 ~~~~~~---~~~~~~gt~~Y~aPE~~~~~------~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~-~~~------~l~ 818 (929)
...... ......||+.|+|||++.+. .++.++|||||||++|||+||..|+......+ ... ...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 554332 22346799999999998754 35678999999999999999998875432111 000 011
Q ss_pred HHHHHhhhcCCcccccCCcccCcc-CHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 819 QWAKLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 819 ~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
......... ..+++.+.... ..+....+.+++.+||+.||++||||.||+++|+++...
T Consensus 239 ~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 239 EEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 111111111 11223332222 345667799999999999999999999999999987643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-43 Score=382.84 Aligned_cols=256 Identities=24% Similarity=0.358 Sum_probs=198.7
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHHHHHHhcccCCCceeEEeeeeeecC----eEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVL 674 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~----~~~L 674 (929)
|.+.+.||+|+||+||+|++. +++.||||+++.... .....+.+|++++++++||||+++++++...+ ..++
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 556789999999999999975 689999999976533 23456899999999999999999999987654 3789
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
||||+++++|.+++. ....+++.+++.++.||++||+|||++ +|+||||||+|||++.++..+|+|||.++..
T Consensus 89 vmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence 999999999998874 345789999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCC--ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 755 VDGAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 755 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ........+....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVREDPIPP 234 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCCCCG
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-------HHHHHHhcCCCCC
Confidence 33222 23344579999999999999999999999999999999999999997654211 1112222221110
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCC-cHHHHHHHHHHhH
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAI 879 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~eVl~~L~~~~ 879 (929)
...... ....+.+++.+|++.||++|| |++|+++.|.++.
T Consensus 235 ---~~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 235 ---SARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---GGTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---chhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 001111 224688999999999999999 8999999888753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=382.98 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=193.8
Q ss_pred HHHhccccccCcEEEEEEEEC--CC--cEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK--DG--KEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~--~~--~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
+.+.+.||+|+||+||+|++. ++ ..||||++.... ....++|.+|+.+|++++||||++++|+|.++ ..++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chhee
Confidence 346688999999999999864 22 368999987542 33356799999999999999999999999764 67899
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
|||+++|++.+++.. ....+++..++.++.|+++||.|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 89 ~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 89 TELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 999999999988753 345689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCce--eeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhhHHHHHHhhhcCCccc
Q 002382 756 DGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG 832 (929)
Q Consensus 756 ~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 832 (929)
...... .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||...... .+..++. ..+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~----~~~~~i~---~~~~~~- 234 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKID---KEGERL- 234 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHH---TSCCCC-
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH----HHHHHHH---hCCCCC-
Confidence 443322 234558889999999999999999999999999999998 89999765422 2223222 111111
Q ss_pred ccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHh
Q 002382 833 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 878 (929)
Q Consensus 833 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~ 878 (929)
..+......+.+++.+||+.||++||||.||.+.|++.
T Consensus 235 --------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11112224688999999999999999999999988764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=388.53 Aligned_cols=261 Identities=25% Similarity=0.379 Sum_probs=209.1
Q ss_pred HHHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCCc-chhHHHHHHHHHhccc-CCCceeEEeeeeeecCeE
Q 002382 601 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS 672 (929)
Q Consensus 601 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~ 672 (929)
..+.+.+.||+|+||.||+|++. +++.||||+++.... ....+|.+|+.+++++ +|||||+++++|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 34557789999999999999863 456899999976543 3455789999999999 699999999999999999
Q ss_pred EEEEEeccCCchhhhhcccc--------------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEec
Q 002382 673 VLVYEFMHNGTLKEHLYGTL--------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD 738 (929)
Q Consensus 673 ~LV~E~~~~gsL~~~L~~~~--------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~ 738 (929)
++|||||++|+|.++++... .....+++..+..++.||++||+|||++ +++||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 99999999999999986432 1233588999999999999999999998 999999999999999
Q ss_pred CCCcEEEEeecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchh
Q 002382 739 KHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRN 816 (929)
Q Consensus 739 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~ 816 (929)
.++.+|++|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+| |.+|+......+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--- 256 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 999999999999987655433 33345679999999999999999999999999999999999 5555554432221
Q ss_pred hHHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 817 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 817 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
+.+.+..... ...+......+.+|+.+|++.||++||||.||++.|++.+.
T Consensus 257 ~~~~i~~~~~-------------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 257 FYKMIKEGFR-------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHHHHHTCC-------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCC-------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 2222211110 11111223468899999999999999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.7e-43 Score=377.52 Aligned_cols=249 Identities=27% Similarity=0.306 Sum_probs=200.8
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc---------hhHHHHHHHHHhcccC-CCceeEEeeeeeecCe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---------GKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR 671 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~---------~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~ 671 (929)
|.+.+.||+|+||+||+|++. +++.||||+++..... ..+.+.+|+.++++++ ||||+++++++.+++.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 446789999999999999985 6889999999765321 1235889999999997 9999999999999999
Q ss_pred EEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCc
Q 002382 672 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 751 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 751 (929)
.++||||+++|+|.+++. ....+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 85 ~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp EEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 999999999999999995 345789999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCceeeeeecCccccCcccccc------CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh
Q 002382 752 KFAVDGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 752 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
+...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....... +.+. .
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~----~~~~----i 227 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----MLRM----I 227 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----H
T ss_pred eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH----HHHH----H
Confidence 8765432 2334569999999999864 346789999999999999999999998654211 1111 1
Q ss_pred hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 826 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+... .. .........++.+++.+|++.+|++|||+.||++|
T Consensus 228 ~~~~~~--~~----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGNYQ--FG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTCCC--CC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhCCCC--CC----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111110 00 00111122468899999999999999999999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=388.03 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=202.0
Q ss_pred HHhccccccCcEEEEEEEECC-Cc--EEEEEEeecC-CcchhHHHHHHHHHhccc-CCCceeEEeeeeeecCeEEEEEEe
Q 002382 604 MLEKKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~~-~~--~vAVK~l~~~-~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
.+.+.||+|+||+||+|++++ +. .||||+++.. .....+.|.+|+++|+++ +||||++++|+|.+.+..++||||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey 92 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence 357899999999999998863 44 4788887644 334456799999999998 799999999999999999999999
Q ss_pred ccCCchhhhhcccc------------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEE
Q 002382 679 MHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (929)
Q Consensus 679 ~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 746 (929)
+++|+|.++|+... .....+++..+..++.||++||.|||++ +|+||||||+|||++.++.+||+
T Consensus 93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEc
Confidence 99999999996531 2346789999999999999999999998 99999999999999999999999
Q ss_pred eecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCC-CCccccccccchhhHHHHHHhh
Q 002382 747 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE-AISNEKFGANCRNIVQWAKLHI 825 (929)
Q Consensus 747 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~-p~~~~~~~~~~~~l~~~~~~~~ 825 (929)
|||+++...... ......||..|+|||.+....++.++|||||||++|||++|.. ||..... ..+.+.+.
T Consensus 170 DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~----~~~~~~i~--- 240 (309)
T d1fvra_ 170 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEKLP--- 240 (309)
T ss_dssp CTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHGG---
T ss_pred cccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH----HHHHHHHH---
Confidence 999997543222 2233458999999999999999999999999999999999764 6654432 22222221
Q ss_pred hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 826 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 826 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
++.. ...+......+.+++.+|++.||++||||+||+++|++++.
T Consensus 241 -~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 241 -QGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp -GTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111 11111223468899999999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-44 Score=388.48 Aligned_cols=259 Identities=25% Similarity=0.429 Sum_probs=205.0
Q ss_pred HHHHhccccccCcEEEEEEEECC--------CcEEEEEEeecCCc-chhHHHHHHHHHhccc-CCCceeEEeeeeeecCe
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR 671 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~~--------~~~vAVK~l~~~~~-~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~~~~ 671 (929)
.+.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +||||++++++|.+++.
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 45567899999999999998642 24799999976543 3357788899999888 89999999999999999
Q ss_pred EEEEEEeccCCchhhhhcccc------------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC
Q 002382 672 SVLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 739 (929)
Q Consensus 672 ~~LV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~ 739 (929)
.++||||+++|+|.++|.... .....+++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence 999999999999999996442 1235689999999999999999999998 9999999999999999
Q ss_pred CCcEEEEeecCcccccCCCC-ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHh-CCCCCccccccccchhh
Q 002382 740 HMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI 817 (929)
Q Consensus 740 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l 817 (929)
++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||++ |..||..... ..+
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~----~~~ 246 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----EEL 246 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHH
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH----HHH
Confidence 99999999999986654332 23344568999999999999999999999999999999998 7888875442 222
Q ss_pred HHHHHHhhhcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 818 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 818 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.+.+ ..+.... .+......+.+++.+|++.+|++|||+.||++.|++++.
T Consensus 247 ~~~i----~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 FKLL----KEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHH----HTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH----HcCCCCC---------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 2222 2221111 111122468899999999999999999999999999865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=378.46 Aligned_cols=259 Identities=21% Similarity=0.216 Sum_probs=194.6
Q ss_pred ccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc-----hhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 607 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~-----~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
++||+|+||+||+|+++ +|+.||||+++..... ..+.+.+|+.+|++++||||+++++++..++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 67999999999999986 6899999998654321 13468899999999999999999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
++++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+........
T Consensus 84 ~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 84 TDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred chHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 887766552 345688899999999999999999998 9999999999999999999999999999865443322
Q ss_pred eeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccC---C
Q 002382 761 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID---P 836 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d---~ 836 (929)
.....||+.|+|||++... .++.++|||||||++|||++|+.||......+....+.+...... ......... .
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~-~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLPDY 234 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC-TTTSSSTTSSTTC
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCC-hhhccchhccchh
Confidence 2335699999999998754 578999999999999999999999976542211111211110000 000000000 0
Q ss_pred ---cccCccC-----HHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 ---SLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ---~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
......+ ......+.+++.+|++.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000111 1122468899999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-43 Score=388.79 Aligned_cols=243 Identities=23% Similarity=0.295 Sum_probs=201.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEe
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF 678 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~ 678 (929)
|.+.+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+++|+.++||||+++++++.+....++||||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence 456689999999999999986 68999999987532 22345688999999999999999999999999999999999
Q ss_pred ccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCC
Q 002382 679 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 758 (929)
Q Consensus 679 ~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 758 (929)
+.+|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 123 ~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 123 VAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp CTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 999999998843 45689999999999999999999998 9999999999999999999999999999865432
Q ss_pred CceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCcc
Q 002382 759 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 838 (929)
Q Consensus 759 ~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 838 (929)
.....||+.|||||++.+..++.++|||||||++|||++|+.||...... .+...+. .+.. ..
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~i~----~~~~------~~ 257 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----QIYEKIV----SGKV------RF 257 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH----HCCC------CC
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH----HHHHHHh----cCCC------CC
Confidence 23456999999999999999999999999999999999999999765421 1111111 1111 01
Q ss_pred cCccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 839 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 839 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
... ....+.+++.+|++.||++|+ |++|+++|
T Consensus 258 p~~----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 258 PSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred Ccc----CCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 111 223578999999999999994 89999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-43 Score=384.21 Aligned_cols=249 Identities=19% Similarity=0.309 Sum_probs=202.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEeccC
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 681 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~~ 681 (929)
|.+.+.||+|+||+||+|+++ +++.||||+++... .....+.+|+++|++++||||+++++++.+++..++|||||++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 456789999999999999987 68899999997654 3345688999999999999999999999999999999999999
Q ss_pred CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC--CcEEEEeecCcccccCCCC
Q 002382 682 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 682 gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~--~~vkL~DFGla~~~~~~~~ 759 (929)
|+|.+++... ...+++.++..++.||++||+|||++ +|+||||||+|||++.+ ..+||+|||+++.....
T Consensus 86 g~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 86 LDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 9999998532 34689999999999999999999998 99999999999999854 58999999999865433
Q ss_pred ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCccc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 839 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 839 (929)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||......+....+.. +... ++....
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~--------~~~~--~~~~~~ 227 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN--------AEYT--FDEEAF 227 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--------TCCC--CCHHHH
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------CCCC--CChhhc
Confidence 233456699999999999999999999999999999999999999976552221111111 1100 010001
Q ss_pred CccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 840 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 840 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... ...+.+++.+|++.||++|||+.|+++|
T Consensus 228 ~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 228 KEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 2357899999999999999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=386.10 Aligned_cols=259 Identities=24% Similarity=0.401 Sum_probs=207.3
Q ss_pred HHHHhccccccCcEEEEEEEEC------CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 674 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~L 674 (929)
.+.+.+.||+|+||+||+|.++ +++.||||+++... ......|.+|++++++++||||++++++|...+..++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence 3456789999999999999874 25789999997553 3334568999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhcccc------ccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEee
Q 002382 675 VYEFMHNGTLKEHLYGTL------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 748 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 748 (929)
||||+++|+|.+++.... .....+++..+..++.|+++||.|||++ +|+||||||+|||++.++++||+||
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeec
Confidence 999999999999985431 1123468889999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCc-eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCC-CCCccccccccchhhHHHHHHhhh
Q 002382 749 GLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFGANCRNIVQWAKLHIE 826 (929)
Q Consensus 749 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~-~p~~~~~~~~~~~~l~~~~~~~~~ 826 (929)
|+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+||. .||...... .+...+ .
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~----~~~~~i----~ 249 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVLRFV----M 249 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----HHHHHH----H
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----H
Confidence 999865443222 233446899999999999999999999999999999999985 667654321 222211 1
Q ss_pred cCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 827 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 827 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
++..... +......+.+++.+|++.+|++||||.||+++|++.++
T Consensus 250 ~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2211111 11122468899999999999999999999999988754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=385.55 Aligned_cols=246 Identities=24% Similarity=0.369 Sum_probs=199.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC---cchhHHHHHHHHHhc-ccCCCceeEEeeeeeecCeEEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLS-RIHHRNLVQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~---~~~~~~f~~Ev~iL~-~l~HpNIv~l~g~~~~~~~~~LV~E 677 (929)
|.+.+.||+|+||+||+|+++ +++.||||++++.. ....+.+..|..++. .++||||+++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 446789999999999999987 68899999997542 222345666776665 6899999999999999999999999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 757 (929)
|+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.....
T Consensus 84 y~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 84 YLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp CCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999985 345688999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCCc
Q 002382 758 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 837 (929)
Q Consensus 758 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 837 (929)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+. .+.. .
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i~----~~~~------~ 221 (320)
T d1xjda_ 157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIR----MDNP------F 221 (320)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH----HCCC------C
T ss_pred c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHH----cCCC------C
Confidence 2 2334456999999999999999999999999999999999999999765421 2222111 1111 1
Q ss_pred ccCccCHHHHHHHHHHHHHccCCCCCCCCcHH-HHHHH
Q 002382 838 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD 874 (929)
Q Consensus 838 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-eVl~~ 874 (929)
+... ....+.+++.+|++.||++||++. |+++|
T Consensus 222 ~p~~----~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 222 YPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp CCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCcc----CCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 1111 223578999999999999999995 77654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.5e-42 Score=386.92 Aligned_cols=247 Identities=25% Similarity=0.325 Sum_probs=196.1
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc---chhHHHHH---HHHHhcccCCCceeEEeeeeeecCeEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTN---EVTLLSRIHHRNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~---~~~~~f~~---Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV 675 (929)
|.+.+.||+|+||+||+|++. +|+.||||++..... .....+.+ |+++++.++||||+++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 346789999999999999987 689999999864321 12233333 47778888999999999999999999999
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 755 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 755 (929)
|||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 mE~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 86 LDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp ECCCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEecCCCcHHHHHH----hcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 99999999999984 345678899999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCccccc
Q 002382 756 DGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 834 (929)
Q Consensus 756 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 834 (929)
... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ...+.+ ... ...
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~---~~~-~~~----- 225 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDR---MTL-TMA----- 225 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-HHHHHH---HSS-SCC-----
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH---hcc-cCC-----
Confidence 432 234569999999999975 568999999999999999999999997654221 111111 111 110
Q ss_pred CCcccCccCHHHHHHHHHHHHHccCCCCCCCCc-----HHHHHHH
Q 002382 835 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD 874 (929)
Q Consensus 835 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eVl~~ 874 (929)
..+.... ...+.+++.+|++.||++||| ++|+++|
T Consensus 226 -~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 226 -VELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -CCCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -CCCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1111122 235789999999999999999 6888876
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-42 Score=379.56 Aligned_cols=247 Identities=22% Similarity=0.255 Sum_probs=193.6
Q ss_pred hccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhccc-CCCceeEEeeeeee----cCeEEEEEEec
Q 002382 606 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE----EGRSVLVYEFM 679 (929)
Q Consensus 606 ~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l-~HpNIv~l~g~~~~----~~~~~LV~E~~ 679 (929)
.+.||+|+||+||+|++. +++.||||+++. ...+.+|++++.++ +||||+++++++.+ ....++|||||
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 356999999999999985 689999999864 34577899887654 89999999999865 46689999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC---CCcEEEEeecCcccccC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DFGla~~~~~ 756 (929)
++|+|.++|... ....+++.++..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+|+....
T Consensus 92 ~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 92 DGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp CSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccC
Confidence 999999999642 235699999999999999999999998 9999999999999985 56799999999986554
Q ss_pred CCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccccCC
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 836 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 836 (929)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. .....+..
T Consensus 167 ~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~----~~i~~~~~------ 234 (335)
T d2ozaa1 167 HNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----TRIRMGQY------ 234 (335)
T ss_dssp CCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCSS------
T ss_pred CCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH----HHHhcCCC------
Confidence 332 334569999999999999999999999999999999999999997654221111111 11111110
Q ss_pred cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 837 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 837 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
.+...........+.+++.+|++.||++|||+.|+++|
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000111223468899999999999999999999885
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-42 Score=373.02 Aligned_cols=263 Identities=21% Similarity=0.260 Sum_probs=195.4
Q ss_pred HHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 604 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 604 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
.+.+.||+|+||+||+|++. +++.||||+++.... .....+.+|+++|++++||||+++++++.+++..++||||+.
T Consensus 5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~ 84 (298)
T d1gz8a_ 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 84 (298)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC
Confidence 45688999999999999985 689999999965432 235678999999999999999999999999999999999997
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
++.+ +++.. .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 85 ~~~~-~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 85 QDLK-KFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp EEHH-HHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred Cchh-hhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 6544 44422 2345689999999999999999999998 99999999999999999999999999998654432 2
Q ss_pred eeeeeecCccccCccccccCc-CCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc------
Q 002382 761 VSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI------ 833 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~~-~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~------ 833 (929)
......||+.|+|||.+.... ++.++||||+||++|||++|+.||......+....+...... ..+......
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT-PDEVVWPGVTSMPDY 236 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTSTTGGGSTTC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCC-Cchhhcccccccccc
Confidence 333456999999999987655 578999999999999999999999754411111111110000 000000000
Q ss_pred ---cCCcccCc---cCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 834 ---IDPSLLDE---YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 834 ---~d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
........ ........+.+++.+|++.||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000 001112467899999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-41 Score=369.97 Aligned_cols=264 Identities=20% Similarity=0.252 Sum_probs=198.0
Q ss_pred HHHhccccccCcEEEEEEEECCCcEEEEEEeecCCc--chhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~--~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.++||+|+||+||+|++++|+.||||+++.... ...+.+.+|+.+|++++||||+++++++...+..++++|++.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 345678999999999999999999999999976532 225678999999999999999999999999999999999998
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCCc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 760 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 760 (929)
++.+..+.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.|........
T Consensus 84 ~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 84 QDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp EEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred hhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 877766652 356799999999999999999999998 999999999999999999999999999986544322
Q ss_pred eeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh--------hcCCcc
Q 002382 761 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI--------ESGDIQ 831 (929)
Q Consensus 761 ~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~--------~~~~~~ 831 (929)
......|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+...++..-..... ......
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 23334589999999998754 568999999999999999999999976542211111111000000 000000
Q ss_pred ccc---CCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 832 GII---DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 832 ~~~---d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... .+.-...........+.+++.+|++.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0000011111122467899999999999999999999865
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=370.09 Aligned_cols=243 Identities=22% Similarity=0.377 Sum_probs=196.1
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcc------hhHHHHHHHHHhcccC--CCceeEEeeeeeecCeE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRS 672 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~------~~~~f~~Ev~iL~~l~--HpNIv~l~g~~~~~~~~ 672 (929)
+|.+.+.||+|+||+||+|++. +++.||||+++..... ....+.+|+.+|++++ ||||+++++++.+++..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 3566789999999999999986 6899999998754211 1244678999999986 89999999999999999
Q ss_pred EEEEEeccC-CchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCC-CcEEEEeecC
Q 002382 673 VLVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGL 750 (929)
Q Consensus 673 ~LV~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGl 750 (929)
++||||+.+ +++.+++. ....+++..+..++.|+++||+|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 85 ~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 999999976 56767663 345789999999999999999999998 99999999999999854 7999999999
Q ss_pred cccccCCCCceeeeeecCccccCccccccCcC-CCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 751 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 751 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
|+..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+.+ +.
T Consensus 158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~--------~~ 220 (273)
T d1xwsa_ 158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--------GQ 220 (273)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--------CC
T ss_pred ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh--------cc
Confidence 9865332 2334569999999999987765 567899999999999999999997532 1111 11
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH--HHHh
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 878 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~--L~~~ 878 (929)
. .+....+ .++.+++.+|++.||++|||++|+++| ++++
T Consensus 221 ~------~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 221 V------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp C------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred c------CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 0 0111222 357899999999999999999999986 5544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=369.99 Aligned_cols=265 Identities=20% Similarity=0.268 Sum_probs=195.6
Q ss_pred HHHHhccccccCcEEEEEEEEC-C-CcEEEEEEeecCC--cchhHHHHHHHHHhccc---CCCceeEEeeeeee-----c
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-D-GKEIAVKVLTSNS--YQGKREFTNEVTLLSRI---HHRNLVQFLGYCQE-----E 669 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~-~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l---~HpNIv~l~g~~~~-----~ 669 (929)
.|.+.+.||+|+||+||+|++. + ++.||||+++... ......+.+|+.+|+.+ +||||++++++|.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 3556789999999999999984 4 5679999986542 22234567888887766 79999999999853 3
Q ss_pred CeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeec
Q 002382 670 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 749 (929)
Q Consensus 670 ~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 749 (929)
...+++|||+.++.+..... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 46799999999887754432 2345688999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcC-
Q 002382 750 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG- 828 (929)
Q Consensus 750 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~- 828 (929)
+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+.+.........
T Consensus 162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 98754322 233456699999999999999999999999999999999999999976542222222222111100000
Q ss_pred ----CcccccC----CcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 829 ----DIQGIID----PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 829 ----~~~~~~d----~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....... ..............+.+++.+|++.||++|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 000001111222457889999999999999999999886
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-40 Score=360.22 Aligned_cols=265 Identities=18% Similarity=0.251 Sum_probs=193.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeee--------cC
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--------EG 670 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~--------~~ 670 (929)
+|.+.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++||||+++++++.. .+
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 3456789999999999999986 78999999986442 2335678899999999999999999998854 34
Q ss_pred eEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecC
Q 002382 671 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 750 (929)
Q Consensus 671 ~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 750 (929)
..++||||+.++.+.... .....++...+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred eEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecce
Confidence 679999999888776554 2345678888999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCC---ceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhh
Q 002382 751 SKFAVDGAS---HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 826 (929)
Q Consensus 751 a~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 826 (929)
++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||......+....+.+.... ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~-~~ 242 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-IT 242 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC-CC
Confidence 976543221 122334699999999998765 6889999999999999999999999754422111122221111 00
Q ss_pred cCCcccc--------cCCcccCccCHH-------HHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 827 SGDIQGI--------IDPSLLDEYDIQ-------SMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 827 ~~~~~~~--------~d~~l~~~~~~~-------~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
....... +........... ....+.+++.+|++.||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000 000000011111 12356789999999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-40 Score=365.52 Aligned_cols=266 Identities=21% Similarity=0.238 Sum_probs=194.5
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCceeEEeeeeeec------CeEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSVLV 675 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~------~~~~LV 675 (929)
|...++||+|+||+||+|++. +|+.||||+++.... ...+|+++|++++||||+++++++... .+.++|
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 334578999999999999986 689999999975432 234799999999999999999998543 357899
Q ss_pred EEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC-cEEEEeecCcccc
Q 002382 676 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFA 754 (929)
Q Consensus 676 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~ 754 (929)
|||++++.+. .+.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 98 ~Ey~~~~~~~-~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 98 LDYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EECCSEEHHH-HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EeccCCccHH-HHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999866443 3332223456789999999999999999999998 999999999999999775 8999999999866
Q ss_pred cCCCCceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHH--------HHHhh
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW--------AKLHI 825 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~--------~~~~~ 825 (929)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+... .....
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 44322 233569999999998875 57899999999999999999999999765422211111110 00000
Q ss_pred ---hcCCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH--HHHh
Q 002382 826 ---ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 878 (929)
Q Consensus 826 ---~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~--L~~~ 878 (929)
........................+.+++.+|++.||++|||+.|+++| ++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0001111111111111111223457899999999999999999999986 5443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-39 Score=355.33 Aligned_cols=259 Identities=21% Similarity=0.271 Sum_probs=196.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCce-eEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNI-v~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||+||+|++. +++.||||++..... ..++..|+++++.++|+|+ +.+.++..+.+..++||||+.
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~ 86 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence 567789999999999999986 688999999875432 3468899999999977665 455556677888899999995
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC---CCcEEEEeecCcccccCC
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDG 757 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DFGla~~~~~~ 757 (929)
++|.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++. +..+||+|||+|+.....
T Consensus 87 -~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 87 -PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp -CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred -Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 556555532 345689999999999999999999998 9999999999999863 557999999999876543
Q ss_pred CCc------eeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 758 ASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 758 ~~~------~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+..+....... ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~ 238 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PIE 238 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-CHH
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-Chh
Confidence 321 2234579999999999999999999999999999999999999997655333222232222221110 000
Q ss_pred cccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHh
Q 002382 832 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV 880 (929)
Q Consensus 832 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~ 880 (929)
.+... ...++.+++..|++.+|++||++.++.+.|+.+..
T Consensus 239 -----~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 239 -----VLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -----HHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -----HhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 01111 22468899999999999999999999999988754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.6e-39 Score=350.19 Aligned_cols=260 Identities=17% Similarity=0.239 Sum_probs=204.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccCC-CceeEEeeeeeecCeEEEEEEecc
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEFMH 680 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~H-pNIv~l~g~~~~~~~~~LV~E~~~ 680 (929)
|.+.+.||+|+||+||+|++. +|+.||||++.... ....+.+|++.++.++| +|++.+++++......++||||+
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 556789999999999999976 68899999986543 23457889999999865 89999999999999999999999
Q ss_pred CCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecC-----CCcEEEEeecCccccc
Q 002382 681 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFAV 755 (929)
Q Consensus 681 ~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~-----~~~vkL~DFGla~~~~ 755 (929)
+++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+...
T Consensus 84 ~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 6899888753 234688999999999999999999998 9999999999999974 5789999999998654
Q ss_pred CCCC------ceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCC
Q 002382 756 DGAS------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 829 (929)
Q Consensus 756 ~~~~------~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 829 (929)
.... .......||+.|||||.+.+..++.++|||||||++|||++|+.||.............. +........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~-i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-IGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-HHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH-HHhccCCCC
Confidence 3321 122345699999999999999999999999999999999999999976553222221111 111111111
Q ss_pred cccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHhHhH
Q 002382 830 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 881 (929)
Q Consensus 830 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 881 (929)
..+ +.... ..++.+++..|++.+|++||+++.+.+.|++++..
T Consensus 237 ~~~-----l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 237 LRE-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HHH-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred hHH-----hcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 111 11112 24688899999999999999999999999887653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-39 Score=350.57 Aligned_cols=261 Identities=19% Similarity=0.216 Sum_probs=199.4
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecCeEEEEEEec
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 679 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~~~~LV~E~~ 679 (929)
|.+.+.||+|+||+||+|++. +++.||||+++... ......+.+|+.+|++++||||+++++++.+....++|++++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 445689999999999999986 68899999997543 233567899999999999999999999999999999999999
Q ss_pred cCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccCCCC
Q 002382 680 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 759 (929)
Q Consensus 680 ~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 759 (929)
.+++|..++. ..+.+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||.++.......
T Consensus 84 ~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 84 DQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp SEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred cccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 9998887764 345678899999999999999999998 999999999999999999999999999986544332
Q ss_pred ceeeeeecCccccCccccccCc-CCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhc---CCc---cc
Q 002382 760 HVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---GDI---QG 832 (929)
Q Consensus 760 ~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~---~~~---~~ 832 (929)
......+++.|+|||.+.... ++.++||||+||++|||++|+.||..... .....+.+...... ... ..
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS---HHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC---HHHHHHHHHhhcCCCChhhhhhhhh
Confidence 223345788999999987655 68999999999999999999999753321 11111111111000 000 00
Q ss_pred ccC--------C-cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 833 IID--------P-SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 833 ~~d--------~-~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+ . .-...........+.+++.+|++.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0 00001111222467899999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=359.25 Aligned_cols=251 Identities=24% Similarity=0.306 Sum_probs=201.2
Q ss_pred HHHhccccccCcEEEEEEEEC----CCcEEEEEEeecCC----cchhHHHHHHHHHhcccCC-CceeEEeeeeeecCeEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSV 673 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~----~~~~vAVK~l~~~~----~~~~~~f~~Ev~iL~~l~H-pNIv~l~g~~~~~~~~~ 673 (929)
|.+.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 567789999999999999863 47899999986432 2234668899999999976 89999999999999999
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+.+|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 106 LILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999884 345667888899999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeeeeecCccccCccccccC--cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcc
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 831 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 831 (929)
.............|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+....+.+.... ...
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~----~~~- 253 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK----SEP- 253 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH----CCC-
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc----CCC-
Confidence 654444444556799999999999764 4678999999999999999999999876543333333332111 110
Q ss_pred cccCCcccCccCHHHHHHHHHHHHHccCCCCCCCC-----cHHHHHHH
Q 002382 832 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD 874 (929)
Q Consensus 832 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eVl~~ 874 (929)
. .+.....++.+++.+|++.||++|| |++|+++|
T Consensus 254 -----~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 254 -----P----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----C----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----C----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 1 1112234688999999999999999 47888875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-39 Score=357.74 Aligned_cols=262 Identities=21% Similarity=0.280 Sum_probs=190.3
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeecC------eEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV 673 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~------~~~ 673 (929)
|.+.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+ ..+
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence 445688999999999999986 68999999997542 233457889999999999999999999997654 569
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+ +.+|...+. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+|+.
T Consensus 100 lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceec
Confidence 999999 556766553 45689999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHh----hhc-
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH----IES- 827 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~----~~~- 827 (929)
.... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...........+....... ...
T Consensus 171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 5432 2345699999999998764 56899999999999999999999997644111111111100000 000
Q ss_pred ---------CCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH--HHHh
Q 002382 828 ---------GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA 878 (929)
Q Consensus 828 ---------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~--L~~~ 878 (929)
..+.+.....+. .........+.+++.+|++.||++|||+.|+++| ++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred cchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000000000000 0011112357799999999999999999999987 6554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-39 Score=358.07 Aligned_cols=262 Identities=21% Similarity=0.277 Sum_probs=191.2
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC-cchhHHHHHHHHHhcccCCCceeEEeeeeeecC----eEEEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVY 676 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~-~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~~----~~~LV~ 676 (929)
|.+.+.||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|+++|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 456789999999999999875 79999999997543 233567889999999999999999999986543 234555
Q ss_pred EeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccccC
Q 002382 677 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 756 (929)
Q Consensus 677 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 756 (929)
+++.+|+|.+++. ...+++..++.++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 90 ~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 90 THLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 6677999999984 34689999999999999999999998 999999999999999999999999999985543
Q ss_pred CCC--ceeeeeecCccccCcccccc-CcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhhhcCCcccc
Q 002382 757 GAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 833 (929)
Q Consensus 757 ~~~--~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 833 (929)
... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+....... .............
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG-ILGSPSQEDLNCI 240 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-HHCSCCHHHHHTC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhh-hccCCChhhhhhh
Confidence 222 12344569999999999854 5678899999999999999999999975442111110000 0000000000000
Q ss_pred ----------cCCcccCccC-----HHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 834 ----------IDPSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 834 ----------~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
..+. ....+ .....++.+++.+|++.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPH-KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCC-CCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCc-cCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00000 0111357899999999999999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-38 Score=351.75 Aligned_cols=258 Identities=18% Similarity=0.274 Sum_probs=193.5
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccC-CCceeEEeeeeee--cCeEEEEEE
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQE--EGRSVLVYE 677 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~--~~~~~LV~E 677 (929)
.|.+.++||+|+||+||+|++. +++.||||+++... .+.+.+|+++|++++ ||||+++++++.. ....++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 4567789999999999999985 68899999987432 467889999999995 9999999999874 456899999
Q ss_pred eccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC-cEEEEeecCcccccC
Q 002382 678 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD 756 (929)
Q Consensus 678 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~ 756 (929)
|+.+++|.... +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+....
T Consensus 113 ~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 99999987654 3578899999999999999999998 999999999999998655 699999999986544
Q ss_pred CCCceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccc-hhhHH---------HHHHhh
Q 002382 757 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANC-RNIVQ---------WAKLHI 825 (929)
Q Consensus 757 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~-~~l~~---------~~~~~~ 825 (929)
... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ..+.. |.....
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 322 2345689999999998765 4789999999999999999999999654311110 01111 100000
Q ss_pred hcC--CcccccCC--------cccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 826 ESG--DIQGIIDP--------SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 826 ~~~--~~~~~~d~--------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
... ........ ............++.+++.+|++.||++|||++|+++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00000000 00000111122467899999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=354.60 Aligned_cols=260 Identities=21% Similarity=0.281 Sum_probs=188.0
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeee------cCeEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRSV 673 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~------~~~~~ 673 (929)
|.+.++||+|+||+||+|++. +|+.||||+++... ......+.+|+.++++++||||+++++++.. ....+
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 455689999999999999987 68999999997653 2334568899999999999999999999854 36789
Q ss_pred EEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 674 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 674 LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
+||||+.++.+. .+. ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+|++|||+++.
T Consensus 99 iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 99 LVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 999999765554 332 3478899999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHH--------------
Q 002382 754 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ-------------- 819 (929)
Q Consensus 754 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~-------------- 819 (929)
.... .......||+.|+|||++.+..++.++||||+||+++||++|+.||...........+.+
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 4432 233445689999999999999999999999999999999999999975431111111111
Q ss_pred -HHHHhhhcC-C-----cccccCCcccC---ccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 820 -WAKLHIESG-D-----IQGIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 820 -~~~~~~~~~-~-----~~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
......... . ........... .........+.+++.+|++.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000011110 0 00011111111 1122344578899999999999999999999988
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-38 Score=349.23 Aligned_cols=259 Identities=20% Similarity=0.257 Sum_probs=190.9
Q ss_pred HHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCC--cchhHHHHHHHHHhcccCCCceeEEeeeeeec-----CeEEE
Q 002382 603 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL 674 (929)
Q Consensus 603 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~--~~~~~~f~~Ev~iL~~l~HpNIv~l~g~~~~~-----~~~~L 674 (929)
|.+.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|+++|++++||||+++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 556789999999999999976 68999999997553 23345788999999999999999999998533 34467
Q ss_pred EEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEEeecCcccc
Q 002382 675 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 754 (929)
Q Consensus 675 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 754 (929)
+++++.+|+|.+++. .+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++...
T Consensus 100 i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 100 LVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp EEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhccc
Confidence 778888999999884 34689999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCCceeeeeecCccccCccccccC-cCCCcCceeeHHHHHHHHHhCCCCCccccccccchhhHHHHHHhh---hc---
Q 002382 755 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI---ES--- 827 (929)
Q Consensus 755 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~---~~--- 827 (929)
.. ......||+.|+|||...+. .++.++|||||||++|||++|+.||...........+........ ..
T Consensus 172 ~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 172 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp TG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred Cc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 22 22345689999999987765 468899999999999999999999975442111111111100000 00
Q ss_pred --------CCcccccCCcccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHHHHH
Q 002382 828 --------GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 874 (929)
Q Consensus 828 --------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eVl~~ 874 (929)
......-...+.. ........+.+++.+|++.||++|||++|+++|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000000000000 001112357899999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.7e-35 Score=325.32 Aligned_cols=269 Identities=19% Similarity=0.263 Sum_probs=191.6
Q ss_pred HHHHhccccccCcEEEEEEEEC-CCcEEEEEEeecCCcchhHHHHHHHHHhcccC-----------CCceeEEeeeeee-
Q 002382 602 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----------HRNLVQFLGYCQE- 668 (929)
Q Consensus 602 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-----------HpNIv~l~g~~~~- 668 (929)
+|.+.++||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|+.+++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4677899999999999999986 689999999975432 2456788998888775 5789999988754
Q ss_pred -cCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCC------
Q 002382 669 -EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM------ 741 (929)
Q Consensus 669 -~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~------ 741 (929)
....+++++++..+........ ......+++..+..++.||+.||+|||+. .+|+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccc
Confidence 4566777777665543333221 13445678889999999999999999983 2899999999999998665
Q ss_pred cEEEEeecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHHHHHHHHhCCCCCccccccccc---hhhH
Q 002382 742 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC---RNIV 818 (929)
Q Consensus 742 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGvvl~elltG~~p~~~~~~~~~~---~~l~ 818 (929)
.++++|||.++..... .....||+.|+|||++....++.++||||+||+++||++|+.||......... ..+.
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 3999999999754322 23456999999999999999999999999999999999999999754321111 1111
Q ss_pred HHHHHhh-----------------hcCCcccccCCc----------ccCccCHHHHHHHHHHHHHccCCCCCCCCcHHHH
Q 002382 819 QWAKLHI-----------------ESGDIQGIIDPS----------LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV 871 (929)
Q Consensus 819 ~~~~~~~-----------------~~~~~~~~~d~~----------l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eV 871 (929)
..+.... ........+... ............+.+++.+|++.||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 1111100 000000000000 0112334566789999999999999999999999
Q ss_pred HHH--HHHh
Q 002382 872 LKD--IQDA 878 (929)
Q Consensus 872 l~~--L~~~ 878 (929)
++| +++.
T Consensus 326 L~Hp~f~~~ 334 (362)
T d1q8ya_ 326 VNHPWLKDT 334 (362)
T ss_dssp HTCGGGTTC
T ss_pred hcCcccCCC
Confidence 886 6544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=2.1e-21 Score=196.18 Aligned_cols=166 Identities=17% Similarity=0.147 Sum_probs=118.7
Q ss_pred HhccccccCcEEEEEEEECCCcEEEEEEeecCCcc------------------hhHHHHHHHHHhcccCCCceeEEeeee
Q 002382 605 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ------------------GKREFTNEVTLLSRIHHRNLVQFLGYC 666 (929)
Q Consensus 605 ~~~~IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~------------------~~~~f~~Ev~iL~~l~HpNIv~l~g~~ 666 (929)
+.++||+|+||+||+|+..+|++||||+++..... .......|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 46899999999999999989999999987632110 112345688899999999999887653
Q ss_pred eecCeEEEEEEeccCCchhhhhccccccccccchHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCeEecCCCcEEEE
Q 002382 667 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS 746 (929)
Q Consensus 667 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 746 (929)
..+++|||+++..+.+ ++......++.|++++|+|||++ +|+||||||+|||++++ .++|+
T Consensus 84 ----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred ----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 2379999998765433 33344567999999999999998 99999999999999865 58999
Q ss_pred eecCcccccCCCCceeeeeecCccccCccccccCcCCCcCceeeHHH
Q 002382 747 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGV 793 (929)
Q Consensus 747 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDVwSlGv 793 (929)
|||+|+...+........ ..... -.|. ..+.|+.++|+||..-
T Consensus 145 DFG~a~~~~~~~~~~~l~--rd~~~-~~~~-f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 145 DFPQSVEVGEEGWREILE--RDVRN-IITY-FSRTYRTEKDINSAID 187 (191)
T ss_dssp CCTTCEETTSTTHHHHHH--HHHHH-HHHH-HHHHHCCCCCHHHHHH
T ss_pred ECCCcccCCCCCcHHHHH--HHHHH-HHHH-HcCCCCCcccHHHHHH
Confidence 999997554322110000 00000 0011 2367888999999653
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.59 E-value=1.2e-16 Score=173.47 Aligned_cols=108 Identities=27% Similarity=0.312 Sum_probs=94.1
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
..|+++++.+.|.+|..+..+++|+.|++++|.+++.+|.+..+++|+.|+|++|+|+|.+|+.|++|++|+.|+|++|+
T Consensus 200 ~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~ 279 (313)
T d1ogqa_ 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279 (313)
T ss_dssp SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCc
Confidence 35666666777777777788888999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccc-cccceeccccCCcccccCC
Q 002382 499 LSGTVPSSL-LSKNVVLNYAGNINLHEGG 526 (929)
Q Consensus 499 l~g~~P~~l-~~~~~~l~~~~n~~lc~~~ 526 (929)
|+|.+|..- ++.+..+.+.+|+.+|+.+
T Consensus 280 l~g~iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 280 LCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp EEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred ccccCCCcccCCCCCHHHhCCCccccCCC
Confidence 999999642 4566778889999999875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.52 E-value=7.8e-15 Score=158.80 Aligned_cols=143 Identities=30% Similarity=0.512 Sum_probs=119.7
Q ss_pred cHHHHHHHHhhcC----CCCcccCCCCCCCCCCCceeEeCCC-CCCCeeEEEecCCCCCc--cCChhhhccccCceeecc
Q 002382 376 DGVAIVSVISLYS----SADWAQEGGDPCLPVPWSWLQCNSD-PQPSITVIHLSSKNLTG--NIPSDLTKLSSLVELWLD 448 (929)
Q Consensus 376 ~~~~~~~l~~l~~----~~~w~~~~~dpc~~~~~~~~~c~~~-~~~~l~~L~L~~n~l~g--~~p~~l~~L~~L~~L~Ls 448 (929)
+..|+.++|+... +.+|.. ++|||. ..|.||.|+.. ...+|+.|+|++|+++| .+|++|++|++|++|+|+
T Consensus 7 e~~aLl~~k~~~~~~~~l~sW~~-~~d~C~-~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls 84 (313)
T d1ogqa_ 7 DKQALLQIKKDLGNPTTLSSWLP-TTDCCN-RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIG 84 (313)
T ss_dssp HHHHHHHHHHHTTCCGGGTTCCT-TSCTTT-TCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEE
T ss_pred HHHHHHHHHHHCCCCCcCCCCCC-CCCCCC-CcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccccc
Confidence 4467888887643 567865 689993 35999999754 34589999999999998 589999999999999998
Q ss_pred C-CcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccccccccccccccc--cceeccccCCc
Q 002382 449 G-NSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS--KNVVLNYAGNI 520 (929)
Q Consensus 449 ~-N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l~~--~~~~l~~~~n~ 520 (929)
+ |+++|.+|. |++|++|++|+|++|+|++..|..+..+.+|+.+++++|++.+.+|..+.. .+..+.+.+|.
T Consensus 85 ~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 85 GINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 7 899988774 999999999999999999999999999999999999999999999988743 34555566653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=7.8e-15 Score=155.17 Aligned_cols=176 Identities=22% Similarity=0.197 Sum_probs=136.9
Q ss_pred ceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCee
Q 002382 341 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (929)
Q Consensus 341 ~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~ 419 (929)
.++.|+|+.|.++.+|+. +..+..|+.|+|..|++... ..+..+..++.++.+.+. .....-....+++|+
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l--~~~~~l~~L~~L~Ls~N~------l~~~~~~~~~l~~L~ 103 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQ------LQSLPLLGQTLPALT 103 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE--ECCSCCTTCCEEECCSSC------CSSCCCCTTTCTTCC
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccccc--cccccccccccccccccc------ccccccccccccccc
Confidence 567788888888888865 78888888888888887642 112222333333222111 111112235678999
Q ss_pred EEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 420 ~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
.|+|++|.+.+..+..+..+.+|+.|++++|.+++.++. +..+++|+.|++++|+|++..|..|..+++|+.|+|++|+
T Consensus 104 ~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 183 (266)
T d1p9ag_ 104 VLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183 (266)
T ss_dssp EEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred cccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCC
Confidence 999999999977788889999999999999999998887 6789999999999999998777889999999999999999
Q ss_pred ccccccccccc--cceeccccCCcccccC
Q 002382 499 LSGTVPSSLLS--KNVVLNYAGNINLHEG 525 (929)
Q Consensus 499 l~g~~P~~l~~--~~~~l~~~~n~~lc~~ 525 (929)
|+ .+|.+++. .+..+.+.||+..|..
T Consensus 184 L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 184 LY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred Cc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 99 99999865 3467888999988864
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.47 E-value=3.4e-14 Score=142.58 Aligned_cols=153 Identities=20% Similarity=0.183 Sum_probs=119.4
Q ss_pred eeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeEEEe
Q 002382 344 SFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL 423 (929)
Q Consensus 344 ~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~L~L 423 (929)
.++.+.+.++++|+.|. +.++.|+|+.|++... .... ...++++|+.|+|
T Consensus 12 ~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~----------~~~~------------------~f~~l~~L~~L~L 61 (192)
T d1w8aa_ 12 TVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRI----------SSDG------------------LFGRLPHLVKLEL 61 (192)
T ss_dssp EEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSB----------CCSC------------------SGGGCTTCCEEEC
T ss_pred EEEEeCCCcCccCCCCC--CCCCEEEeCCCCCccc----------cccc------------------ccCCCceEeeeec
Confidence 46778999999998875 6788999999988530 0000 1234679999999
Q ss_pred cCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccccccc
Q 002382 424 SSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT 502 (929)
Q Consensus 424 ~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~ 502 (929)
++|++++..+..+..+++|+.|+|++|+|++++|. |.++++|++|+|++|+|++..|..|..+++|++|+|++|++...
T Consensus 62 ~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 62 KRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 99999988889999999999999999999999886 89999999999999999977778899999999999999999854
Q ss_pred ccccccc-cceeccccCCcccccCC
Q 002382 503 VPSSLLS-KNVVLNYAGNINLHEGG 526 (929)
Q Consensus 503 ~P~~l~~-~~~~l~~~~n~~lc~~~ 526 (929)
.+...+. ........++...|..+
T Consensus 142 ~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 142 CHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp GGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred cchHHHhhhhhhhcccCCCeEeCCC
Confidence 4433322 22333444555555444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=1.9e-13 Score=145.65 Aligned_cols=184 Identities=17% Similarity=0.150 Sum_probs=127.6
Q ss_pred ceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHHHHHHHhhcCCCCcc------cCCCCCCCCC---CCceeE-
Q 002382 341 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWA------QEGGDPCLPV---PWSWLQ- 409 (929)
Q Consensus 341 ~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~------~~~~dpc~~~---~~~~~~- 409 (929)
.++.|+|+.|.++++|+. +.++..|+.|+++.|.+..+....+.......... ....++..-. ....+.
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 467889999999999986 88999999999988876543222222211111000 0000011000 011111
Q ss_pred ----------eCCCCCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCC
Q 002382 410 ----------CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGP 478 (929)
Q Consensus 410 ----------c~~~~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~ 478 (929)
........|+.|++++|+|++..+..|..+++|+.|+|++|+|++.++. |.++++|+.|++++|++++.
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 1123356789999999999965567788899999999999999988775 78899999999999999988
Q ss_pred CCccccCCCcCccccccccccccccccccc---ccceeccccCCcccccC
Q 002382 479 LPSSLMNLPNLRELYVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEG 525 (929)
Q Consensus 479 ~P~~l~~l~~L~~L~l~~N~l~g~~P~~l~---~~~~~l~~~~n~~lc~~ 525 (929)
.|..|..+++|+.|++++|++++ +|...+ ..+..+.+.+|+..|..
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSC-CCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred ChhHhhhhhhccccccccccccc-ccccccccccccCEEEecCCCCCCCc
Confidence 88999999999999999999984 544443 33467777888877743
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.33 E-value=1.5e-12 Score=130.32 Aligned_cols=120 Identities=23% Similarity=0.288 Sum_probs=100.6
Q ss_pred CceeEeCCCC--------CCCeeEEEecCCCCCccC-ChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCC
Q 002382 405 WSWLQCNSDP--------QPSITVIHLSSKNLTGNI-PSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 474 (929)
Q Consensus 405 ~~~~~c~~~~--------~~~l~~L~L~~n~l~g~~-p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~ 474 (929)
+..|.|+..+ ..+++.|+|++|+|++.+ +..|.+|++|+.|+|++|++++.++. |..+++|+.|+|++|+
T Consensus 10 ~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 10 GTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp TTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred CCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence 4567776443 246899999999998655 55778999999999999999999886 8889999999999999
Q ss_pred cCCCCCccccCCCcCccccccccccccccccccccc---ceeccccCCcccccC
Q 002382 475 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK---NVVLNYAGNINLHEG 525 (929)
Q Consensus 475 l~g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l~~~---~~~l~~~~n~~lc~~ 525 (929)
|++..|..|.++++|+.|+|++|+|+ .+|...|.. +..+.+.+|+..|..
T Consensus 90 l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred ccccCHHHHhCCCcccccccCCcccc-ccCHHHhcCCccccccccccccccccc
Confidence 99777788999999999999999999 787776544 466777888776643
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=3.8e-12 Score=134.15 Aligned_cols=132 Identities=18% Similarity=0.163 Sum_probs=106.1
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
++.|+.|+|+.|.++..|+.+..+..|+.|++..|.+.. ..+ +....+.++
T Consensus 76 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~-------------------~~~----------~~~~~l~~l 126 (266)
T d1p9ag_ 76 LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS-------------------LPL----------GALRGLGEL 126 (266)
T ss_dssp CTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCC-------------------CCS----------STTTTCTTC
T ss_pred cccccccccccccccccccccccccccccccccccccce-------------------eec----------ccccccccc
Confidence 455666666666666666666666666666666665432 011 122346789
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
..|++++|.+++..+..+..+++|+.|++++|+|++.+++ |..+++|++|||++|+|+ .+|+.+..+++|+.|+|++|
T Consensus 127 ~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~N 205 (266)
T d1p9ag_ 127 QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205 (266)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSC
T ss_pred ccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCC
Confidence 9999999999966667788899999999999999999886 888999999999999999 89999999999999999999
Q ss_pred ccc
Q 002382 498 MLS 500 (929)
Q Consensus 498 ~l~ 500 (929)
++.
T Consensus 206 p~~ 208 (266)
T d1p9ag_ 206 PWL 208 (266)
T ss_dssp CBC
T ss_pred CCC
Confidence 986
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.29 E-value=3.4e-12 Score=118.20 Aligned_cols=82 Identities=28% Similarity=0.354 Sum_probs=59.5
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCC--ccccCCCcCcccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLRELY 493 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P--~~l~~l~~L~~L~ 493 (929)
+.|++|+|++|+|+ .+|+.|+.|++|+.|+|++|+|++. |++.++++|++|++++|+|+. +| ..++.+++|+.|+
T Consensus 20 ~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~i~~-~~~~~~l~~~~~L~~L~ 96 (124)
T d1dcea3 20 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQQ-SAAIQPLVSCPRLVLLN 96 (124)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCCS-SSTTGGGGGCTTCCEEE
T ss_pred CCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-CccccccccCeEECCCCccCC-CCCchhhcCCCCCCEEE
Confidence 46777777777777 6777777777777777777777754 457777777777777777773 33 4577777777777
Q ss_pred ccccccc
Q 002382 494 VQNNMLS 500 (929)
Q Consensus 494 l~~N~l~ 500 (929)
+++|+++
T Consensus 97 l~~N~i~ 103 (124)
T d1dcea3 97 LQGNSLC 103 (124)
T ss_dssp CTTSGGG
T ss_pred CCCCcCC
Confidence 7777776
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.28 E-value=3.2e-12 Score=137.28 Aligned_cols=181 Identities=20% Similarity=0.237 Sum_probs=129.0
Q ss_pred cccceeeeeecccCCCCCCCc-cchhccceeccCCCCCccHHH---------------------HHHHHhhcCCCCcccC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVA---------------------IVSVISLYSSADWAQE 395 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~-i~~le~l~~L~l~~n~~~~~~---------------------~~~l~~l~~~~~w~~~ 395 (929)
.++.|+.|++..|.++.++|. |..++.|+.|++.+|++.... ...+........+..
T Consensus 53 ~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~- 131 (305)
T d1xkua_ 53 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL- 131 (305)
T ss_dssp TCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEEC-
T ss_pred ccccccccccccccccccchhhhhCCCccCEecccCCccCcCccchhhhhhhhhccccchhhhhhhhhhcccccccccc-
Confidence 467889999999999999776 888999999988887754311 111111100000000
Q ss_pred CCCCCCC-----------CCCceeEeC--------CCCCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCC
Q 002382 396 GGDPCLP-----------VPWSWLQCN--------SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI 456 (929)
Q Consensus 396 ~~dpc~~-----------~~~~~~~c~--------~~~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~ 456 (929)
...++.. .....+.+. ...+++|+.|+|++|.+++..+..+.+++.++.|++++|++++.+
T Consensus 132 ~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~ 211 (305)
T d1xkua_ 132 GTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 211 (305)
T ss_dssp CSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC
T ss_pred ccccccccCCCccccccccccCccccccCCccccCcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccc
Confidence 0011000 011112211 123567899999999999899999999999999999999999988
Q ss_pred CC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccccccccccccccc---------cceeccccCCcc
Q 002382 457 PD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS---------KNVVLNYAGNIN 521 (929)
Q Consensus 457 p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~g~~P~~l~~---------~~~~l~~~~n~~ 521 (929)
+. +.++++|++|+|++|+|+ .+|+.|.++++|+.|+|++|+|+ .++...+. .+..+.+.+|+.
T Consensus 212 ~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~ 284 (305)
T d1xkua_ 212 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPV 284 (305)
T ss_dssp TTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred cccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC-ccChhhccCcchhcccCCCCEEECCCCcC
Confidence 86 788999999999999999 78999999999999999999999 88765543 224556677764
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.21 E-value=1.1e-11 Score=114.70 Aligned_cols=99 Identities=32% Similarity=0.428 Sum_probs=84.4
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
+.|+|++|+|+ .++. +.+|++|++|+|++|+|++.++.++.+++|+.|+|++|+|+ .+| .++++++|+.|++++|+
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCC-CCcc-cccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 47999999999 7774 99999999999999999988778999999999999999999 566 59999999999999999
Q ss_pred ccccccc--cc--cccceeccccCCccc
Q 002382 499 LSGTVPS--SL--LSKNVVLNYAGNINL 522 (929)
Q Consensus 499 l~g~~P~--~l--~~~~~~l~~~~n~~l 522 (929)
|+ .+|. .+ +..+..+.+.+|+..
T Consensus 77 i~-~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQ-QSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CC-SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cC-CCCCchhhcCCCCCCEEECCCCcCC
Confidence 99 6653 23 234567778888643
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.18 E-value=1.5e-11 Score=130.63 Aligned_cols=113 Identities=18% Similarity=0.107 Sum_probs=91.9
Q ss_pred CCCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCccc
Q 002382 414 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 492 (929)
Q Consensus 414 ~~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 492 (929)
..++|+.|+|++|+|++..+..|.++++|+.|+|++|++++..|. |.++++|++||+++|++++..|..|+++++|+.|
T Consensus 151 ~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L 230 (284)
T d1ozna_ 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEE
T ss_pred cccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEE
Confidence 456899999999999987788999999999999999999999886 8999999999999999998888899999999999
Q ss_pred cccccccccccccccc-ccceeccccCCcccccCC
Q 002382 493 YVQNNMLSGTVPSSLL-SKNVVLNYAGNINLHEGG 526 (929)
Q Consensus 493 ~l~~N~l~g~~P~~l~-~~~~~l~~~~n~~lc~~~ 526 (929)
+|++|++.+.-+...+ .....+....+...|..+
T Consensus 231 ~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p 265 (284)
T d1ozna_ 231 RLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265 (284)
T ss_dssp ECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEES
T ss_pred EecCCCCCCCccchHHHHHHHhCcCCCCceEeCCc
Confidence 9999999866553322 122223333444555443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.13 E-value=3e-11 Score=122.46 Aligned_cols=128 Identities=23% Similarity=0.368 Sum_probs=79.2
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
++.|+.|+|..|.++.++| +..+..|+.|++.+|++... ..+. .+++|
T Consensus 67 l~~L~~L~L~~n~i~~l~~-~~~l~~L~~L~l~~n~i~~l--~~l~-----------------------------~l~~L 114 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDL--SSLK-----------------------------DLKKL 114 (210)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCG--GGGT-----------------------------TCTTC
T ss_pred CCCCCEEeCCCccccCccc-cccCcccccccccccccccc--cccc-----------------------------ccccc
Confidence 5678888999999999886 57888899999998887541 1111 23456
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
+.|++++|.+. .++ .+..+++|+.+++++|.+++. +.+..+++|+.|++++|++++ ++ .+.++++|+.|+|++|+
T Consensus 115 ~~L~l~~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~~-~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~ 189 (210)
T d1h6ta2 115 KSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNH 189 (210)
T ss_dssp CEEECTTSCCC-CCG-GGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSC
T ss_pred ccccccccccc-ccc-ccccccccccccccccccccc-ccccccccccccccccccccc-cc-cccCCCCCCEEECCCCC
Confidence 66666666655 333 355566666666666665542 234555666666666666653 32 25566666666666666
Q ss_pred cccccc
Q 002382 499 LSGTVP 504 (929)
Q Consensus 499 l~g~~P 504 (929)
|+ .+|
T Consensus 190 i~-~l~ 194 (210)
T d1h6ta2 190 IS-DLR 194 (210)
T ss_dssp CC-BCG
T ss_pred CC-CCh
Confidence 65 444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.12 E-value=4.8e-11 Score=119.77 Aligned_cols=150 Identities=20% Similarity=0.242 Sum_probs=105.9
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
+..++.|++..+.++.++ .|..++.|+.|++++|++... ..++++..+....... |...... ...+++.|
T Consensus 39 l~~l~~L~l~~~~i~~l~-~l~~l~nL~~L~Ls~N~l~~~--~~l~~l~~L~~L~l~~---n~~~~~~----~l~~l~~L 108 (199)
T d2omxa2 39 LDQVTTLQADRLGIKSID-GVEYLNNLTQINFSNNQLTDI--TPLKNLTKLVDILMNN---NQIADIT----PLANLTNL 108 (199)
T ss_dssp HTTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCS---SCCCCCG----GGTTCTTC
T ss_pred hcCCCEEECCCCCCCCcc-ccccCCCcCcCccccccccCc--ccccCCcccccccccc---ccccccc----cccccccc
Confidence 556777888888888774 477788888888888876542 2244444444432211 1110111 12356788
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
+.|++++|.+.. ++ .+..|++|+.|++++|++.. ++.+..+++|+.|++++|++++ ++ .++++++|+.|++++|+
T Consensus 109 ~~L~l~~~~~~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~ 183 (199)
T d2omxa2 109 TGLTLFNNQITD-ID-PLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNK 183 (199)
T ss_dssp SEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSC
T ss_pred cccccccccccc-cc-ccchhhhhHHhhhhhhhhcc-cccccccccccccccccccccC-Cc-cccCCCCCCEEECCCCC
Confidence 999999888884 33 48889999999999999875 4568889999999999999984 44 48889999999999999
Q ss_pred cccccc
Q 002382 499 LSGTVP 504 (929)
Q Consensus 499 l~g~~P 504 (929)
|+ .+|
T Consensus 184 i~-~i~ 188 (199)
T d2omxa2 184 VS-DIS 188 (199)
T ss_dssp CC-CCG
T ss_pred CC-CCc
Confidence 98 565
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.12 E-value=3e-11 Score=117.17 Aligned_cols=123 Identities=14% Similarity=0.065 Sum_probs=89.1
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
...+..|+|.+|.++.+|..+..+..|+.|++++|++.. + . ....+++|
T Consensus 17 ~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~--------------l-------------~----~~~~l~~L 65 (162)
T d1a9na_ 17 AVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRK--------------L-------------D----GFPLLRRL 65 (162)
T ss_dssp TTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCE--------------E-------------C----CCCCCSSC
T ss_pred cCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCc--------------c-------------C----CcccCcch
Confidence 446678888999999998777888888888888887753 1 0 01235678
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCC--CCCCCCCCcEEEecCCCcCCCCCc----cccCCCcCccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPS----SLMNLPNLREL 492 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~g~~P~----~l~~l~~L~~L 492 (929)
+.|+|++|+|+...+..+..+++|+.|+|++|+|+.... .+..+++|++|+|++|.++ ..|. .+..+++|+.|
T Consensus 66 ~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~L 144 (162)
T d1a9na_ 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVL 144 (162)
T ss_dssp CEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEE
T ss_pred hhhhcccccccCCCccccccccccccceeccccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCee
Confidence 888888888884334445678888888888888876543 4777888888888888887 4553 46777788776
Q ss_pred c
Q 002382 493 Y 493 (929)
Q Consensus 493 ~ 493 (929)
|
T Consensus 145 D 145 (162)
T d1a9na_ 145 D 145 (162)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.12 E-value=3.8e-11 Score=116.49 Aligned_cols=103 Identities=18% Similarity=0.155 Sum_probs=86.1
Q ss_pred CCCeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccc
Q 002382 415 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 494 (929)
Q Consensus 415 ~~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l 494 (929)
+.++++|+|++|+|+ .+|..+..+++|+.|+|++|+|+.. +.|..+++|++|+|++|+|+...+..+..+++|+.|+|
T Consensus 17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred cCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 458999999999999 7888778899999999999999965 77999999999999999999544445678999999999
Q ss_pred ccccccccccc--cc--cccceeccccCCc
Q 002382 495 QNNMLSGTVPS--SL--LSKNVVLNYAGNI 520 (929)
Q Consensus 495 ~~N~l~g~~P~--~l--~~~~~~l~~~~n~ 520 (929)
++|+|+ .++. .+ +..+..+.+.+|+
T Consensus 95 ~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~ 123 (162)
T d1a9na_ 95 TNNSLV-ELGDLDPLASLKSLTYLCILRNP 123 (162)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSG
T ss_pred cccccc-ccccccccccccccchhhcCCCc
Confidence 999998 6664 22 3445667777875
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.09 E-value=6.3e-11 Score=118.88 Aligned_cols=139 Identities=18% Similarity=0.230 Sum_probs=106.6
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
++.|+.|+|+.|.++.++| +.++..|+.|+++.|.+... ..+..+..+..+.. ..|...... ....+++|
T Consensus 61 l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~l---~~~~~~~~~----~~~~l~~L 130 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADI--TPLANLTNLTGLTL---FNNQITDID----PLKNLTNL 130 (199)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEEC---CSSCCCCCG----GGTTCTTC
T ss_pred CCCcCcCccccccccCccc-ccCCcccccccccccccccc--cccccccccccccc---ccccccccc----ccchhhhh
Confidence 5678999999999999987 89999999999999887552 23444444444422 122111111 12457799
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 492 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L 492 (929)
+.|++++|++. .++ .+..+++|+.|++++|++++.. .++++++|++|+|++|+|+ .+| .+++|++|+.|
T Consensus 131 ~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~-~l~~l~~L~~L~ls~N~i~-~i~-~l~~L~~L~~L 199 (199)
T d2omxa2 131 NRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLK-PLANLTTLERLDISSNKVS-DIS-VLAKLTNLESL 199 (199)
T ss_dssp SEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCC-CCG-GGGGCTTCSEE
T ss_pred HHhhhhhhhhc-ccc-cccccccccccccccccccCCc-cccCCCCCCEEECCCCCCC-CCc-cccCCCCCCcC
Confidence 99999999998 555 5999999999999999999754 5999999999999999999 455 58888888875
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.09 E-value=1e-10 Score=112.55 Aligned_cols=104 Identities=17% Similarity=0.171 Sum_probs=70.4
Q ss_pred EEEecCCCCCccCChhhhccccCceeeccCC-cCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGN-SLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 420 ~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N-~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
.++++++++. .+|..|..+++|+.|+|++| .|+.+.+. |.++++|+.|+|++|+|+...|..|..+++|+.|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 3555566666 56666777777777777655 46666553 777777777777777777555666777777777777777
Q ss_pred cccccccccccccc--eeccccCCcccccC
Q 002382 498 MLSGTVPSSLLSKN--VVLNYAGNINLHEG 525 (929)
Q Consensus 498 ~l~g~~P~~l~~~~--~~l~~~~n~~lc~~ 525 (929)
+|+ .+|..++... ..+.+.+|+..|..
T Consensus 91 ~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 91 ALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp CCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred CCc-ccChhhhccccccccccCCCcccCCc
Confidence 777 7777766533 45666777666543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.09 E-value=1.6e-10 Score=123.57 Aligned_cols=142 Identities=13% Similarity=0.100 Sum_probs=113.5
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (929)
.++.++.+.+..|.++.+|..+ +..|+.|++..|.... ..+ +...+++.
T Consensus 148 ~l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~-------------------~~~----------~~~~~~~~ 196 (305)
T d1xkua_ 148 GMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITK-------------------VDA----------ASLKGLNN 196 (305)
T ss_dssp GCTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCE-------------------ECT----------GGGTTCTT
T ss_pred cccccCccccccCCccccCccc--CCccCEEECCCCcCCC-------------------CCh----------hHhhcccc
Confidence 3566788888889888887764 5678888888776542 011 12344568
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCc-------cccCCCcCc
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS-------SLMNLPNLR 490 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~-------~l~~l~~L~ 490 (929)
++.|++++|++++..+..+.++++|++|+|++|+|+.++++|.++++|++|+|++|+|+ .++. .+..+.+|+
T Consensus 197 l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~ 275 (305)
T d1xkua_ 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYS 275 (305)
T ss_dssp CCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCS
T ss_pred ccccccccccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccC-ccChhhccCcchhcccCCCC
Confidence 99999999999988889999999999999999999988778999999999999999999 4543 345678899
Q ss_pred cccccccccc-ccccccccccc
Q 002382 491 ELYVQNNMLS-GTVPSSLLSKN 511 (929)
Q Consensus 491 ~L~l~~N~l~-g~~P~~l~~~~ 511 (929)
.|+|++|+++ ..+|+..|+..
T Consensus 276 ~L~L~~N~~~~~~~~~~~f~~~ 297 (305)
T d1xkua_ 276 GVSLFSNPVQYWEIQPSTFRCV 297 (305)
T ss_dssp EEECCSSSSCGGGSCGGGGTTC
T ss_pred EEECCCCcCccCcCCHhHhccc
Confidence 9999999985 57777777664
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.03 E-value=1.5e-10 Score=118.43 Aligned_cols=150 Identities=19% Similarity=0.275 Sum_probs=103.1
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
+++|+.|+|..|.++.++| +..++.++.|.+..|.+.. +..+..+..+..+.. ..|. ..++. .....+.+
T Consensus 62 l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~~--i~~l~~l~~L~~l~l---~~~~---~~~~~-~~~~~~~~ 131 (227)
T d1h6ua2 62 LNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDL---TSTQ---ITDVT-PLAGLSNL 131 (227)
T ss_dssp CTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSC--CGGGTTCTTCCEEEC---TTSC---CCCCG-GGTTCTTC
T ss_pred CCCCcEeecCCceeecccc-ccccccccccccccccccc--ccccccccccccccc---cccc---ccccc-hhccccch
Confidence 5677888888888888876 6778888888888777653 222333333333311 1111 11111 11234577
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
..|.++++.+.... .+.++++|+.|++++|++++..+ +.++++|+.|||++|+|++ +| .++++++|+.|+|++|+
T Consensus 132 ~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 132 QVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQ 206 (227)
T ss_dssp CEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSC
T ss_pred hhhhchhhhhchhh--hhccccccccccccccccccchh-hcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCc
Confidence 88888888887433 37788889999999998876543 8888999999999999884 54 38888899999999999
Q ss_pred cccccc
Q 002382 499 LSGTVP 504 (929)
Q Consensus 499 l~g~~P 504 (929)
|+ .+|
T Consensus 207 lt-~i~ 211 (227)
T d1h6ua2 207 IS-DVS 211 (227)
T ss_dssp CC-BCG
T ss_pred CC-CCc
Confidence 88 555
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.02 E-value=3.7e-10 Score=114.19 Aligned_cols=144 Identities=19% Similarity=0.215 Sum_probs=116.9
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
+.+++.|++..+.++.+++ |..+..|+.|++++|++.. -+++ ..+++|
T Consensus 45 L~~L~~L~l~~~~i~~l~~-l~~l~~L~~L~L~~n~i~~-------------------l~~~------------~~l~~L 92 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTD-------------------IKPL------------ANLKNL 92 (210)
T ss_dssp HHTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCC-------------------CGGG------------TTCTTC
T ss_pred hcCccEEECcCCCCCCchh-HhhCCCCCEEeCCCccccC-------------------cccc------------ccCccc
Confidence 5678889999999999875 7889999999999997753 1111 245689
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 498 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~ 498 (929)
+.|+|++|+|+ .+| .+.++++|+.|++++|.+.. ++.+.++++|+.+++++|++++ +..+..+++|+.+++++|+
T Consensus 93 ~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~~-~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~ 167 (210)
T d1h6ta2 93 GWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQ 167 (210)
T ss_dssp CEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCCC-CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSC
T ss_pred ccccccccccc-ccc-cccccccccccccccccccc-cccccccccccccccccccccc--ccccccccccccccccccc
Confidence 99999999999 566 59999999999999999875 5678999999999999999984 3468889999999999999
Q ss_pred ccccccc-cccccceeccccCCc
Q 002382 499 LSGTVPS-SLLSKNVVLNYAGNI 520 (929)
Q Consensus 499 l~g~~P~-~l~~~~~~l~~~~n~ 520 (929)
+++ ++. .-+..+..+.+.+|.
T Consensus 168 l~~-i~~l~~l~~L~~L~Ls~N~ 189 (210)
T d1h6ta2 168 ISD-IVPLAGLTKLQNLYLSKNH 189 (210)
T ss_dssp CCC-CGGGTTCTTCCEEECCSSC
T ss_pred ccc-cccccCCCCCCEEECCCCC
Confidence 994 543 334556677777774
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.01 E-value=2.1e-10 Score=110.28 Aligned_cols=102 Identities=28% Similarity=0.330 Sum_probs=85.0
Q ss_pred CCCCCCCCceeEeCCC----------CCCCeeEEEecCC-CCCccCChhhhccccCceeeccCCcCCCCCCC-CCCCCCC
Q 002382 398 DPCLPVPWSWLQCNSD----------PQPSITVIHLSSK-NLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDL 465 (929)
Q Consensus 398 dpc~~~~~~~~~c~~~----------~~~~l~~L~L~~n-~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~-~~~l~~L 465 (929)
+.|.+..++.+.|+.. .+++|++|+|++| .|+..-++.|.+|++|+.|+|++|+|+++.|. |.++++|
T Consensus 3 ~~C~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L 82 (156)
T d2ifga3 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82 (156)
T ss_dssp SSSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC
T ss_pred CCCCcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccc
Confidence 3465666778888642 3568999999876 58855556799999999999999999999886 8999999
Q ss_pred cEEEecCCCcCCCCCccccCCCcCccccccccccc
Q 002382 466 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 500 (929)
Q Consensus 466 ~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l~ 500 (929)
++|+|++|+|+ .+|..+....+|+.|+|++|++.
T Consensus 83 ~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 99999999999 67776666668999999999985
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.99 E-value=4.3e-10 Score=123.60 Aligned_cols=144 Identities=15% Similarity=0.255 Sum_probs=70.9
Q ss_pred ccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 339 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
++.++.|.+..|.++.+++ +..+..|+.|+++.+++... ..+..+..+..... ..|. ..++.+ ...++++
T Consensus 240 l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~~~l~~~--~~~~~~~~l~~l~~---~~n~---l~~~~~-~~~~~~l 309 (384)
T d2omza2 240 LTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNI--SPLAGLTALTNLEL---NENQ---LEDISP-ISNLKNL 309 (384)
T ss_dssp CTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEEC---CSSC---CSCCGG-GGGCTTC
T ss_pred ccccchhccccCccCCCCc-ccccccCCEeeccCcccCCC--Cccccccccccccc---cccc---cccccc-cchhccc
Confidence 4556677777777777765 56667777777776665421 11111111111100 0000 011110 1123355
Q ss_pred eEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 419 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 419 ~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
+.|+|++|+|++ ++ .+..|++|+.|+|++|+|++ ++.+.+|++|++|+|++|+|++..| +.+|++|+.|+|++|
T Consensus 310 ~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 310 TYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp SEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 555555555553 22 25555555555555555554 2345555555555555555553322 555555555555555
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.91 E-value=5.8e-10 Score=122.54 Aligned_cols=79 Identities=25% Similarity=0.346 Sum_probs=37.6
Q ss_pred CeeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCccccccc
Q 002382 417 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 496 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~ 496 (929)
.++.+++..|++++ ++ .+..+++|+.|+|++|+|++.. .+..+++|+.|+|++|+|+ .+| .|++|++|+.|+|++
T Consensus 286 ~l~~l~~~~n~l~~-~~-~~~~~~~l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~ 360 (384)
T d2omza2 286 ALTNLELNENQLED-IS-PISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGH 360 (384)
T ss_dssp TCSEEECCSSCCSC-CG-GGGGCTTCSEEECCSSCCSCCG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCS
T ss_pred cccccccccccccc-cc-ccchhcccCeEECCCCCCCCCc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCC
Confidence 44455555555542 22 2444555555555555554432 2444555555555555554 232 344555555555555
Q ss_pred cccc
Q 002382 497 NMLS 500 (929)
Q Consensus 497 N~l~ 500 (929)
|+|+
T Consensus 361 N~l~ 364 (384)
T d2omza2 361 NQIS 364 (384)
T ss_dssp SCCC
T ss_pred CcCC
Confidence 5555
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.82 E-value=2.1e-11 Score=122.50 Aligned_cols=116 Identities=19% Similarity=0.290 Sum_probs=88.3
Q ss_pred CCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeEEEecCCCCCc
Q 002382 351 YDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTG 430 (929)
Q Consensus 351 ~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~L~L~~n~l~g 430 (929)
.+..+|..|+.|..|+.|+|+.|++... ..| ..+++|+.|+|++|+|+
T Consensus 36 ~i~~l~~sl~~L~~L~~L~Ls~n~I~~i--~~l-----------------------------~~l~~L~~L~Ls~N~i~- 83 (198)
T d1m9la_ 36 PIEKMDATLSTLKACKHLALSTNNIEKI--SSL-----------------------------SGMENLRILSLGRNLIK- 83 (198)
T ss_dssp TCCCCHHHHHHTTTCCEEECSEEEESCC--CCH-----------------------------HHHTTCCEEECCEEEEC-
T ss_pred chhhhhhHHhcccccceeECcccCCCCc--ccc-----------------------------cCCccccChhhcccccc-
Confidence 4666666788888888888888876530 000 12357888889888888
Q ss_pred cCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCC--ccccCCCcCccccccccccc
Q 002382 431 NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLRELYVQNNMLS 500 (929)
Q Consensus 431 ~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P--~~l~~l~~L~~L~l~~N~l~ 500 (929)
.+|..+..+++|+.|+|++|+|+.. +.+.++++|+.|+|++|+|+ .++ ..+..|++|+.|+|++|+++
T Consensus 84 ~i~~~~~~~~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 84 KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SCSSHHHHHHHCCEEECSEEECCCH-HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccccccccccccccccc-ccccccccccccccccchhc-cccccccccCCCccceeecCCCccc
Confidence 7777667777889999999988864 45778888899999999888 444 46888888999999988887
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.77 E-value=5.6e-09 Score=106.42 Aligned_cols=167 Identities=20% Similarity=0.200 Sum_probs=120.9
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (929)
.+.+++.|++..|.+++++ .|..++.|+.|++.+|++... ..+..+..+..+.. .-|. ...+. ...++++
T Consensus 39 ~l~~L~~L~l~~~~i~~l~-~l~~l~~L~~L~ls~n~i~~~--~~l~~l~~l~~l~~---~~n~---~~~i~-~l~~l~~ 108 (227)
T d1h6ua2 39 DLDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITDL--APLKNLTKITELEL---SGNP---LKNVS-AIAGLQS 108 (227)
T ss_dssp HHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCC--GGGTTCCSCCEEEC---CSCC---CSCCG-GGTTCTT
T ss_pred HcCCcCEEECCCCCCCcch-hHhcCCCCcEeecCCceeecc--cccccccccccccc---cccc---ccccc-ccccccc
Confidence 4678899999999999995 589999999999999987652 22333333333322 1111 11111 1235678
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccc
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 497 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N 497 (929)
|+.|+++++...+.. .+...+.+..|.++++.+.... .+.++++|+.|++++|++++. + .++++++|+.|+|++|
T Consensus 109 L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n 183 (227)
T d1h6ua2 109 IKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS-PLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDN 183 (227)
T ss_dssp CCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSS
T ss_pred ccccccccccccccc--hhccccchhhhhchhhhhchhh-hhccccccccccccccccccc-h-hhcccccceecccCCC
Confidence 999999998887432 3777889999999998887644 477889999999999999843 3 4899999999999999
Q ss_pred cccccccc-cccccceeccccCCc
Q 002382 498 MLSGTVPS-SLLSKNVVLNYAGNI 520 (929)
Q Consensus 498 ~l~g~~P~-~l~~~~~~l~~~~n~ 520 (929)
+++ .+|. .-+..+..+.+.+|.
T Consensus 184 ~l~-~l~~l~~l~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 184 KIS-DISPLASLPNLIEVHLKNNQ 206 (227)
T ss_dssp CCC-CCGGGGGCTTCCEEECTTSC
T ss_pred ccC-CChhhcCCCCCCEEECcCCc
Confidence 999 5654 224555667777773
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.71 E-value=7.3e-11 Score=118.37 Aligned_cols=128 Identities=17% Similarity=0.228 Sum_probs=100.2
Q ss_pred cccceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCC
Q 002382 338 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS 417 (929)
Q Consensus 338 ~l~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~ 417 (929)
.++.|+.|+|+.|.++.++ .|..+..|+.|+++.|.+... ... . ..+++
T Consensus 46 ~L~~L~~L~Ls~n~I~~i~-~l~~l~~L~~L~Ls~N~i~~i-----------~~~----------------~---~~~~~ 94 (198)
T d1m9la_ 46 TLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIKKI-----------ENL----------------D---AVADT 94 (198)
T ss_dssp HTTTCCEEECSEEEESCCC-CHHHHTTCCEEECCEEEECSC-----------SSH----------------H---HHHHH
T ss_pred cccccceeECcccCCCCcc-cccCCccccChhhcccccccc-----------ccc----------------c---ccccc
Confidence 3678899999999999996 489999999999999987530 000 0 01236
Q ss_pred eeEEEecCCCCCccCChhhhccccCceeeccCCcCCCCCC--CCCCCCCCcEEEecCCCcCCCCCcc----------ccC
Q 002382 418 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPSS----------LMN 485 (929)
Q Consensus 418 l~~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~g~~P~~----------l~~ 485 (929)
|+.|+|++|+|+ .++ .+..|++|+.|+|++|+|+.... .+.++++|+.|+|++|.+....+.. +..
T Consensus 95 L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~ 172 (198)
T d1m9la_ 95 LEELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKR 172 (198)
T ss_dssp CCEEECSEEECC-CHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHH
T ss_pred cccccccccccc-ccc-cccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHH
Confidence 999999999999 554 59999999999999999997653 5899999999999999987443332 566
Q ss_pred CCcCccccccccccc
Q 002382 486 LPNLRELYVQNNMLS 500 (929)
Q Consensus 486 l~~L~~L~l~~N~l~ 500 (929)
|++|+.|| +..++
T Consensus 173 lp~L~~LD--~~~I~ 185 (198)
T d1m9la_ 173 LPNLKKLD--GMPVD 185 (198)
T ss_dssp CSSCCEES--SGGGT
T ss_pred CCCcCEeC--CccCC
Confidence 78888765 44444
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=2.4e-08 Score=102.35 Aligned_cols=99 Identities=18% Similarity=0.163 Sum_probs=62.4
Q ss_pred CCeeEEEecCCCCCccCChhhhccc-cCceeeccCCcCCCCCCCCCCCCCCcEE-EecCCCcCCCCCc-cccCCCcCccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLS-SLVELWLDGNSLTGPIPDFSGCPDLRII-HLEDNQLTGPLPS-SLMNLPNLREL 492 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~-~L~~L~Ls~N~l~~~~p~~~~l~~L~~L-~Ls~N~l~g~~P~-~l~~l~~L~~L 492 (929)
..+..+..+++++...-+..+..+. .++.|++++|++++..+...+..+++.+ ++++|+|+ .+|. .|.++++|+.|
T Consensus 128 ~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L 206 (242)
T d1xwdc1 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVIL 206 (242)
T ss_dssp SCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEE
T ss_pred cccccccccccccccccccccccccccceeeecccccccccccccccchhhhccccccccccc-cccHHHhcCCCCCCEE
Confidence 4555555566666643344555553 6777777777777766665455555444 45667777 4443 56777888888
Q ss_pred ccccccccccccccccccceeccc
Q 002382 493 YVQNNMLSGTVPSSLLSKNVVLNY 516 (929)
Q Consensus 493 ~l~~N~l~g~~P~~l~~~~~~l~~ 516 (929)
+|++|+|+ .+|...+..+..|..
T Consensus 207 ~Ls~N~l~-~l~~~~~~~l~~L~~ 229 (242)
T d1xwdc1 207 DISRTRIH-SLPSYGLENLKKLRA 229 (242)
T ss_dssp ECTTSCCC-CCCSSSCTTCCEEES
T ss_pred ECCCCcCC-ccCHHHHcCCccccc
Confidence 88888887 777776666555443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=4.4e-07 Score=92.59 Aligned_cols=86 Identities=22% Similarity=0.264 Sum_probs=68.5
Q ss_pred CCeeEEEecCCCCCccCChhhhccccCcee-eccCCcCCCCCCC-CCCCCCCcEEEecCCCcCCCCCccccCCCcCcccc
Q 002382 416 PSITVIHLSSKNLTGNIPSDLTKLSSLVEL-WLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 493 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~~l~~L~~L~~L-~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~ 493 (929)
..++.|++++|+++ .++..+.++.+++.+ ++++|+|+.+++. |.++++|++|+|++|+|+...+..|.+|++|+.|+
T Consensus 153 ~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~ 231 (242)
T d1xwdc1 153 FESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS 231 (242)
T ss_dssp SSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSS
T ss_pred ccceeeeccccccc-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCc
Confidence 47899999999999 677666677776555 6788999988776 89999999999999999944445789999999887
Q ss_pred cccccccccccc
Q 002382 494 VQNNMLSGTVPS 505 (929)
Q Consensus 494 l~~N~l~g~~P~ 505 (929)
+. ++. .+|+
T Consensus 232 ~~--~l~-~lp~ 240 (242)
T d1xwdc1 232 TY--NLK-KLPT 240 (242)
T ss_dssp EE--SSS-CSCC
T ss_pred CC--CCC-cCCC
Confidence 74 355 5553
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.19 E-value=5.2e-06 Score=88.61 Aligned_cols=96 Identities=20% Similarity=0.205 Sum_probs=64.5
Q ss_pred cceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCee
Q 002382 340 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~ 419 (929)
.++..|+|+.+.++++|+.+. .|+.|+++.|++... + ..+.+|+
T Consensus 38 ~~l~~LdLs~~~L~~lp~~~~---~L~~L~Ls~N~l~~l-----------p----------------------~~~~~L~ 81 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSLPELPP---HLESLVASCNSLTEL-----------P----------------------ELPQSLK 81 (353)
T ss_dssp HTCSEEECTTSCCSCCCSCCT---TCSEEECCSSCCSSC-----------C----------------------CCCTTCC
T ss_pred cCCCEEEeCCCCCCCCCCCCC---CCCEEECCCCCCccc-----------c----------------------cchhhhh
Confidence 356788889999999987654 467778888877530 0 0123677
Q ss_pred EEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcC
Q 002382 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 476 (929)
Q Consensus 420 ~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~ 476 (929)
.|++++|+++ .++. + .+.|++|+|++|.++.. |.+..+++|+.|++++|.++
T Consensus 82 ~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~~l-p~~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 82 SLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLEKL-PELQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp EEECCSSCCS-CCCS-C--CTTCCEEECCSSCCSSC-CCCTTCTTCCEEECCSSCCS
T ss_pred hhhhhhcccc-hhhh-h--ccccccccccccccccc-cchhhhccceeecccccccc
Confidence 7777777777 4443 1 13577777777777654 45666777777777777776
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.08 E-value=2.3e-07 Score=97.62 Aligned_cols=160 Identities=14% Similarity=0.147 Sum_probs=76.1
Q ss_pred ceeeeeecccCCCC--CCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCe
Q 002382 341 FVLSFKFGKTYDSS--RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI 418 (929)
Q Consensus 341 ~l~~l~l~~n~~s~--lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l 418 (929)
.+++|+|+.+.++. ++.++..+..|+.|.+.++.++...+..+.+...+..++.+ -|....-.++..-..++++|
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls---~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS---GCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT---TCBSCCHHHHHHHHHHCTTC
T ss_pred CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc---ccccccccccchhhHHHHhc
Confidence 44555665554432 33445556666666666666655555555554444444321 12111111110000123466
Q ss_pred eEEEecCC-CCCc-cCChhhhcc-ccCceeeccCC--cCCCC-CCC-CCCCCCCcEEEecCC-CcCCCCCccccCCCcCc
Q 002382 419 TVIHLSSK-NLTG-NIPSDLTKL-SSLVELWLDGN--SLTGP-IPD-FSGCPDLRIIHLEDN-QLTGPLPSSLMNLPNLR 490 (929)
Q Consensus 419 ~~L~L~~n-~l~g-~~p~~l~~L-~~L~~L~Ls~N--~l~~~-~p~-~~~l~~L~~L~Ls~N-~l~g~~P~~l~~l~~L~ 490 (929)
++|+|+++ +++. .+...+..+ ++|+.|+|++. .++.. +.. +.++++|++|+|++| .+++..+..+.++++|+
T Consensus 124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~ 203 (284)
T d2astb2 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203 (284)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred cccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCC
Confidence 66666653 3331 122223332 45666666643 23221 222 234566666666654 35555555666666666
Q ss_pred ccccccc-cccccc
Q 002382 491 ELYVQNN-MLSGTV 503 (929)
Q Consensus 491 ~L~l~~N-~l~g~~ 503 (929)
+|+|++| .+++.-
T Consensus 204 ~L~L~~C~~i~~~~ 217 (284)
T d2astb2 204 HLSLSRCYDIIPET 217 (284)
T ss_dssp EEECTTCTTCCGGG
T ss_pred EEECCCCCCCChHH
Confidence 6666663 455433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.06 E-value=6e-06 Score=84.91 Aligned_cols=131 Identities=18% Similarity=0.129 Sum_probs=89.6
Q ss_pred cCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccC-CCceeEEeeeeeecCeEEEEEEeccCCchhhhhcc
Q 002382 612 GGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG 690 (929)
Q Consensus 612 G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~-HpNIv~l~g~~~~~~~~~LV~E~~~~gsL~~~L~~ 690 (929)
++.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.++..++..++||+++++.++.+....
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 33468998865 46778889887654444556788888887763 33356778888888899999999999877554321
Q ss_pred ccccccccchHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------
Q 002382 691 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------------------------------------------------- 721 (929)
Q Consensus 691 ~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------------------------------------------------- 721 (929)
. .....++.++++.++.||+..
T Consensus 104 ~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 104 E---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp C---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred c---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 0 011223444445555555311
Q ss_pred -------CCceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 722 -------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 722 -------~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1248999999999999987666799999875
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.00 E-value=1.1e-05 Score=85.85 Aligned_cols=118 Identities=27% Similarity=0.291 Sum_probs=82.3
Q ss_pred cceeeeeecccCCCCCCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCee
Q 002382 340 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT 419 (929)
Q Consensus 340 ~~l~~l~l~~n~~s~lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~ 419 (929)
++++.|+|+.|.++++|..++ .|+.|++..|++.. +.++ .+.|+
T Consensus 58 ~~L~~L~Ls~N~l~~lp~~~~---~L~~L~l~~n~l~~-----------l~~l----------------------p~~L~ 101 (353)
T d1jl5a_ 58 PHLESLVASCNSLTELPELPQ---SLKSLLVDNNNLKA-----------LSDL----------------------PPLLE 101 (353)
T ss_dssp TTCSEEECCSSCCSSCCCCCT---TCCEEECCSSCCSC-----------CCSC----------------------CTTCC
T ss_pred CCCCEEECCCCCCcccccchh---hhhhhhhhhcccch-----------hhhh----------------------ccccc
Confidence 567889999999999998765 46666777776543 1111 13689
Q ss_pred EEEecCCCCCccCChhhhccccCceeeccCCcCCCCCCCCCCCCCCcEEEecCCCcCCCCCccccCCCcCcccccccccc
Q 002382 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 499 (929)
Q Consensus 420 ~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~P~~l~~l~~L~~L~l~~N~l 499 (929)
.|+|++|.|+ .+|. ++++++|+.|++++|.+...+... ..+..|++.++... .+..+..++.++.|++++|.+
T Consensus 102 ~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~---~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~ 174 (353)
T d1jl5a_ 102 YLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLP---PSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSL 174 (353)
T ss_dssp EEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCC
T ss_pred cccccccccc-cccc-hhhhccceeecccccccccccccc---ccccchhhcccccc--ccccccccccceecccccccc
Confidence 9999999999 7775 788999999999999988655432 34445555555444 234455666666666666665
Q ss_pred c
Q 002382 500 S 500 (929)
Q Consensus 500 ~ 500 (929)
.
T Consensus 175 ~ 175 (353)
T d1jl5a_ 175 K 175 (353)
T ss_dssp S
T ss_pred c
Confidence 5
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.83 E-value=1.5e-06 Score=83.17 Aligned_cols=60 Identities=27% Similarity=0.270 Sum_probs=26.9
Q ss_pred CeeEEEecCCCCCcc--CChhhhccccCceeeccCCcCCCCCC-CCCCCCCCcEEEecCCCcC
Q 002382 417 SITVIHLSSKNLTGN--IPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLT 476 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~--~p~~l~~L~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~ 476 (929)
.|++|+|++|+|+.. ++..+..|++|+.|+|++|+|+...+ .+....+|+.|+|++|.+.
T Consensus 66 ~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 66 ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp TCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred CCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence 455555555555421 12234445555555555555554333 1222234455555555554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.76 E-value=3.6e-06 Score=93.24 Aligned_cols=110 Identities=26% Similarity=0.347 Sum_probs=82.5
Q ss_pred cceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCCCCeeEEEecCCCCCc----cCChhhhcc
Q 002382 364 INKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTG----NIPSDLTKL 439 (929)
Q Consensus 364 ~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~~~l~~L~L~~n~l~g----~~p~~l~~L 439 (929)
.|+.|++..|++....+..+-.. +++++.|+|++|+|+- .++..+..+
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~----------------------------l~~l~~L~L~~~~i~~~~~~~l~~~L~~~ 54 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPL----------------------------LQQCQVVRLDDCGLTEARCKDISSALRVN 54 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHH----------------------------HTTCSEEEEESSCCCHHHHHHHHHHHHTC
T ss_pred CCCEEEeeCCcCChHHHHHHHHh----------------------------CCCCCEEEeCCCCCCHHHHHHHHHHHhcC
Confidence 47888888888877554443222 2367789999999882 456667889
Q ss_pred ccCceeeccCCcCCCC----CC-CCC-CCCCCcEEEecCCCcCCC----CCccccCCCcCcccccccccccc
Q 002382 440 SSLVELWLDGNSLTGP----IP-DFS-GCPDLRIIHLEDNQLTGP----LPSSLMNLPNLRELYVQNNMLSG 501 (929)
Q Consensus 440 ~~L~~L~Ls~N~l~~~----~p-~~~-~l~~L~~L~Ls~N~l~g~----~P~~l~~l~~L~~L~l~~N~l~g 501 (929)
++|+.|+|++|+|+.. +. .+. ...+|++|+|++|+|+.. ++..+..+++|+.|+|++|+++.
T Consensus 55 ~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 55 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 9999999999998631 11 232 345899999999999843 56678889999999999999873
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.75 E-value=1.1e-06 Score=94.67 Aligned_cols=146 Identities=17% Similarity=0.217 Sum_probs=72.9
Q ss_pred ccceeeeeecccCCCC-----CCCccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCC
Q 002382 339 LPFVLSFKFGKTYDSS-----RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSD 413 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~-----lPP~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~ 413 (929)
.+.|+.|+|..|.++. +...+.....|+.|.+..|.+.......+.+........ ....
T Consensus 92 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~----------------~~~~ 155 (344)
T d2ca6a1 92 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVN----------------KKAK 155 (344)
T ss_dssp CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHH----------------HHHH
T ss_pred CCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccc----------------cccc
Confidence 3467888888888766 333455667788999998888665444432221000000 0000
Q ss_pred CCCCeeEEEecCCCCCc----cCChhhhccccCceeeccCCcCCCC-----C-CCCCCCCCCcEEEecCCCcCCC----C
Q 002382 414 PQPSITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGP-----I-PDFSGCPDLRIIHLEDNQLTGP----L 479 (929)
Q Consensus 414 ~~~~l~~L~L~~n~l~g----~~p~~l~~L~~L~~L~Ls~N~l~~~-----~-p~~~~l~~L~~L~Ls~N~l~g~----~ 479 (929)
..+.|+.|++++|.++. .+...+..++.|+.|+|++|+|+.. + ..+..+++|+.|+|++|+++.. +
T Consensus 156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L 235 (344)
T d2ca6a1 156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235 (344)
T ss_dssp TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccc
Confidence 11245555555555441 1222344445555555555555431 1 1244455555555555554411 2
Q ss_pred CccccCCCcCccccccccccc
Q 002382 480 PSSLMNLPNLRELYVQNNMLS 500 (929)
Q Consensus 480 P~~l~~l~~L~~L~l~~N~l~ 500 (929)
...+..+++|+.|+|++|+|+
T Consensus 236 ~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 236 AIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp HHHGGGCTTCCEEECTTCCCC
T ss_pred cccccccccchhhhhhcCccC
Confidence 233445555555555555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.75 E-value=1.1e-06 Score=84.22 Aligned_cols=83 Identities=24% Similarity=0.294 Sum_probs=61.3
Q ss_pred EEEecCCCCCccCChhhhccccCceeeccCCcCCCCCC--C-CCCCCCCcEEEecCCCcCCCCCc-cccCCCcCcccccc
Q 002382 420 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--D-FSGCPDLRIIHLEDNQLTGPLPS-SLMNLPNLRELYVQ 495 (929)
Q Consensus 420 ~L~L~~n~l~g~~p~~l~~L~~L~~L~Ls~N~l~~~~p--~-~~~l~~L~~L~Ls~N~l~g~~P~-~l~~l~~L~~L~l~ 495 (929)
.|++.++... .++..+.++++|++|+|++|+|+...+ . +..+++|+.|||++|+|+ .+++ ......+|+.|+++
T Consensus 46 ~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~ 123 (162)
T d1koha1 46 VLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLD 123 (162)
T ss_dssp CTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCT
T ss_pred hcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecC
Confidence 3444444333 555556789999999999999997643 3 567999999999999999 4554 33345579999999
Q ss_pred ccccccccc
Q 002382 496 NNMLSGTVP 504 (929)
Q Consensus 496 ~N~l~g~~P 504 (929)
+|++++...
T Consensus 124 ~Npl~~~~~ 132 (162)
T d1koha1 124 GNSLSDTFR 132 (162)
T ss_dssp TSTTSSSSS
T ss_pred CCCcCcCcc
Confidence 999985443
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.74 E-value=3.9e-05 Score=78.21 Aligned_cols=76 Identities=20% Similarity=0.146 Sum_probs=55.3
Q ss_pred cccccCc-EEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCC--CceeEEeeeeeecCeEEEEEEeccCCch
Q 002382 608 KIGSGGF-GVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYEFMHNGTL 684 (929)
Q Consensus 608 ~IG~G~f-G~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~H--pNIv~l~g~~~~~~~~~LV~E~~~~gsL 684 (929)
.+..|.. +.||+...+++..+++|.-.... ...+..|...++.+.. -.+.+++.++.+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445554 68999988878888999865432 3357778888877743 3356778888888889999999988766
Q ss_pred hh
Q 002382 685 KE 686 (929)
Q Consensus 685 ~~ 686 (929)
.+
T Consensus 94 ~~ 95 (255)
T d1nd4a_ 94 LS 95 (255)
T ss_dssp TT
T ss_pred cc
Confidence 44
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.63 E-value=4.2e-06 Score=92.64 Aligned_cols=137 Identities=21% Similarity=0.217 Sum_probs=77.3
Q ss_pred ceeeeeecccCCCCCCC-----ccchhccceeccCCCCCccHHHHHHHHhhcCCCCcccCCCCCCCCCCCceeEeCCCCC
Q 002382 341 FVLSFKFGKTYDSSRGP-----LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQ 415 (929)
Q Consensus 341 ~l~~l~l~~n~~s~lPP-----~i~~le~l~~L~l~~n~~~~~~~~~l~~l~~~~~w~~~~~dpc~~~~~~~~~c~~~~~ 415 (929)
.+..|++..|.+...+. .+.....++.++++.|.+....+..+...... ..
T Consensus 256 ~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~------------------------~~ 311 (460)
T d1z7xw1 256 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLE------------------------PG 311 (460)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTS------------------------TT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhccccc------------------------cc
Confidence 45566666666554332 13344556667777777766555555433110 11
Q ss_pred CCeeEEEecCCCCCccCCh----hhhccccCceeeccCCcCCCC----CC-CC-CCCCCCcEEEecCCCcCC----CCCc
Q 002382 416 PSITVIHLSSKNLTGNIPS----DLTKLSSLVELWLDGNSLTGP----IP-DF-SGCPDLRIIHLEDNQLTG----PLPS 481 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~~p~----~l~~L~~L~~L~Ls~N~l~~~----~p-~~-~~l~~L~~L~Ls~N~l~g----~~P~ 481 (929)
..|+.+++++|.++..-.. .+...++|++|+|++|+|+.. +. .+ ...+.|++|+|++|+|+. .+++
T Consensus 312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~ 391 (460)
T d1z7xw1 312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 391 (460)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence 2566777777776643222 233445677777777776532 11 22 235567777777777763 2344
Q ss_pred cccCCCcCcccccccccccc
Q 002382 482 SLMNLPNLRELYVQNNMLSG 501 (929)
Q Consensus 482 ~l~~l~~L~~L~l~~N~l~g 501 (929)
.+..+++|++|+|++|+|+.
T Consensus 392 ~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 392 TLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHCCCCCEEECCSSSCCH
T ss_pred HHhcCCCCCEEECCCCcCCH
Confidence 45566777777777777763
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.59 E-value=1.1e-05 Score=84.28 Aligned_cols=156 Identities=17% Similarity=0.134 Sum_probs=104.4
Q ss_pred ccceeeeeecccCCCC-CCCccchhccceeccCCC-CCccHHHHHHHHh-hcCCCCcccCCCCCCCCCCCceeE-eCCCC
Q 002382 339 LPFVLSFKFGKTYDSS-RGPLLNAMEINKYLERND-GSIDGVAIVSVIS-LYSSADWAQEGGDPCLPVPWSWLQ-CNSDP 414 (929)
Q Consensus 339 l~~l~~l~l~~n~~s~-lPP~i~~le~l~~L~l~~-n~~~~~~~~~l~~-l~~~~~w~~~~~dpc~~~~~~~~~-c~~~~ 414 (929)
.++|++|+|..+.++. .+..|..+..|+.|++.. +.+...++..+.+ ...++..+. .-|....-.++. .-...
T Consensus 70 c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~l---s~c~~~~~~~~~~~~~~~ 146 (284)
T d2astb2 70 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL---SWCFDFTEKHVQVAVAHV 146 (284)
T ss_dssp BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEEC---CCCTTCCHHHHHHHHHHS
T ss_pred CCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccccc---ccccccccccchhhhccc
Confidence 4567888888887664 233477788899999987 4677666666543 355666533 224211111111 00011
Q ss_pred CCCeeEEEecCC--CCCc-cCChhhhccccCceeeccCC-cCCCCC-CCCCCCCCCcEEEecC-CCcCCCCCccccCCCc
Q 002382 415 QPSITVIHLSSK--NLTG-NIPSDLTKLSSLVELWLDGN-SLTGPI-PDFSGCPDLRIIHLED-NQLTGPLPSSLMNLPN 488 (929)
Q Consensus 415 ~~~l~~L~L~~n--~l~g-~~p~~l~~L~~L~~L~Ls~N-~l~~~~-p~~~~l~~L~~L~Ls~-N~l~g~~P~~l~~l~~ 488 (929)
.+.|+.|+|+++ .++. .+..-+.++++|++|+|++| .+++.. ..+.++++|++|+|++ +++++.....++++++
T Consensus 147 ~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~ 226 (284)
T d2astb2 147 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226 (284)
T ss_dssp CTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTT
T ss_pred ccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCC
Confidence 357999999864 3443 23444567899999999886 576544 4588899999999999 5788777778889999
Q ss_pred Ccccccccc
Q 002382 489 LRELYVQNN 497 (929)
Q Consensus 489 L~~L~l~~N 497 (929)
|+.|+++++
T Consensus 227 L~~L~l~~~ 235 (284)
T d2astb2 227 LKTLQVFGI 235 (284)
T ss_dssp CCEEECTTS
T ss_pred CCEEeeeCC
Confidence 999999887
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.50 E-value=7.6e-06 Score=87.96 Aligned_cols=85 Identities=24% Similarity=0.291 Sum_probs=55.2
Q ss_pred CCeeEEEecCCCCCcc----CChhhhccccCceeeccCCcCCCCCC-----CCC--CCCCCcEEEecCCCcCCC----CC
Q 002382 416 PSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIP-----DFS--GCPDLRIIHLEDNQLTGP----LP 480 (929)
Q Consensus 416 ~~l~~L~L~~n~l~g~----~p~~l~~L~~L~~L~Ls~N~l~~~~p-----~~~--~l~~L~~L~Ls~N~l~g~----~P 480 (929)
++|+.|+|++|.++.. +...+..+++|++|+|++|.|++.-. .+. ..+.|++|||++|+|+.. +.
T Consensus 215 ~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~ 294 (344)
T d2ca6a1 215 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 294 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHH
T ss_pred hhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHH
Confidence 4677788888877532 44556677888888888888765311 122 235678888888887632 23
Q ss_pred cccc-CCCcCccccccccccc
Q 002382 481 SSLM-NLPNLRELYVQNNMLS 500 (929)
Q Consensus 481 ~~l~-~l~~L~~L~l~~N~l~ 500 (929)
..+. ++++|+.|+|++|++.
T Consensus 295 ~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 295 TVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHHHHCTTCCEEECTTSBSC
T ss_pred HHHHccCCCCCEEECCCCcCC
Confidence 3332 4567888888888875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.83 E-value=0.0016 Score=70.77 Aligned_cols=76 Identities=17% Similarity=0.152 Sum_probs=47.7
Q ss_pred ccccccCcEEEEEEEECC-CcEEEEEEeecC------C-cchhHHHHHHHHHhcccC-C--CceeEEeeeeeecCeEEEE
Q 002382 607 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSN------S-YQGKREFTNEVTLLSRIH-H--RNLVQFLGYCQEEGRSVLV 675 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~-~~~vAVK~l~~~------~-~~~~~~f~~Ev~iL~~l~-H--pNIv~l~g~~~~~~~~~LV 675 (929)
+.||.|....||+.+..+ ++.++||.-... . .........|.+.|+.+. + ..+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998764 678999965421 0 112233456777777662 2 345556554 44556899
Q ss_pred EEeccCCch
Q 002382 676 YEFMHNGTL 684 (929)
Q Consensus 676 ~E~~~~gsL 684 (929)
||++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.69 E-value=0.00044 Score=65.68 Aligned_cols=83 Identities=11% Similarity=0.078 Sum_probs=46.8
Q ss_pred CeeEEEecCCCCCc----cCChhhhccccCceeeccCCcCCCC-----CCCCCCCCCCcEEEecCCCcCCC-------CC
Q 002382 417 SITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGP-----IPDFSGCPDLRIIHLEDNQLTGP-------LP 480 (929)
Q Consensus 417 ~l~~L~L~~n~l~g----~~p~~l~~L~~L~~L~Ls~N~l~~~-----~p~~~~l~~L~~L~Ls~N~l~g~-------~P 480 (929)
.|+.|+|++|+|.. .+...|...+.|+.|+|++|.|+.. ...+...+.|++|+|++|.+... +.
T Consensus 45 ~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~ 124 (167)
T d1pgva_ 45 HIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMM 124 (167)
T ss_dssp CCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHH
T ss_pred ccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHH
Confidence 46677777777653 2223444556677777777776642 11355566677777777765421 22
Q ss_pred ccccCCCcCcccccccccc
Q 002382 481 SSLMNLPNLRELYVQNNML 499 (929)
Q Consensus 481 ~~l~~l~~L~~L~l~~N~l 499 (929)
..+...+.|+.|+++.+..
T Consensus 125 ~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 125 MAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHCSSCCEEECCCCCH
T ss_pred HHHHhCCCccEeeCcCCCc
Confidence 3333445566666655443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.37 E-value=0.0027 Score=66.86 Aligned_cols=136 Identities=13% Similarity=0.139 Sum_probs=78.4
Q ss_pred EEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCce--eEEee-----eeeecCeEEEEEEeccCCchhhh
Q 002382 615 GVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL--VQFLG-----YCQEEGRSVLVYEFMHNGTLKEH 687 (929)
Q Consensus 615 G~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNI--v~l~g-----~~~~~~~~~LV~E~~~~gsL~~~ 687 (929)
-.||+.+.++|+.+++|+.+.. ....+++..|...+..+...++ +..+. .....+..+.+++++.|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999998654 3345678889888887743222 11111 22445677889999877543210
Q ss_pred --------------hccc-----cccccccch-------------------HHHHHHHHHHHHHHHHHHh----CCCCce
Q 002382 688 --------------LYGT-----LTHEQRINW-------------------IKRLEIAEDAAKGIEYLHT----GCVPAI 725 (929)
Q Consensus 688 --------------L~~~-----~~~~~~l~~-------------------~~~~~i~~qia~gL~yLH~----~~~~~i 725 (929)
++.. ......+++ .....+...+.+.++.+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0100 000011111 1111122222223333322 223479
Q ss_pred ecCCCCCCCeEecCCCcEEEEeecCccc
Q 002382 726 IHRDLKSSNILLDKHMRAKVSDFGLSKF 753 (929)
Q Consensus 726 vHrDIkp~NILl~~~~~vkL~DFGla~~ 753 (929)
||+|+.+.|||++++ ..++||+-++.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.03 E-value=0.00054 Score=65.07 Aligned_cols=85 Identities=15% Similarity=0.237 Sum_probs=64.1
Q ss_pred CCeeEEEecCC-CCCcc----CChhhhccccCceeeccCCcCCCCC-C----CCCCCCCCcEEEecCCCcCCC----CCc
Q 002382 416 PSITVIHLSSK-NLTGN----IPSDLTKLSSLVELWLDGNSLTGPI-P----DFSGCPDLRIIHLEDNQLTGP----LPS 481 (929)
Q Consensus 416 ~~l~~L~L~~n-~l~g~----~p~~l~~L~~L~~L~Ls~N~l~~~~-p----~~~~l~~L~~L~Ls~N~l~g~----~P~ 481 (929)
++|++|+|+++ .++.. +-..+...+.|+.|+|++|.+...- . .+...+.|+.|+|++|.|+.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 58999999974 46532 3345667788999999999997421 1 255678999999999998842 234
Q ss_pred cccCCCcCccccccccccc
Q 002382 482 SLMNLPNLRELYVQNNMLS 500 (929)
Q Consensus 482 ~l~~l~~L~~L~l~~N~l~ 500 (929)
.+...+.|+.|+|++|.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTTTCCCSEEECCCCSSC
T ss_pred HHHhCCcCCEEECCCCcCC
Confidence 5677788999999998766
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.20 E-value=0.032 Score=59.97 Aligned_cols=73 Identities=14% Similarity=0.302 Sum_probs=49.5
Q ss_pred ccccccCcEEEEEEEECC--------CcEEEEEEeecCCcchhHHHHHHHHHhcccCCCce-eEEeeeeeecCeEEEEEE
Q 002382 607 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYE 677 (929)
Q Consensus 607 ~~IG~G~fG~Vy~~~~~~--------~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNI-v~l~g~~~~~~~~~LV~E 677 (929)
+.|+.|-.=.+|+....+ .+.|.+++.-. ........+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 467778888999998764 34677777542 2233456688888888853343 477777743 58999
Q ss_pred eccCCchh
Q 002382 678 FMHNGTLK 685 (929)
Q Consensus 678 ~~~~gsL~ 685 (929)
|+++.++.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876553
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.71 E-value=0.0034 Score=59.03 Aligned_cols=84 Identities=11% Similarity=0.147 Sum_probs=52.3
Q ss_pred CeeEEEecCCCCCcc----CChhhhccccCceeeccCCcCCCC-----CCCCCCCCCCcEEEe--cCCCcCC----CCCc
Q 002382 417 SITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGP-----IPDFSGCPDLRIIHL--EDNQLTG----PLPS 481 (929)
Q Consensus 417 ~l~~L~L~~n~l~g~----~p~~l~~L~~L~~L~Ls~N~l~~~-----~p~~~~l~~L~~L~L--s~N~l~g----~~P~ 481 (929)
.|++|+|++|+|+.. +-..+...+.|+.|++++|.++.. ...+...+.|+.++| ++|++.. .+..
T Consensus 47 ~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~ 126 (166)
T d1io0a_ 47 YVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIAN 126 (166)
T ss_dssp SCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHH
T ss_pred ccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHH
Confidence 677788888877643 333455567788888888777542 123566677776544 4566642 2444
Q ss_pred cccCCCcCccccccccccc
Q 002382 482 SLMNLPNLRELYVQNNMLS 500 (929)
Q Consensus 482 ~l~~l~~L~~L~l~~N~l~ 500 (929)
.+...++|+.|+++.|+..
T Consensus 127 ~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 127 MLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHCSSCCEEECCCSSHH
T ss_pred HHHhCCCcCEEeCcCCCCc
Confidence 5556677777777666543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.25 E-value=0.18 Score=51.70 Aligned_cols=141 Identities=12% Similarity=0.080 Sum_probs=73.0
Q ss_pred ccccCcEEEEEEEECCCcEEEEEEeecCCcchhHHHHHHHHHhcccCCCce-----eEEee---eeeecCeEEEEEEecc
Q 002382 609 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-----VQFLG---YCQEEGRSVLVYEFMH 680 (929)
Q Consensus 609 IG~G~fG~Vy~~~~~~~~~vAVK~l~~~~~~~~~~f~~Ev~iL~~l~HpNI-----v~l~g---~~~~~~~~~LV~E~~~ 680 (929)
|..|---+.|+.+..+| .+++|+..... ...++..|++++..+...++ +...+ +....+....++.+..
T Consensus 26 i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp ECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred CCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 45566678899888755 48899886432 23455667777777643222 21110 1123445566777766
Q ss_pred CCchhhhh--------------cc---ccc---ccc-----------------ccchHHHHHHHHHHHHHHHHHHh-CCC
Q 002382 681 NGTLKEHL--------------YG---TLT---HEQ-----------------RINWIKRLEIAEDAAKGIEYLHT-GCV 722 (929)
Q Consensus 681 ~gsL~~~L--------------~~---~~~---~~~-----------------~l~~~~~~~i~~qia~gL~yLH~-~~~ 722 (929)
+......- +. ... ... ..........+..+...+...+. ...
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 54332110 00 000 000 00011112222233333333332 223
Q ss_pred CceecCCCCCCCeEecCCCcEEEEeecCcc
Q 002382 723 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK 752 (929)
Q Consensus 723 ~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 752 (929)
.++||+|+.+.||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 489999999999999998777899999875
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=92.97 E-value=0.0078 Score=56.40 Aligned_cols=86 Identities=20% Similarity=0.286 Sum_probs=61.1
Q ss_pred CCCeeEEEecC-CCCCcc----CChhhhccccCceeeccCCcCCCCCC-----CCCCCCCCcEEEecCCCcCCC----CC
Q 002382 415 QPSITVIHLSS-KNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIP-----DFSGCPDLRIIHLEDNQLTGP----LP 480 (929)
Q Consensus 415 ~~~l~~L~L~~-n~l~g~----~p~~l~~L~~L~~L~Ls~N~l~~~~p-----~~~~l~~L~~L~Ls~N~l~g~----~P 480 (929)
.+.|+.|+|++ +.++.. +-..+...+.|+.|+|++|.++..-- .+...+.|+.|++++|.++.. +-
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 35899999997 556532 33355678999999999999875321 256678999999999998732 33
Q ss_pred ccccCCCcCccc--cccccccc
Q 002382 481 SSLMNLPNLREL--YVQNNMLS 500 (929)
Q Consensus 481 ~~l~~l~~L~~L--~l~~N~l~ 500 (929)
..+...++|+.+ ++++|++.
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHhCccccEEeeccCCCcCc
Confidence 566777888864 44567775
|